PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tyler, WJ; Tufail, Y; Finsterwald, M; Tauchmann, ML; Olson, EJ; Majestic, C				Tyler, William J.; Tufail, Yusuf; Finsterwald, Michael; Tauchmann, Monica L.; Olson, Emily J.; Majestic, Cassondra			Remote Excitation of Neuronal Circuits Using Low-Intensity, Low-Frequency Ultrasound	PLOS ONE			English	Article								Possessing the ability to noninvasively elicit brain circuit activity yields immense experimental and therapeutic power. Most currently employed neurostimulation methods rely on the somewhat invasive use of stimulating electrodes or photon-emitting devices. Due to its ability to noninvasively propagate through bone and other tissues in a focused manner, the implementation of ultrasound (US) represents a compelling alternative approach to current neuromodulation strategies. Here, we investigated the influence of low-intensity, low-frequency ultrasound (LILFU) on neuronal activity. By transmitting US waveforms through hippocampal slice cultures and ex vivo mouse brains, we determined LILFU is capable of remotely and noninvasively exciting neurons and network activity. Our results illustrate that LILFU can stimulate electrical activity in neurons by activating voltage-gated sodium channels, as well as voltage-gated calcium channels. The LILFU-induced changes in neuronal activity were sufficient to trigger SNARE-mediated exocytosis and synaptic transmission in hippocampal circuits. Because LILFU can stimulate electrical activity and calcium signaling in neurons as well as central synaptic transmission we conclude US provides a powerful tool for remotely modulating brain circuit activity.	[Tyler, William J.; Tufail, Yusuf; Tauchmann, Monica L.; Olson, Emily J.; Majestic, Cassondra] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Tyler, William J.] Arizona State Univ, Harrington Dept Bioengn, Tempe, AZ 85287 USA; [Finsterwald, Michael] Array Therapeut, Scottsdale, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Tyler, WJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	wtyler@asu.edu	Tyler, William/J-1818-2012	Tyler, William/0000-0002-7758-5022	Arizona State University	Arizona State University	Studies were supported by start-up funds provided by Arizona State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2001, PHARMACOL RES, V43, P307, DOI 10.1006/phrs.2000.0794; Andrews RJ, 2003, ANN NY ACAD SCI, V993, P1, DOI 10.1111/j.1749-6632.2003.tb07506.x; Ang ESBC, 2006, P NATL ACAD SCI USA, V103, P12903, DOI 10.1073/pnas.0605294103; Bachtold MR, 1998, ULTRASOUND MED BIOL, V24, P557, DOI 10.1016/S0301-5629(98)00014-3; Bronk P, 2007, J NEUROPHYSIOL, V98, P794, DOI 10.1152/jn.00226.2007; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; CHAPMAN IV, 1980, ULTRASOUND MED BIOL, V6, P47, DOI 10.1016/0301-5629(80)90063-0; Charron F, 2007, ADV EXP MED BIOL, V621, P116, DOI 10.1007/978-0-387-76715-4_9; Clement GT, 2004, ULTRASONICS, V42, P1087, DOI 10.1016/j.ultras.2004.04.003; Clement GT, 2002, PHYS MED BIOL, V47, P1219, DOI 10.1088/0031-9155/47/8/301; Dalecki D, 2004, ANNU REV BIOMED ENG, V6, P229, DOI 10.1146/annurev.bioeng.6.040803.140126; DINNO MA, 1989, PHYS MED BIOL, V34, P1543, DOI 10.1088/0031-9155/34/11/003; Ebisawa K, 2004, TISSUE ENG, V10, P921, DOI 10.1089/1076327041348437; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; FOSTER KR, 1978, J ACOUST SOC AM, V63, P1199, DOI 10.1121/1.381829; FRY FJ, 1958, SCIENCE, V127, P83, DOI 10.1126/science.127.3289.83; FRY WJ, 1968, J ACOUST SOC AM, V44, P919, DOI 10.1121/1.1911230; FRY WJ, 1950, J ACOUST SOC AM, V22, P867, DOI 10.1121/1.1906707; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Gavrilov L R, 1976, Prog Brain Res, V43, P279; Gavrilov LR, 1996, ULTRASOUND MED BIOL, V22, P179, DOI 10.1016/0301-5629(96)83782-3; Gora-Kupilas K, 2005, FOLIA NEUROPATHOL, V43, P31; Guo W, 2007, DEV BIOL, V306, P457, DOI 10.1016/j.ydbio.2007.03.019; Hayner M, 2001, J ACOUST SOC AM, V110, P3319, DOI 10.1121/1.1410964; Hsu HC, 2007, CELL SIGNAL, V19, P2317, DOI 10.1016/j.cellsig.2007.07.006; Hynynen K, 2004, MAGN RESON MED, V52, P100, DOI 10.1002/mrm.20118; Hynynen K, 1998, ULTRASOUND MED BIOL, V24, P275, DOI 10.1016/S0301-5629(97)00269-X; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; MAGEE TR, 1993, J ULTRAS MED, V12, P747, DOI 10.7863/jum.1993.12.12.747; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Meier SD, 2006, J NEUROSCI METH, V155, P251, DOI 10.1016/j.jneumeth.2006.01.009; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MIHRAN RT, 1990, ULTRASOUND MED BIOL, V16, P297, DOI 10.1016/0301-5629(90)90008-Z; Miller Douglas L., 2002, Somatic Cell and Molecular Genetics, V27, P115, DOI 10.1023/A:1022983907223; Molteni R, 2001, BRAIN RES REV, V37, P249, DOI 10.1016/S0165-0173(01)00128-X; MORRIS CE, 2007, LIPID STRESS PLAY ME, P297; MORTIMER AJ, 1988, ULTRASOUND MED BIOL, V14, P499, DOI 10.1016/0301-5629(88)90111-1; Mukai S, 2005, ULTRASOUND MED BIOL, V31, P1713, DOI 10.1016/j.ultrasmedbio.2005.07.012; Naruse K, 2003, J BONE MINER RES, V18, P360, DOI 10.1359/jbmr.2003.18.2.360; NEMA, 2004, AC OUTP MEAS STAND D; O'Brien WD, 2007, PROG BIOPHYS MOL BIO, V93, P212, DOI 10.1016/j.pbiomolbio.2006.07.010; PAOLETTI P, 1994, NEURON, V13, P645, DOI 10.1016/0896-6273(94)90032-9; Reher P, 1999, CYTOKINE, V11, P416, DOI 10.1006/cyto.1998.0444; RINALDI PC, 1991, BRAIN RES, V558, P36, DOI 10.1016/0006-8993(91)90711-4; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sant'Anna EF, 2005, J ORTHOP RES, V23, P646, DOI 10.1016/j.orthres.2004.09.007; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; SUKHAREV S, 2004, SCI STKE, pRE4; Tang CH, 2006, MOL PHARMACOL, V69, P2047, DOI 10.1124/mol.105.022160; ter Haar G, 2007, PROG BIOPHYS MOL BIO, V93, P111, DOI 10.1016/j.pbiomolbio.2006.07.005; Tesseur Ina, 2006, Current Alzheimer Research, V3, P505, DOI 10.2174/156720506779025297; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; Tsui PH, 2005, ULTRASONICS, V43, P560, DOI 10.1016/j.ultras.2004.12.003; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; White PJ, 2006, PHYS MED BIOL, V51, P2293, DOI 10.1088/0031-9155/51/9/013; YOUNG RR, 1961, SCIENCE, V134, P1521, DOI 10.1126/science.134.3489.1521; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	62	385	439	6	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3511	10.1371/journal.pone.0003511	http://dx.doi.org/10.1371/journal.pone.0003511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958151	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131100004
J	Wang, L; Xu, Y; Zhang, C; Ma, Q; Joo, SH; Kim, SK; Xu, ZH; Chong, K				Wang, Lei; Xu, Yunyuan; Zhang, Cui; Ma, Qibin; Joo, Se-Hwan; Kim, Seong-Ki; Xu, Zhihong; Chong, Kang			OsLIC, a Novel CCCH-Type Zinc Finger Protein with Transcription Activation, Mediates Rice Architecture via Brassinosteroids Signaling	PLOS ONE			English	Article							ORYZA-SATIVA L.; GENE-EXPRESSION; GREEN-REVOLUTION; ARABIDOPSIS; MUTANT; ELONGATION; INTERACTS; PREVENTS; HOMOLOG; BIOMASS	Rice architecture is an important agronomic trait and a major limiting factor for its high productivity. Here we describe a novel CCCH-type zinc finger gene, OsLIC (Oraza sativa leaf and tiller angle increased controller), which is involved in the regulation of rice plant architecture. OsLIC encoded an ancestral and unique CCCH type zinc finge protein. It has many orthologous in other organisms, ranging from yeast to humane. Suppression of endogenous OsLIC expression resulted in drastically increased leaf and tiller angles, shortened shoot height, and consequently reduced grain production in rice. OsLIC is predominantly expressed in rice collar and tiller bud. Genetic analysis suggested that OsLIC is epistatic to d2-1, whereas d61-1 is epistatic to OsLIC. Interestingly, sterols were significantly higher in level in transgenic shoots than in the wild type. Genome-wide expression analysis indicated that brassinosteroids (BRs) signal transduction was activated in transgenic lines. Moreover, transcription of OsLIC was induced by 24-epibrassinolide. OsLIC, with a single CCCH motif, displayed binding activity to double-stranded DNA and single-stranded polyrA, polyrU and polyrG but not polyrC. It contains a novel conserved EELR domain among eukaryotes and displays transcriptional activation activity in yeast. OsLIC may be a transcription activator to control rice plant architecture.	[Wang, Lei; Xu, Yunyuan; Zhang, Cui; Ma, Qibin; Xu, Zhihong; Chong, Kang] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Bot, Key Lab Photosynthesis & Environm Mol Physiol, Beijing, Peoples R China; [Joo, Se-Hwan; Kim, Seong-Ki] Chung Ang Univ, Dept Life Sci, Seoul, South Korea	Chinese Academy of Sciences; Institute of Botany, CAS; Chung Ang University	Wang, L (corresponding author), Ohio State Univ, Dept Plant Cellular & Mol Biol, Columbus, OH 43210 USA.	chongk@ibcas.ac.cn	ma, qibin/HDO-2133-2022	Zhang, Cui/0000-0002-6119-5572; WANG, LEI/0000-0002-4912-5387	Major State Basic Research Program of the P. R. China [2005CB120806]; National Science Foundation of China for Distinguished Young Scholars [30525026]; Innovation Grant of the Chinese Academy of Sciences	Major State Basic Research Program of the P. R. China(National Basic Research Program of China); National Science Foundation of China for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Innovation Grant of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Major State Basic Research Program of the P. R. China (2005CB120806), the National Science Foundation of China for Distinguished Young Scholars (30525026) and the Innovation Grant of the Chinese Academy of Sciences.	Arai R, 2003, ADV SPACE RES-SERIES, V31, P1833, DOI 10.1016/S0273-1177(03)80022-4; Bai FW, 2002, ACTA VIROL, V46, P85; Bai MY, 2007, P NATL ACAD SCI USA, V104, P13839, DOI 10.1073/pnas.0706386104; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chono M, 2003, PLANT PHYSIOL, V133, P1209, DOI 10.1104/pp.103.026195; de Vries SC, 2007, DEV CELL, V13, P162, DOI 10.1016/j.devcel.2007.07.009; Duan K, 2006, PLANT J, V47, P519, DOI 10.1111/j.1365-313X.2006.02804.x; Ge L, 2004, PLANT PHYSIOL, V135, P1502, DOI 10.1104/pp.104.041996; GOMPERTS M, 1990, ONCOGENE, V5, P1081; He JX, 2003, PLANT PHYSIOL, V131, P1258, DOI 10.1104/pp.014605; Hong Z, 2005, PLANT CELL, V17, P2243, DOI 10.1105/tpc.105.030973; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Hong Z, 2002, PLANT J, V32, P495, DOI 10.1046/j.1365-313X.2002.01438.x; Huang NN, 2002, DEVELOPMENT, V129, P747; JEFFERSON RA, 1989, NATURE, V342, P837, DOI 10.1038/342837a0; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lan LF, 2004, PLANT MOL BIOL, V54, P471, DOI 10.1023/B:PLAN.0000038254.58491.c7; Lee S, 2008, PLANT J, V54, P93, DOI 10.1111/j.1365-313X.2008.03406.x; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JJ, 2001, PLANT CELL, V13, P2269, DOI 10.1105/tpc.13.10.2269; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Morinaka Y, 2006, PLANT PHYSIOL, V141, P924, DOI 10.1104/pp.106.077081; Murata T, 2000, BIOCHEM BIOPH RES CO, V274, P526, DOI 10.1006/bbrc.2000.3182; Nagano H, 2005, GENES GENET SYST, V80, P351, DOI 10.1266/ggs.80.351; Nam KH, 2004, PLANT CELL, V16, P2406, DOI 10.1105/tpc.104.023903; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Sambrook J., MOL CLONING LAB MANU; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Schmitz RJ, 2005, DEVELOPMENT, V132, P5471, DOI 10.1242/dev.02170; Shen YG, 2003, THEOR APPL GENET, V106, P923, DOI 10.1007/s00122-002-1131-x; Sinclair TR, 1999, SCIENCE, V283, P1456; Tabara H, 1999, DEVELOPMENT, V126, P1; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; Wang L, 2006, CELL RES, V16, P916, DOI 10.1038/sj.cr.7310111; Wang SY, 2007, CHINESE PHYS LETT, V24, P664, DOI 10.1088/0256-307X/24/3/021; Wang YH, 2005, PLANT MOL BIOL, V59, P75, DOI 10.1007/s11103-004-4038-x; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Wang ZY, 2006, CELL RES, V16, P427, DOI 10.1038/sj.cr.7310054; Xu YY, 2005, PLANT MOL BIOL, V57, P773, DOI 10.1007/s11103-005-0952-9; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yang Guangxiao, 2004, Genomics Proteomics & Bioinformatics, V2, P77; Yang GX, 2000, PLANT CELL PHYSIOL, V41, P1243, DOI 10.1093/pcp/pcd050; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x	47	127	163	11	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3521	10.1371/journal.pone.0003521	http://dx.doi.org/10.1371/journal.pone.0003521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953406	Green Published, gold			2022-12-27	WOS:000265130500004
J	Santel, T; Pflug, G; Hemdan, NYA; Schafer, A; Hollenbach, M; Buchold, M; Hintersdorf, A; Lindner, I; Otto, A; Bigl, M; Oerlecke, I; Hutschenreuter, A; Sack, U; Huse, K; Groth, M; Birkemeyer, C; Schellenberger, W; Gebhardt, R; Platzer, M; Weiss, T; Vijayalakshmi, MA; Kruger, M; Birkenmeier, G				Santel, Thore; Pflug, Gabi; Hemdan, Nasr Y. A.; Schaefer, Angelika; Hollenbach, Marcus; Buchold, Martin; Hintersdorf, Anja; Lindner, Inge; Otto, Andreas; Bigl, Marina; Oerlecke, Ilka; Hutschenreuter, Antje; Sack, Ulrich; Huse, Klaus; Groth, Marco; Birkemeyer, Claudia; Schellenberger, Wolfgang; Gebhardt, Rolf; Platzer, Mathias; Weiss, Thomas; Vijayalakshmi, Mookambeswaran A.; Krueger, Monika; Birkenmeier, Gerd			Curcumin Inhibits Glyoxalase 1-A Possible Link to Its Anti-Inflammatory and Anti-Tumor Activity	PLOS ONE			English	Article							BROMOBENZYLGLUTATHIONE CYCLOPENTYL DIESTER; KAPPA-B; GLUTATHIONE DEPLETION; MOLECULAR TARGETS; UP-REGULATION; IN-VITRO; METHYLGLYOXAL; ACTIVATION; APOPTOSIS; CELLS	Background: Glyoxalases (Glo1 and Glo2) are involved in the glycolytic pathway by detoxifying the reactive methylglyoxal (MGO) into D-lactate in a two-step reaction using glutathione (GSH) as cofactor. Inhibitors of glyoxalases are considered as anti-inflammatory and anti-carcinogenic agents. The recent finding that various polyphenols modulate Glo1 activity has prompted us to assess curcumin's potency as an Glo1 inhibitor. Methodology/Principal Findings: Cultures of whole blood cells and tumor cell lines (PC-3, JIM-1, MDA-MD 231 and 1321N1) were set up to investigate the effect of selected polyphenols, including curcumin, on the LPS-induced cytokine production (cytometric bead-based array), cell proliferation (WST-1 assay), cytosolic Glo1 and Glo2 enzymatic activity, apoptosis/necrosis (annexin V-FITC/propidium iodide staining; flow cytometric analysis) as well as GSH and ATP content. Results of enzyme kinetics revealed that curcumin, compared to the polyphenols quercetin, myricetin, kaempferol, luteolin and rutin, elicited a stronger competitive inhibitory effect on Glo1 (K-i = 5.1 +/- 1.4 mu M). Applying a whole blood assay, IC50 values of pro-inflammatory cytokine release (TNF-alpha, IL-6, IL-8, IL-1 beta) were found to be positively correlated with the K-i-values of the aforementioned polyphenols. Moreover, whereas curcumin was found to hamper the growth of breast cancer (JIMT-1, MDA-MB-231), prostate cancer PC-3 and brain astrocytoma 1321N1 cells, no effect on growth or vitality of human primary hepatocytes was elucidated. Curcumin decreased D-lactate release by tumor cells, another clue for inhibition of intracellular Glo1. Conclusions/Significance: The results described herein provide new insights into curcumin's biological activities as they indicate that inhibition of Glo1 by curcumin may result in non-tolerable levels of MGO and GSH, which, in turn, modulate various metabolic cellular pathways including depletion of cellular ATP and GSH content. This may account for curcumin's potency as an anti-inflammatory and anti-tumor agent. The findings support the use of curcumin as a potential therapeutic agent.	[Santel, Thore; Pflug, Gabi; Schaefer, Angelika; Hollenbach, Marcus; Buchold, Martin; Hintersdorf, Anja; Lindner, Inge; Otto, Andreas; Bigl, Marina; Oerlecke, Ilka; Hutschenreuter, Antje; Groth, Marco; Schellenberger, Wolfgang; Gebhardt, Rolf; Birkenmeier, Gerd] Univ Leipzig, Inst Biochem, Leipzig, Germany; [Hemdan, Nasr Y. A.; Sack, Ulrich] Frauenhofer Inst Cell Therapy & Immunol IZI, Leipzig, Germany; [Hemdan, Nasr Y. A.; Sack, Ulrich] Inst Clin Immunol & Transfus Med, Leipzig, Germany; [Hemdan, Nasr Y. A.] Univ Alexandria, Fac Sci, Dept Zool, Alexandria, Egypt; [Huse, Klaus; Groth, Marco; Platzer, Mathias] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Birkemeyer, Claudia] Inst Analytical Chem, Leipzig, Germany; [Weiss, Thomas] Univ Regensburg Hosp, Ctr Liver Cell Res, Dept Surg, D-8400 Regensburg, Germany; [Vijayalakshmi, Mookambeswaran A.] VIT Univ, CBST, Tamil Nadu, India; [Krueger, Monika] Inst Bacteriol & Mycol, Vet Fac, Leipzig, Germany	Leipzig University; Egyptian Knowledge Bank (EKB); Alexandria University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Regensburg	Santel, T (corresponding author), Univ Leipzig, Inst Biochem, Leipzig, Germany.	Gerd.Birkenmeier@medizin.uni-leipzig.de	Hemdan, Nasr Y. A./H-5430-2019; Birkemeyer, Claudia S/L-8687-2015; Hollenbach, Marcus/ABF-7452-2021; Sack, Ulrich/J-6301-2015; Weiss, Thomas S./G-3989-2012	Hemdan, Nasr Y. A./0000-0002-6748-0649; Birkemeyer, Claudia S/0000-0002-8538-8838; Sack, Ulrich/0000-0002-7813-0492; Weiss, Thomas S./0000-0003-0336-0581; Huse, Klaus/0000-0003-3854-1884; Birkenmeier, Gerd/0000-0001-7805-9924; Groth, Marco/0000-0002-9199-8990	Wilhelm Sander-Stiftung [2006.053.1]; BMBF [0313081 F]; Hans Bockler Stiftung [356283]	Wilhelm Sander-Stiftung; BMBF(Federal Ministry of Education & Research (BMBF)); Hans Bockler Stiftung	This study was supported in part by Wilhelm Sander-Stiftung (No. 2006.053.1; GB and IOe), by the BMBF-grant (HepatoSys project 0313081 F; TW and RG) and by Hans Bockler Stiftung (356283; AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; ALEXANDER JA, 1991, J CLIN NEURO-OPHTHAL, V11, P58; Awasthi S, 2000, CHEM-BIOL INTERACT, V128, P19, DOI 10.1016/S0009-2797(00)00185-X; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Biesalski HK, 2007, CURR OPIN CLIN NUTR, V10, P724, DOI 10.1097/MCO.0b013e3282f0cef2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDT RB, 1980, ANAL BIOCHEM, V102, P39, DOI 10.1016/0003-2697(80)90314-0; Chan WH, 2005, ANN NY ACAD SCI, V1042, P372, DOI 10.1196/annals.1338.057; Chaplen FWR, 1998, P NATL ACAD SCI USA, V95, P5533, DOI 10.1073/pnas.95.10.5533; Chen S, 2008, WORLD J GASTROENTERO, V14, P2174, DOI 10.3748/wjg.14.2174; Chen X, 1998, CHEM-BIOL INTERACT, V112, P263, DOI 10.1016/S0009-2797(97)00166-X; de Arriba SG, 2007, NEUROBIOL AGING, V28, P1044, DOI 10.1016/j.neurobiolaging.2006.05.007; DOUGLAS KT, 1985, BIOCHIM BIOPHYS ACTA, V829, P109, DOI 10.1016/0167-4838(85)90074-3; DOUGLAS KT, 1985, BIOCHIM BIOPHYS ACTA, V829, P119, DOI 10.1016/0167-4838(85)90075-5; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Funk JL, 2006, J NAT PROD, V69, P351, DOI 10.1021/np050327j; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Gautam SC, 2007, ADV EXP MED BIOL, V595, P321; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Hollenbach M, 2008, BIOCHEM PHARMACOL, V76, P631, DOI 10.1016/j.bcp.2008.06.006; Jagetia GC, 2007, J CLIN IMMUNOL, V27, P19, DOI 10.1007/s10875-006-9066-7; Joe B, 2004, CRIT REV FOOD SCI, V44, P97, DOI 10.1080/10408690490424702; Kachadourian R, 2007, INT J ONCOL, V31, P161; Kachadourian R, 2006, FREE RADICAL BIO MED, V41, P65, DOI 10.1016/j.freeradbiomed.2006.03.002; KIM KM, 2008, BIOMED PHARMACOTHER; Kowluru RA, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-8; Laga M, 2007, BIOCHEM PHARMACOL, V74, P579, DOI 10.1016/j.bcp.2007.05.026; Lee HJ, 2005, ANN NY ACAD SCI, V1043, P135, DOI 10.1196/annals.1333.017; Liang G, 2008, CHEM PHARM BULL, V56, P162, DOI 10.1248/cpb.56.162; Lin JK, 2007, ADV EXP MED BIOL, V595, P227; Lopez-Lazaro M, 2008, MOL NUTR FOOD RES, V52, pS103, DOI 10.1002/mnfr.200700238; MANNERVIK B, 1982, METHOD ENZYMOL, V90, P535; Manson MM, 2005, EUR J CANCER, V41, P1842, DOI 10.1016/j.ejca.2005.05.008; MCLELLAN AC, 1989, MECH AGEING DEV, V48, P63, DOI 10.1016/0047-6374(89)90026-2; Menon VP, 2007, ADV EXP MED BIOL, V595, P105; Miller AG, 2006, J BIOL CHEM, V281, P11864, DOI 10.1074/jbc.M513813200; Mohandas K M, 1999, Indian J Gastroenterol, V18, P118; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Morin D, 2001, FEBS LETT, V495, P131, DOI 10.1016/S0014-5793(01)02376-6; Nandakumar DN, 2006, ANTIMICROB AGENTS CH, V50, P1859, DOI 10.1128/AAC.50.5.1859-1860.2006; NAOI M, 2008, J NEUROCHEM; Nishiyama T, 2005, J AGR FOOD CHEM, V53, P959, DOI 10.1021/jf0483873; Obajimi O, 2008, CANCER CHEMOTH PHARM, V62, P215, DOI 10.1007/s00280-007-0593-6; Pan MH, 2001, J AGR FOOD CHEM, V49, P1464, DOI 10.1021/jf001129v; Panchatcharam M, 2006, MOL CELL BIOCHEM, V290, P87, DOI 10.1007/s11010-006-9170-2; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Rai D, 2008, BIOCHEM J, V410, P147, DOI 10.1042/BJ20070891; Sakamoto H, 2002, J BIOL CHEM, V277, P45770, DOI 10.1074/jbc.M207485200; Sakamoto H, 2001, CLIN CANCER RES, V7, P2513; Sandur SK, 2007, FREE RADICAL BIO MED, V43, P568, DOI 10.1016/j.freeradbiomed.2007.05.009; Sato S, 2007, J AM CHEM SOC, V129, P873, DOI 10.1021/ja0655643; Scott DW, 2007, J CELL BIOCHEM, V101, P307, DOI 10.1002/jcb.21179; Shangari N, 2004, BIOCHEM PHARMACOL, V68, P1433, DOI 10.1016/j.bcp.2004.06.013; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Siddiqui AM, 2006, CRIT CARE MED, V34, P1874, DOI 10.1097/01.CCM.0000221921.71300.BF; TAKASAWA R, 2008, BIOORG MED CHEM; Thasler Wolfgang E., 2003, Cell and Tissue Banking, V4, P49, DOI 10.1023/A:1026392429112; Thornalley PJ, 1996, BIOCHEM PHARMACOL, V51, P1365, DOI 10.1016/0006-2952(96)00059-7; Vesce S, 2005, J BIOL CHEM, V280, P38720, DOI 10.1074/jbc.M506575200; WARBURG O, 1956, SCIENCE, V124, P269; Weiss TS, 2003, J HEPATOL, V38, P476, DOI 10.1016/S0168-8278(02)00454-3; WILSON BMG, 1991, J IMMUNOL METHODS, V139, P233, DOI 10.1016/0022-1759(91)90193-J; Zuin A, 2005, J BIOL CHEM, V280, P36708, DOI 10.1074/jbc.M508400200	65	130	132	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3508	10.1371/journal.pone.0003508	http://dx.doi.org/10.1371/journal.pone.0003508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IH	18946510	Green Published, Green Submitted, gold			2022-12-27	WOS:000265126200008
J	Baptista, MS; de Carvalho, JX; Hussein, MS				Baptista, Murilo S.; de Carvalho, Josue X.; Hussein, Mahir S.			Finding Quasi-Optimal Network Topologies for Information Transmission in Active Networks	PLOS ONE			English	Article							SMALL-WORLD; SYNCHRONIZATION; ENTROPIES	This work clarifies the relation between network circuit (topology) and behaviour (information transmission and synchronization) in active networks, e.g. neural networks. As an application, we show how one can find network topologies that are able to transmit a large amount of information, possess a large number of communication channels, and are robust under large variations of the network coupling configuration. This theoretical approach is general and does not depend on the particular dynamic of the elements forming the network, since the network topology can be determined by finding a Laplacian matrix (the matrix that describes the connections and the coupling strengths among the elements) whose eigenvalues satisfy some special conditions. To illustrate our ideas and theoretical approaches, we use neural networks of electrically connected chaotic Hindmarsh-Rose neurons.	[Baptista, Murilo S.; de Carvalho, Josue X.; Hussein, Mahir S.] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Baptista, Murilo S.] Univ Porto, Ctr Mat, Porto, Portugal; [Hussein, Mahir S.] Univ Sao Paulo, Inst Phys, BR-05508 Sao Paulo, Brazil	Max Planck Society; Universidade do Porto; Universidade de Sao Paulo	Baptista, MS (corresponding author), Max Planck Inst Phys Komplexer Syst, Dresden, Germany.	murilo.baptista@fc.up.pt	baptista, murilo s/B-7277-2008; Huseein, Mahir/M-4506-2019		Max Planck Institute for the Physics of Complex Systems; FCT; FAPESP; CNPq; Martin Gutzwiller prize	Max Planck Institute for the Physics of Complex Systems(Foundation CELLEX); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Martin Gutzwiller prize	This study was financed by the Max Planck Institute for the Physics of Complex Systems, FCT, FAPESP, CNPq, and the Martin Gutzwiller prize 2007/2008 (MSH).	Baptista MS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026205; Baptista MS, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.045202; BAPTISTA MS, EUROPHYSICS IN PRESS; BAPTISTA MS, BOUNDS KOLMOGO UNPUB; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Chavez M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066107; Chavez M, 2006, CHAOS, V16, DOI 10.1063/1.2180467; Corron NJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.024101; DERMALSBURG CV, 1985, BER BUNSEN PHYS CHEM, V89, P703; DJURFELDT M, 2006, PROJECT REPORT BLUE; Eggermont JJ, 1998, NEUROSCI BIOBEHAV R, V22, P355, DOI 10.1016/S0149-7634(97)00021-3; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; HEAGY JF, 1995, PHYS REV LETT, V74, P4185, DOI 10.1103/PhysRevLett.74.4185; HEAGY JF, 1994, PHYS REV E, V50, P1874, DOI 10.1103/PhysRevE.50.1874; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; Ipsen M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046109; Jirsa VK, 2004, NEUROINFORMATICS, V2, P183, DOI 10.1385/NI:2:2:183; Mendes RV, 1998, PHYS LETT A, V248, P167, DOI 10.1016/S0375-9601(98)00604-5; PALUS M, 2001, SYNCHRONIZATION INFO, P65; Pareti G, 2004, NEUROL SCI, V25, P41, DOI 10.1007/s10072-004-0235-2; Pecora LM, 1998, PHYS REV LETT, V80, P2109, DOI 10.1103/PhysRevLett.80.2109; Pecora LM, 1998, PHYS REV E, V58, P347, DOI 10.1103/PhysRevE.58.347; Perc M, 2007, CHAOS SOLITON FRACT, V31, P280, DOI 10.1016/j.chaos.2005.10.018; Pesin YB., 1977, RUSS MATH SURV, V32, P55, DOI [10.1070/RM1977v032n04ABEH001639, DOI 10.1070/RM1977V032N04ABEH001639]; Rosenblum M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041904; SANLIANG X, 2005, PHYS REV LETT, V95; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Smith VA, 2006, PLOS COMPUT BIOL, V2, P1436, DOI 10.1371/journal.pcbi.0020161; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Wagner C, 2007, INT J BIFURCAT CHAOS, V17, P3409, DOI 10.1142/S0218127407019135; Zhou CS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.034101; Zochowski M, 2004, J PHYS A-MATH GEN, V37, P3823, DOI 10.1088/0305-4470/37/12/007	37	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3479	10.1371/journal.pone.0003479	http://dx.doi.org/10.1371/journal.pone.0003479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941516	Green Submitted, Green Published, gold			2022-12-27	WOS:000265126100010
J	Gomez-Baena, G; Lopez-Lozano, A; Gil-Martinez, J; Lucena, JM; Diez, J; Candau, P; Garcia-Fernandez, JM				Gomez-Baena, Guadalupe; Lopez-Lozano, Antonio; Gil-Martinez, Jorge; Manuel Lucena, Jose; Diez, Jesus; Candau, Pedro; Manuel Garcia-Fernandez, Jose			Glucose Uptake and Its Effect on Gene Expression in Prochlorococcus	PLOS ONE			English	Article							AMINO-ACID-UPTAKE; SP STRAIN PCC-6803; SURFACE WATERS; BACTERIAL PRODUCTION; ADAPTIVE-MECHANISMS; NITROGEN CONTROL; CYANOBACTERIA; METABOLISM; GENOME; CARBON	The marine cyanobacteria Prochlorococcus have been considered photoautotrophic microorganisms, although the utilization of exogenous sugars has never been specifically addressed in them. We studied glucose uptake in different high irradiance-and low irradiance-adapted Prochlorococcus strains, as well as the effect of glucose addition on the expression of several glucose-related genes. Glucose uptake was measured by adding radiolabelled glucose to Prochlorococcus cultures, followed by flow cytometry coupled with cell sorting in order to separate Prochlorococcus cells from bacterial contaminants. Sorted cells were recovered by filtration and their radioactivity measured. The expression, after glucose addition, of several genes (involved in glucose metabolism, and in nitrogen assimilation and its regulation) was determined in the low irradiance-adapted Prochlorococcus SS120 strain by semi-quantitative real time RT-PCR, using the rnpB gene as internal control. Our results demonstrate for the first time that the Prochlorococcus strains studied in this work take up glucose at significant rates even at concentrations close to those found in the oceans, and also exclude the possibility of this uptake being carried out by eventual bacterial contaminants, since only Prochlorococcus cells were used for radioactivity measurements. Besides, we show that the expression of a number of genes involved in glucose utilization (namely zwf, gnd and dld, encoding glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase and lactate dehydrogenase, respectively) is strongly increased upon glucose addition to cultures of the SS120 strain. This fact, taken together with the magnitude of the glucose uptake, clearly indicates the physiological importance of the phenomenon. Given the significant contribution of Prochlorococcus to the global primary production, these findings have strong implications for the understanding of the phytoplankton role in the carbon cycle in nature. Besides, the ability of assimilating carbon molecules could provide additional hints to comprehend the ecological success of Prochlorococcus.	[Gomez-Baena, Guadalupe; Lopez-Lozano, Antonio; Diez, Jesus; Manuel Garcia-Fernandez, Jose] Univ Cordoba, Dept Bioquim & Biol Mol, Cordoba, Spain; [Gil-Martinez, Jorge; Manuel Lucena, Jose; Candau, Pedro] Univ Seville, CSIC, Inst Bioquim Vegetal Fotosintesis, Seville, Spain	Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF)	Gomez-Baena, G (corresponding author), Univ Cordoba, Dept Bioquim & Biol Mol, Edificio Severo Ochoa,Campus Rabanales, Cordoba, Spain.	bb1gafej@uco.es	Gómez-Baena, Guadalupe/N-2368-2013; Diez, Jesús/R-3500-2019; García Fernández, José Manuel/M-2431-2014; Lopez-Lozano, Antonio/F-1295-2016	Gómez-Baena, Guadalupe/0000-0003-3796-3874; Diez, Jesús/0000-0002-1346-3528; García Fernández, José Manuel/0000-0003-2983-1214; Lopez-Lozano, Antonio/0000-0003-1136-9762	Spanish Ministerio de Educacion y Ciencia [BMC2003-09218-CO2-01, BMC2003-09218-CO2-02, BFU2006-10011/BMC]; Universidad de Cordoba; Junta de Andalucia [fellowships]; MEC [fellowships]; Spanish Consejo Superior de Investigaciones Cientificas	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Universidad de Cordoba; Junta de Andalucia(Junta de Andalucia); MEC(European Commission); Spanish Consejo Superior de Investigaciones Cientificas	This work was supported by grants BMC2003-09218-CO2-01, BMC2003-09218-CO2-02 and BFU2006-10011/BMC from Spanish Ministerio de Educacion y Ciencia (MEC, co-funded by the European Social Fund from the European Union), Universidad de Cordoba and Junta de Andalucia (JA). G.G.-B., A.L.-L. and J.G.-M. were recipients of fellowships from JA and MEC and Spanish Consejo Superior de Investigaciones Cientificas.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON SL, 1991, J BACTERIOL, V173, P2761, DOI 10.1128/JB.173.9.2761-2767.1991; AZAM F, 1981, MAR ECOL PROG SER, V6, P213, DOI 10.3354/meps006213; AZAM F, 1977, LIMNOL OCEANOGR, V22, P492, DOI 10.4319/lo.1977.22.3.0492; CARON DA, 2000, MICROBIAL ECOLOGY OC; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; de Marsac NT, 2001, J APPL PHYCOL, V13, P287; Dufresne A, 2003, P NATL ACAD SCI USA, V100, P10020, DOI 10.1073/pnas.1733211100; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Eiler A, 2006, APPL ENVIRON MICROB, V72, P7431, DOI 10.1128/AEM.01559-06; El Alaoui S, 2001, APPL ENVIRON MICROB, V67, P2202, DOI 10.1128/AEM.67.5.2202-2207.2001; Flores E, 2005, BIOCHEM SOC T, V33, P164, DOI 10.1042/BST0330164; Flores E., 1994, MOL BIOL CYANOBACTER, VVol 1, P487; Fuller NJ, 2005, LIMNOL OCEANOGR, V50, P363, DOI 10.4319/lo.2005.50.1.0363; Garcia-Fernandez JM, 2004, MICROBIOL MOL BIOL R, V68, P630, DOI 10.1128/MMBR.68.4.630-638.2004; Garcia-Fernandez JM, 1998, ARCH BIOCHEM BIOPHYS, V359, P17, DOI 10.1006/abbi.1998.0862; Garcia-Fernandez JM, 2004, RES MICROBIOL, V155, P795, DOI 10.1016/j.resmic.2004.06.009; Goericke R, 2000, DEEP-SEA RES PT I, V47, P1183, DOI 10.1016/S0967-0637(99)00108-9; JANNASCH HW, 1974, LIMNOL OCEANOGR, V19, P716, DOI 10.4319/lo.1974.19.4.0716; Johnson Z, 1999, DEEP-SEA RES PT II, V46, P1719, DOI 10.1016/S0967-0645(99)00041-7; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kirchman DL, 2000, MICROBIAL ECOLOGY OC; Lee S, 2007, PLANT PHYSIOL, V145, P1018, DOI 10.1104/pp.107.105023; Lopez-Lozano A, 2002, FEMS MICROBIOL ECOL, V41, P151, DOI 10.1111/j.1574-6941.2002.tb00976.x; LUQUE I, 1994, EMBO J, V13, P2862, DOI 10.1002/j.1460-2075.1994.tb06580.x; Luque I, 2008, CYANOBACTERIA MOL BI; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Marie D, 1999, CURRENT PROTOCOLS CY; MARIE D, 2005, ALGAL CULTURAL TECHN; Mary I, 2008, FEMS MICROBIOL ECOL, V63, P36, DOI 10.1111/j.1574-6941.2007.00414.x; Michelou VK, 2007, APPL ENVIRON MICROB, V73, P5539, DOI 10.1128/AEM.00212-07; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Navarro F, 2000, ARCH BIOCHEM BIOPHYS, V379, P267, DOI 10.1006/abbi.2000.1894; PARSONS TR, 1961, DEEP-SEA RES, V8, P211, DOI 10.1016/0146-6313(61)90022-3; Partensky F, 2003, ADV PHOTO RESPIRAT, V14, P29; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; PEARCE J, 1969, J GEN MICROBIOL, V55, P371, DOI 10.1099/00221287-55-3-371; PELROY RA, 1972, ARCH MIKROBIOL, V87, P303, DOI 10.1007/BF00409131; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRIVALLE LS, 1984, J BACTERIOL, V160, P794, DOI 10.1128/JB.160.2.794-796.1984; Rich J, 1997, DEEP-SEA RES PT II, V44, P1645, DOI 10.1016/S0967-0645(97)00058-1; Rich JH, 1996, LIMNOL OCEANOGR, V41, P595, DOI 10.4319/lo.1996.41.4.0595; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; RIPPKA R, 1972, ARCH MIKROBIOL, V87, P93, DOI 10.1007/BF00424781; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; RUBIN PM, 1977, PLANT PHYSIOL, V60, P407, DOI 10.1104/pp.60.3.407; SANCHEZ JJ, 1975, ARCH MICROBIOL, V104, P57, DOI 10.1007/BF00447300; Singh AK, 2005, J BACTERIOL, V187, P2368, DOI 10.1128/JB.187.7.2368-2376.2005; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1016/S0168-6445(97)00056-9; VACCARO RF, 1968, LIMNOL OCEANOGR, V13, P356, DOI 10.4319/lo.1968.13.2.0356; VAULOT D, 1989, CYTOMETRY, V10, P629, DOI 10.1002/cyto.990100519; Vila-Costa M, 2006, SCIENCE, V314, P652, DOI 10.1126/science.1131043; Zubkov MV, 2008, J PLANKTON RES, V30, P211, DOI 10.1093/plankt/fbm091; Zubkov MV, 2004, FEMS MICROBIOL ECOL, V50, P153, DOI 10.1016/j.femsec.2004.06.009; Zubkov MV, 2005, AQUAT MICROB ECOL, V40, P241, DOI 10.3354/ame040241; Zubkov MV, 2003, APPL ENVIRON MICROB, V69, P1299, DOI 10.1128/AEM.69.2.1299-1304.2003	56	44	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3416	10.1371/journal.pone.0003416	http://dx.doi.org/10.1371/journal.pone.0003416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941506	gold, Green Published			2022-12-27	WOS:000265125600001
J	Ke, XS; Qu, Y; Goldfinger, N; Rostad, K; Hovland, R; Akslen, LA; Rotter, V; Oyan, AM; Kalland, KH				Ke, Xi-Song; Qu, Yi; Goldfinger, Naomi; Rostad, Kari; Hovland, Randi; Akslen, Lars A.; Rotter, Varda; Oyan, Anne Margrete; Kalland, Karl-Henning			Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but without Malignant Transformation	PLOS ONE			English	Article								Background: Epithelial to mesenchymal transition (EMT) has been connected with cancer progression in vivo and the generation of more aggressive cancer cell lines in vitro. EMT has been induced in prostate cancer cell lines, but has previously not been shown in primary prostate cells. The role of EMT in malignant transformation has not been clarified. Methodology/Principal Findings: In a transformation experiment when selecting for cells with loss of contact inhibition, the immortalized prostate primary epithelial cell line, EP156T, was observed to undergo EMT accompanied by loss of contact inhibition after about 12 weeks in continuous culture. The changed new cells were named EPT1. EMT of EPT1 was characterized by striking morphological changes and increased invasion and migration compared with the original EP156T cells. Gene expression profiling showed extensively decreased epithelial markers and increased mesenchymal markers in EPT1 cells, as well as pronounced switches of gene expression modules involved in cell adhesion and attachment. Transformation assays showed that EPT1 cells were sensitive to serum or growth factor withdrawal. Most importantly, EPT1 cells were not able to grow in an anchorage-independent way in soft agar, which is considered a critical feature of malignant transformation. Conclusions/Significance: This work for the first time established an EMT model from primary prostate cells. The results show that EMT can be activated as a coordinated gene expression program in association with early steps of transformation. The model allows a clearer identification of the molecular mechanisms of EMT and its potential role in malignant transformation.	[Ke, Xi-Song; Qu, Yi; Rostad, Kari; Akslen, Lars A.; Oyan, Anne Margrete; Kalland, Karl-Henning] Univ Bergen, Gade Inst, Bergen, Norway; [Goldfinger, Naomi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Hovland, Randi] Haukeland Hosp, Ctr Med Genet & Mol Med, Bergen, Norway; [Akslen, Lars A.] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Oyan, Anne Margrete; Kalland, Karl-Henning] Haukeland Hosp, Dept Microbiol & Immunol, Bergen, Norway	University of Bergen; Weizmann Institute of Science; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Ke, XS (corresponding author), Univ Bergen, Gade Inst, Bergen, Norway.	Kalland@gades.uib.no	Kalland, Karl-Henning/B-9445-2017; Akslen, Lars A./AAG-6097-2021; Akslen, Lars A/C-1202-2017	Kalland, Karl-Henning/0000-0003-4486-2334; Akslen, Lars A./0000-0003-2710-9543; Akslen, Lars A/0000-0003-2710-9543	Helse Vest [911005, 911227, 911401]; Research Council of Norway [154942/310, 163920/V50, 185676/V40]; Norwegian Cancer Society [HS01-2006-0446, HS01-2006-0468]; University of Bergen	Helse Vest; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); University of Bergen	This study was funded by the following grants: Helse Vest (Grants 911005, 911227 and 911401), The Research Council of Norway (Grants 154942/310, 163920/V50, 185676/V40, The Norwegian Cancer Society (grants HS01-2006-0446 and HS01-2006-0468) and the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Beheshti B, 2000, MOL DIAGN, V5, P23, DOI 10.2165/00066982-200005010-00008; Beitzinger M, 2008, EMBO J, V27, P792, DOI 10.1038/emboj.2008.13; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Billottet C, 2008, J CELL BIOCHEM, V104, P826, DOI 10.1002/jcb.21667; BOREK C, 1966, P NATL ACAD SCI USA, V56, P1705, DOI 10.1073/pnas.56.6.1705; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Cao J, 2008, J BIOL CHEM, V283, P6232, DOI 10.1074/jbc.M705759200; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Geiger T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001574; Goldberg JB, 2000, TRENDS MICROBIOL, V8, P60, DOI 10.1016/S0966-842X(99)01689-3; Gotoh N, 2007, INVEST OPHTH VIS SCI, V48, P4679, DOI 10.1167/iovs.07-0091; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Gu XS, 2007, CANCER RES, V67, P4219, DOI 10.1158/0008-5472.CAN-06-3689; Gu YP, 2006, EXP CELL RES, V312, P831, DOI 10.1016/j.yexcr.2005.11.029; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Jarrard DF, 1997, CLIN CANCER RES, V3, P2121; Jiang M, 2008, PROSTATE, V68, P1496, DOI 10.1002/pros.20756; KAIGHN ME, 1989, CANCER RES, V49, P3050; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kiemer AK, 2001, ONCOGENE, V20, P6679, DOI 10.1038/sj.onc.1204872; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Kuettel MR, 1996, CANCER RES, V56, P5; Laffin B, 2008, MOL CELL BIOL, V28, P1936, DOI 10.1128/MCB.01701-07; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee SA, 2008, J CLIN INVEST, V118, P1354, DOI 10.1172/JCI33768; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Luo Y, 2006, CHINESE MED J-PEKING, V119, P713, DOI 10.1097/00029330-200605010-00002; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Miki J, 2008, PROSTATE CANCER P D, V11, P32, DOI 10.1038/sj.pcan.4501018; Mimeault M, 2007, ANN ONCOL, V18, P1605, DOI 10.1093/annonc/mdm070; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Petersen K, 2007, ANAL BIOCHEM, V366, P46, DOI 10.1016/j.ab.2007.03.013; Rhim JS, 1997, CANCER RES, V57, P576; Rubin H, 2005, P NATL ACAD SCI USA, V102, P9276, DOI 10.1073/pnas.0503688102; Rubin H, 2008, P NATL ACAD SCI USA, V105, P6215, DOI 10.1073/pnas.0800747105; Saramaki OR, 2006, INT J CANCER, V119, P1322, DOI 10.1002/ijc.21976; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Serakinci N, 2004, ONCOGENE, V23, P5095, DOI 10.1038/sj.onc.1207651; Spaderna S, 2007, Verh Dtsch Ges Pathol, V91, P21; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Strefford JC, 2001, CANCER GENET CYTOGEN, V124, P112, DOI 10.1016/S0165-4608(00)00339-3; SZILVAY AM, 1995, J VIROL, V69, P3315, DOI 10.1128/JVI.69.6.3315-3323.1995; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tran NL, 1999, AM J PATHOL, V155, P787, DOI 10.1016/S0002-9440(10)65177-2; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; Vincan E, 2007, CELLS TISSUES ORGANS, V185, P20, DOI 10.1159/000101299; Wolter H, 2002, EUR UROL, V41, P328, DOI 10.1016/S0302-2838(02)00035-0; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang SX, 2005, CANCER RES, V65, P5769, DOI 10.1158/0008-5472.CAN-05-0289; Yang Z, 2007, BIOCHEM BIOPH RES CO, V358, P925, DOI 10.1016/j.bbrc.2007.05.023; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103; Zongaro S, 2005, CANCER RES, V65, P11411, DOI 10.1158/0008-5472.CAN-05-1140	75	48	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3368	10.1371/journal.pone.0003368	http://dx.doi.org/10.1371/journal.pone.0003368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852876	Green Published, gold, Green Submitted			2022-12-27	WOS:000265121600001
J	Simhadri, VR; Reiners, KS; Hansen, HP; Topolar, D; Simhadri, VL; Nohroudi, K; Kufer, TA; Engert, A; von Strandmann, EP				Simhadri, Venkateswara Rao; Reiners, Katrin S.; Hansen, Hinrich P.; Topolar, Daniela; Simhadri, Vijaya Lakshmi; Nohroudi, Klaus; Kufer, Thomas A.; Engert, Andreas; von Strandmann, Elke Pogge			Dendritic Cells Release HLA-B-Associated Transcript-3 Positive Exosomes to Regulate Natural Killer Function	PLOS ONE			English	Article								NKp30, a natural cytotoxicity receptor expressed on NK cells is critically involved in direct cytotoxicity against various tumor cells and directs both maturation and selective killing of dendritic cells. Recently the intracellular protein BAT3, which is involved in DNA damage induced apoptosis, was identified as a ligand for NKp30. However, the mechanisms underlying the exposure of the intracellular ligand BAT3 to surface NKp30 and its role in NK-DC cross talk remained elusive. Electron microscopy and flow cytometry demonstrate that exosomes released from 293T cells and iDCs express BAT3 on the surface and are recognized by NKp30-Ig. Overexpression and depletion of BAT3 in 293T cells directly correlates with the exosomal expression level and the activation of NK cell-mediated cytokine release. Furthermore, the NKp30-mediated NK/DC cross talk resulting either in iDC killing or maturation was BAT3-dependent. Taken together this puts forward a new model for the activation of NK cells through intracellular signals that are released via exosomes from accessory cells. The manipulation of the exosomal regulation may offer a novel strategy to induce tumor immunity or inhibit autoimmune diseases caused by NK cell-activation.	[Simhadri, Venkateswara Rao; Reiners, Katrin S.; Hansen, Hinrich P.; Topolar, Daniela; Simhadri, Vijaya Lakshmi; Engert, Andreas; von Strandmann, Elke Pogge] Univ Cologne, Dept Internal Med 1, Lab Immune Therapy, Ctr Integrated Oncol Koeln Bonn, Cologne, Germany; [Nohroudi, Klaus] Univ Hosp Cologne, Inst Anat I, Cologne, Germany; [Kufer, Thomas A.] Univ Cologne, Inst Med Microbiol, Immunol & Hyg, D-5000 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Simhadri, VR (corresponding author), Univ Cologne, Dept Internal Med 1, Lab Immune Therapy, Ctr Integrated Oncol Koeln Bonn, Cologne, Germany.	venkatsimhadri@googlemail.com; elke.pogge@uk-koeln.de	Kufer, Thomas A/I-5146-2015	Kufer, Thomas A/0000-0003-4563-0412; Reiners, Katrin/0000-0002-5908-8823	Deutsche Forschungsgemeinschaft (DFG) [STR 530/5-1]; Deutsche Krebshilfe [107276]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	Research was supported by Deutsche Forschungsgemeinschaft (DFG) (STR 530/5-1) and Deutsche Krebshilfe (107276).	Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Augugliaro R, 2003, EUR J IMMUNOL, V33, P1235, DOI 10.1002/eji.200323896; BIENZ M, 1987, ADV GENET, V24, P31, DOI 10.1016/S0065-2660(08)60006-1; Bloushtain N, 2004, J IMMUNOL, V173, P2392, DOI 10.4049/jimmunol.173.4.2392; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Byrd A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001339; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; DESMOTS F, 2007, J BIOL CHEM; Elsner L, 2007, J IMMUNOL, V179, P5523, DOI 10.4049/jimmunol.179.8.5523; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Garg A, 2006, J IMMUNOL, V177, P6192, DOI 10.4049/jimmunol.177.9.6192; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gasser S, 2006, SEMIN CANCER BIOL, V16, P344, DOI 10.1016/j.semcancer.2006.07.004; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Gehrmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001925; Hershkovitz O, 2008, GLYCOBIOLOGY, V18, P28, DOI 10.1093/glycob/cwm125; Hollins Susan, 2005, Nurs Manag (Harrow), V12, P22; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; LESPAGNOL A, 2008, CELL DEATH DIFFER; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; North J, 2007, J IMMUNOL, V178, P85, DOI 10.4049/jimmunol.178.1.85; Nowbakht P, 2005, BLOOD, V105, P3615, DOI 10.1182/blood-2004-07-2585; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Warren HS, 2005, J IMMUNOL, V175, P207, DOI 10.4049/jimmunol.175.1.207; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579	40	176	185	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3377	10.1371/journal.pone.0003377	http://dx.doi.org/10.1371/journal.pone.0003377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852879	Green Published, Green Submitted, gold			2022-12-27	WOS:000265121600003
J	Ching, OY; Smith, DD; Krontiris, TG				Ching Ouyang; Smith, David D.; Krontiris, Theodore G.			Evolutionary Signatures of Common Human Cis-Regulatory Haplotypes	PLOS ONE			English	Article								Variation in gene expression may give rise to a significant fraction of inter-individual phenotypic variation. Studies searching for the underlying genetic controls for such variation have been conducted in model organisms and humans in recent years. In our previous effort of assessing conserved underlying haplotype patterns across ethnic populations, we constructed common haplotypes using SNPs having conserved linkage disequilibrium (LD) across ethnic populations. These common haplotypes cluster into a simple evolutionary structure based on their frequencies, defining only up to three conserved clusters termed 'haplotype frameworks'. One intriguing preliminary finding was that a significant portion of reported variants strongly associated with cis-regulation tags these globally conserved haplotype frameworks. Here we expand the investigation by collecting genes showing stringently determined cis-association between genotypes and expression phenotypes from major studies. We conducted phylogenetic analysis of current major haplotypes along with the corresponding haplotypes derived from chimpanzee reference sequences. Our analysis reveals that, for the vast majority of such cis-regulatory genes, the tagging SNPs showing the strongest association also tag the haplotype lineages directly separated from ancestry, inferred from either chimpanzee reference sequences or the allele frequency-derived haplotype frameworks, suggesting that the differentially expressed phenotypes were evolved relatively early in human history. Such evolutionary signatures provide keys for a more effective identification of globally-conserved candidate regulatory haplotypes across human genes in future epidemiologic and pharmacogenetic studies.	[Ching Ouyang; Krontiris, Theodore G.] Beckman Res Inst City Hope, Div Mol Med, Duarte, CA USA; [Smith, David D.] Beckman Res Inst City of Hope, Div Informat Sci, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Ching, OY (corresponding author), Beckman Res Inst City Hope, Div Mol Med, Duarte, CA USA.	tkrontir@coh.org	Smith, David/A-4115-2017	Smith, David/0000-0001-9644-2353	Beckman Research Institute of the City of Hope	Beckman Research Institute of the City of Hope	This work was supported by funds from the Beckman Research Institute of the City of Hope.	Akey JM, 2007, NAT GENET, V39, P807, DOI 10.1038/ng0707-807; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; de Bakker PIW, 2006, NAT GENET, V38, P1298, DOI 10.1038/ng1899; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Gibson G, 2005, TRENDS GENET, V21, P616, DOI 10.1016/j.tig.2005.08.010; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ouyang C, 2006, PHARMACOGENET GENOM, V16, P667, DOI 10.1097/01.fpc.0000220569.82842.9b; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Pastinen T, 2006, HUM MOL GENET, V15, pR9, DOI 10.1093/hmg/ddl044; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Spielman RS, 2007, NAT GENET, V39, P808, DOI 10.1038/ng0707-808; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Williams RBH, 2006, NAT GENET, V38, P855, DOI 10.1038/ng0806-855; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858	40	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3362	10.1371/journal.pone.0003362	http://dx.doi.org/10.1371/journal.pone.0003362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846218	Green Published, gold, Green Submitted			2022-12-27	WOS:000265114500004
J	Richter, DC; Ott, F; Auch, AF; Schmid, R; Huson, DH				Richter, Daniel C.; Ott, Felix; Auch, Alexander F.; Schmid, Ramona; Huson, Daniel H.			MetaSim-A Sequencing Simulator for Genomics and Metagenomics	PLOS ONE			English	Article							PHYLOGENETIC CLASSIFICATION; DATABASE; AUTOMATION; EVOLUTION	Background: The new research field of metagenomics is providing exciting insights into various, previously unclassified ecological systems. Next-generation sequencing technologies are producing a rapid increase of environmental data in public databases. There is great need for specialized software solutions and statistical methods for dealing with complex metagenome data sets. Methodology/Principal Findings: To facilitate the development and improvement of metagenomic tools and the planning of metagenomic projects, we introduce a sequencing simulator called MetaSim. Our software can be used to generate collections of synthetic reads that reflect the diverse taxonomical composition of typical metagenome data sets. Based on a database of given genomes, the program allows the user to design a metagenome by specifying the number of genomes present at different levels of the NCBI taxonomy, and then to collect reads from the metagenome using a simulation of a number of different sequencing technologies. A population sampler optionally produces evolved sequences based on source genomes and a given evolutionary tree. Conclusions/Significance: MetaSim allows the user to simulate individual read datasets that can be used as standardized test scenarios for planning sequencing projects or for benchmarking metagenomic software.	[Richter, Daniel C.; Ott, Felix; Auch, Alexander F.; Huson, Daniel H.] Univ Tubingen, ZBIT Ctr Bioinformat Tubingen, Tubingen, Germany; [Schmid, Ramona] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany	Eberhard Karls University of Tubingen; Boehringer Ingelheim	Richter, DC (corresponding author), Univ Tubingen, ZBIT Ctr Bioinformat Tubingen, Tubingen, Germany.	drichter@informatik.uni-tuebingen.de	Huson, Daniel H./AAC-5494-2019					Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bernal A, 2001, NUCLEIC ACIDS RES, V29, P126, DOI 10.1093/nar/29.1.126; Chatterji S, 2008, LECT N BIOINFORMAT, V4955, P17; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; ENGLE ML, 1994, COMPUT APPL BIOSCI, V10, P567; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Harding E., 1971, ADV APPL PROBAB, V3, P44, DOI DOI 10.2307/1426329; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KARLIN S, 1995, TRENDS GENET, V11, P283; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Meldrum D, 2000, GENOME RES, V10, P1081, DOI 10.1101/gr.101400; Meldrum D, 2000, GENOME RES, V10, P1288, DOI 10.1101/gr.157400; MYERS G, 1999, DATASET GENERATOR WH, P202; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pachter L, 2007, NAT METHODS, V4, P479, DOI 10.1038/nmeth0607-479; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	37	279	298	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3373	10.1371/journal.pone.0003373	http://dx.doi.org/10.1371/journal.pone.0003373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841204	gold, Green Published			2022-12-27	WOS:000265113900009
J	Alter, MD; Rubin, DB; Ramsey, K; Halpern, R; Stephan, DA; Abbott, LF; Hen, R				Alter, Mark D.; Rubin, Daniel B.; Ramsey, Keri; Halpern, Rebecca; Stephan, Dietrich A.; Abbott, L. F.; Hen, Rene			Variation in the Large-Scale Organization of Gene Expression Levels in the Hippocampus Relates to Stable Epigenetic Variability in Behavior	PLOS ONE			English	Article								Background: Despite sharing the same genes, identical twins demonstrate substantial variability in behavioral traits and in their risk for disease. Epigenetic factors-DNA and chromatin modifications that affect levels of gene expression without affecting the DNA sequence-are thought to be important in establishing this variability. Epigenetically-mediated differences in the levels of gene expression that are associated with individual variability traditionally are thought to occur only in a gene-specific manner. We challenge this idea by exploring the large-scale organizational patterns of gene expression in an epigenetic model of behavioral variability. Methodology/Findings: To study the effects of epigenetic influences on behavioral variability, we examine gene expression in genetically identical mice. Using a novel approach to microarray analysis, we show that variability in the large-scale organization of gene expression levels, rather than differences in the expression levels of specific genes, is associated with individual differences in behavior. Specifically, increased activity in the open field is associated with increased variance of log-transformed measures of gene expression in the hippocampus, a brain region involved in open field activity. Early life experience that increases adult activity in the open field also similarly modifies the variance of gene expression levels. The same association of the variance of gene expression levels with behavioral variability is found with levels of gene expression in the hippocampus of genetically heterogeneous outbred populations of mice, suggesting that variation in the large-scale organization of gene expression levels may also be relevant to phenotypic differences in outbred populations such as humans. We find that the increased variance in gene expression levels is attributable to an increasing separation of several large, log-normally distributed families of gene expression levels. We also show that the presence of these multiple log-normal distributions of gene expression levels is a universal characteristic of gene expression in eurkaryotes. We use data from the MicroArray Quality Control Project (MAQC) to demonstrate that our method is robust and that it reliably detects biological differences in the large-scale organization of gene expression levels. Conclusions: Our results contrast with the traditional belief that epigenetic effects on gene expression occur only at the level of specific genes and suggest instead that the large-scale organization of gene expression levels provides important insights into the relationship of gene expression with behavioral variability. Understanding the epigenetic, genetic, and environmental factors that regulate the large-scale organization of gene expression levels, and how changes in this large-scale organization influences brain development and behavior will be a major future challenge in the field of behavioral genomics.	[Alter, Mark D.; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Alter, Mark D.; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Rubin, Daniel B.; Abbott, L. F.] Columbia Univ, Dept Neurosci, Div Theoret Neurosci, New York, NY 10027 USA; [Ramsey, Keri; Halpern, Rebecca; Stephan, Dietrich A.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA	Columbia University; Columbia University; Columbia University; Translational Genomics Research Institute	Alter, MD (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	alterm@childpsych.columbia.edu; rh95@columbia.edu		Rubin, Daniel/0000-0001-6982-9587	NARSAD Young Investigator Award [R01 MH068542-6]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068542] Funding Source: NIH RePORTER	NARSAD Young Investigator Award(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	NARSAD Young Investigator Award, R01 MH068542-6	AXEL R, 1976, CELL, V7, P247, DOI 10.1016/0092-8674(76)90024-6; BISHOP JO, 1974, NATURE, V250, P199, DOI 10.1038/250199a0; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; Kazlauckas V, 2005, BEHAV BRAIN RES, V162, P272, DOI 10.1016/j.bbr.2005.03.021; Kendall K., 2007, PSYCHOL MED, P1; Kuznetsov VA, 2002, GENETICS, V161, P1321; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1125, DOI 10.1037/0735-7044.121.5.1125; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; MEANEY MJ, 1991, PSYCHONEUROENDOCRINO, V16, P85, DOI 10.1016/0306-4530(91)90072-2; MEANEY MJ, 1985, BEHAV NEUROSCI, V99, P765, DOI 10.1037/0735-7044.99.4.765; Mortazavi A, 2008, NAT METHODS; MULERONAVARRO S, 2008, CRIT REV ONCOL HEMAT; PETRONIS A, 2006, TRENDS GENET; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; Ponder CA, 2008, BEHAV GENET, V38, P277, DOI 10.1007/s10519-008-9203-6; Ray J, 2005, DEV PSYCHOBIOL, V47, P136, DOI 10.1002/dev.20080; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P3765, DOI 10.1073/pnas.0306244101; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Weaver ICG, 2002, ENDOCR RES, V28, P699, DOI 10.1081/ERC-120016989; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, ANN NY ACAD SCI, V1024, P182, DOI 10.1196/annals.1321.099; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weaver ICG, 2001, MOL CELL ENDOCRINOL, V185, P205, DOI 10.1016/S0303-7207(01)00635-9; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	37	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3344	10.1371/journal.pone.0003344	http://dx.doi.org/10.1371/journal.pone.0003344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836535	gold, Green Published, Green Submitted			2022-12-27	WOS:000265113500008
J	Galvan, I; Alonso-Alvarez, C				Galvan, Ismael; Alonso-Alvarez, Carlos			An Intracellular Antioxidant Determines the Expression of a Melanin-Based Signal in a Bird	PLOS ONE			English	Article							MALE HOUSE SPARROWS; OXIDATIVE STRESS; GLUTATHIONE METABOLISM; BUTHIONINE SULFOXIMINE; PLUMAGE COLORATION; SEXUAL SIGNALS; GREAT TITS; TESTOSTERONE; TYROSINASE; EVOLUTION	To understand how traits used in animal communication evolved and are maintained as honest signals, we need to understand the mechanisms that prevent cheating. It has been proposed that honest signaling is guaranteed by the costs associated with the signal expression. However, the nature of these costs is still under debate. Melanin-based signals are intriguing because their expression seems to be tightly controlled by genes and the resource involved (i.e. melanin) seems to be not limited. However, in vertebrates, low levels of a key intracellular antioxidant (i.e. glutathione) are needed to promote melanogenesis. We propose that melanin- based ornaments can signal the ability to cope with oxidative stress because those individuals with low enough levels of glutathione, such as those required for melanin production, should manage well the whole of the antioxidant machinery in order to maintain a certain oxidative status. We analysed the expression of a melanin- based signal: the well-known black stripe of the great tit (Parus major). Great tit nestlings were injected with a specific inhibitor of glutathione production (DL-buthionine- S, R-sulfoximine; BSO) throughout their development. BSO effectively decreased intracellular glutathione levels without apparent side effects on growth or body condition. Instead, treated nestlings developed black breast stripes 70-100% larger than controls. Moreover, treated nestlings also compensated the decrease in glutathione levels by increasing the levels of circulating antioxidants. Results indicate that melanin- based signals can be at least partially permeable to environmental influences such as those associated to oxidative stress. They also reveal a potential handicap associated to the expression of this kind of signals. Finally, although other contributing factors could have been present, our findings emphasize the role of oxidative stress in shaping the evolution of animal signals in general and, in particular, those produced by pigments.	[Galvan, Ismael] CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, E-28006 Madrid, Spain; [Alonso-Alvarez, Carlos] IREC CSIC UCLM JCCM, Inst Investigac Recursos Cineget, Ciudad Real, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Galvan, I (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, E-28006 Madrid, Spain.	galvan@mncn.csic.es; carlos.alonso@uclm.es	Alonso-Alvarez, Carlos/M-6804-2014; Galvan, Ismael/H-8602-2015	Alonso-Alvarez, Carlos/0000-0002-4765-551X; Galvan, Ismael/0000-0002-6523-8592	Ministerio de Educacion y Ciencia (Spanish Government) [CGL2006-10357-C02-02, CGL2007-61395BOS]; FPI; Ramon y Cajal fellowship; Ministerio de Educacion y Ciencia	Ministerio de Educacion y Ciencia (Spanish Government)(Spanish Government); FPI(Spanish Government); Ramon y Cajal fellowship(Spanish Government); Ministerio de Educacion y Ciencia(Spanish Government)	Financial support was obtained from the CGL2006-10357-C02-02 and CGL2007-61395BOS projects from Ministerio de Educacion y Ciencia (Spanish Government). I.G. benefited from a FPI grant, whereas C.A.-A. from a Ramon y Cajal fellowship, both from Ministerio de Educacion y Ciencia.	AHN DU, 1993, POULTRY SCI, V72, P1972, DOI 10.3382/ps.0721972; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Alonso-Alvarez C, 2006, EVOLUTION, V60, P1913, DOI 10.1111/j.0014-3820.2006.tb00534.x; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; [Anonymous], 2006, SAS MIXED MODELS; [Anonymous], [No title captured]; Badyaev AV, 2000, BIOL J LINN SOC, V69, P153, DOI 10.1111/j.1095-8312.2000.tb01196.x; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; BENEDETTO JP, 1981, J INVEST DERMATOL, V77, P402, DOI 10.1111/1523-1747.ep12494592; Bize P, 2006, EVOLUTION, V60, P2370; Borgia G., 1979, SEXUAL SELECTION REP, P19; Buchanan KL, 2003, BEHAV ECOL SOCIOBIOL, V55, P50, DOI 10.1007/s00265-003-0682-4; Carrascal LM, 1998, AUK, V115, P727, DOI 10.2307/4089420; CHO ES, 1981, J NUTR, V111, P914, DOI 10.1093/jn/111.5.914; DELMARMOL V, 1993, J INVEST DERMATOL, V101, P871, DOI 10.1111/1523-1747.ep12371709; Evans MR, 2000, BEHAV ECOL SOCIOBIOL, V47, P156, DOI 10.1007/s002650050006; Fargallo JA, 2007, J ANIM ECOL, V76, P201, DOI 10.1111/j.1365-2656.2006.01193.x; Fargallo JA, 2007, EVOL ECOL, V21, P157, DOI 10.1007/s10682-006-0020-1; Figuerola J, 2000, IBIS, V142, P482, DOI 10.1111/j.1474-919X.2000.tb04445.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fitze PS, 2002, BEHAV ECOL, V13, P401, DOI 10.1093/beheco/13.3.401; Galvan I, 2006, IBIS, V148, P687, DOI 10.1111/j.1474-919X.2006.00576.x; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Gosler A, 1993, GREAT TIT; Grether GF, 2004, BIOL REV, V79, P583, DOI 10.1017/S1464793103006390; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Griffith SC, 2006, ANIM BEHAV, V71, P749, DOI 10.1016/j.anbehav.2005.07.016; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; HALPRIN KM, 1966, ARCH DERMATOL, V94, P355, DOI 10.1001/archderm.94.3.355; Hartley RC, 2004, TRENDS ECOL EVOL, V19, P353, DOI 10.1016/j.tree.2004.04.002; Hasson O, 1997, J THEOR BIOL, V185, P139, DOI 10.1006/jtbi.1996.0258; Iwata S, 2002, CLIN EXP MED, V2, P99, DOI 10.1007/s102380200013; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; JARVI T, 1984, ANIM BEHAV, V32, P590, DOI 10.1016/S0003-3472(84)80296-1; JARVI T, 1987, ETHOLOGY, V76, P334; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; KARG E, 1993, J INVEST DERMATOL, V100, pS209, DOI 10.1111/1523-1747.ep12465218; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Marchionatti A, 2001, COMP BIOCHEM PHYS C, V129, P85, DOI 10.1016/S1532-0456(01)00185-5; McGraw K.J., 2006, BIRD COLORATION, V1, P177; McGraw KJ, 2007, BEHAV ECOL, V18, P137, DOI 10.1093/beheco/arl059; McGraw KJ., 2006, BIRD COLORATION, P243; MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290; Moreno Juan, 2006, Acta Zoologica Sinica, V52, P202; Niecke M, 2003, OECOLOGIA, V137, P153, DOI 10.1007/s00442-003-1307-3; NORRIS KJ, 1990, BEHAV ECOL SOCIOBIOL, V27, P275; OHTSUKA Y, 1994, EUR J APPL PHYSIOL O, V68, P87, DOI 10.1007/BF00599247; OWENS IPF, 1995, TRENDS ECOL EVOL, V10, P44, DOI 10.1016/S0169-5347(00)88967-3; Poston JP, 2005, ANIM BEHAV, V70, P1171, DOI 10.1016/j.anbehav.2005.02.015; Price TD, 2006, J EXP BIOL, V209, P2368, DOI 10.1242/jeb.02183; Quesada J, 2007, ETHOLOGY, V113, P640, DOI 10.1111/j.1439-0310.2007.01364.x; Rajasekaran NS, 2005, BBA-MOL BASIS DIS, V1741, P103, DOI 10.1016/j.bbadis.2004.11.025; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Sarna T., 2006, PIGMENTARY SYSTEM PH, P311, DOI DOI 10.1002/9780470987100.CH16; Senar JC, 2006, BEHAVIOUR, V143, P589, DOI 10.1163/156853906776759484; Silverin B, 1996, GEN COMP ENDOCR, V103, P150, DOI 10.1006/gcen.1996.0106; Solano F, 2006, PIGM CELL RES, V19, P550, DOI 10.1111/j.1600-0749.2006.00334.x; Soltaninassab SR, 2000, J CELL PHYSIOL, V182, P163, DOI 10.1002/(SICI)1097-4652(200002)182:2<163::AID-JCP4>3.0.CO;2-1; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; West-Eberhard Mary Jane, 2003, pi; WILSON JD, 1992, ANIM BEHAV, V43, P999, DOI 10.1016/0003-3472(92)90013-Y; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	70	125	128	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3335	10.1371/journal.pone.0003335	http://dx.doi.org/10.1371/journal.pone.0003335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RW	18833330	Green Submitted, gold, Green Published			2022-12-27	WOS:000264797400007
J	Hatterer, E; Touret, M; Belin, MF; Honnorat, J; Nataf, S				Hatterer, Eric; Touret, Monique; Belin, Marie-Francoise; Honnorat, Jerome; Nataf, Serge			Cerebrospinal Fluid Dendritic Cells Infiltrate the Brain Parenchyma and Target the Cervical Lymph Nodes under Neuroinflammatory Conditions	PLOS ONE			English	Article								Background: In many neuroinflammatory diseases, dendritic cells (DCs) accumulate in several compartments of the central nervous system (CNS), including the cerebrospinal fluid (CSF). Myeloid DCs invading the inflamed CNS are thus thought to play a major role in the initiation and perpetuation of CNS-targeted autoimmune responses. We previously reported that, in normal rats, DCs injected intra-CSF migrated outside the CNS and reached the B-cell zone of cervical lymph nodes. However, there is yet no information on the migratory behavior of CSF-circulating DCs under neuroinflammatory conditions. Methodology/Principal Findings: To address this issue, we performed in vivo transfer experiments in rats suffering from experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. EAE or control rats were injected intra-CSF with bone marrow-derived myeloid DCs labeled with the fluorescent marker carboxyfluorescein diacetate succinimidyl ester (CFSE). In parallel experiments, fluorescent microspheres were injected intra-CSF to EAE rats in order to track endogenous antigen-presenting cells (APCs). Animals were then sacrificed on day 1 or 8 post-injection and their brain and peripheral lymph nodes were assessed for the presence of microspheres(+) APCs or CFSE(+) DCs by immunohistology and/or FACS analysis. Data showed that in EAE rats, DCs injected intra-CSF substantially infiltrated several compartments of the inflamed CNS, including the periventricular demyelinating lesions. We also found that in EAE rats, as compared to controls, a larger number of intra-CSF injected DCs reached the cervical lymph nodes. This migratory behavior was accompanied by an accentuation of EAE clinical signs and an increased systemic antibody response against myelin oligodendrocyte glycoprotein, a major immunogenic myelin antigen. Conclusions/Significance: Altogether, these results indicate that CSF-circulating DCs are able to both survey the inflamed brain and to reach the cervical lymph nodes. In EAE and maybe multiple sclerosis, CSF-circulating DCs may thus support the immune responses that develop within and outside the inflamed CNS.	[Hatterer, Eric; Touret, Monique; Belin, Marie-Francoise; Honnorat, Jerome; Nataf, Serge] INSERM, U842, Lyon, France; [Hatterer, Eric; Touret, Monique; Belin, Marie-Francoise; Honnorat, Jerome; Nataf, Serge] Univ Lyon, UMR S842, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Hatterer, E (corresponding author), INSERM, U842, Lyon, France.	nataf@lyon.inserm.fr	Honnorat, jerome/G-6394-2017	Honnorat, jerome/0000-0002-4721-5952	INSERM; ARSEP; MRT	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ARSEP; MRT	This work was supported by grants from INSERM and ARSEP (to S. Nataf) and by a fellowship from MRT to E. Hatterer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIGUET P, 1992, J NEUROCHEM, V58, P1676, DOI 10.1111/j.1471-4159.1992.tb10040.x; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Carare RO, 2008, NEUROPATH APPL NEURO, V34, P131, DOI 10.1111/j.1365-2990.2007.00926.x; Carson MJ, 1999, AM J PATHOL, V154, P481, DOI 10.1016/S0002-9440(10)65294-7; Christodoulides M, 2002, INFECT IMMUN, V70, P4035, DOI 10.1128/IAI.70.8.4035-4044.2002; Dubois B, 1999, J IMMUNOL, V162, P3428; Fernandez M, 2004, P NATL ACAD SCI USA, V101, P16363, DOI 10.1073/pnas.0407262101; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Grouard G, 1996, NATURE, V384, P364, DOI 10.1038/384364a0; Hatterer E, 2006, BLOOD, V107, P806, DOI 10.1182/blood-2005-01-0154; Jagessar SA, 2008, J NEUROPATH EXP NEUR, V67, P326, DOI 10.1097/NEN.0b013e31816a6851; Karman J, 2004, J IMMUNOL, V173, P2353, DOI 10.4049/jimmunol.173.4.2353; Kostulas N, 2002, STROKE, V33, P1129, DOI 10.1161/hs0402.105379; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; LININGTON C, 1988, AM J PATHOL, V130, P443; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Marta CB, 2005, P NATL ACAD SCI USA, V102, P13992, DOI 10.1073/pnas.0504979102; Matsuno K, 1996, J EXP MED, V183, P1865, DOI 10.1084/jem.183.4.1865; Mitra R, 2004, FASEB J, V18, P1764, DOI 10.1096/fj.04-1855fje; NEWCOMBE J, 1991, BRAIN, V114, P1013, DOI 10.1093/brain/114.2.1013; O'Connor KC, 2005, J IMMUNOL, V175, P1974, DOI 10.4049/jimmunol.175.3.1974; Pashenkov M, 2002, J NEUROIMMUNOL, V122, P106, DOI 10.1016/S0165-5728(01)00451-9; Pashenkov M, 2001, BRAIN, V124, P480, DOI 10.1093/brain/124.3.480; Schley D, 2006, J THEOR BIOL, V238, P962, DOI 10.1016/j.jtbi.2005.07.005; Serafini B, 2006, J NEUROPATH EXP NEUR, V65, P124, DOI 10.1097/01.jnen.0000199572.96472.1c; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; SHIN TY, 1995, J NEUROIMMUNOL, V56, P171, DOI 10.1016/0165-5728(94)00144-D; Weller RO, 1998, J NEUROPATH EXP NEUR, V57, P885, DOI 10.1097/00005072-199810000-00001	31	57	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3321	10.1371/journal.pone.0003321	http://dx.doi.org/10.1371/journal.pone.0003321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830405	Green Published, Green Submitted, gold			2022-12-27	WOS:000264797300009
J	Jackson, MC; Wolf, C; Johnston, SJ; Raymond, JE; Linden, DEJ				Jackson, Margaret C.; Wolf, Claudia; Johnston, Stephen J.; Raymond, Jane E.; Linden, David E. J.			Neural Correlates of Enhanced Visual Short-Term Memory for Angry Faces: An fMRI Study	PLOS ONE			English	Article							WORKING-MEMORY; FACIAL EXPRESSIONS; SUBTHALAMIC NUCLEUS; PREFRONTAL CORTEX; EMOTION; ATTENTION; RECOGNITION; PERCEPTION; AMYGDALA; AREA	Background: Fluid and effective social communication requires that both face identity and emotional expression information are encoded and maintained in visual short-term memory (VSTM) to enable a coherent, ongoing picture of the world and its players. This appears to be of particular evolutionary importance when confronted with potentially threatening displays of emotion - previous research has shown better VSTM for angry versus happy or neutral face identities. Methodology/Principal Findings: Using functional magnetic resonance imaging, here we investigated the neural correlates of this angry face benefit in VSTM. Participants were shown between one and four to-be-remembered angry, happy, or neutral faces, and after a short retention delay they stated whether a single probe face had been present or not in the previous display. All faces in any one display expressed the same emotion, and the task required memory for face identity. We find enhanced VSTM for angry face identities and describe the right hemisphere brain network underpinning this effect, which involves the globus pallidus, superior temporal sulcus, and frontal lobe. Increased activity in the globus pallidus was significantly correlated with the angry benefit in VSTM. Areas modulated by emotion were distinct from those modulated by memory load. Conclusions/Significance: Our results provide evidence for a key role of the basal ganglia as an interface between emotion and cognition, supported by a frontal, temporal, and occipital network.	[Jackson, Margaret C.; Wolf, Claudia; Johnston, Stephen J.; Raymond, Jane E.; Linden, David E. J.] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales	Bangor University	Jackson, MC (corresponding author), Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales.	m.jackson@bangor.ac.uk	Jackson, Margaret/G-5814-2011; Linden, David E J/C-7355-2013; Linden, David/S-9948-2019	Linden, David E J/0000-0002-5638-9292; Linden, David/0000-0002-5638-9292; Jackson, Margaret/0000-0003-2612-4696	Wellcome Trust [077185/Z/05/Z]; BBSRC (UK) [BBS/B/16178]; Wales Institute of Cognitive Neuroscience (WICN); Biotechnology and Biological Sciences Research Council [BBS/B/16178] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wales Institute of Cognitive Neuroscience (WICN); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MCJ and DEJL were supported by a Wellcome Trust grant to DEJL (grant number 077185/Z/05/Z). Aspects of this research were also supported by BBSRC (UK) grant BBS/B/16178 to JER and the Wales Institute of Cognitive Neuroscience (WICN).	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Borod JC, 1998, NEUROPSYCHOLOGY, V12, P446, DOI 10.1037/0894-4105.12.3.446; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Brosch T, 2008, PSYCHOL SCI, V19, P362, DOI 10.1111/j.1467-9280.2008.02094.x; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Davidson R.J., 1984, EMOTIONS COGNITION B, P320; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; Druzgal TJ, 2003, J COGNITIVE NEUROSCI, V15, P771, DOI 10.1162/089892903322370708; Eastwood JD, 2003, PERCEPT PSYCHOPHYS, V65, P352, DOI 10.3758/BF03194566; Ekman P., 1976, PICTURES FACIAL AFFE; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Ganel T, 2005, NEUROPSYCHOLOGIA, V43, P1645, DOI 10.1016/j.neuropsychologia.2005.01.012; Gray JR, 2002, P NATL ACAD SCI USA, V99, P4115, DOI 10.1073/pnas.062381899; Grosbras MH, 2006, CEREB CORTEX, V16, P1087; Habel U, 2005, NEUROIMAGE, V26, P206, DOI 10.1016/j.neuroimage.2005.01.014; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Heimer G, 2006, J NEURAL TRANSM-SUPP, P17; Jackson MC, 2008, J EXP PSYCHOL HUMAN, V34, P556, DOI 10.1037/0096-1523.34.3.556; JACKSON MC, J EXP PSYCH IN PRESS; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Juth P, 2005, EMOTION, V5, P379, DOI 10.1037/1528-3542.5.4.379; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Karachi C, 2005, MOVEMENT DISORD, V20, P172, DOI 10.1002/mds.20302; Kensinger EA, 2007, CURR DIR PSYCHOL SCI, V16, P213, DOI 10.1111/j.1467-8721.2007.00506.x; Kensinger EA, 2003, EMOTION, V3, P378, DOI 10.1037/1528-3542.3.4.378; Kesler ML, 2001, COGNITIVE BRAIN RES, V11, P213, DOI 10.1016/S0926-6410(00)00073-2; Labar KS, 2007, CURR DIR PSYCHOL SCI, V16, P173, DOI 10.1111/j.1467-8721.2007.00498.x; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lawrence AD, 2002, NEUROREPORT, V13, P881, DOI 10.1097/00001756-200205070-00029; Lawrence AD, 2007, NEUROPSYCHOLOGIA, V45, P65, DOI 10.1016/j.neuropsychologia.2006.04.016; Lewis S, 2003, NEUROREPORT, V14, P1841, DOI 10.1097/00001756-200310060-00017; Linden DEJ, 2007, NEUROSCIENTIST, V13, P257, DOI 10.1177/1073858406298480; Linden DEJ, 2003, NEUROIMAGE, V20, P1518, DOI 10.1016/j.neuroimage.2003.07.021; Lund TE, 2005, NEUROIMAGE, V26, P960, DOI 10.1016/j.neuroimage.2005.02.021; Mayer JS, 2007, NEUROIMAGE, V36, P441, DOI 10.1016/j.neuroimage.2007.03.007; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Mikels JA, 2005, PSYCHOL AGING, V20, P542, DOI 10.1037/0882-7974.20.4.542; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Perlstein WM, 2002, P NATL ACAD SCI USA, V99, P1736, DOI 10.1073/pnas.241650598; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Schneider W., 2002, E PRIME USERS GUIDE; Schroeder U, 2004, J NEUROL NEUROSUR PS, V75, P648, DOI 10.1136/jnnp.2003.019794; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Stip E, 2005, CAN J PSYCHIAT, V50, P909, DOI 10.1177/070674370505001405; Talairach J., 1988, COPLANAR STEREOTAXIC; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Utter AA, 2008, NEUROSCI BIOBEHAV R, V32, P333, DOI 10.1016/j.neubiorev.2006.11.003; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Wright P, 2006, NEUROIMAGE, V29, P628, DOI 10.1016/j.neuroimage.2005.07.047	57	60	60	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3536	10.1371/journal.pone.0003536	http://dx.doi.org/10.1371/journal.pone.0003536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958158	Green Published, gold, Green Accepted			2022-12-27	WOS:000265131100007
J	Blake, S; Deem, SL; Strindberg, S; Maisels, F; Momont, L; Isia, IB; Douglas-Hamilton, I; Karesh, WB; Kock, MD				Blake, Stephen; Deem, Sharon L.; Strindberg, Samantha; Maisels, Fiona; Momont, Ludovic; Isia, Inogwabini-Bila; Douglas-Hamilton, Iain; Karesh, William B.; Kock, Michael D.			Roadless Wilderness Area Determines Forest Elephant Movements in the Congo Basin	PLOS ONE			English	Article							PROTECTED AREAS; AFRICAN ELEPHANTS; CONSERVATION; ROADS; EXTINCTION	A dramatic expansion of road building is underway in the Congo Basin fuelled by private enterprise, international aid, and government aspirations. Among the great wilderness areas on earth, the Congo Basin is outstanding for its high biodiversity, particularly mobile megafauna including forest elephants (Loxodonta africana cyclotis). The abundance of many mammal species in the Basin increases with distance from roads due to hunting pressure, but the impacts of road proliferation on the movements of individuals are unknown. We investigated the ranging behaviour of forest elephants in relation to roads and roadless wilderness by fitting GPS telemetry collars onto a sample of 28 forest elephants living in six priority conservation areas. We show that the size of roadless wilderness is a strong determinant of home range size in this species. Though our study sites included the largest wilderness areas in central African forests, none of 4 home range metrics we calculated, including core area, tended toward an asymptote with increasing wilderness size, suggesting that uninhibited ranging in forest elephants no longer exists. Furthermore we show that roads outside protected areas which are not protected from hunting are a formidable barrier to movement while roads inside protected areas are not. Only 1 elephant from our sample crossed an unprotected road. During crossings her mean speed increased 14-fold compared to normal movements. Forest elephants are increasingly confined and constrained by roads across the Congo Basin which is reducing effective habitat availability and isolating populations, significantly threatening long term conservation efforts. If the current road development trajectory continues, forest wildernesses and the forest elephants they contain will collapse.	[Blake, Stephen; Strindberg, Samantha; Maisels, Fiona; Karesh, William B.; Kock, Michael D.] Wildlife Conservat Soc, Bronx, NY USA; [Blake, Stephen; Deem, Sharon L.] Univ Missouri, Whitney R Harris World Ecol Ctr, Dept Biol, St Louis, MO USA; [Blake, Stephen] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Deem, Sharon L.] St Louis Zoo, WildCare Inst, St Louis, MO USA; [Momont, Ludovic] Museum Natl Hist Nat, Menagerie Jardin Plantes, Lab Conservat Especes, Museum CNRS, Paris, France; [Isia, Inogwabini-Bila] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NZ, Kent, England; [Douglas-Hamilton, Iain] Langata Link Complex, Save the Elephants, Nairobi, Kenya; [Douglas-Hamilton, Iain] Univ Oxford, Dept Zool, Oxford OX1 2JD, England	Wildlife Conservation Society; University of Missouri System; University of Missouri Saint Louis; Max Planck Society; Museum National d'Histoire Naturelle (MNHN); University of Kent; University of Oxford	Blake, S (corresponding author), Wildlife Conservat Soc, Bronx, NY USA.	sblakewcs@gmail.com	Maisels, Fiona/E-7382-2015; Karesh, William/AAU-9084-2020	Maisels, Fiona/0000-0002-0778-0615; Karesh, William/0000-0001-6042-2860; Inogwabini, Bila-Isia/0000-0002-6897-2477	African Elephant Conservation Fund of the United States Fish and Wildlife Service (USFWS); United States Agency for International Development (US-AID CARPE); Save the Elephants; The Especes Phares Project; Central African Protected Areas Network of the European Union; Wildlife conservation Society; WWF-US; Columbus Zoo; Society for Conservation and Development	African Elephant Conservation Fund of the United States Fish and Wildlife Service (USFWS)(US Fish & Wildlife Service); United States Agency for International Development (US-AID CARPE)(United States Agency for International Development (USAID)); Save the Elephants; The Especes Phares Project; Central African Protected Areas Network of the European Union; Wildlife conservation Society; WWF-US; Columbus Zoo; Society for Conservation and Development	This research was funded by the African Elephant Conservation Fund of the United States Fish and Wildlife Service (USFWS), the United States Agency for International Development (US-AID CARPE), Save the Elephants, The Especes Phares Project and the Central African Protected Areas Network of the European Union, Wildlife conservation Society, WWF-US, Columbus Zoo and the Society for Conservation and Development. Richard Ruggiero of USFWS strongly supported this project.	ARMBRUSTER P, 1993, CONSERV BIOL, V7, P602, DOI 10.1046/j.1523-1739.1993.07030602.x; BARNES RFW, 1991, AFR J ECOL, V29, P54, DOI 10.1111/j.1365-2028.1991.tb00820.x; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Blake S, 2001, AFR J ECOL, V39, P178, DOI 10.1046/j.1365-2028.2001.00296.x; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Blom A, 2004, BIODIVERS CONSERV, V13, P2661, DOI 10.1007/s10531-004-2138-1; Chapman CA, 1998, AM J PRIMATOL, V45, P127; Chomitz KM, 2007, AT LOGGERHEADS: AGRICULTURAL EXPANSION, POVERTY REDUCTION, AND ENVIRONMENT IN THE TROPICAL FORESTS, P1, DOI 10.1596/978-0-8213-6735-3; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Hoare RE, 1999, J APPL ECOL, V36, P689, DOI 10.1046/j.1365-2664.1999.00437.x; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; Kamdem-Toham A, 2003, SCIENCE, V299, P346, DOI 10.1126/science.299.5605.346; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Laurance WF, 2006, CONSERV BIOL, V20, P1251, DOI 10.1111/j.1523-1739.2006.00420.x; Powell RA, 2000, METH C CONS, P65; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Spinage C.A., 1994, ELEPHANTS; Strittholt JR, 2001, CONSERV BIOL, V15, P1742, DOI 10.1046/j.1523-1739.2001.99577.x; Team RDC, 2019, R LANG ENV STAT COMP; van Aarde RJ, 2007, BIOL CONSERV, V134, P289, DOI 10.1016/j.biocon.2006.08.027; White L.J.T., 2001, AFRICAN RAIN FOREST; Whyte Ian J., 2003, P332; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; Wittemyer G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1919, DOI 10.1007/s00265-007-0432-0; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	37	131	133	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3546	10.1371/journal.pone.0003546	http://dx.doi.org/10.1371/journal.pone.0003546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958284	Green Submitted, gold, Green Published			2022-12-27	WOS:000265130900008
J	Pontes, MH; Babst, M; Lochhead, R; Oakeson, K; Smith, K; Dale, C				Pontes, Mauricio H.; Babst, Markus; Lochhead, Robert; Oakeson, Kelly; Smith, Kari; Dale, Colin			Quorum Sensing Primes the Oxidative Stress Response in the Insect Endosymbiont, Sodalis glossinidius	PLOS ONE			English	Article							CARBAPENEM ANTIBIOTIC PRODUCTION; LACTONE SIGNAL MOLECULES; III SECRETION SYSTEMS; HEAT-SHOCK PROTEINS; VIBRIO-FISCHERI; SINORHIZOBIUM-MELILOTI; ERWINIA-CAROTOVORA; IRON; BIOSYNTHESIS; GENES	Background: Sodalis glossinidius, a maternally transmitted bacterial endosymbiont of tsetse flies (Glossina spp.), uses an acylated homoserine lactone (AHL)-based quorum sensing system to modulate gene expression in accordance with bacterial cell density. The S. glossinidius quorum sensing system relies on the function of two regulatory proteins; SogI (a LuxI homolog) synthesizes a signaling molecule, characterized as N-(3-oxohexanoyl) homoserine lactone (OHHL), and SogR1 (a LuxR homolog) interacts with OHHL to modulate transcription of specific target genes. Methodology/Principal Findings: We used a tiling microarray to analyze the S. glossinidius transcriptome in the presence and absence of exogenous OHHL. The major finding is that OHHL increases transcription of a large number of genes that are known to be involved in the oxidative stress response. We also show that the obligate symbiont of the rice weevil, Sitophilus oryzae (SOPE), maintains copies of the quorum sensing regulatory genes that are found in S. glossinidius. Molecular evolutionary analyses indicate that these sequences are evolving under stabilizing selection, consistent with the maintenance of their functions in the SOPE symbiosis. Finally, the expression studies in S. glossinidius also reveal that quorum sensing regulates the expression of a cryptic, degenerate gene (carA) that arose from an ancient deletion in the last common ancestor of S. glossinidius and SOPE. Conclusions/Significance: This oxidative stress response is likely mandated under conditions of dense intracellular symbiont infection, when intense metabolic activity is expected to generate a heavy oxidative burden. Such conditions are known to arise in the bacteriocytes of grain weevils, which harbor dense intracellular infections of symbiotic bacteria that are closely related to S. glossinidius. The presence of a degenerate carA sequence in S. glossinidius and SOPE indicates the potential for neofunctionalization to occur during the process of genome degeneration.	[Pontes, Mauricio H.; Babst, Markus; Lochhead, Robert; Oakeson, Kelly; Smith, Kari; Dale, Colin] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Pontes, MH (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	pontes.biology@utah.edu	Lochhead, Robert/AAT-9942-2020; Pontes, Mauricio H./AAV-1024-2020	Pontes, Mauricio H./0000-0002-2618-2039; Lochhead, Robert/0000-0001-7726-0466; Oakeson, Kelly/0000-0001-9070-4850	National Science Foundation [EF-0523818]	National Science Foundation(National Science Foundation (NSF))	Research in our laboratory is supported by a National Science Foundation award EF-0523818 to CD.	Aksoy S, 1997, INSECT MOL BIOL, V6, P183, DOI 10.1111/j.1365-2583.1997.tb00086.x; Andersson RA, 2000, MOL PLANT MICROBE IN, V13, P384, DOI 10.1094/MPMI.2000.13.4.384; Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; BAINTON NJ, 1992, BIOCHEM J, V288, P997, DOI 10.1042/bj2880997; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Broughton WJ, 2006, J BACTERIOL, V188, P3654, DOI 10.1128/JB.188.10.3654-3663.2006; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Campbell GRO, 2002, P NATL ACAD SCI USA, V99, P3938, DOI 10.1073/pnas.062425699; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Chen CY, 1999, MICROBIOL-SGM, V145, P2967, DOI 10.1099/00221287-145-10-2967; CRAWFORD DR, 1994, ENVIRON HEALTH PERSP, V102, P25, DOI 10.2307/3432208; Dale C, 2005, MOL BIOL EVOL, V22, P758, DOI 10.1093/molbev/msi061; Dale C, 1999, INT J SYST BACTERIOL, V49, P267, DOI 10.1016/S0020-7519(01)00151-5; Dale C, 2002, P NATL ACAD SCI USA, V99, P12397, DOI 10.1073/pnas.182213299; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Darby AC, 2005, J BACTERIOL, V187, P5003, DOI 10.1128/JB.187.14.5003-5007.2005; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies BW, 2007, J BACTERIOL, V189, P2101, DOI 10.1128/JB.01377-06; DAZZO FB, 1991, J BACTERIOL, V173, P5371, DOI 10.1128/jb.173.17.5371-5384.1991; DeLoney-Marino CR, 2003, APPL ENVIRON MICROB, V69, P7527, DOI 10.1128/AEM.69.12.7527-7530.2003; Derzelle S, 2002, APPL ENVIRON MICROB, V68, P3780, DOI 10.1128/AEm.68.8.3780-3789.2002; Egland KA, 1999, MOL MICROBIOL, V31, P1197, DOI 10.1046/j.1365-2958.1999.01261.x; Fraysse N, 2002, GLYCOBIOLOGY, V12, P741, DOI 10.1093/glycob/cwf078; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Heddi A, 1998, J MOL EVOL, V47, P52, DOI 10.1007/PL00006362; Heddi A, 2005, CELL MICROBIOL, V7, P293, DOI 10.1111/j.1462-5822.2004.00461.x; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Hossain M, 2003, CURR MICROBIOL, V46, P70, DOI 10.1007/s00284-002-3831-5; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kanai T, 2006, J BIOCHEM, V140, P703, DOI 10.1093/jb/mvj199; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; Kaufmann GF, 2005, P NATL ACAD SCI USA, V102, P309, DOI 10.1073/pnas.0408639102; Kitagawa M, 2002, EUR J BIOCHEM, V269, P2907, DOI 10.1046/j.1432-1033.2002.02958.x; Kitphati W, 2007, APPL ENVIRON MICROB, V73, P4760, DOI 10.1128/AEM.00531-07; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Lewenza S, 2001, J BACTERIOL, V183, P2212, DOI 10.1128/JB.183.7.2212-2218.2001; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; Matuszewska E, 2008, MICROBIOL-SGM, V154, P1739, DOI 10.1099/mic.0.2007/014696-0; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; McFall-Ngai M, 1998, NEW DEVELOPMENTS IN MARINE BIOTECHNOLOGY, P273; MCGOWAN S, 1995, MICROBIOL-SGM, V141, P541, DOI 10.1099/13500872-141-3-541; McGowan SJ, 1996, MOL MICROBIOL, V22, P415, DOI 10.1046/j.1365-2958.1996.00125.x; McGowan SJ, 1997, MOL MICROBIOL, V26, P545, DOI 10.1046/j.1365-2958.1997.6001974.x; Miller JH., 1992, SHORT COURSE BACTERI, P72; Mira A, 2002, MICROBIAL ECOL, V44, P137, DOI 10.1007/s00248-002-0012-9; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Morin D, 2003, J CHROMATOGR A, V1002, P79, DOI 10.1016/S0021-9673(03)00730-1; Niehaus K, 1998, MOL PLANT MICROBE IN, V11, P906, DOI 10.1094/MPMI.1998.11.9.906; Nyholm SV, 2002, APPL ENVIRON MICROB, V68, P5113, DOI 10.1128/AEM.68.10.5113-5122.2002; PAYNE SM, 1994, METHOD ENZYMOL, V235, P329; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Pontes MH, 2006, TRENDS MICROBIOL, V14, P406, DOI 10.1016/j.tim.2006.07.004; QUANDT J, 1992, MOL PLANT MICROBE IN, V5, P420, DOI 10.1094/MPMI-5-420; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; ROLFE B, 1968, J BACTERIOL, V96, P515, DOI 10.1128/JB.96.2.515-524.1968; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Skorupska A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-7; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Takemoto T, 1998, FREE RADICAL BIO MED, V24, P556, DOI 10.1016/S0891-5849(97)00287-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomson NR, 2000, MOL MICROBIOL, V36, P539, DOI 10.1046/j.1365-2958.2000.01872.x; Tindale AE, 2000, MICROBIOL-SGM, V146, P1617, DOI 10.1099/00221287-146-7-1617; Toh H, 2006, GENOME RES, V16, P149, DOI 10.1101/gr.4106106; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Tsuchida T, 2005, MICROB ECOL, V49, P126, DOI 10.1007/s00248-004-0216-2; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Wernegreen JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/nrg931; WINSON MK, 1995, P NATL ACAD SCI USA, V92, P9427, DOI 10.1073/pnas.92.20.9427; Yip ES, 2006, MOL MICROBIOL, V62, P1586, DOI 10.1111/j.1365-2958.2006.05475.x; Zhu J, 2003, APPL ENVIRON MICROB, V69, P6949, DOI 10.1128/AEM.69.11.6949-6953.2003; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	80	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3541	10.1371/journal.pone.0003541	http://dx.doi.org/10.1371/journal.pone.0003541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958153	gold, Green Submitted, Green Published			2022-12-27	WOS:000265130900004
J	Dardente, H; Mendoza, J; Fustin, JM; Challet, E; Hazlerigg, DG				Dardente, Hugues; Mendoza, Jorge; Fustin, Jean-Michel; Challet, Etienne; Hazlerigg, David G.			Implication of the F-Box Protein FBXL21 in Circadian Pacemaker Function in Mammals	PLOS ONE			English	Article							REV-ERB; CLOCK; ALPHA; TRANSCRIPTION; IDENTIFICATION; EXPRESSION; REVEALS; CRYPTOCHROME; COMPONENT; TICKING	In mammals, the circadian clock relies on interlocked feedback loops involving clock genes and their protein products. Posttranslational modifications control intracellular trafficking, functionality and degradation of clock proteins and are keys to the functioning of the clock as recently exemplified for the F-Box protein Fbxl3. The SCFFbxl3 complex directs degradation of CRY1/2 proteins and Fbxl3 murine mutants have a slower clock. To assess whether the role of Fbxl3 is phylogenetically conserved, we investigated its function in the sheep, a diurnal ungulate. Our data show that Fbxl3 function is conserved and further reveal that its closest homologue, the F-Box protein Fbxl21, also binds to CRY1 which impairs its repressive action towards the transcriptional activators CLOCK/BMAL1. However, while Fbxl3 appears to be ubiquitously expressed, Fbxl21 expression is tissue-specific. Furthermore, and in sharp contrast with Fbxl3, Fbxl21 is highly expressed within the suprachiasmatic nuclei, site of the master clock, where it displays marked circadian oscillations apparently driven by members of the PAR-bZIP family. Finally, for both Fbxl3 and Fbxl21 we identified and functionally characterized novel splice-variants, which might reduce CRY1 proteasomal degradation dependent on cell context. Altogether, these data establish Fbxl21 as a novel circadian clock-controlled gene that plays a specific role within the mammalian circadian pacemaker.	[Dardente, Hugues; Fustin, Jean-Michel; Hazlerigg, David G.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Mendoza, Jorge; Challet, Etienne] Inst Neurosci Cellulaires Integratives, Dept Neurobiol Rythmes, UMR7168, Strasbourg, France	University of Aberdeen	Dardente, H (corresponding author), Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland.	h.dardente@abdn.ac.uk	Fustin, Jean-Michel/R-6621-2019; DARDENTE, Hugues/ABI-5590-2020; Challet, Etienne/ABF-7553-2020	Fustin, Jean-Michel/0000-0002-6200-6075; DARDENTE, Hugues/0000-0001-7209-5940; Challet, Etienne/0000-0001-9416-9496	UK Biotechnology and Biological Sciences Research Council; Agence Nationale pour la Recherche; Centre National de la Recherche Scientifique	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	HD and DGH are supported by the UK Biotechnology and Biological Sciences Research Council for continuing support. JM and EC are supported by grants from the Agence Nationale pour la Recherche Jeunes Chercheurs/Jeunes Chercheuses and Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Dardente H, 2007, CHRONOBIOL INT, V24, P195, DOI 10.1080/07420520701283693; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Delerive P, 2002, J BIOL CHEM, V277, P35013, DOI 10.1074/jbc.M202979200; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Fonjallaz P, 1996, EMBO J, V15, P351, DOI 10.1002/j.1460-2075.1996.tb00365.x; Forrest ARR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r5; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raspe E, 2002, J BIOL CHEM, V277, P49275, DOI 10.1074/jbc.M206215200; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schoenhard JA, 2002, AM J PHYSIOL-CELL PH, V283, pC103, DOI 10.1152/ajpcell.00541.2001; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000	39	38	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3530	10.1371/journal.pone.0003530	http://dx.doi.org/10.1371/journal.pone.0003530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953409	Green Published, gold, Green Submitted			2022-12-27	WOS:000265130500008
J	Kedinger, V; Alpy, F; Baguet, A; Polette, M; Stoll, I; Chenard, MP; Tomasetto, C; Rio, MC				Kedinger, Valerie; Alpy, Fabien; Baguet, Aurelie; Polette, Myriam; Stoll, Isabelle; Chenard, Marie-Pierre; Tomasetto, Catherine; Rio, Marie-Christine			Tumor Necrosis Factor Receptor-Associated Factor 4 Is a Dynamic Tight Junction-Related Shuttle Protein Involved in Epithelium Homeostasis	PLOS ONE			English	Article								Background: Despite numerous in vivo evidences that Tumor Necrosis Factor Receptor-Associated Factor 4 (TRAF4) plays a key biological function, how it works at the cellular and molecular level remains elusive. Methodology/Principal Findings: In the present study, we show using immunofluorescence and immuohistochemistry that TRAF4 is a novel player at the tight junctions (TJs). TRAF4 is connected to assembled TJs in confluent epithelial cells, but accumulates in the cytoplasm and/or nucleus when TJs are open in isolated cells or EGTA-treated confluent cells. In vivo, TRAF4 is consistently found at TJs in normal human mammary epithelia as well as in well-differentiated in situ carcinomas. In contrast, TRAF4 is never localized at the plasma membrane of poorly-differentiated invasive carcinomas devoid of correct TJs, but is observed in the cytoplasm and/or nucleus of the cancer cells. Moreover, TRAF4 TJ subcellular localization is remarkably dynamic. Fluorescence recovery after photobleaching (FRAP) experiments show that TRAF4 is highly mobile and shuttles between TJs and the cytoplasm. Finally, we show that intracellular TRAF4 potentiates ERK1/2 phosphorylation in proliferating HeLa cells, an epithelial cell line known to be devoid of TJs. Conclusions/Significance: Collectively, our data strongly support the new concept of TJs as a dynamic structure. Moreover, our results implicate TRAF4 in one of the emerging TJ-dependent signaling pathways that responds to cell polarity by regulating the cell proliferation/differentiation balance, and subsequently epithelium homeostasis. Drastic phenotypes or lethality in TRAF4-deficient mice and drosophila strongly argue in favor of such a function.	[Kedinger, Valerie; Alpy, Fabien; Baguet, Aurelie; Stoll, Isabelle; Tomasetto, Catherine; Rio, Marie-Christine] Univ Strasbourg 1, INSERM, IGBMC, Dept Canc Biol,CNRS,UMR 7104,U596, Illkirch Graffenstaden, France; [Polette, Myriam] Hop Maison Blanche CHU, Lab Pol Bouin, UMR S 514, INSERM, Reims, France; [Chenard, Marie-Pierre] Univ Hautepierre, Ctr Hosp, Serv Anat Pathol Gen, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Strasbourg	Kedinger, V (corresponding author), Univ Strasbourg 1, INSERM, IGBMC, Dept Canc Biol,CNRS,UMR 7104,U596, Illkirch Graffenstaden, France.	rio@igbmc.u-strasbg.fr	Tomasetto, Catherine Laure/J-2783-2014; Chenard, Marie-Pierre/O-2373-2016; POLETTE, Myriam/P-5147-2016; Alpy, Fabien/ABD-5893-2020; Alpy, Fabien/H-8941-2016	Tomasetto, Catherine Laure/0000-0002-1811-5848; Alpy, Fabien/0000-0002-0526-0720; Alpy, Fabien/0000-0002-0526-0720; Baguet, Aurelie/0000-0001-7792-3282; POLETTE, Myriam/0000-0001-8173-3246	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Ha'pital Universitaire de Strasbourg; Association pour la Recherche sur le Cancer; Ligue Nationale Francaise contre le Cancer; Comites du Haut-Rhin et du Bas-Rhin; Institut National du Cancer; Fond National pour la Sante ACI; Ruban Rose prize; Fondation pour la Recherche Medicale fellowship	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ha'pital Universitaire de Strasbourg; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Francaise contre le Cancer(Ligue nationale contre le cancer); Comites du Haut-Rhin et du Bas-Rhin; Institut National du Cancer(Institut National du Cancer (INCA) France); Fond National pour la Sante ACI; Ruban Rose prize; Fondation pour la Recherche Medicale fellowship(Fondation pour la Recherche Medicale)	This work was supported by funds from the Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, the Hapital Universitaire de Strasbourg, the Association pour la Recherche sur le Cancer, and the Ligue Nationale Francaise contre le Cancer and the Comites du Haut-Rhin et du Bas-Rhin, the Institut National du Cancer, Fond National pour la Sante ACI 2004 2007 (CanceropAle Grand-Est), and the Ruban Rose prize. V. K. was a recipient of a Fondation pour la Recherche Medicale fellowship.	Aijaz S, 2006, INT REV CYTOL, V248, P261, DOI 10.1016/S0074-7696(06)48005-0; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Baguet A, 2007, J CELL SCI, V120, P2774, DOI 10.1242/jcs.009225; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Bieche I, 1996, CANCER RES, V56, P3886; Bracke ME, 1996, CURR TOP MICROBIOL, V213, P123; Camilleri-Broet S, 2007, ONCOGENE, V26, P142, DOI 10.1038/sj.onc.1209762; CAVALOC Y, 1994, EMBO J, V13, P2639, DOI 10.1002/j.1460-2075.1994.tb06554.x; Cha GH, 2003, MOL CELL BIOL, V23, P7982, DOI 10.1128/MCB.23.22.7982-7991.2003; Chung JY, 2002, J CELL SCI, V115, P679; Cohen D, 2003, METHODS, V30, P269, DOI 10.1016/S1046-2023(03)00033-1; Fleming TP, 2000, SEMIN CELL DEV BIOL, V11, P291, DOI 10.1006/scdb.2000.0179; Gilles C, 2003, CANCER RES, V63, P2658; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Harder JL, 2008, CELL, V133, DOI 10.1016/j.cell.2008.06.002; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Kedinger V, 2007, ADV EXP MED BIOL, V597, P60; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Lele T, 2006, J CELL BIOCHEM, V99, P1334, DOI 10.1002/jcb.20997; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; Regnier CH, 2002, P NATL ACAD SCI USA, V99, P5585, DOI 10.1073/pnas.052124799; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rothen-Rutishauser B, 2002, J MEMBRANE BIOL, V188, P151, DOI 10.1007/s00232-001-0182-2; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Spiryda LB, 1998, J NEUROSCI RES, V54, P282, DOI 10.1002/(SICI)1097-4547(19981015)54:2<282::AID-JNR16>3.3.CO;2-2; Takai E, 2005, INT J ONCOL, V27, P645; Traweger A, 2003, J BIOL CHEM, V278, P2692, DOI 10.1074/jbc.M206821200; Wang ZL, 2005, ONCOGENE, V24, P4412, DOI 10.1038/sj.onc.1208634	37	23	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3518	10.1371/journal.pone.0003518	http://dx.doi.org/10.1371/journal.pone.0003518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953416	Green Published, gold, Green Submitted			2022-12-27	WOS:000265130500003
J	Wang, C; Yu, J; Kallen, CB				Wang, Cheng; Yu, Jie; Kallen, Caleb B.			Two Estrogen Response Element Sequences Near the PCNA Gene Are Not Responsible for Its Estrogen-Enhanced Expression in MCF7 Cells	PLOS ONE			English	Article								Background: The proliferating cell nuclear antigen (PCNA) is an essential component of DNA replication, cell cycle regulation, and epigenetic inheritance. High expression of PCNA is associated with poor prognosis in patients with breast cancer. The 5'-region of the PCNA gene contains two computationally-detected estrogen response element (ERE) sequences, one of which is evolutionarily conserved. Both of these sequences are of undocumented cis-regulatory function. We recently demonstrated that estradiol (E2) enhances PCNA mRNA expression in MCF7 breast cancer cells. MCF7 cells proliferate in response to E2. Methodology/Principal Findings: Here, we demonstrate that E2 rapidly enhanced PCNA mRNA and protein expression in a process that requires ER alpha as well as de novo protein synthesis. One of the two upstream ERE sequences was specifically bound by ER alpha-containing protein complexes, in vitro, in gel shift analysis. Yet, each ERE sequence, when cloned as a single copy, or when engineered as two tandem copies of the ERE-containing sequence, was not capable of activating a luciferase reporter construct in response to E2. In MCF7 cells, neither ERE-containing genomic region demonstrated E2-dependent recruitment of ER alpha by sensitive ChIP-PCR assays. Conclusion/Significance: We conclude that E2 enhances PCNA gene expression by an indirect process and that computational detection of EREs, even when evolutionarily conserved and when near E2-responsive genes, requires biochemical validation.	[Wang, Cheng; Yu, Jie; Kallen, Caleb B.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA	Emory University	Wang, C (corresponding author), Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA.	caleb.kallen@emory.edu		Kallen, Caleb/0000-0002-4156-6719	Research Scientist Development Program; NIH [5K12HD00849]; Society for Gynecologic Investigation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER	Research Scientist Development Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society for Gynecologic Investigation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	CBK is supported by a grant from the Research Scientist Development Program (NIH-5K12HD00849) and by the Society for Gynecologic Investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTOMAA S, 1993, ANTICANCER RES, V13, P533; ALDER H, 1992, NUCLEIC ACIDS RES, V20, P1769, DOI 10.1093/nar/20.7.1769; ALMENDRAL JM, 1987, P NATL ACAD SCI USA, V84, P1575, DOI 10.1073/pnas.84.6.1575; BASERGA R, 1991, J CELL SCI, V98, P433; Beral V, 2007, LANCET, V369, P1703, DOI 10.1016/S0140-6736(07)60534-0; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bouras T, 2002, CANCER RES, V62, P1289; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Bourdeau V, 2008, NUCLEIC ACIDS RES, V36, P76, DOI 10.1093/nar/gkm945; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; CHANG CD, 1990, MOL CELL BIOL, V10, P3289, DOI 10.1128/MCB.10.7.3289; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; DUBIK D, 1992, ONCOGENE, V7, P1587; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Hong R, 2003, J BIOL CHEM, V278, P44505, DOI 10.1074/jbc.M303138200; Horita K, 2001, EUR J HISTOCHEM, V45, P73; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Huang DY, 1996, J BIOL CHEM, V271, P1218, DOI 10.1074/jbc.271.2.1218; Iida T, 2002, GENES CELLS, V7, P997, DOI 10.1046/j.1365-2443.2002.00584.x; JASKULSKI D, 1988, J BIOL CHEM, V263, P10175; Jin VX, 2004, NUCLEIC ACIDS RES, V32, P6627, DOI 10.1093/nar/gkh1005; Kamalakaran S, 2005, J BIOL CHEM, V280, P21491, DOI 10.1074/jbc.M409176200; Kannabiran C, 1999, ONCOGENE, V18, P7825, DOI 10.1038/sj.onc.1203294; KANNABIRAN C, 1993, J VIROL, V67, P507, DOI 10.1128/JVI.67.1.507-515.1993; Kato T, 2000, BRIT J CANCER, V82, P404, DOI 10.1054/bjoc.1999.0934; Klinge CM, 1997, J BIOL CHEM, V272, P31465, DOI 10.1074/jbc.272.50.31465; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; KONIECKI J, 1991, CANCER RES, V51, P1465; Krieg AJ, 2006, MOL CELL BIOL, V26, P7030, DOI 10.1128/MCB.00322-06; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; LABRIE C, 1993, MOL CELL BIOL, V13, P1697, DOI 10.1128/MCB.13.3.1697; LABRIE C, 1995, NUCLEIC ACIDS RES, V23, P3732, DOI 10.1093/nar/23.18.3732; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lee BH, 1997, P NATL ACAD SCI USA, V94, P4481, DOI 10.1073/pnas.94.9.4481; Lee BH, 1998, J VIROL, V72, P1138, DOI 10.1128/JVI.72.2.1138-1145.1998; Li YY, 2003, FEBS LETT, V544, P112, DOI 10.1016/S0014-5793(03)00485-X; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Liu MS, 1999, J BIOL CHEM, V274, P15433, DOI 10.1074/jbc.274.22.15433; Loven MA, 2001, MOL CELL ENDOCRINOL, V181, P151, DOI 10.1016/S0303-7207(01)00491-9; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Marks JR, 1997, ONCOGENE, V14, P115, DOI 10.1038/sj.onc.1200808; Martin PJ, 2005, NUCLEIC ACIDS RES, V33, P4311, DOI 10.1093/nar/gki745; MARTINEZ E, 1989, EMBO J, V8, P3781, DOI 10.1002/j.1460-2075.1989.tb08555.x; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Morris GF, 1996, P NATL ACAD SCI USA, V93, P895, DOI 10.1073/pnas.93.2.895; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Nair HB, 2005, CANCER RES, V65, P11164, DOI 10.1158/0008-5472.CAN-05-1087; Nardulli AM, 1996, MOL ENDOCRINOL, V10, P694, DOI 10.1210/me.10.6.694; NARITA T, 1993, JPN J CLIN ONCOL, V23, P20; NORRIS J, 1995, J BIOL CHEM, V270, P22777, DOI 10.1074/jbc.270.39.22777; Nunez E, 2008, CELL, V132, P996, DOI 10.1016/j.cell.2008.01.051; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Safe S, 2004, PROG NUCLEIC ACID RE, V77, P1, DOI 10.1016/S0079-6603(04)77001-4; Sanchez R, 2002, BIOESSAYS, V24, P244, DOI 10.1002/bies.10066; SCHIMMELPENNING H, 1993, VIRCHOWS ARCH A, V423, P273, DOI 10.1007/BF01606890; SCHONBORN I, 1995, J CANCER RES CLIN, V121, P115, DOI 10.1007/BF01202223; Schultz-Norton JR, 2007, NUCLEIC ACIDS RES, V35, P5028, DOI 10.1093/nar/gkm533; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; SheenChen SM, 1997, ARCH SURG-CHICAGO, V132, P264; Shimomura Y, 1998, J CLIN ENDOCR METAB, V83, P2192, DOI 10.1210/jc.83.6.2192; SHIPMANAPPASAMY P, 1990, J BIOL CHEM, V265, P19180; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Stender JD, 2007, MOL ENDOCRINOL, V21, P2112, DOI 10.1210/me.2006-0474; Tang SS, 2004, NUCLEIC ACIDS RES, V32, P6212, DOI 10.1093/nar/gkh943; Tommasi S, 1999, J BIOL CHEM, V274, P27829, DOI 10.1074/jbc.274.39.27829; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672; WEISZ A, 1990, NUCLEIC ACIDS RES, V18, P5097, DOI 10.1093/nar/18.17.5097; WEISZ A, 1988, MOL ENDOCRINOL, V2, P816, DOI 10.1210/mend-2-9-816; Wood JR, 1998, MOL CELL BIOL, V18, P1927, DOI 10.1128/MCB.18.4.1927; Wood JR, 2001, MOL ENDOCRINOL, V15, P1114, DOI 10.1210/me.15.7.1114; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776	87	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3523	10.1371/journal.pone.0003523	http://dx.doi.org/10.1371/journal.pone.0003523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949048	Green Published, gold, Green Submitted			2022-12-27	WOS:000265126400008
J	Lower, M; Weydig, C; Metzler, D; Reuter, A; Starzinski-Powitz, A; Wessler, S; Schneider, G				Loewer, Martin; Weydig, Christiane; Metzler, Dirk; Reuter, Andreas; Starzinski-Powitz, Anna; Wessler, Silja; Schneider, Gisbert			Prediction of Extracellular Proteases of the Human Pathogen Helicobacter pylori Reveals Proteolytic Activity of the Hp1018/19 Protein HtrA	PLOS ONE			English	Article								Exported proteases of Helicobacter pylori (H. pylori) are potentially involved in pathogen-associated disorders leading to gastric inflammation and neoplasia. By comprehensive sequence screening of the H. pylori proteome for predicted secreted proteases, we retrieved several candidate genes. We detected caseinolytic activities of several such proteases, which are released independently from the H. pylori type IV secretion system encoded by the cag pathogenicity island (cagPAI). Among these, we found the predicted serine protease HtrA (Hp1019), which was previously identified in the bacterial secretome of H. pylori. Importantly, we further found that the H. pylori genes hp1018 and hp1019 represent a single gene likely coding for an exported protein. Here, we directly verified proteolytic activity of HtrA in vitro and identified the HtrA protease in zymograms by mass spectrometry. Overexpressed and purified HtrA exhibited pronounced proteolytic activity, which is inactivated after mutation of Ser205 to alanine in the predicted active center of HtrA. These data demonstrate that H. pylori secretes HtrA as an active protease, which might represent a novel candidate target for therapeutic intervention strategies.	[Loewer, Martin; Starzinski-Powitz, Anna; Schneider, Gisbert] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, CMP, Frankfurt, Germany; [Weydig, Christiane; Wessler, Silja] Paul Ehrlich Inst, Junior Res Grp, Langen, Germany; [Metzler, Dirk] Goethe Univ, Inst Comp Sci, Frankfurt, Germany; [Reuter, Andreas] Paul Ehrlich Inst, Dept Allergol, Langen, Germany	Goethe University Frankfurt; Paul Ehrlich Institute; Goethe University Frankfurt; Paul Ehrlich Institute	Lower, M (corresponding author), Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, CMP, Frankfurt, Germany.	gisbert.schneider@modlab.de	Wessler, Silja/C-6309-2015; Metzler, Dirk/K-2797-2014	Wessler, Silja/0000-0001-7011-6162; Metzler, Dirk/0000-0003-1027-135X; Schneider, Gisbert/0000-0001-6706-1084; Reuter, Andreas/0000-0002-6082-9000	Beilstein-Institut zur Forderung der Chemischen Wissenschaften Frankfurt am Main (Germany); Centre for Membrane Proteomics (CMP) Frankfurt am Main (Germany); Jurgen-Manchot Stiftung; Paul-Ehrlich Institut Langen (Germany); Deutsche Forschungsgemeinschaft [SFB-579]	Beilstein-Institut zur Forderung der Chemischen Wissenschaften Frankfurt am Main (Germany); Centre for Membrane Proteomics (CMP) Frankfurt am Main (Germany); Jurgen-Manchot Stiftung; Paul-Ehrlich Institut Langen (Germany); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by the Beilstein-Institut zur Forderung der Chemischen Wissenschaften Frankfurt am Main (Germany), the Centre for Membrane Proteomics (CMP) Frankfurt am Main (Germany), the Jurgen-Manchot Stiftung, the Paul-Ehrlich Institut Langen (Germany), and the Deutsche Forschungsgemeinschaft (SFB-579, project A11).	ABDULLAH KM, 1991, J BACTERIOL, V173, P5597, DOI 10.1128/jb.173.18.5597-5603.1991; ALBRECHT M, 2008, MOL NUTR FO IN PRESS; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Backert S, 2008, TRENDS BIOCHEM SCI, V33, P80, DOI 10.1016/j.tibs.2007.10.006; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Bumann D, 2002, INFECT IMMUN, V70, P3396, DOI 10.1128/IAI.70.7.3396-3403.2002; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gooz M, 2001, AM J PHYSIOL-GASTR L, V281, pG823, DOI 10.1152/ajpgi.2001.281.3.G823; Hatakeyama M, 2006, INT J CANCER, V119, P1217, DOI 10.1002/ijc.21831; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; HILLENKAMP F, 1990, METHOD ENZYMOL, V193, P280, DOI 10.1016/0076-6879(90)93420-P; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Min DQ, 2002, J IMMUNOL, V168, P2449, DOI 10.4049/jimmunol.168.5.2449; Oggioni MR, 2003, MOL MICROBIOL, V49, P795, DOI 10.1046/j.1365-2958.2003.03596.x; Okamoto T, 1997, J BIOL CHEM, V272, P6059, DOI 10.1074/jbc.272.9.6059; Peek RM, 2006, J PATHOL, V208, P233, DOI 10.1002/path.1868; Pflock M, 2004, FEMS MICROBIOL LETT, V234, P51, DOI 10.1016/j.femsle.2004.03.023; Piotrowski J, 1997, J PHYSIOL PHARMACOL, V48, P345; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rieder G, 2005, CURR OPIN MICROBIOL, V8, P67, DOI 10.1016/j.mib.2004.12.004; SCHMITT W, 1994, MOL MICROBIOL, V12, P307, DOI 10.1111/j.1365-2958.1994.tb01019.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith TG, 2007, PROTEOMICS, V7, P2240, DOI 10.1002/pmic.200600875; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wessler S, 2000, J BIOL CHEM, V275, P3629, DOI 10.1074/jbc.275.5.3629; Windle HJP, 1997, INFECT IMMUN, V65, P3132, DOI 10.1128/IAI.65.8.3132-3137.1997; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604	36	66	68	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3510	10.1371/journal.pone.0003510	http://dx.doi.org/10.1371/journal.pone.0003510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IH	18946507	gold, Green Submitted, Green Published			2022-12-27	WOS:000265126200010
J	Wiersinga, WJ; Wieland, CW; Roelofs, JJTH; van der Poll, T				Wiersinga, W. Joost; Wieland, Catharina W.; Roelofs, Joris J. T. H.; van der Poll, Tom			MyD88 Dependent Signaling Contributes to Protective Host Defense against Burkholderia pseudomallei	PLOS ONE			English	Article								Background: Toll-like receptors (TLRs) have a central role in the recognition of pathogens and the initiation of the innate immune response. Myeloid differentiation primary-response gene 88 (MyD88) and TIR-domain-containing adaptor protein inducing IFN beta (TRIF) are regarded as the key signaling adaptor proteins for TLRs. Melioidosis, which is endemic in SE-Asia, is a severe infection caused by the gram-negative bacterium Burkholderia pseudomallei. We here aimed to characterize the role of MyD88 and TRIF in host defense against melioidosis. Methodology and Principal Findings: First, we found that MyD88, but not TRIF, deficient whole blood leukocytes released less TNF alpha upon stimulation with B. pseudomallei compared to wild-type (WT) cells. Thereafter we inoculated MyD88 knockout (KO), TRIF mutant and WT mice intranasally with B. pseudomallei and found that MyD88 KO, but not TRIF mutant mice demonstrated a strongly accelerated lethality, which was accompanied by significantly increased bacterial loads in lungs, liver and blood, and grossly enhanced liver damage compared to WT mice. The decreased bacterial clearance capacity of MyD88 KO mice was accompanied by a markedly reduced early pulmonary neutrophil recruitment and a diminished activation of neutrophils after infection with B. pseudomallei. MyD88 KO leukocytes displayed an unaltered capacity to phagocytose and kill B. pseudomallei in vitro. Conclusions: MyD88 dependent signaling, but not TRIF dependent signaling, contributes to a protective host response against B. pseudomallei at least in part by causing early neutrophil recruitment towards the primary site of infection.	[Wiersinga, W. Joost; Wieland, Catharina W.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immunity Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Wiersinga, W. Joost; Wieland, Catharina W.; van der Poll, Tom] Academ Med Ctr, Ctr Expt & Mol Med, Amsterdam, Netherlands; [Roelofs, Joris J. T. H.] Academ Med Ctr, Dept Pathol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Wiersinga, WJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immunity Amsterdam CINIMA, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.j.wiersinga@amc.uva.nl		Roelofs, Joris/0000-0001-9595-6571; Wiersinga, Willem/0000-0003-2277-1343	Dutch Foundation for Tropical Research (WOTRO)	Dutch Foundation for Tropical Research (WOTRO)	We acknowledge the support of the Dutch Foundation for Tropical Research (WOTRO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Albiger B, 2005, CELL MICROBIOL, V7, P1603, DOI 10.1111/j.1462-5822.2005.00578.x; Apisarnthananarak P, 2006, CLIN INFECT DIS, V43, P1618, DOI 10.1086/509643; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Breitbach K, 2006, INFECT IMMUN, V74, P6300, DOI 10.1128/IAI.00966-06; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chua KL, 2003, INFECT IMMUN, V71, P1622, DOI 10.1128/IAI.71.4.1622-1629.2003; DeShazer D, 2004, J BACTERIOL, V186, P3938, DOI 10.1128/JB.186.12.3938-3950.2004; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; Haque A, 2006, J INFECT DIS, V193, P370, DOI 10.1086/498983; Hawn TR, 2006, J INFECT DIS, V193, P1693, DOI 10.1086/504525; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Iimuro Y, 2007, J GASTROEN HEPATOL, V22, pS57, DOI 10.1111/j.1440-1746.2006.04651.x; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Jeyaseelan S, 2007, J IMMUNOL, V178, P3153, DOI 10.4049/jimmunol.178.5.3153; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Knapp S, 2007, J IMMUNOL, V178, P993, DOI 10.4049/jimmunol.178.2.993; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Lauw FN, 1999, J INFECT DIS, V180, P1878, DOI 10.1086/315155; Leaver SK, 2007, CRIT CARE MED, V35, P1404, DOI 10.1097/01.CCM.0000261883.16943.4B; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Leemans JC, 2003, J CLIN INVEST, V111, P681, DOI 10.1172/JCI200316936; Leemans JC, 2001, J IMMUNOL, V166, P4604, DOI 10.4049/jimmunol.166.7.4604; Leendertse M, 2008, J IMMUNOL, V180, P4865, DOI 10.4049/jimmunol.180.7.4865; Liu BP, 2002, INFECT IMMUN, V70, P504, DOI 10.1128/IAI.70.2.504-511.2002; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Naiki Y, 2005, J BIOL CHEM, V280, P29242, DOI 10.1074/jbc.M503225200; Nance SC, 2008, J LEUKOC BIOL; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pilatz S, 2006, INFECT IMMUN, V74, P3576, DOI 10.1128/IAI.01262-05; Power MR, 2007, J IMMUNOL, V178, P3170, DOI 10.4049/jimmunol.178.5.3170; Power MR, 2004, J BIOL CHEM, V279, P49315, DOI 10.1074/jbc.M402111200; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; Russell DG, 2007, CELL MICROBIOL, V9, P849, DOI 10.1111/j.1462-5822.2007.00920.x; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Skerrett SJ, 2004, J IMMUNOL, V172, P3377, DOI 10.4049/jimmunol.172.6.3377; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Ulett GC, 2000, INFECT IMMUN, V68, P2034, DOI 10.1128/IAI.68.4.2034-2042.2000; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; WAN CP, 1993, J IMMUNOL METHODS, V162, P1, DOI 10.1016/0022-1759(93)90400-2; Weighardt H, 2002, J IMMUNOL, V169, P2823, DOI 10.4049/jimmunol.169.6.2823; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wieland CW, 2005, J IMMUNOL, V175, P6042, DOI 10.4049/jimmunol.175.9.6042; Wiersinga WJ, 2008, CELL MICROBIOL, V10, P81, DOI 10.1111/j.1462-5822.2007.01016.x; Wiersinga WJ, 2007, PLOS MED, V4, P1268, DOI 10.1371/journal.pmed.0040248; Wiersinga WJ, 2007, J INFECT DIS, V196, P1707, DOI 10.1086/522141; Wiersinga WJ, 2007, INFECT IMMUN, V75, P3739, DOI 10.1128/IAI.00080-07; Wiersinga Willem Joost, 2007, Curr Infect Dis Rep, V9, P366, DOI 10.1007/s11908-007-0057-5; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007	58	61	62	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3494	10.1371/journal.pone.0003494	http://dx.doi.org/10.1371/journal.pone.0003494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IH	18946505	Green Published, gold, Green Submitted			2022-12-27	WOS:000265126200002
J	Bray, DP; Bennett, M; Stockley, P; Hurst, JL; Kipar, A				Bray, Daniel P.; Bennett, Malcolm; Stockley, Paula; Hurst, Jane L.; Kipar, Anja			Composition and Function of Haemolymphatic Tissues in the European Common Shrew	PLOS ONE			English	Article								Background: Studies of wild animals responding to their native parasites are essential if we are to understand how the immune system functions in the natural environment. While immune defence may bring increased survival, this may come at a resource cost to other physiological traits, including reproduction. Here, we tested the hypothesis that wild common shrews (Sorex araneus), which produce large numbers of offspring during the one breeding season of their short life span, forgo investment in immunity and immune system maintenance, as increased longevity is unlikely to bring further opportunities for mating. In particular, we predicted that adult shrews, with shorter expected lifespans, would not respond as effectively as young animals to infection. Methodology/Principal Findings: We examined haemolymphatic tissues from wild-caught common shrews using light and transmission electron microscopy, applied in conjunction with immunohistology. We compared composition and function of these tissues in shrews of different ages, and the extent and type of inflammatory reactions observed in response to natural parasitic infections. All ages seemed able to mount systemic, specific immune responses, but adult shrews showed some signs of lymphatic tissue exhaustion: lymphatic follicles in adults (n = 21) were both smaller than those in sub-adults (n= 18; Wald = 11.1, p < 0.05) and exhibited greater levels of depletion (Wald = 13.3, p < 0.05). Conclusions/Significance: Contrary to our expectations, shrews respond effectively to their natural parasites, and show little indication of immunosenescence as adults. The pancreas of Aselli, a unique lymphoid organ, may aid in providing efficient immune responses through the storage of large numbers of plasma cells. This may allow older animals to react effectively to previously encountered parasites, but infection by novel agents, and eventual depletion of plasma cell reserves, could both still be factors in the near-synchronous mortality of adult shrews observed shortly after breeding.	[Bray, Daniel P.; Stockley, Paula; Hurst, Jane L.] Univ Liverpool, Fac Vet Sci, Mammalian Behav & Evolut Grp, Neston, Cheshire, England; [Bennett, Malcolm; Kipar, Anja] Univ Liverpool, Fac Vet Sci, Dept Vet Pathol, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Bray, DP (corresponding author), Univ Liverpool, Fac Vet Sci, Mammalian Behav & Evolut Grp, Neston, Cheshire, England.	akipar@liverpool.ac.uk	Bray, Daniel/H-4890-2012; Hurst, Jane L/G-8793-2015; Kipar, Anja/L-7214-2014; Bennett, Malcolm/G-4004-2010	Hurst, Jane L/0000-0002-3728-9624; Kipar, Anja/0000-0001-7289-3459; Bennett, Malcolm/0000-0002-5490-2910; Bennett, Malcolm/0000-0003-0475-390X	Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work formed part of a PhD thesis submitted by DPB, funded by the Biotechnology and Biological Sciences Research Council.	ADAMS LE, 1910, MANCHESTER MEM, V54, P1; Brambell FWR, 1935, PHILOS T ROY SOC B, V225, P1, DOI 10.1098/rstb.1935.0005; Bray DP, 2007, PARASITOLOGY, V134, P819, DOI 10.1017/S0031182007002302; BUCKNER CH, 1969, J MAMMAL, V50, P326, DOI 10.2307/1378350; BUTCHER EC, 1982, ADV EXP MED BIOL, V149, P765; Chu PG, 2001, APPL IMMUNOHISTO M M, V9, P97, DOI 10.1097/00022744-200106000-00001; CHURCHFIELD S, 1981, J ZOOL, V194, P165; CHURCHFIELD S, 1980, ACTA THERIOL, V25, P415, DOI 10.4098/AT.arch.80-38; Churchfield S., 1990, NATURAL HIST SHREWS; CROWCROFT WP, 1957, LIFE SHREW; EWALD JA, 1991, J PARASITOL, V77, P485, DOI 10.2307/3283141; Fernandez-Gutierrez B, 1999, EXP GERONTOL, V34, P217, DOI 10.1016/S0531-5565(98)00068-0; FUKUTA K, 1982, J ANAT, V134, P129; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GENOUD M, 1990, J ZOOL, V220, P41, DOI 10.1111/j.1469-7998.1990.tb04293.x; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Herrera E, 2000, EMBO J, V19, P472, DOI 10.1093/emboj/19.3.472; Holmberg M, 2003, EPIDEMIOL INFECT, V130, P149, DOI 10.1017/S0950268802008075; HOLMES RL, 1965, J ANAT, V99, P445; HOYTE HMD, 1956, PARASITOLOGY, V46, P224, DOI 10.1017/S0031182000026469; Kipar A, 1998, VET IMMUNOL IMMUNOP, V65, P243, DOI 10.1016/S0165-2427(98)00158-5; Kipar A, 1998, VET PATHOL, V35, P43, DOI 10.1177/030098589803500104; Kipar A, 2001, J COMP PATHOL, V125, P182, DOI 10.1053/jcpa.2001.0501; Kohler K., 2000, European Journal of Veterinary Pathology, V6, P107; Laakkonen J, 1998, J PARASITOL, V84, P1300, DOI 10.2307/3284698; Laakkonen J, 2000, ANN ZOOL FENN, V37, P37; Laakkonen J, 1995, MAMMALIA, V59, P623, DOI 10.1515/mamm.1995.59.4.623; Liz JS, 2000, J CLIN MICROBIOL, V38, P1002, DOI 10.1128/JCM.38.3.1002-1007.2000; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lustig A, 2007, CELL IMMUNOL, V245, P42, DOI 10.1016/j.cellimm.2007.03.008; MCCORMICK D, 1992, HISTOPATHOLOGY, V21, P591, DOI 10.1111/j.1365-2559.1992.tb00454.x; MICHIELSEN NORA CROIN, 1966, ARCH NEER ZOOL, V17, P73; MIDDLETON AD, 1931, J ZOOL LOND, P133; Milner RJ, 1996, ONDERSTEPOORT J VET, V63, P309; NAGEL A, 1994, ADV BIOL SHREWS, P421; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; PERNETTA JC, 1977, ACTA THERIOL, V22, P279, DOI 10.4098/AT.arch.77-25; RANDOLPH SE, 1975, J ANIM ECOL, V44, P425, DOI 10.2307/3605; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Roots C. D., 1992, THESIS U LONDON; ROOTS CD, 1994, J HELMINTHOL, V68, P247, DOI 10.1017/S0022149X00014425; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SHILLITO JOY F., 1963, PROC ZOOL SOC LONDON, V140, P99; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Smit FGAM, 1957, HDB IDENTIFICATION B; SNOOK T, 1950, AM J ANAT, V87, P31, DOI 10.1002/aja.1000870103; STOCKLEY P, 1993, P ROY SOC B-BIOL SCI, V254, P173, DOI 10.1098/rspb.1993.0143; Stockley P, 1998, OIKOS, V83, P560, DOI 10.2307/3546682; Stockley P, 1996, BEHAV ECOL, V7, P334, DOI 10.1093/beheco/7.3.334; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Tsiperson VP, 1997, CELL BIOL INT, V21, P359, DOI 10.1006/cbir.1997.0135; TWIGG GI, 1970, J ZOOL, V162, P541; WOLK E, 1981, ACTA THERIOL, V26, P219; Wunschmann A, 2000, VET IMMUNOL IMMUNOP, V73, P83, DOI 10.1016/S0165-2427(99)00156-7; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	55	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3413	10.1371/journal.pone.0003413	http://dx.doi.org/10.1371/journal.pone.0003413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923707	Green Published, gold, Green Submitted			2022-12-27	WOS:000265121800011
J	Haeberle, HA; Duerrstein, C; Rosenberger, P; Hosakote, YM; Kuhlicke, J; Kempf, VAJ; Garofalo, RP; Eltzschig, HK				Haeberle, Helene A.; Duerrstein, Carin; Rosenberger, Peter; Hosakote, Yashoda M.; Kuhlicke, Johannes; Kempf, Volkhard A. J.; Garofalo, Roberto P.; Eltzschig, Holger K.			Oxygen-Independent Stabilization of Hypoxia Inducible Factor (HIF)-1 during RSV Infection	PLOS ONE			English	Article								Background: Hypoxia-inducible factor 1 (HIF)-1 alpha is a transcription factor that functions as master regulator of mammalian oxygen homeostasis. In addition, recent studies identified a role for HIF-1 alpha as transcriptional regulator during inflammation or infection. Based on studies showing that respiratory syncytial virus (RSV) is among the most potent biological stimuli to induce an inflammatory milieu, we hypothesized a role of HIF-1 alpha as transcriptional regulator during infections with RSV. Methodology, Principal Findings: We gained first insight from immunohistocemical studies of RSV-infected human pulmonary epithelia that were stained for HIF-1 alpha. These studies revealed that RSV-positive cells also stained for HIF-1 alpha, suggesting concomitant HIF-activation during RSV infection. Similarly, Western blot analysis confirmed an approximately 8-fold increase in HIF-1 alpha protein 24 h after RSV infection. In contrast, HIF-1 alpha activation was abolished utilizing UV-treated RSV. Moreover, HIF-alpha-regulated genes (VEGF, CD73, FN-1, COX-2) were induced with RSV infection of wild-type cells. In contrast, HIF-1 alpha dependent gene induction was abolished in pulmonary epithelia following siRNA mediated repression of HIF-1 alpha. Measurements of the partial pressure of oxygen in the supernatants of RSV infected epithelia or controls revealed no differences in oxygen content, suggesting that HIF-1 alpha activation is not caused by RSV associated hypoxia. Finally, studies of RSV pneumonitis in mice confirmed HIF-alpha-activation in a murine in vivo model. Conclusions/Significance: Taking together, these studies suggest hypoxia-independent activation of HIF-1 alpha during infection with RSV in vitro and in vivo.	[Haeberle, Helene A.; Duerrstein, Carin; Rosenberger, Peter; Kuhlicke, Johannes; Eltzschig, Holger K.] Univ Tubingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Kempf, Volkhard A. J.] Univ Tubingen, Med Microbiol & Hyg Dept, D-72074 Tubingen, Germany; [Hosakote, Yashoda M.; Garofalo, Roberto P.] Univ Texas, Med Branch, Dept Pediat, Galveston, TX USA; [Eltzschig, Holger K.] Univ Colorado, Hlth Sci Ctr, Dept Anesthesiol & Perioperat Med, Mucosal Inflammat Program, Denver, CO USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Texas System; University of Texas Medical Branch Galveston; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Haeberle, HA (corresponding author), Univ Tubingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	holger.eltzschig@uchsc.edu	Garofalo, Roberto P./AAF-7385-2022; Hosakote, Yashoda/AAP-6845-2020; Garofalo, Roberto P./ABL-2322-2022		Foundation for Anesthesia Education and Research (FAER)	Foundation for Anesthesia Education and Research (FAER)	This manuscript was supported in part by a Foundation for Anesthesia Education and Research (FAER) Grant to HKE.	Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648; Bunn HF, 1998, J EXP BIOL, V201, P1197; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carroll PA, 2006, J VIROL, V80, P10802, DOI 10.1128/JVI.00673-06; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; de Avalos SV, 2002, J BIOL CHEM, V277, P639, DOI 10.1074/jbc.M109037200; ECKLE T, 2007, BLOOD; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Garofalo RP, 2000, AM J RESP CELL MOL, V23, P581, DOI 10.1165/ajrcmb.23.5.f204; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Guido B, 2008, FRONT BIOSCI-LANDMRK, V13, P2588, DOI 10.2741/2868; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Haeberle HA, 2006, J CLIN ANESTH, V18, P96, DOI 10.1016/j.jclinane.2005.06.010; Haeberle HA, 2004, J VIROL, V78, P2232, DOI 10.1128/JVI.78.5.2232-2241.2004; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001; Haeberle HA, 2002, AM J RESP CRIT CARE, V165, P1433, DOI 10.1164/rccm.2109077; Haeberle HA, 2002, J INFECT DIS, V186, P1199, DOI 10.1086/344644; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Han HK, 2007, BIOCHEM BIOPH RES CO, V357, P567, DOI 10.1016/j.bbrc.2007.04.012; HARTMANN H, 2007, GASTROENTER IN PRESS; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Karhausen J, 2005, CELL CYCLE, V4, P256; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Kilani MM, 2004, INFLAMMATION, V28, P245, DOI 10.1007/s10753-004-6047-y; KISCH AL, 1963, P SOC EXP BIOL MED, V112, P583, DOI 10.3181/00379727-112-28111; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kong TQ, 2004, P NATL ACAD SCI USA, V101, P10440, DOI 10.1073/pnas.0401339101; Krishnamachary B, 2003, CANCER RES, V63, P1138; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Kvietikova I, 1997, KIDNEY INT, V51, P564, DOI 10.1038/ki.1997.80; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; MAXWELL PH, 1993, P NATL ACAD SCI USA, V90, P2423, DOI 10.1073/pnas.90.6.2423; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; MOROTEGARCIA JC, 2008, BLOOD; Moskowitz DW, 2006, NEW ENGL J MED, V354, P975; Nasimuzzaman M, 2007, J VIROL, V81, P10249, DOI 10.1128/JVI.00763-07; Olszewska-Pazdrak B, 1998, J VIROL, V72, P4756, DOI 10.1128/JVI.72.6.4756-4764.1998; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Ratcliffe PJ, 2007, J CLIN INVEST, V117, P862, DOI 10.1172/JCI31750; RIUS J, 2008, NATURE; SEMENZA GL, 1994, HEMATOL ONCOL CLIN N, V8, P863, DOI 10.1016/S0889-8588(18)30134-5; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Semenza GL, 2008, CELL, V133, P206, DOI 10.1016/j.cell.2008.04.004; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Spear W, 2006, CELL MICROBIOL, V8, P339, DOI 10.1111/j.1462-5822.2005.00628.x; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; UEBA O, 1978, ACTA MED OKAYAMA, V32, P265; van der Flier M, 2005, SHOCK, V23, P35, DOI 10.1097/01.shk.0000150728.91155.41; van der Flier M, 2001, J INFECT DIS, V183, P149, DOI 10.1086/317643; Wakisaka N, 2004, MOL CELL BIOL, V24, P5223, DOI 10.1128/MCB.24.12.5223-5234.2004; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wotzlaw C, 2007, FASEB J, V21, P700, DOI 10.1096/fj.06-6280com; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	71	60	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2008	3	10							e3352	10.1371/journal.pone.0003352	http://dx.doi.org/10.1371/journal.pone.0003352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DM	18839041	Green Submitted, gold, Green Published			2022-12-27	WOS:000265113700002
J	Kibaya, RS; Bautista, CT; Sawe, FK; Shaffer, DN; Sateren, WB; Scott, PT; Michael, NL; Robb, ML; Birx, DL; de Souza, MS				Kibaya, Rukia S.; Bautista, Christian T.; Sawe, Frederick K.; Shaffer, Douglas N.; Sateren, Warren B.; Scott, Paul T.; Michael, Nelson L.; Robb, Merlin L.; Birx, Deborah L.; de Souza, Mark S.			Reference Ranges for the Clinical Laboratory Derived from a Rural Population in Kericho, Kenya	PLOS ONE			English	Article								The conduct of Phase I/II HIV vaccine trials internationally necessitates the development of region-specific clinical reference ranges for trial enrolment and participant monitoring. A population based cohort of adults in Kericho, Kenya, a potential vaccine trial site, allowed development of clinical laboratory reference ranges. Lymphocyte immunophenotyping was performed on 1293 HIV seronegative study participants. Hematology and clinical chemistry were performed on up to 1541 cohort enrollees. The ratio of males to females was 1.9:1. Means, medians and 95% reference ranges were calculated and compared with those from other nations. The median CD4+ T cell count for the group was 810 cells/mu l. There were significant gender differences for both red and white blood cell parameters. Kenyan subjects had lower median hemoglobin concentrations (9.5 g/dL; range 6.7-11.1) and neutrophil counts (1850 cells/mu l; range 914-4715) compared to North Americans. Kenyan clinical chemistry reference ranges were comparable to those from the USA, with the exception of the upper limits for bilirubin and blood urea nitrogen, which were 2.3-fold higher and 1.5-fold lower, respectively. This study is the first to assess clinical reference ranges for a highland community in Kenya and highlights the need to define clinical laboratory ranges from the national community not only for clinical research but also care and treatment.	[Kibaya, Rukia S.; Sawe, Frederick K.; Shaffer, Douglas N.] US Mil HIV Res Program, Walter Reed Project, Kericho, Kenya; [Bautista, Christian T.; Robb, Merlin L.] Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD USA; [Sateren, Warren B.; Scott, Paul T.; Michael, Nelson L.] US Mil HIV Res Program, Rockville, MD USA; [Birx, Deborah L.] Ctr Dis Control & Prevent, Atlanta, GA USA; [de Souza, Mark S.] AFRIMS, Henry M Jackson Fdn, Dept Retrovirol, Bangkok, Thailand	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); Walter Reed Army Institute of Research (WRAIR); Centers for Disease Control & Prevention - USA; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Kibaya, RS (corresponding author), US Mil HIV Res Program, Walter Reed Project, Kericho, Kenya.	desouzams@afrims.org	Bautista, Christian/B-2812-2011	Bautista, Christian/0000-0002-1228-0754	U. S. Army Medical Research and Materiel Command [W81XWH-04-02-0005]; Henry M. Jackson Foundation for the Advancement of Military Medicine [1Y-A1-26-42-07]	U. S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Medicine	This work was supported by the U. S. Army Medical Research and Materiel Command and its Cooperative Agreement (W81XWH-04-02-0005) with the Henry M. Jackson Foundation for the Advancement of Military Medicine and with an Inter Agency Agreement (1Y-A1-26-42-07) with DAIDS. The opinions expressed herein are those of the authors and do not represent the official position of the U.S. Army or Department of Defense or any organization listed.	Aina O, 2005, CLIN DIAGN LAB IMMUN, V12, P525, DOI 10.1128/CDLI.12.4.525-530.2005; Akhwale WS, 2004, ACTA TROP, V91, P167, DOI 10.1016/j.actatropica.2004.02.010; Ampofo W, 2006, VIRAL IMMUNOL, V19, P260, DOI 10.1089/vim.2006.19.260; BAIN B, 1984, J CLIN PATHOL, V37, P188, DOI 10.1136/jcp.37.2.188; Bass E, 2005, LANCET, V365, P2077, DOI 10.1016/S0140-6736(05)66717-7; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Bussmann H, 2004, CLIN DIAGN LAB IMMUN, V11, P930, DOI 10.1128/CDLI.11.5.930-935.2004; CHOONG ML, 1995, ANN CLIN BIOCHEM, V32, P532, DOI 10.1177/000456329503200603; Clerici M, 2000, AIDS, V14, P2083, DOI 10.1097/00002030-200009290-00003; Esparza J, 2003, CURR MOL MED, V3, P183, DOI 10.2174/1566524033479825; Ezzelle J, 2008, J PHARMACEUT BIOMED, V46, P18, DOI 10.1016/j.jpba.2007.10.010; Foglia G, 2008, EPIDEMIOL INFECT, V136, P694, DOI 10.1017/S0950268807009028; Foglia G, 2004, J CLIN MICROBIOL, V42, P3850, DOI 10.1128/JCM.42.8.3850-3852.2004; Forbes WH, 1941, AM J MED SCI, V201, P407, DOI 10.1097/00000441-194103000-00013; FOY H, 1954, BMJ-BRIT MED J, V1, P294, DOI 10.1136/bmj.1.4857.294; Haddy TB, 1999, J LAB CLIN MED, V133, P15, DOI 10.1053/lc.1999.v133.a94931; Kamwi R, 2006, LANCET, V367, P1978, DOI 10.1016/S0140-6736(06)68879-X; Kassu A, 2001, CLIN DIAGN LAB IMMUN, V8, P1171, DOI 10.1128/CDLI.8.6.1171-1176.2001; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Lee BW, 1996, CYTOMETRY, V26, P8, DOI 10.1002/(SICI)1097-0320(19960315)26:1<8::AID-CYTO2>3.0.CO;2-E; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Maini MK, 1996, GENITOURIN MED, V72, P27; Mair C, 2008, CLIN EXP IMMUNOL, V151, P432, DOI 10.1111/j.1365-2249.2007.03573.x; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; Mohamadnejad M, 2003, WORLD J GASTROENTERO, V9, P2322; NCCLS, 2000, DEF DET REF INT CLIN, V20; Nowicki MJ, 2007, HUM IMMUNOL, V68, P342, DOI 10.1016/j.humimm.2007.01.007; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; SAATHOFF E, 2008, TROP MED INT HLTH; Sateren WB, 2006, JAIDS-J ACQ IMM DEF, V43, P102, DOI 10.1097/01.qai.0000226795.61957.40; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; Tsegaye A, 2003, CLIN IMMUNOL, V109, P338, DOI 10.1016/j.clim.2003.08.008; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995; Urassa WK, 2003, J IMMUNOL METHODS, V277, P65, DOI 10.1016/S0022-1759(03)00174-1; Urassa WK, 1996, E AFR MED J, V73, P670; Webster H. Kyle, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P418; WEISS R, 1990, J CONSULT CLIN PSYCH, V58, P70, DOI 10.1037/h0092559; 1989, MMWR MORB MORTAL WKL, V38, P400; 2006, LANCET, V367, P1213	39	86	87	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3327	10.1371/journal.pone.0003327	http://dx.doi.org/10.1371/journal.pone.0003327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833329	gold, Green Submitted, Green Published			2022-12-27	WOS:000264797400005
J	Musso, T; Scutera, S; Vermi, W; Daniele, R; Fornaro, M; Castagnoli, C; Alotto, D; Ravanini, M; Cambieri, I; Salogni, L; Elia, AR; Giovarelli, M; Facchetti, F; Girolomoni, G; Sozzani, S				Musso, Tiziana; Scutera, Sara; Vermi, William; Daniele, Roberta; Fornaro, Michele; Castagnoli, Carlotta; Alotto, Daniela; Ravanini, Maria; Cambieri, Irene; Salogni, Laura; Elia, Angela Rita; Giovarelli, Mirella; Facchetti, Fabio; Girolomoni, Giampiero; Sozzani, Silvano			Activin A Induces Langerhans Cell Differentiation In Vitro and in Human Skin Explants	PLOS ONE			English	Article								Langerhans cells (LC) represent a well characterized subset of dendritic cells located in the epidermis of skin and mucosae. In vivo, they originate from resident and blood-borne precursors in the presence of keratinocyte-derived TGF beta. In vitro, LC can be generated from monocytes in the presence of GM-CSF, IL-4 and TGF beta. However, the signals that induce LC during an inflammatory reaction are not fully investigated. Here we report that Activin A, a TGF beta family member induced by proinflammatory cytokines and involved in skin morphogenesis and wound healing, induces the differentiation of human monocytes into LC in the absence of TGF beta. Activin A-induced LC are Langerin(+), Birbeck granules(+), E-cadherin(+), CLA(+) and CCR6(+) and possess typical APC functions. In human skin explants, intradermal injection of Activin A increased the number of CD1a(+) and Langerin(+) cells in both the epidermis and dermis by promoting the differentiation of resident precursor cells. High levels of Activin A were present in the upper epidermal layers and in the dermis of Lichen Planus biopsies in association with a marked infiltration of CD1a(+) and Langerin(+) cells. This study reports that Activin A induces the differentiation of circulating CD14(+) cells into LC. Since Activin A is abundantly produced during inflammatory conditions which are also characterized by increased numbers of LC, we propose that this cytokine represents a new pathway, alternative to TGF beta, responsible for LC differentiation during inflammatory/autoimmune conditions.	[Musso, Tiziana; Scutera, Sara] Univ Turin, Dept Publ Hlth & Microbiol, Turin, Italy; [Vermi, William; Ravanini, Maria; Facchetti, Fabio] Univ Brescia, Dept Pathol, I-25121 Brescia, Italy; [Daniele, Roberta; Salogni, Laura; Sozzani, Silvano] Univ Brescia, Dept Biomed Sci & Biotecnol, Sect Gen Pathol & Immunol, I-25121 Brescia, Italy; [Daniele, Roberta; Girolomoni, Giampiero] Univ Verona, Dept Dermatol, I-37100 Verona, Italy; [Fornaro, Michele] Univ Turin, San Luigi Hosp, Dept Clin & Biol Sci, I-10124 Turin, Italy; [Castagnoli, Carlotta; Alotto, Daniela; Cambieri, Irene] CTO Hosp, Dept Plastic Surg, Burn Unit Skin Bank, Turin, Italy; [Elia, Angela Rita; Giovarelli, Mirella] Univ Turin, S Giovanni Battista Hosp, Ctr Expt Res & Med Stud CERMS, I-10124 Turin, Italy	University of Turin; University of Brescia; University of Brescia; University of Verona; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Musso, T (corresponding author), Univ Turin, Dept Publ Hlth & Microbiol, Turin, Italy.	sozzani@med.unibs.it	GIROLOMONI, Giampiero/AAC-3405-2022; Facchetti, Fabio/E-7190-2010; SCUTERA, SARA AGATA CATERINA/AAU-6455-2020; Sozzani, Silvano/C-1447-2009	Facchetti, Fabio/0000-0003-4975-2388; SCUTERA, SARA AGATA CATERINA/0000-0002-7431-0875; Fornaro, Michele/0000-0003-1852-9167; Giovarelli, Mirella/0000-0002-7397-3466; Sozzani, Silvano/0000-0002-3144-8743; VERMI, WILLIAM/0000-0002-2291-2997; MUSSO, Tiziana/0000-0002-7487-6078	AIRC (Associazione Italiana per la Ricerca sul Cancro); MIUR (Ministero dell'Istruzione Universita e Ricerca); Istituto Superiore di Sanita; NOBEL Project Cariplo; Fondazione Piemontese per gli Studi e le Ricerche sulle Ustioni; Compagnia di San Paolo, Fondazione CRT; Ricerca Sanitaria Finalizzata Regione Piemonte	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); MIUR (Ministero dell'Istruzione Universita e Ricerca)(Ministry of Education, Universities and Research (MIUR)); Istituto Superiore di Sanita; NOBEL Project Cariplo; Fondazione Piemontese per gli Studi e le Ricerche sulle Ustioni; Compagnia di San Paolo, Fondazione CRT(Compagnia di San Paolo); Ricerca Sanitaria Finalizzata Regione Piemonte(Regione Piemonte)	This work was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro); MIUR (Ministero dell'Istruzione Universita e Ricerca; Cofin); Istituto Superiore di Sanita; NOBEL Project Cariplo "Genetic and functional genomics of myelomonocytic cells"; Fondazione Piemontese per gli Studi e le Ricerche sulle Ustioni; Compagnia di San Paolo, Fondazione CRT; Ricerca Sanitaria Finalizzata Regione Piemonte.	Arora DS, 1997, J PATHOL, V181, P413, DOI 10.1002/(SICI)1096-9896(199704)181:4<413::AID-PATH789>3.0.CO;2-U; Attisano L, 1996, MOL CELL BIOL, V16, P1066; Bamberger C, 2005, AM J PATHOL, V167, P733, DOI 10.1016/S0002-9440(10)62047-0; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bell D, 1999, ADV IMMUNOL, V72, P255, DOI 10.1016/S0065-2776(08)60023-1; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; CERIO R, 1989, BRIT J DERMATOL, V121, P421, DOI 10.1111/j.1365-2133.1989.tb15509.x; Chen YG, 2002, EXP BIOL MED, V227, P75, DOI 10.1177/153537020222700201; Cumberbatch M, 2000, CLIN EXP DERMATOL, V25, P413, DOI 10.1046/j.1365-2230.2000.00678.x; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; de Gruijl TD, 2006, J IMMUNOL, V176, P7232, DOI 10.4049/jimmunol.176.12.7232; de Gruijl TD, 2002, J IMMUNOL, V169, P5322, DOI 10.4049/jimmunol.169.9.5322; FIVENSON DP, 1995, J CUTAN PATHOL, V22, P223, DOI 10.1111/j.1600-0560.1995.tb00742.x; Fumagalli M, 2007, EXP DERMATOL, V16, P600, DOI 10.1111/j.1600-0625.2007.00571.x; Gatti E, 2000, J IMMUNOL, V164, P3600, DOI 10.4049/jimmunol.164.7.3600; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Gustafson J, 2007, ACTA ODONTOL SCAND, V65, P156, DOI 10.1080/00016350601137251; Hasseus B, 2001, SCAND J IMMUNOL, V54, P516, DOI 10.1046/j.1365-3083.2001.00988.x; Herbst B, 1996, BLOOD, V88, P2541, DOI 10.1182/blood.V88.7.2541.bloodjournal8872541; Hubner G, 1996, EXP CELL RES, V228, P106, DOI 10.1006/excr.1996.0305; Hubner G, 1996, DEV BIOL, V173, P490, DOI 10.1006/dbio.1996.0042; Jones KL, 2004, MOL CELL ENDOCRINOL, V225, P119, DOI 10.1016/j.mce.2004.07.010; KASHIHARA M, 1986, J INVEST DERMATOL, V87, P602, DOI 10.1111/1523-1747.ep12455849; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Larregina AT, 2001, NAT IMMUNOL, V2, P1151, DOI 10.1038/ni731; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; Mc Dermott R, 2002, MOL BIOL CELL, V13, P317, DOI 10.1091/mbc.01-06-0300; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; MEUNIER L, 1993, J IMMUNOL, V151, P4067; Mohamadzadeh M, 2001, J EXP MED, V194, P1013, DOI 10.1084/jem.194.7.1013; Munz B, 1999, EMBO J, V18, P5205, DOI 10.1093/emboj/18.19.5205; NESTLE FO, 1993, J IMMUNOL, V151, P6535; Palucka AK, 2006, NAT IMMUNOL, V7, P223, DOI 10.1038/ni0306-223; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Phillips DJ, 2005, VET IMMUNOL IMMUNOP, V108, P23, DOI 10.1016/j.vetimm.2005.08.011; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Power CA, 1997, J EXP MED, V186, P825, DOI 10.1084/jem.186.6.825; RANDOLPH GJ, 2007, ANN REV IMMUNOL; Santoro A, 2005, J PATHOL, V205, P426, DOI 10.1002/path.1699; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; SOUSA CRE, 1993, J EXP MED, V178, P509, DOI 10.1084/jem.178.2.509; Sozzani S, 2005, CYTOKINE GROWTH F R, V16, P581, DOI 10.1016/j.cytogfr.2005.04.008; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; STINGL G, 1978, J INVEST DERMATOL, V71, P59, DOI 10.1111/1523-1747.ep12544055; Stoitzner P, 2005, EUR J CELL BIOL, V84, P733, DOI 10.1016/j.ejcb.2005.04.003; Strobl H, 1998, IMMUNOBIOLOGY, V198, P588, DOI 10.1016/S0171-2985(98)80080-6; Strobl H, 1996, J IMMUNOL, V157, P1499; Sugerman PB, 2002, CRIT REV ORAL BIOL M, V13, P350, DOI 10.1177/154411130201300405; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Sulyok S, 2004, MOL CELL ENDOCRINOL, V225, P127, DOI 10.1016/j.mce.2004.07.011; TANG AM, 1993, NATURE, V361, P82, DOI 10.1038/361082a0; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Vermi W, 2006, BLOOD, V107, P454, DOI 10.1182/blood-2005-04-1342; Vulcano M, 2003, J IMMUNOL, V170, P3843, DOI 10.4049/jimmunol.170.7.3843; Wankell M, 2001, EMBO J, V20, P5361, DOI 10.1093/emboj/20.19.5361; Yang D, 1999, J IMMUNOL, V163, P1737; Yasaka N, 1996, J DERMATOL SCI, V11, P19, DOI 10.1016/0923-1811(95)00411-4	63	37	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3271	10.1371/journal.pone.0003271	http://dx.doi.org/10.1371/journal.pone.0003271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MG	18813341	Green Submitted, Green Published, gold			2022-12-27	WOS:000264431800009
J	Calcott, B; Balcan, D; Hohenlohe, PA				Calcott, Brett; Balcan, Duygu; Hohenlohe, Paul A.			A Publish-Subscribe Model of Genetic Networks	PLOS ONE			English	Article							REGULATORY NETWORKS; TRANSCRIPTIONAL REGULATION; BOOLEAN DYNAMICS; EVOLUTION; EXPRESSION; CONSTRUCTION; ROBUSTNESS; ELEMENTS; MOTIFS	We present a simple model of genetic regulatory networks in which regulatory connections among genes are mediated by a limited number of signaling molecules. Each gene in our model produces ( publishes) a single gene product, which regulates the expression of other genes by binding to regulatory regions that correspond ( subscribe) to that product. We explore the consequences of this publish-subscribe model of regulation for the properties of single networks and for the evolution of populations of networks. Degree distributions of randomly constructed networks, particularly multimodal in-degree distributions, which depend on the length of the regulatory sequences and the number of possible gene products, differed from simpler Boolean NK models. In simulated evolution of populations of networks, single mutations in regulatory or coding regions resulted in multiple changes in regulatory connections among genes, or alternatively in neutral change that had no effect on phenotype. This resulted in remarkable evolvability in both number and length of attractors, leading to evolved networks far beyond the expectation of these measures based on random distributions. Surprisingly, this rapid evolution was not accompanied by changes in degree distribution; degree distribution in the evolved networks was not substantially different from that of randomly generated networks. The publish-subscribe model also allows exogenous gene products to create an environment, which may be noisy or stable, in which dynamic behavior occurs. In simulations, networks were able to evolve moderate levels of both mutational and environmental robustness.	[Calcott, Brett] Australian Natl Univ, RSSS, Philosophy Program, Canberra, ACT, Australia; [Calcott, Brett] Australian Natl Univ, Ctr Macroevol & Macroecol, Canberra, ACT, Australia; [Balcan, Duygu] Indiana Univ, Sch Informat, Bloomington, IN 47405 USA; [Hohenlohe, Paul A.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Hohenlohe, Paul A.] Univ Oregon, Ctr Ecol & Evol Biol, Eugene, OR 97403 USA	Australian National University; Australian National University; Indiana University System; Indiana University Bloomington; Oregon State University; University of Oregon	Calcott, B (corresponding author), Australian Natl Univ, RSSS, Philosophy Program, Canberra, ACT, Australia.	hohenlop@science.oregonstate.edu	Hohenlohe, Paul/AAE-7744-2019	Hohenlohe, Paul/0000-0002-7616-0161	Santa Fe Institute [Complex Systems Summer School Fellowship]; Cambridge-Templeton Consortium; National Institutes of Health [National Research Service Award Ruth L. Kirschstein Postdoctoral Fellowship]	Santa Fe Institute; Cambridge-Templeton Consortium; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All 3 authors: Santa Fe Institute Complex Systems Summer School Fellowship. BC: Cambridge-Templeton Consortium Research Grant. PH: National Institutes of Health National Research Service Award Ruth L. Kirschstein Postdoctoral Fellowship. Funders had no direct role in any part of the study or manuscript preparation, review, or approval.	Adams MD, 2005, CURR OPIN GENET DEV, V15, P628, DOI 10.1016/j.gde.2005.09.004; Akutsu T, 2000, BIOINFORMATICS, V16, P727, DOI 10.1093/bioinformatics/16.8.727; Aldana M, 2003, PHYSICA D, V185, P45, DOI 10.1016/S0167-2789(03)00174-X; Aldana M, 2003, P NATL ACAD SCI USA, V100, P8710, DOI 10.1073/pnas.1536783100; ALDANA M, 2002, Patent No. 0204062; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Babu MM, 2006, J MOL BIOL, V358, P614, DOI 10.1016/j.jmb.2006.02.019; Balcan D, 2004, EUR PHYS J B, V38, P253, DOI 10.1140/epjb/e2004-00055-7; Balcan D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000501; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Bilke S, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.016129; CILIBERTI S, 2007, PLOS COMP BIOL, V3; Dobrin R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-10; Dorogovtsev SN, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066122; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Enemark J, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/11/P11007; Eugster PT, 2003, ACM COMPUT SURV, V35, P114, DOI 10.1145/857076.857078; Fenster CB, 1997, TRENDS ECOL EVOL, V12, P282, DOI 10.1016/S0169-5347(97)81027-0; Gamma E., 1994, DESIGN PATTERNS ELEM; Gavrilets S, 1997, TRENDS ECOL EVOL, V12, P307, DOI 10.1016/S0169-5347(97)01098-7; Gavrilets S., 2004, FITNESS LANDSCAPES O, pxviii; GEARD N, 2003, P 2003 C EV COMP CAN, P1493; Goutsias J, 2004, BIOPHYS J, V86, P1922, DOI 10.1016/S0006-3495(04)74257-5; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Haag ES, 2007, GENETICA, V129, P45, DOI 10.1007/s10709-006-0032-3; HANSEN TF, 2003, BIOSYSTEMS, V2189, P1; Harrelson GL, 2002, ATHLET THER TODAY, V7, P23, DOI 10.1123/att.7.5.23; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; KANEKO K, 2003, ORIGINATION ORG FORM; Kauffman S, 2004, J THEOR BIOL, V230, P581, DOI 10.1016/j.jtbi.2003.12.017; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KAUFFMAN SA, 1993, ORIDINS ORDER SELF O; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; Laubenbacher R, 2004, J THEOR BIOL, V229, P523, DOI 10.1016/j.jtbi.2004.04.037; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Mungan M, 2005, J PHYS A-MATH GEN, V38, P9599, DOI 10.1088/0305-4470/38/44/001; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Quayle AP, 2006, J THEOR BIOL, V238, P737, DOI 10.1016/j.jtbi.2005.06.020; REIL T, 1999, P 5 EUR C ART LIF, P457; Ribeiro AS, 2007, J THEOR BIOL, V247, P743, DOI 10.1016/j.jtbi.2007.04.020; Schlichting CD, 2003, EVOL DEV, V5, P98, DOI 10.1046/j.1525-142X.2003.03015.x; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serra R, 2007, J THEOR BIOL, V246, P449, DOI 10.1016/j.jtbi.2007.01.012; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Valentine JW, 2000, PALEOBIOLOGY, V26, P513, DOI 10.1666/0094-8373(2000)026<0513:TGPTTE>2.0.CO;2; van Steensel B, 2005, NAT GENET, V37, pS18, DOI 10.1038/ng1559; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; von Dassow G, 1999, J EXP ZOOL, V285, P307, DOI 10.1002/(SICI)1097-010X(19991215)285:4<307::AID-JEZ2>3.3.CO;2-M; Von Dassow G, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P244; Von Dassow G, 2002, J EXP ZOOL, V294, P179, DOI 10.1002/jez.10144; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner A, 2007, BIOSYSTEMS, V88, P163, DOI 10.1016/j.biosystems.2006.06.002; Watson J, 2004, BIOSYSTEMS, V76, P239, DOI 10.1016/j.biosystems.2004.05.016; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; ZHONG W, 2006, SCIENCE, V311	62	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2008	3	9							e3245	10.1371/journal.pone.0003245	http://dx.doi.org/10.1371/journal.pone.0003245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LF	18802467	Green Published, Green Submitted, gold			2022-12-27	WOS:000264428600005
J	Dreher, JC; Koechlin, E; Tierney, M; Grafman, J				Dreher, Jean-Claude; Koechlin, Etienne; Tierney, Michael; Grafman, Jordan			Damage to the Fronto-Polar Cortex Is Associated with Impaired Multitasking	PLOS ONE			English	Article							HUMAN PREFRONTAL CORTEX; DUAL-TASK PERFORMANCE; HUMAN COGNITION; WORKING-MEMORY; HUMANS; FMRI; INFORMATION; INTEGRATION; RETRIEVAL; ACTIVATION	Background: A major question in understanding the functional organization of the brain is to delineate the functional divisions of the prefrontal cortex. Of particular importance to the cognitive capacities that are uniquely human is the fronto-polar cortex (Brodmann's area 10), which is disproportionally larger in humans relative to the rest of the brain than it is in the ape's brain. The specific function of this brain region remains poorly understood, but recent neuroimaging studies have proposed that it may hold goals in mind while exploring and processing secondary goals. Principal Findings: Here we show that the extent of damage to the fronto-polar cortex predicts impairment in the management of multiple goals. This result reveals that the integrity of the fronto-polar cortex is necessary to perform tasks that require subjects to maintain a primary goal in mind while processing secondary goals, an ability which is crucial for complex human cognitive abilities. Conclusion/Significance: These results provide important new insights concerning the cerebral basis of complex human cognition such as planning and multitasking.			Dreher, JC (corresponding author), CNRS, Cognit Neurosci Ctr, Reward & Decis Making Team, UMR 5229, Lyon, France.	dreher@isc.cnrs.fr; grafmanj@ninds.nih.gov	Koechlin, Etienne/AAF-5717-2021; Koechlin, Etienne/E-5061-2016; Dreher, Jean-Claude/H-8949-2017	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311; Dreher, Jean-Claude/0000-0002-2157-1529; Grafman, Jordan H./0000-0001-8645-4457	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003024, ZIANS003024] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; Burgess CP, 2003, J HIGH ENERGY PHYS; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Christoff K, 2003, BEHAV NEUROSCI, V117, P1161, DOI 10.1037/0735-7044.117.6.1161; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; DAMASIO AR, 1995, BRAIN ANATOMY COMPUT; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; Dreher JC, 2002, P NATL ACAD SCI USA, V99, P14595, DOI 10.1073/pnas.222193299; Dreher JC, 2002, NEUROIMAGE, V17, P95, DOI 10.1006/nimg.2002.1169; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Duzel E, 1999, P NATL ACAD SCI USA, V96, P1794, DOI 10.1073/pnas.96.4.1794; Green AE, 2006, BRAIN RES, V1096, P125, DOI 10.1016/j.brainres.2006.04.024; Herath P, 2001, CEREB CORTEX, V11, P796, DOI 10.1093/cercor/11.9.796; Koechlin E, 2002, NEURON, V35, P371, DOI 10.1016/S0896-6273(02)00742-0; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Pallier C, 1997, BEHAV RES METH INS C, V29, P322, DOI 10.3758/BF03200583; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Semendeferi K, 2002, NAT NEUROSCI, V5, P272, DOI 10.1038/nn814; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Stelzel C, 2006, PSYCHOL RES-PSYCH FO, V70, P514, DOI 10.1007/s00426-005-0013-7; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2012, DOI 10.1073/pnas.91.6.2012; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Wylie GR, 2006, CEREB CORTEX, V16, P394, DOI 10.1093/cercor/bhi118	35	74	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3227	10.1371/journal.pone.0003227	http://dx.doi.org/10.1371/journal.pone.0003227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422LA	18795100	Green Submitted, gold, Green Published			2022-12-27	WOS:000264428000009
J	Paterson, DM; Aspden, RJ; Visscher, PT; Consalvey, M; Andres, MS; Decho, AW; Stolz, J; Reid, RP				Paterson, David M.; Aspden, Rebecca J.; Visscher, Pieter T.; Consalvey, Mireille; Andres, Miriam S.; Decho, Alan W.; Stolz, John; Reid, R. Pamela			Light-Dependant Biostabilisation of Sediments by Stromatolite Assemblages	PLOS ONE			English	Article								For the first time we have investigated the natural ecosystem engineering capacity of stromatolitic microbial assemblages. Stromatolites are laminated sedimentary structures formed by microbial activity and are considered to have dominated the shallows of the Precambrian oceans. Their fossilised remains are the most ancient unambiguous record of early life on earth. Stromatolites can therefore be considered as the first recognisable ecosystems on the planet. However, while many discussions have taken place over their structure and form, we have very little information on their functional ecology and how such assemblages persisted despite strong eternal forcing from wind and waves. The capture and binding of sediment is clearly a critical feature for the formation and persistence of stromatolite assemblages. Here, we investigated the ecosystem engineering capacity of stromatolitic microbial assemblages with respect to their ability to stabilise sediment using material from one of the few remaining living stromatolite systems (Highborne Cay, Bahamas). It was shown that the most effective assemblages could produce a rapid (12-24 h) and significant increase in sediment stability that continued in a linear fashion over the period of the experimentation (228 h). Importantly, it was also found that light was required for the assemblages to produce this stabilisation effect and that removal of assemblage into darkness could lead to a partial reversal of the stabilisation. This was attributed to the breakdown of extracellular polymeric substances under anaerobic conditions. These data were supported by microelectrode profiling of oxygen and calcium. The structure of the assemblages as they formed was visualised by low-temperature scanning electron microscopy and confocal laser microscopy. These results have implications for the understanding of early stromatolite development and highlight the potential importance of the evolution of photosynthesis in the mat forming process. The evolution of photosynthesis may have provided an important advance for the niche construction activity of microbial systems and the formation and persistence of the stromatolites which came to dominate shallow coastal environments for 80% of the biotic history of the earth.	[Paterson, David M.; Aspden, Rebecca J.] Univ St Andrews, Sediment Ecol Res Grp, Gatty Marine Lab, Sch Biol, St Andrews, Fife, Scotland; [Visscher, Pieter T.] Univ Connecticut, Dept Marine Sci, Storrs, CT 06269 USA; [Consalvey, Mireille] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand; [Andres, Miriam S.; Reid, R. Pamela] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Geol & Geophys, Coral Gables, FL 33124 USA; [Decho, Alan W.] Univ South Carolina, Arnold Sch Publ Hlth, Dept Environm Hlth Sci, Columbia, SC USA; [Stolz, John] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA USA	University of St Andrews; University of Connecticut; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Miami; University of South Carolina System; University of South Carolina Columbia; Duquesne University	Paterson, DM (corresponding author), Univ St Andrews, Sediment Ecol Res Grp, Gatty Marine Lab, Sch Biol, St Andrews, Fife, Scotland.	dp1@st-andrews.ac.uk	Paterson, David M/D-5202-2013; Decho, Alan W/F-9510-2010; Visscher, Pieter/T-7464-2017	Paterson, David M/0000-0003-1174-6476; Visscher, Pieter/0000-0001-6911-1532	NSF Biocomplexity award	NSF Biocomplexity award	Funding was provided by the NSF Biocomplexity award to the RIBS programme under Dr. P. Reid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres MS, 2006, SEDIMENT GEOL, V185, P319, DOI 10.1016/j.sedgeo.2005.12.020; ASPDEN RJ, 2004, SALT MARSH MICROBIAL; AWRAMIK SM, 1988, P NATL ACAD SCI USA, V85, P1327, DOI 10.1073/pnas.85.5.1327; Casillas-Martinez L, 2005, GEOMICROBIOL J, V22, P269, DOI 10.1080/01490450500182672; CHAFETZ HS, 1986, J SEDIMENT PETROL, V56, P812; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; DADE WB, 1990, GEOMICROBIOL J, V8, P1, DOI 10.1080/01490459009377874; Decho AW, 1999, BIOTECHNIQUES, V27, P1246; Decho AW, 2005, PALAEOGEOGR PALAEOCL, V219, P71, DOI 10.1016/j.palaeo.2004.10.015; DRAVIS JJ, 1983, SCIENCE, V219, P385, DOI 10.1126/science.219.4583.385; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; GRANT J, 1987, NATURE, V330, P244, DOI 10.1038/330244a0; Grotzinger JP, 1999, ANNU REV EARTH PL SC, V27, P313, DOI 10.1146/annurev.earth.27.1.313; LAWTON J, 1995, LINKING SPECIES ECOS; LOREAU M, 2004, BIODIVERSITY ECOSYST; PATERSON DM, 1989, LIMNOL OCEANOGR, V34, P223, DOI 10.4319/lo.1989.34.1.0223; PATERSON DM, 1995, J GEOL SOC LONDON, V152, P131, DOI 10.1144/gsjgs.152.1.0131; Paterson DM, 2000, MICROBIAL SEDIMENTS, P217; Pringault O, 2005, MICROB ECOL, V49, P604, DOI 10.1007/s00248-004-0102-y; Reid P, 2003, FOSSIL AND RECENT BIOFILMS, P103; Reid RP, 2000, NATURE, V406, P989, DOI 10.1038/35023158; Sergeev VN, 2002, MICROBIOLOGY+, V71, P623, DOI 10.1023/A:1021415503436; Stal L.J., 2000, ECOLOGY CYANOBACTERI, P61; STAL LJ, 1985, FEMS MICROBIOL ECOL, V31, P111, DOI 10.1111/j.1574-6968.1985.tb01138.x; Tolhurst TJ, 1999, ESTUAR COAST SHELF S, V49, P281, DOI 10.1006/ecss.1999.0512; Underwood GJC, 2003, ADV BOT RES, V40, P183, DOI 10.1016/S0065-2296(05)40005-1; VASCONCELOS C, 1995, NATURE, V377, P220, DOI 10.1038/377220a0; Visscher PT, 2000, GEOLOGY, V28, P919, DOI 10.1130/0091-7613(2000)028<0919:MOOSRC>2.3.CO;2; Visscher PT, 1998, AM MINERAL, V83, P1482, DOI 10.2138/am-1998-11-1236; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016; VISSCHER PT, 2002, ENV ELECTROCHEMISTRY, P265; Wright DT, 2005, GEOMICROBIOL J, V22, P27, DOI 10.1080/01490450590922532; Zar JH., 1999, BIOSTAT ANAL	33	39	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3176	10.1371/journal.pone.0003176	http://dx.doi.org/10.1371/journal.pone.0003176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KD	18781202	Green Published, gold			2022-12-27	WOS:000264425700008
J	Yoon, KJ; Phelps, DA; Bush, RA; Remack, JS; Billups, CA; Khoury, JD				Yoon, Karina Jin; Phelps, Doris A.; Bush, Rebecca A.; Remack, Joanna S.; Billups, Catherine A.; Khoury, Joseph D.			ICAM-2 Expression Mediates a Membrane-Actin Link, Confers a Nonmetastatic Phenotype and Reflects Favorable Tumor Stage or Histology in Neuroblastoma	PLOS ONE			English	Article								The actin cytoskeleton is a primary determinant of tumor cell motility and metastatic potential. Motility and metastasis are thought to be regulated, in large part, by the interaction of membrane proteins with cytoplasmic linker proteins and of these linker proteins, in turn, with actin. However, complete membrane-to-actin linkages have been difficult to identify. We used co-immunoprecipitation and competitive peptide assays to show that intercellular adhesion molecule-2 (ICAM-2)/alpha-actinin/actin may comprise such a linkage in neuroblastoma cells. ICAM-2 expression limited the motility of these cells and redistributed actin fibers in vitro, and suppressed development of disseminated tumors in an in vivo model of metastatic neuroblastoma. Consistent with these observations, immunohistochemical analysis demonstrated ICAM-2 expression in primary neuroblastoma tumors exhibiting features that are associated with limited metastatic disease and more favorable clinical outcome. In neuroblastoma cell lines, ICAM-2 expression did not affect AKT activation, tumorigenic potential or chemosensitivity, as has been reported for some types of transfected cells. The observed ICAM-2- mediated suppression of metastatic phenotype is a novel function for this protein, and the interaction of ICAM-2/alpha-actinin/actin represents the first complete membrane-linker protein-actin linkage to impact tumor cell motility in vitro and metastatic potential in an in vivo model. Current work focuses on identifying specific protein domains critical to the regulation of neuroblastoma cell motility and metastasis and on determining if these domains represent exploitable therapeutic targets.	[Yoon, Karina Jin; Phelps, Doris A.; Bush, Rebecca A.; Remack, Joanna S.] St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; [Billups, Catherine A.] St Jude Childrens Hosp, Dept Biostat, Memphis, TN USA; [Khoury, Joseph D.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Yoon, KJ (corresponding author), St Jude Childrens Hosp, Dept Mol Pharmacol, 332 N Lauderdale St, Memphis, TN 38105 USA.	karina.yoon@stjude.org	Bush, Rebecca/D-3458-2018	Bush, Rebecca/0000-0003-0388-5134	American Lebanese Syrian Associated Charities [CA21765]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by CA21765 and American Lebanese Syrian Associated Charities.	Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Carpenito C, 1997, SCAND J IMMUNOL, V45, P248, DOI 10.1046/j.1365-3083.1997.d01-391.x; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; GLUCK U, 1994, J CELL SCI, V107, P1773; Heiska L, 1996, J BIOL CHEM, V271, P26214, DOI 10.1074/jbc.271.42.26214; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Huang MT, 2006, BLOOD, V107, P4721, DOI 10.1182/blood-2005-11-4683; Huang MT, 2005, BLOOD, V106, P1636, DOI 10.1182/blood-2004-12-4716; Hunter KW, 2004, TRENDS MOL MED, V10, P201, DOI 10.1016/j.molmed.2004.03.001; IINO H, 1994, CANCER, V73, P1324, DOI 10.1002/1097-0142(19940301)73:5<1324::AID-CNCR2820730503>3.0.CO;2-W; Izzi L, 1999, ONCOGENE, V18, P5563, DOI 10.1038/sj.onc.1202935; James MF, 2004, J CELL SCI, V117, P2951, DOI 10.1242/jcs.01156; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Klaile E, 2005, J CELL SCI, V118, P5513, DOI 10.1242/jcs.02660; KLEINMAN HK, 1998, CURRENT PROTOCOLS CE; Kobayashi H, 2004, CLIN CANCER RES, V10, P572, DOI 10.1158/1078-0432.CCR-1323-03; Kotovuori A, 1999, J IMMUNOL, V162, P6613; KUHLMAN PA, 1992, FEBS LETT, V304, P201, DOI 10.1016/0014-5793(92)80619-R; KUHLMAN PA, 1994, FEBS LETT, V339, P297, DOI 10.1016/0014-5793(94)80434-6; Leung N, 2006, ONCOGENE, V25, P5527, DOI 10.1038/sj.onc.1209541; Makitie T, 2001, INVEST OPHTH VIS SCI, V42, P2442; MARIS JM, 2006, CANC MED, V7, P1990; Melero I, 2003, CLIN CANCER RES, V9, P3546; Menez J, 2004, ONCOGENE, V23, P2630, DOI 10.1038/sj.onc.1207347; Moilanen J, 2003, GYNECOL ONCOL, V90, P273, DOI 10.1016/S0090-8258(03)00262-2; Nikolopoulos SN, 2000, ONCOGENE, V19, P380, DOI 10.1038/sj.onc.1203310; NORTAMO P, 1991, J IMMUNOL, V146, P2530; Perez OD, 2002, IMMUNITY, V16, P51, DOI 10.1016/S1074-7613(02)00266-2; Pietersz GA, 2001, VACCINE, V19, P1397, DOI 10.1016/S0264-410X(00)00373-X; Reiss Y, 1999, INT IMMUNOL, V11, P1527, DOI 10.1093/intimm/11.9.1527; Reyes-Mugica M, 1998, LAB INVEST, V78, P669; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; SCHWAB M, 2000, PATHOLOGY GENETICS T, P153; Simon T, 2004, J PEDIAT HEMATOL ONC, V26, P791; Singh K, 2008, J IMMUNOL, V180, P1971, DOI 10.4049/jimmunol.180.3.1971; SUN CX, 2002, J CELL SCI; Tanaka H, 2004, CLIN CANCER RES, V10, P4885, DOI 10.1158/1078-0432.CCR-0393-03; Thies A, 2002, J CLIN ONCOL, V20, P2530, DOI 10.1200/JCO.2002.05.033; Thompson J, 2001, CANCER CHEMOTH PHARM, V47, P211, DOI 10.1007/s002800000235; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	46	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3629	10.1371/journal.pone.0003629	http://dx.doi.org/10.1371/journal.pone.0003629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978946	gold, Green Published, Green Submitted			2022-12-27	WOS:000265134200011
J	Karnowski, A; Cao, C; Matthias, G; Carotta, S; Corcoran, LM; Martensson, IL; Skok, JA; Matthias, P				Karnowski, Alexander; Cao, Chun; Matthias, Gabriele; Carotta, Sebastian; Corcoran, Lynn M.; Martensson, Inga-Lill; Skok, Jane A.; Matthias, Patrick			Silencing and Nuclear Repositioning of the lambda 5 Gene Locus at the Pre-B Cell Stage Requires Aiolos and OBF-1	PLOS ONE			English	Article							BRUTONS TYROSINE KINASE; DNA-BINDING PROTEINS; TRANSCRIPTION FACTOR; COACTIVATOR; IKAROS; EXPRESSION; RECEPTOR; DIFFERENTIATION; REPRESSION; SELECTION	The chromatin regulator Aiolos and the transcriptional coactivator OBF-1 have been implicated in regulating aspects of B cell maturation and activation. Mice lacking either of these factors have a largely normal early B cell development. However, when both factors are eliminated simultaneously a block is uncovered at the transition between pre-B and immature B cells, indicating that these proteins exert a critical function in developing B lymphocytes. In mice deficient for Aiolos and OBF-1, the numbers of immature B cells are reduced, small pre-BII cells are increased and a significant impairment in immunoglobulin light chain DNA rearrangement is observed. We identified genes whose expression is deregulated in the pre-B cell compartment of these mice. In particular, we found that components of the pre-BCR, such as the surrogate light chain genes lambda 5 and VpreB, fail to be efficiently silenced in double-mutant mice. Strikingly, developmentally regulated nuclear repositioning of the lambda 5 gene is impaired in pre-B cells lacking OBF-1 and Aiolos. These studies uncover a novel role for OBF-1 and Aiolos in controlling the transcription and nuclear organization of genes involved in pre-BCR function.	[Karnowski, Alexander; Cao, Chun; Matthias, Gabriele; Matthias, Patrick] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Karnowski, Alexander; Carotta, Sebastian; Corcoran, Lynn M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Martensson, Inga-Lill] Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge, England; [Skok, Jane A.] UCL, Dept Immunol & Mol Pathol, London WC1E 6BT, England; [Skok, Jane A.] NYU, Sch Med, New York, NY USA	Friedrich Miescher Institute for Biomedical Research; Novartis; Walter & Eliza Hall Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of London; University College London; New York University	Karnowski, A (corresponding author), Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	patrick.matthias@fmi.ch	Corcoran, Lynn M/C-9316-2013; Skok, Jane/ABF-7249-2020	Skok, Jane/0000-0002-4145-1516; Martensson, Inga-Lill/0000-0003-3415-0560	Novartis Research Foundation; BBSRC, UK; The Wellcome Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086852] Funding Source: NIH RePORTER	Novartis Research Foundation; BBSRC, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The Wellcome Trust Fund(Wellcome Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Novartis Research Foundation (to PM), the BBSRC, UK (to ILM) and The Wellcome Trust Fund (to JAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Bartholdy B, 2006, P NATL ACAD SCI USA, V103, P11665, DOI 10.1073/pnas.0509430103; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Brouns GS, 1996, J BIOL CHEM, V271, P19272, DOI 10.1074/jbc.271.32.19272; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Brunner C, 2006, NUCLEIC ACIDS RES, V34, P1807, DOI 10.1093/nar/gkl131; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Casellas R, 2002, CELL, V110, P575, DOI 10.1016/S0092-8674(02)00911-X; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Corcoran LM, 2005, J EXP MED, V201, P1385, DOI 10.1084/jem.20042325; Edry E, 2004, J IMMUNOL, V173, P4265, DOI 10.4049/jimmunol.173.7.4265; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Friedl EM, 1996, J BIOL CHEM, V271, P13927, DOI 10.1074/jbc.271.24.13927; Georgopoulos K, 1997, CURR OPIN IMMUNOL, V9, P222, DOI 10.1016/S0952-7915(97)80139-2; Gstaiger M, 1996, EMBO J, V15, P2781, DOI 10.1002/j.1460-2075.1996.tb00638.x; Hendriks RW, 2004, TRENDS IMMUNOL, V25, P249, DOI 10.1016/j.it.2004.02.011; Hess J, 2001, P NATL ACAD SCI USA, V98, P1745, DOI 10.1073/pnas.041492098; Hoffmann R, 2002, GENOME RES, V12, P98, DOI 10.1101/gr.201501; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Johnson K, 2005, MOL IMMUNOL, V42, P749, DOI 10.1016/j.molimm.2004.06.039; Jumaa H, 2001, EUR J IMMUNOL, V31, P2164, DOI 10.1002/1521-4141(200107)31:7<2164::AID-IMMU2164>3.0.CO;2-S; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim U, 2003, P NATL ACAD SCI USA, V100, P8868, DOI 10.1073/pnas.1033108100; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Lacorazza HD, 2001, J IMMUNOL, V167, P5689, DOI 10.4049/jimmunol.167.10.5689; Laumen H, 2004, NUCLEIC ACIDS RES, V32, P1577, DOI 10.1093/nar/gkh327; LILLYCROP KA, 1994, MOL CELL BIOL, V14, P7633, DOI 10.1128/MCB.14.11.7633; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; LUO Y, 1995, MOL CELL BIOL, V15, P4115; Ma SB, 2008, BLOOD, V111, P1396, DOI 10.1182/blood-2007-08-110106; Malin S, 2005, NUCLEIC ACIDS RES, V33, P4618, DOI 10.1093/nar/gki744; Martin DA, 2007, J IMMUNOL, V179, P4996, DOI 10.4049/jimmunol.179.8.4996; Matthias P, 2005, NAT REV IMMUNOL, V5, P497, DOI 10.1038/nri1633; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Middendorp S, 2002, J IMMUNOL, V168, P2695, DOI 10.4049/jimmunol.168.6.2695; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Mundt C, 2006, INT IMMUNOL, V18, P163, DOI 10.1093/intimm/dxh359; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; PARKER MJ, 2005, EMBO J; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Sabbattini P, 2005, SEMIN IMMUNOL, V17, P121, DOI 10.1016/j.smim.2005.01.004; Sabbattini P, 2001, EMBO J, V20, P2812, DOI 10.1093/emboj/20.11.2812; SAMA G, 2002, ATLAS CERAMBYCIDAE E, V1, P1; Samardzic T, 2002, EUR J IMMUNOL, V32, P2481, DOI 10.1002/1521-4141(200209)32:9<2481::AID-IMMU2481>3.0.CO;2-C; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Schubart DB, 2000, J IMMUNOL, V164, P18, DOI 10.4049/jimmunol.164.1.18; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; ten Boekel E, 1999, CURR TOP MICROBIOL, V246, P3; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; van den Brandt J, 2005, J IMMUNOL, V174, P7845, DOI 10.4049/jimmunol.174.12.7845; van Loo PF, 2007, IMMUNITY, V27, P468, DOI 10.1016/j.immuni.2007.07.018; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wang YH, 1998, J IMMUNOL, V161, P1132; Wen RR, 2004, EMBO J, V23, P4007, DOI 10.1038/sj.emboj.7600405; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Zou XG, 2003, J IMMUNOL, V170, P1354, DOI 10.4049/jimmunol.170.3.1354	72	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3568	10.1371/journal.pone.0003568	http://dx.doi.org/10.1371/journal.pone.0003568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974788	Green Published, gold			2022-12-27	WOS:000265131500003
J	Wiley, CD; Matundan, HH; Duselis, AR; Isaacs, AT; Vrana, PB				Wiley, Christopher D.; Matundan, Harry H.; Duselis, Amanda R.; Isaacs, Alison T.; Vrana, Paul B.			Patterns of Hybrid Loss of Imprinting Reveal Tissue- and Cluster-Specific Regulation	PLOS ONE			English	Article							DNA METHYLATION; DISTAL CHROMOSOME-7; HYDATIDIFORM MOLES; GENE-EXPRESSION; CANDIDATE GENE; CELL-CYCLE; LOCUS; DELETION; PEG10; H19	Background: Crosses between natural populations of two species of deer mice, Peromyscus maniculatus (BW), and P. polionotus (PO), produce parent-of-origin effects on growth and development. BW females mated to PO males (bwxpo) produce growth-retarded but otherwise healthy offspring. In contrast, PO females mated to BW males (POxBW) produce overgrown and severely defective offspring. The hybrid phenotypes are pronounced in the placenta and include POxBW conceptuses which lack embryonic structures. Evidence to date links variation in control of genomic imprinting with the hybrid defects, particularly in the POxBW offspring. Establishment of genomic imprinting is typically mediated by gametic DNA methylation at sites known as gDMRs. However, imprinted gene clusters vary in their regulation by gDMR sequences. Methodology/Principal Findings: Here we further assess imprinted gene expression and DNA methylation at different cluster types in order to discern patterns. These data reveal POxBW misexpression at the Kcnq1ot1 and Peg3 clusters, both of which lose ICR methylation in placental tissues. In contrast, some embryonic transcripts (Peg10, Kcnq1ot1) reactivated the silenced allele with little or no loss of DNA methylation. Hybrid brains also display different patterns of imprinting perturbations. Several cluster pairs thought to use analogous regulatory mechanisms are differentially affected in the hybrids. Conclusions/Significance: These data reinforce the hypothesis that placental and somatic gene regulation differs significantly, as does that between imprinted gene clusters and between species. That such epigenetic regulatory variation exists in recently diverged species suggests a role in reproductive isolation, and that this variation is likely to be adaptive.	[Wiley, Christopher D.; Matundan, Harry H.; Duselis, Amanda R.; Isaacs, Alison T.; Vrana, Paul B.] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92717 USA	University of California System; University of California Irvine	Wiley, CD (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92717 USA.	pvrana@uci.edu		Isaacs, Alison/0000-0002-2452-3338; Wiley, Christopher/0000-0002-7699-6866	U.S. National Science Foundation [MCB-0517754]	U.S. National Science Foundation(National Science Foundation (NSF))	Funded by the U.S. National Science Foundation (MCB-0517754). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima T, 2000, GENOMICS, V67, P248, DOI 10.1006/geno.2000.6266; Arima T, 2006, GENOMICS, V88, P650, DOI 10.1016/j.ygeno.2006.07.005; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; DAWSON WD, 1965, EVOLUTION, V19, P44, DOI 10.2307/2406294; DAWSON WD, 1993, GROWTH DEVELOP AGING, V57, P121; Delaval K, 2006, BIOESSAYS, V28, P453, DOI 10.1002/bies.20407; Duselis AR, 2007, REPROD FERT DEVELOP, V19, P695, DOI 10.1071/RD07015; Duselis AR, 2007, HUM MOL GENET, V16, P808, DOI 10.1093/hmg/ddm025; Duselis AR, 2005, GENESIS, V43, P155, DOI 10.1002/gene.20166; El-Maarri O, 2003, HUM MOL GENET, V12, P1405, DOI 10.1093/hmg/ddg152; Feinberg AP, 2000, CURR TOP MICROBIOL, V249, P87; Fisher RA, 2002, HUM MOL GENET, V11, P3267, DOI 10.1093/hmg/11.26.3267; Fisher RA, 2003, PLACENTA, V24, pS111, DOI 10.1053/plac.2002.0939; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; FUKUDA Y, 1979, J EXP ZOOL, V207, P481, DOI 10.1002/jez.1402070316; Good JM, 2008, EVOLUTION, V62, P50, DOI 10.1111/j.1558-5646.2007.00257.x; Hernandez A, 2002, ENDOCRINOLOGY, V143, P4483, DOI 10.1210/en.2002-220800; Judson H, 2002, NATURE, V416, P539, DOI 10.1038/416539a; Kainz B, 2007, INT J CANCER, V121, P1984, DOI 10.1002/ijc.22929; Kamiya M, 2000, HUM MOL GENET, V9, P453, DOI 10.1093/hmg/9.3.453; Khatib H, 2005, MAMM GENOME, V16, P545, DOI 10.1007/s00335-005-0029-8; Kohda M, 2001, MOL CARCINOGEN, V31, P184, DOI 10.1002/mc.1053; Kou YC, 2008, MOL HUM REPROD, V14, P33, DOI 10.1093/molehr/gam079; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; LI JY, 2007, MOL CELLULAR BIOL; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Loschiavo M, 2007, MAMM GENOME, V18, P75, DOI 10.1007/s00335-006-0083-x; Mackay DJG, 2006, HUM GENET, V119, P179, DOI 10.1007/s00439-005-0127-4; MADDOCK MB, 1979, J EXP ZOOL, V209, P417, DOI 10.1002/jez.1402090307; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Mann JR, 2000, CRIT REV EUKAR GENE, V10, P241; MEISTRICH ML, 2003, CHROMOSOMA; Mizuno Y, 2002, BIOCHEM BIOPH RES CO, V290, P1499, DOI 10.1006/bbrc.2002.6370; Moglabey YB, 1999, HUM MOL GENET, V8, P667, DOI 10.1093/hmg/8.4.667; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; MONK M, 1987, DEVELOPMENT, V99, P371; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Panichkul PC, 2005, J SOC GYNECOL INVEST, V12, P376, DOI 10.1016/j.jsgi.2005.02.011; Paulsen M, 2001, GENOME RES, V11, P2085, DOI 10.1101/gr.206901; Paulsen M, 1998, HUM MOL GENET, V7, P1149, DOI 10.1093/hmg/7.7.1149; Pearsall RS, 1999, GENOMICS, V55, P194, DOI 10.1006/geno.1998.5660; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; RIKKE BA, 1995, GENETICS, V139, P901; ROGERS JF, 1970, J REPROD FERTIL, V21, P255; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Sandell LL, 2003, P NATL ACAD SCI USA, V100, P4622, DOI 10.1073/pnas.0230424100; Schmidt JV, 2000, GENE DEV, V14, P1997; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Shi W, 2004, GENESIS, V39, P65, DOI 10.1002/gene.20027; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Suzuki S, 2005, MECH DEVELOP, V122, P213, DOI 10.1016/j.mod.2004.10.003; Tanaka K, 2001, ONCOLOGY-BASEL, V60, P268, DOI 10.1159/000055328; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Thorvaldsen JL, 2007, CELL, V130, DOI 10.1016/j.cell.2007.08.033; Toppings M, 2008, HUM REPROD, V23, P807, DOI 10.1093/humrep/den009; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tsou AP, 2003, J BIOMED SCI, V10, P625, DOI 10.1159/000073528; Van den Veyver IB, 2006, HUM REPROD UPDATE, V12, P233, DOI 10.1093/humupd/dmk005; van Vliet J, 2007, CELL MOL LIFE SCI, V64, P1531, DOI 10.1007/s00018-007-6526-z; Vrana PB, 2007, J MAMMAL, V88, P5, DOI 10.1644/06-MAMM-S-013R1.1; Vrana PB, 2006, METH MOLEC MED, V121, P439; Vrana PB, 2000, NAT GENET, V25, P120, DOI 10.1038/75518; Vrana PB, 1998, NAT GENET, V20, P362, DOI 10.1038/3833; Vrana PB, 2001, DEV GENES EVOL, V211, P523, DOI 10.1007/s00427-001-0188-x; WAKE N, 1978, J NATL CANCER I, V60, P51, DOI 10.1093/jnci/60.1.51; Wan LB, 2008, ADV GENET, V61, P207, DOI 10.1016/S0065-2660(07)00007-7; Zaitoun I, 2008, J ANIM SCI, V86, P25, DOI 10.2527/jas.2007-0150	78	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3572	10.1371/journal.pone.0003572	http://dx.doi.org/10.1371/journal.pone.0003572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958286	Green Published, gold			2022-12-27	WOS:000265131100025
J	Lai, SL; Chan, TH; Lin, MJ; Huang, WP; Lou, SW; Lee, SJ				Lai, Shih-Lei; Chan, Tun-Hao; Lin, Meng-Ju; Huang, Wei-Pang; Lou, Show-Wan; Lee, Shyh-Jye			Diaphanous-Related Formin 2 and Profilin I Are Required for Gastrulation Cell Movements	PLOS ONE			English	Article								Intensive cellular movements occur during gastrulation. These cellular movements rely heavily on dynamic actin assembly. Rho with its associated proteins, including the Rho-activated formin, Diaphanous, are key regulators of actin assembly in cellular protrusion and migration. However, the function of Diaphanous in gastrulation cell movements remains unclear. To study the role of Diaphanous in gastrulation, we isolated a partial zebrafish diaphanous-related formin 2 (zdia2) clone with its N-terminal regulatory domains. The GTPase binding domain of zDia2 is highly conserved compared to its mammalian homologues. Using a yeast two-hybrid assay, we showed that zDia2 interacts with constitutively-active RhoA and Cdc42. The zdia2 mRNAs were ubiquitously expressed during early embryonic development in zebrafish as determined by RT-PCR and whole-mount in situ hybridization analyses. Knockdown of zdia2 by antisense morpholino oligonucleotides (MOs) blocked epiboly formation and convergent extension in a dose-dependent manner, whereas ectopic expression of a human mdia gene partially rescued these defects. Time-lapse recording further showed that bleb-like cellular processes of blastoderm marginal deep marginal cells and pseudopod-/filopod-like processes of prechordal plate cells and lateral cells were abolished in the zdia2 morphants. Furthermore, zDia2 acts cell-autonomously since transplanted zdia2-knockdown cells exhibited low protrusive activity with aberrant migration in wild type host embryos. Lastly, co-injection of antisense MOs of zdia2 and zebrafish profilin I (zpfn 1), but not zebrafish profilin II, resulted in a synergistic inhibition of gastrulation cell movements. These results suggest that zDia2 in conjunction with zPfn 1 are required for gastrulation cell movements in zebrafish.	[Lai, Shih-Lei; Chan, Tun-Hao; Lin, Meng-Ju; Huang, Wei-Pang; Lee, Shyh-Jye] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Huang, Wei-Pang; Lou, Show-Wan; Lee, Shyh-Jye] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan; [Lou, Show-Wan] Natl Taiwan Univ, Inst Fisheries Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University	Lee, SJ (corresponding author), Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan.	jefflee@ntu.edu.tw	Lai, Ben/AAD-1628-2019; Lee, Shyh-Jye/C-6092-2008; Lai, Shih-Lei/O-1562-2018	Lee, Shyh-Jye/0000-0001-8452-9152; Lai, Shih-Lei/0000-0002-1409-4701; HUANG, WEI-PANG/0000-0001-8410-6555; Lin, Meng-Ju/0000-0001-7971-3668	National Science Council of Taiwan, R.O.C. [NSC94-2311-B-002-019]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by a grant (NSC94-2311-B-002-019) from the National Science Council of Taiwan, R.O.C.	Afshar K, 2000, DEVELOPMENT, V127, P1887; Alberts AS, 2002, CURR BIOL, V12, pR796, DOI 10.1016/S0960-9822(02)01309-X; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cheng JC, 2004, DEV DYNAM, V231, P313, DOI 10.1002/dvdy.20144; Crawford JM, 1998, DEV BIOL, V204, P151, DOI 10.1006/dbio.1998.9061; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; FINK RD, 1988, DEV BIOL, V129, P179, DOI 10.1016/0012-1606(88)90172-8; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; GOLDSCHMIDTCLERMONT PJ, 1992, MOL BIOL CELL, V3, P1015, DOI 10.1091/mbc.3.9.1015; Goto H, 2000, MICROSC RES TECHNIQ, V49, P173, DOI 10.1002/(SICI)1097-0029(20000415)49:2<173::AID-JEMT10>3.0.CO;2-A; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; HOGAN JC, 1977, J EMBRYOL EXP MORPH, V40, P125; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Jopling C, 2005, EMBO REP, V6, P426, DOI 10.1038/sj.embor.7400386; Kane DA, 1996, DEVELOPMENT, V123, P47; Karakesisoglou I, 1996, CELL MOTIL CYTOSKEL, V34, P36; Kato T, 2001, J CELL SCI, V114, P775; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lai SL, 2005, MOL REPROD DEV, V71, P186, DOI 10.1002/mrd.20290; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104; Mabuchi I, 1993, ZYGOTE, V1, P325, DOI 10.1017/S0967199400001659; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Martin P, 2002, CURR OPIN CELL BIOL, V14, P569, DOI 10.1016/S0955-0674(02)00369-1; Matsumura F, 2001, CELL STRUCT FUNCT, V26, P639, DOI 10.1247/csf.26.639; MOCKRIN SC, 1980, BIOCHEMISTRY-US, V19, P5359, DOI 10.1021/bi00564a033; Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nodelman IM, 1999, J MOL BIOL, V294, P1271, DOI 10.1006/jmbi.1999.3318; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sato A, 2006, DEVELOPMENT, V133, P4219, DOI 10.1242/dev.02590; Schier AF, 2001, CURR OPIN GENET DEV, V11, P393, DOI 10.1016/S0959-437X(00)00209-4; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Schluter K, 1998, J CELL SCI, V111, P3261; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; THISSE C, 1993, STRUCTURE ZEBRAFISH, P1203; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Trinkaus J P, 1980, Prog Clin Biol Res, V41, P887; TRINKAUS JP, 1992, J EXP ZOOL, V261, P40, DOI 10.1002/jez.1402610107; TRINKAUS JP, 1992, DEVELOPMENT, P75; Trinkaus JP, 1996, DEV BIOL, V177, P356, DOI 10.1006/dbio.1996.0169; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; Verkhovsky AB, 2003, MOL BIOL CELL, V14, P4667, DOI 10.1091/mbc.E02-10-0630; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; WilliamsMasson EM, 1997, DEVELOPMENT, V124, P2889; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Yang CS, 2000, J CELL BIOL, V150, P1001, DOI 10.1083/jcb.150.5.1001; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	82	31	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3439	10.1371/journal.pone.0003439	http://dx.doi.org/10.1371/journal.pone.0003439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941507	Green Submitted, gold, Green Published			2022-12-27	WOS:000265125900002
J	Shea, KF; Wells, CM; Garner, AP; Jones, GE				Shea, Kerry F.; Wells, Claire M.; Garner, Andrew P.; Jones, Gareth E.			ROCK1 and LIMK2 Interact in Spread but Not Blebbing Cancer Cells	PLOS ONE			English	Article								Cancer cells migrating within a 3D microenvironment are able to adopt either a mesenchymal or amoeboid mode of migration. Amoeboid migration is characterised by membrane blebbing that is dependent on the Rho effectors, ROCK1/2. We identify LIMK2 as the preferred substrate for ROCK1 but find that LIMK2 did not induce membrane blebbing, suggesting that a LIMK2 pathway is not involved in amoeboid-mode migration. In support of this hypothesis, novel FRET data demonstrate a direct interaction between ROCK1 and LIMK2 in polarised but not blebbing cells. Our results point to a specific role for the ROCK1: LIMK2 pathway in mesenchymal-mode migration.	[Shea, Kerry F.; Wells, Claire M.; Jones, Gareth E.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Shea, Kerry F.; Garner, Andrew P.] AstraZeneca, Canc & Infect Res Area, Macclesfield, Cheshire, England; [Wells, Claire M.] Kings Coll London, Div Canc Stud, London, England	University of London; King's College London; AstraZeneca; University of London; King's College London	Shea, KF (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	gareth.jones@kcl.ac.uk	Jones, Gareth E/H-2282-2012	Jones, Gareth E/0000-0001-5879-3048	Medical Research Council (MRC); BBSRC/AstraZeneca plc. [CASE studentship]	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC/AstraZeneca plc.(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)AstraZeneca)	This work was supported by the Medical Research Council (MRC), and the award of a CASE studentship from BBSRC/AstraZeneca plc.	AHMED T, 2008, CELLULAR SIGNALLING; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Honma M, 2006, MOL BIOL CELL, V17, P1888, DOI 10.1091/mbc.E05-12-1173; Hopkins AM, 2007, AM J PHYSIOL-GASTR L, V292, pG806, DOI 10.1152/ajpgi.00333.2006; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kamai T, 2002, BJU INT, V89, P449, DOI 10.1046/j.1464-4096.2001.01920.x; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lawler S, 1999, CURR BIOL, V9, pR800, DOI 10.1016/S0960-9822(99)80493-X; Lin T, 2003, CIRC RES, V92, P1296, DOI 10.1161/01.RES.0000078780.65824.8B; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Pandey D, 2006, BLOOD, V107, P575, DOI 10.1182/blood-2004-11-4377; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Sebbagh M, 2005, J EXP MED, V201, P465, DOI 10.1084/jem.20031877; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Torgerson RR, 1998, J CELL SCI, V111, P2911; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Zhou J, 2003, WORLD J GASTROENTERO, V9, P9, DOI 10.3748/wjg.v9.i1.9	35	17	17	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3398	10.1371/journal.pone.0003398	http://dx.doi.org/10.1371/journal.pone.0003398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852895	Green Submitted, Green Published, gold			2022-12-27	WOS:000265121700006
J	Begliomini, C; Nelini, C; Caria, A; Grodd, W; Castiello, U				Begliomini, Chiara; Nelini, Cristian; Caria, Andrea; Grodd, Wolfgang; Castiello, Umberto			Cortical Activations in Humans Grasp-Related Areas Depend on Hand Used and Handedness	PLOS ONE			English	Article							REACH-TO-GRASP; DORSAL PREMOTOR CORTEX; PRIMARY MOTOR CORTEX; PARIETAL CORTEX; ONLINE ADJUSTMENTS; CEREBELLAR; PRECISION; MOVEMENTS; FMRI; FORCE	Background: In non-human primates grasp-related sensorimotor transformations are accomplished in a circuit involving the anterior intraparietal sulcus (area AIP) and both the ventral and the dorsal sectors of the premotor cortex (vPMC and dPMC, respectively). Although a human homologue of such a circuit has been identified whether activity within this circuit varies depending on handedness has yet to be investigated. Methodology/Principal Findings: We used functional magnetic resonance imaging (fMRI) to explicitly test how handedness modulates activity within human grasping-related brain areas. Right-and left-handers subjects were requested to reach towards and grasp an object with either the right or the left hand using a precision grip while scanned. A kinematic study was conducted with similar procedures as a behavioral counterpart for the fMRI experiment. Results from a factorial design revealed significant activity within the right dPMC, the right cerebellum and AIP bilaterally. The pattern of activity within these areas mirrored the results found for the behavioral study. Conclusion/Significance: Data are discussed in terms of an handedness-independent role for the right dPMC in monitoring hand shaping, the need for bilateral AIP activity for the performance of precision grip movements which varies depending on handedness and the involvement of the cerebellum in terms of its connections with AIP. These results provide the first compelling evidence of specific grasping related neural activity depending on handedness.	[Begliomini, Chiara; Nelini, Cristian; Castiello, Umberto] Univ Padua, Dept Gen Psychol, Padua, Italy; [Caria, Andrea; Grodd, Wolfgang] Univ Tubingen Hosp, Dept Neuroradiol, D-72074 Tubingen, Germany	University of Padua; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Begliomini, C (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	umberto.castiello@unipd.it	BEGLIOMINI, CHIARA/D-1516-2014	BEGLIOMINI, CHIARA/0000-0001-7433-0414; Castiello, Umberto/0000-0003-0629-1286; Caria, Andrea/0000-0003-2017-7084	Italian Ministry of Research and University	Italian Ministry of Research and University(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Italian Ministry of Research and University (MUR) to UC.	Amunts K, 2000, NEUROPSYCHOLOGIA, V38, P304, DOI 10.1016/S0028-3932(99)00075-5; ANNETT M, 1992, BRIT J PSYCHOL, V83, P493, DOI 10.1111/j.2044-8295.1992.tb02455.x; Begliomini C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001108; Begliomini C, 2007, EUR J NEUROSCI, V25, P1245, DOI 10.1111/j.1460-9568.2007.05365.x; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Brochier T, 2007, CURR OPIN NEUROBIOL, V17, P637, DOI 10.1016/j.conb.2007.12.002; CASTIELLO U, 1993, BEHAV BRAIN RES, V56, P43, DOI 10.1016/0166-4328(93)90021-H; Castiello U, 1997, BRAIN, V120, P593, DOI 10.1093/brain/120.4.593; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Castiello U, 2008, NEUROSCIENTIST, V14, P157, DOI 10.1177/1073858407312080; Cavina-Pratesi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000424; Chapman H, 2002, EUR J NEUROSCI, V15, P2037, DOI 10.1046/j.1460-9568.2002.02021.x; Choi HJ, 2006, J COMP NEUROL, V495, P53, DOI 10.1002/cne.20849; Clower DM, 2005, CEREB CORTEX, V15, P913, DOI 10.1093/cercor/bhh190; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; COREN S, 1992, CAUSES CONSEQUENCES; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; CULHAM JC, 2004, FUNCTIONAL NEUROIMAG, V20, P1706; CULHAM JC, 2001, SOC NEUR SAN DIEG CA; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; Davare M, 2007, J NEUROSCI, V27, P3974, DOI 10.1523/JNEUROSCI.0426-07.2007; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ehrsson HH, 2001, J NEUROPHYSIOL, V85, P2613, DOI 10.1152/jn.2001.85.6.2613; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Farne A, 2003, NEUROPSYCHOLOGIA, V41, P739, DOI 10.1016/S0028-3932(02)00177-X; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Geyer S., 2004, ADV ANAT EMBRYOL CEL, V174, P1, DOI [DOI 10.1007/978-3-642-18910-4_1, 10.1007/978-3-642-18910-4_1]; GIBSON AR, 1994, INSIGHTS REACH GRASP, P129; Glaser DE, 2001, NEUROIMAGE, V13, pS127; Glover S, 2005, J COGNITIVE NEUROSCI, V17, P124, DOI 10.1162/0898929052880066; Gomez JE, 2000, EUR J NEUROSCI, V12, P3748, DOI 10.1046/j.1460-9568.2000.00232.x; Gonzalez CLR, 2006, J NEUROPHYSIOL, V95, P3496, DOI 10.1152/jn.01187.2005; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grosskopf A, 2006, EXP BRAIN RES, V168, P230, DOI 10.1007/s00221-005-0083-1; Hagberg GE, 2001, NEUROIMAGE, V14, P1193, DOI 10.1006/nimg.2001.0880; HAGGARD P, 1994, NEUROPSYCHOLOGIA, V32, P827, DOI 10.1016/0028-3932(94)90021-3; HEALEY JM, 1986, CORTEX, V22, P33, DOI 10.1016/S0010-9452(86)80031-4; Hermsdorfer J, 1999, EXP BRAIN RES, V128, P41, DOI 10.1007/s002210050815; HOOVER JE, 1993, SCIENCE, V259, P819, DOI 10.1126/science.7679223; Hopkins WD, 2002, J EXP PSYCHOL GEN, V131, P412, DOI 10.1037//0096-3445.131.3.412; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Lang CE, 1999, J NEUROPHYSIOL, V82, P2108, DOI 10.1152/jn.1999.82.5.2108; Mason CR, 2006, J NEUROPHYSIOL, V95, P144, DOI 10.1152/jn.00492.2005; Mason CR, 1998, J NEUROPHYSIOL, V79, P537, DOI 10.1152/jn.1998.79.2.537; Rand MK, 2000, EXP BRAIN RES, V135, P179, DOI 10.1007/s002210000528; Raos V, 2004, J NEUROPHYSIOL, V92, P1990, DOI 10.1152/jn.00154.2004; Raos V, 2003, J NEUROPHYSIOL, V89, P1503, DOI 10.1152/jn.00661.2002; Rice NJ, 2007, BRAIN RES, V1175, P76, DOI 10.1016/j.brainres.2007.08.009; Rice NJ, 2006, J NEUROSCI, V26, P8176, DOI 10.1523/JNEUROSCI.1641-06.2006; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Sainburg RL, 2004, J NEUROPHYSIOL, V92, P1374, DOI 10.1152/jn.00181.2004; Smeets JBJ, 2001, EXP BRAIN RES, V139, P92, DOI 10.1007/s002210100748; Smith Allan M., 1993, Canadian Journal of Neurological Sciences, V20, pS53; Solodkin A, 2001, EUR J NEUROL, V8, P425, DOI 10.1046/j.1468-1331.2001.00242.x; Timmann D, 1999, J NEUROPHYSIOL, V82, P103, DOI 10.1152/jn.1999.82.1.103; Timmann D, 2001, J NEUROPHYSIOL, V86, P2690, DOI 10.1152/jn.2001.86.6.2690; Tretriluxana J, 2008, EXP BRAIN RES, V188, P305, DOI 10.1007/s00221-008-1364-2; Tunik E, 2005, NAT NEUROSCI, V8, P505, DOI 10.1038/nn1430; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Umilta MA, 2007, J NEUROPHYSIOL, V98, P488, DOI 10.1152/jn.01094.2006; VANKAN PLE, 1994, J PHYSIOL-LONDON, V480, P171, DOI 10.1113/jphysiol.1994.sp020351; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zackowski KM, 2002, EXP BRAIN RES, V146, P511, DOI 10.1007/s00221-002-1191-9	72	59	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3388	10.1371/journal.pone.0003388	http://dx.doi.org/10.1371/journal.pone.0003388			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846222	Green Published, gold, Green Submitted			2022-12-27	WOS:000265114500011
J	Tsang, LH; Cassat, JE; Shaw, LN; Beenken, KE; Smeltzer, MS				Tsang, Laura H.; Cassat, James E.; Shaw, Lindsey N.; Beenken, Karen E.; Smeltzer, Mark S.			Factors Contributing to the Biofilm-Deficient Phenotype of Staphylococcus aureus sarA Mutants	PLOS ONE			English	Article								Mutation of sarA in Staphylococcus aureus results in a reduced capacity to form a biofilm, but the mechanistic basis for this remains unknown. Previous transcriptional profiling experiments identified a number of genes that are differentially expressed both in a biofilm and in a sarA mutant. This included genes involved in acid tolerance and the production of nucleolytic and proteolytic exoenzymes. Based on this we generated mutations in alsSD, nuc and sspA in the S. aureus clinical isolate UAMS-1 and its isogenic sarA mutant and assessed the impact on biofilm formation. Because expression of alsSD was increased in a biofilm but decreased in a sarA mutant, we also generated a plasmid construct that allowed expression of alsSD in a sarA mutant. Mutation of alsSD limited biofilm formation, but not to the degree observed with the corresponding sarA mutant, and restoration of alsSD expression did not restore the ability to form a biofilm. In contrast, concomitant mutation of sarA and nuc significantly enhanced biofilm formation by comparison to the sarA mutant. Although mutation of sspA had no significant impact on the ability of a sarA mutant to form a biofilm, a combination of protease inhibitors (E-64, 1-10-phenanthroline, and dichloroisocoumarin) that was shown to inhibit the production of multiple extracellular proteases without inhibiting growth was also shown to enhance the ability of a sarA mutant to form a biofilm. This effect was evident only when all three inhibitors were used concurrently. This suggests that the reduced capacity of a sarA mutant to form a biofilm involves extracellular proteases of all three classes (serine, cysteine and metalloproteases). Inclusion of protease inhibitors also enhanced biofilm formation in a sarA/nuc mutant, with the combined effect of mutating nuc and adding protease inhibitors resulting in a level of biofilm formation with the sarA mutant that approached that of the UAMS-1 parent strain. These results demonstrate that the inability of a sarA mutant to repress production of extracellular nuclease and multiple proteases have independent but cumulative effects that make a significant contribution to the biofilm-deficient phenotype of an S. aureus sarA mutant.	[Tsang, Laura H.; Cassat, James E.; Beenken, Karen E.; Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Shaw, Lindsey N.] Univ S Florida, Dept Biol, Tampa, FL USA	University of Arkansas System; University of Arkansas Medical Sciences; State University System of Florida; University of South Florida	Tsang, LH (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	smeltzermarks@uams.edu	Shaw, Lindsey/AAI-1741-2020; Smeltzer, Mark/M-2009-2018	Shaw, Lindsey/0000-0002-0629-8990; Smeltzer, Mark/0000-0002-0878-0692	National Institute of Allergy and Infectious Diseases (NIAID) [R01-AI43356]; American Heart Association [Predoctoral Fellowship]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043356] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases (NIAID) grant R01-AI43356 to MS. Further support was provided by an American Heart Association Predoctoral Fellowship to JC.	Angeles Tormo M, 2007, MICROBIOL-SGM, V153, P1702, DOI 10.1099/mic.0.2006/005744-0; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Balaban N, 2007, ANTIMICROB AGENTS CH, V51, P2226, DOI 10.1128/AAC.01097-06; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Cirioni O, 2007, ANTIMICROB AGENTS CH, V51, P4518, DOI 10.1128/AAC.00808-07; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; DeLeo FR, 2008, J EXP MED, V205, P271, DOI 10.1084/jem.20080167; Dubin G, 2008, J MOL BIOL, V379, P343, DOI 10.1016/j.jmb.2008.03.059; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Fitzpatrick F, 2005, J CLIN MICROBIOL, V43, P1973, DOI 10.1128/JCM.43.4.1973-1976.2005; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Giacometti A, 2003, ANTIMICROB AGENTS CH, V47, P1979, DOI 10.1128/AAC.47.6.1979-1983.2003; Gillaspy AF, 1998, INFECT IMMUN, V66, P3170, DOI 10.1128/IAI.66.7.3170-3178.1998; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jefferson KK, 2004, J BACTERIOL, V186, P2449, DOI 10.1128/JB.186.8.2449-2456.2004; Karlsson A, 2002, INFECT IMMUN, V70, P4239, DOI 10.1128/IAI.70.8.4239-4246.2002; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; Kim JH, 2008, J MICROBIOL BIOTECHN, V18, P28; Kiran MD, 2008, MOL PHARMACOL, V73, P1578, DOI 10.1124/mol.107.044164; Korem M, 2005, INFECT IMMUN, V73, P6220, DOI 10.1128/IAI.73.10.6220-6228.2005; Kovacikova G, 2005, MOL MICROBIOL, V57, P420, DOI 10.1111/j.1365-2958.2005.04700.x; LEE CY, 1986, J BACTERIOL, V166, P385, DOI 10.1128/jb.166.2.385-391.1986; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lim Y, 2004, J BACTERIOL, V186, P722, DOI 10.1128/JB.186.3.722-729.2004; McCallum N, 2004, J BACTERIOL, V186, P2966, DOI 10.1128/JB.186.10.2966-2972.2004; MILLER JR, 1987, J BACTERIOL, V169, P3508, DOI 10.1128/jb.169.8.3508-3514.1987; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Pane-Farre J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/j.ijmm.2005.11.011; Popowicz GM, 2006, J MOL BIOL, V358, P270, DOI 10.1016/j.jmb.2006.01.098; Rachid S, 2000, J BACTERIOL, V182, P6824, DOI 10.1128/JB.182.23.6824-6826.2000; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Toledo-Arana A, 2005, J BACTERIOL, V187, P5318, DOI 10.1128/JB.187.15.5318-5329.2005; Tsang LH, 2007, INFECT IMMUN, V75, P4528, DOI 10.1128/IAI.00603-07; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Vautor E, 2008, VET MICROBIOL, V127, P407, DOI 10.1016/j.vetmic.2007.08.018; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004; Welin-Neilands J, 2007, APPL ENVIRON MICROB, V73, P5633, DOI 10.1128/AEM.01049-07; Yang SJ, 2006, MOL MICROBIOL, V60, P458, DOI 10.1111/j.1365-2958.2006.05105.x; Yarwood JA, 2007, J BACTERIOL, V189, P7961, DOI 10.1128/JB.00789-07; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004	56	90	93	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3361	10.1371/journal.pone.0003361	http://dx.doi.org/10.1371/journal.pone.0003361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846215	Green Submitted, Green Published, gold			2022-12-27	WOS:000265114500003
J	Rezaval, C; Berni, J; Gorostiza, EA; Werbajh, S; Fagilde, MM; Fernandez, MP; Beckwith, EJ; Aranovich, EJ; Garcia, CASY; Ceriani, MF				Rezaval, Carolina; Berni, Jimena; Axel Gorostiza, Ezequiel; Werbajh, Santiago; Marta Fagilde, Maria; Paz Fernandez, Maria; Beckwith, Esteban J.; Aranovich, Ezequiel J.; Sabio y Garcia, Carmen A.; Fernanda Ceriani, Maria			A Functional Misexpression Screen Uncovers a Role for Enabled in Progressive Neurodegeneration	PLOS ONE			English	Article							TARGETED GENE-EXPRESSION; AXONAL-TRANSPORT; LOCOMOTOR-ACTIVITY; ACTIN CYTOSKELETON; BRAIN DEGENERATION; ENA/VASP PROTEINS; TYROSINE KINASE; DROSOPHILA; MODEL; MUTATIONS	Drosophila is a well-established model to study the molecular basis of neurodegenerative diseases. We carried out a misexpression screen to identify genes involved in neurodegeneration examining locomotor behavior in young and aged flies. We hypothesized that a progressive loss of rhythmic activity could reveal novel genes involved in neurodegenerative mechanisms. One of the interesting candidates showing progressive arrhythmicity has reduced enabled (ena) levels. ena down-regulation gave rise to progressive vacuolization in specific regions of the adult brain. Abnormal staining of presynaptic markers such as cystein string protein (CSP) suggest that axonal transport could underlie the neurodegeneration observed in the mutant. Reduced ena levels correlated with increased apoptosis, which could be rescued in the presence of p35, a general Caspase inhibitor. Thus, this mutant recapitulates two important features of human neurodegenerative diseases, i.e., vulnerability of certain neuronal populations and progressive degeneration, offering a unique scenario in which to unravel the specific mechanisms in an easily tractable organism.	[Rezaval, Carolina; Berni, Jimena; Axel Gorostiza, Ezequiel; Werbajh, Santiago; Marta Fagilde, Maria; Paz Fernandez, Maria; Beckwith, Esteban J.; Aranovich, Ezequiel J.; Sabio y Garcia, Carmen A.; Fernanda Ceriani, Maria] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Lab Genet Comportamiento, RA-1405 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Rezaval, C (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Lab Genet Comportamiento, RA-1405 Buenos Aires, DF, Argentina.	fceriani@leloir.org.ar	Gorostiza, E. Axel/S-8675-2019; de la Paz Fernandez, Maria/ABC-5366-2020	de la Paz Fernandez, Maria/0000-0002-9261-6114; Gorostiza, E. Axel/0000-0002-0185-971X; Ceriani, Maria/0000-0001-8945-3070; Berni, Jimena/0000-0002-5068-1372; Rezaval, Carolina/0000-0002-1410-5589	Argentine Research Council (CONICET) [graduate fellowships]; Agencia Nacional para la Promocion de Ciencia y Tecnologia (ANPCyT); HHMI International Research Program	Argentine Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional para la Promocion de Ciencia y Tecnologia (ANPCyT)(ANPCyT); HHMI International Research Program	MFC is a member of the Argentine Research Council (CONICET). CR, JB, EAG, MPF and EJB are/were supported by graduate fellowships from CONICET. This work was supported by a grant from the Agencia Nacional para la Promocion de Ciencia y Tecnologia (ANPCyT) and by the HHMI International Research Program to MFC. Funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly M, 2004, DEV CELL, V7, P462, DOI 10.1016/j.devcel.2004.09.008; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Bowman AB, 1999, J CELL BIOL, V146, P165; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUCHANAN RL, 1993, NEURON, V10, P839, DOI 10.1016/0896-6273(93)90200-B; Chan HYE, 2002, HUM MOL GENET, V11, P2895, DOI 10.1093/hmg/11.23.2895; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; da Cruz AB, 2005, MOL BIOL CELL, V16, P2433, DOI 10.1091/mbc.E04-11-1004; Fernandez MD, 2007, P NATL ACAD SCI USA, V104, P5650, DOI 10.1073/pnas.0608260104; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Ghosh S, 2004, HUM MOL GENET, V13, P2011, DOI 10.1093/hmg/ddh214; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Gnerer JP, 2006, P NATL ACAD SCI USA, V103, P14987, DOI 10.1073/pnas.0606887103; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; HAY BA, 1994, DEVELOPMENT, V120, P2121; Helfrich-Forster C, 2003, MICROSC RES TECHNIQ, V62, P94, DOI 10.1002/jemt.10357; Hurd DD, 1996, GENETICS, V144, P1075; Joshi D, 1999, CHRONOBIOL INT, V16, P751, DOI 10.3109/07420529909016942; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kraemer BC, 2007, HUM MOL GENET, V16, P1959, DOI 10.1093/hmg/ddm143; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Martin M, 2005, MOL BIOL CELL, V16, P4225, DOI 10.1091/mbc.E05-02-0116; Min KT, 1997, CURR BIOL, V7, P885, DOI 10.1016/S0960-9822(06)00378-2; Minois N, 2001, EXP GERONTOL, V36, P1137, DOI 10.1016/S0531-5565(00)00263-1; Myers KA, 2006, NEUROSCIENTIST, V12, P107, DOI 10.1177/1073858405283428; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Palladino MJ, 2002, GENETICS, V161, P1197; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rezaval C, 2007, EUR J NEUROSCI, V25, P683, DOI 10.1111/j.1460-9568.2007.05317.x; ROBERTSON HM, 1988, GENETICS, V118, P461; Rohn TT, 2008, J NEUROSCI, V28, P3051, DOI 10.1523/JNEUROSCI.5620-07.2008; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rusu P, 2007, EUR J NEUROSCI, V25, P1079, DOI 10.1111/j.1460-9568.2007.05341.x; Sapp E, 1999, J NEUROPATH EXP NEUR, V58, P165, DOI 10.1097/00005072-199902000-00006; Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324; Shulman JM, 2003, GENETICS, V165, P1233; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Vloeberghs E, 2004, EUR J NEUROSCI, V20, P2757, DOI 10.1111/j.1460-9568.2004.03755.x; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532	59	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3332	10.1371/journal.pone.0003332	http://dx.doi.org/10.1371/journal.pone.0003332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841196	gold, Green Published, Green Submitted			2022-12-27	WOS:000265113900002
J	Barnes, P; Thomas, KL				Barnes, Philip; Thomas, Kerrie L.			Proteolysis of proBDNF Is a Key Regulator in the Formation of Memory	PLOS ONE			English	Article							LONG-TERM POTENTIATION; RANDOMIZED CONTROLLED-TRIAL; NEUROTROPHIC FACTOR; FEAR MEMORY; BASOLATERAL AMYGDALA; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; AVERSIVE MEMORIES; RAT HIPPOCAMPUS; IN-VITRO	It is essential to understand the molecular processes underlying long-term memory to provide therapeutic targets of aberrant memory that produce pathological behaviour in humans. Under conditions of recall, fully-consolidated memories can undergo reconsolidation or extinction. These retrieval-mediated memory processes may rely on distinct molecular processes. The cellular mechanisms initiating the signature molecular events are not known. Using infusions of protein synthesis inhibitors, antisense oligonucleotide targeting brain-derived neurotrophic factor (BDNF) mRNA or tPA-STOP (an inhibitor of the proteolysis of BDNF protein) into the hippocampus of the awake rat, we show that acquisition and extinction of contextual fear memory depended on the increased and decreased proteolysis of proBDNF (precursor BDNF) in the hippocampus, respectively. Conditions of retrieval that are known to initiate the reconsolidation of contextual fear memory, a BDNF-independent memory process, were not correlated with altered proBDNF cleavage. Thus, the processing of BDNF was associated with the acquisition of new information and the updating of information about a salient stimulus. Furthermore, the differential requirement for the processing of proBDNF by tPA in distinct memory processes suggest that the molecular events actively engaged to support the storage and/or the successful retrieval of memory depends on the integration of ongoing experience with past learning.	[Barnes, Philip; Thomas, Kerrie L.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales	Cardiff University	Barnes, P (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales.	ThomasKL5@cf.ac.uk	Thomas, Kerrie L/A-6509-2010	Thomas, Kerrie L/0000-0003-3355-9583	The Royal Society; BBSRC [BB/C00583X]	The Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a research grant from The Royal Society. P.B. was supported by a BBSRC project grant (BB/C00583X). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Berlau DJ, 2006, NEUROBIOL LEARN MEM, V86, P123, DOI 10.1016/j.nlm.2005.12.008; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Bisson JI, 1997, BRIT J PSYCHIAT, V171, P78, DOI 10.1192/bjp.171.1.78; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; FALLS WA, 1992, J NEUROSCI, V12, P854; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Horwood JM, 2004, BEHAV BRAIN RES, V150, P127, DOI 10.1016/S0166-4328(03)00248-1; LaLumiere RT, 2005, LEARN MEMORY, V12, P296, DOI 10.1101/lm.93205; Lee H, 1998, J NEUROSCI, V18, P8444; Lee I, 2003, BEHAV NEUROSCI, V117, P1044, DOI 10.1037/0735-7044.117.5.1044; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; LEWIS DJ, 1979, PSYCHOL BULL, V86, P1054, DOI 10.1037/0033-2909.86.5.1054; Lin CH, 2005, LEARN MEMORY, V12, P130, DOI 10.1101/lm.85304; Lin CH, 2003, J NEUROSCI, V23, P8310; Lin CH, 2003, J NEUROSCI, V23, P1574; Liot G, 2004, J CEREBR BLOOD F MET, V24, P1153, DOI 10.1097/01.WCB.0000134476.93809.75; Liu QR, 2005, AM J MED GENET B, V134B, P93, DOI 10.1002/ajmg.b.30109; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Mayou RA, 2000, BRIT J PSYCHIAT, V176, P589, DOI 10.1192/bjp.176.6.589; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; McCloskey M., 1989, PSYCHOL LEARN MOTIV, V24, P109, DOI [10.1016/S0079-7421(08)60536-8, DOI 10.1016/S0079-7421(08)60536-8]; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Raymond CR, 2007, TRENDS NEUROSCI, V30, P167, DOI 10.1016/j.tins.2007.01.007; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Routtenberg A, 2005, TRENDS NEUROSCI, V28, P12, DOI 10.1016/j.tins.2004.11.006; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Summerton JE, 2007, CURR TOP MED CHEM, V7, P651, DOI 10.2174/156802607780487740; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Szapiro G, 2003, HIPPOCAMPUS, V13, P53, DOI 10.1002/hipo.10043; Ullal GR, 2007, NEUROCHEM INT, V50, P866, DOI 10.1016/j.neuint.2007.02.009; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	60	89	95	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3248	10.1371/journal.pone.0003248	http://dx.doi.org/10.1371/journal.pone.0003248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422MG	18813339	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000264431800002
J	Chatterjee, DK; Sitaraman, K; Baptista, C; Hartley, J; Hill, TM; Munroe, DJ				Chatterjee, Deb K.; Sitaraman, Kalavathy; Baptista, Cassio; Hartley, James; Hill, Thomas M.; Munroe, David J.			Protein Microarray On-Demand: A Novel Protein Microarray System	PLOS ONE			English	Article								We describe a novel, simple and low-cost protein microarray strategy wherein the microarrays are generated by printing expression ready plasmid DNAs onto slides that can be converted into protein arrays on-demand. The printed expression plasmids serve dual purposes as they not only direct the synthesis of the protein of interest; they also serve to capture the newly synthesized proteins through a high affinity DNA-protein interaction. To accomplish this we have exploited the high-affinity binding (similar to 3-7 x 10(-13) M) of E. coli Tus protein to Ter, a 20 bp DNA sequence involved in the regulation of E. coli DNA replication. In our system, each protein of interest is synthesized as a Tus fusion protein and each expression construct directing the protein synthesis contains embedded Ter DNA sequence. The embedded Ter sequence functions as a capture reagent for the newly synthesized Tus fusion protein. This "all DNA'' microarray can be converted to a protein microarray on-demand without need for any additional capture reagent..	[Chatterjee, Deb K.; Sitaraman, Kalavathy; Hartley, James] NCI, Prot Express Lab, SAIC Frederick Inc, Frederick, MD USA; [Baptista, Cassio] NCI, Lab Mol Technol, SAIC Frederick Inc, Frederick, MD USA; [Chatterjee, Deb K.; Sitaraman, Kalavathy; Baptista, Cassio; Hartley, James; Munroe, David J.] NCI, Advanced Technol Program, SAIC Frederick Inc, Frederick, MD USA; [Hill, Thomas M.] Univ North Dakota, Sch Med & Hlth Sci, Dept Microbiol & Immunol, Grand Forks, ND USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of North Dakota Grand Forks	Chatterjee, DK (corresponding author), NCI, Prot Express Lab, SAIC Frederick Inc, Frederick, MD USA.	chatterjee@mail.ncifcrf.gov			National Cancer Institute, National Institutes of Health [N01-CO-12400]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Arenkov P, 2000, ANAL BIOCHEM, V278, P123, DOI 10.1006/abio.1999.4363; BAPTISTA C, 2006, PROTEOMICS BIOL DISC, P189; CoskunAri FF, 1997, J BIOL CHEM, V272, P26448, DOI 10.1074/jbc.272.42.26448; Dietrich HRC, 2004, ANAL CHEM, V76, P4112, DOI 10.1021/ac049737n; Ge H, 2000, Nucleic Acids Res, V28, pe3, DOI 10.1093/nar/28.2.e3; Henderson TA, 2001, MOL GENET GENOMICS, V265, P941; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; MacBeath G, 2000, SCIENCE, V289, P1760; Nord O, 2003, J BIOTECHNOL, V106, P1, DOI 10.1016/j.jbiotec.2003.09.002; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4	13	22	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3265	10.1371/journal.pone.0003265	http://dx.doi.org/10.1371/journal.pone.0003265			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MG	18813342	Green Published, gold, Green Submitted			2022-12-27	WOS:000264431800005
J	Richards, J; McNally, B; Fang, XF; Caligiuri, MA; Zheng, P; Liu, Y				Richards, John; McNally, Beth; Fang, Xianfeng; Caligiuri, Michael A.; Zheng, Pan; Liu, Yang			Tumor Growth Decreases NK and B Cells as well as Common Lymphoid Progenitor	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IMMATURE MYELOID CELLS; FLT3 LIGAND; INTRAEPITHELIAL LYMPHOCYTES; MICE LACKING; GENERATION; SURVIVAL; LEUKEMIA; INTERLEUKIN-15; IDENTIFICATION	Background: It is well established that chronic tumor growth results in functional inactivation of T cells and NK cells. It is less clear, however, whether lymphopoeisis is affected by tumor growth. Principal Findings: In our efforts of analyzing the impact of tumor growth on NK cell development, we observed a major reduction of NK cell numbers in mice bearing multiple lineages of tumor cells. The decrease in NK cell numbers was not due to increased apoptosis or decreased proliferation in the NK compartment. In addition, transgenic expression of IL-15 also failed to rescue the defective production of NK cells. Our systematic characterization of lymphopoeisis in tumor-bearing mice indicated that the number of the common lymphoid progenitor was significantly reduced in tumor-bearing mice. The number of B cells also decreased substantially in tumor bearing mice. Conclusions and Significance: Our data reveal a novel mechanism for tumor evasion of host immunity and suggest a new interpretation for the altered myeloid and lymphoid ratio in tumor bearing hosts.	[Richards, John; McNally, Beth] Ohio State Univ, Med Ctr, Div Canc Immunol, Dept Pathol, Columbus, OH 43210 USA; [Caligiuri, Michael A.] Ohio State Univ, Med Ctr, Comprehensive Canc Ctr, Dept Med, Div Hematol & Oncol, Columbus, OH USA; [McNally, Beth; Fang, Xianfeng; Zheng, Pan; Liu, Yang] Univ Michigan, Comprehensive Canc Ctr, Dept Surg Internal Med Pathol, Div Immunotherapy, Ann Arbor, MI USA; [Fang, Xianfeng] Chinese Acad Sci, Inst Biophys, Beijing, Peoples R China	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; Chinese Academy of Sciences; Institute of Biophysics, CAS	Richards, J (corresponding author), Ohio State Univ, Med Ctr, Div Canc Immunol, Dept Pathol, Columbus, OH 43210 USA.	panz@umich.edu; yangl@umich.edu	fang, xianfeng/E-6301-2012; Zheng, Pan/E-8691-2011	fang, xianfeng/0000-0003-0161-0209; Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	 [P01CA9542];  [R01 CA112001]; NATIONAL CANCER INSTITUTE [R01CA112001, T32CA009542, R01CA058033] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by P01CA9542 and R01 CA112001. The sponsors have no role in study design, collection, analysis, and interpretation of data, writing of the paper, and decision to submit it for publication.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bauernhofer T, 2003, EUR J IMMUNOL, V33, P119, DOI 10.1002/immu.200390014; Bronte V, 2001, J IMMUNOTHER, V24, P431, DOI 10.1097/00002371-200111000-00001; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; de Jonge WJ, 2002, J CLIN INVEST, V110, P1539, DOI [10.1172/JCI200216143, 10.1172/JCI0216143]; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Geldhof Anja B, 2003, Clin Dev Immunol, V10, P71, DOI 10.1080/10446670310001626580; HACKETT J, 1986, P NATL ACAD SCI USA, V83, P3427, DOI 10.1073/pnas.83.10.3427; HALLER O, 1977, J EXP MED, V145, P1411, DOI 10.1084/jem.145.5.1411; Hoang T, 2004, ONCOGENE, V23, P7188, DOI 10.1038/sj.onc.1207937; Kennedy P, 2000, LAT TRADE, V8, P15; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Kusmartsev S, 2002, CANCER IMMUNOL IMMUN, V51, P293, DOI 10.1007/s00262-002-0280-8; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Mellqvist UH, 2000, BLOOD, V96, P1961, DOI 10.1182/blood.V96.5.1961.h8001961_1961_1968; Minagawa M, 2002, J IMMUNOL, V169, P4153, DOI 10.4049/jimmunol.169.8.4153; Pierson BA, 1996, BLOOD, V88, P2279, DOI 10.1182/blood.V88.6.2279.bloodjournal8862279; Prlic M, 2003, J EXP MED, V197, P967, DOI 10.1084/jem.20021847; RICHARDS J, 2006, BLOOD; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; SEAMAN WE, 1981, EXP HEMATOL, V9, P691; Serafini P, 2004, CANCER IMMUNOL IMMUN, V53, P64, DOI 10.1007/s00262-003-0443-2; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Williams NS, 1999, J IMMUNOL, V163, P2648; Williams NS, 1997, J EXP MED, V186, P1609, DOI 10.1084/jem.186.9.1609; Yu HX, 1998, BLOOD, V92, P3647, DOI 10.1182/blood.V92.10.3647.422k43_3647_3657; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	33	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3180	10.1371/journal.pone.0003180	http://dx.doi.org/10.1371/journal.pone.0003180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784839	Green Published, Green Submitted, gold			2022-12-27	WOS:000264425900002
J	Donroe, J; Tincopa, M; Gilman, RH; Brugge, D; Moore, DAJ				Donroe, Joseph; Tincopa, Monica; Gilman, Robert H.; Brugge, Doug; Moore, David A. J.			Pedestrian Road Traffic Injuries in Urban Peruvian Children and Adolescents: Case Control Analyses of Personal and Environmental Risk Factors	PLOS ONE			English	Article								Background: Child pedestrian road traffic injuries (RTIs) are an important cause of death and disability in poorer nations, however RTI prevention strategies in those countries largely draw upon studies conducted in wealthier countries. This research investigated personal and environmental risk factors for child pedestrian RTIs relevant to an urban, developing world setting. Methods: This is a case control study of personal and environmental risk factors for child pedestrian RTIs in San Juan de Miraflores, Lima, Peru. The analysis of personal risk factors included 100 cases of serious pedestrian RTIs and 200 age and gender matched controls. Demographic, socioeconomic, and injury data were collected. The environmental risk factor study evaluated vehicle and pedestrian movement and infrastructure at the sites in which 40 of the above case RTIs occurred and 80 control sites. Findings: After adjustment, factors associated with increased risk of child pedestrian RTIs included high vehicle volume (OR 7.88, 95%CI 1.97-31.52), absent lane demarcations (OR 6.59, 95%CI 1.65-26.26), high vehicle speed (OR 5.35, 95%CI 1.55-18.54, ), high street vendor density (OR 1.25, 95%CI 1.01-1.55), and more children living in the home (OR 1.25, 95%CI 1.00-1.56). Protective factors included more hours/day spent in school (OR 0.52, 95%CI 0.33-0.82) and years of family residence in the same home (OR 0.97, 95%CI 0.95-0.99). Conclusion: Reducing traffic volumes and speeds, limiting the number of street vendors on a given stretch of road, and improving lane demarcation should be evaluated as components of child pedestrian RTI interventions in poorer countries.	[Donroe, Joseph] Asociac Benefica PRISMA, Fogarty Int Ctr, Ellison Med Fdn, Lima, Peru; [Tincopa, Monica] Johns Hopkins Sch Med, Baltimore, MD USA; [Gilman, Robert H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Gilman, Robert H.; Moore, David A. J.] Asociac Benefica PRISMA, Lima, Peru; [Gilman, Robert H.; Moore, David A. J.] Univ Peruana Cayetano Heredia, Lab Investigac Enfermedades Infecciosas, Lima, Peru; [Brugge, Doug] Tufts Univ, Sch Med, Medford, MA 02155 USA; [Moore, David A. J.] Imperial Coll London, Wellcome Ctr Clin Trop Med, Fac Med, Dept Infect Dis & Immun, London, England	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano Heredia; Tufts University; Imperial College London	Donroe, J (corresponding author), Asociac Benefica PRISMA, Fogarty Int Ctr, Ellison Med Fdn, Lima, Peru.	jdonroe@gmail.com	Tincopa, Monica/AAK-7187-2021	Brugge, Doug/0000-0002-6812-2720	Tutorial in Tropical Health at JHU [5T35AI007646]; Fogarty International Center/ Ellison Medical Foundation-Overseas Fellowships in Global Health and Clinical Research; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T35AI007646] Funding Source: NIH RePORTER	Tutorial in Tropical Health at JHU; Fogarty International Center/ Ellison Medical Foundation-Overseas Fellowships in Global Health and Clinical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded in part by the Tutorial in Tropical Health at JHU/Peru Overseas Sites Grant (5T35AI007646) and the Fogarty International Center/ Ellison Medical Foundation-Overseas Fellowships in Global Health and Clinical Research. DAJM is supported by the Wellcome Trust. The authors' work was independent of the funders.	Agran P F, 1998, Inj Prev, V4, P188; Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Bartlett SN, 2002, HEALTH POLICY PLANN, V17, P1, DOI 10.1093/heapol/17.1.1; Brugge D, 2002, J URBAN HEALTH, V79, P87, DOI 10.1093/jurban/79.1.87; Duperrex O, 2002, BRIT MED J, V324, P1129, DOI 10.1136/bmj.324.7346.1129; Forjuoh Samuel N, 2003, Inj Control Saf Promot, V10, P109, DOI 10.1076/icsp.10.1.109.14115; Garg N, 2006, SCAND J PUBLIC HEALT, V34, P100, DOI 10.1080/14034940510032149; Hijar MC, 2001, INJURY, V32, P279, DOI 10.1016/S0020-1383(00)00220-5; Hyder AA, 2003, LANCET, V362, P2034, DOI 10.1016/S0140-6736(03)15145-8; MUELLER BA, 1990, AM J EPIDEMIOL, V132, P550, DOI 10.1093/oxfordjournals.aje.a115691; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; Peden M, 2005, ANN EMERG MED, V46, P158, DOI 10.1016/j.annemergmed.2005.04.017; PEDEN M, P WHO M DEV 5 YEAR S; Peden M., 2004, WORLD REPORT ROAD TR; Perel P, 2004, BMJ-BRIT MED J, V328, P895, DOI 10.1136/bmj.328.7444.895; PLESS IB, 1989, AM J PUBLIC HEALTH, V79, P995, DOI 10.2105/AJPH.79.8.995; PLESS IB, 1989, J PEDIATR-US, V115, P932, DOI 10.1016/S0022-3476(89)80745-0; RIVARA FP, 1985, PEDIATRICS, V76, P375; Rivara FP, 1997, NEW ENGL J MED, V337, P543, DOI 10.1056/NEJM199708213370807; ROBERTS I, 1995, BRIT MED J, V310, P91, DOI 10.1136/bmj.310.6972.91; ROBERTS I, 1995, EPIDEMIOLOGY, V6, P169, DOI 10.1097/00001648-199503000-00014; ROBERTS I, 1993, BRIT MED J, V306, P1737, DOI 10.1136/bmj.306.6894.1737; ROBERTS I, 1995, BRIT MED J, V310, P413, DOI 10.1136/bmj.310.6977.413a; Rodriguez Deysi Yasmin, 2003, Inj Control Saf Promot, V10, P29; STEVENSON MR, 1995, INT J EPIDEMIOL, V24, P957, DOI 10.1093/ije/24.5.957; WHO, 2004, GUID COND COMM SURV; *WHO, 1999, INJ LEAD CAUS GLOB B	29	38	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3166	10.1371/journal.pone.0003166	http://dx.doi.org/10.1371/journal.pone.0003166			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KD	18781206	Green Accepted, Green Published, gold			2022-12-27	WOS:000264425700007
J	Chou, CJ; O'Hare, T; Lefebvre, S; Alvarez, D; Tyner, JW; Eide, CA; Druker, BJ; Gottesfeld, JM				Chou, C. James; O'Hare, Thomas; Lefebvre, Sophie; Alvarez, David; Tyner, Jeffrey W.; Eide, Christopher A.; Druker, Brian J.; Gottesfeld, Joel M.			Growth Arrest of BCR-ABL Positive Cells with a Sequence-Specific Polyamide-Chlorambucil Conjugate	PLOS ONE			English	Article								Chronic myeloid leukemia (CML) is characterized by the presence of a constitutively active Abl kinase, which is the product of a chimeric BCR-ABL gene, caused by the genetic translocation known as the Philadelphia chromosome. Imatinib, a selective inhibitor of the Bcr-Abl tyrosine kinase, has significantly improved the clinical outcome of patients with CML. However, subsets of patients lose their response to treatment through the emergence of imatinib-resistant cells, and imatinib treatment is less durable for patients with late stage CML. Although alternative Bcr-Abl tyrosine kinase inhibitors have been developed to overcome drug resistance, a cocktail therapy of different kinase inhibitors and additional chemotherapeutics may be needed for complete remission of CML in some cases. Chlorambucil has been used for treatment of B cell chronic lymphocytic leukemia, non-Hodgkin's and Hodgkin's disease. Here we report that a DNA sequence-specific pyrrole-imidazole polyamide-chlorambucil conjugate, 1R-Chl, causes growth arrest of cells harboring both unmutated BCR-ABL and three imatinib resistant strains. 1R-Chl also displays selective toxicities against activated lymphocytes and a high dose tolerance in a murine model.	[Chou, C. James; Lefebvre, Sophie; Alvarez, David; Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [O'Hare, Thomas; Tyner, Jeffrey W.; Eide, Christopher A.; Druker, Brian J.] Oregon Hlth & Sci Univ, Canc Inst, Div Hematol & Med Oncol, Portland, OR USA	Scripps Research Institute; Oregon Health & Science University	Chou, CJ (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	joelg@scripps.edu	Chou, C. James/I-6563-2012	Gottesfeld, Joel/0000-0002-4643-5777; Eide, Christopher/0000-0001-8835-8928; Tyner, Jeffrey/0000-0002-2133-0960; Druker, Brian/0000-0001-8331-8206	National Cancer Institute [CA107311]; Defense [CM043013]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA107311] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Defense; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute grant CA107311 and Defense grant CM043013 (Joel M. Gottesfeld), and Howard Hughes Medical Institute (Brian J. Druker). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez D, 2006, CELL CYCLE, V5, P1537, DOI 10.4161/cc.5.14.2913; Brooks N, 1997, BIOORGAN MED CHEM, V5, P1497, DOI 10.1016/S0968-0896(97)00096-5; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Chou CJ, 2008, MOL CANCER THER, V7, P769, DOI 10.1158/1535-7163.MCT-08-0130; Deininger MWN, 2000, CANCER RES, V60, P2049; Dickinson LA, 2004, CHEM BIOL, V11, P1583, DOI 10.1016/j.chembiol.2004.09.004; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Farkas ME, 2007, BIOORGAN MED CHEM, V15, P6927, DOI 10.1016/j.bmc.2007.07.019; Jahagirdar BN, 2001, EXP HEMATOL, V29, P543, DOI 10.1016/S0301-472X(01)00633-6; Lockhart AC, 2004, CLIN CANCER RES, V10, P468, DOI 10.1158/1078-0432.CCR-0658-03; Nicolle A, 2004, LEUKEMIA LYMPHOMA, V45, P271, DOI 10.1080/10428190310001595704; Nimmanapalli R, 2002, CURR OPIN ONCOL, V14, P616, DOI 10.1097/00001622-200211000-00005; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; O'Hare T, 2008, P NATL ACAD SCI USA, V105, P5507, DOI 10.1073/pnas.0800587105; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Olivieri A, 2007, ANN ONCOL, V18, P42, DOI 10.1093/annonc/mdm223; Ottmann OG, 2002, BLOOD, V100, P1965, DOI 10.1182/blood-2001-12-0181; Oyoshi T, 2003, J AM CHEM SOC, V125, P4752, DOI 10.1021/ja029196o; Robak T, 2002, LEUKEMIA, V16, P1015, DOI 10.1038/sj.leu.2402531; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shinohara K, 2004, J AM CHEM SOC, V126, P5113, DOI 10.1021/ja031673v; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Tsai SM, 2007, NUCLEIC ACIDS RES, V35, P307, DOI 10.1093/nar/gkl1025; Urbaniak MD, 2004, J MED CHEM, V47, P4710, DOI 10.1021/jm040790d; von Bubnoff N, 2003, LEUKEMIA, V17, P829, DOI 10.1038/sj.leu.2402889; Weiss GR, 1998, CLIN CANCER RES, V4, P53; Wurtz NR, 2000, CHEM BIOL, V7, P153, DOI 10.1016/S1074-5521(00)00085-5	33	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3593	10.1371/journal.pone.0003593	http://dx.doi.org/10.1371/journal.pone.0003593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974832	gold, Green Submitted, Green Published			2022-12-27	WOS:000265131700014
J	Ogurtsov, AY; Marino-Ramirez, L; Johnson, GR; Landsman, D; Shabalina, SA; Spiridonov, NA				Ogurtsov, Aleksey Y.; Marino-Ramirez, Leonardo; Johnson, Gibbes R.; Landsman, David; Shabalina, Svetlana A.; Spiridonov, Nikolay A.			Expression Patterns of Protein Kinases Correlate with Gene Architecture and Evolutionary Rates	PLOS ONE			English	Article								Background: Protein kinase (PK) genes comprise the third largest superfamily that occupy similar to 2% of the human genome. They encode regulatory enzymes that control a vast variety of cellular processes through phosphorylation of their protein substrates. Expression of PK genes is subject to complex transcriptional regulation which is not fully understood. Principal Findings: Our comparative analysis demonstrates that genomic organization of regulatory PK genes differs from organization of other protein coding genes. PK genes occupy larger genomic loci, have longer introns, spacer regions, and encode larger proteins. The primary transcript length of PK genes, similar to other protein coding genes, inversely correlates with gene expression level and expression breadth, which is likely due to the necessity to reduce metabolic costs of transcription for abundant messages. On average, PK genes evolve slower than other protein coding genes. Breadth of PK expression negatively correlates with rate of non-synonymous substitutions in protein coding regions. This rate is lower for high expression and ubiquitous PKs, relative to low expression PKs, and correlates with divergence in untranslated regions. Conversely, rate of silent mutations is uniform in different PK groups, indicating that differing rates of non-synonymous substitutions reflect variations in selective pressure. Brain and testis employ a considerable number of tissue-specific PKs, indicating high complexity of phosphorylation-dependent regulatory network in these organs. There are considerable differences in genomic organization between PKs up-regulated in the testis and brain. PK genes up-regulated in the highly proliferative testicular tissue are fast evolving and small, with short introns and transcribed regions. In contrast, genes up-regulated in the minimally proliferative nervous tissue carry long introns, extended transcribed regions, and evolve slowly. Conclusions/Significance: PK genomic architecture, the size of gene functional domains and evolutionary rates correlate with the pattern of gene expression. Structure and evolutionary divergence of tissue-specific PK genes is related to the proliferative activity of the tissue where these genes are predominantly expressed. Our data provide evidence that physiological requirements for transcription intensity, ubiquitous expression, and tissue-specific regulation shape gene structure and affect rates of evolution.	[Ogurtsov, Aleksey Y.; Marino-Ramirez, Leonardo; Landsman, David; Shabalina, Svetlana A.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Johnson, Gibbes R.; Spiridonov, Nikolay A.] US FDA, Ctr Drug Evaluat & Res, Div Therapeut Proteins, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); US Food & Drug Administration (FDA)	Ogurtsov, AY (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	shabalin@ncbi.nlm.nih.gov; nikolay.spiridonov@fda.hhs.gov	Mariño-Ramírez, Leonardo/N-5395-2019; Mariño-Ramírez, Leonardo/I-5759-2013; Shabalina, Svetlana/N-8939-2013; Spiridonov, Nikolay/B-6287-2014; Landsman, David/GZK-5496-2022; Landsman, David/C-5923-2009	Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Shabalina, Svetlana/0000-0003-2272-7473; Landsman, David/0000-0002-9819-6675	Intramural Research Program of the National Institutes of Health, National Library of Medicine; NATIONAL LIBRARY OF MEDICINE [ZIALM000084] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Library of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balmer LA, 2001, MOL CELL BIOL, V21, P2070, DOI 10.1128/MCB.21.6.2070-2084.2001; Bernat JA, 2006, HUM MOL GENET, V15, P2098, DOI 10.1093/hmg/ddl133; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Borck G, 2006, HUM MUTAT, V27, P731, DOI 10.1002/humu.20380; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; CHEN KH, 1993, FEBS LETT, V325, P210, DOI 10.1016/0014-5793(93)81075-B; Chen LS, 2003, HUM MOL GENET, V12, P3067, DOI 10.1093/hmg/ddg331; Crocitto LE, 1997, J UROLOGY, V158, P1599, DOI 10.1016/S0022-5347(01)64287-3; Dan C, 2002, MOL CELL BIOL, V22, P567, DOI 10.1128/MCB.22.2.567-577.2002; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Dresios J, 2006, NAT STRUCT MOL BIOL, V13, P30, DOI 10.1038/nsmb1031; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Forrest ARR, 2003, GENOME RES, V13, P1443, DOI 10.1101/gr.954803; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; GODBOUT M, 1994, J NEUROSCI, V14, P1; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hardie DG, 2000, CURR BIOL, V10, pR757, DOI 10.1016/S0960-9822(00)00744-2; HARDIE DG, 1994, CELL SIGNAL, V6, P813; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kimmins S, 2004, REPRODUCTION, V128, P5, DOI 10.1530/rep.1.00170; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kochetov AV, 1998, FEBS LETT, V440, P351, DOI 10.1016/S0014-5793(98)01482-3; Kondrashov AS, 2002, HUM MOL GENET, V11, P669, DOI 10.1093/hmg/11.6.669; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Kueng P, 1997, J CELL BIOL, V139, P1851, DOI 10.1083/jcb.139.7.1851; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marino-Ramirez L, 2004, NUCLEIC ACIDS RES, V32, P949, DOI 10.1093/nar/gkh246; MATVEEVA OV, 1993, NUCLEIC ACIDS RES, V21, P1007, DOI 10.1093/nar/21.4.1007; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Mitchell P, 2001, CURR OPIN CELL BIOL, V13, P320, DOI 10.1016/S0955-0674(00)00214-3; Nakayama T, 2006, HYPERTENSION, V48, P512, DOI 10.1161/01.HYP.0000233877.84343.d7; NAZIPOVA NN, 1995, COMPUT APPL BIOSCI, V11, P423; Ogurtsov AY, 2002, BIOINFORMATICS, V18, P1703, DOI 10.1093/bioinformatics/18.12.1703; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Quintaje SB, 2008, MOL CELL PROTEOMICS, V7, P1409, DOI 10.1074/mcp.R700001-MCP200; Sgourou A, 2004, BRIT J HAEMATOL, V124, P828, DOI 10.1111/j.1365-2141.2004.04835.x; Shabalina SA, 1999, GENET RES, V74, P23, DOI 10.1017/S0016672399003821; Shabalina SA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-105; Shabalina SA, 2003, NUCLEIC ACIDS RES, V31, P5433, DOI 10.1093/nar/gkg751; Shabalina SA, 2001, TRENDS GENET, V17, P373, DOI 10.1016/S0168-9525(01)02344-7; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Signori E, 2001, ONCOGENE, V20, P4596, DOI 10.1038/sj.onc.1204620; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Spiridonov NA, 2005, MOL CELL BIOL, V25, P4250, DOI 10.1128/MCB.25.10.4250-4261.2005; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; SUNYER T, 1990, P NATL ACAD SCI USA, V87, P278, DOI 10.1073/pnas.87.1.278; Takemoto-Kimura S, 2003, J BIOL CHEM, V278, P18597, DOI 10.1074/jbc.M300578200; Tanaka H, 2001, MOL HUM REPROD, V7, P211, DOI 10.1093/molehr/7.3.211; Theil T, 1998, DEVELOPMENT, V125, P443; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang CL, 2006, NUCLEIC ACIDS RES, V34, P2238, DOI 10.1093/nar/gkl248; Zhang Y, 2004, BIOINFORMATICS, V20, P2390, DOI 10.1093/bioinformatics/bth256; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, pW152, DOI 10.1093/nar/gkm381; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172	71	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3599	10.1371/journal.pone.0003599	http://dx.doi.org/10.1371/journal.pone.0003599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974838	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131700020
J	Ibanez, C; Ramos, A; Acebo, P; Contreras, A; Casado, R; Allona, I; Aragoncillo, C				Ibanez, Cristian; Ramos, Alberto; Acebo, Paloma; Contreras, Angela; Casado, Rosa; Allona, Isabel; Aragoncillo, Cipriano			Overall Alteration of Circadian Clock Gene Expression in the Chestnut Cold Response	PLOS ONE			English	Article							LOW-TEMPERATURE; TARGETED DEGRADATION; OSCILLATOR FUNCTION; DORMANCY INDUCTION; CAMBIAL MERISTEM; GROWTH CESSATION; MOLECULAR-BASES; ARABIDOPSIS; REGULATORS; PRR7	Cold acclimation in woody plants may have special features compared to similar processes in herbaceous plants. Recent studies have shown that circadian clock behavior in the chestnut tree (Castanea sativa) is disrupted by cold temperatures and that the primary oscillator feedback loop is not functional at 4 degrees C or in winter. In these conditions, CsTOC1 and CsLHY genes are constantly expressed. Here, we show that this alteration also affects CsPRR5, CsPRR7 and CsPRR9. These genes are homologous to the corresponding Arabidopsis PSEUDO-RESPONSE REGULATOR genes, which are also components of the circadian oscillator feedback network. The practically constant presence of mRNAs of the 5 chestnut genes at low temperature reveals an unknown aspect of clock regulation and suggests a mechanism regulating the transcription of oscillator genes as a whole.	[Ibanez, Cristian; Ramos, Alberto; Acebo, Paloma; Contreras, Angela; Casado, Rosa; Allona, Isabel; Aragoncillo, Cipriano] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden	Umea University	Ibanez, C (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden.	isabel.allona@upm.es	Allona, Isabel/J-5972-2014	Allona, Isabel/0000-0002-7012-2850; CONTRERAS MOGOLLON, ANGELA BIBIANA/0000-0003-3780-8428	Spanish Ministerio de Educacion y Ciencia [AGL2005-00080, fellowship]; Chilean Government-BID [fellowship]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Chilean Government-BID	This research was supported by the Spanish Ministerio de Educacion y Ciencia, grant no. AGL2005-00080 and a predoctoral fellowship (A.C.). C.I. holds a fellowship awarded by the Chilean Government-BID.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Allona I, 1998, P NATL ACAD SCI USA, V95, P9693, DOI 10.1073/pnas.95.16.9693; Arora R, 2003, HORTSCIENCE, V38, P911, DOI 10.21273/HORTSCI.38.5.911; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Bookout A. L., 2006, CURRENT PROTOCOLS MO; Boxall SF, 2005, PLANT PHYSIOL, V137, P969, DOI 10.1104/pp.104.054577; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; CHIARAMAGNONE M, 2005, BRAIN RES MOL BRAIN, V133, P281; Daniel X, 2004, P NATL ACAD SCI USA, V101, P3292, DOI 10.1073/pnas.0400163101; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2006, PLANT J, V48, P962, DOI 10.1111/j.1365-313X.2006.02933.x; Druart N, 2007, PLANT J, V50, P557, DOI 10.1111/j.1365-313X.2007.03077.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eriksson ME, 2003, PLANTA, V218, P159, DOI 10.1007/s00425-003-1106-4; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Farre EM, 2007, PLANT J, V52, P548, DOI 10.1111/j.1365-313X.2007.03258.x; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Gardner MJ, 2006, BIOCHEM J, V397, P15, DOI 10.1042/BJ20060484; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Heide OM, 2005, TREE PHYSIOL, V25, P109, DOI 10.1093/treephys/25.1.109; Kiba T, 2007, PLANT CELL, V19, P2516, DOI 10.1105/tpc.107.053033; Kreps JA, 1997, PLANT CELL, V9, P297, DOI 10.1105/tpc.9.3.297; Lidder P, 2005, PLANT PHYSIOL, V138, P2374, DOI 10.1104/pp.105.060368; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Michael TP, 2003, PLANT PHYSIOL, V132, P629, DOI 10.1104/pp.021006; Miwa K, 2006, PLANT CELL PHYSIOL, V47, P601, DOI 10.1093/pcp/pcj027; Mizuno T, 2005, PLANT CELL PHYSIOL, V46, P677, DOI 10.1093/pcp/pci087; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; Murakami M, 2007, BIOSCI BIOTECH BIOCH, V71, P1107, DOI 10.1271/bbb.70048; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P686, DOI 10.1093/pcp/pci086; Nakamichi N, 2007, PLANT CELL PHYSIOL, V48, P822, DOI 10.1093/pcp/pcm056; NITSCH J. P., 1957, PROC AMER SOC HORT SCI, V70, P526; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Portoles S, 2007, PLANT J, V51, P966, DOI 10.1111/j.1365-313X.2007.03186.x; Ramos A, 2005, P NATL ACAD SCI USA, V102, P7037, DOI 10.1073/pnas.0408549102; Revel FG, 2007, P NATL ACAD SCI USA, V104, P13816, DOI 10.1073/pnas.0704699104; Rohde A, 2007, TRENDS PLANT SCI, V12, P217, DOI 10.1016/j.tplants.2007.03.012; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Schrader J, 2004, PLANT J, V40, P173, DOI 10.1111/j.1365-313X.2004.02199.x; Strauss WM, 1987, CURRENT PROTOCOLS MO, P631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vallone D, 2007, AM J PHYSIOL-REG I, V292, pR160, DOI 10.1152/ajpregu.00370.2006; WAREING PF, 1956, ANNU REV PLANT PHYS, V7, P191, DOI 10.1146/annurev.pp.07.060156.001203; WEISER CJ, 1970, SCIENCE, V169, P1269, DOI 10.1126/science.169.3952.1269; Welling A, 2008, PLANT PHYSIOL, V147, P1199, DOI 10.1104/pp.108.117812; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101	55	53	55	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3567	10.1371/journal.pone.0003567	http://dx.doi.org/10.1371/journal.pone.0003567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958171	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131100023
J	Vitko, I; Shcheglovitov, A; Baumgart, JP; Arias-Olguin, II; Murbartian, J; Arias, JM; Perez-Reyes, E				Vitko, Iuliia; Shcheglovitov, Aleksandr; Baumgart, Joel P.; Arias-Olguin, Imilla I.; Murbartian, Janet; Arias, Juan Manuel; Perez-Reyes, Edward			Orientation of the Calcium Channel beta Relative to the alpha(1)2.2 Subunit Is Critical for Its Regulation of Channel Activity	PLOS ONE			English	Article								Background: The Ca-v beta subunits of high voltage-activated Ca2+ channels control the trafficking and biophysical properties of the alpha(1) subunit. The Ca-v beta-alpha(1) interaction site has been mapped by crystallographic studies. Nevertheless, how this interaction leads to channel regulation has not been determined. One hypothesis is that beta s regulate channel gating by modulating movements of IS6. A key requirement for this direct-coupling model is that the linker connecting IS6 to the alpha-interaction domain (AID) be a rigid structure. Methodology/Principal Findings: The present study tests this hypothesis by altering the flexibility and orientation of this region in alpha(1)2.2, then testing for Ca-v beta regulation using whole cell patch clamp electrophysiology. Flexibility was induced by replacement of the middle six amino acids of the IS6-AID linker with glycine (PG6). This mutation abolished beta 2a and beta 3 subunits ability to shift the voltage dependence of activation and inactivation, and the ability of beta 2a to produce non-activating currents. Orientation of Ca-v beta with respect to alpha(1)2.2 was altered by deletion of 1, 2, or 3 amino acids from the IS6-AID linker (Bdel1, Bdel2, Bdel3, respectively). Again, the ability of Ca-v beta subunits to regulate these biophysical properties were totally abolished in the Bdel1 and Bdel3 mutants. Functional regulation by Ca-v beta subunits was rescued in the Bdel2 mutant, indicating that this part of the linker forms beta-sheet. The orientation of beta with respect to a was confirmed by the bimolecular fluorescence complementation assay. Conclusions/Significance: These results show that the orientation of the Ca-v beta subunit relative to the alpha(1)2.2 subunit is critical, and suggests additional points of contact between these subunits are required for Ca-v beta to regulate channel activity.	[Vitko, Iuliia; Shcheglovitov, Aleksandr; Baumgart, Joel P.; Arias-Olguin, Imilla I.; Murbartian, Janet; Arias, Juan Manuel; Perez-Reyes, Edward] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Vitko, I (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.	eperez@virginia.edu	Baumgart, Joel/K-3139-2014	Baumgart, Joel/0000-0002-1109-2567; Murbartian, Janet/0000-0001-5776-1167	University of Virginia	University of Virginia	This work was funded by the University of Virginia. The University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agler HL, 2005, NEURON, V46, P891, DOI 10.1016/j.neuron.2005.05.011; Arias JM, 2005, FEBS LETT, V579, P3907, DOI 10.1016/j.febslet.2005.06.008; Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; BRUST PF, 1993, NEUROPHARMACOLOGY, V32, P1089, DOI 10.1016/0028-3908(93)90004-M; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 1999, J PHYSIOL-LONDON, V519, P35, DOI 10.1111/j.1469-7793.1999.0035o.x; Feng ZP, 2001, J BIOL CHEM, V276, P45051, DOI 10.1074/jbc.M107784200; Frazier CJ, 2001, J GEN PHYSIOL, V118, P457, DOI 10.1085/jgp.118.5.457; Geib S, 2002, J BIOL CHEM, V277, P10003, DOI 10.1074/jbc.M106231200; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GONOI T, 1987, J GEN PHYSIOL, V89, P253, DOI 10.1085/jgp.89.2.253; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Harry JB, 2004, J BIOL CHEM, V279, P46367, DOI 10.1074/jbc.M409523200; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Helton TD, 2002, J NEUROSCI, V22, P1573, DOI 10.1523/JNEUROSCI.22-05-01573.2002; Hering S, 2002, TRENDS PHARMACOL SCI, V23, P509, DOI 10.1016/S0165-6147(02)02104-1; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; LEUNG AT, 1988, J BIOL CHEM, V263, P994; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qin N, 1996, AM J PHYSIOL-CELL PH, V271, pC1539, DOI 10.1152/ajpcell.1996.271.5.C1539; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Ringer S, 1883, J Physiol, V4, P29; Sandoz G, 2004, P NATL ACAD SCI USA, V101, P6267, DOI 10.1073/pnas.0306804101; Sandoz G, 2001, EUR J NEUROSCI, V14, P987, DOI 10.1046/j.0953-816x.2001.01728.x; Schjott JM, 2003, J BIOL CHEM, V278, P33936, DOI 10.1074/jbc.M302059200; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Sokolov S, 2000, J PHYSIOL-LONDON, V527, P445, DOI 10.1111/j.1469-7793.2000.t01-1-00445.x; Soldatov MM, 2003, TRENDS PHARMACOL SCI, V24, P167, DOI 10.1016/S0165-6147(03)00065-8; Stephens GJ, 2000, J PHYSIOL-LONDON, V525, P377, DOI 10.1111/j.1469-7793.2000.t01-1-00377.x; Striessnig J, 1998, TRENDS PHARMACOL SCI, V19, P108, DOI 10.1016/S0165-6147(98)01171-7; Takahashi SX, 2003, BIOPHYS J, V84, P3007, DOI 10.1016/S0006-3495(03)70027-7; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vance CL, 1998, J BIOL CHEM, V273, P14495, DOI 10.1074/jbc.273.23.14495; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Wakamori M, 1999, J PHYSIOL-LONDON, V517, P659, DOI 10.1111/j.1469-7793.1999.0659s.x; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; Yasuda T, 2004, J GEN PHYSIOL, V123, P401, DOI 10.1085/jgp.200308967	57	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3560	10.1371/journal.pone.0003560	http://dx.doi.org/10.1371/journal.pone.0003560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958281	gold, Green Submitted, Green Published			2022-12-27	WOS:000265131100018
J	Dacher, M; Smith, BH				Dacher, Matthieu; Smith, Brian H.			Olfactory Interference during Inhibitory Backward Pairing in Honey Bees	PLOS ONE			English	Article							LONG-TERM-MEMORY; PROBOSCIS EXTENSION REFLEX; APIS-MELLIFERA; SUCROSE RESPONSIVENESS; DROSOPHILA-MELANOGASTER; ODOR REPRESENTATION; SIDE-SPECIFICITY; PROTEIN-KINASE; ANTENNAL LOBE; BEHAVIOR	Background: Restrained worker honey bees are a valuable model for studying the behavioral and neural bases of olfactory plasticity. The proboscis extension response (PER; the proboscis is the mouthpart of honey bees) is released in response to sucrose stimulation. If sucrose stimulation is preceded one or a few times by an odor (forward pairing), the bee will form a memory for this association, and subsequent presentations of the odor alone are sufficient to elicit the PER. However, backward pairing between the two stimuli (sucrose, then odor) has not been studied to any great extent in bees, although the vertebrate literature indicates that it elicits a form of inhibitory plasticity. Methodology/Principal Findings: If hungry bees are fed with sucrose, they will release a long lasting PER; however, this PER can be interrupted if an odor is presented 15 seconds (but not 7 or 30 seconds) after the sucrose (backward pairing). We refer to this previously unreported process as olfactory interference. Bees receiving this 15 second backward pairing show reduced performance after a subsequent single forward pairing (excitatory conditioning) trial. Analysis of the results supported a relationship between olfactory interference and a form of backward pairing-induced inhibitory learning/memory. Injecting the drug cimetidine into the deutocerebrum impaired olfactory interference. Conclusions/Significance: Olfactory interference depends on the associative link between odor and PER, rather than between odor and sucrose. Furthermore, pairing an odor with sucrose can lead either to association of this odor to PER or to the inhibition of PER by this odor. Olfactory interference may provide insight into processes that gate how excitatory and inhibitory memories for odor-PER associations are formed.	[Dacher, Matthieu; Smith, Brian H.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Dacher, M (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	matthieu.dacher@free.fr	Dacher, Matthieu/F-8407-2010; Hernández, Juan/AAC-6250-2020	Dacher, Matthieu/0000-0001-8607-2889; 	NIH [RR014166, DC007997]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007997] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded by the NIH grants (NCRR grant RR014166 and NIDCD grant DC007997) to BHS. The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Benard J, 2006, ANIM COGN, V9, P257, DOI 10.1007/s10071-006-0032-9; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Bouton ME, 2004, NEUROSCI BIOBEHAV R, V28, P663, DOI 10.1016/j.neubiorev.2004.09.001; Couvillon PA, 2003, J COMP PSYCHOL, V117, P31, DOI 10.1037/0735-7036.117.1.31; Dacher M, 2005, NEUROSCIENCE, V130, P37, DOI 10.1016/j.neuroscience.2004.09.006; DACHER M, 2008, PHYSL BEHAV IN PRESS; Deglise P, 2003, BEHAV NEUROSCI, V117, P540, DOI 10.1037/0735-7044.117.3.540; Deisig N, 2002, LEARN MEMORY, V9, P112, DOI 10.1101/lm.41002; Deisig N, 2001, LEARN MEMORY, V8, P70, DOI 10.1101/lm.8.2.70; Denniston JC, 2007, BEHAV PROCESS, V74, P274, DOI 10.1016/j.beproc.2006.11.003; DETHIER VG, 1963, KNOW FLY; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; El Hassani AK, 2005, PHARMACOL BIOCHEM BE, V82, P30, DOI 10.1016/j.pbb.2005.07.008; Erber J, 1997, J COMP PHYSIOL A, V181, P355, DOI 10.1007/s003590050121; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; Erber J, 1998, J COMP PHYSIOL A, V183, P737, DOI 10.1007/s003590050296; Erber J, 2000, J COMP PHYSIOL A, V186, P557, DOI 10.1007/s003590000111; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Farooqui T, 2003, J NEUROSCI, V23, P5370; Galizia CG, 2001, J INSECT PHYSIOL, V47, P115, DOI 10.1016/S0022-1910(00)00106-2; Gauthier M, 2006, NEUROBIOL LEARN MEM, V86, P164, DOI 10.1016/j.nlm.2006.02.003; Gisselmann G, 2004, NEUROSCI LETT, V372, P151, DOI 10.1016/j.neulet.2004.09.031; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Giurfa M, 2004, LEARN MEMORY, V11, P294, DOI 10.1101/lm.63604; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Grunbaum L, 1998, J NEUROSCI, V18, P4384; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1994, BEHAV NEURAL BIOL, V62, P210, DOI 10.1016/S0163-1047(05)80019-6; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Haupt SS, 2007, J COMP PHYSIOL A, V193, P523, DOI 10.1007/s00359-007-0208-z; Haupt SS, 2005, BEHAV BRAIN RES, V165, P12, DOI 10.1016/j.bbr.2005.06.030; Haupt SS, 2004, J COMP PHYSIOL A, V190, P735, DOI 10.1007/s00359-004-0532-5; Hellstern F, 1998, LEARN MEMORY, V4, P429, DOI 10.1101/lm.4.5.429; Hosler JS, 2000, BEHAV NEUROSCI, V114, P514, DOI 10.1037/0735-7044.114.3.514; Hussaini SA, 2007, LEARN MEMORY, V14, P678, DOI 10.1101/lm.471307; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jones AK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-327; Jones Andrew K., 2006, Invertebrate Neuroscience, V6, P123, DOI 10.1007/s10158-006-0026-y; Kisch J, 1999, BEHAV BRAIN RES, V99, P93, DOI 10.1016/S0166-4328(98)00076-X; KLOPPENBURG P, 1995, J COMP NEUROL, V363, P333, DOI 10.1002/cne.903630213; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; KRASNE FB, 1995, ANNU REV PSYCHOL, V46, P585, DOI 10.1146/annurev.ps.46.020195.003101; LEE ET, 2003, STAT METHODS SURVIVA, P534; Lozano VC, 2001, J COMP PHYSIOL A, V187, P249, DOI 10.1007/s003590100196; Maleszka R, 2000, BEHAV BRAIN RES, V115, P49, DOI 10.1016/S0166-4328(00)00235-7; Menzel R, 2006, CELL, V124, P237, DOI 10.1016/j.cell.2006.01.011; Menzel R, 1999, BEHAV NEUROSCI, V113, P744, DOI 10.1037/0735-7044.113.4.744; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Menzel R., 1990, NEUROBIOLOGY COMP CO, P237; Menzel Randolf, 2006, Behav Cogn Neurosci Rev, V5, P24, DOI 10.1177/1534582306289522; Menzel R, 2006, J COMP PHYSIOL A, V192, P889, DOI 10.1007/s00359-006-0136-3; MERCER AR, 1982, J COMP PHYSIOL, V145, P363, DOI 10.1007/BF00619340; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Muller U, 1996, NEURON, V16, P541, DOI 10.1016/S0896-6273(00)80073-2; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Mwilaria EK, 2008, CHEM SENSES, V33, P267, DOI 10.1093/chemse/bjm085; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Oleskevich S, 1997, J NEUROPHYSIOL, V78, P528, DOI 10.1152/jn.1997.78.1.528; Page RE, 2002, NATURWISSENSCHAFTEN, V89, P91, DOI 10.1007/s00114-002-0299-x; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pelz C, 1997, J EXP BIOL, V200, P837; Ray S, 1997, J APICULT RES, V36, P108, DOI 10.1080/00218839.1997.11100936; Riessberger U, 1997, APIDOLOGIE, V28, P411, DOI 10.1051/apido:19970608; Rogers LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002340; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Sachse Silke, 2006, Front Zool, V3, P22, DOI 10.1186/1742-9994-3-22; Sandoz JC, 2003, NEUROSCIENCE, V120, P1137, DOI 10.1016/S0306-4522(03)00384-1; Sandoz JC, 2002, LEARN MEMORY, V9, P337, DOI 10.1101/lm.50502; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Scheiner R, 2003, APIDOLOGIE, V34, P67, DOI 10.1051/apido:2002050; Scheiner R, 2002, BEHAV BRAIN RES, V136, P545, DOI 10.1016/S0166-4328(02)00205-X; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Shafir S, 2005, ANIM BEHAV, V69, P859, DOI 10.1016/j.anbehav.2004.07.011; Shafir S, 1999, ANIM BEHAV, V57, P1055, DOI 10.1006/anbe.1998.1078; Shafir S, 2002, BEHAV ECOL SOCIOBIOL, V51, P180, DOI 10.1007/s00265-001-0420-8; Stach S, 2004, NATURE, V429, P758, DOI 10.1038/nature02594; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tanimoto H, 2004, NATURE, V430, P983, DOI 10.1038/430983a; Thany SH, 2005, BRAIN RES, V1039, P216, DOI 10.1016/j.brainres.2005.01.056; van Swinderen B, 2005, BIOESSAYS, V27, P321, DOI 10.1002/bies.20195; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; Vergoz V, 2007, SCIENCE, V317, P384, DOI 10.1126/science.1142448; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Vogel EH, 2004, BRAIN RES BULL, V63, P173, DOI 10.1016/j.brainresbull.2004.01.005; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Zheng YC, 2002, J BIOL CHEM, V277, P2000, DOI 10.1074/jbc.M107635200	97	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3513	10.1371/journal.pone.0003513	http://dx.doi.org/10.1371/journal.pone.0003513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IH	18946512	Green Published, Green Submitted, gold			2022-12-27	WOS:000265126200012
J	Eisenhauer, N; Milcu, A; Sabais, ACW; Scheu, S				Eisenhauer, Nico; Milcu, Alexandru; Sabais, Alexander C. W.; Scheu, Stefan			Animal Ecosystem Engineers Modulate the Diversity-Invasibility Relationship	PLOS ONE			English	Article							PLANT DIVERSITY; SEED BANKS; EARTHWORMS; DYNAMICS; GROWTH; SOIL	Background: Invasions of natural communities by non-indigenous species are currently rated as one of the most important global-scale threats to biodiversity. Biodiversity itself is known to reduce invasions and increase stability. Disturbances by ecosystem engineers affect the distribution, establishment, and abundance of species but this has been ignored in studies on diversity-invasibility relationships. Methodology/Principal Findings: We determined natural plant invasion into 46 plots varying in the number of plant species (1, 4, and 16) and plant functional groups (1, 2, 3, and 4) for three years beginning two years after the establishment of the Jena Experiment. We sampled subplots where earthworms were artificially added and others where earthworm abundance was reduced. We also performed a seed-dummy experiment to investigate the role of earthworms as secondary seed dispersers along a plant diversity gradient. Horizontal dispersal and burial of seed dummies were significantly reduced in subplots where earthworms were reduced in abundance. Seed dispersal by earthworms decreased with increasing plant species richness and presence of grasses but increased in presence of small herbs. These results suggest that dense vegetation inhibits the surface activity of earthworms. Further, there was a positive relationship between the number of earthworms and the number and diversity of invasive plants. Hence, earthworms decreased the stability of grassland communities against plant invasion. Conclusions/Significance: Invasibility decreased and stability increased with increasing plant diversity and, most remarkably, earthworms modulated the diversity-invasibility relationship. While the impacts of earthworms were unimportant in low diverse (low earthworm densities) and high diverse (high floral structural complexity) plant communities, earthworms decreased the stability of intermediate diverse plant communities against plant invasion. Overall, the results document that fundamental processes in plant communities like plant seed burial and invader establishment are modulated by soil fauna calling for closer cooperation between soil animal and plant ecologists.	[Eisenhauer, Nico; Sabais, Alexander C. W.; Scheu, Stefan] Tech Univ Darmstadt, Inst Zool, Darmstadt, Germany; [Milcu, Alexandru] Imperial Coll London, Div Biol, NERC Ctr Populat Biol, Silwood Pk Campus, Ascot, Berks, England	Technical University of Darmstadt; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Eisenhauer, N (corresponding author), Tech Univ Darmstadt, Inst Zool, Darmstadt, Germany.	eisenhauer@bio.tu-darmstadt.de	Scheu, Stefan/H-7049-2015; Eisenhauer, Nico/I-5932-2012; Eisenhauer, Nico/I-3191-2019; Milcu, Alexandru/X-6267-2018	Eisenhauer, Nico/0000-0002-0371-6720; Eisenhauer, Nico/0000-0002-0371-6720; Milcu, Alexandru/0000-0002-2889-1234	German Science Foundation [FOR 456]	German Science Foundation(German Research Foundation (DFG))	The present study was funded by the German Science Foundation (FOR 456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 2001, J ARID ENVIRON, V49, P343, DOI 10.1006/jare.2000.0781; Ayanlaja SA, 2001, HORTSCIENCE, V36, P143, DOI 10.21273/HORTSCI.36.1.143; Burnham K. P., 1998, MODEL SELECTION INTE; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Crawley MJ, 1992, SEEDS ECOLOGY REGENE, P157; Decaens T, 2003, ACTA OECOL, V24, P175, DOI 10.1016/S1146-609X(03)00083-3; DECAENS T, 2001, NATURES PLOW SOIL MA, P174; Dukes JS, 2002, ECOL APPL, V12, P602, DOI 10.1890/1051-0761(2002)012[0602:SCADAG]2.0.CO;2; Edwards CA, 1996, BIOL ECOLOGY EARTHWO, DOI DOI 10.1016/S0167-8809(97)88859-7; EISENHAUER N, 2008, INVASIBILITY EXPT GR, P1026; Eisenhauer N, 2008, APPL SOIL ECOL, V38, P79, DOI 10.1016/j.apsoil.2007.07.002; Eisenhauer N, 2009, PEDOBIOLOGIA, V52, P151, DOI 10.1016/j.pedobi.2008.07.002; ELASHOFF JD, 1986, 83 BMDP; Elton C., 1958; FAO UNESCO, 1997, SOIL MAP WORLD; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; FOX JF, 1979, SCIENCE, V204, P1344, DOI 10.1126/science.204.4399.1344; Grant J.D., 1983, P107; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; King TJ, 2007, PLANT ECOL, V193, P233, DOI 10.1007/s11258-006-9261-x; KLUGE G, 2000, KLIMA AUSGEWAHLTER O; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; MCRILL M, 1973, NATURE, V244, P482, DOI 10.1038/243482a0; Meyer AH, 1999, J ECOL, V87, P17, DOI 10.1046/j.1365-2745.1999.00315.x; Milcu A, 2006, FUNCT ECOL, V20, P261, DOI 10.1111/j.1365-2435.2006.01098.x; Milcu A, 2008, ECOLOGY, V89, P1872, DOI 10.1890/07-1377.1; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; Scheiner SM, 2001, DESIGN ANAL ECOLOGIC; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Schulze E, 1994, BIODIVERSITY ECOSYST; Shumway DL, 1994, APPL SOIL ECOL, V1, P11, DOI 10.1016/0929-1393(94)90019-1; THIELEMANN U, 1986, PEDOBIOLOGIA, V29, P296; Thompson K, 2001, SEED SCI RES, V11, P345; Thompson K, 1992, SEEDS ECOLOGY REGENE, P231; Tilman D, 1999, SCIENCE, V286, P1099, DOI 10.1126/science.286.5442.1099; Vitousek PM, 1996, AM SCI, V84, P468; WILLEMS JH, 1994, ECOGRAPHY, V17, P124, DOI 10.1111/j.1600-0587.1994.tb00084.x; Wright JP, 2004, OIKOS, V105, P336, DOI 10.1111/j.0030-1299.2004.12654.x; Zaller JG, 1999, SOIL BIOL BIOCHEM, V31, P517, DOI 10.1016/S0038-0717(98)00126-6; Zaller JG, 2007, EUR J SOIL BIOL, V43, pS86, DOI 10.1016/j.ejsobi.2007.08.010	47	39	40	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3489	10.1371/journal.pone.0003489	http://dx.doi.org/10.1371/journal.pone.0003489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941521	Green Published, gold, Green Submitted			2022-12-27	WOS:000265126100020
J	Wang, S; Raven, JF; Durbin, JE; Koromilas, AE				Wang, Shuo; Raven, Jennifer F.; Durbin, Joan E.; Koromilas, Antonis E.			Stat1 Phosphorylation Determines Ras Oncogenicity by Regulating p27(Kip1)	PLOS ONE			English	Article								Inactivation of p27(Kip1) is implicated in tumorigenesis and has both prognostic and treatment-predictive values for many types of human cancer. The transcription factor Stat1 is essential for innate immunity and tumor immunosurveillance through its ability to act downstream of interferons. Herein, we demonstrate that Stat1 functions as a suppressor of Ras transformation independently of an interferon response. Inhibition of Ras transformation and tumorigenesis requires the phosphorylation of Stat1 at tyrosine 701 but is independent of Stat1 phosphorylation at serine 727. Stat1 induces p27(Kip1) expression in Ras transformed cells at the transcriptional level through mechanisms that depend on Stat1 phosphorylation at tyrosine 701 and activation of Stat3. The tumor suppressor properties of Stat1 in Ras transformation are reversed by the inactivation of p27(Kip1). Our work reveals a novel functional link between Stat1 and p27(Kip1), which act in coordination to suppress the oncogenic properties of activated Ras. It also supports the notion that evaluation of Stat1 phosphorylation in human tumors may prove a reliable prognostic factor for patient outcome and a predictor of treatment response to anticancer therapies aimed at activating Stat1 and its downstream effectors.	[Wang, Shuo; Raven, Jennifer F.; Koromilas, Antonis E.] McGill Univ, Fac Med, Dept Oncol, Montreal, PQ, Canada; [Wang, Shuo; Raven, Jennifer F.; Koromilas, Antonis E.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Durbin, Joan E.] Columbus Childrens Res Inst, Columbus, OH USA; [Durbin, Joan E.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	McGill University; Lady Davis Institute; McGill University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wang, S (corresponding author), McGill Univ, Fac Med, Dept Oncol, Montreal, PQ, Canada.	antonis.koromilas@mcgill.ca			Canadian Breast Cancer Research Alliance (CBCRA); Canadian Institutes of Health Research (CIHR); U.S. Army Pre-doctoral Traineeship Award	Canadian Breast Cancer Research Alliance (CBCRA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); U.S. Army Pre-doctoral Traineeship Award	The work was funded with a grant from the Canadian Breast Cancer Research Alliance (CBCRA) awarded through the Canadian Institutes of Health Research (CIHR) to AEK. JFR is the recipient of a U.S. Army Pre-doctoral Traineeship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2000, MOL CELL BIOL, V20, P4580, DOI 10.1128/MCB.20.13.4580-4590.2000; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; de Koning JP, 2000, ONCOGENE, V19, P3290, DOI 10.1038/sj.onc.1203627; de la Iglesia N, 2008, GENE DEV, V22, P449, DOI 10.1101/gad.1606508; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dimberg A, 2003, BLOOD, V102, P254, DOI 10.1182/blood-2002-10-3149; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; El-Hashemite N, 2004, CANCER RES, V64, P3436, DOI 10.1158/0008-5472.CAN-03-3609; Evdonin A. L., 1998, Molekulyarnaya Biologiya (Moscow), V32, P712; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Fryknas M, 2007, INT J CANCER, V120, P189, DOI 10.1002/ijc.22291; Gopfert U, 2003, HUM MOL GENET, V12, P1767, DOI 10.1093/hmg/ddg177; Goukassian D, 2001, FASEB J, V15, P1877, DOI 10.1096/fj.01-0065com; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Horio Y, 1996, MOL CARCINOGEN, V17, P217, DOI 10.1002/(SICI)1098-2744(199612)17:4<217::AID-MC5>3.0.CO;2-A; Huang SY, 2002, ONCOGENE, V21, P2504, DOI 10.1038/sj.onc.1205341; Itoh Y, 2007, J BIOL CHEM, V282, P390, DOI 10.1074/jbc.M609944200; Jiang H, 2007, NUCLEIC ACIDS RES, V35, P4767, DOI 10.1093/nar/gkm512; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kazemi S, 2004, MOL CELL BIOL, V24, P3415, DOI 10.1128/MCB.24.8.3415-3429.2004; Kerkhoff E, 1998, ONCOGENE, V17, P1457, DOI 10.1038/sj.onc.1202185; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; Kortylewski M, 1999, ONCOGENE, V18, P3742, DOI 10.1038/sj.onc.1202708; Kovacic B, 2006, CANCER CELL, V10, P77, DOI 10.1016/j.ccr.2006.05.025; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Kwon TK, 1996, GENE, V180, P113, DOI 10.1016/S0378-1119(96)00416-7; Laimer K, 2007, CANCER, V110, P326, DOI 10.1002/cncr.22813; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin TS, 2000, ONCOGENE, V19, P2496, DOI 10.1038/sj.onc.1203486; Liu Y, 1996, CANCER RES, V56, P31; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Millard SS, 2000, MOL CELL BIOL, V20, P5947, DOI 10.1128/MCB.20.16.5947-5959.2000; Miskimins WK, 2001, MOL CELL BIOL, V21, P4960, DOI 10.1128/MCB.21.15.4960-4967.2001; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Paris M, 2006, MOL CELL BIOL, V26, P8826, DOI 10.1128/MCB.00575-06; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Sekimoto T, 1996, J BIOL CHEM, V271, P31017, DOI 10.1074/jbc.271.49.31017; Song JH, 2002, MOL CELLS, V13, P322; Terui K, 2004, BIOCHEM J, V380, P203, DOI 10.1042/BJ20031891; Thomas M, 2004, CANCER RES, V64, P8357, DOI 10.1158/0008-5472.CAN-04-1864; Timofeeva OA, 2006, ONCOGENE; Townsend PA, 2005, J CELL SCI, V118, P1629, DOI 10.1242/jcs.01728; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wang S, 2006, J BIOL CHEM, V281, P9439, DOI 10.1074/jbc.M504977200; Wei Q, 2003, MOL CELL BIOL, V23, P4035, DOI 10.1128/MCB.23.12.4035-4045.2003; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Widschwendter A, 2002, CLIN CANCER RES, V8, P3065; Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291; Wong AHT, 2001, J BIOL CHEM, V276, P13727, DOI 10.1074/jbc.M011240200; Xie B, 2001, J BIOL CHEM, V276, P19512, DOI 10.1074/jbc.M009063200; Youlyouz-Marfak I, 2008, CELL DEATH DIFFER, V15, P376, DOI 10.1038/sj.cdd.4402270; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	71	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3476	10.1371/journal.pone.0003476	http://dx.doi.org/10.1371/journal.pone.0003476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941537	Green Published, Green Submitted, gold			2022-12-27	WOS:000265126100007
J	Eccard, JA; Liesenjohann, T				Eccard, Jana Anja; Liesenjohann, Thilo			Foraging Decisions in Risk-Uniform Landscapes	PLOS ONE			English	Article								Behaviour is shaped by evolution as to maximise fitness by balancing gains and risks. Models on decision making in biology, psychology or economy have investigated choices among options which differ in gain and/or risk. Meanwhile, there are decision contexts with uniform risk distributions where options are not differing in risk while the overall risk level may be high. Adequate predictions for the emerging investment patterns in risk uniformity are missing. Here we use foraging behaviour as a model for decision making. While foraging, animals often titrate food and safety from predation and prefer safer foraging options over riskier ones. Risk uniformity can occur when habitat structures are uniform, when predators are omnipresent or when predators are ideal-free distributed in relation to prey availability. However, models and empirical investigations on optimal foraging have mainly investigated choices among options with different predation risks. Based on the existing models on local decision making in risk-heterogeneity we test predictions extrapolated to a landscape level with uniform risk distribution. We compare among landscapes with different risk levels. If the uniform risk is low, local decisions on the marginal value of an option should lead to an equal distribution of foraging effort. If the uniform risk is high, foraging should be concentrated on few options, due to a landscape-wide reduction of the value of missed opportunity costs of activities other than foraging. We provide experimental support for these predictions using foraging small mammals in artificial, risk uniform landscapes. In high risk uniform landscapes animals invested their foraging time in fewer options and accepted lower total returns, compared to their behaviour in low risk-uniform landscapes. The observed trade off between gain and risk, demonstrated here for food reduction and safety increase, may possibly apply also to other contexts of economic decision making.	[Eccard, Jana Anja; Liesenjohann, Thilo] Univ Bielefeld, Bielefeld, Germany; [Eccard, Jana Anja; Liesenjohann, Thilo] Univ Potsdam, Potsdam, Germany	University of Bielefeld; University of Potsdam	Eccard, JA (corresponding author), Univ Bielefeld, Bielefeld, Germany.	eccard@uni-potsdam.de			German Science Foundation (DFG) [EC 361/2]	German Science Foundation (DFG)(German Research Foundation (DFG))	Authors were supported by the German Science Foundation (DFG) with a grant to JAE (EC 361/2).	Barnard C.J., 2004, ANIMAL BEHAV MECH DE; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Eccard JA, 2008, OECOLOGIA, V157, P725, DOI 10.1007/s00442-008-1100-4; Jacob J, 2000, OIKOS, V91, P131, DOI 10.1034/j.1600-0706.2000.910112.x; Kenward R. E., 2003, RANGES6 V1 2 ANAL TR; Kotler BP, 2004, ECOLOGY, V85, P917, DOI 10.1890/03-3002; Kotler BP, 1995, OIKOS, V74, P251, DOI 10.2307/3545654; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; McNamara JM, 2005, P ROY SOC B-BIOL SCI, V272, P929, DOI 10.1098/rspb.2004.3037; Morris DW, 2000, ECOLOGY, V81, P2061, DOI 10.1890/0012-9658(2000)081[2061:OFMMPU]2.0.CO;2; OLSSON O, 2008, ISRAEL J EC IN PRESS; Pusenius J, 2000, OIKOS, V91, P123, DOI 10.1034/j.1600-0706.2000.910111.x; Sundell J, 2002, ANN ZOOL FENN, V39, P325; Tregenza T., 1995, Advances in Ecological Research, V26, P253, DOI 10.1016/S0065-2504(08)60067-7; WINTERHALDER B, 1983, AM NAT, V122, P73, DOI 10.1086/284119	17	21	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3438	10.1371/journal.pone.0003438	http://dx.doi.org/10.1371/journal.pone.0003438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927615	Green Published, Green Submitted, gold			2022-12-27	WOS:000265122400010
J	DaSilva, AF; Becerra, L; Pendse, G; Chizh, B; Tully, S; Borsook, D				DaSilva, Alexandre F.; Becerra, Lino; Pendse, Gautam; Chizh, Boris; Tully, Shannon; Borsook, David			Colocalized Structural and Functional Changes in the Cortex of Patients with Trigeminal Neuropathic Pain	PLOS ONE			English	Article								Background: Recent data suggests that in chronic pain there are changes in gray matter consistent with decreased brain volume, indicating that the disease process may produce morphological changes in the brains of those affected. However, no study has evaluated cortical thickness in relation to specific functional changes in evoked pain. In this study we sought to investigate structural (gray matter thickness) and functional (blood oxygenation dependent level - BOLD) changes in cortical regions of precisely matched patients with chronic trigeminal neuropathic pain (TNP) affecting the right maxillary (V2) division of the trigeminal nerve. The model has a number of advantages including the evaluation of specific changes that can be mapped to known somatotopic anatomy. Methodology/Principal Findings: Cortical regions were chosen based on sensory (Somatosensory cortex (SI and SII), motor (MI) and posterior insula), or emotional (DLPFC, Frontal, Anterior Insula, Cingulate) processing of pain. Both structural and functional (to brush-induced allodynia) scans were obtained and averaged from two different imaging sessions separated by 2-6 months in all patients. Age and gender-matched healthy controls were also scanned twice for cortical thickness measurement. Changes in cortical thickness of TNP patients were frequently colocalized and correlated with functional allodynic activations, and included both cortical thickening and thinning in sensorimotor regions, and predominantly thinning in emotional regions. Conclusions: Overall, such patterns of cortical thickness suggest a dynamic functionally-driven plasticity of the brain. These structural changes, which correlated with the pain duration, age-at-onset, pain intensity and cortical activity, may be specific targets for evaluating therapeutic interventions.	[DaSilva, Alexandre F.; Becerra, Lino; Pendse, Gautam; Tully, Shannon; Borsook, David] Harvard Univ, Med Sch, Mclean Hosp, Brain Imag Ctr, PAIN Grp, Boston, MA USA; [Becerra, Lino; Borsook, David] Harvard Univ, Med Sch, Massachusetts Gen Hosp, Boston, MA USA; [Chizh, Boris] GSK Addenbrooks Hosp, Cambridge, England	Harvard University; Harvard Medical School; McLean Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	DaSilva, AF (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	adasilva@umich.edu			NINDS [R01 NS042721, 1K24NS064050]; GSK; NIDCR [K12-DE014528]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K12DE014528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050, R01NS042721] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); GSK(GlaxoSmithKline); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was primarily supported by NINDS R01 NS042721 and 1K24NS064050 (DB), as well as in part from an investigator initiated grant from GSK (DB). Additional support was provided by NIDCR K12-DE014528 (AFMD).	Anderson BJ, 2002, LEARN MEMORY, V9, P1, DOI 10.1101/lm.43402; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Becerra L, 2006, J NEUROSCI, V26, P10646, DOI 10.1523/JNEUROSCI.2305-06.2006; Brooks JCW, 2007, PAIN, V128, P1, DOI 10.1016/j.pain.2006.12.025; Brooks JCW, 2005, NEUROIMAGE, V27, P201, DOI 10.1016/j.neuroimage.2005.03.041; Caclin A, 2006, EUR J NEUROSCI, V23, P2531, DOI 10.1111/j.1460-9568.2006.04773.x; Carlsson K, 2006, NEUROIMAGE, V32, P1804, DOI 10.1016/j.neuroimage.2006.05.027; Cesa R, 2007, J NEUROSCI, V27, P4603, DOI 10.1523/JNEUROSCI.5617-06.2007; Clarey JC, 1996, CEREB CORTEX, V6, P196, DOI 10.1093/cercor/6.2.196; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DASILVA AF, 2007, THICKENING SOMATOSEN; DaSilva AFM, 2002, J NEUROSCI, V22, P8183; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; Derbyshire SWG, 1999, EUR J PAIN, V3, P103, DOI 10.1053/eujp.1998.0102; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Farina S, 2001, NEUROSCI LETT, V314, P97, DOI 10.1016/S0304-3940(01)02297-2; FELDMAN ML, 1975, ANAT EMBRYOL, V148, P279, DOI 10.1007/BF00319848; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fitzgerald PB, 2006, PSYCHIAT RES-NEUROIM, V148, P33, DOI 10.1016/j.pscychresns.2006.04.006; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Fukuda M, 2008, BRAIN, V131, P1793, DOI 10.1093/brain/awn100; Goldstein RZ, 2007, NEUROSCIENCE, V144, P1153, DOI 10.1016/j.neuroscience.2006.11.024; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Grachev ID, 2003, J NEURAL TRANSM, V110, P287, DOI 10.1007/s00702-002-0781-9; Grachev ID, 2002, J NEURAL TRANSM, V109, P1309, DOI 10.1007/s00702-002-0722-7; Grachev ID, 2000, PAIN, V89, P7, DOI 10.1016/S0304-3959(00)00340-7; GUSTORFF B, 2007, ACTA ANAESTHESIOL SC; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hickmott PW, 2002, J NEUROPHYSIOL, V88, P1288, DOI 10.1152/jn.00994.2001; Hickmott PW, 2006, NEUROSCIENTIST, V12, P16, DOI 10.1177/1073858405282417; Hickmott PW, 2005, NAT NEUROSCI, V8, P140, DOI 10.1038/nn1384; Hoshi E, 2006, NEUROSCI RES, V54, P73, DOI 10.1016/j.neures.2005.10.013; Hsieh JC, 1996, PAIN, V67, P59, DOI 10.1016/0304-3959(96)03066-7; Ito U, 2006, STROKE, V37, P2134, DOI 10.1161/01.STR.0000231875.96714.b1; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; Kaas J, 2003, HUMAN NERVOUS SYSTEM, P1061; Kaas JH, 2000, PROG BRAIN RES, V128, P173; KNIGHT RT, 1995, ADV NEUROL, V66, P21; Kobayashi E, 2006, HUM BRAIN MAPP, V27, P488, DOI 10.1002/hbm.20193; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kwan CL, 2005, NEUROLOGY, V65, P1268, DOI 10.1212/01.wnl.0000180971.95473.cc; LaBuda CJ, 2005, NEUROSCIENCE, V136, P311, DOI 10.1016/j.neuroscience.2005.07.010; LaGraize SC, 2004, EXP NEUROL, V188, P139, DOI 10.1016/j.expneurol.2004.04.003; Li YF, 2007, NEUROSCI LETT, V418, P227, DOI 10.1016/j.neulet.2007.03.023; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Maihofner C, 2006, NEUROLOGY, V66, P711, DOI 10.1212/01.wnl.0000200961.49114.39; Maihofner C, 2003, NEUROLOGY, V61, P1707, DOI 10.1212/01.WNL.0000098939.02752.8E; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Ostrowsky K, 2002, CEREB CORTEX, V12, P376, DOI 10.1093/cercor/12.4.376; Ostrowsky K, 2000, EPILEPSIA, V41, P681, DOI 10.1111/j.1528-1157.2000.tb00228.x; PENDSE G, 2006, SOC NEUR ABSTR, V32, P4925; PENFIELD W, 1950, SECONDARY SENSORY MO, P109; Perlstein WM, 2002, P NATL ACAD SCI USA, V99, P1736, DOI 10.1073/pnas.241650598; PETRIDES M, 2003, HUMAN NERVOUS SYSTEM, P950; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Povedano M, 2007, J PAIN SYMPTOM MANAG, V33, P78, DOI 10.1016/j.jpainsymman.2006.07.012; Romaniello A, 2000, BRAIN RES, V882, P120, DOI 10.1016/S0006-8993(00)02856-0; Schaechter JD, 2006, BRAIN, V129, P2722, DOI 10.1093/brain/awl214; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schreckenberger M, 2005, NEUROLOGY, V64, P1175, DOI 10.1212/01.WNL.0000156353.17305.52; Schweinhardt P, 2006, NEUROIMAGE, V32, P256, DOI 10.1016/j.neuroimage.2006.03.024; SESSLE BJ, 1982, J PHYSIOL-LONDON, V323, P245, DOI 10.1113/jphysiol.1982.sp014071; Skoglund TS, 2004, NEUROSCI RES, V50, P189, DOI 10.1016/j.neures.2004.06.017; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Steen PA, 2007, J COMP NEUROL, V500, P634, DOI 10.1002/cne.21199; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Vees AM, 1998, J COMP NEUROL, V400, P110; Viswanathan V, 2006, NEUROREPORT, V17, P1669, DOI 10.1097/01.wnr.0000239953.60695.08; VOGT B, 2003, HUMAN NERVOUS SYSTEM, P916; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006; Witting N, 2001, NEUROLOGY, V57, P1817, DOI 10.1212/WNL.57.10.1817; YAMAGUCHI S, 1990, BRAIN RES, V521, P281, DOI 10.1016/0006-8993(90)91553-S; Zilles K, 2003, HUMAN NERVOUS SYSTEM, P997	86	100	104	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2008	3	10							e3396	10.1371/journal.pone.0003396	http://dx.doi.org/10.1371/journal.pone.0003396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GT	18923647	Green Submitted, gold, Green Published			2022-12-27	WOS:000265122200001
J	Zhang, XB; Jiang, P; Gong, N; Hu, XL; Fei, D; Xiong, ZQ; Xu, L; Xu, TL				Zhang, Xiao-Bing; Jiang, Peng; Gong, Neng; Hu, Xiao-Ling; Fei, Da; Xiong, Zhi-Qi; Xu, Lin; Xu, Tian-Le			A-Type GABA Receptor as a Central Target of TRPM8 Agonist Menthol	PLOS ONE			English	Article								Menthol is a widely-used cooling and flavoring agent derived from mint leaves. In the peripheral nervous system, menthol regulates sensory transduction by activating TRPM8 channels residing specifically in primary sensory neurons. Although behavioral studies have implicated menthol actions in the brain, no direct central target of menthol has been identified. Here we show that menthol reduces the excitation of rat hippocampal neurons in culture and suppresses the epileptic activity induced by pentylenetetrazole injection and electrical kindling in vivo. We found menthol not only enhanced the currents induced by low concentrations of GABA but also directly activated GABA(A) receptor (GABA(A)R) in hippocampal neurons in culture. Furthermore, in the CA1 region of rat hippocampal slices, menthol enhanced tonic GABAergic inhibition although phasic GABAergic inhibition was unaffected. Finally, the structure-effect relationship of menthol indicated that hydroxyl plays a critical role in menthol enhancement of tonic GABA(A)R. Our results thus reveal a novel cellular mechanism that may underlie the ambivalent perception and psychophysical effects of menthol and underscore the importance of tonic inhibition by GABA(A)Rs in regulating neuronal activity.	[Zhang, Xiao-Bing; Jiang, Peng; Gong, Neng; Hu, Xiao-Ling; Fei, Da; Xiong, Zhi-Qi; Xu, Tian-Le] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; [Xu, Lin] Chinese Acad Sci, Kunming Inst Zool, Lab Learning & Memory, Kunming, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhang, XB (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China.	tlxu@ion.ac.cn	ZHANG, XIAOBING/J-4076-2015	ZHANG, XIAOBING/0000-0002-5707-193X; Jiang, Peng/0000-0002-2650-3082; Xu, Lin/0000-0002-2710-3507	National Natural Science Foundation of China [30621062]; National Basic Research Program of China [2006CB500803]; Knowledge Innovation Project from the Chinese Academy of Sciences [KSCX2-YW-R-35]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Knowledge Innovation Project from the Chinese Academy of Sciences	This study was supported by the National Natural Science Foundation of China (No. 30621062), the National Basic Research Program of China (No. 2006CB500803) and the Knowledge Innovation Project from the Chinese Academy of Sciences (KSCX2-YW-R-35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Croteau RB, 2005, NATURWISSENSCHAFTEN, V92, P562, DOI 10.1007/s00114-005-0055-0; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; Hall AC, 2004, EUR J PHARMACOL, V506, P9, DOI 10.1016/j.ejphar.2004.10.026; Houser CR, 2003, HIPPOCAMPUS, V13, P633, DOI 10.1002/hipo.10108; Huang RQ, 2001, J PHARMACOL EXP THER, V298, P986; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; LIU QY, 1995, J MEMBRANE BIOL, V145, P279; Majkowski J, 1999, Adv Neurol, V81, P105; Mangan PS, 2004, J NEUROPHYSIOL, V91, P946, DOI 10.1152/jn.00547.2003; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Mtchedlishvili Z, 2006, MOL PHARMACOL, V69, P564, DOI 10.1124/mol.105.016683; Namer B, 2005, NEUROREPORT, V16, P955, DOI 10.1097/00001756-200506210-00015; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; OKADA R, 1989, BRAIN RES, V480, P383, DOI 10.1016/0006-8993(89)90212-6; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perkins KL, 2006, J NEUROSCI METH, V154, P1, DOI 10.1016/j.jneumeth.2006.02.010; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Sipila ST, 2005, J NEUROSCI, V25, P5280, DOI 10.1523/JNEUROSCI.0378-05.2005; SOMBATI S, 1995, J NEUROPHYSIOL, V73, P1706, DOI 10.1152/jn.1995.73.4.1706; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tsunashima K, 1997, NEUROSCIENCE, V80, P1019, DOI 10.1016/S0306-4522(97)00144-9; Tsuzuki K, 2004, J NEUROSCI, V24, P762, DOI 10.1523/JNEUROSCI.4658-03.2004; Umezu T, 2001, PHARMACOL BIOCHEM BE, V69, P383, DOI 10.1016/S0091-3057(01)00543-3; WALTHER H, 1986, NEUROSCI LETT, V69, P156, DOI 10.1016/0304-3940(86)90595-1; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Watt EE, 2008, EUR J PHARMACOL, V590, P120, DOI 10.1016/j.ejphar.2008.06.003; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; White H. Steve, 1995, P99; Yeh JH, 2005, BIOCHEM BIOPH RES CO, V338, P1417, DOI 10.1016/j.bbrc.2005.10.103; Yeung JYT, 2003, MOL PHARMACOL, V63, P2, DOI 10.1124/mol.63.1.2; Zuker CS, 2002, NATURE, V416, P27, DOI 10.1038/416027a	41	65	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3386	10.1371/journal.pone.0003386	http://dx.doi.org/10.1371/journal.pone.0003386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852885	Green Published, gold, Green Submitted			2022-12-27	WOS:000265121600010
J	Brumm, J; Conibear, E; Wasserman, WW; Bryan, J				Brumm, Jochen; Conibear, Elizabeth; Wasserman, Wyeth W.; Bryan, Jennifer			Discovery and Expansion of Gene Modules by Seeking Isolated Groups in a Random Graph Process	PLOS ONE			English	Article								Background: A central problem in systems biology research is the identification and extension of biological modules groups of genes or proteins participating in a common cellular process or physical complex. As a result, there is a persistent need for practical, principled methods to infer the modular organization of genes from genome-scale data. Results: We introduce a novel approach for the identification of modules based on the persistence of isolated gene groups within an evolving graph process. First, the underlying genomic data is summarized in the form of ranked gene-gene relationships, thereby accommodating studies that quantify the relevant biological relationship directly or indirectly. Then, the observed gene-gene relationship ranks are viewed as the outcome of a random graph process and candidate modules are given by the identifiable subgraphs that arise during this process. An isolation index is computed for each module, which quantifies the statistical significance of its survival time. Conclusions: The Miso (module isolation) method predicts gene modules from genomic data and the associated isolation index provides a module-specific measure of confidence. Improving on existing alternative, such as graph clustering and the global pruning of dendrograms, this index offers two intuitively appealing features: (1) the score is module-specific; and (2) different choices of threshold correlate logically with the resulting performance, i.e. a stringent cutoff yields high quality predictions, but low sensitivity. Through the analysis of yeast phenotype data, the Miso method is shown to outperform existing alternatives, in terms of the specificity and sensitivity of its predictions.	[Brumm, Jochen; Bryan, Jennifer] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Brumm, Jochen; Conibear, Elizabeth; Wasserman, Wyeth W.] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Conibear, Elizabeth; Wasserman, Wyeth W.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada; [Bryan, Jennifer] Univ British Columbia, Michael Smith Lab, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Child & Family Research Institute; University of British Columbia; University of British Columbia; University of British Columbia	Brumm, J (corresponding author), Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada.	jenny@stat.ubc.ca	Wasserman, Wyeth/I-4866-2015; Conibear, Elizabeth/G-5297-2010	Brumm, Jochen/0000-0001-9518-038X; Wasserman, Wyeth/0000-0001-6098-6412; Bryan, Jennifer/0000-0002-6983-2759; Conibear, Elizabeth/0000-0001-5129-0499	Canadian Institutes of Health Research; National Sciences and Engineering Research Council; Canada Foundation for Innovation; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by funding from the Canadian Institutes of Health Research (EC, WWW, JOB), the National Sciences and Engineering Research Council (JEB), the Canada Foundation for Innovation (WWW) and IBM (WWW). Additional support was provided by the Michael Smith Foundation for Health Research (Career Investigator awards to JEB, EC, and WWW) and CIHR (New Investigator awards to EC and WWW). The funders did not play any role in the design or conduct of the study.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Duda R.O., 2000, PATTERN CLASSIFICATI; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hartuv E, 2000, GENOMICS, V66, P249, DOI 10.1006/geno.2000.6187; Huber W, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S8; Kiemer L, 2007, PROTEOMICS, V7, P932, DOI 10.1002/pmic.200600448; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; LING RF, 1973, J AM STAT ASSOC, V68, P159, DOI 10.2307/2284161; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; R Core Team, 2018, R LANG ENV STAT COMP; Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289; Schluter C, 2008, MOL BIOL CELL, V19, P1282, DOI 10.1091/mbc.E07-07-0659; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stuetzle W, 2003, J CLASSIF, V20, P25, DOI 10.1007/s00357-003-0004-6; STUETZLE W, 2007, 514 U WASH DEP STAT; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; van Dongen S. M., 2000, GRAPH CLUSTERING FLO; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WONG MA, 1983, J ROY STAT SOC B MET, V45, P362	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3358	10.1371/journal.pone.0003358	http://dx.doi.org/10.1371/journal.pone.0003358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DQ	18843375	Green Published, Green Submitted, gold			2022-12-27	WOS:000265114100004
J	Sanford, JR; Coutinho, P; Hackett, JA; Wang, X; Ranahan, W; Caceres, JF				Sanford, Jeremy R.; Coutinho, Pedro; Hackett, Jamie A.; Wang, Xin; Ranahan, William; Caceres, Javier F.			Identification of Nuclear and Cytoplasmic mRNA Targets for the Shuttling Protein SF2/ASF	PLOS ONE			English	Article								The serine and arginine-rich protein family (SR proteins) are highly conserved regulators of pre-mRNA splicing. SF2/ASF, a prototype member of the SR protein family, is a multifunctional RNA binding protein with roles in pre-mRNA splicing, mRNA export and mRNA translation. These observations suggest the intriguing hypothesis that SF2/ASF may couple splicing and translation of specific mRNA targets in vivo. Unfortunately the paucity of endogenous mRNA targets for SF2/ASF has hindered testing of this hypothesis. Here, we identify endogenous mRNAs directly cross-linked to SF2/ASF in different subcellular compartments. Cross-Linking Immunoprecipitation (CLIP) captures the in situ specificity of protein-RNA interaction and allows for the simultaneous identification of endogenous RNA targets as well as the locations of binding sites within the RNA transcript. Using the CLIP method we identified 326 binding sites for SF2/ASF in RNA transcripts from 180 protein coding genes. A purine-rich consensus motif was identified in binding sites located within exon sequences but not introns. Furthermore, 72 binding sites were occupied by SF2/ASF in different sub-cellular fractions suggesting that these binding sites may influence the splicing or translational control of endogenous mRNA targets. We demonstrate that ectopic expression of SF2/ASF regulates the splicing and polysome association of transcripts derived from the SFRS1, PABC1, NETO2 and ENSA genes. Taken together the data presented here indicate that SF2/ASF has the capacity to co-regulate the nuclear and cytoplasmic processing of specific mRNAs and provide further evidence that the nuclear history of an mRNA may influence its cytoplasmic fate.	[Sanford, Jeremy R.; Coutinho, Pedro; Hackett, Jamie A.; Caceres, Javier F.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Sanford, Jeremy R.; Wang, Xin; Ranahan, William] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA	University of Edinburgh; Indiana University System; Indiana University-Purdue University Indianapolis	Sanford, JR (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	sanford@biology.ucsc.edu; Javier.Caceres@hgu.mrc.ac.uk	Caceres, Javier F/D-5260-2013; Wang, Xin/A-1130-2012	Caceres, Javier F/0000-0001-8025-6169; Wang, Xin/0000-0002-5122-2418; Hackett, Jamie/0000-0002-6237-3684	Medical Research Council; EURASNET; Caledonian Research Foundation [postdoctoral fellowship]; American Heart Association [0830206N]; Medical Research Council [MC_U127584479] Funding Source: researchfish; MRC [MC_U127584479] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EURASNET; Caledonian Research Foundation; American Heart Association(American Heart Association); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the Medical Research Council (J.F.C., P.C. and J.A.H) plus additional funds from EURASNET (European Alternative splicing Network) to J.F.C.. J.R.S. was initially supported by a postdoctoral fellowship from the Caledonian Research Foundation and is currently funded by American Heart Association Scientist Development Grant #0830206N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bedard KM, 2007, EMBO J, V26, P459, DOI 10.1038/sj.emboj.7601494; Blanchette M, 2005, GENE DEV, V19, P1306, DOI 10.1101/gad.1314205; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; CAPUTI M, 1994, NUCLEIC ACIDS RES, V22, P1018, DOI 10.1093/nar/22.6.1018; Cazalla D, 2005, PROTEIN EXPRES PURIF, V42, P54, DOI 10.1016/j.pep.2005.03.035; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; de la Grange P, 2005, NUCLEIC ACIDS RES, V33, P4276, DOI 10.1093/nar/gki738; Drummond-Barbosa D, 2004, DEV BIOL, V266, P310, DOI 10.1016/j.ydbio.2003.10.028; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Nagalakshmi U, 2008, SCIENCE; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Olson S, 2007, NAT STRUCT MOL BIOL, V14, P1134, DOI 10.1038/nsmb1339; Ram O, 2007, TRENDS GENET, V23, P5, DOI 10.1016/j.tig.2006.10.002; RAMCHATESINGH J, 1995, MOL CELL BIOL, V15, P4898; Sanford JR, 2005, P NATL ACAD SCI USA, V102, P15042, DOI 10.1073/pnas.0507827102; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; THIERRYMIEG D, 2006, GENOME BIOL S1, V7, pS1211; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Ule J., 2006, NATURE; Wang H, 2004, MOL GENET METAB, V81, P9, DOI 10.1016/j.ymgme.2003.08.003; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhang ZDD, 2007, GENOME RES, V17, P787, DOI 10.1101/gr.5573107	42	91	93	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3369	10.1371/journal.pone.0003369	http://dx.doi.org/10.1371/journal.pone.0003369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841201	Green Published, gold, Green Submitted			2022-12-27	WOS:000265113900006
J	Yoshiike, Y; Minai, R; Matsuo, Y; Chen, YR; Kimura, T; Takashima, A				Yoshiike, Yuji; Minai, Ryoichi; Matsuo, Yo; Chen, Yun-Ru; Kimura, Tetsuya; Takashima, Akihiko			Amyloid Oligomer Conformation in a Group of Natively Folded Proteins	PLOS ONE			English	Article								Recent in vitro and in vivo studies suggest that destabilized proteins with defective folding induce aggregation and toxicity in protein-misfolding diseases. One such unstable protein state is called amyloid oligomer, a precursor of fully aggregated forms of amyloid. Detection of various amyloid oligomers with A11, an anti-amyloid oligomer conformation-specific antibody, revealed that the amyloid oligomer represents a generic conformation and suggested that toxic beta-aggregation processes possess a common mechanism. By using A11 antibody as a probe in combination with mass spectrometric analysis, we identified GroEL in bacterial lysates as a protein that may potentially have an amyloid oligomer conformation. Surprisingly, A11 reacted not only with purified GroEL but also with several purified heat shock proteins, including human Hsp27, 40, 70, 90; yeast Hsp104; and bovine Hsc70. The native folds of A11-reactive proteins in purified samples were characterized by their anti-beta-aggregation activity in terms of both functionality and in contrast to the beta-aggregation promoting activity of misfolded pathogenic amyloid oligomers. The conformation-dependent binding of A11 with natively folded Hsp27 was supported by the concurrent loss of A11 reactivity and anti-beta-aggregation activity of heat-treated Hsp27 samples. Moreover, we observed consistent anti-beta-aggregation activity not only by chaperones containing an amyloid oligomer conformation but also by several A11-immunoreactive non-chaperone proteins. From these results, we suggest that the amyloid oligomer conformation is present in a group of natively folded proteins. The inhibitory effects of A11 antibody on both GroEL/ES-assisted luciferase refolding and Hsp70-mediated decelerated nucleation of A beta aggregation suggested that the A11-binding sites on these chaperones might be functionally important. Finally, we employed a computational approach to uncover possible A11-binding sites on these targets. Since the beta-sheet edge was a common structural motif having the most similar physicochemical properties in the A11-reactive proteins we analyzed, we propose that the beta-sheet edge in some natively folded amyloid oligomers is designed positively to prevent beta aggregation.	[Yoshiike, Yuji; Kimura, Tetsuya; Takashima, Akihiko] RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama, Japan; [Minai, Ryoichi; Matsuo, Yo] RIKEN, Genom Sci Ctr, Computat Proteom Team, Yokohama, Kanagawa, Japan; [Chen, Yun-Ru] Acad Sinica, Genom Res Ctr, Taipei, Taiwan	RIKEN; RIKEN; Academia Sinica - Taiwan	Yoshiike, Y (corresponding author), RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama, Japan.	kenneth@brain.riken.jp	Chen, Yun-Ru/C-9304-2014	Chen, Yun-Ru/0000-0002-6596-6338	Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid for Scientific Research on Priority Areas]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by Grant-in-Aid for Scientific Research on Priority Areas (Research on Pathomechanisms on Brain Disorders) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Ashcroft AE, 2002, J BIOL CHEM, V277, P33115, DOI 10.1074/jbc.M203398200; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; BLAKE CCF, 1977, NATURE, V268, P115, DOI 10.1038/268115a0; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BUSH BL, 1993, J CHEM INF COMP SCI, V33, P756, DOI 10.1021/ci00015a015; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Du YS, 1998, J NEUROCHEM, V70, P1182; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Ermolenko DN, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1233, DOI 10.1007/s10541-005-0069-4; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Ferguson N, 2006, P NATL ACAD SCI USA, V103, P16248, DOI 10.1073/pnas.0607815103; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Jenner L, 1998, STRUCTURE, V6, P595, DOI 10.1016/S0969-2126(98)00061-6; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kameda A, 2005, J MOL BIOL, V348, P383, DOI 10.1016/j.jmb.2005.02.050; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kimura T, 2002, J AM CHEM SOC, V124, P11596, DOI 10.1021/ja026639f; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Schwarzman AL, 1996, CIBA F SYMP, V199, P146; SCHWARZMAN AL, 1994, P NATL ACAD SCI USA, V91, P8368, DOI 10.1073/pnas.91.18.8368; Serag AA, 2002, NAT STRUCT BIOL, V9, P734, DOI 10.1038/nsb838; Stein TD, 2002, J NEUROSCI, V22, P7380; Stockel J, 2001, J MOL BIOL, V313, P861, DOI 10.1006/jmbi.2001.5085; Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Xu Q, 2004, PROTEIN SCI, V13, P1851, DOI 10.1110/ps.04699904; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	50	56	57	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3235	10.1371/journal.pone.0003235	http://dx.doi.org/10.1371/journal.pone.0003235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800165	Green Published, gold, Green Submitted			2022-12-27	WOS:000264428400005
J	Van den Stock, J; van de Riet, WAC; Righart, R; de Gelder, B				Van den Stock, Jan; van de Riet, Wim A. C.; Righart, Ruthger; de Gelder, Beatrice			Neural Correlates of Perceiving Emotional Faces and Bodies in Developmental Prosopagnosia: An Event-Related fMRI-Study	PLOS ONE			English	Article								Many people experience transient difficulties in recognizing faces but only a small number of them cannot recognize their family members when meeting them unexpectedly. Such face blindness is associated with serious problems in everyday life. A better understanding of the neuro-functional basis of impaired face recognition may be achieved by a careful comparison with an equally unique object category and by a adding a more realistic setting involving neutral faces as well facial expressions. We used event-related functional magnetic resonance imaging (fMRI) to investigate the neuro-functional basis of perceiving faces and bodies in three developmental prosopagnosics (DP) and matched healthy controls. Our approach involved materials consisting of neutral faces and bodies as well as faces and bodies expressing fear or happiness. The first main result is that the presence of emotional information has a different effect in the patient vs. the control group in the fusiform face area (FFA). Neutral faces trigger lower activation in the DP group, compared to the control group, while activation for facial expressions is the same in both groups. The second main result is that compared to controls, DPs have increased activation for bodies in the inferior occipital gyrus (IOG) and for neutral faces in the extrastriate body area (EBA), indicating that body and face sensitive processes are less categorically segregated in DP. Taken together our study shows the importance of using naturalistic emotional stimuli for a better understanding of developmental face deficits.	[Van den Stock, Jan; van de Riet, Wim A. C.; Righart, Ruthger; de Gelder, Beatrice] Tilburg Univ, Lab Cognit & Affect Neurosci, NL-5000 LE Tilburg, Netherlands; [Van den Stock, Jan] Univ Hosp Leuven, Old Age Psychiat Dept, Louvain, Belgium; [de Gelder, Beatrice] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA	Tilburg University; KU Leuven; University Hospital Leuven; Harvard University; Massachusetts General Hospital	Van den Stock, J (corresponding author), Tilburg Univ, Lab Cognit & Affect Neurosci, NL-5000 LE Tilburg, Netherlands.	degelder@nmr.mgh.harvard.edu	Van den Stock, J./F-1906-2014	Van den Stock, J./0000-0001-5756-3195	Human Frontiers Science Program [RGP0054/2004-C]; European Commission [FP6-2005-NEST-Path Imp 043403-COBOL]; NWO, Dutch Science Foundation	Human Frontiers Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); NWO, Dutch Science Foundation(Netherlands Organization for Scientific Research (NWO))	The research was partly funded by a Human Frontiers Science Program grant (RGP0054/2004-C), a European Commission grant (FP6-2005-NEST-Path Imp 043403-COBOL) and a NWO grant (Dutch Science Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Baker CI, 2007, NAT NEUROSCI, V10, P3, DOI 10.1038/nn0107-3; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Behrmann M, 2007, CEREB CORTEX, V17, P2354, DOI 10.1093/cercor/bhl144; Bentin S, 1999, NEUROREPORT, V10, P823, DOI 10.1097/00001756-199903170-00029; Bentin S, 2007, J COGNITIVE NEUROSCI, V19, P132, DOI 10.1162/jocn.2007.19.1.132; Benton A., 1983, CONTRIBUTION NEUROPS; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; de Gelder B, 2000, COGN NEUROPSYCHOL, V17, P89, DOI 10.1080/026432900380508; de Gelder B, 2000, NEUROPSYCHOLOGIA, V38, P1271, DOI 10.1016/S0028-3932(00)00039-7; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 1998, VISION RES, V38, P2855, DOI 10.1016/S0042-6989(97)00458-6; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Gelder B, 2000, NEUROREPORT, V11, P3145, DOI 10.1097/00001756-200009280-00021; DEGELDER B, 2003, P NATL ACAD SCI US; DeGutis JM, 2007, J COGNITIVE NEUROSCI, V19, P1790, DOI 10.1162/jocn.2007.19.11.1790; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duchaine BC, 2003, PERCEPTION, V32, P827, DOI 10.1068/p5067; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Eastwood JD, 2003, PERCEPT PSYCHOPHYS, V65, P352, DOI 10.3758/BF03194566; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Farah M.J., 1990, VISUAL AGNOSIA DISOR; Fodor J. A, 1983, MODULARITY MIND; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, J COGNITIVE NEUROSCI, V11, P349, DOI 10.1162/089892999563472; Golarai G, 2007, NAT NEUROSCI, V10, P512, DOI 10.1038/nn1865; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2008, TRENDS COGN SCI, V12, P152, DOI 10.1016/j.tics.2008.01.009; Grueter M, 2007, CORTEX, V43, P734, DOI 10.1016/S0010-9452(08)70502-1; GUYER AE, 2008, J COGN NEUROSCI; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Hadjikhani N, 2002, HUM BRAIN MAPP, V16, P176, DOI 10.1002/hbm.10043; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Johnson-Frey SH, 2003, NEURON, V39, P1053, DOI 10.1016/S0896-6273(03)00524-5; Jones RD, 2001, J CLIN EXP NEUROPSYC, V23, P265, DOI 10.1076/jcen.23.3.265.1183; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kennerknecht I, 2006, AM J MED GENET A, V140A, P1617, DOI 10.1002/ajmg.a.31343; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Le Grand R, 2006, BRAIN COGNITION, V61, P139, DOI 10.1016/j.bandc.2005.11.005; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Lundqvist D., 1998, KAROLINSKA DIRECTED; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Nunn JA, 2001, NEUROCASE, V7, P15, DOI 10.1093/neucas/7.1.15; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Puce A, 1996, J NEUROSCI, V16, P5205; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Riddoch MJ., 1993, BORB BIRMINGHAM OBJE; RIGHART R, 2007, P NATL ACAD SCI US; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Rotshtein P, 2001, NEURON, V32, P747, DOI 10.1016/S0896-6273(01)00513-X; Russell, 1974, APPROACH ENV PSYCHOL; Sorger B, 2007, NEUROIMAGE, V35, P836, DOI 10.1016/j.neuroimage.2006.09.051; Steeves JKE, 2006, NEUROPSYCHOLOGIA, V44, P594, DOI 10.1016/j.neuropsychologia.2005.06.013; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Surguladze SA, 2003, NEUROIMAGE, V19, P1317, DOI 10.1016/S1053-8119(03)00085-5; Talairach J., 1988, COPLANAR STEREOTAXIC; VANDERIET WAC, SOC NEUROSC IN PRESS; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2001, NEUROLOGY, V56, P153, DOI 10.1212/WNL.56.2.153; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Warrington E.K., 1984, RECOGNITION MEMORY T; Williams MA, 2007, CURR BIOL, V17, P1259, DOI 10.1016/j.cub.2007.06.042; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	77	51	51	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3195	10.1371/journal.pone.0003195	http://dx.doi.org/10.1371/journal.pone.0003195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LB	18797499	Green Published, Green Submitted, gold			2022-12-27	WOS:000264428200002
J	Chang, HCH; Dimlich, DN; Yokokura, T; Mukherjee, A; Kankel, MW; Sen, A; Sridhar, V; Fulga, TA; Hart, AC; Van Vactor, D; Artavanis-Tsakonas, S				Chang, Howard Chia-Hao; Dimlich, Douglas N.; Yokokura, Takakazu; Mukherjee, Ashim; Kankel, Mark W.; Sen, Anindya; Sridhar, Vasanthi; Fulga, Tudor A.; Hart, Anne C.; Van Vactor, David; Artavanis-Tsakonas, Spyros			Modeling Spinal Muscular Atrophy in Drosophila	PLOS ONE			English	Article							REGULATES SYNAPTIC GROWTH; MOTOR-NEURONS; SMN COMPLEX; MOUSE MODEL; SINGLE NUCLEOTIDE; II RECEPTOR; GENE SMN1; EXPRESSION; SURVIVAL; PROTEIN	Spinal Muscular Atrophy (SMA), a recessive hereditary neurodegenerative disease in humans, has been linked to mutations in the survival motor neuron (SMN) gene. SMA patients display early onset lethality coupled with motor neuron loss and skeletal muscle atrophy. We used Drosophila, which encodes a single SMN ortholog, survival motor neuron (Smn), to model SMA, since reduction of Smn function leads to defects that mimic the SMA pathology in humans. Here we show that a normal neuromuscular junction (NMJ) structure depends on SMN expression and that SMN concentrates in the postsynaptic NMJ regions. We conducted a screen for genetic modifiers of an Smn phenotype using the Exelixis collection of transposon-induced mutations, which affects approximately 50% of the Drosophila genome. This screen resulted in the recovery of 27 modifiers, thereby expanding the genetic circuitry of Smn to include several genes not previously known to be associated with this locus. Among the identified modifiers was wishful thinking (wit), a type II BMP receptor, which was shown to alter the Smn NMJ phenotype. Further characterization of two additional members of the BMP signaling pathway, Mothers against dpp (Mad) and Daughters against dpp (Dad), also modify the Smn NMJ phenotype. The NMJ defects caused by loss of Smn function can be ameliorated by increasing BMP signals, suggesting that increased BMP activity in SMA patients may help to alleviate symptoms of the disease. These results confirm that our genetic approach is likely to identify bona fide modulators of SMN activity, especially regarding its role at the neuromuscular junction, and as a consequence, may identify putative SMA therapeutic targets.	[Chang, Howard Chia-Hao; Dimlich, Douglas N.; Yokokura, Takakazu; Kankel, Mark W.; Sen, Anindya; Sridhar, Vasanthi; Fulga, Tudor A.; Van Vactor, David; Artavanis-Tsakonas, Spyros] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02163 USA; [Mukherjee, Ashim] Banaras Hindu Univ, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India; [Hart, Anne C.] Harvard Univ, Sch Med, Canc Ctr, Massachusetts Gen Hosp, Dept Pathol, Cambridge, MA 02138 USA; [Artavanis-Tsakonas, Spyros] Coll France, Paris, France	Harvard University; Harvard Medical School; Banaras Hindu University (BHU); Harvard University; Massachusetts General Hospital; UDICE-French Research Universities; PSL Research University Paris; College de France	Chang, HCH (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02163 USA.	artavanis@hms.harvard.edu		Chang, Howard/0000-0003-4310-8890; Viswanathan, Vasanthi/0000-0001-9878-3629; Fulga, Tudor/0000-0002-1056-0082; Van Vactor, Jr., David L./0000-0001-8156-9482	SMA foundation; NIH	SMA foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SMA foundation, NIH	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Frugier T, 2002, CURR OPIN GENET DEV, V12, P294, DOI 10.1016/S0959-437X(02)00301-5; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Inoue H, 1998, MOL BIOL CELL, V9, P2145, DOI 10.1091/mbc.9.8.2145; Jablonka S, 2006, HUM MOL GENET, V15, P511, DOI 10.1093/hmg/ddi467; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kankel MW, 2007, GENETICS, V177, P2493, DOI 10.1534/genetics.107.080994; KARIYA S, 2008, HUM MOL GENET; Khalsa O, 1998, DEVELOPMENT, V125, P2723; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lee S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001404; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Massenet S, 2002, MOL CELL BIOL, V22, P6533, DOI 10.1128/MCB.22.18.6533-6541.2002; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; MICHELSON AM, 1994, DEVELOPMENT, V120, P755; Miguel-Aliaga I, 2000, FEBS LETT, V486, P99, DOI 10.1016/S0014-5793(00)02243-2; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Pan LY, 2004, CURR BIOL, V14, P1863, DOI 10.1016/j.cub.2004.09.085; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	66	133	134	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3209	10.1371/journal.pone.0003209	http://dx.doi.org/10.1371/journal.pone.0003209			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791638	Green Published, gold, Green Submitted			2022-12-27	WOS:000264427700004
J	Sohi, MK; Veselkov, DA; Laponogov, I; Pan, XS; Fisher, LM; Sanderson, MR				Sohi, Maninder K.; Veselkov, Dennis A.; Laponogov, Ivan; Pan, Xiao-Su; Fisher, L. Mark; Sanderson, Mark R.			The Difficult Case of Crystallization and Structure Solution for the ParC55 Breakage-Reunion Domain of Topoisomerase IV from Streptococcus pneumoniae	PLOS ONE			English	Article								Background: Streptococcus pneumoniae is the major cause of community-acquired pneumonia and is also associated with bronchitis, meningitis, otitis and sinusitis. The emergence and increasing prevalence of resistance to penicillin and other antibiotics has led to interest in other anti-pneumonococcal drugs such as quinolones that target the enzymes DNA gyrase and topoisomerase IV. During crystallization and in the avenues to finding a method to determine phases for the structure of the ParC55 breakage-reunion domain of topoisomerase IV from Streptococcus pneumoniae, obstacles were faced at each stage of the process. These problems included: majority of the crystals being twinned, either non-diffracting or exhibiting a high mosaic spread. The crystals, which were grown under conditions that favoured diffraction, were difficult to flash-freeze without loosing diffraction. The initial structure solution by molecular replacement failed and the approach proved to be unviable due to the complexity of the problem. In the end the successful structure solution required an in-depth data analysis and a very detailed molecular replacement search. Methodology/Principal Findings: Crystal anti-twinning agents have been tested and two different methods of flash freezing have been compared. The fragility of the crystals did not allow the usual method of transferring the crystals into the heavy atom solution. Consequently, it was necessary to co-crystallize in the presence of the heavy atom compound. The multiple isomorphous replacement approach was unsuccessful because the 7 cysteine mutants which were engineered could not be successfully derivatized. Ultimately, molecular replacement was used to solve the structure by sorting through a large number of solutions in space group P1 using CNS. Conclusions/Significance: The main objective of this paper is to describe the obstacles which were faced and overcome in order to acquire data sets on such difficult crystals and determine phases for successful structure solution.	[Sohi, Maninder K.; Veselkov, Dennis A.; Laponogov, Ivan; Sanderson, Mark R.] Kings Coll London, Sch Biomed & Hlth Sci, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Pan, Xiao-Su; Fisher, L. Mark] Univ London, Div Basic Med Sci, Mol & Metabol Signalling Ctr, Mol Genet Grp, London WC1E 7HU, England	University of London; King's College London; University of London	Sohi, MK (corresponding author), Kings Coll London, Sch Biomed & Hlth Sci, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	lfisher@sgul.ac.uk; mark.sanderson@kcl.ac.uk		Fisher, Larry Mark/0000-0002-2172-3369	Biothechnology and Biological Sciences Research Council [C16747]; BBSRC [BB/D01882X/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D01882X/1] Funding Source: researchfish; Medical Research Council [MC_U117533887] Funding Source: researchfish	Biothechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Project Grant C16747 from the Biothechnology and Biological Sciences Research Council to L.M. Fisher and M.R. Sanderson.	[Anonymous], ACTA CRYSTALLOGR D, V50, P760; Bates A.D., 2005, DNA TOPOLOGY; Berger JM, 1998, BBA-GENE STRUCT EXPR, V1400, P3, DOI 10.1016/S0167-4781(98)00124-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carr SB, 2006, ACTA CRYSTALLOGR F, V62, P1164, DOI 10.1107/S1744309106044150; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; HATFULL GF, 1989, J MOL BIOL, V208, P661, DOI 10.1016/0022-2836(89)90156-3; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kabsch W, 1993, P CCP4 STUD WEEK WAR, P63; Laponogov I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000301; Leo E, 2005, J BIOL CHEM, V280, P14252, DOI 10.1074/jbc.M500156200; Levine C, 1998, BBA-GENE STRUCT EXPR, V1400, P29, DOI 10.1016/S0167-4781(98)00126-2; Maxwell A, 1996, NAT STRUCT BIOL, V3, P109, DOI 10.1038/nsb0296-109; Maxwell A, 2005, BIOCHEM SOC T, V33, P1460, DOI 10.1042/BST0331460; MCPHERSON A, 1990, EUR J BIOCHEM, V189, P1, DOI 10.1111/j.1432-1033.1990.tb15454.x; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan XS, 1999, ANTIMICROB AGENTS CH, V43, P1129, DOI 10.1128/AAC.43.5.1129; Pan XS, 1997, ANTIMICROB AGENTS CH, V41, P471, DOI 10.1128/AAC.41.2.471; Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465; Sohi M, 2000, FEBS LETT, V465, P161, DOI 10.1016/S0014-5793(99)01690-7; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831	28	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3201	10.1371/journal.pone.0003201	http://dx.doi.org/10.1371/journal.pone.0003201			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787651	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000264426200006
J	Tundup, S; Pathak, N; Ramanadham, M; Mukhopadhyay, S; Murthy, KJR; Ehtesham, NZ; Hasnain, SE				Tundup, Smanla; Pathak, Niteen; Ramanadham, M.; Mukhopadhyay, Sangita; Murthy, K. J. R.; Ehtesham, Nasreen Z.; Hasnain, Seyed E.			The Co-Operonic PE25/PPE41 Protein Complex of Mycobacterium tuberculosis Elicits Increased Humoral and Cell Mediated Immune Response	PLOS ONE			English	Article							CD8(+) T-CELLS; INTERFERON-GAMMA; GENE-EXPRESSION; BCG VACCINE; PE; ANTIGEN; PPE; RV2430C; ESAT-6; TRANSLOCATION	Background: Many of the PE/PPE proteins are either surface localized or secreted outside and are thought to be a source of antigenic variation in the host. The exact role of these proteins are still elusive. We previously reported that the PPE41 protein induces high B cell response in TB patients. The PE/PPE genes are not randomly distributed in the genome but are organized as operons and the operon containing PE25 and PPE41 genes co-transcribe and their products interact with each other. Methodology/Principal Finding: We now describe the antigenic properties of the PE25, PPE41 and PE25/PPE41 protein complex coded by a single operon. The PPE41 and PE25/PPE41 protein complex induces significant (p<.0001) B cell response in sera derived from TB patients and in mouse model as compared to the PE25 protein. Further, mice immunized with the PE25/PPE41 complex and PPE41 proteins showed significant (p<0.00001) proliferation of splenocyte as compared to the mice immunized with the PE25 protein and saline. Flow cytometric analysis showed 15-22% enhancement of CD8(+) and CD4(+) T cell populations when immunized with the PPE41 or PE25/PPE41 complex as compared to a marginal increase (8-10%) in the mice immunized with the PE25 protein. The PPE41 and PE25/PPE41 complex can also induce higher levels of IFN-gamma, TNF-alpha and IL-2 cytokines. Conclusion: While this study documents the differential immunological respo nse to the complex of PE and PPE vis-a-vis the individual proteins, it also highlights their potential as a candidate vaccine against tuberculosis.	[Tundup, Smanla; Pathak, Niteen; Mukhopadhyay, Sangita; Hasnain, Seyed E.] Ctr DNA Fingerprinting & Diagnost, Mol & Cellular Biol Lab, Hyderabad, Andhra Pradesh, India; [Tundup, Smanla; Ramanadham, M.] Univ Hyderabad, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Murthy, K. J. R.] Mahavir Hosp, Immunol Unit, Hyderabad, Andhra Pradesh, India; [Ehtesham, Nasreen Z.] Natl Inst Nutr, Hyderabad, Andhra Pradesh, India; [Hasnain, Seyed E.] HCU Campus, Inst Life Sci, Hyderabad, Andhra Pradesh, India; [Hasnain, Seyed E.] Jawaharlal Nehru Ctr Advanced Sci Res, Bangalore, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); University of Hyderabad; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Tundup, S (corresponding author), Ctr DNA Fingerprinting & Diagnost, Mol & Cellular Biol Lab, Hyderabad, Andhra Pradesh, India.	vc@uohyd.ernet.in	EHTESHAM, NASREEN ZAFAR/AAI-3169-2020	Mukhopadhyay, Sangita/0000-0002-5511-3315; Hasnain, Seyed/0000-0002-2967-0791	Department of Biotechnology (DBT), India; Bose National Fellow of the Ministry of Science & Technology, Government of India; CSIR [Senior Research Fellow]	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); Bose National Fellow of the Ministry of Science & Technology, Government of India; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The financial support for the work carried out was provided by the Department of Biotechnology (DBT), India. Seyed E. Hasnain is a J.C. Bose National Fellow of the Ministry of Science & Technology, Government of India. S. T. is a CSIR Senior Research Fellow.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; BREWER TF, 1995, CLIN INFECT DIS, V20, P126, DOI 10.1093/clinids/20.1.126; Campuzano J, 2007, VACCINE, V25, P3722, DOI 10.1016/j.vaccine.2006.12.042; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Choudhary RK, 2004, PROTEIN EXPRES PURIF, V36, P249, DOI 10.1016/j.pep.2004.03.016; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Valliere S, 2005, INFECT IMMUN, V73, P6711, DOI 10.1128/IAI.73.10.6711-6720.2005; Delogu G, 2001, INFECT IMMUN, V69, P5606, DOI 10.1128/IAI.69.9.5606-5611.2001; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Ganguly N, 2008, IMMUNOL CELL BIOL, V86, P98, DOI 10.1038/sj.icb.7100117; Ganguly N, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-24; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Golby P, 2007, MICROBIOL-SGM, V153, P3323, DOI 10.1099/mic.0.2007/009894-0; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Khan N, 2006, BLOOD, V107, P1513, DOI 10.1182/blood-2005-04-1707; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Rehren G, 2007, TUBERCULOSIS, V87, P347, DOI 10.1016/j.tube.2007.02.004; Serbina NV, 2001, INFECT IMMUN, V69, P4320, DOI 10.1128/IAI.69.7.4320-4328.2001; Serbina NV, 2001, J IMMUNOL, V167, P6991, DOI 10.4049/jimmunol.167.12.6991; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Woodworth JSM, 2006, CRIT REV IMMUNOL, V26, P317, DOI 10.1615/CritRevImmunol.v26.i4.30	35	57	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3586	10.1371/journal.pone.0003586	http://dx.doi.org/10.1371/journal.pone.0003586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974870	Green Published, gold			2022-12-27	WOS:000265131700009
J	Maximino, C				Maximino, Caio			Evolutionary Changes in the Complexity of the Tectum of Nontetrapods: A Cladistic Approach	PLOS ONE			English	Article								Background: The tectum is a structure localized in the roof of the midbrain in vertebrates, and is taken to be highly conserved in evolution. The present article assessed three hypotheses concerning the evolution of lamination and citoarchitecture of the tectum of nontetrapod animals: 1) There is a significant degree of phylogenetic inertia in both traits studied (number of cellular layers and number of cell classes in tectum); 2) Both traits are positively correlated accross evolution after correction for phylogeny; and 3) Different developmental pathways should generate different patterns of lamination and cytoarchitecture. Methodology/Principal Findings: The hypotheses were tested using analytical-computational tools for phylogenetic hypothesis testing. Both traits presented a considerably large phylogenetic signal and were positively associated. However, no difference was found between two clades classified as per the general developmental pathways of their brains. Conclusions/Significance: The evidence amassed points to more variation in the tectum than would be expected by phylogeny in three species from the taxa analysed; this variation is not better explained by differences in the main course of development, as would be predicted by the developmental clade hypothesis. Those findings shed new light on the evolution of an functionally important structure in nontetrapods, the most basal radiations of vertebrates.	[Maximino, Caio] Univ Estadual Paulista, Lab Psychobiol & Expt Psychopatol, Dept Psychol, Bauru, Brazil	Universidade Estadual Paulista	Maximino, C (corresponding author), Univ Estadual Paulista, Lab Psychobiol & Expt Psychopatol, Dept Psychol, Bauru, Brazil.	caio.maximino@gmail.com	Maximino, Caio/G-5726-2013	Maximino, Caio/0000-0002-3261-9196				Baez J, 2003, BRAIN RES, V975, P48, DOI 10.1016/S0006-8993(03)02586-1; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Butler A.B., 2005, COMP VERTEBRATE NEUR, Vsecond; CLAIRAMBAULT P, 1974, Bollettino di Zoologia, V41, P107; Ebbesson S.O.E., 1984, P33; Eldredge N., 1980, PHYLOGENETIC PATTERN; FARNER HP, 1978, J HIRNFORSCH, V19, P333; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; GAZE R M, 1970, Experimental Brain Research, V10, P171; GAZE RM, 1969, J PHYSIOL-LONDON, V200, P128; GRAY GE, 1992, DEVELOPMENT, V114, P271; Hall BK, 2003, BIOL PHILOS, V18, P219, DOI 10.1023/A:1023984018531; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HEIER P, 1948, ACTA ANAT, V5, P7; Huber GC, 1933, P NATL ACAD SCI USA, V19, P15, DOI 10.1073/pnas.19.1.15; HUBER R, 1992, ENVIRON BIOL FISH, V33, P153, DOI 10.1007/BF00002561; Huber R, 1997, BRAIN BEHAV EVOLUT, V50, P167, DOI 10.1159/000113330; Iwahori N, 1996, ANAT EMBRYOL, V193, P271; JACOBSON M, 1965, EXP NEUROL, V13, P418, DOI 10.1016/0014-4886(65)90128-7; Kennedy M.C., 1984, P1; Kotrschal K, 1998, REV FISH BIOL FISHER, V8, P373, DOI 10.1023/A:1008839605380; Lazar G, 1999, ANAT EMBRYOL, V199, P185, DOI 10.1007/s004290050219; LEGHISSA S, 1955, Z Anat Entwicklungsgesch, V118, P427, DOI 10.1007/BF00523312; Maddison D.R., 2007, MESQUITE 2 MODULAR S; MANSO MJ, 1991, J COMP NEUROL, V307, P335, DOI 10.1002/cne.903070212; MEEK J, 1978, J COMP NEUROL, V182, P89, DOI 10.1002/cne.901820107; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Northcutt RG, 2002, INTEGR COMP BIOL, V42, P743, DOI 10.1093/icb/42.4.743; NORTHCUTT RG, 1983, FISH NEUROBIOLOGY BE, V2, P1; Odenthal J, 2000, DEV BIOL, V219, P350, DOI 10.1006/dbio.1999.9589; PASQUALE EB, 2005, EPH RECEPTOR SIGNALL; Puelles L, 2002, BRAIN RES BULL, V57, P243, DOI 10.1016/S0361-9230(01)00693-1; PUELLES L, 1978, NEUROSCIENCE, V3, P307, DOI 10.1016/0306-4522(78)90079-9; RAMON P, 1899, REV TRIMEST MICROGR, V4, P87; Redies C, 1996, DEV BIOL, V180, P413, DOI 10.1006/dbio.1996.0315; REPERANT J, 1986, BRAIN RES REV, V11, P227, DOI 10.1016/0165-0173(86)90013-5; Rohlf FJ, 1981, STAT TABLES; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHWASSAN HO, 1965, J COMP NEUROL, P113; SCICOLONE G, 2001, BRAIN RES B, V55, P695; SMEETS WJAJ, 1981, J COMP NEUROL, V195, P1, DOI 10.1002/cne.901950103; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	47	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3582	10.1371/journal.pone.0003582	http://dx.doi.org/10.1371/journal.pone.0003582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974789	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131500010
J	Kim, W; Gordon, D; Sebat, J; Ye, KQ; Finch, SJ				Kim, Wonkuk; Gordon, Derek; Sebat, Jonathan; Ye, Kenny Q.; Finch, Stephen J.			Computing Power and Sample Size for Case-Control Association Studies with Copy Number Polymorphism: Application of Mixture-Based Likelihood Ratio Test	PLOS ONE			English	Article							CONTROL GENETIC ASSOCIATION; SNP GENOTYPING ERRORS; ALLELE FREQUENCY DATABASE; GENOME-WIDE ASSOCIATION; DIVERSE POPULATIONS; MISCLASSIFICATION; RISK; SUSCEPTIBILITY; PHENOTYPE; SCHEME	Recent studies suggest that copy number polymorphisms (CNPs) may play an important role in disease susceptibility and onset. Currently, the detection of CNPs mainly depends on microarray technology. For case-control studies, conventionally, subjects are assigned to a specific CNP category based on the continuous quantitative measure produced by microarray experiments, and cases and controls are then compared using a chi-square test of independence. The purpose of this work is to specify the likelihood ratio test statistic (LRTS) for case-control sampling design based on the underlying continuous quantitative measurement, and to assess its power and relative efficiency (as compared to the chi-square test of independence on CNP counts). The sample size and power formulas of both methods are given. For the latter, the CNPs are classified using the Bayesian classification rule. The LRTS is more powerful than this chi-square test for the alternatives considered, especially alternatives in which the at-risk CNP categories have low frequencies. An example of the application of the LRTS is given for a comparison of CNP distributions in individuals of Caucasian or Taiwanese ethnicity, where the LRTS appears to be more powerful than the chi-square test, possibly due to misclassification of the most common CNP category into a less common category.	[Kim, Wonkuk] Univ S Florida, Dept Math & Stat, Tampa, FL 33620 USA; [Gordon, Derek] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Sebat, Jonathan] Cold Spring Harbor Lab, Cold Spring Harbor, NY USA; [Ye, Kenny Q.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA; [Finch, Stephen J.] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY USA	State University System of Florida; University of South Florida; Rutgers State University New Brunswick; Cold Spring Harbor Laboratory; Yeshiva University; Albert Einstein College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kim, W (corresponding author), Univ S Florida, Dept Math & Stat, Tampa, FL 33620 USA.	gordon@biology.rutgers.edu	Gordon, Derek/AAU-2281-2020; Kim, Wonkuk/AAC-9608-2019; Ye, Kenny/U-2341-2019; Ye, Kenny/GSM-7731-2022	Gordon, Derek/0000-0003-2945-1748; Kim, Wonkuk/0000-0001-6912-0842; Ye, Kenny/0000-0002-1466-855X; Sebat, Jonathan/0000-0002-9087-526X	National Institutes of Health [P41 HG004222-01]; The Simons Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Simons Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	National Institutes of Health (grant P41 HG004222-01), The Simons Foundation	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Ahn K, 2007, ANN HUM GENET, V71, P249, DOI 10.1111/j.1469-1809.2006.00318.x; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Anderson TW., 2003, INTRO MULTIVARIATE S, V3; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Cheung K H, 2000, Pac Symp Biocomput, P639; Cheung KH, 2000, NUCLEIC ACIDS RES, V28, P361, DOI 10.1093/nar/28.1.361; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Corbiere F, 2007, COMPUT METH PROG BIO, V85, P173, DOI 10.1016/j.cmpb.2006.10.008; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; FRANK B, 2007, CARCINOGENESIS; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gordon D, 2005, J CLIN INVEST, V115, P1408, DOI 10.1172/JCI24756; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Gordon D., 2006, ENCY GENETICS GENOMI; Gordon D., 2004, STAT APPL GENET MOL, V3, P26, DOI [10.2202/1544-6115.1085, DOI 10.2202/1544-6115.1085]; Gordon D, 2007, GENET EPIDEMIOL, V31, P853, DOI 10.1002/gepi.20246; GOVERDHAN SV, 2007, EYE; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; HATHAWAY RJ, 1986, J STAT COMPUT SIM, V23, P211, DOI 10.1080/00949658608810872; HATHAWAY RJ, 1985, ANN STAT, V13, P795, DOI 10.1214/aos/1176349557; Healy J, 2003, GENOME RES, V13, P2306, DOI 10.1101/gr.1350803; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; HSIEH FY, 1989, STAT MED, V8, P795, DOI 10.1002/sim.4780080704; Ji F, 2005, STAT APPL GENET MOL, V4; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Kang SJ, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P116; Kang SJ, 2004, GENET EPIDEMIOL, V26, P132, DOI 10.1002/gepi.10301; Kang SJ, 2004, HUM HERED, V58, P139, DOI 10.1159/000083540; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kolmogoroff A, 1941, ANN MATH STAT, V12, P461, DOI 10.1214/aoms/1177731684; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Levenstien MA, 2006, PLOS GENET, V2, P1156, DOI 10.1371/journal.pgen.0020127; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McLachlan G., 2000, WILEY SER PROB STAT; MITRA SK, 1958, ANN MATH STAT, V29, P1221, DOI 10.1214/aoms/1177706453; MOTE VL, 1965, BIOMETRIKA, V52, P95, DOI 10.1093/biomet/52.1-2.95; Osier MV, 2001, NUCLEIC ACIDS RES, V29, P317, DOI 10.1093/nar/29.1.317; Ott J., 1999, ANAL HUMAN GENETIC L; Ozaki K, 2005, CELL MOL LIFE SCI, V62, P1804, DOI 10.1007/s00018-005-5098-z; Pollex RL, 2007, CIRCULATION, V115, P3130, DOI 10.1161/CIRCULATIONAHA.106.677591; Pollex RL, 2007, CURR OPIN LIPIDOL, V18, P174, DOI 10.1097/MOL.0b013e32802e6c12; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smirnov N., 1939, B MOSCOW U, V2, P3; TENENBEI.A, 1972, TECHNOMETRICS, V14, P187, DOI 10.2307/1266930; TENENBEIN A, 1970, J AM STAT ASSOC, V65, P1350, DOI 10.2307/2284301; TITTERINGTON D, 1985, STAT ANAL FINITE MIX, P254; VANDERVAART AW, 1998, ASYMPTOTIC STAT CSIS; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wegscheider BJ, 2007, OPHTHALMOLOGY, V114, P738, DOI 10.1016/j.ophtha.2006.07.048; White SJ, 2007, CYTOGENET GENOME RES, V118, P19, DOI 10.1159/000106437; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Yu CE, 2002, AM J HUM GENET, V71, P100, DOI 10.1086/341291; 2007, ILLUMINA GENCALL DAT	62	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3475	10.1371/journal.pone.0003475	http://dx.doi.org/10.1371/journal.pone.0003475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941524	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000265126100006
J	Mohamood, AS; Bargatze, D; Xiao, ZX; Jie, CF; Yagita, H; Ruben, D; Watson, J; Chakravarti, S; Schneck, JP; Hamad, ARA				Mohamood, Abdiaziz S.; Bargatze, Dylan; Xiao, Zuoxiang; Jie, Chunfa; Yagita, Hideo; Ruben, Dawn; Watson, Julie; Chakravarti, Shukti; Schneck, Jonathan P.; Hamad, Abdel Rahim A.			Fas-Mediated Apoptosis Regulates the Composition of Peripheral alpha beta T Cell Repertoire by Constitutively Purging Out Double Negative T Cells	PLOS ONE			English	Article								Background: The Fas pathway is a major regulator of T cell homeostasis, however, the T cell population that is controlled by the Fas pathway in vivo is poorly defined. Although CD4 and CD8 single positive (SP) T cells are the two major T cell subsets in the periphery of wild type mice, the repertoire of mice bearing loss-of-function mutation in either Fas (lpr mice) or Fas ligand (gld mice) is predominated by CD4(-) CD8(-) double negative alpha beta T cells that also express B220 and generally referred to as B220(+) DN T cells. Despite extensive analysis, the basis of B220(+) DN T cell lymphoproliferation remains poorly understood. In this study we re-examined the issue of why T cell lymphoproliferation caused by gld mutation is predominated by B220(+) DN T cells. Methodology and Principal Findings: We combined the following approaches to study this question: Gene transcript profiling, BrdU labeling, and apoptosis assays. Our results show that B220(+) DN T cells are proliferating and dying at exceptionally high rates than SP T cells in the steady state. The high proliferation rate is restricted to B220(+) DN T cells found in the gut epithelium whereas the high apoptosis rate occurred both in the gut epithelium and periphery. However, only in the periphery, apoptosis of B220(+) DN T cell is Fas-dependent. When the Fas pathway is genetically impaired, apoptosis of peripheral B220(+) DN T cells was reduced to a baseline level similar to that of SP T cells. Under these conditions of normalized apoptosis, B220(+) DN T cells progressively accumulate in the periphery, eventually resulting in B220(+) DN T cell lymphoproliferation. Conclusions/Significance: The Fas pathway plays a critical role in regulating the tissue distribution of DN T cells through targeting and elimination of DN T cells from the periphery in the steady state. The results provide new insight into pathogenesis of DN T cell lymphoproliferation.	[Mohamood, Abdiaziz S.; Bargatze, Dylan; Xiao, Zuoxiang; Schneck, Jonathan P.; Hamad, Abdel Rahim A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Jie, Chunfa] Johns Hopkins Univ, Sch Med, Inst Genet Med, Baltimore, MD 21218 USA; [Ruben, Dawn; Watson, Julie] Johns Hopkins Univ, Sch Med, Dept Mol & Comparative Pathobiol, Baltimore, MD 21218 USA; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo, Japan; [Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Juntendo University; Johns Hopkins University	Mohamood, AS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	ahamad@jhmi.edu			NIH [DK069279, DK 066039]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK066039, R21DK069279] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH DK069279 and NIH DK 066039	ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Borrmann CM, 2000, ANN NY ACAD SCI, V915, P144; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Clark LB, 1999, J IMMUNOL, V162, P2546; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; DAVIES MDJ, 1981, GUT, V22, P481, DOI 10.1136/gut.22.6.481; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; GIESE T, 1994, J IMMUNOL, V152, P2000; GIESE T, 1993, J IMMUNOL, V151, P597; GIESE T, 1995, INT IMMUNOL, V7, P1213, DOI 10.1093/intimm/7.8.1213; GILLETTEFERGUSON I, 1994, EUR J IMMUNOL, V24, P1181, DOI 10.1002/eji.1830240526; GONZALO JA, 1994, CLIN IMMUNOL IMMUNOP, V71, P176, DOI 10.1006/clin.1994.1069; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Hamad ARA, 2003, J IMMUNOL, V171, P2421, DOI 10.4049/jimmunol.171.5.2421; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hughes RC, 2001, BIOCHIMIE, V83, P667; Inagaki-Ohara K, 2005, BIOCHEM BIOPH RES CO, V331, P977, DOI 10.1016/j.bbrc.2005.04.025; Inki P, 1996, ANN MED, V28, P63, DOI 10.3109/07853899608999076; Johansson M, 2003, J IMMUNOL, V170, P1659, DOI 10.4049/jimmunol.170.4.1659; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kayagaki N, 1997, P NATL ACAD SCI USA, V94, P3914, DOI 10.1073/pnas.94.8.3914; KOTZIN BL, 1988, J EXP MED, V168, P2221, DOI 10.1084/jem.168.6.2221; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; LANDOLFI MMT, 1993, J IMMUNOL, V151, P1086; Lohman BL, 1996, J VIROL, V70, P8199, DOI 10.1128/JVI.70.11.8199-8203.1996; MALDONADO MA, 1995, J EXP MED, V181, P641, DOI 10.1084/jem.181.2.641; Miethke T, 1996, EUR J IMMUNOL, V26, P1459, DOI 10.1002/eji.1830260709; MOGIL RJ, 1995, INT IMMUNOL, V7, P1451, DOI 10.1093/intimm/7.9.1451; Mohamood AS, 2007, AM J PATHOL, V171, P97, DOI 10.2353/ajpath.2007.070148; Mohamood AS, 2006, INT IMMUNOL, V18, P1265, DOI 10.1093/intimm/dxl057; MOUNTZ JD, 1990, J IMMUNOL, V144, P2159; Nochi T, 2004, CLIN IMMUNOL, V113, P326, DOI 10.1016/j.clim.2004.08.013; OHTEKI T, 1990, J EXP MED, V172, P7, DOI 10.1084/jem.172.1.7; PRASAD VS, 1991, J IMMUNOL, V147, P4200; Rao VK, 2005, BRIT J HAEMATOL, V129, P534, DOI 10.1111/j.1365-2141.2005.05496.x; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Renno T, 1996, J EXP MED, V183, P431, DOI 10.1084/jem.183.2.431; ROTHGEB CL, 1984, BEHAV SOC SCI LIBR, V3, P1, DOI 10.1300/J103v03n04_01; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; SCHMIDT A, 1994, EUR J CELL BIOL, V65, P229; SINGER PA, 1989, J EXP MED, V170, P1869, DOI 10.1084/jem.170.6.1869; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Tan KH, 2003, EXP CELL RES, V284, P283, DOI 10.1016/S0014-4827(02)00056-3; Teachey DT, 2008, BLOOD, V111, P705, DOI 10.1182/blood-2007-05-087353; ten Bosch JV, 2002, BRIT J HAEMATOL, V117, P176, DOI 10.1046/j.1365-2141.2002.03357.x; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Van Parijs L, 1998, IMMUNITY, V8, P265, DOI 10.1016/S1074-7613(00)80478-1; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; WATANABE Y, 1994, SCAND J IMMUNOL, V39, P419, DOI 10.1111/j.1365-3083.1994.tb03395.x; Worth A, 2006, BRIT J HAEMATOL, V133, P124, DOI 10.1111/j.1365-2141.2006.05993.x; Xiao S, 2004, INT IMMUNOL, V16, P759, DOI 10.1093/intimm/dxh078; Yamagiwa S, 1998, J IMMUNOL, V160, P2665; ZHOU T, 1992, J EXP MED, V176, P1063, DOI 10.1084/jem.176.4.1063	58	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3465	10.1371/journal.pone.0003465	http://dx.doi.org/10.1371/journal.pone.0003465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941614	Green Published, Green Submitted, gold			2022-12-27	WOS:000265125900009
J	Maurer, J; Nelson, B; Cecena, G; Bajpai, R; Mercola, M; Terskikh, A; Oshima, RG				Maurer, Jochen; Nelson, Brandon; Cecena, Grace; Bajpai, Ruchi; Mercola, Mark; Terskikh, Alexey; Oshima, Robert G.			Contrasting Expression of Keratins in Mouse and Human Embryonic Stem Cells	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEINS; MONOCLONAL-ANTIBODIES; CARCINOMA-CELLS; CYTOSKELETAL ELEMENTS; REGULATORY ELEMENT; GENE-EXPRESSION; BINDING SITES; SELF-RENEWAL; DIFFERENTIATION; LINES	RNA expression data reveals that human embryonic stem (hES) cells differ from mouse ES (mES) cells in the expression of RNAs for keratin intermediate filament proteins. These differences were confirmed at the cellular and protein level and may reflect a fundamental difference in the epithelial nature of embryonic stem cells derived from mouse and human blastocysts. Mouse ES cells express very low levels of the simple epithelial keratins K8, K18 and K19. By contrast hES cells express moderate levels of the RNAs for these intermediate filament proteins as do mouse stem cells derived from the mouse epiblast. Expression of K8 and K18 RNAs are correlated with increased c-Jun RNA expression in both mouse and human ES cell cultures. However, decreasing K8 and K18 expression associated with differentiation to neuronal progenitor cells is correlated with increasing expression of the Snai2 (Slug) transcriptional repression and not decreased Jun expression. Increasing K7 expression is correlated with increased CDX2 and decreased Oct4 RNA expression associated with the formation of trophoblast derivatives by hES cells. Our study supports the view that hES cells are more similar to mouse epiblast cells than mouse ES cells and is consistent with the epithelial nature of hES cells. Keratin intermediate filament expression in hES cells may modulate sensitivity to death receptor mediated apoptosis and stress.	[Maurer, Jochen; Nelson, Brandon; Cecena, Grace; Bajpai, Ruchi; Mercola, Mark; Terskikh, Alexey; Oshima, Robert G.] Burnham Inst Med Res, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Maurer, J (corresponding author), Burnham Inst Med Res, La Jolla, CA USA.	rgoshima@burnham.org	Maurer, Jochen/G-4832-2018; Terskikh, Alexey/U-8407-2019	Maurer, Jochen/0000-0003-3962-3128; Bajpai, Ruchi/0000-0001-7737-3567	California Institute for Regenerative Medicine [RS1-00283-1, RC1-00132-1, CL1-00511-1, RS1-00466-1]; NIH [R37HL059592-11]; CIRM [postdoctoral training fellowship]	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine)	This work was supported by grants from the California Institute for Regenerative Medicine RS1-00283-1(RGO), RC1-00132-1(MM), CL1-00511-1(MM), RS1-00466-1 (AT) and the NIH R37HL059592-11(MM). RB was supported by a CIRM postdoctoral training fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; Barcova M, 2007, HUMAN STEM CELL MANUAL: A LABORATORY GUIDE, P227, DOI 10.1016/B978-012370465-8/50022-3; BARIBAULT H, 1991, J CELL BIOL, V115, P1675, DOI 10.1083/jcb.115.6.1675; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; BOTTGER V, 1995, EUR J BIOCHEM, V231, P475, DOI 10.1111/j.1432-1033.1995.tb20721.x; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; BRULET P, 1980, P NATL ACAD SCI-BIOL, V77, P4113, DOI 10.1073/pnas.77.7.4113; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; CHISHOLM JC, 1987, DEVELOPMENT, V101, P565; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; FRANKE WW, 1981, EXP CELL RES, V131, P299, DOI 10.1016/0014-4827(81)90234-2; FUJIMURA Y, 1994, NUCLEIC ACIDS RES, V22, P613, DOI 10.1093/nar/22.4.613; Inada H, 2001, J CELL BIOL, V155, P415, DOI 10.1083/jcb.200103078; JACKSON BW, 1980, DIFFERENTIATION, V17, P161, DOI 10.1111/j.1432-0436.1980.tb01093.x; JACKSON BW, 1981, DIFFERENTIATION, V20, P203, DOI 10.1111/j.1432-0436.1981.tb01177.x; KEMLER R, 1981, J EMBRYOL EXP MORPH, V64, P45; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Liu Y, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-20; Lu H, 2005, EUR J CELL BIOL, V84, P709, DOI 10.1016/j.ejcb.2005.04.001; Neznanov N, 1997, J BIOL CHEM, V272, P27549, DOI 10.1074/jbc.272.44.27549; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; OSHIMA R, 1978, DIFFERENTIATION, V11, P149, DOI 10.1111/j.1432-0436.1978.tb00978.x; OSHIMA RG, 1990, GENE DEV, V4, P835, DOI 10.1101/gad.4.5.835; OSHIMA RG, 1981, J BIOL CHEM, V256, P8124; PANKOV R, 1994, MOL CELL BIOL, V14, P7744, DOI 10.1128/MCB.14.12.7744; PANKOV R, 1994, P NATL ACAD SCI USA, V91, P873, DOI 10.1073/pnas.91.3.873; PAULIN D, 1982, DIFFERENTIATION, V22, P90, DOI 10.1111/j.1432-0436.1982.tb01231.x; Potgens AJG, 2001, PLACENTA, V22, P251, DOI 10.1053/plac.2000.0597; Rhodes K, 1998, J BIOL CHEM, V273, P26534, DOI 10.1074/jbc.273.41.26534; Schwartz CM, 2005, STEM CELLS DEV, V14, P517, DOI 10.1089/scd.2005.14.517; STASIAK PC, 1989, J INVEST DERMATOL, V92, P707, DOI 10.1111/1523-1747.ep12721500; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; Tripathi MK, 2005, BIOCHEM BIOPH RES CO, V329, P508, DOI 10.1016/j.bbrc.2005.02.006; Watson ED, 2007, DEVELOPMENT, V134, P1809, DOI 10.1242/dev.02843; Wen F, 2007, DEV BIOL, V312, P284, DOI 10.1016/j.ydbio.2007.09.024	44	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3451	10.1371/journal.pone.0003451	http://dx.doi.org/10.1371/journal.pone.0003451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941637	Green Published, gold, Green Submitted			2022-12-27	WOS:000265125600010
J	Herrera, FE; Chesi, A; Paleologou, KE; Schmid, A; Munoz, A; Vendruscolo, M; Gustincich, S; Lashuel, HA; Carloni, P				Herrera, Fernando E.; Chesi, Alessandra; Paleologou, Katerina E.; Schmid, Adrian; Munoz, Adriana; Vendruscolo, Michele; Gustincich, Stefano; Lashuel, Hilal A.; Carloni, Paolo			Inhibition of alpha-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region	PLOS ONE			English	Article								The interplay between dopamine and alpha-synuclein (AS) plays a central role in Parkinson's disease (PD). PD results primarily from a severe and selective devastation of dopaminergic neurons in substantia nigra pars compacta. The neuropathological hallmark of the disease is the presence of intraneuronal proteinaceous inclusions known as Lewy bodies within the surviving neurons, enriched in filamentous AS. In vitro, dopamine inhibits AS fibril formation, but the molecular determinants of this inhibition remain obscure. Here we use molecular dynamic (MD) simulations to investigate the binding of dopamine and several of its derivatives onto conformers representative of an NMR ensemble of AS structures in aqueous solution. Within the limitations inherent to MD simulations of unstructured proteins, our calculations suggest that the ligands bind to the (YEMPS129)-Y-125 region, consistent with experimental findings. The ligands are further stabilized by long-range electrostatic interactions with glutamate 83 (E83) in the NAC region. These results suggest that by forming these interactions with AS, dopamine may affect AS aggregation and fibrillization properties. To test this hypothesis, we investigated in vitro the effects of dopamine on the aggregation of mutants designed to alter or abolish these interactions. We found that point mutations in the (YEMPS129)-Y-125 region do not affect AS aggregation, which is consistent with the fact that dopamine interacts non-specifically with this region. In contrast, and consistent with our modeling studies, the replacement of glutamate by alanine at position 83 (E83A) abolishes the ability of dopamine to inhibit AS fibrillization.	[Herrera, Fernando E.; Munoz, Adriana; Carloni, Paolo] INFM DEMOCRITOS, Int Sch Adv Studies SISSA, Trieste, Italy; [Herrera, Fernando E.; Chesi, Alessandra; Munoz, Adriana; Gustincich, Stefano; Carloni, Paolo] Italian Inst Technol, SISSA Unit, Trieste, Italy; [Chesi, Alessandra; Munoz, Adriana; Gustincich, Stefano] Int Sch Advanced Stud SISSA, Sector Neurobiol, Trieste, Italy; [Chesi, Alessandra; Munoz, Adriana; Gustincich, Stefano] Int Sch Advanced Stud SISSA, Sector Neurobiol, Giovanni Armenise Harvard Fdn Lab, Trieste, Italy; [Paleologou, Katerina E.; Schmid, Adrian; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne EPFL, Brain Mind Inst, Lab Mol Neurobiol & Neuroproteom, Lausanne, Switzerland; [Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1TN, England	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Cambridge	Herrera, FE (corresponding author), INFM DEMOCRITOS, Int Sch Adv Studies SISSA, Trieste, Italy.	gustinci@sissa.it; carloni@sissa.it	Carloni, Paolo/H-8736-2013; Vendruscolo, Michele/F-5901-2012; Lashuel, Hilal/M-3500-2017; Chesi, Alessandra/AAT-8248-2020; Chesi, Alessandra/N-7693-2017	Vendruscolo, Michele/0000-0002-3616-1610; Herrera, Fernando E./0000-0002-8595-3382; Schmid, Adrien W./0000-0001-6671-7950; Gustincich, Stefano/0000-0002-2749-2514; Chesi, Alessandra/0000-0002-0954-7446	Telethon [GGP06268]; IIT; GRAND; MURST FIRB; The Giovanni Armenise-Harvard Foundation; Swiss National Science Foundation [310000-110027]	Telethon(Fondazione Telethon); IIT(Istituto Italiano di Tecnologia - IIT); GRAND; MURST FIRB; The Giovanni Armenise-Harvard Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Telethon grant# GGP06268, IIT, GRAND, MURST FIRB and the "The Giovanni Armenise-Harvard Foundation" for financial support. This work was also supported by the Swiss National Science Foundation (HLA, 310000-110027).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; ADELMAN SA, 1976, J CHEM PHYS, V64, P2375, DOI 10.1063/1.432526; Allen M. P., 1987, COMPUTER SIMULATIONS; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barcelo-Coblijn G, 2007, J NEUROCHEM, V101, P132, DOI 10.1111/j.1471-4159.2006.04348.x; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bertoncini CW, 2007, J MOL BIOL, V372, P708, DOI 10.1016/j.jmb.2007.07.009; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bisaglia M, 2007, J BIOL CHEM, V282, P15597, DOI 10.1074/jbc.M610893200; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cole NB, 2005, J BIOL CHEM, V280, P9678, DOI 10.1074/jbc.M409946200; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; Corona-Avendano S, 2007, J PHYS CHEM B, V111, P1640, DOI 10.1021/jp0637227; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Fountaine TM, 2007, J NEUROSCI RES, V85, P351, DOI 10.1002/jnr.21125; FRISCH MJ, 2001, GAUSSIAN 98; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Green Mario, 2005, Proceedings of the American Association for Cancer Research Annual Meeting, V46, P280; Guidoni L, 2000, FEBS LETT, V477, P37, DOI 10.1016/S0014-5793(00)01712-9; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; HAWKINS GD, 1995, CHEM PHYS LETT, V246, P122, DOI 10.1016/0009-2614(95)01082-K; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ischiropoulos H, 2003, ANN NY ACAD SCI, V991, P93; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; MCLACHLAN AD, 1979, J MOL BIOL, V128, P49, DOI 10.1016/0022-2836(79)90308-5; Micheletti C, 2000, PROTEINS, V40, P662, DOI 10.1002/1097-0134(20000901)40:4<662::AID-PROT90>3.0.CO;2-F; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; *OPENEYE SCI SOFTW, 2005, EON; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Rivers RC, 2008, PROTEIN SCI, V17, P887, DOI 10.1110/ps.073181508; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Slutzki M, 2006, J MOL BIOL, V360, P1019, DOI 10.1016/j.jmb.2006.05.069; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Takeda A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/19365; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	69	90	93	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3394	10.1371/journal.pone.0003394	http://dx.doi.org/10.1371/journal.pone.0003394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852892	Green Published, gold, Green Submitted			2022-12-27	WOS:000265121700003
J	Imamura, S; Uchiyama, J; Koshimizu, E; Hanai, JI; Raftopoulou, C; Murphey, RD; Bayliss, PE; Imai, Y; Burns, CE; Masutomi, K; Gagos, S; Zon, LI; Roberts, TM; Kishi, S				Imamura, Shintaro; Uchiyama, Junzo; Koshimizu, Eriko; Hanai, Jun-ichi; Raftopoulou, Christina; Murphey, Ryan D.; Bayliss, Peter E.; Imai, Yoichi; Burns, Caroline Erter; Masutomi, Kenkichi; Gagos, Sarantis; Zon, Leonard I.; Roberts, Thomas M.; Kishi, Shuji			A Non-Canonical Function of Zebrafish Telomerase Reverse Transcriptase Is Required for Developmental Hematopoiesis	PLOS ONE			English	Article								Although it is clear that telomerase expression is crucial for the maintenance of telomere homeostasis, there is increasing evidence that the TERT protein can have physiological roles that are independent of this central function. To further examine the role of telomerase during vertebrate development, the zebrafish telomerase reverse transcriptase (zTERT) was functionally characterized. Upon zTERT knockdown, zebrafish embryos show reduced telomerase activity and are viable, but develop pancytopenia resulting from aberrant hematopoiesis. The blood cell counts in TERT-depleted zebrafish embryos are markedly decreased and hematopoietic cell differentiation is impaired, whereas other somatic lineages remain morphologically unaffected. Although both primitive and definitive hematopoiesis is disrupted by zTERT knockdown, the telomere lengths are not significantly altered throughout early development. Induced p53 deficiency, as well as overexpression of the anti-apoptotic proteins Bcl-2 and E1B-19K, significantly relieves the decreased blood cells numbers caused by zTERT knockdown, but not the impaired blood cell differentiation. Surprisingly, only the reverse transcriptase motifs of zTERT are crucial, but the telomerase RNA-binding domain of zTERT is not required, for rescuing complete hematopoiesis. This is therefore the first demonstration of a non-canonical catalytic activity of TERT, which is different from 'authentic'' telomerase activity, is required for during vertebrate hematopoiesis. On the other hand, zTERT deficiency induced a defect in hematopoiesis through a potent and specific effect on the gene expression of key regulators in the absence of telomere dysfunction. These results suggest that TERT non-canonically functions in hematopoietic cell differentiation and survival in vertebrates, independently of its role in telomere homeostasis. The data also provide insights into a non-canonical pathway by which TERT functions to modulate specification of hematopoietic stem/progenitor cells during vertebrate development. (276 words)	[Imamura, Shintaro; Koshimizu, Eriko; Kishi, Shuji] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA; [Uchiyama, Junzo; Bayliss, Peter E.; Roberts, Thomas M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA USA; [Hanai, Jun-ichi] Beth Israel Deaconess Med Ctr, Dept Med, Renal Div, Boston, MA USA; [Murphey, Ryan D.; Burns, Caroline Erter; Zon, Leonard I.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp Boston,Div Hematol Oncol, Boston, MA USA; [Raftopoulou, Christina; Gagos, Sarantis] Biomed Res Fdn Acad Athens Greece, Lab Genet, Athens, Greece; [Imai, Yoichi] Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA USA; [Masutomi, Kenkichi] Natl Canc Ctr, Canc Stem Cell Project, Tokyo, Japan	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Academy of Athens; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; National Cancer Center - Japan	Imamura, S (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA.	s.kishi@mac.com		Bayliss, Peter/0000-0003-4807-6365; Raftopoulou, Christina/0000-0002-5132-2822; GAGOS, SARANTIS/0000-0003-4907-7706; Imai, Yoichi/0000-0002-2938-6133	A-T Childrens Project; Ellison Medical Foundation; NIA/NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK067179] Funding Source: NIH RePORTER	A-T Childrens Project; Ellison Medical Foundation(Lawrence Ellison Foundation); NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is funded by research grants from the A-T Childrens Project, the Ellison Medical Foundation and NIA/NIH to S.K..	ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Armstrong L, 2005, STEM CELLS, V23, P516, DOI 10.1634/stemcells.2004-0269; Artandi SE, 2002, TRENDS MOL MED, V8, P44, DOI 10.1016/S1471-4914(01)02222-5; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Bachand F, 2001, MOL CELL BIOL, V21, P1888, DOI 10.1128/MCB.21.5.1888-1897.2001; Beattie TL, 2000, MOL BIOL CELL, V11, P3329, DOI 10.1091/mbc.11.10.3329; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 2005, EMBO J, V24, P1095, DOI 10.1038/sj.emboj.7600598; Blasco MA, 1996, NAT GENET, V12, P200, DOI 10.1038/ng0296-200; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bousman S, 2003, J EXP ZOOL PART B, V295B, P82, DOI 10.1002/jez.b.00007; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; Bryan TM, 1999, CURR OPIN CELL BIOL, V11, P318, DOI 10.1016/S0955-0674(99)80043-X; Bryan TM, 2000, MOL CELL, V6, P493, DOI 10.1016/S1097-2765(00)00048-4; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Calado RT, 2006, BIOESSAYS, V28, P109, DOI 10.1002/bies.20365; Chai WH, 2006, MOL CELL, V21, P427, DOI 10.1016/j.molcel.2005.12.004; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiang YJ, 2004, MOL CELL BIOL, V24, P7024, DOI 10.1128/MCB.24.16.7024-7031.2004; CHIOU SK, 1994, MOL CELL BIOL, V14, P2556, DOI 10.1128/MCB.14.4.2556; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Craven SE, 2005, BLOOD, V105, P3528, DOI 10.1182/blood-2004-03-1089; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; DEJONG JL, 2005, ANN REV GENET; Dooley KA, 2005, DEV BIOL, V277, P522, DOI 10.1016/j.ydbio.2004.09.004; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Friedman KL, 1999, GENE DEV, V13, P2863, DOI 10.1101/gad.13.21.2863; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; GESERICK C, 2006, ONCOGENE; GESERICK C, 2006, MECH AGEING DEV; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Goytisolo FA, 2000, J EXP MED, V192, P1625, DOI 10.1084/jem.192.11.1625; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; Harrington L, 2004, ONCOGENE, V23, P7283, DOI 10.1038/sj.onc.1207948; Hatakeyama H, 2008, MECH AGEING DEV, V129, P550, DOI 10.1016/j.mad.2008.05.006; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hiyama E, 2002, ONCOGENE, V21, P643, DOI 10.1038/sj.onc.1205070; Hsia N, 2005, EXP HEMATOL, V33, P1007, DOI 10.1016/j.exphem.2005.06.013; Jagadeesh S, 2006, BIOCHEM BIOPH RES CO, V347, P774, DOI 10.1016/j.bbrc.2006.06.172; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Kelleher C, 2002, TRENDS BIOCHEM SCI, V27, P572, DOI 10.1016/S0968-0004(02)02206-5; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Klapper W, 1998, FEBS LETT, V434, P409, DOI 10.1016/S0014-5793(98)01020-5; KRAEMER K, 2006, INT J CANC; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lansdorp PM, 2005, ANN NY ACAD SCI, V1044, P220, DOI 10.1196/annals.1349.027; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; Liu TX, 2003, DEV CELL, V5, P903, DOI 10.1016/S1534-5807(03)00339-3; Liu Y, 2002, P NATL ACAD SCI USA, V99, P3597, DOI 10.1073/pnas.062549199; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; Long QM, 1997, DEVELOPMENT, V124, P4105; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; Lue NF, 2005, P NATL ACAD SCI USA, V102, P9778, DOI 10.1073/pnas.0502252102; Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Moriarty TJ, 2002, MOL CELL BIOL, V22, P1253, DOI 10.1128/MCB.22.4.1253-1265.2002; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orkin SH, 1997, ANNU REV GENET, V31, P33, DOI 10.1146/annurev.genet.31.1.33; Peng Y, 2001, MOL CELL, V7, P1201, DOI 10.1016/S1097-2765(01)00268-4; Poon SSS, 2001, METHOD CELL BIOL, V64, P69; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Ransom DG, 1996, DEVELOPMENT, V123, P311; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367; Shafizadeh E, 2004, CURR OPIN HEMATOL, V11, P255, DOI 10.1097/01.moh.0000138686.15806.71; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Smith CD, 2003, MOL BIOL CELL, V14, P556, DOI 10.1091/mbc.E02-08-0457; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; STARLING JA, 1990, NUCLEIC ACIDS RES, V18, P6881, DOI 10.1093/nar/18.23.6881; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Sun CF, 2008, GENE, V420, P90, DOI 10.1016/j.gene.2008.05.013; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Tsai SB, 2007, AGING CELL, V6, P209, DOI 10.1111/j.1474-9726.2007.00278.x; Veitonmaki N, 2003, FASEB J, V17, P764, DOI 10.1096/fj.02-0599-fje; Venkatesan RN, 1998, P NATL ACAD SCI USA, V95, P14763, DOI 10.1073/pnas.95.25.14763; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Xia JQ, 2000, MOL CELL BIOL, V20, P5196, DOI 10.1128/MCB.20.14.5196-5207.2000; Xiang H, 2002, ONCOGENE, V21, P3784, DOI 10.1038/sj.onc.1205455; Xie MY, 2008, J BIOL CHEM, V283, P2049, DOI 10.1074/jbc.M708032200; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Young JI, 2003, J BIOL CHEM, V278, P19904, DOI 10.1074/jbc.M301685200; Yu RM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-27; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423; Zimmermann S, 2004, STEM CELLS, V22, P741, DOI 10.1634/stemcells.22-5-741	110	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3364	10.1371/journal.pone.0003364	http://dx.doi.org/10.1371/journal.pone.0003364			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846223	gold, Green Submitted, Green Published			2022-12-27	WOS:000265114500005
J	Hiramatsu, C; Melin, AD; Aureli, F; Schaffner, CM; Vorobyev, M; Matsumoto, Y; Kawamura, S				Hiramatsu, Chihiro; Melin, Amanda D.; Aureli, Filippo; Schaffner, Colleen M.; Vorobyev, Misha; Matsumoto, Yoshifumi; Kawamura, Shoji			Importance of Achromatic Contrast in Short-Range Fruit Foraging of Primates	PLOS ONE			English	Article								Trichromatic primates have a 'red-green' chromatic channel in addition to luminance and 'blue-yellow' channels. It has been argued that the red-green channel evolved in primates as an adaptation for detecting reddish or yellowish objects, such as ripe fruits, against a background of foliage. However, foraging advantages to trichromatic primates remain unverified by behavioral observation of primates in their natural habitats. New World monkeys (platyrrhines) are an excellent model for this evaluation because of the highly polymorphic nature of their color vision due to allelic variation of the L-M opsin gene on the X chromosome. In this study we carried out field observations of a group of wild, frugivorous black-handed spider monkeys (Ateles geoffroyi frontatus, Gray 1842, Platyrrhini), consisting of both dichromats (n = 12) and trichromats (n = 9) in Santa Rosa National Park, Costa Rica. We determined the color vision types of individuals in this group by genotyping their L-M opsin and measured foraging efficiency of each individual for fruits located at a grasping distance. Contrary to the predicted advantage for trichromats, there was no significant difference between dichromats and trichromats in foraging efficiency and we found that the luminance contrast was the main determinant of the variation of foraging efficiency among red-green, blue-yellow and luminance contrasts. Our results suggest that luminance contrast can serve as an important cue in short-range foraging attempts despite other sensory cues that could be available. Additionally, the advantage of red-green color vision in primates may not be as salient as previously thought and needs to be evaluated in further field observations.	[Hiramatsu, Chihiro; Matsumoto, Yoshifumi; Kawamura, Shoji] Univ Tokyo, Gradu Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Melin, Amanda D.] Univ Calgary, Dept Anthropol, Calgary, AB T2N 1N4, Canada; [Aureli, Filippo] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolut Anthropol & Palaeoecol, Liverpool, Merseyside, England; [Schaffner, Colleen M.] Univ Chester, Dept Pyschol, Chester, Cheshire, England; [Vorobyev, Misha] Univ Auckland, Dept Optomet & Vision Sci, Auckland, New Zealand	University of Tokyo; University of Calgary; Liverpool John Moores University; University of Chester; University of Auckland	Hiramatsu, C (corresponding author), Natl Inst Physiol Sci, Div Sensory & Cognit Informat, Okazaki, Aichi 444, Japan.	Kawamura@k.u-tokyo.ac.jp		Aureli, Filippo/0000-0002-0671-013X; Melin, Amanda/0000-0002-0612-2514	Japan Society for the Promotion of Science (JSPS) [15-11926, 16405015, 19207018]; Alberta Ingenuity Fund; National Sciences and Engineering Research Council of Canada; Leakey Foundation; North of England Zoological Society; The British Academy	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alberta Ingenuity Fund; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Leakey Foundation; North of England Zoological Society; The British Academy	This study was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Fellows (15-11926) to C.H., grants from the Alberta Ingenuity Fund and National Sciences and Engineering Research Council of Canada to A.D.M., the Leakey Foundation and the North of England Zoological Society to F.A., The British Academy to C.M.S., and Grants-in-Aid for Scientific Research (B) (16405015) and (A) (19207018) from JSPS to S.K..	Allen G., 1879, COLOR SENSE ITS ORIG; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Asensio N, 2008, BEHAVIOUR, V145, P983, DOI 10.1163/156853908784089234; Aureli F, 2008, CAM S BIO EVOL ANTHR, V55, P236; Boinski S., 2000, MOVE WHY ANIMALS TRA; Brown H., 1999, APPL MIXED MODELS ME; Caine NG, 2002, EAT OR BE EATEN, P58, DOI 10.1017/CBO9780511610233.005; Caine NG, 2003, INT J PRIMATOL, V24, P1163, DOI 10.1023/B:IJOP.0000005985.18112.25; Caine NG, 2000, P ROY SOC B-BIOL SCI, V267, P439, DOI 10.1098/rspb.2000.1019; Campbell CJ, 2005, INT J PRIMATOL, V26, P1039, DOI 10.1007/s10764-005-6457-1; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; CHAPMAN C, 1988, PRIMATES, V29, P177, DOI 10.1007/BF02381121; CHAPMAN CA, 1989, OECOLOGIA, V79, P506, DOI 10.1007/BF00378668; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; De Araujo MFP, 2006, AM J PRIMATOL, V68, P1129, DOI 10.1002/ajp.20312; Di Fiore A, 2004, MOL ECOL NOTES, V4, P246, DOI 10.1111/j.1471-8286.2004.00631.x; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Dominy NJ, 2004, AM J PRIMATOL, V62, P189, DOI 10.1002/ajp.20015; Dominy NJ, 2003, ANIM BEHAV, V66, P829, DOI 10.1006/anbe.2003.2288; Dominy NJ, 2003, J HUM EVOL, V44, P25, DOI 10.1016/S0047-2484(02)00167-7; Fernandez AA, 2007, AM NAT, V170, P10, DOI 10.1086/518566; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hiramatsu C, 2005, AM J PRIMATOL, V67, P447, DOI 10.1002/ajp.20199; Hiramatsu C, 2004, VISION RES, V44, P2225, DOI 10.1016/j.visres.2004.04.008; Jacobs GH, 2007, INT J PRIMATOL, V28, P729, DOI 10.1007/s10764-007-9168-y; Jacobs GH, 2005, J OPT SOC AM A, V22, P2072, DOI 10.1364/JOSAA.22.002072; Jacobs GH, 1996, NATURE, V382, P156, DOI 10.1038/382156a0; Jacobs GH, 1998, VISION RES, V38, P3307, DOI 10.1016/S0042-6989(97)00405-7; Jacobs GH, 2001, P ROY SOC B-BIOL SCI, V268, P695, DOI 10.1098/rspb.2000.1421; JACOBS GH, 1993, VISION RES, V33, P1773, DOI 10.1016/0042-6989(93)90168-V; Jacobs GH, 1996, P NATL ACAD SCI USA, V93, P577, DOI 10.1073/pnas.93.2.577; Janzen D.H., 1986, GUANACASTE NATL PARK; Kawamura S, 2001, GENE, V269, P45, DOI 10.1016/S0378-1119(01)00454-1; Kinzey WG., 1997, NEW WORLD PRIMATES E; KOLB H, 1991, J COMP NEUROL, V303, P617, DOI 10.1002/cne.903030408; Levenson DH, 2007, AM J PRIMATOL, V69, P757, DOI 10.1002/ajp.20402; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LU C, 1972, INVEST OPHTH VISUAL, V11, P482; Lucas PW, 2003, EVOLUTION, V57, P2636, DOI 10.1554/03-168; Lucas PW, 1998, FOLIA PRIMATOL, V69, P139, DOI 10.1159/000021576; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Melin AD, 2008, BEHAV ECOL SOCIOBIOL, V62, P659, DOI 10.1007/s00265-007-0490-3; Melin AD, 2007, ANIM BEHAV, V73, P205, DOI 10.1016/j.anbehav.2006.07.003; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; MULLEN KT, 1985, J PHYSIOL-LONDON, V359, P381, DOI 10.1113/jphysiol.1985.sp015591; Nunes A, 1995, FOLIA PRIMATOL, V65, P85, DOI 10.1159/000156873; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Parraga CA, 2002, CURR BIOL, V12, P483, DOI 10.1016/S0960-9822(02)00718-2; Pinheiro J, 2001, MIXED EFFECTS MODELS; Regan BC, 1998, VISION RES, V38, P3321, DOI 10.1016/S0042-6989(97)00462-8; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Riba-Hernandez P, 2005, AM J PRIMATOL, V67, P411, DOI 10.1002/ajp.20196; Riba-Hernandez P, 2004, J EXP BIOL, V207, P2465, DOI 10.1242/jeb.01046; Rowe MP, 2007, VISUAL NEUROSCI, V24, P17, DOI 10.1017/S0952523807230159; Saito A, 2005, AM J PRIMATOL, V67, P425, DOI 10.1002/ajp.20197; Silveira LCL, 1999, VISUAL NEUROSCI, V16, P333, DOI 10.1017/S0952523899162138; Smith AC, 2005, INT J PRIMATOL, V26, P337, DOI 10.1007/s10764-005-2928-7; Smith AC, 2003, AM J PRIMATOL, V61, P145, DOI 10.1002/ajp.10117; Smith AC, 2003, J EXP BIOL, V206, P3159, DOI 10.1242/jeb.00536; Stoner KE, 2005, AM J PRIMATOL, V67, P399, DOI 10.1002/ajp.20195; Sumner P, 2000, J EXP BIOL, V203, P1987; Sumner P, 2000, J EXP BIOL, V203, P1963; Sumner P, 2003, AM J PRIMATOL, V59, P67, DOI 10.1002/ajp.10066; Surridge AK, 2002, AM J PRIMATOL, V56, P185, DOI 10.1002/ajp.1073; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Talebi MG, 2006, MOL ECOL, V15, P551, DOI 10.1111/j.1365-294X.2005.02822.x; VANROOSMALEN MGM, 1985, ACTA AMAZON, V15, P3; Vogel ER, 2007, BEHAV ECOL, V18, P292, DOI 10.1093/beheco/arl082; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Vorobyev M, 2001, VISION RES, V41, P639, DOI 10.1016/S0042-6989(00)00288-1; Vorobyev Misha, 2004, Clin Exp Optom, V87, P230; WYZECKI G, 1982, COLOR SCI CONCEPTS M; Yamada ES, 1996, VISUAL NEUROSCI, V13, P1011, DOI 10.1017/S0952523800007677; Yokoyama S, 2001, GENETICS, V158, P1697	75	74	75	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3356	10.1371/journal.pone.0003356	http://dx.doi.org/10.1371/journal.pone.0003356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836576	gold, Green Submitted, Green Published			2022-12-27	WOS:000265113500011
J	Moussion, C; Ortega, N; Girard, JP				Moussion, Christine; Ortega, Nathalie; Girard, Jean-Philippe			The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel 'Alarmin'?	PLOS ONE			English	Article								Background: Interleukin-33 (IL-33) is an IL-1-like cytokine ligand for the IL-1 receptor-related protein ST2, that activates mast cells and Th2 lymphocytes, and induces production of Th2-associated cytokines in vivo. We initially discovered IL-33 as a nuclear factor (NF-HEV) abundantly expressed in high endothelial venules from lymphoid organs, that associates with chromatin and exhibits transcriptional regulatory properties. This suggested that, similarly to IL-1 alpha and chromatin-associated cytokine HMGB1, IL-33 may act as both a cytokine and a nuclear factor. Although the activity of recombinant IL-33 has been well characterized, little is known yet about the expression pattern of endogenous IL-33 in vivo. Methodology/Principal Findings: Here, we show that IL-33 is constitutively and abundantly expressed in normal human tissues. Using a combination of human tissue microarrays and IL-33 monoclonal and polyclonal antibodies, we found that IL-33 is a novel nuclear marker of the endothelium widely expressed along the vascular tree. We observed abundant nuclear expression of IL-33 in endothelial cells from both large and small blood vessels in most normal human tissues, as well as in human tumors. In addition to endothelium, we also found constitutive nuclear expression of IL-33 in fibroblastic reticular cells of lymphoid tissues, and epithelial cells of tissues exposed to the environment, including skin keratinocytes and epithelial cells of the stomach, tonsillar crypts and salivary glands. Conclusions/Significance: Together, our results indicate that, unlike inducible cytokines, IL-33 is constitutively expressed in normal human tissues. In addition, they reveal that endothelial cells and epithelial cells constitute major sources of IL-33 in vivo. Based on these findings, we speculate that IL-33 may function, similarly to the prototype 'alarmin' HMGB1, as an endogenous 'danger' signal to alert the immune system after endothelial or epithelial cell damage during trauma or infection.	[Moussion, Christine; Ortega, Nathalie; Girard, Jean-Philippe] CNRS, IPBS Inst Pharmacol & Struct Biol, Toulouse, France; [Moussion, Christine; Ortega, Nathalie; Girard, Jean-Philippe] Univ Toulouse, UPS, IPBS, F-31042 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Moussion, C (corresponding author), CNRS, IPBS Inst Pharmacol & Struct Biol, Toulouse, France.	Jean-Philippe.Girard@ipbs.fr	GIRARD, Jean-Philippe/F-5229-2010; Ortega, Nathalie/C-3382-2019	GIRARD, Jean-Philippe/0000-0002-9154-1691; 	Ligue Nationale contre le Cancer (Equipe labellisee); ANR-programme blanc "Cuboidale"; egion Midi-Pyrenees and MAIN European Network of Excellence [FP6-502935]	Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); ANR-programme blanc "Cuboidale"(French National Research Agency (ANR)); egion Midi-Pyrenees and MAIN European Network of Excellence	This work was supported by grants from Ligue Nationale contre le Cancer (Equipe labellisee), ANR-programme blanc "Cuboidale", Region Midi-Pyrenees and MAIN European Network of Excellence (FP6-502935). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Brunner M, 2004, INTENS CARE MED, V30, P1468, DOI 10.1007/s00134-004-2184-x; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; GADINA M, 2007, SCI STKE, pPE31; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; HAUSER C, 1986, J IMMUNOL, V136, P3317; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Kuroiwa K, 2001, BIOCHEM BIOPH RES CO, V284, P1104, DOI 10.1006/bbrc.2001.5090; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; MIZUTANI H, 1991, J CLIN INVEST, V87, P1066, DOI 10.1172/JCI115067; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Onda H, 1999, J CEREBR BLOOD F MET, V19, P1279, DOI 10.1097/00004647-199911000-00013; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; ROUSSEL L, 2008, EMBO REP; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Tajima S, 2003, CHEST, V124, P1206, DOI 10.1378/chest.124.4.1206; TOCCANIERPELTE MF, 1987, AM J PATHOL, V129, P109; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101	42	863	901	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3331	10.1371/journal.pone.0003331	http://dx.doi.org/10.1371/journal.pone.0003331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836528	gold, Green Published			2022-12-27	WOS:000265113500002
J	Kacherovsky, N; Tachibana, C; Amos, E; Fox, D; Young, ET				Kacherovsky, Nataly; Tachibana, Christine; Amos, Emily; Fox, David, III; Young, Elton T.			Promoter Binding by the Adr1 Transcriptional Activator May Be Regulated by Phosphorylation in the DNA-Binding Region	PLOS ONE			English	Article								Background: Post-translational modification regulates promoter-binding by Adr1, a Zn-finger transcriptional activator of glucose-regulated genes. Support for this model includes the activation of an Adr1-dependent gene in the absence of Adr1 protein synthesis, and a requirement for the kinase Snf1 for Adr1 DNA-binding. A fusion protein with the Adr1 DNA-binding domain and a heterologous activation domain is glucose-regulated, suggesting that the DNA binding region is the target of regulation. Methodology/Principal Findings: Peptide mapping identified serine 98 adjacent to the Zn-fingers as a phosphorylation site. An antibody specific for phosphorylated serine 98 on Adr1 showed that the level of phosphorylated Adr1 relative to the level of total Adr1 decreased with glucose derepression, in a Snf1-dependent manner. Relative phosphorylation decreased in a PHO85 mutant, and this mutant constitutively expressed an Adr1-dependent reporter. Pho85 did not phosphorylate Adr1 in vitro, suggesting that it affects Adr1 indirectly. Mutation of serine 98 to the phosphomimetic amino acid aspartate reduced in vitro DNA-binding of the recombinant Adr1 DNA-binding domain. Mutation to aspartate or alanine affected activation of a reporter by full-length Adr1, and in vivo promoter binding. Conclusions/Significance: Mutation of Adr1 serine 98 affects in vitro and in vivo DNA binding, and phosphorylation of serine 98 in vivo correlates with glucose availability, suggesting that Adr1 promoter-binding is regulated in part by serine 98 phosphorylation.	[Kacherovsky, Nataly; Tachibana, Christine; Amos, Emily; Fox, David, III; Young, Elton T.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kacherovsky, N (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	ety@u.washington.edu			NIGMS [26079]; NIDDK [67276]	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIGMS 26079 and NIDDK67276.	Biddick RK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001436; BLUMBERG H, 1987, NATURE, V328, P443, DOI 10.1038/328443a0; Bowers PW, 1999, NAT STRUCT BIOL, V6, P478; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brachmann CB, 1998, YEAST, V14, P115; CAMIER S, 1992, MOL CELL BIOL, V12, P5758, DOI 10.1128/MCB.12.12.5758; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; CHERRY JR, 1989, CELL, V56, P409, DOI 10.1016/0092-8674(89)90244-4; COOK WJ, 1994, J BIOL CHEM, V269, P9374; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; DENIS CL, 1992, MOL CELL BIOL, V12, P1507, DOI 10.1128/MCB.12.4.1507; DENIS CL, 1991, J BIOL CHEM, V266, P17932; DENIS CL, 1987, MOL GEN GENET, V208, P101, DOI 10.1007/BF00330429; Dombek KM, 1997, MOL CELL BIOL, V17, P1450, DOI 10.1128/MCB.17.3.1450; DOMBEK KM, 1993, MOL CELL BIOL, V13, P4391, DOI 10.1128/MCB.13.7.4391; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Huang DQ, 1996, MOL CELL BIOL, V16, P4357; Huang DQ, 1998, MOL CELL BIOL, V18, P3289, DOI 10.1128/MCB.18.6.3289; IRANI M, 1987, MOL CELL BIOL, V7, P1233, DOI 10.1128/MCB.7.3.1233; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; Nishizawa M, 2004, YEAST, V21, P903, DOI 10.1002/yea.1138; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Schaufler LE, 2003, J MOL BIOL, V329, P931, DOI 10.1016/S0022-2836(03)00550-3; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sloan JS, 1999, J BIOL CHEM, V274, P37575, DOI 10.1074/jbc.274.53.37575; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Tachibana C, 2007, J BIOL CHEM, V282, P37308, DOI 10.1074/jbc.M707363200; THUKRAL SK, 1991, MOL CELL BIOL, V11, P1566, DOI 10.1128/MCB.11.3.1566; THUKRAL SK, 1989, MOL CELL BIOL, V9, P2360, DOI 10.1128/MCB.9.6.2360; Timblin BK, 1996, GENETICS, V143, P57; Voronkova V, 2006, GENETICS, V172, P2123, DOI 10.1534/genetics.105.048231; WILLIAMSON VM, 1980, NATURE, V283, P214, DOI 10.1038/283214a0; Young ET, 2008, MOL CELL BIOL, V28, P2509, DOI 10.1128/MCB.00658-07; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Young ET, 2002, J BIOL CHEM, V277, P38095, DOI 10.1074/jbc.M206158200; Young ET, 2000, BIOCHEMISTRY-US, V39, P567, DOI 10.1021/bi992049r; Yuzyuk T, 2002, MOL BIOL CELL, V13, P2869, DOI 10.1091/mbc.02-01-0004; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	43	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3213	10.1371/journal.pone.0003213	http://dx.doi.org/10.1371/journal.pone.0003213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791642	Green Submitted, gold, Green Published			2022-12-27	WOS:000264427700008
J	Livny, J; Teonadi, H; Livny, M; Waldor, MK				Livny, Jonathan; Teonadi, Hidayat; Livny, Miron; Waldor, Matthew K.			High-Throughput, Kingdom-Wide Prediction and Annotation of Bacterial Non-Coding RNAs	PLOS ONE			English	Article								Background: Diverse bacterial genomes encode numerous small non-coding RNAs (sRNAs) that regulate myriad biological processes. While bioinformatic algorithms have proven effective in identifying sRNA-encoding loci, the lack of tools and infrastructure with which to execute these computationally demanding algorithms has limited their utilization. Genome-wide predictions of sRNA-encoding genes have been conducted in less than 3% of all sequenced bacterial strains, leading to critical gaps in current annotations. The relative paucity of genome-wide sRNA prediction represents a critical gap in current annotations of bacterial genomes and has limited examination of larger issues in sRNA biology, such as sRNA evolution. Methodology/Principal Findings: We have developed and deployed SIPHT, a high throughput computational tool that utilizes workflow management and distributed computing to effectively conduct kingdom-wide predictions and annotations of intergenic sRNA-encoding genes. Candidate sRNA-encoding loci are identified based on the presence of putative Rho-independent terminators downstream of conserved intergenic sequences, and each locus is annotated for several features, including conservation in other species, association with one of several transcription factor binding sites and homology to any of over 300 previously identified sRNAs and cis-regulatory RNA elements. Using SIPHT, we conducted searches for putative sRNA-encoding genes in all 932 bacterial replicons in the NCBI database. These searches yielded nearly 60% of previously confirmed sRNAs, hundreds of previously annotated cis-encoded regulatory RNA elements such as riboswitches, and over 45,000 novel candidate intergenic loci. Conclusions/Significance: Candidate loci were identified across all branches of the bacterial evolutionary tree, suggesting a central and ubiquitous role for RNA-mediated regulation among bacterial species. Annotation of candidate loci by SIPHT provides clues into the potential biological function of thousands of previously confirmed and candidate regulatory RNAs and affords new insights into the evolution of bacterial riboregulation.	[Livny, Jonathan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Labs, Boston, MA 02115 USA; [Teonadi, Hidayat; Livny, Miron] Univ Wisconsin, Comput Sci Dept, Madison, WI 53706 USA; [Waldor, Matthew K.] Harvard Univ, Brigham & Womens Hosp, Harvard Med Sch, Howard Hughes Med Inst, Channing Lab, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Livny, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Labs, Boston, MA 02115 USA.	jlivny@rics.bwh.harvard.edu		Waldor, Matthew/0000-0003-1843-7000	National Institutes of Health [AI-42347]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347, R01AI042347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health (AI-42347); Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Au N, 2005, J BACTERIOL, V187, P7655, DOI 10.1128/JB.187.22.7655-7666.2005; Axmann IM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r73; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; Cirz RT, 2006, J BACTERIOL, V188, P7101, DOI 10.1128/JB.00807-06; Davis BM, 2005, J BACTERIOL, V187, P4005, DOI 10.1128/JB.187.12.4005-4014.2005; De Gregorio E, 2005, J BACTERIOL, V187, P7945, DOI 10.1128/JB.187.23.7945-7954.2005; del Val C, 2007, MOL MICROBIOL, V66, P1080, DOI 10.1111/j.1365-2958.2007.05978.x; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grundy FJ, 2004, CURR OPIN MICROBIOL, V7, P126, DOI 10.1016/j.mib.2004.02.013; Hershberg R, 2003, NUCLEIC ACIDS RES, V31, P1813, DOI 10.1093/nar/gkg297; HULTON CSJ, 1991, MOL MICROBIOL, V5, P825, DOI 10.1111/j.1365-2958.1991.tb00755.x; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Liu X, 2001, Pac Symp Biocomput, P127; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Livny J, 2007, CURR OPIN MICROBIOL, V10, P96, DOI 10.1016/j.mib.2007.03.005; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Makita Y, 2004, NUCLEIC ACIDS RES, V32, pD75, DOI 10.1093/nar/gkh074; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; McArthur SD, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-52; Mellin JR, 2007, J BACTERIOL, V189, P3686, DOI 10.1128/JB.01890-06; Mey AR, 2005, INFECT IMMUN, V73, P8167, DOI 10.1128/IAI.73.12.8167-8178.2005; Moller T, 2002, GENE DEV, V16, P1696, DOI 10.1101/gad.231702; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Pichon C, 2003, BIOINFORMATICS, V19, P1707, DOI 10.1093/bioinformatics/btg235; RHODIUS VA, 2005, PLOS BIOL, V4, P757; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Saetrom P, 2005, NUCLEIC ACIDS RES, V33, P3263, DOI 10.1093/nar/gki644; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Silvaggi JM, 2006, J BACTERIOL, V188, P532, DOI 10.1128/JB.188.2.532-541.2006; SITTKA A, 2008, PLOS GENETI IN PRESS; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Thain D, 2005, CONCURR COMP-PRACT E, V17, P323, DOI 10.1002/cpe.938; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; U'Ren JM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-23; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Vogel J, 2004, CURR BIOL, V14, P2271, DOI 10.1016/j.cub.2004.12.003; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Wilson LA, 2006, MOL BIOL EVOL, V23, P1156, DOI 10.1093/molbev/msj125; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x; Zhang Y, 2004, BIOINFORMATICS, V20, P599, DOI 10.1093/bioinformatics/btg457; Zhou DS, 2006, FEMS MICROBIOL LETT, V258, P9, DOI 10.1111/j.1574-6968.2006.00208.x	60	158	167	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3197	10.1371/journal.pone.0003197	http://dx.doi.org/10.1371/journal.pone.0003197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787707	gold, Green Published, Green Submitted			2022-12-27	WOS:000264426200003
J	Krishnan, K; Salomonis, N; Guo, S				Krishnan, Keerthi; Salomonis, Nathan; Guo, Su			Identification of Spt5 Target Genes in Zebrafish Development Reveals Its Dual Activity In Vivo	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION ELONGATION-FACTOR; CHROMATIN-STRUCTURE; MICROARRAY DATA; P-TEFB; PROTEIN; ACTIVATION; EXPRESSION; PROMOTER; TAT	Spt5 is a conserved essential protein that represses or stimulates transcription elongation in vitro. Immunolocalization studies on Drosophila polytene chromosomes suggest that Spt5 is associated with many loci throughout the genome. However, little is known about the prevalence and identity of Spt5 target genes in vivo during development. Here, we identify direct target genes of Spt5 using fog(sk8) zebrafish mutant, which disrupts the foggy/spt5 gene. We identified that fog(sk8) and their wildtype siblings differentially express less than 5% of genes examined. These genes participate in diverse biological processes from stress response to cell fate specification. Up-regulated genes exhibit shorter overall gene length compared to all genes examined. Through chromatin immunoprecipitation in zebrafish embryos, we identified a subset of developmentally critical genes that are bound by both Spt5 and RNA polymerase II. The protein occupancy patterns on these genes are characteristic of both repressive and stimulatory elongation regulation. Together our findings establish Spt5 as a dual regulator of transcription elongation in vivo and identify a small but diverse set of target genes critically dependent on Spt5 during development.	[Krishnan, Keerthi; Salomonis, Nathan; Guo, Su] Univ Calif San Francisco, Dept Biopharm Sci, Programs Human Genet & Pharm Sci & Pharmacogenom, San Francisco, CA 94143 USA; [Salomonis, Nathan] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Krishnan, K (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	suguo@itsa.ucsf.edu			NIH [NS042626]; UCSF [Graduate Student Research Award]; J. David Gladstone Institutes [T32GM07175]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042626] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF; J. David Gladstone Institutes(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NIH grant NS042626. K. Krishnan was a recipient of a UCSF Graduate Student Research Award. N. Salomonis was supported by the J. David Gladstone Institutes and T32GM07175. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Blackwell TK, 2003, CURR BIOL, V13, pR915, DOI 10.1016/j.cub.2003.11.013; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Bourgeois CF, 2002, MOL CELL BIOL, V22, P1079, DOI 10.1128/MCB.22.4.1079-1093.2002; COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826; Conaway JW, 1999, ANNU REV BIOCHEM, V68, P301, DOI 10.1146/annurev.biochem.68.1.301; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Dudoit S, 2003, BIOTECHNIQUES, P45; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Graunke DM, 1999, NUCLEIC ACIDS RES, V27, P3881, DOI 10.1093/nar/27.19.3881; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Jennings BH, 2004, CURR BIOL, V14, P1680, DOI 10.1016/j.cub.2004.08.066; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Kawahara A, 2005, P NATL ACAD SCI USA, V102, P361, DOI 10.1073/pnas.0408726102; Keegan BR, 2002, DEVELOPMENT, V129, P1623; Kim D, 2001, MOL CELLS, V11, P267; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lavoie SB, 2001, J MOL BIOL, V312, P675, DOI 10.1006/jmbi.2001.4991; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Osterlund T, 2006, TRENDS CELL BIOL, V16, P176, DOI 10.1016/j.tcb.2006.02.004; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Pei Y, 2003, J BIOL CHEM, V278, P43346, DOI 10.1074/jbc.M307319200; POLLARD KS, 2002, CYBERNETICS INFORM, V2, P318; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smith WC, 1999, TRENDS GENET, V15, P3, DOI 10.1016/S0168-9525(98)01641-2; Stachora AA, 1997, FEBS LETT, V409, P74, DOI 10.1016/S0014-5793(97)00486-9; SWANSON MS, 1992, GENETICS, V132, P325; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; THISSE B, 2004, EXPRESSION ZEBRAFISH; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wen YX, 1999, GENE DEV, V13, P1774, DOI 10.1101/gad.13.14.1774; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; WINSTON F, 1984, GENETICS, V107, P179; Winston F, 2001, GENOME BIOL, V2; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Wu-Baer F, 1998, J MOL BIOL, V277, P179, DOI 10.1006/jmbi.1997.1601; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	61	34	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3621	10.1371/journal.pone.0003621	http://dx.doi.org/10.1371/journal.pone.0003621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978947	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000265134200008
J	Brudevold, R; Hole, T; Hammerstrom, J				Brudevold, Robert; Hole, Torstein; Hammerstrom, Jens			Hyperferritinemia Is Associated with Insulin Resistance and Fatty Liver in Patients without Iron Overload	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SERUM FERRITIN; HEREDITARY HEMOCHROMATOSIS; METABOLIC SYNDROME; STORES; PREVALENCE	Objective: During the last 10 years we have experienced an increasing number of referrals due to hyperferritinemia. This is probably due to increased awareness of hereditary hemochromatosis, and the availability of a genetic test for this condition. Most of these referred patients were over-weight middle-aged men with elevated ferritin levels, but without the hemochromatosis-predisposing gene mutations. We evaluated the relationship between hyperferritinemia and the metabolic syndrome in 40 patients. Methods: Forty consecutive patients referred for hyperferritinemia were investigated. The examination programme included medical history, clinical investigation and venous blood samples drawn after an overnight fast. This resulted in 34 patients with unexplained hyperferritinemia, which were further examined. Liver biopsy was successfully performed in 29 subjects. Liver iron stores were assessed morphologically, and by quantitative phlebotomy in 16 patients. Results: The majority of the patients had markers of the metabolic syndrome, and 18 patients (52%) fulfilled the IDF-criteria for the metabolic syndrome. Mean body mass index was elevated (28,8 +/- 4,2), mean diastolic blood pressure was 88,5 +/- 10,5 mmHg, and mean fasting insulin C-peptide 1498 +/- 539 pmol/l. Liver histology showed steatosis and nuclear glycogen inclusions in most patients (19 out of 29). Only four patients had increased iron stores by histology, of which two could be explained by alcohol consumption. Fourteen of 16 patients normalized ferritin levels after phlebotomy of a cumulative blood amount corresponding to normal iron stores. Ferritin levels were significantly related to insulin C-peptide level (p<0.002) and age (p<0.002). Conclusion: The present results suggest that liver steatosis and insulin resistance but not increased iron load is frequently seen in patients referred for suspected hemochromatosis on the basis of hyperferritinemia. The ferritin level seems to be positively associated to insulin resistance.	[Brudevold, Robert; Hole, Torstein] Aalesund Hosp, Dept Med, Alesund, Norway; [Hammerstrom, Jens] St Olavs Hosp, Dept Med, Trondheim, Norway; [Hole, Torstein; Hammerstrom, Jens] Norwegian Univ Sci & Technol NTNU, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Brudevold, R (corresponding author), Aalesund Hosp, Dept Med, Alesund, Norway.	robert.brudevold@helse-sunnmore.no						Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210; Bonora E, 2003, DIABETES CARE, V26, P1251, DOI 10.2337/diacare.26.4.1251; CARAMIA F, 1968, J CLIN PATHOL, V21, P19, DOI 10.1136/jcp.21.1.19; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DINNEEN SF, 1994, MAYO CLIN PROC, V69, P13, DOI 10.1016/S0025-6196(12)61605-X; DINNEEN SF, 1992, IRISH J MED SCI, V161, P636, DOI 10.1007/BF02983771; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fernandez-Real JM, 1998, DIABETES CARE, V21, P62, DOI 10.2337/diacare.21.1.62; Ferrannini E, 2000, LANCET, V355, P2181, DOI 10.1016/S0140-6736(00)02397-7; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hernandez C, 2005, DIABETIC MED, V22, P97, DOI 10.1111/j.1464-5491.2004.01331.x; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Hsueh WA, 2003, AM J CARDIOL, V92, p10J, DOI 10.1016/S0002-9149(03)00611-8; Jandl J.H., 1996, BLOOD TXB HEMATOLOGY; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; Moirand R, 1997, LANCET, V349, P95, DOI 10.1016/S0140-6736(96)06034-5; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P2534, DOI 10.1073/pnas.94.6.2534; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; POLONSKY KS, 1984, DIABETES, V33, P486, DOI 10.2337/diabetes.33.5.486; SEARLE J, 1987, PATHOLOGY LIVER; Sjoholm A, 2005, LANCET, V365, P610, DOI 10.1016/S0140-6736(05)70804-7; Tavill AS, 2001, HEPATOLOGY, V33, P1321, DOI 10.1053/jhep.2001.24783; Tuomainen TP, 1997, DIABETES CARE, V20, P426, DOI 10.2337/diacare.20.3.426; WALTERS GO, 1973, J CLIN PATHOL, V26, P770, DOI 10.1136/jcp.26.10.770; WORWOOD M, 1986, CLIN SCI, V70, P215, DOI 10.1042/cs0700215; Worwood M, 1994, IRON METABOLISM HLTH, P449	30	50	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3547	10.1371/journal.pone.0003547	http://dx.doi.org/10.1371/journal.pone.0003547			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958176	Green Published, gold, Green Submitted			2022-12-27	WOS:000265130900009
J	Kimura, T; Yamashita, S; Nakao, S; Park, JM; Murayama, M; Mizoroki, T; Yoshiike, Y; Sahara, N; Takashima, A				Kimura, Tetsuya; Yamashita, Shunji; Nakao, Shinobu; Park, Jung-Mi; Murayama, Miyuki; Mizoroki, Tatsuya; Yoshiike, Yuji; Sahara, Naruhiko; Takashima, Akihiko			GSK-3 beta Is Required for Memory Reconsolidation in Adult Brain	PLOS ONE			English	Article								Activation of GSK-3 beta is presumed to be involved in various neurodegenerative diseases, including Alzheimer's disease (AD), which is characterized by memory disturbances during early stages of the disease. The normal function of GSK-3 beta in adult brain is not well understood. Here, we analyzed the ability of heterozygote GSK-3 beta knockout (GSK+/-) mice to form memories. In the Morris water maze (MWM), learning and memory performance of GSK+/- mice was no different from that of wild-type (WT) mice for the first 3 days of training. With continued learning on subsequent days, however, retrograde amnesia was induced in GSK+/- mice, suggesting that GSK+/- mice might be impaired in their ability to form long-term memories. In contextual fear conditioning (CFC), context memory was normally consolidated in GSK+/- mice, but once the original memory was reactivated, they showed reduced freezing, suggesting that GSK+/- mice had impaired memory reconsolidation. Biochemical analysis showed that GSK-3 beta was activated after memory reactivation in WT mice. Intraperitoneal injection of a GSK-3 inhibitor before memory reactivation impaired memory reconsolidation in WT mice. These results suggest that memory reconsolidation requires activation of GSK-3 beta in the adult brain.	[Kimura, Tetsuya; Yamashita, Shunji; Nakao, Shinobu; Park, Jung-Mi; Murayama, Miyuki; Mizoroki, Tatsuya; Yoshiike, Yuji; Sahara, Naruhiko; Takashima, Akihiko] RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama, Japan	RIKEN	Takashima, A (corresponding author), RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama, Japan.	kenneth@brain.riken.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grant-in-Aid for Scientific Research on Priority Areas (Research on Pathomechanisms on Brain Disorders) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Artinian J, 2007, HIPPOCAMPUS, V17, P181, DOI 10.1002/hipo.20256; Biedenkapp JC, 2004, BEHAV NEUROSCI, V118, P956, DOI 10.1037/0735-7044.118.5.956; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Diamond DM, 2005, HIPPOCAMPUS, V15, P1006, DOI 10.1002/hipo.20107; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Engel T, 2006, J NEUROSCI, V26, P5083, DOI 10.1523/JNEUROSCI.0604-06.2006; Engel T, 2006, NEUROBIOL AGING, V27, P1258, DOI 10.1016/j.neurobiolaging.2005.06.010; Engel T, 2006, J NEUROCHEM, V99, P1445, DOI 10.1111/j.1471-4159.2006.04139.x; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Goedert M, 1991, BRAIN PATHOL, V1, P279, DOI 10.1111/j.1750-3639.1991.tb00671.x; Gomez-Sintes R, 2007, EMBO J, V26, P2743, DOI 10.1038/sj.emboj.7601725; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hernandez F, 2002, J NEUROCHEM, V83, P1529, DOI 10.1046/j.1471-4159.2002.01269.x; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hooper C, 2007, EUR J NEUROSCI, V25, P81, DOI 10.1111/j.1460-9568.2006.05245.x; Imahori K, 1997, J BIOCHEM, V121, P179; Iqbal K, 1996, ANN NY ACAD SCI, V777, P132, DOI 10.1111/j.1749-6632.1996.tb34411.x; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kimura T, 2007, EMBO J, V26, P5143, DOI 10.1038/sj.emboj.7601917; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Lee V M, 1992, Curr Opin Neurobiol, V2, P653, DOI 10.1016/0959-4388(92)90034-I; Lovestone S, 2007, TRENDS NEUROSCI, V30, P142, DOI 10.1016/j.tins.2007.02.002; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; O'Brien WT, 2007, BIOL PSYCHIAT, V61, P139, DOI 10.1016/j.biopsych.2006.11.008; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Riccio DC, 2002, INTEGR PHYS BEH SCI, V37, P245, DOI 10.1007/BF02734247; Rossato JI, 2006, LEARN MEMORY, V13, P431, DOI 10.1101/lm.315206; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Takashima A, 1996, NEUROSCI LETT, V203, P33, DOI 10.1016/0304-3940(95)12257-5; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; Takashima A, 1998, NEUROSCI RES, V31, P317, DOI 10.1016/S0168-0102(98)00061-3; Takashima A, 2006, J ALZHEIMERS DIS, V9, P309; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x	40	111	111	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3540	10.1371/journal.pone.0003540	http://dx.doi.org/10.1371/journal.pone.0003540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958152	Green Published, gold, Green Submitted			2022-12-27	WOS:000265130900003
J	Cardone, RA; Busco, G; Greco, MR; Bellizzi, A; Accardi, R; Cafarelli, A; Monterisi, S; Carratu, P; Casavola, V; Paradiso, A; Tommasino, M; Reshkin, SJ				Cardone, Rosa A.; Busco, Giovanni; Greco, Maria R.; Bellizzi, Antonia; Accardi, Rosita; Cafarelli, Antonella; Monterisi, Stefania; Carratu, Pierluigi; Casavola, Valeria; Paradiso, Angelo; Tommasino, Massimo; Reshkin, Stephan J.			HPV16 E7-Dependent Transformation Activates NHE1 through a PKA-RhoA-Iinduced Inhibition of p38alpha	PLOS ONE			English	Article								Background: Neoplastic transformation originates from a large number of different genetic alterations. Despite this genetic variability, a common phenotype to transformed cells is cellular alkalinization. We have previously shown in human keratinocytes and a cell line in which transformation can be turned on and followed by the inducible expression of the E7 oncogene of human papillomavirus type 16 (HPV16), that intracellular alkalinization is an early and essential physiological event driven by the up-regulation of the Na/H-+(+) exchanger isoform 1 (NHE1) and is necessary for the development of other transformed phenotypes and the in vivo tumor formation in nude mice. Methodology: Here, we utilize these model systems to elucidate the dynamic sequence of alterations of the upstream signal transduction systems leading to the transformation-dependent activation of NHE1. Principal Findings: We observe that a down-regulation of p38 MAPK activity is a fundamental step in the ability of the oncogene to transform the cell. Further, using pharmacological agents and transient transfections with dominant interfering, constitutively active, phosphorylation negative mutants and siRNA strategy to modify specific upstream signal transduction components that link HPV16 E7 oncogenic signals to up-regulation of the NHE1, we demonstrate that the stimulation of NHE1 activity is driven by an early rise in cellular cAMP resulting in the down-stream inhibition of p38 MAPK via the PKA-dependent phosphorylation of the small G-protein, RhoA, and its subsequent inhibition. Conclusions: All together these data significantly improve our knowledge concerning the basic cellular alterations involved in oncogene-driven neoplastic transformation.	[Cardone, Rosa A.; Busco, Giovanni; Greco, Maria R.; Cafarelli, Antonella; Monterisi, Stefania; Casavola, Valeria; Reshkin, Stephan J.] Univ Bari, Dept Gen & Environm Physiol, Bari, Italy; [Bellizzi, Antonia; Paradiso, Angelo] Natl Canc Inst Giovanni Paolo II, Clin Expt Oncol Lab, Bari, Italy; [Carratu, Pierluigi] Univ Bari, Dept Resp Med, I-70121 Bari, Italy; [Accardi, Rosita; Tommasino, Massimo] IARC WHO, Infect & Canc Biol Grp, Lyon, France	Universita degli Studi di Bari Aldo Moro; IRCCS Istituto Tumori Bari Giovanni Paolo II; Universita degli Studi di Bari Aldo Moro; World Health Organization; International Agency for Research on Cancer (IARC)	Cardone, RA (corresponding author), Univ Bari, Dept Gen & Environm Physiol, Bari, Italy.	reshkin@biologia.uniba.it	Busco, Giovanni/F-2711-2018; paradiso, angelo V/J-9457-2018; Carratu, Pierluigi/K-4120-2016	Busco, Giovanni/0000-0001-6859-9468; Carratu, Pierluigi/0000-0003-2208-6215; GRECO, Maria Raffaella/0000-0001-7454-8990; CASAVOLA, Valeria/0000-0003-4471-4948; Reshkin, Stephan/0000-0001-9757-5908	Italian Association For Cancer Research	Italian Association For Cancer Research(Fondazione AIRC per la ricerca sul cancro)	Italian Association For Cancer Research, l'AIRC. This non-profit organization had no role in any of these activities.	Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Ahn BH, 2007, BBA-MOL CELL RES, V1773, P1721, DOI 10.1016/j.bbamcr.2007.06.001; BANKS L, 1990, ONCOGENE, V5, P1383; Bradham C, 2006, CELL CYCLE, V5, P824, DOI 10.4161/cc.5.8.2685; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Cardone RA, 2005, MOL BIOL CELL, V16, P3117, DOI 10.1091/mbc.e04-10-0945; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; Charette ST, 2007, ONCOGENE, V26, P7386, DOI 10.1038/sj.onc.1210541; Chen D, 2007, CANCER RES, V67, P8914, DOI 10.1158/0008-5472.CAN-06-4751; Cuadrado A, 2007, EMBO J, V26, P2115, DOI 10.1038/sj.emboj.7601657; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Dreissigacker U, 2006, CELL SIGNAL, V18, P1156, DOI 10.1016/j.cellsig.2005.09.004; Durst M, 1995, CANCER GENET CYTOGEN, V85, P105, DOI 10.1016/0165-4608(95)00155-7; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Farrow B, 2003, SURGERY, V134, P197, DOI 10.1067/msy.2003.220; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harguindey S, 2005, BBA-REV CANCER, V1756, P1, DOI 10.1016/j.bbcan.2005.06.004; Hsiao PW, 2007, TOXICOL APPL PHARM, V222, P97, DOI 10.1016/j.taap.2007.04.007; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jia ZJ, 2006, BIOL CELL, V98, P337, DOI 10.1042/BC20050088; Kennedy NJ, 2007, CANCER CELL, V11, P101, DOI 10.1016/j.ccr.2007.01.009; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Kim SY, 2008, J BIOL CHEM, V283, P1350, DOI 10.1074/jbc.M702344200; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; Kobayashi Y, 2005, J BIOL CHEM, V280, P11395, DOI 10.1074/jbc.M411189200; Kralova J, 2008, ONCOGENE, V27, P3010, DOI 10.1038/sj.onc.1210960; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Leone V, 2007, AM J PHYSIOL-GASTR L, V293, pG673, DOI 10.1152/ajpgi.00584.2006; Lovett FA, 2006, J CELL SCI, V119, P4828, DOI 10.1242/jcs.03278; MANSUR CP, 1993, BIOCHIM BIOPHYS ACTA, V1155, P323, DOI 10.1016/0304-419X(93)90013-3; Mantovani G, 2008, ONCOGENE, V27, P1834, DOI 10.1038/sj.onc.1210831; Mantovani G, 2008, EXP CELL RES, V314, P123, DOI 10.1016/j.yexcr.2007.08.024; Mao XH, 2004, EXP CELL RES, V292, P304, DOI 10.1016/j.yexcr.2003.09.012; Moule SK, 1998, FEBS LETT, V439, P287, DOI 10.1016/S0014-5793(98)01392-1; Murthy KS, 2003, AM J PHYSIOL-GASTR L, V284, pG1006, DOI 10.1152/ajpgi.00465.2002; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; PHELPS WC, 1992, J VIROL, V66, P2418, DOI 10.1128/JVI.66.4.2418-2427.1992; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reshkin SJ, 2003, CLIN CANCER RES, V9, P2366; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Robinson-White AJ, 2008, J CLIN ENDOCR METAB, V93, P1020, DOI 10.1210/jc.2007-2331; Ruesch LN, 1998, J VIROL, V72, P5016, DOI 10.1128/JVI.72.6.5016-5024.1998; Townsend TA, 2008, J BIOL CHEM, V283, P13834, DOI 10.1074/jbc.M710607200; Vanni C, 2007, CELL CYCLE, V6, P2058, DOI 10.4161/cc.6.16.4574; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wang DA, 2005, J BIOL CHEM, V280, P19243, DOI 10.1074/jbc.M411472200; Wu R, 2007, MOL MED, V13, P143, DOI 10.2119/2007-00005.Wu; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamashita M, 2008, J ENDOCRINOL, V196, P601, DOI 10.1677/JOE-07-0532; Yano M, 2007, CIRC RES, V100, P1442, DOI 10.1161/01.RES.0000268411.49545.9c; Yaqub S, 2008, CANCER IMMUNOL IMMUN, V57, P813, DOI 10.1007/s00262-007-0417-x; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Zaccolo M, 2002, CURR OPIN CELL BIOL, V14, P160, DOI 10.1016/S0955-0674(02)00316-2; Zeidan A, 2008, CARDIOVASC RES, V77, P64, DOI 10.1093/cvr/cvm020; Zhou SX, 2008, CELL SIGNAL, V20, P695, DOI 10.1016/j.cellsig.2007.12.005; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	67	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3529	10.1371/journal.pone.0003529	http://dx.doi.org/10.1371/journal.pone.0003529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953413	Green Published, gold			2022-12-27	WOS:000265130500007
J	Bault, N; Coricelli, G; Rustichini, A				Bault, Nadege; Coricelli, Giorgio; Rustichini, Aldo			Interdependent Utilities: How Social Ranking Affects Choice Behavior	PLOS ONE			English	Article							DECISION; REGRET; CONSEQUENCES	Organization in hierarchical dominance structures is prevalent in animal societies, so a strong preference for higher positions in social ranking is likely to be an important motivation of human social and economic behavior. This preference is also likely to influence the way in which we evaluate our outcome and the outcome of others, and finally the way we choose. In our experiment participants choose among lotteries with different levels of risk, and can observe the choice that others have made. Results show that the relative weight of gains and losses is the opposite in the private and social domain. For private outcomes, experience and anticipation of losses loom larger than gains, whereas in the social domain, gains loom larger than losses, as indexed by subjective emotional evaluations and physiological responses. We propose a theoretical model (interdependent utilities), predicting the implication of this effect for choice behavior. The relatively larger weight assigned to social gains strongly affects choices, inducing complementary behavior: faced with a weaker competitor, participants adopt a more risky and dominant behavior.	[Bault, Nadege; Coricelli, Giorgio] Univ Lyon 1, CNRS, UMR5229, Inst Sci Cognit,Ctr Neurosci Cognit, Bron, France; [Coricelli, Giorgio] Univ Trent, Ctr Mind Brain Sci, CIMeC, I-38100 Trento, Italy; [Rustichini, Aldo] Univ Minnesota, Dept Econom, Minneapolis, MN 55455 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Trento; University of Minnesota System; University of Minnesota Twin Cities	Bault, N (corresponding author), Univ Lyon 1, CNRS, UMR5229, Inst Sci Cognit,Ctr Neurosci Cognit, Bron, France.	coricelli@isc.cnrs.fr; arust@econ.umn.edu	Bault, Nadège/L-9907-2019	Bault, Nadège/0000-0001-8244-6062	Human Frontier Science Program [RGP 56/2005]; ANR; PAT (Provincia Autonoma di Trento); National Science Foundation [SES-0452477]	Human Frontier Science Program(Human Frontier Science Program); ANR(French National Research Agency (ANR)); PAT (Provincia Autonoma di Trento)(Autonomous Province of Trento); National Science Foundation(National Science Foundation (NSF))	We gratefully acknowledge financial support from the Human Frontier Science Program (HFSP, RGP 56/2005), ANR and PAT (Provincia Autonoma di Trento) to G.C.; and the National Science Foundation (SES-0452477) to A.R.	ABEL AB, 1990, AM ECON REV, V80, P38; BARTON RA, 1993, ANIM BEHAV, V46, P777, DOI 10.1006/anbe.1993.1255; Boucsein W., 1992, ELECTRODERMAL ACTIVI; Buunk AP, 2007, ORGAN BEHAV HUM DEC, V102, P3, DOI 10.1016/j.obhdp.2006.09.007; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Clark AE, 1996, J PUBLIC ECON, V61, P359, DOI 10.1016/0047-2727(95)01564-7; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; DAWSON ME, 2000, HDB PSYCHOPHYSIOLOGY, P200; Duesenberry J.S., 1949, INCOME SAVING THEORY, DOI 10.2307/2226615; Ferrer-i-Carbonell A, 2005, J PUBLIC ECON, V89, P997, DOI 10.1016/j.jpubeco.2004.06.003; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Foster DP, 1999, GAME ECON BEHAV, V29, P7, DOI 10.1006/game.1999.0740; Frijda N. H., 1986, EMOTIONS STUDIES EMO; GALI J, 1994, J MONEY CREDIT BANK, V26, P1, DOI 10.2307/2078030; Gneezy U, 2000, Q J ECON, V115, P791, DOI 10.1162/003355300554917; Hart S, 2005, ECONOMETRICA, V73, P1401, DOI 10.1111/j.1468-0262.2005.00625.x; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; LOEWENSTEIN GF, 1989, J PERS SOC PSYCHOL, V57, P426, DOI 10.1037/0022-3514.57.3.426; Luttmer EFP, 2005, Q J ECON, V120, P963, DOI 10.1093/qje/120.3.963; Maslow AH, 1937, PSYCHOL REV, V44, P404, DOI 10.1037/h0056714; Megiddo N., 1980, International Journal of Game Theory, V9, P157, DOI 10.1007/BF01781370; Mellers BA, 2000, PSYCHOL BULL, V126, P910, DOI 10.1037/0033-2909.126.6.910; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Orthony A., 1988, COGNITIVE STRUCTURE; Roese Neal J., 1995, WHAT MIGHT HAVE BEEN; Shamay-Tsoory SG, 2007, BRAIN, V130, P1663, DOI 10.1093/brain/awm093; Sidanius J., 1999, SOCIAL DOMINANCE INT; STRACK F, 1990, BRIT J SOC PSYCHOL, V29, P303, DOI 10.1111/j.2044-8309.1990.tb00912.x; Suls J., 2000, HDB SOCIAL COMP THEO; Tiedens LZ, 2003, J PERS SOC PSYCHOL, V84, P558, DOI 10.1037/0022-3514.84.3.558; Veblen Thorstein, 1975, THEORY LEISURE CLASS; WILLS TA, 1981, PSYCHOL BULL, V90, P245, DOI 10.1037/0033-2909.90.2.245; WOOD JV, 1989, PSYCHOL BULL, V106, P231, DOI 10.1037/0033-2909.106.2.231; Zeelenberg M, 2004, ORGAN BEHAV HUM DEC, V93, P155, DOI 10.1016/j.obhdp.2003.10.001	35	71	72	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3477	10.1371/journal.pone.0003477	http://dx.doi.org/10.1371/journal.pone.0003477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IG	18941538	Green Submitted, Green Published, gold			2022-12-27	WOS:000265126100008
J	Vali, B; Yue, FY; Jones, RB; Sheth, PM; Kaul, R; Betts, MR; Wong, D; Kovacs, C; Loutfy, M; Common, A; Halpenny, R; Ostrowski, MA				Vali, Bahareh; Yue, Feng Yun; Jones, R. Brad; Sheth, Prameet M.; Kaul, Rupert; Betts, Michael R.; Wong, David; Kovacs, Colin; Loutfy, Mona; Common, Andrew; Halpenny, Roberta; Ostrowski, Mario A.			HIV-Specific T-Cells Accumulate in the Liver in HCV/HIV Co-Infection	PLOS ONE			English	Article								Background and Aims: Hepatitis C Virus (HCV)-related liver disease progresses more rapidly in individuals co-infected with Human Immunodeficiency Virus-1 (HIV), although the underlying immunologic mechanisms are unknown. We examined whether HIV-specific T-cells are identified in the liver of HCV/HIV co-infected individuals and promote liver inflammation through bystander immune responses. Methods: Ex-vivo intra-hepatic lymphocytes from HCV mono-infected and HCV/HIV co-infected individuals were assessed for immune responses to HIV and HCV antigens by polychromatic flow cytometry. Results: HCV/HIV liver biopsies had similar frequencies of lymphocytes but lower percentages of CD4(+) T-cells compared to HCV biopsies. In co-infection, intra-hepatic HIV-specific CD8(+) and CD4(+) T-cells producing IFN-gamma and TNF-alpha were detected and were comparable in frequency to those that were HCV-specific. In co-infected individuals, viral-specific CD8(+) T-cells produced more of the fibrogenic cytokine, TNF-alpha. In both mono-and co-infected individuals, intra-hepatic HCV-specific T-cells were poorly functional compared to HIV-specific T-cells. In co-infection, HAART was not associated with a reconstitution of intra-hepatic CD4(+) T-cells and was associated with reduction in both HIV and HCV-specific intra-hepatic cytokine responses. Conclusion: The accumulation of functional HIV-specific T-cells in the liver during HCV/HIV co-infection may represent a bystander role for HIV in inducing faster progression of liver disease.	[Vali, Bahareh; Sheth, Prameet M.; Kaul, Rupert; Ostrowski, Mario A.] Univ Toronto, Inst Med Sci, Dept Med, Toronto, ON M5S 1A1, Canada; [Yue, Feng Yun; Jones, R. Brad; Kaul, Rupert; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Betts, Michael R.] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Wong, David] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Kovacs, Colin; Loutfy, Mona; Halpenny, Roberta] Canadian Immunodeficiency Res Collaborat, Toronto, ON, Canada; [Common, Andrew; Ostrowski, Mario A.] St Michaels Hosp, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Pennsylvania; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Vali, B (corresponding author), Univ Toronto, Inst Med Sci, Dept Med, Toronto, ON M5S 1A1, Canada.	bahareh.vali@utoronto.ca		Kaul, Rupert/0000-0002-1586-4093; Wong, David/0000-0002-3310-3538	CANFAR (Canadian Foundation for AIDS Research)	CANFAR (Canadian Foundation for AIDS Research)	Financial support for this study was obtained from CANFAR (Canadian Foundation for AIDS Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatrakchi N, 2005, J INFECT DIS, V191, P702, DOI 10.1086/427778; Banner BF, 1997, VIRCHOWS ARCH, V431, P181, DOI 10.1007/s004280050086; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; CAO YZ, 1992, AIDS, V6, P65, DOI 10.1097/00002030-199201000-00008; Chan HLY, 2005, WORLD J GASTROENTERO, V11, P2148, DOI 10.3748/wjg.v11.i14.2148; Crispe IN, 2000, IMMUNOL REV, V174, P47, DOI 10.1034/j.1600-0528.2002.017412.x; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dutoit V, 2005, EUR J IMMUNOL, V35, P3493, DOI 10.1002/eji.200535035; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Graham CS, 2004, HEPATOLOGY, V40, P125, DOI 10.1002/hep.20258; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; KHATIB R, 1993, INFECTION, V21, P112, DOI 10.1007/BF01710744; Kim AY, 2006, PLOS MED, V3, P2324, DOI 10.1371/journal.pmed.0030492; Kitamura K, 2002, LAB INVEST, V82, P571, DOI 10.1038/labinvest.3780452; Lauer GM, 2002, J VIROL, V76, P2817, DOI 10.1128/JVI.76.6.2817-2826.2002; Makedonas G, 2006, SPRINGER SEMIN IMMUN, V28, P209, DOI 10.1007/s00281-006-0025-4; Pol S, 1998, J HEPATOL, V28, P945, DOI 10.1016/S0168-8278(98)80341-3; Polakos NK, 2006, AM J PATHOL, V168, P1169, DOI 10.2353/ajpath.2006.050875; Sheth PM, 2005, J IMMUNOL, V175, P4789, DOI 10.4049/jimmunol.175.7.4789; Simeonova PP, 2001, TOXICOL APPL PHARM, V177, P112, DOI 10.1006/taap.2001.9304; Spangenberg HC, 2005, HEPATOLOGY, V42, P828, DOI 10.1002/hep.20856; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Thomas DL, 1996, J INFECT DIS, V174, P690, DOI 10.1093/infdis/174.4.690; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Valdez H, 2002, AIDS, V16, P1113, DOI 10.1097/00002030-200205240-00004; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Zhang LQ, 2002, J VIROL, V76, P5271, DOI 10.1128/JVI.76.10.5271-5273.2002	30	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3454	10.1371/journal.pone.0003454	http://dx.doi.org/10.1371/journal.pone.0003454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941622	Green Published, gold			2022-12-27	WOS:000265125600013
J	Ideses, Y; Brill-Karniely, Y; Haviv, L; Ben-Shaul, A; Bernheim-Groswasser, A				Ideses, Yaron; Brill-Karniely, Yifat; Haviv, Lior; Ben-Shaul, Avinoam; Bernheim-Groswasser, Anne			Arp2/3 Branched Actin Network Mediates Filopodia-Like Bundles Formation In Vitro	PLOS ONE			English	Article								During cellular migration, regulated actin assembly takes place at the cell leading edge, with continuous disassembly deeper in the cell interior. Actin polymerization at the plasma membrane results in the extension of cellular protrusions in the form of lamellipodia and filopodia. To understand how cells regulate the transformation of lamellipodia into filopodia, and to determine the major factors that control their transition, we studied actin self-assembly in the presence of Arp2/3 complex, WASp-VCA and fascin, the major proteins participating in the assembly of lamellipodia and filopodia. We show that in the early stages of actin polymerization fascin is passive while Arp2/3 mediates the formation of dense and highly branched aster-like networks of actin. Once filaments in the periphery of an aster get long enough, fascin becomes active, linking the filaments into bundles which emanate radially from the aster's surface, resulting in the formation of star-like structures. We show that the number of bundles nucleated per star, as well as their thickness and length, is controlled by the initial concentration of Arp2/3 complex ([Arp2/3]). Specifically, we tested several values of [Arp2/3] and found that for given initial concentrations of actin and fascin, the number of bundles per star, as well as their length and thickness are larger when [Arp2/3] is lower. Our experimental findings can be interpreted and explained using a theoretical scheme which combines Kinetic Monte Carlo simulations for aster growth, with a simple mechanistic model for bundles' formation and growth. According to this model, bundles emerge from the aster's (sparsely branched) surface layer. Bundles begin to form when the bending energy associated with bringing two filaments into contact is compensated by the energetic gain resulting from their fascin linking energy. As time evolves the initially thin and short bundles elongate, thus reducing their bending energy and allowing them to further associate and create thicker bundles, until all actin monomers are consumed. This process is essentially irreversible on the time scale of actin polymerization. Two structural parameters, L, which is proportional to the length of filament tips at the aster periphery and b, the spacing between their origins, dictate the onset of bundling; both depending on [Arp2/3]. Cells may use a similar mechanism to regulate filopodia formation along the cell leading edge. Such a mechanism may allow cells to have control over the localization of filopodia by recruiting specific proteins that regulate filaments length (e. g., Dia2) to specific sites along lamellipodia.	[Ideses, Yaron; Haviv, Lior; Bernheim-Groswasser, Anne] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Brill-Karniely, Yifat; Ben-Shaul, Avinoam] Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel	Ben Gurion University; Hebrew University of Jerusalem	Ideses, Y (corresponding author), Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel.	bernheim@bgu.ac.il	Brill-Karniely, Yifat/GSO-2750-2022; Bernheim, Anne/AAM-5969-2020	Bernheim-Groswasser, Anne/0000-0003-3999-6098; Brill-Karniely, Yifat/0000-0002-8842-9105	Joseph and May Winston Foundation Career Development Chair in Chemical Engineering; Israel Cancer Association [20070020B]; Israel Science Foundation [551/04, 659/06]; US-Israel Binational Science Foundation [2006-401]	Joseph and May Winston Foundation Career Development Chair in Chemical Engineering; Israel Cancer Association; Israel Science Foundation(Israel Science Foundation); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	A.B.G. wishes to thank the Joseph and May Winston Foundation Career Development Chair in Chemical Engineering, the Israel Cancer Association (grant No. 20070020B) and the Israel Science Foundation (grant No. 551/04) for financial support. A.B.S. thanks the US-Israel Binational Science Foundation (BSF grant 2006-401), and the Israel Science Foundation (ISF grant 659/06) for financial support. The Fritz Haber research center, where the calculations were carried out, is supported by the Minerva foundation, Germany.	Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; Atilgan E, 2006, BIOPHYS J, V90, P65, DOI 10.1529/biophysj.105.071480; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Haviv L, 2006, P NATL ACAD SCI USA, V103, P4906, DOI 10.1073/pnas.0508269103; Haviv L, 2008, EUR BIOPHYS J BIOPHY, V37, P447, DOI 10.1007/s00249-007-0236-1; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Le Y, 2006, BIOPHYS J, V90, P4295, DOI 10.1529/biophysj.105.076968; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Ono S, 1997, J BIOL CHEM, V272, P2527; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Resch GP, 2002, J CELL SCI, V115, P1877; Schafer DA, 2004, NATURE, V430, P734, DOI 10.1038/430734a; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Takenawa T, 2001, J CELL SCI, V114, P1801; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Yang L, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021911	34	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2008	3	9							e3297	10.1371/journal.pone.0003297	http://dx.doi.org/10.1371/journal.pone.0003297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MN	18820726	Green Published, Green Submitted, gold			2022-12-27	WOS:000264432500007
J	McDevitt, JJ; Milton, DK; Rudnick, SN; First, MW				McDevitt, James J.; Milton, Donald K.; Rudnick, Stephen N.; First, Melvin W.			Inactivation of Poxviruses by Upper-Room UVC Light in a Simulated Hospital Room Environment	PLOS ONE			English	Article							ULTRAVIOLET GERMICIDAL IRRADIATION; SERRATIA-MARCESCENS; RELATIVE-HUMIDITY; TRANSMISSION; SENSITIVITY; SMALLPOX; EFFICACY; AIR; BCG	In the event of a smallpox outbreak due to bioterrorism, delays in vaccination programs may lead to significant secondary transmission. In the early phases of such an outbreak, transmission of smallpox will take place especially in locations where infected persons may congregate, such as hospital emergency rooms. Air disinfection using upper-room 254 nm (UVC) light can lower the airborne concentrations of infective viruses in the lower part of the room, and thereby control the spread of airborne infections among room occupants without exposing occupants to a significant amount of UVC. Using vaccinia virus aerosols as a surrogate for smallpox we report on the effectiveness of air disinfection, via upper-room UVC light, under simulated real world conditions including the effects of convection, mechanical mixing, temperature and relative humidity. In decay experiments, upper-room UVC fixtures used with mixing by a conventional ceiling fan produced decreases in airborne virus concentrations that would require additional ventilation of more than 87 air changes per hour. Under steady state conditions the effective air changes per hour associated with upper-room UVC ranged from 18 to 1000. The surprisingly high end of the observed range resulted from the extreme susceptibility of vaccinia virus to UVC at low relative humidity and use of 4 UVC fixtures in a small room with efficient air mixing. Increasing the number of UVC fixtures or mechanical ventilation rates resulted in greater fractional reduction in virus aerosol and UVC effectiveness was higher in winter compared to summer for each scenario tested. These data demonstrate that upper-room UVC has the potential to greatly reduce exposure to susceptible viral aerosols. The greater survival at baseline and greater UVC susceptibility of vaccinia under winter conditions suggest that while risk from an aerosol attack with smallpox would be greatest in winter, protective measures using UVC may also be most efficient at this time. These data may also be relevant to influenza, which also has improved aerosol survival at low RH and somewhat similar sensitivity to UVC.	[McDevitt, James J.; Milton, Donald K.; Rudnick, Stephen N.; First, Melvin W.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Milton, Donald K.] Univ Massachusetts, Dept Work Environm, Lowell, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Lowell	McDevitt, JJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	Donald_Milton@uml.edu	Milton, Donald K/G-3286-2010	Milton, Donald K/0000-0002-0550-7834	NIH [R21AI053522]; NIEHS Center [P30ES000002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI053522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grant R21AI053522 "Prevention of airborne smallpox transmission" and by NIEHS Center grant P30ES000002.	Brickner PW, 2003, PUBLIC HEALTH REP, V118, P99, DOI 10.1016/S0033-3549(04)50225-X; CINCINNATI OH, 2008, THRESHOLD LIMIT VALU, P144; First M. W, 1999, ASHRAE T, V105, P877; First M, 2007, J OCCUP ENVIRON HYG, V4, P321, DOI 10.1080/15459620701271693; First MW, 2005, J OCCUP ENVIRON HYG, V2, P285, DOI 10.1080/15459620590952224; First MW N.E., 1999, T AM SOC HEAT REFRIG, V105, P869; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Ko G, 2000, TUBERCLE LUNG DIS, V80, P217, DOI 10.1054/tuld.2000.0249; McDevitt JJ, 2007, APPL ENVIRON MICROB, V73, P5760, DOI 10.1128/AEM.00110-07; Nicas M, 1999, Appl Occup Environ Hyg, V14, P317; RILEY RL, 1972, APPL MICROBIOL, V23, P1113, DOI 10.1128/AEM.23.6.1113-1120.1972; RILEY RL, 1976, AM REV RESPIR DIS, V113, P413; Rudnick SN, 2003, INDOOR AIR, V13, P237, DOI 10.1034/j.1600-0668.2003.00189.x; Rudnick SN, 2007, J OCCUP ENVIRON HYG, V4, P352, DOI 10.1080/15459620701298167; SATTAR AS, 1987, CRC CRIT R ENVIRON, V17, P88; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; WEHRLE PF, 1970, B WORLD HEALTH ORGAN, V43, P669; Xu P, 2005, ENVIRON SCI TECHNOL, V39, P9656, DOI 10.1021/es0504892; Xu P, 2003, ATMOS ENVIRON, V37, P405, DOI 10.1016/S1352-2310(02)00825-7	20	35	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3186	10.1371/journal.pone.0003186	http://dx.doi.org/10.1371/journal.pone.0003186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KD	18781204	Green Published, Green Submitted, gold			2022-12-27	WOS:000264425700012
J	Enoch, MA; Shen, PH; Ducci, F; Yuan, QP; Liu, JX; White, KV; Albaugh, B; Hodgkinson, CA; Goldman, D				Enoch, Mary-Anne; Shen, Pei-Hong; Ducci, Francesca; Yuan, Qiaoping; Liu, Jixia; White, Kenneth V.; Albaugh, Bernard; Hodgkinson, Colin A.; Goldman, David			Common Genetic Origins for EEG, Alcoholism and Anxiety: The Role of CRH-BP	PLOS ONE			English	Article								The resting EEG is a dynamic index of cortical activation, cognitive function and consciousness and is therefore an intermediate phenotype for many behaviors in which arousal is implicated such as anxiety and alcoholism. We performed a dense whole genome linkage scan using 3878 unlinked SNPs in a large pedigree derived from a population isolate sample of 328 Plains American Indians. Alpha (8-13 Hz), theta (4-8 Hz) and beta (13-30 Hz) EEG power was heritable (0.58-0.27) and stable over a 2 year period (r = 0.82-0.53). Genetic correlations between frequency bands were high (0.75). Linkage peaks for EEG power in all three frequency bands converged on chromosome 5q13-14 with genome-wide significant LOD scores of 3.5 (empirical p<0.0001) for alpha and beta power. A logical candidate gene, corticotropin releasing hormone-binding protein (CRH-BP), was located at the apex of these convergent linkage peaks. CRH-BP was significantly associated with alpha power in the Plains Indians and also in a replication sample of 188 Caucasians. Moreover, the same SNPs and haplotypes, located within the CRH-BP haplotype block, were also associated with anxiety disorders in the Plains Indians and alcohol use disorders in the Caucasians. CRH-BP modulates CRH which influences cortical and hippocampal EEG activity and is the primary mediator of the neuroendocrine stress response. Our results suggest a likely role for CRH-BP in stress-related alcoholism and highlight the use of the resting EEG as an intermediate phenotype for arousal-related behaviors such as anxiety and addiction.	[Enoch, Mary-Anne; Shen, Pei-Hong; Ducci, Francesca; Yuan, Qiaoping; Liu, Jixia; White, Kenneth V.; Hodgkinson, Colin A.; Goldman, David] NIAAA, Neurogenet Lab, NIH, Bethesda, MD USA; [Albaugh, Bernard] Ctr Human Behav Studies Inc, Weatherford, OK USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Enoch, MA (corresponding author), NIAAA, Neurogenet Lab, NIH, Bethesda, MD USA.	maenoch@niaaa.nih.gov	Goldman, David/F-9772-2010; Majid, Salma/AAT-2616-2020	Goldman, David/0000-0002-1724-5405; Majid, Salma/0000-0002-1724-5405; Shen, Pei-Hong/0000-0002-8031-9374; Yuan, Qiaoping/0000-0002-5880-8702; Hodgkinson, Colin/0000-0002-5365-8119	Intramural Research Program of NIAAA, NIH; Office of Research on Minority Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301, ZIAAA000281, ZIAAA000280] Funding Source: NIH RePORTER	Intramural Research Program of NIAAA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Office of Research on Minority Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Intramural Research Program of NIAAA, NIH, and in part by the Office of Research on Minority Health.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Anokhin AP, 2006, BIOL PSYCHOL, V71, P289, DOI 10.1016/j.biopsycho.2005.06.004; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Bauer LO, 2001, NEUROPSYCHOPHARMACOL, V25, P332, DOI 10.1016/S0893-133X(01)00236-6; Behan DP, 1997, J NEUROCHEM, V68, P2053; BERRIDGE CW, 1994, BRAIN RES BULL, V35, P597, DOI 10.1016/0361-9230(94)90174-0; Bruijnzeel AW, 2005, BRAIN RES REV, V49, P505, DOI 10.1016/j.brainresrev.2005.01.007; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Chan RKW, 2000, NEUROSCIENCE, V101, P115, DOI 10.1016/S0306-4522(00)00322-5; Chapman CA, 1999, J NEUROSCI, V19, P8637; Coles M. G. H., 1986, PSYCHOPHYSIOLOGY SYS, P183; COPPOLA R, 1979, ELECTROEN CLIN NEURO, V46, P224, DOI 10.1016/0013-4694(79)90073-7; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Edgar JC, 2005, EVENT RELATED POTENT; EHLERS CL, 1990, BIOL PSYCHIAT, V27, P631, DOI 10.1016/0006-3223(90)90531-6; Enoch MA, 1999, ALCOHOL CLIN EXP RES, V23, P1312, DOI 10.1111/j.1530-0277.1999.tb04352.x; Feige B, 2005, J NEUROPHYSIOL, V93, P2864, DOI 10.1152/jn.00721.2004; Finn PR, 1999, ALCOHOL CLIN EXP RES, V23, P256, DOI 10.1111/j.1530-0277.1999.tb04108.x; Gelernter J, 2007, BIOL PSYCHIAT, V61, P119, DOI 10.1016/j.biopsych.2006.08.023; Ghosh S, 2003, AM J MED GENET B, V118B, P66, DOI 10.1002/ajmg.b.10057; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Guiard BP, 2008, INT J NEUROPSYCHOPH, V11, P625, DOI 10.1017/S1461145707008383; Hodgkinson CA, 2008, ALCOHOL ALCOHOLISM, V43, P505, DOI 10.1093/alcalc/agn032; Hughes SW, 2007, INT J PSYCHOPHYSIOL, V64, P3, DOI 10.1016/j.ijpsycho.2006.08.004; Jedema HP, 2004, J NEUROSCI, V24, P9703, DOI 10.1523/JNEUROSCI.2830-04.2004; Karolyi IJ, 1999, P NATL ACAD SCI USA, V96, P11595, DOI 10.1073/pnas.96.20.11595; KOZELKA JW, 1990, J CLIN NEUROPHYSIOL, V7, P191, DOI 10.1097/00004691-199004000-00004; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Leal SM, 2005, HUM HERED, V60, P119, DOI 10.1159/000088914; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; Miller R, 2007, INT J PSYCHOPHYSIOL, V64, P18, DOI 10.1016/j.ijpsycho.2006.07.009; Niedermeyer E, 1993, ELECTROENCEPHALOGRAP, P97; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; ORNSTEIN K, 1987, J NEURAL TRANSM, V70, P183, DOI 10.1007/BF01253597; PAGE ME, 1993, NEUROSCI LETT, V164, P81, DOI 10.1016/0304-3940(93)90862-F; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; POLLOCK VE, 1991, ELECTROEN CLIN NEURO, V79, P20, DOI 10.1016/0013-4694(91)90152-T; Porjesz B, 2002, P NATL ACAD SCI USA, V99, P3729, DOI 10.1073/pnas.052716399; Rangaswamy M, 2004, INT J PSYCHOPHYSIOL, V51, P239, DOI 10.1016/j.ijpsycho.2003.09.003; Rangaswamy M, 2003, ALCOHOL CLIN EXP RES, V27, P607, DOI 10.1097/01.ALC.0000060523.95470.8F; Rangaswamy M, 2002, BIOL PSYCHIAT, V52, P831, DOI 10.1016/S0006-3223(02)01362-8; SALINSKY MC, 1991, ELECTROEN CLIN NEURO, V79, P382, DOI 10.1016/0013-4694(91)90203-G; Smit CM, 2006, INT J PSYCHOPHYSIOL, V61, P235, DOI 10.1016/j.ijpsycho.2005.10.004; Smit DJA, 2005, PSYCHOPHYSIOLOGY, V42, P691, DOI 10.1111/j.1469-8986.2005.00352.x; STEINLEIN O, 1992, GENOMICS, V12, P69, DOI 10.1016/0888-7543(92)90408-K; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tang YQ, 2007, BEHAV GENET, V37, P302, DOI 10.1007/s10519-006-9133-0; Ungless MA, 2003, NEURON, V39, P401, DOI 10.1016/S0896-6273(03)00461-6; van Beijsterveldt CEM, 2002, BIOL PSYCHOL, V61, P111, DOI 10.1016/S0301-0511(02)00055-8; vanBeijsterveldt CEM, 1996, AM J HUM GENET, V58, P562; VOGEL F, 1970, HUMANGENETIK, V10, P91, DOI 10.1007/BF00295509; Wang B, 2007, PSYCHOPHARMACOLOGY, V193, P283, DOI 10.1007/s00213-007-0782-3; Westphal NJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1878, DOI 10.2741/1931; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Woods RJ, 1999, J CLIN ENDOCR METAB, V84, P2788, DOI 10.1210/jc.84.8.2788; Woods RJ, 1997, J CLIN ENDOCR METAB, V82, P1566, DOI 10.1210/jc.82.5.1566; Zietsch BP, 2007, BIOL PSYCHOL, V75, P154, DOI 10.1016/j.biopsycho.2007.01.004	58	72	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3620	10.1371/journal.pone.0003620	http://dx.doi.org/10.1371/journal.pone.0003620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974851	Green Published, gold, Green Submitted			2022-12-27	WOS:000265131700032
J	Busuttil, RA; Munoz, DP; Garcia, AM; Rodier, F; Kim, WH; Suh, Y; Hasty, P; Campisi, J; Vijg, J				Busuttil, Rita A.; Munoz, Denise P.; Garcia, Ana Maria; Rodier, Francis; Kim, Woo Ho; Suh, Yousin; Hasty, Paul; Campisi, Judith; Vijg, Jan			Effect of Ku80 Deficiency on Mutation Frequencies and Spectra at a LacZ Reporter Locus in Mouse Tissues and Cells	PLOS ONE			English	Article							STRAND BREAK REPAIR; STEM-CELLS; DNA; ACCUMULATION; SENESCENCE; CANCER; CAPACITY; DELETION; BRAIN; LIVER	Non-homologous end joining (NHEJ) is thought to be an important mechanism for preventing the adverse effects of DNA double strand breaks (DSBs) and its absence has been associated with premature aging. To investigate the effect of inactivated NHEJ on spontaneous mutation frequencies and spectra in vivo and in cultured cells, we crossed a Ku80-deficient mouse with mice harboring a lacZ-plasmid-based mutation reporter. We analyzed various organs and tissues, as well as cultured embryonic fibroblasts, for mutations at the lacZ locus. When comparing mutant with wild-type mice, we observed a significantly higher number of genome rearrangements in liver and spleen and a significantly lower number of point mutations in liver and brain. The reduced point mutation frequency was not due to a decrease in small deletion mutations thought to be a hallmark of NHEJ, but could be a consequence of increased cellular responses to unrepaired DSBs. Indeed, we found a substantial increase in persistent 53BP1 and gamma H2AX DNA damage foci in Ku80(-/-) as compared to wild-type liver. Treatment of cultured Ku80-deficient or wild-type embryonic fibroblasts, either proliferating or quiescent, with hydrogen peroxide or bleomycin showed no differences in the number or type of induced genome rearrangements. However, after such treatment, Ku80-deficient cells did show an increased number of persistent DNA damage foci. These results indicate that Ku80-dependent repair of DNA damage is predominantly error-free with the effect of alternative more error-prone pathways creating genome rearrangements only detectable after extended periods of time, i.e., in young adult animals. The observed premature aging likely results from a combination of increased cellular senescence and an increased load of stable, genome rearrangements.	[Busuttil, Rita A.; Munoz, Denise P.; Campisi, Judith; Vijg, Jan] Buck Inst Age Res, Novato, CA USA; [Garcia, Ana Maria] Univ Texas, Dept Biol, San Antonio, TX USA; [Rodier, Francis; Campisi, Judith] Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA USA; [Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Suh, Yousin] Albert Einstein Coll Med, Dept Med, Bronx, NY USA; [Hasty, Paul] Univ Texas, Hlth Sci Ctr, Dept Mol Med, San Antonio, TX USA	Buck Institute for Research on Aging; University of Texas System; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Seoul National University (SNU); Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Health San Antonio	Busuttil, RA (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.	jvijg@aecom.yu.edu	Kim, Wooho/G-3703-2011	Hasty, Paul/0000-0003-3046-0131; Rodier, Francis/0000-0003-2523-309X	NIH [AG17242]; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by NIH program project grant AG17242.	Andressoo JO, 2006, CELL CYCLE, V5, P2886, DOI 10.4161/cc.5.24.3565; Bau DT, 2004, CANCER RES, V64, P5013, DOI 10.1158/0008-5472.CAN-04-0403; BISHOP JM, 1995, GENE DEV, V9, P1309, DOI 10.1101/gad.9.11.1309; BOERRIGTER METI, 1995, NATURE, V377, P657, DOI 10.1038/377657a0; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Busuttil RA, 2006, DNA REPAIR, V5, P52, DOI 10.1016/j.dnarep.2005.07.006; Busuttil RA, 2005, CANCER RES, V65, P11271, DOI 10.1158/0008-5472.CAN-05-2980; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Busuttil RA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000876; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431; Dolle MET, 2002, GENOME RES, V12, P1732, DOI 10.1101/gr.125502; Dolle MET, 2002, NUCLEIC ACIDS RES, V30, P545, DOI 10.1093/nar/30.2.545; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Garcia Ana Maria, 2007, Methods Mol Biol, V371, P267; Hasty P, 2004, AGING CELL, V3, P55, DOI 10.1111/j.1474-9728.2004.00082.x; Honma M, 2007, DNA REPAIR, V6, P781, DOI 10.1016/j.dnarep.2007.01.004; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; Narayanan L, 1997, P NATL ACAD SCI USA, V94, P3122, DOI 10.1073/pnas.94.7.3122; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Suh Y, 2002, NAT MED, V8, P3, DOI 10.1038/nm0102-3; Suh YS, 2000, CANCER RES, V60, P5067; Vijg J, 2005, AGING CELL, V4, P331, DOI 10.1111/j.1474-9726.2005.00179.x; Vijg J., 2007, AGING GENOME; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Wei K, 2002, TRENDS MOL MED, V8, P346, DOI 10.1016/S1471-4914(02)02359-6; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020	39	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3458	10.1371/journal.pone.0003458	http://dx.doi.org/10.1371/journal.pone.0003458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941635	Green Published, Green Submitted, gold			2022-12-27	WOS:000265125600016
J	Puiu, D; Salzberg, SL				Puiu, Daniela; Salzberg, Steven L.			Re-Assembly of the Genome of Francisella tularensis Subsp holarctica OSU18	PLOS ONE			English	Article								Francisella tularensis is a highly infectious human intracellular pathogen that is the causative agent of tularemia. It occurs in several major subtypes, including the live vaccine strain holarctica (type B). F. tularensis is classified as category A biodefense agent in part because a relatively small number of organisms can cause severe illness. Three complete genomes of subspecies holarctica have been sequenced and deposited in public archives, of which OSU18 was the first and the only strain for which a scientific publication has appeared [1]. We re-assembled the OSU18 strain using both de novo and comparative assembly techniques, and found that the published sequence has two large inversion mis-assemblies. We generated a corrected assembly of the entire genome along with detailed information on the placement of individual reads within the assembly. This assembly will provide a more accurate basis for future comparative studies of this pathogen.	[Puiu, Daniela; Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Puiu, D (corresponding author), Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	salzberg@umd.edu	Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011	Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432	US Department of Homeland Security Science and Technology Directorate [W81XWH-05-2-0051, NBCH2070002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	US Department of Homeland Security Science and Technology Directorate(United States Department of Homeland Security (DHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by the US Department of Homeland Security Science and Technology Directorate under awards W81XWH-05-2-0051 and NBCH2070002.	Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Enserink M, 2008, SCIENCE, V321, P898, DOI 10.1126/science.321.5891.898; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Petrosino JF, 2006, J BACTERIOL, V188, P6977, DOI 10.1128/JB.00506-06; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Phillippy AM, 2007, PLOS COMPUT BIOL, V3, P887, DOI 10.1371/journal.pcbi.0030098; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Salzberg SL, 2004, PLOS BIOL, V2, P1273, DOI 10.1371/journal.pbio.0020285; Salzberg SL, 2005, BIOINFORMATICS, V21, P4320, DOI 10.1093/bioinformatics/bti769; Schatz MC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r34; White JR, 2008, BIOINFORMATICS, V24, P462, DOI 10.1093/bioinformatics/btm632	16	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3427	10.1371/journal.pone.0003427	http://dx.doi.org/10.1371/journal.pone.0003427			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927608	Green Published, gold, Green Submitted			2022-12-27	WOS:000265122400003
J	Palmeira, VF; Kneipp, LF; Rozental, S; Alviano, CS; Santos, ALS				Palmeira, Vanila F.; Kneipp, Lucimar F.; Rozental, Sonia; Alviano, Celuta S.; Santos, Andre L. S.			Beneficial Effects of HIV Peptidase Inhibitors on Fonsecaea pedrosoi: Promising Compounds to Arrest Key Fungal Biological Processes and Virulence	PLOS ONE			English	Article							SECRETED ASPARTYL PROTEINASES; CANDIDA-ALBICANS; ANTIRETROVIRAL THERAPY; IN-VITRO; PROTEASE INHIBITORS; CHROMOBLASTOMYCOSIS; COMBINATION; INDINAVIR; PATHOGEN; CRYPTOSPORIDIUM	Background: Fonsecaea pedrosoi is the principal etiologic agent of chromoblastomycosis, a fungal disease whose pathogenic events are poorly understood. Current therapy for chromoblastomycosis is suboptimal due to toxicity of the available therapeutic agents and the emergence of drug resistance. Compounding these problems is the fact that endemic countries and regions are economically poor. Purpose and Principal Findings: In the present work, we have investigated the effect of human immunodeficiency virus (HIV) peptidase inhibitors (PIs) on the F. pedrosoi conidial secreted peptidase, growth, ultrastructure and interaction with different mammalian cells. All the PIs impaired the acidic conidial-derived peptidase activity in a dose-dependent fashion, in which nelfinavir produced the best inhibitory effect. F. pedrosoi growth was also significantly reduced upon exposure to PIs, especially nelfinavir and saquinavir. PIs treatment caused profound changes in the conidial ultrastructure as shown by transmission electron microscopy, including invaginations in the cytoplasmic membrane, disorder and detachment of the cell wall, enlargement of fungi cytoplasmic vacuoles, and abnormal cell division. The synergistic action on growth ability between nelfinavir and amphotericin B, when both were used at sub-inhibitory concentrations, was also observed. PIs reduced the adhesion and endocytic indexes during the interaction between conidia and epithelial cells (CHO), fibroblasts or macrophages, in a cell type-dependent manner. Moreover, PIs interfered with the conidia into mycelia transformation when in contact with CHO and with the susceptibility killing by macrophage cells. Conclusions/Significance: Overall, by providing the first evidence that HIV PIs directly affects F. pedrosoi development and virulence, these data add new insights on the wide-spectrum efficacy of HIV PIs, further arguing for the potential chemotherapeutic targets for aspartyl-type peptidase produced by this human pathogen.	[Palmeira, Vanila F.; Santos, Andre L. S.] Univ Fed Rio de Janeiro, CCS, Lab Estudos Integrados Bioquim Microbiana, Dept Microbiol Geral,IMPPG, Rio De Janeiro, Brazil; [Palmeira, Vanila F.; Alviano, Celuta S.] Univ Fed Rio de Janeiro, CCS, Dept Microbiol Geral, Lab Estrutura Microrganismos, Rio De Janeiro, Brazil; [Kneipp, Lucimar F.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Taxonom, Bioquim Bioprospeccao Fungos, Rio De Janeiro, Brazil; [Rozental, Sonia] Univ Fed Rio de Janeiro, CCS, IBCCF, Lab Biol Celular Fungos, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Palmeira, VF (corresponding author), Univ Fed Rio de Janeiro, CCS, Lab Estudos Integrados Bioquim Microbiana, Dept Microbiol Geral,IMPPG, Rio De Janeiro, Brazil.	andre@micro.ufrj.br	Alviano, Celuta/V-3878-2019; Santos, André/Z-5853-2019; Rozental, Sonia/A-8537-2013; KNEIPP, LUCIMAR/AAK-5141-2020	Alviano, Celuta/0000-0002-0806-6712; Santos, André/0000-0003-0821-8592; Rozental, Sonia/0000-0002-3659-5945; 	MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro); FUJB (Fundacao Universitaria Jose Bonifacio); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FUJB (Fundacao Universitaria Jose Bonifacio); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Brazilian agencies: MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro), FUJB (Fundacao Universitaria Jose Bonifacio) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior).	Alviano CS, 1999, GLYCOCONJUGATE J, V16, P545, DOI 10.1023/A:1007078106280; Alviano DS, 2004, ARCH MICROBIOL, V181, P278, DOI 10.1007/s00203-004-0653-9; Andrade TS, 2004, MYCOSES, V47, P216, DOI 10.1111/j.1439-0507.2004.00984.x; Andrews L, 2000, INFECT DIS CLIN N AM, V14, P901, DOI 10.1016/S0891-5520(05)70139-2; Atzori C, 2003, J ANTIMICROB CHEMOTH, V52, P276, DOI 10.1093/jac/dkg314; Blasi E, 2004, FEMS IMMUNOL MED MIC, V42, P187, DOI 10.1016/j.femsim.2004.05.001; Bobin S, 1998, PATHOL BIOL, V46, P418; Bonifaz A, 1997, INT J DERMATOL, V36, P542, DOI 10.1046/j.1365-4362.1997.00085.x; BUROKERKILGORE M, 1993, ANAL BIOCHEM, V208, P387, DOI 10.1006/abio.1993.1066; Casolari C, 2004, PHARMACOL RES, V50, P605, DOI 10.1016/j.phrs.2004.06.008; Cassone A, 1999, J INFECT DIS, V180, P448, DOI 10.1086/314871; Dash C, 2003, CRIT REV BIOCHEM MOL, V38, P89, DOI 10.1080/713609213; De Hoog GS, 2000, MED MYCOL, V38, P243, DOI 10.1080/mmy.38.s1.243.250; Esterre F, 2000, CLIN DIAGN LAB IMMUN, V7, P497, DOI 10.1128/CDLI.7.3.497-500.2000; Esterre P, 1996, AM J TROP MED HYG, V55, P45, DOI 10.4269/ajtmh.1996.55.45; FARBIARZ SR, 1990, J MED VET MYCOL, V28, P373; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Gallagher JC, 2003, EXPERT OPIN PHARMACO, V4, P147, DOI 10.1517/eoph.4.2.147.21077; Gruber A, 1999, IMMUNOBIOLOGY, V201, P133, DOI 10.1016/S0171-2985(99)80052-7; Gruber A, 1999, IMMUNOPHARMACOLOGY, V41, P227, DOI 10.1016/S0162-3109(99)00035-1; Gupta AK, 2002, MED MYCOL, V40, P529; Hommer V, 2003, J ANTIMICROB CHEMOTH, V52, P359, DOI 10.1093/jac/dkg357; Kneipp LF, 2004, MICROBIOL-SGM, V150, P3355, DOI 10.1099/mic.0.27405-0; Korting HC, 1999, ANTIMICROB AGENTS CH, V43, P2038, DOI 10.1128/AAC.43.8.2038; Kwon-Chung KJ, 1992, CHROMOBLASTOMYCOSIS, P337; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Limongi CL, 1997, MYCOPATHOLOGIA, V138, P127, DOI 10.1023/A:1006841529438; Limongi CL, 2001, MED MYCOL, V39, P429, DOI 10.1080/714031051; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malhotra U, 2000, J INFECT DIS, V181, P121, DOI 10.1086/315202; Manfredi R, 2003, INT J ANTIMICROB AG, V22, P449, DOI 10.1016/S0924-8579(03)00113-4; Marques SA, 2000, MED MYCOL, V38, P269, DOI 10.1080/mmy.38.s1.269.279; Martinez RL, 2007, CLIN DERMATOL, V25, P188, DOI 10.1016/j.clindermatol.2006.05.007; Mastroianni CM, 1999, AIDS, V13, P883, DOI 10.1097/00002030-199905280-00003; Mezzaroma I, 1999, AIDS, V13, P1187, DOI 10.1097/00002030-199907090-00006; Monari C, 2005, J INFECT DIS, V191, P307, DOI 10.1086/426828; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; OLIVEIRA LG, 1983, REV SOC BRAS MED TRO, V7, P7; Palmeira VF, 2006, RES MICROBIOL, V157, P819, DOI 10.1016/j.resmic.2006.07.003; Palmeira VF, 2006, FEMS IMMUNOL MED MIC, V46, P21, DOI 10.1111/j.1574-695X.2005.00003.x; Pernerstorfer-Schoen H, 2001, AIDS, V15, P725, DOI 10.1097/00002030-200104130-00008; Poirriez J, 2000, AM J TROP MED HYG, V63, P61, DOI 10.4269/ajtmh.2000.63.61; Porter S R, 1998, Oral Dis, V4, P159; Powderly WG, 1998, JAMA-J AM MED ASSOC, V280, P72, DOI 10.1001/jama.280.1.72; Rippon JW., 1988, MED MYCOLOGY PATHOGE, P276; ROZENTAL S, 1994, MYCOPATHOLOGIA, V126, P85, DOI 10.1007/BF01146200; RUCHEL R, 1990, ZBL BAKT-INT J MED M, V273, P391; Saag MS, 1998, CURR CLIN TOPICS INF, V18, P154; Santos ALS, 2007, FEMS MICROBIOL REV, V31, P570, DOI 10.1111/j.1574-6976.2007.00077.x; Savoia D, 2005, INT J ANTIMICROB AG, V26, P92, DOI 10.1016/j.ijantimicag.2005.04.003	51	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3382	10.1371/journal.pone.0003382	http://dx.doi.org/10.1371/journal.pone.0003382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852883	Green Published, Green Submitted, gold			2022-12-27	WOS:000265121600007
J	Chen, JN; Kinter, M; Shank, S; Cotton, C; Kelley, TJ; Ziady, AG				Chen, Junnan; Kinter, Michael; Shank, Samuel; Cotton, Calvin; Kelley, Thomas J.; Ziady, Assem G.			Dysfunction of Nrf-2 in CF Epithelia Leads to Excess Intracellular H2O2 and Inflammatory Cytokine Production	PLOS ONE			English	Article								Cystic fibrosis is characterized by recurring pulmonary exacerbations that lead to the deterioration of lung function and eventual lung failure. Excessive inflammatory responses by airway epithelia have been linked to the overproduction of the inflammatory cytokine IL-6 and IL-8. The mechanism by which this occurs is not fully understood, but normal IL-1 beta mediated activation of the production of these cytokines occurs via H2O2 dependent signaling. Therefore, we speculated that CFTR dysfunction causes alterations in the regulation of steady state H2O2. We found significantly elevated levels of H2O2 in three cultured epithelial cell models of CF, one primary and two immortalized. Increases in H2O2 heavily contributed to the excessive IL-6 and IL-8 production in CF epithelia. Proteomic analysis of three in vitro and two in vivo models revealed a decrease in antioxidant proteins that regulate H2O2 processing, by >= 2 fold in CF vs. matched normal controls. When cells are stimulated, differential expression in CF versus normal is enhanced; corresponding to an increase in H2O2 mediated production of IL-6 and IL-8. The cause of this redox imbalance is a decrease by similar to 70% in CF cells versus normal in the expression and activity of the transcription factor Nrf-2. Inhibition of CFTR function in normal cells produced this phenotype, while N-acetyl cysteine, selenium, an activator of Nrf-2, and the overexpression of Nrf-2 all normalized H2O2 processing and decreased IL-6 and IL-8 to normal levels, in CF cells. We conclude that a paradoxical decrease in Nrf-2 driven antioxidant responses in CF epithelia results in an increase in steady state H2O2, which in turn contributes to the overproduction of the pro-inflammatory cytokines IL-6 and IL-8. Treatment with antioxidants can ameliorate exaggerated cytokine production without affecting normal responses.	[Chen, Junnan; Shank, Samuel; Cotton, Calvin; Kelley, Thomas J.; Ziady, Assem G.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Kinter, Michael] Oklahoma Med Res Fdn, Free Radical Biol & Aging Res Program, Oklahoma City, OK USA	Case Western Reserve University; Oklahoma Medical Research Foundation	Ziady, AG (corresponding author), Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA.	agz2@case.edu		Kinter, Michael/0000-0001-7409-8918	Cystic Fibrosis Foundation Therapeutic Inc. [ZIADY-Y03FGO]	Cystic Fibrosis Foundation Therapeutic Inc.	This work was supported by a grant from the Cystic Fibrosis Foundation Therapeutic Inc. (ZIADY-Y03FGO).	ARMITAGE P, 2002, STAT METHODS MED RES, P307; Beyer TA, 2007, CELL DEATH DIFFER, V14, P1250, DOI 10.1038/sj.cdd.4402133; Blackwell TS, 2001, AM J PHYSIOL-LUNG C, V281, pL69, DOI 10.1152/ajplung.2001.281.1.L69; Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; HAYASHI T, 1993, J BIOL CHEM, V268, P11380; Ionescu AA, 2002, AM J RESP CRIT CARE, V165, P495, DOI 10.1164/ajrccm.165.4.2104065; Iwasaki K, 2007, J BIOL CHEM, V282, P22335, DOI 10.1074/jbc.M701477200; Jones KL, 2000, PEDIATR PULM, V30, P79, DOI 10.1002/1099-0496(200008)30:2<79::AID-PPUL1>3.0.CO;2-1; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kinter M., 2000, PROTEIN SEQUENCING I, DOI 10.1002/0471721980; Kraynack NC, 2002, AM J PHYSIOL-LUNG C, V283, pL604, DOI 10.1152/ajplung.00459.2001; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Li Q, 2006, J BIOL CHEM, V281, P1495, DOI 10.1074/jbc.M511153200; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Muhlebach MS, 1999, AM J RESP CRIT CARE, V160, P186, DOI 10.1164/ajrccm.160.1.9808096; Musial J, 2001, INT J CARDIOL, V77, P247, DOI 10.1016/S0167-5273(00)00439-3; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Oermann CM, 1999, CHEST, V115, P1053, DOI 10.1378/chest.115.4.1053; Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Pervaiz S, 2002, BIOCHEM BIOPH RES CO, V290, P1145, DOI 10.1006/bbrc.2001.6274; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Pollard HB, 2006, MOL CELL PROTEOMICS, V5, P1628, DOI 10.1074/mcp.M600091-MCP200; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Rowinsky EK, 1999, J CLIN ONCOL, V17, P3631, DOI 10.1200/JCO.1999.17.11.3631; Roxo-Rosa M, 2006, PROTEOMICS, V6, P2314, DOI 10.1002/pmic.200500273; Sakoda K, 2006, J DENT RES, V85, P520, DOI 10.1177/154405910608500608; Schwarzer C, 2007, FREE RADICAL BIO MED, V43, P300, DOI 10.1016/j.freeradbiomed.2007.04.015; SHAPIRO BL, 1989, LIFE SCI, V44, P1327, DOI 10.1016/0024-3205(89)90389-5; Sigal N, 2003, J BIOL CHEM, V278, P4854, DOI 10.1074/jbc.M211011200; van Heeckeren AM, 2004, AM J PHYSIOL-LUNG C, V287, pL944, DOI 10.1152/ajplung.00387.2003; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; White NM, 2007, AM J PHYSIOL-LUNG C, V292, pL476, DOI 10.1152/ajplung.00262.2006; Wright Jeffrey G, 2003, Am J Respir Med, V2, P211; Yao H, 2007, BIOCHEM SOC T, V35, P1151, DOI 10.1042/BST0351151; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974	47	80	82	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3367	10.1371/journal.pone.0003367	http://dx.doi.org/10.1371/journal.pone.0003367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846238	Green Published, gold, Green Submitted			2022-12-27	WOS:000265114500007
J	Meulle, A; Salles, B; Daviaud, D; Valet, P; Muller, C				Meulle, Aline; Salles, Bernard; Daviaud, Daniele; Valet, Philippe; Muller, Catherine			Positive Regulation of DNA Double Strand Break Repair Activity during Differentiation of Long Life Span Cells: The Example of Adipogenesis	PLOS ONE			English	Article								Little information is available on the ability of terminally differentiated cells to efficiently repair DNA double strand breaks (DSBs), and one might reasonably speculate that efficient DNA repair of these threatening DNA lesions, is needed in cells of long life span with no or limited regeneration from precursor. Few tissues are available besides neurons that allow the study of DNA DSBs repair activity in very long-lived cells. Adipocytes represent a suitable model since it is generally admitted that there is a very slow turnover of adipocytes in adult. Using both Pulse Field Gel Electrophoresis (PFGE) and the disappearance of the phosphorylated form of the histone variant H2AX, we demonstrated that the ability to repair DSBs is increased during adipocyte differentiation using the murine pre-adipocyte cell line, 3T3F442A. In mammalian cells, DSBs are mainly repaired by the non-homologous end-joining pathway (NHEJ) that relies on the DNA dependent protein kinase (DNA-PK) activity. During the first 24 h following the commitment into adipogenesis, we show an increase in the expression and activity of the catalytic sub-unit of the DNA-PK complex, DNA-PKcs. The increased in DNA DSBs repair activity observed in adipocytes was due to the increase in DNA-PK activity as shown by the use of DNA-PK inhibitor or sub-clones of 3T3F442A deficient in DNA-PKcs using long term RNA interference. Interestingly, the up-regulation of DNA-PK does not regulate the differentiation program itself. Finally, similar positive regulation of DNA-PKcs expression and activity was observed during differentiation of primary culture of pre-adipocytes isolated from human sub-cutaneous adipose tissue. Our results show that DNA DSBs repair activity is up regulated during the early commitment into adipogenesis due to an up-regulation of DNA-PK expression and activity. In opposition to the general view that DNA DSBs repair is decreased during differentiation, our results demonstrate that an up-regulation of this process might be observed in post-mitotic long-lived cells.	[Meulle, Aline; Salles, Bernard; Daviaud, Daniele; Valet, Philippe; Muller, Catherine] Univ Toulouse, Toulouse, France; [Meulle, Aline; Salles, Bernard; Muller, Catherine] Inst Pharmacol & Structural Biol, CNRS, UMR 5089, Toulouse, France; [Daviaud, Daniele; Valet, Philippe] INSERM, U858 Equipe 3, Toulouse, France	Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm)	Meulle, A (corresponding author), Univ Toulouse, Toulouse, France.	salles@ipbs.fr; muller@ipbs.fr	Valet, Philippe/N-7472-2017; Meulle, Aline/M-6370-2014; MULLER, Catherine/E-2060-2011; MULLER, Catherine/M-2185-2018	Valet, Philippe/0000-0001-6520-7393; 	Canceropole Grand Sud-Ouest; Institut National du Cancer [PL2006_035]; Electricite de France; Ligue Nationale contre le Cancer	Canceropole Grand Sud-Ouest; Institut National du Cancer(Institut National du Cancer (INCA) France); Electricite de France; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	This work was supported by the Canceropole Grand Sud-Ouest, the Institut National du Cancer (INCA grants PL2006_035), the Electricite de France and the Ligue Nationale contre le Cancer (Equipe Labelisee) (AM, BS and CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Ader I, 2002, ONCOGENE, V21, P6471, DOI 10.1038/sj.onc.1205838; AJMANI AK, 1995, J EXP MED, V181, P2049, DOI 10.1084/jem.181.6.2049; Audebert M, 2006, J MOL BIOL, V356, P257, DOI 10.1016/j.jmb.2005.11.028; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Biard DSF, 2005, MOL CANCER RES, V3, P519, DOI 10.1158/1541-7786.MCR-05-0044; Boulton S, 1996, CARCINOGENESIS, V17, P2285, DOI 10.1093/carcin/17.11.2285; Bouquet F, 2006, CELL CYCLE, V5, P1116, DOI 10.4161/cc.5.10.2799; Bour S, 2007, BIOCHIMIE, V89, P916, DOI 10.1016/j.biochi.2007.02.013; Bracker TU, 2006, STEM CELLS, V24, P722, DOI 10.1634/stemcells.2005-0227; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; CEDERVALL B, 1995, RADIAT RES, V143, P8, DOI 10.2307/3578920; Costes SV, 2006, RADIAT RES, V165, P505, DOI 10.1667/RR3538.1; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; Engeli S, 2004, J LIPID RES, V45, P1640, DOI 10.1194/jlr.M300322-JLR200; FARMER SR, 2006, P NATL ACAD SCI USA, V99, P15345; FINNIE NJ, 1995, P NATL ACAD SCI USA, V92, P320, DOI 10.1073/pnas.92.1.320; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Friedberg EC, 2004, CURR OPIN GENET DEV, V14, P5, DOI 10.1016/j.gde.2003.11.001; Gobbel GT, 2003, BRAIN RES, V980, P221, DOI 10.1016/S0006-8993(03)02977-9; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Jeggo PA, 2006, DNA REPAIR, V5, P1192, DOI 10.1016/j.dnarep.2006.05.011; Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064; Kubota N, 1998, CANCER LETT, V133, P161, DOI 10.1016/S0304-3835(98)00221-3; Latella L, 2004, MOL CELL BIOL, V24, P6350, DOI 10.1128/MCB.24.14.6350-6361.2004; Lee SE, 1997, MOL CELL BIOL, V17, P1425, DOI 10.1128/MCB.17.3.1425; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; MERLO D, 2005, CELL, V72, P131; Muller C, 1998, NUCLEIC ACIDS RES, V26, P1382, DOI 10.1093/nar/26.6.1382; Muller C, 2001, ONCOGENE, V20, P4373, DOI 10.1038/sj.onc.1204571; MURRAY D, 1987, RADIAT RES, V109, P153, DOI 10.2307/3576876; Nawrocki AR, 2005, DRUG DISCOV TODAY, V10, P1219, DOI 10.1016/S1359-6446(05)03569-5; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; Nouspikel T, 2007, NEUROSCIENCE, V145, P1213, DOI 10.1016/j.neuroscience.2006.07.006; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Nowak E, 2006, RADIAT RES, V165, P155, DOI 10.1667/RR3496.1; Okayasu R, 1998, RADIAT RES, V149, P440, DOI 10.2307/3579783; Price BD, 1996, CANCER RES, V56, P246; Ren KQ, 2002, J NEUROCHEM, V80, P949, DOI 10.1046/j.0022-3042.2002.00776.x; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Sjakste N, 2007, EUR J HISTOCHEM, V51, P81; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Stenerlow B, 2003, RADIAT RES, V159, P502, DOI 10.1667/0033-7587(2003)159[0502:MOPDDS]2.0.CO;2; Tabocchini MA, 2000, MUTAT RES-DNA REPAIR, V461, P71, DOI 10.1016/S0921-8777(00)00041-0; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; WETERINGS E, 2004, J CELL BIOL; WETERINGS E, 2007, J CELL BIOL; Wyman C, 2004, CURR BIOL, V14, pR629, DOI 10.1016/j.cub.2004.07.049; Xu WM, 2000, NAT CELL BIOL, V2, P339, DOI 10.1038/35014028; ZHANG WW, 1992, BIOCHEM BIOPH RES CO, V186, P574, DOI 10.1016/S0006-291X(05)80847-2	58	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3345	10.1371/journal.pone.0003345	http://dx.doi.org/10.1371/journal.pone.0003345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846213	Green Published, Green Submitted, gold			2022-12-27	WOS:000265114500002
J	Camacho, CJ				Camacho, Carlos J.			Quantitative Modeling of Currents from a Voltage Gated Ion Channel Undergoing Fast Inactivation	PLOS ONE			English	Article								Ion channels play a central role in setting gradients of ion concentration and electrostatic potentials, which in turn regulate sensory systems and other functions. Based on the structure of the open configuration of the Kv1.2 channel and the suggestion that the two ends of the N-terminal inactivating peptide form a bivalent complex that simultaneously blocks the channel pore and binds to the cytoplasmic T1 domain, we propose a six state kinetic model that for the first time reproduces the kinetics of recovery of the Drosophila Shaker over the full range of time scales and hyperpolarization potentials, including tail currents. The model is motivated by a normal mode analysis of the inactivated channel that suggests that a displacement consistent with models of the closed state propagates to the T1 domain via the S1-T1 linker. This motion stretches the bound (inactivating) peptide, hastening the unblocking of the pore. This pulling force is incorporated into the rates of the open to blocked states, capturing the fast recovery phase of the current for repolarization events shorter than 1 ms. If the membrane potential is hyperpolarized, essential dynamics further suggests that the T1 domain returns to a configuration where the peptide is unstretched and the S1-T1 linker is extended. Coupling this novel hyperpolarized substate to the closed, open and blocked pore states is enough to quantitatively estimate the number of open channels as a function of time and membrane potential. A straightforward prediction of the model is that a slow ramping of the potential leads to very small currents.	[Camacho, Carlos J.] Univ Pittsburgh, Dept Computat Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Camacho, CJ (corresponding author), Univ Pittsburgh, Dept Computat Biol, Pittsburgh, PA 15260 USA.	ccamacho@pitt.edu			National Science Foundation [MCB-0444291/0744077]; Direct For Biological Sciences [0744077] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation MCB-0444291/0744077. NSF played no role in this research.	ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Camacho CJ, 2005, BIOINFORMATICS, V21, P2534, DOI 10.1093/bioinformatics/bti322; Camacho CJ, 2001, P NATL ACAD SCI USA, V98, P10636, DOI 10.1073/pnas.181147798; CHEN CF, 1990, J GEN PHYSIOL, V96, P603, DOI 10.1085/jgp.96.3.603; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P473, DOI 10.1113/jphysiol.1952.sp004718; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Johnstone DB, 1997, NEURON, V19, P151, DOI 10.1016/S0896-6273(00)80355-4; Kuo CC, 1997, J NEUROSCI, V17, P3436; Kurata HT, 2002, J BIOL CHEM, V277, P29045, DOI 10.1074/jbc.M111470200; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Rodriguez BM, 1996, NEUROPHARMACOLOGY, V35, P775, DOI 10.1016/0028-3908(96)00111-6; Roux MJ, 1998, J GEN PHYSIOL, V111, P625, DOI 10.1085/jgp.111.5.625; Shrivastava IH, 2006, BIOPHYS J, V90, P3929, DOI 10.1529/biophysj.105.080093; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Valadie H, 2003, J MOL BIOL, V332, P657, DOI 10.1016/S0022-2836(03)00851-9; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	34	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3342	10.1371/journal.pone.0003342	http://dx.doi.org/10.1371/journal.pone.0003342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833322	gold, Green Accepted, Green Published			2022-12-27	WOS:000264797400010
J	van Raalten, TR; Ramsey, NF; Duyn, J; Jansma, JM				van Raalten, Tamar R.; Ramsey, Nick F.; Duyn, Jeff; Jansma, Johan M.			Practice Induces Function-Specific Changes in Brain Activity	PLOS ONE			English	Article							VERBAL WORKING-MEMORY; DUAL-TASK INTERFERENCE; EVENT-RELATED FMRI; SHORT-TERM-MEMORY; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; CORTICAL ACTIVITY; COGNITIVE TASK; MRI; PERFORMANCE	Background: Practice can have a profound effect on performance and brain activity, especially if a task can be automated. Tasks that allow for automatization typically involve repeated encoding of information that is paired with a constant response. Much remains unknown about the effects of practice on encoding and response selection in an automated task. Methodology: To investigate function-specific effects of automatization we employed a variant of a Sternberg task with optimized separation of activity associated with encoding and response selection by means of m-sequences. This optimized randomized event-related design allows for model free measurement of BOLD signals over the course of practice. Brain activity was measured at six consecutive runs of practice and compared to brain activity in a novel task. Principal Findings: Prompt reductions were found in the entire cortical network involved in encoding after a single run of practice. Changes in the network associated with response selection were less robust and were present only after the third run of practice. Conclusions/Significance: This study shows that automatization causes heterogeneous decreases in brain activity across functional regions that do not strictly track performance improvement. This suggests that cognitive performance is supported by a dynamic allocation of multiple resources in a distributed network. Our findings may bear importance in understanding the role of automatization in complex cognitive performance, as increased encoding efficiency in early stages of practice possibly increases the capacity to otherwise interfering information.	[van Raalten, Tamar R.; Ramsey, Nick F.] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [van Raalten, Tamar R.] Univ Med Ctr Utrecht, Dept Child & Adolescent Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Duyn, Jeff] NIH, NINDS, Lab Mol Funct Imag, Bethesda, MD USA; [Jansma, Johan M.] NIH, NIMH, Sect Neuroimag Mood & Anxiety Disorders, Bethesda, MD USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	van Raalten, TR (corresponding author), Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	t.vanraalten@umcutrecht.nl	Duyn, Jozef H/F-2483-2010	Lauwereyns, Jan/0000-0003-0551-2550; ramsey, nick/0000-0002-7136-259X	Netherlands Organisation for Scientific Research; Utrecht University [016.036.401]; Organisation for Scientific Research [R-95-405]; Foundation de Drie Lichten in the Netherlands; NIH, NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003027, ZIANS003027] Funding Source: NIH RePORTER	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Utrecht University; Organisation for Scientific Research; Foundation de Drie Lichten in the Netherlands(Netherlands Government); NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was sponsored by Netherlands Organisation for Scientific Research and Utrecht University, Grant 016.036.401, Netherlands, Organisation for Scientific Research Travel Grant R-95-405 and by Foundation de Drie Lichten in the Netherlands. This research was supported (in part) by the Intramural Research Program of the NIH, NINDS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura M, 2007, PSYCHIAT RES-NEUROIM, V154, P103, DOI 10.1016/j.pscychresns.2006.08.002; Bedwell JS, 2005, INT J NEUROSCI, V115, P1017, DOI 10.1080/00207450590901530; BODURKA J, 2004, SCALABLE MULTICHANNE; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Bor D, 2007, CEREB CORTEX, V17, P778, DOI 10.1093/cercor/bhk035; BRUDER H, 1992, MAGNET RESON MED, V23, P311, DOI 10.1002/mrm.1910230211; Cairo TA, 2004, COGNITIVE BRAIN RES, V21, P377, DOI 10.1016/j.cogbrainres.2004.06.014; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; Chen SHA, 2005, NEUROPSYCHOLOGIA, V43, P1227, DOI 10.1016/j.neuropsychologia.2004.12.015; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; de Zwart JA, 2002, MAGNET RESON MED, V47, P1218, DOI 10.1002/mrm.10169; DEZWART J, 2004, SIGNAL NOISE RATIO P; Garavan H, 2000, MICROSC RES TECHNIQ, V51, P54, DOI 10.1002/1097-0029(20001001)51:1<54::AID-JEMT6>3.0.CO;2-J; Habeck C, 2005, COGNITIVE BRAIN RES, V23, P207, DOI 10.1016/j.cogbrainres.2004.10.010; Jansma JM, 2007, HUM BRAIN MAPP, V28, P431, DOI 10.1002/hbm.20297; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; Jonides J, 2004, NAT NEUROSCI, V7, P10, DOI 10.1038/nn0104-10; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Kassubek J, 2001, COGNITIVE BRAIN RES, V10, P207, DOI 10.1016/S0926-6410(00)00037-9; Kellman P, 2003, NEUROIMAGE, V19, P190, DOI 10.1016/S1053-8119(03)00056-9; Kelly AMC, 2006, NEUROIMAGE, V31, P866, DOI 10.1016/j.neuroimage.2006.01.008; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kirschen MP, 2005, NEUROIMAGE, V24, P462, DOI 10.1016/j.neuroimage.2004.08.036; Koch K, 2006, BRAIN RES, V1107, P140, DOI 10.1016/j.brainres.2006.06.003; Landau SM, 2004, NEUROIMAGE, V22, P211, DOI 10.1016/j.neuroimage.2004.01.003; Manoach DS, 2003, NEUROIMAGE, V20, P1670, DOI 10.1016/j.neuroimage.2003.08.002; Manoach DS, 1997, NEUROREPORT, V8, P545, DOI 10.1097/00001756-199701200-00033; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; Masterman DL, 1997, J PSYCHOPHARMACOL, V11, P107, DOI 10.1177/026988119701100203; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Poldrack RA, 1998, CEREB CORTEX, V8, P1, DOI 10.1093/cercor/8.1.1; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Ramsey NF, 2004, BRAIN, V127, P517, DOI 10.1093/brain/awh060; Ruthruff E, 2006, PSYCHOL RES-PSYCH FO, V70, P125, DOI 10.1007/s00426-004-0192-7; Ruthruff E, 2001, J EXP PSYCHOL HUMAN, V27, P3, DOI 10.1037/0096-1523.27.1.3; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Rypma B, 2006, NEUROSCIENCE, V139, P223, DOI 10.1016/j.neuroscience.2005.07.062; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Toni I, 1998, NEUROIMAGE, V8, P50, DOI 10.1006/nimg.1998.0349; Westerberg H, 2007, PHYSIOL BEHAV, V92, P186, DOI 10.1016/j.physbeh.2007.05.041; Woodward TS, 2006, NEUROSCIENCE, V139, P317, DOI 10.1016/j.neuroscience.2005.05.043	49	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3270	10.1371/journal.pone.0003270	http://dx.doi.org/10.1371/journal.pone.0003270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RU	18827897	Green Submitted, Green Published, gold			2022-12-27	WOS:000264797200001
J	Naganawa, S; Yokoyama, M; Shiino, T; Suzuki, T; Ishigatsubo, Y; Ueda, A; Shirai, A; Takeno, M; Hayakawa, S; Sato, S; Tochikubo, O; Kiyoura, S; Sawada, K; Ikegami, T; Kanda, T; Kitamura, K; Sato, H				Naganawa, Satoshi; Yokoyama, Masaru; Shiino, Teiichiro; Suzuki, Takeyuki; Ishigatsubo, Yoshiaki; Ueda, Atsuhisa; Shirai, Akira; Takeno, Mitsuhiro; Hayakawa, Satoshi; Sato, Shigehiro; Tochikubo, Osamu; Kiyoura, Shingo; Sawada, Kaori; Ikegami, Takashi; Kanda, Tadahito; Kitamura, Katsuhiko; Sato, Hironori			Net Positive Charge of HIV-1 CRF01_AE V3 Sequence Regulates Viral Sensitivity to Humoral Immunity	PLOS ONE			English	Article								The third variable region (V3) of the human immunodeficiency virus type 1 (HIV-1) envelope gp120 subunit participates in determination of viral infection coreceptor tropism and host humoral immune responses. Positive charge of the V3 plays a key role in determining viral coreceptor tropism. Here, we examined by bioinformatics, experimental, and protein modelling approaches whether the net positive charge of V3 sequence regulates viral sensitivity to humoral immunity. We chose HIV-1 CRF01_AE strain as a model virus to address the question. Diversity analyses using CRF01_AE V3 sequences from 37 countries during 1984 and 2005 (n=1361) revealed that reduction in the V3's net positive charge makes V3 less variable due to limited positive selection. Consistently, neutralization assay using CRF01_AE V3 recombinant viruses (n=30) showed that the reduction in the V3's net positive charge rendered HIV-1 less sensitive to neutralization by the blood anti-V3 antibodies. The especially neutralization resistant V3 sequences were the particular subset of the CCR5-tropic V3 sequences with net positive charges of +2 to +4. Molecular dynamics simulation of the gp120 monomers showed that the V3's net positive charge regulates the V3 configuration. This and reported gp120 structural data predict a less-exposed V3 with a reduced net positive charge in the native gp120 trimer context. Taken together, these data suggest a key role of the V3's net positive charge in the immunological escape and coreceptor tropism evolution of HIV-1 CRF01_AE in vivo. The findings have molecular implications for the adaptive evolution and vaccine design of HIV-1.	[Naganawa, Satoshi; Tochikubo, Osamu; Kitamura, Katsuhiko] Yokohama City Univ, Sch Med, Dept Publ Hlth, Kanagawa, Japan; [Yokoyama, Masaru; Kanda, Tadahito; Sato, Hironori] Natl Inst Infect Dis, Ctr Pathogen Genom, Tokyo, Japan; [Shiino, Teiichiro] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Suzuki, Takeyuki; Ishigatsubo, Yoshiaki; Ueda, Atsuhisa; Takeno, Mitsuhiro] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Kanagawa, Japan; [Shirai, Akira] Yokohama City Univ, Sch Med, Coll Nursing, Kanagawa, Japan; [Naganawa, Satoshi; Hayakawa, Satoshi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Tokyo, Japan; [Sato, Shigehiro] Iwate Med Univ, Dept Bacteriol, Iwate, Japan; [Kiyoura, Shingo] SGI Japan Ltd, Tokyo, Japan; [Sawada, Kaori; Ikegami, Takashi] Ryoka Syst Inc, Tokyo, Japan	Yokohama City University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Yokohama City University; Yokohama City University; Nihon University; Iwate Medical University	Naganawa, S (corresponding author), Yokohama City Univ, Sch Med, Dept Publ Hlth, Kanagawa, Japan.				Ministry of Health, Labor and Welfare for HIV/AIDS research; IMAI Memorial Trust for AIDS Research, Japan	Ministry of Health, Labor and Welfare for HIV/AIDS research; IMAI Memorial Trust for AIDS Research, Japan	This work was supported by grants from the Ministry of Health, Labor and Welfare for HIV/AIDS research, and the IMAI Memorial Trust for AIDS Research, Japan.	Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; BONHOEFFER S, 1995, NATURE, V376, P125, DOI 10.1038/376125a0; BOUHABIB DC, 1994, J VIROL, V68, P6006, DOI 10.1128/JVI.68.9.6006-6013.1994; Burton DR, 1997, P NATL ACAD SCI USA, V94, P10018, DOI 10.1073/pnas.94.19.10018; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cavacini LA, 2002, AIDS, V16, P2409, DOI 10.1097/00002030-200212060-00005; Chabot DJ, 2000, J VIROL, V74, P4404, DOI 10.1128/JVI.74.9.4404-4413.2000; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; CORNELISSEN M, 1995, J VIROL, V69, P1810, DOI 10.1128/JVI.69.3.1810-1818.1995; Desrosiers RC, 1999, NAT MED, V5, P723, DOI 10.1038/10439; Fouts TR, 1997, J VIROL, V71, P2779, DOI 10.1128/JVI.71.4.2779-2785.1997; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Ida S, 1997, AIDS RES HUM RETROV, V13, P1597, DOI 10.1089/aid.1997.13.1597; Kato K, 1999, J VIROL, V73, P5520, DOI 10.1128/JVI.73.7.5520-5526.1999; Kusagawa S, 2002, AIDS RES HUM RETROV, V18, P115, DOI 10.1089/08892220252779656; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; MILICH L, 1993, J VIROL, V67, P5623, DOI 10.1128/JVI.67.9.5623-5634.1993; MOORE JP, 1995, J VIROL, V69, P101, DOI 10.1128/JVI.69.1.101-109.1995; NEI M, 1986, MOL BIOL EVOL, V3, P418; Oka T, 2007, J VIROL, V81, P6798, DOI 10.1128/JVI.02840-06; OTA T, 1994, MOL BIOL EVOL, V11, P613; Parren PWHI, 1998, J VIROL, V72, P3512, DOI 10.1128/JVI.72.5.3512-3519.1998; PAU CP, 1993, AIDS, V7, P337, DOI 10.1097/00002030-199303000-00005; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; PRATT RD, 1995, J INFECT DIS, V172, P851, DOI 10.1093/infdis/172.3.851; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sato H, 1999, VIROLOGY, V257, P491, DOI 10.1006/viro.1999.9670; Sato H, 1999, J VIROL, V73, P3551, DOI 10.1128/JVI.73.5.3551-3559.1999; Sato H, 2001, J VIROL, V75, P5604, DOI 10.1128/JVI.75.12.5604-5613.2001; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Shannon CE, 1997, M D COMPUT, V14, P306; Shiino T, 2000, J VIROL, V74, P1069, DOI 10.1128/JVI.74.3.1069-1078.2000; SIMMONDS P, 1990, J VIROL, V64, P5840, DOI 10.1128/JVI.64.12.5840-5850.1990; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Song H, 2007, J VIROL, V81, P7280, DOI 10.1128/JVI.00406-07; Speck RF, 1997, J VIROL, V71, P7136, DOI 10.1128/JVI.71.9.7136-7139.1997; STAMATATOS L, 1995, J VIROL, V69, P6191, DOI 10.1128/JVI.69.10.6191-6198.1995; TAJIMA F, 1989, GENETICS, V123, P585; Yamaguchi Y, 1997, P NATL ACAD SCI USA, V94, P1264, DOI 10.1073/pnas.94.4.1264; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	48	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3206	10.1371/journal.pone.0003206	http://dx.doi.org/10.1371/journal.pone.0003206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787705	Green Published, gold, Green Submitted			2022-12-27	WOS:000264426200011
J	Hadchouel, A; Decobert, F; Franco-Montoya, ML; Halphen, I; Jarreau, PH; Boucherat, O; Martin, E; Benachi, A; Amselem, S; Bourbon, J; Danan, C; Delacourt, C				Hadchouel, Alice; Decobert, Fabrice; Franco-Montoya, Marie-Laure; Halphen, Isabelle; Jarreau, Pierre-Henri; Boucherat, Olivier; Martin, Emmanuel; Benachi, Alexandra; Amselem, Serge; Bourbon, Jacques; Danan, Claude; Delacourt, Christophe			Matrix Metalloproteinase Gene Polymorphisms and Bronchopulmonary Dysplasia: Identification of MMP16 as a New Player in Lung Development	PLOS ONE			English	Article							PREMATURE-INFANTS; EXPRESSION; ACTIVATION; INHIBITORS; PROMOTER; MT1-MMP; PRETERM; AIRWAYS	Backgound: Alveolarization requires coordinated extracellular matrix remodeling, a process in which matrix metalloproteinases (MMPs) play an important role. We postulated that polymorphisms in MMP genes might affect MMP function in preterm lungs and thus influence the risk of bronchopulmonary dysplasia (BPD). Methods and Findings: Two hundred and eighty-four consecutive neonates with a gestational age of,28 weeks were included in this prospective study. Forty-five neonates developed BPD. Nine single-nucleotide polymorphisms (SNPs) were sought in the MMP2, MMP14 and MMP16 genes. After adjustment for birth weight and ethnic origin, the TT genotype of MMP16 C/T (rs2664352) and the GG genotype of MMP16 A/G (rs2664349) were found to protect from BPD. These genotypes were also associated with a smaller active fraction of MMP2 and with a 3-fold-lower MMP16 protein level in tracheal aspirates collected within 3 days after birth. Further evaluation of MMP16 expression during the course of normal human and rat lung development showed relatively low expression during the canalicular and saccular stages and a clear increase in both mRNA and protein levels during the alveolar stage. In two newborn rat models of arrested alveolarization the lung MMP16 mRNA level was less than 50% of normal. Conclusions: MMP16 may be involved in the development of lung alveoli. MMP16 polymorphisms appear to influence not only the pulmonary expression and function of MMP16 but also the risk of BPD in premature infants.	[Hadchouel, Alice; Decobert, Fabrice; Franco-Montoya, Marie-Laure; Halphen, Isabelle; Boucherat, Olivier; Benachi, Alexandra; Bourbon, Jacques; Danan, Claude; Delacourt, Christophe] IMRB, INSERM, U841, Equipe 06, Creteil, France; [Hadchouel, Alice; Decobert, Fabrice; Franco-Montoya, Marie-Laure; Halphen, Isabelle; Jarreau, Pierre-Henri; Boucherat, Olivier; Benachi, Alexandra; Bourbon, Jacques; Danan, Claude; Delacourt, Christophe] PremUp, Paris, France; [Decobert, Fabrice; Danan, Claude] Ctr Hosp Intercommunal, Creteil, France; [Jarreau, Pierre-Henri] Hop Cochin, AP HP, Serv Med Neonatale Port Royal, Paris, France; [Martin, Emmanuel] IntegraGen, Evry, France; [Benachi, Alexandra] Hop Necker Enfants Malad, AP HP, Serv Obstet Gynecol, Paris, France; [Amselem, Serge] GH Armand Trousseau, INSERM, U654, Paris, France; [Danan, Claude] Ctr Hosp Intercommunal, Unite Fonctionnelle Rech Clin, Creteil, France; [Delacourt, Christophe] Univ Paris 12, Fac Med, IFR10, Creteil, France; [Jarreau, Pierre-Henri] Univ Paris 05, Fac Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite	Hadchouel, A (corresponding author), IMRB, INSERM, U841, Equipe 06, Creteil, France.	christophe.delacourt@chicreteil.fr	Delacourt, Christophe/K-6161-2019		INSERM Programme Hospitalier de Recherche Clinique AOR03 - Assistance Publique - Hopitaux de Paris; Association des Juniors en Pediatrie	INSERM Programme Hospitalier de Recherche Clinique AOR03 - Assistance Publique - Hopitaux de Paris; Association des Juniors en Pediatrie	INSERM Programme Hospitalier de Recherche Clinique AOR03 - Assistance Publique - Hopitaux de Paris. AH was founded by a grant from Association des Juniors en Pediatrie.	Atkinson JJ, 2005, DEV DYNAM, V232, P1079, DOI 10.1002/dvdy.20267; Bhandari V, 2006, PEDIATRICS, V117, P1901, DOI 10.1542/peds.2005-1414; Boucherat O, 2007, PHYSIOL GENOMICS, V32, P128, DOI 10.1152/physiolgenomics.00108.2007; Boucherat O, 2007, PEDIATR RES, V62, P20, DOI 10.1203/PDR.0b013e3180686cc5; Boucherat O, 2007, AM J RESP CRIT CARE, V175, P1066, DOI 10.1164/rccm.200601-050OC; Boucherat O, 2007, PLOS MED, V4, P1205, DOI 10.1371/journal.pmed.0040237; Buckley S, 2002, AM J PHYSIOL-LUNG C, V283, pL747, DOI 10.1152/ajplung.00415.2001; BURRI PH, 1984, ANNU REV PHYSIOL, V46, P617, DOI 10.1146/annurev.ph.46.030184.003153; Danan C, 2002, AM J RESP CRIT CARE, V165, P1384, DOI 10.1164/rccm.200112-134BC; Danan C, 2002, AM J PHYSIOL-LUNG C, V283, pL1086, DOI 10.1152/ajplung.00066.2002; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Garcia-Alvarez J, 2006, SARCOIDOSIS VASC DIF, V23, P13; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Jiang AX, 2003, J BIOL CHEM, V278, P38765, DOI 10.1074/jbc.M306618200; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kazzi S Nadya J, 2004, Pediatrics, V114, pe243, DOI 10.1542/peds.114.2.e243; Kheradmand F, 2002, J CELL SCI, V115, P839; Manar Martha H, 2004, J Perinatol, V24, P30, DOI 10.1038/sj.jp.7211020; Matsumoto SI, 1997, BBA-GENE STRUCT EXPR, V1354, P159, DOI 10.1016/S0167-4781(97)00120-6; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Price SJ, 2001, J BIOL CHEM, V276, P7549, DOI 10.1074/jbc.M010242200; Rova M, 2004, HUM MOL GENET, V13, P1095, DOI 10.1093/hmg/ddh132; Saitoh W, 2006, INT J MOL MED, V17, P621; Schulz CG, 2004, PEDIATR RES, V55, P794, DOI 10.1203/01.PDR.0000120683.68630.FB; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; TAKINO T, 1995, J BIOL CHEM, V270, P23013, DOI 10.1074/jbc.270.39.23013; Walsh LA, 2007, INT J DEV BIOL, V51, P389, DOI 10.1387/ijdb.062253lw; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204; Yu CY, 2002, CANCER RES, V62, P6430; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhou YF, 2005, CARCINOGENESIS, V26, P1117, DOI 10.1093/carcin/bgi057	31	44	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3188	10.1371/journal.pone.0003188	http://dx.doi.org/10.1371/journal.pone.0003188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784838	Green Submitted, gold, Green Published			2022-12-27	WOS:000264425900008
J	Telle, S; Thines, M				Telle, Sabine; Thines, Marco			Amplification of cox2 (similar to 620 bp) from 2 mg of Up to 129 Years Old Herbarium Specimens, Comparing 19 Extraction Methods and 15 Polymerases	PLOS ONE			English	Article							DNA EXTRACTION; SEQUENCE; PRESERVATION; PROTOCOLS	During the past years an increasing number of studies have focussed on the use of herbarium specimens for molecular phylogenetic investigations and several comparative studies have been published. However, in the studies reported so far usually rather large amounts of material (typically around 100 mg) were sampled for DNA extraction. This equals an amount roughly equivalent to 8 cm 2 of a medium thick leaf. For investigating the phylogeny of plant pathogens, such large amounts of tissue are usually not available or would irretrievably damage the specimens. Through systematic comparison of 19 DNA extraction protocols applied to only 2 mg of infected leaf tissue and testing 15 different DNA polymerases, we could successfully amplify a mitochondrial DNA region (cox2;similar to 620 bp) from herbarium specimens well over a hundred years old. We conclude that DNA extraction and the choice of DNA polymerase are crucial factors for successful PCR amplification from small samples of historic herbarium specimens. Through a combination of suitable DNA extraction protocols and DNA polymerases, only a fraction of the preserved plant material commonly used is necessary for successful PCR amplification. This facilitates the potential use of a far larger number of preserved specimens for molecular phylogenetic investigation and provides access to a wealth of genetic information in preserved in specimens deposited in herbaria around the world without reducing their scientific or historical value.	[Telle, Sabine; Thines, Marco] Univ Hohenheim, Inst Bot 210, D-7000 Stuttgart, Germany	University Hohenheim	Telle, S (corresponding author), Univ Hohenheim, Inst Bot 210, D-7000 Stuttgart, Germany.	thines@uni-hohenheim.de	Thines, Marco/H-1685-2011	Telle, Sabine/0000-0002-0584-2093	German Science Foundation (DFG)	German Science Foundation (DFG)(German Research Foundation (DFG))	This study was funded by a research grant of the German Science Foundation (DFG) granted to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aras Sumer, 2006, Turkish Journal of Botany, V30, P449; Asif MJ, 2005, PLANT MOL BIOL REP, V23, P185, DOI 10.1007/BF02772709; BRUNS TD, 1990, MYCOLOGIA, V82, P175, DOI 10.2307/3759846; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; Drabkova L, 2002, PLANT MOL BIOL REP, V20, P161, DOI 10.1007/BF02799431; Elbaum R, 2006, J ARCHAEOL SCI, V33, P77, DOI 10.1016/j.jas.2005.06.011; Erickson DL, 2005, P NATL ACAD SCI USA, V102, P18315, DOI 10.1073/pnas.0509279102; Goes-Neto A., 2005, BIOTEMAS, V18, P19, DOI [10.5007/%25x, DOI 10.5007/%25X, DOI 10.5007/%25x]; HEDGES SB, 1995, SCIENCE, V268, P1191, DOI 10.1126/science.7761839; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Hudspeth DSS, 2000, MYCOLOGIA, V92, P674, DOI 10.2307/3761425; Jankowiak K, 2005, TAXON, V54, P335, DOI 10.2307/25065361; Klintschar M, 2000, J FORENSIC SCI, V45, P669; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Lee SB, 1990, PCR PROTOCOLS GUIDE; Li WB, 2007, P NATL ACAD SCI USA, V104, P18427, DOI 10.1073/pnas.0705590104; Li WB, 2006, J MICROBIOL METH, V65, P237, DOI 10.1016/j.mimet.2005.07.014; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lister DL, 2008, TAXON, V57, P254, DOI 10.2307/25065966; May KJ, 2004, MYCOL RES, V108, P471, DOI [10.1017/S0953756204009876, 10.1017/s0953756204009876]; Mullis K, 1992, Biotechnology, V24, P17; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; PAABO S, 1985, NATURE, V314, P644, DOI 10.1038/314644a0; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Poinar H, 2003, CURR BIOL, V13, P1150, DOI 10.1016/S0960-9822(03)00450-0; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Ribeiro RA, 2007, GENET MOL RES, V6, P173; Ristaino JB, 2001, NATURE, V411, P695, DOI 10.1038/35079606; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVOLAINEN V, 1995, PLANT SYST EVOL, V197, P87, DOI 10.1007/BF00984634; Trout CL, 1997, PLANT DIS, V81, P1042, DOI 10.1094/PDIS.1997.81.9.1042; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Walters C, 2006, SEED SCI RES, V16, P169, DOI [10.1079/ssr2006246, 10.1079/SSR2006246]; WOODWARD SR, 1994, SCIENCE, V266, P1229	34	81	88	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3584	10.1371/journal.pone.0003584	http://dx.doi.org/10.1371/journal.pone.0003584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974835	gold, Green Published, Green Submitted			2022-12-27	WOS:000265131700008
J	Cao, F; Wagner, RA; Wilson, KD; Xie, XY; Fu, JD; Drukker, M; Lee, A; Li, RA; Gambhir, SS; Weissman, IL; Robbins, RC; Wu, JC				Cao, Feng; Wagner, Roger A.; Wilson, Kitchener D.; Xie, Xiaoyan; Fu, Ji-Dong; Drukker, Micha; Lee, Andrew; Li, Ronald A.; Gambhir, Sanjiv S.; Weissman, Irving L.; Robbins, Robert C.; Wu, Joseph C.			Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							DIFFERENTIATION; EXPRESSION; NETWORKS; HEART; PROTECTION; SURVIVAL; MYOCYTES; DEVELOP; REPAIR; NANOG	Human embryonic stemcells (hESCs) can serve as a potentially limitless source of cells that may enable regeneration of diseased tissue and organs. Here we investigate the use of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in promoting recovery from cardiac ischemia reperfusion injury in a mouse model. Using microarrays, we have described the hESC-CM transcriptome within the spectrum of changes that occur between undifferentiated hESCs and fetal heart cells. The hESC-CMs expressed cardiomyocyte genes at levels similar to those found in 20-week fetal heart cells, making this population a good source of potential replacement cells in vivo. Echocardiographic studies showed significant improvement in heart function by 8 weeks after transplantation. Finally, we demonstrate long-term engraftment of hESC-CMs by using molecular imaging to track cellular localization, survival, and proliferation in vivo. Taken together, global gene expression profiling of hESC differentiation enables a systems-based analysis of the biological processes, networks, and genes that drive hESC fate decisions, and studies such as this will serve as the foundation for future clinical applications of stem cell therapies.	[Cao, Feng; Wilson, Kitchener D.; Xie, Xiaoyan; Lee, Andrew; Gambhir, Sanjiv S.; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Wagner, Roger A.; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Div Cardiol, Stanford, CA 94305 USA; [Wilson, Kitchener D.; Gambhir, Sanjiv S.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Drukker, Micha; Weissman, Irving L.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Robbins, Robert C.] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Fu, Ji-Dong; Li, Ronald A.] Univ Calif Davis, Dept Cell Biol & Human Anat, Stem Cell Program, Davis, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of California System; University of California Davis	Cao, F (corresponding author), Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA.	joewu@stanford.edu	Fu, Jidong/E-8173-2012; Lee, Andrew/GVU-2817-2022; Wilson, Kitchener/A-7146-2016; Li, Ronald/E-9833-2010; Wu, Joseph/H-1067-2013	Drukker, Micha/0000-0002-4279-1125; Fu, Jidong/0000-0003-2797-5193; Wu, Joseph/0000-0002-6068-8041	BWF CAMS; Stanford Cardiovascular Institute; NIH [HL089027, CA114747, HL076445, HL72857]; CIRM [RS1-00322]; NATIONAL CANCER INSTITUTE [P50CA114747] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072857, K08HL076445, R21HL089027, R33HL089027] Funding Source: NIH RePORTER	BWF CAMS; Stanford Cardiovascular Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the BWF CAMS, Stanford Cardiovascular Institute, NIH HL089027, and CIRM RS1-00322 (JCW). This work was also supported in part by NIH CA114747 (SSG), NIH HL076445 (RAW), and NIH HL72857 (RAL).	Baker NL, 2007, ANN NEUROL, V62, P390, DOI 10.1002/ana.21213; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Collins KA, 2003, PHYSIOL GENOMICS, V13, P227, DOI 10.1152/physiolgenomics.00005.2003; CROTTI L, 2007, HUM GENET, V120, P912; Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d; Gambhir SS, 1999, NUCL MED BIOL, V26, P481, DOI 10.1016/S0969-8051(99)00021-9; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Hentschke M, 2006, J BIOL CHEM, V281, P33497, DOI 10.1074/jbc.M606975200; Holaska JM, 2006, HUM MOL GENET, V15, P3459, DOI 10.1093/hmg/ddl423; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; LEOR J, 2007, HEART, V12, P12; Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; Luo XB, 2007, J CELL PHYSIOL, V212, P358, DOI 10.1002/jcp.21030; Masaki H, 2007, J BIOL CHEM, V282, P33034, DOI 10.1074/jbc.M703245200; McMartin GA, 2003, J ANAT, V203, P369, DOI 10.1046/j.1469-7580.2003.00228.x; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Michele DE, 2002, CIRC RES, V91, P255, DOI 10.1161/01.RES.0000027530.58419.82; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; MURAGAKI Y, 1991, EUR J BIOCHEM, V197, P615, DOI 10.1111/j.1432-1033.1991.tb15951.x; Newton-Cheh C, 2007, CIRCULATION, V116, P1128, DOI 10.1161/CIRCULATIONAHA.107.710780; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; PFEFFER MA, 1995, ANNU REV MED, V46, P455, DOI 10.1146/annurev.med.46.1.455; Plaisier E, 2007, NEW ENGL J MED, V357, P2687, DOI 10.1056/NEJMoa071906; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Schulz WA, 2007, EPIGENETICS-US, V2, P37, DOI 10.4161/epi.2.1.4067; Synnergren J, 2008, STEM CELLS, V26, P1831, DOI 10.1634/stemcells.2007-1033; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; VANAMERONGEN MJ, 2008, J CELLULAR IN PRESS; Wagner RA, 2005, DEV BIOL, V288, P595, DOI 10.1016/j.ydbio.2005.09.036; WEBB GC, 1993, GENOMICS, V18, P464, DOI 10.1006/geno.1993.1505; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894	46	170	175	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3474	10.1371/journal.pone.0003474	http://dx.doi.org/10.1371/journal.pone.0003474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941512	Green Published, gold, Green Submitted			2022-12-27	WOS:000265126100005
J	Tirino, V; Desiderio, V; d'Aquino, R; De Francesco, F; Pirozzi, G; Galderisi, U; Cavaliere, C; De Rosa, A; Papaccio, G				Tirino, Virginia; Desiderio, Vincenzo; d'Aquino, Riccardo; De Francesco, Francesco; Pirozzi, Giuseppe; Galderisi, Umberto; Cavaliere, Carlo; De Rosa, Alfredo; Papaccio, Gianpaolo			Detection and Characterization of CD133(+) Cancer Stem Cells in Human Solid Tumours	PLOS ONE			English	Article								Background: Osteosarcoma is the most common primary tumour of bone. Solid tumours are made of heterogeneous cell populations, which display different goals and roles in tumour economy. A rather small cell subset can hold or acquire stem potentials, gaining aggressiveness and increasing expectancy of recurrence. The CD133 antigen is a pentaspan membrane glycoprotein, which has been proposed as a cancer stem cell marker, since it has been previously demonstrated to be capable of identifying a cancer initiating subpopulation in brain, colon, melanoma and other solid tumours. Therefore, our aim was to observe the possible presence of cells expressing the CD133 antigen within solid tumour cell lines of osteosarcoma and, then, understand their biological characteristics and performances. Methodology and Principal Findings: In this study, using SAOS2, MG63 and U2OS, three human sarcoma cell lines isolated from young Caucasian subjects, we were able to identify and characterize, among them, CD133(+) cells showing the following features: high proliferation rate, cell cycle detection in a G2\M phase, positivity for Ki-67, and expression of ABCG2 transporters. In addition, at the FACS, we were able to observe the CD133(+) cell fraction showing side population profile and forming sphere-clusters in serum-free medium with a high clonogenic efficiency. Conclusions: Taken together, our findings lead to the thought that we can assume that we have identified, for the first time, CD133(+) cells within osteosarcoma cell lines, showing many features of cancer stem cells. This can be of rather interest in order to design new therapies against the bone cancer.	[Tirino, Virginia; Desiderio, Vincenzo; d'Aquino, Riccardo; De Francesco, Francesco; Papaccio, Gianpaolo] Univ Naples 2, Sez Istol & Embriol, Dipartimento Med Sperimentale, Naples, Italy; [Pirozzi, Giuseppe] INT, Dipartimento Oncol Sperimentale, Naples, Italy; [Galderisi, Umberto] Univ Naples 2, Sez Biotecnol, Dipartimento Med Sperimentale, Naples, Italy; [Cavaliere, Carlo] Univ Naples 2, Sez Anatom Umana, Dipartimento Med Pubbl Prevent, Naples, Italy; [De Rosa, Alfredo] Ateneo Napoli 2, Dipartimento Sci Odontostomatol Ortodont Chirurg, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Tirino, V (corresponding author), Univ Naples 2, Sez Istol & Embriol, Dipartimento Med Sperimentale, Naples, Italy.	gianpaolo.papaccio@unina2.it	Cavaliere, Carlo/K-6544-2016; desiderio, vincenzo/K-4244-2018; De Francesco, Francesco/D-8080-2016; Papaccio, Gianpaolo/B-7150-2014	Cavaliere, Carlo/0000-0002-3297-2213; De Francesco, Francesco/0000-0003-2977-7828; Papaccio, Gianpaolo/0000-0002-4014-5306; desiderio, vincenzo/0000-0003-1819-6083; GALDERISI, Umberto/0000-0003-0909-7403; Tirino, Virginia/0000-0003-2731-5718	MURST (Italy); 2nd University of Naples	MURST (Italy)(Ministry of Education, Universities and Research (MIUR)); 2nd University of Naples	MURST (Italy), 2nd University of Naples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Costea DE, 2006, ORAL DIS, V12, P443, DOI 10.1111/j.1601-0825.2006.01264.x; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Fargeas CA, 2003, STEM CELLS, V21, P506, DOI 10.1634/stemcells.21-4-506; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Hirschmann-Jax C, 2005, CELL CYCLE, V4, P203; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Klein MJ, 2006, AM J CLIN PATHOL, V125, P555, DOI 10.1309/UC6KQHLD9LV2KENN; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Pascal Laura E, 2007, BMC Urol, V7, P6, DOI 10.1186/1471-2490-7-6; Pautke C, 2004, ANTICANCER RES, V24, P3743; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; RAILE K, 1994, J CELL PHYSIOL, V159, P531, DOI 10.1002/jcp.1041590317; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; TAKEUCHI Y, 1995, J CELL PHYSIOL, V162, P315, DOI 10.1002/jcp.1041620303; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Xu Z, 2006, CANCER RES, V66, P6657, DOI 10.1158/0008-5472.CAN-05-3624; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164	32	218	235	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3469	10.1371/journal.pone.0003469	http://dx.doi.org/10.1371/journal.pone.0003469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941626	Green Published, Green Submitted, gold			2022-12-27	WOS:000265125900012
J	Tilquin, M; Paris, M; Reynaud, S; Despres, L; Ravanel, P; Geremia, RA; Gury, J				Tilquin, Mathieu; Paris, Margot; Reynaud, Stephane; Despres, Laurence; Ravanel, Patrick; Geremia, Roberto A.; Gury, Jerome			Long Lasting Persistence of Bacillus thuringiensis Subsp israelensis (Bti) in Mosquito Natural Habitats	PLOS ONE			English	Article								Background: The detrimental effects of chemical insecticides on the environment and human health have lead to the call for biological alternatives. Today, one of the most promising solutions is the use of spray formulations based on Bacillus thuringiensis subsp. israelensis (Bti) in insect control programs. As a result, the amounts of Bti spread in the environment are expected to increase worldwide, whilst the common belief that commercial Bti is easily cleared from the ecosystem has not yet been clearly established. Methodology/Main Findings: In this study, we aimed to determine the nature and origin of the high toxicity toward mosquito larvae found in decaying leaf litter collected in several natural mosquito breeding sites in the Rhone-Alpes region. From the toxic fraction of the leaf litter, we isolated B. cereus-like bacteria that were further characterized as B. thuringiensis subsp. israelensis using PCR amplification of specific toxin genes. Immunological analysis of these Bti strains showed that they belong to the H14 group. We finally used amplified length polymorphism (AFLP) markers to show that the strains isolated from the leaf litter were closely related to those present in the commercial insecticide used for field application, and differed from natural worldwide genotypes. Conclusions/Significance: Our results raise the issue of the persistence, potential proliferation and environmental accumulation of human-spread Bti in natural mosquito habitats. Such Bti environmental persistence may lengthen the exposure time of insects to this bio-insecticide, thereby increasing the risk of resistance acquisition in target insects, and of a negative impact on non-target insects.	[Tilquin, Mathieu] Floralis UJF Filiale, Gieres, France; [Tilquin, Mathieu; Paris, Margot; Reynaud, Stephane; Despres, Laurence; Ravanel, Patrick; Geremia, Roberto A.; Gury, Jerome] Univ Joseph Fourier, CNRS, UMR 5553, Lab Ecol Alpine LECA, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Tilquin, M (corresponding author), Floralis UJF Filiale, Gieres, France.	roberto.geremia@ujf-grenoble.fr	Paris, Margot/AAD-1971-2020; Reynaud, Stephane/H-5493-2013; Geremia, Roberto A/A-7972-2010; Paris, Margot/C-8076-2012; Despres, Laurence/AAC-9518-2021	Paris, Margot/0000-0001-7328-3820; Reynaud, Stephane/0000-0003-0248-0602; Despres, Laurence/0000-0002-0660-6260	Floralis [0501545401]; UJF filiale [0501545401]; Region Rhone-Alps [0501545401]; Demoustication Rhone-Alps; TOXNUC	Floralis; UJF filiale; Region Rhone-Alps(Region Auvergne-Rhone-Alpes); Demoustication Rhone-Alps(Region Auvergne-Rhone-Alpes); TOXNUC	This work was supported financially by Floralis, UJF filiale, Region Rhone-Alps (grant 0501545401 to L.D.) and Demoustication Rhone-Alps (Collaborative research grant to M.P. and L.D.). Mathieu Tilquin was supported by the Grant 0501545401 from Floralis, UJF Filiale, Rhone Alpes region. Jerome Gury was supported by the TOXNUC program. The agency Demoustication Rhone Alpes provided financial support but also data (date, sites and times) on Bti spraying.	ADDISON JA, 1993, CAN J FOREST RES, V23, P2329, DOI 10.1139/x93-287; AKIBA Y, 1991, JPN J APPL ENTOMOL Z, V26, P477; BACKER N, 1993, BACILLUS THURINGIENS, P147; BenDov E, 1997, APPL ENVIRON MICROB, V63, P4883, DOI 10.1128/AEM.63.12.4883-4890.1997; Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI 10.1128/AEM.68.10.5082-5095.2002; Blanco MGM, 2002, J AM MOSQUITO CONTR, V18, P352; Boisvert M, 2000, BIOCONTROL SCI TECHN, V10, P517, DOI 10.1080/095831500750016361; Bonin A, 2005, METHOD ENZYMOL, V395, P145, DOI 10.1016/S0076-6879(05)95010-6; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Boyer S, 2007, ENVIRON TOXICOL CHEM, V26, P157, DOI 10.1897/06-205R.1; Bravo A, 1998, APPL ENVIRON MICROB, V64, P4965; Burke SA, 2004, APPL ENVIRON MICROB, V70, P2786, DOI 10.1128/AEM.70.5.2786-2790.2004; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; Damgaard PH, 1997, J APPL MICROBIOL, V82, P253, DOI 10.1111/j.1365-2672.1997.tb02859.x; David JP, 2000, J CHEM ECOL, V26, P901, DOI 10.1023/A:1005456124756; David JP, 2003, MED VET ENTOMOL, V17, P151, DOI 10.1046/j.1365-2915.2003.00432.x; David JP, 2003, MOL ECOL, V12, P1951, DOI 10.1046/j.1365-294X.2003.01870.x; David JP, 2000, J INVERTEBR PATHOL, V75, P9, DOI 10.1006/jipa.1999.4886; De Respinis S, 2006, LETT APPL MICROBIOL, V43, P495, DOI 10.1111/j.1472-765x.2006.01999.x; DELUCCA AJ, 1981, CAN J MICROBIOL, V27, P865, DOI 10.1139/m81-137; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Georghiou GP, 1997, APPL ENVIRON MICROB, V63, P1095, DOI 10.1128/AEM.63.3.1095-1101.1997; GILL SS, 1987, INFECT IMMUN, V55, P1300, DOI 10.1128/IAI.55.5.1300-1308.1987; Hajaij M, 2005, MICROB ECOL, V50, P475, DOI 10.1007/s00248-005-0247-3; Hendriksen NB, 2002, CAN J MICROBIOL, V48, P256, DOI [10.1139/w02-009, 10.1139/W02-009]; Hernandez CS, 2005, J INVERTEBR PATHOL, V88, P8, DOI 10.1016/j.jip.2004.10.006; Hill KK, 2004, APPL ENVIRON MICROB, V70, P1068, DOI 10.1128/AEM.70.2.1068-1080.2004; Ibarra JE, 2003, APPL ENVIRON MICROB, V69, P5269, DOI 10.1128/AEM.69.9.5269-5274.2003; Janssen P, 1996, MICROBIOL-UK, V142, P1881, DOI 10.1099/13500872-142-7-1881; Keto-Timonen R, 2006, J CLIN MICROBIOL, V44, P4057, DOI 10.1128/JCM.01275-06; Kokotovic B, 2007, J CLIN MICROBIOL, V45, P3921, DOI 10.1128/JCM.00906-07; Maduell P, 2008, MICROB ECOL, V55, P212, DOI 10.1007/s00248-007-9268-4; MARTIN WF, 1989, BACILLUS THURINGIENS; NAAVON A, 2000, ENTOMOPATHOGENIC BAC, P355; Nester E., 2002, 100 YEARS BACILLUS T; Nguyen TTH, 1999, J VECTOR ECOL, V24, P138; Pattanayak D, 2000, WORLD J MICROB BIOT, V16, P667, DOI 10.1023/A:1008936127319; PEARSON D, 1987, BIOTECHNOL LETT, V9, P771, DOI 10.1007/BF01028282; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Porcar M, 2000, J APPL MICROBIOL, V89, P309, DOI 10.1046/j.1365-2672.2000.01115.x; Raymond M., 1993, PROBIT CNRS UMII; Regis L, 2001, TRENDS PARASITOL, V17, P377, DOI 10.1016/S1471-4922(01)01953-5; Ryu C, 2005, APPL ENVIRON MICROB, V71, P4664, DOI 10.1128/AEM.71.8.4664-4671.2005; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Smits PH, 1997, BCPC SYMP SER, P21; THOMAS WE, 1983, FEBS LETT, V154, P362, DOI 10.1016/0014-5793(83)80183-5; Tilquin M, 2002, J CHEM ECOL, V28, P1497, DOI 10.1023/A:1019920310315; Tilquin M, 2002, J AGR FOOD CHEM, V50, P6378, DOI 10.1021/jf0205155; TILQUIN M, 2002, ACTIVE INSECTICIDE M; Van der Zwet WC, 2000, J CLIN MICROBIOL, V38, P4131, DOI 10.1128/JCM.38.11.4131-4136.2000; van Rossem MC, 2007, J HOSP INFECT, V67, P142, DOI 10.1016/j.jhin.2007.07.018; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Whatmore AM, 2005, J CLIN MICROBIOL, V43, P761, DOI 10.1128/JCM.43.2.761-769.2005; *WHO, 1985, TDRBCVSPHAERICUS853; *WHO, 1999, 114 WHO, P217; WHO (World Health Organization), 2020, 22 WHO; Wirth MC, 2005, APPL ENVIRON MICROB, V71, P185, DOI 10.1128/AEM.71.1.185-189.2005	58	50	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3432	10.1371/journal.pone.0003432	http://dx.doi.org/10.1371/journal.pone.0003432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941501	gold, Green Published, Green Submitted			2022-12-27	WOS:000265125600002
J	Derikx, JPM; Matthijsen, RA; de Bruine, AP; van Bijnen, AA; Heineman, E; van Dam, RM; Dejong, CHC; Buurman, WA				Derikx, Joep P. M.; Matthijsen, Robert A.; de Bruine, Adriaan P.; van Bijnen, Annemarie A.; Heineman, Erik; van Dam, Ronald M.; Dejong, Cornelis H. C.; Buurman, Wim A.			Rapid Reversal of Human Intestinal Ischemia-Reperfusion Induced Damage by Shedding of Injured Enterocytes and Reepithelialisation	PLOS ONE			English	Article								Intestinal ischemia-reperfusion (IR) is a phenomenon related to physiological conditions (e.g. exercise, stress) and to pathophysiological events (e.g. acute mesenteric ischemia, aortic surgery). Although intestinal IR has been studied extensively in animals, results remain inconclusive and data on human intestinal IR are scarce. Therefore, an experimental harmless model for human intestinal IR was developed, enabling us to clarify the sequelae of human intestinal IR for the first time. Methods and Findings: In 30 patients undergoing pancreatico-duodenectomy we took advantage of the fact that in this procedure a variable length of jejunum is removed. Isolated jejunum (5 cm) was subjected to 30 minutes ischemia followed by reperfusion. Intestinal Fatty Acid Binding Protein (I-FABP) arteriovenous concentration differences across the bowel segment were measured before and after ischemia to assess epithelial cell damage. Tissue sections were collected after ischemia and at 25, 60 and 120 minutes reperfusion and stained with H&E, and for I-FABP and the apoptosis marker M30. Bonferroni's test was used to compare I-FABP differences. Mean (SEM) arteriovenous concentration gradients of I-FABP across the jejunum revealed rapidly developing epithelial cell damage. I-FABP release significantly increased from 290 (46) pg/ml before ischemia towards 3,997 (554) pg/ml immediately after ischemia (p<0.001) and declined gradually to 1,143 (237) pg/ml within 1 hour reperfusion (p<0.001). Directly after ischemia the intestinal epithelial lining was microscopically normal, while subepithelial spaces appeared at the villus tip. However, after 25 minutes reperfusion, enterocyte M30 immunostaining was observed at the villus tip accompanied by shedding of mature enterocytes into the lumen and loss of I-FABP staining. Interestingly, within 60 minutes reperfusion the epithelial barrier resealed, while debris of apoptotic, shedded epithelial cells was observed in the lumen. At the same time, M30 immunoreactivity was absent in intact epithelial lining. Conclusions: This is the first human study to clarify intestinal IR induced cell damage and repair and its direct consequences. It reveals a unique, endogenous clearing mechanism for injured enterocytes: rapid detachment of damaged apoptotic enterocytes into the lumen. This process is followed by repair of the epithelial continuity within an hour, resulting in a normal epithelial lining.	[Derikx, Joep P. M.; Matthijsen, Robert A.; van Bijnen, Annemarie A.; Heineman, Erik; van Dam, Ronald M.; Dejong, Cornelis H. C.; Buurman, Wim A.] Maastricht Univ, Med Ctr, Sch Nutr & Metab NUTRIM, Dept Surg, Maastricht, Netherlands; [de Bruine, Adriaan P.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst CARIM, Dept Pathol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Derikx, JPM (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr & Metab NUTRIM, Dept Surg, Maastricht, Netherlands.	w.buurman@ah.unimaas.nl	Heineman, Erik/ABG-9592-2021	derikx, joep/0000-0003-0694-7679	Netherlands Organisation for Health Research and Development [912-03-013, 920-03-438]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was financially supported by the Netherlands Organisation for Health Research and Development (ZonMw Grant 912-03-013, to WA Buurman) and the Netherlands Organisation for Health Research and Development (AGIKO-stipendium 920-03-438, to JPM Derikx).	[Anonymous], 2000, Gastroenterology, V118, P951; Arumugam TV, 2004, SHOCK, V21, P401, DOI 10.1097/00024382-200405000-00002; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Blikslager AT, 2008, GASTROENTEROLOGY, V134, P346, DOI 10.1053/j.gastro.2007.11.049; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Bullen TF, 2006, LAB INVEST, V86, P1052, DOI 10.1038/labinvest.3700464; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Daemen MARC, 2002, TRANSPLANTATION, V73, P1693; Dufour G, 2004, J BIOL CHEM, V279, P44113, DOI 10.1074/jbc.M405323200; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fouquet S, 2004, J BIOL CHEM, V279, P43061, DOI 10.1074/jbc.M405095200; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fukatsu K, 2006, CRIT CARE MED, V34, P182, DOI 10.1097/01.CCM.0000196207.86570.16; Gassler N, 2007, GASTROENTEROLOGY, V133, P587, DOI 10.1053/j.gastro.2007.06.005; HAGLUND U, 1975, GUT, V16, P979, DOI 10.1136/gut.16.12.979; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017; Ikeda H, 1998, GUT, V42, P530, DOI 10.1136/gut.42.4.530; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Jeukendrup AE, 2000, CLIN SCI, V98, P47, DOI 10.1042/CS19990258; Kerstens HMJ, 2000, J HISTOCHEM CYTOCHEM, V48, P709, DOI 10.1177/002215540004800515; KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Mallick IH, 2004, DIGEST DIS SCI, V49, P1359, DOI 10.1023/B:DDAS.0000042232.98927.91; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; MOORE R, 1989, LAB INVEST, V60, P237; MOORE R, 1992, GASTROENTEROLOGY, V102, P119, DOI 10.1016/0016-5085(92)91791-2; Oldenburg WA, 2004, ARCH INTERN MED, V164, P1054, DOI 10.1001/archinte.164.10.1054; Panes J, 1998, GASTROENTEROLOGY, V114, P1066, DOI 10.1016/S0016-5085(98)70328-2; PARK PO, 1992, CRIT CARE MED, V20, P135, DOI 10.1097/00003246-199201000-00026; PARK PO, 1990, SURGERY, V107, P574; Pelsers MMAL, 2005, CLIN CHIM ACTA, V352, P15, DOI 10.1016/j.cccn.2004.09.001; Perko MJ, 1998, J PHYSIOL-LONDON, V513, P907, DOI 10.1111/j.1469-7793.1998.907ba.x; Podolsky DK, 1997, J GASTROENTEROL, V32, P122, DOI 10.1007/BF01213309; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Rokyta R, 2002, PFLUG ARCH EUR J PHY, V443, P852, DOI 10.1007/s00424-001-0761-1; Semenza GL, 2000, J CLIN INVEST, V106, P613, DOI 10.1172/JCI10913; Vachon PH, 2002, GASTROENTEROLOGY, V123, P1980, DOI 10.1053/gast.2002.37072; Veenstra RP, 2007, DIGESTION, V75, P205, DOI 10.1159/000109373; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	43	80	87	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3428	10.1371/journal.pone.0003428	http://dx.doi.org/10.1371/journal.pone.0003428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927609	gold, Green Published			2022-12-27	WOS:000265122400004
J	Bollongino, R; Elsner, J; Vigne, JD; Burger, J				Bollongino, Ruth; Elsner, Julia; Vigne, Jean-Denis; Burger, Joachim			Y-SNPs Do Not Indicate Hybridisation between European Aurochs and Domestic Cattle	PLOS ONE			English	Article							ANCIENT DNA	Background: Previous genetic studies of modern and ancient mitochondrial DNA have confirmed the Near Eastern origin of early European domestic cattle. However, these studies were not able to test whether hybridisation with male aurochs occurred post-domestication. To address this issue, Gotherstrom and colleagues (2005) investigated the frequencies of two Y-chromosomal haplotypes in extant bulls. They found a significant influence of wild aurochs males on domestic populations thus challenging the common view on early domestication and Neolithic stock-rearing. To test their hypothesis, we applied these Y-markers on Neolithic bone specimens from various European archaeological sites. Methods and Findings: Here, we have analysed the ancient DNA of 59 Neolithic skeletal samples. After initial molecular sexing, two segregating Y-SNPs were identified in 13 bulls. Strikingly, our results do not support the hypothesis that these markers distinguish European aurochs from domesticated cattle. Conclusions: The model of a rapid introduction of domestic cattle into Central Europe without significant crossbreeding with local wild cattle remains unchallenged.	[Bollongino, Ruth; Elsner, Julia; Burger, Joachim] Johannes Gutenberg Univ Mainz, Inst Anthropol, Palaeogenet Grp, Mainz, Germany; [Bollongino, Ruth; Vigne, Jean-Denis] Mus Natl Hist Nat, Dept Ecol Gest Biodiv, CNRS, USM 303, Paris, France	Johannes Gutenberg University of Mainz; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN)	Bollongino, R (corresponding author), Johannes Gutenberg Univ Mainz, Inst Anthropol, Palaeogenet Grp, Mainz, Germany.	bollongi@uni-mainz.de	Smejda, Ladislav/B-8474-2008		University of Mainz; BMBF; French ANR	University of Mainz; BMBF(Federal Ministry of Education & Research (BMBF)); French ANR(French National Research Agency (ANR))	Geocycles cluster of excellence, University of Mainz, BMBF, The French ANR (CHRONOBOS project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollongino R, 2006, BIOL LETTERS, V2, P155, DOI 10.1098/rsbl.2005.0404; Burger J, 2004, MOL PHYLOGENET EVOL, V30, P841, DOI 10.1016/j.ympev.2003.07.020; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Scheu A, 2008, J ARCHAEOL SCI, V35, P1257, DOI 10.1016/j.jas.2007.08.012; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; van Vuure C., 2005, RETRACING AUROCHS HI, P167	7	59	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3418	10.1371/journal.pone.0003418	http://dx.doi.org/10.1371/journal.pone.0003418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432GO	18852900	gold, Green Published, Green Submitted			2022-12-27	WOS:000265121700011
J	Catania, KC				Catania, Kenneth C.			Worm Grunting, Fiddling, and Charming-Humans Unknowingly Mimic a Predator to Harvest Bait	PLOS ONE			English	Article							ANCIENT ESCAPE CIRCUIT; AVIAN PREDATOR; EASTERN MOLE; PREY; EXPLOITATION; SENSITIVITY; EARTHWORMS; BEHAVIOR	Background: For generations many families in and around Florida's Apalachicola National Forest have supported themselves by collecting the large endemic earthworms (Diplocardia mississippiensis). This is accomplished by vibrating a wooden stake driven into the soil, a practice called "worm grunting''. In response to the vibrations, worms emerge to the surface where thousands can be gathered in a few hours. Why do these earthworms suddenly exit their burrows in response to vibrations, exposing themselves to predation? Principal Findings: Here it is shown that a population of eastern American moles (Scalopus aquaticus) inhabits the area where worms are collected and that earthworms have a pronounced escape response from moles consisting of rapidly exiting their burrows to flee across the soil surface. Recordings of vibrations generated by bait collectors and moles suggest that "worm grunters'' unknowingly mimic digging moles. An alternative possibility, that worms interpret vibrations as rain and surface to avoid drowning is not supported. Conclusions: Previous investigations have revealed that both wood turtles and herring gulls vibrate the ground to elicit earthworm escapes, indicating that a range of predators may exploit the predator-prey relationship between earthworms and moles. In addition to revealing a novel escape response that may be widespread among soil fauna, the results show that humans have played the role of "rare predators'' in exploiting the consequences of a sensory arms race.	[Catania, Kenneth C.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Catania, KC (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	ken.catania@vanderbilt.edu			National Science Foundation Career Award [0238364]; MacArthur Award	National Science Foundation Career Award(National Science Foundation (NSF)); MacArthur Award	National Science Foundation Career Award # 0238364, MacArthur Award	Arlton A. V., 1936, Journal of Mammalogy, V17, P349, DOI 10.2307/1374401; BROWER K, 1999, ATLANTIC MONTHLY, V283, P91; BULLOCK TH, 1945, J NEUROPHYSIOL, V8, P55, DOI 10.1152/jn.1945.8.1.55; Catania KC, 1997, J COMP NEUROL, V378, P337, DOI 10.1002/(SICI)1096-9861(19970217)378:3<337::AID-CNE3>3.0.CO;2-4; Chuang SC, 2008, INVERTEBR BIOL, V127, P80, DOI 10.1111/j.1744-7410.2007.00117.x; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; DAVENPORT J, 1994, REV FISH BIOL FISHER, V4, P184, DOI 10.1007/BF00044128; Dawkins R., 1982, pi; DREW MC, 1983, PLANT SOIL, V75, P179, DOI 10.1007/BF02375564; Drewes C.D., 1984, P43; DYCHE LL, 1903, T KANSAS ACAD SCI, V18, P183; Godfrey GK, 1960, LIFE MOLE; Gorman M.L, 1990, NATURAL HIST MOLES; Hartman GD, 2000, AM MIDL NAT, V144, P342, DOI 10.1674/0003-0031(2000)144[0342:DOTMSA]2.0.CO;2; HARVEY MJ, 1976, AM MIDL NAT, V95, P436, DOI 10.2307/2424406; Hendrix PF, 2006, BIOL INVASIONS, V8, P1201, DOI 10.1007/s10530-006-9048-y; Hendrix Paul F., 1994, Megadrilogica, V5, P73; HICKMAN J. C., 1984, MADRONO, V31, P249; HOY RR, 1989, ANNU REV NEUROSCI, V12, P355, DOI 10.1146/annurev.ne.12.030189.002035; Jablonski PG, 2005, ETHOLOGY, V111, P381, DOI 10.1111/j.1439-0310.2004.01059.x; Jablonski PG, 2001, BRAIN BEHAV EVOLUT, V58, P218, DOI 10.1159/000057565; Jablonski PG, 2001, P ROY SOC B-BIOL SCI, V268, P1017, DOI 10.1098/rspb.2001.1623; Jablonski PG, 1999, BEHAV ECOL, V10, P7, DOI 10.1093/beheco/10.1.7; Jablonski PG, 2000, BRAIN BEHAV EVOLUT, V56, P94, DOI 10.1159/000006680; James Samuel W., 2004, P75; Kaufmann J.H., 1989, Bulletin of the Chicago Herpetological Society, V24, P125; KAUFMANN JH, 1986, COPEIA, P1001, DOI 10.2307/1445299; KAUFMANN JH, 1989, NAT HIST, P8; Kuralt Charles, 1985, ROAD C KURALT; Roeder K.D., 1963, NERVE CELLS INSECT B; SCHEFFER TH, 1914, USDA FARMERS B, V583, P3; TINBERGEN N., 1953, HERRING GULLS WORLD; TOBIN TC, 2002, ST PETERSBURG T 0414; WHITAKER J O JR, 1974, Proceedings of the Indiana Academy of Science, V83, P478; Wickler W., 1968, MIMICRY PLANTS ANIMA; Yates T.L., 1982, P37; ZEILER D, 1969, INT TURT TORT SOC J, V3, P30; Zeiller D., 1969, Int. Turtle Tortoise Soc. J., V3, P6	38	28	30	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3472	10.1371/journal.pone.0003472	http://dx.doi.org/10.1371/journal.pone.0003472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852902	gold, Green Published, Green Submitted			2022-12-27	WOS:000265121700013
J	Li, WZ; Wooley, JC; Godzik, A				Li, Weizhong; Wooley, John C.; Godzik, Adam			Probing Metagenomics by Rapid Cluster Analysis of Very Large Datasets	PLOS ONE			English	Article							PHYLOGENETIC CLASSIFICATION; PROTEIN SEQUENCES; REDUNDANCY; STRATEGIES; ALGORITHM; UNIPROT; SETS	Background: The scale and diversity of metagenomic sequencing projects challenge both our technical and conceptual approaches in gene and genome annotations. The recent Sorcerer II Global Ocean Sampling (GOS) expedition yielded millions of predicted protein sequences, which significantly altered the landscape of known protein space by more than doubling its size and adding thousands of new families (Yooseph et al., 2007 PLoS Biol 5, e16). Such datasets, not only by their sheer size, but also by many other features, defy conventional analysis and annotation methods. Methodology/Principal Findings: In this study, we describe an approach for rapid analysis of the sequence diversity and the internal structure of such very large datasets by advanced clustering strategies using the newly modified CD-HIT algorithm. We performed a hierarchical clustering analysis on the 17.4 million Open Reading Frames (ORFs) identified from the GOS study and found over 33 thousand large predicted protein clusters comprising nearly 6 million sequences. Twenty percent of these clusters did not match known protein families by sequence similarity search and might represent novel protein families. Distributions of the large clusters were illustrated on organism composition, functional class, and sample locations. Conclusion/Significance: Our clustering took about two orders of magnitude less computational effort than the similar protein family analysis of original GOS study. This approach will help to analyze other large metagenomic datasets in the future. A Web server with our clustering results and annotations of predicted protein clusters is available online at http://tools.camera.calit2.net/gos under the CAMERA project.	[Li, Weizhong] Univ Calif San Diego, Calif Inst Telecommun & Informat Technol, La Jolla, CA 92093 USA; [Wooley, John C.; Godzik, Adam] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Godzik, Adam] Burnham Inst Med Res, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Li, WZ (corresponding author), Univ Calif San Diego, Calif Inst Telecommun & Informat Technol, La Jolla, CA 92093 USA.	adam@burnham.org	WU, TAKLON/A-2827-2010; Godzik, Adam/AAW-1467-2020; Li, Weizhong/A-9735-2008; Godzik, Adam/A-7279-2009	Godzik, Adam/0000-0002-2425-852X; Li, Weizhong/0000-0003-1804-9403; Godzik, Adam/0000-0002-2425-852X	Gordon and Betty Moore Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work was partly supported by the CAMERA project (http://camera.calit2.net) which is funded by the Gordon and Betty Moore Foundation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Enright AJ, 2000, BIOINFORMATICS, V16, P451, DOI 10.1093/bioinformatics/16.5.451; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Holm L, 1998, BIOINFORMATICS, V14, P423, DOI 10.1093/bioinformatics/14.5.423; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WZ, 2002, BIOINFORMATICS, V18, P77, DOI 10.1093/bioinformatics/18.1.77; Li WZ, 2002, PROTEIN ENG, V15, P643, DOI 10.1093/protein/15.8.643; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Mika S, 2003, NUCLEIC ACIDS RES, V31, P3789, DOI 10.1093/nar/gkg620; Park J, 2000, BIOINFORMATICS, V16, P458, DOI 10.1093/bioinformatics/16.5.458; Pipenbacher P, 2002, BIOINFORMATICS, V18, pS182, DOI 10.1093/bioinformatics/18.suppl_2.S182; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasson Ori, 2002, Bioinformatics, V18 Suppl 1, pS14; Schloss PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-34; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tress ML, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-213; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Yona G, 1999, PROTEINS, V37, P360, DOI 10.1002/(SICI)1097-0134(19991115)37:3<360::AID-PROT5>3.0.CO;2-Z; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	40	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3375	10.1371/journal.pone.0003375	http://dx.doi.org/10.1371/journal.pone.0003375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846219	Green Published, gold			2022-12-27	WOS:000265114500008
J	Alves, S; Nascimento-Ferreira, I; Auregan, G; Hassig, R; Dufour, N; Brouillet, E; de Lima, MCP; Hantraye, P; de Almeida, LP; Deglon, N				Alves, Sandro; Nascimento-Ferreira, Isabel; Auregan, Gwennaelle; Hassig, Raymonde; Dufour, Noelle; Brouillet, Emmanuel; de Lima, Maria C. Pedroso; Hantraye, Philippe; de Almeida, Luis Pereira; Deglon, Nicole			Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph Disease	PLOS ONE			English	Article								Recent studies have demonstrated that RNAi is a promising approach for treating autosomal dominant disorders. However, discrimination between wild-type and mutant transcripts is essential, to preserve wild-type expression and function. A single nucleotide polymorphism (SNP) is present in more than 70% of patients with Machado-Joseph disease (MJD). We investigated whether this SNP could be used to inactivate mutant ataxin-3 selectively. Lentiviral-mediated silencing of mutant human ataxin-3 was demonstrated in vitro and in a rat model of MJD in vivo. The allele-specific silencing of ataxin-3 significantly decreased the severity of the neuropathological abnormalities associated with MJD. These data demonstrate that RNAi has potential for use in MJD treatment and constitute the first proof-of-principle for allele-specific silencing in the central nervous system.	[Alves, Sandro; Nascimento-Ferreira, Isabel; de Lima, Maria C. Pedroso; de Almeida, Luis Pereira] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Alves, Sandro; Nascimento-Ferreira, Isabel; de Almeida, Luis Pereira] Univ Coimbra, Fac Pharm, P-3000 Coimbra, Portugal; [de Lima, Maria C. Pedroso] Univ Coimbra, Fac Sci, P-3000 Coimbra, Portugal; [Alves, Sandro; Auregan, Gwennaelle; Hassig, Raymonde; Dufour, Noelle; Brouillet, Emmanuel; Hantraye, Philippe; Deglon, Nicole] Inst Mol Imag I2BM, Mol Imag Res Ctr MIRCen, CEA, Orsay, France; [Auregan, Gwennaelle; Hassig, Raymonde; Dufour, Noelle; Brouillet, Emmanuel; Hantraye, Philippe; Deglon, Nicole] CNRS, URA 2210, Orsay, France	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; CEA; Centre National de la Recherche Scientifique (CNRS)	Alves, S (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	luispa@cnc.uc.pt	Brouillet, Emmanuel/B-4784-2014; Deglon, Nicole/A-2265-2012; de Lima, Maria da Conceição Monteiro/AAS-5602-2021; de Almeida, Luis Pereira/O-8196-2019; de Almeida, Luis Pereira/A-4605-2009	Brouillet, Emmanuel/0000-0001-6322-7403; Deglon, Nicole/0000-0003-4475-9476; de Lima, Maria da Conceição Monteiro/0000-0003-1844-5027; de Almeida, Luis Pereira/0000-0001-5831-3307; de Almeida, Luis Pereira/0000-0001-5831-3307; Alves, Sandro/0000-0002-1396-7523	Commissariat a L'Energie Atomique (CEA); National Ataxia Foundation (NAF); Portuguese Foundation for Science and Technology [POCI/SAU-MMO/56055/2004, PTDC/SAU-FCF/70384/2006, SFRH/BD/12675/2003, SFRH/BD/29479/2006]	Commissariat a L'Energie Atomique (CEA)(French Atomic Energy Commission); National Ataxia Foundation (NAF); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by the Commissariat a L'Energie Atomique (CEA), the National Ataxia Foundation (NAF) and the Portuguese Foundation for Science and Technology (POCI/SAU-MMO/56055/2004 and PTDC/SAU-FCF/70384/2006). Sandro Alves and Isabel Nascimento-Ferreira were supported by the Portuguese Foundation for Science and Technology (Fellowships SFRH/BD/12675/2003 and SFRH/BD/29479/2006, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVES S, 2008, HUM MOL GENET; Arango M, 2006, J NEUROSCI, V26, P4649, DOI 10.1523/JNEUROSCI.5409-05.2006; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; CANCEL G, 1995, AM J HUM GENET, V57, P809; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; CLARKE PGH, 1992, TRENDS NEUROSCI, V15, P211, DOI 10.1016/0166-2236(92)90036-8; de Almeida LP, 2002, J NEUROSCI, V22, P3473; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Gaspar C, 1996, HUM GENET, V98, P620, DOI 10.1007/s004390050270; Gaspar C, 2001, AM J HUM GENET, V68, P523, DOI 10.1086/318184; Gonzalez-Alegre P, 2003, ANN NEUROL, V53, P781, DOI 10.1002/ana.10548; Gwinn-Hardy K, 2001, ARCH NEUROL-CHICAGO, V58, P296, DOI 10.1001/archneur.58.2.296; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hottinger AF, 2000, J NEUROSCI, V20, P5587, DOI 10.1523/JNEUROSCI.20-15-05587.2000; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; LANG AE, 1994, ANN NEUROL, V36, P443, DOI 10.1002/ana.410360318; LI LB, 2008, NATURE; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACEDORIBEIRO S, 2007, INTERACTIONS NEURONS; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; Matsumura R, 1996, HUM GENET, V98, P643, DOI 10.1007/s004390050276; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Palfi S, 2007, MOL THER, V15, P1444, DOI 10.1038/sj.mt.6300185; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; RANUM LPW, 1995, AM J HUM GENET, V57, P603; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Regulier E, 2003, HUM MOL GENET, V12, P2827, DOI 10.1093/hmg/ddg305; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rodrigues AJ, 2007, FASEB J, V21, P1126, DOI 10.1096/fj.06-7002com; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; Schmidt T, 1998, BRAIN PATHOL, V8, P669, DOI 10.1111/j.1750-3639.1998.tb00193.x; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Sobue G, 1996, J NEUROL NEUROSUR PS, V60, P354, DOI 10.1136/jnnp.60.3.354-a; STEVANIN G, 1995, AM J HUM GENET, V57, P1247; SUDARSKY L, 1995, CLIN NEUROSCI, V3, P17; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Wullner U, 2005, ARCH NEUROL-CHICAGO, V62, P1280, DOI 10.1001/archneur.62.8.1280; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Xia XG, 2006, NEUROBIOL DIS, V23, P578, DOI 10.1016/j.nbd.2006.04.019	41	116	130	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3341	10.1371/journal.pone.0003341	http://dx.doi.org/10.1371/journal.pone.0003341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841197	Green Submitted, gold, Green Published			2022-12-27	WOS:000265113900004
J	Sereno, PC; Martinez, RN; Wilson, JA; Varricchio, DJ; Alcober, OA; Larsson, HCE				Sereno, Paul C.; Martinez, Ricardo N.; Wilson, Jeffrey A.; Varricchio, David J.; Alcober, Oscar A.; Larsson, Hans C. E.			Evidence for Avian Intrathoracic Air Sacs in a New Predatory Dinosaur from Argentina	PLOS ONE			English	Article								Background: Living birds possess a unique heterogeneous pulmonary system composed of a rigid, dorsally-anchored lung and several compliant air sacs that operate as bellows, driving inspired air through the lung. Evidence from the fossil record for the origin and evolution of this system is extremely limited, because lungs do not fossilize and because the bellow-like air sacs in living birds only rarely penetrate (pneumatize) skeletal bone and thus leave a record of their presence. Methodology/Principal Findings: We describe a new predatory dinosaur from Upper Cretaceous rocks in Argentina, Aerosteon riocoloradensis gen. et sp. nov., that exhibits extreme pneumatization of skeletal bone, including pneumatic hollowing of the furcula and ilium. In living birds, these two bones are pneumatized by diverticulae of air sacs ( clavicular, abdominal) that are involved in pulmonary ventilation. We also describe several pneumatized gastralia ("stomach ribs''), which suggest that diverticulae of the air sac system were present in surface tissues of the thorax. Conclusions/Significance: We present a four-phase model for the evolution of avian air sacs and costosternal-driven lung ventilation based on the known fossil record of theropod dinosaurs and osteological correlates in extant birds: (1) Phase I-Elaboration of paraxial cervical air sacs in basal theropods no later than the earliest Late Triassic. (2) Phase II-Differentiation of avian ventilatory air sacs, including both cranial ( clavicular air sac) and caudal (abdominal air sac) divisions, in basal tetanurans during the Jurassic. A heterogeneous respiratory tract with compliant air sacs, in turn, suggests the presence of rigid, dorsally attached lungs with flow-through ventilation. (3) Phase III-Evolution of a primitive costosternal pump in maniraptoriform theropods before the close of the Jurassic. (4) Phase IV-Evolution of an advanced costosternal pump in maniraptoran theropods before the close of the Jurassic. In addition, we conclude: (5) The advent of avian unidirectional lung ventilation is not possible to pinpoint, as osteological correlates have yet to be identified for uni- or bidirectional lung ventilation. (6) The origin and evolution of avian air sacs may have been driven by one or more of the following three factors: flow-through lung ventilation, locomotory balance, and/or thermal regulation.	[Sereno, Paul C.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Martinez, Ricardo N.; Alcober, Oscar A.] Museo Ciencias Nat, San Juan, PR USA; [Wilson, Jeffrey A.] Univ Michigan, Dept Geol Sci, Museum Paleontol, Ann Arbor, MI 48109 USA; [Varricchio, David J.] Montana State Univ, Dept Earth Sci, Bozeman, MT USA; [Larsson, Hans C. E.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2T5, Canada	University of Chicago; University of Michigan System; University of Michigan; Montana State University System; Montana State University Bozeman; McGill University	Sereno, PC (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	dinosaur@uchicago.edu	Wilson, Jeffrey/C-2737-2008; Larsson, Hans/AAD-4579-2019	Larsson, Hans/0000-0002-6377-4770	National Geographic Society; The David and Lucile Packard Foundation; Pritzker Foundation	National Geographic Society(National Geographic Society); The David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Pritzker Foundation	Fieldwork and lab work was funded by National Geographic Society, The David and Lucile Packard Foundation, and the Pritzker Foundation (to PCS).	Alcober O., 1998, Journal of Vertebrate Paleontology, V18, p23A; BERNSTEIN MH, 1976, RESP PHYSIOL, V26, P371, DOI 10.1016/0034-5687(76)90007-4; Bezuidenhout AJ, 1999, ONDERSTEPOORT J VET, V66, P317; BONAPARTE J F, 1986, Annales de Paleontologie, V72, P325; Bonaparte J.F., 1990, NATURAL HIST MUSEUM, V416, P1; Brainerd EL, 2006, RESP PHYSIOL NEUROBI, V154, P73, DOI 10.1016/j.resp.2006.06.003; Britt BB, 1998, NATURE, V395, P374, DOI 10.1038/26469; BRITT BB, 1993, THESIS U CALGARY CAL; Brochu C., 2002, J VERTEBRATE PALEO S, V7, P1, DOI DOI 10.1671/0272-4634(2002)022[0001:ARAOPA]2.0.CO;2; BROWN RE, 1995, J EXP BIOL, V198, P2349; Burnham DA, 2004, LIFE O PAST, P67; CARRIER DR, 1987, PALEOBIOLOGY, V13, P326; Carrier DR, 2000, AM ZOOL, V40, P87, DOI 10.1668/0003-1569(2000)040[0087:TIOVAL]2.0.CO;2; Carrier DR, 2001, J EXP BIOL, V204, P3917; Carrier DR, 2000, PALEOBIOLOGY, V26, P271, DOI 10.1666/0094-8373(2000)026<0271:TEOPAI>2.0.CO;2; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; Christiansen P, 2000, P ROY SOC B-BIOL SCI, V267, P2501, DOI 10.1098/rspb.2000.1311; Claessens LPAM, 2004, J VERTEBR PALEONTOL, V24, P89, DOI 10.1671/A1116-8; Codd JR, 2008, P ROY SOC B-BIOL SCI, V275, P157, DOI 10.1098/rspb.2007.1233; Codd JR, 2005, J EXP BIOL, V208, P849, DOI 10.1242/jeb.01489; Coria R., 2000, GAIA, V102, P89; Coria RA, 2006, GEODIVERSITAS, V28, P71; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Currie Philip J., 2000, Geodiversitas, V22, P207; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Duncker H.-R., 1978, P2; DUNCKER HR, 1972, RESP PHYSIOL, V14, P44, DOI 10.1016/0034-5687(72)90016-3; DUNCKER HR, 1989, LIFE SCI R, V45, P147; DUNCKER HR, 1971, ERGEBNISSE ANATOMIE, V0045, P00001; Eaton G. F., 1910, Memoirs of the Connecticut Academy of Arts and Sciences New Haven, V2; Farmer CG, 2006, RESP PHYSIOL NEUROBI, V154, P89, DOI 10.1016/j.resp.2006.04.014; Gilmore C. W., 1925, Memoirs of the Carnegie Museum, V10, P347; Gilmore CW., 1920, B US NATL MUSEUM, V110, P1, DOI [10.5479/si.03629236.110.i, DOI 10.5479/SI.03629236.110.I]; Gower DJ, 2001, NATURWISSENSCHAFTEN, V88, P119, DOI 10.1007/s001140100206; Gradstein F.M, 2012, GEOLOGIC TIME SCALE; Harris JD, 1998, NEW MEXICO MUSEUM NA, V13, P1, DOI DOI 10.1080/0022293460865417; Hengst R, 1998, SCIENCE, V281, P47; Hicks JW, 1999, RESP PHYSIOL, V117, P73, DOI 10.1016/S0034-5687(99)00060-2; HOGG DA, 1984, J ANAT, V138, P617; HOLLAND WJ, 1906, MEM CARNEGIE MUS, V2, P225; HOWSE SCB, 1986, ZOOL J LINN SOC-LOND, V88, P307, DOI 10.1111/j.1096-3642.1986.tb02249.x; Ji Q, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)420<0001:AEODAI>2.0.CO;2; King A. S., 1966, International Review of General and Experimental Zoology, V2, P171; KING A. S., 1956, BRIT VET JOUR, V112, P279; KING A. S., 1957, ACTA ANAT, V31, P220; Krause DW, 2007, J VERTEBR PALEONTOL, V27, P1, DOI 10.1671/0272-4634(2007)27[1:OOTHOD]2.0.CO;2; KUETHE DO, 1988, J EXP BIOL, V136, P1; Larson Peter L., 1997, P65; Leanza HA, 2004, CRETACEOUS RES, V25, P61, DOI 10.1016/j.cretres.2003.10.005; M?ller B., 1908, SMITHSONIAN MISCELLA, V50, P365; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Martinez RD, 2004, J VERTEBR PALEONTOL, V24, P107, DOI 10.1671/9.1; MARTINEZ RN, PLOS ONE; McLelland J., 1989, P221; Nesbitt SJ, 2006, P ROY SOC B-BIOL SCI, V273, P1045, DOI 10.1098/rspb.2005.3426; NICHOLLS EL, 1981, CAN J EARTH SCI, V18, P518, DOI 10.1139/e81-045; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Novas FE, 2005, NATURWISSENSCHAFTEN, V92, P226, DOI 10.1007/s00114-005-0623-3; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; O'Connor PM, 2004, J MORPHOL, V261, P141, DOI 10.1002/jmor.10190; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Osmolska H., 1972, PALAEONTOLOGIA POLON, V27, P103; PAUL GS, 2001, P INT S HON JH OSTR, P463; Pennycuick CJ, 1986, ORIGIN BIRDS EVOLUTI, P83; Perez-Moreno Bernardino P., 1999, Rivista del Museo Civico di Scienze Naturali "Enrico Caffi", V20, P121; PEREZMORENO BP, 1994, NATURE, V370, P363, DOI 10.1038/370363a0; Perreau J, 1998, CRYPTOGAMIE MYCOL, V19, P1; Perry SF, 2004, RESP PHYSIOL NEUROBI, V144, P125, DOI 10.1016/j.resp.2004.06.018; PERRY SF, 2001, P INT S HON JH OSTR, P429; Powell F.L., 2000, P233, DOI 10.1016/B978-012747605-6/50011-0; RICHARDSON FRANK, 1939, CONDOR, V41, P13, DOI 10.2307/1364267; Ruben JA, 1997, SCIENCE, V278, P1267, DOI 10.1126/science.278.5341.1267; Ruben JA, 1999, SCIENCE, V283, P514, DOI 10.1126/science.283.5401.514; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; Scheid P., 1989, P369; SCHMIDTN.K, 1969, CONDOR, V71, P341, DOI 10.2307/1365733; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; STOVALL JW, 1950, AM MIDL NAT, V43, P696, DOI 10.2307/2421859; SUES HD, J VERT PALEONTOL, V22, P535; VARRICCHIO DJ, 2008, ACTA PALAEO IN PRESS; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P241	94	93	100	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2008	3	9							e3303	10.1371/journal.pone.0003303	http://dx.doi.org/10.1371/journal.pone.0003303			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MO	18825273	Green Published, gold			2022-12-27	WOS:000264432600001
J	Webb, N; Connolly, G; Tellam, J; Yap, AS; Khanna, R				Webb, Natasha; Connolly, Geoff; Tellam, Judy; Yap, Alpha S.; Khanna, Rajiv			Epstein-Barr Virus Associated Modulation of Wnt Pathway Is Not Dependent on Latent Membrane Protein-1	PLOS ONE			English	Article								Previous studies have indicated that Epstein-Barr virus (EBV) can modulate the Wnt pathway in virus-infected cells and this effect is mediated by EBV-encoded oncogene latent membrane protein 1 (LMP1). Here we have reassessed the role of LMP1 in regulating the expression of various mediators of the canonical Wnt cascade. Contradicting the previous finding, we found that the levels of E-cadherin, beta-catenin, Glycogen Synthase Kinase 3 beta (GSK3 beta), axin and a-catenin were not affected by the expression of LMP1 sequences from normal B cells or nasopharyngeal carcinoma. Moreover, we also show that LMP1 expression had no detectable effect on the E-cadherin and alpha-catenin interaction and did not induce transcriptional activation of beta-catenin. Taken together these studies demonstrate that EBV-mediated activation of Wnt pathway is not dependent on the expression of LMP1.	[Webb, Natasha; Connolly, Geoff; Tellam, Judy; Khanna, Rajiv] Queensland Inst Med Res, Australian Ctr Vaccine Dev, Brisbane, Qld 4006, Australia; [Yap, Alpha S.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute; University of Queensland	Webb, N (corresponding author), Queensland Inst Med Res, Australian Ctr Vaccine Dev, Brisbane, Qld 4006, Australia.	rajiv.khanna@qimr.edu.au	Yap, Alpha S./J-1554-2014; Khanna, Rajiv/A-7691-2008	Yap, Alpha S./0000-0002-1038-8956; Khanna, Rajiv/0000-0003-2241-0353	Queensland Cancer Fund; National Health and Medical Research Council (Australia)	Queensland Cancer Fund; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by research funding from the Queensland Cancer Fund and the National Health and Medical Research Council (Australia).	Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Everly DN, 2004, J VIROL, V78, P11648, DOI 10.1128/JVI.78.21.11648-11655.2004; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P1447, DOI 10.1073/pnas.94.4.1447; Kao RH, 2002, ANTICANCER RES, V22, P4109; Khanna R, 2005, NAT CLIN PRACT ONCOL, V2, P138, DOI 10.1038/ncponc0107; Khanna R, 2000, ANNU REV MICROBIOL, V54, P19, DOI 10.1146/annurev.micro.54.1.19; Kieff E., 1996, EPSTEINBARR VIRUS IT, P2343; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Lam N, 2003, EMBO J, V22, P3027, DOI 10.1093/emboj/cdg284; Lo AKF, 2004, INT J CANCER, V109, P919, DOI 10.1002/ijc.20051; Miller WE, 1998, ONCOGENE, V16, P1869, DOI 10.1038/sj.onc.1201696; Miller WE, 1997, J VIROL, V71, P586, DOI 10.1128/JVI.71.1.586-594.1997; Morrison JA, 2005, J VIROL, V79, P2375, DOI 10.1128/JVI.79.4.2375-2382.2005; Morrison JA, 2004, CANCER RES, V64, P5251, DOI 10.1158/0008-5472.CAN-04-0538; Morrison JA, 2003, J VIROL, V77, P12276, DOI 10.1128/JVI.77.22.12276-12284.2003; Shackelford J, 2003, P NATL ACAD SCI USA, V100, P15572, DOI 10.1073/pnas.2636947100; Tan E-L, 2007, Exp Oncol, V29, P166; Tellam J, 2003, BLOOD, V102, P4535, DOI 10.1182/blood-2003-03-0870; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tsai CN, 2002, P NATL ACAD SCI USA, V99, P10084, DOI 10.1073/pnas.152059399; Tsao SW, 2003, EUR J CANCER, V39, P524, DOI 10.1016/S0959-8049(02)00494-X	23	19	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3254	10.1371/journal.pone.0003254	http://dx.doi.org/10.1371/journal.pone.0003254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LY	18806872	gold, Green Published			2022-12-27	WOS:000264430800004
J	Ejima, A; Griffith, LC				Ejima, Aki; Griffith, Leslie C.			Courtship Initiation Is Stimulated by Acoustic Signals in Drosophila melanogaster	PLOS ONE			English	Article								Finding a mating partner is a critical task for many organisms. It is in the interest of males to employ multiple sensory modalities to search for females. In Drosophila melanogaster, vision is thought to be the most important courtship stimulating cue at long distance, while chemosensory cues are used at relatively short distance. In this report, we show that when visual cues are not available, sounds produced by the female allow the male to detect her presence in a large arena. When the target female was artificially immobilized, the male spent a prolonged time searching before starting courtship. This delay in courtship initiation was completely rescued by playing either white noise or recorded fly movement sounds to the male, indicating that the acoustic and/or seismic stimulus produced by movement stimulates courtship initiation, most likely by increasing the general arousal state of the male. Mutant males expressing tetanus toxin ( TNT) under the control of Gr68a-GAL4 had a defect in finding active females and a delay in courtship initiation in a large arena, but not in a small arena. Gr68a-GAL4 was found to be expressed pleiotropically not only in putative gustatory pheromone receptor neurons but also in mechanosensory neurons, suggesting that Gr68a-positive mechanosensory neurons, not gustatory neurons, provide motion detection necessary for courtship initiation. TNT/Gr68a males were capable of discriminating the copulation status and age of target females in courtship conditioning, indicating that female discrimination and formation of olfactory courtship memory are independent of the Gr68a-expressing neurons that subserve gustation and mechanosensation. This study suggests for the first time that mechanical signals generated by a female fly have a prominent effect on males' courtship in the dark and leads the way to studying how multimodal sensory information and arousal are integrated in behavioral decision making.	[Ejima, Aki; Griffith, Leslie C.] Brandeis Univ, Natl Ctr Behav Genom, Dept Biol, Waltham, MA 02454 USA	Brandeis University	Ejima, A (corresponding author), Brandeis Univ, Natl Ctr Behav Genom, Dept Biol, Waltham, MA 02454 USA.	aki@brandeis.edu		Griffith, Leslie/0000-0003-3164-9876	NIH [R01 GM54408, P30 NS045713, S10 RR16780]; NIMH [R25 MH059472]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH059472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045713, P01NS044232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant R01 GM54408 to LCG. The Brandeis confocal imaging facility is supported by NIH grants P30 NS045713 and S10 RR16780. The sound recording room was provided by MBL Neural Systems and Behavior course supported by NIMH R25 MH059472.	Barth FG, 2004, CURR OPIN NEUROBIOL, V14, P415, DOI 10.1016/j.conb.2004.07.005; BURNET B, 1971, ANIM BEHAV, V19, P409, DOI 10.1016/S0003-3472(71)80025-8; CROSSLEY SA, 1995, ANIM BEHAV, V50, P827, DOI 10.1016/0003-3472(95)80142-1; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; EWING AW, 1968, BEHAVIOUR, V31, P288, DOI 10.1163/156853968X00298; GAILEY DA, 1986, BEHAV GENET, V16, P375, DOI 10.1007/BF01071319; Gopfert MC, 2001, NATURE, V411, P908, DOI 10.1038/35082144; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; GREENSPAN RJ, 1995, SCI AM, V272, P72, DOI 10.1038/scientificamerican0495-72; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Joiner MA, 2000, LEARN MEMORY, V7, P32, DOI 10.1101/lm.7.1.32; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; MARKOW TA, 1987, P NATL ACAD SCI USA, V84, P6200, DOI 10.1073/pnas.84.17.6200; PAILLETTE M, 1991, Bioacoustics, V3, P247; PECHINE JM, 1988, J CHEM ECOL, V14, P1071, DOI 10.1007/BF01019336; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P565; SPIETH HT, 1966, ANIM BEHAV, V14, P226, DOI 10.1016/S0003-3472(66)80076-3; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; Tauber E, 2001, J COMP PHYSIOL A, V187, P341, DOI 10.1007/s003590100206; TOMPKINS L, 1983, BEHAV GENET, V13, P565, DOI 10.1007/BF01076402; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051	30	66	66	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2008	3	9							e3246	10.1371/journal.pone.0003246	http://dx.doi.org/10.1371/journal.pone.0003246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LF	18802468	Green Published, Green Submitted, gold			2022-12-27	WOS:000264428600006
J	Sentandreu, V; Jimenez-Hernandez, N; Torres-Puente, M; Bracho, MA; Valero, A; Gosalbes, MJ; Ortega, E; Moya, A; Gonzalez-Candelas, F				Sentandreu, Vicente; Jimenez-Hernandez, Nuria; Torres-Puente, Manuela; Alma Bracho, Maria; Valero, Ana; Jose Gosalbes, Maria; Ortega, Enrique; Moya, Andres; Gonzalez-Candelas, Fernando			Evidence of Recombination in Intrapatient Populations of Hepatitis C Virus	PLOS ONE			English	Article							SENSITIVITY-DETERMINING REGION; RIBAVIRIN COMBINATION THERAPY; QUASI-SPECIES HETEROGENEITY; PCR-MEDIATED RECOMBINATION; E2 ENVELOPE GLYCOPROTEIN; AMINO-ACID SUBSTITUTIONS; NONSTRUCTURAL 5A REGION; OPEN READING FRAME; INTERFERON SENSITIVITY; GENOTYPE 1B	Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of substantial morbidity and mortality in the future. HCV is characterized by a high level of genetic heterogeneity. Although homologous recombination has been demonstrated in many members of the family Flaviviridae, to which HCV belongs, there are only a few studies reporting recombination on natural populations of HCV, suggesting that these events are rare in vivo. Furthermore, these few studies have focused on recombination between different HCV genotypes/subtypes but there are no reports on the extent of intra-genotype or intra-subtype recombination between viral strains infecting the same patient. Given the important implications of recombination for RNA virus evolution, our aim in this study has been to assess the existence and eventually the frequency of intragenic recombination on HCV. For this, we retrospectively have analyzed two regions of the HCV genome (NS5A and E1-E2) in samples from two different groups: (i) patients infected only with HCV (either treated with interferon plus ribavirin or treatment naive), and (ii) HCV-HIV co-infected patients (with and without treatment against HIV). The complete data set comprised 17712 sequences from 136 serum samples derived from 111 patients. Recombination analyses were performed using 6 different methods implemented in the program RDP3. Recombination events were considered when detected by at least 3 of the 6 methods used and were identified in 10.7% of the amplified samples, distributed throughout all the groups described and the two genomic regions studied. The resulting recombination events were further verified by detailed phylogenetic analyses. The complete experimental procedure was applied to an artificial mixture of relatively closely viral populations and the ensuing analyses failed to reveal artifactual recombination. From these results we conclude that recombination should be considered as a potentially relevant mechanism generating genetic variation in HCV and with important implications for the treatment of this infection.	[Sentandreu, Vicente; Jimenez-Hernandez, Nuria; Torres-Puente, Manuela; Alma Bracho, Maria; Valero, Ana; Jose Gosalbes, Maria; Moya, Andres; Gonzalez-Candelas, Fernando] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain; [Jimenez-Hernandez, Nuria; Alma Bracho, Maria; Jose Gosalbes, Maria; Moya, Andres; Gonzalez-Candelas, Fernando] CIBER Epidemiol Salud Publ CIBERESP, Barcelona, Spain; [Ortega, Enrique] Hosp Gen Univ, Unidad Enfermedades Infecciosas, Valencia, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Clinic Universitari de Valencia	Sentandreu, V (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain.	fernando.gonzalez@uv.es	Rello, Ana Valero/J-9479-2015; Sentandreu, Vicente/AAH-5972-2020; Bracho, Maria/K-6018-2014; Torres-Puente, Manuela/P-1791-2016; Hernández, Nuria Jiménez/H-1982-2015; Gosalbes, Maria Jose/C-7194-2011; Moya, Andrés/A-8190-2008; Candelas, Fernando Gonzalez/G-5681-2010	Rello, Ana Valero/0000-0002-0126-1128; Bracho, Maria/0000-0002-9204-5526; Torres-Puente, Manuela/0000-0002-8352-180X; Hernández, Nuria Jiménez/0000-0002-9107-056X; Gosalbes, Maria Jose/0000-0003-0460-1105; Moya, Andrés/0000-0002-2867-1119; Candelas, Fernando Gonzalez/0000-0002-0879-5798	Conselleria de Sanitat i Consum Generalitat Valenciana (Spain); Ministerio de Educacion y Ciencia [BFU2005 00503]	Conselleria de Sanitat i Consum Generalitat Valenciana (Spain)(Center for Forestry Research & Experimentation (CIEF)); Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by the Conselleria de Sanitat i Consum Generalitat Valenciana (Spain) and project BFU2005 00503 from Ministerio de Educacion y Ciencia.	Accapezzato D, 2002, EUR J GASTROEN HEPAT, V14, P879, DOI 10.1097/00042737-200208000-00012; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bracho MA, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-13; Becher P, 2001, J VIROL, V75, P6256, DOI 10.1128/JVI.75.14.6256-6264.2001; Bernardin F, 2006, J VIRAL HEPATITIS, V13, P532, DOI 10.1111/j.1365-2893.2006.00722.x; Blackard JT, 2007, J INFECT DIS, V195, P1765, DOI 10.1086/518251; Blackard JT, 2007, J INFECT DIS, V195, P519, DOI 10.1086/510858; Carvajal-Rodriguez A, 2007, INFECT GENET EVOL, V7, P476, DOI 10.1016/j.meegid.2007.02.001; Chambers TJ, 2005, J VIROL, V79, P3071, DOI 10.1128/JVI.79.5.3071-3083.2005; Chayama K, 1997, HEPATOLOGY, V25, P745, DOI 10.1002/hep.510250342; Chung RT, 1999, J MED VIROL, V58, P353, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;353::AID-JMV6&gt;3.0.CO;2-C; Colina R, 2004, J GEN VIROL, V85, P31, DOI 10.1099/vir.0.19472-0; *CTR NAC EP, 2006, VIG EP SIDA ESP; Dahari H, 2005, J HEPATOL, V42, P491, DOI 10.1016/j.jhep.2004.12.017; Di Liberto G, 2006, GASTROENTEROLOGY, V131, P76, DOI 10.1053/j.gastro.2006.04.016; Donlin MJ, 2007, J VIROL, V81, P8211, DOI 10.1128/JVI.00487-07; DURANTE ME, 2003, J MED VIROL, V70, P62; Duverlie G, 1998, J GEN VIROL, V79, P1373, DOI 10.1099/0022-1317-79-6-1373; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Farci P, 2000, SEMIN LIVER DIS, V20, P103; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Fleury HJ, 2006, AIDS RES HUM RETROV, V22, P357, DOI 10.1089/aid.2006.22.357; Forton DM, 2004, J VIROL, V78, P5170, DOI 10.1128/JVI.78.10.5170-5183.2004; Gale M, 1998, PHARMACOL THERAPEUT, V78, P29, DOI 10.1016/S0163-7258(97)00165-4; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Guettouche T, 2005, ANTIVIR THER, V10, P593; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Herring BL, 2004, J INFECT DIS, V190, P1396, DOI 10.1086/424491; Hofgartner WT, 1997, J MED VIROL, V53, P118, DOI 10.1002/(SICI)1096-9071(199710)53:2<118::AID-JMV3>3.0.CO;2-C; Ibarrola N, 1999, AM J GASTROENTEROL, V94, P2487; Jimenez-Hernandez N, 2007, J GEN VIROL, V88, P123, DOI 10.1099/vir.0.82277-0; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Kageyama S, 2006, J MED VIROL, V78, P1423, DOI 10.1002/jmv.20714; Kalinina O, 2004, J GEN VIROL, V85, P1853, DOI 10.1099/vir.0.79984-0; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; KATO N, 1993, J VIROL, V67, P3923, DOI 10.1128/JVI.67.7.3923-3930.1993; Khorsi H, 1997, J HEPATOL, V27, P72, DOI 10.1016/S0168-8278(97)80282-6; KOIZUMI K, 1995, HEPATOLOGY, V22, P30, DOI 10.1002/hep.1840220106; Kuiken C, 2006, HEPATOLOGY, V44, P1355, DOI 10.1002/hep.21377; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Legrand-Abravanel F, 2007, J VIROL, V81, P4357, DOI 10.1128/JVI.02639-06; LeGuen B, 1997, HEPATOLOGY, V25, P1250, DOI 10.1002/hep.510250531; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Minosse C, 2006, J INFECT DIS, V194, P1529, DOI 10.1086/508889; Moreau I, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-95; Moreno MP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-87; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Murayama M, 2007, J MED VIROL, V79, P35, DOI 10.1002/jmv.20766; Noppornpanth S, 2006, J VIROL, V80, P7569, DOI 10.1128/JVI.00312-06; OKADA S, 1992, HEPATOLOGY, V16, P619, DOI 10.1002/hep.1840160302; OKAMOTO H, 1992, VIROLOGY, V188, P331, DOI 10.1016/0042-6822(92)90762-E; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pascu M, 2004, GUT, V53, P1345, DOI 10.1136/gut.2003.031336; Peeters M, 2001, AIDS REV, V3, P3; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Polyak SJ, 1997, J INFECT DIS, V175, P1101, DOI 10.1086/516448; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Rispeter K, 1998, J HEPATOL, V29, P352, DOI 10.1016/S0168-8278(98)80051-2; Roque-Afonso AM, 2005, J VIROL, V79, P6349, DOI 10.1128/JVI.79.10.6349-6357.2005; Saiz JC, 1998, J INFECT DIS, V177, P839, DOI 10.1086/515243; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; SCHINKEL J, 2001, 8 INT S HEP C VIR RE, P266; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shafikhani S, 2002, ENVIRON MICROBIOL, V4, P482, DOI 10.1046/j.1462-2920.2002.00326.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; SMITH JM, 1992, J MOL EVOL, V34, P126; Squadrito G, 1999, J HEPATOL, V30, P1023, DOI 10.1016/S0168-8278(99)80255-4; Squadrito G, 1997, GASTROENTEROLOGY, V113, P567, DOI 10.1053/gast.1997.v113.pm9247477; STADEN R, 1999, COMPUTER METHODS MOL, P115; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TANIGUCHI S, 1993, VIROLOGY, V195, P297, DOI 10.1006/viro.1993.1378; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson BJ, 2005, CLIN MICROBIOL INFEC, V11, P86, DOI 10.1111/j.1469-0691.2004.01061.x; Torres-Puente M, 2008, J VIRAL HEPATITIS, V15, P188, DOI 10.1111/j.1365-2893.2007.00929.x; Torres-Puente M, 2007, J GEN VIROL, V88, P2198, DOI 10.1099/vir.0.82855-0; Troesch M, 2006, VIROLOGY, V352, P357, DOI 10.1016/j.virol.2006.05.015; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; Twiddy SS, 2003, J GEN VIROL, V84, P429, DOI 10.1099/vir.0.18660-0; Viazov S, 2000, INFECTION, V28, P21, DOI 10.1007/s150100050005; Watanabe H, 2001, J INFECT DIS, V183, P1195, DOI 10.1086/319674; WEINER AJ, 1992, P NATL ACAD SCI USA, V89, P3468, DOI 10.1073/pnas.89.8.3468; Witherell GW, 2001, J MED VIROL, V63, P8, DOI 10.1002/1096-9071(200101)63:1&lt;8::AID-JMV1001&gt;3.0.CO;2-K; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Worobey M, 1999, P NATL ACAD SCI USA, V96, P7352, DOI 10.1073/pnas.96.13.7352; Worobey M, 2001, MOL BIOL EVOL, V18, P254, DOI 10.1093/oxfordjournals.molbev.a003799; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; Yun AB, 1996, J MED VIROL, V49, P155, DOI 10.1002/(SICI)1096-9071(199607)49:3<155::AID-JMV1>3.0.CO;2-3; Zein NN, 2000, CLIN MICROBIOL REV, V13, P223, DOI 10.1128/CMR.13.2.223-235.2000; Zeuzem S, 1997, HEPATOLOGY, V25, P740, DOI 10.1002/hep.510250341; zur Wiesch JS, 2003, ARCH VIROL, V148, P1247, DOI 10.1007/s00705-003-0115-8	103	53	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3239	10.1371/journal.pone.0003239	http://dx.doi.org/10.1371/journal.pone.0003239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800167	gold, Green Published, Green Submitted			2022-12-27	WOS:000264428400008
J	Sugiura, Y; Shimma, S; Konishi, Y; Yamada, MK; Setou, M				Sugiura, Yuki; Shimma, Shuichi; Konishi, Yoshiyuki; Yamada, Maki K.; Setou, Mitsutoshi			Imaging Mass Spectrometry Technology and Application on Ganglioside Study; Visualization of Age-Dependent Accumulation of C20-Ganglioside Molecular Species in the Mouse Hippocampus	PLOS ONE			English	Article								Gangliosides are particularly abundant in the central nervous system (CNS) and thought to play important roles in memory formation, neuritogenesis, synaptic transmission, and other neural functions. Although several molecular species of gangliosides have been characterized and their individual functions elucidated, their differential distribution in the CNS are not well understood. In particular, whether the different molecular species show different distribution patterns in the brain remains unclear. We report the distinct and characteristic distributions of ganglioside molecular species, as revealed by imaging mass spectrometry (IMS). This technique can discriminate the molecular species, raised from both oligosaccharide and ceramide structure by determining the difference of the mass-to-charge ratio, and structural analysis by tandem mass spectrometry. Gangliosides in the CNS are characterized by the structure of the long-chain base (LCB) in the ceramide moiety. The LCB of the main ganglioside species has either 18 or 20 carbons (i.e., C18- or C20-sphingosine); we found that these 2 types of gangliosides are differentially distributed in the mouse brain. While the C18- species was widely distributed throughout the frontal brain, the C20-species selectively localized along the entorhinal-hippocampus projections, especially in the molecular layer (ML) of the dentate gyrus (DG). We revealed development- and aging-related accumulation of the C20 species in the ML-DG. Thus it is possible to consider that this brain-region specific regulation of LCB chain length is particularly important for the distinct function in cells of CNS.	[Sugiura, Yuki; Setou, Mitsutoshi] Tokyo Inst Technol, Dept Biosci & Biotechnol, Kanagawa, Japan; [Sugiura, Yuki; Konishi, Yoshiyuki; Yamada, Maki K.; Setou, Mitsutoshi] Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo, Japan; [Shimma, Shuichi; Setou, Mitsutoshi] Natl Inst Physiol Sci, Okazaki, Aichi, Japan; [Setou, Mitsutoshi] Hamamatsu Med Sch, Dept Mol Anat, Hamamatsu, Shizuoka, Japan	Tokyo Institute of Technology; Mitsubishi Kagaku Institute of Life Sciences (MITILS); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Hamamatsu University School of Medicine	Sugiura, Y (corresponding author), Tokyo Inst Technol, Dept Biosci & Biotechnol, Kanagawa, Japan.	setou@hama-med.ac.jp	Yamada, Maki K./A-1573-2015; Yamada, Maki/U-5251-2019; Shimma, Shuichi/L-5975-2019	Yamada, Maki K./0000-0002-1956-6069; Sugiura, Yuki/0000-0002-6983-8958	SENTAN program of the Japan Science and Technology Agency; Japan Society for the Promotion of Science [WAKATE S]	SENTAN program of the Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the SENTAN program of the Japan Science and Technology Agency, and a WAKATE S grant from the Japan Society for the Promotion of Science to M. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CALDERON RO, 1995, J NEUROCHEM, V64, P424; Chaurand P, 2008, MOL CELL PROTEOMICS, V7, P411, DOI 10.1074/mcp.M700190-MCP200; GARRETT TJ, 2006, INT J MASS SPECTROM, V260, P11; GLASIER MM, 1995, NEUROBIOL LEARN MEM, V64, P203, DOI 10.1006/nlme.1995.0003; GomezIsla T, 1996, J NEUROSCI, V16, P4491; HANDA S, 1984, J BIOCHEM-TOKYO, V95, P1323, DOI 10.1093/oxfordjournals.jbchem.a134738; Harvey DJ, 1996, J CHROMATOGR A, V720, P429, DOI 10.1016/0021-9673(95)00307-X; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V146, P219, DOI 10.1002/cne.901460206; Iwabuchi K, 1998, J BIOL CHEM, V273, P9130, DOI 10.1074/jbc.273.15.9130; Iwabuchi K, 1998, J BIOL CHEM, V273, P33766, DOI 10.1074/jbc.273.50.33766; JUNGALWALA FB, 1979, J LIPID RES, V20, P579; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kasahara K, 2000, J BIOL CHEM, V275, P34701, DOI 10.1074/jbc.M003163200; KOTANI M, 1995, BRAIN RES, V700, P40, DOI 10.1016/0006-8993(95)00923-E; KOTANI M, 1993, GLYCOBIOLOGY, V3, P137, DOI 10.1093/glycob/3.2.137; MANSSON JE, 1978, J NEUROCHEM, V30, P273, DOI 10.1111/j.1471-4159.1978.tb07064.x; MASCO D, 1990, BRAIN RES, V514, P84, DOI 10.1016/0006-8993(90)90438-H; MASSERINI M, 1990, BIOCHEM J, V271, P107, DOI 10.1042/bj2710107; PALESTINI P, 1991, J NEUROCHEM, V56, P2048, DOI 10.1111/j.1471-4159.1991.tb03465.x; PALESTINI P, 1990, J NEUROCHEM, V54, P230, DOI 10.1111/j.1471-4159.1990.tb13305.x; Powell AK, 1996, RAPID COMMUN MASS SP, V10, P1027; Prinetti A, 1999, J BIOL CHEM, V274, P20916, DOI 10.1074/jbc.274.30.20916; RAHMANN H, 1995, BEHAV BRAIN RES, V66, P105, DOI 10.1016/0166-4328(94)00131-X; Ramirez JJ, 1998, RESTOR NEUROL NEUROS, V12, P203; RAMIREZ OA, 1990, BRAIN RES, V506, P291, DOI 10.1016/0006-8993(90)91264-H; Rubakhin SS, 2007, CURR PHARM DESIGN, V13, P3325, DOI 10.2174/138161207782360708; SAMBASIVARAO K, 1964, J LIPID RES, V15, P103; Schwartz SA, 2003, J MASS SPECTROM, V38, P699, DOI 10.1002/jms.505; SCHWARZ HP, 1967, J NEUROCHEM, V14, P91, DOI 10.1111/j.1471-4159.1967.tb09497.x; Sekiya S, 2005, ANAL CHEM, V77, P4962, DOI 10.1021/ac050287o; SHIMMA S, 2007, J MASS SPECTROM SOC, V55; Shimma S, 2008, ANAL CHEM, V80, P878, DOI 10.1021/ac071301v; Shimma S, 2007, J CHROMATOGR B, V855, P98, DOI 10.1016/j.jchromb.2007.02.037; Sonnino S, 2000, BBA-REV BIOMEMBRANES, V1469, P63, DOI 10.1016/S0005-2736(00)00210-8; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; SUGIURA Y, 2006, J MASS SPECTROM SOC, V54, P4; Sugiura Y, 2006, ANAL CHEM, V78, P8227, DOI 10.1021/ac060974v; Sugiyama E, 1997, GLYCOBIOLOGY, V7, P719, DOI 10.1093/glycob/7.5.719; VALSECCHI M, 1993, J NEUROCHEM, V60, P193, DOI 10.1111/j.1471-4159.1993.tb05837.x; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; VANECHTEN G, 1993, J BIOL CHEM, V268, P5341; YU RK, 1988, J NEUROCHEM, V50, P1825, DOI 10.1111/j.1471-4159.1988.tb02484.x	42	113	118	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3232	10.1371/journal.pone.0003232	http://dx.doi.org/10.1371/journal.pone.0003232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800170	Green Submitted, Green Published, gold			2022-12-27	WOS:000264428400003
J	Fagundes, NJR; Kanitz, R; Bonatto, SL				Fagundes, Nelson J. R.; Kanitz, Ricardo; Bonatto, Sandro L.			A Reevaluation of the Native American MtDNA Genome Diversity and Its Bearing on the Models of Early Colonization of Beringia	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; TIME DEPENDENCY; REGION; ORIGIN; SINGLE; HAPLOGROUPS; EVOLUTION; MIGRATION; SEQUENCES; SELECTION	The Americas were the last continents to be populated by humans, and their colonization represents a very interesting chapter in our species' evolution in which important issues are still contentious or largely unknown. One difficult topic concerns the details of the early peopling of Beringia, such as for how long it was colonized before people moved into the Americas and the demography of this occupation. A recent work using mitochondrial genome ( mtDNA) data presented evidence for a so called "three-stage model'' consisting of a very early expansion into Beringia followed by,20,000 years of population stability before the final entry into the Americas. However, these results are in disagreement with other recent studies using similar data and methods. Here, we reanalyze their data to check the robustness of this model and test the ability of Native American mtDNA to discriminate details of the early colonization of Beringia. We apply the Bayesian Skyline Plot approach to recover the past demographic dynamic underpinning these events using different mtDNA data sets. Our results refute the specific details of the "three-stage model'', since the early stage of expansion into Beringia followed by a long period of stasis could not be reproduced in any mtDNA data set cleaned from non-Native American haplotypes. Nevertheless, they are consistent with a moderate population bottleneck in Beringia associated with the Last Glacial Maximum followed by a strong population growth around 18,000 years ago as suggested by other recent studies. We suggest that this bottleneck erased the signals of ancient demographic history from recent Native American mtDNA pool, and conclude that the proposed early expansion and occupation of Beringia is an artifact caused by the misincorporation of non-Native American haplotypes.	[Fagundes, Nelson J. R.; Kanitz, Ricardo; Bonatto, Sandro L.] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil; [Fagundes, Nelson J. R.] Univ Fed Rio Grande do Sul, Dept Genet Inst Biociencias, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul	Fagundes, NJR (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil.	slbonatto@pucrs.br	Kanitz, Ricardo/F-4177-2012; Bonatto, Sandro L/A-1240-2010; Fagundes, Nelson/F-7490-2014	Kanitz, Ricardo/0000-0003-4759-0207; Bonatto, Sandro L/0000-0002-0064-467X; Fagundes, Nelson/0000-0003-0456-0323	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grants to SLB, and by CNPq scholarships to RK and NJRF.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Bandelt HJ, 2008, INT J LEGAL MED, V122, P11, DOI 10.1007/s00414-006-0151-5; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Battilana J, 2007, ANN HUM GENET, V71, P64, DOI 10.1111/j.1469-1809.2006.00296.x; Battilana J, 2006, ANN HUM BIOL, V33, P142, DOI 10.1080/03014460500487347; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Bonatto SL, 1997, AM J HUM GENET, V61, P1413, DOI 10.1086/301629; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dixon E.J., 1993, QUEST ORIGINS 1 AM; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ellis N, 2002, GENOME RES, V12, P339; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fagundes NJR, 2005, ANN HUM GENET, V69, P389, DOI 10.1046/j.1529-8817.2005.00163.x; FLADMARK KR, 1979, AM ANTIQUITY, V44, P55, DOI 10.2307/279189; Forster P, 1996, AM J HUM GENET, V59, P935; GIBERT MTP, 2008, SCIENCE, V320, P786; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; GONZALESJOSE R, 2008, AM J PHYS A IN PRESS; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kitchen A, 2008, MOL PHYLOGENET EVOL, V46, P673, DOI 10.1016/j.ympev.2007.09.005; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Salzano FM, 2007, ANTHROPOLOGICAL GENETICS: THEORY, METHODS AND APPLICATIONS, P433; Schurr TG, 2004, ANNU REV ANTHROPOL, V33, P551, DOI 10.1146/annurev.anthro.33.070203.143932; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185	40	54	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3157	10.1371/journal.pone.0003157	http://dx.doi.org/10.1371/journal.pone.0003157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LB	18797501	Green Published, Green Submitted, gold			2022-12-27	WOS:000264428200001
J	Larsson, O; Diebold, D; Fan, DH; Peterson, M; Nho, RS; Bitterman, PB; Henke, CA				Larsson, Ola; Diebold, Deanna; Fan, Danhua; Peterson, Mark; Nho, Richard Seonghun; Bitterman, Peter B.; Henke, Craig A.			Fibrotic Myofibroblasts Manifest Genome-Wide Derangements of Translational Control	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; HUMAN LUNG FIBROBLASTS; I COLLAGEN MATRICES; GENE-EXPRESSION; MESENCHYMAL TRANSITION; EPITHELIAL-CELLS; MESSENGER-RNAS; APOPTOSIS; CONTRACTION; VIABILITY	Background: As a group, fibroproliferative disorders of the lung, liver, kidney, heart, vasculature and integument are common, progressive and refractory to therapy. They can emerge following toxic insults, but are frequently idiopathic. Their enigmatic propensity to resist therapy and progress to organ failure has focused attention on the myofibroblast-the primary effector of the fibroproliferative response. We have recently shown that aberrant beta 1 integrin signaling in fibrotic fibroblasts results in defective PTEN function, unrestrained Akt signaling and subsequent activation of the translation initiation machinery. How this pathological integrin signaling alters the gene expression pathway has not been elucidated. Results: Using a systems approach to study this question in a prototype fibrotic disease, Idiopathic Pulmonary Fibrosis (IPF); here we show organized changes in the gene expression pathway of primary lung myofibroblasts that persist for up to 9 sub-cultivations in vitro. When comparing IPF and control myofibroblasts in a 3-dimensional type I collagen matrix, more genes differed at the level of ribosome recruitment than at the level of transcript abundance, indicating pathological translational control as a major characteristic of IPF myofibroblasts. To determine the effect of matrix state on translational control, myofibroblasts were permitted to contract the matrix. Ribosome recruitment in control myofibroblasts was relatively stable. In contrast, IPF cells manifested large alterations in the ribosome recruitment pattern. Pathological studies suggest an epithelial origin for IPF myofibroblasts through the epithelial to mesenchymal transition (EMT). In accord with this, we found systems-level indications for TGF-beta-driven EMT as one source of IPF myofibroblasts. Conclusions: These findings establish the power of systems level genome-wide analysis to provide mechanistic insights into fibrotic disorders such as IPF. Our data point to derangements of translational control downstream of aberrant beta 1 integrin signaling as a fundamental component of IPF pathobiology and indicates that TGF-beta-driven EMT is one source for IPF myofibroblasts.	[Larsson, Ola; Diebold, Deanna; Fan, Danhua; Peterson, Mark; Nho, Richard Seonghun; Bitterman, Peter B.; Henke, Craig A.] Univ Minnesota, Dept Med, Div Pulm, Minneapolis, MN 55455 USA; [Larsson, Ola] McGill Univ, Dept Biochem, Montreal, PQ H3A 2T5, Canada; [Fan, Danhua] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; McGill University; University of Minnesota System; University of Minnesota Twin Cities	Larsson, O (corresponding author), Univ Minnesota, Dept Med, Div Pulm, Box 736 UMHC, Minneapolis, MN 55455 USA.	ola.larsson@mail.mcgill.ca	Larsson, Ola/F-8151-2013	BITTERMAN, PETER/0000-0002-7995-7117; Larsson, Ola/0000-0003-1412-1308	ALA [RT-10053N, HL073719, HL076779, HL 074882]; Swedish Research Council [post-doctoral fellowship]; Knut and Alice Wallenberg foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073719, R01HL076779, R01HL074882] Funding Source: NIH RePORTER	ALA; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by ALA grant RT-10053N (to D. Diebold), HL073719, HL076779 (P.B.), and HL 074882 (C.H.). O.L. was supported by a post-doctoral fellowship from the Swedish Research Council during the majority of the study and a fellowship from the Knut and Alice Wallenberg foundation during the completion of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2005, BIOINFORMATICS, V21, P2988, DOI 10.1093/bioinformatics/bti457; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Aono Y, 2005, AM J RESP CRIT CARE, V171, P1279, DOI 10.1164/rccm.200404-531OC; BITTERMAN PB, 1991, FIBROPROLIFERATIVE D, pS81; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chilosi M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-95; Choi ES, 2004, AM J RESP CRIT CARE, V170, P508, DOI 10.1164/rccm.200401-002OC; Cosgrove GP, 2004, AM J RESP CRIT CARE, V170, P242, DOI 10.1164/rccm.200308-1151OC; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Enomoto N, 2006, CHEST, V130, P22, DOI 10.1378/chest.130.1.22; Fluck J, 1998, J INVEST DERMATOL, V110, P153, DOI 10.1046/j.1523-1747.1998.00095.x; Frankel SK, 2006, AM J RESP CELL MOL, V34, P293, DOI 10.1165/rcmb.2005-0155OC; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Gruber MP, 2006, AM J RESP CELL MOL, V35, P65, DOI 10.1165/rcmb.2004-0261OC; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Kaminski Naftali, 2006, Proc Am Thorac Soc, V3, P339, DOI 10.1513/pats.200601-011TK; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; LADIN DA, 1998, WOUND REPAIR REGEN, P28; Larsson O, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-129; Larsson O, 2007, CANCER RES, V67, P6814, DOI 10.1158/0008-5472.CAN-07-0752; Larsson O, 2006, NUCLEIC ACIDS RES, V34, P4375, DOI 10.1093/nar/gkl558; Larsson O, 2006, OMICS, V10, P381, DOI 10.1089/omi.2006.10.381; Li S, 2003, J BIOL CHEM, V278, P3015, DOI 10.1074/jbc.M208821200; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Moodley YP, 2004, J PATHOL, V202, P486, DOI 10.1002/path.1531; Moodley YP, 2003, AM J PATHOL, V163, P345, DOI 10.1016/S0002-9440(10)63658-9; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Nicholson AG, 2002, AM J RESP CRIT CARE, V166, P173, DOI 10.1164/rccm.2109039; Norman JT, 1999, EXP NEPHROL, V7, P167; Oostendorp RAJ, 1999, LEUKEMIA, V13, P499, DOI 10.1038/sj.leu.2401373; Pacanowski MA, 2005, ANN PHARMACOTHER, V39, P1678, DOI 10.1345/aph.1E672; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Renzoni EA, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-24; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Santiago B, 2001, ARTHRITIS RHEUM-US, V44, P1667, DOI 10.1002/1529-0131(200107)44:7<1667::AID-ART291>3.0.CO;2-Y; SCHUTTERT JB, 2003, PFLUGERS ARCH, P387; SELMAN M, 1986, THORAX, V41, P355, DOI 10.1136/thx.41.5.355; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200; TORRY DJ, 1994, J CLIN INVEST, V93, P1525, DOI 10.1172/JCI117131; Tsujita-Kyutoku M, 2005, IN VIVO, V19, P959; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wennmalm K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r109; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; WYNN TA, 2004, FIBROTIC DIS T H1 TH, P583; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	56	81	84	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3220	10.1371/journal.pone.0003220	http://dx.doi.org/10.1371/journal.pone.0003220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795102	Green Published, gold, Green Submitted			2022-12-27	WOS:000264428000004
J	Bonde, S; Chan, KM; Zavazava, N				Bonde, Sabrina; Chan, Kun-Ming; Zavazava, Nicholas			ES-Cell Derived Hematopoietic Cells Induce Transplantation Tolerance	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HOXB4; ENGRAFTMENT; EXPRESSION; EXPANSION; PROMOTES; CONFERS	Background: Bone marrow cells induce stable mixed chimerism under appropriate conditioning of the host, mediating the induction of transplantation tolerance. However, their strong immunogenicity precludes routine use in clinical transplantation due to the need for harsh preconditioning and the requirement for toxic immunosuppression to prevent rejection and graft-versus-host disease. Alternatively, embryonic stem (ES) cells have emerged as a potential source of less immunogenic hematopoietic progenitor cells (HPCs). Up till now, however, it has been difficult to generate stable hematopoietic cells from ES cells. Methodology/Principal Findings: Here, we derived CD45(+) HPCs from HOXB4-transduced ES cells and showed that they poorly express MHC antigens. This property allowed their long-term engraftment in sublethally irradiated recipients across MHC barriers without the need for immunosuppressive agents. Although donor cells declined in peripheral blood over 2 months, low level chimerism was maintained in the bone marrow of these mice over 100 days. More importantly, chimeric animals were protected from rejection of donor-type cardiac allografts. Conclusions: Our data show, for the first time, the efficacy of ES-derived CD45(+) HPCs to engraft in allogenic recipients without the use of immunosuppressive agents, there by protecting cardiac allografts from rejection.	[Bonde, Sabrina; Chan, Kun-Ming; Zavazava, Nicholas] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Chan, Kun-Ming] Chang Gung Univ, Coll Med, Chang Gung Memorial Hosp, Dept Gen Surg, Tao Yuan, Taiwan	University of Iowa; Chang Gung Memorial Hospital; Chang Gung University	Bonde, S (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	nicholas-zavazava@uiowa.edu			NIH/NHLBI; Department of Veterans Affairs; ROTRF	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs(US Department of Veterans Affairs); ROTRF	Grant Support: NIH/NHLBI; Department of Veterans Affairs; ROTRF. None of the sponsors were involved in the conducting, analysis or publication of the data.	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BILLINGHAM RE, 1956, NATURE, V178, P514, DOI 10.1038/178514a0; Bonde S, 2006, STEM CELLS, V24, P2192, DOI 10.1634/stemcells.2006-0022; Bowles KM, 2006, STEM CELLS, V24, P1359, DOI 10.1634/stemcells.2005-0210; Burt RK, 2004, J EXP MED, V199, P895, DOI 10.1084/jem.20031916; Chan KM, 2008, BLOOD, V111, P2953, DOI 10.1182/blood-2007-10-117366; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Haanstra KG, 2007, AM J TRANSPLANT, V7, P2236, DOI 10.1111/j.1600-6143.2007.01917.x; Honig GR, 2004, BLOOD CELL MOL DIS, V32, P5, DOI 10.1016/j.bcmd.2003.09.008; JUST U, 1991, CELL, V64, P1163, DOI 10.1016/0092-8674(91)90271-Y; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Pilat S, 2005, P NATL ACAD SCI USA, V102, P12101, DOI 10.1073/pnas.0505624102; Potocnik AJ, 1997, P NATL ACAD SCI USA, V94, P10295, DOI 10.1073/pnas.94.19.10295; Potocnik AJ, 1997, IMMUNOL LETT, V57, P131, DOI 10.1016/S0165-2478(97)00089-8; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Schiedlmeier B, 2003, BLOOD, V101, P1759, DOI 10.1182/blood-2002-03-0767; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; SYKES M, 1999, HEMATOPOETIC CELL TR, P300; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; WEISSMANN A, 1889, ESSAYS HEREDITARY KI, V25; Zavazava N, 1996, NAT MED, V2, P1005, DOI 10.1038/nm0996-1005; Zhang XB, 2006, PLOS MED, V3, P687, DOI 10.1371/journal.pmed.0030173	27	38	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3212	10.1371/journal.pone.0003212	http://dx.doi.org/10.1371/journal.pone.0003212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791641	Green Published, gold, Green Submitted			2022-12-27	WOS:000264427700007
J	Huang, YX; Krasnitz, M; Rabadan, R; Witten, DM; Song, Y; Levine, AJ; Ho, DD; Robins, H				Huang, Yaoxing; Krasnitz, Michael; Rabadan, Raul; Witten, Daniela M.; Song, Yang; Levine, Arnold J.; Ho, David D.; Robins, Harlan			A Recoding Method to Improve the Humoral Immune Response to an HIV DNA Vaccine	PLOS ONE			English	Article								This manuscript describes a novel strategy to improve HIV DNA vaccine design. Employing a new information theory based bioinformatic algorithm, we identify a set of nucleotide motifs which are common in the coding region of HIV, but are under-represented in genes that are highly expressed in the human genome. We hypothesize that these motifs contribute to the poor protein expression of gag, pol, and env genes from the c-DNAs of HIV clinical isolates. Using this approach and beginning with a codon optimized consensus gag gene, we recode the nucleotide sequence so as to remove these motifs without modifying the amino acid sequence. Transfecting the recoded DNA sequence into a human kidney cell line results in doubling the gag protein expression level compared to the codon optimized version. We then turn both sequences into DNA vaccines and compare induced antibody response in a murine model. Our sequence, which has the motifs removed, induces a five-fold increase in gag antibody response compared to the codon optimized vaccine.	[Huang, Yaoxing; Song, Yang; Ho, David D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Krasnitz, Michael; Rabadan, Raul; Levine, Arnold J.] Inst Advanced Study, Princeton, NJ USA; [Witten, Daniela M.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Robins, Harlan] Fred Hutchinson Canc Res Ctr, Computat Biol Grp, Seattle, WA USA	Rockefeller University; Institute for Advanced Study - USA; Stanford University; Fred Hutchinson Cancer Center	Huang, YX (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA.	hrobins@fhcrc.org	Rabadan, Raul/AAZ-7367-2020	Rabadan, Raul/0000-0001-7946-9255	Simons Foundation; Ambrose Monell Foundation; Leon Levy Foundation; Irene Diamond Fund	Simons Foundation; Ambrose Monell Foundation; Leon Levy Foundation; Irene Diamond Fund	This work was supported in part by the Simons Foundation, the Ambrose Monell Foundation, and the Leon Levy Foundation. YH, YS, and DH are supported in part by the Irene Diamond Fund.	Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Kotsopoulou E, 2000, J VIROL, V74, P4839, DOI 10.1128/JVI.74.10.4839-4852.2000; Laddy DJ, 2006, INT REV IMMUNOL, V25, P99, DOI 10.1080/08830180600785827; Liu MA, 2006, HUM GENE THER, V17, P1051, DOI 10.1089/hum.2006.17.1051; Robins H, 2005, J BACTERIOL, V187, P8370, DOI 10.1128/JB.187.24.8370-8374.2005; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997	6	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3214	10.1371/journal.pone.0003214	http://dx.doi.org/10.1371/journal.pone.0003214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791646	Green Published, gold, Green Submitted			2022-12-27	WOS:000264427700009
J	Muller, O; De Allegri, M; Becher, H; Tiendrebogo, J; Beiersmann, C; Ye, M; Kouyate, B; Sie, A; Jahn, A				Mueller, Olaf; De Allegri, Manuela; Becher, Heiko; Tiendrebogo, Justin; Beiersmann, Claudia; Ye, Maurice; Kouyate, Bocar; Sie, Ali; Jahn, Albrecht			Distribution Systems of Insecticide-Treated Bed Nets for Malaria Control in Rural Burkina Faso: Cluster-Randomized Controlled Trial	PLOS ONE			English	Article							MOSQUITO NETS; CHILD-MORTALITY; WASH RESISTANCE; YOUNG-CHILDREN; WESTERN KENYA; MORBIDITY; COVERAGE; AREA; TRANSMISSION; PREVENTION	Background: Insecticide-impregnated bed nets (ITNs) have been shown to be a highly effective tool against malaria in the endemic regions of sub-Saharan Africa (SSA). There are however different opinions about the role of ITN social marketing and ITN free distribution in the roll-out of ITN programmes. The objective of this study was to evaluate the effects of free ITN distribution through antenatal care services in addition to an ITN social marketing programme in an area typical for rural SSA. Methods: A cluster-randomised controlled ITN trial took place in the whole Kossi Province in north-western Burkina Faso, an area highly endemic for malaria. Twelve clusters were assigned to long-term ITN (Serena brand) social marketing plus free ITN (Serena brand) distribution to all pregnant women attending governmental antenatal care services (group A), and 13 clusters to ITN social marketing only (group B). The intervention took place during the rainy season of 2006 and thereafter. The trial was evaluated through a representative household survey at baseline and after one year. Serena ITN household ownership was the primary outcome measure. Findings: A total of 1052 households were visited at baseline in February 2006 and 1050 at follow-up in February 2007. Overall Serena ITN household ownership increased from 16% to 28% over the study period, with a significantly higher increase in group A (13% to 35%) than in group B (18% to 23%) (p<0.001). Interpretation: The free distribution of ITNs to pregnant women through governmental antenatal care services in addition to ITN social marketing substantially improved ITN household ownership in rural Burkina Faso.	[Mueller, Olaf; De Allegri, Manuela; Becher, Heiko; Beiersmann, Claudia; Jahn, Albrecht] Heidelberg Univ, Dept Trop Hyg & Publ Hlth, Heidelberg, Germany; [Tiendrebogo, Justin; Ye, Maurice; Sie, Ali] Ctr Rech Sante Nouna, Nouna, Burkina Faso; [Kouyate, Bocar] Ctr Natl Rech Format Paludisme, Ouagadougou, Burkina Faso	Ruprecht Karls University Heidelberg	Muller, O (corresponding author), Heidelberg Univ, Dept Trop Hyg & Publ Hlth, Heidelberg, Germany.	olaf.mueller@urz.uni-heidelberg.de	Becher, Heiko/ABI-1234-2020	SIE, Ali/0000-0002-3959-2520	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by a grant of the Deutsche Forschungsgemeinschaft (SFB 544 "Control of Tropical Infectious Diseases" at the Ruprecht-Karls-University Heidelberg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, INS TREAT MOSQ NETS; Binka FN, 1998, AM J TROP MED HYG, V59, P80, DOI 10.4269/ajtmh.1998.59.80; Binka FN, 2002, T ROY SOC TROP MED H, V96, P597, DOI 10.1016/S0035-9203(02)90321-4; Breman JG, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P413; Brentlinger PE, 2003, LANCET INFECT DIS, V3, P467, DOI 10.1016/s1473-3099(03)00717-5; *CDCP, 2005, MMWR-MORBID MORTAL W, V55, P913; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P994; Curtis C, 2003, LANCET INFECT DIS, V3, P304, DOI 10.1016/S1473-3099(03)00612-1; Dabire RK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-12; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; DAlessandro U, 1996, T ROY SOC TROP MED H, V90, P487, DOI 10.1016/S0035-9203(96)90289-8; Diallo DA, 2004, B WORLD HEALTH ORGAN, V82, P85; DOLAN G, 1993, T ROY SOC TROP MED H, V87, P620, DOI 10.1016/0035-9203(93)90262-O; Feachem RGA, 2007, JAMA-J AM MED ASSOC, V297, P2281, DOI 10.1001/jama.297.20.2281; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Frey C, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-70; Gimnig JE, 2005, TROP MED INT HEALTH, V10, P1022, DOI 10.1111/j.1365-3156.2005.01481.x; Gonzalez JO, 2002, T ROY SOC TROP MED H, V96, P370, DOI 10.1016/S0035-9203(02)90363-9; Grabowsky M, 2005, TROP MED INT HEALTH, V10, P1151, DOI 10.1111/j.1365-3156.2005.01502.x; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Hamel MJ, 2001, B WORLD HEALTH ORGAN, V79, P1014; Hanson K, 2003, B WORLD HEALTH ORGAN, V81, P269; Hawley WA, 2003, AM J TROP MED HYG, V68, P168, DOI 10.4269/ajtmh.2003.68.168; Hung LQ, 2002, B WORLD HEALTH ORGAN, V80, P660; Ilboudo-Sanogo E, 2001, T ROY SOC TROP MED H, V95, P353, DOI 10.1016/S0035-9203(01)90179-8; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kouyate B, 2007, PLOS MED, V4, P997, DOI 10.1371/journal.pmed.0040127; Kroeger A, 2004, T ROY SOC TROP MED H, V98, P152, DOI 10.1016/S0035-9203(03)00038-5; Lengeler C., 2004, COCHRANE LIB; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; Maxwell CA, 2002, TROP MED INT HEALTH, V7, P1003, DOI 10.1046/j.1365-3156.2002.00966.x; Milligan P, 2004, INT J EPIDEMIOL, V33, P469, DOI 10.1093/ije/dyh096; Muller O, 2006, B WORLD HEALTH ORGAN, V84, P120, DOI 10.2471/BLT.05.023150; Muller O, 2003, TROP MED INT HEALTH, V8, P853, DOI 10.1046/j.1365-3156.2003.01119.x; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; Muller O, 2001, BMJ-BRIT MED J, V322, P1567, DOI 10.1136/bmj.322.7302.1567; Muller O, 1997, SOC SCI MED, V44, P1903, DOI 10.1016/S0277-9536(96)00299-7; Mushi AK, 2003, HEALTH POLICY PLANN, V18, P163, DOI 10.1093/heapol/czg021; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Okrah J, 2002, TROP MED INT HEALTH, V7, P240, DOI 10.1046/j.1365-3156.2002.00856.x; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Schellenberg JRMA, 1999, T ROY SOC TROP MED H, V93, P225, DOI 10.1016/S0035-9203(99)90001-9; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50; TRAORE C, 2003, THESIS R KARLS U HEI; vanBortel W, 1996, TROP MED INT HEALTH, V1, P71, DOI 10.1046/j.1365-3156.1996.d01-14.x; Victora CG, 2004, LANCET, V364, P1541, DOI 10.1016/S0140-6736(04)17279-6; Whitty CJM, 2002, BMJ-BRIT MED J, V325, P1221, DOI 10.1136/bmj.325.7374.1221; WHO, 2002, WHOCDSRBM200243; Yates A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-52; ZIMICKI S, 1996, NET GAIN NEW METHOD, P111; [No title captured]	54	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3182	10.1371/journal.pone.0003182	http://dx.doi.org/10.1371/journal.pone.0003182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784840	gold, Green Submitted, Green Published			2022-12-27	WOS:000264425900004
J	Vyleta, NP; Smith, SM				Vyleta, Nicholas P.; Smith, Stephen M.			Fast Inhibition of Glutamate-Activated Currents by Caffeine	PLOS ONE			English	Article							RECEPTORS; RELEASE; CHANNEL	Background: Caffeine stimulates calcium-induced calcium release (CICR) in many cell types. In neurons, caffeine stimulates CICR presynaptically and thus modulates neurotransmitter release. Methodology/Principal Findings: Using the whole-cell patch-clamp technique we found that caffeine ( 20 mM) reversibly increased the frequency and decreased the amplitude of miniature excitatory postsynaptic currents (mEPSCs) in neocortical neurons. The increase in mEPSC frequency is consistent with a presynaptic mechanism. Caffeine also reduced exogenously applied glutamate-activated currents, confirming a separate postsynaptic action. This inhibition developed in tens of milliseconds, consistent with block of channel currents. Caffeine ( 20 mM) did not reduce currents activated by exogenous NMDA, indicating that caffeine block is specific to non-NMDA type glutamate receptors. Conclusions/Significance: Caffeine-induced inhibition of mEPSC amplitude occurs through postsynaptic block of non-NMDA type ionotropic glutamate receptors. Caffeine thus has both pre and postsynaptic sites of action at excitatory synapses.	[Vyleta, Nicholas P.; Smith, Stephen M.] Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, Portland, OR 97201 USA	Oregon Health & Science University	Vyleta, NP (corresponding author), Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	smisteph@ohsu.edu		Smith, Stephen/0000-0002-0331-7615	NINDS [R01-NS 43444]; Multidisciplinary Research Training in Pulmonary Medicine [1T32 HL083808]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043444] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Multidisciplinary Research Training in Pulmonary Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS (R01-NS 43444) and Multidisciplinary Research Training in Pulmonary Medicine Training Grant (1T32 HL083808).	Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; BEZPROZVANNY I, 1994, MOL BIOL CELL, V5, P97, DOI 10.1091/mbc.5.1.97; Cysneiros RM, 2007, CLIN PHARMACOL THER, V82, P54, DOI 10.1038/sj.clpt.6100211; DALY JW, 1983, CELL MOL NEUROBIOL, V3, P69, DOI 10.1007/BF00734999; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; EHRLICH BE, 1994, TRENDS PHARM SCI, V15; Gundlfinger A, 2007, J PHYSIOL-LONDON, V582, P263, DOI 10.1113/jphysiol.2007.132613; Liu XR, 2006, DRUG METAB DISPOS, V34, P1443, DOI 10.1124/dmd.105.008201; Martin ED, 2003, J NEUROPHYSIOL, V89, P3029, DOI 10.1152/jn.00601.2002; Morton-Jones RT, 2008, CELL CALCIUM, V43, P356, DOI 10.1016/j.ceca.2007.07.003; MRVOS RM, 1989, VET HUM TOXICOL, V31, P571; ROUSSEAU E, 1988, ARCH BIOCHEM BIOPHYS, V267, P75, DOI 10.1016/0003-9861(88)90010-0; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Simkus CRL, 2002, J PHYSIOL-LONDON, V545, P521, DOI 10.1113/jphysiol.2002.022103; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Traynelis SF, 1998, J NEUROSCI METH, V86, P25, DOI 10.1016/S0165-0270(98)00140-X; Wu XS, 2007, J NEUROSCI, V27, P3046, DOI 10.1523/JNEUROSCI.4415-06.2007	17	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3155	10.1371/journal.pone.0003155	http://dx.doi.org/10.1371/journal.pone.0003155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KD	18781199	gold, Green Published, Green Submitted			2022-12-27	WOS:000264425700006
J	Liu, G; Min, HY; Yue, SB; Chen, CZ				Liu, Gwen; Min, Hyeyoung; Yue, Sibiao; Chen, Chang-Zheng			Pre-miRNA Loop Nucleotides Control the Distinct Activities of mir-181a-1 and mir-181c in Early T Cell Development	PLOS ONE			English	Article								Background: Mature miRNAs can often be classified into large families, consisting of members with identical seeds (nucleotides 2 through 7 of the mature miRNAs) and highly homologous similar to 21-nucleotide (nt) mature miRNA sequences. However, it is unclear whether members of a miRNA gene family, which encode identical or nearly identical mature miRNAs, are functionally interchangeable in vivo. Methods and Findings: We show that mir-181a-1, but not mir-181c, can promote CD4 and CD8 double-positive (DP) T cell development when ectopically expressed in thymic progenitor cells. The distinct activities of mir-181a-1 and mir-181c are largely determined by their unique pre-miRNA loop nucleotides-not by the one-nucleotide difference in their mature miRNA sequences. Moreover, the activity of mir-181a-1 on DP cell development can be quantitatively influenced by nucleotide changes in its pre-miRNA loop region. We find that both the strength and the functional specificity of miRNA genes can be controlled by the pre-miRNA loop nucleotides. Intriguingly, we note that mutations in the pre-miRNA loop regions affect pre-miRNA and mature miRNA processing, but find no consistent correlation between the effects of pre-miRNA loop mutations on the levels of mature miRNAs and the activities of the mir-181a-1/c genes. Conclusions: These results demonstrate that pre-miRNA loop nucleotides play a critical role in controlling the activity of miRNA genes and that members of the same miRNA gene families could have evolved to achieve different activities via alterations in their pre-miRNA loop sequences, while maintaining identical or nearly identical mature miRNA sequences.	[Liu, Gwen; Min, Hyeyoung; Yue, Sibiao; Chen, Chang-Zheng] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA	Stanford University	Liu, G (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA.	czchen@stanford.edu	yue, sibiao/M-2610-2014	Chen, Chang-Zheng/0000-0002-1620-242X	NIH [R01-HL081612]; Baxter and Terman faculty awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baxter and Terman faculty awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH R01-HL081612 grant and the Baxter and Terman faculty awards (to C.-Z. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; EGUCHI Y, 1991, ANNU REV BIOCHEM, V60, P631, DOI 10.1146/annurev.bi.60.070191.003215; Forsyth D, 1907, Q J MED, V1, P287; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; TOMIZAWA J, 1984, CELL, V38, P861, DOI 10.1016/0092-8674(84)90281-2; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	27	93	106	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3592	10.1371/journal.pone.0003592	http://dx.doi.org/10.1371/journal.pone.0003592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974849	Green Submitted, Green Published, gold			2022-12-27	WOS:000265131700013
J	Perez, LE; Desponts, C; Parquet, N; Kerr, WG				Perez, Lia E.; Desponts, Caroline; Parquet, Nancy; Kerr, William G.			SH2-Inositol Phosphatase 1 Negatively Influences Early Megakaryocyte Progenitors	PLOS ONE			English	Article								Background: The SH2-containing-5'-inositol phosphatase-1 (SHIP) influences signals downstream of cytokine/chemokine receptors that play a role in megakaryocytopoiesis, including thrombopoietin, stromal-cell-derived-Factor-1/CXCL-12 and interleukin-3. We hypothesize that SHIP might control megakaryocytopoiesis through effects on proliferation of megakaryocyte progenitors (MKP) and megakaryocytes (MK). Methodology and Principal Findings: Herein, we report the megakaryocytic phenotype and MK functional assays of hematopoietic organs of two strains of SHIP deficient mice with deletion of the SHIP promoter/first exon or the inositol phosphatase domain. Both SHIP deficient strains exhibit a profound increase in MKP numbers in bone marrow (BM), spleen and blood as analyzed by flow cytometry (Lin(-)c-Kit(+)CD41(+)) and functional assays (CFU-MK). SHIP deficient MKP display increased phosphorylation of Signal Transducers and Activators of Transcription 3 (STAT-3), protein kinase B (PKB/AKT) and extracellular signal-regulated kinases (ERKs). Despite increased MKP content, total body number of mature MK (Lin(-)c-kit(-)CD41(+)) are not significantly changed as SHIP deficient BM contains reduced MK while spleen MK numbers are increased. Reduction of CXCR-4 expression in SHIP deficient MK may influence MK localization to the spleen instead of the BM. Endomitosis, process involved in MK maturation, was preserved in SHIP deficient MK. Circulating platelets and red blood cells are also reduced in SHIP deficient mice. Conclusions/Significance: SHIP may play an important role in regulation of essential signaling pathways that control early megakaryocytopoiesis in vivo.	[Parquet, Nancy] H Lee Moffit Comprehens Canc Ctr & Res Inst, Blood & Marrow Transplantat Program, Tampa, FL USA; [Desponts, Caroline; Kerr, William G.] H Lee Moffitt Comprehens Canc Ctr & Res Inst, Immunol Program, Tampa, FL USA; [Desponts, Caroline] Scripps Res Inst, Dept Chem, San Diego, CA USA	H Lee Moffitt Cancer Center & Research Institute; Scripps Research Institute	Perez, LE (corresponding author), H Lee Moffit Comprehens Canc Ctr & Res Inst, Blood & Marrow Transplantat Program, Tampa, FL USA.	William.Kerr@moffitt.org	Kerr, William G/B-8616-2015	Kerr, William G/0000-0002-4720-7135	NIH [RO1 DK54767, RO1 HL72523]; Moffitt Cancer Center; NHLBI [1 K08 HL77662-01A1]; Newman Scholar of the Leukemia and Lymphoma Society of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL077662, R01HL072523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054767] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moffitt Cancer Center; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Newman Scholar of the Leukemia and Lymphoma Society of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the NIH (RO1 DK54767, RO1 HL72523) and academic development funds from Moffitt Cancer Center. LEP is supported by NHLBI K08 Career Development Award (1 K08 HL77662-01A1). WGK is The Newman Scholar of the Leukemia and Lymphoma Society of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; BURSTEIN SA, 1981, J CELL PHYSIOL, V109, P333, DOI 10.1002/jcp.1041090217; BURSTEIN SA, 1983, CLIN HAEMATOL, V12, P3; Chernock RD, 2001, BLOOD, V97, P608, DOI 10.1182/blood.V97.3.608; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; Desponts C, 2006, BLOOD, V107, P4338, DOI 10.1182/blood-2005-12-5021; Drachman JG, 1997, BLOOD, V89, P483, DOI 10.1182/blood.V89.2.483; Drachman JG, 1997, P NATL ACAD SCI USA, V94, P2350, DOI 10.1073/pnas.94.6.2350; Geddis AE, 2001, J BIOL CHEM, V276, P34473, DOI 10.1074/jbc.M105178200; Giuriato S, 1997, J BIOL CHEM, V272, P26857, DOI 10.1074/jbc.272.43.26857; Giuriato S, 2003, BIOCHEM J, V376, P199, DOI 10.1042/BJ20030581; Hamada T, 1998, J EXP MED, V188, P539, DOI 10.1084/jem.188.3.539; HARKER LA, 1969, J CLIN INVEST, V48, P963, DOI 10.1172/JCI106077; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Helgason CD, 2003, BLOOD, V102, P3541, DOI 10.1182/blood-2002-12-3939; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hodohara K, 2000, BLOOD, V95, P769, DOI 10.1182/blood.V95.3.769.003a49_769_775; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; Kaushansky K, 1998, NEW ENGL J MED, V339, P746, DOI 10.1056/NEJM199809103391107; KAUSHANSKY K, 1994, STEM CELLS, V12, P91; KAUSHANSKY K, 1994, STEM CELLS S1, V12, P96; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; Kim CH, 1999, J CLIN INVEST, V104, P1751, DOI 10.1172/JCI7310; Kuter D J, 1996, Stem Cells, V14 Suppl 1, P88; Lane WJ, 2000, BLOOD, V96, P4152; Lannutti BJ, 2006, ONCOGENE, V25, P3316, DOI 10.1038/sj.onc.1209351; LIU L, 1994, MOL CELL BIOL, V14, P6926, DOI 10.1128/MCB.14.10.6926; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; LOK S, 1994, STEM CELLS, V12, P586, DOI 10.1002/stem.5530120606; LOK S, 1994, NATURE, V369, P565, DOI 10.1038/369565a0; MOODY JL, 2004, BLOOD; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Perez LE, 2004, EXP HEMATOL, V32, P300, DOI 10.1016/j.exphem.2003.12.005; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Wang JF, 1998, BLOOD, V92, P756, DOI 10.1182/blood.V92.3.756.415k36_756_764; Wang JW, 2002, SCIENCE, V295, P2094, DOI 10.1126/science.1068438	37	15	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3565	10.1371/journal.pone.0003565	http://dx.doi.org/10.1371/journal.pone.0003565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958162	Green Submitted, Green Published, gold			2022-12-27	WOS:000265131100021
J	Meeren, HKM; Hadjikhani, N; Ahlfors, SP; Hamalainen, MS; de Gelder, B				Meeren, Hanneke K. M.; Hadjikhani, Nouchine; Ahlfors, Seppo P.; Hamalainen, Matti S.; de Gelder, Beatrice			Early Category-Specific Cortical Activation Revealed by Visual Stimulus Inversion	PLOS ONE			English	Article							HUMAN EXTRASTRIATE CORTEX; DEPTH-RECORDED POTENTIALS; EMOTIONAL BODY LANGUAGE; SURFACE-BASED ANALYSIS; FACE-SELECTIVE CORTEX; UPSIDE-DOWN FACES; SPATIAL-FREQUENCY; INFEROTEMPORAL CORTEX; SPATIOTEMPORAL STAGES; COORDINATE SYSTEM	Visual categorization may already start within the first 100-ms after stimulus onset, in contrast with the long-held view that during this early stage all complex stimuli are processed equally and that category-specific cortical activation occurs only at later stages. The neural basis of this proposed early stage of high-level analysis is however poorly understood. To address this question we used magnetoencephalography and anatomically-constrained distributed source modeling to monitor brain activity with millisecond-resolution while subjects performed an orientation task on the upright and upside-down presented images of three different stimulus categories: faces, houses and bodies. Significant inversion effects were found for all three stimulus categories between 70-100-ms after picture onset with a highly category-specific cortical distribution. Differential responses between upright and inverted faces were found in well-established face-selective areas of the inferior occipital cortex and right fusiform gyrus. In addition, early category-specific inversion effects were found well beyond visual areas. Our results provide the first direct evidence that category-specific processing in high-level category-sensitive cortical areas already takes place within the first 100-ms of visual processing, significantly earlier than previously thought, and suggests the existence of fast category-specific neocortical routes in the human brain.	[Meeren, Hanneke K. M.; de Gelder, Beatrice] Tilburg Univ, Cognit & Affect Neurosci Lab, NL-5000 LE Tilburg, Netherlands; [Hadjikhani, Nouchine; Ahlfors, Seppo P.; Hamalainen, Matti S.; de Gelder, Beatrice] Athinoula A Martinos Ctr Biomed Imaging, MGH, MIT, HMS, Charlestown, MA USA; [Hadjikhani, Nouchine; Ahlfors, Seppo P.; Hamalainen, Matti S.; de Gelder, Beatrice] Harvard Univ, MIT Hlth Sci & Technol, Cambridge, MA USA; [Hadjikhani, Nouchine] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland	Tilburg University; Massachusetts Institute of Technology (MIT); Harvard University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Meeren, HKM (corresponding author), Tilburg Univ, Cognit & Affect Neurosci Lab, NL-5000 LE Tilburg, Netherlands.	nouchine@nmr.mg.harvard.edu	Hamalainen, Matti S/C-8507-2013; Hadjikhani, Nouchine/C-2018-2008; Ahlfors, Seppo/P-3644-2016	Hadjikhani, Nouchine/0000-0003-4075-3106; Ahlfors, Seppo/0000-0001-7674-6931	National Institutes of Health [RO1NS44824, P41 RR14075]; Netherlands Organization for Scientific Research [R 95-403, 451-05-014]; MIND institute; Center for Functional Neuroimaging Technologies; The Whitaker Foundation [RG-01-0294]; Swiss National Foundation [PPOOB 110741]; HFSP [RGP0054/2004-C]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); MIND institute; Center for Functional Neuroimaging Technologies; The Whitaker Foundation; Swiss National Foundation(Swiss National Science Foundation (SNSF)); HFSP(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by the National Institutes of Health (NIH grant no. RO1NS44824 to NH) and the Netherlands Organization for Scientific Research (NWO grants no. R 95-403 and no. 451-05-014 to HKMM). MSH, SPA and BdG were supported by the MIND institute, MSH by the Center for Functional Neuroimaging Technologies (NIH grant P41 RR14075), SPA by The Whitaker Foundation (RG-01-0294) and NH by the Swiss National Foundation (PPOOB 110741). Partial support was also provided by the HFSP grant RGP0054/2004-C to BdG.	Aguirre GK, 1999, NEUROREPORT, V10, P189, DOI 10.1097/00001756-199901180-00036; Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; ALLISON T, 1994, CEREB CORTEX, V4, P544, DOI 10.1093/cercor/4.5.544; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; BARBEAU EJ, 2007, SPATIO TEMPORAL DYNA; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Berthoz A, 1997, PHILOS T R SOC B, V352, P1437, DOI 10.1098/rstb.1997.0130; Braeutigam S, 2001, NEUROREPORT, V12, P1531, DOI 10.1097/00001756-200105250-00046; Burgess N, 2001, NEUROIMAGE, V14, P439, DOI 10.1006/nimg.2001.0806; Butler T, 2006, NEUROIMAGE, V32, P445, DOI 10.1016/j.neuroimage.2006.03.030; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; de Gelder B, 2001, ACTA PSYCHOL, V107, P183, DOI 10.1016/S0001-6918(01)00024-5; de Gelder BC, 2003, P NATL ACAD SCI USA, V100, P13105, DOI 10.1073/pnas.1735530100; Debruille JB, 1998, NEUROREPORT, V9, P3349, DOI 10.1097/00001756-199810260-00002; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Downing PE, 2004, COGNITION, V93, pB27, DOI 10.1016/j.cognition.2003.10.010; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Ekman P., 1976, PICTURES FACIAL AFFE; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2006, NEUROPSYCHOLOGIA, V44, P1145, DOI 10.1016/j.neuropsychologia.2005.10.009; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; George N, 1997, NEUROREPORT, V8, P1417, DOI 10.1097/00001756-199704140-00019; GIVRE SJ, 1994, VISION RES, V34, P415, DOI 10.1016/0042-6989(94)90156-2; Gliga T, 2005, J COGNITIVE NEUROSCI, V17, P1328, DOI 10.1162/0898929055002481; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Greene E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000871; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P51, DOI 10.1016/0928-4257(94)90093-0; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Herrmann MJ, 2005, BRAIN TOPOGR, V18, P77, DOI 10.1007/s10548-005-0277-7; Herrmann MJ, 2005, J NEURAL TRANSM, V112, P1073, DOI 10.1007/s00702-004-0250-8; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Itier RJ, 2004, NEUROIMAGE, V21, P1518, DOI 10.1016/j.neuroimage.2003.12.016; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Itier RJ, 2006, BRAIN RES, V1115, P108, DOI 10.1016/j.brainres.2006.07.072; JEFFREYS DA, 1989, EXP BRAIN RES, V78, P193; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Kucian K, 2007, J NEURAL TRANSM, V114, P675, DOI 10.1007/s00702-006-0604-5; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; Lin FH, 2006, HUM BRAIN MAPP, V27, P1, DOI 10.1002/hbm.20155; Linkenkaer-Hansen K, 1998, NEUROSCI LETT, V253, P147, DOI 10.1016/S0304-3940(98)00586-2; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Mack ML, 2008, PSYCHON B REV, V15, P28, DOI 10.3758/PBR.15.1.28; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Morris JP, 2007, NEUROPSYCHOLOGIA, V45, P3087, DOI 10.1016/j.neuropsychologia.2007.05.020; Mouchetant-Rostaing Y, 2000, NEUROREPORT, V11, P2521, DOI 10.1097/00001756-200008030-00035; Mouchetant-Rostaing Y, 2000, EUR J NEUROSCI, V12, P303, DOI 10.1046/j.1460-9568.2000.00888.x; Okazaki Y, 2007, BIOPSYCHOSOC MED, V1, DOI 10.1186/1751-0759-1-23; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Portin K, 1999, EXP BRAIN RES, V124, P287, DOI 10.1007/s002210050625; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Righart R, 2007, P NATL ACAD SCI USA, V104, P17234, DOI 10.1073/pnas.0707753104; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Seeck M, 1997, NEUROLOGY, V49, P1312, DOI 10.1212/WNL.49.5.1312; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Tamietto M, 2007, J COGNITIVE NEUROSCI, V19, P445, DOI 10.1162/jocn.2007.19.3.445; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TANAKA K, 1993, SCIENCE, V262, P685, DOI 10.1126/science.8235589; Tanskanen T, 2005, CEREB CORTEX, V15, P526, DOI 10.1093/cercor/bhh152; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; Thierry G, 2006, NEUROIMAGE, V32, P871, DOI 10.1016/j.neuroimage.2006.03.060; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tsao DY, 2008, NAT NEUROSCI, V11, P877, DOI 10.1038/nn.2158; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; Van Rullen R, 1998, BIOSYSTEMS, V48, P229, DOI 10.1016/S0303-2647(98)00070-7; VanRullen R, 2002, VISION RES, V42, P2593, DOI 10.1016/S0042-6989(02)00298-5; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Watanabe S, 2003, NEUROSCIENCE, V116, P879, DOI 10.1016/S0306-4522(02)00752-2; Winston JS, 2003, CURR BIOL, V13, P1824, DOI 10.1016/j.cub.2003.09.038; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	115	48	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3503	10.1371/journal.pone.0003503	http://dx.doi.org/10.1371/journal.pone.0003503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IH	18946504	Green Published, Green Submitted, gold			2022-12-27	WOS:000265126200006
J	Mkwanazi, NB; Patel, D; Newell, ML; Rollins, NC; Coutsoudis, A; Coovadia, HM; Bland, RM				Mkwanazi, Ntombizodumo B.; Patel, Deven; Newell, Marie-Louise; Rollins, Nigel C.; Coutsoudis, A.; Coovadia, H. M.; Bland, R. M.			Rapid Testing May Not Improve Uptake of HIV Testing and Same Day Results in a Rural South African Community: A Cohort Study of 12,000 Women	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; PREVENTION; ACCEPTABILITY; INTRAPARTUM; ZIDOVUDINE; NEVIRAPINE; UGANDA; TRIAL	Background: Rapid testing of pregnant women aims to increase uptake of HIV testing and results and thus optimize care. We report on the acceptability of HIV counselling and testing, and uptake of results, before and after the introduction of rapid testing in this area. Methods and Principal Findings: HIV counsellors offered counselling and testing to women attending 8 antenatal clinics, prior to enrolment into a study examining infant feeding and postnatal HIV transmission. From August 2001 to April 2003, blood was sent for HIV ELISA testing in line with the Prevention of Mother-to-Child Transmission (PMTCT) programme in the district. From May 2003 to September 2004 women were offered a rapid HIV test as part of the PMTCT programme, but also continued to have ELISA testing for study purposes. Of 12,323 women counselled, 5,879 attended clinic prior to May 2003, and 6,444 after May 2003 when rapid testing was introduced; of whom 4,324 (74.6%) and 4,810 (74.6%) agreed to have an HIV test respectively. Of the 4,810 women who had a rapid HIV test, only 166 (3.4%) requested to receive their results on the same day as testing, the remainder opted to return for results at a later appointment. Women with secondary school education were less likely to agree to testing than those with no education (AOR 0.648, p < 0.001), as were women aged 2135 (AOR 0.762, p < 0.001) and > 35 years (AOR 0.756, p < 0.01) compared to those < 20 years. Conclusions: Contrary to other reports, few women who had rapid tests accepted their HIV results the same day. Finding strategies to increase the proportion of pregnant women knowing their HIV results is critical so that appropriate care can be given.	[Mkwanazi, Ntombizodumo B.; Newell, Marie-Louise; Bland, R. M.] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa; [Patel, Deven; Newell, Marie-Louise] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Rollins, Nigel C.; Coutsoudis, A.] Univ KwaZulu Natal, Dept Paediat & Child Hlth, Durban, South Africa; [Coovadia, H. M.] Univ KwaZulu Natal, Ctr HIV AIDS Networking, Durban, South Africa; [Bland, R. M.] Univ Glasgow, Div Dev Med, Glasgow G12 8QQ, Lanark, Scotland	University of Kwazulu Natal; University of London; University College London; University of Kwazulu Natal; University of Kwazulu Natal; University of Glasgow	Mkwanazi, NB (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa.	rbland@africacentre.ac.za	Mkwanazi, Ntombizodumo/AAS-9635-2020; Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Bland, Ruth/0000-0003-1675-9268; Mkwanazi, Ntombizodumo Brilliant/0000-0003-2868-5905; Patel, Deven/0000-0002-1154-3444	Wellcome Trust, UK [063009/Z/00/2, 050534]	Wellcome Trust, UK(Wellcome Trust)	This study was supported by grants from Wellcome Trust, UK (#063009/Z/00/2 and #050534).	Bajunirwe Francis, 2005, AIDS Res Ther, V2, P10, DOI 10.1186/1742-6405-2-10; COOVADIA H, 2007, LANCET, V369, P1607; Ekouevi DK, 2004, AIDS, V18, P697, DOI 10.1097/00002030-200403050-00018; Galvan FH, 2004, AIDS PATIENT CARE ST, V18, P15, DOI 10.1089/108729104322740875; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hutchinson AB, 2006, AIDS, V20, P1597, DOI 10.1097/01.aids.0000238405.93249.16; Hutchinson PL, 2006, AIDS CARE, V18, P446, DOI 10.1080/09540120500213511; *KZ NAT PROV DEP H, 2003, PROT PHAS IMPL COMPR; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Matovu JKB, 2005, AIDS, V19, P503, DOI 10.1097/01.aids.0000162339.43310.33; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Pignatelli S, 2006, TROP MED INT HEALTH, V11, P350, DOI 10.1111/j.1365-3156.2006.01564.x; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Rollins NC, 2007, JAIDS-J ACQ IMM DEF, V44, P321, DOI 10.1097/QAI.0b013e31802ea4b0; TANSER F, 2007, INT J EPIDEMIOL, P1; Tanser F, 2006, SOC SCI MED, V63, P691, DOI 10.1016/j.socscimed.2006.01.015; Thielman NM, 2006, AM J PUBLIC HEALTH, V96, P114, DOI 10.2105/AJPH.2004.056796; *UNAIDS WHO, 2005, AIDS EP UPD; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; *WHO UNICEF UNAIDS, 2000, HIV INF FEED COUNS T; World Health Organization & Unicef, 1993, BREASTF COUNS TRAIN	21	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3501	10.1371/journal.pone.0003501	http://dx.doi.org/10.1371/journal.pone.0003501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IH	18946509	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000265126200005
J	Quintana, FJ; Solomon, A; Cohen, IR; Nussbaum, G				Quintana, Francisco J.; Solomon, Aderet; Cohen, Irun R.; Nussbaum, Gabriel			Induction of IgG3 to LPS via Toll-Like Receptor 4 Co-Stimulation	PLOS ONE			English	Article							CLASS-SWITCH RECOMBINATION; B-CELLS; MONOCLONAL-ANTIBODIES; CPG DNA; ACTIVATION; RESPONSES; IMMUNE; MICE; LIPOPOLYSACCHARIDE; INNATE	B-cells integrate antigen-specific signals transduced via the B-cell receptor (BCR) and antigen non-specific co-stimulatory signals provided by cytokines and CD40 ligation in order to produce IgG antibodies. Toll-like receptors (TLRs) also provide co-stimulation, but the requirement for TLRs to generate T-cell independent and T-cell dependent antigen specific antibody responses is debated. Little is known about the role of B-cell expressed TLRs in inducing antigen-specific antibodies to antigens that also activate TLR signaling. We found that mice lacking functional TLR4 or its adaptor molecule MyD88 harbored significantly less IgG3 natural antibodies to LPS, and required higher amounts of LPS to induce anti-LPS IgG3. In vitro, BCR and TLR4 signaling synergized, lowering the threshold for production of T-cell independent IgG3 and IL-10. Moreover, BCR and TLR4 directly associate through the transmembrane domain of TLR4. Thus, in vivo, BCR/TLR synergism could facilitate the induction of IgG3 antibodies against microbial antigens that engage both innate and adaptive B-cell receptors. Vaccines might exploit BCR/TLR synergism to rapidly induce antigen-specific antibodies before significant T-cell responses arise.	[Quintana, Francisco J.] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Quintana, Francisco J.; Cohen, Irun R.; Nussbaum, Gabriel] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Solomon, Aderet; Nussbaum, Gabriel] Hebrew Univ Jerusalem, Hadassah Sch Dental Med, Inst Dental Sci, IL-91905 Jerusalem, Israel	Harvard University; Harvard Medical School; Weizmann Institute of Science; Hebrew University of Jerusalem	Quintana, FJ (corresponding author), Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	fquintana@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020		Juvenile Diabetes Research Foundation International; Center for the Study of Emerging Diseases, Jerusalem; International Human Frontier Science Program Organization	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Center for the Study of Emerging Diseases, Jerusalem; International Human Frontier Science Program Organization(Human Frontier Science Program)	Part of the study was supported by a grant from the Juvenile Diabetes Research Foundation International. Aspects of the study were funded by a grant from the Center for the Study of Emerging Diseases, Jerusalem. FJQ was supported by a long-term fellowship from the International Human Frontier Science Program Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A., 2017, CELLULAR MOL IMMUNOL, P281; Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BOULIANNE GL, 1984, NATURE, V312, P643, DOI 10.1038/312643a0; BRIERE F, 1994, J EXP MED, V179, P757, DOI 10.1084/jem.179.2.757; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; COHEN IR, 1966, SCIENCE, V152, P1257, DOI 10.1126/science.152.3726.1257; Coutinho A, 1995, CURR OPIN IMMUNOL, V7, P812, DOI 10.1016/0952-7915(95)80053-0; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; DURHAM JA, 1988, J CLIN MICROBIOL, V26, P885, DOI 10.1128/JCM.26.5.885-889.1988; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Fang T, 2001, J IMMUNOL, V167, P3846, DOI 10.4049/jimmunol.167.7.3846; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Gianotti L, 1996, BURNS, V22, P120, DOI 10.1016/0305-4179(95)00100-X; Han JH, 2007, IMMUNITY, V27, P64, DOI 10.1016/j.immuni.2007.05.018; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; Hopkins WJ, 2003, J INFECT DIS, V187, P418, DOI 10.1086/367963; Hopkins WJ, 1998, INFECT IMMUN, V66, P2798, DOI 10.1128/IAI.66.6.2798-2802.1998; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; MINER KM, 1986, INFECT IMMUN, V52, P56, DOI 10.1128/IAI.52.1.56-62.1986; Nemazee D, 2006, NATURE, V441, pE4, DOI 10.1038/nature04875; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Quintana FJ, 2001, J AUTOIMMUN, V17, P191, DOI 10.1006/jaut.2001.0544; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rickert RC, 2005, CURR OPIN IMMUNOL, V17, P237, DOI 10.1016/j.coi.2005.03.001; Rifkin IR, 2003, NAT IMMUNOL, V4, P650, DOI 10.1038/ni0703-650; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SCOTT DW, 1970, CLIN EXP IMMUNOL, V6, P313; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Snapper CM, 1997, IMMUNITY, V6, P217, DOI 10.1016/S1074-7613(00)80324-6; SPELLMAN JM, 1979, INFECT IMMUN, V24, P371, DOI 10.1128/IAI.24.2.371-378.1979; Stavnezer J, 2000, CURR TOP MICROBIOL, V245, P127; Ueda Y, 2007, J IMMUNOL, V178, P3593, DOI 10.4049/jimmunol.178.6.3593; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6	53	27	27	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3509	10.1371/journal.pone.0003509	http://dx.doi.org/10.1371/journal.pone.0003509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IH	18946502	Green Published, Green Submitted, gold			2022-12-27	WOS:000265126200009
J	Guimaraes, AJ; Hamilton, AJ; Guedes, HLD; Nosanchuk, JD; Zancope-Oliveira, RM				Guimaraes, Allan Jefferson; Hamilton, Andrew John; Guedes, Herbert Leonel de M.; Nosanchuk, Joshua Daniel; Zancope-Oliveira, Rosely Maria			Biological Function and Molecular Mapping of M Antigen in Yeast Phase of Histoplasma capsulatum	PLOS ONE			English	Article								Histoplasmosis, due to the intracellular fungus Histoplasma capsulatum, can be diagnosed by demonstrating the presence of antibodies specific to the immunodominant M antigen. However, the role of this protein in the pathogenesis of histoplasmosis has not been elucidated. We sought to structurally and immunologically characterize the protein, determine yeast cell surface expression, and confirm catalase activity. A 3D-rendering of the M antigen by homology modeling revealed that the structures and domains closely resemble characterized fungal catalases. We generated monoclonal antibodies (mAbs) to the protein and determined that the M antigen is present on the yeast cell surface and in cell wall/cell membrane preparations. Similarly, we found that the majority of catalase activity was in extracts containing fungal surface antigens and that the M antigen is not significantly secreted by live yeast cells. The mAbs also identified unique epitopes on the M antigen. The localization of the M antigen to the cell surface of H. capsulatum yeast and the characterization of the protein's major epitopes have important implications since it demonstrates that although the protein may participate in protecting the fungus against oxidative stress it is also accessible to host immune cells and antibody.	[Guimaraes, Allan Jefferson; Nosanchuk, Joshua Daniel] Yeshiva Univ, Albert Einstein Coll Med, Dept Med & Microbiol & Immunol, Div Infect Dis, Bronx, NY USA; [Guimaraes, Allan Jefferson; Guedes, Herbert Leonel de M.; Zancope-Oliveira, Rosely Maria] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Setor Imunodiagnost, Lab Micol, Rio De Janeiro, Brazil; [Hamilton, Andrew John] Kings Coll London, Guys Hosp, St Johns Inst Dermatol, London, England; [Guedes, Herbert Leonel de M.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Bioquim Proteinas Peptideos, Rio De Janeiro, Brazil	Yeshiva University; Albert Einstein College of Medicine; Fundacao Oswaldo Cruz; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Fundacao Oswaldo Cruz	Guimaraes, AJ (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Med & Microbiol & Immunol, Div Infect Dis, Bronx, NY USA.	nosanchu@aecom.yu.edu	Guimaraes, Allan J/E-2160-2014; Guimaraes, Allan/AAQ-2343-2020; de Matos Guedes, Herbert L/K-6191-2014; Nosanchuk, Joshua/AAS-7801-2021; Zancope-Oliveira, Rosely/I-1955-2013	Guimaraes, Allan J/0000-0002-2856-9667; Guimaraes, Allan/0000-0002-2856-9667; de Matos Guedes, Herbert L/0000-0002-3819-3069; 	Wellcome Trust [061158/Z/00/JC/KO]; CNPq [476055/2003-2, 306288/2006-0]; FAPERJ [E-26/170.308/2002]; NIH [D43-TW007129, AI52733, AI056070-01A2, AI-51519]; Fogarty International Center; Center for AIDS Research at the Albert Einstein College of Medicine; Montefiore Medical Center; FOGARTY INTERNATIONAL CENTER [D43TW007129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052733, P30AI051519, R01AI056070] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Center for AIDS Research at the Albert Einstein College of Medicine; Montefiore Medical Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by The Wellcome Trust 061158/Z/00/JC/KO, CNPq 476055/2003-2, and FAPERJ E-26/170.308/2002. A.J.G. was supported in part by an Interhemispheric Research Training Grant in Infectious Diseases, Fogarty International Center (NIH D43-TW007129). J.D.N. is supported in part by NIH AI52733 and AI056070-01A2, and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center (NIH AI-51519). R.M.Z.O. is in part supported by CNPq 306288/2006-0.	ALBUQUERQUE PC, 2003, AN 22 C BRAS MICR 22, P86; Albuquerque PC, 2008, CELL MICROBIOL, V10, P1695, DOI 10.1111/j.1462-5822.2008.01160.x; Allendoerfer R, 1997, J INFECT DIS, V175, P905, DOI 10.1086/513989; Bai ZH, 2003, CRIT REV BIOTECHNOL, V23, P267, DOI 10.1080/07388550390449294; Bleau G, 1998, ANAL BIOCHEM, V263, P13, DOI 10.1006/abio.1998.2801; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calera JA, 1997, INFECT IMMUN, V65, P4718, DOI 10.1128/IAI.65.11.4718-4724.1997; CASADEVALL A, 1992, J IMMUNOL METHODS, V154, P27, DOI 10.1016/0022-1759(92)90209-C; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; DEEPE GS, 1995, INFECT IMMUN, V63, P3151, DOI 10.1128/IAI.63.8.3151-3157.1995; DEEPE GS, 1994, J LAB CLIN MED, V123, P201; DISALVO AF, 1980, J CLIN MICROBIOL, V11, P238, DOI 10.1128/JCM.11.3.238-241.1980; EISSENBERG LG, 1991, CLIN MICROBIOL REV, V4, P411, DOI 10.1128/CMR.4.4.411-421.1991; Garre V, 1998, PHYTOPATHOLOGY, V88, P744, DOI 10.1094/PHYTO.1998.88.8.744; GAUTMAN DK, 2005, APOPTOSIS, V11, P39; Gomez BL, 1997, J CLIN MICROBIOL, V35, P2618, DOI 10.1128/JCM.35.10.2618-2622.1997; GOMEZ FJ, 1991, INFECT IMMUN, V59, P4459, DOI 10.1128/IAI.59.12.4459-4464.1991; Guedes HLD, 2003, J CLIN MICROBIOL, V41, P535, DOI 10.1128/JCM.41.2.535-539.2003; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guimaraes AJ, 2004, J MED MICROBIOL, V53, P509, DOI 10.1099/jmm.0.05469-0; Guimaraes AJ, 2005, 105 GEN M AM SOC MIC; Guimaraes AJ, 2006, BRAZ J MICROBIOL, V37, P1, DOI 10.1590/S1517-83822006000100001; HAMILTON AJ, 1990, T ROY SOC TROP MED H, V84, P425, DOI 10.1016/0035-9203(90)90347-H; Hamilton AJ, 1998, MED MYCOL, V36, P351, DOI 10.1046/j.1365-280X.1998.00174.x; HAMILTON AJ, 1990, J GEN MICROBIOL, V136, P331, DOI 10.1099/00221287-136-2-331; HAMILTON AJ, 1990, J MED VET MYCOL, V28, P479; HOWARD DH, 1983, INFECT IMMUN, V39, P1161, DOI 10.1128/IAI.39.3.1161-1166.1983; Izawa S, 1996, BIOCHEM J, V320, P61, DOI 10.1042/bj3200061; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Johnson CH, 2002, MICROBIOL-SGM, V148, P1129, DOI 10.1099/00221287-148-4-1129; KAUFMAN L, 1992, CLIN INFECT DIS, V14, pS23, DOI 10.1093/clinids/14.Supplement_1.S23; KAUFMAN L, 1983, MYCOPATHOLOGIA, V82, P3, DOI 10.1007/BF00436938; KAUFMAN L, 1987, ANNU REV MICROBIOL, V41, P209, DOI 10.1146/annurev.mi.41.100187.001233; Kim KA, 2000, INFECT IMMUN, V68, P3861, DOI 10.1128/IAI.68.7.3861-3866.2000; KLITE PD, 1965, J LAB CLIN MED, V66, P770; Klotz MG, 1997, MOL BIOL EVOL, V14, P951, DOI 10.1093/oxfordjournals.molbev.a025838; KUMAR S, 2008, BRIEF BIOINFORM; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li Yi, 2007, J Biomol Tech, V18, P185; MARESCA B, 1989, MICROBIOL REV, V53, P186, DOI 10.1128/MMBR.53.2.186-209.1989; Mate MJ, 1999, J BIOL CHEM, V274, P27717, DOI 10.1074/jbc.274.39.27717; MEDOFF G, 1987, INFECT IMMUN, V55, P1355, DOI 10.1128/IAI.55.6.1355-1358.1987; Moreira SFI, 2004, YEAST, V21, P173, DOI 10.1002/yea.1077; MURSHUDOV G, 2006, PDB DATA BANK; Nakagawa Y, 2003, MICROBIOL IMMUNOL, V47, P395, DOI 10.1111/j.1348-0421.2003.tb03376.x; NETTO C F, 1955, Arq Cir Clin Exp, V18, P197; Nosanchuk JD, 2003, J CLIN INVEST, V112, P1164, DOI [10.1172/JCI200319361, 10.1172/JCI19361]; Paris S, 2003, INFECT IMMUN, V71, P3551, DOI 10.1128/IAI.71.6.3551-3562.2003; Pizzini CV, 1999, CLIN DIAGN LAB IMMUN, V6, P20, DOI 10.1128/CDLI.6.1.20-23.1999; Pongpom P, 2005, MED MYCOL, V43, P403, DOI 10.1080/13693780400007144; Reiss E, 2000, MED MYCOL, V38, P147, DOI 10.1080/mmy.38.s1.147.159; Rementeria Aitor, 2005, Revista Iberoamericana de Micologia, V22, P1, DOI 10.1016/S1130-1406(05)70001-2; SCOTT EN, 1989, J CLIN MICROBIOL, V27, P300, DOI 10.1128/JCM.27.2.300-304.1989; SELS AA, 1980, EUR J BIOCHEM, V112, P283, DOI 10.1111/j.1432-1033.1980.tb07204.x; Sestero CM, 2006, MYCOPATHOLOGIA, V162, P33, DOI 10.1007/s11046-006-0028-7; Skamnioti P, 2007, MOL PLANT MICROBE IN, V20, P568, DOI 10.1094/MPMI-20-5-0568; STANDARD PG, 1976, J CLIN MICROBIOL, V3, P191; WHEAT J, 1986, J CLIN MICROBIOL, V23, P493, DOI 10.1128/JCM.23.3.493-499.1986; Zamocky M, 1999, PROG BIOPHYS MOL BIO, V72, P19, DOI 10.1016/S0079-6107(98)00058-3; Zancope-Oliveira RM, 1999, INFECT IMMUN, V67, P1947; ZANCOPEOLIVEIRA RM, 1993, J MED VET MYCOL, V31, P29; ZANCOPEOLIVEIRA RM, 1994, CLIN DIAGN LAB IMMUN, V1, P563; ZANCOPEOLIVEIRA RM, 1994, CLIN DIAGN LAB IMMUN, V1, P390	63	35	35	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3449	10.1371/journal.pone.0003449	http://dx.doi.org/10.1371/journal.pone.0003449			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927619	Green Published, gold			2022-12-27	WOS:000265122400014
J	Tsuruda, JM; Amdam, GV; Page, RE				Tsuruda, Jennifer M.; Amdam, Gro V.; Page, Robert E., Jr.			Sensory Response System of Social Behavior Tied to Female Reproductive Traits	PLOS ONE			English	Article							COLONY-LEVEL SELECTION; DIVISION-OF-LABOR; HONEY-BEES; FORAGING BEHAVIOR; WORKER STERILITY; JUVENILE-HORMONE; SUCROSE RESPONSIVENESS; VITELLOGENIN; THRESHOLDS; INSECT	Background: Honey bees display a complex set of anatomical, physiological, and behavioral traits that correlate with the colony storage of surplus pollen ( pollen hoarding). We hypothesize that the association of these traits is a result of pleiotropy in a gene signaling network that was co-opted by natural selection to function in worker division of labor and foraging specialization. By acting on the gene network, selection can change a suite of traits, including stimulus/response relationships that affect individual foraging behavior and alter the colony level trait of pollen hoarding. The 'pollen-hoarding syndrome' of honey bees is the best documented syndrome of insect social organization. It can be exemplified as a link between reproductive anatomy ( ovary size), physiology ( yolk protein level), and foraging behavior in honey bee strains selected for pollen hoarding, a colony level trait. The syndrome gave rise to the forager-Reproductive Ground Plan Hypothesis (RGPH), which proposes that the regulatory control of foraging onset and foraging preference toward nectar or pollen was derived from a reproductive signaling network. This view was recently challenged. To resolve the controversy, we tested the associations between reproductive anatomy, physiology, and stimulus/response relationships of behavior in wild-type honey bees. Methodology/Principal Findings: Central to the stimulus/response relationships of honey bee foraging behavior and pollen hoarding is the behavioral trait of sensory sensitivity to sucrose (an important sugar in nectar). To test the linkage of reproductive traits and sensory response systems of social behavior, we measured sucrose responsiveness with the proboscis extension response (PER) assay and quantified ovary size and vitellogenin ( yolk precursor) gene expression in 6-7day-old bees by counting ovarioles (ovary filaments) and by using semiquantitative real time RT-PCR. We show that bees with larger ovaries (more ovarioles) are characterized by higher levels of vitellogenin mRNA expression and are more responsive to sucrose solutions, a trait that is central to division of labor and foraging specialization. Conclusions/Significance: Our results establish that in wild-type honey bees, ovary size and vitellogenin mRNA level covary with the sucrose sensory response system, an important component of foraging behavior. This finding validates links between reproductive physiology and behavioral-trait associations of the pollen-hoarding syndrome of honey bees, and supports the forager-RGPH. Our data address a current evolutionary debate, and represent the first direct demonstration of the links between reproductive anatomy, physiology, and behavioral response systems that are central to the control of complex social behavior in insects.	[Tsuruda, Jennifer M.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Amdam, Gro V.; Page, Robert E., Jr.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Amdam, Gro V.] Norwegian Univ Life Sci, Dept Chem, Biotechnol & Food Sci, As, Norway	University of California System; University of California Davis; Arizona State University; Arizona State University-Tempe; Norwegian University of Life Sciences	Tsuruda, JM (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	Gro.Amdam@asu.edu			Norwegian Research Council [175413, 180504, 185306]; US National Science Foundation [0615502]; PEW Foundation; National Institute on Aging [P01 AG22500]; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); US National Science Foundation(National Science Foundation (NSF)); PEW Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support to GVA was provided by the Norwegian Research Council (175413, 180504 and 185306), the U. S. National Science Foundation (0615502), and the PEW Foundation. The National Institute on Aging (NIA P01 AG22500) provided support to REP.	Amdam GV, 2007, AM NAT, V170, P37, DOI 10.1086/518183; Amdam GV, 2006, BEHAV BRAIN RES, V169, P201, DOI 10.1016/j.bbr.2006.01.006; Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; AMDAM GV, 2008, BRAIN BEHAV IN PRESS; Atchley DPD, 2005, PHYSIOL BEHAV, V86, P265, DOI 10.1016/j.physbeh.2005.08.001; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Calderone NW, 1996, ANIM BEHAV, V51, P631, DOI 10.1006/anbe.1996.0068; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Engels W., 1990, Advances in Invertebrate Reproduction, V5, P495; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; Humphries MA, 2003, J COMP PHYSIOL A, V189, P555, DOI 10.1007/s00359-003-0433-z; JAYCOX ER, 1974, ANN ENTOMOL SOC AM, V67, P529, DOI 10.1093/aesa/67.4.529; KLOWDEN MJ, 1990, EXPERIENTIA, V46, P660, DOI 10.1007/BF01939928; MAGNARELLI LA, 1978, J MED ENTOMOL, V14, P527, DOI 10.1093/jmedent/14.5.527; Montague CE, 1998, EVOLUTION, V52, P1408, DOI 10.1111/j.1558-5646.1998.tb02022.x; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Oldroyd BP, 1999, P ROY SOC B-BIOL SCI, V266, P1335, DOI 10.1098/rspb.1999.0784; Oldroyd BP, 1999, P ROY SOC B-BIOL SCI, V266, P1875, DOI 10.1098/rspb.1999.0860; OXLEY PR, 2008, GENETICS, V180, P359; PAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P135, DOI 10.1007/BF00170718; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; PAGE RE, 2008, ORG INSECT IN PRESS; Page RE, 2007, BIOESSAYS, V29, P334, DOI 10.1002/bies.20549; Page RE, 2006, CURR TOP DEV BIOL, V74, P253, DOI 10.1016/S0070-2153(06)74008-X; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pankiw T, 2000, BEHAV ECOL SOCIOBIOL, V47, P265, DOI 10.1007/s002650050664; Pankiw T, 2003, BEHAV ECOL SOCIOBIOL, V54, P458, DOI 10.1007/s00265-003-0640-1; Pankiw T, 2004, BEHAV ECOL SOCIOBIOL, V55, P286, DOI 10.1007/s00265-003-0714-0; ROBINSON GE, 1987, BEHAV ECOL SOCIOBIOL, V20, P329, DOI 10.1007/BF00300679; Rueppell O, 2006, GENETICS, V172, P243, DOI 10.1534/genetics.105.046490; Ruppell O, 2004, J HERED, V95, P481, DOI 10.1093/jhered/esh072; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Snodgrass R.E., 1956, ANATOMY HONEY BEE; THAN TT, 1994, PHYSIOL BEHAV, V56, P237, DOI 10.1016/0031-9384(94)90189-9; Thompson GJ, 2006, INSECT MOL BIOL, V15, P637, DOI 10.1111/j.1365-2583.2006.00678.x; West-Eberhard M.J., 1987, P35; West-Eberhard Mary Jane, 1996, P290	41	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3397	10.1371/journal.pone.0003397	http://dx.doi.org/10.1371/journal.pone.0003397			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852894	Green Submitted, gold, Green Published			2022-12-27	WOS:000265121700005
J	Masse, I; Molin, L; Mouchiroud, L; Vanhems, P; Palladino, F; Billaud, M; Solari, F				Masse, Ingrid; Molin, Laurent; Mouchiroud, Laurent; Vanhems, Philippe; Palladino, Francesca; Billaud, Marc; Solari, Florence			A Novel Role for the SMG-1 Kinase in Lifespan and Oxidative Stress Resistance in Caenorhabditis elegans	PLOS ONE			English	Article								The PTEN tumour suppressor encodes a phosphatase, and its daf-18 orthologue in Caenorhabditis elegans negatively regulates the insulin/IGF-1 DAF-2 receptor pathway that influences lifespan in worms and other species. In order to identify new DAF-18 regulated pathways involved in aging, we initiated a candidate RNAi feeding screen for clones that lengthen lifespan. Here, we report that smg-1 inactivation increases average lifespan in a daf-18 dependent manner. Genetic analysis is consistent with SMG-1 acting at least in part in parallel to the canonical DAF-2 receptor pathway, but converging on the transcription factor DAF-16/FOXO. SMG-1 is a serine-threonine kinase which plays a conserved role in nonsense-mediated mRNA decay (NMD) in worms and mammals. In addition, human SMG-1 has also been implicated in the p53-mediated response to genotoxic stress. The effect of smg-1 inactivation on lifespan appears to be unrelated to its NMD function, but requires the p53 tumour suppressor orthologue cep-1. Furthermore, smg-1 inactivation confers a resistance to oxidative stress in a daf-18-, daf-16- and cep-1-dependent manner. We propose that the role of SMG-1 in lifespan regulation is at least partly dependent on its function in oxidative stress resistance. Taken together, our results unveil a novel role for SMG-1 in lifespan regulation.	[Masse, Ingrid; Molin, Laurent; Mouchiroud, Laurent; Billaud, Marc; Solari, Florence] Univ Claude Bernard Lyon 1, CNRS, UMR5201 Domaine Rockefeller, Lab Genet Signalisat Canc, Lyon, France; [Vanhems, Philippe] Univ Lyon 1, CNRS, UMR 5558, Lab Biomet Biol Evol, Lyon, France; [Palladino, Francesca] CNRS, UMR5161, Ecole Normale Superieure Lyon, Lab Biol Mol Cellule, Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet	Masse, I (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, Ecole Normale Super Lyon, INRA,CNRS,UMR5242, F-69365 Lyon, France.	Marc.Billaud@univ-lyon1.fr; florence.solari@recherche.univ-lyon1.fr	Billaud, Marc N/M-6954-2013; Solari, Florence/G-8907-2017	Solari, Florence/0000-0002-4173-8314; MASSE, Ingrid/0000-0003-3193-970X	CNRS; la Ligue Nationale Contre le Cancer; Region Rhone-Alpes [fellowship]; French Ministry of Research [fellowship]	CNRS(Centre National de la Recherche Scientifique (CNRS)); la Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This study was supported by grants from CNRS and la Ligue Nationale Contre le Cancer. I.M. and L.M. were recipients of a fellowship from the Region Rhone-Alpes and from the French Ministry of Research, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders KR, 2003, EMBO J, V22, P641, DOI 10.1093/emboj/cdg056; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Arum O, 2007, J GERONTOL A-BIOL, V62, P951, DOI 10.1093/gerona/62.9.951; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; Crockett DK, 2005, PROTEOMICS, V5, P1250, DOI 10.1002/pmic.200401046; Denning G, 2001, J BIOL CHEM, V276, P22709, DOI 10.1074/jbc.C100144200; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; DORMAN JB, 1995, GENETICS, V141, P1399; DUSENBERY DB, 1975, GENETICS, V80, P297; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Garigan D, 2002, GENETICS, V161, P1101; GEHEN SC, 2008, ONCOGENE; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Grimson A, 2004, MOL CELL BIOL, V24, P7483, DOI 10.1128/MCB.24.17.7483-7490.2004; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; HODGKIN J, 1989, GENETICS, V123, P301; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Longman D, 2007, GENE DEV, V21, P1075, DOI 10.1101/gad.417707; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Oliveira V, 2008, J BIOL CHEM, V283, P13174, DOI 10.1074/jbc.M708008200; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Rouault JP, 1999, CURR BIOL, V9, P329, DOI 10.1016/S0960-9822(99)80143-2; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Solari F, 2005, ONCOGENE, V24, P20, DOI 10.1038/sj.onc.1207978; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Tijsterman M, 2002, CURR BIOL, V12, P1535, DOI 10.1016/S0960-9822(02)01110-7; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001	43	44	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3354	10.1371/journal.pone.0003354	http://dx.doi.org/10.1371/journal.pone.0003354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836529	Green Submitted, Green Published, gold			2022-12-27	WOS:000265113500010
J	Vetter, P; Butterworth, B; Bahrami, B				Vetter, Petra; Butterworth, Brian; Bahrami, Bahador			Modulating Attentional Load Affects Numerosity Estimation: Evidence against a Pre-Attentive Subitizing Mechanism	PLOS ONE			English	Article							DISCRIMINATION; ENUMERATION; SEARCH; NUMBER	Traditionally, the visual enumeration of a small number of items (1 to about 4), referred to as subitizing, has been thought of as a parallel and pre-attentive process and functionally different from the serial attentive enumeration of larger numerosities. We tested this hypothesis by employing a dual task paradigm that systematically manipulated the attentional resources available to an enumeration task. Enumeration accuracy for small numerosities was severely decreased as more attentional resources were taken away from the numerical task, challenging the traditionally held notion of subitizing as a pre-attentive, capacity-independent process. Judgement of larger numerosities was also affected by dual task conditions and attentional load. These results challenge the proposal that small numerosities are enumerated by a mechanism separate from large numerosities and support the idea of a single, attention-demanding enumeration mechanism.	[Vetter, Petra; Butterworth, Brian; Bahrami, Bahador] UCL, Inst Cognit Neurosci, London, England; [Vetter, Petra; Butterworth, Brian; Bahrami, Bahador] UCL, Dept Psychol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Vetter, P (corresponding author), UCL, Inst Cognit Neurosci, London, England.	p.vetter@ucl.ac.uk		Vetter, Petra/0000-0001-6516-4637	European Marie Curie; Marie Curie Early Stage Research Fellowship; UCL Graduate School Research Scholarship; Overseas Research Scholarship	European Marie Curie(European Commission); Marie Curie Early Stage Research Fellowship; UCL Graduate School Research Scholarship; Overseas Research Scholarship	This work was supported by a European Marie Curie Research Training Network grant to Butterworth, a Marie Curie Early Stage Research Fellowship to Vetter and a UCL Graduate School Research Scholarship and an Overseas Research Scholarship to Bahrami.	BALAKRISHNAN JD, 1992, PSYCHOL RES-PSYCH FO, V54, P80, DOI 10.1007/BF00937136; BALAKRISHNAN JD, 1991, PERCEPT PSYCHOPHYS, V50, P555, DOI 10.3758/BF03207540; Di Lollo V, 2001, J EXP PSYCHOL GEN, V130, P479, DOI 10.1037/0096-3445.130.3.479; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Egeth HE, 2008, VIS COGN, V16, P463, DOI 10.1080/13506280801937939; Jevons W.S., 1871, NATURE, V3, P281, DOI [10.1038/003281a0, DOI 10.1038/003281A0]; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; JULESZ B, 1984, DYNAMIC ASPECTS NEOC, P585; KAUFMAN EL, 1949, AM J PSYCHOL, V62, P498, DOI 10.2307/1418556; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Nakayama K, 1998, ATTENTIVE BRAIN, P279; Olivers CNL, 2008, VIS COGN, V16, P439, DOI 10.1080/13506280701825861; Piazza M, 2003, P ROY SOC B-BIOL SCI, V270, P1237, DOI 10.1098/rspb.2003.2356; Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980; Railo H, 2008, COGNITION, V107, P82, DOI 10.1016/j.cognition.2007.08.004; Ross J, 2003, PERCEPTION, V32, P867, DOI 10.1068/p5029; SAGI D, 1984, PERCEPTION, V13, P619, DOI 10.1068/p130619; Sathian K, 1999, J COGNITIVE NEUROSCI, V11, P36, DOI 10.1162/089892999563238; Simon TJ, 1996, PERCEPT PSYCHOPHYS, V58, P915, DOI 10.3758/BF03205493; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; TRICK LM, 1993, J EXP PSYCHOL HUMAN, V19, P331, DOI 10.1037/0096-1523.19.2.331; Vuilleumier PO, 2000, BRAIN, V123, P1263, DOI 10.1093/brain/123.6.1263; Wender KF, 2000, PSYCHOL RES-PSYCH FO, V64, P81, DOI 10.1007/s004260000021	25	91	93	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3269	10.1371/journal.pone.0003269	http://dx.doi.org/10.1371/journal.pone.0003269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422MG	18813345	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000264431800008
J	Fukami, H; Chen, CA; Budd, AF; Collins, A; Wallace, C; Chuang, YY; Chen, C; Dai, CF; Iwao, K; Sheppard, C; Knowlton, N				Fukami, Hironobu; Chen, Chaolun Allen; Budd, Ann F.; Collins, Allen; Wallace, Carden; Chuang, Yao-Yang; Chen, Chienhsun; Dai, Chang-Feng; Iwao, Kenji; Sheppard, Charles; Knowlton, Nancy			Mitochondrial and Nuclear Genes Suggest that Stony Corals Are Monophyletic but Most Families of Stony Corals Are Not (Order Scleractinia, Class Anthozoa, Phylum Cnidaria)	PLOS ONE			English	Article							EVOLUTION; TREE; SYSTEMATICS; PHYLOGENY; GENOME; MODEL	Modern hard corals (Class Hexacorallia; Order Scleractinia) are widely studied because of their fundamental role in reef building and their superb fossil record extending back to the Triassic. Nevertheless, interpretations of their evolutionary relationships have been in flux for over a decade. Recent analyses undermine the legitimacy of traditional suborders, families and genera, and suggest that a non-skeletal sister clade (Order Corallimorpharia) might be imbedded within the stony corals. However, these studies either sampled a relatively limited array of taxa or assembled trees from heterogeneous data sets. Here we provide a more comprehensive analysis of Scleractinia (127 species, 75 genera, 17 families) and various outgroups, based on two mitochondrial genes (cytochrome oxidase I, cytochrome b), with analyses of nuclear genes (beta-tubulin, ribosomal DNA) of a subset of taxa to test unexpected relationships. Eleven of 16 families were found to be polyphyletic. Strikingly, over one third of all families as conventionally defined contain representatives from the highly divergent "robust'' and "complex'' clades. However, the recent suggestion that corallimorpharians are true corals that have lost their skeletons was not upheld. Relationships were supported not only by mitochondrial and nuclear genes, but also often by morphological characters which had been ignored or never noted previously. The concordance of molecular characters and more carefully examined morphological characters suggests a future of greater taxonomic stability, as well as the potential to trace the evolutionary history of this ecologically important group using fossils.	[Fukami, Hironobu] Kyoto Univ, Seto Marine Biol Lab, Field Sci Educ & Res Ctr, Wakayama, Japan; [Chen, Chaolun Allen; Chuang, Yao-Yang; Chen, Chienhsun] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Chen, Chaolun Allen; Chuang, Yao-Yang; Chen, Chienhsun; Dai, Chang-Feng] Natl Taiwan Univ, Inst Oceanography, Taipei, Taiwan; [Budd, Ann F.] Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA; [Collins, Allen] Smithsonian Inst, MRC 153, Natl Museum Nat Hist, NOAA Fisheries Serv, Natl Syst Lab, Washington, DC USA; [Wallace, Carden] Museum Trop Queensland, Townsville, Qld, Australia; [Iwao, Kenji] Akajima Marine Sci Lab, Okinawa, Japan; [Sheppard, Charles] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Knowlton, Nancy] Univ Calif San Diego, Scripps Inst Oceanography, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Knowlton, Nancy] Smithsonian Inst, MRC 163, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC USA	Kyoto University; Academia Sinica - Taiwan; National Taiwan University; University of Iowa; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Warwick; University of California System; University of California San Diego; Scripps Institution of Oceanography; Smithsonian Institution; Smithsonian National Museum of Natural History	Fukami, H (corresponding author), Kyoto Univ, Seto Marine Biol Lab, Field Sci Educ & Res Ctr, Wakayama, Japan.	knowlton@si.edu	Collins, Allen G/A-7944-2008	Collins, Allen G/0000-0002-3664-9691; DAI, CHANG-FENG/0000-0003-2242-5643; sheppard, charles/0000-0002-2579-5124	US NSF [DEB0344310, 0343208, 0531779]; Academia Sinica [PhD fellowships]; Genomics and Proteinomics; Grant-in-Aid for Young Scientists [18770013]	US NSF(National Science Foundation (NSF)); Academia Sinica(Academia Sinica - Taiwan); Genomics and Proteinomics; Grant-in-Aid for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported through funding by US NSF grants to Nancy Knowlton and Ann Budd (DEB0344310, 0343208), by Academia Sinica Thematic grants (2002 2004, 2005 2007) and a Genomics and Proteinomics grant (2006 2007) to Chaolun Allen Chen, by a Grant-in-Aid for Young Scientists (B) (No. 18770013) to Hironobu Fukami, and by a US NSF Assembling the Tree of Life grant (0531779) to Allen Collins, Daphne Fautin, and Paulyn Cartwright. Yao-Yang Chuang and Chien-Hsun Chen received PhD fellowships from the Biodiversity Research Centre, Academia Sinica.	ALLOITEAU J, 1957, CONTRIBUTION SYSTEMA, P1; [Anonymous], 2006, THESIS U TEXAS AUSTI; Beagley CT, 1998, GENETICS, V148, P1091; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Benzoni F, 2007, CONTRIB ZOOL, V76, P35, DOI 10.1163/18759866-07601004; Boury-Esnault N, 2006, CAN J ZOOL, V84, P205, DOI 10.1139/Z06-003; Brugler MR, 2007, MOL PHYLOGENET EVOL, V42, P776, DOI 10.1016/j.ympev.2006.08.016; Buckley TR, 2002, SYST BIOL, V51, P509, DOI 10.1080/10635150290069922; BUDD AF, 2008, ACTA ZOOL IN PRESS, V89; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chase MW, 2000, TAXON, V49, P685, DOI 10.2307/1223971; Chen CA, 2004, ZOOL STUD, V43, P759; Chen L, 2002, BIOORG MED CHEM LETT, V12, P137, DOI 10.1016/S0960-894X(01)00711-9; Cuif JP, 2003, ZOOL SCR, V32, P459, DOI 10.1046/j.1463-6409.2003.00133.x; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; DENHARTOG JC, 1980, ZOOL VERH-LEIDEN, V176, P1; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; GOLOBOFF P, 2000, TNT TREE ANAL USING; Kerr AM, 2005, BIOL REV, V80, P543, DOI 10.1017/S1464793105006780; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Le Goff-Vitry MC, 2004, MOL PHYLOGENET EVOL, V30, P167, DOI 10.1016/S1055-7903(03)00162-3; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Romano SL, 1997, J MOL EVOL, V45, P397, DOI 10.1007/PL00006245; Romano SL, 2000, B MAR SCI, V67, P1043; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Swofford DL, 2002, PAUP PHYLOGENETIC AN; VAUGHAN TW, 1943, SPEC PAP GEOL SOC AM, V44, P1; Veron JEN, 1996, CORAL REEFS, V15, P1; Wei NWV, 2006, ZOOL STUD, V45, P404; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136	37	230	240	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3222	10.1371/journal.pone.0003222	http://dx.doi.org/10.1371/journal.pone.0003222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795098	Green Published, Green Submitted, gold			2022-12-27	WOS:000264428000005
J	Biswas, S; Russell, RJ; Jackson, CJ; Vidovic, M; Ganeshina, O; Oakeshott, JG; Claudianos, C				Biswas, Sunita; Russell, Robyn J.; Jackson, Colin J.; Vidovic, Maria; Ganeshina, Olga; Oakeshott, John G.; Claudianos, Charles			Bridging the Synaptic Gap: Neuroligins and Neurexin I in Apis mellifera	PLOS ONE			English	Article							CELL-ADHESION; MUSHROOM BODIES; HONEY-BEE; INHIBITORY SYNAPSES; ALPHA-NEUREXINS; CA2+ BINDING; PROTEIN; ACETYLCHOLINESTERASE; DOMAIN; BETA	Vertebrate studies show neuroligins and neurexins are binding partners in a trans-synaptic cell adhesion complex, implicated in human autism and mental retardation disorders. Here we report a genetic analysis of homologous proteins in the honey bee. As in humans, the honeybee has five large (31-246 kb, up to 12 exons each) neuroligin genes, three of which are tightly clustered. RNA analysis of the neuroligin-3 gene reveals five alternatively spliced transcripts, generated through alternative use of exons encoding the cholinesterase-like domain. Whereas vertebrates have three neurexins the bee has just one gene named neurexin I (400 kb, 28 exons). However alternative isoforms of bee neurexin I are generated by differential use of 12 splice sites, mostly located in regions encoding LNS subdomains. Some of the splice variants of bee neurexin I resemble the vertebrate alpha- and beta-neurexins, albeit in vertebrates these forms are generated by alternative promoters. Novel splicing variations in the 39 region generate transcripts encoding alternative trans-membrane and PDZ domains. Another 39 splicing variation predicts soluble neurexin I isoforms. Neurexin I and neuroligin expression was found in brain tissue, with expression present throughout development, and in most cases significantly up-regulated in adults. Transcripts of neurexin I and one neuroligin tested were abundant in mushroom bodies, a higher order processing centre in the bee brain. We show neuroligins and neurexins comprise a highly conserved molecular system with likely similar functional roles in insects as vertebrates, and with scope in the honeybee to generate substantial functional diversity through alternative splicing. Our study provides important prerequisite data for using the bee as a model for vertebrate synaptic development.	[Biswas, Sunita; Ganeshina, Olga; Claudianos, Charles] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Biswas, Sunita; Vidovic, Maria] Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT, Australia; [Biswas, Sunita; Russell, Robyn J.; Jackson, Colin J.; Oakeshott, John G.; Claudianos, Charles] CSIRO Entomol, Canberra, ACT, Australia	University of Queensland; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Biswas, S (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	c.claudianos@uq.edu.au	Russell, Robyn/C-5449-2008; Jackson, Colin J/C-1500-2008; Oakeshott, John G/B-5365-2009	Russell, Robyn/0000-0001-5600-3305; Jackson, Colin J/0000-0001-6150-3822; Oakeshott, John G/0000-0001-8324-7874; Claudianos, Charles/0000-0002-9799-9572	Australian National University [PhD Scholarship Award]	Australian National University(Australian National University)	Australian National University PhD Scholarship Award to Sunita Biswas	Andres C, 1997, P NATL ACAD SCI USA, V94, P8173, DOI 10.1073/pnas.94.15.8173; Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Berninghausen O, 2007, J NEUROCHEM, V103, P1855, DOI 10.1111/j.1471-4159.2007.04918.x; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Bolliger MF, 2008, P NATL ACAD SCI USA, V105, P6421, DOI 10.1073/pnas.0801383105; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Collins AM, 2004, INSECT MOL BIOL, V13, P141, DOI 10.1111/j.0962-1075.2004.00469.x; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Comoletti D, 2007, STRUCTURE, V15, P693, DOI 10.1016/j.str.2007.04.010; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dong HH, 2004, J NEUROSCI, V24, P8950, DOI 10.1523/JNEUROSCI.2106-04.2004; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Ganeshina O, 2000, J COMP NEUROL, V417, P349, DOI 10.1002/(SICI)1096-9861(20000214)417:3&lt;349::AID-CNE8&gt;3.0.CO;2-E; Gasteiger E, 2001, Curr Issues Mol Biol, V3, P47; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gilbert M, 2001, GLIA, V34, P151, DOI 10.1002/glia.1050; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Grifman M, 1998, P NATL ACAD SCI USA, V95, P13935, DOI 10.1073/pnas.95.23.13935; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; Hata Y, 1996, J NEUROSCI, V16, P2488; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Higgins D G, 1994, Methods Mol Biol, V25, P307; Hoffman RC, 2004, BIOCHEMISTRY-US, V43, P1496, DOI 10.1021/bi035278t; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jackson CJ, 2007, J MOL BIOL, V367, P1047, DOI 10.1016/j.jmb.2007.01.032; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kalay E, 2005, J MOL MED, V83, P1025, DOI 10.1007/s00109-005-0719-4; Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195; Kenyon F., 1896, J COMP NEUROL, V6, P133, DOI DOI 10.1002/CNE.910060302; Kenyon F.C, 1896, AM NAT, V30, P643, DOI [10.1086/276450, DOI 10.1086/276450]; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Klagges BRE, 1996, J NEUROSCI, V16, P3154; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwon JY, 2004, GENOMICS, V83, P600, DOI 10.1016/j.ygeno.2003.10.008; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; LIAO J, 1993, J NEUROCHEM, V61, P1127, DOI 10.1111/j.1471-4159.1993.tb03629.x; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Meyer G, 2004, NEUROPHARMACOLOGY, V47, P724, DOI 10.1016/j.neuropharm.2004.06.023; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROCHEM, V71, P1339; MOBBS PG, 1984, J INSECT PHYSIOL, V30, P43, DOI 10.1016/0022-1910(84)90107-0; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Mungenast AE, 2005, J NEUROENDOCRINOL, V17, P208, DOI 10.1111/j.1365-2826.2005.01293.x; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OBRO NF, 2008, CANC LETT, DOI DOI 10.1016/J.CAN6ET.2007.11.030; Philibert RA, 2000, GENE, V246, P303, DOI 10.1016/S0378-1119(00)00049-4; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Rissone A, 2007, MOL BIOL EVOL, V24, P236, DOI 10.1093/molbev/msl147; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell RJ, 1996, INSECT BIOCHEM MOLEC, V26, P235, DOI 10.1016/0965-1748(95)00081-X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; Sambrook J., 2001, MOL CLONING LAB MANU; Sarmiento JM, 2004, J BIOL CHEM, V279, P47017, DOI 10.1074/jbc.M410011200; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Scholl FG, 2003, TRENDS NEUROSCI, V26, P618, DOI 10.1016/j.tins.2003.09.004; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sheckler LR, 2006, J BIOL CHEM, V281, P22896, DOI 10.1074/jbc.M603464200; Srivatsan M, 2006, BIOINFORMATION, V1, P281, DOI 10.6026/97320630001281; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; SUSSMAN JL, 1993, CHEM-BIOL INTERACT, V87, P187, DOI 10.1016/0009-2797(93)90042-W; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Talebizadeh Z, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036897; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Tsigelny I, 2000, PROTEIN SCI, V9, P180; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Vidovic M, 2007, DEV NEUROBIOL, V67, P233, DOI 10.1002/dneu.20341; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	112	46	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3542	10.1371/journal.pone.0003542	http://dx.doi.org/10.1371/journal.pone.0003542			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974885	Green Published, gold			2022-12-27	WOS:000265131700001
J	Lazzari, V; Charles, C; Tafforeau, P; Vianey-Liaud, M; Aguilar, JP; Jaeger, JJ; Michaux, J; Viriot, L				Lazzari, Vincent; Charles, Cyril; Tafforeau, Paul; Vianey-Liaud, Monique; Aguilar, Jean-Pierre; Jaeger, Jean-Jacques; Michaux, Jacques; Viriot, Laurent			Mosaic Convergence of Rodent Dentitions	PLOS ONE			English	Article							MAMMALIAN TEETH; MUROID RODENTS; PHYLOGENY; MICROWEAR; MASTICATION; RAT	Background: Understanding mechanisms responsible for changes in tooth morphology in the course of evolution is an area of investigation common to both paleontology and developmental biology. Detailed analyses of molar tooth crown shape have shown frequent homoplasia in mammalian evolution, which requires accurate investigation of the evolutionary pathways provided by the fossil record. The necessity of preservation of an effective occlusion has been hypothesized to functionally constrain crown morphological changes and to also facilitate convergent evolution. The Muroidea superfamily constitutes a relevant model for the study of molar crown diversification because it encompasses one third of the extant mammalian biodiversity. Methodology/Principal Findings: Combined microwear and 3D-topographic analyses performed on fossil and extant muroid molars allow for a first quantification of the relationships between changes in crown morphology and functionality of occlusion. Based on an abundant fossil record and on a well resolved phylogeny, our results show that the most derived functional condition associates longitudinal chewing and non interlocking of cusps. This condition has been reached at least 7 times within muroids via two main types of evolutionary pathways each respecting functional continuity. In the first type, the flattening of tooth crown which induces the removal of cusp interlocking occurs before the rotation of the chewing movement. In the second type however, flattening is subsequent to rotation of the chewing movement which can be associated with certain changes in cusp morphology. Conclusion/Significance: The reverse orders of the changes involved in these different pathways reveal a mosaic evolution of mammalian dentition in which direction of chewing and crown shape seem to be partly decoupled. Either can change in respect to strong functional constraints affecting occlusion which thereby limit the number of the possible pathways. Because convergent pathways imply distinct ontogenetic trajectories, new Evo/Devo comparative studies on cusp morphogenesis are necessary.	[Lazzari, Vincent; Vianey-Liaud, Monique; Aguilar, Jean-Pierre] Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, F-34095 Montpellier, France; [Lazzari, Vincent; Tafforeau, Paul] European Synchrotron Radiat Facil, BP220, Grenoble, France; [Charles, Cyril; Jaeger, Jean-Jacques] Univ Poitiers, CNRS, UMR 6046, Inst Int Paleoprimatol Paleontol Humaine, Evolut, Poitiers, France; [Michaux, Jacques] Univ Montpellier 2, CNRS, UMR 5554, Ecole Pratique Hautes Etudes Inst Sci Evolut, F-34095 Montpellier, France; [Viriot, Laurent] Univ Lyon 1, INRA, CNRS, UMR 5242, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON)	Lazzari, V (corresponding author), Univ Bonn, Steinmann Inst, D-5300 Bonn, Germany.	lazzari@uni-bonn.de; Laurent.Viriot@univ-poitiers.fr	Charles, Cyril/E-7606-2011	Charles, Cyril/0000-0002-6930-039X; Tafforeau, Paul/0000-0002-5962-1683; Lazzari, Vincent/0000-0002-8210-2646; Viriot, Laurent/0000-0003-2092-588X	Institut des Sciences de l'Evolution of the Universite de Montpellier 2; Institut International de Paleoprimatologie et Paleontologie Humaine, Evolution et Paleoenvironnement of the Universite of Poitiers; European Synchrotron Radiation Facility; Ministere de la Recherche [PhD fellowships]; Alexander von Humboldt Foundation [research fellow]; QUENOTTES ANR project; NSF RHOI "Small Mammals" [BCS-0321893]	Institut des Sciences de l'Evolution of the Universite de Montpellier 2; Institut International de Paleoprimatologie et Paleontologie Humaine, Evolution et Paleoenvironnement of the Universite of Poitiers; European Synchrotron Radiation Facility; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); QUENOTTES ANR project(French National Research Agency (ANR)); NSF RHOI "Small Mammals"(National Science Foundation (NSF))	This study was supported by the Institut des Sciences de l'Evolution of the Universite de Montpellier 2 (MVL, JM, JPA, VL), the Institut International de Paleoprimatologie et Paleontologie Humaine, Evolution et Paleoenvironnement of the Universite of Poitiers (JJJ, LV), the European Synchrotron Radiation Facility (PT) and PhD fellowships of the Ministere de la Recherche (VL, CC). VL is a research fellow of Alexander von Humboldt Foundation. This is publication ISEM (UMR 5554 CNRS) n ISE-M2008-092. Scientific missions of CC and LV have been financially supported by the QUENOTTES ANR project and NSF RHOI "Small Mammals" (Award #BCS-0321893).	Butler PM., 1985, EVOLUTIONARY RELATIO, P381; Butler PM., 1980, PALAEOVERTEBRATA MEM, V9 Ext, P249; Charles C, 2007, NATURWISSENSCHAFTEN, V94, P71, DOI 10.1007/s00114-006-0161-7; Darviche D., 1978, THESIS U MONTPELLIER; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Feist M, 2005, AM J BOT, V92, P1152, DOI 10.3732/ajb.92.7.1152; Fejfar Oldrich, 1999, P365; HERSHKOVITZ P, 1962, EVOLUTION NEOTROPICA, P46; HIIEMAE KM, 1968, J ZOOL, V154, P139; HIKIDA T, 1980, Japanese Journal of Ecology, V30, P109; HUNTER JP, 1995, P NATL ACAD SCI USA, V92, P10718, DOI 10.1073/pnas.92.23.10718; Jacobs Louis L., 2005, P63; Jaeger J. J., 1977, Palaeovertebrata, V8, P1; Janis C.M., 1988, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V53, P367; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jernvall J, 2000, YEARB PHYS ANTHROPOL, V43, P171; JERNVALL J, 1999, PALEONTOLOGICA ELECT, V2; Kalin Daniel, 1999, P373; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; King SJ, 2005, P NATL ACAD SCI USA, V102, P16579, DOI 10.1073/pnas.0508377102; Lazzari V, 2008, PALEOBIOLOGY, V34, P46, DOI 10.1666/06052.1; MCNAUGHTON SJ, 1985, ECOLOGY, V66, P528, DOI 10.2307/1940401; Michaux J, 2001, MOL BIOL EVOL, V18, P2017, DOI 10.1093/oxfordjournals.molbev.a003743; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; OFFERMANS M, 1990, J MORPHOL, V205, P353, DOI 10.1002/jmor.1052050310; Osborn, 1907, EVOLUTION MAMMALIAN, P48; Schaub S., 1938, Abhandlungen der Schweizerischen Palaeontologischen Gesellschaft Geneve, V61, P1; Sese C., 1989, AM MUS NOVIT, V11, P185; SOLOUNIAS N, 1993, J ZOOL, V229, P421, DOI 10.1111/j.1469-7998.1993.tb02646.x; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P447, DOI 10.1002/ajpa.1330800405; TONG H, 1989, MEMOIRES SOC GEOLOGI, P155; Ungar Peter, 2000, Palaeontologia Electronica, V3, P1; Ungar PS, 2003, P NATL ACAD SCI USA, V100, P3874, DOI 10.1073/pnas.0637016100; WALKER A, 1978, SCIENCE, V201, P908, DOI 10.1126/science.684415; WEIJS WA, 1975, J MORPHOL, V145, P107, DOI 10.1002/jmor.1051450107; Xu X, 2005, DEV DYNAM, V232, P75, DOI 10.1002/dvdy.20197	40	53	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3607	10.1371/journal.pone.0003607	http://dx.doi.org/10.1371/journal.pone.0003607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974837	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131700023
J	Price, MN; Dehal, PS; Arkin, AP				Price, Morgan N.; Dehal, Paramvir S.; Arkin, Adam P.			FastBLAST: Homology Relationships for Millions of Proteins	PLOS ONE			English	Article							DATABASE; CLASSIFICATION; INFORMATION; ORTHOLOGS; FAMILIES; TOOLS	Background: All-versus-all BLAST, which searches for homologous pairs of sequences in a database of proteins, is used to identify potential orthologs, to find new protein families, and to provide rapid access to these homology relationships. As DNA sequencing accelerates and data sets grow, all-versus-all BLAST has become computationally demanding. Methodology/Principal Findings: We present FastBLAST, a heuristic replacement for all-versus-all BLAST that relies on alignments of proteins to known families, obtained from tools such as PSI-BLAST and HMMer. FastBLAST avoids most of the work of all-versus-all BLAST by taking advantage of these alignments and by clustering similar sequences. FastBLAST runs in two stages: the first stage identifies additional families and aligns them, and the second stage quickly identifies the homologs of a query sequence, based on the alignments of the families, before generating pairwise alignments. On 6.53 million proteins from the non-redundant Genbank database ("NR''), FastBLAST identifies new families 25 times faster than all-versus-all BLAST. Once the first stage is completed, FastBLAST identifies homologs for the average query in less than 5 seconds (8.6 times faster than BLAST) and gives nearly identical results. For hits above 70 bits, FastBLAST identifies 98% of the top 3,250 hits per query. Conclusions/Significance: FastBLAST enables research groups that do not have supercomputers to analyze large protein sequence data sets. FastBLAST is open source software and is available at http://microbesonline.org/fastblast.	[Price, Morgan N.; Dehal, Paramvir S.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Price, Morgan N.; Dehal, Paramvir S.; Arkin, Adam P.] Virtual Inst Microb Stress & Survival, Berkeley, CA USA; [Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Price, MN (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	morgannprice@yahoo.com	Arkin, Adam P/A-6751-2008; Arkin, Adam/M-9941-2019	Arkin, Adam P/0000-0002-4999-2931; Arkin, Adam/0000-0002-4999-2931; Price, Morgan/0000-0002-4251-0362	US Department of Energy Genomics: GTL program [DE-AC02-05CH11231]	US Department of Energy Genomics: GTL program(United States Department of Energy (DOE))	This work was supported by a grant to A.P.A. from the US Department of Energy Genomics: GTL program (DE-AC02-05CH11231). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Dehal PS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-201; Durbin R., 1998, BIOL SEQUENCE ANAL P; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li WZ, 2002, BIOINFORMATICS, V18, P77, DOI 10.1093/bioinformatics/18.1.77; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024; Price MN, 2007, PLOS COMPUT BIOL, V3, P1739, DOI 10.1371/journal.pcbi.0030175; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Selengut JD, 2007, NUCLEIC ACIDS RES, V35, pD260, DOI 10.1093/nar/gkl1043; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Wilson D, 2007, NUCLEIC ACIDS RES, V35, pD308, DOI 10.1093/nar/gkl910; Wu CH, 2004, NUCLEIC ACIDS RES, V32, pD112, DOI 10.1093/nar/gkh097; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zmasek CM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-14	22	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3589	10.1371/journal.pone.0003589	http://dx.doi.org/10.1371/journal.pone.0003589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974889	Green Submitted, Green Published, gold			2022-12-27	WOS:000265131700011
J	Geier, F; Lohmann, JU; Gerstung, M; Maier, AT; Timmer, J; Fleck, C				Geier, Florian; Lohmann, Jan U.; Gerstung, Moritz; Maier, Annette T.; Timmer, Jens; Fleck, Christian			A Quantitative and Dynamic Model for Plant Stem Cell Regulation	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; ARABIDOPSIS SHOOT; WUSCHEL; CLV3; GROWTH; POPULATION; EXPRESSION; CYTOKININS; CLAVATA; GENES	Plants maintain pools of totipotent stem cells throughout their entire life. These stem cells are embedded within specialized tissues called meristems, which form the growing points of the organism. The shoot apical meristem of the reference plant Arabidopsis thaliana is subdivided into several distinct domains, which execute diverse biological functions, such as tissue organization, cell-proliferation and differentiation. The number of cells required for growth and organ formation changes over the course of a plants life, while the structure of the meristem remains remarkably constant. Thus, regulatory systems must be in place, which allow for an adaptation of cell proliferation within the shoot apical meristem, while maintaining the organization at the tissue level. To advance our understanding of this dynamic tissue behavior, we measured domain sizes as well as cell division rates of the shoot apical meristem under various environmental conditions, which cause adaptations in meristem size. Based on our results we developed a mathematical model to explain the observed changes by a cell pool size dependent regulation of cell proliferation and differentiation, which is able to correctly predict CLV3 and WUS over-expression phenotypes. While the model shows stem cell homeostasis under constant growth conditions, it predicts a variation in stem cell number under changing conditions. Consistent with our experimental data this behavior is correlated with variations in cell proliferation. Therefore, we investigate different signaling mechanisms, which could stabilize stem cell number despite variations in cell proliferation. Our results shed light onto the dynamic constraints of stem cell pool maintenance in the shoot apical meristem of Arabidopsis in different environmental conditions and developmental states.	[Geier, Florian; Gerstung, Moritz; Timmer, Jens; Fleck, Christian] Univ Freiburg, Dept Math & Phys, Freiburg, Germany; [Geier, Florian] Univ Freiburg, Dept Biol, D-7800 Freiburg, Germany; [Lohmann, Jan U.; Maier, Annette T.] Max Plank Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Lohmann, Jan U.] Heidelberg Univ, D-6900 Heidelberg, Germany; [Gerstung, Moritz] Swiss Fed Inst Technol, D BSSE, Dept Biosyst Sci & Engn, Basel, Switzerland; [Timmer, Jens] Freiburg Inst Advanced Studies, Freiburg, Germany; [Geier, Florian; Fleck, Christian] Ctr Biol Syst Analysis, Freiburg, Germany	University of Freiburg; University of Freiburg; Max Planck Society; Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Geier, F (corresponding author), Univ Freiburg, Dept Math & Phys, Freiburg, Germany.	jlohmann@meristemania.org	Lohmann, Jan/T-3776-2019; Fleck, Christian/D-1620-2012	Lohmann, Jan/0000-0003-3667-187X; Fleck, Christian/0000-0002-6371-4495; Gerstung, Moritz/0000-0001-6709-963X	EU FP6 COSBICS [512060]; BMBF NGFN II [101 35 05 201]; Konrad Adenauer Foundation; EMBO; HFSP; Max Plack Society	EU FP6 COSBICS; BMBF NGFN II(Federal Ministry of Education & Research (BMBF)); Konrad Adenauer Foundation; EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); Max Plack Society	This project was supported by EU FP6 COSBICS project (512060), by BMBF NGFN II 101 35 05 201 to FG, a Ph.D. fellowship of the Konrad Adenauer Foundation to ATM and funds from the EMBO Young Investigator Programme, a Career Development Award from HFSP and the Max Plack Society to JUL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SU, 2008, PLANT CELL, V20, P88, DOI 10.1105/tpc.107.054676; Brand U, 2002, PLANT PHYSIOL, V129, P565, DOI 10.1104/pp.001867; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Brand U, 2001, BIOESSAYS, V23, P134, DOI 10.1002/1521-1878(200102)23:2&lt;134::AID-BIES1020&gt;3.0.CO;2-3; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Gallois JL, 2002, DEVELOPMENT, V129, P3207; Gordon SP, 2007, DEVELOPMENT, V134, P3539, DOI 10.1242/dev.010298; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Gross-Hardt R, 2003, J CELL SCI, V116, P1659, DOI 10.1242/jcs.00406; Heisler MG, 2007, CURR OPIN PLANT BIOL, V10, P92, DOI 10.1016/j.pbi.2006.11.005; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Jonsson H, 2005, BIOINFORMATICS, V21, pI232, DOI 10.1093/bioinformatics/bti1036; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; Menges M, 2002, J BIOL CHEM, V277, P41987, DOI 10.1074/jbc.M207570200; Muller R, 2006, PLANT CELL, V18, P1188, DOI 10.1105/tpc.105.040444; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Reddy GV, 2007, NAT REV MOL CELL BIO, V8, P491, DOI 10.1038/nrm2188; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Rojo E, 2002, PLANT CELL, V14, P969, DOI 10.1105/tpc.002196; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Sharma VK, 2003, P NATL ACAD SCI USA, V100, P11823, DOI 10.1073/pnas.1834206100; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Veit B, 2006, PLANT MOL BIOL, V60, P793, DOI 10.1007/s11103-006-0033-8; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928	32	46	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3553	10.1371/journal.pone.0003553	http://dx.doi.org/10.1371/journal.pone.0003553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958283	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131100012
J	Ma, LJ; Walter, B; DeGuzman, A; Muller, HK; Walker, AM				Ma, Lisa J.; Walter, Barbara; DeGuzman, Ariel; Muller, H. Konrad; Walker, Ameae M.			Trans-Epithelial Immune Cell Transfer during Suckling Modulates Delayed-Type Hypersensitivity in Recipients as a Function of Gender	PLOS ONE			English	Article								Introduction: Breast feeding has long term effects on the developing immune system which outlive passive immunization of the neonate. We have investigated the transfer of milk immune cells and examined the result of transfer once the recipients were adult. Methods: Non-transgenic mouse pups were foster-nursed by green fluorescent protein (GFP) transgenic dams for 3 weeks and the fate of GFP+ cells was followed by FACS analysis, immunohistochemistry and RT-PCR for GFP and appropriate immune cell markers. Pups suckled by non-transgenic dams served as controls. Results: Despite a preponderance of B cells and macrophages in the stomach contents of the pups, most cells undergoing trans-epithelial migration derived from the 3-4% of milk cells positive for T lymphocyte markers. These cells homed to the spleen and thymus, with maximal accumulation at 3-4 weeks. By sensitizing dams with an antigen which elicits a T cell-mediated delayed-type-hypersensitivity (DTH) response, we determined that nursing by a sensitized dam (compared to a non-sensitized dam) amplified a subsequent DTH response in females and yet suppressed one in males. Discussion: These results suggest that clinical evaluation weighing the pros and cons of nursing male versus female children by mothers with genetically-linked hypersensitivity diseases, such as celiac disease and eczema, or those in regions of the world with endemic DTH-eliciting diseases, such as tuberculosis, may be warranted.	[Ma, Lisa J.; DeGuzman, Ariel; Walker, Ameae M.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Walter, Barbara] Univ Calif Riverside, Inst Integrative Genome Biol, Riverside, CA USA; [Muller, H. Konrad] Univ Tasmania, Hobart, Tas 7001, Australia	University of California System; University of California Riverside; University of California System; University of California Riverside; University of Tasmania	Ma, LJ (corresponding author), Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA.	ameae.walker@ucr.edu			California Breast Cancer Research Program [10PB-0127]; Cancer Federation; Frances Marlatt Baugh award	California Breast Cancer Research Program; Cancer Federation; Frances Marlatt Baugh award	This work was supported by California Breast Cancer Research Program grant 10PB-0127 and a grant from the Cancer Federation to AMW. L Ma was a recipient of the Frances Marlatt Baugh award during this period. The study sponsors played no role in study design or collection, analysis and interpretation of the data nor in the writing of the manuscript or decision to publish.	Agostoni Carlo, 2001, Nutrition and Health (Bicester), V15, P183; Arvola M, 2000, BIOL REPROD, V63, P1817, DOI 10.1095/biolreprod63.6.1817; BOASS A, 1963, AM J PHYSIOL, V204, P101, DOI 10.1152/ajplegacy.1963.204.1.101; CALLAGHAN JM, 1990, J CELL SCI, V95, P563; CAMPBELL DA, 1984, TRANSPLANTATION, V37, P340, DOI 10.1097/00007890-198404000-00004; CARLSTEN H, 1989, IMMUNOLOGY, V68, P209; Ellis LA, 1997, J NUTR, V127, pS985, DOI 10.1093/jn/127.5.985S; Goldman AS, 1996, J MAMMARY GLAND BIOL, V1, P251, DOI 10.1007/BF02018078; HEAD JR, 1977, TRANSPLANT P, V9, P1465; HUGHES A, 1988, IMMUNOLOGY, V64, P213; JAIN L, 1989, ARCH DIS CHILD-FETAL, V64, P930, DOI 10.1136/adc.64.7_Spec_No.930; Ma LJ, 2007, J ENDOCRINOL, V193, P291, DOI 10.1677/JOE-06-0024; MIDDLETON PA, 1984, CELL IMMUNOL, V88, P421, DOI 10.1016/0008-8749(84)90175-8; MIKKELSEN HB, 1988, CELL TISSUE RES, V252, P301; MILLER SC, 1981, J REPROD IMMUNOL, V3, P187, DOI 10.1016/0165-0378(81)90060-7; Oddy W H, 2001, Breastfeed Rev, V9, P11; Oddy Wendy H, 2002, Breastfeed Rev, V10, P5; PITT J, 1977, PEDIATR RES, V11, P906, DOI 10.1203/00006450-197708000-00011; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; SCHLESINGER JJ, 1977, LANCET, V2, P529; SCHNORR KL, 1984, J REPROD IMMUNOL, V6, P329, DOI 10.1016/0165-0378(84)90031-7; SEELIG LL, 1981, TRANSPLANT P, V13, P1245; SHELDRAKE RF, 1985, RES VET SCI, V39, P10, DOI 10.1016/S0034-5288(18)31762-4; SILVERS WK, 1975, J IMMUNOL, V115, P1117; TATEMATSU M, 1975, CELL DIFFER DEV, V4, P285, DOI 10.1016/0045-6039(75)90013-5; Tuboly S, 2002, ADV EXP MED BIOL, V503, P107; TUBOLY S, 1995, ACTA VET HUNG, V43, P105; Van de Perre P, 2003, VACCINE, V21, P3374, DOI 10.1016/S0264-410X(03)00336-0; van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x; Verthelyi D, 2001, INT IMMUNOPHARMACOL, V1, P983, DOI 10.1016/S1567-5769(01)00044-3; WEILER IJ, 1983, AM J REPROD IMMUNOL, V4, P95, DOI 10.1111/j.1600-0897.1983.tb00261.x; Zhou L, 2000, IMMUNOLOGY, V101, P570, DOI 10.1046/j.1365-2567.2000.00144.x	32	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3562	10.1371/journal.pone.0003562	http://dx.doi.org/10.1371/journal.pone.0003562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958163	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131100019
J	Zeki, S; Romaya, JP				Zeki, Semir; Romaya, John Paul			Neural Correlates of Hate	PLOS ONE			English	Article								In this work, we address an important but unexplored topic, namely the neural correlates of hate. In a block-design fMRI study, we scanned 17 normal human subjects while they viewed the face of a person they hated and also faces of acquaintances for whom they had neutral feelings. A hate score was obtained for the object of hate for each subject and this was used as a covariate in a between-subject random effects analysis. Viewing a hated face resulted in increased activity in the medial frontal gyrus, right putamen, bilaterally in premotor cortex, in the frontal pole and bilaterally in the medial insula. We also found three areas where activation correlated linearly with the declared level of hatred, the right insula, right premotor cortex and the right fronto-medial gyrus. One area of deactivation was found in the right superior frontal gyrus. The study thus shows that there is a unique pattern of activity in the brain in the context of hate. Though distinct from the pattern of activity that correlates with romantic love, this pattern nevertheless shares two areas with the latter, namely the putamen and the insula.	[Zeki, Semir; Romaya, John Paul] UCL, Dept Cell & Dev Biol, Wellcome Lab Neurobiol, London, England	University of London; University College London	Zeki, S (corresponding author), UCL, Dept Cell & Dev Biol, Wellcome Lab Neurobiol, London, England.	zeki.pa@ucl.ac.uk	Zeki, Semir/AAA-1789-2020	Romaya, John/0000-0002-4857-3997; Lauwereyns, Jan/0000-0003-0551-2550	Wellcome Trust, London, UK	Wellcome Trust, London, UK(Wellcome Trust)	The work was supported by the Wellcome Trust, London, UK. The funding body had no role in the design, execution or analysis of the study.	ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Beaver JD, 2008, J NEUROSCI, V28, P2719, DOI 10.1523/JNEUROSCI.0033-08.2008; Boecker H, 2008, NEUROIMAGE, V39, P1356, DOI 10.1016/j.neuroimage.2007.09.069; Bufkin JL, 2005, TRAUMA VIOLENCE ABUS, V6, P176, DOI 10.1177/1524838005275089; DENSON TF, 2008, TRAUMA VIOLENCE ABUS, V6, P176; Elliott R, 2003, J NEUROSCI, V23, P303; Evans A. C., 1992, Society for Neuroscience Abstracts, V18, P408; Friston K, STAT PARAMETRIC MAPP; HADJIKHANI N, 2008, BRAIN COGNITION; HANAKAWA T, 2008, MOTOR PLANNING IMAGE; HATFIELD E, 1986, J ADOLESCENCE, V9, P383, DOI 10.1016/S0140-1971(86)80043-4; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kipps CM, 2007, J COGNITIVE NEUROSCI, V19, P1206, DOI 10.1162/jocn.2007.19.7.1206; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Lane RD, 1997, AM J PSYCHIAT, V154, P926; McClure EB, 2004, BIOL PSYCHIAT, V55, P1047, DOI 10.1016/j.biopsych.2004.02.013; MCGUIRE PK, 1994, BRIT J PSYCHIAT, V164, P459, DOI 10.1192/bjp.164.4.459; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; Noesselt T, 2005, CURR BIOL, V15, P424, DOI 10.1016/j.cub.2004.12.075; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; POLINE JB, 1997, HUMAN BRAIN FUNCTION, P85; Ramnani N, 2003, CEREB CORTEX, V13, P318, DOI 10.1093/cercor/13.3.318; Sambataro F, 2006, EUR J NEUROSCI, V24, P2355, DOI 10.1111/j.1460-9568.2006.05120.x; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; STERNBERG RJ, 2004, PSYCHOL HATE AMERICA, P37; Surguladze SA, 2003, NEUROIMAGE, V19, P1317, DOI 10.1016/S1053-8119(03)00085-5; Thielscher A, 2007, J NEUROSCI, V27, P2908, DOI 10.1523/JNEUROSCI.3024-06.2007; TIZABI Y, 1980, COMMUN PSYCHOPHARMAC, V4, P433	32	98	101	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3556	10.1371/journal.pone.0003556	http://dx.doi.org/10.1371/journal.pone.0003556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958169	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131100014
J	Schneider, K; Meyer-Koenig, U; Hufert, FT				Schneider, Kerstin; Meyer-Koenig, Ursula; Hufert, Frank T.			Human Cytomegalovirus Impairs the Function of Plasmacytoid Dendritic Cells in Lymphoid Organs	PLOS ONE			English	Article								Human dendritic cells (DCs) are the main antigen presenting cells (APC) and can be divided into two main populations, myeloid and plasmacytoid DCs (pDCs), the latter being the main producers of Type I Interferon. The vast majority of pDCs can be found in lymphoid organs, where the main pool of all immune cells is located, but a minority of pDCs also circulate in peripheral blood. Human cytomegalovirus (HCMV) employs multiple mechanisms to evade the immune system. In this study, we could show that pDCs obtained from lymphoid organs (tonsils) (tpDCs) and from blood (bpDCs) are different subpopulations in humans. Interestingly, these populations react in opposite manner to HCMV-infection. TpDCs were fully permissive for HCMV. Their IFN-alpha production and the expression of costimulatory and adhesion molecules were altered after infection. In contrast, in bpDCs HCMV replication was abrogated and the cells were activated with increased IFN-alpha production and upregulation of MHC class I, costimulatory, and adhesion molecules. HCMV-infection of both, tpDCs and bpDCs, led to a decreased T cell stimulation, probably mediated through a soluble factor produced by HCMV-infected pDCs. We propose that the HCMV-mediated impairment of tpDCs is a newly discovered mechanism selectively targeting the host's major population of pDCs residing in lymphoid organs.	[Schneider, Kerstin; Meyer-Koenig, Ursula] Univ Freiburg, Inst Med Microbiol & Hyg, Dept Virol, Freiburg, Germany; [Hufert, Frank T.] Univ Gottingen, Med Ctr, Inst Virol, D-3400 Gottingen, Germany	University of Freiburg; University of Gottingen	Schneider, K (corresponding author), Univ Freiburg, Inst Med Microbiol & Hyg, Dept Virol, Freiburg, Germany.	fhufert@gwdg.de			Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (BMBF) [FKZ01KI9951]	Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the "Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie (BMBF)" grant FKZ01KI9951. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; ALCAMI J, 1991, J GEN VIROL, V72, P2765, DOI 10.1099/0022-1317-72-11-2765; Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Arrode G, 2003, CURR TOP MICROBIOL, V276, P277; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Avigan D, 1999, BLOOD REV, V13, P51, DOI 10.1016/S0268-960X(99)90023-1; Beck K, 2003, EUR J IMMUNOL, V33, P1528, DOI 10.1002/eji.200323612; Benedict CA, 2008, J IMMUNOL, V180, P4836, DOI 10.4049/jimmunol.180.7.4836; Briere F, 2002, HUM IMMUNOL, V63, P1081, DOI 10.1016/S0198-8859(02)00746-2; BROWNE H, 1990, NATURE, V347, P770, DOI 10.1038/347770a0; Brune W, 2001, SCIENCE, V291, P303, DOI 10.1126/science.291.5502.303; Chang WLW, 2004, J VIROL, V78, P8720, DOI 10.1128/JVI.78.16.8720-8731.2004; CHEE MS, 1990, NATURE, V344, P774, DOI 10.1038/344774a0; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; del Hoyo GM, 2002, NATURE, V415, P1043, DOI 10.1038/4151043a; Ellsmore V, 2003, J GEN VIROL, V84, P639, DOI 10.1099/vir.0.18812-0; Fuchs A, 2005, BLOOD, V106, P2076, DOI 10.1182/blood-2004-12-4802; Grigoleit U, 2002, BRIT J HAEMATOL, V119, P189, DOI 10.1046/j.1365-2141.2002.03798.x; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Hengel H, 1997, CURR OPIN IMMUNOL, V9, P470, DOI 10.1016/S0952-7915(97)80097-0; HILL S, 1994, IMMUNOLOGY, V83, P295; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Kvale EO, 2006, BLOOD, V107, P2022, DOI 10.1182/blood-2005-05-2016; Larsson M, 2004, SEMIN IMMUNOL, V16, P147, DOI 10.1016/j.smim.2004.02.002; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; LIU R, 1994, NUCLEIC ACIDS RES, V22, P2453, DOI 10.1093/nar/22.13.2453; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; MICHELSON S, 1994, J VIROL, V68, P5730, DOI 10.1128/JVI.68.9.5730-5737.1994; Miller DM, 1998, J EXP MED, V187, P675, DOI 10.1084/jem.187.5.675; Moutaftsi M, 2002, BLOOD, V99, P2913, DOI 10.1182/blood.V99.8.2913; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naniche D, 2000, CELL MOL LIFE SCI, V57, P1399, DOI 10.1007/PL00000625; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; Presti RM, 1998, J EXP MED, V188, P577, DOI 10.1084/jem.188.3.577; Raftery MJ, 2001, IMMUNITY, V15, P997, DOI 10.1016/S1074-7613(01)00239-4; Raftery MJ, 2004, J IMMUNOL, V173, P3383, DOI 10.4049/jimmunol.173.5.3383; Riegler S, 2000, J GEN VIROL, V81, P393, DOI 10.1099/0022-1317-81-2-393; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; Senechal B, 2004, BLOOD, V103, P4207, DOI 10.1182/blood-2003-12-4350; Sinclair J, 1996, INTERVIROLOGY, V39, P293, DOI 10.1159/000150501; SINCLAIR JH, 1992, J GEN VIROL, V73, P433, DOI 10.1099/0022-1317-73-2-433; Sinzger C, 1996, INTERVIROLOGY, V39, P302, DOI 10.1159/000150502; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; Streblow DN, 1999, CELL, V99, P511, DOI 10.1016/S0092-8674(00)81539-1; Summers KL, 2001, AM J PATHOL, V159, P285, DOI 10.1016/S0002-9440(10)61694-X; Varani S, 2007, J IMMUNOL, V179, P7767, DOI 10.4049/jimmunol.179.11.7767; VONLAER D, 1995, BLOOD, V86, P4086, DOI 10.1182/blood.V86.11.4086.bloodjournal86114086; VONLAER D, 1995, J INFECT DIS, V172, P365, DOI 10.1093/infdis/172.2.365; Wiertz EJHJ, 1997, MOL MED TODAY, V3, P116, DOI 10.1016/S1357-4310(96)10059-9; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; Zhang Z, 2005, CELL MOL IMMUNOL, V2, P411	55	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3482	10.1371/journal.pone.0003482	http://dx.doi.org/10.1371/journal.pone.0003482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941519	Green Published, gold, Green Submitted			2022-12-27	WOS:000265126100013
J	Mehats, C; Franco-Montoya, ML; Boucherat, O; Lopez, E; Schmitz, T; Zana, E; Evain-Brion, D; Bourbon, J; Delacourt, C; Jarreau, PH				Mehats, Celine; Franco-Montoya, Marie-Laure; Boucherat, Olivier; Lopez, Emmanuel; Schmitz, Thomas; Zana, Elodie; Evain-Brion, Daniele; Bourbon, Jacques; Delacourt, Christophe; Jarreau, Pierre-Henri			Effects of Phosphodiesterase 4 Inhibition on Alveolarization and Hyperoxia Toxicity in Newborn Rats	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; BIRTH-WEIGHT INFANTS; GENE-EXPRESSION; BRONCHOPULMONARY DYSPLASIA; POSTNATAL-DEVELOPMENT; CAFFEINE THERAPY; COUNT METHOD; LUNG INJURY; GROWTH; INFLAMMATION	Background: Prolonged neonatal exposure to hyperoxia is associated with high mortality, leukocyte influx in airspaces, and impaired alveolarization. Inhibitors of type 4 phosphodiesterases are potent anti-inflammatory drugs now proposed for lung disorders. The current study was undertaken to determine the effects of the prototypal phosphodiesterase-4 inhibitor rolipram on alveolar development and on hyperoxia-induced lung injury. Methodology/Findings: Rat pups were placed under hyperoxia (FiO(2)>95%) or room air from birth, and received rolipram or its diluent daily until sacrifice. Mortality rate, weight gain and parameters of lung morphometry were recorded on day 10. Differential cell count and cytokine levels in bronchoalveolar lavage and cytokine mRNA levels in whole lung were recorded on day 6. Rolipram diminished weight gain either under air or hyperoxia. Hyperoxia induced huge mortality rate reaching 70% at day 10, which was prevented by rolipram. Leukocyte influx in bronchoalveolar lavage under hyperoxia was significantly diminished by rolipram. Hyperoxia increased transcript and protein levels of IL-6, MCP1, and osteopontin; rolipram inhibited the increase of these proteins. Alveolarization was impaired by hyperoxia and was not restored by rolipram. Under room air, rolipram-treated pups had significant decrease of Radial Alveolar Count. Conclusions: Although inhibition of phosphodiesterases 4 prevented mortality and lung inflammation induced by hyperoxia, it had no effect on alveolarization impairment, which might be accounted for by the aggressiveness of the model. The less complex structure of immature lungs of rolipram-treated pups as compared with diluent-treated pups under room air may be explained by the profound effect of PDE4 inhibition on weight gain that interfered with normal alveolarization.	[Mehats, Celine; Lopez, Emmanuel; Schmitz, Thomas; Zana, Elodie; Evain-Brion, Daniele; Jarreau, Pierre-Henri] INSERM, U767, Paris, France; [Mehats, Celine; Lopez, Emmanuel; Schmitz, Thomas; Evain-Brion, Daniele; Jarreau, Pierre-Henri] Univ Paris 05, Fac Med, Paris, France; [Franco-Montoya, Marie-Laure; Boucherat, Olivier; Bourbon, Jacques; Delacourt, Christophe] INSERM, U841, IMRB, Equipe 06, Creteil, France; [Bourbon, Jacques; Delacourt, Christophe] Univ Paris 12, Fac Med, IFR 10, F-94010 Creteil, France; [Mehats, Celine; Franco-Montoya, Marie-Laure; Boucherat, Olivier; Lopez, Emmanuel; Schmitz, Thomas; Zana, Elodie; Evain-Brion, Daniele; Bourbon, Jacques; Delacourt, Christophe; Jarreau, Pierre-Henri] PremUP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite	Mehats, C (corresponding author), INSERM, U767, Paris, France.	pierre-henri.jarreau@cch.aphp.fr	Delacourt, Christophe/K-6161-2019; Mehats, Celine/D-8650-2017	Mehats, Celine/0000-0002-3677-2024	Universites de Paris	Universites de Paris	This work was supported by a Legs Poix grant of la Chancellerie des Universites de Paris 2006.	Auten RL, 2001, AM J PHYSIOL-LUNG C, V281, pL336, DOI 10.1152/ajplung.2001.281.2.L336; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; BARNETTE MS, 1995, J PHARMACOL EXP THER, V273, P1396; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Boswell-Smith V, 2006, J ALLERGY CLIN IMMUN, V117, P1237, DOI 10.1016/j.jaci.2006.02.045; Boucherat O, 2007, PHYSIOL GENOMICS, V32, P128, DOI 10.1152/physiolgenomics.00108.2007; Bourbon J, 2005, PEDIATR RES, V57, p38R, DOI 10.1203/01.PDR.0000159630.35883.BE; BURRI PH, 1974, ANAT REC, V178, P711, DOI 10.1002/ar.1091780405; COONEY TP, 1982, THORAX, V37, P572, DOI 10.1136/thx.37.8.572; COONEY TP, 1982, THORAX, V37, P580, DOI 10.1136/thx.37.8.580; Dagues N, 2007, TOXICOL SCI, V100, P238, DOI 10.1093/toxsci/kfm161; Deng H, 2000, AM J RESP CRIT CARE, V162, P2316, DOI 10.1164/ajrccm.162.6.9911020; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; DEVISSER YP, 2007, EUR RESP J; Giembycz MA, 2006, BRIT J CLIN PHARMACO, V62, P138, DOI 10.1111/j.1365-2125.2006.02640.x; Hsiao R, 2005, PEDIATRICS, V116, pE43, DOI 10.1542/peds.2004-1379; Huston E, 1996, J BIOL CHEM, V271, P31334, DOI 10.1074/jbc.271.49.31334; Iona S, 1998, MOL PHARMACOL, V53, P23, DOI 10.1124/mol.53.1.23; Jin SLC, 1999, P NATL ACAD SCI USA, V96, P11998, DOI 10.1073/pnas.96.21.11998; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kinsella JP, 2006, LANCET, V367, P1421, DOI 10.1016/S0140-6736(06)68615-7; Larson JL, 1996, PHARMACOL TOXICOL, V78, P44, DOI 10.1111/j.1600-0773.1996.tb00178.x; Lopez E, 2006, AM J RESP CELL MOL, V34, P738, DOI 10.1165/rcmb.2005-0254OC; MASSARO D, 1985, J CLIN INVEST, V76, P1297, DOI 10.1172/JCI112103; Massaro D, 2007, AM J PHYSIOL-LUNG C, V292, pL1313, DOI 10.1152/ajplung.00146.2006; MERRITT TA, 1983, J CLIN INVEST, V72, P656, DOI 10.1172/JCI111015; NAURECKAS ET, 1994, EUR RESPIR J, V7, P1397, DOI 10.1183/09031936.94.07081397; NIELSON CP, 1990, J ALLERGY CLIN IMMUN, V86, P801, DOI 10.1016/S0091-6749(05)80186-1; Oger S, 2002, J CLIN ENDOCR METAB, V87, P5524, DOI 10.1210/jc.2002-020575; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Saugstad Ola Didrik, 2003, Semin Neonatol, V8, P39, DOI 10.1016/S1084-2756(02)00194-X; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; Schmidt B, 2007, NEW ENGL J MED, V357, P1893, DOI 10.1056/NEJMoa073679; Schmitz T, 2007, J IMMUNOL, V178, P1115, DOI 10.4049/jimmunol.178.2.1115; SCHUDT C, 1991, N-S ARCH PHARMACOL, V344, P682; SCHWABE U, 1976, MOL PHARMACOL, V12, P900; Spina D, 2003, DRUGS, V63, P2575, DOI 10.2165/00003495-200363230-00002; Spoto G, 1998, LIFE SCI, V63, pPL349, DOI 10.1016/S0024-3205(98)00513-X; Tang HF, 2005, AM J RESP CRIT CARE, V171, P823, DOI 10.1164/rccm.200406-771OC; ter Horst SAJ, 2004, J APPL PHYSIOL, V97, P2014, DOI 10.1152/japplphysiol.00452.2004; THOMPSON WJ, 1971, J BIOL CHEM, V246, P3145; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; Vozzelli MA, 2004, AM J PHYSIOL-LUNG C, V286, pL488, DOI 10.1152/ajplung.00414.2002; Wagenaar GTA, 2004, FREE RADICAL BIO MED, V36, P782, DOI 10.1016/j.freeradbiomed.2003.12.007; Wang P, 1999, MOL PHARMACOL, V56, P170, DOI 10.1124/mol.56.1.170; Waszak P, 2002, HUM GENE THER, V13, P1873, DOI 10.1089/104303402760372963; WEIBEL ER, 1997, LUNG SCI FDN, P333; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P825, DOI 10.1016/S0002-9378(97)70276-X; Zanardo V, 2002, AM J PERINAT, V19, P379, DOI 10.1055/s-2002-35612; ZELTNER TB, 1987, RESP PHYSIOL, V67, P247, DOI 10.1016/0034-5687(87)90057-0	51	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3445	10.1371/journal.pone.0003445	http://dx.doi.org/10.1371/journal.pone.0003445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941502	Green Published, Green Submitted, gold			2022-12-27	WOS:000265125600007
J	Kolupaeva, V; Laplantine, E; Basilico, C				Kolupaeva, Victoria; Laplantine, Emmanuel; Basilico, Claudio			PP2A-Mediated Dephosphorylation of p107 Plays a Critical Role in Chondrocyte Cell Cycle Arrest by FGF	PLOS ONE			English	Article								FGF signaling inhibits chondrocyte proliferation, a cell type-specific response that is the basis for several genetic skeletal disorders caused by activating FGFR mutations. This phenomenon requires the function of the p107 and p130 members of the Rb protein family, and p107 dephosphorylation is one of the earliest distinguishing events in FGF-induced growth arrest. To determine whether p107 dephoshorylation played a critical role in the chondrocyte response to FGF, we sought to counteract this process by overexpressing in RCS chondrocytes the cyclin D1/cdk4 kinase complex. CyclinD/cdk4-expressing RCS cells became resistant to FGF-induced p107 dephosphorylation and growth arrest, and maintained significantly high levels of cyclin E/cdk2 activity and of phosphorylated p130 at later times of FGF treatment. We explored the involvement of a phosphatase in p107 dephosphorylation. Expression of the SV40 small T-Ag, which inhibits the activity of the PP2A phosphatase, or knockdown of the expression of the PP2A catalytic subunit by RNA interference prevented p107 dephosphorylation and FGF-induced growth arrest of RCS cells. Furthermore, an association between p107 and PP2A was induced by FGF treatment. Our data show that p107 dephosphorylation is a key event in FGF-induced cell cycle arrest and indicate that in chondrocytes FGF activates the PP2A phosphatase to promote p107 dephosphorylation.	[Kolupaeva, Victoria; Laplantine, Emmanuel; Basilico, Claudio] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University	Kolupaeva, V (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	claudio.basilico@med.nyu.edu			NICDR [DE013745]; NCI [T32 CA009161]; NATIONAL CANCER INSTITUTE [T32CA009161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013745] Funding Source: NIH RePORTER	NICDR; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This investigation was supported by PHS Grant DE013745 from the NICDR, and by a postdoctoral fellowship from the NCI Training Grant T32 CA009161 to V.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa T, 2001, J BIOL CHEM, V276, P29347, DOI 10.1074/jbc.M101859200; Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Aviezer D, 2003, CURR DRUG TARGETS, V4, P353, DOI 10.2174/1389450033490993; BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; Bruce JL, 2000, MOL CELL, V6, P737, DOI 10.1016/S1097-2765(00)00072-1; Cheng LY, 2000, J BIOL CHEM, V275, P30317, DOI 10.1074/jbc.M005707200; Cicchillitti L, 2003, J BIOL CHEM, V278, P19509, DOI 10.1074/jbc.M300511200; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Coleman KG, 1997, J BIOL CHEM, V272, P18869, DOI 10.1074/jbc.272.30.18869; Dailey L, 2003, J CELL BIOL, V161, P1053, DOI 10.1083/jcb.200302075; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Farkas T, 2002, J BIOL CHEM, V277, P26741, DOI 10.1074/jbc.M200381200; Garriga J, 2004, CELL CYCLE, V3, P1320, DOI 10.4161/cc.3.10.1183; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Hansen K, 2001, EMBO J, V20, P422, DOI 10.1093/emboj/20.3.422; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; KLEINBERGER T, 1993, J VIROL, V67, P7556, DOI 10.1128/JVI.67.12.7556-7560.1993; Krucher NA, 2006, EXP CELL RES, V312, P2757, DOI 10.1016/j.yexcr.2006.05.002; Laplantine E, 2002, J CELL BIOL, V158, P741, DOI 10.1083/jcb.200205025; Leng XH, 2002, MOL CELL BIOL, V22, P2242, DOI 10.1128/MCB.22.7.2242-2254.2002; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Magenta A, 2008, MOL CELL BIOL, V28, P873, DOI 10.1128/MCB.00480-07; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; MUKHOPADHYAY K, 1995, J BIOL CHEM, V270, P27711, DOI 10.1074/jbc.270.46.27711; MUNGRE S, 1994, J VIROL, V68, P1675, DOI 10.1128/JVI.68.3.1675-1681.1994; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Priore R, 2006, J CELL PHYSIOL, V207, P800, DOI 10.1002/jcp.20620; QIN XQ, 1995, MOL CELL BIOL, V15, P742; Raucci A, 2004, J BIOL CHEM, V279, P1747, DOI 10.1074/jbc.M310384200; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Shtrichman R, 2000, ONCOGENE, V19, P3757, DOI 10.1038/sj.onc.1203705; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Swingle Mark, 2007, V365, P23; Voorhoeve PM, 1999, ONCOGENE, V18, P515, DOI 10.1038/sj.onc.1202316; Vuocolo S, 2003, J BIOL CHEM, V278, P41881, DOI 10.1074/jbc.M302715200; Wei Y, 2003, MOL CELL BIOL, V23, P3669, DOI 10.1128/MCB.23.10.3669-3680.2003; Xiao ZX, 1996, P NATL ACAD SCI USA, V93, P4633, DOI 10.1073/pnas.93.10.4633; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; Yeh N, 2007, MOL CELL BIOL, V27, P5161, DOI 10.1128/MCB.02431-06; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhao Q, 2004, J BIOL CHEM, V279, P12560, DOI 10.1074/jbc.M308242200	47	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3447	10.1371/journal.pone.0003447	http://dx.doi.org/10.1371/journal.pone.0003447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927618	Green Published, gold, Green Submitted			2022-12-27	WOS:000265122400013
J	Lu, M; Zhang, QP; Deng, M; Miao, J; Guo, YH; Gao, W; Cui, QH				Lu, Ming; Zhang, Qipeng; Deng, Min; Miao, Jing; Guo, Yanhong; Gao, Wei; Cui, Qinghua			An Analysis of Human MicroRNA and Disease Associations	PLOS ONE			English	Article							EXPRESSION; NETWORK; GENES; RNA; COEXPRESSION; REPRESSION; PROFILES; TARGET	It has been reported that increasingly microRNAs are associated with diseases. However, the patterns among the microRNA-disease associations remain largely unclear. In this study, in order to dissect the patterns of microRNA-disease associations, we performed a comprehensive analysis to the human microRNA-disease association data, which is manually collected from publications. We built a human microRNA associated disease network. Interestingly, microRNAs tend to show similar or different dysfunctional evidences for the similar or different disease clusters, respectively. A negative correlation between the tissue-specificity of a microRNA and the number of diseases it associated was uncovered. Furthermore, we observed an association between microRNA conservation and disease. Finally, we uncovered that microRNAs associated with the same disease tend to emerge as predefined microRNA groups. These findings can not only provide help in understanding the associations between microRNAs and human diseases but also suggest a new way to identify novel disease-associated microRNAs.	[Lu, Ming; Zhang, Qipeng; Deng, Min; Cui, Qinghua] Peking Univ, Hlth Sci Ctr, Dept Med Informat, Beijing 100871, Peoples R China; [Lu, Ming; Zhang, Qipeng; Deng, Min; Guo, Yanhong; Gao, Wei; Cui, Qinghua] Peking Univ, Minist Ed Key Lab Mol Cardiol, Beijing, Peoples R China; [Miao, Jing] Peking Univ First Hosp, Dept Pediat, Beijing, Peoples R China	Peking University; Peking University; Peking University	Cui, QH (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Med Informat, Beijing 100871, Peoples R China.	cuiqinghua@bjmu.edu.cn	GUO, Yanhong/B-5325-2012; Guo, Yanhong/D-9764-2012	Miao, Jing/0000-0003-0642-9740	National Basic Research program of China [2007CB512100]; Peking University [985-2-108-121]	National Basic Research program of China(National Basic Research Program of China); Peking University(Peking University)	This research was supported by the National Basic Research program of China (2007CB512100) and the 985 project of Peking University (No. 985-2-108-121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cui QH, 2007, TRENDS GENET, V23, P372, DOI 10.1016/j.tig.2007.04.003; Cui QH, 2007, BIOCHEM BIOPH RES CO, V352, P733, DOI 10.1016/j.bbrc.2006.11.080; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	27	677	705	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3420	10.1371/journal.pone.0003420	http://dx.doi.org/10.1371/journal.pone.0003420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923704	gold, Green Published			2022-12-27	WOS:000265121800015
J	Jiang, DH; Wang, YQ; Wang, YZ; He, YH				Jiang, Danhua; Wang, Yuqi; Wang, Yizhong; He, Yuehui			Repression of FLOWERING LOCUS C and FLOWERING LOCUS T by the Arabidopsis Polycomb Repressive Complex 2 Components	PLOS ONE			English	Article								Polycomb group (PcG) proteins are evolutionarily conserved in animals and plants, and play critical roles in the regulation of developmental gene expression. Here we show that the Arabidopsis Polycomb repressive complex 2 (PRC2) subunits CURLY LEAF (CLF), EMBRYONIC FLOWER 2 (EMF2) and FERTILIZATION INDEPENDENT ENDOSPERM ( FIE) repress the expression of FLOWERING LOCUS C (FLC), a central repressor of the floral transition in Arabidopsis and FLC relatives. In addition, CLF directly interacts with and mediates the deposition of repressive histone H3 lysine 27 trimethylation (H3K27me3) into FLC and FLC relatives, which suppresses active histone H3 lysine 4 trimethylation (H3K4me3) in these loci. Furthermore, we show that during vegetative development CLF and FIE strongly repress the expression of FLOWERING LOCUS T ( FT), a key flowering-time integrator, and that CLF also directly interacts with and mediates the deposition of H3K27me3 into FT chromatin. Our results suggest that PRC2-like complexes containing CLF, EMF2 and FIE, directly interact with and deposit into FT, FLC and FLC relatives repressive trimethyl H3K27 leading to the suppression of active H3K4me3 in these loci, and thus repress the expression of these flowering genes. Given the central roles of FLC and FT in flowering-time regulation in Arabidopsis, these findings suggest that the CLF-containing PRC2-like complexes play a significant role in control of flowering in Arabidopsis.	[Jiang, Danhua; Wang, Yuqi; Wang, Yizhong; He, Yuehui] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Jiang, Danhua; Wang, Yuqi; Wang, Yizhong; He, Yuehui] Temasek Life Sci Lab, Singapore, Singapore	National University of Singapore	Jiang, DH (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbshy@nus.edu.sg	HE, Yuehui/Y-8792-2018; HE, Yuehui/H-9795-2012	HE, Yuehui/0000-0003-3304-4555; HE, Yuehui/0000-0003-3304-4555; JIANG, DANHUA/0000-0003-0892-8842	Academic Research Fund (AcRF) [R-154-000-294-112, T207B3105]; National University of Singapore; Singapore Ministry of Education [T207B3105]; Temasek Life Sciences Laboratory	Academic Research Fund (AcRF); National University of Singapore(National University of Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); Temasek Life Sciences Laboratory(National University of Singapore)	Supported by Academic Research Fund (AcRF) Tier 1 grants (R-154-000-294-112) from the National University of Singapore and an AcRF Tier 2 grant (T207B3105) from the Singapore Ministry of Education and by the Temasek Life Sciences Laboratory to Y.H.	Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Barrero JM, 2007, PLANT CELL, V19, P2822, DOI 10.1105/tpc.107.054130; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Bouveret R, 2006, DEVELOPMENT, V133, P1693, DOI 10.1242/dev.02340; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Choi K, 2007, DEVELOPMENT, V134, P1931, DOI 10.1242/dev.001891; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P83, DOI 10.1590/S1677-04202007000200001; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Guitton AE, 2005, INT J DEV BIOL, V49, P707, DOI 10.1387/ijdb.051990ag; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; He YH, 2004, GENE DEV, V18, P2774, DOI 10.1101/gad.1244504; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Jiang D, 2007, PLANT CELL, V19, P2975, DOI 10.1105/tpc.107.052373; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Katz A, 2004, PLANT J, V37, P707, DOI 10.1111/j.1365-313X.2003.01996.x; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; Koornneef M, 1998, GENETICS, V148, P885; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Moon YH, 2003, PLANT CELL, V15, P681, DOI 10.1105/tpc.007831; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nicolas E, 2000, J BIOL CHEM, V275, P9797, DOI 10.1074/jbc.275.13.9797; Niu LF, 2007, EMBO REP, V8, P1190, DOI 10.1038/sj.embor.7401111; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pei YX, 2007, PLANT PHYSIOL, V144, P1913, DOI 10.1104/pp.107.099531; Pien S, 2008, PLANT CELL, V20, P580, DOI 10.1105/tpc.108.058172; Pien S, 2007, BBA-GENE STRUCT EXPR, V1769, P375, DOI 10.1016/j.bbaexp.2007.01.010; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Schmitz RJ, 2008, P NATL ACAD SCI USA, V105, P411, DOI 10.1073/pnas.0710423104; Schonrock N, 2006, GENE DEV, V20, P1667, DOI 10.1101/gad.377206; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 2006, PLANT J, V45, P871, DOI 10.1111/j.1365-313X.2006.02652.x; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; SUNG ZR, 1992, SCIENCE, V258, P1645, DOI 10.1126/science.258.5088.1645; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Tie F, 2001, DEVELOPMENT, V128, P275; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Yoshida N, 2001, PLANT CELL, V13, P2471, DOI 10.1105/tpc.13.11.2471; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283	73	213	230	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3404	10.1371/journal.pone.0003404	http://dx.doi.org/10.1371/journal.pone.0003404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852898	Green Published, gold, Green Submitted			2022-12-27	WOS:000265121700009
J	Bruin, JE; Petre, MA; Raha, S; Morrison, KM; Gerstein, HC; Holloway, AC				Bruin, Jennifer E.; Petre, Maria A.; Raha, Sandeep; Morrison, Katherine M.; Gerstein, Hertzel C.; Holloway, Alison C.			Fetal and Neonatal Nicotine Exposure in Wistar Rats Causes Progressive Pancreatic Mitochondrial Damage and Beta Cell Dysfunction	PLOS ONE			English	Article							ENZYME GENE-EXPRESSION; MATERNAL SMOKING; PREGNANCY; APOPTOSIS; GROWTH; BIRTH; OVERWEIGHT; ORIGINS; OBESITY; OVARIAN	Nicotine replacement therapy (NRT) is currently recommended as a safe smoking cessation aid for pregnant women. However, fetal and neonatal nicotine exposure in rats causes mitochondrial-mediated beta cell apoptosis at weaning, and adult-onset dysglycemia, which we hypothesize is related to progressive mitochondrial dysfunction in the pancreas. Therefore in this study we examined the effect of fetal and neonatal exposure to nicotine on pancreatic mitochondrial structure and function during postnatal development. Female Wistar rats were given saline (vehicle control) or nicotine bitartrate (1 mg/kg/d) via subcutaneous injection for 2 weeks prior to mating until weaning. At 3-4, 15 and 26 weeks of age, oral glucose tolerance tests were performed, and pancreas tissue was collected for electron microscopy, enzyme activity assays and islet isolation. Following nicotine exposure mitochondrial structural abnormalities were observed beginning at 3 weeks and worsened with advancing age. Importantly the appearance of these structural defects in nicotine-exposed animals preceded the onset of glucose intolerance. Nicotine exposure also resulted in significantly reduced pancreatic respiratory chain enzyme activity, degranulation of beta cells, elevated islet oxidative stress and impaired glucose-stimulated insulin secretion compared to saline controls at 26 weeks of age. Taken together, these data suggest that maternal nicotine use during pregnancy results in postnatal mitochondrial dysfunction that may explain, in part, the dysglycemia observed in the offspring from this animal model. These results clearly indicate that further investigation into the safety of NRT use during pregnancy is warranted.	[Bruin, Jennifer E.; Petre, Maria A.; Holloway, Alison C.] McMaster Univ, Dept Obstet & Gynecol, Div Reprod Biol, Hamilton, ON, Canada; [Raha, Sandeep; Morrison, Katherine M.] McMaster Univ, Dept Pediat, Hamilton, ON L8S 4L8, Canada; [Gerstein, Hertzel C.] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University; McMaster University	Bruin, JE (corresponding author), McMaster Univ, Dept Obstet & Gynecol, Div Reprod Biol, Hamilton, ON, Canada.	hollow@mcmaster.ca	Morrison, Katherine/AAO-8046-2021; Gerstein, Hertzel/ABB-8781-2020; Dalton-O'Reilly, Jessica/AAM-8569-2021; Gerstein, Hertzel C/B-1235-2013	Morrison, Katherine/0000-0002-1737-256X; Gerstein, Hertzel/0000-0001-8072-2836; Gerstein, Hertzel C/0000-0001-8072-2836; Bruin, Jennifer/0000-0003-2326-7819; Raha, Sandeep/0000-0001-7307-3292	Canadian Institutes of Health Research [MOP 86474]; Ontario Women's Health Council; CIHR Institute of Gender and Health Doctoral research award; CIHR Strategic Training Program in Tobacco Research Fellowship; Ashley Studentship for Research in Tobacco Control; Population Health Institute Chair in Diabetes Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Women's Health Council; CIHR Institute of Gender and Health Doctoral research award(Canadian Institutes of Health Research (CIHR)); CIHR Strategic Training Program in Tobacco Research Fellowship(Canadian Institutes of Health Research (CIHR)); Ashley Studentship for Research in Tobacco Control; Population Health Institute Chair in Diabetes Research	Funding for this project was provided by the Canadian Institutes of Health Research (MOP 86474) to Drs. Holloway and Morrison. Ms. Bruin was funded by an Ontario Women's Health Council/CIHR Institute of Gender and Health Doctoral research award and a CIHR Strategic Training Program in Tobacco Research Fellowship. Both Ms. Bruin and Ms. Petre were supported by an Ashley Studentship for Research in Tobacco Control. Dr. Gerstein holds the Population Health Institute Chair in Diabetes Research (sponsored by Aventis). Dr. Raha was provided salary support by Mr. Warren Lammert and Ms. Kathy Corkins and the Hamilton Health Sciences Foundation. We thank the staff of the McMaster University Central Animal Facility, Ms. Jillian Hyslop and Ms. Lisa Kellenberger for their assistance with the animal work and the staff of the McMaster University Electron Microscopy Facility for their excellent technical support with the EM analysis.	Andres R L, 2000, Semin Neonatol, V5, P231, DOI 10.1053/siny.2000.0025; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Bergmann KE, 2003, INT J OBESITY, V27, P162, DOI 10.1038/sj.ijo.802200; Bruin JE, 2008, FREE RADICAL BIO MED, V44, P1919, DOI 10.1016/j.freeradbiomed.2008.02.010; Bruin JE, 2008, TOXICOL SCI, V103, P362, DOI 10.1093/toxsci/kfn012; Bruin JE, 2007, J ENDOCRINOL, V194, P171, DOI 10.1677/JOE-07-0050; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chan CB, 1998, MOL CELL ENDOCRINOL, V136, P119, DOI 10.1016/S0303-7207(97)00220-7; Cnattingius S, 2002, SEMIN PERINATOL, V26, P286, DOI 10.1053/sper.2002.34771; Faiz A S, 2003, J Matern Fetal Neonatal Med, V13, P175, DOI 10.1080/713605832; Ginzel KH, 2007, J HEALTH PSYCHOL, V12, P215, DOI 10.1177/1359105307074240; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Holloway AC, 2006, ENDOCRINE, V30, P213, DOI 10.1385/ENDO:30:2:213; Holloway AC, 2005, DIABETOLOGIA, V48, P2661, DOI 10.1007/s00125-005-0022-5; Husain K, 2001, ALCOHOL, V25, P89, DOI 10.1016/S0741-8329(01)00176-8; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Leibowitz G, 2002, ENDOCRINOLOGY, V143, P3214, DOI 10.1210/en.2002-220174; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Maechler P, 2006, BIOCHEM SOC T, V34, P824, DOI 10.1042/BST0340824; Maechler P, 2006, INT J BIOCHEM CELL B, V38, P696, DOI 10.1016/j.biocel.2005.12.006; Marchetti P, 2006, NUTR METAB CARDIOVAS, V16, pS3, DOI 10.1016/j.numecd.2005.10.017; Momose K, 2006, MED MOL MORPHOL, V39, P146, DOI 10.1007/s00795-006-0324-9; Montgomery SM, 2002, BRIT MED J, V324, P26, DOI 10.1136/bmj.324.7328.26; Nordentoft M, 1996, AM J PUBLIC HEALTH, V86, P347, DOI 10.2105/AJPH.86.3.347; Ontario Medical Association, 1999, RETH STOP SMOK MED M; Ozokutan BH, 2005, BIOL NEONATE, V88, P113, DOI 10.1159/000086130; Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024; Power C, 2002, INT J EPIDEMIOL, V31, P413, DOI 10.1093/ije/31.2.413; Robinson JS, 2000, EUR J OBSTET GYN R B, V92, P13, DOI 10.1016/S0301-2115(00)00421-8; Shiverick KT, 1999, PLACENTA, V20, P265, DOI 10.1053/plac.1998.0377; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Silva JP, 2002, BBA-BIOENERGETICS, V1555, P106, DOI 10.1016/S0005-2728(02)00263-3; Simmons RA, 2006, FREE RADICAL BIO MED, V40, P917, DOI 10.1016/j.freeradbiomed.2005.12.018; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Tang C, 2007, DIABETES, V56, P2722, DOI 10.2337/db07-0279; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Toschke AM, 2002, EUR J PEDIATR, V161, P445, DOI 10.1007/s00431-002-0983-z; Vik T, 1996, EARLY HUM DEV, V45, P245, DOI 10.1016/0378-3782(96)01735-5; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WETSCHER GJ, 1995, FREE RADICAL BIO MED, V18, P877, DOI 10.1016/0891-5849(94)00221-5; Wideroe M, 2003, PAEDIATR PERINAT EP, V17, P171, DOI 10.1046/j.1365-3016.2003.00481.x	45	66	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3371	10.1371/journal.pone.0003371	http://dx.doi.org/10.1371/journal.pone.0003371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18852877	Green Published, gold, Green Submitted			2022-12-27	WOS:000265113900007
J	McDougall, SJ; Peters, JH; LaBrant, L; Wang, X; Koop, DR; Andresen, MC				McDougall, Stuart J.; Peters, James H.; LaBrant, Lia; Wang, Xin; Koop, Dennis R.; Andresen, Michael C.			Paired Assessment of Volatile Anesthetic Concentrations with Synaptic Actions Recorded In Vitro	PLOS ONE			English	Article							GABA RELEASE; GENERAL-ANESTHETICS; 2ND-ORDER NEURONS; ISOFLURANE; TRANSMISSION; GLUTAMATE; CURRENTS	The volatile anesthetic isoflurane poses a number of experimental challenges in the laboratory. Due to its rapid evaporation, the open conditions of most in vitro electrophysiological recording systems make the determination of actual isoflurane concentrations a challenge. Since the absolute anesthetic concentration in solution is directly related to efficacy, concentration measurements are important to allow comparisons between laboratory and clinical studies. In this study we quantify the sources of isoflurane loss during experimentation and describe a method for the measurement of isoflurane concentrations using gas chromatography and mass spectrometry simultaneous to in vitro electrophysiological measurements. Serial samples of perfused bath solution allowed correlation of isoflurane concentrations with ongoing biological effects. Saturated physiological solutions contained 13.4 +/- 0.2 mM isoflurane and were diluted to desired "nominal'' concentrations for experiments. The perfusion system established stable isoflurane concentrations within the bath by 2 minutes. However, bath isoflurane concentrations varied substantially and unpredictably between experiments. The magnitudes of such discrepancies in isoflurane concentrations spanned clinically important levels. Our studies suggest that, despite countermeasures, solution handling significantly impacted the isoflurane content in the tissue bath. The magnitude of these discrepancies appears to necessitate systematic direct measurement of bath isoflurane concentrations during most in vitro conditions.	[McDougall, Stuart J.; Peters, James H.; LaBrant, Lia; Andresen, Michael C.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Koop, Dennis R.] Oregon Hlth & Sci Univ, Portland, OR USA; [Wang, Xin] George Washington Univ, Dept Pharmacol & Physiol, Washington, DC USA	Oregon Health & Science University; Oregon Health & Science University; George Washington University	McDougall, SJ (corresponding author), Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA.	Andresen.ohsu@gmail.com	McDougall, Stuart/J-8310-2012	McDougall, Stuart/0000-0002-8778-675X; Andresen, Michael/0000-0003-0524-1172	National Institutes of Health [HL-058760]; National Health and Medical Research Council of Australia [Martin Fellow]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041119, F32HL088894, R01HL058760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Institutes of Health (HL-058760) and the National Health and Medical Research Council of Australia for which SJM is a C.J. Martin Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doyle MW, 2004, J NEUROSCI METH, V137, P37, DOI 10.1016/j.jneumeth.2004.02.007; Doyle MW, 2001, J NEUROPHYSIOL, V85, P2213, DOI 10.1152/jn.2001.85.5.2213; Eger EI, 2001, ANESTHESIOLOGY, V94, P915, DOI 10.1097/00000542-200105000-00032; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Franks NP, 1996, ANESTHESIOLOGY, V84, P716, DOI 10.1097/00000542-199603000-00027; Hagan CE, 1998, J NEUROSCI METH, V81, P177, DOI 10.1016/S0165-0270(98)00029-6; Haseneder R, 2004, ANESTH ANALG, V98, P1718, DOI 10.1213/01.ANE.0000112309.80017.3F; Hendrickx Jan Fa, 2008, BMC Anesthesiol, V8, P2, DOI 10.1186/1471-2253-8-2; Jin YH, 2004, J NEUROSCI, V24, P9332, DOI 10.1523/JNEUROSCI.1991-04.2004; Jinks SL, 2005, ANESTHESIOLOGY, V103, P567, DOI 10.1097/00000542-200509000-00020; JONES MV, 1992, J PHYSIOL-LONDON, V449, P279, DOI 10.1113/jphysiol.1992.sp019086; KHARASCH ED, 1994, CLIN PHARMACOL THER, V55, P434, DOI 10.1038/clpt.1994.53; MacIver MB, 1996, ANESTHESIOLOGY, V85, P823, DOI 10.1097/00000542-199610000-00018; McDougall SJ, 2008, NEUROPHARMACOLOGY, V54, P552, DOI 10.1016/j.neuropharm.2007.11.001; Peters JH, 2008, ANESTHESIOLOGY, V108, P675, DOI 10.1097/ALN.0b013e318167af9a; Scheller M, 1997, ANESTHESIOLOGY, V86, P118, DOI 10.1097/00000542-199701000-00016; Simon W, 2001, ANESTHESIOLOGY, V94, P1058, DOI 10.1097/00000542-200106000-00021; Westphalen RI, 2006, J PHARMACOL EXP THER, V316, P216, DOI 10.1124/jpet.105.090662; Westphalen RI, 2003, J PHARMACOL EXP THER, V304, P1188, DOI 10.1124/jpet.102.044685; Wu XS, 2004, ANESTHESIOLOGY, V100, P663, DOI 10.1097/00000542-200403000-00029	20	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3372	10.1371/journal.pone.0003372	http://dx.doi.org/10.1371/journal.pone.0003372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841202	Green Published, gold			2022-12-27	WOS:000265113900008
J	Cadotte, AJ; DeMarse, TB; He, P; Ding, MZ				Cadotte, Alex J.; DeMarse, Thomas B.; He, Ping; Ding, Mingzhou			Causal Measures of Structure and Plasticity in Simulated and Living Neural Networks	PLOS ONE			English	Article							PARTIAL DIRECTED COHERENCE; GRANGER CAUSALITY; FUNCTIONAL CONNECTIVITY; NEURONAL AVALANCHES; LINEAR-DEPENDENCE; CORTICAL-NEURONS; DYNAMICS; PATTERNS; FEEDBACK; CULTURE	A major goal of neuroscience is to understand the relationship between neural structures and their function. Recording of neural activity with arrays of electrodes is a primary tool employed toward this goal. However, the relationships among the neural activity recorded by these arrays are often highly complex making it problematic to accurately quantify a network's structural information and then relate that structure to its function. Current statistical methods including cross correlation and coherence have achieved only modest success in characterizing the structural connectivity. Over the last decade an alternative technique known as Granger causality is emerging within neuroscience. This technique, borrowed from the field of economics, provides a strong mathematical foundation based on linear auto-regression to detect and quantify "causal'' relationships among different time series. This paper presents a combination of three Granger based analytical methods that can quickly provide a relatively complete representation of the causal structure within a neural network. These are a simple pairwise Granger causality metric, a conditional metric, and a little known computationally inexpensive subtractive conditional method. Each causal metric is first described and evaluated in a series of biologically plausible neural simulations. We then demonstrate how Granger causality can detect and quantify changes in the strength of those relationships during plasticity using 60 channel spike train data from an in vitro cortical network measured on a microelectrode array. We show that these metrics can not only detect the presence of causal relationships, they also provide crucial information about the strength and direction of that relationship, particularly when that relationship maybe changing during plasticity. Although we focus on the analysis of multichannel spike train data the metrics we describe are applicable to any stationary time series in which causal relationships among multiple measures is desired. These techniques can be especially useful when the interactions among those measures are highly complex, difficult to untangle, and maybe changing over time.	[Cadotte, Alex J.; DeMarse, Thomas B.; He, Ping; Ding, Mingzhou] Univ Florida, Dept Pediat Neurol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Cadotte, AJ (corresponding author), Univ Florida, Dept Pediat Neurol, Gainesville, FL 32610 USA.	tdemarse@bme.ufl.edu						ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; Aertsen A, 2001, NOVART FDN SYMP, V239, P193; AERTSEN A, 2001, NOVART FDN SYMP, V239, P204; AERTSEN A, 2001, NOVART FDN SYMP, V239, P234; [Anonymous], 2020, INFECT DIS POVERTY, DOI DOI 10.1186/s40249-020-00640-3; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bernasconi C, 1999, BIOL CYBERN, V81, P199, DOI 10.1007/s004220050556; Bi GQ, 1999, NATURE, V401, P792, DOI 10.1038/44573; Branch DW, 2000, IEEE T BIO-MED ENG, V47, P290, DOI 10.1109/10.827289; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Cadotte AJ, 2005, J NEURAL ENG, V2, P114, DOI 10.1088/1741-2560/2/4/007; CARNEY P, SEIZURE PREDICTION E; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Eichler M, 2006, BIOL CYBERN, V94, P469, DOI 10.1007/s00422-006-0062-z; Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Freiwald WA, 1999, J NEUROSCI METH, V94, P105, DOI 10.1016/S0165-0270(99)00129-6; Gerstein G., 1999, CRC METH NEUROSCI S, P157; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gross G.W., 1999, OSCILLATIONS NEURAL, P3; Guo SX, 2008, J NEUROSCI METH, V172, P79, DOI 10.1016/j.jneumeth.2008.04.011; Guo SX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000087; Harris RE, 2002, J NEUROPHYSIOL, V88, P188, DOI 10.1152/jn.00722.2001; Hesse W, 2003, J NEUROSCI METH, V124, P27, DOI 10.1016/S0165-0270(02)00366-7; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jimbo Y, 2000, BIOL CYBERN, V83, P1, DOI 10.1007/PL00007970; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Keinan A, 2004, NEURAL COMPUT, V16, P1887, DOI 10.1162/0899766041336387; Latham PE, 2000, J NEUROPHYSIOL, V83, P808, DOI 10.1152/jn.2000.83.2.808; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Liang HL, 2000, NEUROREPORT, V11, P2875, DOI 10.1097/00001756-200009110-00009; Liang HL, 2002, NEUROREPORT, V13, P2011, DOI 10.1097/00001756-200211150-00004; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; MORF M, 1978, IEEE T GEOSCI REMOTE, V16, P85, DOI 10.1109/TGE.1978.294569; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Salazar RF, 2004, EUR J NEUROSCI, V20, P1391, DOI 10.1111/j.1460-9568.2004.03579.x; Sameshima K, 1999, J NEUROSCI METH, V94, P93, DOI 10.1016/S0165-0270(99)00128-4; Sato JR, 2006, NEUROIMAGE, V31, P187, DOI 10.1016/j.neuroimage.2005.11.039; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Seth AK, 2007, NEURAL COMPUT, V19, P910, DOI 10.1162/neco.2007.19.4.910; Tabak J, 2003, NEUROREPORT, V14, P1445, DOI 10.1097/00001756-200308060-00008; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; WHEELER BC, 1986, IEEE T BIO-MED ENG, V33, P1204, DOI 10.1109/TBME.1986.325701; Wiener N, 1956, THEORY PREDICTION MO; Zhu LQ, 2005, MATH BIOSCI ENG, V2, P1; Zhu LQ, 2003, NEURAL COMPUT, V15, P2359, DOI 10.1162/089976603322362392	59	58	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2008	3	10							e3355	10.1371/journal.pone.0003355	http://dx.doi.org/10.1371/journal.pone.0003355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DM	18839039	Green Submitted, Green Published, gold			2022-12-27	WOS:000265113700003
J	Rodriguez, M; Lustigman, S; Montero, E; Oksov, Y; Lobo, CA				Rodriguez, Marilis; Lustigman, Sara; Montero, Estrella; Oksov, Yelena; Lobo, Cheryl A.			PfRH5: A Novel Reticulocyte-Binding Family Homolog of Plasmodium falciparum that Binds to the Erythrocyte, and an Investigation of Its Receptor	PLOS ONE			English	Article								Multiple interactions between parasite ligands and their receptors on the human erythrocyte are a condition of successful Plasmodium falciparum invasion. The identification and characterization of these receptors presents a major challenge in the effort to understand the mechanism of invasion and to develop the means to prevent it. We describe here a novel member of the reticulocyte-binding family homolog (RH) of P. falciparum, PfRH5, and show that it binds to a previously unrecognized receptor on the RBC. PfRH5 is expressed as a 63 kDa protein and localized at the apical end of the invasive merozoite. We have expressed a fragment of PfRH5 which contains the RBC-binding domain and exhibits the same pattern of interactions with the RBC as the parent protein. Attachment is inhibited if the target cells are exposed to high concentrations of trypsin, but not to lower concentrations or to chymotrypsin or neuraminidase. We have determined the affinity, copy number and apparent molecular mass of the receptor protein. Thus, we have shown that PfRH5 is a novel erythrocyte-binding ligand and the identification and partial characterization of the new RBC receptor may indicate the existence of an unrecognized P. falciparum invasion pathway	[Rodriguez, Marilis; Montero, Estrella; Lobo, Cheryl A.] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Blood Borne Parasites, New York, NY 10021 USA; [Lustigman, Sara] New York Blood Ctr, Lindsley Kimball Res Inst, Lab Mol Parasitol, New York, NY USA; [Oksov, Yelena] New York Blood Ctr, Lindsley Kimball Res Inst, New York, NY USA	New York Blood Center; New York Blood Center; New York Blood Center	Rodriguez, M (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Blood Borne Parasites, New York, NY 10021 USA.	clobo@nybloodcenter.org	Montero, Estrella/M-3648-2018	Montero, Estrella/0000-0002-3852-960X	VP fund for new initiatives; New York Blood Center; National Blood Foundation	VP fund for new initiatives; New York Blood Center; National Blood Foundation	This work was supported by the VP fund for new initiatives, (Mohandas Narla) New York Blood Center and the National Blood Foundation.	Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Baum J, 2003, INFECT IMMUN, V71, P1856, DOI 10.1128/IAI.71.4.1856-1863.2003; Binks RH, 1999, MOL BIOCHEM PARASIT, V103, P123, DOI 10.1016/S0166-6851(99)00115-2; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DOLAN SA, 1990, J CLIN INVEST, V86, P618, DOI 10.1172/JCI114753; DOLAN SA, 1994, MOL BIOCHEM PARASIT, V64, P55, DOI 10.1016/0166-6851(94)90134-1; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; GRATZER WB, 1993, SEMIN HEMATOL, V30, P232; Guinovart C, 2006, CURR MOL MED, V6, P137, DOI 10.2174/156652406776055131; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Jennings CV, 2007, INFECT IMMUN, V75, P3531, DOI 10.1128/IAI.00122-07; Khan SM, 2001, MOL BIOCHEM PARASIT, V117, P1, DOI 10.1016/S0166-6851(01)00333-4; Lobo CA, 2004, INFECT IMMUN, V72, P5886, DOI 10.1128/IAI.72.10.5886-5891.2004; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Lobo CA, 2003, MOL BIOCHEM PARASIT, V128, P59, DOI 10.1016/S0166-6851(03)00050-1; Lobo CA, 2006, MOL BIOCHEM PARASIT, V149, P246, DOI 10.1016/j.molbiopara.2006.05.011; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; MITCHELL GH, 1986, BLOOD, V67, P1519; Okoyeh JN, 1999, INFECT IMMUN, V67, P5784, DOI 10.1128/IAI.67.11.5784-5791.1999; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Reid M, 1997, BLOOD GROUP ANTIGEN; SAMYELLOWE TY, 1988, J CELL BIOL, V106, P1507, DOI 10.1083/jcb.106.5.1507; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Su XZ, 1998, EXP PARASITOL, V89, P262, DOI 10.1006/expr.1998.4299; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WAHLGREN M, 1983, CLIN EXP IMMUNOL, V54, P135	33	78	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3300	10.1371/journal.pone.0003300	http://dx.doi.org/10.1371/journal.pone.0003300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18827878	Green Published, gold, Green Submitted			2022-12-27	WOS:000264797200007
J	Calvanese, V; Horrillo, A; Hmadcha, A; Suarez-Alvarez, B; Fernandez, AF; Lara, E; Casado, S; Menendez, P; Bueno, C; Garcia-Castro, J; Rubio, R; Lapunzina, P; Alaminos, M; Borghese, L; Terstegge, S; Harrison, NJ; Moore, HD; Brustle, O; Lopez-Larrea, C; Andrews, PW; Soria, B; Esteller, M; Fraga, MF				Calvanese, Vincenzo; Horrillo, Angelica; Hmadcha, Abdelkrim; Suarez-Alvarez, Beatriz; Fernandez, Agustin F.; Lara, Ester; Casado, Sara; Menendez, Pablo; Bueno, Clara; Garcia-Castro, Javier; Rubio, Ruth; Lapunzina, Pablo; Alaminos, Miguel; Borghese, Lodovica; Terstegge, Stefanie; Harrison, Neil J.; Moore, Harry D.; Bruestle, Oliver; Lopez-Larrea, Carlos; Andrews, Peter W.; Soria, Bernat; Esteller, Manel; Fraga, Mario F.			Cancer Genes Hypermethylated in Human Embryonic Stem Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; CPG METHYLATION; DIFFERENTIATION; RUNX3; INACTIVATION; POLYCOMB; PROTEIN; DLC-1	Developmental genes are silenced in embryonic stem cells by a bivalent histone-based chromatin mark. It has been proposed that this mark also confers a predisposition to aberrant DNA promoter hypermethylation of tumor suppressor genes (TSGs) in cancer. We report here that silencing of a significant proportion of these TSGs in human embryonic and adult stem cells is associated with promoter DNA hypermethylation. Our results indicate a role for DNA methylation in the control of gene expression in human stem cells and suggest that, for genes repressed by promoter hypermethylation in stem cells in vivo, the aberrant process in cancer could be understood as a defect in establishing an unmethylated promoter during differentiation, rather than as an anomalous process of de novo hypermethylation.	[Calvanese, Vincenzo; Fernandez, Agustin F.; Lara, Ester; Casado, Sara; Esteller, Manel; Fraga, Mario F.] Spanish Natl Canc Res Ctr CNIO, Canc Epigenet Grp, Madrid, Spain; [Horrillo, Angelica; Hmadcha, Abdelkrim] Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Seville, Spain; [Suarez-Alvarez, Beatriz; Lopez-Larrea, Carlos; Soria, Bernat] HUCA, Unidad Histocompatibil, Oviedo, Spain; [Fernandez, Agustin F.; Esteller, Manel] Catalan Inst Oncol ICO, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Menendez, Pablo; Bueno, Clara; Garcia-Castro, Javier; Rubio, Ruth] Univ Granada, Inst Investigaciones Biomed, Parque Tecnol Salud, Andalusian Stem Cell Bank BACM, E-18071 Granada, Spain; [Lapunzina, Pablo] Ctr Investigacion Biomed Red Enfermedades Raras, Hosp Univ La Paz, Madrid CIBERER, Madrid, Spain; [Alaminos, Miguel] Univ Granada, Dept Histol, E-18071 Granada, Spain; [Borghese, Lodovica; Terstegge, Stefanie; Bruestle, Oliver] Univ Bonn, Hertie Fdn, LIFE & BRAIN Ctr, Inst Reconstruct Neurobiol, D-5300 Bonn, Germany; [Harrison, Neil J.; Moore, Harry D.; Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Fraga, Mario F.] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Central University Hospital Asturias; Catalan Institute of Oncology; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; University of Granada; University of Bonn; University of Sheffield; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Calvanese, V (corresponding author), Spanish Natl Canc Res Ctr CNIO, Canc Epigenet Grp, Madrid, Spain.	mesteller@cnio.es; mffraga@cnio.es	Garcia-Castro, Javier/ABC-9741-2021; Calvanese, Vincenzo/AAO-4311-2020; Bujan, Pablo Menendez/W-3736-2017; Fraga, Mario F/H-7824-2017; , Bernat/AAL-6470-2021; Hmadcha, Abdelkrim/T-1173-2019; Esteller, Manel/L-5956-2014; Garcia-Castro, Javier/H-5274-2011; Fernandez, Agustin F./N-7302-2014; Calvanese, Vincenzo/E-1145-2016; ALAMINOS, MIGUEL/N-9960-2016; Lapunzina, Pablo/L-7075-2014	Garcia-Castro, Javier/0000-0001-7604-1640; Calvanese, Vincenzo/0000-0002-7937-1511; Bujan, Pablo Menendez/0000-0001-9372-1007; Fraga, Mario F/0000-0001-8450-2603; Hmadcha, Abdelkrim/0000-0002-4105-3702; Esteller, Manel/0000-0003-4490-6093; Garcia-Castro, Javier/0000-0001-7604-1640; Fernandez, Agustin F./0000-0002-3792-4085; Calvanese, Vincenzo/0000-0002-7937-1511; ALAMINOS, MIGUEL/0000-0003-4876-2672; Lapunzina, Pablo/0000-0002-6324-4825; Rubio Amador, Ruth/0000-0003-3263-0819; Andrews, Peter/0000-0001-7215-4410; Lopez-Larrea, Carlos/0000-0001-9988-1730; Soria, Bernat/0000-0002-2356-0380	European Union [LSHG-CT-2006-018739]; Spanish Ramon & Cajal Programme; Health Department of the Spanish Government [PI061267, PI051707]; Health and Education and Science Departments of the Spanish Government [FIS01-04, MCYT08-03, FU2004-02073, MEC09-05]; TRANSFOG [LSHC-CT-2004-503438]; Spanish Association Against Cancer (AECC); FPU Spanish Research Programme [Fellowship]; Consejeria de Salud de la Junta de Andalucia [0029, 0030/2006]; Spanish Ministry of Health [FIS PI070026]; International Jose Carreras Foundation against Leukemia [EDThomas-05]; ISCIII; DFG; Hertie Foundation; Fundacion Progreso y Salud; Instituto de Salud Carlos III-Red Espanola de Terapia Celular [RD06/0010/0025]; MRC; MRC [G0801059, G0700785, G0300268] Funding Source: UKRI; Medical Research Council [G0801059, G0300268, G0700785] Funding Source: researchfish	European Union(European Commission); Spanish Ramon & Cajal Programme(Spanish Government); Health Department of the Spanish Government; Health and Education and Science Departments of the Spanish Government; TRANSFOG; Spanish Association Against Cancer (AECC); FPU Spanish Research Programme; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); International Jose Carreras Foundation against Leukemia; ISCIII(Instituto de Salud Carlos III); DFG(German Research Foundation (DFG)); Hertie Foundation; Fundacion Progreso y Salud; Instituto de Salud Carlos III-Red Espanola de Terapia Celular; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was primarily supported by the European Union (LSHG-CT-2006-018739; ESTOOLS). MFF is funded by the Spanish Ramon & Cajal Programme and the Health Department of the Spanish Government (PI061267). The Cancer Epigenetics group at the CNIO is supported by the Health (FIS01-04) and Education and Science (I+D+I MCYT08-03, FU2004-02073/BMC and Consolider MEC09-05) Departments of the Spanish Government, the European Grant TRANSFOG LSHC-CT-2004-503438, and the Spanish Association Against Cancer (AECC). VC is a recipient of a Fellowship from the FPU Spanish Research Programme. CLL and BSA are supported by the Health Department of the Spanish Government (PI051707). The BACM is supported by the Consejeria de Salud de la Junta de Andalucia (0029 and, 0030/2006 to PM) and, the Spanish Ministry of Health to PM (FIS PI070026). CB is supported by the International Jose Carreras Foundation against Leukemia (EDThomas-05) and the ISCIII (FIS 3+3 contract). The Institute of Reconstructive Neurobiology received additional funding from the DFG and the Hertie Foundation. BS, AbH and AnH are supported by the Fundacion Progreso y Salud and Instituto de Salud Carlos III-Red Espanola de Terapia Celular (RD06/0010/0025 ). PWA, NH and HDM are also supported by the MRC.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Choi SC, 2004, EXP MOL MED, V36, P515, DOI 10.1038/emm.2004.66; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Conway KE, 2000, CANCER RES, V60, P6236; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fraga MF, 2008, CANCER RES, V68, P4116, DOI 10.1158/0008-5472.CAN-08-0085; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kang MI, 2007, J CELL BIOCHEM, V102, P224, DOI 10.1002/jcb.21291; Lagarkova MA, 2006, CELL CYCLE, V5, P416, DOI 10.4161/cc.5.4.2440; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levanon D, 2003, EMBO REP, V4, P560, DOI 10.1038/sj.embor.embor868; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Woerner SM, 2007, GENE CHROMOSOME CANC, V46, P1080, DOI 10.1002/gcc.20493; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Ying JM, 2007, EPIGENETICS-US, V2, P15, DOI 10.4161/epi.2.1.3883; Yuan BZ, 2003, CANCER GENET CYTOGEN, V140, P113, DOI 10.1016/S0165-4608(02)00674-X; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	39	66	68	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2008	3	9							e3294	10.1371/journal.pone.0003294	http://dx.doi.org/10.1371/journal.pone.0003294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MN	18820729	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000264432500004
J	Berg, RW; Ditlevsen, S; Hounsgaard, J				Berg, Rune W.; Ditlevsen, Susanne; Hounsgaard, Jorn			Intense Synaptic Activity Enhances Temporal Resolution in Spinal Motoneurons	PLOS ONE			English	Article							LUMBAR MOTONEURONS; NETWORK ACTIVITY; IN-VIVO; BALANCED INHIBITION; BACKGROUND ACTIVITY; FICTIVE LOCOMOTION; CORTICAL-NEURONS; PYRAMIDAL CELLS; SCRATCH REFLEX; EXCITATION	In neurons, spike timing is determined by integration of synaptic potentials in delicate concert with intrinsic properties. Although the integration time is functionally crucial, it remains elusive during network activity. While mechanisms of rapid processing are well documented in sensory systems, agility in motor systems has received little attention. Here we analyze how intense synaptic activity affects integration time in spinal motoneurons during functional motor activity and report a 10-fold decrease. As a result, action potentials can only be predicted from the membrane potential within 10 ms of their occurrence and detected for less than 10 ms after their occurrence. Being shorter than the average inter-spike interval, the AHP has little effect on integration time and spike timing, which instead is entirely determined by fluctuations in membrane potential caused by the barrage of inhibitory and excitatory synaptic activity. By shortening the effective integration time, this intense synaptic input may serve to facilitate the generation of rapid changes in movements.	[Berg, Rune W.; Hounsgaard, Jorn] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Ditlevsen, Susanne] Univ Copenhagen, Dept Math Sci, DK-1168 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Berg, RW (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	rune2earth@gmail.com	Berg, Rune W/C-9717-2014; Ditlevsen, Susanne/F-6708-2012; Berg, Rune W./X-7293-2019	Berg, Rune W/0000-0001-6376-9368; Ditlevsen, Susanne/0000-0002-1998-2783; Berg, Rune W./0000-0001-6376-9368; hounsgaard, jorn/0000-0003-1523-0485	Carlsberg foundation; Novo Nordisk foundation; Lundbeck foundation	Carlsberg foundation(Carlsberg Foundation); Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck foundation(Lundbeckfonden)	This work was funded by the Carlsberg foundation (RB), the Novo Nordisk foundation (RB), the Lundbeck foundation (SD and JH) and FIST (JH). Role of sponsors: None.	Alaburda A, 2005, J NEUROSCI, V25, P6316, DOI 10.1523/JNEUROSCI.0843-05.2005; Alaburda A, 2003, J NEUROSCI, V23, P8625; Baca SM, 2008, NEURON, V57, P276, DOI 10.1016/j.neuron.2007.11.028; BARRETT JN, 1975, FED PROC, V34, P1398; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Berg RW, 2007, SCIENCE, V315, P390, DOI 10.1126/science.1134960; Berkowitz A, 2001, J NEUROPHYSIOL, V86, P1017, DOI 10.1152/jn.2001.86.2.1017; BERNANDER OJD, 1991, PNAS, V88; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BorgGraham L, 1996, J PHYSIOLOGY-PARIS, V90, P185, DOI 10.1016/S0928-4257(97)81421-0; BROWNSTONE RM, 1992, EXP BRAIN RES, V90, P441; Brownstone RM, 2006, PROG NEUROBIOL, V78, P156, DOI 10.1016/j.pneurobio.2006.04.002; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chmykhova NM, 2005, BRAIN RES BULL, V66, P381, DOI 10.1016/j.brainresbull.2004.08.008; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Del Negro CA, 2002, NEURON, V34, P821, DOI 10.1016/S0896-6273(02)00712-2; Delgado-Lezama R, 1999, PROG BRAIN RES, V123, P57, DOI 10.1016/S0079-6123(08)62844-7; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Ditlevsen S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011907; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; GRANIT R, 1966, J PHYSIOL-LONDON, V187, P379, DOI 10.1113/jphysiol.1966.sp008097; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Guillamon A, 2006, J PHYSIOL-PARIS, V100, P31, DOI 10.1016/j.jphysparis.2006.09.010; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V398, P575, DOI 10.1113/jphysiol.1988.sp017058; Hyngstrom AS, 2007, NAT NEUROSCI, V10, P363, DOI 10.1038/nn1852; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; KEIFER J, 1983, BRAIN RES, V266, P148, DOI 10.1016/0006-8993(83)91318-5; Kernell D., 2006, MOTONEURONE ITS MUSC; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Mazzoni A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000439; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; Monier C, 2008, J NEUROSCI METH, V169, P323, DOI 10.1016/j.jneumeth.2007.11.008; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Parkis MA, 1999, J NEUROSCI, V19, P2368; Perreault MC, 2002, J NEUROSCI, V22, P8259; Powers RK, 2000, J NEUROPHYSIOL, V83, P483, DOI 10.1152/jn.2000.83.1.483; Press W., 1992, NUMERICAL RECIPES FO; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; RAPP M, 1992, NEURAL COMPUT, V4, P518, DOI 10.1162/neco.1992.4.4.518; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; ROBERTSON GA, 1988, J PHYSIOL-LONDON, V404, P101, DOI 10.1113/jphysiol.1988.sp017281; RODIECK RW, 1962, BIOPHYS J, V2, P351, DOI 10.1016/S0006-3495(62)86860-X; RUIGROK TJH, 1984, J COMP NEUROL, V230, P413, DOI 10.1002/cne.902300309; SCHMIDT BJ, 1994, EXP BRAIN RES, V99, P214; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHEFCHYK SJ, 1985, J NEUROPHYSIOL, V54, P1101, DOI 10.1152/jn.1985.54.5.1101; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; STEIN RB, 2005, NAT REV NEUROSCI, V25, P4985; Taylor J. R., 1982, INTRO ERROR ANAL STU; Tiesinga PHE, 2000, PHYS REV E, V62, P8413, DOI 10.1103/PhysRevE.62.8413; Toledo-Rodriguez M, 2005, TRENDS NEUROSCI, V28, P534, DOI 10.1016/j.tins.2005.08.001; TUCKWELL HC, INTRO THEORETICAL TH; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591	61	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3218	10.1371/journal.pone.0003218	http://dx.doi.org/10.1371/journal.pone.0003218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795101	Green Published, gold, Green Submitted			2022-12-27	WOS:000264428000002
J	Chevalier, J; Mulfinger, C; Garnotel, E; Nicolas, P; Davin-Regli, A; Pages, JM				Chevalier, Jacqueline; Mulfinger, Celine; Garnotel, Eric; Nicolas, Pierre; Davin-Regli, Anne; Pages, Jean-Marie			Identification and Evolution of Drug Efflux Pump in Clinical Enterobacter aerogenes Strains Isolated in 1995 and 2003	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; GRAM-NEGATIVE BACTERIA; MULTIDRUG-RESISTANCE; PSEUDOMONAS-AERUGINOSA; MOLECULAR EPIDEMIOLOGY; ANTIBIOTIC-RESISTANCE; PORIN ALTERATION; INHIBITORS; CHLORAMPHENICOL; IMIPENEM	Background: The high mortality impact of infectious diseases will increase due to accelerated evolution of antibiotic resistance in important human pathogens. Development of antibiotic resistance is a evolutionary process inducing the erosion of the effectiveness of our arsenal of antibiotics. Resistance is not necessarily limited to a single class of antibacterial agents but may affect many unrelated compounds; this is termed 'multidrug resistance' (MDR). The major mechanism of MDR is the active expulsion of drugs by bacterial pumps; the treatment of Gram negative bacterial infections is compromised due to resistance mechanisms including the expression of efflux pumps that actively expel various usual antibiotics (beta-lactams, quinolones, ... ). Methodology/Principal Findings: Enterobacter aerogenes has emerged among Enterobacteriaceae associated hospital infections during the last twenty years due to its faculty of adaptation to antibiotic stresses. Clinical isolates of E. aerogenes belonging to two strain collections isolated in 1995 and 2003 respectively, were screened to assess the involvement of efflux pumps in antibiotic resistance. Drug susceptibility assays were performed on all bacterial isolates and an efflux pump inhibitor (PA beta N) previously characterized allowed to decipher the role of efflux in the resistance. Accumulation of labelled chloramphenicol was monitored in the presence of an energy poison to determine the involvement of active efflux on the antibiotic intracellular concentrations. The presence of the PA beta N-susceptible efflux system was also identified in resistant E. aerogenes strains. Conclusions/Significance: For the first time a noticeable increase in clinical isolates containing an efflux mechanism susceptible to pump inhibitor is report within an 8 year period. After the emergence of extended spectrum beta-lactamases in E. aerogenes and the recent characterisation of porin mutations in clinical isolates, this study describing an increase in inhibitor-susceptible efflux throws light on a new step in the evolution of mechanism in E. aerogenes.	[Chevalier, Jacqueline; Mulfinger, Celine; Garnotel, Eric; Nicolas, Pierre; Davin-Regli, Anne; Pages, Jean-Marie] Fac Med & Pharm, UMR MD1, IFR 48, Marseille, France; [Garnotel, Eric] HIA Laveran, Serv Biol, Marseille, France; [Nicolas, Pierre] IMTSSA, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite	Chevalier, J (corresponding author), Fac Med & Pharm, UMR MD1, IFR 48, Marseille, France.	Jean-Marie.PAGES@univmed.fr	PAGES, jean-marie/F-2555-2013	PAGES, jean-marie/0000-0001-7092-7977	Service de Sante des Armees [2004RC16]; Universite de la Mediterranee; Eloi Collery prize: Academie Nationale de Medecine	Service de Sante des Armees; Universite de la Mediterranee; Eloi Collery prize: Academie Nationale de Medecine	This study was supported by the Service de Sante des Armees (contrat recherche clinique n 2004RC16 and livre rouge operation 23e), by the Universite de la Mediterranee and from Eloi Collery prize: Academie Nationale de Medecine (J.-M. Pages).	Aeschlimann JR, 2003, PHARMACOTHERAPY, V23, P916, DOI 10.1592/phco.23.7.916.32722; Arpin C, 2003, ANTIMICROB AGENTS CH, V47, P3506, DOI 10.1128/AAC.47.11.3506-3514.2003; Arpin C, 1996, J CLIN MICROBIOL, V34, P2163, DOI 10.1128/JCM.34.9.2163-2169.1996; Bernstein C, 1999, CURR MICROBIOL, V39, P68, DOI 10.1007/s002849900420; Bornet C, 2003, BIOCHEM BIOPH RES CO, V301, P985, DOI 10.1016/S0006-291X(03)00074-3; Bornet C, 2000, J CLIN MICROBIOL, V38, P1048, DOI 10.1128/JCM.38.3.1048-1052.2000; Bosi C, 1999, J CLIN MICROBIOL, V37, P2165, DOI 10.1128/JCM.37.7.2165-2169.1999; Braibant M, 2005, ANTIMICROB AGENTS CH, V49, P2965, DOI 10.1128/AAC.49.7.2965-2971.2005; Buckley AM, 2006, CELL MICROBIOL, V8, P847, DOI 10.1111/j.1462-5822.2005.00671.x; Canton R, 2002, J CLIN MICROBIOL, V40, P1237, DOI 10.1128/JCM.40.4.1237-1243.2002; Charrel RN, 1996, ANTIMICROB AGENTS CH, V40, P2854, DOI 10.1128/AAC.40.12.2854; Chollet R, 2004, ANTIMICROB AGENTS CH, V48, P3621, DOI 10.1128/AAC.48.9.3621-3624.2004; DavinRegli A, 1996, J CLIN MICROBIOL, V34, P1474, DOI 10.1128/JCM.34.6.1474-1480.1996; DAVINREGLI A, 2006, REGULATION EFFLUX PU; De Gheldre Y, 2001, J CLIN MICROBIOL, V39, P889, DOI 10.1128/JCM.39.3.889-896.2001; Dumarche P, 2002, ANTIMICROB AGENTS CH, V46, P1128, DOI 10.1128/AAC.46.4.1128-1131.2002; Elkins CA, 2003, DRUG RESIST UPDATE, V6, P9, DOI 10.1016/S1368-7646(03)00004-9; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P423, DOI 10.1093/jac/dkl183; Gayet S, 2003, ANTIMICROB AGENTS CH, V47, P1555, DOI 10.1128/AAC.47.5.1555-1559.2003; George AM, 1996, FEMS MICROBIOL LETT, V139, P1, DOI 10.1016/0378-1097(96)00127-9; Ghisalberti D, 2005, BIOCHEM BIOPH RES CO, V328, P1113, DOI 10.1016/j.bbrc.2005.01.069; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Goshi S, 2002, J HOSP INFECT, V51, P221, DOI 10.1053/jhin.2002.1255; Hasdemir UO, 2004, J CLIN MICROBIOL, V42, P2701, DOI 10.1128/JCM.42.6.2701-2706.2004; Lavigne JP, 2004, J CLIN MICROBIOL, V42, P3805, DOI 10.1128/JCM.42.8.3805-3808.2004; Lomovskaya O, 2006, BIOCHEM PHARMACOL, V71, P910, DOI 10.1016/j.bcp.2005.12.008; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Machado E, 2007, J ANTIMICROB CHEMOTH, V60, P1370, DOI 10.1093/jac/dkm381; Mallea M, 1998, MICROBIOL-UK, V144, P3003, DOI 10.1099/00221287-144-11-3003; Mallea M, 2002, BIOCHEM BIOPH RES CO, V293, P1370, DOI 10.1016/S0006-291X(02)00404-7; Masi M, 2006, J ANTIMICROB CHEMOTH, V57, P1223, DOI 10.1093/jac/dkl139; Mazzariol A, 2002, ANTIMICROB AGENTS CH, V46, P3984, DOI 10.1128/AAC.46.12.3984-3986.2002; Pages JM, 2005, TRENDS MOL MED, V11, P382, DOI 10.1016/j.molmed.2005.06.006; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K., 2008, MICROBE, V3, P179, DOI DOI 10.1128/MICR0BE.3.179.1; Pradel E, 2002, ANTIMICROB AGENTS CH, V46, P2640, DOI 10.1128/AAC.46.8.2640-2643.2002; Quale J, 2006, ANTIMICROB AGENTS CH, V50, P1633, DOI 10.1128/AAC.50.5.1633-1641.2006; Ricci V, 2006, ANTIMICROB AGENTS CH, V50, P38, DOI 10.1128/AAC.50.1.38-42.2006; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8; Saenz Y, 2004, J ANTIMICROB CHEMOTH, V53, P544, DOI 10.1093/jac/dkh117; Saito R, 2006, J ANTIMICROB CHEMOTH, V58, P673, DOI 10.1093/jac/dkl297; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thiolas A, 2005, ANTIMICROB AGENTS CH, V49, P1354, DOI 10.1128/AAC.49.4.1354-1358.2005; Thiolas A, 2004, BIOCHEM BIOPH RES CO, V317, P851, DOI 10.1016/j.bbrc.2004.03.130; Viveiros M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000365; Vonberg RP, 2007, J HOSP INFECT, V65, P372, DOI 10.1016/j.jhin.2006.12.010; Warner DM, 2007, J INFECT DIS, V196, P1804, DOI 10.1086/522964; Wenzel RP, 2003, ANTIMICROB AGENTS CH, V47, P3089, DOI 10.1128/AAC.47.10.3089-3098.2003; Yan MG, 2006, J ANTIMICROB CHEMOTH, V58, P1154, DOI 10.1093/jac/dkl412; 2006, EARSS ANN REPORTS	53	36	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3203	10.1371/journal.pone.0003203	http://dx.doi.org/10.1371/journal.pone.0003203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787654	Green Submitted, gold, Green Published			2022-12-27	WOS:000264426200008
J	Keating, BJ; Tischfield, S; Murray, SS; Bhangale, T; Price, TS; Glessner, JT; Galver, L; Barrett, JC; Grant, SFA; Farlow, DN; Chandrupatla, HR; Hansen, M; Ajmal, S; Papanicolaou, GJ; Guo, YR; Li, MY; DerOhannessian, S; de Bakker, PIW; Bailey, SD; Montpetit, A; Edmondson, AC; Taylor, K; Gai, XW; Wang, SS; Fornage, M; Shaikh, T; Groop, L; Boehnke, M; Hall, AS; Hattersley, AT; Frackelton, E; Patterson, N; Chiang, CWK; Kim, CE; Fabsitz, RR; Ouwehand, W; Price, AL; Munroe, P; Caulfield, M; Drake, T; Boerwinkle, E; Reich, D; Whitehead, AS; Cappola, TP; Samani, NJ; Lusis, AJ; Schadt, E; Wilson, JG; Koenig, W; McCarthy, MI; Kathiresan, S; Gabriel, SB; Hakonarson, H; Anand, SS; Reilly, M; Engert, JC; Nickerson, DA; Rader, DJ; Hirschhorn, JN; FitzGerald, GA				Keating, Brendan J.; Tischfield, Sam; Murray, Sarah S.; Bhangale, Tushar; Price, Thomas S.; Glessner, Joseph T.; Galver, Luana; Barrett, Jeffrey C.; Grant, Struan F. A.; Farlow, Deborah N.; Chandrupatla, Hareesh R.; Hansen, Mark; Ajmal, Saad; Papanicolaou, George J.; Guo, Yiran; Li, Mingyao; DerOhannessian, Stephanie; de Bakker, Paul I. W.; Bailey, Swneke D.; Montpetit, Alexandre; Edmondson, Andrew C.; Taylor, Kent; Gai, Xiaowu; Wang, Susanna S.; Fornage, Myriam; Shaikh, Tamim; Groop, Leif; Boehnke, Michael; Hall, Alistair S.; Hattersley, Andrew T.; Frackelton, Edward; Patterson, Nick; Chiang, Charleston W. K.; Kim, Cecelia E.; Fabsitz, Richard R.; Ouwehand, Willem; Price, Alkes L.; Munroe, Patricia; Caulfield, Mark; Drake, Thomas; Boerwinkle, Eric; Reich, David; Whitehead, A. Stephen; Cappola, Thomas P.; Samani, Nilesh J.; Lusis, A. Jake; Schadt, Eric; Wilson, James G.; Koenig, Wolfgang; McCarthy, Mark I.; Kathiresan, Sekar; Gabriel, Stacey B.; Hakonarson, Hakon; Anand, Sonia S.; Reilly, Muredach; Engert, James C.; Nickerson, Deborah A.; Rader, Daniel J.; Hirschhorn, Joel N.; FitzGerald, Garret A.			Concept, Design and Implementation of a Cardiovascular Gene-Centric 50 K SNP Array for Large-Scale Genomic Association Studies	PLOS ONE			English	Article							WIDE ASSOCIATION; RISK-FACTORS; LOCI; DISEASE; HEART; SUSCEPTIBILITY; TRIGLYCERIDES	A wealth of genetic associations for cardiovascular and metabolic phenotypes in humans has been accumulating over the last decade, in particular a large number of loci derived from recent genome wide association studies (GWAS). True complex disease-associated loci often exert modest effects, so their delineation currently requires integration of diverse phenotypic data from large studies to ensure robust meta-analyses. We have designed a gene-centric 50 K single nucleotide polymorphism (SNP) array to assess potentially relevant loci across a range of cardiovascular, metabolic and inflammatory syndromes. The array utilizes a "cosmopolitan'' tagging approach to capture the genetic diversity across similar to 2,000 loci in populations represented in the HapMap and SeattleSNPs projects. The array content is informed by GWAS of vascular and inflammatory disease, expression quantitative trait loci implicated in atherosclerosis, pathway based approaches and comprehensive literature searching. The custom flexibility of the array platform facilitated interrogation of loci at differing stringencies, according to a gene prioritization strategy that allows saturation of high priority loci with a greater density of markers than the existing GWAS tools, particularly in African HapMap samples. We also demonstrate that the IBC array can be used to complement GWAS, increasing coverage in high priority CVD-related loci across all major HapMap populations. DNA from over 200,000 extensively phenotyped individuals will be genotyped with this array with a significant portion of the generated data being released into the academic domain facilitating in silico replication attempts, analyses of rare variants and cross-cohort meta-analyses in diverse populations. These datasets will also facilitate more robust secondary analyses, such as explorations with alternative genetic models, epistasis and gene-environment interactions.	[Keating, Brendan J.; Whitehead, A. Stephen; Reilly, Muredach; Rader, Daniel J.; FitzGerald, Garret A.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Tischfield, Sam; Farlow, Deborah N.; de Bakker, Paul I. W.; Patterson, Nick; Chiang, Charleston W. K.; Reich, David; Kathiresan, Sekar; Gabriel, Stacey B.; Hirschhorn, Joel N.] MIT, Broad Inst Harvard, Cambridge, MA 02139 USA; [Tischfield, Sam; Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Endocrinol, Program Genom, Boston, MA USA; [Murray, Sarah S.] Scripps Genom Med, La Jolla, CA USA; [Bhangale, Tushar; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Price, Thomas S.] MRC SGDP Ctr, Inst Psychiat, London, England; [Glessner, Joseph T.; Grant, Struan F. A.; Gai, Xiaowu; Shaikh, Tamim; Frackelton, Edward; Kim, Cecelia E.; Hakonarson, Hakon] CHOP, Dept Pediat, Div Human Genet, Ctr Applied Genom, Philadelphia, PA USA; [Barrett, Jeffrey C.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England; [Chandrupatla, Hareesh R.; Ajmal, Saad; Li, Mingyao; DerOhannessian, Stephanie; Edmondson, Andrew C.; Cappola, Thomas P.; Reilly, Muredach; Rader, Daniel J.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Galver, Luana; Hansen, Mark] Illumina Inc, San Diego, CA USA; [Papanicolaou, George J.; Fabsitz, Richard R.] NHLBI, Div Prevent & Populat Sci, Bethesda, MD USA; [Guo, Yiran] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [de Bakker, Paul I. W.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA USA; [Taylor, Kent] Cedars Sinai Med Ctr, Med Genet Inst, Los Angeles, CA USA; [Wang, Susanna S.; Drake, Thomas; Lusis, A. Jake] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Fornage, Myriam] Univ Texas, Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Groop, Leif] Lund Univ, Dept Clin Sci Malmoe, Diabetes & Endocrinol, S-22100 Lund, Sweden; [Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Hall, Alistair S.] Univ Leeds, Leeds Inst Genet, Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England; [Hattersley, Andrew T.] Peninsula Med Sch, Inst Biomed & Clin Sci, Diabetes Genet Grp, Exeter, Devon, England; [Chiang, Charleston W. K.; Reich, David; Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Munroe, Patricia] Barts & The London, Dept Clin Pharmacol, London, England; [Ouwehand, Willem] Univ Cambridge, NHS Blood & Transplant, Dept Haematol, Cambridge CB2 1TN, England; [Munroe, Patricia; Caulfield, Mark] Barts & The London, William Harvey Res Inst, London, England; [Boerwinkle, Eric] Univ Texas, Hlth Sci Ctr, Human Genet Ctr, Houston, TX USA; [Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England; [Schadt, Eric] Merck & Co Inc, Rosetta Inpharmat LLC, Seattle, WA USA; [Wilson, James G.] Univ Mississippi, Med Ctr, VA Med Ctr, University, MS 38677 USA; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiol Div, Boston, MA USA; [Anand, Sonia S.] McMaster Univ, Hamilton Gen Hosp, Hamilton Hlth Sci, Clin Epidemiol & Biostat, Populat Genom Program, Hamilton, ON L8S 4L8, Canada; [Bailey, Swneke D.; Engert, James C.] McGill Univ, Dept Med & Human Genet, Montreal, PQ H3A 2T5, Canada; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Cambridge, MA 02138 USA; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford Ctr Diabetes, Endocrinol & Metabolism, Oxford OX1 2JD, England; [Lusis, A. Jake] Univ Calif Los Angeles, Sch Med, Dept Microbiol, Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Montpetit, Alexandre] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; University of Washington; University of Washington Seattle; University of London; King's College London; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Oxford; Wellcome Centre for Human Genetics; University of Pennsylvania; Illumina; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Beijing Genomics Institute (BGI); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of Texas System; University of Texas Health Science Center Houston; Lund University; University of Michigan System; University of Michigan; University of Leeds; University of Exeter; Harvard University; Harvard Medical School; University of London; Queen Mary University London; University of Cambridge; University of London; Queen Mary University London; University of Texas System; University of Texas Health Science Center Houston; University of Leicester; Merck & Company; University of Mississippi; University of Mississippi Medical Center; Ulm University; Harvard University; Massachusetts General Hospital; McMaster University; McGill University; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Keating, BJ (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	FitzGerald, Garret A/A-4222-2010; de Bakker, Paul IW/B-8730-2009; Chiang, Charleston W. K./H-3169-2019; Price, Thomas S./B-7372-2008; Hall, Alistair/K-1953-2019; Guo, Yiran/H-4120-2011; McCarthy, Mark/M-3763-2015	de Bakker, Paul IW/0000-0001-7735-7858; Chiang, Charleston W. K./0000-0002-0668-7865; Price, Thomas S./0000-0001-7356-2109; Barrett, Jeffrey/0000-0002-1152-370X; Koenig, Wolfgang/0000-0002-2064-9603; Hattersley, Andrew/0000-0001-5620-473X; Engert, James/0000-0001-8411-4790; Edmondson, Andrew/0000-0003-0313-0743; Glessner, Joseph/0000-0001-5131-2811; Munroe, Patricia/0000-0002-4176-2947; gai, Xiaowu/0000-0001-8679-9703; Caulfield, Mark/0000-0001-9295-3594; Reilly, Muredach/0000-0002-3035-9386; McCarthy, Mark/0000-0002-4393-0510; Hall, Alistair/0000-0003-0306-7887	National Institute of Health Clinical and Translational Research Award [RR U54 RR023567]; University of Pennsylvania; National Heart, Lung and Blood Institute [N01-HC-65226, U01 HL66642]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088577, R01HL065226, U01HL066642] Funding Source: NIH RePORTER; Medical Research Council [G9817803B] Funding Source: researchfish	National Institute of Health Clinical and Translational Research Award; University of Pennsylvania; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a National Institute of Health Clinical and Translational Research Award (RR U54 RR023567) to the University of Pennsylvania and National Heart, Lung and Blood Institute (N01-HC-65226). Tushar Bhangale's work was supported by the Program for Genomic Applications supported by the NHLBI (U01 HL66642).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Anderson CA, 2008, AM J HUM GENET, V83, P112, DOI 10.1016/j.ajhg.2008.06.008; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Danesh J, 2007, EUR J EPIDEMIOL, V22, P129, DOI 10.1007/s10654-006-9096-8; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Eberle MA, 2007, PLOS GENET, V3, P1827, DOI 10.1371/journal.pgen.0030170; Evans DM, 2008, EUR J HUM GENET, V16, P718, DOI 10.1038/sj.ejhg.5202011; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; HILL WG, 1968, GENETICS, V60, P615; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kullo IJ, 2007, NAT CLIN PRACT CARD, V4, P558, DOI 10.1038/ncpcardio0982; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Mayer B, 2007, CLIN RES CARDIOL, V96, P1, DOI 10.1007/s00392-006-0447-y; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Wang SS, 2007, CIRC RES, V101, pE11, DOI 10.1161/CIRCRESAHA.107.152975; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zeggini E, 2008, NAT GENET; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	39	324	328	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3583	10.1371/journal.pone.0003583	http://dx.doi.org/10.1371/journal.pone.0003583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974833	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131700007
J	Marrone, A; Ballantyne, J				Marrone, April; Ballantyne, Jack			Sequence Specificity of BAL 31 Nuclease for ssDNA Revealed by Synthetic Oligomer Substrates Containing Homopolymeric Guanine Tracts	PLOS ONE			English	Article								Background: The extracellular nuclease from Alteromonas espejiana, BAL 31 catalyzes the degradation of single-stranded and linear duplex DNA to 5'-mononucleotides, cleaves negatively supercoiled DNA to the linear duplex form, and cleaves duplex DNA in response to the presence of apurinic sites. Principal Findings: In this work we demonstrate that BAL 31 activity is affected by the presence of guanine in singlestranded DNA oligomers. Specifically, nuclease activity is shown to be affected by guanine's presence in minimal homopolymeric tracts in the middle of short oligomer substrates and also by its presence at the 39 end of ten and twenty base oligomers. GNC rich regions in dsDNA are known to cause a decrease in the enzyme's nuclease activity which has been attributed to the increased thermal stability of these regions, thus making it more difficult to unwind the strands required for enzyme access. Our results indicate that an additional phenomenon could be wholly or partly responsible for the loss of activity in these GNC rich regions. Thus the presence of a guanine tract per se impairs the enzyme's functionality, possibly due to the tract's bulky nature and preventing efficient progression through the active site. Conclusions: This study has revealed that the general purpose BAL 31 nuclease commonly used in molecular genetics exhibits a hithertofore non-characterized degree of substrate specificity with respect to single-stranded DNA (ssDNA) oligomers. Specifically, BAL 31 nuclease activity was found to be affected by the presence of guanine in ssDNA oligomers.	[Marrone, April; Ballantyne, Jack] Univ Cent Florida, Dept Chem, Grad Program Chem, Orlando, FL 32816 USA; [Marrone, April; Ballantyne, Jack] Natl Ctr Forens Sci, Orlando, FL USA	State University System of Florida; University of Central Florida	Marrone, A (corresponding author), Univ Cent Florida, Dept Chem, Grad Program Chem, Orlando, FL 32816 USA.	jballant@mail.ucf.edu		Ballantyne, Jack/0000-0002-9681-2120	State of Florida	State of Florida	This work was funded by the State of Florida to the UCF Center for Forensic Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	GRAY HB, 1975, NUCLEIC ACIDS RES, V2, P1459, DOI 10.1093/nar/2.9.1459; HAUSER CR, 1991, GENET ANAL-BIOMOL E, V8, P139, DOI 10.1016/1050-3862(91)90022-J; HENRIQUEZ V, 1990, NUCLEIC ACIDS RES, V18, P6735, DOI 10.1093/nar/18.22.6735; LEGERSKI RJ, 1978, NUCLEIC ACIDS RES, V5, P1445, DOI 10.1093/nar/5.5.1445; LIPSETT MN, 1964, J BIOL CHEM, V239, P1250; LU T, 1995, BBA-PROTEIN STRUCT M, V1251, P125, DOI 10.1016/0167-4838(95)00091-8; Miller J.N., 2000, STAT CHEMOMETRICS AN, Vfourth; PONCZ M, 1982, P NATL ACAD SCI-BIOL, V79, P4298, DOI 10.1073/pnas.79.14.4298; RALPH RK, 1962, J AM CHEM SOC, V84, P2265, DOI 10.1021/ja00870a055; TALMADGE K, 1980, GENE, V12, P235, DOI 10.1016/0378-1119(80)90105-5; Tavazzi B, 2005, CLIN BIOCHEM, V38, P997, DOI 10.1016/j.clinbiochem.2005.08.002; WEI CF, 1983, J BIOL CHEM, V258, P3506; ZHEN WP, 1986, BIOCHEMISTRY-US, V25, P6598, DOI 10.1021/bi00369a039; ZHOU XG, 1990, BIOCHIM BIOPHYS ACTA, V1049, P83, DOI 10.1016/0167-4781(90)90087-I	14	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3595	10.1371/journal.pone.0003595	http://dx.doi.org/10.1371/journal.pone.0003595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974878	Green Published, gold			2022-12-27	WOS:000265131700016
J	Dent, AE; Bergmann-Leitner, ES; Wilson, DW; Tisch, DJ; Kimmel, R; Vulule, J; Sumba, PO; Beeson, JG; Angov, E; Moormann, AM; Kazura, JW				Dent, Arlene E.; Bergmann-Leitner, Elke S.; Wilson, Danny W.; Tisch, Daniel J.; Kimmel, Rhonda; Vulule, John; Sumba, Peter Odada; Beeson, James G.; Angov, Evelina; Moormann, Ann M.; Kazura, James W.			Antibody-Mediated Growth Inhibition of Plasmodium falciparum: Relationship to Age and Protection from Parasitemia in Kenyan Children and Adults	PLOS ONE			English	Article								Background: Antibodies that impair Plasmodium falciparum merozoite invasion and intraerythrocytic development are one of several mechanisms that mediate naturally acquired immunity to malaria. Attempts to correlate anti-malaria antibodies with risk of infection and morbidity have yielded inconsistent results. Growth inhibition assays (GIA) offer a convenient method to quantify functional antibody activity against blood stage malaria. Methods: A treatment-time-to-infection study was conducted over 12-weeks in a malaria holoendemic area of Kenya. Plasma collected from healthy individuals (98 children and 99 adults) before artemether-lumefantrine treatment was tested by GIA in three separate laboratories. Results: Median GIA levels varied with P. falciparum line (D10, 8.8%; 3D7, 34.9%; FVO, 51.4% inhibition). The magnitude of growth inhibition decreased with age in all P. falciparum lines tested with the highest median levels among children,4 years compared to adults (e.g. 3D7, 45.4% vs. 30.0% respectively, p = 0.0003). Time-to-infection measured by weekly blood smears was significantly associated with level of GIA controlling for age. Upper quartile inhibition activity was associated with less risk of infection compared to individuals with lower levels (e.g. 3D7, hazard ratio = 1.535, 95% CI = 1.012-2.329; p = 0.0438). Various GIA methodologies had little effect on measured parasite growth inhibition. Conclusion: Plasma antibody-mediated growth inhibition of blood stage P. falciparum decreases with age in residents of a malaria holoendemic area. Growth inhibition assay may be a useful surrogate of protection against infection when outcome is controlled for age.	[Dent, Arlene E.; Tisch, Daniel J.; Kimmel, Rhonda; Moormann, Ann M.; Kazura, James W.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Bergmann-Leitner, Elke S.; Angov, Evelina] Walter Reed Army Inst Res, Silver Spring, MD USA; [Wilson, Danny W.; Beeson, James G.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Wilson, Danny W.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Vulule, John; Sumba, Peter Odada] Kenya Govt Med Res Ctr, Kisumu, Kenya	Case Western Reserve University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Walter & Eliza Hall Institute; University of Melbourne; Kenya Medical Research Institute	Dent, AE (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	jxk14@po.cwru.edu	Bergmann-Leitner, Elke S./B-3548-2011; Tisch, Daniel/Q-5044-2019; Bergmann-Leitner, Elke/I-5431-2019; Wilson, Danny W/E-6186-2019	Bergmann-Leitner, Elke S./0000-0002-8571-8956; Bergmann-Leitner, Elke/0000-0002-8571-8956; Wilson, Danny W/0000-0002-5073-1405; Moormann, Ann/0000-0003-1113-2829	NIH [AI43906, AI0702427]; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043906, U01AI043906] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by NIH grant AI43906 (JWK) and the National Health and Medical Research Council of Australia (Career Development Award and project grant to JGB; postgraduate scholarship to DWW). AED was supported by NIH training grant AI0702427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDT AR, 1994, PARASITOLOGY, V108, pS19, DOI 10.1017/S0031182000075685; Bergmann-Leitner ES, 2008, AM J TROP MED HYG, V78, P468, DOI 10.4269/ajtmh.2008.78.468; Bergmann-Leitner ES, 2006, AM J TROP MED HYG, V75, P437, DOI 10.4269/ajtmh.2006.75.437; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; Bolad A, 2003, AM J TROP MED HYG, V68, P728, DOI 10.4269/ajtmh.2003.68.728; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; Bull PC, 2002, J INFECT DIS, V185, P1688, DOI 10.1086/340420; Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926; Cavanagh DR, 2004, INFECT IMMUN, V72, P6492, DOI 10.1128/IAI.72.11.6492-6502.2004; Chelimo K, 2005, PEDIATR INFECT DIS J, V24, P680, DOI 10.1097/01.inf.0000172151.28851.fd; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Cortes A, 2005, INFECT IMMUN, V73, P422, DOI 10.1128/IAI.73.1.422-430.2005; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; Dent A, 2006, J IMMUNOL, V177, P7139, DOI 10.4049/jimmunol.177.10.7139; Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045; DRUILHE P, 1994, IMMUNOL LETT, V41, P115, DOI 10.1016/0165-2478(94)90118-X; Eisen DP, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-86; Flyg BW, 1997, CLIN EXP IMMUNOL, V107, P321; Good MF, 2005, TRENDS IMMUNOL, V26, P295, DOI 10.1016/j.it.2005.04.005; GRIMBERG BT, 2008, MONITORING PLASMODIU; Iyer JK, 2007, MOL MICROBIOL, V65, P333, DOI 10.1111/j.1365-2958.2007.05786.x; JACOBBERGER JW, 1992, CELL PROLIFERAT, V25, P431, DOI 10.1111/j.1365-2184.1992.tb01452.x; John CC, 2004, INFECT IMMUN, V72, P5135, DOI 10.1128/IAI.72.9.5135-5142.2004; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Mackintosh CL, 2008, INT J PARASITOL, V38, P1445, DOI 10.1016/j.ijpara.2008.03.009; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; MCCALLUM FJ, 2008, PLOSONE IN PRESS; MCGREGOR IA, 1964, AM J TROP MED HYG, V13, P237, DOI 10.4269/ajtmh.1964.13.237; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Miller LH, 1998, NAT MED, V4, P520, DOI 10.1038/nm0598supp-520; Mlambo G, 2007, EXP PARASITOL, V115, P211, DOI 10.1016/j.exppara.2006.08.003; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Newbold CI, 1997, ANN TROP MED PARASIT, V91, P551, DOI 10.1080/00034989760923; O'Donnell RA, 2000, NAT MED, V6, P91, DOI 10.1038/71595; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Oeuvray C, 2000, INFECT IMMUN, V68, P2617, DOI 10.1128/IAI.68.5.2617-2620.2000; Okech RN, 2006, AM J TROP MED HYG, V74, P191, DOI 10.4269/ajtmh.2006.74.191; Omosun YO, 2005, ACTA TROP, V95, P233, DOI 10.1016/j.actatropica.2005.06.019; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Polhemus ME, 2007, VACCINE, V25, P4203, DOI 10.1016/j.vaccine.2007.03.012; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2003, INFECT IMMUN, V71, P1833, DOI 10.1128/IAI.71.4.1833-1842.2003; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Sarr JB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-117; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Singh S, 2003, INFECT IMMUN, V71, P6766, DOI 10.1128/IAI.71.12.6766-6774.2003; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; SY NE, 1990, AM J TROP MED HYG, V43, P243, DOI 10.4269/ajtmh.1990.43.243; Thera MA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010034; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Withers MR, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010032; Yone CLRP, 2005, INFECT IMMUN, V73, P2281, DOI 10.1128/IAI.73.4.2281-2287.2005	64	61	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3557	10.1371/journal.pone.0003557	http://dx.doi.org/10.1371/journal.pone.0003557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958285	Green Submitted, Green Published, gold			2022-12-27	WOS:000265131100015
J	Ratier, L; Urrutia, M; Paris, G; Zarebski, L; Frasch, AC; Goldbaum, FA				Ratier, Laura; Urrutia, Mariela; Paris, Gaston; Zarebski, Laura; Frasch, Alberto C.; Goldbaum, Fernando A.			Relevance of the Diversity among Members of the Trypanosoma Cruzi Trans-Sialidase Family Analyzed with Camelids Single-Domain Antibodies	PLOS ONE			English	Article							AMINO-ACID REPEATS; RANGELI SIALIDASE; IN-VITRO; INHIBITORS; INFECTION; ENZYME; SERA; APOPTOSIS; INCREASE; IMMUNITY	The sialic acid present in the protective surface mucin coat of Trypanosoma cruzi is added by a membrane anchored trans-sialidase (TcTS), a modified sialidase that is expressed from a large gene family. In this work, we analyzed single domain camelid antibodies produced against trans-sialidase. Llamas were immunized with a recombinant trans-sialidase and inhibitory single-domain antibody fragments were obtained by phage display selection, taking advantage of a screening strategy using an inhibition test instead of the classic binding assay. Four single domain antibodies displaying strong trans-sialidase inhibition activity against the recombinant enzyme were identified. They share the same complementarity-determining region 3 length (17 residues) and have very similar sequences. This result indicates that they likely derived from a unique clone. Probably there is only one structural solution for tight binding inhibitory antibodies against the TcTS used for immunization. To our surprise, this single domain antibody that inhibits the recombinant TcTS, failed to inhibit the enzymatic activity present in parasite extracts. Analysis of individual recombinant trans-sialidases showed that enzymes expressed from different genes were inhibited to different extents (from 8 to 98%) by the llama antibodies. Amino acid changes at key positions are likely to be responsible for the differences in inhibition found among the recombinant enzymes. These results suggest that the presence of a large and diverse trans-sialidase family might be required to prevent the inhibitory response against this essential enzyme and might thus constitute a novel strategy of T. cruzi to evade the host immune system.	[Ratier, Laura; Frasch, Alberto C.] Univ Nacl Gen San Martin CONICET, Inst Invest Biotecchnol Inst Tecnol Chascomus IIB, Buenos Aires, DF, Argentina; [Urrutia, Mariela; Paris, Gaston; Zarebski, Laura; Goldbaum, Fernando A.] Inst Investigaciones Bioquim Buenos Aires CONICET, Fdn Inst Leloir, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Ratier, L (corresponding author), Univ Nacl Gen San Martin CONICET, Inst Invest Biotecchnol Inst Tecnol Chascomus IIB, Buenos Aires, DF, Argentina.	cfrasch@iib.unsam.edu.ar; fgoldbaum@leloir.org.ar	; Paris, Gaston/J-6100-2014	Urrutia, Mariela/0000-0002-5224-9735; Goldbaum, Fernando/0000-0001-6235-3002; Frasch, Alberto Carlos/0000-0001-7532-653X; Paris, Gaston/0000-0001-5984-7394	National Institutes of Health [AI060645-01]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas; Howard Hughes Medical Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from the National Institutes of Health, grant AI060645-01 to ACF, Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and the Consejo Nacional de Investigaciones Cientificas y Tecnicas. The work of ACF and FAG was partially supported by International Research Scholar grants from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFRANCHINO JL, 1989, MOL BIOCHEM PARASIT, V34, P221, DOI 10.1016/0166-6851(89)90050-9; Agusti R, 2004, GLYCOBIOLOGY, V14, P659, DOI 10.1093/glycob/cwh079; Amaya MF, 2003, J MOL BIOL, V325, P773, DOI 10.1016/S0022-2836(02)01306-2; Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Buscaglia CA, 1998, J INFECT DIS, V177, P431, DOI 10.1086/514199; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; Buscaglia CA, 1999, BLOOD, V93, P2025, DOI 10.1182/blood.V93.6.2025.406k19_2025_2032; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 1997, GLYCOBIOLOGY, V7, P1167, DOI 10.1093/glycob/7.8.1167; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Craig PO, 2005, PROTEINS, V61, P1089, DOI 10.1002/prot.20635; Cremona ML, 1999, GLYCOBIOLOGY, V9, P581, DOI 10.1093/glycob/9.6.581; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Fontanella GH, 2008, VACCINE, V26, P2322, DOI 10.1016/j.vaccine.2008.02.060; FRASCH ACC, 1994, PARASITOLOGY, V108, pS37, DOI 10.1017/S0031182000075703; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Gupta S, 2005, CURR OPIN MICROBIOL, V8, P428, DOI 10.1016/j.mib.2005.06.011; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2005, VET MICROBIOL, V111, P89, DOI 10.1016/j.vetmic.2005.09.005; Hoft DF, 2007, J IMMUNOL, V179, P6889, DOI 10.4049/jimmunol.179.10.6889; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; LEGUIZAMON MS, 1994, INFECT IMMUN, V62, P3441; LEGUIZAMON MS, 1994, J INFECT DIS, V170, P1570, DOI 10.1093/infdis/170.6.1570; Leguizamon MS, 1997, J INFECT DIS, V175, P1272, DOI 10.1086/593697; Mucci J, 2002, P NATL ACAD SCI USA, V99, P3896, DOI 10.1073/pnas.052496399; Mucci J, 2006, CELL MICROBIOL, V8, P1086, DOI 10.1111/j.1462-5822.2006.00689.x; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Paris G, 2005, J MOL BIOL, V345, P923, DOI 10.1016/j.jmb.2004.09.031; Paris G, 2001, GLYCOBIOLOGY, V11, P305, DOI 10.1093/glycob/11.4.305; PEREIRACHIOCCOLA VL, 1994, INFECT IMMUN, V62, P2973, DOI 10.1128/IAI.62.7.2973-2978.1994; Pitcovsky TA, 2002, J INFECT DIS, V186, P397, DOI 10.1086/341463; Pitcovsky TA, 2001, INFECT IMMUN, V69, P1869, DOI 10.1128/IAI.69.3.1869-1875.2001; POLLEVICK GD, 1993, MOL BIOCHEM PARASIT, V59, P171, DOI 10.1016/0166-6851(93)90018-S; Rastam L, 1996, INT J EPIDEMIOL, V25, P953, DOI 10.1093/ije/25.5.953; SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; Tarleton RL, 2007, CURR OPIN IMMUNOL, V19, P430, DOI 10.1016/j.coi.2007.06.003; Todeschini AR, 2000, GLYCOBIOLOGY, V10, P213, DOI 10.1093/glycob/10.2.213; Tomlinson S, 1996, NAT BIOTECHNOL, V14, P717, DOI 10.1038/nbt0696-717; Transue TR, 1998, PROTEINS, V32, P515, DOI 10.1002/(SICI)1097-0134(19980901)32:4<515::AID-PROT9>3.0.CO;2-E; Tribulatti MV, 2005, INFECT IMMUN, V73, P201, DOI 10.1128/IAI.73.1.201-207.2005; Vasconcelos JR, 2004, HUM GENE THER, V15, P878, DOI 10.1089/hum.2004.15.878	47	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3524	10.1371/journal.pone.0003524	http://dx.doi.org/10.1371/journal.pone.0003524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949046	Green Submitted, gold, Green Published			2022-12-27	WOS:000265126400009
J	Asquith, B				Asquith, Becca			The Evolutionary Selective Advantage of HIV-1 Escape Variants and the Contribution of Escape to the HLA-Associated Risk of AIDS Progression	PLOS ONE			English	Article								HIV-1 escape from surveillance by cytotoxic T lymphocytes (CTL) is thought to cause at least transient weakening of immune control. However, the CTL response is highly adaptable and the long-term consequences of viral escape are not fully understood. The objective of this study was to address the question "to what extent does HIV-1 escape from CTL contribute to HLA-associated AIDS progression?'' We combined an analysis of 21 escape events in longitudinally-studied HIV-1 infected people with a population-level analysis of the functional CTL response in 150 subjects (by IFNg ELISpot) and an analysis of the HIV-1 sequence database to quantify the contribution of escape to the HLA-associated rate of AIDS progression. We found that CTL responses restricted by protective HLA class I alleles, which are associated with slow progression to AIDS, recognised epitopes where escape variants had a weak evolutionary selective advantage (P=0.008) and occurred infrequently (P=0.017). Epitopes presented by protective HLA class I alleles were more likely to elicit a CTL response (P=0.001) and less likely to contain sequence variation (P=0.006). A third of between-individual variation in HLA-associated disease risk was predicted by the selective advantage of escape variants: a doubling in the evolutionary selective advantage was associated with a decrease in the AIDS-free period of 1.2 yrs. These results contribute to our understanding of what makes a CTL response protective and why some individuals progress to AIDS more rapidly than others.	[Asquith, Becca] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England	Imperial College London	Asquith, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England.	b.asquith@imperial.ac.uk		Asquith, Becca/0000-0002-5911-3160	RCUK; Medical Research Council [G0601072] Funding Source: researchfish; MRC [G0601072] Funding Source: UKRI	RCUK(UK Research & Innovation (UKRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by RCUK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Asquith B, 2006, PLOS BIOL, V4, P583, DOI 10.1371/journal.pbio.0040090; Asquith B, 2007, P NATL ACAD SCI USA, V104, P6365, DOI 10.1073/pnas.0700666104; BAILEY JR, 2006, J EXP MED; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frater AJ, 2007, J VIROL, V81, P6742, DOI 10.1128/JVI.00022-07; Ganusov VV, 2006, PLOS COMPUT BIOL, V2, P182, DOI 10.1371/journal.pcbi.0020024; Geels MJ, 2006, VIROLOGY, V345, P209, DOI 10.1016/j.virol.2005.09.023; Geels MJ, 2003, J VIROL, V77, P12430, DOI 10.1128/JVI.77.23.12430-12440.2003; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Jamieson BD, 2003, J IMMUNOL, V171, P5372, DOI 10.4049/jimmunol.171.10.5372; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kent SJ, 2005, TRENDS MICROBIOL, V13, P243, DOI 10.1016/j.tim.2005.03.011; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOENIG WJ, 1995, PLAST RECONSTR SURG, V95, P1; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Marsh S. G. E., 2000, HLA FACTSBOOK; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Milicic A, 2005, J VIROL, V79, P13953, DOI 10.1128/JVI.79.22.13953-13962.2005; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; MUNOZ A, 1989, AM J EPIDEMIOL, V130, P530, DOI 10.1093/oxfordjournals.aje.a115367; NOWAK MA, 1991, SCIENCE, V254, P963, DOI 10.1126/science.1683006; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Oxenius A, 2004, J INFECT DIS, V190, P713, DOI 10.1086/422760; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Scherer A, 2004, P NATL ACAD SCI USA, V101, P12266, DOI 10.1073/pnas.0404091101; Schreuder GMT, 2005, HUM IMMUNOL, V66, P170, DOI 10.1016/j.humimm.2004.09.017; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Silvestri G, 2003, J CLIN INVEST, V112, P821, DOI 10.1172/JCI200319799; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	47	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3486	10.1371/journal.pone.0003486	http://dx.doi.org/10.1371/journal.pone.0003486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941529	Green Published, Green Submitted, gold			2022-12-27	WOS:000265126100017
J	Yuan, CH; He, QY; Peng, K; Diao, JB; Jiang, LP; Tang, X; Liang, SP				Yuan, Chun-Hua; He, Quan-Yuan; Peng, Kuan; Diao, Jian-Bo; Jiang, Li-Ping; Tang, Xing; Liang, Song-Ping			Discovery of a Distinct Superfamily of Kunitz-Type Toxin (KTT) from Tarantulas	PLOS ONE			English	Article								Background: Kuntiz-type toxins (KTTs) have been found in the venom of animals such as snake, cone snail and sea anemone. The main ancestral function of Kunitz-type proteins was the inhibition of a diverse array of serine proteases, while toxic activities (such as ion-channel blocking) were developed under a variety of Darwinian selection pressures. How new functions were grafted onto an old protein scaffold and what effect Darwinian selection pressures had on KTT evolution remains a puzzle. Principal Findings: Here we report the presence of a new superfamily of KTTs in spiders (Tarantulas: Ornithoctonus huwena and Ornithoctonus hainana), which share low sequence similarity to known KTTs and is clustered in a distinct clade in the phylogenetic tree of KTT evolution. The representative molecule of spider KTTs, HWTX-XI, purified from the venom of O. huwena, is a bi-functional protein which is a very potent trypsin inhibitor (about 30-fold more strong than BPTI) as well as a weak Kv1.1 potassium channel blocker. Structural analysis of HWTX-XI in 3-D by NMR together with comparative function analysis of 18 expressed mutants of this toxin revealed two separate sites, corresponding to these two activities, located on the two ends of the cone-shape molecule of HWTX-XI. Comparison of non-synonymous/synonymous mutation ratios (v) for each site in spider and snake KTTs, as well as PBTI like body Kunitz proteins revealed high Darwinian selection pressure on the binding sites for Kv channels and serine proteases in snake, while only on the proteases in spider and none detected in body proteins, suggesting different rates and patterns of evolution among them. The results also revealed a series of key events in the history of spider KTT evolution, including the formation of a novel KTT family (named sub-Kuntiz-type toxins) derived from the ancestral native KTTs with the loss of the second disulfide bridge accompanied by several dramatic sequence modifications. Conclusions/Significance: These finding illustrate that the two activity sites of Kunitz-type toxins are functionally and evolutionally independent and provide new insights into effects of Darwinian selection pressures on KTT evolution, and mechanisms by which new functions can be grafted onto old protein scaffolds.	[Yuan, Chun-Hua; He, Quan-Yuan; Peng, Kuan; Diao, Jian-Bo; Jiang, Li-Ping; Tang, Xing; Liang, Song-Ping] Hunan Normal Univ, Key Lab Prot Chem & Dev Biol, Minist Educ, Coll Life Sci, Changsha, Hunan, Peoples R China	Hunan Normal University	Yuan, CH (corresponding author), Hunan Normal Univ, Key Lab Prot Chem & Dev Biol, Minist Educ, Coll Life Sci, Changsha, Hunan, Peoples R China.	liangsp@hunnu.edu.cn			National Natural Science Foundation of China [30170193, 30430170]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (30170193, 30430170)to SP Liang.	Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Bayrhuber M, 2005, J BIOL CHEM, V280, P23766, DOI 10.1074/jbc.C500064200; BERNDT KD, 1992, J MOL BIOL, V227, P757, DOI 10.1016/0022-2836(92)90222-6; BERNDT KD, 1993, J MOL BIOL, V234, P735, DOI 10.1006/jmbi.1993.1623; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CREIGHTON TE, 1992, SCIENCE, V256, P111, DOI 10.1126/science.1373519; DEISENHOFER J, 1975, ACTA CRYSTALLOGR B, V31, P238, DOI 10.1107/S0567740875002415; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diao JB, 2003, TOXICON, V42, P715, DOI 10.1016/j.toxicon.2003.08.007; Dy CY, 2006, ACTA CRYSTALLOGR D, V62, P980, DOI [10.1107/S0907444906021123, 10.1107/S0907444906021122]; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2006, MOL DIVERS, V10, P545, DOI 10.1007/s11030-006-9050-4; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Gasparini S, 1998, J BIOL CHEM, V273, P25393, DOI 10.1074/jbc.273.39.25393; He QY, 2008, NUCLEIC ACIDS RES, V36, pD293, DOI 10.1093/nar/gkm832; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KASSELL B, 1965, BIOCHEM BIOPH RES CO, V18, P255, DOI 10.1016/0006-291X(65)90749-7; Katoh E, 2000, BIOPOLYMERS, V54, P44, DOI 10.1002/(SICI)1097-0282(200007)54:1<44::AID-BIP50>3.0.CO;2-Z; King GF, 2004, TOXICON, V43, P471, DOI 10.1016/j.toxicon.2004.02.001; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LANCELIN JM, 1994, NAT STRUCT BIOL, V1, P246, DOI 10.1038/nsb0494-246; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Otlewski J, 2001, ACTA BIOCHIM POL, V48, P419; Sasaki SD, 2004, BIOCHIMIE, V86, P643, DOI 10.1016/j.biochi.2004.09.010; SCHWEITZ H, 1995, J BIOL CHEM, V270, P25121, DOI 10.1074/jbc.270.42.25121; SKARZYNSKI T, 1992, J MOL BIOL, V224, P671, DOI 10.1016/0022-2836(92)90552-U; SOKOLOVSKY M, 1992, J NEUROCHEM, V59, P809, DOI 10.1111/j.1471-4159.1992.tb08318.x; STRYDOM DJ, 1977, BIOCHIM BIOPHYS ACTA, V491, P361, DOI 10.1016/0005-2795(77)90279-3; STRYDOM DJ, 1973, NATURE-NEW BIOL, V243, P88; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang FC, 1999, EUR J BIOCHEM, V263, P222, DOI 10.1046/j.1432-1327.1999.00494.x; WANG JF, 1993, ACTA SCI NAT U NORM, V16, P4; Xiao YC, 2004, J BIOL CHEM, V279, P26220, DOI 10.1074/jbc.M401387200; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yuan CH, 2007, J PROTEOME RES, V6, P2792, DOI 10.1021/pr0700192; Zupunski V, 2003, FEBS LETT, V547, P131, DOI 10.1016/S0014-5793(03)00693-8	45	93	130	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3414	10.1371/journal.pone.0003414	http://dx.doi.org/10.1371/journal.pone.0003414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923708	Green Published, gold, Green Submitted			2022-12-27	WOS:000265121800012
J	Daetwyler, HD; Villanueva, B; Woolliams, JA				Daetwyler, Hans D.; Villanueva, Beatriz; Woolliams, John A.			Accuracy of Predicting the Genetic Risk of Disease Using a Genome-Wide Approach	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; TRAITS; LOCI; SUSCEPTIBILITY; ASSOCIATION	Background: The prediction of the genetic disease risk of an individual is a powerful public health tool. While predicting risk has been successful in diseases which follow simple Mendelian inheritance, it has proven challenging in complex diseases for which a large number of loci contribute to the genetic variance. The large numbers of single nucleotide polymorphisms now available provide new opportunities for predicting genetic risk of complex diseases with high accuracy. Methodology/Principal Findings: We have derived simple deterministic formulae to predict the accuracy of predicted genetic risk from population or case control studies using a genome-wide approach and assuming a dichotomous disease phenotype with an underlying continuous liability. We show that the prediction equations are special cases of the more general problem of predicting the accuracy of estimates of genetic values of a continuous phenotype. Our predictive equations are responsive to all parameters that affect accuracy and they are independent of allele frequency and effect distributions. Deterministic prediction errors when tested by simulation were generally small. The common link among the expressions for accuracy is that they are best summarized as the product of the ratio of number of phenotypic records per number of risk loci and the observed heritability. Conclusions/Significance: This study advances the understanding of the relative power of case control and population studies of disease. The predictions represent an upper bound of accuracy which may be achievable with improved effect estimation methods. The formulae derived will help researchers determine an appropriate sample size to attain a certain accuracy when predicting genetic risk.	[Daetwyler, Hans D.; Woolliams, John A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Daetwyler, Hans D.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Villanueva, Beatriz] Scottish Agr Coll, Sustainable Livestock Syst, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Wageningen University & Research; Scottish Agricultural College	Daetwyler, HD (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	hans.daetwyler@roslin.ed.ac.uk	Daetwyler, Hans D/H-9775-2019	Daetwyler, Hans D/0000-0002-3018-3640	Marie Curie Host Fellowships; Scottish Executive Environment and Rural Affairs Department (SEERAD); Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BBS/E/D/05191133] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191133] Funding Source: researchfish	Marie Curie Host Fellowships(European Commission); Scottish Executive Environment and Rural Affairs Department (SEERAD); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	HDD is supported by the SABRETRAIN Project, which is funded by the Marie Curie Host Fellowships for Early Stage Research Training, as part of the 6th Framework Program of the European Commission. BV receives support from the Scottish Executive Environment and Rural Affairs Department (SEERAD), and JAW receives funding from the Biotechnology and Biological Sciences Research Council (BBSRC).	Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bijma P, 1999, GENETICS, V151, P1197; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chamberlain AJ, 2007, GENETICS, V177, P1117, DOI 10.1534/genetics.107.077784; Dekkers J C M, 2004, J Anim Sci, V82 E-Suppl, pE313; Falconer D. S., 1996, INTRO QUANTITATIVE G; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Lynch M., 1998, GENETICS ANAL QUANTI; McRae AF, 2002, GENETICS, V160, P1113; Meuwissen THE, 2001, GENETICS, V157, P1819; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; RISCH N, 1991, AM J HUM GENET, V48, P1058; ROBERTSON A, 1961, GENET RES, V2, P189, DOI 10.1017/S0016672300000690; ROBERTSON A, 1949, GENETICS, V34, P395; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; SHRINER D, 2008, NUCLEIC ACIDS RES, P36; SOLBERG TR, 2008, J ANIMAL SC IN PRESS; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Xu SZ, 2003, GENETICS, V163, P789; Yi NJ, 2008, GENETICS, V179, P1045, DOI 10.1534/genetics.107.085589	30	448	461	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3395	10.1371/journal.pone.0003395	http://dx.doi.org/10.1371/journal.pone.0003395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852893	Green Published, Green Submitted, gold			2022-12-27	WOS:000265121700004
J	Vargas, AO; Kohlsdorf, T; Fallon, JF; VandenBrooks, J; Wagner, GP				Vargas, Alexander O.; Kohlsdorf, Tiana; Fallon, John F.; VandenBrooks, John; Wagner, Guenter P.			The Evolution of HoxD-11 Expression in the Bird Wing: Insights from Alligator mississippiensis	PLOS ONE			English	Article							LIMB DEVELOPMENT; GENE-EXPRESSION; SONIC-HEDGEHOG; DIGIT IDENTITY; SHH; HOMOLOGY; ORIGIN; BUD	Background: Comparative morphology identifies the digits of the wing of birds as 1,2 and 3, but they develop at embryological positions that become digits 2, 3 and 4 in other amniotes. A hypothesis to explain this is that a homeotic frame shift of digital identity occurred in the evolution of the bird wing, such that digits 1,2 and 3 are developing from embryological positions 2, 3 and 4. Digit 1 of the mouse is the only digit that shows no late expression of HoxD-11. This is also true for the anterior digit of the bird wing, suggesting this digit is actually a digit 1. If this is the case, we can expect closer relatives of birds to show no HoxD-11 expression only in digit 1. To test this prediction we investigate HoxD-11 expression in crocodilians, the closest living relatives of birds. Methodology/Principal Findings: Using degenerate primers we cloned a 606 nucleotide fragment of exon 1 of the alligator HoxD-11 gene and used it for whole-mount in-situ detection in alligator embryos. We found that in the pentadactyl forelimbs of alligator, as in the mouse, late expression of HoxD-11 is absent only in digit 1. Conclusions/Significance: The ancestral condition for amniotes is that late-phase HoxD-11 expression is absent only in digit 1. The biphalangeal morphology and lack of HoxD-11 expression of the anterior digit of the wing is like digit 1 of alligator and mouse, but its embryological position as digit 2 is derived. HoxD-11 expression in alligator is consistent with the hypothesis that both digit morphology as well as HoxD-11 expression are shifted towards posterior in the bird wing.	[Vargas, Alexander O.; Kohlsdorf, Tiana; Wagner, Guenter P.] Yale Univ, Dept Ecol & Evol Biol, New Haven, CT 06520 USA; [Fallon, John F.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; [VandenBrooks, John] Yale Peabody Mus Nat Hist, Dept Geol & Geophys, New Haven, CT USA	Yale University; University of Wisconsin System; University of Wisconsin Madison	Vargas, AO (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile.	thearchosaur@gmail.com	Vargas, Alexander O/L-3788-2017; Kohlsdorf, Tiana/C-3463-2012	Kohlsdorf, Tiana/0000-0002-3873-2042; Wagner, Gunter/0000-0002-3097-002X; Vargas, Alexander/0000-0002-2009-7116	NSF [IOB 002488]; PEW Latin American Program of fellowships in Biomedical sciences	NSF(National Science Foundation (NSF)); PEW Latin American Program of fellowships in Biomedical sciences	Financial support came from NSF grant IOB 002488. Alexander Vargas is a fellow of PEW Latin American Program of fellowships in Biomedical sciences.	Blanco MJ, 1998, DEV GENES EVOL, V208, P175, DOI 10.1007/s004270050172; Burke AC, 1997, SCIENCE, V278, P666, DOI 10.1126/science.278.5338.666; Chatterjee S, 1998, SCIENCE, V280, DOI 10.1126/science.280.5362.355a; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Davis AP, 1996, DEVELOPMENT, V122, P1175; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; DONOGHUE MJ, 1989, EVOLUTION, V43, P1137, DOI [10.2307/2409353, 10.1111/j.1558-5646.1989.tb02565.x]; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Knezevic V, 1997, DEVELOPMENT, V124, P4523; Lee MSY, 2004, ASSEMBLING THE TREE OF LIFE, P451; Meyer A, 2003, ANNU REV ECOL EVOL S, V34, P311, DOI 10.1146/annurev.ecolsys.34.011802.132351; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; MORGAN BA, 1992, NATURE, V358, P236, DOI 10.1038/358236a0; MULLER GB, 1990, J MORPHOL, V203, P151, DOI 10.1002/jmor.1052030204; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; Panman L, 2006, DEVELOPMENT, V133, P3419, DOI 10.1242/dev.02529; Reno PL, 2008, J EXP ZOOL PART B, V310B, P240, DOI 10.1002/jez.b.21207; Romer AS, 1950, VERTEBRATE BODY; Shapiro Michael D., 2007, P225; Shubin N., 1994, INTERPRETING HIERARC, P201; Suzuki T, 2004, DEV CELL, V6, P43, DOI 10.1016/S1534-5807(03)00401-5; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; Vargas AO, 2005, J EXP ZOOL PART B, V304B, P86, DOI 10.1002/jez.b.21023; Wagner GP, 2005, THEOR BIOSCI, V124, P165, DOI 10.1016/j.thbio.2005.07.002; Wagner GP, 1999, P NATL ACAD SCI USA, V96, P5111, DOI 10.1073/pnas.96.9.5111; Wagner GP, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-213; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; YOKOUCHI Y, 1991, NATURE, V353, P443, DOI 10.1038/353443a0; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695	34	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3325	10.1371/journal.pone.0003325	http://dx.doi.org/10.1371/journal.pone.0003325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833328	Green Published, gold, Green Submitted			2022-12-27	WOS:000264797400003
J	Munshi-South, J				Munshi-South, Jason			Female-Biased Dispersal and Gene Flow in a Behaviorally Monogamous Mammal, the Large Treeshrew (Tupaia tana)	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; EFFECTIVE POPULATION-SIZE; TAILED DWARF LEMUR; MICROSATELLITE ANALYSIS; RELATEDNESS; EVOLUTION; CONSEQUENCES; STRATEGIES; COALESCENT; PHILOPATRY	Background: Female-biased dispersal (FBD) is predicted to occur in monogamous species due to local resource competition among females, but evidence for this association in mammals is scarce. The predicted relationship between FBD and monogamy may also be too simplistic, given that many pair-living mammals exhibit substantial extra-pair paternity. Methodology/Principal Findings: I examined whether dispersal and gene flow are female-biased in the large treeshrew (Tupaia tana) in Borneo, a behaviorally monogamous species with a genetic mating system characterized by high rates (50%) of extra-pair paternity. Genetic analyses provided evidence of FBD in this species. As predicted for FBD, I found lower mean values for the corrected assignment index for adult females than for males using seven microsatellite loci, indicating that female individuals were more likely to be immigrants. Adult female pairs were also less related than adult male pairs. Furthermore, comparison of Bayesian coalescent-based estimates of migration rates using maternally and bi-parentally inherited genetic markers suggested that gene flow is female-biased in T. tana. The effective number of migrants between populations estimated from mitochondrial DNA sequence was three times higher than the number estimated using autosomal microsatellites. Conclusions/Significance: These results provide the first evidence of FBD in a behaviorally monogamous species without mating fidelity. I argue that competition among females for feeding territories creates a sexual asymmetry in the costs and benefits of dispersal in treeshrews.	[Munshi-South, Jason] Univ Maryland, Dept Biol, Behavior, Ecol, Evolut & Syst Program, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Munshi-South, J (corresponding author), CUNY, Dept Nat Sci, Baruch Coll, New York, NY 10021 USA.	Jason.Munshi-South@baruch.cuny.edu	Munshi-South, Jason/A-3385-2009	Munshi-South, Jason/0000-0002-8067-4341	Institute of Tropical Biology and Conservation; University of Malaysia, Sabah; Danum Valley Management Committee; Royal Society Southeast Asian Rainforest Research Programme; Animal Behavior Society; University of Maryland; Cleveland Zoological Society; Sigma Xi; American Society of Mammalogists; Explorers Club	Institute of Tropical Biology and Conservation; University of Malaysia, Sabah; Danum Valley Management Committee; Royal Society Southeast Asian Rainforest Research Programme; Animal Behavior Society; University of Maryland; Cleveland Zoological Society; Sigma Xi; American Society of Mammalogists; Explorers Club	Institute of Tropical Biology and Conservation, University of Malaysia, Sabah, Danum Valley Management Committee, Royal Society Southeast Asian Rainforest Research Programme, Animal Behavior Society, University of Maryland, Cleveland Zoological Society, Sigma Xi, American Society of Mammalogists, and Explorers Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo ZAID, 2004, MOL ECOL, V13, P837, DOI 10.1111/j.1365-294X.2004.02132.x; Banks SC, 2002, J ZOOL, V256, P389, DOI 10.1017/S0952836902000432; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Biek R, 2006, BIOL LETT-UK, V2, P312, DOI 10.1098/rsbl.2005.0437; Blundell GM, 2002, MOL ECOL, V11, P289, DOI 10.1046/j.0962-1083.2001.01440.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bradley BJ, 2004, CURR BIOL, V14, P510, DOI 10.1016/j.cub.2004.02.062; Brookfield H.C., 1995, PLACE FOREST ENV SOC; Brotherton Peter N. M., 2003, P42; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Cutrera AP, 2005, MOL ECOL, V14, P2511, DOI 10.1111/j.1365-294X.2005.02551.x; DIETZ JM, 1993, ANIM BEHAV, V46, P1067, DOI 10.1006/anbe.1993.1297; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; Douadi MI, 2007, MOL ECOL, V16, P2247, DOI 10.1111/j.1365-294X.2007.03286.x; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Emmons L.H., 2000, TUPAI FIELD STUDY BO; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Fietz J, 2000, BEHAV ECOL SOCIOBIOL, V49, P8, DOI 10.1007/s002650000269; Fontanillas P, 2004, EVOLUTION, V58, P886; Fredsted T, 2007, BEHAV ECOL SOCIOBIOL, V61, P943, DOI 10.1007/s00265-006-0323-9; Gardner A, 2004, J EVOLUTION BIOL, V17, P1195, DOI 10.1111/j.1420-9101.2004.00775.x; Gerlach G, 2001, MOL ECOL, V10, P2307, DOI 10.1046/j.0962-1083.2001.01369.x; Goossens B, 1998, BEHAV ECOL SOCIOBIOL, V43, P281, DOI 10.1007/s002650050492; Goossens B, 2001, MOL ECOL, V10, P41, DOI 10.1046/j.1365-294X.2001.01192.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J, 1996, GENETICS, V144, P1933; Goudet J., 2002, FSTAT PROGRAM ESTIMA; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammond RL, 2006, P ROY SOC B-BIOL SCI, V273, P479, DOI 10.1098/rspb.2005.3257; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hazlitt SL, 2004, MOL ECOL, V13, P3621, DOI 10.1111/j.1365-294X.2004.02342.x; HOOD G, 2005, POPTOOLS VERSION 2 6; Hudson RR, 2000, GENETICS, V155, P2011; Ji W, 2001, MOL ECOL, V10, P1527, DOI 10.1046/j.1365-294X.2001.01287.x; Johns AG., 1997, TIMBER PRODUCTION BI; Kays RW, 2000, MOL ECOL, V9, P743, DOI 10.1046/j.1365-294x.2000.00921.x; Kitchen AM, 2006, ANIM BEHAV, V71, P1029, DOI 10.1016/j.anbehav.2005.06.015; Langergraber KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000973; Ligon JD, 1999, EVOLUTION AVIAN BREE; Lynch M, 1999, GENETICS, V152, P1753; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Martin JK, 2007, BEHAVIOUR, V144, P1419, DOI 10.1163/156853907782418240; MCCRACKEN GF, 1984, Z TIERPSYCHOL, V66, P55; Mossman CA, 1999, MOL ECOL, V8, P1063, DOI 10.1046/j.1365-294x.1999.00652.x; Muller AE, 2000, BIOL REV, V75, P405, DOI 10.1017/S0006323100005533; Munshi-South J, 2006, MOL ECOL NOTES, V6, P698, DOI 10.1111/j.1471-8286.2006.01314.x; Munshi-South J, 2007, J MAMMAL, V88, P1427, DOI 10.1644/06-MAMM-A-295R1.1; Munshi-South J, 2007, BEHAV ECOL SOCIOBIOL, V62, P201, DOI 10.1007/s00265-007-0454-7; Nei M., 1987, MOL EVOLUTIONARY GEN; Nichols J., 2001, DISPERSAL; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Perrin N, 1999, AM NAT, V154, P282, DOI 10.1086/303236; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Pusey A.E., 1987, P250; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Reichard Ulrich H., 2003, P3; Ritland K, 2004, FOREST ECOL MANAG, V197, P171, DOI 10.1016/j.foreco.2004.05.012; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schulke O, 2005, INT J PRIMATOL, V26, P903, DOI 10.1007/s10764-005-5328-0; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Sun LX, 2000, CAN J ZOOL, V78, P393, DOI 10.1139/cjz-78-3-393; Thomas SC, 2005, PHILOS T R SOC B, V360, P1457, DOI 10.1098/rstb.2005.1675; Van de Casteele T, 2001, MOL ECOL, V10, P1539, DOI 10.1046/j.1365-294X.2001.01288.x; Whitmore T.C., 1984, TROPICAL RAM FORESTS; WOLFF JO, 1994, OIKOS, V71, P349, DOI 10.2307/3546284; WOLFF JO, 1993, OIKOS, V68, P173, DOI 10.2307/3545324; Wright TF, 2005, MOL ECOL, V14, P1197, DOI 10.1111/j.1365-294X.2005.02466.x	73	12	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3228	10.1371/journal.pone.0003228	http://dx.doi.org/10.1371/journal.pone.0003228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LB	18797506	Green Submitted, Green Published, gold			2022-12-27	WOS:000264428200007
J	Turner, TL; Von Wettberg, EJ; Nuzhdin, SV				Turner, Thomas L.; Von Wettberg, Eric J.; Nuzhdin, Sergey V.			Genomic Analysis of Differentiation between Soil Types Reveals Candidate Genes for Local Adaptation in Arabidopsis lyrata	PLOS ONE			English	Article							SERPENTINE SOILS; SELECTION; EVOLUTION; IDENTIFICATION; POLYMORPHISMS; NEUTRALITY; FREQUENCY	Serpentine soil, which is naturally high in heavy metal content and has low calcium to magnesium ratios, comprises a difficult environment for most plants. An impressive number of species are endemic to serpentine, and a wide range of non-endemic plant taxa have been shown to be locally adapted to these soils. Locating genomic polymorphisms which are differentiated between serpentine and non-serpentine populations would provide candidate loci for serpentine adaptation. We have used the Arabidopsis thaliana tiling array, which has 2.85 million probes throughout the genome, to measure genetic differentiation between populations of Arabidopsis lyrata growing on granitic soils and those growing on serpentinic soils. The significant overrepresentation of genes involved in ion transport and other functions provides a starting point for investigating the molecular basis of adaptation to soil ion content, water retention, and other ecologically and economically important variables. One gene in particular, calcium-exchanger 7, appears to be an excellent candidate gene for adaptation to low Ca: Mg ratio in A. lyrata.	[Turner, Thomas L.; Von Wettberg, Eric J.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Turner, Thomas L.; Nuzhdin, Sergey V.] Univ Southern Calif, Los Angeles, CA USA	University of California System; University of California Davis; University of Southern California	Turner, TL (corresponding author), Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA.	habarimbu@gmail.com	von Wettberg, Eric/C-1115-2016	von Wettberg, Eric/0000-0002-2724-0317	NSF [Predoctoral Fellowship, DEB0548991]; Center for Population Biology at UC Davis; NIH [NRSA Postdoctoral Fellowship, RGM076643]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076643] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Center for Population Biology at UC Davis; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF Predoctoral Fellowship and the Center for Population Biology at UC Davis (TLT), an NIH NRSA Postdoctoral Fellowship (EVW), NIH grant RGM076643 (SVN), and NSF grant DEB0548991 (SVN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; [Anonymous], 2002, GEOLOGY PLANT LIFE E; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Berglund ABN, 2004, NEW PHYTOL, V161, P199, DOI 10.1046/j.1469-8137.2003.00934.x; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Bradshaw HD, 2005, NEW PHYTOL, V167, P81, DOI 10.1111/j.1469-8137.2005.01408.x; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; FU YX, 1993, GENETICS, V133, P693; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Hahn MW, 2008, EVOLUTION, V62, P255, DOI 10.1111/j.1558-5646.2007.00308.x; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kruckeberg A.R., 1984, CALIFORNIA SERPENTIN; KRUCKEBERG AR, 1951, AM J BOT, V38, P408, DOI 10.2307/2438248; LATHAM RE, 1993, BARTONIA S, V57, P61; LEWONTIN RC, 1973, GENETICS, V74, P175; Lynch M, 2007, ORIGINS GENOME ARCHI; Nuzhdin SV, 2007, HEREDITY, V99, P313, DOI 10.1038/sj.hdy.6801003; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Rhoads A. F., 1993, VASCULAR FLORA PENNS; ROBERTSON A, 1975, GENETICS, V81, P775; Ronald J, 2005, GENOME RES, V15, P284, DOI 10.1101/gr.2850605; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Safford H. D., 2005, Madrono, V52, P222, DOI 10.3120/0024-9637(2005)52[222:SEITCF]2.0.CO;2; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TAJIMA F, 1989, GENETICS, V123, P585; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Thornton KR, 2007, HEREDITY, V98, P340, DOI 10.1038/sj.hdy.6800967; Turner TL, 2008, GENETICS, V179, P455, DOI 10.1534/genetics.107.083659; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wright JW, 2007, PLANT SOIL, V293, P209, DOI 10.1007/s11104-006-9181-5; Wright JW, 2006, EVOL ECOL RES, V8, P1	40	41	42	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3183	10.1371/journal.pone.0003183	http://dx.doi.org/10.1371/journal.pone.0003183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784841	Green Submitted, Green Published, gold			2022-12-27	WOS:000264425900005
J	Lecca, D; Trincavelli, ML; Gelosa, P; Sironi, L; Ciana, P; Fumagalli, M; Villa, G; Verderio, C; Grumelli, C; Guerrini, U; Tremoli, E; Rosa, P; Cuboni, S; Martini, C; Buffo, A; Cimino, M; Abbracchio, MP				Lecca, Davide; Trincavelli, Maria Letizia; Gelosa, Paolo; Sironi, Luigi; Ciana, Paolo; Fumagalli, Marta; Villa, Giovanni; Verderio, Claudia; Grumelli, Carlotta; Guerrini, Uliano; Tremoli, Elena; Rosa, Patrizia; Cuboni, Serena; Martini, Claudia; Buffo, Annalisa; Cimino, Mauro; Abbracchio, Maria P.			The Recently Identified P2Y-Like Receptor GPR17 Is a Sensor of Brain Damage and a New Target for Brain Repair	PLOS ONE			English	Article								Deciphering the mechanisms regulating the generation of new neurons and new oligodendrocytes, the myelinating cells of the central nervous system, is of paramount importance to address new strategies to replace endogenous damaged cells in the adult brain and foster repair in neurodegenerative diseases. Upon brain injury, the extracellular concentrations of nucleotides and cysteinyl-leukotrienes (cysLTs), two families of endogenous signaling molecules, are markedly increased at the site of damage, suggesting that they may act as "danger signals'' to alert responses to tissue damage and start repair. Here we show that, in brain telencephalon, GPR17, a recently deorphanized receptor for both uracil nucleotides and cysLTs (e. g., UDPglucose and LTD(4)), is normally present on neurons and on a subset of parenchymal quiescent oligodendrocyte precursor cells. We also show that induction of brain injury using an established focal ischemia model in the rodent induces profound spatiotemporal-dependent changes of GPR17. In the lesioned area, we observed an early and transient up-regulation of GPR17 in neurons expressing the cellular stress marker heat shock protein 70. Magnetic Resonance Imaging in living mice showed that the in vivo pharmacological or biotechnological knock down of GPR17 markedly prevents brain infarct evolution, suggesting GPR17 as a mediator of neuronal death at this early ischemic stage. At later times after ischemia, GPR17 immuno-labeling appeared on microglia/macrophages infiltrating the lesioned area to indicate that GPR17 may also acts as a player in the remodeling of brain circuitries by microglia. At this later stage, parenchymal GPR17(+) oligodendrocyte progenitors started proliferating in the peri-injured area, suggesting initiation of remyelination. To confirm a specific role for GPR17 in oligodendrocyte differentiation, the in vitro exposure of cortical pre-oligodendrocytes to the GPR17 endogenous ligands UDPglucose and LTD4 promoted the expression of myelin basic protein, confirming progression toward mature oligodendrocytes. Thus, GPR17 may act as a "sensor'' that is activated upon brain injury on several embryonically distinct cell types, and may play a key role in both inducing neuronal death inside the ischemic core and in orchestrating the local remodeling/repair response. Specifically, we suggest GPR17 as a novel target for therapeutic manipulation to foster repair of demyelinating wounds, the types of lesions that also occur in patients with multiple sclerosis.	[Lecca, Davide; Gelosa, Paolo; Sironi, Luigi; Ciana, Paolo; Fumagalli, Marta; Villa, Giovanni; Guerrini, Uliano; Tremoli, Elena; Abbracchio, Maria P.] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Trincavelli, Maria Letizia; Cuboni, Serena; Martini, Claudia] Univ Pisa, Dept Psychiat, Neurobiol, Pharmacol & Biotechnol, I-56100 Pisa, Italy; [Villa, Giovanni] IRCCS, Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Verderio, Claudia; Grumelli, Carlotta; Rosa, Patrizia] Univ Milan, CNR, Inst Neurosci, I-20122 Milan, Italy; [Tremoli, Elena] IRCCS, Monzino Cardiol Ctr, Milan, Italy; [Buffo, Annalisa] Univ Turin, Dept Neurosci, I-10124 Turin, Italy; [Cimino, Mauro] Univ Urbino, Inst Pharmacol & Pharmacognosy, I-61029 Urbino, Italy	University of Milan; University of Pisa; IRCCS Bonino Pulejo; Consiglio Nazionale delle Ricerche (CNR); University of Milan; IRCCS Centro Cardiologico Monzino; University of Turin; University of Urbino	Lecca, D (corresponding author), Univ Milan, Dept Pharmacol Sci, Milan, Italy.	mariapia.abbracchio@unimi.it	Verderio, Claudia/K-4415-2016; tremoli, elena/C-1035-2011; Sironi, Luigi/S-8174-2016; Lecca, Davide/A-8850-2010; Buffo, Annalisa/O-7207-2019; Abbracchio, Maria Pia/B-9342-2014; Fumagalli, Marta/AEP-4117-2022; Martini, Claudia/AAC-4089-2019; Buffo, Annalisa/K-4560-2016; Gelosa, Paolo/K-5210-2016; Messier, Claude/A-2322-2008; Ciana, Paolo/F-9224-2012; Trincavelli, Maria Letizia/M-1921-2015; TREMOLI, ELENA/I-8126-2018	Verderio, Claudia/0000-0001-7216-5873; Lecca, Davide/0000-0002-3258-363X; Buffo, Annalisa/0000-0001-7637-0006; Abbracchio, Maria Pia/0000-0002-7833-3388; Martini, Claudia/0000-0001-9379-3027; Buffo, Annalisa/0000-0001-7637-0006; Gelosa, Paolo/0000-0003-4442-537X; Messier, Claude/0000-0002-4791-1763; Trincavelli, Maria Letizia/0000-0001-8124-977X; Rosa, Patrizia/0000-0002-2590-6955; SIRONI, LUIGI/0000-0002-4738-3454; CIANA, PAOLO/0000-0001-5771-5638; Fumagalli, Marta/0000-0002-0158-842X; TREMOLI, ELENA/0000-0002-0929-6106	Italian Ministry of Education; Progetti FIRB2003 [RBNE03YA3L_009]; COFIN-MIUR [2006059022]; CARIPLO Foundation [2006/0882]; University of Milan; Fondazione CRT; Centro Neurolesi "Bonino-Pulejo", Messina, Italy [fellowship]	Italian Ministry of Education; Progetti FIRB2003; COFIN-MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); CARIPLO Foundation(Fondazione Cariplo); University of Milan; Fondazione CRT(Fondazione CRT); Centro Neurolesi "Bonino-Pulejo", Messina, Italy	This project was supported by the Italian Ministry of Education, Progetti FIRB2003 #RBNE03YA3L_009 and COFIN-MIUR 2006059022 "PURINOCEPTORS AND NEUROPROTECTION" to MPA, and by the CARIPLO Foundation Grant 2006/0882 "GENOMICS AND PROTEOMICS OF G PROTEIN-COUPLED RECEPTORS: NOVEL TARGETS FOR THE DIAGNOSIS AND PREVENTION OF HUMAN DISEASES" to prof. Francesco Clementi, University of Milan, by the Progetto Alfieri, Fondazione CRT to AB. GV has been supported by a fellowship by the Centro Neurolesi "Bonino-Pulejo", Messina, Italy.	Abbracchio MP, 2003, TRENDS PHARMACOL SCI, V24, P52, DOI 10.1016/S0165-6147(02)00038-X; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Armstrong JN, 1996, NEUROSCIENCE, V74, P685, DOI 10.1016/0306-4522(96)00164-9; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Ballerini P, 2005, INT J IMMUNOPATH PH, V18, P255, DOI 10.1177/039463200501800208; Blasius R, 1998, J NEUROCHEM, V70, P1357; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Bruzzone S, 2004, J NEUROCHEM, V89, P264, DOI 10.1111/j.1471-4159.2003.02326.x; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Capra V, 2005, J CELL SCI, V118, P5625, DOI 10.1242/jcs.02668; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Ciceri P, 2001, BRIT J PHARMACOL, V133, P1323, DOI 10.1038/sj.bjp.0704189; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Drazen JM, 2003, ADV EXP MED BIOL, V525, P1; Fumagalli M, 2004, BIOCHEM PHARMACOL, V68, P113, DOI 10.1016/j.bcp.2004.02.038; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gregersen R, 2001, EXP BRAIN RES, V138, P384, DOI 10.1007/s002210100715; Guerrini U, 2002, STROKE, V33, P825, DOI 10.1161/hs0302.104111; Kotani M, 2001, BRIT J PHARMACOL, V133, P138, DOI 10.1038/sj.bjp.0704038; Maisel M, 2007, STEM CELLS, V25, P1231, DOI 10.1634/stemcells.2006-0617; Marteau F, 2003, MOL PHARMACOL, V64, P104, DOI 10.1124/mol.64.1.104; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Menegon A, 2002, J NEUROSCI, V22, P7016; Okano H, 2007, J NEUROCHEM, V102, P1459, DOI 10.1111/j.1471-4159.2007.04674.x; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Samuelsson B, 2000, AM J RESP CRIT CARE, V161, pS2, DOI 10.1164/ajrccm.161.supplement_1.ltta-1; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Stein CA, 2001, J CLIN INVEST, V108, P641, DOI 10.1172/JCI13885; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Tepper JM, 1997, J NEUROSCI, V17, P2519; Van Oekelen D, 2003, BRAIN RES REV, V42, P123, DOI 10.1016/S0165-0173(03)00153-X	37	178	189	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3579	10.1371/journal.pone.0003579	http://dx.doi.org/10.1371/journal.pone.0003579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974869	Green Submitted, Green Published, gold			2022-12-27	WOS:000265131700005
J	Pulskens, WP; Teske, GJ; Butter, LM; Roelofs, JJ; van der Poll, T; Florquin, S; Leemans, JC				Pulskens, Wilco P.; Teske, Gwendoline J.; Butter, Loes M.; Roelofs, Joris J.; van der Poll, Tom; Florquin, Sandrine; Leemans, Jaklien C.			Toll-Like Receptor-4 Coordinates the Innate Immune Response of the Kidney to Renal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							CYTOKINE PRODUCTION; CUTTING EDGE; IFN-GAMMA; TLR4; ISCHEMIA; CELLS; TOLL-LIKE-RECEPTOR-4; PROLIFERATION; INHIBITION; ACTIVATION	Toll-like receptors (TLRs) can detect endogenous danger molecules released upon tissue injury resulting in the induction of a proinflammatory response. One of the TLR family members, TLR4, is constitutively expressed at RNA level on renal epithelium and this expression is enhanced upon renal ischemia/reperfusion (I/R) injury. The functional relevance of this organ-specific upregulation remains however unknown. We therefore investigated the specific role of TLR4 and the relative contribution of its two downstream signaling cascades, the MyD88-dependent and TRIF-dependent cascades in renal damage by using TLR4-/-, MyD88-/- and TRIF-mutant mice that were subjected to renal ischemia/reperfusion injury. Our results show that TLR4 initiates an exaggerated proinflammatory response upon I/R injury, as reflected by lower levels of chemokines and infiltrating granulocytes, less renal damage and a more preserved renal function in TLR4-/- 2 mice as compared to wild type mice. In vitro studies demonstrate that renal tubular epithelial cells can coordinate an immune response to ischemic injury in a TLR4-dependent manner. In vivo we found that epithelial- and leukocyte-associated functional TLR4 contribute in a similar proportion to renal dysfunction and injury as assessed by bone marrow chimeric mice. Surprisingly, no significant differences were found in renal function and inflammation in MyD88-/- and TRIF-mutant mice compared with their wild types, suggesting that selective targeting of TLR4 directly may be more effective for the development of therapeutic tools to prevent I/R injury than targeting the intracellular pathways used by TLR4. In conclusion, we identified TLR4 as a cellular sentinel for acute renal damage that subsequently controls the induction of an innate immune response.	[Pulskens, Wilco P.; Teske, Gwendoline J.; Butter, Loes M.; Roelofs, Joris J.; Florquin, Sandrine; Leemans, Jaklien C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1012 WX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Pulskens, WP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	w.p.pulskens@amc.uva.nl	Leemans, Jaklien/AAM-4958-2020; Pulskens, Wilco/P-6023-2015; Florquin, Sandrine/B-8242-2012	Pulskens, Wilco/0000-0001-9697-3189; Florquin, Sandrine/0000-0002-9676-1722; Roelofs, Joris/0000-0001-9595-6571	Dutch Scientific Organization	Dutch Scientific Organization(Netherlands Organization for Scientific Research (NWO))	This study has been founded by Dutch Scientific Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arko-Mensah J, 2007, SCAND J IMMUNOL, V65, P148, DOI 10.1111/j.1365-3083.2006.01888.x; Cunningham PN, 2004, J IMMUNOL, V172, P2629, DOI 10.4049/jimmunol.172.4.2629; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; Daha MR, 2000, NEPHROL DIAL TRANSPL, V15, P41, DOI 10.1093/ndt/15.suppl_6.41; de Graaf R, 2006, MICROBES INFECT, V8, P1859, DOI 10.1016/j.micinf.2006.02.024; Fitzgerald KA, 2000, MICROBES INFECT, V2, P933, DOI 10.1016/S1286-4579(00)00396-8; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Gil ML, 2006, MICROBES INFECT, V8, P2299, DOI 10.1016/j.micinf.2006.03.014; Goldstein DR, 2003, J CLIN INVEST, V111, P1571, DOI 10.1172/JCI200317573; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hoshino K, 1999, J IMMUNOL, V162, P3749; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kim BS, 2005, TRANSPLANTATION, V79, P1370, DOI 10.1097/01.TP.0000158355.83327.62; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Meldrum KK, 2001, J SURG RES, V99, P288, DOI 10.1006/jsre.2001.6201; MORSE HC, 1992, J IMMUNOL, V149, P3129; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; O'Neill LAJ, 2002, CURR TOP MICROBIOL, V270, P47; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Samarasinghe R, 2006, J INTERF CYTOK RES, V26, P893, DOI 10.1089/jir.2006.26.893; Schnare M, 2006, INT ARCH ALLERGY IMM, V139, P75, DOI 10.1159/000090001; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; Shimamoto A, 2006, ANN THORAC SURG, V82, P2017, DOI 10.1016/j.athoracsur.2006.06.079; Stokman G, 2005, J AM SOC NEPHROL, V16, P1684, DOI 10.1681/ASN.2004080678; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Wang K, 2007, CHEM BIODIVERS, V4, P514, DOI 10.1002/cbdv.200790044; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Wolfs TGAM, 2002, J IMMUNOL, V168, P1286, DOI 10.4049/jimmunol.168.3.1286; WU H, 2007, J CLIN INVEST; Yamaji M, 2002, PHOTOCH PHOTOBIO SCI, V1, P169, DOI 10.1039/b110092k; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115; Zhong B, 2006, VIROLOGY, V352, P14, DOI 10.1016/j.virol.2006.04.029	42	179	193	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3596	10.1371/journal.pone.0003596	http://dx.doi.org/10.1371/journal.pone.0003596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974879	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131700017
J	Heath, M; Maraj, A; Godbolt, B; Binsted, G				Heath, Matthew; Maraj, Anika; Godbolt, Bryan; Binsted, Gordon			Action Without Awareness: Reaching to an Object You Do Not Remember Seeing	PLOS ONE			English	Article							MULLER-LYER-ILLUSION; CONSCIOUS AWARENESS; VISUAL INFORMATION; TARGET FEATURES; CLOSED-LOOP; VISION; MEMORY; PERCEPTION; MOVEMENTS; HAND	Background: Previous work by our group has shown that the scaling of reach trajectories to target size is independent of obligatory awareness of that target property and that "action without awareness'' can persist for up to 2000 ms of visual delay. In the present investigation we sought to determine if the ability to scale reaching trajectories to target size following a delay is related to the pre-computing of movement parameters during initial stimulus presentation or the maintenance of a sensory (i.e., visual) representation for on-demand response parameterization. Methodology/Principal Findings: Participants completed immediate or delayed (i.e., 2000 ms) perceptual reports and reaching responses to different sized targets under non-masked and masked target conditions. For the reaching task, the limb associated with a trial (i.e., left or right) was not specified until the time of response cuing: a manipulation that prevented participants from pre-computing the effector-related parameters of their response. In terms of the immediate and delayed perceptual tasks, target size was accurately reported during non-masked trials; however, for masked trials only a chance level of accuracy was observed. For the immediate and delayed reaching tasks, movement time as well as other temporal kinematic measures (e. g., times to peak acceleration, velocity and deceleration) increased in relation to decreasing target size across non-masked and masked trials. Conclusions/Significance: Our results demonstrate that speed-accuracy relations were observed regardless of whether participants were aware (i.e., non-masked trials) or unaware (i.e., masked trials) of target size. Moreover, the equivalent scaling of immediate and delayed reaches during masked trials indicates that a persistent sensory-based representation supports the unconscious and metrical scaling of memory-guided reaching.	[Heath, Matthew; Maraj, Anika] Univ Western Ontario, Sch Kinesiol, London, ON, Canada; [Godbolt, Bryan] Univ Western Ontario, Dept Elect & Comp Engn, London, ON N6A 3K7, Canada; [Binsted, Gordon] Univ British Columbia, Sch Human Kinet, Kelowna, BC, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of British Columbia	Heath, M (corresponding author), Univ Western Ontario, Sch Kinesiol, London, ON, Canada.	mheath2@uwo.ca			Natural Sciences and Engineering Research Council of Canada Discovery Grants; University of Western Ontario Major Academic Development Fund	Natural Sciences and Engineering Research Council of Canada Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Western Ontario Major Academic Development Fund	Natural Sciences and Engineering Research Council of Canada Discovery Grants (MH, GB) and a University of Western Ontario Major Academic Development Fund (MH) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; Binsted G, 2007, P NATL ACAD SCI USA, V104, P12669, DOI 10.1073/pnas.0702307104; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRIDGEMAN B, 1979, J EXP PSYCHOL HUMAN, V5, P692, DOI 10.1037/0096-1523.5.4.692; Bruno N, 2008, NEUROSCI BIOBEHAV R, V32, P423, DOI 10.1016/j.neubiorev.2007.08.006; BRYDEN MP, 1977, NEUROPSYCHOLOGIA, V15, P617, DOI 10.1016/0028-3932(77)90067-7; Danckert J, 2005, NEUROSCI BIOBEHAV R, V29, P1035, DOI 10.1016/j.neubiorev.2005.02.001; Daprati E, 1997, NEUROPSYCHOLOGIA, V35, P1577, DOI 10.1016/S0028-3932(97)00061-4; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; ELLIOTT D, 1987, Q J EXP PSYCHOL-A, V39, P541, DOI 10.1080/14640748708401802; ELLIOTT D, 1995, PSYCHOL RES-PSYCH FO, V58, P2; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Elliott Digby, 1996, P143; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Gail A, 2006, J NEUROSCI, V26, P9376, DOI 10.1523/JNEUROSCI.1570-06.2006; Glover S, 2004, BEHAV BRAIN SCI, V27, P3; Glover S, 2001, EXP BRAIN RES, V137, P254, DOI 10.1007/s002210000651; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Heath M, 2005, J MOTOR BEHAV, V37, P179, DOI 10.3200/JMBR.37.3.179-185; Heath M, 2004, EXP BRAIN RES, V158, P378, DOI 10.1007/s00221-004-1988-9; Heath M, 2004, MOTOR CONTROL, V8, P76, DOI 10.1123/mcj.8.1.76; Heath M, 2008, EXP BRAIN RES, V188, P517, DOI 10.1007/s00221-008-1385-x; HENRY FM, 1960, RES QUART, V31, P448, DOI 10.1080/10671188.1960.10762052; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Hu Y, 2000, J COGNITIVE NEUROSCI, V12, P856, DOI 10.1162/089892900562462; HYMAN R, 1953, J EXP PSYCHOL, V45, P188, DOI 10.1037/h0056940; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Krigolson A, 2004, HUM MOVEMENT SCI, V23, P861, DOI 10.1016/j.humov.2004.10.011; Marzi CA, 1996, NEUROPSYCHOLOGIA, V34, P9, DOI 10.1016/0028-3932(95)00059-3; Milner A. D., 1995, VISUAL BRAIN ACTION; Neely KA, 2008, EXP BRAIN RES, V186, P375, DOI 10.1007/s00221-007-1238-z; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; PERENIN MT, 1975, NEUROPSYCHOLOGIA, V13, P1, DOI 10.1016/0028-3932(75)90041-X; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Ro T, 2008, NEUROPSYCHOLOGIA, V46, P379, DOI 10.1016/j.neuropsychologia.2007.09.005; Rossetti Y, 1998, CONSCIOUS COGN, V7, P520, DOI 10.1006/ccog.1998.0370; Schindler I, 2004, NAT NEUROSCI, V7, P779, DOI 10.1038/nn1273; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; WEISKRANTZ L, 2008, EXP BRAIN R IN PRESS; Weiskrantz L, 1990, BLINDSIGHT CASE STUD; Westwood DA, 2000, EXP BRAIN RES, V134, P456, DOI 10.1007/s002210000489; Westwood DA, 2005, BRAIN COGNITION, V57, P257, DOI 10.1016/j.bandc.2004.08.055; Westwood DA, 2003, SPATIAL VISION, V16, P243, DOI 10.1163/156856803322467518	47	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3539	10.1371/journal.pone.0003539	http://dx.doi.org/10.1371/journal.pone.0003539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432JY	18953411	gold, Green Published, Green Submitted			2022-12-27	WOS:000265130500013
J	Colzato, LS; van den Wildenberg, WPM; Hommel, B				Colzato, Lorenza S.; van den Wildenberg, Wery P. M.; Hommel, Bernhard			Reduced Spontaneous Eye Blink Rates in Recreational Cocaine Users: Evidence for Dopaminergic Hypoactivity	PLOS ONE			English	Article							IMPAIRED INHIBITORY CONTROL; SPONTANEOUS EYEBLINK RATE; COGNITIVE CONTROL; PARKINSONS-DISEASE; PREFRONTAL CORTEX; MONKEYS; DYSFUNCTION; MECHANISMS; ADDICTION; RECEPTORS	Chronic use of cocaine is associated with a reduced density of dopaminergic D2 receptors in the striatum, with negative consequences for cognitive control processes. Increasing evidence suggests that cognitive control is also affected in recreational cocaine consumers. This study aimed at linking these observations to dopaminergic malfunction by studying the spontaneous eyeblink rate (EBR), a marker of striatal dopaminergic functioning, in adult recreational users and a cocaine-free sample that was matched on age, race, gender, and personality traits. Correlation analyses show that EBR is significantly reduced in recreational users compared to cocaine-free controls, suggesting that cocaine use induces hypoactivity in the subcortical dopamine system.	[Colzato, Lorenza S.; Hommel, Bernhard] Leiden Univ, Inst Psychol Res, Leiden, Netherlands; [van den Wildenberg, Wery P. M.] Univ Amsterdam, Amsterdam Ctr Study Adapt Control Brain & Behav, Psychol Dept, NL-1012 WX Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Amsterdam	Colzato, LS (corresponding author), Leiden Univ, Inst Psychol Res, Leiden, Netherlands.	colzato@fsw.leidenuniv.nl	Colzato, Lorenza S/H-6296-2013; Hommel, Bernhard/F-8173-2010	Hommel, Bernhard/0000-0003-4731-5125; Colzato, Lorenza/0000-0003-1735-1280	Netherlands Organization for Scientific Research (NWO) [VENI]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The research of LSC and WPMvdW is supported by a VENI grant from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Barbato G, 2000, PSYCHIAT RES, V93, P145, DOI 10.1016/S0165-1781(00)00108-6; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; BLIN O, 1990, BRIT J CLIN PHARMACO, V30, P769, DOI 10.1111/j.1365-2125.1990.tb03848.x; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Bolla KI, 1998, J NEUROPSYCH CLIN N, V10, P280, DOI 10.1176/jnp.10.3.280; CASCELLA NG, 1991, BRIT J PSYCHIAT, V159, P217, DOI 10.1192/bjp.159.2.217; Colzato LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001143; Colzato LS, 2007, NEUROPSYCHOLOGIA, V45, P2387, DOI 10.1016/j.neuropsychologia.2007.03.004; Colzato LS, 2005, EUR J NEUROSCI, V21, P591, DOI 10.1111/j.1460-9568.2005.03868.x; COLZATO LS, PERS INDIV IN PRESS; COLZATO LS, 2008, COCAINE COGNIT UNPUB; COLZATO LS, NEUROPSYCHO IN PRESS; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Deuschl G, 1998, J NEUROL NEUROSUR PS, V64, P320, DOI 10.1136/jnnp.64.3.320; Dreisbach G, 2005, BEHAV NEUROSCI, V119, P483, DOI 10.1037/0735-7044.119.2.483; Eysenck HJ., 1993, MANUAL EYSENCK PERSO, DOI 10.1037/t05461-000; Fillmore MT, 2005, EXP CLIN PSYCHOPHARM, V13, P200, DOI 10.1037/1064-1297.13.3.200; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; FREED WJ, 1980, BIOL PSYCHIAT, V15, P329; Hershey T, 2004, COGNITIVE BRAIN RES, V20, P438, DOI 10.1016/j.cogbrainres.2004.03.018; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Jovanovski D, 2005, J CLIN EXP NEUROPSYC, V27, P189, DOI 10.1080/13803390490515694; KARSON CN, 1983, BRAIN, V106, P643, DOI 10.1093/brain/106.3.643; Kleven MS, 1996, J PHARMACOL EXP THER, V279, P1211; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; POPE HG, 1995, DRUG ALCOHOL DEPEN, V38, P25, DOI 10.1016/0376-8716(95)01097-I; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Raven JohnC., 1988, ADV PROGRESSIVE MATR; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Seeman P, 2006, SYNAPSE, V60, P319, DOI 10.1002/syn.20303; SHUKLA D, 1985, NEUROLOGY, V35, P286, DOI 10.1212/WNL.35.2.286; Spencer TJ, 2002, ARCH NEUROL-CHICAGO, V59, P314, DOI 10.1001/archneur.59.2.314; Stein DJ, 2002, LANCET, V360, P397, DOI 10.1016/S0140-6736(02)09620-4; Taylor JR, 1999, EXP NEUROL, V158, P214, DOI 10.1006/exnr.1999.7093; van der Post J, 2004, J PSYCHOPHARMACOL, V18, P109, DOI 10.1177/0269881104042832; Verdejo-Garcia AJ, 2005, ADDICT BEHAV, V30, P89, DOI 10.1016/j.addbeh.2004.04.015; Volkow ND, 1999, J PSYCHOPHARMACOL, V13, P337, DOI 10.1177/026988119901300406	42	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3461	10.1371/journal.pone.0003461	http://dx.doi.org/10.1371/journal.pone.0003461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IG	18941515	Green Published, gold, Green Submitted			2022-12-27	WOS:000265126100002
J	Siegfried, N; Clarke, M; Volmink, J; Van der Merwe, L				Siegfried, Nandi; Clarke, Michael; Volmink, Jimmy; Van der Merwe, Lize			African HIV/AIDS Trials Are More Likely to Report Adequate Allocation Concealment and Random Generation than North American Trials	PLOS ONE			English	Article							METHODOLOGICAL QUALITY; CLINICAL-TRIALS; JOURNAL IMPACT; PREDICTORS; THERAPY; SOUTH; HIV	Background: Adherence to good methodological quality is necessary to minimise bias in randomised conrolled trials (RCTs). Specific trial characteristics are associated with better trial quality, but no studies to date are specific to HIV/AIDS or African trials. We postulated that location may negatively impact on trial quality in regions where resources are scarce. Methods: 1) To compare the methodological quality of all HIV/AIDS RCTs conducted in Africa with a random sample of similar trials conducted in North America; 2) To assess whether location is predictive of trial quality. We searched MEDLINE, EMBASE, CENTRAL and LILACS. Eligible trials were 1) randomized, 2) evaluations of preventive or treatment interventions for HIV/AIDS, 3) reported before 2004, and 4) conducted wholly or partly (if multi-centred) in Africa or North America. We assessed adequacy of random generation, allocation concealment and masking of assessors. Using univariate and multivariate logistic regression analyses we evaluated the association between location (Africa versus North America) and these domains. Findings: The African search yielded 12,815 records, from which 80 trials were identified. The North American search yielded 13,158 records from which 785 trials were identified and a random sample of 114 selected for analysis. African trials were three times more likely than North American trials to report adequate allocation concealment (OR = 3.24; 95% CI: 1.59 to 6.59; p < 0.01) and twice as likely to report adequate generation of the sequence (OR = 2.36; 95% CI: 1.20 to 4.67; p = 0.01), after adjusting for other confounding factors. Additional significant factors positively associated with quality were an a priori sample size power calculation, restricted randomization and inclusion of a flow diagram detailing attrition. We did not detect an association between location and outcome assessor masking. Conclusions: The higher quality of reporting of methodology in African trials is noteworthy. Most African trials are externally funded, and it is possible that stricter agency requirements when leading trials in other countries and greater experience and training of principal investigators of an international stature, may account for this difference.	[Siegfried, Nandi; Clarke, Michael] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Siegfried, Nandi; Clarke, Michael] United Kingdom Cochrane Ctr, Oxford, England; [Volmink, Jimmy] Univ Stellenbosch, Fac Hlth Sci, ZA-7600 Stellenbosch, South Africa; [Van der Merwe, Lize] MRC, Biostat Unit, Cape Town, South Africa; [Van der Merwe, Lize] Univ Western Cape, Dept Stat, ZA-7535 Bellville, South Africa	University of Oxford; Cochrane Centre; Stellenbosch University; University of the Western Cape	Siegfried, N (corresponding author), MRC, S African Cochrane Ctr, Cape Town, South Africa.	nandi.siegfried@mrc.ac.za	van der Merwe, Lize/D-3148-2012	van der Merwe, Lize/0000-0001-9705-8126	Nuffield Dominions Trust	Nuffield Dominions Trust	Nandi Siegfried was supported by the Nuffield Dominions Trust. The funder was not involved in the design and conduct of the study, or in the collection, management, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Altman DG., 1999, PRACTICAL STAT MED R; Balasubramanian SP, 2006, ANN SURG, V244, P663, DOI 10.1097/01.sla.0000217640.11224.05; Ballantyne A, 2005, BIOETHICS, V19, P476, DOI 10.1111/j.1467-8519.2005.00459.x; Boutron I, 2003, JAMA-J AM MED ASSOC, V290, P1062, DOI 10.1001/jama.290.8.1062; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Cohen J, 2000, SCIENCE, V288, P2155, DOI 10.1126/science.288.5474.2155; *COMM REV HIVNET 0, 2005, REV HIVNET 012 PER H; Crumley Ellen T, 2005, BMC Med Res Methodol, V5, P24, DOI 10.1186/1471-2288-5-24; Edejer TTT, 1999, BMJ-BRIT MED J, V319, P438, DOI 10.1136/bmj.319.7207.438; Edwards P, 2002, STAT MED, V21, P1635, DOI 10.1002/sim.1190; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; *ENCY BRIT, 2007, ENCY BRIT ONL; Gluud LL, 2005, AM J GASTROENTEROL, V100, P2431, DOI 10.1111/j.1572-0241.2005.00327.x; Gonzalez-Block Miguel A, 2004, Health Res Policy Syst, V2, P6, DOI 10.1186/1478-4505-2-6; GROOPMAN JE, 1984, ANN INTERN MED, V100, P671, DOI 10.7326/0003-4819-100-5-671; Ha TC, 2006, ANN ACAD MED SINGAP, V35, P911; Horton R, 2000, LANCET, V355, P2231, DOI 10.1016/S0140-6736(00)02414-4; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Juni P, 2001, SYSTEMATIC REV HLTH, P87; Kjaergard LL, 1999, HEPATOLOGY, V30, P1134, DOI 10.1002/hep.510300510; Kjaergard LL, 2002, AM J GASTROENTEROL, V97, P2708; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Ruiz-Canela M, 2001, J MED ETHICS, V27, P172, DOI 10.1136/jme.27.3.172; Schulz KF, 2002, JAMA-J AM MED ASSOC, V288, P2406, DOI 10.1001/jama.288.19.2406; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SCHULZ KF, 1995, CAN MED ASSOC J, V153, P783; SEGLEN PO, 1997, BMJ, V314; Siegfried N, 2005, BRIT MED J, V331, P742, DOI 10.1136/bmj.331.7519.742; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; *US NAT LIB MED, 2007, ABR IND MED AIM J TI; Yousefi-Nooraie Reza, 2006, BMC Med Res Methodol, V6, P37, DOI 10.1186/1471-2288-6-37; 2000, LANCET, V356, P1043	36	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3491	10.1371/journal.pone.0003491	http://dx.doi.org/10.1371/journal.pone.0003491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941523	Green Published, gold			2022-12-27	WOS:000265126100022
J	Mugnier, B; Nal, B; Verthuy, C; Boyer, C; Lam, D; Chasson, L; Nieoullon, V; Chazal, G; Guo, XJ; He, HT; Rueff-Juy, D; Alcover, A; Ferrier, P				Mugnier, Benedicte; Nal, Beatrice; Verthuy, Christophe; Boyer, Claude; Lam, David; Chasson, Lionel; Nieoullon, Vincent; Chazal, Genevieve; Guo, Xiao-Jun; He, Hai-Tao; Rueff-Juy, Dominique; Alcover, Andres; Ferrier, Pierre			Coronin-1A Links Cytoskeleton Dynamics to TCR alpha beta-Induced Cell Signaling	PLOS ONE			English	Article								Actin polymerization plays a critical role in activated T lymphocytes both in regulating T cell receptor (TCR)-induced immunological synapse (IS) formation and signaling. Using gene targeting, we demonstrate that the hematopoietic specific, actin-and Arp2/3 complex-binding protein coronin-1A contributes to both processes. Coronin-1A-deficient mice specifically showed alterations in terminal development and the survival of alpha beta T cells, together with defects in cell activation and cytokine production following TCR triggering. The mutant T cells further displayed excessive accumulation yet reduced dynamics of F-actin and the WASP-Arp2/3 machinery at the IS, correlating with extended cell-cell contact. Cell signaling was also affected with the basal activation of the stress kinases sAPK/JNK1/2; and deficits in TCR-induced Ca(2+) influx and phosphorylation and degradation of the inhibitor of NF-kappa B (I kappa B). Coronin-1A therefore links cytoskeleton plasticity with the functioning of discrete TCR signaling components. This function may be required to adjust TCR responses to selecting ligands accounting in part for the homeostasis defect that impacts alpha beta T cells in coronin-1A deficient mice, with the exclusion of other lympho/hematopoietic lineages.	[Mugnier, Benedicte; Nal, Beatrice; Verthuy, Christophe; Boyer, Claude; Lam, David; Chasson, Lionel; Guo, Xiao-Jun; He, Hai-Tao; Ferrier, Pierre] Univ Aix Marseille, Ctr Immunol Marseille Luminy, Marseille, France; [Mugnier, Benedicte; Nal, Beatrice; Verthuy, Christophe; Boyer, Claude; Lam, David; Chasson, Lionel; Guo, Xiao-Jun; He, Hai-Tao; Ferrier, Pierre] CNRS, UMR 6102, Marseille, France; [Mugnier, Benedicte; Nal, Beatrice; Verthuy, Christophe; Boyer, Claude; Lam, David; Chasson, Lionel; Guo, Xiao-Jun; He, Hai-Tao; Ferrier, Pierre] Inserm, U 631, Marseille, France; [Nieoullon, Vincent; Chazal, Genevieve] Inst Biol Dev Marseille, Inserm, U 382, Marseille, France; [Guo, Xiao-Jun] Univ Aix Marseille, Lab Interact Mol Syst Membranaires, Marseille, France; [Nal, Beatrice; Alcover, Andres] CNRS, URA 1961, Unite Biol Cellulaire Lymphocytes, Paris, France; [Rueff-Juy, Dominique] Inst Pasteur, Unite Immunophysiopathol Infect, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Mugnier, B (corresponding author), Univ Aix Marseille, Ctr Immunol Marseille Luminy, Marseille, France.	ferrier@ciml.univ-mrs.fr	Lam, David/AAI-3657-2020; Guo, Xiao-Jun/M-9454-2016; HE, Hai-Tao/O-6551-2016; NAL, Beatrice/GYU-8888-2022	HE, Hai-Tao/0000-0002-6594-290X; Nal, Beatrice/0000-0003-3452-7524; Alcover, Andres/0000-0002-9507-3450	Inserm; CNRS; Association pour la Recherche sur le Cancer (ARC) [fellowship]; Fondation Princesse Grace de Monaco; Commission of the European Communities; Ministere de l'Education Nationale et de la Recherche [ACI #108]; Ligue Nationale Contre le Cancer [fellowship]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation Princesse Grace de Monaco; Commission of the European Communities(European Commission); Ministere de l'Education Nationale et de la Recherche; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by Inserm, CNRS, the Association pour la Recherche sur le Cancer (ARC), the Fondation Princesse Grace de Monaco, and the Commission of the European Communities (to PF); and from the Ministere de l'Education Nationale et de la Recherche (ACI #108) (to PF and AA). BN was supported by fellowships from the Ligue Nationale Contre le Cancer and ARC. BM was supported by a fellowship from ARC.	Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Auphan-Anezin N, 2003, J IMMUNOL, V170, P2442, DOI 10.4049/jimmunol.170.5.2442; Ben-Sasson SZ, 2001, J IMMUNOL, V166, P112, DOI 10.4049/jimmunol.166.1.112; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; BIRCHALL AM, 1994, J PHARMACOL EXP THER, V268, P922; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Cemerski S, 2006, CURR OPIN IMMUNOL, V18, P298, DOI 10.1016/j.coi.2006.03.011; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Davanture S, 2005, J IMMUNOL, V175, P3140, DOI 10.4049/jimmunol.175.5.3140; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; FORGER N, 2006, SCIENCE, V313, P839; Freitas AA, 1996, EUR J IMMUNOL, V26, P2640, DOI 10.1002/eji.1830261115; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Grogan A, 1997, J CELL SCI, V110, P3071; Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023; Hommel M, 2007, J IMMUNOL, V179, P2250, DOI 10.4049/jimmunol.179.4.2250; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Kappes DJ, 2005, NAT IMMUNOL, V6, P761, DOI 10.1038/ni1230; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Love PE, 2000, J IMMUNOL, V165, P3080, DOI 10.4049/jimmunol.165.6.3080; Lucas B, 1999, IMMUNITY, V10, P367, DOI 10.1016/S1074-7613(00)80036-9; Machesky LM, 1997, BIOCHEM J, V328, P105; Manicassamy S, 2008, J IMMUNOL, V180, P106, DOI 10.4049/jimmunol.180.1.106; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022; Nemeth ZH, 2004, J CELL PHYSIOL, V200, P71, DOI 10.1002/jcp.10477; OBERHUBER H, 1991, J BIOL CHEM, V266, P1437; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Richie LI, 2002, IMMUNITY, V16, P595, DOI 10.1016/S1074-7613(02)00299-6; Rivas FV, 2004, MOL CELL BIOL, V24, P1628, DOI 10.1128/MCB.24.4.1628-1639.2004; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rosentreter A, 2007, EXP CELL RES, V313, P878, DOI 10.1016/j.yexcr.2006.12.015; Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235; Schuller S, 2001, CELL MICROBIOL, V3, P785, DOI 10.1046/j.1462-5822.2001.00155.x; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Sechi AS, 2004, TRENDS IMMUNOL, V25, P257, DOI 10.1016/j.it.2004.03.003; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; VALERA A, 1994, HUM GENE THER, V5, P449, DOI 10.1089/hum.1994.5.4-449; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891; Weil R, 2006, CELL DEATH DIFFER, V13, P826, DOI 10.1038/sj.cdd.4401856; Yasutomo K, 2000, J IMMUNOL, V165, P3015, DOI 10.4049/jimmunol.165.6.3015	63	58	58	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3467	10.1371/journal.pone.0003467	http://dx.doi.org/10.1371/journal.pone.0003467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941544	Green Published, gold, Green Submitted			2022-12-27	WOS:000265125900011
J	Mathew-Fenn, RS; Das, R; Silverman, JA; Walker, PA; Harbury, PAB				Mathew-Fenn, Rebecca S.; Das, Rhiju; Silverman, Joshua A.; Walker, Peter A.; Harbury, Pehr A. B.			A Molecular Ruler for Measuring Quantitative Distance Distributions	PLOS ONE			English	Article							INTERCALATIVE BINDING; NUCLEIC-ACIDS; RAY; ETHIDIUM; SCATTERING; SUBUNIT; DNA	We report a novel molecular ruler for measurement of distances and distance distributions with accurate external calibration. Using solution X-ray scattering we determine the scattering interference between two gold nanocrystal probes attached site-specifically to a macromolecule of interest. Fourier transformation of the interference pattern provides a model-independent probability distribution for the distances between the probe centers-of-mass. To test the approach, we measure end-to-end distances for a variety of DNA structures. We demonstrate that measurements with independently prepared samples and using different X-ray sources are highly reproducible, we demonstrate the quantitative accuracy of the first and second moments of the distance distributions, and we demonstrate that the technique recovers complex distribution shapes. Distances measured with the solution scattering-interference ruler match the corresponding crystallographic values, but differ from distances measured previously with alternate ruler techniques. The X-ray scattering interference ruler should be a powerful tool for relating crystal structures to solution structures and for studying molecular fluctuations.	[Mathew-Fenn, Rebecca S.; Das, Rhiju; Silverman, Joshua A.; Walker, Peter A.; Harbury, Pehr A. B.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Mathew-Fenn, Rebecca S.; Harbury, Pehr A. B.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Mathew-Fenn, RS (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	harbury@cmgm.stanford.edu		Das, Rhiju/0000-0001-7497-0972	National Institutes of Health [GM068126-01]; National Science Foundation; U.S. Department of Energy [W-31-109-Eng-38]; NIH Director's Pioneer Award [DP OD000429-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068126] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (GM068126-01 to P.B.H.). We acknowledge additional funding from the National Institutes of Health (training grant fellowship to R.S.F., and support of SSRL), the National Science Foundation (graduate fellowship to R.D.), the U.S. Department of Energy (Contract W-31-109-Eng-38 to APS and support of SSRL), and the NIH Director's Pioneer Award DP OD000429-01 to P.B.H.	Ackerson CJ, 2005, J AM CHEM SOC, V127, P6550, DOI 10.1021/ja046114i; Bai Y, 2005, P NATL ACAD SCI USA, V102, P1035, DOI 10.1073/pnas.0404448102; Balasubramanian R, 2005, J AM CHEM SOC, V127, P8126, DOI 10.1021/ja050793v; Beno MA, 2001, NUCL INSTRUM METH A, V467, P690, DOI 10.1016/S0168-9002(01)00455-7; Cai Q, 2006, NUCLEIC ACIDS RES, V34, P4722, DOI 10.1093/nar/gkl546; Cantor C.R., 1980, BIOPHYSICAL CHEM 2; CAPEL MS, 1988, J MOL BIOL, V200, P65, DOI 10.1016/0022-2836(88)90334-8; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Chen LL, 1996, J MOL BIOL, V261, P658, DOI 10.1006/jmbi.1996.0491; Davies DB, 1996, BIOPOLYMERS, V38, P745, DOI 10.1002/(SICI)1097-0282(199602)38:6<745::AID-BIP6>3.0.CO;2-V; GRAVES DE, 1983, ANAL BIOCHEM, V134, P73, DOI 10.1016/0003-2697(83)90265-8; Hastie T, 2001, ELEMENTS STAT LEARNI, P214; HOPPE W, 1972, ISRAEL J CHEM, V10, P321; HUANG TC, 1993, J APPL CRYSTALLOGR, V26, P180, DOI 10.1107/S0021889892009762; KASTRUP RV, 1978, BIOCHEMISTRY-US, V17, P4855, DOI 10.1021/bi00616a002; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KRATKY O, 1948, MONATSH CHEM, V78, P295, DOI 10.1007/BF01141535; KRATKY O, 1947, MONATSH CHEM, V77, P224, DOI 10.1007/BF00899014; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Laurence TA, 2005, P NATL ACAD SCI USA, V102, P17348, DOI 10.1073/pnas.0508584102; Lipfert J, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2194484; MATHEWFENN RS, 2008, SCI REMEASU IN PRESS; MIAKELYE RC, 1983, BIOPHYS J, V41, P287, DOI 10.1016/S0006-3495(83)84440-3; NELSON JW, 1984, BIOPOLYMERS, V23, P213, DOI 10.1002/bip.360230205; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Petrascu AM, 1998, J MACROMOL SCI PHYS, VB37, P463, DOI 10.1080/00222349808220487; Schaaff TG, 1998, J PHYS CHEM B, V102, P10643, DOI 10.1021/jp9830528; Schaaff TG, 2004, ANAL CHEM, V76, P6187, DOI 10.1021/ac0353482; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; SKILLING J, 1999, QUANTIFIED MAXIMUM E; Svergun D, 1987, STRUCTURE ANAL SMALL, DOI 10.1007/978-1-4757-6624-0_1; TSAI CC, 1975, P NATL ACAD SCI USA, V72, P628, DOI 10.1073/pnas.72.2.628; VAINSHTEIN BK, 1980, FEBS LETT, V116, P107, DOI 10.1016/0014-5793(80)80539-4; WIKISOURCE FREE LIB	34	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3229	10.1371/journal.pone.0003229	http://dx.doi.org/10.1371/journal.pone.0003229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927606	Green Published, gold, Green Submitted			2022-12-27	WOS:000265122400001
J	Honma, A; Takakura, K; Nishida, T				Honma, Atsushi; Takakura, Koh-ichi; Nishida, Takayoshi			Optimal-Foraging Predator Favors Commensalistic Batesian Mimicry	PLOS ONE			English	Article							WARNING COLORATION; MUELLERIAN MIMICRY; RISK-TAKING; MODEL; PREY; MEMORY; PALATABILITY; BUTTERFLIES; EVOLUTION; SELECTION	Background: Mimicry, in which one prey species (the Mimic) imitates the aposematic signals of another prey (the Model) to deceive their predators, has attracted the general interest of evolutionary biologists. Predator psychology, especially how the predator learns and forgets, has recently been recognized as an important factor in a predator-prey system. This idea is supported by both theoretical and experimental evidence, but is also the source of a good deal of controversy because of its novel prediction that in a Model/Mimic relationship even a moderately unpalatable Mimic increases the risk of the Model (quasi-Batesian mimicry). Methodology/Principal Findings: We developed a psychology-based Monte Carlo model simulation of mimicry that incorporates a "Pavlovian'' predator that practices an optimal foraging strategy, and examined how various ecological and psychological factors affect the relationships between a Model prey species and its Mimic. The behavior of the predator in our model is consistent with that reported by experimental studies, but our simulation's predictions differed markedly from those of previous models of mimicry because a more abundant Mimic did not increase the predation risk of the Model when alternative prey were abundant. Moreover, a quasi-Batesian relationship emerges only when no or very few alternative prey items were available. Therefore, the availability of alternative prey rather than the precise method of predator learning critically determines the relationship between Model and Mimic. Moreover, the predation risk to the Model and Mimic is determined by the absolute density of the Model rather than by its density relative to that of the Mimic. Conclusions/Significance: Although these predictions are counterintuitive, they can explain various kinds of data that have been offered in support of competitive theories. Our model results suggest that to understand mimicry in nature it is important to consider the likely presence of alternative prey and the possibility that predation pressure is not constant.	[Honma, Atsushi; Nishida, Takayoshi] Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Kyoto, Japan; [Takakura, Koh-ichi] Osaka City Inst Publ Hlth & Environm Sci, Osaka, Japan	Kyoto University	Honma, A (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto, Japan.	honma@ethol.zool.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Kyoto University	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyoto University	AH was supported in part as a member of the 21st Century COE program for Innovative Food and Environmental Studies Pioneered by Entomomimetic Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and also financially supported in part by the Global COE Program A06 to Kyoto University. These sponsors did not have any role in the scientific activity itself.	ALCOCK J, 1970, ANIM BEHAV, V18, P733, DOI 10.1016/0003-3472(70)90019-9; AVERY ML, 1985, J WILDLIFE MANAGE, V49, P1116, DOI 10.2307/3801404; Bates H.W., 1862, T LINN SOC LOND, V23, P495; BENSON WW, 1977, EVOLUTION, V31, P454, DOI 10.1111/j.1558-5646.1977.tb01031.x; BOUTON ME, 1994, J EXP PSYCHOL-ANIM B, V20, P219, DOI 10.1037/0097-7403.20.3.219; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; BROWER JV, 1960, AM NAT, V94, P271, DOI 10.1086/282128; BROWER JV, 1958, EVOLUTION, V12, P32, DOI 10.1111/j.1558-5646.1958.tb02926.x; Bush Robert R., 1955, STOCHASTIC MODELS LE; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; Dall SRX, 2002, PHILOS T R SOC B, V357, P1519, DOI 10.1098/RSTB.2002.1061; DILL LM, 1975, CAN J ZOOL, V53, P1614, DOI 10.1139/z75-195; Endler J.A., 1991, P169; Fisher RA, 1930, GENETICAL THEORY NAT; Franks DW, 2004, P ROY SOC B-BIOL SCI, V271, P191, DOI 10.1098/rspb.2003.2582; Gavrilets S, 1998, J THEOR BIOL, V191, P415, DOI 10.1006/jtbi.1997.0615; GETTY T, 1985, AM NAT, V125, P239, DOI 10.1086/284339; GITTLEMAN JL, 1980, ANIM BEHAV, V28, P897, DOI 10.1016/S0003-3472(80)80150-3; GREIGSMITH PW, 1987, ETHOLOGY, V74, P155; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOLLING CS, 1959, CAN ENTOMOL, V91, P292; HOLLING CS, 1963, P INT C ZOOL WASHING, V4, P166; Holmgren NMA, 1999, BIOL J LINN SOC, V66, P145; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HUHEEY J E, 1988, American Naturalist, V131, pS22, DOI 10.1086/284765; HUHEEY JE, 1980, J HERPETOL, V14, P223, DOI 10.2307/1563543; HUHEEY JE, 1976, EVOLUTION, V30, P86, DOI 10.1111/j.1558-5646.1976.tb00884.x; HUHEEY JE, 1964, ECOLOGY, V45, P185, DOI 10.2307/1937125; Joron M, 1998, TRENDS ECOL EVOL, V13, P461, DOI 10.1016/S0169-5347(98)01483-9; Joron M, 2005, J THEOR BIOL, V237, P87, DOI 10.1016/j.jtbi.2005.04.005; Joron M, 1999, EVOL ECOL, V13, P721, DOI 10.1023/A:1010875213123; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Kokko H, 2003, ECOL LETT, V6, P1068, DOI 10.1046/j.1461-0248.2003.00532.x; KRAEMER PJ, 1993, COMPAR COGN, P87; KREBS JR, 1977, ANIM BEHAV, V25, P30, DOI 10.1016/0003-3472(77)90064-1; Lindstrom L, 2001, P NATL ACAD SCI USA, V98, P9181, DOI 10.1073/pnas.161071598; MALLET J, 1995, BIOL J LINN SOC, V55, P159, DOI 10.1111/j.1095-8312.1995.tb01057.x; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mallet J, 2001, P NATL ACAD SCI USA, V98, P8928, DOI 10.1073/pnas.171326298; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; MULLER F., 1879, T ENTOMOL SOC LOND, V1879, pxx; NICHOLSON A. J., 1927, AUSTRALIAN ZOOL, V5, P10; OWEN RE, 1984, J THEOR BIOL, V109, P217, DOI 10.1016/S0022-5193(84)80004-1; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; PLATT AP, 1971, EVOLUTION, V25, P692, DOI 10.1111/j.1558-5646.1971.tb01927.x; Poulton E. B., 1909, Annals of the Entomological Society of America, V2; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rowland HM, 2007, NATURE, V448, P64, DOI 10.1038/nature05899; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SHEPPARD PM, 1977, EVOLUTION, V31, P452, DOI 10.1111/j.1558-5646.1977.tb01030.x; Sherratt TN, 2004, J THEOR BIOL, V228, P217, DOI 10.1016/j.jtbi.2003.12.009; Sherratt TN, 2003, OIKOS, V103, P93, DOI 10.1034/j.1600-0706.2003.12576.x; Skelhorn J, 2006, ANIM BEHAV, V71, P1111, DOI 10.1016/j.anbehav.2005.08.011; Spear N. E., 1971, P45; Spear NE, 1978, PROCESSING MEMORIES; Speed MP, 1999, ANIM BEHAV, V57, P203, DOI 10.1006/anbe.1998.0943; SPEED MP, 1993, ANIM BEHAV, V45, P571, DOI 10.1006/anbe.1993.1067; Speed MP, 2000, P ROY SOC B-BIOL SCI, V267, P725, DOI 10.1098/rspb.2000.1063; Speed MP, 1999, EVOL ECOL, V13, P755, DOI 10.1023/A:1010871106763; Speed MP, 1999, BIOL J LINN SOC, V67, P281, DOI 10.1006/bijl.1998.0310; Srygley RB, 1998, BIOL J LINN SOC, V64, P41, DOI 10.1006/bijl.1997.0200; Stephens D.W., 1986, pi; SWYNNERTON CFM, 1915, P ENTOMOL SOC LOND, V1, pR32; TURNER JRG, 1987, ECOL ENTOMOL, V12, P81, DOI 10.1111/j.1365-2311.1987.tb00987.x; TURNER JRG, 1984, BIOL J LINN SOC, V23, P247, DOI 10.1111/j.1095-8312.1984.tb00143.x; Turner JRG, 1996, PHILOS T ROY SOC B, V351, P1157, DOI 10.1098/rstb.1996.0100; TURNER JRG, 1995, BIODIVERSITY EVOLUTI, P131; TURNER JRG, 1984, BIOL BUTTERFLIES, P141; Wickler W., 1968, MIMICRY PLANTS ANIMA; Zahavi A, 1997, HANDICAP PRINCIPLE M	72	10	11	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3411	10.1371/journal.pone.0003411	http://dx.doi.org/10.1371/journal.pone.0003411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432GP	18923676	Green Published, Green Submitted, gold			2022-12-27	WOS:000265121800009
J	David-Jurgens, M; Churs, L; Berkefeld, T; Zepka, RF; Dinse, HR				David-Juergens, Marianne; Churs, Lydia; Berkefeld, Thomas; Zepka, Roberto F.; Dinse, Hubert R.			Differential Effects of Aging on Fore- and Hindpaw Maps of Rat Somatosensory Cortex	PLOS ONE			English	Article								Getting older is associated with a decline of cognitive and sensorimotor abilities, but it remains elusive whether age-related changes are due to accumulating degenerational processes, rendering them largely irreversible, or whether they reflect plastic, adaptational and presumably compensatory changes. Using aged rats as a model we studied how aging affects neural processing in somatosensory cortex. By multi-unit recordings in the fore- and hindpaw cortical maps we compared the effects of aging on receptive field size and response latencies. While in aged animals response latencies of neurons of both cortical representations were lengthened by approximately the same amount, only RFs of hindpaw neurons showed severe expansion with only little changes of forepaw RFs. To obtain insight into parallel changes of walking behavior, we recorded footprints in young and old animals which revealed a general age-related impairment of walking. In addition we found evidence for a limb-specific deterioration of the hindlimbs that was not observed in the forelimbs. Our results show that age-related changes of somatosensory cortical neurons display a complex pattern of regional specificity and parameter-dependence indicating that aging acts rather selectively on cortical processing of sensory information. The fact that RFs of the fore- and hindpaws do not co-vary in aged animals argues against degenerational processes on a global scale. We therefore conclude that age-related alterations are composed of plastic-adaptive alterations in response to modified use and degenerational changes developing with age. As a consequence, age-related changes need not be irreversible but can be subject to amelioration through training and stimulation.	[David-Juergens, Marianne; Churs, Lydia; Berkefeld, Thomas; Zepka, Roberto F.; Dinse, Hubert R.] Ruhr Univ Bochum, Inst Neuroinformat, Dept Theoret Biol, Neural Plast Lab, Bochum, Germany	Ruhr University Bochum	David-Jurgens, M (corresponding author), Ruhr Univ Bochum, Inst Neuroinformat, Dept Theoret Biol, Neural Plast Lab, Bochum, Germany.	hubert.dinse@neuroinformatik.ruhr-uni-bochum.de		dinse, hubert/0000-0001-9024-0451	Deutsche Forschungsgemeinschaft [Di 334/10]; Sandoz Foundation for Gerontological Research [EU-94-1-029]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sandoz Foundation for Gerontological Research	This research was supported by the Deutsche Forschungsgemeinschaft (Di 334 / 10 to HD) and by a Research Grant of the Sandoz Foundation for Gerontological Research (EU-94-1-029).	Abbott A, 2004, NATURE, V428, P116, DOI 10.1038/428116a; AHMAD A, 1993, J COMP NEUROL, V334, P631, DOI 10.1002/cne.903340410; Bergman E, 2002, NEUROBIOL AGING, V23, P271, DOI 10.1016/S0197-4580(01)00274-3; Bock O, 2002, NEUROSCI BIOBEHAV R, V26, P761, DOI 10.1016/S0149-7634(02)00063-5; CONNOR JR, 1982, EXP NEUROL, V78, P466, DOI 10.1016/0014-4886(82)90064-4; Coq JO, 2001, NEUROSCIENCE, V104, P705, DOI 10.1016/S0306-4522(01)00123-3; CUMMINS RA, 1973, NATURE, V243, P516, DOI 10.1038/243516a0; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Dinse HR, 1997, ADV NEUROL, V73, P159; Dinse HR, 2006, ANN NEUROL, V60, P88, DOI 10.1002/ana.20862; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Engineer ND, 2004, J NEUROPHYSIOL, V92, P73, DOI 10.1152/jn.00059.2004; Floel A, 2005, STROKE, V36, P530, DOI 10.1161/01.STR.0000154867.01422.76; GARDNER EP, 1989, J NEUROPHYSIOL, V62, P1437, DOI 10.1152/jn.1989.62.6.1437; Godde B, 1996, NEUROREPORT, V8, P281, DOI 10.1097/00001756-199612200-00056; HIMANN JE, 1988, MED SCI SPORT EXER, V20, P161, DOI 10.1249/00005768-198820020-00010; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim CBY, 1997, ANAT REC, V247, P119, DOI 10.1002/(SICI)1097-0185(199701)247:1<119::AID-AR14>3.0.CO;2-S; Klapdor K, 1997, J NEUROSCI METH, V75, P49, DOI 10.1016/S0165-0270(97)00042-3; KLITGAARD H, 1989, J APPL PHYSIOL, V67, P1409, DOI 10.1152/jappl.1989.67.4.1409; Kornatz KW, 2005, J APPL PHYSIOL, V98, P2072, DOI 10.1152/japplphysiol.01149.2004; LARSSON L, 1979, J APPL PHYSIOL, V46, P451, DOI 10.1152/jappl.1979.46.3.451; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Liepert J, 1995, ELECTROMYOGR MOTOR C, V97, P382, DOI 10.1016/0924-980X(95)00194-P; MARSHALL JF, 1982, J GERONTOL, V37, P548, DOI 10.1093/geronj/37.5.548; Martin GM, 2001, SCIENCE, V294, P13, DOI 10.1126/science.294.5540.13; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; Peters A, 2002, J COMP NEUROL, V442, P277, DOI 10.1002/cne.10099; Peters A, 1997, NEUROBIOL AGING, V18, P29, DOI 10.1016/S0197-4580(96)00208-4; Ragert P, 2004, NEUROSCI LETT, V356, P91, DOI 10.1016/j.neulet.2003.11.034; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reinke H, 1996, NEUROSCI LETT, V216, P171, DOI 10.1016/S0304-3940(96)13039-1; SAITO S, 1994, J NEUROSCI RES, V39, P57, DOI 10.1002/jnr.490390108; Sathian K, 1997, NEUROLOGY, V49, P168, DOI 10.1212/WNL.49.1.168; Sawaki L, 2003, ANN NEUROL, V53, P521, DOI 10.1002/ana.10529; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; SCHUURMAN T, 1989, NIMODIPINE CENTRAL N, P195; Smith CD, 2005, NEUROBIOL AGING, V26, P883, DOI 10.1016/j.neurobiolaging.2004.08.014; SNYDER DL, 1990, J GERONTOL, V45, pB52, DOI 10.1093/geronj/45.2.B52; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; SPEAR PD, 1994, J NEUROPHYSIOL, V72, P402, DOI 10.1152/jn.1994.72.1.402; SPENGLER F, 1995, NEUROREPORT, V6, P469, DOI 10.1097/00001756-199502000-00016; Sprott RL, 1997, EXP GERONTOL, V32, P205, DOI 10.1016/S0531-5565(96)00065-4; Stevens JC, 1996, SOMATOSENS MOT RES, V13, P153, DOI 10.3109/08990229609051403; Stevens JC, 1996, J EXP PSYCHOL-APPL, V2, P91, DOI 10.1037/1076-898X.2.2.91; STOLL S, 1990, ARCH GERONTOL GERIAT, V10, P261, DOI 10.1016/0167-4943(90)90027-4; Tremblay F, 2003, SOMATOSENS MOT RES, V20, P127, DOI 10.1080/0899022031000105154; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WIETHOLTER H, 1990, J NEUROSCI METH, V32, P199, DOI 10.1016/0165-0270(90)90141-2; WOITTIEZ RD, 1985, J MORPHOL, V184, P375, DOI 10.1002/jmor.1051840311; WOODWARD KL, 1993, SOMATOSENS MOT RES, V10, P63, DOI 10.3109/08990229309028824; Xerri C, 2005, BEHAV BRAIN RES, V162, P207, DOI 10.1016/j.bbr.2005.03.003; XERRI C, 1994, J NEUROSCI, V14, P1710, DOI 10.1523/JNEUROSCI.14-03-01710.1994	56	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3399	10.1371/journal.pone.0003399	http://dx.doi.org/10.1371/journal.pone.0003399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852896	Green Published, Green Submitted, gold			2022-12-27	WOS:000265121700007
J	De Filippis, L; Ferrari, D; Nodari, LR; Amati, B; Snyder, E; Vescovi, AL				De Filippis, Lidia; Ferrari, Daniela; Nodari, Laura Rota; Amati, Bruno; Snyder, Evan; Vescovi, Angelo Luigi			Immortalization of Human Neural Stem Cells with the c-Myc Mutant T58A	PLOS ONE			English	Article								Human neural stem cells (hNSC) represent an essential source of renewable brain cells for both experimental studies and cell replacement therapies. Their relatively slow rate of proliferation and physiological senescence in culture make their use cumbersome under some experimental and pre-clinical settings. The immortalization of hNSC with the v-myc gene (v-IhNSC) has been shown to generate stem cells endowed with enhanced proliferative capacity, which greatly facilitates the study of hNSCs, both in vitro and in vivo. Despite the excellent safety properties displayed by v-IhNSCs - which do not transform in vitro and are not tumorigenic in vivo - the v-myc gene contains several mutations and recombination elements, whose role(s) and effects remains to be elucidated, yielding unresolved safety concerns. To address this issue, we used a c-myc T58A retroviral vector to establish an immortal cell line (T-IhNSC) from the same hNSCs used to generate the original v-IhNSCs and compared their characteristics with the latter, with hNSC and with hNSC immortalized using c-myc wt (c-IhNSC). T-IhNSCs displayed an enhanced self-renewal ability, with their proliferative capacity and clonogenic potential being remarkably comparable to those of v-IhNSC and higher than wild type hNSCs and c-IhNSCs. Upon growth factors removal, T-IhNSC promptly gave rise to well-differentiated neurons, astrocytes and most importantly, to a heretofore undocumented high percentage of human oligodendrocytes (up to 23%). Persistent growth-factor dependence, steady functional properties, lack of ability to generate colonies in soft-agar colony-forming assay and to establish tumors upon orthotopic transplantation, point to the fact that immortalization by c-myc T58A does not bring about tumorigenicity in hNSCs. Hence, this work describes a novel and continuous cell line of immortalized human multipotent neural stem cells, in which the immortalizing agent is represented by a single gene which, in turn, carries a single and well characterized mutation. From a different perspective, these data report on a safe approach to increase human neural stem cells propagation in culture, without altering their basic properties. These T-IhNSC line provides a versatile model for the elucidation of the mechanisms involved in human neural stem cells expansion and for development of high throughput assays for both basic and translational research on human neural cell development. The improved proclivity of T-IhNSC to generate human oligodendrocytes propose T-IhNSC as a feasible candidate for the design of experimental and, perhaps, therapeutic approaches in demyelinating diseases.	[De Filippis, Lidia; Ferrari, Daniela; Nodari, Laura Rota; Vescovi, Angelo Luigi] Univ Bicocca Millan, Milan, Italy; [Amati, Bruno] Ist Oncol Europeo, Milan, Italy; [Snyder, Evan] Burnham Inst Med Res, Stem Cell & Regenerat Program, La Jolla, CA USA	University of Milano-Bicocca; IRCCS European Institute of Oncology (IEO); Sanford Burnham Prebys Medical Discovery Institute	De Filippis, L (corresponding author), Univ Bicocca Millan, Milan, Italy.	defilippis.lidia@hsr.it	Amati, Bruno/AAM-3418-2020; Vescovi, Angelo Luigi/A-4919-2015; Ferrari, Daniela/AHE-7647-2022; De Filippis, Lidia/H-3098-2017	Vescovi, Angelo Luigi/0000-0002-1742-4112; Ferrari, Daniela/0000-0001-7251-9854; Amati, Bruno/0000-0002-2958-1799; De Filippis, Lidia/0000-0002-2196-9430	ONLUS association Neurothon; Cariplo; Ministero della Sanita	ONLUS association Neurothon; Cariplo(Fondazione Cariplo); Ministero della Sanita(Ministry of Health, Italy)	The studies performed in this paper were funded by ONLUS association Neurothon, Cariplo and by Ministero della Sanita which provided essential financial support for all the experiments.	Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Ayuso-Sacido A, 2008, NEUROSURGERY, V62, P223, DOI 10.1227/01.NEU.0000311081.50648.4C; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; DEFILIPPIS L, 2007, STEM CELLS; Francis JS, 2006, J NEUROSCI RES, V84, P151, DOI 10.1002/jnr.20866; FRYKBERG L, 1987, ONCOGENE, V1, P415; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, CURR OPIN NEUROBIOL, V8, P671, DOI 10.1016/S0959-4388(98)80098-6; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Gritti A, 1996, J NEUROSCI, V16, P1091; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; HENRIKSSON M, 1993, ONCOGENE, V8, P3199; Lee CM, 1999, ONCOGENE, V18, P2997, DOI 10.1038/sj.onc.1202786; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Martinez-Serrano Alberto, 2001, Current Gene Therapy, V1, P279, DOI 10.2174/1566523013348562; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Nishiyama A, 1996, J NEUROSCI RES, V43, P315, DOI 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.3.CO;2-3; PAPAS TS, 1985, CANCER RES, V45, P4568; Popescu NC, 2002, J CELL MOL MED, V6, P151, DOI 10.1111/j.1582-4934.2002.tb00183.x; PULVERER BJ, 1994, ONCOGENE, V9, P59; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; SYMONDS G, 1989, ONCOGENE, V4, P285; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Vescovi AL, 1999, J NEUROTRAUM, V16, P689, DOI 10.1089/neu.1999.16.689; Villa A, 2002, BRAIN RES BULL, V57, P789, DOI 10.1016/S0361-9230(01)00776-6; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110	36	30	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3310	10.1371/journal.pone.0003310	http://dx.doi.org/10.1371/journal.pone.0003310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18836552	Green Published, gold, Green Submitted			2022-12-27	WOS:000264797300003
J	Huber, S; Schrader, J; Fritz, G; Presser, K; Schmitt, S; Waisman, A; Luth, S; Blessing, M; Herkel, J; Schramm, C				Huber, Samuel; Schrader, Joerg; Fritz, Gerhard; Presser, Katrin; Schmitt, Steffen; Waisman, Ari; Lueth, Stefan; Blessing, Manfred; Herkel, Johannes; Schramm, Christoph			P38 MAP Kinase Signaling Is Required for the Conversion of CD4+CD25-T Cells into iTreg	PLOS ONE			English	Article								CD4+CD25+ regulatory T cells (Treg) are important mediators of immune tolerance. A subset of Treg can be generated in the periphery by TGF-beta dependent conversion of conventional CD4+CD25- T cells into induced Treg (iTreg). In chronic viral infection or malignancy, such induced iTreg, which limit the depletion of aberrant or infected cells, may be of pathogenic relevance. To identify potential targets for therapeutic intervention, we investigated the TGF-beta signaling in Treg. In contrast to conventional CD4+ T cells, Treg exhibited marked activation of the p38 MAP kinase pathway. Inhibition of p38 MAP kinase activity prevented the TGF-beta-dependent conversion of CD4+CD25- T cells into Foxp3+ iTreg in vitro. Of note, the suppressive capacity of nTreg was not affected by inhibiting p38 MAP kinase. Our findings indicate that signaling via p38 MAP kinase seems to be important for the peripheral generation of iTreg; p38 MAP kinase could thus be a therapeutic target to enhance immunity to chronic viral infection or cancer.	[Huber, Samuel; Schrader, Joerg; Presser, Katrin; Lueth, Stefan; Herkel, Johannes; Schramm, Christoph] Univ Klinikum Hamburg Eppendorf, Med Klin, Hamburg, Germany; [Fritz, Gerhard] Univ Giessen, Inst Pharmakol & Toxikol, D-35390 Giessen, Germany; [Schmitt, Steffen] Univ Heidelberg, DKFZ, D-6900 Heidelberg, Germany; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Med Klin, D-6500 Mainz, Germany; [Blessing, Manfred] Univ Leipzig, Biotechnol Biomedizin Zent, Leipzig, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Justus Liebig University Giessen; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; Leipzig University	Huber, S (corresponding author), Univ Klinikum Hamburg Eppendorf, Med Klin, Hamburg, Germany.	cschramm@uke.de	Waisman, Ari/C-7383-2015	Waisman, Ari/0000-0003-4304-8234; Herkel, Johannes/0000-0001-9055-9999; Huber, Samuel/0000-0001-9325-8227; Schramm, Christoph/0000-0002-4264-1928; Luth, Stefan/0000-0001-9946-0960	Novartis Research Foundation; Universitat Hamburg; DFG [SCHR781/1-1 SCHR781/1-2 HE 3532/2-1]; Werner-Otto Stiftung	Novartis Research Foundation; Universitat Hamburg; DFG(German Research Foundation (DFG)); Werner-Otto Stiftung	DFG SCHR781/1-1 SCHR781/1-2 HE 3532/2-1, Novartis Research Foundation, Universitat Hamburg NWF-07/04, Werner-Otto Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HS, 2007, BLOOD, V109, P4351, DOI 10.1182/blood-2006-09-047563; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; HORWITZ DA, 2008, TRENDS IMMUNOL; Huber S, 2006, FRONT BIOSCI-LANDMRK, V11, P1014, DOI 10.2741/1859; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim JE, 2006, J IMMUNOL, V176, P2833, DOI 10.4049/jimmunol.176.5.2833; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Kogkopoulou O, 2006, J LEUKOCYTE BIOL, V79, P1052, DOI 10.1189/jlb.0705418; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Liu VC, 2007, J IMMUNOL, V178, P2883, DOI 10.4049/jimmunol.178.5.2883; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Salojin KV, 1999, J IMMUNOL, V163, P844; Schramm C, 2004, INT IMMUNOL, V16, P1241, DOI 10.1093/intimm/dxh126; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Suri-Payer E, 1999, EUR J IMMUNOL, V29, P669, DOI 10.1002/(SICI)1521-4141(199902)29:02<669::AID-IMMU669>3.0.CO;2-J; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhang J, 1999, J IMMUNOL, V162, P3819	31	56	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3302	10.1371/journal.pone.0003302	http://dx.doi.org/10.1371/journal.pone.0003302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18827879	Green Submitted, Green Published, gold			2022-12-27	WOS:000264797200008
J	Savolainen, L; Pusa, L; Kim, HJ; Sillanpaa, H; Seppala, I; Tuuminen, T				Savolainen, Laura; Pusa, Liana; Kim, Hwa-Jung; Sillanpaa, Heidi; Seppala, Ilkka; Tuuminen, Tamara			Pilot Study of Diagnostic Potential of the Mycobacterium tuberculosis Recombinant HBHA Protein in a Vaccinated Population in Finland	PLOS ONE			English	Article								Background: In recent years T cell based interferon gamma release assays (IGRA) have been developed for immunodiagnosis of M. tuberculosis infection. At present these assays do not discriminate between disease and latency. Therefore, more promising antigens and diagnostic tools are continuously being searched for tuberculosis immunodiagnostics. The heparin binding hemagglutinin (HBHA) is a surface protein of M. tuberculosis which promotes bacterial aggregation and adhesion to non-phagocytic cells. It has been previously assumed that native, methylated form of this protein would be a promising antigen to discriminate latent from active infection. Methodology and Principal Findings: We performed a pilot investigation to study humoral and T-cell mediated immunological responses to recombinant HBHA produced in M. smegmatis or to synthetic peptides in patients with recent or past tuberculosis, with atypical mycobacteriosis, or in healthy vaccinated individuals. The T cell reactivities to HBHA were compared to the respective reactivities towards Purified Protein Derivative (PPD) and two surface secreted proteins, ie. Early Secretory Antigen Target-6 (ESAT-6) and Culture Filtrate Protein-10 (CFP-10). Our pilot results indicate that methylated recombinant HBHA induced a strong T cell mediated immune response and the production of IgG and IgM-class antibodies in all patient groups, most surprisingly in young Finnish vaccinees, as well. We observed a positive correlation between the reactivities to HBHA and non-specific PPD among all studied subjects. As expected, ESAT-6 and CFP-10 were the most powerful antigens to discriminate disease from immunity caused by vaccination. Conclusions: On the basis of results of this exploratory investigation we raise concerns that in countries like Finland, where BCG vaccination was routinely used, HBHA utility might not be sufficient for diagnostics because of inability to explicitly discriminate tuberculosis infection from immunoreactivity caused by previous BCG vaccination.	[Savolainen, Laura; Sillanpaa, Heidi; Seppala, Ilkka; Tuuminen, Tamara] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland; [Pusa, Liana] Lansi Uusimaa Hosp, Tammisaari, Finland; [Kim, Hwa-Jung] Chungnam Natl Univ, Coll Med, Dept Microbiol, Taejon, South Korea; [Seppala, Ilkka; Tuuminen, Tamara] Helsinki Univ Hosp, HUSLAB, Div Clin Microbiol, Helsinki, Finland	University of Helsinki; Chungnam National University; University of Helsinki; Helsinki University Central Hospital	Savolainen, L (corresponding author), Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland.	tamara.tuuminen@helsinki.fi		Kim, Hwa-Jung/0000-0002-1127-0909; Sillanpaa, Heidi/0000-0001-6649-6828; Savolainen, Laura/0000-0003-2527-4211	Finnish Lung Health Association; Pulmonary Association Heli; Tuberculosis Association of the University of Tampere	Finnish Lung Health Association; Pulmonary Association Heli; Tuberculosis Association of the University of Tampere	We wish to thank the following private Finnish foundations for financial support: Finnish Lung Health Association (Filha ry), Pulmonary Association Heli, and the Tuberculosis Association of the University of Tampere. MD Raimo Tuuminen is acknowledged for help in data analysis.	Chee CBE, 2008, J CLIN MICROBIOL, V46, P1935, DOI 10.1128/JCM.02403-07; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Dheda K, 2005, CURR OPIN PULM MED, V11, P195, DOI 10.1097/01.mcp.0000158726.13159.5e; Hougardy JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000926; LABARGA A, 2007, WEB SERVICE EUROPEAN; Locht C, 2006, TUBERCULOSIS, V86, P303, DOI 10.1016/j.tube.2006.01.016; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; National Public Health Institute, 2008, INF DIS FINL 2007, V9; Pethe K, 2002, P NATL ACAD SCI USA, V99, P10759, DOI 10.1073/pnas.162246899; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Shin AR, 2006, CLIN VACCINE IMMUNOL, V13, P869, DOI 10.1128/CVI.00103-06; Sillanpaa H, 2007, INT J MED MICROBIOL, V297, P45, DOI 10.1016/j.ijmm.2006.09.001; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Tuuminen T, 2007, J IMMUNOL, V179, P1988, DOI 10.4049/jimmunol.179.3.1988; Van Epps HL, 2002, J EXP MED, V196, P579, DOI 10.1084/jem.20011255; Zanetti S, 2005, CLIN DIAGN LAB IMMUN, V12, P1135, DOI 10.1128/CDLI.12.9.1135-1138.2005	17	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2008	3	9							e3272	10.1371/journal.pone.0003272	http://dx.doi.org/10.1371/journal.pone.0003272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MH	18815611	Green Published, gold, Green Submitted			2022-12-27	WOS:000264431900002
J	Ruiz, L; Traskine, M; Ferrer, I; Castro, E; Leal, JFM; Kaufman, M; Carnero, A				Ruiz, Lidia; Traskine, Magali; Ferrer, Irene; Castro, Estrella; Leal, Juan F. M.; Kaufman, Marcelline; Carnero, Amancio			Characterization of the p53 Response to Oncogene-Induced Senescence	PLOS ONE			English	Article								Background: P53 activation can trigger various outcomes, among them reversible growth arrest or cellular senescence. It is a live debate whether these outcomes are influenced by quantitative or qualitative mechanisms. Furthermore, the relative contribution of p53 to Ras-induced senescence is also matter of controversy. Methodology/Principal Findings: This study compared situations in which different signals drove senescence with increasing levels of p53 activation. The study revealed that the levels of p53 activation do not determine the outcome of the response. This is further confirmed by the clustering of transcriptional patterns into two broad groups: p53-activated or p53-inactivated, i.e., growth and cellular arrest/senescence. Furthermore, while p53-dependent transcription decreases after 24 hrs in the presence of active p53, senescence continues. Maintaining cells in the arrested state for long periods does not switch reversible arrest to cellular senescence. Together, these data suggest that a Ras-dependent, p53-independent, second signal is necessary to induce senescence. This study tested whether PPP1CA (the catalytic subunit of PP1 alpha), recently identified as contributing to Ras-induced senescence, might be this second signal. PPP1CA is induced by Ras; its inactivation inhibits Ras-induced senescence, presumably by inhibiting pRb dephosphorylation. Finally, PPP1CA seems to strongly colocalize with pRb only during senescence. Conclusions: The levels of p53 activation do not determine the outcome of the response. Rather, p53 activity seems to act as a necessary but not sufficient condition for senescence to arise. Maintaining cells in the arrested state for long periods does not switch reversible arrest to cellular senescence. PPP1CA is induced by Ras; its inactivation inhibits Ras-induced senescence, presumably by inhibiting pRb dephosphorylation. Finally, PPP1CA seems to strongly co-localize with pRb only during senescence, suggesting that PP1 alpha activation during senescence may be the second signal contributing to the irreversibility of the senescent phenotype.	[Ruiz, Lidia; Ferrer, Irene; Castro, Estrella; Leal, Juan F. M.; Carnero, Amancio] CNIO, Expt Therapeut Programme, Madrid, Spain; [Traskine, Magali; Kaufman, Marcelline] Free Univ Brussels, Fac Sci, Unit Theoretical & Computat Biol, B-1050 Brussels, Belgium	Centro Nacional de Investigaciones Oncologicas (CNIO); Universite Libre de Bruxelles; Vrije Universiteit Brussel	Ruiz, L (corresponding author), CNIO, Expt Therapeut Programme, Madrid, Spain.	acarnero@cnio.es	Leal, Juan F Martinez/N-6328-2013; Ferrer, Irene/C-9418-2015; Ruiz, Lidia/L-1620-2014; IBIS, CANCER/P-3323-2015	Leal, Juan F Martinez/0000-0002-7538-0875; Ferrer, Irene/0000-0002-2748-2607; Ruiz, Lidia/0000-0003-1430-9618; Carnero, Amancio/0000-0003-4357-3979	Ministerio de Educacion y Ciencia [SAF2005-00944, fellowship]; Fundacion Mutua Madrilena; EU	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); EU(European Commission)	This work has been supported by grants from the Ministerio de Educacion y Ciencia (SAF2005-00944), Fundacion Mutua Madrilena and the EU (from VI framework, Project COMBIO, Project NETSENSOR). IF is supported by a fellowship from the Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS AS, 1993, P NATL ACAD SCI USA, V90, P388, DOI 10.1073/pnas.90.2.388; Ayllon V, 2000, EMBO J, V19, P2237, DOI 10.1093/emboj/19.10.2237; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Berndt N, 1997, CURR BIOL, V7, P375, DOI 10.1016/S0960-9822(06)00185-0; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Carbone R, 2002, ONCOGENE, V21, P1633, DOI 10.1038/sj.onc.1205227; Carnero A, 2000, NUCLEIC ACIDS RES, V28, P2234, DOI 10.1093/nar/28.11.2234; Castro ME, 2008, CARCINOGENESIS, V29, P491, DOI 10.1093/carcin/bgm246; Castro ME, 2004, J CELL BIOCHEM, V92, P514, DOI 10.1002/jcb.20079; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Collado M, 2005, CELL CYCLE, V4, P1722, DOI 10.4161/cc.4.12.2260; Daubechies I, 2004, COMMUN PUR APPL MATH, V57, P1413, DOI 10.1002/cpa.20042; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Evan GI, 2005, COLD SH Q B, V70, P263, DOI 10.1101/sqb.2005.70.054; Ferbeyre G, 2000, GENE DEV, V14, P2015; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Goodrich DW, 2006, ONCOGENE, V25, P5233, DOI 10.1038/sj.onc.1209616; Insinga A, 2004, EMBO J, V23, P1144, DOI 10.1038/sj.emboj.7600109; Jimenez-Velasco A, 2005, LEUKEMIA, V19, P2347, DOI 10.1038/sj.leu.2403974; Kapoor M, 1998, P NATL ACAD SCI USA, V95, P2834, DOI 10.1073/pnas.95.6.2834; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Lohrum MAE, 2000, TRENDS CELL BIOL, V10, P197, DOI 10.1016/S0962-8924(00)01736-0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Lu H, 1998, P NATL ACAD SCI USA, V95, P6399, DOI 10.1073/pnas.95.11.6399; Maeda Y, 2006, BIOCHEM J, V400, P303, DOI 10.1042/BJ20060614; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Nakano H, 2007, INT J RADIAT ONCOL, V68, P883, DOI 10.1016/j.ijrobp.2007.03.007; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nelson DA, 1997, J BIOL CHEM, V272, P4528, DOI 10.1074/jbc.272.7.4528; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Rajesh D, 1999, MOL PHARMACOL, V56, P515, DOI 10.1124/mol.56.3.515; Rubin Ethel, 1998, Frontiers in Bioscience, V3, pD1209; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Vidal A, 2007, FRONT BIOSCI-LANDMRK, V12, P4483, DOI 10.2741/2403; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Zhao RB, 2000, GENE DEV, V14, P981; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	57	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3230	10.1371/journal.pone.0003230	http://dx.doi.org/10.1371/journal.pone.0003230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800172	Green Published, Green Submitted, gold			2022-12-27	WOS:000264428400001
J	Mankar, M; Joshi, RS; Belsare, PV; Jog, MM; Watve, MG				Mankar, Manasee; Joshi, Radhika S.; Belsare, Prajakta V.; Jog, Maithili M.; Watve, Milind G.			Obesity as a Perceived Social Signal	PLOS ONE			English	Article							INSULIN; EXPERIENCE	Fat accumulation has been classically considered as a means of energy storage. Obese people are theorized as metabolically 'thrifty', saving energy during times of food abundance. However, recent research has highlighted many neuro-behavioral and social aspects of obesity, with a suggestion that obesity, abdominal obesity in particular, may have evolved as a social signal. We tested here whether body proportions, and abdominal obesity in particular, are perceived as signals revealing personality traits. Faceless drawings of three male body forms namely lean, muscular and feminine, each with and without abdominal obesity were shown in a randomized order to a group of 222 respondents. A list of 30 different adjectives or short descriptions of personality traits was given to each respondent and they were asked to allocate the most appropriate figure to each of them independently. The traits included those directly related to physique, those related to nature, attitude and moral character and also those related to social status. For 29 out of the 30 adjectives people consistently attributed specific body forms. Based on common choices, the 30 traits could be clustered into distinct 'personalities' which were strongly associated with particular body forms. A centrally obese figure was perceived as "lethargic, greedy, political, money-minded, selfish and rich''. The results show that body proportions are perceived to reflect personality traits and this raises the possibility that in addition to energy storage, social selection may have played some role in shaping the biology of obesity.	[Mankar, Manasee; Joshi, Radhika S.; Belsare, Prajakta V.; Watve, Milind G.] Abasaheb Garware Coll, Dept Microbiol, Pune, Maharashtra, India; [Jog, Maithili M.] Abasaheb Garware Coll, Dept Biotechnol, Pune, Maharashtra, India; [Watve, Milind G.] Anujeeva Biosci Pvt Ltd, Pune, Maharashtra, India		Mankar, M (corresponding author), Abasaheb Garware Coll, Dept Microbiol, Pune, Maharashtra, India.	milind_watve@yahoo.com		JOSHI, RADHIKA/0000-0002-4313-2586				Black AE, 1996, EUR J CLIN NUTR, V50, P72; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Briers B, 2006, PSYCHOL SCI, V17, P939, DOI 10.1111/j.1467-9280.2006.01808.x; Chang VW, 2002, SOCIOL HEALTH ILL, V24, P151, DOI 10.1111/1467-9566.00289; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Elliott R, 2003, J NEUROSCI, V23, P303; Esposito K, 2005, INT J IMPOT RES, V17, P391, DOI 10.1038/sj.ijir.3901333; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Lachmann M, 2001, P NATL ACAD SCI USA, V98, P13189, DOI 10.1073/pnas.231216498; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; NEEL JV, 1962, AM J HUM GENET, V14, P353; Norman RJ, 1998, REPROD FERT DEVELOP, V10, P55, DOI 10.1071/R98010; O'Rahilly S, 2006, PHILOS T R SOC B, V361, P1095, DOI 10.1098/rstb.2006.1850; Pond CM, 2001, P NUTR SOC, V60, P365, DOI 10.1079/PNS200198; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rule NO, 2008, J EXP SOC PSYCHOL, V44, P1100, DOI 10.1016/j.jesp.2007.12.001; Speakman John R, 2006, Diab Vasc Dis Res, V3, P7, DOI 10.3132/dvdr.2006.010; Stoger R, 2008, BIOESSAYS, V30, P156, DOI 10.1002/bies.20700; Watve MG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-61; Wells JCK, 2007, BIOL REV, V82, P143, DOI 10.1111/j.1469-185X.2006.00007.x; Westerterp KR, 2008, INT J OBESITY, V32, P1256, DOI 10.1038/ijo.2008.74; Zahavi A, 1997, HANDICAP PRINCIPLE M; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	29	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3187	10.1371/journal.pone.0003187	http://dx.doi.org/10.1371/journal.pone.0003187			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422KF	18784836	Green Submitted, gold, Green Published			2022-12-27	WOS:000264425900007
J	Taube, R; Zhu, Q; Xu, C; Diaz-Griffero, F; Sui, J; Kamau, E; Dwyer, M; Aird, D; Marasco, WA				Taube, Ran; Zhu, Quan; Xu, Chen; Diaz-Griffero, Felipe; Sui, Jianhua; Kamau, Erick; Dwyer, Markryan; Aird, Daniel; Marasco, Wayne A.			Lentivirus Display: Stable Expression of Human Antibodies on the Surface of Human Cells and Virus Particles	PLOS ONE			English	Article								Background: Isolation of human antibodies using current display technologies can be limited by constraints on protein expression, folding and post-translational modifications. Here we describe a discovery platform that utilizes self-inactivating (SIN) lentiviral vectors for the surface display of high-affinity single-chain variable region (scFv) antibody fragments on human cells and lentivirus particles. Methodology/Principal Findings: Bivalent scFvFc human antibodies were fused in frame with different transmembrane (TM) anchoring moieties to allow efficient high- level expression on human cells and the optimal TM was identified. The addition of an eight amino acid HIV-1 gp41 envelope incorporation motif further increased scFvFc expression on human cells and incorporation into lentiviral particles. Both antibody-displaying human cells and virus particles bound antigen specifically. Sulfation of CDR tyrosine residues, a property recently shown to broaden antibody binding affinity and antigen recognition was also demonstrated. High level scFvFc expression and stable integration was achieved in human cells following transduction with IRES containing bicistronic SIN lentivectors encoding ZsGreen when scFvFc fusion proteins were expressed from the first cassette. Up to 10(6)-fold enrichment of antibody expressing cells was achieved with one round of antigen coupled magnetic bead pre-selection followed by FACS sorting. Finally, the scFvFc displaying human cells could be used directly in functional biological screens with remarkable sensitivity. Conclusions/Significance: This antibody display platform will complement existing technologies by virtue of providing properties unique to lentiviruses and antibody expression in human cells, which, in turn, may aid the discovery of novel therapeutic human mAbs.	[Taube, Ran; Zhu, Quan; Xu, Chen; Diaz-Griffero, Felipe; Sui, Jianhua; Kamau, Erick; Dwyer, Markryan; Aird, Daniel; Marasco, Wayne A.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA USA; [Taube, Ran; Zhu, Quan; Xu, Chen; Sui, Jianhua; Marasco, Wayne A.] Harvard Med Sch, Dept Med, Boston, MA USA; [Diaz-Griffero, Felipe] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Taube, R (corresponding author), Ben Gurion Univ Negev, Dept Virol, IL-84105 Beer Sheva, Israel.	Wayne_Marasco@dfci.harvard.edu	TAUBE, RAN/F-2029-2012	TAUBE, RAN/0000-0002-2062-4537; SUI, JIANHUA/0000-0002-1272-9662	National Institutes of Health [AI061318, AI58804]; Israeli government [Bikura fellowship]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI058804, U01AI061318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israeli government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by the National Institutes of Health grants, AI061318 (W. A. Marasco) and AI58804 (Q. Zhu). RT was supported by the Israeli government "Bikura" fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Bai JR, 2003, J BIOL CHEM, V278, P1433, DOI 10.1074/jbc.M208297200; Brown C, 2007, PULM PHARMACOL THER, V20, P90, DOI 10.1016/j.pupt.2005.12.009; Choe H, 2003, CELL, V114, P161, DOI 10.1016/S0092-8674(03)00508-7; Cumbers SJ, 2002, NAT BIOTECHNOL, V20, P1129, DOI 10.1038/nbt752; Daugherty PS, 2000, J IMMUNOL METHODS, V243, P211, DOI 10.1016/S0022-1759(00)00236-2; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Gura T, 2002, NATURE, V417, P584, DOI 10.1038/417584a; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Ikeda Y, 2003, NAT BIOTECHNOL, V21, P569, DOI 10.1038/nbt815; Klages N, 2000, MOL THER, V2, P170, DOI 10.1006/mthe.2000.0103; Lin AH, 2001, HUM GENE THER, V12, P323, DOI 10.1089/10430340150503957; MINTZ KP, 1994, J BIOL CHEM, V269, P4845; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Ogueta SB, 2001, MOL MED, V7, P569, DOI 10.1007/BF03401863; Reichert J, 2004, NAT REV DRUG DISCOV, V3, P383, DOI 10.1038/nrd1386; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Souriau C, 2003, EXPERT OPIN BIOL TH, V3, P305, DOI 10.1517/eobt.3.2.305.21159; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Sui JH, 2005, J VIROL, V79, P5900, DOI 10.1128/JVI.79.10.5900-5906.2005; Urban JH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni033; VanAntwerp JJ, 2000, BIOTECHNOL PROGR, V16, P31, DOI 10.1021/bp990133s; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; Weiner LM, 2005, NAT BIOTECHNOL, V23, P556, DOI 10.1038/nbt0505-556; Xu C, 2007, J IMMUNOL, V179, P2408, DOI 10.4049/jimmunol.179.4.2408; Yang L, 2006, P NATL ACAD SCI USA, V103, P11479, DOI 10.1073/pnas.0604993103; Yuan QA, 2006, MOL CANCER THER, V5, P2096, DOI 10.1158/1535-7163.MCT-06-0115; ZHU Q, 2004, GENE THERAPY MOL BIO, V8, P91	34	23	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3181	10.1371/journal.pone.0003181	http://dx.doi.org/10.1371/journal.pone.0003181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784843	gold, Green Submitted, Green Published			2022-12-27	WOS:000264425900003
J	Mankowski, JL; Queen, SE; Fernandez, CS; Tarwater, PM; Karper, JM; Adams, RJ; Kent, SJ				Mankowski, Joseph L.; Queen, Suzanne E.; Fernandez, Caroline S.; Tarwater, Patrick M.; Karper, Jami M.; Adams, Robert J.; Kent, Stephen J.			Natural Host Genetic Resistance to Lentiviral CNS Disease: A Neuroprotective MHC Class I Allele in SIV-Infected Macaques	PLOS ONE			English	Article								Human immunodeficiency virus (HIV) infection frequently causes neurologic disease even with anti-retroviral treatment. Although associations between MHC class I alleles and acquired immunodeficiency syndrome (AIDS) have been reported, the role MHC class I alleles play in restricting development of HIV-induced organ-specific diseases, including neurologic disease, has not been characterized. This study examined the relationship between expression of the MHC class I allele Mane-A*10 and development of lentiviral-induced central nervous system (CNS) disease using a well-characterized simian immunodeficiency (SIV)/pigtailed macaque model. The risk of developing CNS disease (SIV encephalitis) was 2.5 times higher for animals that did not express the MHC class I allele Mane-A* 10 (P = 0.002; RR = 2.5). Animals expressing the Mane-A* 10 allele had significantly lower amounts of activated macrophages, SIV RNA, and neuronal dysfunction in the CNS than Mane-A*10 negative animals (P<0.001). Mane-A*10 positive animals with the highest CNS viral burdens contained SIV gag escape mutants at the Mane-A*10-restricted KP9 epitope in the CNS whereas wild type KP9 sequences dominated in the brain of Mane-A*10 negative animals with comparable CNS viral burdens. These concordant findings demonstrate that particular MHC class I alleles play major neuroprotective roles in lentiviral-induced CNS disease.	[Mankowski, Joseph L.; Queen, Suzanne E.; Karper, Jami M.; Adams, Robert J.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA; [Mankowski, Joseph L.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21218 USA; [Mankowski, Joseph L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA; [Fernandez, Caroline S.; Kent, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Tarwater, Patrick M.] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, El Paso, TX USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Melbourne; Texas Tech University System; Texas Tech University	Mankowski, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA.	jmankows@jhmi.edu	Kent, Stephen/AAL-5101-2020	Kent, Stephen/0000-0002-8539-4891	NIH [RR019995, NS055651, NS047984, NS055648, HL75840, MH69116, MH070306]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR019995] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH070306, R01MH069116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047984, R01NS055648] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH RR019995 (RJA). In addition, animal studies were supported by NIH NS055651, NS047984, NS055648, HL75840, MH69116, and MH070306.	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Babas T, 2006, AIDS, V20, P197, DOI 10.1097/01.aids.0000198078.24584.21; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Cherry CL, 2008, AIDS RES HUM RETROV, V24, P117, DOI 10.1089/aid.2007.0168; Clements JE, 2002, J INFECT DIS, V186, P905, DOI 10.1086/343768; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; FELLAY J, 2007, WHOLE GENOME ASS STU; Fernandez CS, 2005, J VIROL, V79, P5721, DOI 10.1128/JVI.79.9.5721-5731.2005; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Mankowski JL, 2002, J NEUROPATH EXP NEUR, V61, P85, DOI 10.1093/jnen/61.1.85; Mankowski JL, 2002, J INFECT DIS, V186, pS199, DOI 10.1086/344938; McCrossan M, 2006, BRAIN, V129, P503, DOI 10.1093/brain/awh695; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Moniuszko M, 2003, J VIROL, V77, P12346, DOI 10.1128/JVI.77.22.12346-12351.2003; O'Connor DH, 2003, J VIROL, V77, P9029, DOI 10.1128/JVI.77.16.9029-9040.2003; Pratt BF, 2006, IMMUNOGENETICS, V58, P995, DOI 10.1007/s00251-006-0164-8; Sauermann Ulrike, 2001, Current Molecular Medicine (Hilversum), V1, P515; Smith MZ, 2005, J VIROL, V79, P684, DOI 10.1128/JVI.79.2.684-695.2005; Smith MZ, 2005, J MED PRIMATOL, V34, P282, DOI 10.1111/j.1600-0684.2005.00126.x; Weed MR, 2003, J NEUROVIROL, V9, P452, DOI 10.1080/13550280390218751; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003; Zink MC, 1997, AM J PATHOL, V151, P793	25	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3603	10.1371/journal.pone.0003603	http://dx.doi.org/10.1371/journal.pone.0003603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978944	Green Published, gold			2022-12-27	WOS:000265134200002
J	Ding, Y; Larson, G; Rivas, G; Lundberg, C; Geller, L; Ouyang, C; Weitzel, J; Archambeau, J; Slater, J; Daly, MB; Benson, AB; Kirkwood, JM; O'Dwyer, PJ; Sutphen, R; Stewart, JA; Johnson, D; Nordborg, M; Krontiris, TG				Ding, Yan; Larson, Garrett; Rivas, Guillermo; Lundberg, Cathryn; Geller, Louis; Ouyang, Ching; Weitzel, Jeffrey; Archambeau, John; Slater, Jerry; Daly, Mary B.; Benson, Al B.; Kirkwood, John M.; O'Dwyer, Peter J.; Sutphen, Rebecca; Stewart, James A.; Johnson, David; Nordborg, Magnus; Krontiris, Theodore G.			Strong Signature of Natural Selection within an FHIT Intron Implicated in Prostate Cancer Risk	PLOS ONE			English	Article								Previously, a candidate gene linkage approach on brother pairs affected with prostate cancer identified a locus of prostate cancer susceptibility at D3S1234 within the fragile histidine triad gene (FHIT), a tumor suppressor that induces apoptosis. Subsequent association tests on 16 SNPs spanning approximately 381 kb surrounding D3S1234 in Americans of European descent revealed significant evidence of association for a single SNP within intron 5 of FHIT. In the current study, resequencing and genotyping within a 28.5 kb region surrounding this SNP further delineated the association with prostate cancer risk to a 15 kb region. Multiple SNPs in sequences under evolutionary constraint within intron 5 of FHIT defined several related haplotypes with an increased risk of prostate cancer in European-Americans. Strong associations were detected for a risk haplotype defined by SNPs 138543, 142413, and 152494 in all cases (Pearson's chi(2) = 12.34, df 1, P = 0.00045) and for the homozygous risk haplotype defined by SNPs 144716, 142413, and 148444 in cases that shared 2 alleles identical by descent with their affected brothers (Pearson's chi(2) = 11.50, df 1, P = 0.00070). In addition to highly conserved sequences encompassing SNPs 148444 and 152413, population studies revealed strong signatures of natural selection for a 1 kb window covering the SNP 144716 in two human populations, the European American (pi = 0.0072, Tajima's D = 3.31, 14 SNPs) and the Japanese (pi = 0.0049, Fay & Wu's H = 8.05, 14 SNPs), as well as in chimpanzees (Fay & Wu's H = 8.62, 12 SNPs). These results strongly support the involvement of the FHIT intronic region in an increased risk of prostate cancer.	[Ding, Yan; Larson, Garrett; Rivas, Guillermo; Lundberg, Cathryn; Geller, Louis; Ouyang, Ching; Krontiris, Theodore G.] Beckman Res Inst City Hope, Div Mol Med, Duarte, CA USA; [Weitzel, Jeffrey] City of Hope, Dept Canc Genet, Duarte, CA USA; [Archambeau, John; Slater, Jerry] Loma Linda Sch Med, Dept Radiat Med, Loma Linda, CA USA; [Daly, Mary B.] Fox Chase Canc Ctr, Dept Populat Sci, Philadelphia, PA USA; [Benson, Al B.] Northwestern Univ, Sch Med, Robert J Lurie Comprehensive Canc Ctr, Dept Med, Div Hematol Oncol, Chicago, IL USA; [Kirkwood, John M.] Univ Pittsburgh, Canc Ctr, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15260 USA; [O'Dwyer, Peter J.] Univ Penn, Canc Ctr, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Sutphen, Rebecca] Univ S Florida, H. Lee Moffitt Canc Ctr & Res Inst, Interdisciplinary Oncol Program, Tampa, FL USA; [Stewart, James A.] Univ Wisconsin, Sch Med, Comprehensive Canc Ctr, Madison, WI 53706 USA; [Johnson, David] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA; [Nordborg, Magnus] Univ Southern California, Dept Mol & Computat Biol, Biol Sci, Los Angeles, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Loma Linda University; Fox Chase Cancer Center; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University	Ding, Y (corresponding author), Beckman Res Inst City Hope, Div Mol Med, Duarte, CA USA.	tkrontir@coh.org		Nordborg, Magnus/0000-0001-7178-9748	NIH [AG15720, HG-002790]; DOE [PC020680]; Beckman Research Institute of the City of Hope; NATIONAL CANCER INSTITUTE [RC4CA153828, R01CA106414] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015720] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); Beckman Research Institute of the City of Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	YD, GL, GR, CL, CO, TGK were supported by NIH AG15720, DOE PC020680, and the Beckman Research Institute of the City of Hope. LG, JW, JA, JS, MBD, ABB, JMK, PJO, RS, JAS, DJ were supported by NIH AG15720. MN was supported by NIH HG-002790.	Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker NA, 2002, ONCOGENE, V21, P8713, DOI 10.1038/sj.onc.1205950; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Chizhikov V, 2002, ONCOGENE, V21, P2398, DOI 10.1038/sj.onc.1205310; De la Vega FM, 2005, GENOME RES, V15, P454, DOI 10.1101/gr.3241705; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; DUDBRIDGE E, 2006, UNPHASED USER GUIDE; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fay JC, 2000, GENETICS, V155, P1405; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Fouts RL, 2003, CANCER-AM CANCER SOC, V97, P1447, DOI 10.1002/cncr.11201; FU YX, 1993, GENETICS, V133, P693; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Guo ZY, 2000, PROSTATE, V43, P101; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Huebner K, 2003, BRIT J CANCER, V88, P1501, DOI 10.1038/sj.bjc.6600937; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Larson GP, 2005, CANCER RES, V65, P805; Latil A, 1998, ONCOGENE, V16, P1863, DOI 10.1038/sj.onc.1201703; Levin AM, 2007, CANCER EPIDEM BIOMAR, V16, P1294, DOI 10.1158/1055-9965.EPI-06-1054; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nelson HH, 1998, CANCER RES, V58, P1804; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Preacher K.J., 2001, CALCULATION CHI SQUA; Reis EM, 2004, ONCOGENE, V23, P6684, DOI 10.1038/sj.onc.1207880; Rhim JS, 1997, CANCER RES, V57, P576; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Sozzi G, 1998, CANCER RES, V58, P5032; Spencer CCA, 2004, BIOINFORMATICS, V20, P3673, DOI 10.1093/bioinformatics/bth417; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Vecchione A, 2001, CLIN CANCER RES, V7, P1306; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yu N, 2003, GENETICS, V164, P1511	50	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3533	10.1371/journal.pone.0003533	http://dx.doi.org/10.1371/journal.pone.0003533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953408	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000265130500010
J	Boris Schmid, V; Kesmir, C; de Boer, RJ				Boris Schmid, V; Kesmir, Can; de Boer, Rob J.			The Specificity and Polymorphism of the MHC Class I Prevents the Global Adaptation of HIV-1 to the Monomorphic Proteasome and TAP	PLOS ONE			English	Article								The large diversity in MHC class I molecules in a population lowers the chance that a virus infects a host to which it is pre-adapted to escape the MHC binding of CTL epitopes. However, viruses can also lose CTL epitopes by escaping the monomorphic antigen processing components of the pathway (proteasome and TAP) that create the epitope precursors. If viruses were to accumulate escape mutations affecting these monomorphic components, they would become pre-adapted to all hosts regardless of the MHC polymorphism. To assess whether viruses exploit this apparent vulnerability, we study the evolution of HIV-1 with bioinformatic tools that allow us to predict CTL epitopes, and quantify the frequency and accumulation of antigen processing escapes. We found that within hosts, proteasome and TAP escape mutations occur frequently. However, on the population level these escapes do not accumulate: the total number of predicted epitopes and epitope precursors in HIV-1 clade B has remained relatively constant over the last 30 years. We argue that this lack of adaptation can be explained by the combined effect of the MHC polymorphism and the high specificity of individual MHC molecules. Because of these two properties, only a subset of the epitope precursors in a host are potential epitopes, and that subset differs between hosts. We estimate that upon transmission of a virus to a new host 39%-66% of the mutations that caused epitope precursor escapes are released from immune selection pressure.	[Boris Schmid, V; Kesmir, Can; de Boer, Rob J.] Univ Utrecht, Inst Theoret Phys, NL-3508 TA Utrecht, Netherlands; [Kesmir, Can] Univ Utrecht, Acad Biomed Ctr, NL-3508 TC Utrecht, Netherlands	Utrecht University; Utrecht University	Boris Schmid, V (corresponding author), Univ Utrecht, Inst Theoret Phys, NL-3508 TA Utrecht, Netherlands.	boris.schmid@gmail.com	de Boer, Rob/B-6050-2011; Schmid, Boris V./P-9013-2016; Kesmir, Can/B-9410-2011	de Boer, Rob/0000-0002-2130-691X; Schmid, Boris V./0000-0003-0452-623X; 	Utrecht University; Netherlands Organization for Scientific Research	Utrecht University; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was funded by Utrecht University and the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Asquith B, 2006, PLOS BIOL, V4, P583, DOI 10.1371/journal.pbio.0040090; Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; Barouch DH, 2005, NAT IMMUNOL, V6, P247, DOI 10.1038/ni1167; Baugh LL, 2008, J VIROL, V82, P9657, DOI 10.1128/JVI.00107-08; Beekman NJ, 2000, J IMMUNOL, V164, P1898, DOI 10.4049/jimmunol.164.4.1898; BERGMANN CC, 1994, J VIROL, V68, P5306, DOI 10.1128/JVI.68.8.5306-5310.1994; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; BODMER WF, 1972, NATURE, V237, P139, DOI 10.1038/237139a0; Borghans JAM, 2004, IMMUNOGENETICS, V55, P732, DOI 10.1007/s00251-003-0630-5; Brander C, 1999, J VIROL, V73, P10191, DOI 10.1128/JVI.73.12.10191-10198.1999; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Burroughs NJ, 2004, IMMUNOGENETICS, V56, P311, DOI 10.1007/s00251-004-0691-0; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Doytchinova IA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-131; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fortier MH, 2008, J EXP MED, V205, P595, DOI 10.1084/jem.20071985; Frankild S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001831; Frater AJ, 2007, J VIROL, V81, P6742, DOI 10.1128/JVI.00022-07; Furutsuki T, 2004, J VIROL, V78, P8437, DOI 10.1128/JVI.78.16.8437-8445.2004; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Groothuis TAM, 2005, IMMUNOL REV, V207, P60, DOI 10.1111/j.0105-2896.2005.00305.x; Gubler B, 1998, MOL IMMUNOL, V35, P427, DOI 10.1016/S0161-5890(98)00059-5; Hakenberg Jorg, 2003, Appl Bioinformatics, V2, P155; Herbeck JT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001525; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Karlsson AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000225; Kaslow RA, 2001, J VIROL, V75, P8681, DOI 10.1128/JVI.75.18.8681-8689.2001; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; KIMURA M, 1991, P NATL ACAD SCI USA, V88, P5969, DOI 10.1073/pnas.88.14.5969; Klein MR, 1998, J GEN VIROL, V79, P2191, DOI 10.1099/0022-1317-79-9-2191; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kuiken Carla, 2003, AIDS Reviews, V5, P52; Kutsch O, 2002, AIDS RES HUM RETROV, V18, P1319, DOI 10.1089/088922202320886361; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; Lundegaard C, 2006, TRENDS BIOTECHNOL, V24, P537, DOI 10.1016/j.tibtech.2006.10.001; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Maurer K, 2008, JAIDS-J ACQ IMM DEF, V48, P133, DOI 10.1097/QAI.0b013e31816fdc4a; Milicic A, 2005, J IMMUNOL, V175, P4618, DOI 10.4049/jimmunol.175.7.4618; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Muller V, 2006, AIDS, V20, P889, DOI 10.1097/01.aids.0000218553.51908.6b; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; PARKER KC, 1994, J IMMUNOL, V152, P163; Paulsson KM, 2004, CELL MOL LIFE SCI, V61, P2446, DOI 10.1007/s00018-004-4113-0; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Poon AFY, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030045; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Sacha JB, 2007, J VIROL, V81, P11703, DOI 10.1128/JVI.00926-07; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Scheliens IMM, 2008, AIDS, V22, P33, DOI 10.1097/QAD.0b013e3282f15622; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SLADE RW, 1992, GENETICS, V132, P861; SNELL GD, 1968, FOLIA BIOL-PRAGUE, V14, P335; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; van Baalen CA, 2002, EUR J IMMUNOL, V32, P2644, DOI 10.1002/1521-4141(200209)32:9<2644::AID-IMMU2644>3.0.CO;2-R; Walker BA, 2005, IMMUNOGENETICS, V57, P232, DOI 10.1007/s00251-005-0786-2; WHITNEY JB, 1985, P NATL ACAD SCI USA, V82, P7646, DOI 10.1073/pnas.82.22.7646; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yokomaku Y, 2004, J VIROL, V78, P1324, DOI 10.1128/JVI.78.3.1324-1332.2004; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002; Zafiropoulos A, 2004, P ROY SOC B-BIOL SCI, V271, pS53, DOI 10.1098/rsbl.2003.0088; Zhang D, 2003, BLOOD, V101, P226, DOI 10.1182/blood-2002-03-0791	75	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3525	10.1371/journal.pone.0003525	http://dx.doi.org/10.1371/journal.pone.0003525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949050	Green Published, Green Submitted, gold			2022-12-27	WOS:000265126400010
J	Bornmann, L; Wallon, G; Ledin, A				Bornmann, Lutz; Wallon, Gerlind; Ledin, Anna			Does the Committee Peer Review Select the Best Applicants for Funding? An Investigation of the Selection Process for Two European Molecular Biology Organization Programmes	PLOS ONE			English	Article							CITATION COUNTS; H-INDEX; PUBLICATION; ARTICLES; VALIDITY; PAY	Does peer review fulfill its declared objective of identifying the best science and the best scientists? In order to answer this question we analyzed the Long-Term Fellowship and the Young Investigator programmes of the European Molecular Biology Organization. Both programmes aim to identify and support the best post doctoral fellows and young group leaders in the life sciences. We checked the association between the selection decisions and the scientific performance of the applicants. Our study involved publication and citation data for 668 applicants to the Long-Term Fellowship programme from the year 1998 (130 approved, 538 rejected) and 297 applicants to the Young Investigator programme (39 approved and 258 rejected applicants) from the years 2001 and 2002. If quantity and impact of research publications are used as a criterion for scientific achievement, the results of (zero-truncated) negative binomial models show that the peer review process indeed selects scientists who perform on a higher level than the rejected ones subsequent to application. We determined the extent of errors due to over-estimation (type I errors) and under-estimation (type 2 errors) of future scientific performance. Our statistical analyses point out that between 26% and 48% of the decisions made to award or reject an application show one of both error types. Even though for a part of the applicants, the selection committee did not correctly estimate the applicant's future performance, the results show a statistically significant association between selection decisions and the applicants' scientific achievements, if quantity and impact of research publications are used as a criterion for scientific achievement.	[Bornmann, Lutz] Swiss Fed Inst Technol, Zurich, Switzerland; [Wallon, Gerlind; Ledin, Anna] European Mol Biol Org EMBO, Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich	Bornmann, L (corresponding author), Swiss Fed Inst Technol, Zurich, Switzerland.	bornmann@gess.ethz.ch	Bornmann, Lutz/A-3926-2008	Bornmann, Lutz/0000-0003-0810-7091				Aksnes DW, 2008, J AM SOC INF SCI TEC, V59, P838, DOI 10.1002/asi.20788; Bornmann L, 2005, SCIENTOMETRICS, V65, P391, DOI 10.1007/s11192-005-0281-4; Bornmann L., 2008, EUROPEAN SCI EDITING, V34, P35; Bornmann L, 2008, J DOC, V64, P45, DOI 10.1108/00220410810844150; Bornmann L, 2008, J AM SOC INF SCI TEC, V59, P1841, DOI 10.1002/asi.20901; Bornmann L, 2008, RES EVALUAT, V17, P149, DOI 10.3152/095820208X319166; Bornmann L, 2007, J INFORMETR, V1, P204, DOI 10.1016/j.joi.2007.01.002; Bornmann L, 2007, J AM SOC INF SCI TEC, V58, P1381, DOI 10.1002/asi.20609; Bornmann L, 2007, J AM SOC INF SCI TEC, V58, P1100, DOI 10.1002/asi.20531; Bornmann L, 2006, SCIENTOMETRICS, V68, P427, DOI 10.1007/s11192-006-0121-1; BORNSTEIN RF, 1991, BEHAV BRAIN SCI, V14, P138, DOI 10.1017/S0140525X00065717; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; COLE S, 1981, SCIENCE, V214, P881, DOI 10.1126/science.7302566; Cole S, 1992, MAKING SCI NATURE SO; DEWITT TW, 1980, SCIENTOMETRICS, V2, P265, DOI 10.1007/BF02016348; *EV LTD, 2007, US BIBL MEAS RES QUA; Freeman R, 2001, SCIENCE, V294, P2293, DOI 10.1126/science.1067477; Garfield E, 2002, SCIENTIST, V16, P10; Geisler E., 2000, METRICS SCI TECHNOLO; Harnad S, 2007, PROCEEDINGS OF ISSI 2007: 11TH INTERNATIONAL CONFERENCE OF THE INTERNATIONAL SOCIETY FOR SCIENTOMETRICS AND INFORMETRICS, VOLS I AND II, P27; HAUSMAN J, 1984, ECONOMETRICA, V52, P909, DOI 10.2307/1911191; Hemlin S., 1996, SOC EPISTEMOL, V10, P209, DOI [10.1080/02691729608578815, DOI 10.1080/02691729608578815]; HERBERTZ H, 1995, SCIENTOMETRICS, V33, P117, DOI 10.1007/BF02020777; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; HORNBOSTEL S, SCIENTOMETRICS; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jayasinghe U. W., 2003, PEER REV ASSESSMENT; Jennings C.G., 2006, QUALITY VALUE TRUE P; Johnson VE, 2008, P NATL ACAD SCI USA, V105, P11076, DOI 10.1073/pnas.0804538105; Joint Committee on Quantitative Assessment of Research, 2008, CIT STAT REP INT MAT; Ledin A, 2007, EMBO REP, V8, P982, DOI 10.1038/sj.embor.7401109; Leimu R, 2005, TRENDS ECOL EVOL, V20, P28, DOI 10.1016/j.tree.2004.10.010; Lokker C, 2008, BMJ-BRIT MED J, V336, P655, DOI 10.1136/bmj.39482.526713.BE; Long J.S., 2006, REGRESSION MODELS CA; Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160; Melin G., 2006, Science and Public Policy, V33, P702, DOI 10.3152/147154306781778579; NEUHAUS C, SCIENTOMETR IN PRESS; *NIH, 2000, REC CHANG NIHS CTR S; ROSS PF, 1980, SCI SELF MANAGEMENT; SMITH R, 1988, BRIT MED J, V296, P774, DOI 10.1136/bmj.296.6624.774; StataCorp L, 2007, STAT DAT AN STAT SOF; Stehbens WE, 1999, MED HYPOTHESES, V52, P31, DOI 10.1054/mehy.1997.0628; Thorngate W, 2002, MINING ARCH ANAL CIH; Van Raan A, 1999, SCIENTOMETRICS, V45, P417, DOI 10.1007/BF02457601; van Raan AFJ, 2005, MEAS-INTERDISCIP RES, V3, P50, DOI 10.1207/s15366359mea0301_7; VANDENBESSELAAR P, 2007, 0704 RATH I SCISA; VINKLER P, 1986, SCIENTOMETRICS, V10, P157, DOI 10.1007/BF02026039; Vinkler P, 1997, SCIENTOMETRICS, V40, P163, DOI 10.1007/BF02459266; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Ziman J. M., 2000, REAL SCI WHAT IT IS; [No title captured], DOI DOI 10.1002/3527602208	53	69	69	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3480	10.1371/journal.pone.0003480	http://dx.doi.org/10.1371/journal.pone.0003480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IG	18941530	Green Submitted, Green Published, gold			2022-12-27	WOS:000265126100011
J	Ramjee, G; van der Straten, A; Chipato, T; de Bruyn, G; Blanchard, K; Shiboski, S; Cheng, H; Montgomery, E; Padian, N				Ramjee, Gita; van der Straten, Ariane; Chipato, Tsungai; de Bruyn, Guy; Blanchard, Kelly; Shiboski, Stephen; Cheng, Helen; Montgomery, Elizabeth; Padian, Nancy		MIRA Team	The Diaphragm and Lubricant Gel for Prevention of Cervical Sexually Transmitted Infections: Results of a Randomized Controlled Trial	PLOS ONE			English	Article								Background: We evaluated the effectiveness of the Ortho All-Flex Diaphragm, lubricant gel (Replens (R)) and condoms compared to condoms alone on the incidence of chlamydial and gonococcal infections in an open-label randomized controlled trial among women at risk of HIV/STI infections. Methods: We randomized 5045 sexually-active women at three sites in Southern Africa. Participants who tested positive for curable STIs were treated prior to enrollment as per local guidelines. Women were followed quarterly and tested for Chlamydia trachomatis (CT) or Neisseria gonorrhoeae (GC) infection by nucleic-acid amplification testing (Roche Amplicor (R)) using first-catch urine specimens. STIs detected at follow-up visits were treated. We compared the incidence of first infection after randomization between study arms in both intent-to-treat (ITT) and per-protocol populations. Findings: Baseline demographic, behavioral and clinical characteristics were balanced across study arms. Nearly 80% of participants were under 35 years of age. Median follow-up time was 21 months and the retention rate was over 93%. There were 471 first chlamydia infections, 247 in the intervention arm and 224 in the control arm with an overall incidence of 6.2/100 woman-years (wy) (relative hazard (RH) 1.11, 95% Confidence Interval (CI): 0.93-1.33; p = 0.25) and 192 first gonococcal infections, 95 in the intervention arm and 97 in the control arm with an overall incidence of 2.4/100wy (RH 0.98, 95% CI: 0.74-1.30; p = 0.90). Per protocol results indicated that when diaphragm adherence was defined as "always use'' since the last visit, there was a significant reduction in the incidence of GC infection among women randomized to the intervention arm (RH 0.61, 95% CI: 0.41-0.91, P = 0.02). Interpretation: There was no difference by study arm in the rate of acquisition of CT or GC. However, our per-protocol results suggest that consistent use of the diaphragm may reduce acquisition of GC.	[Ramjee, Gita] MRC, Durban, South Africa; [van der Straten, Ariane; Cheng, Helen; Montgomery, Elizabeth; Padian, Nancy] RTI Int, San Francisco, CA USA; [Chipato, Tsungai] Univ Zimbabwe, UCSF, Collaborative Res Programme Womens Hlth, Harare, Zimbabwe; [de Bruyn, Guy] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Blanchard, Kelly] Ibis Reproduct Hlth, Cambridge, MA USA; [Shiboski, Stephen] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [van der Straten, Ariane] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA	Research Triangle Institute; University of Zimbabwe; University of Witwatersrand; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ramjee, G (corresponding author), MRC, Durban, South Africa.	ramjeeg@mrc.ac.za	de Bruyn, Guy/E-5574-2010	de Bruyn, Guy/0000-0002-8028-4474; van der Straten, Ariane/0000-0001-8536-648X; Montgomery, Elizabeth/0000-0002-5477-4445	Bill and Melinda Gates Foundation [21082]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding was obtained from the Bill and Melinda Gates Foundation (number 21082). The sponsor maintained oversight of the trial and had input into key scientific decisions. The sponsor was not involved in the collection, analysis and interpretation of the data or in the preparation, review or approval of the manuscript.	Behets FMTF, 2008, SEX TRANSM DIS, V35, P238, DOI 10.1097/OLQ.0b013e31815abaa2; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Diggle D. J, 2002, ANAL LONGITUDINAL DA; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Gray RH, 2001, AM J OBSTET GYNECOL, V185, P1209, DOI 10.1067/mob.2001.118158; Gregson S, 2007, PLOS MED, V4, P545, DOI 10.1371/journal.pmed.0040102; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; KEITH L, 1976, Journal of the American Venereal Disease Association, V3, P17; KELAGHAN J, 1982, JAMA-J AM MED ASSOC, V248, P184, DOI 10.1001/jama.248.2.184; Luchters S, 2007, EUR J CONTRACEP REPR, V12, P345, DOI 10.1080/13625180701516989; MAGDER LS, 1988, AM J EPIDEMIOL, V128, P298, DOI 10.1093/oxfordjournals.aje.a114970; Moench TR, 2001, AIDS, V15, P1595, DOI 10.1097/00002030-200109070-00001; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; Ramjee G, 2008, JAIDS-J ACQ IMM DEF, V47, P93, DOI 10.1097/QAI.0b013e31815c71f7; ROSENBERG MJ, 1992, AM J PUBLIC HEALTH, V82, P669, DOI 10.2105/AJPH.82.5.669; *UNAIDS WHO, 2007, UNAIDS AIDS EP UPD; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Van der Pol B, 2001, J CLIN MICROBIOL, V39, P3092, DOI 10.1128/JCM.39.9.3092-3098.2001; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3	23	33	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3488	10.1371/journal.pone.0003488	http://dx.doi.org/10.1371/journal.pone.0003488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941533	Green Submitted, gold, Green Published			2022-12-27	WOS:000265126100019
J	Cardo-Vila, M; Zurita, AJ; Giordano, RJ; Sun, J; Rangel, R; Guzman-Rojas, L; Anobom, CD; Valente, AP; Almeida, FCL; Lahdenranta, J; Kolonin, MG; Arap, W; Pasqualini, R				Cardo-Vila, Marina; Zurita, Amado J.; Giordano, Ricardo J.; Sun, Jessica; Rangel, Roberto; Guzman-Rojas, Liliana; Anobom, Cristiane D.; Valente, Ana P.; Almeida, Fabio C. L.; Lahdenranta, Johanna; Kolonin, Mikhail G.; Arap, Wadih; Pasqualini, Renata			A Ligand Peptide Motif Selected from a Cancer Patient Is a Receptor-Interacting Site within Human Interleukin-11	PLOS ONE			English	Article								Interleukin-11 (IL-11) is a pleiotropic cytokine approved by the FDA against chemotherapy-induced thrombocytopenia. From a combinatorial selection in a cancer patient, we isolated an IL-11-like peptide mapping to domain I of the IL-11 (sequence CGRRAGGSC). Although this motif has ligand attributes, it is not within the previously characterized interacting sites. Here we design and validate in-tandem binding assays, site-directed mutagenesis and NMR spectroscopy to show (i) the peptide mimics a receptor-binding site within IL-11, (ii) the binding of CGRRAGGSC to the IL-11R alpha is functionally relevant, (iii) Arg(4) and Ser(8) are the key residues mediating the interaction, and (iv) the IL-11-like motif induces cell proliferation through STAT3 activation. These structural and functional results uncover an as yet unrecognized receptor-binding site in human IL-11. Given that IL-11R alpha has been proposed as a target in human cancer, our results provide clues for the rational design of targeted drugs.	[Cardo-Vila, Marina; Zurita, Amado J.; Giordano, Ricardo J.; Sun, Jessica; Rangel, Roberto; Guzman-Rojas, Liliana; Lahdenranta, Johanna; Kolonin, Mikhail G.; Arap, Wadih; Pasqualini, Renata] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Anobom, Cristiane D.; Valente, Ana P.; Almeida, Fabio C. L.] Fed Univ, Natl NMR Ctr, BR-21941 Rio De Janeiro, Brazil	University of Texas System; UTMD Anderson Cancer Center	Cardo-Vila, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	warap@mdanderson.org; rpasqual@mdanderson.org	Bom, Cristiane Dinis Ano/X-9461-2019; Rangel, Roberto/AHE-6583-2022; Almeida, Fabio/O-4989-2018; Valente, Ana Paula/J-3010-2017; Giordano, Ricardo/A-2074-2010	Rangel, Roberto/0000-0002-9088-7957; Almeida, Fabio/0000-0001-6046-7006; Valente, Ana Paula/0000-0001-7219-1123; Giordano, Ricardo/0000-0001-8116-6771; Kolonin, Mikhail/0000-0002-3743-7869	National Cancer Institute; U.S. Department of Defense; Prostate Cancer Foundation; Marcus Foundation; Gillson-Longenbaugh Foundation; Susan G. Komen Breast Cancer Foundation; Instituto de Salud Carlos III (Spain); Odyssey Program of The University of Texas M. D. Anderson Cancer Center; National Research Council (Brazil); Rio de Janeiro State Research Support Foundation; NATIONAL CANCER INSTITUTE [P50CA140388] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense(United States Department of Defense); Prostate Cancer Foundation; Marcus Foundation; Gillson-Longenbaugh Foundation; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); Odyssey Program of The University of Texas M. D. Anderson Cancer Center; National Research Council (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Research Support Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Specialized Program in Research Excellence (SPORE) of the National Cancer Institute (to WA and RP), from the U.S. Department of Defense (to MGK, WA, and RP), and by awards from the Prostate Cancer Foundation, the Marcus Foundation and the Gillson-Longenbaugh Foundation (to WA and RP). MCV received a postdoctoral fellowship from the Susan G. Komen Breast Cancer Foundation. AJZ received a postdoctoral fellowship from the Instituto de Salud Carlos III (Spain); RR is a Scholar from the Odyssey Program of The University of Texas M. D. Anderson Cancer Center. CDA received a predoctoral fellowship from the National Research Council (Brazil). FCLA and APV received support from the Rio de Janeiro State Research Support Foundation and the National Research Council (Brazil). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Barton VA, 1999, J BIOL CHEM, V274, P5755, DOI 10.1074/jbc.274.9.5755; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Boulanger MJ, 2004, J MOL BIOL, V335, P641, DOI 10.1016/j.jmb.2003.10.070; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Campbell CL, 2001, AM J PATHOL, V158, P25, DOI 10.1016/S0002-9440(10)63940-5; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Ciapponi L, 1995, J BIOL CHEM, V270, P31249, DOI 10.1074/jbc.270.52.31249; Cruzeiro-Silva C, 2007, BBA-BIOMEMBRANES, V1768, P3182, DOI 10.1016/j.bbamem.2007.08.022; Cwirla SE, 1997, SCIENCE, V276, P1696, DOI 10.1126/science.276.5319.1696; Czupryn M, 1995, ANN NY ACAD SCI, V762, P152; CZUPRYN MJ, 1995, J BIOL CHEM, V270, P978, DOI 10.1074/jbc.270.2.978; Dahmen H, 1998, BIOCHEM J, V331, P695, DOI 10.1042/bj3310695; Du XX, 1997, BLOOD, V89, P3897, DOI 10.1182/blood.V89.11.3897; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; FOURCIN M, 1994, EUR J IMMUNOL, V24, P277, DOI 10.1002/eji.1830240143; Giordano RJ, 2005, CHEM BIOL, V12, P1075, DOI 10.1016/j.chembiol.2005.07.008; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; Greiser JS, 2002, J BIOL CHEM, V277, P26959, DOI 10.1074/jbc.M204113200; Grotzinger J, 1999, BIOL CHEM, V380, P803, DOI 10.1515/BC.1999.100; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Harmegnies D, 2003, BIOCHEM J, V375, P23, DOI 10.1042/BJ20030459; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hermanns HM, 2005, NAT STRUCT MOL BIOL, V12, P476, DOI 10.1038/nsmb0605-476; Hudson KR, 1996, J BIOL CHEM, V271, P11971, DOI 10.1074/jbc.271.20.11971; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Koivunen E, 1999, NAT BIOTECHNOL, V17, P768, DOI 10.1038/11703; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kurth I, 1999, J IMMUNOL, V162, P1480; Lebeau B, 1997, FEBS LETT, V407, P141, DOI 10.1016/S0014-5793(97)00326-8; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; MCDONALD NQ, 1995, EMBO J, V14, P2689, DOI 10.1002/j.1460-2075.1995.tb07269.x; Muller-Newen G, 2000, J BIOL CHEM, V275, P4579, DOI 10.1074/jbc.275.7.4579; Muller-Newen Gerhard, 2003, Sci STKE, V2003, pPE40, DOI 10.1126/stke.2003.201.pe40; PANAYOTATOS N, 1995, J BIOL CHEM, V270, P14007, DOI 10.1074/jbc.270.23.14007; Pentz RD, 2005, NAT MED, V11, P1145, DOI 10.1038/nm1105-1145; Pentz RD, 2003, HASTINGS CENT REP, V33, P20, DOI 10.2307/3527910; Pillutla RC, 2002, J BIOL CHEM, V277, P22590, DOI 10.1074/jbc.M202119200; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pires JR, 2001, J MOL BIOL, V314, P1147, DOI 10.1006/jmbi.2000.5199; Schleinkofer K, 2001, J MOL BIOL, V306, P263, DOI 10.1006/jmbi.2000.4387; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; Schuster B, 2003, FEBS LETT, V538, P113, DOI 10.1016/S0014-5793(03)00154-6; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Tacken I, 1999, EUR J BIOCHEM, V265, P645, DOI 10.1046/j.1432-1327.1999.00755.x; Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147; Varghese JN, 2002, P NATL ACAD SCI USA, V99, P15959, DOI 10.1073/pnas.232432399; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	62	28	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3452	10.1371/journal.pone.0003452	http://dx.doi.org/10.1371/journal.pone.0003452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941632	gold, Green Published, Green Submitted			2022-12-27	WOS:000265125600011
J	Yang, PH; Wang, JW; Gong, GC; Sun, XZ; Zhang, R; Du, Z; Liu, Y; Li, R; Ding, FR; Tang, B; Dai, YP; Li, N				Yang, Penghua; Wang, Jianwu; Gong, Guochun; Sun, Xiuzhu; Zhang, Ran; Du, Zhuo; Liu, Ying; Li, Rong; Ding, Fangrong; Tang, Bo; Dai, Yunping; Li, Ning			Cattle Mammary Bioreactor Generated by a Novel Procedure of Transgenic Cloning for Large-Scale Production of Functional Human Lactoferrin	PLOS ONE			English	Article							RECOMBINANT HUMAN LACTOFERRIN; ESCHERICHIA-COLI; BOVINE LACTOFERRIN; HUMAN-MILK; IN-VITRO; EXPRESSION; IRON; MICE; COWS; CHROMATOGRAPHY	Large-scale production of biopharmaceuticals by current bioreactor techniques is limited by low transgenic efficiency and low expression of foreign proteins. In general, a bacterial artificial chromosome (BAC) harboring most regulatory elements is capable of overcoming the limitations, but transferring BAC into donor cells is difficult. We describe here the use of cattle mammary bioreactor to produce functional recombinant human lactoferrin (rhLF) by a novel procedure of transgenic cloning, which employs microinjection to generate transgenic somatic cells as donor cells. Bovine fibroblast cells were co-microinjected for the first time with a 150-kb BAC carrying the human lactoferrin gene and a marker gene. The resulting transfection efficiency of up to 15.79x10(-2) percent was notably higher than that of electroporation and lipofection. Following somatic cell nuclear transfer, we obtained two transgenic cows that secreted rhLF at high levels, 2.5 g/l and 3.4 g/l, respectively. The rhLF had a similar pattern of glycosylation and proteolytic susceptibility as the natural human counterpart. Biochemical analysis revealed that the iron-binding and releasing properties of rhLF were identical to that of native hLF. Importantly, an antibacterial experiment further demonstrated that rhLF was functional. Our results indicate that co-microinjection with a BAC and a marker gene into donor cells for somatic cell cloning indeed improves transgenic efficiency. Moreover, the cattle mammary bioreactors generated with this novel procedure produce functional rhLF on an industrial scale.	[Yang, Penghua; Wang, Jianwu; Gong, Guochun; Sun, Xiuzhu; Zhang, Ran; Du, Zhuo; Tang, Bo; Dai, Yunping; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Liu, Ying; Li, Rong; Ding, Fangrong; Tang, Bo] Beijing Genprotein Biotechnol Comp, Beijing, Peoples R China	China Agricultural University	Yang, PH (corresponding author), Yangtze Univ, Coll Life Sci, Jinzhou, Hubei, Peoples R China.	ninglbau@public3.bta.net.cn	Du, Zhuo/AAD-2263-2019; Liu, Ying/T-5064-2019	Du, Zhuo/0000-0002-6322-4656; 	State High-tech Research Development Program of China	State High-tech Research Development Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the State High-tech Research Development Program of China.	Baveye S, 1999, CLIN CHEM LAB MED, V37, P281, DOI 10.1515/CCLM.1999.049; BROCK JH, 1980, ARCH DIS CHILD, V55, P417, DOI 10.1136/adc.55.6.417; Brophy B, 2003, NAT BIOTECHNOL, V21, P157, DOI 10.1038/nbt783; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chong DKX, 2000, TRANSGENIC RES, V9, P71, DOI 10.1023/A:1008977630179; CRICHTON RR, 1987, EUR J BIOCHEM, V164, P485, DOI 10.1111/j.1432-1033.1987.tb11155.x; DAVIDSON LA, 1987, ACTA PAEDIATR SCAND, V76, P733, DOI 10.1111/j.1651-2227.1987.tb10557.x; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Eyestone WH, 1999, THERIOGENOLOGY, V51, P509, DOI 10.1016/S0093-691X(98)00244-1; FOLEY AA, 1987, ANAL BIOCHEM, V162, P296, DOI 10.1016/0003-2697(87)90040-6; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Gong GC, 2004, MOL REPROD DEV, V69, P278, DOI 10.1002/mrd.20130; Hejna JA, 1998, NUCLEIC ACIDS RES, V26, P1124, DOI 10.1093/nar/26.4.1124; Hyvonen P, 2006, INFECT IMMUN, V74, P6206, DOI 10.1128/IAI.00238-06; Isamida T, 1998, J VET MED SCI, V60, P241, DOI 10.1292/jvms.60.241; IYER S, 1993, EUR J CLIN NUTR, V47, P232; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; KRIMPENFORT P, 1991, BIO-TECHNOL, V9, P844, DOI 10.1038/nbt0991-844; LEGRAND D, 1995, FEBS LETT, V365, P57, DOI 10.1016/0014-5793(95)00441-B; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; LIANG QW, 1993, J AGR FOOD CHEM, V41, P1800, DOI 10.1021/jf00034a053; Liu ZL, 2004, ANIM BIOTECHNOL, V15, P21, DOI 10.1081/ABIO-120029810; Lonnerdal B, 2006, AM J CLIN NUTR, V83, P305; LONNERDAL B, 1995, ANNU REV NUTR, V15, P93, DOI 10.1146/annurev.nu.15.070195.000521; Lopez M, 1997, GLYCOBIOLOGY, V7, P635, DOI 10.1093/glycob/7.5.635; Magin-Lachmann C, 2004, J GENE MED, V6, P195, DOI 10.1002/jgm.481; Naot D, 2005, CLIN MED RES, V3, P93, DOI 10.3121/cmr.3.2.93; Nuijens JH, 1997, J BIOL CHEM, V272, P8802, DOI 10.1074/jbc.272.13.8802; Palmano KP, 2002, J CHROMATOGR A, V947, P307, DOI 10.1016/S0021-9673(01)01563-1; PETIT BS, 2003, EUR J BIOCHEM, V270, P3235; PLATENBURG GJ, 1994, TRANSGENIC RES, V3, P99, DOI 10.1007/BF01974087; ROSENKRANS C F JR, 1991, Theriogenology, V35, P266, DOI 10.1016/0093-691X(91)90242-6; Salmon V, 1998, PROTEIN EXPRES PURIF, V13, P127, DOI 10.1006/prep.1998.0886; SPIK G, 1982, EUR J BIOCHEM, V121, P413, DOI 10.1111/j.1432-1033.1982.tb05803.x; STOWELL KM, 1991, BIOCHEM J, V276, P349, DOI 10.1042/bj2760349; Takahashi S, 2004, CLONING STEM CELLS, V6, P165, DOI 10.1089/1536230041372265; Tian XC, 2005, P NATL ACAD SCI USA, V102, P6261, DOI 10.1073/pnas.0500140102; van Berkel PHC, 2002, NAT BIOTECHNOL, V20, P484, DOI 10.1038/nbt0502-484; van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4; van Veen HA, 2004, EUR J BIOCHEM, V271, P678, DOI 10.1111/j.1432-1033.2003.03965.x; van Veen HA, 2002, ANAL BIOCHEM, V309, P60, DOI 10.1016/S0003-2697(02)00273-7; VANBERKEL PHC, 1995, BIOCHEM J, V312, P107, DOI 10.1042/bj3120107; Vorland LH, 1999, APMIS, V107, P971, DOI 10.1111/j.1699-0463.1999.tb01499.x; Wakabayashi H, 2002, J MED MICROBIOL, V51, P844, DOI 10.1099/0022-1317-51-10-844; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wall RJ, 1999, LIVEST PROD SCI, V59, P243, DOI 10.1016/S0301-6226(99)00030-5; Walsh MK, 2003, CLONING STEM CELLS, V5, P213, DOI 10.1089/153623003769645875; WARD PP, 1992, GENE, V122, P219, DOI 10.1016/0378-1119(92)90054-S; WARD PP, 1995, BIO-TECHNOL, V13, P498, DOI 10.1038/nbt0595-498; Wee G, 2006, J BIOL CHEM, V281, P6048, DOI 10.1074/jbc.M511340200; XIE HX, 1983, CELL STRUCT FUNCT, V8, P315, DOI 10.1247/csf.8.315; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zhang XF, 2005, BIOCHEM BIOPH RES CO, V333, P58, DOI 10.1016/j.bbrc.2005.05.072; Zhao CJ, 2006, ANIM BIOTECHNOL, V17, P13, DOI 10.1080/10495390500460940; Zimecki M, 2004, INFLAMM RES, V53, P292, DOI 10.1007/s00011-004-1257-1	55	89	111	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3453	10.1371/journal.pone.0003453	http://dx.doi.org/10.1371/journal.pone.0003453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941633	Green Published, Green Submitted, gold			2022-12-27	WOS:000265125600012
J	Clarke, TF; Clark, PL				Clarke, Thomas F., IV; Clark, Patricia L.			Rare Codons Cluster	PLOS ONE			English	Article								Most amino acids are encoded by more than one codon. These synonymous codons are not used with equal frequency: in every organism, some codons are used more commonly, while others are more rare. Though the encoded protein sequence is identical, selective pressures favor more common codons for enhanced translation speed and fidelity. However, rare codons persist, presumably due to neutral drift. Here, we determine whether other, unknown factors, beyond neutral drift, affect the selection and/or distribution of rare codons. We have developed a novel algorithm that evaluates the relative rareness of a nucleotide sequence used to produce a given protein sequence. We show that rare codons, rather than being randomly scattered across genes, often occur in large clusters. These clusters occur in numerous eukaryotic and prokaryotic genomes, and are not confined to unusual or rarely expressed genes: many highly expressed genes, including genes for ribosomal proteins, contain rare codon clusters. A rare codon cluster can impede ribosome translation of the rare codon sequence. These results indicate additional selective pressures govern the use of synonymous codons, and specifically that local pauses in translation can be beneficial for protein biogenesis.	[Clarke, Thomas F., IV; Clark, Patricia L.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Clarke, TF (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	pclark1@nd.edu	Clark, Patricia/C-9850-2009	Clark, Patricia/0000-0001-5462-8248	NIH [GM74807]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074807] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by an award from the NIH (GM74807). The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Clark PL, 2001, J BIOL CHEM, V276, P25411, DOI 10.1074/jbc.M008490200; Cortazzo P, 2002, BIOCHEM BIOPH RES CO, V293, P537, DOI 10.1016/S0006-291X(02)00226-7; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Gu WJ, 2003, IEEE T NANOBIOSCI, V2, P150, DOI 10.1109/TNB.2003.817024; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Makhoul CH, 2002, J BIOMOL STRUCT DYN, V20, P413, DOI 10.1080/07391102.2002.10506859; MEDIGUE C, 1991, J MOL BIOL, V222, P851, DOI 10.1016/0022-2836(91)90575-Q; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Smith NGC, 2001, J MOL EVOL, V53, P225, DOI 10.1007/s002390010212; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Thanaraj TA, 1996, PROTEIN SCI, V5, P1973, DOI 10.1002/pro.5560051003; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; TSAI CJ, J MOL BIOL IN PRESS; VARENNE S, 1986, J THEOR BIOL, V120, P99, DOI 10.1016/S0022-5193(86)80020-0; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; VARENNE S, 1989, BIOCHIMIE, V71, P1221, DOI 10.1016/0300-9084(89)90027-8; Widmann M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-207	27	129	133	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3412	10.1371/journal.pone.0003412	http://dx.doi.org/10.1371/journal.pone.0003412			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923675	Green Published, gold, Green Submitted			2022-12-27	WOS:000265121800010
J	Goletti, D; Stefania, C; Butera, O; Amicosante, M; Ernst, M; Sauzullo, I; Vullo, V; Cirillo, D; Borroni, E; Markova, R; Drenska, R; Dominguez, J; Latorre, I; Angeletti, C; Navarra, A; Petrosillo, N; Lauria, FN; Ippolito, G; Migliori, GB; Lange, C; Girardi, E				Goletti, Delia; Stefania, Carrara; Butera, Ornella; Amicosante, Massimo; Ernst, Martin; Sauzullo, Ilaria; Vullo, Vincenzo; Cirillo, Daniela; Borroni, Emanuele; Markova, Roumiana; Drenska, Roumiana; Dominguez, Jose; Latorre, Irene; Angeletti, Claudio; Navarra, Assunta; Petrosillo, Nicola; Lauria, Francesco Nicola; Ippolito, Giuseppe; Migliori, Giovanni Battista; Lange, Christoph; Girardi, Enrico			Accuracy of Immunodiagnostic Tests for Active Tuberculosis Using Single and Combined Results: A Multicenter TBNET-Study	PLOS ONE			English	Article							CELL-BASED ASSAY; MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; BLOOD-TESTS; T-CELLS; INFECTION; DIAGNOSIS; ANTIGEN; GAMMA; METAANALYSIS	Background: The clinical application of IFN-gamma release assays (IGRAs) has recently improved the diagnosis of latent tuberculosis infection. In a multicenter study of the Tuberculosis Network European Trialsgroup (TBNET) we aimed to ascertain in routine clinical practice the accuracy of a novel assay using selected peptides encoded in the mycobacterial genomic region of difference (RD) 1 for the diagnosis of active tuberculosis in comparison with tuberculin skin test (TST), QuantiFERON-TB GOLD In-Tube (Cellestis Ltd., Carnegie, Australia) and T-SPOT. TB (Oxfordimmunotec, Abingdon, UK). Principal Findings: 425 individuals from 6 different European centres were prospectively enrolled. We found that sensitivity of the novel test, TST, QuantiFERON-TB GOLD In-Tube and T-SPOT. TB was respectively 73.1%, 85.3%, 78.1%, and 85.2%; specificity was respectively 70.6%, 48.0%, 61.9% and 44.3%; positive likelihood ratios were respectively 2.48, 1.64, 2.05, and 1.53; negative likelihood ratios were respectively 0.38, 0.31, 0.35, 0.33. Sensitivity of TST combined with the novel test, QuantiFERON-TB GOLD In-Tube and T-SPOT. TB increased up to 92.4%, 97.7% and 97.1%, respectively. The likelihood ratios of combined negative results of TST with, respectively, the novel test, QuantiFERON-TB GOLD In-Tube and T-SPOT. TB were 0.19, 0.07 and 0.10. Conclusions: The assay based on RD1 selected peptides has similar accuracy for active tuberculosis compared with TST and commercial IGRAs. Then, independently of the spectrum of antigens used in the assays to elicit mycobacterial specific immune responses, the novel test, IGRAs, and the TST do not allow an accurate identification of active tuberculosis in clinical practice. However, the combined use of the novel assay or commercial IGRAs with TST may allow exclusion of tuberculosis.	[Goletti, Delia; Stefania, Carrara; Butera, Ornella] IRCCS, Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy; [Amicosante, Massimo] Univ Tor Vergata, Dept Internal Med, Rome, Italy; [Ernst, Martin; Lange, Christoph] Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany; [Sauzullo, Ilaria; Vullo, Vincenzo] Univ Roma La Sapienza, Infect & Trop Dis Dept, Rome, Italy; [Cirillo, Daniela; Borroni, Emanuele] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, Milan, Italy; [Markova, Roumiana; Drenska, Roumiana] Natl Ctr Infect & Parassit Dis, Dept Immunol & Allergol, Sofia, Bulgaria; [Dominguez, Jose; Latorre, Irene] Univ Autonoma Barcelona, CIBER Enfermedades Respirat, Fdn Inst Invest Ciencies Salut Germans Trias Pujol, Barcelona, Spain; [Angeletti, Claudio; Navarra, Assunta; Lauria, Francesco Nicola; Ippolito, Giuseppe; Girardi, Enrico] INMI L Spallanzani, Dept Epidemiol & Preclin Res, Rome, Italy; [Petrosillo, Nicola] INMI L Spallanzani, Clin Dept, Rome, Italy; [Migliori, Giovanni Battista] IRCCS, S Maugeri Fdn, WHO Collaborat Ctr Tuberculosis & Lung Dis, Tradate, Italy	University of Rome Tor Vergata; Forschungszentrum Borstel; Sapienza University Rome; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; Istituti Clinici Scientifici Maugeri IRCCS	Goletti, D (corresponding author), IRCCS, Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy.	d.goletti@tiscali.it	Petrosillo, Nicola/AAZ-2095-2021; Lange, Christoph/J-6289-2012; Ippolito, Giuseppe/J-7207-2017; Latorre, Irene/H-8814-2017; Migliori, Giovanni Battista/AAB-8589-2020; Cirillo, Daniela Maria/AAB-3646-2019; goletti, delia/AAM-6577-2020; Borroni, Emanuele/K-5179-2016	Lange, Christoph/0000-0002-9691-4741; Latorre, Irene/0000-0001-8159-2455; Migliori, Giovanni Battista/0000-0002-2597-574X; Cirillo, Daniela Maria/0000-0001-6415-1535; Goletti, Delia/0000-0001-8360-4376; Dominguez, Jose/0000-0001-7888-0309; Girardi, Enrico/0000-0001-8182-5896; Ippolito, Giuseppe/0000-0002-1076-2979; Borroni, Emanuele/0000-0001-6780-5119; NAVARRA, ASSUNTA/0000-0002-3662-4312; Amicosante, Massimo/0000-0002-2372-3311; petrosillo, nicola/0000-0002-2585-7567; Sauzullo, Ilaria/0000-0002-0060-0749	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	The paper was supported by grants from the Italian Ministry of Health (Progetto di Ricerca I.S.S. n. 06.76 and Ricerca Corrente INMI).	Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Dominguez J, 2008, CLIN VACCINE IMMUNOL, V15, P168, DOI 10.1128/CVI.00364-07; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Goletti D, 2005, CLIN DIAGN LAB IMMUN, V12, P1311, DOI 10.1128/CDLI.12.11.1311-1316.2005; Goletti D, 2006, CLIN MICROBIOL INFEC, V12, P544, DOI 10.1111/j.1469-0691.2006.01391.x; Goletti D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-5; Goletti D, 2006, J INFECT DIS, V194, P984, DOI 10.1086/507427; Jafari C, 2008, EUR RESPIR J, V31, P261, DOI 10.1183/09031936.00096707; Jafari C, 2006, AM J RESP CRIT CARE, V174, P1048, DOI 10.1164/rccm.200604-465OC; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; MIGLIORI GB, 1994, EUR RESPIR J, V7, P946; Ormerod P, 2000, THORAX, V55, P887; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; PAI M, 2008, ANN INTERN MED, V5, P149; Piana F, 2006, EUR RESPIR J, V28, P31, DOI 10.1183/09031936.06.00110205; PICKER LJ, 1993, J IMMUNOL, V150, P1122; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; Scarpellini P, 2004, J CLIN MICROBIOL, V42, P3469, DOI 10.1128/JCM.42.8.3469-3474.2004; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Streitz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000735; TENDAM HG, 1985, WHOTB85145, P1; Vincenti D, 2003, MOL MED, V9, P105, DOI 10.1007/BF03402042; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; Wilkinson KA, 2005, CLIN INFECT DIS, V40, P184, DOI 10.1086/426139	34	83	89	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3417	10.1371/journal.pone.0003417	http://dx.doi.org/10.1371/journal.pone.0003417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923709	gold, Green Published, Green Submitted			2022-12-27	WOS:000265121800014
J	Lewinsohn, DA; Zalwango, S; Stein, CM; Mayanja-Kizza, H; Okwera, A; Boom, WH; Mugerwa, RD; Whalen, CC				Lewinsohn, Deborah A.; Zalwango, Sarah; Stein, Catherine M.; Mayanja-Kizza, Harriet; Okwera, Alphonse; Boom, W. Henry; Mugerwa, Roy D.; Whalen, Christopher C.			Whole Blood Interferon-Gamma Responses to Mycobacterium tuberculosis Antigens in Young Household Contacts of Persons with Tuberculosis in Uganda	PLOS ONE			English	Article								Background: Due to immunologic immaturity, IFN-gamma-producing T cell responses may be decreased in young children compared to adults, thus we hypothesized that IFN-gamma responses to mycobacterial antigens in household contacts exposed to Mycobacterium tuberculosis (Mtb) would be impaired in young children relative to adults. The objective of this study was to compare whole blood IFN-gamma production in response to mycobacterial antigens between children and adults in Uganda. Methodology/Principal Findings: We studied household contacts of persons with culture-positive pulmonary tuberculosis (TB) enrolled in a cohort study conducted in Kampala, Uganda. Whole blood IFN-gamma production in response to Mtb culture-filtrate antigens was measured by ELISA and compared between infants (<2 years old, n = 80), young children (2 < 5 years old, n = 216), older children (5 < 15 years old, n = 443) and adults (>= 15 years old, n = 528). We evaluated the relationship between IFN-gamma responses and the tuberculin skin test (TST), and between IFN-gamma responses and epidemiologic factors that reflect exposure to Mtb, and the effect of prior BCG vaccination on IFN-gamma responses. Young household contacts demonstrated robust IFN-gamma responses comparable to those of adults that were associated with TST and known risk factors for infection. There was no effect of prior BCG immunization on the IFN-gamma response. Conclusions/Significance: Young children in a TB endemic setting can mount robust IFN-gamma responses generally comparable to those of adults, and as in adults, these responses correlated with the TST and known epidemiologic risk factors for Mtb infection.	[Lewinsohn, Deborah A.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Zalwango, Sarah; Mayanja-Kizza, Harriet; Okwera, Alphonse; Mugerwa, Roy D.] Uganda CWRU, Res Collaborat, Kampala, Uganda; [Whalen, Christopher C.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Stein, Catherine M.; Boom, W. Henry; Whalen, Christopher C.] Case Western Reserve Univ, Sch Med, TB Res Unit, Cleveland, OH 44106 USA; [Stein, Catherine M.; Mayanja-Kizza, Harriet; Mugerwa, Roy D.] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda; [Okwera, Alphonse] Mulago Hosp, Kampala, Uganda; [Okwera, Alphonse] Natl TB & Leprosy Program, Kampala, Uganda; [Boom, W. Henry] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Boom, W. Henry] Univ Hosp Case Med Ctr, Cleveland, OH USA	Oregon Health & Science University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Makerere University; Mulago National Referral Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital	Lewinsohn, DA (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.	lewinsde@ohsu.edu	Stein, Catherine/P-9498-2019; Mayanja-Kizza, Harriet/AAM-5372-2020	Stein, Catherine/0000-0002-9763-5023; Mayanja-Kizza, Harriet/0000-0002-9297-6208	Tuberculosis Research Unit (TBRU); United States National Institutes of Allergy and Infectious Diseases [NO1-AI-45244, AI-95383]; United States National Institutes of Health and Human Services [HHSN266200700022C, NO1-AI-70022]; National Center for Research Resources [RR03655]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095383, N01AI045244] Funding Source: NIH RePORTER	Tuberculosis Research Unit (TBRU); United States National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States National Institutes of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole by the Tuberculosis Research Unit (TBRU), established with Federal funds from the United States National Institutes of Allergy and Infectious Diseases & the United States National Institutes of Health and Human Services, under Contract Nos. NO1-AI-45244/AI-95383 and HHSN266200700022C / NO1-AI-70022. Some of the results of this paper were obtained by using the program package S.A.G.E., which is supported by a U.S. Public Health Service Resource Grant (RR03655) from the National Center for Research Resources. Funders had no role in study design, data collection and analysis, and interpretation of data; writing of the paper; and decision to submit it for publication.	Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007; Dominguez J, 2008, CLIN VACCINE IMMUNOL, V15, P168, DOI 10.1128/CVI.00364-07; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Kampmann B, 2006, LANCET, V368, P282, DOI 10.1016/S0140-6736(06)69064-8; Lewinsohn DA, 2004, INT J TUBERC LUNG D, V8, P658; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Mudido PM, 1999, INT J TUBERC LUNG D, V3, P891; Nakaoka H, 2006, EMERG INFECT DIS, V12, P1383, DOI 10.3201/eid1209.051606; Nelson Lisa J, 2004, Semin Pediatr Infect Dis, V15, P150, DOI 10.1053/j.spid.2004.05.007; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Okada K, 2008, EPIDEMIOL INFECT, V136, P1179, DOI 10.1017/S0950268807009831; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Tsiouris SJ, 2006, INT J TUBERC LUNG D, V10, P939; Whalen CC, 2006, AM J TROP MED HYG, V75, P55, DOI 10.4269/ajtmh.2006.75.55; 2007, SAGE 5 4 STAT ANAL G	21	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3407	10.1371/journal.pone.0003407	http://dx.doi.org/10.1371/journal.pone.0003407			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923705	Green Published, Green Submitted, gold			2022-12-27	WOS:000265121800006
J	Wu, ST; Zhang, Y				Wu, Sitao; Zhang, Yang			ANGLOR: A Composite Machine-Learning Algorithm for Protein Backbone Torsion Angle Prediction	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; SUPPORT VECTOR MACHINES; PATTERN-RECOGNITION; LOCAL-STRUCTURE; SEQUENCE; RESTRAINTS; DYNAMICS; SERVER	We developed a composite machine-learning based algorithm, called ANGLOR, to predict real-value protein backbone torsion angles from amino acid sequences. The input features of ANGLOR include sequence profiles, predicted secondary structure and solvent accessibility. In a large-scale benchmarking test, the mean absolute error (MAE) of the phi/psi prediction is 28 degrees/46 degrees, which is similar to 10% lower than that generated by software in literature. The prediction is statistically different from a random predictor (or a purely secondary-structure-based predictor) with p-value <1.0X10(-300) (or <1.0X10(-148)) by Wilcoxon signed rank test. For some residues (ILE, LEU, PRO and VAL) and especially the residues in helix and buried regions, the MAE of phi angles is much smaller (10-20 degrees) than that in other environments. Thus, although the average accuracy of the ANGLOR prediction is still low, the portion of the accurately predicted dihedral angles may be useful in assisting protein fold recognition and ab initio 3D structure modeling.	[Wu, Sitao; Zhang, Yang] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Wu, ST (corresponding author), Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA.	yzhang@ku.edu	Wu, Sitao/E-8098-2011; YZ, YZ/B-3243-2011		Alfred P. Sloan Foundation; NSF Career Award [0746198]; NIH [GM-083107]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083107] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NSF Career Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project is supported in part by the Alfred P. Sloan Foundation, NSF Career Award 0746198, and NIH grant GM-083107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Branden C., 1999, INTRO PROTEIN STRUCT; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Bystroff C, 2000, J MOL BIOL, V301, P173, DOI 10.1006/jmbi.2000.3837; Chang C.-C., LIBSVM LIB SUPPORT V; Chen HL, 2005, NUCLEIC ACIDS RES, V33, P3193, DOI 10.1093/nar/gki633; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; de Brevern Alexandre G, 2004, In Silico Biol, V4, P381; Dor O, 2007, PROTEINS, V68, P76, DOI 10.1002/prot.21408; Fitzkee NC, 2004, PROTEIN SCI, V13, P633, DOI 10.1110/ps.03503304; Haykin S., 1999, NEURAL NEWORKS COMPR; HOBOHM U, 1994, PROTEIN SCI, V3, P522; Huang YM, 2006, BIOINFORMATICS, V22, P413, DOI 10.1093/bioinformatics/bti828; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karchin R, 2003, PROTEINS, V51, P504, DOI 10.1002/prot.10369; Kuang R, 2004, BIOINFORMATICS, V20, P1612, DOI 10.1093/bioinformatics/bth136; Mooney C, 2006, J COMPUT BIOL, V13, P1489, DOI 10.1089/cmb.2006.13.1489; Neal S, 2006, MAGN RESON CHEM, V44, pS158, DOI 10.1002/mrc.1832; Nissen S., FAST ARTIFICIAL NEUR; Vapnik V., 2013, NATURE STAT LAERNING; Wood MJ, 2005, PROTEINS, V59, P476, DOI 10.1002/prot.20435; WU S, PROTEINS; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Zaman MH, 2003, J MOL BIOL, V331, P693, DOI 10.1016/S0022-2836(03)00765-4; Zhang C, 2002, P NATL ACAD SCI USA, V99, P3581, DOI 10.1073/pnas.052003799; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/j.sbi.2008.02.004; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zimmermann O, 2006, BIOINFORMATICS, V22, P3009, DOI 10.1093/bioinformatics/btl489	32	62	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3400	10.1371/journal.pone.0003400	http://dx.doi.org/10.1371/journal.pone.0003400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923703	Green Submitted, Green Published, gold			2022-12-27	WOS:000265121800002
J	Zhang, F; Wang, YP; Deng, HW				Zhang, Feng; Wang, Yuping; Deng, Hong-Wen			Comparison of Population-Based Association Study Methods Correcting for Population Stratification	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC ASSOCIATION; LINKAGE DISEQUILIBRIUM; ALLELIC ASSOCIATION; TRAITS; FAMILY; TESTS	Population stratification can cause spurious associations in population-based association studies. Several statistical methods have been proposed to reduce the impact of population stratification on population-based association studies. We simulated a set of stratified populations based on the real haplotype data from the HapMap ENCODE project, and compared the relative power, type I error rates, accuracy and positive prediction value of four prevailing population-based association study methods: traditional case-control tests, structured association (SA), genomic control (GC) and principal components analysis (PCA) under various population stratification levels. Additionally, we evaluated the effects of sample sizes and frequencies of disease susceptible allele on the performance of the four analytical methods in the presence of population stratification. We found that the performance of PCA was very stable under various scenarios. Our comparison results suggest that SA and PCA have comparable performance, if sufficient ancestral informative markers are used in SA analysis. GC appeared to be strongly conservative in significantly stratified populations. It may be better to apply GC in the stratified populations with low stratification level. Our study intends to provide a practical guideline for researchers to select proper study methods and make appropriate inference of the results in population-based association studies.			Zhang, F (corresponding author), Xi An Jiao Tong Univ, Inst Mol Genet, Sch Life Sci & Technol, Xian 710049, Shaanxi, Peoples R China.	hwdeng@mail.xjtu.edn.cn		Deng, Hong-Wen/0000-0002-0387-8818	Xi'an Jiaotong University; Ministry of Education of China, NIH [R01 AR050496, R21 AG 027110, R01 AG026564, P50 AR055081]; National Science Foundation of China; Huo Ying Dong Education Foundation; HuNan Province; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER	Xi'an Jiaotong University(Xi'an Jiaotong University); Ministry of Education of China, NIH; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huo Ying Dong Education Foundation; HuNan Province; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was partially supported by Xi'an Jiaotong University. The investigators of this work were also benefited from grants from the Ministry of Education of China, NIH (R01 AR050496, R21 AG 027110, R01 AG026564 and P50 AR055081), National Science Foundation of China, Huo Ying Dong Education Foundation and HuNan Province.	Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Deng HW, 2001, GENETICS, V159, P1319; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Epstein MP, 2007, AM J HUM GENET, V80, P921, DOI 10.1086/516842; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Kohler K, 2006, ANN HUM GENET, V70, P98, DOI 10.1111/j.1529-8817.2005.00214.x; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; LONG JC, 1991, GENETICS, V127, P417; Luo XG, 2007, HUM MOL GENET, V16, P380, DOI 10.1093/hmg/ddl460; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; Pharoah PDP, 2007, PLOS GENET, V3, P401, DOI 10.1371/journal.pgen.0030042; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; RISCH N, 1996, SCIENCE, V273, P1517; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; The International HapMap Consortium, 2005, NATURE, V437, P1299, DOI DOI 10.1038/NATURE04226; Wawro N, 2006, BIOMETRICAL J, V48, P420, DOI 10.1002/bimj.200410214	25	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3392	10.1371/journal.pone.0003392	http://dx.doi.org/10.1371/journal.pone.0003392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852890	Green Published, gold, Green Submitted			2022-12-27	WOS:000265121700001
J	Kitazoe, Y; Kishino, H; Hasegawa, M; Nakajima, N; Thorne, JL; Tanaka, M				Kitazoe, Yasuhiro; Kishino, Hirohisa; Hasegawa, Masami; Nakajima, Noriaki; Thorne, Jeffrey L.; Tanaka, Masashi			Adaptive Threonine Increase in Transmembrane Regions of Mitochondrial Proteins in Higher Primates	PLOS ONE			English	Article								Background: The mitochondrial (mt) gene tree of placental mammals reveals a very strong acceleration of the amino acid (AA) replacement rate and a change in AA compositional bias in the lineage leading to the higher primates (simians), in contrast to the nuclear gene tree. Whether this acceleration and compositional bias were caused by adaptive evolution at the AA level or directional mutation pressure at the DNA level has been vigorously debated. Methodology/Principal Findings: Our phylogenetic analysis indicates that the rate acceleration in the simian lineage is accompanied by a marked increase in threonine (Thr) residues in the transmembrane helix regions of mt DNA-encoded proteins. This Thr increase involved the replacement of hydrophobic AAs in the membrane interior. Even after accounting for lack of independence due to phylogeny, a regression analysis reveals a statistical significant positive correlation between Thr composition and longevity in primates. Conclusion/Significance: Because crucial roles of Thr and Ser in membrane proteins have been proposed to be the formation of hydrogen bonds enhancing helix-helix interactions, the Thr increase detected in the higher primates might be adaptive by serving to reinforce stability of mt proteins in the inner membrane. The correlation between Thr composition in the membrane interior and the longevity of animals is striking, especially because some mt functions are thought to be involved in aging.	[Kitazoe, Yasuhiro; Nakajima, Noriaki] Kochi Med Sch, Ctr Med Informat Sci, Kochi, Japan; [Kishino, Hirohisa] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Hasegawa, Masami] Fudan Univ, Sch Life Sci, Shanghai, Peoples R China; [Thorne, Jeffrey L.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC USA; [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longevity & Hlth, Tokyo, Japan	Kochi University; University of Tokyo; Fudan University; University of North Carolina; North Carolina State University; Tokyo Metropolitan Institute of Gerontology	Kitazoe, Y (corresponding author), Kochi Med Sch, Ctr Med Informat Sci, Kochi, Japan.	kitazoey@kochi-u.ac.jp	Kishino, Hirohisa/U-9311-2019		Japan Society for the Promotion of Science (JSPS) [B-19300094]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [A-15200051]; Third-Term Comprehensive 10-year Strategy for Cancer Control; Program Research Grants for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare of Japan [17A-10]; Takeda Science Foundation [I-2007]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Third-Term Comprehensive 10-year Strategy for Cancer Control(Ministry of Health, Labour and Welfare, Japan); Program Research Grants for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare of Japan; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by a Grant-in-Aid for Scientific Research (B-19300094) from the Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Scientific Research (A-15200051 to M.T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a grant from the Third-Term Comprehensive 10-year Strategy for Cancer Control (to M.T.), grant 17A-10 from the Program Research Grants for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare of Japan (to M.T.), and a grant from the Takeda Science Foundation (I-2007 to M.T.).	Adamian L, 2002, PROTEINS, V47, P209, DOI 10.1002/prot.10071; Adkins RM, 1996, MOL BIOL EVOL, V13, P1393, DOI 10.1093/oxfordjournals.molbev.a025586; Andrews TD, 1998, J MOL EVOL, V47, P249, DOI 10.1007/PL00006382; Bilal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002421; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; COOPER GM, 2006, CELL MOL APPROACH, P433; COWAN R, 1990, Peptide Research, V3, P75; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; de Magalhaes JP, 2005, NUCLEIC ACIDS RES, V33, pD537, DOI 10.1093/nar/gki017; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Gibson A, 2005, MOL BIOL EVOL, V22, P251, DOI 10.1093/molbev/msi012; Goldberg A, 2003, P NATL ACAD SCI USA, V100, P5873, DOI 10.1073/pnas.0931463100; Grossman LI, 2001, MOL PHYLOGENET EVOL, V18, P26, DOI 10.1006/mpev.2000.0890; Hasegawa M, 2003, GENES GENET SYST, V78, P267, DOI 10.1266/ggs.78.267; Hildebrand PW, 2008, BIOPHYS J, V94, P1945, DOI 10.1529/biophysj.107.110395; Kitazoe Y, 2005, MOL BIOL EVOL, V22, P704, DOI 10.1093/molbev/msi051; Kitazoe Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000384; Lehmann G, 2008, REJUV RES, V11, P409, DOI 10.1089/rej.2008.0676; Moosmann B, 2008, AGING CELL, V7, P32, DOI 10.1111/j.1474-9726.2007.00349.x; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Okabayashi T, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-41; PERNA NT, 1995, MOL BIOL EVOL, V12, P359; Pham NA, 2004, MICROSC MICROANAL, V10, P247, DOI 10.1017/S143192760404005X; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; ROHFL FJ, 2001, EVOLUTION, V55, P2143; Schmitz J, 2002, MOL BIOL EVOL, V19, P544, DOI 10.1093/oxfordjournals.molbev.a004110; SPEAKMAN JR, 2008, J EXP BIO, V208, P1717; SUEOKA N, 1992, J MOL EVOL, V34, P95, DOI 10.1007/BF00182387; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Wu W, 1997, J MOL EVOL, V44, P477, DOI 10.1007/PL00006172; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; SOSUI WWW SERVER CLA; TMHMM SERVER V 2 0 P	34	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3343	10.1371/journal.pone.0003343	http://dx.doi.org/10.1371/journal.pone.0003343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836526	Green Published, Green Submitted, gold			2022-12-27	WOS:000265113500007
J	Dermody, JL; Dreyfuss, JM; Villen, J; Ogundipe, B; Gygi, SP; Park, PJ; Ponticelli, AS; Moore, CL; Buratowski, S; Bucheli, ME				Dermody, Jessica L.; Dreyfuss, Jonathan M.; Villen, Judit; Ogundipe, Babatunde; Gygi, Steven P.; Park, Peter J.; Ponticelli, Alfred S.; Moore, Claire L.; Buratowski, Stephen; Bucheli, Miriam E.			Unphosphorylated SR-Like Protein Npl3 Stimulates RNA Polymerase II Elongation	PLOS ONE			English	Article								The production of a functional mRNA is regulated at every step of transcription. An area not well-understood is the transition of RNA polymerase II from elongation to termination. The S. cerevisiae SR-like protein Npl3 functions to negatively regulate transcription termination by antagonizing the binding of polyA/termination proteins to the mRNA. In this study, Npl3 is shown to interact with the CTD and have a direct stimulatory effect on the elongation activity of the polymerase. The interaction is inhibited by phosphorylation of Npl3. In addition, Casein Kinase 2 was found to be required for the phosphorylation of Npl3 and affect its ability to compete against Rna15 (Cleavage Factor I) for binding to polyA signals. Our results suggest that phosphorylation of Npl3 promotes its dissociation from the mRNA/RNAP II, and contributes to the association of the polyA/termination factor Rna15. This work defines a novel role for Npl3 in elongation and its regulation by phosphorylation.	[Dermody, Jessica L.; Buratowski, Stephen; Bucheli, Miriam E.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ogundipe, Babatunde; Moore, Claire L.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Medford, MA 02155 USA; [Villen, Judit; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Cambridge, MA 02138 USA; [Ponticelli, Alfred S.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY USA; [Dreyfuss, Jonathan M.; Park, Peter J.] Harvard Partners Ctr Genet & Genom, Boston, MA USA	Harvard University; Harvard Medical School; Tufts University; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Harvard University	Dermody, JL (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	Miriam_Bucheli@hms.harvard.edu		Dreyfuss, Jonathan/0000-0001-7242-3991; Bucheli, Miriam/0000-0002-3757-8522; Park, Peter/0000-0001-9378-960X; Villen, Judit/0000-0002-1005-1739	NIH [1K01CA115515-01A1, GM51124, GM46498, GM56663, GM68887];  [5F31GM075383-03]; NATIONAL CANCER INSTITUTE [K01CA115515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046498, F31GM075383, R01GM051124, R29GM046498, R01GM056663, R01GM068887, R29GM051124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants 1K01CA115515-01A1 to M.B., GM51124 to A.S.P., GM46498 and GM56663 to S.B., GM68887 to C.M., and fellowship 5F31GM075383-03 to J.D.	*AFF, 2005, GENECHIP WHOL TRANSC; Aranda A, 2001, MOL CELL, V7, P1003, DOI 10.1016/S1097-2765(01)00235-0; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; BUCHELI M, 2007, POLYADENYLATION SITE; Bucheli ME, 2005, EMBO J, V24, P2150, DOI 10.1038/sj.emboj.7600687; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Calvo O, 2005, EMBO J, V24, P1009, DOI 10.1038/sj.emboj.7600575; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; Deka P, 2008, J MOL BIOL, V375, P136, DOI 10.1016/j.jmb.2007.09.029; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; FLACH J, 1994, MOL CELL BIOL, V14, P8399, DOI 10.1128/MCB.14.12.8399; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Gilbert W, 2001, RNA, V7, P302, DOI 10.1017/S1355838201002369; Grossman MJ, 2001, GEOMORPHOLOGY, V39, P21, DOI 10.1016/S0169-555X(01)00049-6; He XY, 2005, MOL CELL, V19, P619, DOI 10.1016/j.molcel.2005.07.016; Hirose Y, 2000, GENE DEV, V14, P1415; Huang CJ, 2007, FEBS LETT, V581, P223, DOI 10.1016/j.febslet.2006.12.015; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; Kaneko S, 2005, MOL CELL, V20, P91, DOI 10.1016/j.molcel.2005.08.033; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LUND MK, 2008, MOL CELL BIOL; McBride AE, 2005, J BIOL CHEM, V280, P30888, DOI 10.1074/jbc.M505831200; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Rosonina E, 2006, GENE DEV, V20, P1050, DOI 10.1101/gad.1431606; Ryan K, 2007, RNA BIOL, V4, P26, DOI 10.4161/rna.4.1.4365; Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200; Sarno S, 1997, BIOCHEMISTRY-US, V36, P11717, DOI 10.1021/bi9705772; Sawa C, 2004, MOL CELL BIOL, V24, P4734, DOI 10.1128/MCB.24.11.4734-4742.2004; Shankar S, 2007, MOL CELL, V27, P914, DOI 10.1016/j.molcel.2007.07.025; Shen HH, 2006, GENE DEV, V20, P1755, DOI 10.1101/gad.1422106; Shen HH, 2004, MOL CELL, V16, P363, DOI 10.1016/j.molcel.2004.10.021; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Tacke R, 1997, P NATL ACAD SCI USA, V94, P1148, DOI 10.1073/pnas.94.4.1148; *TEAM RDC, 2007, LANG ENV STAT COMP; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Velazquez-Dones A, 2005, J BIOL CHEM, V280, P41761, DOI 10.1074/jbc.M504156200; WONG CM, 2007, MOL CELL BIOL; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao J, 1999, MOL CELL BIOL, V19, P7733; Ziegler LM, 2003, J BIOL CHEM, V278, P48950, DOI 10.1074/jbc.M309656200; Zielinski R, 2006, MOL CELL BIOCHEM, V286, P191, DOI 10.1007/s11010-005-9104-4	60	51	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3273	10.1371/journal.pone.0003273	http://dx.doi.org/10.1371/journal.pone.0003273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818768	Green Submitted, Green Published, gold			2022-12-27	WOS:000264432300001
J	Qin, J; Tsai, MJ; Tsai, SY				Qin, Jun; Tsai, Ming-Jer; Tsai, Sophia Y.			Essential Roles of COUP-TFII in Leydig Cell Differentiation and Male Fertility	PLOS ONE			English	Article								Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII; also known as NR2F2), is an orphan nuclear receptor of the steroid/thyroid hormone receptor superfamily. COUP-TFII-null mice die during the early embryonic development due to angiogenesis and cardiovascular defects. To circumvent the early embryonic lethality and investigate the physiological function of COUP-TFII, we knocked out COUP-TFII gene in a time-specific manner by using a tamoxifen inducible Cre recombinase. The ablation of COUP-TFII during pre-pubertal stages of male development results in infertility, hypogonadism and spermatogenetic arrest. Homozygous adult male mutants are defective in testosterone synthesis, and administration of testosterone could largely rescue the mutant defects. Notably, the rescued results also provide the evidence that the major function of adult Leydig cell is to synthesize testosterone. Further phenotypic analysis reveals that Leydig cell differentiation is arrested at the progenitor cell stage in the testes of null mice. The failure of testosterone to resumption of Leydig cell maturation in the null mice indicates that COUP-TFII itself is essential for this process. In addition, we identify that COUP-TFII plays roles in progenitor Leydig cell formation and early testis organogenesis, as demonstrated by the ablation of COUP-TFII at E18.5. On the other hand, when COUP-TFII is deleted in the adult stage after Leydig cells are well differentiated, there are no obvious defects in reproduction and Leydig cell function. Taken together, these results indicate that COUP-TFII plays a major role in differentiation, but not the maintenance of Leydig cells.	[Qin, Jun; Tsai, Ming-Jer; Tsai, Sophia Y.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Tsai, Ming-Jer; Tsai, Sophia Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Qin, J (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	mtsai@bcm.tmc.edu; stsai@bcm.tmc.edu	Qin, Jun/A-1148-2010	Qin, Jun/0000-0002-2263-128X	NIH [DK45641, HD17379, HL076448, P01DK59820]; National Institute of Child Health and Human Development [U54-HD28934]; University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017379, R37HD017379] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045641, R37DK045641, P01DK059820] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK45641 and HD17379 (MJT), HL076448 (SYT) and P01DK59820 (SYT and MJT). Ligand assay was supported by National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction Research) grant U54-HD28934 to the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core.	Akingbemi BT, 2003, ENDOCRINOLOGY, V144, P84, DOI 10.1210/en.2002-220292; Ariyaratne HBS, 2000, BIOL REPROD, V63, P1115, DOI 10.1095/biolreprod63.4.1115; Ge RS, 2006, P NATL ACAD SCI USA, V103, P2719, DOI 10.1073/pnas.0507692103; Gnessi L, 2000, J CELL BIOL, V149, P1019, DOI 10.1083/jcb.149.5.1019; Habert R, 2001, MOL CELL ENDOCRINOL, V179, P47, DOI 10.1016/S0303-7207(01)00461-0; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; HARDY MP, 1990, ENDOCRINOLOGY, V127, P488, DOI 10.1210/endo-127-1-488; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hirashima M, 2006, ENDOTHELIUM-J ENDOTH, V13, P137, DOI 10.1080/10623320600698078; Holdcraft RW, 2004, INT J ANDROL, V27, P335, DOI 10.1111/j.1365-2605.2004.00502.x; Kurihara I, 2007, PLOS GENET, V3, P1053, DOI 10.1371/journal.pgen.0030102; Lee CT, 2004, MOL CELL BIOL, V24, P10835, DOI 10.1128/MCB.24.24.10835-10843.2004; Lei ZM, 2001, MOL ENDOCRINOL, V15, P184, DOI 10.1210/me.15.1.184; Lui WY, 2003, BIOL REPROD, V68, P1087, DOI 10.1095/biolreprod.102.010371; Lundwall A, 1997, EUR J BIOCHEM, V249, P39, DOI 10.1111/j.1432-1033.1997.t01-2-00039.x; Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101; Mann DR, 1996, J ENDOCRINOL, V149, P191, DOI 10.1677/joe.0.1490191; Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Nakamura T, 2004, NAT GENET, V36, P528, DOI 10.1038/ng1344; O'Shaughnessy PJ, 2002, BIOL REPROD, V66, P966, DOI 10.1095/biolreprod66.4.966; ODELL WD, 1974, ENDOCRINOLOGY, V95, P1380, DOI 10.1210/endo-95-5-1380; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Petit FG, 2007, P NATL ACAD SCI USA, V104, P6293, DOI 10.1073/pnas.0702039104; Qian YM, 2001, ENDOCRINOLOGY, V142, P5342, DOI 10.1210/en.142.12.5342; SAEZ JM, 1994, ENDOCR REV, V15, P574, DOI 10.1210/er.15.5.574; STEINBERGER E, 1971, PHYSIOL REV, V51, P1, DOI 10.1152/physrev.1971.51.1.1; Takamoto N, 2005, MOL ENDOCRINOL, V19, P2299, DOI 10.1210/me.2005-0019; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Wang GM, 2003, ENDOCRINOLOGY, V144, P5058, DOI 10.1210/en.2003-0563; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; Wolgemuth DJ, 2002, RECENT PROG HORM RES, V57, P75, DOI 10.1210/rp.57.1.75; Yan W, 2000, DEV BIOL, V227, P169, DOI 10.1006/dbio.2000.9885; Yan W, 2003, P NATL ACAD SCI USA, V100, P10546, DOI 10.1073/pnas.1837812100; You LR, 2005, P NATL ACAD SCI USA, V102, P16351, DOI 10.1073/pnas.0507832102; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zhang FP, 2004, ENDOCRINOLOGY, V145, P1453, DOI 10.1210/en.2003-1049	38	80	83	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3285	10.1371/journal.pone.0003285	http://dx.doi.org/10.1371/journal.pone.0003285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818749	Green Published, gold, Green Submitted			2022-12-27	WOS:000264432300007
J	Logan, DW; Marton, TF; Stowers, L				Logan, Darren W.; Marton, Tobias F.; Stowers, Lisa			Species Specificity in Major Urinary Proteins by Parallel Evolution	PLOS ONE			English	Article								Species-specific chemosignals, pheromones, regulate social behaviors such as aggression, mating, pup-suckling, territory establishment, and dominance. The identity of these cues remains mostly undetermined and few mammalian pheromones have been identified. Genetically-encoded pheromones are expected to exhibit several different mechanisms for coding 1) diversity, to enable the signaling of multiple behaviors, 2) dynamic regulation, to indicate age and dominance, and 3) species-specificity. Recently, the major urinary proteins (Mups) have been shown to function themselves as genetically-encoded pheromones to regulate species-specific behavior. Mups are multiple highly related proteins expressed in combinatorial patterns that differ between individuals, gender, and age; which are sufficient to fulfill the first two criteria. We have now characterized and fully annotated the mouse Mup gene content in detail. This has enabled us to further analyze the extent of Mup coding diversity and determine their potential to encode species-specific cues. Our results show that the mouse Mup gene cluster is composed of two subgroups: an older, more divergent class of genes and pseudogenes, and a second class with high sequence identity formed by recent sequential duplications of a single gene/pseudogene pair. Previous work suggests that truncated Mup pseudogenes may encode a family of functional hexapeptides with the potential for pheromone activity. Sequence comparison, however, reveals that they have limited coding potential. Similar analyses of nine other completed genomes find Mup gene expansions in divergent lineages, including those of rat, horse and grey mouse lemur, occurring independently from a single ancestral Mup present in other placental mammals. Our findings illustrate that increasing genomic complexity of the Mup gene family is not evolutionarily isolated, but is instead a recurring mechanism of generating coding diversity consistent with a species-specific function in mammals.	[Logan, Darren W.; Marton, Tobias F.; Stowers, Lisa] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Logan, DW (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	stowers@scripps.edu	Logan, Darren/D-5629-2009; Stowers, Lisa/K-6137-2015	Logan, Darren/0000-0003-1545-5510; Stowers, Lisa/0000-0002-4403-1269	NIDCD; Pew Charitable Trusts; Skaggs Institute; The Helen L. Dorris Institute for the Study of Neurological and Psychiatric Disorders of Children and Adolescents	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Pew Charitable Trusts; Skaggs Institute; The Helen L. Dorris Institute for the Study of Neurological and Psychiatric Disorders of Children and Adolescents	This work was supported by NIDCD, Pew Charitable Trusts, Skaggs Institute, and The Helen L. Dorris Institute for the Study of Neurological and Psychiatric Disorders of Children and Adolescents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SD, 2005, BIOCHEM J, V391, P343, DOI 10.1042/BJ20050404; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; Beynon RJ, 2002, J CHEM ECOL, V28, P1429, DOI 10.1023/A:1016252703836; Beynon RJ, 2008, CHEM SIGNAL, V11, P37, DOI 10.1007/978-0-387-73945-8_3; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; BISHOP JO, 1982, EMBO J, V1, P615, DOI 10.1002/j.1460-2075.1982.tb01217.x; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cheetham SA, 2007, CURR BIOL, V17, P1771, DOI 10.1016/j.cub.2007.10.007; CLARE BW, 1985, ADV DYNAMIC STEREOCH, V1, P1; CLARK AJ, 1985, EMBO J, V4, P3159, DOI 10.1002/j.1460-2075.1985.tb04059.x; CLARK AJ, 1984, EMBO J, V3, P2055, DOI 10.1002/j.1460-2075.1984.tb02091.x; CLARK AJ, 1982, GENE, V18, P221, DOI 10.1016/0378-1119(82)90159-7; Demas GE, 1999, PHYSIOL BEHAV, V66, P59, DOI 10.1016/S0031-9384(98)00268-6; Emes RD, 2004, GENOME RES, V14, P1516, DOI 10.1101/gr.2540304; Emes RD, 2004, GENOME RES, V14, P591, DOI 10.1101/gr.1940604; FINLAYSON JS, 1965, SCIENCE, V149, P981, DOI 10.1126/science.149.3687.981; Flower DR, 1996, BIOCHEM J, V318, P1; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Gregoire C, 1996, J BIOL CHEM, V271, P32951, DOI 10.1074/jbc.271.51.32951; HARR R, 1982, NUCLEIC ACIDS RES, V10, P365, DOI 10.1093/nar/10.1.365; HASTIE ND, 1979, CELL, V17, P449, DOI 10.1016/0092-8674(79)90171-5; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krieger J, 1999, J BIOL CHEM, V274, P4655, DOI 10.1074/jbc.274.8.4655; Kruczek M, 2007, PHYSIOL BEHAV, V90, P483, DOI 10.1016/j.physbeh.2006.10.012; KUHN NJ, 1984, NUCLEIC ACIDS RES, V12, P6073, DOI 10.1093/nar/12.15.6073; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KURTZ D T, 1981, Journal of Molecular and Applied Genetics, V1, P29; KURTZ DT, 1977, P NATL ACAD SCI USA, V74, P4791, DOI 10.1073/pnas.74.11.4791; Lane RP, 2004, GENOME RES, V14, P603, DOI 10.1101/gr.2117004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laukaitis CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-46; Laukaitis CM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-40; Loebel D, 2000, BIOCHEM J, V350, P369, DOI 10.1042/0264-6021:3500369; MACINNES JI, 1986, MOL CELL BIOL, V6, P3563, DOI 10.1128/MCB.6.10.3563; Marchese S, 1998, EUR J BIOCHEM, V252, P563, DOI 10.1046/j.1432-1327.1998.2520563.x; Marchlewska-Koj A, 2000, J CHEM ECOL, V26, P2355, DOI 10.1023/A:1005578911652; McFadyen DA, 1999, MAMM GENOME, V10, P463, DOI 10.1007/s003359901024; More L, 2006, CHEM SENSES, V31, P393, DOI 10.1093/chemse/bjj043; Mucignat-Caretta C, 2006, J NEUROCHEM, V99, P881, DOI 10.1111/j.1471-4159.2006.04127.x; MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; NEI M, 1986, MOL BIOL EVOL, V3, P418; PAYNE AP, 1973, PHYSIOL BEHAV, V10, P629, DOI 10.1016/0031-9384(73)90235-7; Robertson DHL, 1996, BIOCHEM J, V316, P265, DOI 10.1042/bj3160265; Robertson DHL, 1997, RAPID COMMUN MASS SP, V11, P786, DOI 10.1002/(SICI)1097-0231(19970422)11:7<786::AID-RCM876>3.0.CO;2-8; Robertson DHL, 2007, J CHEM ECOL, V33, P613, DOI 10.1007/s10886-006-9247-0; ROY AK, 1966, P SOC EXP BIOL MED, V121, P894; ROY AK, 1966, BIOCHIM BIOPHYS ACTA, V127, P72, DOI 10.1016/0304-4165(66)90477-6; ROY AK, 1966, BIOCHIM BIOPHYS ACTA, V127, P82, DOI 10.1016/0304-4165(66)90478-8; ROY AK, 1967, NATURE, V214, P618, DOI 10.1038/214618b0; SHAHAN K, 1987, MOL CELL BIOL, V7, P1947, DOI 10.1128/MCB.7.5.1947; SHAHAN K, 1987, MOL CELL BIOL, V7, P1938, DOI 10.1128/MCB.7.5.1938; Sherborne AL, 2007, CURR BIOL, V17, P2061, DOI 10.1016/j.cub.2007.10.041; Shi P, 2005, J MOL EVOL, V60, P566, DOI 10.1007/s00239-004-0172-y; Storz JF, 2007, GENETICS, V177, P481, DOI 10.1534/genetics.107.078550; Stowers L, 2005, NEURON, V46, P699, DOI 10.1016/j.neuron.2005.04.032; SZOKA PR, 1978, GENETICS, V90, P597; Thom MD, 2008, CURR BIOL, V18, P619, DOI 10.1016/j.cub.2008.03.056; Wang W, 2005, GENOME RES, V15, P1258, DOI 10.1101/gr.3929705; Yang H, 2005, GENOMICS, V86, P306, DOI 10.1016/j.ygeno.2005.05.012	65	118	124	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2008	3	9							e3280	10.1371/journal.pone.0003280	http://dx.doi.org/10.1371/journal.pone.0003280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MH	18815613	gold, Green Submitted, Green Published			2022-12-27	WOS:000264431900006
J	Temime, L; Boelle, PY; Opatowski, L; Guillemot, D				Temime, Laura; Boelle, Pierre-Yves; Opatowski, Lulla; Guillemot, Didier			Impact of Capsular Switch on Invasive Pneumococcal Disease Incidence in a Vaccinated Population	PLOS ONE			English	Article							PNEUMONIAE SEROTYPE 19A; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; CONJUGATE VACCINATION; NONVACCINE SEROTYPES; UNITED-STATES; DAY-CARE; CHILDREN; RESISTANCE; EMERGENCE	Background: Despite the dramatic decline in the incidence of invasive pneumococcal disease (IPD) observed since the introduction of conjugate vaccination, it is feared that several factors may undermine the future effectiveness of the vaccines. In particular, pathogenic pneumococci may switch their capsular types and evade vaccine-conferred immunity. Methodology/Principal Findings: Here, we first review the literature and summarize the available epidemiological data on capsular switch for S. pneumoniae. We estimate the weekly probability that a persistently carried strain may switch its capsule from four studies, totalling 516 children and 6 years of follow-up, at 1.5 x 10(-3)/week [4.6 x 10(-5)-4.8 x 10(-3)/week]. There is not enough power to assess an increase in this frequency in vaccinated individuals. Then, we use a mathematical model of pneumococcal transmission to quantify the impact of capsular switch on the incidence of IPD in a vaccinated population. In this model, we investigate a wide range of values for the frequency of vaccine-selected capsular switch. Predictions show that, with vaccine-independent switching only, IPD incidence in children should be down by 48% 5 years after the introduction of the vaccine with high coverage. Introducing vaccine-selected capsular switch at a frequency up to 0.01/week shows little effect on this decrease; yearly, at most 3 excess cases of IPD per 10 6 children might occur due to switched pneumococcal strains. Conclusions: Based on all available data and model predictions, the existence of capsular switch by itself should not impact significantly the efficacy of pneumococcal conjugate vaccination on IPD incidence. This optimistic result should be tempered by the fact that the selective pressure induced by the vaccine is currently increasing along with vaccine coverage worldwide; continued surveillance of pneumococcal populations remains of the utmost importance, in particular during clinical trials of the new conjugate vaccines.	[Temime, Laura] CNAM, Paris, France; [Boelle, Pierre-Yves] INSERM, UMR S707, Paris, France; [Boelle, Pierre-Yves] Univ Paris 06, F-75252 Paris, France; [Opatowski, Lulla; Guillemot, Didier] PhEMI, Inst Pasteur, Paris, France; [Opatowski, Lulla; Guillemot, Didier] INSERM, U 657, Paris, France; [Opatowski, Lulla; Guillemot, Didier] Univ Versailles St Quentin, Fac Med Paris France Ouest, Versailles, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Temime, L (corresponding author), CNAM, Paris, France.	laura.temime@cnam.fr	Guillemot, Didier/AAN-3051-2020; Opatowski, Lulla/I-3143-2015; Temime, Laura/G-7010-2011	Opatowski, Lulla/0000-0001-8348-700X; Temime, Laura/0000-0002-8850-5403; Guillemot, Didier/0000-0002-8497-1765; Boelle, Pierre-Yves/0000-0002-5367-8232				Aristegui J, 2007, EUR J CLIN MICROBIOL, V26, P303, DOI 10.1007/s10096-007-0294-4; Austrian R, 1999, J INFECT DIS, V179, pS338, DOI 10.1086/513841; BARNES DM, 1995, J INFECT DIS, V171, P890, DOI 10.1093/infdis/171.4.890; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bogaert D, 2005, J CLIN MICROBIOL, V43, P74, DOI 10.1128/JCM.43.1.74-83.2005; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Cauchemez S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-14; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Frazao N, 2005, PEDIATR INFECT DIS J, V24, P243, DOI 10.1097/01.inf.0000154326.77617.3e; Fry AM, 2002, VACCINE, V21, P303, DOI 10.1016/S0264-410X(02)00451-6; GRATTEN M, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P501; Hanage WP, 2004, INFECT IMMUN, V72, P76, DOI 10.1128/IAI.72.1.76-81.2004; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Inostroza J, 1998, CLIN DIAGN LAB IMMUN, V5, P176, DOI 10.1128/CDLI.5.2.176-180.1998; Jefferies JMC, 2004, J CLIN MICROBIOL, V42, P5681, DOI 10.1128/JCM.42.12.5681-5688.2004; Kadioglu A, 2002, INFECT IMMUN, V70, P2886, DOI 10.1128/IAI.70.6.2886-2890.2002; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; KELLY T, 1994, INFECT IMMUN, V62, P1813, DOI 10.1128/IAI.62.5.1813-1819.1994; Lepoutre A., 2007, Bulletin Epidemiologique Hebdomadaire, P37; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Lipsitch M, 2007, J R SOC INTERFACE, V4, P787, DOI 10.1098/rsif.2007.0229; Lipsitch M, 2007, J INFECT DIS, V196, P1221, DOI 10.1086/521831; Long SS, 2005, CLIN INFECT DIS, V41, P30, DOI 10.1086/430608; Meats E, 2003, J CLIN MICROBIOL, V41, P386, DOI 10.1128/JCM.41.1.386-392.2003; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Nebenzahl YM, 2004, FEMS MICROBIOL LETT, V233, P147, DOI 10.1016/j.femsle.2004.02.003; Nesin M, 1998, J INFECT DIS, V177, P707, DOI 10.1086/514242; O'Brien KL, 2003, VACCINE, V21, P1815, DOI 10.1016/S0264-410X(02)00807-1; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Porat N, 2004, J INFECT DIS, V190, P2154, DOI 10.1086/425908; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Sleeman K, 2001, J INFECT DIS, V183, P239, DOI 10.1086/317924; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Sluijter M, 1998, J CLIN MICROBIOL, V36, P2248, DOI 10.1128/JCM.36.8.2248-2253.1998; Temime L, 2006, PEDIATR INFECT DIS J, V25, P382, DOI 10.1097/01.inf.0000210460.21966.f1; Temime L, 2005, EPIDEMIOL INFECT, V133, P493, DOI 10.1017/S0950268804003565; Temime L, 2004, ANTIMICROB AGENTS CH, V48, P2206, DOI 10.1128/AAC.48.6.2206-2213.2004; TOMASZ A, 2000, STREPTOCOCCUS PNEUMO, P491; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	48	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2008	3	9							e3244	10.1371/journal.pone.0003244	http://dx.doi.org/10.1371/journal.pone.0003244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LF	18802466	Green Submitted, Green Published, gold			2022-12-27	WOS:000264428600004
J	Khoja, S; Ojwang, P; Khan, S; Okinda, N; Harania, R; Ali, S				Khoja, Suhail; Ojwang, Peter; Khan, Saeed; Okinda, Nancy; Harania, Reena; Ali, Syed			Genetic Analysis of HIV-1 Subtypes in Nairobi, Kenya	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MOLECULAR EPIDEMIOLOGY; MALE CIRCUMCISION; 4 CITIES; DIVERSITY; VACCINE; INFECTION; IDENTIFICATION; TRANSMISSION; SPREAD	Background: Genetic analysis of a viral infection helps in following its spread in a given population, in tracking the routes of infection and, where applicable, in vaccine design. Additionally, sequence analysis of the viral genome provides information about patterns of genetic divergence that may have occurred during viral evolution. Objective: In this study we have analyzed the subtypes of Human Immunodeficiency Virus -1 (HIV-1) circulating in a diverse sample population of Nairobi, Kenya. Methodology: 69 blood samples were collected from a diverse subject population attending the Aga Khan University Hospital in Nairobi, Kenya. Total DNA was extracted from peripheral blood mononuclear cells (PBMCs), and used in a Polymerase Chain Reaction (PCR) to amplify the HIV gag gene. The PCR amplimers were partially sequenced, and alignment and phylogenetic analysis of these sequences was performed using the Los Alamos HIV Database. Results: Blood samples from 69 HIV-1 infected subjects from varying ethnic backgrounds were analyzed. Sequence alignment and phylogenetic analysis showed 39 isolates to be subtype A, 13 subtype D, 7 subtype C, 3 subtype AD and CRF01_AE, 2 subtype G and 1 subtype AC and 1 AG. Deeper phylogenetic analysis revealed HIV subtype A sequences to be highly divergent as compared to subtypes D and C. Conclusion: Our analysis indicates that HIV-1 subtypes in the Nairobi province of Kenya are dominated by a genetically diverse clade A. Additionally, the prevalence of highly divergent, complex subtypes, intersubtypes, and the recombinant forms indicates viral mixing in Kenyan population, possibly as a result of dual infections.			Khoja, S (corresponding author), Aga Khan Univ Hosp, Dept Biol & Biomed Sci, Karachi, Pakistan.	syed.ali@aku.edu	Abidi, Syed Hani/G-9457-2013; Khan, Saeed/D-5098-2014	Abidi, Syed Hani/0000-0001-9497-0902; OKINDA, NANCY/0000-0003-1373-5607; Khan, Saeed/0000-0003-0910-4095	University Research Council, Aga Khan University, Karachi; Higher Education Commission, Pakistan [20-775]	University Research Council, Aga Khan University, Karachi; Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	This study was partly funded by the University Research Council, Aga Khan University, Karachi, the Higher Education Commission, Pakistan, grant 20-775. The experimental work was performed in the Juma Research Laboratory, Aga Khan University Hospital, Karachi, Pakistan.	Auvert B, 2001, AIDS, V15, pS31, DOI 10.1097/00002030-200108004-00004; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Belda FJ, 1997, J ACQ IMMUN DEF SYND, V16, P63, DOI 10.1097/00042560-199709010-00010; Brennan CA, 2006, J MED VIROL, V78, pS24, DOI 10.1002/jmv.20603; Dowling WE, 2002, AIDS, V16, P1809, DOI 10.1097/00002030-200209060-00015; Essex M, 1999, ADV VIRUS RES, V53, P71, DOI 10.1016/S0065-3527(08)60343-7; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hanke T, 2000, NAT MED, V6, P951, DOI 10.1038/79626; Heyndrickx L, 2000, J VIROL, V74, P363, DOI 10.1128/JVI.74.1.363-370.2000; Ho DD, 1995, J BIOL REG HOMEOS AG, V9, P76; Holmes EC, 2001, BIOL REV, V76, P239, DOI 10.1017/S1464793101005668; JANSSENS W, 1994, AIDS RES HUM RETROV, V10, P1577, DOI 10.1089/aid.1994.10.1577; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kandathil AJ, 2005, INDIAN J MED RES, V121, P333; Kato S, 2003, AIDS RES HUM RETROV, V19, P1057, DOI 10.1089/088922203322588431; Khan S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-164; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuiken C, 2000, AM J EPIDEMIOL, V152, P814, DOI 10.1093/aje/152.9.814; Lihana RW, 2006, AIDS RES HUM RETROV, V22, P1172, DOI 10.1089/aid.2006.22.1172; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Luginaah I, 2005, SOC SCI MED, V60, P1219, DOI 10.1016/j.socscimed.2004.07.010; MADDISON DR, 2000, MACCLADE VERSION 4; Malim MH, 2001, CELL, V104, P469, DOI 10.1016/S0092-8674(01)00234-3; McCutchan FE, 2000, AIDS, V14, pS31; Mertens T E, 1995, AIDS, V9 Suppl A, pS259; Morison L, 2001, AIDS, V15, pS109, DOI 10.1097/00002030-200108004-00012; Mwau M, 2004, J GEN VIROL, V85, P911, DOI 10.1099/vir.0.19701-0; Neilson JR, 1999, J VIROL, V73, P4393, DOI 10.1128/JVI.73.5.4393-4403.1999; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Peeters M, 2000, AIDS, V14, pS129; Poss M, 1997, AIDS RES HUM RETROV, V13, P493, DOI 10.1089/aid.1997.13.493; Robbins KE, 1999, AIDS RES HUM RETROV, V15, P329, DOI 10.1089/088922299311295; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHARP PM, 1995, PHILOS T R SOC B, V349, P41, DOI 10.1098/rstb.1995.0089; Songok EM, 2003, AIDS RES HUM RETROV, V19, P161, DOI 10.1089/088922203762688676; Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Tatt ID, 2001, AIDS, V15, pS59, DOI 10.1097/00002030-200100005-00009; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P4419, DOI 10.1073/pnas.90.10.4419; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; UNAIDS/WHO, 2006, 2006 REP GLOB AIDS E; Yang CF, 2003, AIDS, V17, P1667, DOI 10.1097/00002030-200307250-00011; Zachar V, 1996, AIDS RES HUM RETROV, V12, P75, DOI 10.1089/aid.1996.12.75	48	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3191	10.1371/journal.pone.0003191	http://dx.doi.org/10.1371/journal.pone.0003191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784834	Green Published, gold, Green Submitted			2022-12-27	WOS:000264425900010
J	Muller, H; Mancuso, F				Muller, Heiko; Mancuso, Francesco			Identification and Analysis of Co-Occurrence Networks with NetCutter	PLOS ONE			English	Article							PROBABILISTIC MODEL; REGULATORY NETWORKS; GENES; MODULES; ASSOCIATION; INFORMATION; DISCOVERY; ELEMENTS; DATABASE; MOTIFS	Background: Co-occurrence analysis is a technique often applied in text mining, comparative genomics, and promoter analysis. The methodologies and statistical models used to evaluate the significance of association between co-occurring entities are quite diverse, however. Methodology/Principal Findings: We present a general framework for co-occurrence analysis based on a bipartite graph representation of the data, a novel co-occurrence statistic, and software performing co-occurrence analysis as well as generation and analysis of co-occurrence networks. We show that the overall stringency of co-occurrence analysis depends critically on the choice of the null-model used to evaluate the significance of co-occurrence and find that random sampling from a complete permutation set of the bipartite graph permits co-occurrence analysis with optimal stringency. We show that the Poisson-binomial distribution is the most natural co-occurrence probability distribution when vertex degrees of the bipartite graph are variable, which is usually the case. Calculation of Poisson-binomial P-values is difficult, however. Therefore, we propose a fast bi-binomial approximation for calculation of P-values and show that this statistic is superior to other measures of association such as the Jaccard coefficient and the uncertainty coefficient. Furthermore, co-occurrence analysis of more than two entities can be performed using the same statistical model, which leads to increased signal-to-noise ratios, robustness towards noise, and the identification of implicit relationships between co-occurring entities. Using NetCutter, we identify a novel protein biosynthesis related set of genes that are frequently coordinately deregulated in human cancer related gene expression studies. NetCutter is available at http://bio.ifom-ieo-campus.it/NetCutter/). Conclusion: Our approach can be applied to any set of categorical data where co-occurrence analysis might reveal functional relationships such as clinical parameters associated with cancer subtypes or SNPs associated with disease phenotypes. The stringency of our approach is expected to offer an advantage in a variety of applications.	[Muller, Heiko; Mancuso, Francesco] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Mancuso, Francesco] Consortium Genom Technol Cogentech, Milan, Italy	IRCCS European Institute of Oncology (IEO)	Muller, H (corresponding author), European Inst Oncol, Dept Expt Oncol, Milan, Italy.	heiko.muller@ifom-ieo-campus.it	Mancuso, Francesco/N-8058-2019; Mancuso, Francesco Mattia/A-8404-2012	Mancuso, Francesco/0000-0001-5499-6630; Muller, Heiko/0000-0001-9873-3146	AIRC (Italian Association of Cancer Research); CARIPLO (Cassa di Risparmio della Regione Lombardia)	AIRC (Italian Association of Cancer Research)(Fondazione AIRC per la ricerca sul cancro); CARIPLO (Cassa di Risparmio della Regione Lombardia)(Fondazione Cariplo)	This work was supported by grants from AIRC (Italian Association of Cancer Research) and CARIPLO (Cassa di Risparmio della Regione Lombardia).	Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Brazma A, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P65; Chaussabel D, 2002, GENOME BIOL, V3; Chen SX, 1997, STAT SINICA, V7, P875; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding J, 2002, Pac Symp Biocomput, P326; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Finocchiaro G, 2007, NUCLEIC ACIDS RES, V35, P2343, DOI 10.1093/nar/gkm119; Flake GW, 2002, COMPUTER, V35, P66, DOI 10.1109/2.989932; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goodman L. A., 1979, MEASURES ASS CROSS C; Halfon MS, 2002, GENOME RES, V12, P1019, DOI 10.1101/gr.228902; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Kel A, 1999, J MOL BIOL, V288, P353, DOI 10.1006/jmbi.1999.2684; Manke T, 2003, J MOL BIOL, V333, P75, DOI 10.1016/j.jmb.2003.08.004; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Masys DR, 2001, BIOINFORMATICS, V17, P319, DOI 10.1093/bioinformatics/17.4.319; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Rebholz-Schuhmann D, 2004, NUCLEIC ACIDS RES, V32, P135, DOI 10.1093/nar/gkh162; Rindflesch T C, 2000, Pac Symp Biocomput, P517; Schuemie MJ, 2004, BIOINFORMATICS, V20, P2597, DOI 10.1093/bioinformatics/bth291; Smalheiser NR, 1998, COMPUT METH PROG BIO, V57, P149, DOI 10.1016/S0169-2607(98)00033-9; Snel B, 2002, P NATL ACAD SCI USA, V99, P5890, DOI 10.1073/pnas.092632599; Stapley B J, 2000, Pac Symp Biocomput, P529; Sudarsanam P, 2002, GENOME RES, V12, P1723, DOI 10.1101/gr.301202; Tanabe L, 1999, BIOTECHNIQUES, V27, P1210, DOI 10.2144/99276bc03; TARJAN RE, 1972, SIAM J COMP; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Wasserman WW, 1998, J MOL BIOL, V278, P167, DOI 10.1006/jmbi.1998.1700; Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Zhu SF, 2005, BIOINFORMATICS, V21, P245, DOI 10.1093/bioinformatics/bti1141; Zhu S, 2006, CANCER INFORM, V2, P361	43	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3178	10.1371/journal.pone.0003178	http://dx.doi.org/10.1371/journal.pone.0003178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KD	18781200	Green Submitted, Green Published, gold			2022-12-27	WOS:000264425700010
J	Yang, T; Knowles, JK; Lu, Q; Zhang, H; Arancio, O; Moore, LA; Chang, T; Wang, Q; Andreasson, K; Rajadas, J; Fuller, GG; Xie, YM; Massa, SM; Longo, FM				Yang, Tao; Knowles, Juliet K.; Lu, Qun; Zhang, Hong; Arancio, Ottavio; Moore, Laura A.; Chang, Timothy; Wang, Qian; Andreasson, Katrin; Rajadas, Jayakumar; Fuller, Gerald G.; Xie, Youmei; Massa, Stephen M.; Longo, Frank M.			Small Molecule, Non-Peptide p75(NTR) Ligands Inhibit A beta-Induced Neurodegeneration and Synaptic Impairment	PLOS ONE			English	Article								The p75 neurotrophin receptor (p75(NTR)) is expressed by neurons particularly vulnerable in Alzheimer's disease (AD). We tested the hypothesis that non-peptide, small molecule p75(NTR) ligands found to promote survival signaling might prevent A beta-induced degeneration and synaptic dysfunction. These ligands inhibited Ab-induced neuritic dystrophy, death of cultured neurons and A beta-induced death of pyramidal neurons in hippocampal slice cultures. Moreover, ligands inhibited A beta-induced activation of molecules involved in AD pathology including calpain/cdk5, GSK3b and c-Jun, and tau phosphorylation, and prevented A beta-induced inactivation of AKT and CREB. Finally, a p75(NTR) ligand blocked A beta-induced hippocampal LTP impairment. These studies support an extensive intersection between p75(NTR) signaling and A beta pathogenic mechanisms, and introduce a class of specific small molecule ligands with the unique ability to block multiple fundamental AD-related signaling pathways, reverse synaptic impairment and inhibit Ab-induced neuronal dystrophy and death.	[Yang, Tao; Knowles, Juliet K.; Chang, Timothy; Wang, Qian; Andreasson, Katrin; Rajadas, Jayakumar; Longo, Frank M.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Yang, Tao; Knowles, Juliet K.; Moore, Laura A.; Xie, Youmei; Longo, Frank M.] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA; [Lu, Qun] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC USA; [Zhang, Hong; Arancio, Ottavio] Columbia Univ, Taub Inst, Dept Pathol, New York, NY 10027 USA; [Rajadas, Jayakumar; Fuller, Gerald G.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Massa, Stephen M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, Dept Neurol, Lab Computat Neurochem & Drug Discovery, San Francisco, CA USA	Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; East Carolina University; Columbia University; Stanford University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Yang, T (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	longo@stanford.edu	Rajadas, Jayakumar/AHC-0630-2022; arancio, ottavio/AAB-7959-2019	Knowles, Juliet/0000-0002-9214-2991; arancio, ottavio/0000-0001-6335-164X; Rajadas, Jayakumar/0000-0001-6520-3923; Fuller, Gerald/0000-0002-2924-053X	Institute for the Study of Aging; Alzheimer's Association; Eastern Chapter of the North Carolina Alzheimer's Association; NINDS [F30 NA051971]; NIA [AG026630]; NCI [CA111891, NS049442]; Veterans Administration; NATIONAL CANCER INSTITUTE [R01CA111891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442, F30NS051971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG026630] Funding Source: NIH RePORTER	Institute for the Study of Aging; Alzheimer's Association(Alzheimer's Association); Eastern Chapter of the North Carolina Alzheimer's Association; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Administration(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by the Institute for the Study of Aging (FL), Alzheimer's Association (FL), the Eastern Chapter of the North Carolina Alzheimer's Association (FL), NINDS F30 NA051971 (JK), NIA AG026630 (QL), NCI CA111891 (QL), NS049442 (OA) and the Veterans Administration (SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo MA, 2006, MOL BIOL CELL, V17, P3369, DOI 10.1091/mbc.E05-12-1144; Balaraman Y, 2006, CELL MOL LIFE SCI, V63, P1226, DOI 10.1007/s00018-005-5597-y; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Bozyczko-Coyne D, 2001, J NEUROCHEM, V77, P849, DOI 10.1046/j.1471-4159.2001.00294.x; Coulson EJ, 2000, J BIOL CHEM, V275, P30537, DOI 10.1074/jbc.M005214200; Coulson EJ, 2006, J NEUROCHEM, V98, P654, DOI 10.1111/j.1471-4159.2006.03905.x; Cragnolini AB, 2008, TRENDS NEUROSCI, V31, P99, DOI 10.1016/j.tins.2007.11.005; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; EICHLER ME, 1992, J NEUROCHEM, V58, P263, DOI 10.1111/j.1471-4159.1992.tb09305.x; Ferreira A, 1997, MOL CELL NEUROSCI, V9, P220, DOI 10.1006/mcne.1997.0615; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; Harris CA, 2002, J NEUROSCI, V22, P103, DOI 10.1523/JNEUROSCI.22-01-00103.2002; Hashiguchi M, 2002, J BIOL CHEM, V277, P44525, DOI 10.1074/jbc.M207426200; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hu XY, 2002, EXP NEUROL, V178, P104, DOI 10.1006/exnr.2002.8018; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lee YB, 2000, BRAIN RES, V864, P220, DOI 10.1016/S0006-8993(00)02180-6; Levresse V, 2000, J NEUROSCI RES, V62, P799; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Linggi MS, 2005, J BIOL CHEM, V280, P13801, DOI 10.1074/jbc.M410435200; Longo FM, 1997, J NEUROSCI RES, V48, P1, DOI 10.1002/(SICI)1097-4547(19970401)48:1<1::AID-JNR1>3.0.CO;2-K; Longo FM, 2008, CNS NEUROL DISORD-DR, V7, P63, DOI 10.2174/187152708783885093; Longo FM, 2007, CURR ALZHEIMER RES, V4, P503, DOI 10.2174/156720507783018316; Massa SM, 2006, J NEUROSCI, V26, P5288, DOI 10.1523/JNEUROSCI.3547-05.2006; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; McCullough L, 2004, J NEUROSCI, V24, P257, DOI 10.1523/JNEUROSCI.4485-03.2004; MUFSON EJ, 1992, P NATL ACAD SCI USA, V89, P569, DOI 10.1073/pnas.89.2.569; Nassif M, 2007, NEUROCHEM INT, V50, P229, DOI 10.1016/j.neuint.2006.08.008; RABIZADEH S, 1994, P NATL ACAD SCI USA, V91, P10703, DOI 10.1073/pnas.91.22.10703; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Sandoval M, 2007, J NEUROCHEM, V101, P1672, DOI 10.1111/j.1471-4159.2007.04519.x; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Thakur A, 2007, J NEUROSCI RES, V85, P1668, DOI 10.1002/jnr.21298; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Wei WL, 2002, J BIOL CHEM, V277, P17649, DOI 10.1074/jbc.M111704200; Widenbrant MJO, 2006, BIOPHYS J, V91, P4071, DOI 10.1529/biophysj.106.085944; Williams R, 2002, MATER WORLD, V10, P20; YAAR M, 2007, NEUROPATHOL APPL NEU; Yang T, 2003, J NEUROSCI, V23, P3353; Yoshida H, 2004, J NEUROCHEM, V90, P352, DOI 10.1111/j.1471-4159.2004.02479.x; Zhu LQ, 2007, J NEUROSCI, V27, P12211, DOI 10.1523/JNEUROSCI.3321-07.2007	49	106	111	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3604	10.1371/journal.pone.0003604	http://dx.doi.org/10.1371/journal.pone.0003604			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978948	gold, Green Published, Green Submitted			2022-12-27	WOS:000265134200003
J	Song, GS; Wang, L				Song, Guisheng; Wang, Li			MiR-433 and miR-127 Arise from Independent Overlapping Primary Transcripts Encoded by the miR-433-127 Locus	PLOS ONE			English	Article							GENE STRUCTURE; MICRORNAS; RECEPTOR	MicroRNAs play significant roles in development, metabolism and carcinogenesis, however, limited information is available about their primary transcripts and the transcriptional regulation of the microRNA genes. We report here the cloning of two primary miRNAs (pri-miR-433 and pri-miR-127) encoded by the miR-433-127 locus. Using both database mining and experimental methods, we isolated the full-length primary transcripts of the mouse miR-433 and miR-127 and demonstrated that they overlapped in a 59-39 unidirectional way. These two miRNA genes are expressed in a compact space by using overlapping coding regions. This is the first report to identify an economical structure for miR-433 and miR-127 genes, which may be a novel way of miRNA gene to maximize the genetic information in order to fit the complex physiological function of mammalian organism.	[Song, Guisheng; Wang, Li] Univ Utah, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Song, GS (corresponding author), Univ Utah, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	wang@hsc.utah.edu	song, guisheng/E-4913-2011		American Liver Foundation [Liver Scholar Award]; American Association for the Study of Liver Diseases [Liver Scholar Award]; American Diabetes Association [Junior Faculty Award]; NIH NIDDK [DK080440]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440] Funding Source: NIH RePORTER	American Liver Foundation; American Association for the Study of Liver Diseases; American Diabetes Association(American Diabetes Association); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by funds from American Liver Foundation/American Association for the Study of Liver Diseases (Liver Scholar Award), American Diabetes Association (Junior Faculty Award), NIH NIDDK DK080440 to L.W.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batshake B, 1996, BIOCHEM BIOPH RES CO, V227, P70, DOI 10.1006/bbrc.1996.1469; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Fukuda Y, 2003, GENE, V323, P181, DOI 10.1016/j.gene.2003.09.021; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Herzog H, 1997, GENOMICS, V41, P315, DOI 10.1006/geno.1997.4684; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sandmann T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001265; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; SONG GS, 2008, NUCL ACIDS RES  0906; Zhou CC, 2003, GENE, V305, P161, DOI 10.1016/S0378-1119(02)01235-0	24	46	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3574	10.1371/journal.pone.0003574	http://dx.doi.org/10.1371/journal.pone.0003574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974780	Green Submitted, Green Published, gold			2022-12-27	WOS:000265131500006
J	Croyle, MA; Patel, A; Tran, KN; Gray, M; Zhang, Y; Strong, JE; Feldmann, H; Kobinger, GP				Croyle, Maria A.; Patel, Ami; Tran, Kaylie N.; Gray, Michael; Zhang, Yi; Strong, James E.; Feldmann, Heinz; Kobinger, Gary P.			Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice	PLOS ONE			English	Article								Pre-existing immunity to human adenovirus serotype 5 (Ad5) is common in the general population. Bypassing pre-existing immunity could maximize Ad5 vaccine efficacy. Vaccination by the intramuscular (I.M.), nasal (I.N.) or oral (P.O.) route with Ad5 expressing Ebola Zaire glycoprotein (Ad5-ZGP) fully protected naive mice against lethal challenge with Ebola. In the presence of pre-existing immunity, only mice vaccinated I.N. survived. The frequency of IFN-gamma+ CD8+ T cells was reduced by 80% and by 15% in animals vaccinated by the I.M. and P.O. routes respectively. Neutralizing antibodies could not be detected in serum from either treatment group. Pre-existing immunity did not compromise the frequency of IFN-gamma+ CD8+ T cells (3.9 +/- 1% naive vs. 3.6 +/- 1% pre-existing immunity, PEI) nor anti-Ebola neutralizing antibody (NAB, 40 +/- 10 reciprocal dilution, both groups). The number of INF-gamma+ CD8+ cells detected in bronchioalveolar lavage fluid (BAL) after I.N. immunization was not compromised by pre-existing immunity to Ad5 (146 +/- 14, naive vs. 120 +/- 16 SFC/million MNCs, PEI). However, pre-existing immunity reduced NAB levels in BAL by similar to 25% in this group. To improve the immune response after oral vaccination, the Ad5-based vaccine was PEGylated. Mice given the modified vaccine did not survive challenge and had reduced levels of IFN-gamma+ CD8+ T cells 10 days after administration (0.3 +/- 0.3% PEG vs. 1.7 +/- 0.5% unmodified). PEGylation did increase NAB levels 2-fold. These results provide some insight about the degree of T and B cell mediated immunity necessary for protection against Ebola virus and suggest that modification of the virus capsid can influence the type of immune response elicited by an Ad5-based vaccine.	[Croyle, Maria A.] Univ Texas Austin, Coll Pharm, Div Pharmaceut, Austin, TX 78712 USA; [Croyle, Maria A.] Univ Texas, Inst Cellular & Mol Biol, Austin, TX USA; [Patel, Ami; Tran, Kaylie N.; Gray, Michael; Strong, James E.; Feldmann, Heinz; Kobinger, Gary P.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada; [Patel, Ami; Strong, James E.; Feldmann, Heinz; Kobinger, Gary P.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3T 2N2, Canada; [Zhang, Yi] Univ Michigan, Div Immunol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Strong, James E.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Public Health Agency of Canada; University of Manitoba; University of Michigan System; University of Michigan; University of Manitoba	Croyle, MA (corresponding author), Univ Texas Austin, Coll Pharm, Div Pharmaceut, Austin, TX 78712 USA.	gary_kobinger@phac-aspc.gc.ca	Croyle, Maria/L-4586-2019	Croyle, Maria/0000-0003-0809-901X	NIH; CRTI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRTI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH, CRTI	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Appaiahgari MB, 2006, MICROBES INFECT, V8, P92, DOI 10.1016/j.micinf.2005.05.023; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Beer SJ, 1998, GENE THER, V5, P740, DOI 10.1038/sj.gt.3300647; Boyer JL, 2005, HUM GENE THER, V16, P157, DOI 10.1089/hum.2005.16.157; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Bukreyev A, 2006, J VIROL, V80, P2267, DOI 10.1128/JVI.80.5.2267-2279.2006; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Cheng X, 2003, PHARM RES-DORDR, V20, P1444, DOI 10.1023/A:1025714412337; Croyle MA, 2005, GENE THER, V12, P579, DOI 10.1038/sj.gt.3302441; Croyle MA, 2002, HUM GENE THER, V13, P1887, DOI 10.1089/104303402760372972; Croyle MA, 2001, J VIROL, V75, P4792, DOI 10.1128/JVI.75.10.4792-4801.2001; Croyle MA, 2000, HUM GENE THER, V11, P1713, DOI 10.1089/10430340050111368; DUNCAN SJ, 1978, J GEN VIROL, V40, P45, DOI 10.1099/0022-1317-40-1-45; Eto Y, 2005, J GENE MED, V7, P604, DOI 10.1002/jgm.699; Gallo P, 2005, GENE THER, V12, pS84, DOI 10.1038/sj.gt.3302619; Gerdts V, 2007, FUTURE MICROBIOL, V2, P667, DOI 10.2217/17460913.2.6.667; Gibb TR, 2001, J COMP PATHOL, V125, P233, DOI 10.1053/jcpa.2001.0502; Hartman ZC, 2008, VIRUS RES, V132, P1, DOI 10.1016/j.virusres.2007.10.005; Hashimoto M, 2005, INFECT IMMUN, V73, P6885, DOI 10.1128/IAI.73.10.6885-6891.2005; Hoenen T, 2006, J VIROL, V80, P7260, DOI 10.1128/JVI.00051-06; Holterman L, 2004, J VIROL, V78, P13207, DOI 10.1128/JVI.78.23.13207-13215.2004; Iwasaki T, 2004, ACTA NEUROPATHOL, V108, P485, DOI 10.1007/s00401-004-0909-0; Jaax NK, 1996, ARCH PATHOL LAB MED, V120, P140; JOHNSON E, 1995, INT J EXP PATHOL, V76, P227; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Kobinger GP, 2006, VIROLOGY, V346, P394, DOI 10.1016/j.virol.2005.10.042; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; KRESGE KJ, 2005, IAVI REP, V9, P24; Laddy DJ, 2007, VACCINE, V25, P2984, DOI 10.1016/j.vaccine.2007.01.063; Lefrancois L, 2006, ANNU REV IMMUNOL, V24, P681, DOI 10.1146/annurev.immunol.24.021605.090650; Lemckert AAC, 2005, J VIROL, V79, P9694, DOI 10.1128/JVI.79.15.9694-9701.2005; Liniger M, 2007, EXPERT REV VACCINES, V6, P255, DOI 10.1586/14760584.6.2.255; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Mohamadzadeh M, 2007, NAT REV IMMUNOL, V7, P556, DOI 10.1038/nri2098; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; O'Riordan CR, 1999, HUM GENE THER, V10, P1349, DOI 10.1089/10430349950018021; OSTEN P, 2007, HDB EXP PHARM, V1788, P177; Papp Z, 1999, VACCINE, V17, P933, DOI 10.1016/S0264-410X(98)00279-5; Patel A, 2007, J INFECT DIS, V196, pS413, DOI 10.1086/520603; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; Rao M, 1999, VACCINE, V17, P2991, DOI 10.1016/S0264-410X(99)00170-X; Reed DS, 2007, VACCINE, V25, P1923, DOI 10.1016/j.vaccine.2006.11.037; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Sailaja G, 2002, GENE THER, V9, P1722, DOI 10.1038/sj.gt.3301858; Santosuosso M, 2005, VIRAL IMMUNOL, V18, P283, DOI 10.1089/vim.2005.18.283; Steel JC, 2004, J PHARM PHARMACOL, V56, P1371, DOI 10.1211/0022357044643; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Van Kampen KR, 2005, VACCINE, V23, P1029, DOI 10.1016/j.vaccine.2004.07.043; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Wortmann A, 2008, MOL THER, V16, P154, DOI 10.1038/sj.mt.6300306; Xiang ZQ, 2003, J IMMUNOL, V171, P4287, DOI 10.4049/jimmunol.171.8.4287; Xiang ZQ, 2003, J VIROL, V77, P10780, DOI 10.1128/JVI.77.20.10780-10789.2003; Yang ZY, 2003, J VIROL, V77, P799, DOI 10.1128/JVI.77.1.799-803.2003; Youil R, 2002, HUM GENE THER, V13, P311, DOI 10.1089/10430340252769824; Zeng MT, 2007, VACCINE, V25, P7540, DOI 10.1016/j.vaccine.2007.08.035; Zhi Y, 2006, HUM GENE THER, V17, P500, DOI 10.1089/hum.2006.17.500; Zhou DM, 2006, MOL THER, V14, P662, DOI 10.1016/j.ymthe.2006.03.027	60	121	128	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3548	10.1371/journal.pone.0003548	http://dx.doi.org/10.1371/journal.pone.0003548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958172	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131100008
J	Dolman, G				Dolman, Gaynor			Evidence for Differential Assortative Female Preference in Association with Refugial Isolation of Rainbow Skinks in Australia's Tropical Rainforests	PLOS ONE			English	Article							SEXUAL SELECTION; COMPARATIVE PHYLOGEOGRAPHY; POPULATION-GENETICS; EVOLUTION; SPECIATION; PATTERNS; DIVERGENCE; MODELS; DISPERSAL; COMPLEX	Background: Divergence driven by female preference can give rise to pre-mating isolation more rapidly than post-mating isolation can evolve through the accumulation of allelic incompatibilities. Moreover pre-mating isolation may be more effective at maintaining morphological differentiation between divergent populations. In the context of Australian rainforest endemic skinks that were historically subjected to refugial isolation, this study examined the following predictions: 1) that assortative female preference is associated with more recent divergence of southern C. rubrigularis (SRED) and C. rhomboidalis (BLUE), but not with deeply divergent S-RED and northern C. rubrigularis (N-RED); and 2) that upon secondary contact, morphological differentiation is maintained between S-RED and BLUE, whereas N-RED and S-RED remain morphogically indistinguishable. Principal Findings: Female preference trials found no evidence for assortative female preference between N-RED and SRED, supporting a previous genetic hybrid zone study which inferred post-mating but no pre-mating isolation. In contrast there is evidence for assortative female preference between S-RED and BLUE, with BLUE females preferring to associate with BLUE males, but S-RED females showing no preference. Multi-locus coalescent analyses, used to estimate post-divergence gene-flow between proximally located S-RED and BLUE populations, rejected zero gene-flow from BLUE to S-RED and thus RED and BLUE have maintained morphological differentiation despite secondary contact. Morphometric analyses confirmed a lack of morphological divergence between N-RED and S-RED and established that BLUE is morphologically divergent from RED in traits other than throat colour. Conclusions/Significance: Long-term isolation has been sufficient to generate post-mating isolation but no morphological divergence between N-RED and S-RED. In contrast, greater morphological differentiation is associated with evidence for assortative female preference between more recently diverged S-RED and BLUE. Combined with previous estimates of lineage-wide gene flow, these results are consistent with the suggestion that assortative female preference is more effective than post-mating isolation in maintaining morphological differentiation between divergent populations.	[Dolman, Gaynor] CSIRO Sustainable Ecosyst, Australian Natl Wildlife Collect, Canberra, ACT, Australia; [Dolman, Gaynor] Univ Queensland, Sch Integrat Biol, St Lucia, Qld 4067, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Dolman, G (corresponding author), CSIRO Sustainable Ecosyst, Australian Natl Wildlife Collect, Canberra, ACT, Australia.	gaynor.dolman@csiro.au	Dolman, Gaynor/CAH-1635-2022; Dolman, Gaynor/I-4497-2015	Dolman, Gaynor/0000-0001-7611-6841	CRC for Tropical Rainforest Ecology and Management	CRC for Tropical Rainforest Ecology and Management(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by a Student Research Support Scheme grant from the CRC for Tropical Rainforest Ecology and Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SJ, 1996, EVOLUTION, V50, P1024, DOI 10.1111/j.1558-5646.1996.tb02343.x; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Chapple DG, 2005, MOL ECOL, V14, P1215, DOI 10.1111/j.1365-294X.2005.02486.x; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; Coyne JA, 1997, EVOLUTION, V51, P295, DOI [10.1111/j.1558-5646.1997.tb02412.x, 10.2307/2410984]; COYNE JA, 2004, SPECIATION, P383; Dobzhansky T., 1937; Dolman G, 2006, EVOLUTION, V60, P573, DOI 10.1554/05-487.1; Dolman G, 2004, MOL ECOL NOTES, V4, P185, DOI 10.1111/j.1471-8286.2004.00609.x; DOUGHTY P, 1994, ANIM BEHAV, V47, P227, DOI 10.1006/anbe.1994.1029; Endler J.A., 1977, Monographs in Population Biology, pi; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Fisher RA, 1930, GENETICAL THEORY NAT; Gleason JM, 1998, EVOLUTION, V52, P1493, DOI [10.2307/2411319, 10.1111/j.1558-5646.1998.tb02031.x]; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hoskin CJ, 2005, NATURE, V437, P1353, DOI 10.1038/nature04004; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; INGRAM G, 1989, Memoirs of the Queensland Museum, V27, P443; KANESHIRO KY, 1980, EVOLUTION, V34, P437, DOI 10.1111/j.1558-5646.1980.tb04833.x; Kershaw A. P., 2005, Tropical rainforests: past, present and future, P374; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lane Amanda M., 2006, Herpetological Review, V37, P46; Langkilde T, 2003, HERPETOL J, V13, P141; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Muller HJ, 1942, BIOL S, V6, P71; Nielsen R, 2001, GENETICS, V158, P885; Ord TJ, 2006, J EVOLUTION BIOL, V19, P797, DOI 10.1111/j.1420-9101.2005.01050.x; ORR HA, 1995, GENETICS, V139, P1805; Phillips BL, 2004, EVOLUTION, V58, P1536; Rassmann K, 1997, MOL ECOL, V6, P437, DOI 10.1046/j.1365-294X.1997.00209.x; Sasa MM, 1998, EVOLUTION, V52, P1811, DOI 10.1111/j.1558-5646.1998.tb02258.x; Schneider C, 1999, P ROY SOC B-BIOL SCI, V266, P191, DOI 10.1098/rspb.1999.0621; Schneider CJ, 1999, P NATL ACAD SCI USA, V96, P13869, DOI 10.1073/pnas.96.24.13869; SHINE R, 1992, AM NAT, V139, P1257, DOI 10.1086/285385; Smadja C, 2004, J EVOLUTION BIOL, V17, P165, DOI 10.1046/j.1420-9101.2003.00647.x; Stuart-Fox DM, 2004, P ROY SOC B-BIOL SCI, V271, P2249, DOI 10.1098/rspb.2004.2802; Stuart-Fox DM, 2001, AUST J ZOOL, V49, P119, DOI 10.1071/ZO00092; Sumner J, 2001, MOL ECOL, V10, P1917, DOI 10.1046/j.0962-1083.2001.01337.x; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; WATANABE TK, 1979, SCIENCE, V205, P906, DOI 10.1126/science.205.4409.906; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; WHITTIER J, 1994, HERPETOLOGY AUSTR DI, P305; Williams SE, 1997, P ROY SOC B-BIOL SCI, V264, P709, DOI 10.1098/rspb.1997.0101; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Wong BBM, 2004, J EVOLUTION BIOL, V17, P701, DOI 10.1046/j.1420-9101.2003.00651.x	49	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3499	10.1371/journal.pone.0003499	http://dx.doi.org/10.1371/journal.pone.0003499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958149	Green Published, gold, Green Submitted			2022-12-27	WOS:000265131100002
J	Pei, YF; Li, J; Zhang, L; Papasian, CJ; Deng, HW				Pei, Yu-Fang; Li, Jian; Zhang, Lei; Papasian, Christopher J.; Deng, Hong-Wen			Analyses and Comparison of Accuracy of Different Genotype Imputation Methods	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; HAPLOTYPE RECONSTRUCTION; MISSING GENOTYPES; STATISTICAL-MODEL; POPULATION-DATA; SUSCEPTIBILITY; IDENTIFICATION; RESOLUTION; INFERENCE	The power of genetic association analyses is often compromised by missing genotypic data which contributes to lack of significant findings, e. g., in in silico replication studies. One solution is to impute untyped SNPs from typed flanking markers, based on known linkage disequilibrium (LD) relationships. Several imputation methods are available and their usefulness in association studies has been demonstrated, but factors affecting their relative performance in accuracy have not been systematically investigated. Therefore, we investigated and compared the performance of five popular genotype imputation methods, MACH, IMPUTE, fastPHASE, PLINK and Beagle, to assess and compare the effects of factors that affect imputation accuracy rates (ARs). Our results showed that a stronger LD and a lower MAF for an untyped marker produced better ARs for all the five methods. We also observed that a greater number of haplotypes in the reference sample resulted in higher ARs for MACH, IMPUTE, PLINK and Beagle, but had little influence on the ARs for fastPHASE. In general, MACH and IMPUTE produced similar results and these two methods consistently outperformed fastPHASE, PLINK and Beagle. Our study is helpful in guiding application of imputation methods in association analyses when genotype data are missing.	[Pei, Yu-Fang; Zhang, Lei; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Xian 710049, Shaanxi, Peoples R China; [Pei, Yu-Fang; Li, Jian; Zhang, Lei; Papasian, Christopher J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO USA; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Peoples R China	Xi'an Jiaotong University; University of Missouri System; University of Missouri Kansas City; Hunan Normal University	Pei, YF (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Xian 710049, Shaanxi, Peoples R China.	hwdeng@mail.xjtu.edu.cn	Zhang, Lei/L-1016-2016; Li, Jian/G-4445-2015	Zhang, Lei/0000-0002-1007-4834; Deng, Hong-Wen/0000-0002-0387-8818	NIH [R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081, R21 AA015973]; National Science Foundation of China; Huo Ying Dong Education Foundation; Xi'an Jiaotong University; Ministry of Education of China; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huo Ying Dong Education Foundation; Xi'an Jiaotong University(Xi'an Jiaotong University); Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Investigators of this work were partially supported by grants from NIH (R01 AR050496, R21 AG027110, R01 AG026564, P50 AR055081 and R21 AA015973). The study was also benefited from grants from National Science Foundation of China, Huo Ying Dong Education Foundation, HuNan Province, Xi'an Jiaotong University, and the Ministry of Education of China.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; ENFRON B, 2004, ANN STAT, P407; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Greenspan G, 2004, J COMPUT BIOL, V11, P495, DOI 10.1089/1066527041410300; HASTIE T, 2001, ELEMENTS SATAISTICAL; Kimmel G, 2005, P NATL ACAD SCI USA, V102, P158, DOI 10.1073/pnas.0404730102; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Li Y, 2006, AM J HUM GENET S, VS79, P2290; LI Y, 2006, MARKOV MODEL RAPID H; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nannya Y, 2007, HUM MOL GENET, V16, P2494, DOI 10.1093/hmg/ddm205; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Therneau TM., 2015, INTRO RECURSIVE PART; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yu ZX, 2007, HUM GENET, V122, P495, DOI 10.1007/s00439-007-0427-y	32	102	109	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3551	10.1371/journal.pone.0003551	http://dx.doi.org/10.1371/journal.pone.0003551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958166	Green Submitted, Green Published, gold			2022-12-27	WOS:000265131100010
J	Stairs, DB; Nakagawa, H; Klein-Szanto, A; Mitchell, SD; Silberg, DG; Tobias, JW; Lynch, JP; Rustgi, AK				Stairs, Douglas B.; Nakagawa, Hiroshi; Klein-Szanto, Andres; Mitchell, Shukriyyah D.; Silberg, Debra G.; Tobias, John W.; Lynch, John P.; Rustgi, Anil K.			Cdx1 and c-Myc Foster the Initiation of Transdifferentiation of the Normal Esophageal Squamous Epithelium toward Barrett's Esophagus	PLOS ONE			English	Article								Background: Barrett's esophagus is a premalignant condition whereby the normal stratified squamous esophageal epithelium undergoes a transdifferentiation program resulting in a simple columnar epithelium reminiscent of the small intestine. These changes are typically associated with the stratified squamous epithelium chronically exposed to acid and bile salts as a result of gastroesophageal reflux disease (GERD). Despite this well-defined epidemiologic association between acid reflux and Barrett's esophagus, the genetic changes that induce this transdifferentiation process in esophageal keratinocytes have remained undefined. Methodology/Principal Findings: To begin to identify the genetic changes responsible for transdifferentiaiton in Barrett's esophagus, we performed a microarray analysis of normal esophageal, Barrett's esophagus and small intestinal biopsy specimens to identify candidate signaling pathways and transcription factors that may be involved. Through this screen we identified the Cdx1 homeodomain transcription factor and the c-myc pathway as possible candidates. Cdx1 and c-myc were then tested for their ability to induce transdifferentiation in immortalized human esophageal keratinocytes using organotypic culturing methods. Analyses of these cultures reveal that c-myc and cdx1 cooperate to induce mucin production and changes in keratin expression that are observed in the epithelium of Barrett's esophagus. Conclusions/Significance: These data demonstrate the ability of Cdx1 and c-myc to initiate the earliest stages of transdifferentiation of esophageal keratinocytes toward a cell fate characteristic of Barrett's esophagus.	[Stairs, Douglas B.; Nakagawa, Hiroshi; Mitchell, Shukriyyah D.; Silberg, Debra G.; Lynch, John P.; Rustgi, Anil K.] Univ Penn, Dept Med, Div Gastroenterol, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Stairs, Douglas B.; Nakagawa, Hiroshi; Mitchell, Shukriyyah D.; Silberg, Debra G.; Lynch, John P.; Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Dept Genet, Div Gastroenterol, Philadelphia, PA 19104 USA; [Tobias, John W.] Univ Penn, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA; [Klein-Szanto, Andres] Fox Chase Canc Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Fox Chase Cancer Center	Stairs, DB (corresponding author), Univ Penn, Dept Med, Div Gastroenterol, Abramson Canc Ctr, Philadelphia, PA 19104 USA.	anil2@mail.med.upenn.edu	Klein-Szanto, A./E-6218-2010		NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068366] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by NIH grants to AKR, DBS, HN, GDW and JPL and an NIH P30 Center grant to AKR, GDW, JT, HN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Almeida R, 2003, J PATHOL, V199, P36, DOI 10.1002/path.1246; Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; BROERS JLV, 1993, AM J RESP CELL MOL, V9, P33, DOI 10.1165/ajrcmb/9.1.33; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cook MB, 2007, CANCER EPIDEM BIOMAR, V16, P2090, DOI 10.1158/1055-9965.EPI-07-0432; Dahlberg PS, 2004, ANN THORAC SURG, V77, P1008, DOI 10.1016/j.athoracsur.2003.09.051; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; El-Serag HB, 2006, GASTROINTEST ENDOSC, V64, P17, DOI 10.1016/j.gie.2005.08.041; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fitzgerald RC, 2006, GUT, V55, P1810, DOI 10.1136/gut.2005.089144; Guo RJ, 2004, CANCER BIOL THER, V3, P593, DOI 10.4161/cbt.3.7.913; Han JC, 2007, APMIS, V115, P1331, DOI 10.1111/j.1600-0643.2007.00695.x; Harada H, 2003, MOL CANCER RES, V1, P729; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; KLEIN N, 1993, LAB INVEST, V68, P26; Knoepfler PS, 2007, CANCER RES, V67, P5061, DOI 10.1158/0008-5472.CAN-07-0426; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maley Carlo C, 2006, J Natl Compr Canc Netw, V4, P367; Maley CC, 2005, SEMIN CANCER BIOL, V15, P474, DOI 10.1016/j.semcancer.2005.06.004; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Mutoh H, 2004, GUT, V53, P1416, DOI 10.1136/gut.2003.032482; Mutoh H, 2002, BIOCHEM BIOPH RES CO, V294, P470, DOI 10.1016/S0006-291X(02)00480-1; Okawa T, 2007, GENE DEV, V21, P2788, DOI 10.1101/gad.1544507; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ostrowski J, 2007, J MOL MED, V85, P733, DOI 10.1007/s00109-007-0176-3; Park J, 2001, GENE DEV, V15, P1619, DOI 10.1101/gad.900101; Schmidt MK, 2007, DIS ESOPHAGUS, V20, P212, DOI 10.1111/j.1442-2050.2007.00673.x; Silberg DG, 1997, GASTROENTEROLOGY, V113, P478, DOI 10.1053/gast.1997.v113.pm9247467; Silberg DG, 2002, GASTROENTEROLOGY, V122, P689, DOI 10.1053/gast.2002.31902; Suh ER, 2002, J BIOL CHEM, V277, P35795, DOI 10.1074/jbc.M205567200; Takaoka M, 2004, ONCOGENE, V23, P6760, DOI 10.1038/sj.onc.1207923; Tselepis C, 2003, GUT, V52, P174, DOI 10.1136/gut.52.2.174; van den Akker E, 2002, DEVELOPMENT, V129, P2181; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Wang S, 2006, ONCOGENE, V25, P3346, DOI 10.1038/sj.onc.1209357; WATERS CM, 1991, ONCOGENE, V6, P797; Watts GS, 2007, INT J CANCER, V121, P2132, DOI 10.1002/ijc.22898; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wong NACS, 2005, P NATL ACAD SCI USA, V102, P7565, DOI 10.1073/pnas.0502031102; Wong NACS, 2004, P NATL ACAD SCI USA, V101, P574, DOI 10.1073/pnas.0307190101; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Zhang GX, 2004, WORLD J GASTROENTERO, V10, P1759	48	88	89	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3534	10.1371/journal.pone.0003534	http://dx.doi.org/10.1371/journal.pone.0003534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953412	Green Published, Green Submitted, gold			2022-12-27	WOS:000265130500011
J	Comabella, M; Craig, DW; Camina-Tato, M; Morcillo, C; Lopez, C; Navarro, A; Rio, J; Montalban, X; Martin, R				Comabella, Manuel; Craig, David W.; Camina-Tato, Montse; Morcillo, Carlos; Lopez, Cristina; Navarro, Arcadi; Rio, Jordi; Montalban, Xavier; Martin, Roland		BiomarkerMS Study Grp	Identification of a Novel Risk Locus for Multiple Sclerosis at 13q31.3 by a Pooled Genome-Wide Scan of 500,000 Single Nucleotide Polymorphisms	PLOS ONE			English	Article								Multiple sclerosis is a chronic inflammatory demyelinating disease of the central nervous system with an important genetic component and strongest association driven by the HLA genes. We performed a pooling-based genome-wide association study of 500,000 SNPs in order to find new loci associated with the disease. After applying several criteria, 320 SNPs were selected from the microarrays and individually genotyped in a first and independent Spanish Caucasian replication cohort. The 8 most significant SNPs validated in this cohort were also genotyped in a second US Caucasian replication cohort for confirmation. The most significant association was obtained for SNP rs3129934, which neighbors the HLA-DRB/DQA loci and validates our pooling-based strategy. The second strongest association signal was found for SNP rs1327328, which resides in an unannotated region of chromosome 13 but is in linkage disequilibrium with nearby functional elements that may play important roles in disease susceptibility. This region of chromosome 13 has not been previously identified in MS linkage genome screens and represents a novel risk locus for the disease.	[Comabella, Manuel; Camina-Tato, Montse; Lopez, Cristina; Rio, Jordi; Montalban, Xavier] HUVH, CEM Cat, UNIC, Barcelona, Spain; [Craig, David W.] Translat Genom Res Inst TGen, Neurogenom Div, Phoenix, AZ USA; [Morcillo, Carlos; Navarro, Arcadi] Univ Pompeu Fabra, Dept Ciencies Expt Salut, Barcelona, Spain; [Morcillo, Carlos] Natl Inst Bioinformat INB, Barcelona, Spain; [Navarro, Arcadi; Martin, Roland] Inst Catalana Recerca Estudis Avancats ICREA, Barcelona, Spain; NINDS, NIH, Bethesda, MD USA	Hospital Universitari Vall d'Hebron; Translational Genomics Research Institute; Pompeu Fabra University; ICREA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Comabella, M (corresponding author), HUVH, CEM Cat, UNIC, Barcelona, Spain.	mcomabel@ir.vhebron.net	Montalban, Xavier/J-5938-2016; Navarro, Arcadi/F-1592-2011; Craig, David Wesley/K-6961-2019	Montalban, Xavier/0000-0002-0098-9918; Navarro, Arcadi/0000-0003-2162-8246; Craig, David Wesley/0000-0003-2040-1955; Martin, Roland/0000-0002-0982-1329; Rio, Jordi/0000-0003-4546-7627; Comabella Lopez, Manuel/0000-0002-2373-6657; Lopez Garcia, Cristina/0000-0002-2861-929X	Spain's National Institute for Bioinformatics; ICREA Funding Source: Custom	Spain's National Institute for Bioinformatics; ICREA(ICREA)	The Institute for Neuroimmunology and Clinical MS Research is supported by the Gemeinnutzige Hertie Foundation. This work has been supported by Spain's National Institute for Bioinformatics, a platform of Genoma Espana.	Barcellos LF, 2002, BRAIN, V125, P150; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Faust PL, 2005, J INHERIT METAB DIS, V28, P369, DOI 10.1007/s10545-005-7059-y; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; Gootjes J, 2004, EUR J HUM GENET, V12, P115, DOI 10.1038/sj.ejhg.5201090; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Iglesias AH, 2004, J NEUROIMMUNOL, V150, P163, DOI 10.1016/j.jneuroim.2004.01.017; Krause Cindy, 2006, Hum Mutat, V27, P1157, DOI 10.1002/humu.9462; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; MORCILLOSUAREZ C, 2008, BIOINFORMAT IN PRESS; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Oksenberg JR, 2005, GENES IMMUN, V6, P375, DOI 10.1038/sj.gene.6364237; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Pearson JV, 2007, AM J HUM GENET, V80, P126, DOI 10.1086/510686; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rane S, 2007, CELL CYCLE, V6, P1850, DOI 10.4161/cc.6.15.4551; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Villoslada P, 2002, J NEUROIMMUNOL, V130, P194, DOI 10.1016/S0165-5728(02)00215-1; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593	22	84	90	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3490	10.1371/journal.pone.0003490	http://dx.doi.org/10.1371/journal.pone.0003490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941528	gold, Green Published			2022-12-27	WOS:000265126100021
J	Chavanas, S; Adoue, V; Mechin, MC; Ying, SB; Dong, SJ; Duplan, H; Charveron, M; Takahara, H; Serre, G; Simon, M				Chavanas, Stephane; Adoue, Veronique; Mechin, Marie-Claire; Ying, Shibo; Dong, Sijun; Duplan, Helene; Charveron, Marie; Takahara, Hidenari; Serre, Guy; Simon, Michel			Long-Range Enhancer Associated with Chromatin Looping Allows AP-1 Regulation of the Peptidylarginine Deiminase 3 Gene in Differentiated Keratinocyte	PLOS ONE			English	Article							NUCLEAR-FACTOR-Y; ACTIVATOR PROTEIN-1 ACTIVATION; NF-Y; TRANSCRIPTION FACTORS; PROMOTER ACTIVITY; PROXIMAL PROMOTER; GROWTH-FACTOR; EXPRESSION; SP1; MOUSE	Transcription control at a distance is a critical mechanism, particularly for contiguous genes. The peptidylarginine deiminases (PADs) catalyse the conversion of protein-bound arginine into citrulline (deimination), a critical reaction in the pathophysiology of multiple sclerosis, Alzheimer's disease and rheumatoid arthritis, and in the metabolism of the major epidermal barrier protein filaggrin, a strong predisposing factor for atopic dermatitis. PADs are encoded by 5 clustered PADI genes (1p35-6). Unclear are the mechanisms controlling the expression of the gene PADI3 encoding the PAD3 isoform, a strong candidate for the deimination of filaggrin in the terminally differentiating epidermal keratinocyte. We describe the first PAD Intergenic Enhancer (PIE), an evolutionary conserved non coding segment located 86-kb from the PADI3 promoter. PIE is a strong enhancer of the PADI3 promoter in Ca2+- differentiated epidermal keratinocytes, and requires bound AP-1 factors, namely c-Jun and c-Fos. As compared to proliferative keratinocytes, calcium stimulation specifically associates with increased local DNase I hypersensitivity around PIE, and increased physical proximity of PIE and PADI3 as assessed by Chromosome Conformation Capture. The specific AP-1 inhibitor nordihydroguaiaretic acid suppresses the calcium-induced increase of PADI3 mRNA levels in keratinocytes. Our findings pave the way to the exploration of deimination control during tumorigenesis and wound healing, two conditions for which AP-1 factors are critical, and disclose that long-range transcription control has a role in the regulation of the gene PADI3. Since invalidation of distant regulators causes a variety of human diseases, PIE results to be a plausible candidate in association studies on deimination-related disorders or atopic disease.	[Chavanas, Stephane; Adoue, Veronique; Mechin, Marie-Claire; Serre, Guy; Simon, Michel] Univ Toulouse 3, CNRS, UMR 5165, CHU Purpan, F-31062 Toulouse, France; [Ying, Shibo; Dong, Sijun; Takahara, Hidenari] Ibaraki Univ, Sch Agr, Dept Appl Biol Resource Sci, Ami, Ibaraki, Japan; [Duplan, Helene; Charveron, Marie] Inst Rech Pierre Fabre, Toulouse, France	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Ibaraki University; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chavanas, S (corresponding author), Univ Toulouse 3, CNRS, UMR 5165, CHU Purpan, F-31062 Toulouse, France.	chavanas@udear.cnrs.fr	Simon, Michel/B-7308-2011; DONG, SIJUN/C-8807-2018; Chavanas, stephane/K-1183-2014; Ying, Shibo/K-2514-2016	Simon, Michel/0000-0003-3655-6329; chavanas, stephane/0000-0003-4323-2656; Takahara, Hidenari/0000-0003-2373-8588; Ying, Shibo/0000-0001-5275-9383; Adoue, Veronique/0000-0003-3548-7456	Institut National de la Sante et de la Recherche Medicale (INSERM); Paul Sabatier University (UPS); Centre National de la Recherche Scientifique (CNRS); European Social Fund (ESF); European Regional Development Fund (ERDF); Pierre-Fabre Research Institute (CERPER, Toulouse)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Paul Sabatier University (UPS); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Social Fund (ESF)(European Social Fund (ESF)); European Regional Development Fund (ERDF)(European Commission); Pierre-Fabre Research Institute (CERPER, Toulouse)	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Paul Sabatier University (UPS), Centre National de la Recherche Scientifique (CNRS), European Social Fund (ESF), European Regional Development Fund (ERDF) and Pierre-Fabre Research Institute (CERPER, Toulouse).	Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Antonini D, 2006, MOL CELL BIOL, V26, P3308, DOI 10.1128/MCB.26.8.3308-3318.2006; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; BOYCE ST, 1983, J INVEST DERMATOL, V81, pS33, DOI 10.1111/1523-1747.ep12540422; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Chavanas S, 2004, GENE, V330, P19, DOI 10.1016/j.gene.2003.12.038; Chavanas S, 2006, J DERMATOL SCI, V44, P63, DOI 10.1016/j.jdermsci.2006.07.004; Chen WX, 1998, J BIOL CHEM, V273, P32176, DOI 10.1074/jbc.273.48.32176; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOMANN FE, 1994, CELL GROWTH DIFFER, V5, P9; DONG S, 2007, J INVEST DERMATOL; Dong S, 2007, MOL ENDOCRINOL, V21, P1617, DOI 10.1210/me.2006-0550; Dong S, 2006, BIOCHEM J, V397, P449, DOI 10.1042/BJ20051939; Dong SJ, 2005, J INVEST DERMATOL, V124, P1026, DOI 10.1111/j.0022-202X.2005.23690.x; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; Galliano MF, 2006, J BIOL CHEM, V281, P5780, DOI 10.1074/jbc.M508017200; Ge YB, 2001, BIOCHEM J, V357, P97, DOI 10.1042/0264-6021:3570097; Germain S, 1998, J BIOL CHEM, V273, P25292, DOI 10.1074/jbc.273.39.25292; Gonzales M, 2002, MOL CARCINOGEN, V34, P102, DOI 10.1002/mc.10052; Jang SI, 1996, J BIOL CHEM, V271, P24105, DOI 10.1074/jbc.271.39.24105; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Layon ME, 2007, J MOL BIOL, V366, P737, DOI 10.1016/j.jmb.2006.11.094; Liang FQ, 2001, J BIOL CHEM, V276, P1516, DOI 10.1074/jbc.M006350200; Liu GY, 2006, APOPTOSIS, V11, P183, DOI 10.1007/s10495-006-3715-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lok CN, 2002, BIOCHEM J, V368, P741, DOI 10.1042/BJ20020791; Magan N, 2003, BIOCHEM J, V374, P723, DOI 10.1042/BJ20030032; Martin N, 2004, GENOME RES, V14, P2430, DOI 10.1101/gr.2709404; McArthur M, 2001, J MOL BIOL, V313, P27, DOI 10.1006/jmbi.2001.4969; Mechin MC, 2005, CELL MOL LIFE SCI, V62, P1984, DOI 10.1007/s00018-005-5196-y; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Nachat R, 2005, J INVEST DERMATOL, V124, P384, DOI 10.1111/j.0022-202X.2004.23568.x; Neub A, 2007, J INVEST DERMATOL, V127, P2453, DOI 10.1038/sj.jid.5700864; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Park S, 2004, J CELL BIOCHEM, V91, P973, DOI 10.1002/jcb.10768; Park S, 1998, CANCER LETT, V127, P23, DOI 10.1016/S0304-3835(97)00543-0; Ransone Lynn J., 1993, Gene Expression, V3, P37; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Romano RA, 2006, J INVEST DERMATOL, V126, P1469, DOI 10.1038/sj.jid.5700297; Rossi A, 1998, J INVEST DERMATOL, V110, P34, DOI 10.1046/j.1523-1747.1998.00071.x; Rubtsov MA, 2006, P NATL ACAD SCI USA, V103, P17690, DOI 10.1073/pnas.0603819103; Ruocco KM, 2007, J BIOMOL SCREEN, V12, P133, DOI 10.1177/1087057106296686; Schmidt M, 2000, J BIOL CHEM, V275, P41011, DOI 10.1074/jbc.M003716200; Senshu T, 1996, BIOCHEM BIOPH RES CO, V225, P712, DOI 10.1006/bbrc.1996.1240; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sim EUH, 2002, ONCOGENE, V21, P2948, DOI 10.1038/sj.onc.1205373; Soutoglou E, 2001, EMBO J, V20, P1984, DOI 10.1093/emboj/20.8.1984; Teixe T, 2008, MOL IMMUNOL, V45, P2905, DOI 10.1016/j.molimm.2008.01.033; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Vilar JMG, 2005, CURR OPIN GENET DEV, V15, P136, DOI 10.1016/j.gde.2005.02.005; Virolle T, 1998, J BIOL CHEM, V273, P17318, DOI 10.1074/jbc.273.28.17318; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wang YN, 2003, J BIOL CHEM, V278, P45848, DOI 10.1074/jbc.M302630200; Yamada K, 2000, J BIOL CHEM, V275, P18129, DOI 10.1074/jbc.M001543200; Yamaguchi H, 1999, BIOCHEM J, V340, P767, DOI 10.1042/0264-6021:3400767; Zhao JQ, 2003, FEBS LETT, V536, P111, DOI 10.1016/S0014-5793(03)00038-3	66	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2008	3	10							e3408	10.1371/journal.pone.0003408	http://dx.doi.org/10.1371/journal.pone.0003408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GT	18923650	Green Submitted, gold, Green Published			2022-12-27	WOS:000265122200002
J	Isik, N; Hereld, D; Jin, T				Isik, Nilgun; Hereld, Dale; Jin, Tian			Fluorescence Resonance Energy Transfer Imaging Reveals that Chemokine-Binding Modulates Heterodimers of CXCR4 and CCR5 Receptors	PLOS ONE			English	Article								Background: Dimerization has emerged as an important feature of chemokine G-protein-coupled receptors. CXCR4 and CCR5 regulate leukocyte chemotaxis and also serve as a co-receptor for HIV entry. Both receptors are recruited to the immunological synapse during T-cell activation. However, it is not clear whether they form heterodimers and whether ligand binding modulates the dimer formation. Methodology/Principal Findings: Using a sensitive Fluorescence Resonance Energy Transfer (FRET) imaging method, we investigated the formation of CCR5 and CXCR4 heterodimers on the plasma membrane of live cells. We found that CCR5 and CXCR4 exist as constitutive heterodimers and ligands of CCR5 and CXCR4 promote different conformational changes within these preexisting heterodimers. Ligands of CCR5, in contrast to a ligand of CXCR4, induced a clear increase in FRET efficiency, indicating that selective ligands promote and stabilize a distinct conformation of the heterodimers. We also found that mutations at C-terminus of CCR5 reduced its ability to form heterodimers with CXCR4. In addition, ligands induce different conformational transitions of heterodimers of CXCR4 and CCR5 or CCR5(STA) and CCR5(Delta 4). Conclusions/Significance: Taken together, our data suggest a model in which CXCR4 and CCR5 spontaneously form heterodimers and ligand-binding to CXCR4 or CCR5 causes different conformational changes affecting heterodimerization, indicating the complexity of regulation of dimerization/function of these chemokine receptors by ligand binding.	[Isik, Nilgun; Hereld, Dale; Jin, Tian] NIAID, Chemotaxis Signal Sect, Immunogenet Lab, NIH,Twinbrook Facil 2, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Isik, N (corresponding author), NIAID, Chemotaxis Signal Sect, Immunogenet Lab, NIH,Twinbrook Facil 2, Rockville, MD USA.	tjin@niaid.nih.gov			IATAP program from NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000928, Z01AI000928] Funding Source: NIH RePORTER	IATAP program from NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by IATAP program from NIH.	Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Gosling J, 1997, P NATL ACAD SCI USA, V94, P5061, DOI 10.1073/pnas.94.10.5061; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hereld D, 2008, EUR J IMMUNOL, V38, P334, DOI 10.1002/eji.200738101; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Jiao XM, 2005, MOL CELL BIOL, V25, P5752, DOI 10.1128/MCB.25.13.5752-5762.2005; JIN T, 2008, CHEMOTAXIS CHEMOKINE; Kramer JM, 2006, J IMMUNOL, V176, P711, DOI 10.4049/jimmunol.176.2.711; Lazzarino DA, 2000, IMMUNOL LETT, V74, P189, DOI 10.1016/S0165-2478(00)00258-3; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Murphy PM, 2000, PHARMACOL REV, V52, P145; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Pello OM, 2008, EUR J IMMUNOL, V38, P537, DOI 10.1002/eji.200737630; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; SIEGEL RM, 2000, SCI STKE, pPL1; Soriano SF, 2003, EUR J IMMUNOL, V33, P1328, DOI 10.1002/eji.200323897; Strange PG, 2008, CURR OPIN DRUG DISC, V11, P196; Venkatesan S, 2001, J BIOL CHEM, V276, P40133, DOI 10.1074/jbc.M105722200; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Xu X, 2007, J CELL BIOL, V178, P141, DOI 10.1083/jcb.200611096; Yi L, 2006, J BIOL CHEM, V281, P35446, DOI 10.1074/jbc.M607302200	27	46	50	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2008	3	10							e3424	10.1371/journal.pone.0003424	http://dx.doi.org/10.1371/journal.pone.0003424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GT	18923649	Green Published, Green Submitted, gold			2022-12-27	WOS:000265122200005
J	Pecze, L; Szabo, K; Szell, M; Josvay, K; Kaszas, K; Kusz, E; Letoha, T; Prorok, J; Koncz, I; Toth, A; Kemeny, L; Vizler, C; Olah, Z				Pecze, Laszlo; Szabo, Kornelia; Szell, Marta; Josvay, Katalin; Kaszas, Krisztian; Kusz, Erzsebet; Letoha, Tamas; Prorok, Janos; Koncz, Istvan; Toth, Andras; Kemeny, Lajos; Vizler, Csaba; Olah, Zoltan			Human Keratinocytes Are Vanilloid Resistant	PLOS ONE			English	Article							CAPSAICIN RECEPTOR TRPV1; POSTHERPETIC NEURALGIA; DIFFERENTIAL EXPRESSION; MICE LACKING; 1 VR1; RAT; PAIN; CELLS; NEURONS; CHANNEL	Background: Use of capsaicin or resiniferatoxin (RTX) as analgesics is an attractive therapeutic option. RTX opens the cation channel inflammatory pain/vanilloid receptor type 1 (TRPV1) permanently and selectively removes nociceptive neurons by Ca2+-cytotoxicity. Paradoxically, not only nociceptors, but non-neuronal cells, including keratinocytes express full length TRPV1 mRNA, while patient dogs and experimental animals that underwent topical treatment or anatomically targeted molecular surgery have shown neither obvious behavioral, nor pathological side effects. Methods: To address this paradox, we assessed the vanilloid sensitivity of the HaCaT human keratinocyte cell line and primary keratinocytes from skin biopsies. Results: Although both cell types express TRPV1 mRNA, neither responded to vanilloids with Ca2+-cytotoxicity. Only ectopic overproduction of TRPV1 rendered HaCaT cells sensitive to low doses (1-50 nM) of vanilloids. The TRPV1-mediated and nonreceptor specific Ca2+-cytotoxity ([RTX] > 15 mu M) could clearly be distinguished, thus keratinocytes were indeed resistant to vanilloid-induced, TRPV1-mediated Ca2+-entry. Having a wider therapeutic window than capsaicin, RTX was effective in subnanomolar range, but even micromolar concentrations could not kill human keratinocytes. Keratinocytes showed orders of magnitudes lower TRPV1 mRNA level than sensory ganglions, the bona fide therapeutic targets in human pain management. In addition to TRPV1, TRPV1b, a dominant negative splice variant was also noted in keratinocytes. Conclusion: TRPV1B expression, together with low TRPV1 expression, may explain the vanilloid paradox: even genuinely TRPV1 mRNA positive cells can be spared with therapeutic (up to micromolar) doses of RTX. This additional safety information might be useful for planning future human clinical trials.	[Pecze, Laszlo; Josvay, Katalin; Kaszas, Krisztian; Kusz, Erzsebet; Letoha, Tamas; Vizler, Csaba; Olah, Zoltan] Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, Szeged, Hungary; [Szabo, Kornelia; Szell, Marta] Hungarian Acad Sci, Dermatol Res Grp, Szeged, Hungary; [Letoha, Tamas] Univ Szeged, Dept Med Chem, Albert Szent Gyorgyi Med & Pharm Ctr, Szeged, Hungary; [Prorok, Janos; Koncz, Istvan; Toth, Andras] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Albert Szent Gyorgyi Med & Pharm Ctr, Szeged, Hungary; [Kemeny, Lajos] Univ Szeged, Dept Dermatol & Allergol, Albert Szent Gyorgyi Med & Pharm Ctr, Szeged, Hungary; [Olah, Zoltan] Acheuron Ltd, Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; Szeged University; Szeged University; Szeged University	Pecze, L (corresponding author), Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, Szeged, Hungary.	oz@acheuron.com	Letoha, Tamas/ABG-6348-2020; Kemeny, Lajos/ABF-1339-2021	Kemeny, Lajos/0000-0002-2119-9501	Hungarian Ministry of Health [552/2006]; National Office for Research and Technology [OM-00051/2005, OMFB-01575/2006, OMFB-01576/2006, OMFB-01630/2006]; Anyos Jedlik Program [NKFP-1-00019/2005, GVOP-3.3.1-05/1.-2005-05-0057/3.0]; Zoltan Magyary Postdoctoral Fellowship Fund; Hungarian Academy of Sciences [Janos Bolyai Research Scholarship];  [MC-IRG030854-PAINKILLER]	Hungarian Ministry of Health; National Office for Research and Technology(National Office for Research and Technology); Anyos Jedlik Program; Zoltan Magyary Postdoctoral Fellowship Fund; Hungarian Academy of Sciences(Hungarian Academy of Sciences); 	This work has been supported by grants of the Hungarian Ministry of Health (552/2006), and the National Office for Research and Technology (OM-00051/2005 and OMFB-01575/2006). ZO was also supported by MC-IRG030854-PAINKILLER; Anyos Jedlik Program NKFP-1-00019/2005; GVOP-3.3.1-05/1.-2005-05-0057/3.0. CV was also supported by grants of the National Office for Research and Technology (OM-00051/2005 and OMFB-01575/2006) and the Hungarian Ministry of Health (552/2006). TL was also supported by grants of the National Office for Research and Technology (OMFB-01576/2006 and OMFB-01630/2006) and the Zoltan Magyary Postdoctoral Fellowship Fund. This paper was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri-Haber N, 2004, J NEUROSCI, V24, P4444, DOI 10.1523/JNEUROSCI.0242-04.2004; Alper BS, 2002, J FAM PRACTICE, V51, P121; Argoff Charles E, 2003, Curr Pain Headache Rep, V7, P34, DOI 10.1007/s11916-003-0007-3; Athanasiou A, 2007, BIOCHEM BIOPH RES CO, V354, P50, DOI 10.1016/j.bbrc.2006.12.179; Basu S, 2005, P NATL ACAD SCI USA, V102, P5120, DOI 10.1073/pnas.0407780102; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Bodo E, 2005, AM J PATHOL, V166, P985, DOI 10.1016/S0002-9440(10)62320-6; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brown DC, 2005, ANESTHESIOLOGY, V103, P1052, DOI 10.1097/00000542-200511000-00020; BUCCI FA, 1988, AM J OPHTHALMOL, V106, P758, DOI 10.1016/0002-9394(88)90727-1; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Denda M, 2001, BIOCHEM BIOPH RES CO, V285, P1250, DOI 10.1006/bbrc.2001.5299; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gopinath Preethi, 2005, BMC Womens Health, V5, P2, DOI 10.1186/1472-6874-5-2; Guler AD, 2002, J NEUROSCI, V22, P6408; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; HUTSAI M, 1992, NEUROSCI LETT, V143, P251, DOI 10.1016/0304-3940(92)90276-D; Inoue K, 2002, BIOCHEM BIOPH RES CO, V291, P124, DOI 10.1006/bbrc.2002.6393; JENSEN PKA, 1990, VIRCHOWS ARCH B, V59, P17, DOI 10.1007/BF02899382; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kofalvi A, 2006, NEUROSCI LETT, V403, P151, DOI 10.1016/j.neulet.2006.04.030; Levey DJ, 2006, OECOLOGIA, V150, P61, DOI 10.1007/s00442-006-0496-y; Liapi A, 2005, EUR J NEUROSCI, V22, P825, DOI 10.1111/j.1460-9568.2005.04270.x; LYNN B, 1990, PAIN, V41, P61, DOI 10.1016/0304-3959(90)91110-5; Macho A, 1999, CELL DEATH DIFFER, V6, P155, DOI 10.1038/sj.cdd.4400465; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Nagy I, 2004, EUR J PHARMACOL, V500, P351, DOI 10.1016/j.ejphar.2004.07.037; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; O'Connell PJ, 2005, FEBS LETT, V579, P5135, DOI 10.1016/j.febslet.2005.08.023; Olah Z, 2001, J BIOL CHEM, V276, P31163, DOI 10.1074/jbc.M101607200; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Olah Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000545; Paramio JM, 1998, ONCOGENE, V17, P949, DOI 10.1038/sj.onc.1202031; Pareek TK, 2007, P NATL ACAD SCI USA, V104, P660, DOI 10.1073/pnas.0609916104; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Pivarcsi A, 2001, ARCH DERMATOL RES, V293, P206, DOI 10.1007/s004030100217; Roberts JC, 2004, BRAIN RES, V995, P176, DOI 10.1016/j.brainres.2003.10.001; Sathianathan V, 2003, EUR J NEUROSCI, V18, P2477, DOI 10.1046/j.1460-9568.2003.03004.x; Simpson DM, 2008, NEUROLOGY, V70, P2305, DOI 10.1212/01.wnl.0000314647.35825.9c; Southall MD, 2003, J PHARMACOL EXP THER, V304, P217, DOI 10.1124/jpet.102.040675; Stander S, 2001, J AM ACAD DERMATOL, V44, P471, DOI 10.1067/mjd.2001.110059; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; Szallasi A, 1999, PHARMACOL REV, V51, P159; Szallasi A, 2006, N-S ARCH PHARMACOL, V373, P273, DOI 10.1007/s00210-006-0072-3; Tahim AS, 2005, NEUROSCIENCE, V136, P539, DOI 10.1016/j.neuroscience.2005.08.005; Tender GC, 2005, J NEUROSURG, V102, P522, DOI 10.3171/jns.2005.102.3.0522; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Vos MH, 2006, J NEUROCHEM, V99, P1088, DOI 10.1111/j.1471-4159.2006.04145.x; WATSON CPN, 1988, PAIN, V35, P289, DOI 10.1016/0304-3959(88)90139-X; WINTER J, 1992, NEUROSCI LETT, V146, P48, DOI 10.1016/0304-3940(92)90169-8; WINTER J, 1995, BRIT J ANAESTH, V75, P157, DOI 10.1093/bja/75.2.157; Witte DG, 2002, J BIOMOL SCREEN, V7, P466, DOI 10.1177/108705702237679	62	43	43	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3419	10.1371/journal.pone.0003419	http://dx.doi.org/10.1371/journal.pone.0003419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852901	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000265121700012
J	Pirozhkova, I; Petrov, A; Dmitriev, P; Laoudj, D; Lipinski, M; Vassetzky, Y				Pirozhkova, Iryna; Petrov, Andrei; Dmitriev, Petr; Laoudj, Dalila; Lipinski, Marc; Vassetzky, Yegor			A Functional Role for 4qA/B in the Structural Rearrangement of the 4q35 Region and in the Regulation of FRG1 and ANT1 in Facioscapulohumeral Dystrophy	PLOS ONE			English	Article								The number of D4Z4 repeats in the subtelomeric region of chromosome 4q is strongly reduced in patients with Facio-Scapulo-Humeral Dystrophy (FSHD). We performed chromosome conformation capture (3C) analysis to document the interactions taking place among different 4q35 markers. We found that the reduced number of D4Z4 repeats in FSHD myoblasts was associated with a global alteration of the three-dimensional structure of the 4q35 region. Indeed, differently from normal myoblasts, the 4qA/B marker interacted directly with the promoters of the FRG1 and ANT1 genes in FSHD cells. Along with the presence of a newly identified transcriptional enhancer within the 4qA allele, our demonstration of an interaction occurring between chromosomal segments located megabases away on the same chromosome 4q allows to revisit the possible mechanisms leading to FSHD.	[Pirozhkova, Iryna; Petrov, Andrei; Dmitriev, Petr; Lipinski, Marc; Vassetzky, Yegor] Univ Paris 11, CNRS, UMR Interact Mol & Canc 8126, Inst Cancerol Gustave Roussy, Villejuif, France; [Laoudj, Dalila] Univ Montpellier 1, INSERM, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Pirozhkova, I (corresponding author), Univ Paris 11, CNRS, UMR Interact Mol & Canc 8126, Inst Cancerol Gustave Roussy, Villejuif, France.	vassetzky@igr.fr	Vassetzky, Yegor S/C-6447-2008; Vassetzky, Yegor/M-3383-2019	Vassetzky, Yegor S/0000-0003-3101-7043; Vassetzky, Yegor/0000-0003-3101-7043; Pirozhkova, Iryna/0000-0001-8196-7069	Association Francaise contre les Myopathies (AFM) [fellowship]; Fondation pour la Recherche Medicale [fellowship]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by grants to YSV and DL from the Association Francaise contre les Myopathies (AFM). IP was a recipient of an AFM fellowship, and AP of a fellowship from the Fondation pour la Recherche Medicale.	BARRO M, 2008, J CELL MOL IN PRESS; Cai ST, 1999, METHODS, V19, P394, DOI 10.1006/meth.1999.0875; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; DMITRIEV P, 2008, NEUROMUSCUL IN PRESS, DOI DOI 10.1016/J.NMD.2008.1009.1004; Eivazova ER, 2007, GENES IMMUN, V8, P35, DOI 10.1038/sj.gene.6364349; Eivazova ER, 2004, P NATL ACAD SCI USA, V101, P251, DOI 10.1073/pnas.0303919101; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabellini D, 2005, NATURE; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Keeney S, 1996, GENES CELLS, V1, P475, DOI 10.1046/j.1365-2443.1996.d01-257.x; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; LI K, 1990, J BIOL CHEM, V265, P20585; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Petrov A, 2008, GENOME RES, V18, P39, DOI 10.1101/gr.6620908; Rijkers T, 2004, J MED GENET, V41, P826, DOI 10.1136/jmg.2004.019364; Stout K, 1999, CHROMOSOME RES, V7, P323, DOI 10.1023/A:1009287111661; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; van der Maarel SM, 2007, BBA-MOL BASIS DIS, V1772, P186, DOI 10.1016/j.bbadis.2006.05.009; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; van Geel M, 1999, GENOMICS, V61, P55, DOI 10.1006/geno.1999.5942; van Koningsbruggen S, 2007, CHROMOSOMA, V116, P53, DOI 10.1007/s00412-006-0083-3; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P581, DOI 10.1093/hmg/5.5.581; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327	32	36	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3389	10.1371/journal.pone.0003389	http://dx.doi.org/10.1371/journal.pone.0003389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852887	Green Submitted, gold, Green Published			2022-12-27	WOS:000265121600012
J	Mack, B; Gires, O				Mack, Brigitte; Gires, Olivier			CD44s and CD44v6 Expression in Head and Neck Epithelia	PLOS ONE			English	Article								Background: CD44 splice variants are long-known as being associated with cell transformation. Recently, the standard form of CD44 (CD44s) was shown to be part of the signature of cancer stem cells (CSCs) in colon, breast, and in head and neck squamous cell carcinomas (HNSCC). This is somewhat in contradiction to previous reports on the expression of CD44s in HNSCC. The aim of the present study was to clarify the actual pattern of CD44 expression in head and neck epithelia. Methods: Expression of CD44s and CD44v6 was analysed by immunohistochemistry with specific antibodies in primary head and neck tissues. Scoring of all specimens followed a two-parameters system, which implemented percentages of positive cells and staining intensities from - to +++ (score = % x intensity; resulting max. score 300). In addition, cell surface expression of CD44s and CD44v6 was assessed in lymphocytes and HNSCC. Results: In normal epithelia CD44s and CD44v6 were expressed in 60-95% and 50-80% of cells and yielded mean scores with a standard error of a mean (SEM) of 249.5 +/- 14.5 and 198 +/- 11.13, respectively. In oral leukoplakia and in moderately differentiated carcinomas CD44s and CD44v6 levels were slightly increased (278.9 +/- 7.16 and 242 +/- 11.7; 291.8 +/- 5.88 and 287.3 +/- 6.88). Carcinomas in situ displayed unchanged levels of both proteins whereas poorly differentiated carcinomas consistently expressed diminished CD44s and CD44v6 levels. Lymphocytes and HNSCC lines strongly expressed CD44s but not CD44v6. Conclusion: CD44s and CD44v6 expression does not distinguish normal from benign or malignant epithelia of the head and neck. CD44s and CD44v6 were abundantly present in the great majority of cells in head and neck tissues, including carcinomas. Hence, the value of CD44s as a marker for the definition of a small subset of cells (i.e. less than 10%) representing head and neck cancer stem cells may need revision.	[Mack, Brigitte] Univ Munich, Grosshadern Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany; [Gires, Olivier] Univ Munich, Head & Neck Res Dept, German Res Ctr Environm Hlth, Helmholtz Zent Munchen,Clin Cooperat Grp Mol Oncol, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Mack, B (corresponding author), Univ Munich, Grosshadern Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany.	olivier.gires@med.uni-muenchen.de	Gires, Olivier/V-2689-2017	Gires, Olivier/0000-0002-2292-7064				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Gires O, 2008, ATLAS GENET CYTOGENE; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; HeroldMende C, 1996, J PATHOL, V179, P66, DOI 10.1002/(SICI)1096-9896(199605)179:1<66::AID-PATH544>3.0.CO;2-5; Kawano T, 2004, AURIS NASUS LARYNX, V31, P35, DOI 10.1016/j.anl.2003.09.005; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Marhaba R, 2005, CELL SIGNAL, V17, P961, DOI 10.1016/j.cellsig.2004.11.017; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Okamoto I, 1999, J BIOL CHEM, V274, P25525, DOI 10.1074/jbc.274.36.25525; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pries R, 2008, IN VIVO, V22, P89; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Prince MEP, 2008, J CLIN ONCOL, V26, P2871, DOI 10.1200/JCO.2007.15.1613; Reichart PA, 2005, ORAL ONCOL, V41, P551, DOI 10.1016/j.oraloncology.2004.12.003; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Soukka T, 1997, CANCER RES, V57, P2281; Staibano S, 2007, BRIT J CANCER, V97, P1545, DOI 10.1038/sj.bjc.6604070; TROWBRIDGE IS, 1982, IMMUNOGENETICS, V15, P299, DOI 10.1007/BF00364338; Van Hal NLW, 1999, INT J CANCER, V82, P837, DOI 10.1002/(SICI)1097-0215(19990909)82:6<837::AID-IJC12>3.3.CO;2-8; Van Hal NLW, 1999, CLIN CANCER RES, V5, P3534; Wiesner M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001464	30	121	126	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3360	10.1371/journal.pone.0003360	http://dx.doi.org/10.1371/journal.pone.0003360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DQ	18852874	Green Published, gold			2022-12-27	WOS:000265114100005
J	Dowd, SE; Wolcott, RD; Sun, Y; McKeehan, T; Smith, E; Rhoads, D				Dowd, Scot E.; Wolcott, Randall D.; Sun, Yan; McKeehan, Trevor; Smith, Ethan; Rhoads, Daniel			Polymicrobial Nature of Chronic Diabetic Foot Ulcer Biofilm Infections Determined Using Bacterial Tag Encoded FLX Amplicon Pyrosequencing (bTEFAP)	PLOS ONE			English	Article								Background: Diabetic extremity ulcers are associated with chronic infections. Such ulcer infections are too often followed by amputation because there is little or no understanding of the ecology of such infections or how to control or eliminate this type of chronic infection. A primary impediment to the healing of chronic wounds is biofilm phenotype infections. Diabetic foot ulcers are the most common, disabling, and costly complications of diabetes. Here we seek to derive a better understanding of the polymicrobial nature of chronic diabetic extremity ulcer infections. Methods and Findings: Using a new bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP) approach we have evaluated the bacterial diversity of 40 chronic diabetic foot ulcers from different patients. The most prevalent bacterial genus associated with diabetic chronic wounds was Corynebacterium spp. Findings also show that obligate anaerobes including Bacteroides, Peptoniphilus, Fingoldia, Anaerococcus, and Peptostreptococcus spp. are ubiquitous in diabetic ulcers, comprising a significant portion of the wound biofilm communities. Other major components of the bacterial communities included commonly cultured genera such as Streptococcus, Serratia, Staphylococcus and Enterococcus spp. Conclusions: In this article, we highlight the patterns of population diversity observed in the samples and introduce preliminary evidence to support the concept of functional equivalent pathogroups (FEP). Here we introduce FEP as consortia of genotypically distinct bacteria that symbiotically produce a pathogenic community. According to this hypothesis, individual members of these communities when they occur alone may not cause disease but when they coaggregate or consort together into a FEP the synergistic effect provides the functional equivalence of well-known pathogens, such as Staphylococcus aureus, giving the biofilm community the factors necessary to maintain chronic biofilm infections. Further work is definitely warranted and needed in order to prove whether the FEPs concept is a viable hypothesis. The findings here also suggest that traditional culturing methods may be extremely biased as a diagnostic tool as they select for easily cultured organisms such as Staphylococcus aureus and against difficult to culture bacteria such as anaerobes. While PCR methods also have bias, further work is now needed in comparing traditional culture results to high-resolution molecular diagnostic methods such as bTEFAP.	[Dowd, Scot E.; Sun, Yan; McKeehan, Trevor] Res & Testing Lab, Lubbock, TX USA; [Wolcott, Randall D.; Rhoads, Daniel] Southwest Region Wound Care Ctr, Lubbock, TX USA; [Dowd, Scot E.; Smith, Ethan] Med Biofilm Res Inst, Lubbock, TX USA		Dowd, SE (corresponding author), Res & Testing Lab, Lubbock, TX USA.	sdowd@pathogenresearch.org	Rhoads, Daniel/AAN-5250-2020; Dowd, Scot E/M-5386-2017	Rhoads, Daniel/0000-0002-7636-5191; Dowd, Scot E/0000-0002-6296-1427	Research and Testing Laboratory	Research and Testing Laboratory	Research was funded by Research and Testing Laboratory internal research funds.	Adler AI, 1999, DIABETES CARE, V22, P1029, DOI 10.2337/diacare.22.7.1029; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BESSMAN AN, 1992, DIABETES CARE, V15, P1531, DOI 10.2337/diacare.15.11.1531; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Bowler P G, 1999, J Wound Care, V8, P216; Bowler PG, 1999, INT J DERMATOL, V38, P573, DOI 10.1046/j.1365-4362.1999.00738.x; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; Bradshaw DJ, 1996, MICROBIOL-UK, V142, P623, DOI 10.1099/13500872-142-3-623; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; BROOK I, 1987, CRC CR REV MICROBIOL, V14, P171, DOI 10.3109/10408418709104438; Brook I, 1998, INT J DERMATOL, V37, P426, DOI 10.1046/j.1365-4362.1998.00445.x; BROOK I, 1988, SURGERY, V104, P843; CARTWRIGHT CP, 1994, J CLIN MICROBIOL, V32, P1825, DOI 10.1128/JCM.32.7.1825-1826.1994; *CDCDFWC, 1999, DIABETES CARE, V22, P1354; CEILLEY RI, 1977, ARCH DERMATOL, V113, P646, DOI 10.1001/archderm.113.5.646; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Davis Stephen C, 2006, Curr Diab Rep, V6, P439, DOI 10.1007/s11892-006-0076-x; Dowd SE, 2007, FOODBORNE PATHOG DIS, V4, P187, DOI 10.1089/fpd.2006.0075; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P20, DOI 10.1097/01.blo.0000175124.52590.c0; HANSSON C, 1995, ACTA DERM-VENEREOL, V75, P24; HARTEMANNHEURTI.A, 2008, DIABETES METAB; Howell-Jones RS, 2005, J ANTIMICROB CHEMOTH, V55, P143, DOI 10.1093/jac/dkh513; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; KONTIAINEN S, 1988, ACTA DERM-VENEREOL, V68, P240; MACFARLANE DE, 1986, T ROY SOC TROP MED H, V80, P553, DOI 10.1016/0035-9203(86)90137-9; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; MAYRAND D, 1980, INFECT IMMUN, V27, P44, DOI 10.1128/IAI.27.1.44-50.1980; *MMWR, 2003, MMWR-MORBID MORTAL W, V52, P1098; *NAT DIAB INF CLEA, 2005, NAT DIAB STAT; Palmer RJ, 2006, J BACTERIOL, V188, P4117, DOI 10.1128/JB.01958-05; Palumbo P.J, 1985, DIABETES AM DIABETES; PECORARO RE, 1991, DIABETES, V40, P1305, DOI 10.2337/diabetes.40.10.1305; Percival SL, 2008, WOUND REPAIR REGEN, V16, P52, DOI 10.1111/j.1524-475X.2007.00350.x; Ramsey SD, 1999, PHARMACOECONOMICS, V16, P285, DOI 10.2165/00019053-199916030-00005; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Rasmussen K, 1998, BIOTECHNOL BIOENG, V59, P302, DOI 10.1002/(SICI)1097-0290(19980805)59:3<302::AID-BIT6>3.0.CO;2-F; ROTSTEIN OD, 1988, CAN J MICROBIOL, V34, P352, DOI 10.1139/m88-064; SMITH ADAM, 2004, WOUND CARE PRACTICE, P3; SUNDQVIST GK, 1979, INFECT IMMUN, V25, P685, DOI 10.1128/IAI.25.2.685-693.1979; Trengove N J, 1996, J Wound Care, V5, P277; Urbancic-Rovan V, 2000, DIABETIC MED, V17, P814, DOI 10.1046/j.1464-5491.2000.00374-2.x; von Graevenitz A, 1998, INFECTION, V26, P40; WHEAT LJ, 1986, ARCH INTERN MED, V146, P1935, DOI 10.1001/archinte.146.10.1935; Wolcott R D, 2008, J Wound Care, V17, P145; Wolcott RD, 2008, JAMA-J AM MED ASSOC, V299, P2682, DOI 10.1001/jama.299.22.2682	52	374	389	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3326	10.1371/journal.pone.0003326	http://dx.doi.org/10.1371/journal.pone.0003326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833331	Green Published, gold, Green Submitted			2022-12-27	WOS:000264797400004
J	El-Manzalawy, Y; Dobbs, D; Honavar, V				El-Manzalawy, Yasser; Dobbs, Drena; Honavar, Vasant			On Evaluating MHC-II Binding Peptide Prediction Methods	PLOS ONE			English	Article							PROTEIN; MOLECULES; CLASSIFICATION; DATABASE	Choice of one method over another for MHC-II binding peptide prediction is typically based on published reports of their estimated performance on standard benchmark datasets. We show that several standard benchmark datasets of unique peptides used in such studies contain a substantial number of peptides that share a high degree of sequence identity with one or more other peptide sequences in the same dataset. Thus, in a standard cross-validation setup, the test set and the training set are likely to contain sequences that share a high degree of sequence identity with each other, leading to overly optimistic estimates of performance. Hence, to more rigorously assess the relative performance of different prediction methods, we explore the use of similarity-reduced datasets. We introduce three similarity-reduced MHC-II benchmark datasets derived from MHCPEP, MHCBN, and IEDB databases. The results of our comparison of the performance of three MHC-II binding peptide prediction methods estimated using datasets of unique peptides with that obtained using their similarity-reduced counterparts shows that the former can be rather optimistic relative to the performance of the same methods on similarity-reduced counterparts of the same datasets. Furthermore, our results demonstrate that conclusions regarding the superiority of one method over another drawn on the basis of performance estimates obtained using commonly used datasets of unique peptides are often contradicted by the observed performance of the methods on the similarity-reduced versions of the same datasets. These results underscore the importance of using similarity-reduced datasets in rigorously comparing the performance of alternative MHC-II peptide prediction methods.	[El-Manzalawy, Yasser; Honavar, Vasant] Iowa State Univ, Dept Comp Sci, Ctr Computat Intelligence Learning & Discovery, Ames, IA 50011 USA; [Dobbs, Drena] Iowa State Univ, Ctr Computat Intelligence, Learning & Discovery, Bioinformat & Computat Biol Grad Program, Dept Genet, Dev & Cell Biol, Ames, IA 50011 USA	Iowa State University; Iowa State University	El-Manzalawy, Y (corresponding author), Iowa State Univ, Dept Comp Sci, Ctr Computat Intelligence Learning & Discovery, Ames, IA 50011 USA.	yasser@iastate.edu	El-Manzalawy, Yasser/ABE-3489-2020; Honavar, Vasant G/K-9835-2015	Honavar, Vasant G/0000-0001-5399-3489; Dobbs, Drena/0000-0003-4404-9554	Egyptian Government [doctoral fellowship]; National Institutes of Health [GM066387]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R33GM066387, R21GM066387] Funding Source: NIH RePORTER	Egyptian Government; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by a doctoral fellowship from the Egyptian Government to Yasser EL-Manzalawy and a grant from the National Institutes of Health (GM066387) to Vasant Honavar.	Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bhasin M, 2003, BIOINFORMATICS, V19, P665, DOI 10.1093/bioinformatics/btg055; Bhasin M, 2004, BIOINFORMATICS, V20, P421, DOI 10.1093/bioinformatics/btg424; Brusic V, 1998, NUCLEIC ACIDS RES, V26, P368, DOI 10.1093/nar/26.1.368; BURDEN F, 2006, J MOL GRAPH MODEL, P481; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Chinnasamy A, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P387; Cui J, 2007, MOL IMMUNOL, V44, P866, DOI 10.1016/j.molimm.2006.04.001; Demsar J, 2006, J MACH LEARN RES, V7, P1; Donnes P, 2006, NUCLEIC ACIDS RES, V34, pW194, DOI 10.1093/nar/gkl284; Fisher Ronald A., 1973, STAT METHODS SCI INF; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Garcia JE, 2007, BIOCHEM BIOPH RES CO, V355, P409, DOI 10.1016/j.bbrc.2007.01.167; Gowthaman U, 2008, J PROTEOME RES, V7, P154, DOI 10.1021/pr070527b; Hertz T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S3; Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071; LESLIE C, 2002, P PSB, V7, P566; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Mallios RR, 2003, HUM IMMUNOL, V64, P852, DOI 10.1016/S0198-8859(03)00142-3; Mamitsuka H, 1998, PROTEINS, V33, P460, DOI 10.1002/(SICI)1097-0134(19981201)33:4<460::AID-PROT2>3.0.CO;2-M; Murugan Naveen, 2005, Immunome Res, V1, P6, DOI 10.1186/1745-7580-1-6; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Noguchi H, 2002, J BIOSCI BIOENG, V94, P264, DOI 10.1263/jbb.94.264; OSULLIVAN D, 1991, J IMMUNOL, V146, P1240; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Platt J., 1999, FAST TRAINING SUPPOR; RAGHAVA G, MHCBENCH EVALUATION; Rajapakse M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-459; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; Saigo H, 2004, BIOINFORMATICS, V20, P1682, DOI 10.1093/bioinformatics/bth141; Salomon J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-501; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Tsoumakas G., 2007, INT J DATA WAREHOUS, V3, P1; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Witten I. H., 2005, DATA MINING PRACTICA; YU H, 2006, 8 INT C SIGN PROC; Zhang GL, 2007, J IMMUNOL METHODS, V320, P143, DOI 10.1016/j.jim.2006.12.011	42	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3268	10.1371/journal.pone.0003268	http://dx.doi.org/10.1371/journal.pone.0003268			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MG	18813344	Green Published, gold, Green Submitted			2022-12-27	WOS:000264431800007
J	Thomas, T; Evans, FF; Schleheck, D; Mai-Prochnow, A; Burke, C; Penesyan, A; Dalisay, DS; Stelzer-Braid, S; Saunders, N; Johnson, J; Ferriera, S; Kjelleberg, S; Egan, S				Thomas, Torsten; Evans, Flavia F.; Schleheck, David; Mai-Prochnow, Anne; Burke, Catherine; Penesyan, Anahit; Dalisay, Doralyn S.; Stelzer-Braid, Sacha; Saunders, Neil; Johnson, Justin; Ferriera, Steve; Kjelleberg, Staffan; Egan, Suhelen			Analysis of the Pseudoalteromonas tunicata Genome Reveals Properties of a Surface-Associated Life Style in the Marine Environment	PLOS ONE			English	Article							MERCURY-RESISTANT BACTERIA; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; CHITIN DEGRADATION; PROTEIN; BIOSYNTHESIS; SEQUENCE; GENES; IDENTIFICATION; COLONIZATION	Background: Colonisation of sessile eukaryotic host surfaces (e. g. invertebrates and seaweeds) by bacteria is common in the marine environment and is expected to create significant inter-species competition and other interactions. The bacterium Pseudoalteromonas tunicata is a successful competitor on marine surfaces owing primarily to its ability to produce a number of inhibitory molecules. As such P. tunicata has become a model organism for the studies into processes of surface colonisation and eukaryotic host-bacteria interactions. Methodology/Principal Findings: To gain a broader understanding into the adaptation to a surface-associated life-style, we have sequenced and analysed the genome of P. tunicata and compared it to the genomes of closely related strains. We found that the P. tunicata genome contains several genes and gene clusters that are involved in the production of inhibitory compounds against surface competitors and secondary colonisers. Features of P. tunicata's oxidative stress response, iron scavenging and nutrient acquisition show that the organism is well adapted to high-density communities on surfaces. Variation of the P. tunicata genome is suggested by several landmarks of genetic rearrangements and mobile genetic elements (e. g. transposons, CRISPRs, phage). Surface attachment is likely to be mediated by curli, novel pili, a number of extracellular polymers and potentially other unexpected cell surface proteins. The P. tunicata genome also shows a utilisation pattern of extracellular polymers that would avoid a degradation of its recognised hosts, while potentially causing detrimental effects on other host types. In addition, the prevalence of recognised virulence genes suggests that P. tunicata has the potential for pathogenic interactions. Conclusions/Significance: The genome analysis has revealed several physiological features that would provide P. tunciata with competitive advantage against other members of the surface-associated community. We have also identified properties that could mediate interactions with surfaces other than its currently recognised hosts. This together with the detection of known virulence genes leads to the hypothesis that P. tunicata maintains a carefully regulated balance between beneficial and detrimental interactions with a range of host surfaces.	[Thomas, Torsten; Evans, Flavia F.; Schleheck, David; Mai-Prochnow, Anne; Burke, Catherine; Penesyan, Anahit; Stelzer-Braid, Sacha; Kjelleberg, Staffan; Egan, Suhelen] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Johnson, Justin; Ferriera, Steve] J Craig Venter Inst, Rockville, MD USA; [Schleheck, David] Univ Konstanz, Dept Biol, D-7750 Constance, Germany; [Mai-Prochnow, Anne] Univ Nottingham, Ctr Biomol Sci, Inst Infect, Immun & Inflammat, Nottingham NG7 2RD, England; [Dalisay, Doralyn S.] Unive Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Saunders, Neil] Univ Queensland, Sch Mol & Microb Sci, St Lucia, Qld 4067, Australia; [Stelzer-Braid, Sacha] Prince Wales Hosp, S East Area Lab Serv, Randwick, NSW, Australia	University of New South Wales Sydney; J. Craig Venter Institute; University of Konstanz; University of Nottingham; University of California System; University of California San Diego; University of Queensland	Thomas, T (corresponding author), Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia.	t.thomas@unsw.edu.au	Burke, Catherine/C-5664-2014; Penesyan, Anahit/A-9442-2012; Kjelleberg, Staffan/AAB-4641-2020; Kjelleberg, Staffan/C-9229-2015; Saunders, Neil/B-5325-2010; Dalisay, Doralyn S/I-7558-2016; Mai-Prochnow, Anne/D-3954-2013; Penesyan, Anahit/Y-6884-2019	Penesyan, Anahit/0000-0002-2502-0740; Kjelleberg, Staffan/0000-0003-4271-6413; Kjelleberg, Staffan/0000-0003-4271-6413; Saunders, Neil/0000-0003-2139-6107; Mai-Prochnow, Anne/0000-0003-0136-9144; Penesyan, Anahit/0000-0002-2502-0740; Thomas, Torsten/0000-0001-9557-3001; Stelzer-Braid, Sacha/0000-0001-6037-9305; Burke, Catherine/0000-0002-8917-0019; Egan, Suhelen/0000-0003-3286-4279; Dalisay, Doralyn/0000-0003-2850-7797	Betty and Gordon Moore Foundation; Australian Research Council Discovery Project	Betty and Gordon Moore Foundation(Gordon and Betty Moore Foundation); Australian Research Council Discovery Project(Australian Research Council)	Sequencing and assembly were supported by the Betty and Gordon Moore Foundation as part of its Marine Microbial Sequencing Project (www.moore.org/marinemicro). The JCVI software team, under the leadership of Saul A. Kravitz, manages assembly and Web delivery of data for the GBMF-funded project (http://moore.jcvi.org). This research was also supported by funds provided by the Australian Research Council Discovery Project scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; BARTLETT DH, 1989, J BACTERIOL, V171, P1763, DOI 10.1128/jb.171.3.1763-1766.1989; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Baynham PJ, 2006, J BACTERIOL, V188, P132, DOI 10.1128/JB.188.1.132-140.2006; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; BERK SG, 2001, INT BIODETERIATION B, V34, P387; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Bowman JP, 2007, MAR DRUGS, V5, P220, DOI 10.3390/md20070017; Braithwaite RA, 2005, ADV MAR BIOL, V47, P215; Burke C, 2007, ENVIRON MICROBIOL, V9, P814, DOI 10.1111/j.1462-2920.2006.01177.x; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; CARSIOTIS M, 1989, INFECT IMMUN, V57, P3276, DOI 10.1128/IAI.57.11.3276-3280.1989; Casadevall A, 2007, EUKARYOT CELL, V6, P2169, DOI 10.1128/EC.00308-07; Chiu HH, 2007, INT J SYST EVOL MICR, V57, P1209, DOI 10.1099/ijs.0.64762-0; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Dalisay DS, 2006, MICROBIOL-SGM, V152, P2875, DOI 10.1099/mic.0.29158-0; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Egan S, 2002, ENVIRON MICROBIOL, V4, P433, DOI 10.1046/j.1462-2920.2002.00322.x; Egan S, 2001, FEMS MICROBIOL ECOL, V35, P67, DOI 10.1111/j.1574-6941.2001.tb00789.x; Egan S, 2008, CURR OPIN MICROBIOL, V11, P219, DOI 10.1016/j.mib.2008.04.001; Eilers H, 2000, APPL ENVIRON MICROB, V66, P3044, DOI 10.1128/AEM.66.7.3044-3051.2000; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; FONG ST, 1995, MOL MICROBIOL, V15, P1127, DOI 10.1111/j.1365-2958.1995.tb02286.x; Franco AV, 1998, J BACTERIOL, V180, P2670, DOI 10.1128/JB.180.10.2670-2675.1998; Franks A, 2006, APPL ENVIRON MICROB, V72, P6079, DOI 10.1128/AEM.00559-06; Franks A, 2005, MOLECULES, V10, P1286, DOI 10.3390/10101286; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haas BJ, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-7; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Higgins BP, 2007, P NATL ACAD SCI USA, V104, P1901, DOI 10.1073/pnas.0608633104; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; HOLMSTROM C, 1992, APPL ENVIRON MICROB, V58, P2111; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; Huxley-Jones J, 2007, MATRIX BIOL, V26, P2, DOI 10.1016/j.matbio.2006.09.008; Ivanova EP, 2002, CURR MICROBIOL, V44, P357, DOI 10.1007/s00284-001-0017-5; James SG, 1996, APPL ENVIRON MICROB, V62, P2783, DOI 10.1128/AEM.62.8.2783-2788.1996; Jeter C, 2005, MOL PLANT MICROBE IN, V18, P1235, DOI 10.1094/MPMI-18-1235; Kanamori T, 2004, J BACTERIOL, V186, P2532, DOI 10.1128/JB.186.9.2532-2539.2004; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Kolowith LC, 2001, LIMNOL OCEANOGR, V46, P309, DOI 10.4319/lo.2001.46.2.0309; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LeCleir GR, 2004, APPL ENVIRON MICROB, V70, P6977, DOI 10.1128/AEM.70.12.6977-6983.2004; Ling JML, 2006, CAN J MICROBIOL, V52, P831, DOI 10.1139/W06-042; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MAIPROCHNOW A, 2008, J BACTERIOL; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Markowitz Victor M., 2007, V395, P35; Matthysse AG, 2004, P NATL ACAD SCI USA, V101, P986, DOI 10.1073/pnas.0303623101; MATZ C, 2008, PLOS ONE IN PRESS; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Miyamoto K, 2007, ARCH MICROBIOL, V188, P619, DOI 10.1007/s00203-007-0283-0; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Morelle S, 2003, J BACTERIOL, V185, P2618, DOI 10.1128/JB.185.8.2618-2627.2003; Oppermann-Sanio FB, 2002, NATURWISSENSCHAFTEN, V89, P11, DOI 10.1007/s00114-001-0280-0; Potin P, 2002, CURR OPIN PLANT BIOL, V5, P308, DOI 10.1016/S1369-5266(02)00273-X; Preston GM, 2005, FEMS MICROBIOL REV, V29, P331, DOI 10.1016/j.femsre.2004.12.004; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Qian PY, 2007, MAR BIOTECHNOL, V9, P399, DOI 10.1007/s10126-007-9001-9; Ramaiah N, 2003, MICROB ECOL, V45, P444, DOI 10.1007/s00248-001-1068-7; Rao D, 2005, APPL ENVIRON MICROB, V71, P1729, DOI 10.1128/AEM.71.4.1729-1736.2005; Rao D, 2007, APPL ENVIRON MICROB, V73, P7844, DOI 10.1128/AEM.01543-07; Robertus JD, 1999, EXS, V87, P125; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; RUSSELL MA, 1994, MOL MICROBIOL, V13, P973, DOI 10.1111/j.1365-2958.1994.tb00489.x; Rychel AL, 2006, MOL BIOL EVOL, V23, P541, DOI 10.1093/molbev/msj055; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; SMITH DC, 1992, NATURE, V359, P139, DOI 10.1038/359139a0; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; SPANGENBERG C, 1995, FEMS MICROBIOL LETT, V125, P265; STELZER S, 2006, THESIS U NEW S WALES; Stelzer S, 2006, MICROBIOL-SGM, V152, P1385, DOI 10.1099/mic.0.28740-0; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Suzumura M, 1998, LIMNOL OCEANOGR, V43, P1553, DOI 10.4319/lo.1998.43.7.1553; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Techkarnjanaruk S, 1999, MICROBIOL-SGM, V145, P925, DOI 10.1099/13500872-145-4-925; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Tsujibo H, 1999, J BACTERIOL, V181, P5461, DOI 10.1128/JB.181.17.5461-5466.1999; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vera J, 1998, APPL ENVIRON MICROB, V64, P4378; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Vogan CL, 2002, MICROBIOL-SGM, V148, P743, DOI 10.1099/00221287-148-3-743; Wang Y, 2006, J ENVIRON SCI, V18, P543; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531	96	100	102	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3252	10.1371/journal.pone.0003252	http://dx.doi.org/10.1371/journal.pone.0003252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MG	18813346	Green Published, gold, Green Submitted			2022-12-27	WOS:000264431800003
J	Basha, G; Lizee, G; Reinicke, AT; Seipp, RP; Omilusik, KD; Jefferies, WA				Basha, Genc; Lizee, Gregory; Reinicke, Anna T.; Seipp, Robyn P.; Omilusik, Kyla D.; Jefferies, Wilfred A.			MHC Class I Endosomal and Lysosomal Trafficking Coincides with Exogenous Antigen Loading in Dendritic Cells	PLOS ONE			English	Article								Background: Cross-presentation by dendritic cells (DCs) is a crucial prerequisite for effective priming of cytotoxic T-cell responses against bacterial, viral and tumor antigens; however, this antigen presentation pathway remains poorly defined. Methodology/Principal Findings: In order to develop a comprehensive understanding of this process, we tested the hypothesis that the internalization of MHC class I molecules (MHC-I) from the cell surface is directly involved in cross-presentation pathway and the loading of antigenic peptides. Here we provide the first examination of the internalization of MHC-I in DCs and we demonstrate that the cytoplasmic domain of MHC-I appears to act as an addressin domain to route MHC-I to both endosomal and lysosomal compartments of DCs, where it is demonstrated that loading of peptides derived from exogenously-derived proteins occurs. Furthermore, by chasing MHC-I from the cell surface of normal and transgenic DCs expressing mutant forms of MHC-I, we observe that a tyrosine-based endocytic trafficking motif is required for the constitutive internalization of MHC-I molecules from the cell surface into early endosomes and subsequently deep into lysosomal peptide-loading compartments. Finally, our data support the concept that multiple pathways of peptide loading of cross-presented antigens may exist depending on the chemical nature and size of the antigen requiring processing. Conclusions/Significance: We conclude that DCs have 'hijacked' and adapted a common vacuolar/endocytic intracellular trafficking pathway to facilitate MHC I access to the endosomal and lysosomal compartments where antigen processing and loading and antigen cross-presentation takes place.	[Basha, Genc; Lizee, Gregory; Reinicke, Anna T.; Seipp, Robyn P.; Omilusik, Kyla D.; Jefferies, Wilfred A.] Univ British Columbia, Dept Microbiol & Immunol, Michael Smith Labs, Biomed Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Basha, Genc; Lizee, Gregory; Reinicke, Anna T.; Seipp, Robyn P.; Omilusik, Kyla D.; Jefferies, Wilfred A.] Univ British Columbia, Dept Zool, Michael Smith Lab, Biomed Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Basha, Genc; Lizee, Gregory; Reinicke, Anna T.; Seipp, Robyn P.; Omilusik, Kyla D.; Jefferies, Wilfred A.] Univ British Columbia, Dept Med Genet, Michael Smith Lab, Biomed Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Basha, G (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Michael Smith Labs, Biomed Res Ctr, Vancouver, BC V5Z 1M9, Canada.	wilf@brc.ubc.ca		Basha, Genc/0000-0003-0471-2892; Lizee, Gregory/0000-0003-4449-7461; Omilusik, Kyla/0000-0003-3675-048X	Canadian Institute for Health Research (CIHR); BC Transplantation Society; Michael Smith Foundation for Health Research (MSHRF); Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); BC Transplantation Society; Michael Smith Foundation for Health Research (MSHRF)(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was funded by Canadian Institute for Health Research (CIHR), BC Transplantation Society and the Michael Smith Foundation for Health Research (MSHRF). R.P.S. gratefully acknowledges funding from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Michael Smith Foundation for Health Research (MSFHR).	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Bachmann MF, 1995, EUR J IMMUNOL, V25, P3445, DOI 10.1002/eji.1830251236; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; BLANDER JM, 2006, TOLL DEPENDENT SELEC; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; DASGUPTA JD, 1988, J IMMUNOL, V141, P2577; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Guermonprez P, 2005, SPRINGER SEMIN IMMUN, V26, P257, DOI 10.1007/s00281-004-0176-0; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Imai J, 2005, INT IMMUNOL, V17, P45, DOI 10.1093/intimm/dxh184; Kleijmeer MJ, 2001, TRAFFIC, V2, P124, DOI 10.1034/j.1600-0854.2001.020207.x; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Liu TM, 1997, J IMMUNOL, V159, P5364; Lizee G, 2005, TRENDS IMMUNOL, V26, P141, DOI 10.1016/j.it.2005.01.005; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; MacAry PA, 2001, P NATL ACAD SCI USA, V98, P3982, DOI 10.1073/pnas.071477498; MCCLUSKEY J, 1986, EMBO J, V5, P2477, DOI 10.1002/j.1460-2075.1986.tb04524.x; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Palliser D, 2005, J IMMUNOL, V174, P1879, DOI 10.4049/jimmunol.174.4.1879; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; Ramirez MC, 2004, TRENDS MICROBIOL, V12, P204, DOI 10.1016/j.tim.2004.03.008; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Santos SG, 2004, J BIOL CHEM, V279, P53062, DOI 10.1074/jbc.M408794200; Shen LJ, 2006, CURR OPIN IMMUNOL, V18, P85, DOI 10.1016/j.coi.2005.11.003; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; SUGITA M, 1995, J BIOL CHEM, V270, P1443, DOI 10.1074/jbc.270.3.1443; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3	33	64	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2008	3	9							e3247	10.1371/journal.pone.0003247	http://dx.doi.org/10.1371/journal.pone.0003247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LF	18802471	gold, Green Published, Green Submitted			2022-12-27	WOS:000264428600007
J	Kitazaki, M; Kobiki, H; Maloney, LT				Kitazaki, Michiteru; Kobiki, Hisashi; Maloney, Laurence T.			Effect of Pictorial Depth Cues, Binocular Disparity Cues and Motion Parallax Depth Cues on Lightness Perception in Three-Dimensional Virtual Scenes	PLOS ONE			English	Article							RECOGNIZED VISUAL SPACE; PERCEIVED SPATIAL ARRANGEMENT; SURFACE COLOR-PERCEPTION; VIEWED SCENES; ILLUMINATION; CONSTANCY; SEGMENTATION; REFLECTANCE; BRIGHTNESS; ROUGHNESS	Background: Surface lightness perception is affected by scene interpretation. There is some experimental evidence that perceived lightness under bi-ocular viewing conditions is different from perceived lightness in actual scenes but there are also reports that viewing conditions have little or no effect on perceived color. We investigated how mixes of depth cues affect perception of lightness in three-dimensional rendered scenes containing strong gradients of illumination in depth. Methodology/Principal Findings: Observers viewed a virtual room (4 m width x 5 m height x 17.5 m depth) with checkerboard walls and floor. In four conditions, the room was presented with or without binocular disparity (BD) depth cues and with or without motion parallax (MP) depth cues. In all conditions, observers were asked to adjust the luminance of a comparison surface to match the lightness of test surfaces placed at seven different depths (8.5-17.5 m) in the scene. We estimated lightness versus depth profiles in all four depth cue conditions. Even when observers had only pictorial depth cues (no MP, no BD), they partially but significantly discounted the illumination gradient in judging lightness. Adding either MP or BD led to significantly greater discounting and both cues together produced the greatest discounting. The effects of MP and BD were approximately additive. BD had greater influence at near distances than far. Conclusions/Significance: These results suggest the surface lightness perception is modulated by three-dimensional perception/interpretation using pictorial, binocular-disparity, and motion-parallax cues additively. We propose a two-stage (2D and 3D) processing model for lightness perception.	[Kitazaki, Michiteru] Toyohashi Univ Technol, Res Ctr Future Vehicle, Aichi, Japan; [Kobiki, Hisashi] Toshiba Co Ltd, Corporate Res & Dev Ctr, Kanagawa, Japan; [Maloney, Laurence T.] NYU, Ctr Neural Sci, Dept Psychol, New York, NY USA	Toyohashi University of Technology; Toshiba Corporation; New York University	Kitazaki, M (corresponding author), Toyohashi Univ Technol, Res Ctr Future Vehicle, Tempakucho, Aichi, Japan.	mich@tutkie.tut.ac.jp	Kitazaki, Mitchiteru/AAI-6554-2020	Kitazaki, Mitchiteru/0000-0003-0966-4842	Nissan Science Foundation; MEXT Japan; NIH [EY08266]; NATIONAL EYE INSTITUTE [R01EY008266] Funding Source: NIH RePORTER	Nissan Science Foundation; MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Nissan Science Foundation to MK, for designing and conducting experiments, collecting data, and writing the manuscript. The Global COE Program: Frontiers of Intelligent Sensing by MEXT Japan to HK, for research meetings. NIH EY08266 to LTM, for the design of the study and modeling.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; Adelson E.H., 1991, COMPUTATIONAL MODELS, P3; Anderson BL, 2005, NATURE, V434, P79, DOI 10.1038/nature03271; Anderson BL, 2003, PSYCHOL REV, V110, P785, DOI 10.1037/0033-295X.110.4.785; Basri R, 2003, IEEE T PATTERN ANAL, V25, P218, DOI 10.1109/TPAMI.2003.1177153; Bloj MG, 1999, NATURE, V402, P877, DOI 10.1038/47245; Boyaci H, 2003, J VISION, V3, P541, DOI 10.1167/3.8.2; Boyaci H, 2004, J VISION, V4, P664, DOI 10.1167/4.9.1; Boyaci H, 2006, VISUAL NEUROSCI, V23, P311, DOI 10.1017/S0952523806233431; Brunswik E, 1929, Z PSYCHOL PHYSIOL SI, V109, P40; Doerschner K, 2007, VISION RES, V47, P3409, DOI 10.1016/j.visres.2007.09.020; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; FLOCK HR, 1970, PERCEPT PSYCHOPHYS, V8, P251, DOI 10.3758/BF03210216; Gershun A., 1939, J MATH PHYS, V18, P51, DOI [10.1002/sapm193918151, DOI 10.1002/SAPM193918151]; GILCHRIST AL, 1980, PERCEPT PSYCHOPHYS, V28, P527, DOI 10.3758/BF03198821; GILCHRIST AL, 1977, SCIENCE, V195, P185, DOI 10.1126/science.831266; GOGEL WC, 1969, PERCEPT PSYCHOPHYS, V5, P13, DOI 10.3758/BF03210471; Ho YX, 2006, J VISION, V6, P634, DOI 10.1167/6.5.8; Ho YX, 2007, J VISION, V7, DOI 10.1167/7.1.1; HOCHBERG JE, 1954, J EXP PSYCHOL, V47, P263, DOI 10.1037/h0056283; Ikeda M, 1998, OPT REV, V5, P380, DOI 10.1007/s10043-998-0380-6; Ikeda M, 1998, OPT REV, V5, P200, DOI 10.1007/s10043-998-0200-z; Knill D. C., 1996, PERCEPTION BAYESIAN, P1, DOI [DOI 10.1017/CBO9780511984037, 10.1017/cbo9780511984037, 10.1017/CBO9780511984037]; Kraft JM, 2002, PERCEPTION, V31, P247, DOI 10.1068/p08sp; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Levine M., 2000, FUNDAMENTALS SENSATI; Logvinenko AD, 2002, PERCEPTION, V31, P73, DOI 10.1068/p3171; Logvinenko AD, 2008, PERCEPT PSYCHOPHYS, V70, P828, DOI 10.3758/PP.70.5.828; Mamassian P, 2002, NEU INF PRO, P13; Mamassian P, 2001, VISION RES, V41, P2653, DOI 10.1016/S0042-6989(01)00147-X; MERSHON DH, 1970, AM J PSYCHOL, V83, P55, DOI 10.2307/1420855; Mizokami Y, 1998, OPT REV, V5, P315, DOI 10.1007/s10043-998-0315-2; Mizokami Y, 2004, OPT REV, V11, P288, DOI 10.1007/s10043-004-0288-8; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; NAKAYAMA K, 1992, SCIENCE, V257, P1357, DOI 10.1126/science.1529336; Purves D., 2003, WHY WE SEE WHAT WE E; RAMANATHAN R, 2001, ESSAYS ECONOMETRICS, P497; Ripamonti C, 2004, J VISION, V4, P747, DOI 10.1167/4.9.7; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; SCHIRILLO J, 1990, PERCEPT PSYCHOPHYS, V48, P82, DOI 10.3758/BF03205014; SCHIRILLO JA, 1993, J OPT SOC AM A, V10, P2442, DOI 10.1364/JOSAA.10.002442; Snyder JL, 2005, J VISION, V5, P863, DOI 10.1167/5.10.8; Thouless RH, 1931, B J PSYCHOL-GEN SECT, V21, P339, DOI 10.1111/j.2044-8295.1931.tb00597.x; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Werner A, 2006, PERCEPTION, V35, P1171, DOI 10.1068/p5476; Wolff W, 1933, PSYCHOL FORSCH, V18, P90, DOI 10.1007/BF02409628; Yang JN, 2002, VISION RES, V42, P1979, DOI 10.1016/S0042-6989(02)00098-6	47	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3177	10.1371/journal.pone.0003177	http://dx.doi.org/10.1371/journal.pone.0003177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422KD	18781201	Green Published, Green Submitted, gold			2022-12-27	WOS:000264425700009
J	Szafran, AT; Szwarc, M; Marcelli, M; Mancini, MA				Szafran, Adam T.; Szwarc, Maria; Marcelli, Marco; Mancini, Michael A.			Androgen Receptor Functional Analyses by High Throughput Imaging: Determination of Ligand, Cell Cycle, and Mutation-Specific Effects	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; COMPLEMENTARY-DNA; NUCLEAR RECEPTOR; BINDING DOMAIN; IN-VITRO; TRANSCRIPTION; EXPRESSION; DYNAMICS; COMPARTMENTALIZATION; PHOSPHORYLATION	Background: Understanding how androgen receptor (AR) function is modulated by exposure to steroids, growth factors or small molecules can have important mechanistic implications for AR-related disease therapies (e. g., prostate cancer, androgen insensitivity syndrome, AIS), and in the analysis of environmental endocrine disruptors. Methodology/Principal Findings: We report the development of a high throughput (HT) image- based assay that quantifies AR subcellular and subnuclear distribution, and transcriptional reporter gene activity on a cell-by-cell basis. Furthermore, simultaneous analysis of DNA content allowed determination of cell cycle position and permitted the analysis of cell cycle dependent changes in AR function in unsynchronized cell populations. Assay quality for EC50 coefficients of variation were 5-24%, with Z' values reaching 0.91. This was achieved by the selective analysis of cells expressing physiological levels of AR, important because minor over-expression resulted in elevated nuclear speckling and decreased transcriptional reporter gene activity. A small screen of AR-binding ligands, including known agonists, antagonists, and endocrine disruptors, demonstrated that nuclear translocation and nuclear "speckling'' were linked with transcriptional output, and specific ligands were noted to differentially affect measurements for wild type versus mutant AR, suggesting differing mechanisms of action. HT imaging of patient-derived AIS mutations demonstrated a proof-of-principle personalized medicine approach to rapidly identify ligands capable of restoring multiple AR functions. Conclusions/Significance: HT imaging-based multiplex screening will provide a rapid, systems-level analysis of compounds/RNAi that may differentially affect wild type AR or clinically relevant AR mutations.	[Szafran, Adam T.; Szwarc, Maria; Marcelli, Marco; Mancini, Michael A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Marcelli, Marco] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Szafran, AT (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	mancini@bcm.edu	marcelli, marco/AGR-6853-2022		NIDDK [DK-55622, HD-07495]; VA Merit Review Grant; John S. Dunn Chemical Genomics Consortium; Dan L. Duncan BCM Cancer Center; Keck Center of the Gulf Coast Consortia; NIH [5 T90 DK070109-03, 5 R90 DK071505-03]; Cancer Center Institute, Warsaw, Poland; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007495, P30HD007495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055622, R90DK071505, T90DK070109] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); VA Merit Review Grant(US Department of Veterans Affairs); John S. Dunn Chemical Genomics Consortium; Dan L. Duncan BCM Cancer Center; Keck Center of the Gulf Coast Consortia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Institute, Warsaw, Poland; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by NIDDK grants DK-55622 (MAM) and HD-07495 (Center for Reproductive Biology, BW O'Malley) for support of the Integrated Microscopy Core in addition to a VA Merit Review Grant (MM). The John S. Dunn Chemical Genomics Consortium provided support for automation hardware. The Dan L. Duncan BCM Cancer Center provided support for hardware and software. In addition, this work was supported in part by a training fellowships from the Pharmacoinformatics Training Program of the Keck Center of the Gulf Coast Consortia (NIH Grant No. 5 T90 DK070109-03 and 5 R90 DK071505-03), and The Cancer Center Institute, Warsaw, Poland (MS). No funding sources had any role in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Berno V, 2006, METHOD ENZYMOL, V414, P188, DOI 10.1016/s0076-6879(06)14011-2; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Dehm SM, 2005, EXPERT REV ANTICANC, V5, P63, DOI 10.1586/14737140.5.1.63; DEVORE J, 1995, PRABABILITY STAT ENG; DOERING CH, 1984, J STEROID BIOCHEM, V20, P1157, DOI 10.1016/0022-4731(84)90360-1; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Gasparri F, 2006, J BIOMOL SCREEN, V11, P586, DOI 10.1177/1087057106289406; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Guo JM, 2007, MOL CANCER THER, V6, P907, DOI 10.1158/1535-7163.MCT-06-0231; HOECK W, 1992, J STEROID BIOCHEM, V41, P283, DOI 10.1016/0960-0760(92)90353-K; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; HU JM, 1994, MOL ENDOCRINOL, V8, P1709, DOI 10.1210/me.8.12.1709; ICCVAM, 2006, NIH PUB; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Korner W, 2004, ENVIRON HEALTH PERSP, V112, P695, DOI 10.1289/ehp.112-1241964; Lee S, 2006, METHOD ENZYMOL, V414, P468, DOI 10.1016/S0076-6879(06)14025-2; Lombardo F, 2005, J Endocrinol Invest, V28, P51; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; MARCELLI M, 1994, J CLIN INVEST, V94, P1642, DOI 10.1172/JCI117507; Marcelli M, 2003, CONT ENDOCRINOL, P157; Marcelli M, 2000, CANCER RES, V60, P944; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Martinez ED, 2002, J BIOL CHEM, V277, P29719, DOI 10.1074/jbc.M112134200; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Morelock MM, 2005, ASSAY DRUG DEV TECHN, V3, P483, DOI 10.1089/adt.2005.3.483; Narayanan R, 2005, MOL CELL BIOL, V25, P2885, DOI 10.1128/MCB.25.8.2885-2898.2005; Pienta KJ, 2005, CA-CANCER J CLIN, V55, P300, DOI 10.3322/canjclin.55.5.300; Pirog EC, 1999, J CLIN ENDOCR METAB, V84, P3217, DOI 10.1210/jc.84.9.3217; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Saitoh M, 2002, MOL ENDOCRINOL, V16, P694, DOI 10.1210/me.16.4.694; Sharp ZD, 2004, J CELL BIOCHEM, V92, P664, DOI 10.1002/jcb.20028; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Sultan C, 2001, MOL CELL ENDOCRINOL, V178, P99, DOI 10.1016/S0303-7207(01)00430-0; Taplin ME, 1999, CANCER RES, V59, P2511; TILLEY WD, 1989, P NATL ACAD SCI USA, V86, P327, DOI 10.1073/pnas.86.1.327; Tomura A, 2001, J BIOL CHEM, V276, P28395, DOI 10.1074/jbc.M101755200; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; Uzumcu M, 2004, REPROD TOXICOL, V18, P765, DOI 10.1016/j.reprotox.2004.05.008; van Royen ME, 2007, J CELL BIOL, V177, P63, DOI 10.1083/jcb.200609178; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; WONG CI, 1995, J BIOL CHEM, V270, P19998, DOI 10.1074/jbc.270.34.19998; YUAN SX, 1993, CANCER RES, V53, P1304; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698; [No title captured]	49	46	46	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3605	10.1371/journal.pone.0003605	http://dx.doi.org/10.1371/journal.pone.0003605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978937	Green Submitted, Green Published, gold			2022-12-27	WOS:000265134200004
J	Chen, YH; Su, LH; Huang, YC; Wang, YT; Kao, YY; Sun, CH				Chen, Yi-Hsiu; Su, Li-Hsin; Huang, Yu-Chang; Wang, Yi-Ting; Kao, Yu-Yun; Sun, Chin-Hung			UPF1, a Conserved Nonsense-Mediated mRNA Decay Factor, Regulates Cyst Wall Protein Transcripts in Giardia lamblia	PLOS ONE			English	Article								The Giardia lamblia cyst wall is required for survival outside the host and infection. Three cyst wall protein (cwp) genes identified to date are highly up-regulated during encystation. However, little is known of the molecular mechanisms governing their gene regulation. Messenger RNAs containing premature stop codons are rapidly degraded by a nonsense-mediated mRNA decay (NMD) system to avoid production of non-functional proteins. In addition to RNA surveillance, NMD also regulates thousands of naturally occurring transcripts through a variety of mechanisms. It is interesting to know the NMD pathway in the primitive eukaryotes. Previously, we have found that the giardial homologue of a conserved NMD factor, UPF1, may be functionally conserved and involved in NMD and in preventing nonsense suppression. In this study, we tested the hypothesis that NMD factors can regulate some naturally occurring transcripts in G. lamblia. We found that overexpression of UPF1 resulted in a significant decrease of the levels of CWP1 and cyst formation and of the endogenous cwp1-3, and myb2 mRNA levels and stability. This indicates that NMD could contribute to the regulation of the cwp1-3 and myb2 transcripts, which are key to G. lamblia differentiation into cyst. Interestingly, we also found that UPF1 may be involved in regulation of eight other endogenous genes, including up-regulation of the translation elongation factor gene, whose product increases translation which is required for NMD. Our results indicate that NMD factor could contribute to the regulation of not only nonsense containing mRNAs, but also mRNAs of the key encystation-induced genes and other endogenous genes in the early-diverging eukaryote, G. lamblia.	[Chen, Yi-Hsiu; Su, Li-Hsin; Huang, Yu-Chang; Wang, Yi-Ting; Kao, Yu-Yun; Sun, Chin-Hung] Natl Taiwan Univ, Coll Med, Dept Parasitol, Taipei 10764, Taiwan	National Taiwan University	Chen, YH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Parasitol, Taipei 10764, Taiwan.	chinhsun@ntu.edu.tw	Shin, Jerry/AAO-2515-2021	SUN, CHIN-HUNG/0000-0002-8604-8085	National Science Council [96-2320-B-002-040-MY3]; National Health Research Institutes in Taiwan [NHRI-EX96-9510NC, NHRI-EX97-9510NC]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants from the National Science Council (NSC 96-2320-B-002-040-MY3) and the National Health Research Institutes (NHRI-EX96-9510NC and NHRI-EX97-9510NC) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Applequist SE, 1997, NUCLEIC ACIDS RES, V25, P814, DOI 10.1093/nar/25.4.814; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Dahlseid JN, 1998, GENETICS, V150, P1019; Ford AS, 2006, EUKARYOT CELL, V5, P301, DOI 10.1128/EC.5.2.301-312.2006; Gonzalez CI, 2001, GENE, V274, P15, DOI 10.1016/S0378-1119(01)00552-2; HASHIMOTO T, 1994, MOL BIOL EVOL, V11, P65; HASHIMOTO T, 1995, MOL BIOL EVOL, V12, P782; He F, 1997, MOL CELL BIOL, V17, P1580, DOI 10.1128/MCB.17.3.1580; Huang YC, 2008, J BIOL CHEM, V283, P31021, DOI 10.1074/jbc.M805023200; Kebaara B, 2003, NUCLEIC ACIDS RES, V31, P3157, DOI 10.1093/nar/gkg430; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; Lelivelt MJ, 1999, MOL CELL BIOL, V19, P6710; Li L, 2006, MOL MICROBIOL, V59, P202, DOI 10.1111/j.1365-2958.2005.04896.x; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maderazo AB, 2000, MOL CELL BIOL, V20, P4591, DOI 10.1128/MCB.20.13.4591-4603.2000; Marshall MM, 1997, CLIN MICROBIOL REV, V10, P67, DOI 10.1128/CMR.10.1.67; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Ondarza R. N., 2007, Infectious Disorders - Drug Targets, V7, P266, DOI 10.2174/187152607782110059; Page MF, 1999, MOL CELL BIOL, V19, P5943; Perlick HA, 1996, P NATL ACAD SCI USA, V93, P10928, DOI 10.1073/pnas.93.20.10928; Sanders J, 1996, J CELL SCI, V109, P1113; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2006, MOL BIOCHEM PARASIT, V146, P45, DOI 10.1016/j.molbiopara.2005.10.017; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Sun CH, 1998, MOL BIOCHEM PARASIT, V92, P123, DOI 10.1016/S0166-6851(97)00239-9; Taylor R, 2005, EUKARYOT CELL, V4, P2066, DOI 10.1128/EC.4.12.2066-2077.2005; Wang CH, 2007, J BIOL CHEM, V282, P8905, DOI 10.1074/jbc.M611170200; Wang WR, 2006, MOL CELL BIOL, V26, P3390, DOI 10.1128/MCB.26.9.3390-3400.2006; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Wilkinson MF, 2005, TRENDS GENET, V21, P143, DOI 10.1016/j.tig.2005.01.007; WOLFE MS, 1992, CLIN MICROBIOL REV, V5, P93, DOI 10.1128/CMR.5.1.93-100.1992	47	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3609	10.1371/journal.pone.0003609	http://dx.doi.org/10.1371/journal.pone.0003609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974834	Green Submitted, gold, Green Published			2022-12-27	WOS:000265131700025
J	Kojic, LD; Wiseman, SM; Ghaidi, F; Joshi, B; Nedev, H; Saragovi, HU; Nabi, IR				Kojic, Liliana D.; Wiseman, Sam M.; Ghaidi, Fariba; Joshi, Bharat; Nedev, Hinyu; Saragovi, H. Uri; Nabi, Ivan R.			Raft-Dependent Endocytosis of Autocrine Motility Factor/Phosphoglucose Isomerase: A Potential Drug Delivery Route for Tumor Cells	PLOS ONE			English	Article								Background: Autocrine motility factor/phosphoglucose isomerase (AMF/PGI) is the extracellular ligand for the gp78/AMFR receptor overexpressed in a variety of human cancers. We showed previously that raft-dependent internalization of AMF/PGI is elevated in metastatic MDA-435 cells, but not metastatic, caveolin-1-expressing MDA-231 cells, relative to non-metastatic MCF7 and dysplastic MCF10A cells suggesting that it might represent a tumor cell-specific endocytic pathway. Methodology/Principal Findings: Similarly, using flow cytometry, we demonstrate that raft-dependent endocytosis of AMF/PGI is increased in metastatic HT29 cancer cells expressing low levels of caveolin-1 relative to metastatic, caveolin-1expressing, HCT116 colon cells and non-metastatic Caco-2 cells. Therefore, we exploited the raft-dependent internalization of AMF/PGI as a potential tumor-cell specific targeting mechanism. We synthesized an AMF/PGI-paclitaxel conjugate and found it to be as efficient as free paclitaxel in inducing cytotoxicity and apoptosis in tumor cells that readily internalize AMF/PGI compared to tumor cells that poorly internalize AMF/PGI. Murine K1735-M1 and B16-F1 melanoma cells internalize FITC-conjugated AMF/PGI and are acutely sensitive to AMF/PGI-paclitaxel mediated cytotoxicity in vitro. Moreover, following in vivo intratumoral injection, FITC-conjugated AMF/PGI is internalized in K1735-M1 tumors. Intratumoral injection of AMF/PGI-paclitaxel induced significantly higher tumor regression compared to free paclitaxel, even in B16-F1 cells, known to be resistant to taxol treatment. Treatment with AMF/PGI-paclitaxel significantly prolonged the median survival time of tumor bearing mice. Free AMF/PGI exhibited a pro-survival role, reducing the cytotoxic effect of both AMF/PGI-paclitaxel and free paclitaxel suggesting that AMF/PGI-paclitaxel targets a pathway associated with resistance to chemotherapeutic agents. AMF/PGI-FITC uptake by normal murine spleen and thymus cells was negligible both in vitro and following intravenous injection in vivo where AMF/PGI-FITC was selectively internalized by subcutaneous B16-F1 tumor cells. Conclusions/Significance: The raft-dependent endocytosis of AMF/PGI may therefore represent a tumor cell specific endocytic pathway of potential value for drug delivery to tumor cells.	[Kojic, Liliana D.; Ghaidi, Fariba; Joshi, Bharat; Nabi, Ivan R.] Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada; [Wiseman, Sam M.; Ghaidi, Fariba] Univ British Columbia, St Pauls Hosp, Dept Surg, Vancouver, BC V5Z 1M9, Canada; [Nedev, Hinyu; Saragovi, H. Uri] McGill Univ, Lady Davis Res Inst, Montreal, PQ H3A 2T5, Canada	University of British Columbia; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; McGill University	Kojic, LD (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada.	irnabi@interchange.ubc.ca	Nabi, Ivan/GWZ-5144-2022	Nabi, Ivan/0000-0002-0670-0513	Canadian Institutes for Health Research [MOP-64333]; Michael Smith Scholar	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Scholar	Supported by grant MOP-64333 to IRN and SMW from the Canadian Institutes for Health Research. SMW is a Michael Smith Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; BAUMANN M, 1990, CANCER INVEST, V8, P351, DOI 10.3109/07357909009012053; BENLIMAME N, 1995, J CELL BIOL, V129, P459, DOI 10.1083/jcb.129.2.459; Benlimame N, 1998, MOL BIOL CELL, V9, P1773, DOI 10.1091/mbc.9.7.1773; BODANSKY O, 1954, CANCER, V7, P1200, DOI 10.1002/1097-0142(195411)7:6<1200::AID-CNCR2820070612>3.0.CO;2-9; CHAPUT M, 1988, NATURE, V332, P454, DOI 10.1038/332454a0; Chiu CG, 2008, EXPERT REV ANTICANC, V8, P207, DOI 10.1586/14737140.8.2.207; FAIK P, 1988, NATURE, V332, P455, DOI 10.1038/332455a0; FILELLA X, 1991, TUMOR BIOL, V12, P360, DOI 10.1159/000217737; Funasaka T, 2005, FASEB J, V19, P1422, DOI 10.1096/fj.05-3699com; Funasaka T, 2002, INT J CANCER, V101, P217, DOI 10.1002/ijc.10617; Funasaka T, 2001, BIOCHEM BIOPH RES CO, V285, P118, DOI 10.1006/bbrc.2001.5135; Funasaka T, 2007, J BIOL CHEM, V282, P36362, DOI 10.1074/jbc.M706301200; Goetz JG, 2006, BIOCHEM SOC T, V34, P370, DOI 10.1042/BST0340370; Goetz JG, 2007, J CELL SCI, V120, P3553, DOI 10.1242/jcs.03486; Guillemard V, 2004, CURR CANCER DRUG TAR, V4, P313, DOI 10.2174/1568009043332989; Guillemard V, 2001, CANCER RES, V61, P694; GUIRGUIS R, 1990, J OCCUP ENVIRON MED, V32, P846, DOI 10.1097/00043764-199009000-00017; GURNEY ME, 1986, SCIENCE, V234, P574, DOI 10.1126/science.3020690; GURNEY ME, 1986, J CELL BIOL, V102, P2264, DOI 10.1083/jcb.102.6.2264; Haga A, 2003, INT J CANCER, V107, P707, DOI 10.1002/ijc.11449; JOSHI B, 2008, CANC RES IN PRESS; KANBE K, 1994, BBA-MOL CELL RES, V1222, P395, DOI 10.1016/0167-4889(94)90046-9; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Kojic LD, 2007, J BIOL CHEM, V282, P29305, DOI 10.1074/jbc.M704069200; KUMAR N, 1981, J BIOL CHEM, V256, P435; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; LAJOIE P, 2007, J CELL MOL MED UNPUB; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; Leclerc N, 2000, J NEUROSCI RES, V60, P602, DOI 10.1002/(SICI)1097-4547(20000601)60:5<602::AID-JNR5>3.0.CO;2-F; LIOTTA LA, 1986, P NATL ACAD SCI USA, V83, P3302, DOI 10.1073/pnas.83.10.3302; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; NABI IR, 1990, CANCER RES, V50, P409; NABI IR, 1988, CANCER RES, V48, P1258; NABI IR, 1987, INT J CANCER, V40, P396, DOI 10.1002/ijc.2910400319; Niinaka Y, 1998, CANCER RES, V58, P2667; PATEL PS, 1995, NEOPLASMA, V42, P271; Predescu SA, 2007, AM J PHYSIOL-LUNG C, V293, pL823, DOI 10.1152/ajplung.00436.2006; SCHWARTZ MK, 1973, CLIN CHEM, V19, P10; Silletti S, 1998, INT J CANCER, V76, P129, DOI 10.1002/(SICI)1097-0215(19980330)76:1<129::AID-IJC20>3.0.CO;2-6; Silletti S, 1998, INT J CANCER, V76, P120, DOI 10.1002/(SICI)1097-0215(19980330)76:1<120::AID-IJC19>3.3.CO;2-G; Silletti S, 1996, AM J PATHOL, V148, P1649; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Tsutsumi S, 2004, CLIN CANCER RES, V10, P7775, DOI 10.1158/1078-0432.CCR-04-1015; Tsutsumi S, 2003, CANCER RES, V63, P242; Tsutsumi S, 2002, CANCER RES, V62, P4484; Wang HJ, 2000, J CELL BIOL, V150, P1489, DOI 10.1083/jcb.150.6.1489; Watanabe H, 1996, CANCER RES, V56, P2960; Xu W, 1996, BLOOD, V87, P4502, DOI 10.1182/blood.V87.11.4502.bloodjournal87114502; Yanagawa T, 2004, LAB INVEST, V84, P513, DOI 10.1038/labinvest.3700057; Yang JL, 2005, ONCOLOGY-BASEL, V69, P224, DOI 10.1159/000088070	53	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3597	10.1371/journal.pone.0003597	http://dx.doi.org/10.1371/journal.pone.0003597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974847	gold, Green Submitted, Green Published			2022-12-27	WOS:000265131700018
J	Cai, XJ; Clapham, DE				Cai, Xinjiang; Clapham, David E.			Evolutionary Genomics Reveals Lineage-Specific Gene Loss and Rapid Evolution of a Sperm-Specific Ion Channel Complex: CatSpers and CatSper beta	PLOS ONE			English	Article								The mammalian CatSper ion channel family consists of four sperm-specific voltage-gated Ca(2+) channels that are crucial for sperm hyperactivation and male fertility. All four CatSper subunits are believed to assemble into a heteromultimeric channel complex, together with an auxiliary subunit, CatSperb. Here, we report a comprehensive comparative genomics study and evolutionary analysis of CatSpers and CatSperb, with important correlation to physiological significance of molecular evolution of the CatSper channel complex. The development of the CatSper channel complex with four CatSpers and CatSperb originated as early as primitive metazoans such as the Cnidarian Nematostella vectensis. Comparative genomics revealed extensive lineage-specific gene loss of all four CatSpers and CatSperb through metazoan evolution, especially in vertebrates. The CatSper channel complex underwent rapid evolution and functional divergence, while distinct evolutionary constraints appear to have acted on different domains and specific sites of the four CatSper genes. These results reveal unique evolutionary characteristics of sperm-specific Ca(2+) channels and their adaptation to sperm biology through metazoan evolution.	[Cai, Xinjiang] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Cai, Xinjiang] Duke Univ, Med Ctr, Dept Med Cardiol, Durham, NC 27706 USA; [Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Cambridge, MA 02138 USA; [Clapham, David E.] Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA USA	Duke University; Duke University; Harvard University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Cai, XJ (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	xinjiang.cai@duke.edu	Clapham, David/R-5974-2019; Cai, Xinjiang/F-4843-2010; Clapham, David/S-1123-2019	Cai, Xinjiang/0000-0001-8933-7133; Clapham, David/0000-0002-4459-9428	National Institutes of Health [HD045339, U01 45857]; American Heart Association [0625403U]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in part, by National Institutes of Health Grants HD045339 and NIH/U01 45857 (D.E.C.), and a Postdoctoral Fellowship Award (0625403U) from the American Heart Association (X.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson JO, 2001, SCIENCE, V292, P1848, DOI 10.1126/science.1062241; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cai XJ, 2008, MOL BIOL EVOL, V25, P1357, DOI 10.1093/molbev/msn077; Cai XJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000609; Cai XJ, 2008, J PHYSIOL-LONDON, V586, P925, DOI 10.1113/jphysiol.2007.149153; Cai XJ, 2007, J MOL BIOL, V368, P1284, DOI 10.1016/j.jmb.2007.03.022; Cai XJ, 2006, MOL BIOL EVOL, V23, P550, DOI 10.1093/molbev/msj056; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Clapham DE, 2005, PHARMACOL REV, V57, P451, DOI 10.1124/pr.57.4.7; Cosson J, 2008, REPRODUCTION, V136, P277, DOI 10.1530/REP-07-0522; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; Galindo BE, 2007, BIOCHEM BIOPH RES CO, V354, P668, DOI 10.1016/j.bbrc.2007.01.035; Fauci LJ, 2006, ANNU REV FLUID MECH, V38, P371, DOI 10.1146/annurev.fluid.37.061903.175725; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hofmann F, 2005, PHARMACOL REV, V57, P455, DOI 10.1124/pr.57.4.8; Ishijima S, 2002, MOL REPROD DEV, V61, P376, DOI 10.1002/mrd.10017; Ito M, 2004, P NATL ACAD SCI USA, V101, P10566, DOI 10.1073/pnas.0402692101; Jackson HA, 2007, PHYSIOL GENOMICS, V29, P231, DOI 10.1152/physiolgenomics.00142.2006; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Jin JL, 2007, BIOL REPROD, V77, P37, DOI 10.1095/biolreprod.107.060186; Jin JL, 2005, BIOL REPROD, V73, P1235, DOI 10.1095/biolreprod.105.045468; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Lawson C, 2007, MOL HUM REPROD, V13, P307, DOI 10.1093/molehr/gam012; Li W. H, 1997, MOL EVOLUTION; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Lobley Anna, 2003, Reprod Biol Endocrinol, V1, P53, DOI 10.1186/1477-7827-1-53; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; ODA S, 1993, CELL MOTIL CYTOSKEL, V25, P171, DOI 10.1002/cm.970250206; Okamura Y, 2005, PHYSIOL GENOMICS, V22, P269, DOI 10.1152/physiolgenomics.00229.2004; On C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-127; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Podlaha O, 2005, MOL BIOL EVOL, V22, P1845, DOI 10.1093/molbev/msi178; Podlaha O, 2003, P NATL ACAD SCI USA, V100, P12241, DOI 10.1073/pnas.2033555100; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Salzberg SL, 2001, SCIENCE, V292, P1903, DOI 10.1126/science.1061036; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Strunker T, 2006, NAT CELL BIOL, V8, P1149, DOI 10.1038/ncb1473; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; THOMSON MF, 1991, J REPROD FERTIL, V93, P385, DOI 10.1530/jrf.0.0930385; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Torres YP, 2007, J BIOL CHEM, V282, P24485, DOI 10.1074/jbc.R700022200; Trevino CL, 2001, FEBS LETT, V509, P119, DOI 10.1016/S0014-5793(01)03134-9; Vazquez-Martinez O, 2003, J CELL SCI, V116, P2483, DOI 10.1242/jcs.00455; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wang YF, 2001, GENETICS, V158, P1311; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010	69	77	79	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3569	10.1371/journal.pone.0003569	http://dx.doi.org/10.1371/journal.pone.0003569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974790	Green Submitted, Green Published, gold			2022-12-27	WOS:000265131500004
J	Menon, BB; Dou, Z; Heinhorst, S; Shively, JM; Cannon, GC				Menon, Balaraj B.; Dou, Zhicheng; Heinhorst, Sabine; Shively, Jessup M.; Cannon, Gordon C.			Halothiobacillus neapolitanus Carboxysomes Sequester Heterologous and Chimeric RubisCO Species	PLOS ONE			English	Article								Background: The carboxysome is a bacterial microcompartment that consists of a polyhedral protein shell filled with ribulose 1,5-bisphosphate carboxylase/oxygenase (RubisCO), the enzyme that catalyzes the first step of CO(2) fixation via the Calvin-Benson-Bassham cycle. Methodology/Principal Findings: To analyze the role of RubisCO in carboxysome biogenesis in vivo we have created a series of Halothiobacillus neapolitanus RubisCO mutants. We identified the large subunit of the enzyme as an important determinant for its sequestration into alpha-carboxysomes and found that the carboxysomes of H. neapolitanus readily incorporate chimeric and heterologous RubisCO species. Intriguingly, a mutant lacking carboxysomal RubisCO assembles empty carboxysome shells of apparently normal shape and composition. Conclusions/Significance: These results indicate that carboxysome shell architecture is not determined by the enzyme they normally sequester. Our study provides, for the first time, clear evidence that carboxysome contents can be manipulated and suggests future nanotechnological applications that are based upon engineered protein microcompartments.	[Menon, Balaraj B.; Dou, Zhicheng; Heinhorst, Sabine; Cannon, Gordon C.] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Shively, Jessup M.] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29631 USA	University of Southern Mississippi; Clemson University	Menon, BB (corresponding author), Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	gordon.cannon@usm.edu			National Science Foundation [MCB-0818680, DBI-0619455, DMR-0213883]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grants MCB-0818680, DBI-0619455 and DMR-0213883 from the National Science Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICHAY D, 1993, PLANT MOL BIOL, V23, P465, DOI 10.1007/BF00019295; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; ANDREWS TJ, 1985, J BIOL CHEM, V260, P4632; Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; Baker SH, 1998, J BACTERIOL, V180, P4133, DOI 10.1128/JB.180.16.4133-4139.1998; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Cai F, 2008, ARCH MICROBIOL, V189, P141, DOI 10.1007/s00203-007-0305-y; CANNON GC, 1983, ARCH MICROBIOL, V134, P52, DOI 10.1007/BF00429407; Cannon GC, 2003, CURR MICROBIOL, V46, P115, DOI 10.1007/s00284-002-3825-3; Cannon GC, 2002, FUNCT PLANT BIOL, V29, P175, DOI 10.1071/PP01200; Cot SSW, 2008, J BACTERIOL, V190, P936, DOI 10.1128/JB.01283-07; Dou ZC, 2008, J BIOL CHEM, V283, P10377, DOI 10.1074/jbc.M709285200; ENGLISH RS, 1995, APPL ENVIRON MICROB, V61, P3256, DOI 10.1128/AEM.61.9.3256-3260.1995; Getzoff TP, 1998, PLANT PHYSIOL, V116, P695, DOI 10.1104/pp.116.2.695; Heinhorst S, 2002, CURR MICROBIOL, V45, P115, DOI 10.1007/s00284-001-0094-5; Heinhorst S., 2006, COMPLEX INTRACELLULA, P141; Heinhorst S, 2006, J BACTERIOL, V188, P8087, DOI 10.1128/JB.00990-06; Hernandez JM, 1996, J BACTERIOL, V178, P347, DOI 10.1128/jb.178.2.347-356.1996; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Kanevski I, 1999, PLANT PHYSIOL, V119, P133, DOI 10.1104/pp.119.1.133; Karkehabadi S, 2005, BIOCHEMISTRY-US, V44, P9851, DOI 10.1021/bi050537v; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Long BM, 2007, J BIOL CHEM, V282, P29323, DOI 10.1074/jbc.M703896200; Ludwig M, 2000, J PHYCOL, V36, P1109, DOI 10.1046/j.1529-8817.2000.00028.x; ORUS MI, 1995, PLANT PHYSIOL, V107, P1159, DOI 10.1104/pp.107.4.1159; PIERCE J, 1989, P NATL ACAD SCI USA, V86, P5753, DOI 10.1073/pnas.86.15.5753; PRICE GD, 1991, CAN J BOT, V69, P963, DOI 10.1139/b91-124; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; READ BA, 1992, BIOCHEMISTRY-US, V31, P5553, DOI 10.1021/bi00139a018; Scott KM, 2006, PLOS BIOL, V4, P2196, DOI 10.1371/journal.pbio.0040383; Shively J. M., 2006, COMPLEX INTRACELLULA; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; VANDERVIES SM, 1986, EMBO J, V5, P2439, DOI 10.1002/j.1460-2075.1986.tb04519.x; Wang YL, 2001, ARCH BIOCHEM BIOPHYS, V396, P35, DOI 10.1006/abbi.2001.2555; Whitney SM, 2003, PLANT PHYSIOL, V133, P287, DOI 10.1104/pp.103.026146; Yoshizawa Y, 2004, J BACTERIOL, V186, P5685, DOI 10.1128/JB.186.17.5685-5691.2004; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	40	66	71	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3570	10.1371/journal.pone.0003570	http://dx.doi.org/10.1371/journal.pone.0003570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974784	Green Submitted, Green Published, gold			2022-12-27	WOS:000265131500005
J	Sanchez-Fernandez, MA; Gallois, A; Riedl, T; Jurdic, P; Hoflack, B				Sanchez-Fernandez, Maria Arantzazu; Gallois, Anne; Riedl, Thilo; Jurdic, Pierre; Hoflack, Bernard			Osteoclasts Control Osteoblast Chemotaxis via PDGF-BB/PDGF Receptor Beta Signaling	PLOS ONE			English	Article								Background: Bone remodeling relies on the tightly regulated interplay between bone forming osteoblasts and bone digesting osteoclasts. Several studies have now described the molecular mechanisms by which osteoblasts control osteoclastogenesis and bone degradation. It is currently unclear whether osteoclasts can influence bone rebuilding. Methodology/Principal Findings: Using in vitro cell systems, we show here that mature osteoclasts, but not their precursors, secrete chemotactic factors recognized by both mature osteoblasts and their precursors. Several growth factors whose expression is upregulated during osteoclastogenesis were identified by DNA microarrays as candidates mediating osteoblast chemotaxis. Our subsequent functional analyses demonstrate that mature osteoclasts, whose platelet-derived growth factor bb (PDGF-bb) expression is reduced by siRNAs, exhibit a reduced capability of attracting osteoblasts. Conversely, osteoblasts whose platelet-derived growth factor receptor beta (PDGFR-beta) expression is reduced by siRNAs exhibit a lower capability of responding to chemotactic factors secreted by osteoclasts. Conclusions/Significance: We conclude that, in vitro mature osteoclasts control osteoblast chemotaxis via PDGF-bb/PDGFR-beta signaling. This may provide one key mechanism by which osteoclasts control bone formation in vivo.	[Sanchez-Fernandez, Maria Arantzazu; Riedl, Thilo; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany; [Gallois, Anne; Jurdic, Pierre] Univ Claude Bernard Lyon 1, INRA, CNRS, Ecole Normale Superieure Lyon, Inst Genom Fonction, Lyon, France	Technische Universitat Dresden; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Sanchez-Fernandez, MA (corresponding author), Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany.	bernard.hoflack@biotec.tu-dresden.de	HOFLACK, Bernard/AAZ-6668-2020		TU-Dresden [HWP-1207]; BMBF [0313815B]; DFG [TRR 13/2-08, HO 2584/2-1, HO 2584/1-1]; Fondation pour la Recherche Medicale;  [SMWK-EFRE 1203]	TU-Dresden(European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); 	This work was supported in part by grants from TU-Dresden (HWP-1207), SMWK-EFRE 1203, BMBF (0313815B) and DFG (TRR 13/2-08, HO 2584/2-1, HO 2584/1-1) as well as by Fondation pour la Recherche Medicale (PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila HL, 2005, IMMUNOL REV, V208, P7, DOI 10.1111/j.0105-2896.2005.00333.x; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; Chandrasekhar S, 1996, J CELL PHYSIOL, V169, P481, DOI 10.1002/(SICI)1097-4652(199612)169:3<481::AID-JCP8>3.0.CO;2-K; Czupalla C, 2006, MOL CELL PROTEOMICS, V5, P134, DOI 10.1074/mcp.M500291-MCP200; Czupalla C, 2005, PROTEOMICS, V5, P3868, DOI 10.1002/pmic.200402059; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219; Fierro F, 2007, CELL PROLIFERAT, V40, P355, DOI 10.1111/j.1365-2184.2007.00438.x; Glass DA, 2006, ANN NY ACAD SCI, V1068, P117, DOI 10.1196/annals.1346.015; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; HooshmandRad R, 1997, EXP CELL RES, V234, P434, DOI 10.1006/excr.1997.3636; Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167; Kallin A, 2004, J BIOL CHEM, V279, P17897, DOI 10.1074/jbc.M312996200; Kaminski WE, 2001, BLOOD, V97, P1990, DOI 10.1182/blood.V97.7.1990; Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003; Kawamata A, 2008, J CELL BIOCHEM, V103, P1037, DOI 10.1002/jcb.21660; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kubota K, 2002, J BONE MINER RES, V17, P257, DOI 10.1359/jbmr.2002.17.2.257; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1; O'Sullivan S, 2007, J BONE MINER RES, V22, P1679, DOI 10.1359/JBMR.070719; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; TOKUNAGA A, 2008, J BONE MINER RES; Wagner EF, 2002, ANN RHEUM DIS, V61, P40, DOI 10.1136/ard.61.suppl_2.ii40; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang Q, 2008, J BIOL CHEM, V283, P13491, DOI 10.1074/jbc.M708055200; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	41	78	87	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3537	10.1371/journal.pone.0003537	http://dx.doi.org/10.1371/journal.pone.0003537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953417	Green Published, gold, Green Submitted			2022-12-27	WOS:000265130500012
J	Rabaneda-Bueno, R; Rodriguez-Girones, MA; Aguado-De-La-Paz, S; Fernandez-Montraveta, C; De Mas, E; Wise, DH; Moya-Larano, J				Rabaneda-Bueno, Ruben; Rodriguez-Girones, Miguel A.; Aguado-de-la-Paz, Sara; Fernandez-Montraveta, Carmen; De Mas, Eva; Wise, David H.; Moya-Larano, Jordi			Sexual Cannibalism: High Incidence in a Natural Population with Benefits to Females	PLOS ONE			English	Article							MEDITERRANEAN TARANTULAS; DOLOMEDES TRITON; FOOD LIMITATION; SPIDER; PATTERNS; BEHAVIOR; GROWTH; CONSEQUENCES; SURVIVORSHIP; COHABITATION	Background: Sexual cannibalism may be a form of extreme sexual conflict in which females benefit more from feeding on males than mating with them, and males avoid aggressive, cannibalistic females in order to increase net fitness. A thorough understanding of the adaptive significance of sexual cannibalism is hindered by our ignorance of its prevalence in nature. Furthermore, there are serious doubts about the food value of males, probably because most studies that attempt to document benefits of sexual cannibalism to the female have been conducted in the laboratory with non-natural alternative prey. Thus, to understand more fully the ecology and evolution of sexual cannibalism, field experiments are needed to document the prevalence of sexual cannibalism and its benefits to females. Methodology/Principal Findings: We conducted field experiments with the Mediterranean tarantula (Lycosa tarantula), a burrowing wolf spider, to address these issues. At natural rates of encounter with males, approximately a third of L. tarantula females cannibalized the male. The rate of sexual cannibalism increased with male availability, and females were more likely to kill and consume an approaching male if they had previously mated with another male. We show that females benefit from feeding on a male by breeding earlier, producing 30% more offspring per egg sac, and producing progeny of higher body condition. Offspring of sexually cannibalistic females dispersed earlier and were larger later in the season than spiderlings of non-cannibalistic females. Conclusions/Significance: In nature a substantial fraction of female L. tarantula kill and consume approaching males instead of mating with them. This behaviour is more likely to occur if the female has mated previously. Cannibalistic females have higher rates of reproduction, and produce higher-quality offspring, than non-cannibalistic females. Our findings further suggest that female L. tarantula are nutrient-limited in nature and that males are high-quality prey. The results of these field experiments support the hypothesis that sexual cannibalism is adaptive to females.	[Rabaneda-Bueno, Ruben; Rodriguez-Girones, Miguel A.; De Mas, Eva; Moya-Larano, Jordi] CSIC, Estn Expt Zonas Aridas, Dpto Ecol Func & Evolut, Almeria, Spain; [Aguado-de-la-Paz, Sara; Fernandez-Montraveta, Carmen] Univ Autonoma Madrid, Dpto Psicol Biol Salud, E-28049 Madrid, Spain; [Wise, David H.] Univ Illinois, Inst Environm Sci & Policy, Dept Biol Sci, Chicago, IL 60680 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Autonomous University of Madrid; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rabaneda-Bueno, R (corresponding author), CSIC, Estn Expt Zonas Aridas, Dpto Ecol Func & Evolut, Almeria, Spain.	jordi@eeza.csic.es	De Mas, Eva/H-9172-2015; Aguado, Sara/J-5698-2015; Rodriguez-Girones, Miguel A/H-1859-2015; Moya-Laraño, Jordi/K-8596-2014; Fernandez-Montraveta, Carmen/B-7178-2011; Bueno, Rubén Rabaneda/AAC-4048-2021; Wise, David./J-6111-2019	De Mas, Eva/0000-0001-8225-5805; Aguado, Sara/0000-0002-4703-6890; Rodriguez-Girones, Miguel A/0000-0002-5619-9819; Moya-Laraño, Jordi/0000-0001-7141-3206; Fernandez-Montraveta, Carmen/0000-0001-5790-1414; Bueno, Rubén Rabaneda/0000-0003-0701-8564; Wise, David./0000-0003-4072-0080	Spanish Ministry of Science and Technology (MCYT) [I3P-BPD2004-CSIC]; MEC [CGL2004-03153, CGL2007-60520]	Spanish Ministry of Science and Technology (MCYT)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MEC(European Commission)	This paper has been written under a Ramon y Cajal research contract from the Spanish Ministry of Science and Technology (MCYT) to JML and an I3P-BPD2004-CSIC scholarship to RRB. This work has been funded by MEC grants CGL2004-03153 and CGL2007-60520 to JML, MARG, RRB, CFM and DHW.	Arnqvist G, 1997, EVOL ECOL, V11, P255, DOI 10.1023/A:1018412302621; Collett D, 2003, C&H TEXT STAT SCI, P45; Craig CL, 2000, MOL BIOL EVOL, V17, P1904, DOI 10.1093/oxfordjournals.molbev.a026292; Cross WF, 2003, ECOL LETT, V6, P721, DOI 10.1046/j.1461-0248.2003.00481.x; Cross WF, 2007, ECOLOGY, V88, P2563, DOI 10.1890/06-1348.1; Elgar MA, 2004, ADV STUD BEHAV, V34, P135, DOI 10.1016/S0065-3454(04)34004-0; ELGAR MA, 1988, ANIM BEHAV, V36, P1511, DOI 10.1016/S0003-3472(88)80221-5; Elgar Mark A., 1998, P307, DOI 10.1016/B978-012100543-6/50034-9; Elgar Mark A., 1992, P128; Erez T, 2005, ETHOLOGY, V111, P693, DOI 10.1111/j.1439-0310.2005.01090.x; Fernandez-Montraveta C, 2007, J EVOLUTION BIOL, V20, P1689, DOI 10.1111/j.1420-9101.2007.01399.x; Fernandez-Montraveta C, 2003, CAN J ZOOL, V81, P552, DOI [10.1139/z03-015, 10.1139/Z03-015]; Foellmer Matthias W., 2007, P71; Fromhage L, 2003, BEHAV ECOL SOCIOBIOL, V55, P60, DOI 10.1007/s00265-003-0656-6; Fromhage L, 2005, BEHAV ECOL, V16, P377, DOI 10.1093/beheco/ari011; GREENSTONE MH, 1979, NATURE, V282, P501, DOI 10.1038/282501a0; Herberstein ME, 2002, BEHAV ECOL SOCIOBIOL, V51, P440, DOI 10.1007/s00265-002-0460-8; Humphreys W.F., 1983, Bulletin of the British Arachnological Society, V6, P124; Jackson R.R., 1980, Bulletin of the British Arachnological Society, V5, P129; Johns PM, 1997, TRENDS ECOL EVOL, V12, P127, DOI 10.1016/S0169-5347(97)01005-7; Johnson JC, 2005, BEHAV ECOL, V16, P269, DOI 10.1093/beheco/arh152; Johnson JC, 2001, ANIM BEHAV, V61, P905, DOI 10.1006/anbe.2000.1679; Kreiter N, 1996, J ARACHNOL, V24, P24; Maxwell MR, 2000, ECOL ENTOMOL, V25, P54, DOI 10.1046/j.1365-2311.2000.00227.x; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Mayntz D, 2006, J ANIM ECOL, V75, P288, DOI 10.1111/j.1365-2656.2006.01046.x; Mayntz D, 2001, OECOLOGIA, V127, P207, DOI 10.1007/s004420000591; Moya-Larano J, 2002, EVOLUTION, V56, P420, DOI 10.1111/j.0014-3820.2002.tb01351.x; Moya-Larano J, 2004, ETHOLOGY, V110, P717, DOI 10.1111/j.1439-0310.2004.01012.x; Moya-Larano J, 2000, ANIM BEHAV, V60, P307, DOI 10.1006/anbe.2000.1495; Moya-Larano J, 2003, ANIM BEHAV, V66, P469, DOI 10.1006/anbe.2003.2262; Moya-Larano J, 2003, OIKOS, V101, P539, DOI 10.1034/j.1600-0706.2003.12316.x; Moya-Larano J, 2002, FUNCT ECOL, V16, P734, DOI 10.1046/j.1365-2435.2002.00685.x; Moya-Larano J, 2002, ECOLOGY, V83, P356, DOI 10.2307/2680019; Moya-Larano J, 1998, INVESTIGACION GESTIO, V3, P73; Moya-Larano Jordi, 2003, Revista Iberica de Aracnologia, V7, P211; Moya-Larano J, 2007, ECOLOGY, V88, P1454, DOI 10.1890/05-1474; MOYALARANO J, 2008, J ANIM ECOL IN PRESS; MOYALARANO J, 1999, THESIS AUTONOMOUS U; MOYALARANO J, 1996, REV SUISSE ZOOL, P491; NEWMAN JA, 1991, AM NAT, V138, P1372, DOI 10.1086/285292; Orta JM, 1993, B ACCADEMIA GIOENIA, V26, P15; PARELLADA X, 1998, 2 TROBADES ESTUDIOSO, V26, P15; Piepho HP, 2003, J AGRON CROP SCI, V189, P310, DOI 10.1046/j.1439-037X.2003.00049.x; Prenter J, 2006, ANIM BEHAV, V71, P481, DOI 10.1016/j.anbehav.2005.05.011; SAMU F, 1993, OECOLOGIA, V94, P139, DOI 10.1007/BF00317315; Schneider JM, 2002, J EVOLUTION BIOL, V15, P84, DOI 10.1046/j.1420-9101.2002.00363.x; Schneider JM, 1998, OIKOS, V83, P496, DOI 10.2307/3546677; Toft S, 1999, OECOLOGIA, V119, P191, DOI 10.1007/s004420050776; UETZ GW, 1992, J ARACHNOL, V20, P207; VOLLRATH F, 1992, NATURE, V360, P156, DOI 10.1038/360156a0; Wagner JD, 1996, ECOLOGY, V77, P639, DOI 10.2307/2265637; Wagner JD, 1997, OECOLOGIA, V109, P474, DOI 10.1007/s004420050107; Wilder SM, 2008, ANIM BEHAV, V76, P439, DOI 10.1016/j.anbehav.2008.01.023; Williams JL, 2006, BEHAV ECOL, V17, P586, DOI 10.1093/beheco/ark003; Wise DH, 2006, ANNU REV ENTOMOL, V51, P441, DOI 10.1146/annurev.ento.51.110104.150947; Wise DH, 1993, SPIDERS ECOLOGICAL W	57	38	40	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3484	10.1371/journal.pone.0003484	http://dx.doi.org/10.1371/journal.pone.0003484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941517	Green Published, Green Submitted, gold			2022-12-27	WOS:000265126100015
J	Watanabe, Y; Sato, K				Watanabe, Yuuki; Sato, Katsufumi			Functional Dorsoventral Symmetry in Relation to Lift-Based Swimming in the Ocean Sunfish Mola mola	PLOS ONE			English	Article								The largest (up to 2 tons) and a globally distributed teleost-the ocean sunfish Mola mola-is commonly regarded as a planktonic fish because of its unusual shape including absence of caudal fin. This common view was recently questioned because the horizontal movements of the ocean sunfish tracked by acoustic telemetry were independent of ocean currents. However, direct information regarding their locomotor performance under natural conditions is still lacking. By using multi-sensor tags, we show that sunfish indeed swam continuously with frequent vertical movements at speeds of 0.4-0.7 m s(-1), which is similar to the records of other large fishes such as salmons, marlins, and pelagic sharks. The acceleration data revealed that they stroked their dorsal and anal fins synchronously (dominant frequency, 0.3-0.6 Hz) to generate a lift-based thrust, as penguins do using two symmetrical flippers. Morphological studies of sunfish (mass, 2-959 kg) showed that the dorsal and anal fins had similar external (symmetrical shape and identical area) and internal (identical locomotory muscle mass) features; however, the muscle shape differed markedly. We conclude that ocean sunfish have functional dorsoventral symmetry with regards to the non-homologous dorsal and anal fins that act as a pair of vertical hydrofoils. Although sunfish lack a swimbladder, we found that they are neutrally buoyant independent of depth because of their subcutaneous gelatinous tissue that has low density and is incompressible. Efficient lift-based swimming in conjunction with neutral buoyancy enables sunfish to travel long distances both horizontally and vertically.	[Sato, Katsufumi] Univ Tokyo, Ocean Res Inst, Int Coastal Res Ctr, Otsuchi, Iwate, Japan; [Watanabe, Yuuki] Natl Inst Polar Res, Tokyo, Japan	University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Watanabe, Y (corresponding author), Univ Tokyo, Ocean Res Inst, Int Coastal Res Ctr, Otsuchi, Iwate, Japan.	watanabe.yuuki@nipr.ac.jp	Watanabe, Yuuki/D-5079-2012	Watanabe, Yuuki/0000-0001-9731-1769	Japan Society for the Promotion of Science [19255001, Fellowships for Young Scientists]; Bio-logging Science of The University of Tokyo (UTBLS)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bio-logging Science of The University of Tokyo (UTBLS)	This work was funded by the Japan Society for the Promotion of Science (19255001), the JSPS Research Fellowships for Young Scientists (to Y.W.), and the program "Bio-logging Science of The University of Tokyo (UTBLS)" led by N. Miyazaki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M.N., 1967, FUNCTIONAL DESIGN FI; Alexander RM., 2003, PRINCIPLES ANIMAL LO; Arreola VI, 1996, P ROY SOC B-BIOL SCI, V263, P1689, DOI 10.1098/rspb.1996.0247; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; BLAKE RW, 1978, J MAR BIOL ASSOC UK, V58, P73, DOI 10.1017/S0025315400024401; BLOCK BA, 1992, J EXP BIOL, V166, P267; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; Cartamil DP, 2004, MAR ECOL PROG SER, V266, P245, DOI 10.3354/meps266245; CORNER EDS, 1969, PROC R SOC SER B-BIO, V171, P415, DOI 10.1098/rspb.1969.0003; Gordon MS, 1996, J FISH BIOL, V49, P319; Gregory WK, 1934, COPEIA, V4, P145; Hoerner S. F, 1965, HOERNER FLUID DYNAMI, V2nd; Hove JR, 2001, J EXP BIOL, V204, P1459; Johnson GD, 2005, J MORPHOL, V266, P11, DOI 10.1002/jmor.10242; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; KAWAKAMI Y, 2005, B TOTTORI PREF MUS, V42, P29; MAGNUSON JJ, 1970, COPEIA, P56, DOI 10.2307/1441976; McCANN CHARLES, 1961, REC DOMINION MUS, V4, P7; Nelson JS., 2016, FISHES WORLD, DOI DOI 10.1002/9781119174844.FMATTER; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Sato K, 2008, J EXP BIOL, V211, P58, DOI 10.1242/jeb.009811; Sato K, 2007, P R SOC B, V274, P471, DOI 10.1098/rspb.2006.0005; Tanaka H, 2005, MAR ECOL PROG SER, V291, P307, DOI 10.3354/meps291307; Tanaka H, 2001, J EXP BIOL, V204, P3895; Vogel S., 1994, LIFE MOVING FLUIDS P; Walker JA, 2000, P ROY SOC B-BIOL SCI, V267, P1875, DOI 10.1098/rspb.2000.1224; Watanabe Y, 2008, J ZOOL, V275, P381, DOI 10.1111/j.1469-7998.2008.00451.x; Watanabe Y, 2004, MAR ECOL PROG SER, V279, P283, DOI 10.3354/meps279283; Webb Paul W., 1993, P47; WEBB PW, 1984, AM ZOOL, V24, P107; WEIHS D, 1973, NATURE, V245, P48, DOI 10.1038/245048a0; YANCEY PH, 1989, MAR BIOL, V103, P453, DOI 10.1007/BF00399577; Zar JH, 1999, BIOSTATISTICAL ANAL	33	38	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3446	10.1371/journal.pone.0003446	http://dx.doi.org/10.1371/journal.pone.0003446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941510	gold, Green Published, Green Submitted			2022-12-27	WOS:000265126100001
J	Wan, XF; Nguyen, T; Davis, CT; Smith, CB; Zhao, ZM; Carrel, M; Inui, K; Do, HT; Mai, DT; Jadhao, S; Balish, A; Shu, B; Luo, F; Emch, M; Matsuoka, Y; Lindstrom, SE; Cox, NJ; Nguyen, CV; Klimov, A; Donis, RO				Wan, Xiu-Feng; Nguyen, Tung; Davis, C. Todd; Smith, Catherine B.; Zhao, Zi-Ming; Carrel, Margaret; Inui, Kenjiro; Do, Hoa T.; Mai, Duong T.; Jadhao, Samadhan; Balish, Amanda; Shu, Bo; Luo, Feng; Emch, Michael; Matsuoka, Yumiko; Lindstrom, Stephen E.; Cox, Nancy J.; Nguyen, Cam V.; Klimov, Alexander; Donis, Ruben O.			Evolution of Highly Pathogenic H5N1 Avian Influenza Viruses in Vietnam between 2001 and 2007	PLOS ONE			English	Article							INFERENCE; VACCINATION; EMERGENCE; OUTBREAK; MRBAYES	Highly pathogenic avian influenza (HPAI) H5N1 viruses have caused dramatic economic losses to the poultry industry of Vietnam and continue to pose a serious threat to public health. As of June 2008, Vietnam had reported nearly one third of worldwide laboratory confirmed human H5N1 infections. To better understand the emergence, spread and evolution of H5N1 in Vietnam we studied over 300 H5N1 avian influenza viruses isolated from Vietnam since their first detection in 2001. Our phylogenetic analyses indicated that six genetically distinct H5N1 viruses were introduced into Vietnam during the past seven years. The H5N1 lineage that evolved following the introduction in 2003 of the A/duck/Hong Kong/821/2002-like viruses, with clade 1 hemagglutinin (HA), continued to predominate in southern Vietnam as of May 2007. A virus with a clade 2.3.4 HA newly introduced into northern Vietnam in 2007, reassorted with pre-existing clade 1 viruses, resulting in the emergence of novel genotypes with neuraminidase (NA) and/or internal gene segments from clade 1 viruses. A total of nine distinct genotypes have been present in Vietnam since 2001, including five that were circulating in 2007. At least four of these genotypes appear to have originated in Vietnam and represent novel H5N1 viruses not reported elsewhere. Geographic and temporal analyses of H5N1 infection dynamics in poultry suggest that the majority of viruses containing new genes were first detected in northern Vietnam and subsequently spread to southern Vietnam after reassorting with pre-existing local viruses in northern Vietnam. Although the routes of entry and spread of H5N1 in Vietnam remain speculative, enhanced poultry import controls and virologic surveillance efforts may help curb the entry and spread of new HPAI viral genes.	[Wan, Xiu-Feng; Davis, C. Todd; Smith, Catherine B.; Zhao, Zi-Ming; Jadhao, Samadhan; Balish, Amanda; Shu, Bo; Matsuoka, Yumiko; Lindstrom, Stephen E.; Cox, Nancy J.; Klimov, Alexander; Donis, Ruben O.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Wan, Xiu-Feng; Zhao, Zi-Ming] Georgia Inst Technol, Sch Biol, Atlanta, GA USA; [Nguyen, Tung; Inui, Kenjiro; Do, Hoa T.; Mai, Duong T.; Nguyen, Cam V.] Natl Ctr Vet Diagnost, Dept Anim Hlth, Hanoi, Vietnam; [Carrel, Margaret; Emch, Michael] Univ N Carolina, Dept Geography, Chapel Hill, NC USA; [Inui, Kenjiro] Food & Agr Org Vietnam, Hanoi, Vietnam; [Luo, Feng] Clemson Univ, Sch Comput, Clemson, SC 29631 USA	Centers for Disease Control & Prevention - USA; University System of Georgia; Georgia Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; Food & Agriculture Organization of the United Nations (FAO); Clemson University	Wan, XF (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	rvd6@cdc.gov			Centers for Disease Control and Prevention; NSF [BCS-0717688, EPS-0447660]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NSF(National Science Foundation (NSF))	This work was funded in part by the Centers for Disease Control and Prevention. ME and XFW were partially supported by NSF Award BCS-0717688 and FL by NSF EPSCoT grant EPS-0447660.	Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Bao YM, 2004, J VIROL, V78, P7291, DOI 10.1128/JVI.78.14.7291-7298.2004; Capua I, 2007, VACCINE, V25, P4987, DOI 10.1016/j.vaccine.2007.01.113; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1204; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; CHEN H, 2006, P NATL ACAD SCI US; Duan L, 2007, J VIROL, V81, P7529, DOI 10.1128/JVI.00327-07; Ellis TM, 2004, AVIAN PATHOL, V33, P405, DOI 10.1080/03079450410001724012; *FAO, 2006, BIRD FLU OUTBR CONT; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Nguyen DC, 2005, J VIROL, V79, P4201, DOI 10.1128/JVI.79.7.4201-4212.2005; Nguyen TD, 2008, EMERG INFECT DIS, V14, P632, DOI 10.3201/eid1404.071343; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; SWOFFORD DL, 1998, PAUP PHYLOGENIC ANAL; Wallace RG, 2007, P NATL ACAD SCI USA, V104, P4473, DOI 10.1073/pnas.0700435104; Wan X-F., 1998, ISOLATION CHARACTERI; Wan XF, 2005, ARCH VIROL, V150, P1257, DOI 10.1007/s00705-004-0474-9; WAN XF, 2008, J BIOINFORM IN PRESS; Wan XF, 2007, BIOINFORMATICS, V23, P2368, DOI 10.1093/bioinformatics/btm354; Wan YF, 2007, AVIAN DIS, V51, P434, DOI 10.1637/7625-042706R1.1; Wang J, 2008, J VIROL, V82, P3405, DOI 10.1128/JVI.02468-07; Webster RG, 2007, AVIAN DIS, V51, P269, DOI 10.1637/7641-050206R.1; *WHO, 2007, CUM NUMB CONF HUM CA; *WHO, 2008, EMERG INFECT DIS JUL; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhao ZM, 2008, J GEN VIROL, V89, P2182, DOI 10.1099/vir.0.2008/001875-0; Zwickl DJ., 2006, THESIS	37	95	97	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3462	10.1371/journal.pone.0003462	http://dx.doi.org/10.1371/journal.pone.0003462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941631	Green Published, gold, Green Submitted			2022-12-27	WOS:000265125900006
J	Alelu-Paz, R; Iturrieta-Zuazo, I; Byne, W; Haroutunian, V; Garcia-Villanueva, M; Rabano, A; Garcia-Amado, M; Prensa, L; Gimenez-Amaya, JM				Alelu-Paz, Raul; Iturrieta-Zuazo, Ignacio; Byne, William; Haroutunian, Vahram; Garcia-Villanueva, Mercedes; Rabano, Alberto; Garcia-Amado, Maria; Prensa, Lucia; Manuel Gimenez-Amaya, Jose			A New Antigen Retrieval Technique for Human Brain Tissue	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; SUBSTANCE-P; MONOCLONAL-ANTIBODIES; FORMALIN FIXATION; NUCLEAR ANTIGEN; IMMUNOHISTOCHEMISTRY; PARAFFIN; PROTEIN; HEAT; IMMUNOREACTIVITY	Immunohistochemical staining of tissues is a powerful tool used to delineate the presence or absence of an antigen. During the last 30 years, antigen visualization in human brain tissue has been significantly limited by the masking effect of fixatives. In the present study, we have used a new method for antigen retrieval in formalin-fixed human brain tissue and examined the effectiveness of this protocol to reveal masked antigens in tissues with both short and long formalin fixation times. This new method, which is based on the use of citraconic acid, has not been previously utilized in brain tissue although it has been employed in various other tissues such as tonsil, ovary, skin, lymph node, stomach, breast, colon, lung and thymus. Thus, we reported here a novel method to carry out immunohistochemical studies in free-floating human brain sections. Since fixation of brain tissue specimens in formaldehyde is a commonly method used in brain banks, this new antigen retrieval method could facilitate immunohistochemical studies of brains with prolonged formalin fixation times.	[Alelu-Paz, Raul; Iturrieta-Zuazo, Ignacio; Garcia-Amado, Maria; Prensa, Lucia; Manuel Gimenez-Amaya, Jose] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain; [Iturrieta-Zuazo, Ignacio; Garcia-Amado, Maria] Univ Navarra, Clin Univ, Lab Neuromorfol Funcion, E-31080 Pamplona, Spain; [Byne, William; Haroutunian, Vahram] Mount Sinai Sch Med, Dept Psychiat, New York, NY USA; [Byne, William; Haroutunian, Vahram] Bronx Vet Affairs Med Ctr, Bronx, NY USA; [Garcia-Villanueva, Mercedes] Hosp Ramon & Cajal, Dept Anat Patol, Madrid, Spain; [Rabano, Alberto] Hosp Alcorcon, Lab Neuropatol, Madrid, Spain	Autonomous University of Madrid; University of Navarra; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Hospital Universitario Ramon y Cajal; Alcorcon Foundation University Hospital	Alelu-Paz, R (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain.	josemanuel.gimenezamaya@uam.es	byne, william/AAS-2338-2021; Waldvogel, Henry/D-6691-2012; Garcia-Amado Sancho, Maria/K-2705-2014	Alelu-Paz, Raul/0000-0002-3686-6506; Waldvogel, Henry/0000-0003-2165-8568; Garcia-Amado Sancho, Maria/0000-0001-6778-5680; Prensa Sepulveda, Lucia/0000-0003-2217-3271	Spanish Ministerio de Educacion y Ciencia [BFU2006-01189]	Spanish Ministerio de Educacion y Ciencia(Spanish Government)	This study was supported by a grant from the Spanish Ministerio de Educacion y Ciencia (BFU2006-01189). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alelu-Paz R, 2007, J NEURAL TRANSM, V114, P969, DOI 10.1007/s00702-007-0633-8; BANKFALVI A, 1994, J PATHOL, V174, P223, DOI 10.1002/path.1711740312; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CELIO MR, 1990, CELL CALCIUM, V11, P599, DOI 10.1016/0143-4160(90)90014-L; CHEN Y, 1993, MOL PHARMACOL, V44, P8; CUELLO AC, 1979, P NATL ACAD SCI USA, V76, P3532, DOI 10.1073/pnas.76.7.3532; CUELLO AC, 1984, J HISTOCHEM CYTOCHEM, V32, P947, DOI 10.1177/32.9.6086744; Dapson RW, 2007, BIOTECH HISTOCHEM, V82, P133, DOI 10.1080/10520290701567916; EVERS P, 1994, J HISTOCHEM CYTOCHEM, V42, P1555, DOI 10.1177/42.12.7983356; Fortin M, 1998, NEUROSCIENCE, V84, P537, DOI 10.1016/S0306-4522(97)00486-7; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Garcia-Cabezas MA, 2007, NEUROIMAGE, V34, P965, DOI 10.1016/j.neuroimage.2006.07.032; HELANDER KG, 1994, BIOTECH HISTOCHEM, V69, P177, DOI 10.3109/10520299409106282; HIRAI T, 1989, BRAIN RES REV, V14, P1, DOI 10.1016/0165-0173(89)90007-6; Holmes A, 2003, TRENDS PHARMACOL SCI, V24, P580, DOI 10.1016/j.tips.2003.09.011; IGARASHI H, 1994, APMIS, V102, P295, DOI 10.1111/j.1699-0463.1994.tb04879.x; Jones E.G., 1998, Handbook of Chemical Neuroanatomy, V14, P1; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Jones EG, 1985, THALAMUS; KALIN NH, 1988, BRAIN RES, V457, P130, DOI 10.1016/0006-8993(88)90064-9; KAWAI K, 1994, PATHOL INT, V44, P759; Keeble JE, 2004, NEUROSCI LETT, V361, P176, DOI 10.1016/j.neulet.2003.12.020; Kiernan J.A., 2000, MICROSC TODAY, V1, P8, DOI [10.1017/S1551929500057060, DOI 10.1017/S1551929500057060]; MASON JT, 1991, J HISTOCHEM CYTOCHEM, V39, P225, DOI 10.1177/39.2.1987266; Morel A, 1997, J COMP NEUROL, V387, P588, DOI 10.1002/(SICI)1096-9861(19971103)387:4<588::AID-CNE8>3.0.CO;2-Z; Munkle MC, 2000, J CHEM NEUROANAT, V19, P155, DOI 10.1016/S0891-0618(00)00060-0; Namimatsu S, 2005, J HISTOCHEM CYTOCHEM, V53, P3, DOI 10.1369/jhc.4C6466.2005; Napier TC, 1999, ANN NY ACAD SCI, V877, P176, DOI 10.1111/j.1749-6632.1999.tb09268.x; NORTON AJ, 1994, J PATHOL, V173, P371, DOI 10.1002/path.1711730413; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; olszewski j, 1952, THALAMUS MACACA MULA; PASHA T, 1995, LAB INVEST, V72, pA167; Pearse A.G.E., 1968, HISTOCHEMISTRY THEOR; Pileri SA, 1997, J PATHOL, V183, P116; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; SCHMAUSS C, 1984, J PHARMACOL EXP THER, V228, P1; Shi SR, 1999, J HISTOTECHNOL, V22, P177; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; SHI SR, 1995, J HISTOCHEM CYTOCHEM, V43, P193, DOI 10.1177/43.2.7822775; Shi SR, 1997, J HISTOCHEM CYTOCHEM, V45, P327, DOI 10.1177/002215549704500301; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; SUURMEIJER AJH, 1993, EUR J MORPHOL, V31, P144; Taylor CR, 1995, CAP TODAY, V9, P16; Uroz V, 2004, SYNAPSE, V51, P173, DOI 10.1002/syn.10298; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	46	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3378	10.1371/journal.pone.0003378	http://dx.doi.org/10.1371/journal.pone.0003378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852880	gold, Green Published, Green Submitted			2022-12-27	WOS:000265121600004
J	Fragoso-Loyo, H; Cabiedes, J; Orozco-Narvaez, A; Davila-Maldonado, L; Atisha-Fregoso, Y; Diamond, B; Llorente, L; Sanchez-Guerrero, J				Fragoso-Loyo, Hilda; Cabiedes, Javier; Orozco-Narvaez, Alejandro; Davila-Maldonado, Luis; Atisha-Fregoso, Yemil; Diamond, Betty; Llorente, Luis; Sanchez-Guerrero, Jorge			Serum and Cerebrospinal Fluid Autoantibodies in Patients with Neuropsychiatric Lupus Erythematosus. Implications for Diagnosis and Pathogenesis	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; GLUTAMATE-RECEPTOR ANTIBODIES; ANTIPHOSPHOLIPID ANTIBODIES; ASSOCIATION; MANIFESTATIONS; PERMEABILITY; PREVALENCE; DISEASE; DAMAGE	Background: Despite the uncertainty in the diagnosis of neuropsychiatric involvement in systemic lupus erythematosus (SLE), attempts have been made to record the association of certain antibodies in serum with neuropsychiatric (NP) manifestations. We aimed to assess the behaviour and the association of serum and cerebrospinal fluid (CSF) autoantibodies with NP manifestations in SLE patients (NPSLE). Methodology/Principal Findings: Forty-seven SLE patients, hospitalized because of NP manifestations were included. They were evaluated at hospitalization and six months later, and serum and CSF samples were obtained at each evaluation. As controls, serum samples were taken from 49 non-NPSLE patients at hospitalization and six months later; serum and CSF samples were also obtained from 6 SLE patients with septic meningitis, 16 surgical SLE patients and 25 patients without autoimmune diseases. Antinuclear, anti-dsDNA, anti-ribosomal P, Anti-N-Methyl-D-Aspartate receptor (NMDAR), anticardiolipin, and anti-beta 2 glycoprotein-I antibodies were measured. In serum, anti-ribosomal P, anti-NMDAR, and other antibodies did not differentiate among SLE groups, and the levels of all antibodies were similar among the SLE groups. Sixmonths later, this scenario remained unchanged and the decrease in the levels of some autoantibodies reflected a decline in disease activity, rather than a change in NPSLE. In CSF, only the presence and the levels of anti-NMDAR antibodies showed a characteristic distribution in central NPSLE and septic meningitis patients. Six months later the prevalence of most antibodies in CSF did not change, however the levels of anti-dsDNA, anti-ribosomal P, and anti-NMDAR decreased. Conclusion: In NPSLE, autoantibodies in serum do not reflect their behaviour in CSF. All autoantibodies were elevated in septic meningitis reflecting the global penetration of serum antibodies into the CSF in this condition. Anti-NMDAR antibodies in CSF identified patients with central NPSLE; their continued presence in CSF 6 months after neurologic symptoms raise questions regarding the conditions under which they are pathogenic.	[Fragoso-Loyo, Hilda; Cabiedes, Javier; Atisha-Fregoso, Yemil; Llorente, Luis; Sanchez-Guerrero, Jorge] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico; [Orozco-Narvaez, Alejandro; Davila-Maldonado, Luis] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Neurol, Mexico City, DF, Mexico; [Diamond, Betty] Feinstein Inst Med Res, Manhasset, NY USA	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Northwell Health	Fragoso-Loyo, H (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico.	jsanchezguerrero7@gmail.com	Llorente, Luis/GQP-7202-2022	Llorente, Luis/0000-0002-3464-3747				Abbott NJ, 2003, LUPUS, V12, P908, DOI 10.1191/0961203303lu501oa; Abdel-Rahman A, 2002, NEUROBIOL DIS, V10, P306, DOI 10.1006/nbdi.2002.0524; Ainiala H, 2001, NEUROLOGY, V57, P496, DOI 10.1212/WNL.57.3.496; Appenzeller S, 2005, ARTHRITIS RHEUM-US, V52, P2783, DOI 10.1002/art.21271; BLUESTEIN HG, 1981, AM J MED, V70, P240, DOI 10.1016/0002-9343(81)90756-7; BONFA E, 1987, NEW ENGL J MED, V317, P265, DOI 10.1056/NEJM198707303170503; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; Correale J, 2007, AUTOIMMUNITY, V40, P148, DOI 10.1080/08916930601183522; DEVINSKY O, 1988, ANN NEUROL, V23, P380, DOI 10.1002/ana.410230411; Esposito P, 2002, J PHARMACOL EXP THER, V303, P1061, DOI 10.1124/jpet.102.038497; Fragoso-Loyo H, 2007, ARTHRITIS RHEUM-US, V56, P1242, DOI 10.1002/art.22451; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2002, J RHEUMATOL, V29, P288; Greenwood DLV, 2002, AUTOIMMUNITY, V35, P79, DOI 10.1080/08916930290016547; HANLY JG, 1992, J RHEUMATOL, V19, P732; Hanly JG, 2004, J RHEUMATOL, V31, P2156; Hanly JG, 2006, J RHEUMATOL, V33, P1553; Hawkins BT, 2004, BRAIN RES, V1027, P48, DOI 10.1016/j.brainres.2004.08.043; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; HAY EM, 1993, BRIT J RHEUMATOL, V32, P329; HERRANZ MT, 1994, ARTHRITIS RHEUM, V37, P568, DOI 10.1002/art.1780370418; Isshi K, 1998, ARTHRITIS RHEUM, V41, P1819, DOI 10.1002/1529-0131(199810)41:10<1819::AID-ART14>3.3.CO;2-P; Jennekens FGI, 2002, RHEUMATOLOGY, V41, P619, DOI 10.1093/rheumatology/41.6.619; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Kozora E, 2005, COGN BEHAV NEUROL, V18, P159, DOI 10.1097/01.wnn.0000181543.05064.4b; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Mikdashi J, 2004, RHEUMATOLOGY, V43, P1555, DOI 10.1093/rheumatology/keh384; PEREIRA RMR, 1992, LUPUS, V1, P175; Ruiz-Irastorza G, 2001, LANCET, V357, P1027, DOI 10.1016/S0140-6736(00)04239-2; Sanchez-Guerrero J, 2008, NAT CLIN PRACT RHEUM, V4, P112, DOI 10.1038/ncprheum0726; SCHNEEBAUM AB, 1991, AM J MED, V90, P54, DOI 10.1016/0002-9343(91)90506-S; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TOUBI E, 1995, AM J MED, V99, P397, DOI 10.1016/S0002-9343(99)80188-0; WEST SG, 1995, AM J MED, V99, P153, DOI 10.1016/S0002-9343(99)80135-1; Yoshio T, 2006, ARTHRITIS RHEUM, V54, P675, DOI 10.1002/art.21547; Zandman-Goddard G, 2007, SEMIN ARTHRITIS RHEU, V36, P297, DOI 10.1016/j.semarthrit.2006.11.003	36	123	130	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3347	10.1371/journal.pone.0003347	http://dx.doi.org/10.1371/journal.pone.0003347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836530	Green Published, gold, Green Submitted			2022-12-27	WOS:000265113500009
J	Spoden, G; Freitag, K; Husmann, M; Boller, K; Sapp, M; Lambert, C; Florin, L				Spoden, Gilles; Freitag, Kirsten; Husmann, Matthias; Boller, Klaus; Sapp, Martin; Lambert, Carsten; Florin, Luise			Clathrin- and Caveolin-Independent Entry of Human Papillomavirus Type 16-Involvement of Tetraspanin-Enriched Microdomains (TEMs)	PLOS ONE			English	Article								Background: Infectious entry of human papillomaviruses into their host cells is an important step in the viral life cycle. For cell binding these viruses use proteoglycans as initial attachment sites. Subsequent transfer to a secondary receptor molecule seems to be involved in virus uptake. Depending on the papillomavirus subtype, it has been reported that entry occurs by clathrin- or caveolin-mediated mechanisms. Regarding human papillomavirus type 16 (HPV16), the primary etiologic agent for development of cervical cancer, clathrin- mediated endocytosis was described as infectious entry pathway. Methodology/Principal Findings: Using immunofluorescence and infection studies we show in contrast to published data that infectious entry of HPV16 occurs in a clathrin- and caveolin-independent manner. Inhibition of clathrin- and caveolin/raft-dependent endocytic pathways by dominant-negative mutants and siRNA-mediated knockdown, as well as inhibition of dynamin function, did not impair infection. Rather, we provide evidence for involvement of tetraspanin-enriched microdomains (TEMs) in HPV16 endocytosis. Following cell attachment, HPV16 particles colocalized with the tetraspanins CD63 and CD151 on the cell surface. Notably, tetraspanin-specific antibodies and siRNA inhibited HPV16 cell entry and infection, confirming the importance of TEMs for infectious endocytosis of HPV16. Conclusions/Significance: Tetraspanins fulfill various roles in the life cycle of a number of important viral pathogens, including human immunodeficiency virus (HIV) and hepatitis C virus (HCV). However, their involvement in endocytosis of viral particles has not been proven. Our data indicate TEMs as a novel clathrin- and caveolin-independent invasion route for viral pathogens and especially HPV16.	[Spoden, Gilles; Freitag, Kirsten; Husmann, Matthias; Lambert, Carsten; Florin, Luise] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Mainz, Germany; [Boller, Klaus] Paul Ehrlich Inst, Langen, Germany; [Sapp, Martin] LSU, Hlth Sci Ctr, Ctr Mol Tumor Virol, Feist Weiller Canc Ctr, Dept Microbiol & Immunol, Shreveport, LA USA	Johannes Gutenberg University of Mainz; Paul Ehrlich Institute; Louisiana State University System; Louisiana State University; Louisiana State University Health Sciences Center at Shreveport	Spoden, G (corresponding author), Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Mainz, Germany.	lambert@uni-mainz.de			Deutsche Forschungsgemeinschaft [SFB 490/D2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (SFB 490/D2).	Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; Bousarghin L, 2003, J VIROL, V77, P3846, DOI 10.1128/JVI.77.6.3846-3850.2003; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Culp TD, 2006, VIROLOGY, V347, P147, DOI 10.1016/j.virol.2005.11.025; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Day PM, 2003, VIROLOGY, V307, P1, DOI 10.1016/S0042-6822(02)00143-5; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; EVANDER M, 1997, J VIROL, V71; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Giroglou T, 2001, VACCINE, V19, P1783, DOI 10.1016/S0264-410X(00)00370-4; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Ho SH, 2006, J VIROL, V80, P6487, DOI 10.1128/JVI.02539-05; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Leder C, 2001, J VIROL, V75, P9201, DOI 10.1128/JVI.75.19.9201-9209.2001; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMillan NAJ, 1999, VIROLOGY, V261, P271, DOI 10.1006/viro.1999.9825; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Rommel O, 2005, J MED VIROL, V75, P114, DOI 10.1002/jmv.20245; SAPP M, 1994, J GEN VIROL, V75, P3375, DOI 10.1099/0022-1317-75-12-3375; Selinka HC, 2007, J VIROL, V81, P10970, DOI 10.1128/JVI.00998-07; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; Smith JL, 2007, J VIROL, V81, P9922, DOI 10.1128/JVI.00988-07; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Swedlow JR, 2007, METHOD CELL BIOL, V81, P447, DOI 10.1016/S0091-679X(06)81021-6; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; von Lindern JJ, 2003, J VIROL, V77, P3624, DOI 10.1128/JVI.77.6.3624-3633.2003; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Yang RC, 2003, J VIROL, V77, P3531, DOI 10.1128/JVI.77.6.3531-3541.2003; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004	58	158	162	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3313	10.1371/journal.pone.0003313	http://dx.doi.org/10.1371/journal.pone.0003313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18836553	Green Submitted, Green Published, gold			2022-12-27	WOS:000264797300004
J	Gavrilets, S; Duenez-Guzman, EA; Vose, MD				Gavrilets, Sergey; Duenez-Guzman, Edgar A.; Vose, Michael D.			Dynamics of Alliance Formation and the Egalitarian Revolution	PLOS ONE			English	Article							COALITION-FORMATION; SOCIAL BRAIN; MODEL; EVOLUTION; COOPERATION; RECIPROCITY; DOMINANCE; ALTRUISM; BABOONS; ORIGIN	Background: Arguably the most influential force in human history is the formation of social coalitions and alliances (i.e., long-lasting coalitions) and their impact on individual power. Understanding the dynamics of alliance formation and its consequences for biological, social, and cultural evolution is a formidable theoretical challenge. In most great ape species, coalitions occur at individual and group levels and among both kin and non-kin. Nonetheless, ape societies remain essentially hierarchical, and coalitions rarely weaken social inequality. In contrast, human hunter-gatherers show a remarkable tendency to egalitarianism, and human coalitions and alliances occur not only among individuals and groups, but also among groups of groups. These observations suggest that the evolutionary dynamics of human coalitions can only be understood in the context of social networks and cognitive evolution. Methodology/Principal Findings: Here, we develop a stochastic model describing the emergence of networks of allies resulting from within-group competition for status or mates between individuals utilizing dyadic information. The model shows that alliances often emerge in a phase transition-like fashion if the group size, awareness, aggressiveness, and persuasiveness of individuals are large and the decay rate of individual affinities is small. With cultural inheritance of social networks, a single leveling alliance including all group members can emerge in several generations. Conclusions/Significance: We propose a simple and flexible theoretical approach for studying the dynamics of alliance emergence applicable where game-theoretic methods are not practical. Our approach is both scalable and expandable. It is scalable in that it can be generalized to larger groups, or groups of groups. It is expandable in that it allows for inclusion of additional factors such as behavioral, genetic, social, and cultural features. Our results suggest that a rapid transition from a hierarchical society of great apes to an egalitarian society of hunter-gatherers (often referred to as "egalitarian revolution'') could indeed follow an increase in human cognitive abilities. The establishment of stable group-wide egalitarian alliances creates conditions promoting the origin of cultural norms favoring the group interests over those of individuals.	[Gavrilets, Sergey] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Gavrilets, Sergey] Univ Tennessee, Dept Math, Knoxville, TN 37996 USA; [Duenez-Guzman, Edgar A.; Vose, Michael D.] Univ Tennessee, Dept Electrical Engn & Comp Sci, Knoxville, TN 37996 USA; [Gavrilets, Sergey] Univ Tennessee, Natl Inst Math & Biol Synthesis, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Gavrilets, S (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	sergey@tiem.utk.edu		Duenez-Guzman, Edgar/0000-0002-6212-9104	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by a grant from the NIH	Alexander R.D., 1990, DID HUMANS EVOLVE RE; [Anonymous], 2018, HIST DYNAMICS WHY ST, DOI DOI 10.23943/PRINCETON/9780691180779.001.0001; [Anonymous], 1997, MACHIAVELLIAN INTELL; [Anonymous], 1987, EVOLUTION HUMAN SOC; Bach LA, 2006, J THEOR BIOL, V238, P426, DOI 10.1016/j.jtbi.2005.06.007; Boehm C., 1999, HIERARCHY FOREST EVO; BOEHM C, 2007, CURRENT ANTHR; Bonabeau E, 1999, B MATH BIOL, V61, P727, DOI 10.1006/bulm.1999.0108; Bonabeau E, 1996, B MATH BIOL, V58, P661, DOI 10.1007/BF02459478; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Byrne R., 1988, MACHIAVELLIAN INTELL; CARNEIRO RL, 1970, SCIENCE, V169, P733, DOI 10.1126/science.169.3947.733; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Connor R, 2005, ANIM BEHAV, V69, P127, DOI 10.1016/j.anbehav.2004.02.022; Connor RC, 2001, P ROY SOC B-BIOL SCI, V268, P263, DOI 10.1098/rspb.2000.1357; De Waal F., 2000, CHIMPANZEE POLITICS; Dugatkin LA, 1998, P ROY SOC B-BIOL SCI, V265, P2121, DOI 10.1098/rspb.1998.0548; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; Flinn MV, 2005, EVOL HUM BEHAV, V26, P10, DOI 10.1016/j.evolhumbehav.2004.08.005; Gavrilets S, 2006, P NATL ACAD SCI USA, V103, P16823, DOI 10.1073/pnas.0601428103; Geary D. C., 2005, ORIGIN MIND EVOLUTIO, DOI DOI 10.1037/10871-000; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hammerstein P, 2003, DAHL WS ENV, P83; Harcourt AH., 1992, COALITIONS ALLIANCES; HELMBOLD RL, 1993, EUR J OPER RES, V65, P278, DOI 10.1016/0377-2217(93)90341-J; Hruschka DJ, 2006, J THEOR BIOL, V239, P1, DOI 10.1016/j.jtbi.2005.07.006; Humphrey NK., 1976, GROWING POINTS ETHOL, P303; Iannone G, 2002, AM ANTHROPOL, V104, P68, DOI 10.1525/aa.2002.104.1.68; Johnstone RA, 2000, P ROY SOC B-BIOL SCI, V267, P17, DOI 10.1098/rspb.2000.0960; JOLLY A, 1966, SCIENCE, V153, P501, DOI 10.1126/science.153.3735.501; Kahan J.P., 1984, THEORY COALITION FOR; Kingman JFC, 2002, J APPL PROBAB, V39, P455, DOI 10.1017/S0021900200021719; Klusch M, 2002, IEEE INTELL SYST, V17, P42, DOI 10.1109/MIS.2002.1005630; KNAUFT BM, 1991, CURR ANTHROPOL, V32, P391, DOI 10.1086/203975; Konishi H, 2003, J ECON THEORY, V110, P1, DOI 10.1016/S0022-0531(03)00004-8; LANDAU H. G., 1951, BULL MATH BIOPHYS, V13, P1, DOI 10.1007/BF02478336; Landau H.G., 1951, B MATH BIOPHYS, V13, P245, DOI DOI 10.1007/BF02477920; Lusseau D, 2006, J ANIM ECOL, V75, P14, DOI 10.1111/j.1365-2656.2005.01013.x; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7229, DOI 10.1073/pnas.092080099; Marcus J, 1992, NATL GEOGR RES EXPLO, V8, P392; Mesterton-Gibbons M, 2007, BEHAV ECOL, V18, P277, DOI 10.1093/beheco/arl084; Mitani JC, 2003, BEHAVIOUR, V140, P869, DOI 10.1163/156853903770238355; Myerson Roger B., 1991, GAME THEORY ANAL CON; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newton-Fisher NE, 2004, PRIMATES, V45, P81, DOI 10.1007/s10329-003-0064-6; NOE R, 1994, ANIM BEHAV, V47, P211, DOI 10.1006/anbe.1994.1024; Noe Ronald, 1992, P285; Pacheco JM, 2006, J THEOR BIOL, V243, P437, DOI 10.1016/j.jtbi.2006.06.027; Pandit SA, 2003, BEHAV ECOL SOCIOBIOL, V55, P161, DOI 10.1007/s00265-003-0692-2; Pemantle R, 2004, MATH SOC SCI, V48, P315, DOI 10.1016/j.mathsocsci.2004.03.007; Pemantle R, 2004, STOCH PROC APPL, V109, P1, DOI 10.1016/j.spa.2003.08.003; Richerson PJ., 2005, NOT GENES ALONE CULT; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Rubin P. H., 2002, DARWINIAN POLITICS E; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Skyrms B, 2000, P NATL ACAD SCI USA, V97, P9340, DOI 10.1073/pnas.97.16.9340; Stevens JR, 2005, ANNU REV ECOL EVOL S, V36, P499, DOI 10.1146/annurev.ecolsys.36.113004.083814; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Turchin P., 2005, WAR PEACE WAR LIFE C; Van Schaik CP, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P3; Van Schaik CP, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P151; van Schaik CP, 2004, BEHAV ECOL SOCIOBIOL, V57, P101, DOI 10.1007/s00265-004-0818-1; Vervaecke H, 2000, PRIMATES, V41, P249, DOI 10.1007/BF02557595; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; White KG, 2001, ANIM LEARN BEHAV, V29, P193, DOI 10.3758/BF03192887; Whitehead H, 2005, ANIM BEHAV, V69, P117, DOI 10.1016/j.anbehav.2004.02.021; Widdig A, 2000, AM J PRIMATOL, V50, P37, DOI 10.1002/(SICI)1098-2345(200001)50:1<37::AID-AJP4>3.3.CO;2-V; Wilson ML, 2002, P ROY SOC B-BIOL SCI, V269, P1107, DOI 10.1098/rspb.2001.1926; Wittig RM, 2007, BEHAV ECOL SOCIOBIOL, V61, P899, DOI 10.1007/s00265-006-0319-5; Wrangham RW, 1999, YEARB PHYS ANTHROPOL, V42, P1; WRIGHT HT, 1977, ANNU REV ANTHROPOL, V6, P379, DOI 10.1146/annurev.an.06.100177.002115	73	45	45	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3293	10.1371/journal.pone.0003293	http://dx.doi.org/10.1371/journal.pone.0003293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RU	18827928	Green Published, gold, Green Submitted			2022-12-27	WOS:000264797200004
J	Motamayor, JC; Lachenaud, P; Mota, JWDE; Loor, R; Kuhn, DN; Brown, JS; Schnell, RJ				Motamayor, Juan C.; Lachenaud, Philippe; da Silva e Mota, Jay Wallace; Loor, Rey; Kuhn, David N.; Brown, J. Steven; Schnell, Raymond J.			Geographic and Genetic Population Differentiation of the Amazonian Chocolate Tree (Theobroma cacao L)	PLOS ONE			English	Article							INTERNATIONAL-COCOA-GENEBANK; MICROSATELLITE MARKERS; SPECIES RICHNESS; DIVERSITY; GERMPLASM; DIVERSIFICATION; VARIABILITY; SIMULATION; INFERENCE; TRINIDAD	Numerous collecting expeditions of Theobroma cacao L. germplasm have been undertaken in Latin-America. However, most of this germplasm has not contributed to cacao improvement because its relationship to cultivated selections was poorly understood. Germplasm labeling errors have impeded breeding and confounded the interpretation of diversity analyses. To improve the understanding of the origin, classification, and population differentiation within the species, 1241 accessions covering a large geographic sampling were genotyped with 106 microsatellite markers. After discarding mislabeled samples, 10 genetic clusters, as opposed to the two genetic groups traditionally recognized within T. cacao, were found by applying Bayesian statistics. This leads us to propose a new classification of the cacao germplasm that will enhance its management. The results also provide new insights into the diversification of Amazon species in general, with the pattern of differentiation of the populations studied supporting the palaeoarches hypothesis of species diversification. The origin of the traditional cacao cultivars is also enlightened in this study.	[Motamayor, Juan C.; Kuhn, David N.; Brown, J. Steven; Schnell, Raymond J.] ARS, USDA, Subtrop Hort Res Stn, Miami, FL USA; [Motamayor, Juan C.] MARS Inc, Hackettstown, NJ USA; [Lachenaud, Philippe] CIRAD Bios, UPR, Montpellier, France; [da Silva e Mota, Jay Wallace] CEPLAC SUPOR AMAZONIA, Belem, Para, Brazil; [Loor, Rey] INIAP, Estac Expt Pichilingue, Los Rios, Ecuador	United States Department of Agriculture (USDA); Mars; CIRAD	Motamayor, JC (corresponding author), ARS, USDA, Subtrop Hort Res Stn, Miami, FL USA.	juan.motamayor@effem.com			U.S. Department of Agriculture [6631-21000-012-00D]; MARS Inc	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); MARS Inc	Funded by the U.S. Department of Agriculture (Project Number: 6631-21000-012-00D) and MARS Inc. The funders had no role in study design, data collection or analysis, writing the paper, or the decision to submit it for publication. The publication contents are solely the responsibility of the authors and do not necessarily represent the official views of USDA nor MARS Inc.	Allen J.B., 1983, COCOA GROWERS B, V34, P74; Bartley BGD, 2005, GENETIC DIVERSITY OF CACAO AND ITS UTILIZATION: BOTANY, PRODUCTION AND USES, P1, DOI 10.1079/9780851996196.0000; BEKELE FL, 2004, EXAMINING PHENOTYPIC; Bekele FL, 2006, GENET RESOUR CROP EV, V53, P933, DOI 10.1007/s10722-004-6692-x; Brown JS, 2005, J AM SOC HORTIC SCI, V130, P366, DOI 10.21273/JASHS.130.3.366; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; Cervantes-Martinez C, 2006, TREE GENET GENOMES, V2, P152, DOI 10.1007/s11295-006-0038-0; CHALMERS WS, 1973, REPORT VISIT ECUADOR; Cheesman E. E., 1944, TROP AGRIC [TRINIDAD], V21, P144; CHEVENET F, 2006, TREEDYN ANNOTATIONS; *CORP M, 2006, MAPINFO PROF; Cuatrecasas J., 1964, CONTRIB US NAT MUS, V35, P379, DOI DOI 10.1016/0165-5728(95)00055-7; DELACRUZ M, 1995, NATURE, V375, P542, DOI 10.1038/375542a0; *ESRI, 2006, ARCGIS 9 0; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 2005, EVOLUTIONARY BIOINFO; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; Goudet J., 2002, FSTAT PROGRAM ESTIMA; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J., 1977, Amazoniana, V6, P161; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hubert N, 2007, MOL ECOL, V16, P2115, DOI 10.1111/j.1365-294X.2007.03267.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Lachenaud P, 2005, ACTA BOT GALLICA, V152, P325, DOI 10.1080/12538078.2005.10515493; Lanaud C, 1999, MOL ECOL, V8, P2141, DOI 10.1046/j.1365-294x.1999.00802.x; LANGELLA O., 1999, POPULATIONS POPULATI; LAURENT V, 1994, THEOR APPL GENET, V88, P193, DOI 10.1007/BF00225897; Lerceteau E, 1997, THEOR APPL GENET, V95, P10, DOI 10.1007/s001220050527; LOCKWOOD G, 1985, SPAN, V28, P14; Lougheed SC, 1999, P ROY SOC B-BIOL SCI, V266, P1829, DOI 10.1098/rspb.1999.0853; Mao, 1999, POPGENE VERSION 1 3; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Motamayor JC, 2003, HEREDITY, V91, P322, DOI 10.1038/sj.hdy.6800298; Motamayor JC, 2002, HEREDITY, V89, P380, DOI 10.1038/sj.hdy.6800156; MOTAMAYOR JC, 2001, ETUDE DIVERSITE GENE; Motilal L, 2003, GENET RESOUR CROP EV, V50, P799, DOI 10.1023/A:1025950902827; Pound F.J., 1938, ARCH CACAO RES, VVol. 1, P20; PRANCE G T, 1973, Acta Amazonica, V3, P5; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2004, DOCUMENTATION STRUCT; Pugh T, 2004, THEOR APPL GENET, V108, P1151, DOI 10.1007/s00122-003-1533-4; REMSEN JV, 1983, BIOTROPICA, V15, P223, DOI 10.2307/2387833; Schnell RJ, 2005, J AM SOC HORTIC SCI, V130, P181, DOI 10.21273/JASHS.130.2.181; Sereno ML, 2006, CONSERV GENET, V7, P13, DOI 10.1007/s10592-005-7568-0; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Sounigo O, 2005, GENET RESOUR CROP EV, V52, P1111, DOI 10.1007/s10722-004-6110-4; WADSWORTH RM, 2000, INT COCOA GERMPLASM, V51; WARREN J, 1992, COCOA BREEDING 21 CE, P215; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P439; YIN JPT, 2004, EXPT AGR, V40	50	271	275	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3311	10.1371/journal.pone.0003311	http://dx.doi.org/10.1371/journal.pone.0003311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18827930	Green Published, gold			2022-12-27	WOS:000264797200013
J	Xu, Z; Zhang, F; Xu, BS; Tan, JZ; Li, SL; Li, CX; Zhou, H; Zhu, H; Zhang, J; Duan, QB; Jin, L				Xu, Zhi; Zhang, Fan; Xu, Bosong; Tan, Jingze; Li, Shilin; Li, Chunxiang; Zhou, Hui; Zhu, Hong; Zhang, Jun; Duan, Qingbo; Jin, Li			Mitochondrial DNA Evidence for a Diversified Origin of Workers Building Mausoleum for First Emperor of China	PLOS ONE			English	Article							ANCIENT DNA; GENETIC-ANALYSIS; ENZYMATIC AMPLIFICATION; MISCODING LESIONS; ASIAN POPULATIONS; SKELETAL REMAINS; HUMAN-EVOLUTION; SEQUENCE; EXTRACTION; DAMAGE	Variant studies on ancient DNA have attempted to reveal individual origin. Here, based on cloning sequencing and polymerase chain reaction-restriction fragment length polymorphisms, we analyzed polymorphisms in the first hypervariable region and coding regions of mitochondrial DNA of 19 human bone remains which were excavated from a tomb near the Terra Cotta Warriors and dated some 2,200 years before present. With the aim of shedding light on origins of these samples who were supposed to be workers building the mausoleum for the First Emperor of China, we compared them with 2,164 mtDNA profiles from 32 contemporary Chinese populations at both population and individual levels. Our results showed that mausoleum-building workers may be derived from very diverse sources of origin.	[Xu, Zhi; Zhang, Fan; Xu, Bosong; Tan, Jingze; Li, Shilin; Jin, Li] Fudan Univ, Minist Educ MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Li, Chunxiang; Zhou, Hui; Zhu, Hong] Jilin Univ, Res Ctr Chinese Frontier Archaeol, Ancient DNA Lab, Changchun, Peoples R China; [Zhang, Jun] Chinese Acad Soc Sci, Inst Archaeol, Beijing, Peoples R China; [Duan, Qingbo] Shaanxi Provinc Inst Cultural Relics & Archaeol, Xian, Peoples R China; [Jin, Li] Chinese Acad Sci, Shanghai Inst Biol Sci, Max Planck Soc, Beijing 100864, Peoples R China	Fudan University; Jilin University; Chinese Academy of Social Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Xu, Z (corresponding author), Fudan Univ, Minist Educ MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China.	ljin007@gmail.com	Anthropology, MOE KeyLab Fudan/A-9454-2010; Xu, Zhi/I-2546-2012; Jin, Li/C-1468-2009; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; Zhou, Hui/0000-0001-5858-5636	National Natural Science Foundation of China [30571013]; Science and Technology Commission of Shanghai Municipality [05pj14023]; Outstanding Young Scientist Award; Chinese National Natural Science Foundation [30625016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Outstanding Young Scientist Award; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30571013), the Science and Technology Commission of Shanghai Municipality (05pj14023) and Outstanding Young Scientist Award (A category), Chinese National Natural Science Foundation (30625016).	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BROTHERTON P, 2007, NUCL ACIDS RES; Caramelli D, 2007, HUM GENET, V122, P327, DOI 10.1007/s00439-007-0403-6; Caramelli D, 2007, FORENSIC SCI INT, V173, P36, DOI 10.1016/j.forsciint.2007.01.020; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Cooper A, 2000, SCIENCE, V289, P1139; DESALLE R, 1993, EXPERIENTIA, V49, P906, DOI 10.1007/BF01952607; Dissing J, 2007, FORENSIC SCI INT, V166, P21, DOI 10.1016/j.forsciint.2006.03.020; Endicott P, 2003, AM J HUM GENET, V72, P178, DOI 10.1086/345487; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gao SZ, 2007, AM J PHYS ANTHROPOL, V133, P1128, DOI 10.1002/ajpa.20623; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Hebsgaard MB, 2007, J MOL EVOL, V64, P50, DOI 10.1007/s00239-006-0017-y; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Horai S, 1996, AM J HUM GENET, V59, P579; HORAI S, 1990, AM J HUM GENET, V46, P828; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Kemp BM, 2005, FORENSIC SCI INT, V154, P53, DOI 10.1016/j.forsciint.2004.11.017; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Kong QP, 2003, HUM GENET, V113, P391, DOI 10.1007/s00439-003-1004-7; KUROSAKI K, 1993, AM J HUM GENET, V53, P638; Lalueza-Fox C, 2004, P ROY SOC B-BIOL SCI, V271, P941, DOI 10.1098/rspb.2004.2698; MacHugh DE., 2000, ANCIENT BIOMOLECULES, V3, P81; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Oota H, 1999, AM J HUM GENET, V64, P250, DOI 10.1086/302197; Oota H, 2002, AM J PHYS ANTHROPOL, V118, P146, DOI 10.1002/ajpa.10056; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PAABO S, 1990, J BIOL CHEM, V265, P4718; Ricaut FX, 2005, AM J PHYS ANTHROPOL, V126, P458, DOI 10.1002/ajpa.20257; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Sato T, 2007, J HUM GENET, V52, P618, DOI 10.1007/s10038-007-0164-z; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Tomory G, 2007, AM J PHYS ANTHROPOL, V134, P354, DOI 10.1002/ajpa.20677; Topf AL, 2006, MOL BIOL EVOL, V23, P152, DOI 10.1093/molbev/msj013; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wallace DC, 1997, P NATL ACAD SCI USA, V94, P14900, DOI 10.1073/pnas.94.26.14900; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Xie CZ, 2007, P R SOC B, V274, P1597, DOI 10.1098/rspb.2007.0219; XUE F, 2008, EUR J HUM GENET; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yao YG, 2003, MOL BIOL EVOL, V20, P214, DOI 10.1093/molbev/msg026; ZHAO T, 1989, HUM GENET, V83, P101, DOI 10.1007/BF00286699	54	12	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3275	10.1371/journal.pone.0003275	http://dx.doi.org/10.1371/journal.pone.0003275			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RU	18833341	Green Published, gold, Green Submitted			2022-12-27	WOS:000264797200002
J	Schleinitz, N; March, ME; Long, EO				Schleinitz, Nicolas; March, Michael E.; Long, Eric O.			Recruitment of Activation Receptors at Inhibitory NK Cell Immune Synapses	PLOS ONE			English	Article								Natural killer (NK) cell activation receptors accumulate by an actin-dependent process at cytotoxic immune synapses where they provide synergistic signals that trigger NK cell effector functions. In contrast, NK cell inhibitory receptors, including members of the MHC class I-specific killer cell Ig-like receptor (KIR) family, accumulate at inhibitory immune synapses, block actin dynamics, and prevent actin-dependent phosphorylation of activation receptors. Therefore, one would predict inhibition of actin-dependent accumulation of activation receptors when inhibitory receptors are engaged. By confocal imaging of primary human NK cells in contact with target cells expressing physiological ligands of NK cell receptors, we show here that this prediction is incorrect. Target cells included a human cell line and transfected Drosophila insect cells that expressed ligands of NK cell activation receptors in combination with an MHC class I ligand of inhibitory KIR. The two NK cell activation receptors CD2 and 2B4 accumulated and co-localized with KIR at inhibitory immune synapses. In fact, KIR promoted CD2 and 2B4 clustering, as CD2 and 2B4 accumulated more efficiently at inhibitory synapses. In contrast, accumulation of KIR and of activation receptors at inhibitory synapses correlated with reduced density of the integrin LFA-1. These results imply that inhibitory KIR does not prevent CD2 and 2B4 signaling by blocking their accumulation at NK cell immune synapses, but by blocking their ability to signal within inhibitory synapses.	[Schleinitz, Nicolas; March, Michael E.; Long, Eric O.] NIH, NIAID, Lab Immunogenet, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schleinitz, N (corresponding author), CHU Concept, AP HM, Serv Med Interne, Marseille, France.	eLong@nih.gov	March, Michael/AAB-6502-2019; Long, Eric O/G-5475-2011; schleinitz, nicolas/AAL-6751-2020	March, Michael/0000-0001-9173-6862; Long, Eric O/0000-0002-7793-3728; schleinitz, nicolas/0000-0001-9449-3392	NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000525, ZIAAI001117, ZIAAI000525] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CR, 2006, J IMMUNOL, V177, P6904, DOI 10.4049/jimmunol.177.10.6904; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Burshtyn DN, 1999, J IMMUNOL, V162, P897; Carlin LM, 2001, J EXP MED, V194, P1507, DOI 10.1084/jem.194.10.1507; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Dietrich J, 2001, J IMMUNOL, V166, P2514, DOI 10.4049/jimmunol.166.4.2514; Endt J, 2007, J IMMUNOL, V178, P5606, DOI 10.4049/jimmunol.178.9.5606; Fassett MS, 2001, P NATL ACAD SCI USA, V98, P14547, DOI 10.1073/pnas.211563598; Faure M, 2003, J IMMUNOL, V170, P6107, DOI 10.4049/jimmunol.170.12.6107; Guerra N, 2002, BLOOD, V100, P2874, DOI 10.1182/blood-2002-02-0643; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Olcese L, 1996, J IMMUNOL, V156, P4531; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; Rajagopalan S, 1997, J EXP MED, V185, P1523, DOI 10.1084/jem.185.8.1523; Roda-Navarro P, 2004, J IMMUNOL, V173, P3640, DOI 10.4049/jimmunol.173.6.3640; Standeven LJ, 2004, J IMMUNOL, V173, P5617, DOI 10.4049/jimmunol.173.9.5617; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Treanor B, 2006, J CELL BIOL, V174, P153, DOI 10.1083/jcb.200601108; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Vyas YM, 2004, J IMMUNOL, V173, P1571, DOI 10.4049/jimmunol.173.3.1571; Watzl C, 2000, J IMMUNOL, V165, P3545, DOI 10.4049/jimmunol.165.7.3545; Watzl C, 2003, J EXP MED, V197, P77, DOI 10.1084/jem.20020427; Winter CC, 1998, J IMMUNOL, V161, P571; Wulfing C, 2000, P NATL ACAD SCI USA, V97, P10150, DOI 10.1073/pnas.97.18.10150	30	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3278	10.1371/journal.pone.0003278	http://dx.doi.org/10.1371/journal.pone.0003278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818767	Green Submitted, gold, Green Published			2022-12-27	WOS:000264432300003
J	Yi, M; Stephens, RM				Yi, Ming; Stephens, Robert M.			SLEPR: A Sample-Level Enrichment-Based Pathway Ranking Method-Seeking Biological Themes through Pathway-Level Consistency	PLOS ONE			English	Article							GENE SET ENRICHMENT; HUMAN-DISEASE; EXPRESSION; MICROARRAY; PATTERNS; IDENTIFICATION; SELECTION; NETWORKS; MEDICINE; ONTOLOGY	Analysis of microarray and other high throughput data often involves identification of genes consistently up or down-regulated across samples as the first step in extraction of biological meaning. This gene-level paradigm can be limited as a result of valid sample fluctuations and biological complexities. In this report, we describe a novel method, SLEPR, which eliminates this limitation by relying on pathway-level consistencies. Our method first selects the sample-level differentiated genes from each individual sample, capturing genes missed by other analysis methods, ascertains the enrichment levels of associated pathways from each of those lists, and then ranks annotated pathways based on the consistency of enrichment levels of individual samples from both sample classes. As a proof of concept, we have used this method to analyze three public microarray datasets with a direct comparison with the GSEA method, one of the most popular pathway-level analysis methods in the field. We found that our method was able to reproduce the earlier observations with significant improvements in depth of coverage for validated or expected biological themes, but also produced additional insights that make biological sense. This new method extends existing analyses approaches and facilitates integration of different types of HTP data.	[Yi, Ming; Stephens, Robert M.] SAIC Frederick Inc, NCI Frederick, Adv Technol Program, Adv Biomed Comp Ctr, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Yi, M (corresponding author), SAIC Frederick Inc, NCI Frederick, Adv Technol Program, Adv Biomed Comp Ctr, Frederick, MD USA.	bobs@ncifcrf.gov		Yi, Ming/0000-0001-9098-1364	National Cancer Institute, National Institute of Health [N01-CO-12400]	National Cancer Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institute of Health, under Contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Burke S, 2001, LC GC EUROPE ONLIN S, V2, P19; Cordes N, 2006, CANCER LETT, V242, P11, DOI 10.1016/j.canlet.2005.12.004; Damian D, 2004, NAT GENET, V36, P663, DOI 10.1038/ng0704-663a; Dohr S, 2005, NUCLEIC ACIDS RES, V33, P864, DOI 10.1093/nar/gki230; Draghici S, 2003, BIOINFORMATICS, V19, P1348, DOI 10.1093/bioinformatics/btg165; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Draghici S, 2001, Curr Opin Drug Discov Devel, V4, P332; Efroni S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000425; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hsieh WP, 2003, GENETICS, V165, P747; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lian H, 2008, BIOSTATISTICS, V9, P411, DOI 10.1093/biostatistics/kxm042; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Lyons-Weiler J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-110; Manoli T, 2006, BIOINFORMATICS, V22, P2500, DOI 10.1093/bioinformatics/btl424; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nadon R, 2002, TRENDS GENET, V18, P265, DOI 10.1016/S0168-9525(02)02665-3; Pavlidis P, 2004, NEUROCHEM RES, V29, P1213, DOI 10.1023/B:NERE.0000023608.29741.45; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Pavlidis Paul, 2002, Pac Symp Biocomput, P474; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; Perkel JM, 2006, SCIENTIST, V20, P68; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Rhodin M, 2005, EQUINE VET J, V37, P7, DOI 10.2746/0425164054406928; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Seo S, 2006, THESIS U PITTSBURGH; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tibshirani R, 2007, BIOSTATISTICS, V8, P2, DOI 10.1093/biostatistics/kxl005; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; Welsh JB, 2001, CANCER RES, V61, P5974; Wu BL, 2007, BIOSTATISTICS, V8, P566, DOI 10.1093/biostatistics/kxl029; Yi M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-30; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	58	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3288	10.1371/journal.pone.0003288	http://dx.doi.org/10.1371/journal.pone.0003288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818771	Green Published, Green Submitted, gold			2022-12-27	WOS:000264432300010
J	Alexandrova, AY; Arnold, K; Schaub, S; Vasiliev, JM; Meister, JJ; Bershadsky, AD; Verkhovsky, AB				Alexandrova, Antonina Y.; Arnold, Katya; Schaub, Sebastien; Vasiliev, Jury M.; Meister, Jean-Jacques; Bershadsky, Alexander D.; Verkhovsky, Alexander B.			Comparative Dynamics of Retrograde Actin Flow and Focal Adhesions: Formation of Nascent Adhesions Triggers Transition from Fast to Slow Flow	PLOS ONE			English	Article								Dynamic actin network at the leading edge of the cell is linked to the extracellular matrix through focal adhesions (FAs), and at the same time it undergoes retrograde flow with different dynamics in two distinct zones: the lamellipodium (peripheral zone of fast flow), and the lamellum (zone of slow flow located between the lamellipodium and the cell body). Cell migration involves expansion of both the lamellipodium and the lamellum, as well as formation of new FAs, but it is largely unknown how the position of the boundary between the two flow zones is defined, and how FAs and actin flow mutually influence each other. We investigated dynamic relationship between focal adhesions and the boundary between the two flow zones in spreading cells. Nascent FAs first appeared in the lamellipodium. Within seconds after the formation of new FAs, the rate of actin flow decreased locally, and the lamellipodium/ lamellum boundary advanced towards the new FAs. Blocking fast actin flow with cytochalasin D resulted in rapid dissolution of nascent FAs. In the absence of FAs (spreading on poly-L-lysine-coated surfaces) retrograde flow was uniform and the velocity transition was not observed. We conclude that formation of FAs depends on actin dynamics, and in its turn, affects the dynamics of actin flow by triggering transition from fast to slow flow. Extension of the cell edge thus proceeds through a cycle of lamellipodium protrusion, formation of new FAs, advance of the lamellum, and protrusion of the lamellipodium from the new base.	[Alexandrova, Antonina Y.; Schaub, Sebastien; Meister, Jean-Jacques; Verkhovsky, Alexander B.] Ecole Polytech Fed Lausanne, Lab Cell Biophys, Lausanne, Switzerland; [Alexandrova, Antonina Y.; Vasiliev, Jury M.] Moscow MV Lomonosov State Univ, Belozersky Inst Phys & Chem Biol, Moscow, Russia; [Arnold, Katya; Bershadsky, Alexander D.] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Vasiliev, Jury M.] Russian Acad Med Sci, Canc Res Ctr, Moscow, Russia; [Schaub, Sebastien] CNRS, UMR 6543, Inst Biol Dev Canc, Nice, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Lomonosov Moscow State University; Weizmann Institute of Science; Russian Academy of Medical Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Alexandrova, AY (corresponding author), Ecole Polytech Fed Lausanne, Lab Cell Biophys, Lausanne, Switzerland.	alexander.bershadsky@weizmann.ac.il; alexander.verkhovsky@epfl.ch	Verkhovsky, Alexander B/L-6057-2013; Alexandrova, Antonina/R-7449-2019	Bershadsky, Alexander/0000-0002-9571-7375; Verkhovsky, Alexander/0000-0001-8269-1172; Schaub, Sebastien/0000-0002-9624-3271	Swiss Science Foundation [3100-61589, 3100-112413]; Israel Science Foundation; Joseph Moss Chair of Biomedical Research	Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Israel Science Foundation(Israel Science Foundation); Joseph Moss Chair of Biomedical Research	Supported by the Swiss Science Foundation grants 3100-61589 and 3100-112413 (A.B.V.) and Israel Science Foundation (A.D.B.). A.D.B holds the Joseph Moss Chair of Biomedical Research.	Anderson KI, 2000, CURR BIOL, V10, P253, DOI 10.1016/S0960-9822(00)00357-2; Ballestrem C, 1998, J CELL SCI, V111, P1649; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Bruinsma R, 2005, BIOPHYS J, V89, P87, DOI 10.1529/biophysj.104.048280; Choidas A, 1998, EUR J CELL BIOL, V77, P81, DOI 10.1016/S0171-9335(98)80075-7; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Cramer Louise P., 1997, Frontiers in Bioscience (online), V2, pD260; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Endlich N, 2007, CELL MOTIL CYTOSKEL, V64, P966, DOI 10.1002/cm.20237; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; HARRIS AK, 1994, INT REV CYTOL, V150, P35; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Jay DG, 2000, J NEUROBIOL, V44, P114, DOI 10.1002/1097-4695(200008)44:2<114::AID-NEU3>3.0.CO;2-8; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; LEE J, 1993, SYM SOC EXP BIOL, V47, P73; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nicolas A, 2004, P NATL ACAD SCI USA, V101, P12520, DOI 10.1073/pnas.0403539101; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RINNERTHALER G, 1988, J CELL BIOL, V106, P747, DOI 10.1083/jcb.106.3.747; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Suter DM, 1998, J CELL BIOL, V141, P227, DOI 10.1083/jcb.141.1.227; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; THERIOT JA, 1992, J CELL BIOL, V119, P367, DOI 10.1083/jcb.119.2.367; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; Verkhovsky AB, 1997, J CELL SCI, V110, P1693; Verkhovsky AB, 2003, MOL BIOL CELL, V14, P4667, DOI 10.1091/mbc.E02-10-0630; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; VOLBERG T, 1994, CELL MOTIL CYTOSKEL, V29, P321, DOI 10.1002/cm.970290405; Webb DJ, 2003, CURR OPIN CELL BIOL, V15, P614, DOI 10.1016/S0955-0674(03)00105-4; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	54	174	176	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3234	10.1371/journal.pone.0003234	http://dx.doi.org/10.1371/journal.pone.0003234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800171	Green Published, gold, Green Submitted			2022-12-27	WOS:000264428400004
J	Schmidt, MR; Appel, MC; Giassi, LJ; Greiner, DL; Shultz, LD; Woodland, RT				Schmidt, Madelyn R.; Appel, Michael C.; Giassi, Lisa J.; Greiner, Dale L.; Shultz, Leonard D.; Woodland, Robert T.			Human BLyS Facilitates Engraftment of Human PBL Derived B Cells in Immunodeficient Mice	PLOS ONE			English	Article								The production of fully immunologically competent humanized mice engrafted with peripheral lymphocyte populations provides a model for in vivo testing of new vaccines, the durability of immunological memory and cancer therapies. This approach is limited, however, by the failure to efficiently engraft human B lymphocytes in immunodeficient mice. We hypothesized that this deficiency was due to the failure of the murine microenvironment to support human B cell survival. We report that while the human B lymphocyte survival factor, B lymphocyte stimulator (BLyS/BAFF) enhances the survival of human B cells ex vivo, murine BLyS has no such protective effect. Although human B cells bound both human and murine BLyS, nuclear accumulation of NF-kappa B p52, an indication of the induction of a protective anti-apoptotic response, following stimulation with human BLyS was more robust than that induced with murine BLyS suggesting a fundamental disparity in BLyS receptor signaling. Efficient engraftment of both human B and T lymphocytes in NOD rag1(-/-) Prf1(-/-) immunodeficient mice treated with recombinant human BLyS is observed after adoptive transfer of human PBL relative to PBS treated controls. Human BLyS treated recipients had on average 40-fold higher levels of serum Ig than controls and mounted a de novo antibody response to the thymus-independent antigens in pneumovax vaccine. The data indicate that production of fully immunologically competent humanized mice from PBL can be markedly facilitated by providing human BLyS.	[Schmidt, Madelyn R.; Woodland, Robert T.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; [Appel, Michael C.] Natl Inst Diabetes & Digest & Kidney Dis NIDDK, NIH, Bethesda, MD USA; [Giassi, Lisa J.; Greiner, Dale L.] Univ Massachusetts, Med Sch, Div Diabetes, Dept Med, Amherst, MA 01003 USA; [Shultz, Leonard D.] Jackson Lab, Bar Harbor, ME USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Massachusetts System; University of Massachusetts Amherst; Jackson Laboratory	Schmidt, MR (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA.	Madelyn.Schmidt@umassmed.edu			National Institutes of Health [AI 041054, AI57463, HL77642, AI46629]; Diabetes Endocrinology Research Center (DERC) [DK32520]; Cancer Center Core [CA34196]; Beta Cell Biology Consortium; Juvenile Diabetes Foundation, International; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI057463, P01AI046629, R01AI041054, R21AI041054, R01AI084800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center (DERC); Cancer Center Core; Beta Cell Biology Consortium; Juvenile Diabetes Foundation, International; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants AI 041054, AI57463, HL77642, AI46629, an institutional Diabetes Endocrinology Research Center (DERC) grant DK32520, a Cancer Center Core grant CA34196, the Beta Cell Biology Consortium, and the Juvenile Diabetes Foundation, International. Human Genome Sciences supplied human recombinant BLyS for some experiments. The contents, study design and interpretation of the data in this publication are solely the responsibility of the authors and do not represent the views of the funding agencies.	Agenes F, 1999, J EXP MED, V189, P319, DOI 10.1084/jem.189.2.319; Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; Baker KP, 2004, AUTOIMMUN REV, V3, P368, DOI 10.1016/j.autrev.2004.02.001; Berney T, 2001, TRANSPLANTATION, V72, P133, DOI 10.1097/00007890-200107150-00026; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Cabatingan MS, 2002, J IMMUNOL, V169, P6795, DOI 10.4049/jimmunol.169.12.6795; Cao TH, 2001, J VIROL, V75, P6359, DOI 10.1128/JVI.75.14.6359-6366.2001; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Collins CE, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1855; Cuss AK, 2006, J IMMUNOL, V176, P1506, DOI 10.4049/jimmunol.176.3.1506; Day ES, 2005, BIOCHEMISTRY-US, V44, P1919, DOI 10.1021/bi048227k; Depraetere S, 2001, J IMMUNOL, V166, P2929, DOI 10.4049/jimmunol.166.5.2929; Di Ianni M, 2002, CANCER GENE THER, V9, P756, DOI 10.1038/sj.cgt.7700495; Diaz-de-Durana Y, 2006, BLOOD, V107, P594, DOI 10.1182/blood-2004-12-4708; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Gordon NC, 2003, BIOCHEMISTRY-US, V42, P5977, DOI 10.1021/bi034017g; Hase H, 2004, BLOOD, V103, P2257, DOI 10.1182/blood-2003-08-2694; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Huard B, 2001, J IMMUNOL, V167, P6225, DOI 10.4049/jimmunol.167.11.6225; Kanakaraj P, 2001, CYTOKINE, V13, P25, DOI 10.1006/cyto.2000.0793; Kerre TCC, 2002, BLOOD, V99, P1620, DOI 10.1182/blood.V99.5.1620; Kikuchi Kentaro, 2003, Clin Dev Immunol, V10, P197, DOI 10.1080/10446670310001642122; Kim HM, 2003, NAT STRUCT BIOL, V10, P342, DOI 10.1038/nsb925; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; KUMAR CS, 1989, J BIOL CHEM, V264, P17939; Losi CG, 2006, J CLIN IMMUNOL, V26, P396, DOI 10.1007/s10875-006-9026-2; Macchiarini Francesca, 2005, J Exp Med, V202, P1307, DOI 10.1084/jem.20051547; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Mackay F, 2006, SEMIN IMMUNOL, V18, P284, DOI 10.1016/j.smim.2006.04.005; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Marleau AM, 2005, J LEUKOCYTE BIOL, V78, P575, DOI 10.1189/jlb.0105050; MCKENZIE ANJ, 1991, EMBO J, V10, P1193, DOI 10.1002/j.1460-2075.1991.tb08060.x; Ng LG, 2005, MOL IMMUNOL, V42, P763, DOI 10.1016/j.molimm.2004.06.041; Novak AJ, 2004, BLOOD, V103, P689, DOI 10.1182/blood-2003-06-2043; Oren DA, 2002, NAT STRUCT BIOL, V9, P288, DOI 10.1038/nsb769; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; Prlic M, 2002, MICROBES INFECT, V4, P531, DOI 10.1016/S1286-4579(02)01569-1; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2003, TRANSPLANTATION, V76, P1036, DOI 10.1097/01.TP.0000083041.44829.2C; Shultz LD, 2000, J IMMUNOL, V164, P2496, DOI 10.4049/jimmunol.164.5.2496; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Smirnova AS, 2008, MOL IMMUNOL, V45, P1179, DOI 10.1016/j.molimm.2007.07.028; Stewart DM, 2003, CLIN IMMUNOL, V109, P137, DOI 10.1016/S1521-6616(03)00215-8; Stohl William, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P351; Stohl William, 2002, Curr Rheumatol Rep, V4, P345, DOI 10.1007/s11926-002-0044-7; Tam WF, 2001, MOL CELL BIOL, V21, P4837, DOI 10.1128/MCB.21.14.4837-4846.2001; TAVERNIER J, 1989, DNA-J MOLEC CELL BIO, V8, P491, DOI 10.1089/dna.1.1989.8.491; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Tournoy KG, 2000, CLIN EXP IMMUNOL, V119, P231, DOI 10.1046/j.1365-2249.2000.01099.x; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Turgeon NA, 2003, EXP BIOL MED, V228, P1096, DOI 10.1177/153537020322800918; van Rijn RS, 2003, BLOOD, V102, P2522, DOI 10.1182/blood-2002-10-3241; Wager EJ, 2000, J IMMUNOL, V165, P518, DOI 10.4049/jimmunol.165.1.518; WILLIAMS IR, 1991, J IMMUNOL, V147, P3752; Woodland RT, 2008, BLOOD, V111, P750, DOI 10.1182/blood-2007-03-077222; Woodland RT, 2006, SEMIN IMMUNOL, V18, P318, DOI 10.1016/j.smim.2006.06.001; Woodland RT, 2005, SEMIN IMMUNOL, V17, P209, DOI 10.1016/j.smim.2005.02.006; Woodland RT, 1996, J IMMUNOL, V156, P2143; Ye OR, 2004, EUR J IMMUNOL, V34, P2750, DOI 10.1002/eji.200425198; Yoshioka M, 1999, CYTOKINE, V11, P863, DOI 10.1006/cyto.1998.0499; Zhang X, 2005, INT IMMUNOL, V17, P779, DOI 10.1093/intimm/dxh259	73	44	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3192	10.1371/journal.pone.0003192	http://dx.doi.org/10.1371/journal.pone.0003192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784835	Green Published, gold, Green Submitted			2022-12-27	WOS:000264425900011
J	Roato, I; D'Amelio, P; Gorassini, E; Grimaldi, A; Bonello, L; Fiori, C; Delsedime, L; Tizzani, A; De Libero, A; Isaia, G; Ferracini, R				Roato, Ilaria; D'Amelio, Patrizia; Gorassini, Eva; Grimaldi, Anastasia; Bonello, Lisa; Fiori, Cristian; Delsedime, Luisa; Tizzani, Alessandro; De Libero, Alfredo; Isaia, Giancarlo; Ferracini, Riccardo			Osteoclasts Are Active in Bone Forming Metastases of Prostate Cancer Patients	PLOS ONE			English	Article								Background: Bone forming metastases are a common and disabling consequence of prostate cancer (CaP). The potential role of osteoclast activity in CaP bone metastases is not completely explained. In this study, we investigated ex vivo whether the osteolytic activity is present and how it is ruled in CaP patients with bone forming metastases. Methodology: Forty-six patients affected by newly diagnosed CaP and healthy controls were enrolled. At diagnosis, 37 patients had a primary tumour only, while 9 had primary tumour and concomitant bone forming metastases. In all patients there was no evidence of metastasis to other non-bone sites. For all patients and controls we collected blood and urinary samples. We evaluated patients' bone homeostasis; we made peripheral blood mononuclear cell (PBMC) cultures to detect in vitro osteoclastogenesis; we dosed serum expression of molecules involved in cancer induced osteoclatogenesis, such as RANKL, OPG, TNF-alpha, DKK-1 and IL-7. By Real-Time PCR, we quantified DKK-1 and IL-7 gene expression on micro-dissected tumour and healthy tissue sections. Principal Findings: CaP bone metastatic patients showed bone metabolism disruption with increased bone resorption and formation compared to non-bone metastatic patients and healthy controls. The CaP PBMC cultures showed an enhanced osteoclastogenesis in bone metastatic patients, due to an increase of RANKL/OPG ratio. We detected increased DKK-1 serum levels and tissue gene expression in patients compared to controls. IL- 7 resulted high in patients' sera, but its tissue gene expression was comparable in patients and controls. Conclusions: We demonstrated ex vivo that osteoclastogenesis is an active mechanism in tumour nesting of bone forming metastatic cancer and that serum DKK-1 levels are increased in CaP patients, suggesting to deeply investigate its role as tumour marker.	[Roato, Ilaria; Gorassini, Eva; Bonello, Lisa; Ferracini, Riccardo] Ctr Expt Res & Med Studies Univ, Turin, Italy; [Roato, Ilaria; Ferracini, Riccardo] Ctr Expt Res & Studies Univ, Dept Med Oncol 2, Turin, Italy; [D'Amelio, Patrizia; Grimaldi, Anastasia; Isaia, Giancarlo; Ferracini, Riccardo] Ctr Expt Res & Studies Univ, Dept Internal Med, Turin, Italy; [Fiori, Cristian; Tizzani, Alessandro; De Libero, Alfredo; Ferracini, Riccardo] Ctr Expt Res & Studies Univ, Dept Urol, Turin, Italy; [Delsedime, Luisa; Ferracini, Riccardo] Ctr Expt Res & Studies Univ, Dept Pathol, Turin, Italy; [Ferracini, Riccardo] Ctr Expt Res & Studies Univ, Dept Orthopaed, Turin, Italy		Roato, I (corresponding author), Ctr Expt Res & Med Studies Univ, Turin, Italy.	roato78@libero.it	Ferracini, Riccardo/AAL-4622-2020; D'AMELIO, PATRIZIA/K-3042-2016	D'AMELIO, PATRIZIA/0000-0002-4467-8337; Roato, Ilaria/0000-0003-3029-4743	Compagnia di San Paolo and Regione Piemonte	Compagnia di San Paolo and Regione Piemonte(Compagnia di San Paolo)	This study was supported by Compagnia di San Paolo and Regione Piemonte (Ricerca Sanitaria Finalizzata 2008).	Al-Rawi MAA, 2003, HISTOL HISTOPATHOL, V18, P911, DOI 10.14670/HH-18.911; Brown JE, 2005, JNCI-J NATL CANCER I, V97, P59, DOI 10.1093/jnci/dji002; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Colucci S, 2007, J PATHOL, V212, P47, DOI 10.1002/path.2153; Corey E, 2005, CANCER RES, V65, P1710, DOI 10.1158/0008-5472.CAN-04-2033; D'Amelio P, 2008, BONE, V43, P92, DOI 10.1016/j.bone.2008.02.017; D'Amelio P, 2006, BONE, V39, P658, DOI 10.1016/j.bone.2006.03.009; Ebert W, 2004, ANTICANCER RES, V24, P3193; Emami KH, 2007, CANCER LETT, V253, P170, DOI 10.1016/j.canlet.2006.12.040; Giuliani N, 2005, BLOOD, V106, P2472, DOI 10.1182/blood-2004-12-4986; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; Halleen JM, 2001, CLIN CHEM, V47, P597; JACOBS SC, 1983, UROLOGY, V21, P337, DOI 10.1016/0090-4295(83)90147-4; Keller ET, 2004, J CELL BIOCHEM, V91, P718, DOI 10.1002/jcb.10662; Keller ET, 2001, CANCER METAST REV, V20, P333, DOI 10.1023/A:1015599831232; KILLIAN CS, 1990, CANCER INVEST, V8, P27, DOI 10.3109/07357909009017544; Lau YS, 2007, BRIT J CANCER, V96, P1716, DOI 10.1038/sj.bjc.6603774; Levasseur R, 2005, JOINT BONE SPINE, V72, P207, DOI 10.1016/j.jbspin.2004.10.008; Li ZG, 2008, ONCOGENE, V27, P596, DOI 10.1038/sj.onc.1210694; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Mancini I, 2004, J CLIN ONCOL, V22, P3587, DOI 10.1200/JCO.2004.07.054; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Roato I, 2004, FASEB J, V18, P228, DOI 10.1096/fj.04-1823fje; ROATO I, 2007, LUNG CANC; Roato I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000124; Schwartz GG, 2008, CANCER EPIDEM BIOMAR, V17, P478, DOI 10.1158/1055-9965.EPI-07-2747; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685	31	65	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3627	10.1371/journal.pone.0003627	http://dx.doi.org/10.1371/journal.pone.0003627			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978943	Green Submitted, Green Published, gold			2022-12-27	WOS:000265134200010
J	Bandera, A; Trabattoni, D; Pacei, M; Fasano, F; Suardi, E; Cesari, M; Marchetti, G; Pogliani, EM; Franzetti, F; Clerici, M; Gori, A				Bandera, Alessandra; Trabattoni, Daria; Pacei, Michela; Fasano, Francesca; Suardi, Elisa; Cesari, Miriam; Marchetti, Giulia; Pogliani, Enrico M.; Franzetti, Fabio; Clerici, Mario; Gori, Andrea			Fully Immunocompetent CD8+T Lymphocytes Are Present in Autologous Haematopoietic Stem Cell Transplantation Recipients Despite an Ineffectual T-Helper Response	PLOS ONE			English	Article							IMMUNE RECONSTITUTION; DISTINCT PATTERNS; MEMORY; CD8(+); HETEROGENEITY; CHEMOTHERAPY; MATURATION; PHENOTYPE; LYMPHOMA; ANTIGENS	Background: Reduced CD4 T lymphocytes counts can be observed in HIV infection and in patients undergoing autologous haematopoietic stem cell transplantation (ASCT). Nevertheless, whereas opportunistic infections (OI) are frequent in HIV-infected individuals with low cell counts, OI are uncommon in ASCT patients. Methodology/Principal Findings: To verify whether this observation could be secondary to intrinsic HIV-correlated T cell defects, we performed in-depth immunologic analyses in 10 patients with comparable CD4 counts in whom lymphopenia was secondary either to HIV-infection or ASCT-associated immunosuppressive therapy and compared them to age-matched healthy subjects. Results showed the presence of profound alterations in CD4+ T lymphocytes in both groups of patients with respect to healthy controls. Thus, a low percentage of CCR7+ CD4+ T cells and a compensative expansion of CD45RA-2CCR7- CD4+ T cells, a reduced IL-2/IFN-gamma cytokine production and impaired recall antigens-specific proliferative responses were detected both in ASCT and HIV patients. In stark contrast, profound differences were detected in CD8+ T-cells between the two groups of patients. Thus, mature CD8+ T cell prevailed in ASCT patients in whom significantly lower CD45RA-CCR7- cells, higher CD45RA+CCR7- CD8+ cells, and an expansion of CCR7+ CD8+ cells was detected; this resulted in higher IFN-gamma +/TNF alpha production and granzyme CD8+ expression. The presence of strong CD8 T cells mediated immune responses justifies the more favorable clinical outcome of ASCT compared to HIV patients. Conclusion/Significance: These results indicate that CD8 T cells maturation and functions can be observed even in the face of a profound impairment of CD4+ T lymphocytes in ASCT but not in HIV patients. Primary HIV-associated CD8 defects or an imprinting by an intact CD4 T cell system in ASCT could justify these results.	[Bandera, Alessandra; Suardi, Elisa; Gori, Andrea] Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy; [Trabattoni, Daria; Pacei, Michela; Fasano, Francesca] Univ Milan, LITA VIALBA, Dept Preclin Sci, I-20122 Milan, Italy; [Cesari, Miriam; Marchetti, Giulia; Franzetti, Fabio; Gori, Andrea] Univ Milan, Luigi Sacco Hosp, Dept Clin Sci, Infect Dis Sect, I-20122 Milan, Italy; [Marchetti, Giulia] Univ Milan, San Paolo Hosp, Clin Infect Dis, I-20122 Milan, Italy; [Pogliani, Enrico M.] Univ Milano Bicocca, San Gerardo Hosp, Hematol Div, Bone Marrow Transplant Unit, Monza, Italy; [Clerici, Mario] Fdn Don C Gnocchi, IRCCS, Milan, Italy; [Clerici, Mario] Univ Milan, Dept Biomed Sci & Technol, I-20122 Milan, Italy	San Gerardo Hospital; University of Milano-Bicocca; University of Milan; University of Milan; Luigi Sacco Hospital; San Paolo-Polo Universitaria Hospital; University of Milan; San Gerardo Hospital; University of Milano-Bicocca; IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Milan	Bandera, A (corresponding author), Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy.	a.bandera@hsgerardo.org	Bandera, Alessandra/D-6255-2015; Gori, Andrea/AAC-6078-2022; Trabattoni, Daria/G-7424-2012; Marchetti, Giulia/GPX-7655-2022; franzetti, fabio/AAK-9158-2020; Bandera, Alessandra/AAC-6081-2022; MARCHETTI, GIULIA CARLA/K-4384-2018	Trabattoni, Daria/0000-0001-9535-3359; franzetti, fabio/0000-0001-9253-4453; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828; BANDERA, ALESSANDRA/0000-0001-9440-4601; Clerici, Mario/0000-0001-5920-6191; Bandera, Alessandra/0000-0003-1626-0328	Ermenegildo Zegna Foundation, Italy; AHSI Company, Milan, Italy	Ermenegildo Zegna Foundation, Italy; AHSI Company, Milan, Italy	The present study was funded by a grant from Ermenegildo Zegna Foundation, Italy, and AHSI Company, Milan, Italy. The funders supported the study and concorded with the authors about the design and the management of the study.	Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Barlogie B, 2004, BLOOD, V103, P20, DOI 10.1182/blood-2003-04-1045; Bourgeois C, 2003, EUR J IMMUNOL, V33, P3225, DOI 10.1002/eji.200324576; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chandrasekar PH, 2001, CLIN INFECT DIS, V32, P546, DOI 10.1086/318715; CLERICI M, 1989, NATURE, V339, P383, DOI 10.1038/339383a0; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; Ellefsen K, 2002, EUR J IMMUNOL, V32, P3756, DOI 10.1002/1521-4141(200212)32:12<3756::AID-IMMU3756>3.0.CO;2-E; Ferrari V, 2006, CLIN IMMUNOL, V119, P261, DOI 10.1016/j.clim.2005.12.001; Frere P, 2006, EUR J HAEMATOL, V76, P102, DOI 10.1111/j.1600-0609.2005.00569.x; Gorschluter M, 2007, LEUKEMIA LYMPHOMA, V48, P506, DOI 10.1080/10428190601094347; Guillaume T, 1998, BLOOD, V92, P1471, DOI 10.1182/blood.V92.5.1471; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2004, EUR J IMMUNOL, V34, P3525, DOI 10.1002/eji.200425324; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Harari A, 2002, BLOOD, V100, P1381, DOI 10.1182/blood-2001-11-0080; Hess C, 2004, LANCET, V363, P863, DOI 10.1016/S0140-6736(04)15735-8; Inokuma M, 2007, J IMMUNOL, V179, P2627, DOI 10.4049/jimmunol.179.4.2627; Jones J L, 1999, MMWR CDC Surveill Summ, V48, P1; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; LOSSOS IS, 1995, TRANSPLANTATION, V60, P672, DOI 10.1097/00007890-199510150-00010; Mackall CL, 1997, BLOOD, V89, P3700, DOI 10.1182/blood.V89.10.3700.3700_3700_3707; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Palmer BE, 2004, J IMMUNOL, V172, P3337, DOI 10.4049/jimmunol.172.5.3337; Reich G, 2001, BONE MARROW TRANSPL, V27, P525, DOI 10.1038/sj.bmt.1702822; Reimer P, 2003, ANN HEMATOL, V82, P263, DOI 10.1007/s00277-003-0630-4; Trabattoni D, 2004, AIDS, V18, P859, DOI 10.1097/00002030-200404090-00003; van Imhoff GW, 2005, J CLIN ONCOL, V23, P3793, DOI 10.1200/JCO.2005.07.039; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598	29	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3616	10.1371/journal.pone.0003616	http://dx.doi.org/10.1371/journal.pone.0003616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974880	Green Published, gold, Green Submitted			2022-12-27	WOS:000265131700030
J	Chen, JD; Futami, K; Petillo, D; Peng, J; Wang, PF; Knol, J; Li, Y; Khoo, SK; Huang, D; Qian, CN; Zhao, P; Dykyma, K; Zhang, R; Cao, B; Yang, XJ; Furge, K; Williams, BO; Teh, BT				Chen, Jindong; Futami, Kunihiko; Petillo, David; Peng, Jun; Wang, Pengfei; Knol, Jared; Li, Yan; Khoo, Sok-Kean; Huang, Dan; Qian, Chao-Nan; Zhao, Ping; Dykyma, Karl; Zhang, Racheal; Cao, Brian; Yang, Ximing J.; Furge, Kyle; Williams, Bart O.; Teh, Bin Tean			Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia	PLOS ONE			English	Article								The Birt-Hogg-Dube (BHD) disease is a genetic cancer syndrome. The responsible gene, BHD, has been identified by positional cloning and thought to be a novel tumor suppressor gene. BHD mutations cause many types of diseases including renal cell carcinomas, fibrofolliculomas, spontaneous pneumothorax, lung cysts, and colonic polyps/cancers. By combining Gateway Technology with the Ksp-Cre gene knockout system, we have developed a kidney-specific BHD knockout mouse model. BHD flox/flox/Ksp-Cre mice developed enlarged kidneys characterized by polycystic kidneys, hyperplasia, and cystic renal cell carcinoma. The affected BHD flox/flox/Ksp-Cre mice died of renal failure at approximate three weeks of age, having blood urea nitrogen levels over tenfold higher than those of BHD flox/+/Ksp-Cre and wild-type littermate controls. We further demonstrated that these phenotypes were caused by inactivation of BHD and subsequent activation of the mTOR pathway. Application of rapamycin, which inhibits mTOR activity, to the affected mice led to extended survival and inhibited further progression of cystogenesis. These results provide a correlation of kidney-targeted gene inactivation with renal carcinoma, and they suggest that the BHD product FLCN, functioning as a cyst and tumor suppressor, like other hamartoma syndrome-related proteins such as PTEN, LKB1, and TSC1/2, is a component of the mTOR pathway, constituting a novel FLCN-mTOR signaling branch that regulates cell growth/proliferation.	[Chen, Jindong; Futami, Kunihiko; Petillo, David; Li, Yan; Khoo, Sok-Kean; Huang, Dan; Qian, Chao-Nan; Zhang, Racheal; Teh, Bin Tean] Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI USA; [Futami, Kunihiko] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Tokyo, Japan; [Peng, Jun] Cleveland Clin, Genom Med Inst, Cleveland, OH USA; [Wang, Pengfei] Stowers Inst Med Res, Kansas City, MO USA; [Knol, Jared; Williams, Bart O.] Van Andel Res Inst, Lab Cell Signaling & Cancinogenesis, Grand Rapids, MI USA; [Khoo, Sok-Kean] Van Andel Res Inst, Lab Germline Modificat & Cytogenet, Grand Rapids, MI USA; [Qian, Chao-Nan] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China; [Zhao, Ping; Cao, Brian] Van Andel Res Inst, Lab Antibody Technol, Grand Rapids, MI USA; [Dykyma, Karl; Furge, Kyle] Van Andel Res Inst, Lab Computat Biol, Grand Rapids, MI USA; [Yang, Ximing J.] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA; [Teh, Bin Tean] Natl Canc Ctr, NCCS, VARI Translat Canc Res Lab, Singapore, Singapore	Van Andel Institute; Tokyo University of Marine Science & Technology; Cleveland Clinic Foundation; Stowers Institute for Medical Research; Van Andel Institute; Van Andel Institute; Sun Yat Sen University; Van Andel Institute; Van Andel Institute; Northwestern University; Feinberg School of Medicine; National Cancer Centre Singapore (NCCS)	Chen, JD (corresponding author), Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI USA.	jin-dong.chen@vai.org; bin.teh@vai.org	FUTAMI, Kunihiko/O-1964-2014; Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301; Teh, Bin Tean/0000-0003-1514-1124; Khoo, Sok Kean/0000-0003-3836-5497	Japan Amway [postdoctoral fellowship]; National Cancer Center [postdoctoral fellowship]; Van Andel Foundation	Japan Amway; National Cancer Center; Van Andel Foundation	K.F. and S.K.K. were funded by the Japan Amway and the National Cancer Center postdoctoral fellowship grant, respectively. J.K. was supported by the Frederik and Lena Meijer student internship. This work was also supported by the Van Andel Foundation.	Azoulay S, 2007, VIRCHOWS ARCH, V451, P905, DOI 10.1007/s00428-007-0483-7; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Deshpande R B, 1986, J Postgrad Med, V32, P239; FELDBERG MAM, 1982, AM J ROENTGENOL, V138, P953, DOI 10.2214/ajr.138.5.953; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Han KR, 2004, UROL ONCOL-SEMIN ORI, V22, P410, DOI 10.1016/S1078-1439(03)00173-X; HARTMAN DS, 1992, AM J ROENTGENOL, V159, P1235, DOI 10.2214/ajr.159.6.1442390; HARTMAN DS, 1986, UROLOGY, V28, P145, DOI 10.1016/0090-4295(86)90109-3; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Khoo SK, 2003, CANCER RES, V63, P4583; Khoo SK, 2001, ONCOGENE, V20, P5239, DOI 10.1038/sj.onc.1204703; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lindor NM, 2001, INT J DERMATOL, V40, P653, DOI 10.1046/j.1365-4362.2001.01287-4.x; Lingaas F, 2003, HUM MOL GENET, V12, P3043, DOI 10.1093/hmg/ddg336; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Nassir A, 2002, UROLOGY, V60, P421, DOI 10.1016/S0090-4295(02)01742-9; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Okimoto K, 2004, CURR MOL MED, V4, P887, DOI 10.2174/1566524043359737; Okimoto K, 2004, P NATL ACAD SCI USA, V101, P2023, DOI 10.1073/pnas.0308071100; Pavlovich CP, 2002, AM J SURG PATHOL, V26, P1542, DOI 10.1097/00000478-200212000-00002; Pollard PJ, 2007, CANCER CELL, V11, P311, DOI 10.1016/j.ccr.2007.02.005; Schmidt LS, 2005, AM J HUM GENET, V76, P1023, DOI 10.1086/430842; Schmidt LS, 2001, AM J HUM GENET, V69, P876, DOI 10.1086/323744; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Singh SR, 2006, ONCOGENE, V25, P5933, DOI 10.1038/sj.onc.1209593; Toro J R, 2002, J Med Genet, V39, pE10, DOI 10.1136/jmg.39.2.e10; Truong LD, 2003, ADV ANAT PATHOL, V10, P135, DOI 10.1097/00125480-200305000-00003; van Slegtenhorst M, 2007, J BIOL CHEM, V282, P24583, DOI 10.1074/jbc.M700857200; Vocke CD, 2005, J NATL CANCER I, V97, P931, DOI 10.1093/jnci/dji154; Wang P., 2006, TRANSGENICS, V4, P215; Warren MB, 2004, MODERN PATHOL, V17, P998, DOI 10.1038/modpathol.3800152; Welsch MJ, 2005, INT J DERMATOL, V44, P668, DOI 10.1111/j.1365-4632.2004.02095.x; Yousef George M., 2005, Int. braz j urol., V31, P465, DOI 10.1590/S1677-55382005000500008; Yousef GM, 2005, INT BRAZ J UROL, V31, P467	36	108	111	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3581	10.1371/journal.pone.0003581	http://dx.doi.org/10.1371/journal.pone.0003581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974783	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131500009
J	Tougard, C; Renvoise, E; Petitjean, A; Quere, JP				Tougard, Christelle; Renvoise, Elodie; Petitjean, Amelie; Quere, Jean-Pierre			New Insight into the Colonization Processes of Common Voles: Inferences from Molecular and Fossil Evidence	PLOS ONE			English	Article							MITOCHONDRIAL CYTOCHROME-B; GLACIAL REFUGIA; MICROTUS-ARVALIS; COMPARATIVE PHYLOGEOGRAPHY; GENETIC-STRUCTURE; DNA POLYMORPHISM; NORTHERN REFUGIA; URSUS-ARCTOS; EUROPE; POPULATIONS	Elucidating the colonization processes associated with Quaternary climatic cycles is important in order to understand the distribution of biodiversity and the evolutionary potential of temperate plant and animal species. In Europe, general evolutionary scenarios have been defined from genetic evidence. Recently, these scenarios have been challenged with genetic as well as fossil data. The origins of the modern distributions of most temperate plant and animal species could predate the Last Glacial Maximum. The glacial survival of such populations may have occurred in either southern (Mediterranean regions) and/or northern (Carpathians) refugia. Here, a phylogeographic analysis of a widespread European small mammal (Microtus arvalis) is conducted with a multidisciplinary approach. Genetic, fossil and ecological traits are used to assess the evolutionary history of this vole. Regardless of whether the European distribution of the five previously identified evolutionary lineages is corroborated, this combined analysis brings to light several colonization processes of M. arvalis. The species' dispersal was relatively gradual with glacial survival in small favourable habitats in Western Europe (from Germany to Spain) while in the rest of Europe, because of periglacial conditions, dispersal was less regular with bottleneck events followed by postglacial expansions. Our study demonstrates that the evolutionary history of European temperate small mammals is indeed much more complex than previously suggested. Species can experience heterogeneous evolutionary histories over their geographic range. Multidisciplinary approaches should therefore be preferentially chosen in prospective studies, the better to understand the impact of climatic change on past and present biodiversity.	[Tougard, Christelle; Renvoise, Elodie; Petitjean, Amelie] Univ Bourgogne, CNRS, UMR, uB 5561, F-21004 Dijon, France; [Quere, Jean-Pierre] Ctr Biol Gest Populat, Campus Int Baillarguet, INRA, UMR 1062, Montferrier Sur Lez, France	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; INRAE; Institut de Recherche pour le Developpement (IRD)	Tougard, C (corresponding author), Univ Montpellier 2, CNRS Um2, UMR 5554, Inst Sci Evolut Montpellier, Montpellier, France.	Christelle.Tougard@univ-montp2.fr			CNRS (French Government)	CNRS (French Government)(Centre National de la Recherche Scientifique (CNRS))	CNRS (French Government) provided financial support for the experiment realization. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Baker RJ, 1996, NATURE, V380, P707, DOI 10.1038/380707a0; BENNETT KD, 1997, EVOLUTION ECOLOGY PA, P259; BENOIT M, 2007, FOURRAGES, V191, P347; Bhagwat SA, 2008, J BIOGEOGR, V35, P464, DOI 10.1111/j.1365-2699.2007.01861.x; Bilton DT, 1998, P ROY SOC B-BIOL SCI, V265, P1219, DOI 10.1098/rspb.1998.0423; Brunhoff C, 2003, MOL ECOL, V12, P957, DOI 10.1046/j.1365-294X.2003.01796.x; CAMPY M, 1993, QUATERNARY RES, V40, P318, DOI 10.1006/qres.1993.1085; Chaline J, 1999, ANN ZOOL FENN, V36, P239; CHALINE J, 1989, 27 S GALL PREH ED CN, P97; COOPER SJB, 1995, MOL ECOL, V4, P49, DOI 10.1111/j.1365-294X.1995.tb00191.x; Deffontaine V, 2005, MOL ECOL, V14, P1727, DOI 10.1111/j.1365-294X.2005.02506.x; DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N; Delattre P, 1996, LANDSCAPE ECOL, V11, P279, DOI 10.1007/BF02059855; DELATTRE P, 1992, AGR ECOSYST ENVIRON, V39, P153, DOI 10.1016/0167-8809(92)90051-C; Delattre P, 1999, LANDSCAPE ECOL, V14, P401, DOI 10.1023/A:1008022727025; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubey S, 2007, J EVOLUTION BIOL, V20, P1799, DOI 10.1111/j.1420-9101.2007.01382.x; Dubey S, 2006, MOL PHYLOGENET EVOL, V38, P635, DOI 10.1016/j.ympev.2005.11.005; *EPICA COMM MEMB, 2004, NATURE, V0429; EVIN J, 1989, 27 S GALL PREH, P53; Fedorov VB, 2008, MOL ECOL, V17, P598, DOI 10.1111/j.1365-294X.2007.03595.x; Fedorov VB, 2001, P ROY SOC B-BIOL SCI, V268, P809, DOI 10.1098/rspb.2001.1584; Fink S, 2004, MOL ECOL, V13, P3501, DOI 10.1111/j.1365-294X.2004.02351.x; GIRAUDOUX P, 1994, ACTA OECOL, V15, P385; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guiter F, 2003, QUATERN INT, V111, P59, DOI 10.1016/S1040-6182(03)00015-6; Haase M, 2003, J EVOLUTION BIOL, V16, P415, DOI 10.1046/j.1420-9101.2003.00542.x; Haring E, 2000, J ZOOL SYST EVOL RES, V38, P231, DOI 10.1046/j.1439-0469.2000.384139.x; Haynes S, 2003, MOL ECOL, V12, P951, DOI 10.1046/j.1365-294X.2003.01795.x; Heckel G, 2005, EVOLUTION, V59, P2231; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hofreiter M, 2004, P NATL ACAD SCI USA, V101, P12963, DOI 10.1073/pnas.0403618101; HOWELL N, 1989, J MOL EVOL, V29, P157, DOI 10.1007/BF02100114; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaarola M, 2004, MOL PHYLOGENET EVOL, V33, P647, DOI 10.1016/j.ympev.2004.07.015; Jaarola M, 2004, HEREDITY, V92, P228, DOI 10.1038/sj.hdy.6800400; Jaarola M, 2002, MOL ECOL, V11, P2613, DOI 10.1046/j.1365-294X.2002.01639.x; Klotz S, 2003, GLOBAL PLANET CHANGE, V36, P277, DOI 10.1016/S0921-8181(02)00222-9; Kotlik P, 2001, MOL ECOL, V10, P2177, DOI 10.1046/j.0962-1083.2001.01344.x; Kotlik P, 2006, P NATL ACAD SCI USA, V103, P14860, DOI 10.1073/pnas.0603237103; Kowalski K., 2001, FOLIA QUATERNARIA, V72, P1; Lee-Yaw JA, 2008, MOL ECOL, V17, P867, DOI 10.1111/j.1365-294X.2007.03611.x; LELOUARN H, 2003, RONGEURS FRANCE; LELOUARN H, 1970, ANN ZOOL ECOL ANIM, V2, P423; Martin Y, 2000, MOL PHYLOGENET EVOL, V16, P37, DOI 10.1006/mpev.1999.0760; Michaux JR, 2005, HEREDITY, V94, P52, DOI 10.1038/sj.hdy.6800561; MILLS JN, 1995, METHODS TRAPPING SMA; Mitchell-Jones AJ, 1999, ATLAS EUROPEAN MAMMA, P484; Muller UC, 2003, QUATERNARY RES, V59, P235, DOI 10.1016/S0033-5894(03)00005-X; Nesbo CL, 1999, MOL ECOL, V8, P1387, DOI 10.1046/j.1365-294x.1999.00699.x; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Palme AE, 2002, MOL ECOL, V11, P1769, DOI 10.1046/j.1365-294X.2002.01581.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PRIMAULT J, 2007, GROTTE TAILLIS COTEA, P150; Rafinski J, 2000, HEREDITY, V84, P610, DOI 10.1046/j.1365-2540.2000.00707.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Schweizer M, 2007, MOL ECOL, V16, P2463, DOI 10.1111/j.1365-294X.2007.03284.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SLATKIN M, 1991, GENETICS, V129, P555; Sommer R, 2004, MAMMAL REV, V34, P249, DOI 10.1111/j.1365-2907.2004.00043.x; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; SPITZ F, 1977, Bulletin OEPP, V7, P165; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Stewart JR, 2003, SCIENCE, V299, P825; Svenning JC, 2002, BIOL CONSERV, V104, P133, DOI 10.1016/S0006-3207(01)00162-8; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028; Tougard C, 2001, MOL PHYLOGENET EVOL, V19, P34, DOI 10.1006/mpev.2000.0903; Tougard C, 2008, BIOL J LINN SOC, V93, P309, DOI 10.1111/j.1095-8312.2007.00926.x; Triant DA, 2006, GENETICA, V128, P95, DOI 10.1007/s10709-005-5538-6; Valdiosera CE, 2007, MOL ECOL, V16, P5140, DOI 10.1111/j.1365-294X.2007.03590.x; van Kolfschoten T., 1996, EARLY MIDDLE PLEISTO, P227, DOI DOI 10.1201/9781003077879-16; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002	80	51	53	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3532	10.1371/journal.pone.0003532	http://dx.doi.org/10.1371/journal.pone.0003532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958287	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131100006
J	Cubbon, RM; Abbas, A; Wheatcroft, SB; Kilcullen, N; Das, R; Morrell, C; Barth, JH; Kearney, MT; Hall, AS				Cubbon, Richard M.; Abbas, Afroze; Wheatcroft, Stephen B.; Kilcullen, Niamh; Das, Raj; Morrell, Christine; Barth, Julian H.; Kearney, Mark T.; Hall, Alistair S.		EMMACE 2 Investigators	Diabetes Mellitus and Mortality after Acute Coronary Syndrome as a First or Recurrent Cardiovascular Event	PLOS ONE			English	Article								Background: Diabetes Mellitus (DM) is associated with adverse cardiovascular prognosis. However, the risk associated with DM may vary between individuals according to their overall cardiovascular risk burden. Therefore, we aimed to determine whether DM is associated with poor outcome in patients presenting with Acute Coronary Syndrome (ACS) according to the index episode being a first or recurrent cardiovascular event. Methods and Findings: We conducted a retrospective analysis of a prospective cohort study involving 2499 consecutively admitted patients with confirmed ACS in 11 UK hospitals during 2003. Usual care was provided for all participants. Demographic factors, co-morbidity and treatment (during admission and at discharge) factors were recorded. The primary outcome was all cause mortality (median 2 year follow up), compared for cohorts with and without DM according to their prior cardiovascular disease (CVD) disease status. Adjusted analyses were performed with Cox proportional hazards regression analysis. Within the entire cohort, DM was associated with an unadjusted 45% increase in mortality. However, in patients free of a history of CVD, mortality of those with and without DM was similar (18.8% and 19.7% respectively; p=0.74). In the group with CVD, mortality of patients with DM was significantly higher than those without DM (46.7% and 33.2% respectively; p, 0.001). The age and sex adjusted interaction between DM and CVD in predicting mortality was highly significant (p=0.002) and persisted after accounting for comorbidities and treatment factors (p=0.006). Of patients free of CVD, DM was associated with smaller elevation of Troponin I (p < 0.001). However in patients with pre-existing CVD Troponin I was similar (p=0.992). Conclusions: DM is only associated with worse outcome after ACS in patients with a pre-existing history of CVD. Differences in the severity of myocyte necrosis may account for this. Further investigation is required, though our findings suggest that aggressive primary prevention of CVD in patients with DM may have beneficially modified their first presentation with (and mortality after) ACS.	[Cubbon, Richard M.; Abbas, Afroze; Wheatcroft, Stephen B.; Kearney, Mark T.] Univ Leeds, LIGHT Labs, Leeds Inst Genet Hlth & Therapeut, Div Cardiovasc & Diabet Res, Leeds, W Yorkshire, England; [Kilcullen, Niamh; Das, Raj; Morrell, Christine; Hall, Alistair S.] Leeds Gen Infirmary, C NET Grp, Leeds, W Yorkshire, England; [Barth, Julian H.] Leeds Gen Infirmary, Dept Clin Biochem & Immunol, Leeds, W Yorkshire, England	University of Leeds; Leeds General Infirmary; Leeds General Infirmary	Cubbon, RM (corresponding author), Univ Leeds, LIGHT Labs, Leeds Inst Genet Hlth & Therapeut, Div Cardiovasc & Diabet Res, Leeds, W Yorkshire, England.	m.t.kearney@leeds.ac.uk	Hall, Alistair/K-1953-2019; Barth, Julian H/F-6028-2010		Beckman Coulter; AstraZeneca; Sanofi-Aventis; British Heart Foundation [fellowships]	Beckman Coulter; AstraZeneca(AstraZeneca); Sanofi-Aventis(Sanofi-Aventis); British Heart Foundation(British Heart Foundation)	Beckman Coulter, AstraZeneca and Sanofi-Aventis provided research grants for the EMMACE-2 study. Dr. Cubbon and Dr. Abbas receive support from British Heart Foundation clinical PhD fellowships. Dr. Wheatcroft receives support from a British Heart Foundation intermediate fellowship. Dr. Das and Dr. Kilcullen were supported by British Heart Foundation junior research fellowships; the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294; Das R, 2006, HEART, V92, P21, DOI 10.1136/hrt.2004.046441; Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765; Evans JMM, 2002, BRIT MED J, V324, P939, DOI 10.1136/bmj.324.7343.939; Goraya TY, 2002, J AM COLL CARDIOL, V40, P946, DOI 10.1016/S0735-1097(02)02065-X; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Howard BV, 2006, DIABETES CARE, V29, P391, DOI 10.2337/diacare.29.02.06.dc05-1299; Kleiman NS, 2005, HEART, V91, P1121, DOI 10.1136/hrt.2004.056085; Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014; Natali A, 2000, DIABETOLOGIA, V43, P632, DOI 10.1007/s001250051352; Ryden L, 2007, EUR HEART J SUPPL, V9, pC3, DOI 10.1093/eurheartj/ehl261	11	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3483	10.1371/journal.pone.0003483	http://dx.doi.org/10.1371/journal.pone.0003483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941531	Green Submitted, Green Published, gold			2022-12-27	WOS:000265126100014
J	Hannoush, RN				Hannoush, Rami N.			Kinetics of Wnt-Driven beta-Catenin Stabilization Revealed by Quantitative and Temporal Imaging	PLOS ONE			English	Article								The Wnt/beta-catenin signal transduction pathway regulates a broad range of developmental processes. Aberrant activation of the Wnt pathway leads to cancer and degenerative diseases. beta-catenin is a key signaling molecule that is frequently used as a direct monitor of Wnt pathway activation. This paper describes a multi-parametric method for quantitative analysis of cellular beta-catenin protein levels in a rapid and high-throughput manner. The assay offers temporally resolved detection of Wnt-stimulated accumulation of beta-catenin, simultaneously detecting cell number, and it sheds light onto the kinetics of posttranslational stabilization of beta-catenin.	Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech	Hannoush, RN (corresponding author), Genentech Inc, Dept Prot Engn, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	hannoush.rami@gene.com			Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	This work was funded by Genentech, Inc.	Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Naik S, 2007, P NATL ACAD SCI USA, V104, P17465, DOI 10.1073/pnas.0704465104; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Smith PJ, 1999, J IMMUNOL METHODS, V229, P131, DOI 10.1016/S0022-1759(99)00116-7; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601	17	38	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3498	10.1371/journal.pone.0003498	http://dx.doi.org/10.1371/journal.pone.0003498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941539	Green Published, Green Submitted, gold			2022-12-27	WOS:000265126100025
J	Sun, Y; Li, H; Liu, Y; Mattson, MP; Rao, MS; Zhan, M				Sun, Yu; Li, Huai; Liu, Ying; Mattson, Mark P.; Rao, Mahendra S.; Zhan, Ming			Evolutionarily Conserved Transcriptional Co-Expression Guiding Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; DIVERGENT PATHS; SRC FAMILY; PLURIPOTENCY; MOUSE; NETWORK; MAINTENANCE; INDUCTION	Background: Understanding the molecular mechanisms controlling pluripotency in embryonic stem cells (ESCs) is of central importance towards realizing their potentials in medicine and science. Cross-species examination of transcriptional co-expression allows elucidation of fundamental and species-specific mechanisms regulating ESC self-renewal or differentiation. Methodology/Principal Findings: We examined transcriptional co-expression of ESCs from pathways to global networks under the framework of human-mouse comparisons. Using generalized singular value decomposition and comparative partition around medoids algorithms, evolutionarily conserved and divergent transcriptional co-expression regulating pluripotency were identified from ESC-critical pathways including ACTIVIN/NODAL, ATK/PTEN, BMP, CELL CYCLE, JAK/STAT, PI3K, TGF beta and WNT. A set of transcription factors, including FOX, GATA, MYB, NANOG, OCT, PAX, SOX and STAT, and the FGF response element were identified that represent key regulators underlying the transcriptional co-expression. By transcriptional intervention conducted in silico, dynamic behavior of pathways was examined, which demonstrate how much and in which specific ways each gene or gene combination effects the behavior transition of a pathway in response to ESC differentiation or pluripotency induction. The global co-expression networks of ESCs were dominated by highly connected hub genes such as IGF2, JARID2, LCK, MYCN, NASP, OCT4, ORC1L, PHC1 and RUVBL1, which are possibly critical in determining the fate of ESCs. Conclusions/Significance: Through these studies, evolutionary conservation at genomic, transcriptomic, and network levels is shown to be an effective predictor of molecular factors and mechanisms controlling ESC development. Various hypotheses regarding mechanisms controlling ESC development were generated, which could be further validated by in vitro experiments. Our findings shed light on the systems-level understanding of how ESC differentiation or pluripotency arises from the connectivity or networks of genes, and provide a "road-map'' for further experimental investigation.	[Sun, Yu; Li, Huai; Zhan, Ming] NIA, Bioinformat Unit, Res Resources Branch, NIH, Baltimore, MD 21224 USA; [Liu, Ying; Rao, Mahendra S.] Invitrogen Corp, CRL, Carlsbad, CA USA; [Mattson, Mark P.] NIA, Lab Neurosci, NIH, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Thermo Fisher Scientific; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sun, Y (corresponding author), NIA, Bioinformat Unit, Res Resources Branch, NIH, Baltimore, MD 21224 USA.	zhanmi@mail.nih.gov	Mattson, Mark P/F-6038-2012		Intramural Research Program at the National Institute on Aging, NIH; NATIONAL INSTITUTE ON AGING [Z01AG000324, Z01AG000619, ZICAG000619, ZIAAG000324] Funding Source: NIH RePORTER	Intramural Research Program at the National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program at the National Institute on Aging, NIH.	Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; BAI ZJ, 1993, SIAM J SCI COMPUT, V14, P1464, DOI 10.1137/0914085; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Battista S, 2003, FASEB J, V17, P1496, DOI 10.1096/fj.02-0977fje; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138; Cervera RP, 2007, CLIN PHARMACOL THER, V82, P310, DOI 10.1038/sj.clpt.6100278; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Feng Y, 2003, CANCER RES, V63, P8726; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Fujimoto A, 2006, STEM CELLS, V24, P595, DOI 10.1634/stemcells.2005-0301; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Giuliano CJ, 2005, BBA-GENE STRUCT EXPR, V1731, P48, DOI 10.1016/j.bbaexp.2005.08.006; Haremaki T, 2003, DEVELOPMENT, V130, P4907, DOI 10.1242/dev.00718; Hong YH, 1996, MECH DEVELOP, V60, P33, DOI 10.1016/S0925-4773(96)00596-5; Hughes M, 2004, DEV BIOL, V271, P26, DOI 10.1016/j.ydbio.2004.03.029; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; KAUFMAN L, 1990, FITTING GROUPS DATA; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; Li H, 2006, BIOINFORMATICS, V22, P96, DOI 10.1093/bioinformatics/bti752; Li H, 2008, FRONT BIOSCI-LANDMRK, V13, P263, DOI 10.2741/2677; Li H, 2007, BIOINFORMATICS, V23, P473, DOI 10.1093/bioinformatics/btl640; Li H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-103; Liu Y, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-20; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Martindill DMJ, 2007, NAT CELL BIOL, V9, P1131, DOI 10.1038/ncb1633; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Mitalipov S, 2007, STEM CELLS, V25, P581, DOI 10.1634/stemcells.2006-0120; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Qiu XB, 1998, J BIOL CHEM, V273, P27786, DOI 10.1074/jbc.273.43.27786; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Soodeen-Karamath S, 2001, MOL REPROD DEV, V58, P137, DOI 10.1002/1098-2795(200102)58:2&lt;137::AID-MRD2&gt;3.0.CO;2-6; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sun Y, 2007, GENOMICS, V89, P22, DOI 10.1016/j.ygeno.2006.09.010; Sun Y, 2006, CRIT REV EUKAR GENE, V16, P211, DOI 10.1615/CritRevEukarGeneExpr.v16.i3.20; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; THMELS J, 2005, PLOS GENET, V1, pE39; Toyoda M, 2000, BIOCHEM BIOPH RES CO, V274, P332, DOI 10.1006/bbrc.2000.3138; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Van der Laan MJ, 2003, J STAT COMPUT SIM, V73, P575, DOI 10.1080/0094965031000136012; van Noort V, 2004, EMBO REP, V5, P280, DOI 10.1038/sj.embor.7400090; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; YOSHIDA K, 1994, MECH DEVELOP, V45, P163, DOI 10.1016/0925-4773(94)90030-2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhan M, 2005, CELL BIOCHEM BIOPHYS, V43, P379, DOI 10.1385/CBB:43:3:379; ZHAN M, GENOMIC MED IN PRESS; Zhan M, 2008, FRONT BIOSCI-LANDMRK, V13, P276, DOI 10.2741/2678	83	39	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3406	10.1371/journal.pone.0003406	http://dx.doi.org/10.1371/journal.pone.0003406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923680	Green Published, gold, Green Submitted			2022-12-27	WOS:000265121800005
J	Serandour, J; Reynaud, S; Willison, J; Patouraux, J; Gaude, T; Ravanel, P; Lemperiere, G; Raveton, M				Serandour, Julien; Reynaud, Stephane; Willison, John; Patouraux, Joelle; Gaude, Thierry; Ravanel, Patrick; Lemperiere, Guy; Raveton, Muriel			Ubiquitous Water-Soluble Molecules in Aquatic Plant Exudates Determine Specific Insect Attraction	PLOS ONE			English	Article								Plants produce semio-chemicals that directly influence insect attraction and/or repulsion. Generally, this attraction is closely associated with herbivory and has been studied mainly under atmospheric conditions. On the other hand, the relationship between aquatic plants and insects has been little studied. To determine whether the roots of aquatic macrophytes release attractive chemical mixtures into the water, we studied the behaviour of mosquito larvae using olfactory experiments with root exudates. After testing the attraction on Culex and Aedes mosquito larvae, we chose to work with Coquillettidia species, which have a complex behaviour in nature and need to be attached to plant roots in order to obtain oxygen. This relationship is non-destructive and can be described as commensal behaviour. Commonly found compounds seemed to be involved in insect attraction since root exudates from different plants were all attractive. Moreover, chemical analysis allowed us to identify a certain number of commonly found, highly water-soluble, low-molecular-weight compounds, several of which ( glycerol, uracil, thymine, uridine, thymidine) were able to induce attraction when tested individually but at concentrations substantially higher than those found in nature. However, our principal findings demonstrated that these compounds appeared to act synergistically, since a mixture of these five compounds attracted larvae at natural concentrations (0.7 nM glycerol, <0.5 nM uracil, 0.6 nM thymine, 2.8 nM uridine, 86 nM thymidine), much lower than those found for each compound tested individually. These results provide strong evidence that a mixture of polyols (glycerol), pyrimidines (uracil, thymine), and nucleosides (uridine, thymidine) functions as an efficient attractive signal in nature for Coquillettidia larvae. We therefore show for the first time, that such commonly found compounds may play an important role in plant-insect relationships in aquatic eco-systems.	[Serandour, Julien; Reynaud, Stephane; Patouraux, Joelle; Gaude, Thierry; Ravanel, Patrick; Lemperiere, Guy; Raveton, Muriel] Univ Grenoble 1, Lab Ecol Alpine, Equipe Perturbat Environm & Xenobiot, CNRS,UMR 5553, Grenoble, France; [Willison, John] CEA Grenoble, Inst Rech Technol Sci Vivant, UJF, CEA, CNRS, UMR 5249,Lab Chim Biol Metaux, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Serandour, J (corresponding author), Univ Grenoble 1, Lab Ecol Alpine, Equipe Perturbat Environm & Xenobiot, CNRS,UMR 5553, BP 53, Grenoble, France.	muriel.raveton@ujf-grenoble.fr	Reynaud, Stephane/H-5493-2013; Raveton, Muriel/K-1403-2013	Reynaud, Stephane/0000-0003-0248-0602; 				Apperson CS, 2002, J MED ENTOMOL, V39, P777, DOI 10.1603/0022-2585-39.5.777; Bartlet E, 1997, ENTOMOL EXP APPL, V85, P257, DOI 10.1023/A:1003140219888; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bosak PJ, 2002, J AM MOSQUITO CONTR, V18, P280; Cancrini G, 2006, J MED ENTOMOL, V43, P574, DOI 10.1603/0022-2585(2006)43[574:NVODIR]2.0.CO;2; Carr W.E.S., 1988, P3; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Chaton PF, 2001, PESTIC BIOCHEM PHYS, V69, P183, DOI 10.1006/pest.2000.2536; CLEMENTS AN, 1999, BIOL MOSQUITOES, V2, P74; Cupp EW, 2007, J MED ENTOMOL, V44, P117, DOI 10.1603/0022-2585(2007)44[117:WNVIIM]2.0.CO;2; Cupp EW, 2003, AM J TROP MED HYG, V68, P495, DOI 10.4269/ajtmh.2003.68.495; D'Alessandro M, 2006, ANALYST, V131, P24, DOI 10.1039/b507589k; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; EVANS WG, 1982, J CHEM ECOL, V8, P671, DOI 10.1007/BF00989636; Ferry A, 2007, J CHEM ECOL, V33, P2064, DOI 10.1007/s10886-007-9373-3; Fink P, 2007, MAR FRESHW BEHAV PHY, V40, P155, DOI 10.1080/10236240701602218; FOOTE BA, 1995, ANNU REV ENTOMOL, V40, P417, DOI 10.1146/annurev.en.40.010195.002221; HOULIHAN DF, 1969, J ZOOL, V159, P249; Kalinova J, 2007, J AGR FOOD CHEM, V55, P6453, DOI 10.1021/jf070795u; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P250, DOI 10.1094/MPMI-19-0250; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; KAUFMAN MG, 2007, SOIL BIOL BIOCHEM, DOI DOI 10.1007/S00248-007-9310-6; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kidd PS, 2001, J EXP BOT, V52, P1339, DOI 10.1093/jexbot/52.359.1339; KLINGER TS, 1985, MAR BEHAV PHYSIOL, V11, P327, DOI 10.1080/10236248509387057; Kramer C, 2008, SOIL BIOL BIOCHEM, V40, P425, DOI 10.1016/j.soilbio.2007.09.016; Kumar R, 2006, CURR SCI INDIA, V91, P885; LAURENCE B. R., 1960, BULL ENT RES, V51, P491, DOI 10.1017/S0007485300055127; Manda H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-113; Mandalakas AM, 2005, EMERG INFECT DIS, V11, P1774, DOI 10.3201/eid1111.040933; MANN KH, 1984, J EXP MAR BIOL ECOL, V79, P233, DOI 10.1016/0022-0981(84)90197-7; Marko MD, 2005, J CHEM ECOL, V31, P2857, DOI 10.1007/s10886-005-8399-7; MAY B M, 1970, New Zealand Entomologist, V4, P7; METCALF RL, 1992, CHEM ECOLOGY PLANT K, P64; MILLER V, 1976, J CHROMATOGR, V119, P355, DOI 10.1016/S0021-9673(00)86799-0; Rahman YJ, 2000, J CHEM ECOL, V26, P679, DOI 10.1023/A:1005428221952; Raveton M, 1997, PESTIC BIOCHEM PHYS, V58, P199, DOI 10.1006/pest.1997.2303; Rejmankova Eliska, 2000, Aquatic Ecology, V34, P413, DOI 10.1023/A:1011416006562; ROSELAND CR, 1992, ENTOMOL EXP APPL, V62, P99, DOI 10.1007/BF00345480; SAGLIO P, 1990, J FISH BIOL, V37, P887, DOI 10.1111/j.1095-8649.1990.tb03592.x; Serandour J, 2006, ENTOMOL EXP APPL, V120, P195, DOI 10.1111/j.1570-7458.2006.00444.x; TAKABAYASHI J, 1995, J CHEM ECOL, V21, P273, DOI 10.1007/BF02036717; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; Vinson S.B., 1987, P 6 INT S INS PLANT, P109; WAGNER KG, 1992, INT REV CYTOL, V134, P1, DOI 10.1016/S0074-7696(08)62027-6; Wei J. N., 2007, PLOS ONE, V9, P1; Weissburg MJ, 2002, J CHEM ECOL, V28, P1953, DOI 10.1023/A:1020741710060; Wenger K, 2005, J ENVIRON QUAL, V34, P2187, DOI 10.2134/jeq2004.0409; Wu C.-Y., 1990, Chinese Journal of Entomology, V10, P151; Xia S, 2007, PLOS BIOL, V5, P2398, DOI 10.1371/journal.pbio.0050264; Yoon HR, 2007, ARCH PHARM RES, V30, P387, DOI 10.1007/BF02977623	53	12	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3350	10.1371/journal.pone.0003350	http://dx.doi.org/10.1371/journal.pone.0003350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841203	gold, Green Submitted, Green Published			2022-12-27	WOS:000265113900005
J	Yang, CC; Shih, YH; Ko, MH; Hsu, SY; Cheng, H; Fu, YS				Yang, Chang-Ching; Shih, Yang-Hsin; Ko, Miau-Hwa; Hsu, Shao-Yun; Cheng, Henrich; Fu, Yu-Show			Transplantation of Human Umbilical Mesenchymal Stem Cells from Wharton's Jelly after Complete Transection of the Rat Spinal Cord	PLOS ONE			English	Article								Background: Human umbilical mesenchymal stem cells (HUMSCs) isolated from Wharton's jelly of the umbilical cord can be easily obtained and processed compared with embryonic or bone marrow stem cells. These cells may be a valuable source in the repair of spinal cord injury. Methodology/Principal Findings: We examine the effects of HUMSC transplantation after complete spinal cord transection in rats. Approximately 5610 5 HUMSCs were transplanted into the lesion site. Three groups of rats were implanted with either untreated HUMSCs (referred to as the stem cell group), or HUMSCs treated with neuronal conditioned medium (NCM) for either three days or six days (referred to as NCM-3 and NCM-6 days, respectively). The control group received no HUMSCs in the transected spinal cord. Three weeks after transplantation, significant improvements in locomotion were observed in all the three groups receiving HUMSCs (stem cell, NCM-3 and NCM-6 days groups). This recovery was accompanied by increased numbers of regenerated axons in the corticospinal tract and neurofilament-positive fibers around the lesion site. There were fewer microglia and reactive astrocytes in both the rostral and caudal stumps of the spinal cord in the stem cell group than in the control group. Transplanted HUMSCs survived for 16 weeks and produced large amounts of human neutrophil-activating protein-2, neurotrophin-3, basic fibroblast growth factor, glucocorticoid induced tumor necrosis factor receptor, and vascular endothelial growth factor receptor 3 in the host spinal cord, which may help spinal cord repair. Conclusions/Significance: Transplantation of HUMSCs is beneficial to wound healing after spinal cord injury in rats.	[Yang, Chang-Ching; Hsu, Shao-Yun] Natl Yang Ming Univ, Inst Anat & Cell Biol, Sch Med, Taipei 112, Taiwan; [Shih, Yang-Hsin] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei, Taiwan; [Shih, Yang-Hsin] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Ko, Miau-Hwa] China Med Univ, Sch Med, Dept Anat, Taichung, Taiwan; [Cheng, Henrich] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Neural Regenerat Lab, Taipei, Taiwan; [Cheng, Henrich] Natl Yang Ming Univ, Sch Med, Dept Pharmacol, Taipei, Taiwan; [Fu, Yu-Show] Natl Yang Ming Univ, Sch Med, Dept Anat & Cell Biol, Taipei, Taiwan; [Fu, Yu-Show] Taipei City Hosp, Dept Ed & Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Medical University; China Medical University Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Yang, CC (corresponding author), Natl Yang Ming Univ, Inst Anat & Cell Biol, Sch Med, Taipei 112, Taiwan.	hc_cheng@vghtpe.gov.tw; ysfu@ym.edu.tw			National Science Council [NSC97-2314-B-075-011-MY3]; Taipei Veterans General Hospital [V96C1-102]; Ministry of Education, Aim for the Top University Plan [97A-C-T159]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This work was supported by the Grant NSC97-2314-B-075-011-MY3 from the National Science Council, Grant V96C1-102 from the Taipei Veterans General Hospital, Grant 97A-C-T159 from Ministry of Education, Aim for the Top University Plan.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; BJORKLUND A, 1993, NATURE, V362, P414, DOI 10.1038/362414a0; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451; Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; Dasari VR, 2007, NEUROCHEM RES, V32, P2080, DOI 10.1007/s11064-007-9368-z; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Fu YS, 2004, J BIOMED SCI, V11, P652, DOI 10.1159/000079678; Gibson CL, 2005, GLIA, V50, P417, DOI 10.1002/glia.20143; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Horner PJ, 2000, J NEUROSCI, V20, P2218; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Kassam A, 2004, ENT-EAR NOSE THROAT, V83, P52; Kassam A, 2004, ENT-EAR NOSE THROAT, V83, P50; Kassam Amin, 2004, Ear Nose Throat J, V83, P246; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kitamura Y, 2005, J PHARMACOL SCI, V97, P289, DOI 10.1254/jphs.SC0040129; Kitamura Y, 2004, J PHARMACOL SCI, V94, P203, DOI 10.1254/jphs.94.203; Kojima A, 2000, J NEUROPATH EXP NEUR, V59, P687, DOI 10.1093/jnen/59.8.687; Kojima A, 2002, J NEUROTRAUM, V19, P223, DOI 10.1089/08977150252806974; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lee TT, 1999, J NEUROTRAUM, V16, P347, DOI 10.1089/neu.1999.16.347; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Manoonkitiwongsa PS, 2004, J CEREBR BLOOD F MET, V24, P693, DOI 10.1097/01.WCB.0000126236.54306.21; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Marti HH, 1998, P NATL ACAD SCI USA, V95, P15809, DOI 10.1073/pnas.95.26.15809; Maurer MH, 2003, NEUROSCI LETT, V344, P165, DOI 10.1016/S0304-3940(03)00407-5; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Perrin LA, 2004, GENE THER, V11, P512, DOI 10.1038/sj.gt.3302173; Petter-Puchner AH, 2007, EXP TOXICOL PATHOL, V58, P237, DOI 10.1016/j.etp.2006.07.004; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Robinson CJ, 2001, J CELL SCI, V114, P853; Rogove AD, 2002, CELL DEATH DIFFER, V9, P801, DOI 10.1038/sj.cdd.4401041; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Song S, 2004, EXP NEUROL, V185, P191, DOI 10.1016/j.expneurol.2003.09.003; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170, DOI 10.1097/01.wcb.0000037988.07114.98; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Taoka Y, 1998, PROG NEUROBIOL, V56, P341, DOI 10.1016/S0301-0082(98)00049-5; Teng YD, 1999, J NEUROSCI, V19, P7037, DOI 10.1523/JNEUROSCI.19-16-07037.1999; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Tsai EC, 2005, J NEUROPATH EXP NEUR, V64, P230, DOI 10.1093/jnen/64.3.230; Tuszynski MH, 2003, EXP NEUROL, V181, P47, DOI 10.1016/S0014-4886(02)00055-9; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yick LW, 2003, EXP NEUROL, V182, P160, DOI 10.1016/S0014-4886(02)00052-3; Yoshihara T, 2007, J NEUROTRAUM, V24, P1026, DOI 10.1089/neu.2007.132R; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	68	182	207	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3336	10.1371/journal.pone.0003336	http://dx.doi.org/10.1371/journal.pone.0003336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18852872	Green Published, gold, Green Submitted			2022-12-27	WOS:000265113500004
J	Baumgartner, W; Fidler, F; Weth, A; Habbecke, M; Jakob, P; Butenweg, C; Bohme, W				Baumgartner, Werner; Fidler, Florian; Weth, Agnes; Habbecke, Martin; Jakob, Peter; Butenweg, Christoph; Boehme, Wolfgang			Investigating the Locomotion of the Sandfish in Desert Sand Using NMR-Imaging	PLOS ONE			English	Article								The sandfish (Scincus scincus) is a lizard having the remarkable ability to move through desert sand for significant distances. It is well adapted to living in loose sand by virtue of a combination of morphological and behavioural specializations. We investigated the bodyform of the sandfish using 3D-laserscanning and explored its locomotion in loose desert sand using fast nuclear magnetic resonance (NMR) imaging. The sandfish exhibits an in-plane meandering motion with a frequency of about 3 Hz and an amplitude of about half its body length accompanied by swimming-like (or trotting) movements of its limbs. No torsion of the body was observed, a movement required for a digging-behaviour. Simple calculations based on the Janssen model for granular material related to our findings on bodyform and locomotor behaviour render a local decompaction of the sand surrounding the moving sandfish very likely. Thus the sand locally behaves as a viscous fluid and not as a solid material. In this fluidised sand the sandfish is able to "swim'' using its limbs.	[Baumgartner, Werner; Weth, Agnes] Rhein Westfal TH Aachen, Dept Cellular Neurob, Aachen, Germany; [Fidler, Florian; Jakob, Peter] Univ Wurzburg, Dept Expt Phys 5, D-97070 Wurzburg, Germany; [Habbecke, Martin] Rhein Westfal TH Aachen, Inst Computergraph & Multimedia, Aachen, Germany; [Butenweg, Christoph] Rhein Westfal TH Aachen, Chair Struct Stat & Dyn, Aachen, Germany; [Boehme, Wolfgang] Zool Forschungsmuseum Alexander Koenig ZFMK, Bonn, Germany	RWTH Aachen University; University of Wurzburg; RWTH Aachen University; RWTH Aachen University; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Baumgartner, W (corresponding author), Rhein Westfal TH Aachen, Dept Cellular Neurob, Aachen, Germany.	werner@bio2.rwth-aachen.de	Baumgartner, Werner/C-5013-2012	Baumgartner, Werner/0000-0002-3160-2050; Jakob, Peter/0000-0002-3481-5545				Anderson S.C, 1999, LIZARDS IRAN; Arnold E.N, 1977, Bulletin Br Mus nat Hist (Zool), V31, P189; ARNOLD EN, 1995, J ZOOL, V235, P351, DOI 10.1111/j.1469-7998.1995.tb01758.x; Baumgartner W, 2007, J BIONIC ENG, V4, P1, DOI 10.1016/S1672-6529(07)60006-7; BELLAIRS A, 1971, REPTILIEN; Besl P. J., 1988, Machine Vision and Applications, V1, P127, DOI 10.1007/BF01212277; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bons J, 1996, AMPHIBIENS REPTILES; BRANDT JF, 1829, MED ZOOLOGIE ODER GE; DISI JF, 2001, AMPHIBIANS REPTILES; DURAN J, 2000, SANDS POWDERS GRAINS; El Toubi M. R., 1938, Bulletin of the Faculty of Science Cairo, V14, P5; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; Halloy Monique, 1998, Herpetological Monographs, V12, P1, DOI 10.2307/1467019; Hartmann U.-K., 1989, Herpetofauna (Weinstadt), V11, P12; Hartmann U.-K., 1989, Herpetofauna (Weinstadt), V11, P17; HARTMANN UK, 1986, BIOL APOTHEKERSKINKS; HORNUNG A, 2006, P 4 EUR S GEOM PROC, P41; Laurenti JN, 1768, SPECIMEN MEDICUM EXH; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; LUKE C, 1986, BIOL J LINN SOC, V27, P1, DOI 10.1111/j.1095-8312.1986.tb01723.x; Mateo J. A., 2004, AMPHIBIANS REPTILES, DOI 10.1643/0045-8511(2007)2007[772:TAAROT]2.0.CO;2; MERTENS R, 1972, Salamandra, V8, P117; Nance HA, 2007, AFR J HERPETOL, V56, P39, DOI 10.1080/21564574.2007.9635552; Pough FH, 2001, HERPETOLOGY; RECHENBERG I, 2004, REIBUNG VERSCHLEISS; SUKHANOV BV, 1968, OBSHCHAYA SISTEMA SI; TERCAFS RR, 1961, B SOC ROY ZOOL ANVER, V10, P3	28	39	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3309	10.1371/journal.pone.0003309	http://dx.doi.org/10.1371/journal.pone.0003309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18836551	Green Published, Green Submitted, gold			2022-12-27	WOS:000264797200012
J	Jetz, W; Freckleton, RP; McKechnie, AE				Jetz, Walter; Freckleton, Robert P.; McKechnie, Andrew E.			Environment, Migratory Tendency, Phylogeny and Basal Metabolic Rate in Birds	PLOS ONE			English	Article							EVAPORATIVE WATER-LOSS; PHENOTYPIC FLEXIBILITY; ENERGY-EXPENDITURE; BODY-COMPOSITION; SLOW PACE; ADAPTATION; ALLOMETRY; PRODUCTIVITY; TEMPERATURE; ADJUSTMENTS	Basal metabolic rate (BMR) represents the minimum maintenance energy requirement of an endotherm and has far-reaching consequences for interactions between animals and their environments. Avian BMR exhibits considerable variation that is independent of body mass. Some long-distance migrants have been found to exhibit particularly high BMR, traditionally interpreted as being related to the energetic demands of long-distance migration. Here we use a global dataset to evaluate differences in BMR between migrants and non-migrants, and to examine the effects of environmental variables. The BMR of migrant species is significantly higher than that of non-migrants. Intriguingly, while the elevated BMR of migrants on their breeding grounds may reflect the metabolic machinery required for long-distance movements, an alternative (and statistically stronger) explanation is their occupation of predominantly cold high-latitude breeding areas. Among several environmental predictors, average annual temperature has the strongest effect on BMR, with a 50% reduction associated with a 20 degrees C gradient. The negative effects of temperature variables on BMR hold separately for migrants and non-migrants and are not due their different climatic associations. BMR in migrants shows a much lower degree of phylogenetic inertia. Our findings indicate that migratory tendency need not necessarily be invoked to explain the higher BMR of migrants. A weaker phylogenetic signal observed in migrants supports the notion of strong phenotypic flexibility in this group which facilitates migration-related BMR adjustments that occur above and beyond environmental conditions. In contrast to the findings of previous analyses of mammalian BMR, primary productivity, aridity or precipitation variability do not appear to be important environmental correlates of avian BMR. The strong effects of temperature-related variables and varying phylogenetic effects reiterate the importance of addressing both broad-scale and individual-scale variation for understanding the determinants of BMR.	[Jetz, Walter] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Freckleton, Robert P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [McKechnie, Andrew E.] Univ Pretoria, Dept Zool & Entomol, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-0002 Pretoria, South Africa	University of California System; University of California San Diego; University of Sheffield; National Research Foundation - South Africa; University of Pretoria	Jetz, W (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	wjetz@ucsd.edu	Freckleton, Rob P/B-6455-2013; McKechnie, Andrew E/E-4398-2010; Jetz, Walter/ABF-1517-2020	McKechnie, Andrew E/0000-0002-1524-1021; Jetz, Walter/0000-0002-1971-7277; Freckleton, Robert/0000-0002-8338-864X	Emmy Noether Program of the Deutsche Forschungsgesellschaft (DFG); National Science Foundation [BCS-0648733]; National Research Foundation; DST/NRF Centre of Excellence at the Percy FitzPatrick Institute; Royal Society University Research Fellow; University of Oxford [Astor Travel Grant]	Emmy Noether Program of the Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); National Research Foundation; DST/NRF Centre of Excellence at the Percy FitzPatrick Institute(Department of Science & Technology (India)); Royal Society University Research Fellow(Royal Society of London); University of Oxford	W.J. was funded by the Emmy Noether Program of the Deutsche Forschungsgesellschaft (DFG) and the National Science Foundation (grant BCS-0648733). A.E.M. received funding from the National Research Foundation and the DST/NRF Centre of Excellence at the Percy FitzPatrick Institute. RPF is a Royal Society University Research Fellow. The study was facilitated by an Astor Travel Grant from the University of Oxford to R.P.F. and W.J.	Ahn C-H, 1994, J JAPANESE SOC PHOTO, V33, P12, DOI DOI 10.4287/JSPRS.33.2_12; Anderson KJ, 2005, ECOL LETT, V8, P310, DOI 10.1111/j.1461-0248.2005.00723.x; Battley PF, 2001, CONDOR, V103, P838, DOI 10.1650/0010-5422(2001)103[0838:BMRDDL]2.0.CO;2; Battley PF, 2001, PHYSIOL BIOCHEM ZOOL, V74, P435, DOI 10.1086/320432; BENNETT PM, 1987, J ZOOL, V213, P327, DOI 10.1111/j.1469-7998.1987.tb03708.x; Broggi J, 2005, EVOLUTION, V59, P1600; Chappell MA, 1999, J EXP BIOL, V202, P2269; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Dawson W.R., 2000, P343, DOI 10.1016/B978-012747605-6/50015-8; Dietz MW, 1999, J EXP BIOL, V202, P2831; Elgar MA, 1987, FUNCT ECOL, V1, P25, DOI 10.2307/2389354; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Jackson S, 1996, EVOLUTION, V50, P1638, DOI [10.2307/2410900, 10.1111/j.1558-5646.1996.tb03936.x]; KERSTEN M, 1987, ARDEA, V75, P175; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; Klaassen M, 2004, COMP BIOCHEM PHYS A, V137, P639, DOI 10.1016/j.cbpb.2003.12.004; Kvist A, 2001, FUNCT ECOL, V15, P465, DOI 10.1046/j.0269-8463.2001.00549.x; Liknes ET, 2002, CONDOR, V104, P548, DOI 10.1650/0010-5422(2002)104[0548:SAITAG]2.0.CO;2; Lindstrom A, 2003, CONDOR, V105, P420, DOI 10.1650/7222; LINDSTROM A, 1995, P ROY SOC B-BIOL SCI, V261, P337, DOI 10.1098/rspb.1995.0156; Lindstrom A, 1997, J AVIAN BIOL, V28, P87, DOI 10.2307/3677098; Louw G.N., 1982, ECOLOGY DESERT ORGAN; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; Maddocks TA, 2000, J ZOOL, V252, P327; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; McKechnie AE, 2006, P ROY SOC B-BIOL SCI, V273, P931, DOI 10.1098/rspb.2005.3415; MCKECHNIE AE, 2008, J COMP PHYSL B; McKechnie AE, 2008, J COMP PHYSIOL B, V178, P235, DOI 10.1007/s00360-007-0218-8; McKechnie AE, 2007, J EXP BIOL, V210, P97, DOI 10.1242/jeb.02615; MCNAB BK, 1963, ECOL MONOGR, V33, P63, DOI 10.2307/1948477; MCNAB BK, 1986, ECOL MONOGR, V56, P1, DOI 10.2307/2937268; Mueller P, 2001, P NATL ACAD SCI USA, V98, P12550, DOI 10.1073/pnas.221456698; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PIERSMA T, 1995, J COMP PHYSIOL B, V165, P37, DOI 10.1007/BF00264684; Piersma T, 2002, INTEGR COMP BIOL, V42, P51, DOI 10.1093/icb/42.1.51; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Rezende EL, 2002, J EXP BIOL, V205, P101; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; Schmidt-Nielsen K., 1990, ANIMAL PHYSL ADAPTAT; SWANSON DL, 1991, CONDOR, V93, P538, DOI 10.2307/1368185; Tieleman BI, 2003, P ROY SOC B-BIOL SCI, V270, P207, DOI 10.1098/rspb.2002.2205; Tieleman BI, 2000, PHYSIOL BIOCHEM ZOOL, V73, P461, DOI 10.1086/317740; Tieleman BI, 2003, ECOLOGY, V84, P1800, DOI 10.1890/0012-9658(2003)084[1800:PVOLAA]2.0.CO;2; Vezina F, 2003, INTEGR COMP BIOL, V43, P1040; WEATHERS WW, 1979, OECOLOGIA, V42, P81, DOI 10.1007/BF00347620; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P929, DOI 10.1086/425186; White CR, 2007, P ROY SOC B-BIOL SCI, V274, P287, DOI 10.1098/rspb.2006.3727; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P9340, DOI 10.1073/pnas.0702212104; Wikelski M, 2003, P ROY SOC B-BIOL SCI, V270, P2383, DOI 10.1098/rspb.2003.2500; Williams JB, 2000, J EXP BIOL, V203, P3153; WITHERS PC, 1992, COMP ANIMAL PHYSL; WOODWARD FI, 1995, GLOBAL BIOGEOCHEM CY, V9, P471, DOI 10.1029/95GB02432	59	75	75	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2008	3	9							e3261	10.1371/journal.pone.0003261	http://dx.doi.org/10.1371/journal.pone.0003261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MA	18810267	gold, Green Published, Green Submitted			2022-12-27	WOS:000264431000003
J	Allard, JS; Heilbronn, LK; Smith, C; Hunt, ND; Ingram, DK; Ravussin, E; de Cabo, R				Allard, Joanne S.; Heilbronn, Leonie K.; Smith, Carolina; Hunt, Nicole D.; Ingram, Donald K.; Ravussin, Eric; de Cabo, Rafael		Pennington CALERIE Team	In Vitro Cellular Adaptations of Indicators of Longevity in Response to Treatment with Serum Collected from Humans on Calorie Restricted Diets	PLOS ONE			English	Article								Calorie restriction (CR) produces several health benefits and increases lifespan in many species. Studies suggest that alternate-day fasting (ADF) and exercise can also provide these benefits. Whether CR results in lifespan extension in humans is not known and a direct investigation is not feasible. However, phenotypes observed in CR animals when compared to ad libitum fed (AL) animals, including increased stress resistance and changes in protein expression, can be simulated in cells cultured with media supplemented with blood serum from CR and AL animals. Two pilot studies were undertaken to examine the effects of ADF and CR on indicators of health and longevity in humans. In this study, we used sera collected from those studies to culture human hepatoma cells and assessed the effects on growth, stress resistance and gene expression. Cells cultured in serum collected at the end of the dieting period were compared to cells cultured in serum collected at baseline (before the dieting period). Cells cultured in serum from ADF participants, showed a 20% increase in Sirt1 protein which correlated with reduced triglyceride levels. ADF serum also induced a 9% decrease in proliferation and a 25% increase in heat resistance. Cells cultured in serum from CR participants induced an increase in Sirt1 protein levels by 17% and a 30% increase in PGC-1a mRNA levels. This first in vitro study utilizing human serum to examine effects on markers of health and longevity in cultured cells resulted in increased stress resistance and an up-regulation of genes proposed to be indicators of increased longevity. The use of this in vitro technique may be helpful for predicting the potential of CR, ADF and other dietary manipulations to affect markers of longevity in humans.	[Allard, Joanne S.; Smith, Carolina; Hunt, Nicole D.; Ingram, Donald K.; de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA; [Heilbronn, Leonie K.; Ingram, Donald K.; Ravussin, Eric] Pennington Biomed Res Ctr, Baton Rouge, LA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Allard, JS (corresponding author), NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA.	decabora@grc.nia.nih.gov	de Cabo, Rafael/E-7996-2010; Heilbronn, Leonie K/H-1874-2013; Ravussin, Eric/N-1985-2017; de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael/0000-0003-2830-5693; Heilbronn, Leonie K/0000-0003-2106-7303; Ravussin, Eric/0000-0003-2129-547X; de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442	Research Program of the NIH, National Institute on Aging [U01 AG20478]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000368, U01AG020478] Funding Source: NIH RePORTER	Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging, and also in part by research grant U01 AG20478 from the National Institutes of Health.	ALBANES D, 1988, JNCI-J NATL CANCER I, V80, P772, DOI 10.1093/jnci/80.10.772; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; AUSTAD SN, 1989, EXP GERONTOL, V24, P83, DOI 10.1016/0531-5565(89)90037-5; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Colom B, 2007, CARDIOVASC RES, V74, P456, DOI 10.1016/j.cardiores.2007.02.001; Corton JC, 2005, J GERONTOL A-BIOL, V60, P1494, DOI 10.1093/gerona/60.12.1494; de Cabo R, 2003, EXP GERONTOL, V38, P631, DOI 10.1016/S0531-5565(03)00055-X; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gomez CR, 2006, MECH AGEING DEV, V127, P257, DOI 10.1016/j.mad.2005.10.002; GOODRICK CL, 1980, GERONTOLOGY, V26, P22, DOI 10.1159/000212390; GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q; Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Heilbronn LK, 2005, OBES RES, V13, P574, DOI 10.1038/oby.2005.61; Heilbronn LK, 2005, AM J CLIN NUTR, V81, P69; HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; Hisahara S, 2005, J PHARMACOL SCI, V98, P200, DOI 10.1254/jphs.FMJ05001X2; HOLLOSZY JO, 1988, J GERONTOL, V43, pB149, DOI 10.1093/geronj/43.6.B149; Ingram DK, 2006, BIOGERONTOLOGY, V7, P143, DOI 10.1007/s10522-006-9013-2; JAMES SJ, 1994, CANCER RES, V54, P5508; Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315; Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lopez-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Masoro EJ, 2001, AGING-CLIN EXP RES, V13, P261; Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Mulligan JD, 2008, EXP GERONTOL, V43, P146, DOI 10.1016/j.exger.2007.10.011; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Redman LM, 2007, J CLIN ENDOCR METAB, V92, P865, DOI 10.1210/jc.2006-2184; RETZLAFF E, 1966, GERIATRICS, V21, P171; RIABOWOL KT, 1988, SCIENCE, V242, P433, DOI 10.1126/science.3175665; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Selsby JT, 2005, EXP GERONTOL, V40, P37, DOI 10.1016/j.exger.2004.08.012; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-353; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Walford RL, 2002, J GERONTOL A-BIOL, V57, pB211, DOI 10.1093/gerona/57.6.B211; Willcox DC, 2006, BIOGERONTOLOGY, V7, P173, DOI 10.1007/s10522-006-9008-z; Wolkow CA, 2002, TRENDS NEUROSCI, V25, P212, DOI 10.1016/S0166-2236(02)02133-1; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	56	57	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3211	10.1371/journal.pone.0003211	http://dx.doi.org/10.1371/journal.pone.0003211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791640	Green Submitted, gold, Green Published			2022-12-27	WOS:000264427700006
J	Taylor, BS; Barretina, J; Socci, ND; DeCarolis, P; Ladanyi, M; Meyerson, M; Singer, S; Sander, C				Taylor, Barry S.; Barretina, Jordi; Socci, Nicholas D.; DeCarolis, Penelope; Ladanyi, Marc; Meyerson, Matthew; Singer, Samuel; Sander, Chris			Functional Copy-Number Alterations in Cancer	PLOS ONE			English	Article							RESOLUTION GENOMIC PROFILES; LUNG-CANCER; FINE-SCALE; ADIPOCYTE DIFFERENTIATION; HUMAN-BREAST; MUTATIONS; RECOMBINATION; AMPLIFICATION; ABERRATIONS; EXPRESSION	Understanding the molecular basis of cancer requires characterization of its genetic defects. DNA microarray technologies can provide detailed raw data about chromosomal aberrations in tumor samples. Computational analysis is needed (1) to deduce from raw array data actual amplification or deletion events for chromosomal fragments and (2) to distinguish causal chromosomal alterations from functionally neutral ones. We present a comprehensive computational approach, RAE, designed to robustly map chromosomal alterations in tumor samples and assess their functional importance in cancer. To demonstrate the methodology, we experimentally profile copy number changes in a clinically aggressive subtype of soft-tissue sarcoma, pleomorphic liposarcoma, and computationally derive a portrait of candidate oncogenic alterations and their target genes. Many affected genes are known to be involved in sarcomagenesis; others are novel, including mediators of adipocyte differentiation, and may include valuable therapeutic targets. Taken together, we present a statistically robust methodology applicable to high-resolution genomic data to assess the extent and function of copy-number alterations in cancer.	[Taylor, Barry S.; Socci, Nicholas D.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Taylor, Barry S.] Weill Cornell Grad Sch Med Sci, Dept Physiol & Biophys, New York, NY USA; [Barretina, Jordi; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [Barretina, Jordi; Meyerson, Matthew] Massachusetts Inst Technol MIT, Broad Inst Harvard, Cambridge, MA USA; [DeCarolis, Penelope; Singer, Samuel] Memorial Sloan Kettering Canc Ctr, Sarcoma Biol Lab, Sarcoma Dis Management Program, New York, NY USA; [Ladanyi, Marc] Memorial Sloan Kettering Canc Ctr, Dept Pathol & Human Oncol, Pathogenesis Program, New York, NY USA; [Singer, Samuel] Memorial Sloan Kettering Canc Ctr, Dept Surg, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Taylor, BS (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, 1275 York Ave, New York, NY 10021 USA.	copy-number@cbio.mskcc.org	Sander, Chris/H-1452-2011; Ladanyi, Marc/AAG-8585-2019; Meyerson, Matthew L/E-7123-2012; Barretina, Jordi/A-7192-2013	Sander, Chris/0000-0001-6059-6270; Singer, Samuel/0000-0001-9713-8230; Barretina, Jordi/0000-0002-3478-4080	The Soft Tissue Sarcoma Program Project [P01 CA047179]; The Sarcoma Genome Project; The Kristen Ann Carr Fund; NATIONAL CANCER INSTITUTE [P01CA047179] Funding Source: NIH RePORTER	The Soft Tissue Sarcoma Program Project; The Sarcoma Genome Project; The Kristen Ann Carr Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by: The Soft Tissue Sarcoma Program Project (P01 CA047179, S.S., N.D.S and C.S.), The Sarcoma Genome Project, and by The Kristen Ann Carr Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Ambrosini G, 2007, ONCOGENE, V26, P3473, DOI 10.1038/sj.onc.1210136; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; COOP G, 2008, SCIENCE; Dalal KM, 2006, ANN SURG, V244, P381, DOI 10.1097/01.sla.0000234795.98607.00; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Emanuel BS, 2007, NAT REV GENET, V8, P869, DOI 10.1038/nrg2136; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fletcher CDM., 2002, WHO CLASSIFICATION T; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Fritz B, 2002, CANCER RES, V62, P2993; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guttman M, 2007, PLOS GENET, V3, P1464, DOI 10.1371/journal.pgen.0030143; HAHN SA, 1995, CANCER RES, V55, P4670; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ida K, 1997, BLOOD, V90, P4699, DOI 10.1182/blood.V90.12.4699.4699_4699_4704; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; King AA, 2000, AM J MED GENET, V93, P388, DOI 10.1002/1096-8628(20000828)93:5<388::AID-AJMG8>3.0.CO;2-#; LADANYI M, 2008, ENZINGER WEISSS SOFT; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Lupski JR, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-242; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MACK TM, 1995, CANCER-AM CANCER SOC, V75, P211, DOI 10.1002/1097-0142(19950101)75:1+<211::AID-CNCR2820751309>3.0.CO;2-X; Major JE, 2007, BIOINFORMATICS, V23, P3091, DOI 10.1093/bioinformatics/btm339; Mariani O, 2007, CANCER CELL, V11, P361, DOI 10.1016/j.ccr.2007.02.007; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; *NAT CANC I NHGRI, 2007, CANC GEN ATL; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rieker RJ, 2002, INT J CANCER, V99, P68, DOI 10.1002/ijc.10287; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rubin AF, 2007, SCIENCE, V317, DOI 10.1126/science.1138956; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shah SP, 2007, BIOINFORMATICS, V23, pI450, DOI 10.1093/bioinformatics/btm221; Singer S, 2007, CANCER RES, V67, P6626, DOI 10.1158/0008-5472.CAN-07-0584; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Strathdee G, 2002, SEMIN CANCER BIOL, V12, P373, DOI 10.1016/S1044-579X(02)00057-3; Takahashi N, 2002, J BIOL CHEM, V277, P16906, DOI 10.1074/jbc.M200585200; Tanaka K, 2006, DNA SEQUENCE, V17, P242, DOI 10.1080/10425170600805433; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; WEIR BA, 2007, NATURE; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Wong FL, 1997, JAMA-J AM MED ASSOC, V278, P1262, DOI 10.1001/jama.278.15.1262; Wood LD, 2007, SCIENCE	62	120	127	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3179	10.1371/journal.pone.0003179	http://dx.doi.org/10.1371/journal.pone.0003179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784837	Green Published, gold, Green Submitted			2022-12-27	WOS:000264425900001
J	Irrcher, I; Ljubicic, V; Kirwan, AF; Hood, DA				Irrcher, Isabella; Ljubicic, Vladimir; Kirwan, Angie F.; Hood, David A.			AMP-Activated Protein Kinase-Regulated Activation of the PGC-1 alpha Promoter in Skeletal Muscle Cells	PLOS ONE			English	Article								The mechanisms by which PGC-1 alpha gene expression is controlled in skeletal muscle remains largely undefined. Thus, we sought to investigate the transcriptional regulation of PGC-1 alpha using AICAR, an activator of AMPK, that is known to increase PGC-1 alpha expression. A 2.2 kb fragment of the human PGC-1 alpha promoter was cloned and sequence analysis revealed that this TATA-less sequence houses putative consensus sites including a GC-box, a CRE, several IRSs, a SRE, binding sites for GATA, MEF2, p 53, NF-kappa B, and EBox binding proteins. AMPK activation for 24 hours increased PGC-1 alpha promoter activity with concomitant increases in mRNA expression. The effect of AICAR on transcriptional activation was mediated by an overlapping GATA/EBox binding site at 2495 within the PGC-1 alpha promoter based on gel shift analyses that revealed increases in GATA/EBox DNA binding. Mutation of the EBox within the GATA/EBox binding site in the promoter reduced basal promoter activity and completely abolished the AICAR effect. Supershift analyses identified USF-1 as a DNA binding transcription factor potentially involved in regulating PGC-1 alpha promoter activity, which was confirmed in vivo by ChIP. Overexpression of either GATA-4 or USF-1 alone increased the p851 PGC-1 alpha promoter activity by 1.7- and 2.0-fold respectively, while co-expression of GATA-4 and USF-1 led to an additive increase in PGC-1 alpha promoter activity. The USF-1-mediated increase in PGC-1 alpha promoter activation led to similar increases at the mRNA level. Our data identify a novel AMPK-mediated regulatory pathway that regulates PGC-1 alpha gene expression. This could represent a potential therapeutic target to control PGC-1 alpha expression in skeletal muscle.	[Ljubicic, Vladimir; Hood, David A.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Ljubicic, Vladimir; Hood, David A.] York Univ, Muscle Hlth Res Ctr, N York, ON M3J 1P3, Canada; [Irrcher, Isabella; Kirwan, Angie F.; Hood, David A.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada	York University - Canada; York University - Canada; York University - Canada	Hood, DA (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	dhood@yorku.ca			Canadian Institutes of Health Research; Natural Science and Engineering Research Council of Canada [scholarships]; Heart and Stroke Foundation of Canada [scholarships]; Canada Research Chair in Cell Physiology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Research Chair in Cell Physiology(Canada Research Chairs)	This project was funded by the Canadian Institutes of Health Research, and the Natural Science and Engineering Research Council of Canada (NSERC; DAH). II and VL were recipients of scholarships from NSERC. VL was the recipient of a scholarship from the Heart and Stroke Foundation of Canada. DAH is the holder of a Canada Research Chair in Cell Physiology. The funding sources had no role in the design and conduct of the study, in the collection, analysis, and interpretation of data, and in the preparation, review, or approval of the manuscript.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC790, DOI 10.1152/ajpcell.00425.2003; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Connor MK, 2001, J BIOL CHEM, V276, P15898, DOI 10.1074/jbc.M100272200; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; Feingold K, 2004, AM J PHYSIOL-ENDOC M, V286, pE201, DOI 10.1152/ajpendo.00205.2003; Fujii N, 2000, BIOCHEM BIOPH RES CO, V273, P1150, DOI 10.1006/bbrc.2000.3073; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hawley JA, 2004, DIABETES-METAB RES, V20, P383, DOI 10.1002/dmrr.505; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Irrcher I, 2003, SPORTS MED, V33, P783, DOI 10.2165/00007256-200333110-00001; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Luo X, 1996, MOL CELL BIOL, V16, P1367; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Moore ML, 2001, J BIOL CHEM, V276, P1026, DOI 10.1074/jbc.M009352200; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ojuka EO, 2003, FASEB J, V17, P675, DOI 10.1096/fj.02-0951com; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Planavila A, 2005, BBA-MOL CELL BIOL L, V1736, P120, DOI 10.1016/j.bbalip.2005.08.001; Ponticos M, 1998, EMBO J, V17, P1688, DOI 10.1093/emboj/17.6.1688; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003; Terada S, 2005, ACTA PHYSIOL SCAND, V184, P59, DOI 10.1111/j.1365-201X.2005.01423.x; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Weitzel JM, 2003, J MOL ENDOCRINOL, V31, P291, DOI 10.1677/jme.0.0310291; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu D, 2002, BIOCHEM BIOPH RES CO, V294, P245, DOI 10.1016/S0006-291X(02)00464-3	52	150	153	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3614	10.1371/journal.pone.0003614	http://dx.doi.org/10.1371/journal.pone.0003614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974883	Green Published, gold			2022-12-27	WOS:000265131700028
J	Gumy, C; Chandsawangbhuwana, C; Dzyakanchuk, AA; Kratschmar, DV; Baker, ME; Odermatt, A				Gumy, Christel; Chandsawangbhuwana, Charlie; Dzyakanchuk, Anna A.; Kratschmar, Denise V.; Baker, Michael E.; Odermatt, Alex			Dibutyltin Disrupts Glucocorticoid Receptor Function and Impairs Glucocorticoid-Induced Suppression of Cytokine Production	PLOS ONE			English	Article								Background: Organotins are highly toxic and widely distributed environmental chemicals. Dibutyltin (DBT) is used as stabilizer in the production of polyvinyl chloride plastics, and it is also the major metabolite formed from tributyltin (TBT) in vivo. DBT is immunotoxic, however, the responsible targets remain to be defined. Due to the importance of glucocorticoids in immune-modulation, we investigated whether DBT could interfere with glucocorticoid receptor (GR) function. Methodology: We used HEK-293 cells transiently transfected with human GR as well as rat H4IIE hepatoma cells and native human macrophages and human THP-1 macrophages expressing endogenous receptor to study organotin effects on GR function. Docking of organotins was used to investigate the binding mechanism. Principal Findings: We found that nanomolar concentrations of DBT, but not other organotins tested, inhibit ligand binding to GR and its transcriptional activity. Docking analysis indicated that DBT inhibits GR activation allosterically by inserting into a site close to the steroid-binding pocket, which disrupts a key interaction between the A-ring of the glucocorticoid and the GR. DBT inhibited glucocorticoid-induced expression of phosphoenolpyruvate carboxykinase (PEPCK) and tyrosine-aminotransferase (TAT) and abolished the glucocorticoid-mediated transrepression of TNF-alpha-induced NF-kappa B activity. Moreover, DBT abrogated the glucocorticoid-mediated suppression of interleukin-6 (IL-6) and TNF-alpha production in lipopolysaccharide (LPS)-stimulated native human macrophages and human THP-1 macrophages. Conclusions: DBT inhibits ligand binding to GR and subsequent activation of the receptor. By blocking GR activation, DBT may disturb metabolic functions and modulation of the immune system, providing an explanation for some of the toxic effects of this organotin.	[Gumy, Christel; Dzyakanchuk, Anna A.; Kratschmar, Denise V.; Odermatt, Alex] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Gumy, Christel] Univ Bern, Dept Nephrol & Hypertens, CH-3012 Bern, Switzerland; [Chandsawangbhuwana, Charlie; Baker, Michael E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Bern; University of California System; University of California San Diego	Baker, ME (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	mbaker@ucsd.edu; Alex.Odermatt@unibas.ch		Baker, Michael/0000-0003-4387-3269; Winter, denise V./0000-0002-3764-1747; Odermatt, Alex/0000-0002-6820-2712	Swiss National Science Foundation [310000-112279, 4050-066575]; Novartis Chair of Molecular and Systems Toxicology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Chair of Molecular and Systems Toxicology	This work was supported by grants from the Swiss National Science Foundation (No 310000-112279 and NRP50 "Endocrine Disruptors" No 4050-066575). A.O. has a Novartis Chair of Molecular and Systems Toxicology. The authors of this manuscript have nothing to declare.	Apostolova G, 2005, AM J PHYSIOL-ENDOC M, V288, pE957, DOI 10.1152/ajpendo.00442.2004; Atanasov AG, 2005, ENVIRON HEALTH PERSP, V113, P1600, DOI 10.1289/ehp.8209; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhosle NB, 2004, CHEMOSPHERE, V57, P897, DOI 10.1016/j.chemosphere.2004.06.037; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Chicano JJ, 2001, BBA-BIOMEMBRANES, V1510, P330, DOI 10.1016/S0005-2736(00)00365-5; Chrousos GP, 2007, STRESS, V10, P213, DOI 10.1080/10253890701292119; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Evans SM, 2000, SCI TOTAL ENVIRON, V258, P73, DOI 10.1016/S0048-9697(00)00507-6; FENT K, 2005, HDB ENV CHEM, V5, DOI DOI 10.1007/1698_1005_1050; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; Gennari A, 2000, TOXICOL APPL PHARM, V169, P185, DOI 10.1006/taap.2000.9076; GRUN F, 2006, MOL ENDOCRINOL; Grun F, 2006, ENDOCRINOLOGY, V147, pS50, DOI 10.1210/en.2005-1129; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Inadera H, 2005, TOXICOL LETT, V159, P226, DOI 10.1016/j.toxlet.2005.05.015; Jenkins SM, 2004, DEV BRAIN RES, V151, P1, DOI 10.1016/j.devbrainres.2004.03.015; Kannan K, 1999, ARCH ENVIRON CON TOX, V36, P462, DOI 10.1007/PL00006619; Kato T, 2004, EUR J IMMUNOL, V34, P1312, DOI 10.1002/eji.200324667; KRAJNC EI, 1984, TOXICOL APPL PHARM, V75, P363, DOI 10.1016/0041-008X(84)90176-5; Liu JY, 2002, J AGR FOOD CHEM, V50, P6683, DOI 10.1021/jf025712i; MERKORD J, 1989, EXP PATHOL-JENA, V36, P59, DOI 10.1016/S0232-1513(89)80113-6; Merkord J, 2001, HUM EXP TOXICOL, V20, P386, DOI 10.1191/096032701682692964; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nakanishi T, 2005, MOL ENDOCRINOL, V19, P2502, DOI 10.1210/me.2004-0397; Nielsen JB, 2002, ENVIRON RES, V88, P129, DOI 10.1006/enrs.2001.4321; Odermatt A, 2006, J STEROID BIOCHEM, V102, P222, DOI 10.1016/j.jsbmb.2006.09.010; Ohhira S, 2003, ARCH TOXICOL, V77, P138, DOI 10.1007/s00204-002-0428-5; Omura Minoru, 2004, Environ Sci, V11, P123; Rebuffat AG, 2004, MOL CELL ENDOCRINOL, V214, P27, DOI 10.1016/j.mce.2003.11.027; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sadiki AI, 1999, CHEMOSPHERE, V38, P1541, DOI 10.1016/S0045-6535(98)00374-9; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; SEINEN W, 1977, TOXICOL APPL PHARM, V42, P213, DOI 10.1016/0041-008X(77)90211-3; SNOEIJ NJ, 1988, INT J IMMUNOPHARMACO, V10, P891, DOI 10.1016/0192-0561(88)90014-8; Sternberg RM, 2006, AQUAT TOXICOL, V78, P233, DOI 10.1016/j.aquatox.2006.03.004; Takahashi S, 1999, ARCH ENVIRON CON TOX, V37, P50, DOI 10.1007/s002449900489; Takahashi S, 1999, ENVIRON POLLUT, V106, P213, DOI 10.1016/S0269-7491(99)00068-8; Tschopp CM, 2006, BLOOD, V108, P2290, DOI 10.1182/blood-2006-03-010348; Ueno S, 2003, ARCH TOXICOL, V77, P173, DOI 10.1007/s00204-002-0429-4; Ueno S, 1997, ARCH TOXICOL, V71, P513, DOI 10.1007/s002040050421; Whalen MM, 1999, ENVIRON RES, V81, P108, DOI 10.1006/enrs.1999.3968; Zhang JH, 2005, P NATL ACAD SCI USA, V102, P2707, DOI 10.1073/pnas.0409663102	43	60	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3545	10.1371/journal.pone.0003545	http://dx.doi.org/10.1371/journal.pone.0003545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958157	Green Published, Green Submitted, gold			2022-12-27	WOS:000265130900007
J	Roark, EA; Haldar, K				Roark, Everett A.; Haldar, Kasturi			Effects of Lysosomal Membrane Protein Depletion on the Salmonella-Containing Vacuole	PLOS ONE			English	Article								Salmonella is an intracellular bacterial pathogen that replicates within a membrane-bound vacuole in host cells. The major lysosomal membrane proteins 1 and 2 (LAMP-1 and LAMP-2) are recruited to the Salmonella-containing vacuole as well as Salmonella-associated filaments (Sifs) that emerge from the vacuole. LAMP-1 is a dominant membrane marker for the vacuole and Sifs. Its colocalization with both is dependent on a major secreted bacterial virulence protein, SifA. Here, we show that SifA is required for the recruitment of LAMP-2 and can be used as a second independent marker for both the bacterial vacuolar membrane and Sifs. Further, RNAi studies revealed that in LAMP-1 depleted cells, the bacteria remain membrane bound as measured by their association with LAMP-2 protein. In contrast, LAMP-2 depletion increased the amount of LAMP-1 free bacteria. Together, the data suggests that despite its abundance, LAMP-1 is not essential, but LAMP-2 may be partially important for the Salmonella-containing vacuolar membrane.	[Roark, Everett A.; Haldar, Kasturi] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Roark, Everett A.; Haldar, Kasturi] Northwestern Univ, Dept Pathol, Chicago, IL USA	University of Notre Dame; Northwestern University	Haldar, K (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	khaldar@nd.edu	Haldar, Kasturi/C-6685-2014		Region V Great Lakes Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases Award [1-U54-057153]; Diversifying Higher Education Faculty in Illinois Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	Region V Great Lakes Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Diversifying Higher Education Faculty in Illinois Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the VA merit award (K.H.). K.H. acknowledges membership within and support from the Region V Great Lakes Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases Award 1-U54-057153). This work was also supported by the Diversifying Higher Education Faculty in Illinois Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejewski N, 1999, J BIOL CHEM, V274, P12692, DOI 10.1074/jbc.274.18.12692; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Finlay BB, 2000, PHILOS T ROY SOC B, V355, P623, DOI 10.1098/rstb.2000.0603; GALAN JE, 1989, P NATL ACAD SCI USA, V58, P1879; Gallois A, 2001, J IMMUNOL, V166, P5741, DOI 10.4049/jimmunol.166.9.5741; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161; JONES BD, 1994, INFECT IMMUN, V62, P3745, DOI 10.1128/IAI.62.9.3745-3752.1994; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; McGhie EJ, 2001, EMBO J, V20, P2131, DOI 10.1093/emboj/20.9.2131; MILLS SD, 1994, MICROB PATHOGENESIS, V17, P409, DOI 10.1006/mpat.1994.1086; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; Nishino Ichizo, 2003, Curr Neurol Neurosci Rep, V3, P64, DOI 10.1007/s11910-003-0040-y; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Penheiter KL, 1997, MOL MICROBIOL, V24, P697, DOI 10.1046/j.1365-2958.1997.3741745.x; PORTILLO FG, 1995, J CELL BIOL, V129, P81; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Stypmann J, 2006, BASIC RES CARDIOL, V101, P281, DOI 10.1007/s00395-006-0591-6; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009; ZWEU E, 2008, TROP MED INT HEALTH, V13, P532	36	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3538	10.1371/journal.pone.0003538	http://dx.doi.org/10.1371/journal.pone.0003538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958159	Green Submitted, Green Published, gold			2022-12-27	WOS:000265130900002
J	Egea, PF; Napetschnig, J; Walter, P; Stroud, RM				Egea, Pascal F.; Napetschnig, Johanna; Walter, Peter; Stroud, Robert M.			Structures of SRP54 and SRP19, the Two Proteins that Organize the Ribonucleic Core of the Signal Recognition Particle from Pyrococcus furiosus	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; NUCLEOTIDE SPECIFICITY; ANGSTROM RESOLUTION; NUCLEAR EXPORT; GTPASES FFH; INDUCED FIT; S-DOMAIN; 4.5S RNA; COMPLEX; BINDING	In all organisms the Signal Recognition Particle (SRP), binds to signal sequences of proteins destined for secretion or membrane insertion as they emerge from translating ribosomes. In Archaea and Eucarya, the conserved ribonucleoproteic core is composed of two proteins, the accessory protein SRP19, the essential GTPase SRP54, and an evolutionarily conserved and essential SRP RNA. Through the GTP-dependent interaction between the SRP and its cognate receptor SR, ribosomes harboring nascent polypeptidic chains destined for secretion are dynamically transferred to the protein translocation apparatus at the membrane. We present here high-resolution X-ray structures of SRP54 and SRP19, the two RNA binding components forming the core of the signal recognition particle from the hyper-thermophilic archaeon Pyrococcus furiosus (Pfu). The 2.5 angstrom resolution structure of free Pfu-SRP54 is the first showing the complete domain organization of a GDP bound full-length SRP54 subunit. In its ras-like GTPase domain, GDP is found tightly associated with the protein. The flexible linker that separates the GTPase core from the hydrophobic signal sequence binding M domain, adopts a purely alpha-helical structure and acts as an articulated arm allowing the M domain to explore multiple regions as it scans for signal peptides as they emerge from the ribosomal tunnel. This linker is structurally coupled to the GTPase catalytic site and likely to propagate conformational changes occurring in the M domain through the SRP RNA upon signal sequence binding. Two different 1.8 angstrom resolution crystal structures of free Pfu-SRP19 reveal a compact, rigid and well-folded protein even in absence of its obligate SRP RNA partner. Comparison with other SRP19.SRP RNA structures suggests the rearrangement of a disordered loop upon binding with the RNA through a reciprocal induced-fit mechanism and supports the idea that SRP19 acts as a molecular scaffold and a chaperone, assisting the SRP RNA in adopting the conformation required for its optimal interaction with the essential subunit SRP54, and proper assembly of a functional SRP.	[Egea, Pascal F.; Walter, Peter; Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Napetschnig, Johanna] Rockefeller Univ, Howard Hughes Med Inst, Lab Cell Biol, New York, NY USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; Rockefeller University	Egea, PF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	pascal@msg.ucsf.edu; stroud@msg.ucsf.edu	egea, pascal/V-7662-2019; Egea, Pascal Francois/AAI-2759-2020	egea, pascal/0000-0003-4432-8625; 	NIH [GM60641]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM60641 to R.M.S. that supports P.F.E and NIH grants to P.W. P.W is an investigator from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alavian CN, 2004, BIOCHEM BIOPH RES CO, V313, P351, DOI 10.1016/j.bbrc.2003.11.126; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Bhuiyan SH, 2000, NUCLEIC ACIDS RES, V28, P1365, DOI 10.1093/nar/28.6.1365; Bradshaw N, 2007, MOL BIOL CELL, V18, P2728, DOI 10.1091/mbc.e07-02-0117; Buskiewicz I, 2005, RNA, V11, P947, DOI 10.1261/rna.7242305; Buskiewicz I, 2005, J MOL BIOL, V351, P417, DOI 10.1016/j.jmb.2005.06.023; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; Ciufo LF, 2000, CURR BIOL, V10, P1256, DOI 10.1016/S0960-9822(00)00743-0; Clemons WM, 1999, J MOL BIOL, V292, P697, DOI 10.1006/jmbi.1999.3090; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Diener JL, 2000, BIOCHEMISTRY-US, V39, P12862, DOI 10.1021/bi001180s; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Focia PJ, 2006, J MOL BIOL, V360, P631, DOI 10.1016/j.jmb.2006.05.031; Focia PJ, 2004, PROTEINS, V54, P222, DOI 10.1002/prot.10598; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Freymann DM, 1999, NAT STRUCT BIOL, V6, P793, DOI 10.1038/11572; Gawronski-Salerno J, 2007, PROTEINS, V66, P984, DOI 10.1002/prot.21200; Gawronski-Salerno J, 2007, J STRUCT BIOL, V158, P122, DOI 10.1016/j.jsb.2006.10.025; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Grosshans H, 2001, J CELL BIOL, V153, P745, DOI 10.1083/jcb.153.4.745; Hainzl T, 2005, RNA, V11, P1043, DOI 10.1261/rna.2080205; Hainzl T, 2002, NATURE, V417, P767, DOI 10.1038/nature00768; Hainzl T, 2007, P NATL ACAD SCI USA, V104, P14911, DOI 10.1073/pnas.0702467104; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; Jacobson MR, 1998, P NATL ACAD SCI USA, V95, P7981, DOI 10.1073/pnas.95.14.7981; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Kuglstatter A, 2002, NAT STRUCT BIOL, V9, P740, DOI 10.1038/nsb843; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Maeshima H, 2001, FEBS LETT, V507, P336, DOI 10.1016/S0014-5793(01)02996-9; Maity TS, 2007, J MOL BIOL, V369, P512, DOI 10.1016/j.jmb.2007.03.032; Maity TS, 2006, BIOCHEMISTRY-US, V45, P14955, DOI 10.1021/bi060890g; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagai K, 2003, EMBO J, V22, P3479, DOI 10.1093/emboj/cdg337; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oubridge C, 2002, MOL CELL, V9, P1251, DOI 10.1016/S1097-2765(02)00530-0; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Pakhomova ON, 2002, J MOL BIOL, V317, P145, DOI 10.1006/jmbi.2002.5411; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Politz JC, 2000, P NATL ACAD SCI USA, V97, P55, DOI 10.1073/pnas.97.1.55; Rose MA, 2001, NAT STRUCT BIOL, V8, P515, DOI 10.1038/88577; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; Sauer-Eriksson AE, 2003, CURR OPIN STRUC BIOL, V13, P64, DOI 10.1016/S0959-440X(02)00010-6; Shan SO, 2005, BIOCHEMISTRY-US, V44, P6214, DOI 10.1021/bi0500980; Shan SO, 2003, P NATL ACAD SCI USA, V100, P4480, DOI 10.1073/pnas.0737693100; SIEGEL V, 1988, EMBO J, V7, P1769, DOI 10.1002/j.1460-2075.1988.tb03007.x; Spanggord RJ, 2005, NAT STRUCT MOL BIOL, V12, P1116, DOI 10.1038/nsmb1025; Strub MP, 2003, STRUCTURE, V11, P1359, DOI 10.1016/j.str.2003.09.014; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tozik I, 2002, NUCLEIC ACIDS RES, V30, P4166, DOI 10.1093/nar/gkf548; Wild K, 2001, SCIENCE, V294, P598, DOI 10.1126/science.1063839; Yin JM, 2004, RNA, V10, P574, DOI 10.1261/rna.5232404; Yurist S, 2007, J BACTERIOL, V189, P276, DOI 10.1128/JB.01410-06	63	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3528	10.1371/journal.pone.0003528	http://dx.doi.org/10.1371/journal.pone.0003528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953414	Green Published, gold			2022-12-27	WOS:000265130500006
J	Coady, TH; Baughan, TD; Shababi, M; Passini, MA; Lorson, CL				Coady, Tristan H.; Baughan, Travis D.; Shababi, Monir; Passini, Marco A.; Lorson, Christian L.			Development of a Single Vector System that Enhances Trans-Splicing of SMN2 Transcripts	PLOS ONE			English	Article								RNA modalities are developing as a powerful means to re-direct pathogenic pre-mRNA splicing events. Improving the efficiency of these molecules in vivo is critical as they move towards clinical applications. Spinal muscular atrophy (SMA) is caused by loss of SMN1. A nearly identical copy gene called SMN2 produces low levels of functional protein due to alternative splicing. We previously reported a trans-splicing RNA (tsRNA) that re-directed SMN2 splicing. Now we show that reducing the competition between endogenous splices sites enhanced the efficiency of trans-splicing. A single vector system was developed that expressed the SMN tsRNA and a splice-site blocking antisense (ASO-tsRNA). The ASO-tsRNA vector significantly elevated SMN levels in primary SMA patient fibroblasts, within the central nervous system of SMA mice and increased SMN-dependent in vitro snRNP assembly. These results demonstrate that the ASO-tsRNA strategy provides insight into the trans-splicing mechanism and a means of significantly enhancing trans-splicing activity in vivo.	[Coady, Tristan H.; Shababi, Monir; Lorson, Christian L.] Univ Missouri, Bond Life Sci Ctr, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Baughan, Travis D.; Lorson, Christian L.] Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Passini, Marco A.] Genzyme Corp, Framingham, MA USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Sanofi-Aventis; Genzyme Corporation	Coady, TH (corresponding author), Univ Missouri, Bond Life Sci Ctr, Dept Vet Pathobiol, Columbia, MO 65211 USA.	lorsonc@missouri.edu			MDA; FightSMA; National Institutes of Health [R01 NS41584, R01 HD054413];  [T32 GM008396]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041584] Funding Source: NIH RePORTER	MDA(Muscular Dystrophy Association); FightSMA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	T.H.C. is supported by Training Grant T32 GM008396. This work was funded by grants from the MDA (M.S.), FightSMA (C.L.L.) and the National Institutes of Health (C.L.L, R01 NS41584; R01 HD054413).	Baughan T, 2006, MOL THER, V14, P54, DOI 10.1016/j.ymthe.2006.01.012; BUTCHBACH ME, 2007, NEUROBIOL DIS; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Coady TH, 2007, MOL THER, V15, P1471, DOI 10.1038/sj.mt.6300222; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; DiMatteo D, 2008, EXP CELL RES, V314, P878, DOI 10.1016/j.yexcr.2007.10.012; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Garcia-Blanco MA, 2003, J CLIN INVEST, V112, P474, DOI 10.1172/JCI200319462; Hengge UR, 2008, J INVEST DERMATOL, V128, P499, DOI 10.1038/sj.jid.5701241; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Madocsai C, 2005, MOL THER, V12, P1013, DOI 10.1016/j.ymthe.2005.08.022; MARQUIS J, 2007, MOL THER; Oskoui M, 2007, NEUROLOGY, V69, P1931, DOI 10.1212/01.wnl.0000290830.40544.b9; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Rodriguez-Martin T, 2005, P NATL ACAD SCI USA, V102, P15659, DOI 10.1073/pnas.0503150102; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Sumner Charlotte J, 2006, NeuroRx, V3, P235, DOI 10.1016/j.nurx.2006.01.010; Wally V, 2008, J INVEST DERMATOL, V128, P568, DOI 10.1038/sj.jid.5701152; Wolstencroft EC, 2005, HUM MOL GENET, V14, P1199, DOI 10.1093/hmg/ddi131; Wood M, 2007, PLOS GENET, V3, P845, DOI 10.1371/journal.pgen.0030109; Zayed H, 2007, MOL THER, V15, P1273, DOI 10.1038/sj.mt.6300178	27	66	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3468	10.1371/journal.pone.0003468	http://dx.doi.org/10.1371/journal.pone.0003468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941511	Green Submitted, Green Published, gold			2022-12-27	WOS:000265126100003
J	Sorber, K; Chiu, C; Webster, D; Dimon, M; Ruby, JG; Hekele, A; DeRisi, JL				Sorber, Katherine; Chiu, Charles; Webster, Dale; Dimon, Michelle; Ruby, J. Graham; Hekele, Armin; DeRisi, Joseph L.			The Long March: A Sample Preparation Technique that Enhances Contig Length and Coverage by High-Throughput Short-Read Sequencing	PLOS ONE			English	Article								High-throughput short-read technologies have revolutionized DNA sequencing by drastically reducing the cost per base of sequencing information. Despite producing gigabases of sequence per run, these technologies still present obstacles in resequencing and de novo assembly applications due to biased or insufficient target sequence coverage. We present here a simple sample preparation method termed the "long march'' that increases both contig lengths and target sequence coverage using high-throughput short-read technologies. By incorporating a Type IIS restriction enzyme recognition motif into the sequencing primer adapter, successive rounds of restriction enzyme cleavage and adapter ligation produce a set of nested sub-libraries from the initial amplicon library. Sequence reads from these sub-libraries are offset from each other with enough overlap to aid assembly and contig extension. We demonstrate the utility of the long march in resequencing of the Plasmodium falciparum transcriptome, where the number of genomic bases covered was increased by 39%, as well as in metagenomic analysis of a serum sample from a patient with hepatitis B virus (HBV)-related acute liver failure, where the number of HBV bases covered was increased by 42%. We also offer a theoretical optimization of the long march for de novo sequence assembly.	[Sorber, Katherine; Chiu, Charles; Webster, Dale; Dimon, Michelle; Ruby, J. Graham; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Webster, Dale; Dimon, Michelle] Univ Calif San Francisco, Biol & Med Informat Program, San Francisco, CA 94143 USA; [Hekele, Armin] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Chiu, Charles] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; [DeRisi, Joseph L.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Sorber, K (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	joe@derisilab.ucsf.edu		Chiu, Charles/0000-0003-2915-2094; Lontok, Katherine/0000-0001-7127-340X	Howard Hughes Medical Institute; Doris Duke Charitable Foundation; David and Lucile Packard Foundation; National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by Howard Hughes Medical Institute, Doris Duke Charitable Foundation and David and Lucile Packard Foundation grants to JLD. KS was supported in part by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Chaisson M, 2004, BIOINFORMATICS, V20, P2067, DOI 10.1093/bioinformatics/bth205; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; HADI SM, 1979, J MOL BIOL, V134, P655, DOI 10.1016/0022-2836(79)90372-3; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; JANULAITIS A, 1983, FEBS LETT, V151, P243, DOI 10.1016/0014-5793(83)80078-7; Knight R, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng030; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Mardis ER, 2007, NAT METHODS, V4, P613, DOI 10.1038/nmeth0807-613; Mashayekhi F, 2007, ANAL BIOCHEM, V363, P275, DOI 10.1016/j.ab.2007.02.002; MathieuDaude F, 1996, NUCLEIC ACIDS RES, V24, P2080, DOI 10.1093/nar/24.11.2080; OKAMOTO H, 1986, J GEN VIROL, V67, P2305, DOI 10.1099/0022-1317-67-11-2305; PETRUSYTE M, 1988, GENE, V74, P89, DOI 10.1016/0378-1119(88)90259-4; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Salas-Solano O, 1998, ANAL CHEM, V70, P3996, DOI 10.1021/ac980457f; Sanger F, 1992, Biotechnology, V24, P104; Seo TS, 2004, P NATL ACAD SCI USA, V101, P5488, DOI 10.1073/pnas.0401138101; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Siegel AF, 2000, GENOMICS, V68, P237, DOI 10.1006/geno.2000.6303; Stoeckert CJ, 2006, TRENDS PARASITOL, V22, P543, DOI 10.1016/j.pt.2006.09.005; Wai CT, 2005, J VIRAL HEPATITIS, V12, P192, DOI 10.1111/j.1365-2893.2005.00581.x; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Whiteford N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni170; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07	29	25	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3495	10.1371/journal.pone.0003495	http://dx.doi.org/10.1371/journal.pone.0003495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941527	gold, Green Published, Green Submitted			2022-12-27	WOS:000265126100024
J	Nienhaus, A; Kromark, K; Raulf-Heimsoth, M; van Kampen, V; Merget, R				Nienhaus, Albert; Kromark, Kathrin; Raulf-Heimsoth, Monika; van Kampen, Vera; Merget, Rolf			Outcome of Occupational Latex Allergy-Work Ability and Quality of Life	PLOS ONE			English	Article							NATURAL-RUBBER LATEX; HEALTH-CARE WORKERS; INDEX DLQI; ASTHMA; QUESTIONNAIRE; IMPACT; SENSITIZATION; IMPAIRMENT; PREVALENCE; VALIDATION	Objective: The quality of life (QOL) and work ability of health care workers allergic to natural rubber latex (NRL) were assessed after implementation of regulations on powder-free NRL gloves in Germany. Methods: 196 HCW with reported NRL allergy answered a questionnaire (response rate 58%) containing the Work Ability Index (WAI), Mini Asthma Quality of Life Questionnaire (MiniAQLQ), and Dermatology Life Quality Index (DLQI). Results: 63.2% still had NRL-related symptoms during the last 6 month. However on a scale from 0 to 10, the intensity of NRL-related symptoms decreased from 8.5 before to 2.3 after implementation of regulations on powder-free NRL gloves. A higher number of subjects were able to avoid NRL in the private than in the work environment (85% vs. 61%). NRL-related symptoms decreased and WAI increased with successful avoidance of NRL at workplace (b = 0.23, p = 0.003). QOL was only little affected by NRL allergy (mean: MiniAQLQ = 6.0; DLQI = 4.1). Conclusions: Although there was improvement after implementation of powder-free NRL gloves, there is still a considerable number of HCW with NRL-related symptoms. Further investigations on latex avoidance and the cause of persisiting allergic symptoms in HCW with NRL allergy are therefore needed.	[Nienhaus, Albert; Kromark, Kathrin] Inst Statutory Accid Insurance Hlth & Welf Serv, Hamburg, Germany; [Raulf-Heimsoth, Monika; van Kampen, Vera; Merget, Rolf] Ruhr Univ Bochum, German Social Accident Insurance, Res Inst Occupat Med, BGFA, Bochum, Germany	Ruhr University Bochum	Nienhaus, A (corresponding author), Inst Statutory Accid Insurance Hlth & Welf Serv, Hamburg, Germany.	albert.nienhaus@bgw-online.de	van Kampen, Vera/AAH-3657-2019					Acero S, 2003, J INVEST ALLERG CLIN, V13, P155; Al-Otaibi S, 2005, OCCUP MED-OXFORD, V55, P88, DOI 10.1093/occmed/kqi001; Allmers H, 2004, J ALLERGY CLIN IMMUN, V114, P347, DOI 10.1016/j.jaci.2004.05.054; Allmers H, 2002, J ALLERGY CLIN IMMUN, V110, P318, DOI 10.1067/mai.2002.126461; ARELLANO R, 1992, ANESTHESIOLOGY, V77, P905, DOI 10.1097/00000542-199211000-00011; Edelstam G, 2002, INT ARCH OCC ENV HEA, V75, P267, DOI 10.1007/s00420-001-0296-y; Filon FL, 2006, OCCUP ENVIRON MED, V63, P121, DOI 10.1136/oem.2003.011460; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Gradwell C, 2002, BRIT J DERMATOL, V147, P513, DOI 10.1046/j.1365-2133.2002.04901.x; Groneberg DA, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-3; Hachem JP, 2002, CONTACT DERMATITIS, V46, P220, DOI 10.1034/j.1600-0536.2002.460406.x; Hahn HB, 2001, J AM ACAD DERMATOL, V45, P44, DOI 10.1067/mjd.2001.110880; Hemery ML, 2004, ALLERGY, V59, P1013, DOI 10.1111/j.1398-9995.2004.00484.x; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Horwitz IB, 2000, J OCCUP ENVIRON MED, V42, P932, DOI 10.1097/00043764-200009000-00018; Hutchings CV, 2001, CONTACT DERMATITIS, V45, P17, DOI 10.1034/j.1600-0536.2001.045001017.x; Ilmarinen J, 1997, SCAND J WORK ENV HEA, V23, P49; Ind PW, 2004, RESP MED, V98, P464, DOI 10.1016/j.rmed.2003.07.010; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Kernick D, 2000, BRIT J GEN PRACT, V50, P555; Korniewicz Denise M, 2005, AAOHN J, V53, P388; Kujala VM, 1997, AM J IND MED, V32, P197, DOI 10.1002/(SICI)1097-0274(199709)32:3<197::AID-AJIM3>3.0.CO;2-V; Latza U, 2005, INT ARCH OCC ENV HEA, V78, P394, DOI 10.1007/s00420-004-0594-2; Lewis V, 2004, J INVEST DERM SYMP P, V9, P169, DOI 10.1111/j.1087-0024.2004.09113.x; Lewis VJ, 2004, CONTACT DERMATITIS, V51, P317, DOI 10.1111/j.0105-1873.2004.0459i.x; Pinnock H, 2005, J CLIN EPIDEMIOL, V58, P809, DOI 10.1016/j.jclinepi.2005.01.010; RAULFHEIMSOTH M, 2003, AKTUEL DERMATOL, V29, P176; Reilly MC, 2003, J AM ACAD DERMATOL, V48, P128, DOI 10.1067/mjd.2003.128; Rueff F, 2004, ANN ALLERG ASTHMA IM, V92, P530, DOI 10.1016/S1081-1206(10)61760-7; Schwartz C, 2006, QUAL LIFE RES, V15, P1503, DOI 10.1007/s11136-006-0008-x; Schwartz CE, 1999, SOC SCI MED, V48, P1531, DOI 10.1016/S0277-9536(99)00047-7; Thinschmidt M, 2007, ZENTRALBLATT ARB ARB, V57, P212, DOI 10.1007/BF03349124; TUOMI K, 1991, SCAND J WORK ENV HEA, V17, P67; Turjanmaa K, 2002, J ALLERGY CLIN IMMUN, V110, pS70, DOI 10.1067/mai.2002.125332; Vandenplas O, 2002, J ALLERGY CLIN IMMUN, V109, P125, DOI 10.1067/mai.2002.120760; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; YASSIN MS, 1994, ANN ALLERGY, V72, P245	38	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3459	10.1371/journal.pone.0003459	http://dx.doi.org/10.1371/journal.pone.0003459			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941629	Green Published, gold			2022-12-27	WOS:000265125900004
J	Starck, SR; Ow, YK; Jiang, V; Tokuyama, M; Rivera, M; Qi, X; Roberts, RW; Shastri, N				Starck, Shelley R.; Ow, Yongkai; Jiang, Vivian; Tokuyama, Maria; Rivera, Mark; Qi, Xin; Roberts, Richard W.; Shastri, Nilabh			A Distinct Translation Initiation Mechanism Generates Cryptic Peptides for Immune Surveillance	PLOS ONE			English	Article							MESSENGER-RNA; PROTEIN-SYNTHESIS; ENTRY SITE; RIBOSOME; COMPLEXES; CODON; DEGRADATION; BRUCEANTIN; INHIBITORS; PRODUCTS	MHC class I molecules present a comprehensive mixture of peptides on the cell surface for immune surveillance. The peptides represent the intracellular protein milieu produced by translation of endogenous mRNAs. Unexpectedly, the peptides are encoded not only in conventional AUG initiated translational reading frames but also in alternative cryptic reading frames. Here, we analyzed how ribosomes recognize and use cryptic initiation codons in the mRNA. We find that translation initiation complexes assemble at non-AUG codons but differ from canonical AUG initiation in response to specific inhibitors acting within the peptidyl transferase and decoding centers of the ribosome. Thus, cryptic translation at non-AUG start codons can utilize a distinct initiation mechanism which could be differentially regulated to provide peptides for immune surveillance.	[Starck, Shelley R.; Ow, Yongkai; Jiang, Vivian; Tokuyama, Maria; Rivera, Mark; Shastri, Nilabh] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Qi, Xin] Univ Texas, Southwestern Med Ctr, Dept Biochem, Howard Hughes Med Inst, Dallas, TX USA; [Roberts, Richard W.] Univ So Calif, Dept Chem, Chem Engn, & Biol, Los Angeles, CA USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Southern California	Starck, SR (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	nshastri@socrates.berkeley.edu			NIH [NRSA fellowship]; Cancer Research Institute [postdoctoral fellowship]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute	S.R.S. was supported in part by an NIH training grant, a postdoctoral fellowship from the Cancer Research Institute and the NRSA fellowship from the National Institutes of Health. This research was supported by grants from the National Institutes of Health to N.S..	ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; CIGAN AM, 1988, SCIENCE, V242, P93, DOI 10.1126/science.3051379; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dinos G, 2004, MOL CELL, V13, P113, DOI 10.1016/S1097-2765(04)00002-4; DOUDNA JA, 2007, TRANSLATIONAL CONTRO, P129; Hammer GE, 2007, IMMUNITY, V26, P397, DOI 10.1016/j.immuni.2007.04.003; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Ho O, 2006, J IMMUNOL, V177, P8283, DOI 10.4049/jimmunol.177.12.8283; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801; KOLB M, 1982, J MED CHEM, V25, P550, DOI 10.1021/jm00347a014; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; KOZAK M, 1978, J BIOL CHEM, V253, P6568; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; Kozak M, 1998, NUCLEIC ACIDS RES, V26, P4853, DOI 10.1093/nar/26.21.4853; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KUPCHAN SM, 1975, J ORG CHEM, V40, P648, DOI 10.1021/jo00893a023; Lee J, 1999, BIOORG MED CHEM LETT, V9, P1365, DOI 10.1016/S0960-894X(99)00206-1; LIAO LL, 1976, MOL PHARMACOL, V12, P167; Malarkannan S, 2000, IMMUNITY, V13, P333, DOI 10.1016/S1074-7613(00)00033-9; Malarkannan S, 1999, IMMUNITY, V10, P681, DOI 10.1016/S1074-7613(00)80067-9; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; MERRICK WC, 2000, PROTEIN BIOSYNTHESIS, P89; Nemeth AL, 2007, FEBS J, V274, P1610, DOI 10.1111/j.1742-4658.2007.05708.x; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Rajbhandary Uttam L., 1995, P511; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; RODRIGUEZFONSECA C, 1995, J MOL BIOL, V247, P224, DOI 10.1006/jmbi.1994.0135; Sarnow P, 2003, J VIROL, V77, P2801, DOI 10.1128/JVI.77.5.2801-2806.2003; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schwab SR, 2004, PLOS BIOL, V2, P1774, DOI 10.1371/journal.pbio.0020366; Schwab SR, 2003, SCIENCE, V301, P1367, DOI 10.1126/science.1085650; Shastri N, 2005, IMMUNOL REV, V207, P31, DOI 10.1111/j.0105-2896.2005.00321.x; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	47	39	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3460	10.1371/journal.pone.0003460	http://dx.doi.org/10.1371/journal.pone.0003460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941630	Green Published, Green Submitted, gold			2022-12-27	WOS:000265125900005
J	Juleff, N; Windsor, M; Reid, E; Seago, J; Zhang, ZD; Monaghan, P; Morrison, IW; Charleston, B				Juleff, Nicholas; Windsor, Miriam; Reid, Elizabeth; Seago, Julian; Zhang, Zhidong; Monaghan, Paul; Morrison, Ivan W.; Charleston, Bryan			Foot-and-Mouth Disease Virus Persists in the Light Zone of Germinal Centres	PLOS ONE			English	Article								Foot-and-mouth disease virus (FMDV) is one of the most contagious viruses of animals and is recognised as the most important constraint to international trade in animals and animal products. Two fundamental problems remain to be understood before more effective control measures can be put in place. These problems are the FMDV "carrier state'' and the short duration of immunity after vaccination which contrasts with prolonged immunity after natural infection. Here we show by laser capture microdissection in combination with quantitative real-time reverse transcription polymerase chain reaction, immunohistochemical analysis and corroborate by in situ hybridization that FMDV locates rapidly to, and is maintained in, the light zone of germinal centres following primary infection of naive cattle. We propose that maintenance of non-replicating FMDV in these sites represents a source of persisting infectious virus and also contributes to the generation of long-lasting antibody responses against neutralising epitopes of the virus.	[Juleff, Nicholas; Windsor, Miriam; Reid, Elizabeth; Seago, Julian; Zhang, Zhidong; Monaghan, Paul; Charleston, Bryan] Inst Anim Hlth, Pirbright Lab, Surrey, England; [Juleff, Nicholas; Morrison, Ivan W.] Univ Edinburgh, Ctr Trop Vet Med, Easter Bush Vet Ctr, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Edinburgh	Juleff, N (corresponding author), Inst Anim Hlth, Pirbright Lab, Surrey, England.	nicholas.juleff@bbsrc.ac.uk	Monaghan, Paul/H-1973-2013	zhang, zhidong/0000-0002-2186-7661; Zhang, Zhixiang/0000-0002-1161-5065; Charleston, Bryan/0000-0002-6952-9338	Biotechnology and Biological Sciences Research Council, United Kingdom; Biotechnology and Biological Sciences Research Council [BBS/B/00549] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by the Biotechnology and Biological Sciences Research Council, United Kingdom. B.C. is a Jenner Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Alexandersen S, 2002, MICROBES INFECT, V4, P1099, DOI 10.1016/S1286-4579(02)01634-9; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; Brocchi E, 1998, VET QUART, V20, pS20; Brocchi EC A., 1983, ATTI SOC ITALIANA SC, V36, P576; COOK JKA, 1993, AVIAN PATHOL, V22, P257, DOI 10.1080/03079459308418919; CUNLIFFE HR, 1964, CORNELL VET, V54, P501; DeDiego M, 1997, ARCH VIROL, V142, P2021, DOI 10.1007/s007050050219; Doel TR, 2005, CURR TOP MICROBIOL, V288, P103; Domingo E, 2002, COMP IMMUNOL MICROB, V25, P297, DOI 10.1016/S0147-9571(02)00027-9; DONALDSON AI, 1989, RES VET SCI, V46, P9, DOI 10.1016/S0034-5288(18)31109-3; Gatto D, 2007, J IMMUNOL, V178, P67, DOI 10.4049/jimmunol.178.1.67; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; HOWARD C, 1991, VET IMMUNOL IMMUNOP, V27, P1, DOI 10.1016/0165-2427(91)90066-L; Ilott MC, 1997, EPIDEMIOL INFECT, V118, P181, DOI 10.1017/S0950268896007376; Keele BF, 2008, J VIROL, V82, P5548, DOI 10.1128/JVI.00124-08; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; Lefevre EA, 2007, J LEUKOCYTE BIOL, V82, P666, DOI 10.1189/jlb.0107050; Liebler-Tenorio EM, 2006, VET RES, V37, P257, DOI 10.1051/vetres:2006001; MANDEL TE, 1980, IMMUNOL REV, V53, P29, DOI 10.1111/j.1600-065X.1980.tb01039.x; MASON PW, 1993, VIROLOGY, V192, P568, DOI 10.1006/viro.1993.1073; Monaghan P, 2005, J GEN VIROL, V86, P2769, DOI 10.1099/vir.0.81172-0; Murphy MLP, 1999, VIRUS RES, V62, P67, DOI 10.1016/S0168-1702(99)00050-7; Murray SE, 2004, J NEUROIMMUNOL, V156, P31, DOI 10.1016/j.jneuroim.2004.06.015; Perry BD, 2007, VET REC, V160, P238, DOI 10.1136/vr.160.7.238; Quan M, 2004, J COMP PATHOL, V131, P294, DOI 10.1016/j.jcpa.2004.05.002; Rigden RC, 2002, IMMUNOLOGY, V106, P537, DOI 10.1046/j.1365-2567.2002.01460.x; Rouiller I, 1998, J VIROL, V72, P2373, DOI 10.1128/JVI.72.3.2373-2387.1998; Simon ID, 2007, J VIROL, V81, P2078, DOI 10.1128/JVI.02525-06; Smith BA, 2001, J IMMUNOL, V166, P690, DOI 10.4049/jimmunol.166.1.690; SUTMOLLER P, 1965, VET REC, V77, P968, DOI 10.1136/vr.77.33.968; SZAKAL AK, 1988, J IMMUNOL, V140, P341; TEW JG, 1979, IMMUNOLOGY, V37, P69; Valarcher JF, 2003, J VIROL, V77, P8426, DOI 10.1128/JVI.77.15.8426-8439.2003; Vosloo W, 1996, J GEN VIROL, V77, P1457, DOI 10.1099/0022-1317-77-7-1457; Yang H, 1999, J HISTOCHEM CYTOCHEM, V47, P431, DOI 10.1177/002215549904700402; Yin JL, 2001, IMMUNOL CELL BIOL, V79, P213, DOI 10.1046/j.1440-1711.2001.01002.x; Zhang ZD, 2004, J GEN VIROL, V85, P2567, DOI 10.1099/vir.0.80011-0	40	63	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3434	10.1371/journal.pone.0003434	http://dx.doi.org/10.1371/journal.pone.0003434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941503	Green Published, gold, Green Submitted			2022-12-27	WOS:000265125600003
J	Milne, K; Barnes, RO; Girardin, A; Mawer, MA; Nesslinger, NJ; Ng, A; Nielsen, JS; Sahota, R; Tran, E; Webb, JR; Wong, MQ; Wick, DA; Wray, A; McMurtrie, E; Kobel, M; Kalloger, SE; Gilks, CB; Watson, PH; Nelson, BH				Milne, Katy; Barnes, Rebecca O.; Girardin, Adam; Mawer, Melanie A.; Nesslinger, Nancy J.; Ng, Alvin; Nielsen, Julie S.; Sahota, Robert; Tran, Eric; Webb, John R.; Wong, May Q.; Wick, Darin A.; Wray, Andrew; McMurtrie, Elissa; Koebel, Martin; Kalloger, Steven E.; Gilks, C. Blake; Watson, Peter H.; Nelson, Brad H.			Tumor-Infiltrating T Cells Correlate with NY-ESO-1-Specific Autoantibodies in Ovarian Cancer	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; INTRAPERITONEAL ADOPTIVE IMMUNOTHERAPY; FOLATE BINDING-PROTEIN; ACTIVATED KILLER-CELL; RECOMBINANT INTERLEUKIN-2; BREAST-CANCER; LYMPHOCYTES RECOGNIZE; HER2/NEU EXPRESSION; ANTIGEN-EXPRESSION; INTERFERON-GAMMA	Background: Tumor-infiltrating CD8+ T cells are correlated with prolonged progression-free and overall survival in epithelial ovarian cancer (EOC). A significant fraction of EOC patients mount autoantibody responses to various tumor antigens, however the relationship between autoantibodies and tumor-infiltrating T cells has not been investigated in EOC or any other human cancer. We hypothesized that autoantibody and T cell responses may be correlated in EOC and directed toward the same antigens. Methodology and Principal Findings: We obtained matched serum and tumor tissue from 35 patients with high-grade serous ovarian cancer. Serum samples were assessed by ELISA for autoantibodies to the common tumor antigen NY-ESO-1. Tumor tissue was examined by immunohistochemistry for expression of NY-ESO-1, various T cell markers (CD3, CD4, CD8, CD25, FoxP3, TIA-1 and Granzyme B) and other immunological markers (CD20, MHC class I and MHC class II). Lymphocytic infiltrates varied widely among tumors and included cells positive for CD3, CD8, TIA-1, CD25, FoxP3 and CD4. Twenty-six percent (9/35) of patients demonstrated serum IgG autoantibodies to NY-ESO-1, which were positively correlated with expression of NY-ESO-1 antigen by tumor cells (r = 0.57, p = 0.0004). Autoantibodies to NY-ESO-1 were associated with increased tumor-infiltrating CD8+, CD4+ and FoxP3+ cells. In an individual HLA-A2+ patient with autoantibodies to NY-ESO-1, CD8+ T cells isolated from solid tumor and ascites were reactive to NY-ESO-1 by IFN-gamma ELISPOT and MHC class I pentamer staining. Conclusion and Significance: We demonstrate that tumor-specific autoantibodies and tumor-infiltrating T cells are correlated in human cancer and can be directed against the same target antigen. This implies that autoantibodies may collaborate with tumor-infiltrating T cells to influence clinical outcomes in EOC. Furthermore, serological screening methods may prove useful for identifying clinically relevant T cell antigens for immunotherapy.	[Milne, Katy; Barnes, Rebecca O.; Girardin, Adam; Mawer, Melanie A.; Nesslinger, Nancy J.; Ng, Alvin; Nielsen, Julie S.; Sahota, Robert; Tran, Eric; Webb, John R.; Wong, May Q.; Wick, Darin A.; Wray, Andrew; Watson, Peter H.; Nelson, Brad H.] BC Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada; [Girardin, Adam; Tran, Eric; Webb, John R.; Watson, Peter H.; Nelson, Brad H.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 2Y2, Canada; [McMurtrie, Elissa] BC Canc Agcy, Victoria, BC, Canada; [Koebel, Martin; Kalloger, Steven E.; Gilks, C. Blake] Vancouver Gen Hosp, Dept Anat Pathol, Vancouver, BC, Canada; [Watson, Peter H.] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Nelson, Brad H.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of Victoria; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Milne, K (corresponding author), BC Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada.	bnelson@bccancer.bc.ca	Kalloger, Steve/B-3949-2010; Nelson, Brad H/K-2622-2014; Köbel, Martin/A-7373-2011	Watson, Peter/0000-0002-1642-0638; Kobel, Martin/0000-0002-6615-2037; Nelson, Brad/0000-0002-4445-5539; Milne, Katy/0000-0001-5616-1821	British Columbia Cancer Foundation; Canary Foundation; U.S. Department of Defense [OC000018]	British Columbia Cancer Foundation; Canary Foundation; U.S. Department of Defense(United States Department of Defense)	British Columbia Cancer Foundation, Canary Foundation, U.S. Department of Defense (OC000018). None of the sponsors had any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Akahiro Jun-ichi, 2004, Int J Clin Oncol, V9, P42, DOI 10.1007/s10147-003-0360-6; AOKI Y, 1991, CANCER RES, V51, P1934; Bagnoli M, 2007, MOL CANCER THER, V6, P762, DOI 10.1158/1535-7163.MCT-06-0357; BAMIAS A, 2007, GYNECOL ONCOL; Bookman MA, 2005, INT J GYNECOL CANCER, V15, P212, DOI 10.1111/j.1525-1438.2005.00444.x; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Carson WE, 2004, CLIN CANCER RES, V10, P3401, DOI 10.1158/1078-0432.CCR-1016-03; Chan OTM, 2000, CANCER IMMUNOL IMMUN, V49, P181, DOI 10.1007/s002620000122; Chatterjee M, 2006, CANCER RES, V66, P1181, DOI 10.1158/0008-5472.CAN-04-2962; Crane IJ, 2005, CRIT REV IMMUNOL, V25, P75, DOI 10.1615/CritRevImmunol.v25.i2.10; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dadmarz R D, 1996, Cancer J Sci Am, V2, P263; Demaria S, 2001, CLIN CANCER RES, V7, P3025; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Duncan TJ, 2007, CLIN CANCER RES, V13, P4139, DOI 10.1158/1078-0432.CCR-06-2833; Fitzpatrick FA, 2003, INT IMMUNOPHARMACOL, V3, P1699, DOI 10.1016/j.intimp.2003.08.007; Freedman R S, 1996, Cancer Treat Res, V82, P115; Freedman RS, 1996, HUM GENE THER, V7, P1351, DOI 10.1089/hum.1996.7.11-1351; FREEDMAN RS, 1994, J IMMUNOTHER, V16, P198, DOI 10.1097/00002371-199410000-00004; Freedman RS, 2000, CLIN CANCER RES, V6, P2268; Fujimoto K, 2006, ANTICANCER RES, V26, P4015; Fujita K, 1995, CLIN CANCER RES, V1, P501; Gadducci A, 1999, GYNECOL ONCOL, V72, P76, DOI 10.1006/gyno.1998.5101; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Geisler JP, 2002, JNCI-J NATL CANCER I, V94, P61; GILKS CB, 2008, HUMAN PATHO IN PRESS; Gimotty PA, 2007, DIS MARKERS, V23, P445, DOI 10.1155/2007/508350; Goedegebuure PS, 1997, CELL IMMUNOL, V175, P150, DOI 10.1006/cimm.1996.1055; Goodell V, 2006, J CLIN ONCOL, V24, P762, DOI 10.1200/JCO.2005.03.2813; HALAPI E, 1993, CANCER IMMUNOL IMMUN, V36, P191, DOI 10.1007/BF01741091; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hayashi K, 1999, GYNECOL ONCOL, V74, P86, DOI 10.1006/gyno.1999.5430; Helal TE, 2004, PATHOL ONCOL RES, V10, P80, DOI 10.1007/BF02893460; Hilton JL, 2002, JNCI-J NATL CANCER I, V94, P1396; Hogdall EVS, 2002, APMIS, V110, P545, DOI 10.1034/j.1600-0463.2002.11007805.x; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; IKARASHI H, 1994, CANCER RES, V54, P190; IOANNIDES CG, 1991, CANCER RES, V51, P4257; IOANNIDES CG, 1991, J IMMUNOL, V146, P1700; Kanavaros P, 2000, LEUKEMIA LYMPHOMA, V38, P317, DOI 10.3109/10428190009087022; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; Kooi S, 1996, CELL IMMUNOL, V174, P116, DOI 10.1006/cimm.1996.0301; Kusuda T, 2005, ONCOL REP, V13, P1153; Ladoire S, 2008, CLIN CANCER RES, V14, P2413, DOI 10.1158/1078-0432.CCR-07-4491; LAMBECK A, 2007, INT J CANC; LINEHAN DC, 1995, SURG ONCOL, V4, P41, DOI 10.1016/S0960-7404(10)80030-1; Luborsky JL, 2005, AM J REPROD IMMUNOL, V54, P55, DOI 10.1111/j.1600-0897.2005.00287.x; Marth C, 2004, AM J OBSTET GYNECOL, V191, P1598, DOI 10.1016/j.ajog.2004.05.007; Mayerhofer K, 1999, ANTICANCER RES, V19, P875; MOORE DH, 1990, GYNECOL ONCOL, V38, P458, DOI 10.1016/0090-8258(90)90091-X; Negus RPM, 1997, AM J PATHOL, V150, P1723; Nelson BH, 2008, IMMUNOL REV, V222, P101, DOI 10.1111/j.1600-065X.2008.00614.x; Nijman HW, 2001, EUR J OBSTET GYN R B, V94, P114, DOI 10.1016/S0301-2115(00)00294-3; Odunsi K, 2003, CANCER RES, V63, P6076; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Ozols RF, 2000, SEMIN ONCOL, V27, P47; Pappas J, 2005, CELL IMMUNOL, V234, P81, DOI 10.1016/j.cellimm.2005.05.001; PEOPLES GE, 1993, J IMMUNOL, V151, P5481; Peoples GE, 1998, ANN SURG ONCOL, V5, P743, DOI 10.1007/BF02303486; PEOPLES GE, 1993, J IMMUNOL, V151, P5472; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P432, DOI 10.1073/pnas.92.2.432; Peoples GE, 1999, CLIN CANCER RES, V5, P4214; PEOPLES GE, 1994, J IMMUNOL, V152, P4993; PEOPLES GE, 1993, SURGERY, V114, P227; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Raspollini MR, 2005, ANN ONCOL, V16, P590, DOI 10.1093/annonc/mdi112; Riesbeck K, 1999, ANTI-CANCER DRUG, V10, P219, DOI 10.1097/00001813-199902000-00011; Rolland P, 2007, CLIN CANCER RES, V13, P3591, DOI 10.1158/1078-0432.CCR-06-2087; Santin AD, 2004, INT J GYNECOL CANCER, V14, P64, DOI 10.1111/j.1048-891x.2004.014175.x; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shah CA, 2008, GYNECOL ONCOL, V109, P215, DOI 10.1016/j.ygyno.2008.01.010; STEIS RG, 1990, J CLIN ONCOL, V8, P1618, DOI 10.1200/JCO.1990.8.10.1618; STEWART JA, 1990, CANCER RES, V50, P6302; Stone B, 2003, INT J CANCER, V104, P73, DOI 10.1002/ijc.10900; Tomsova M, 2008, GYNECOL ONCOL, V108, P415, DOI 10.1016/j.ygyno.2007.10.016; Tsavaris N, 2002, BRIT J CANCER, V87, P21, DOI 10.1038/sj.bjc.6600347; TSUDA H, 1994, GYNECOL ONCOL, V52, P218, DOI 10.1006/gyno.1994.1034; Tsuda N, 2007, CANCER RES, V67, P8378, DOI 10.1158/0008-5472.CAN-07-0327; URBA WJ, 1989, J NATL CANCER I, V81, P602, DOI 10.1093/jnci/81.8.602; Vogl FD, 2000, BRIT J CANCER, V83, P1338, DOI 10.1054/bjoc.2000.1446; Wasserfall CH, 2006, AUTOIMMUN REV, V5, P424, DOI 10.1016/j.autrev.2005.12.002; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Woo EY, 2001, CANCER RES, V61, P4766; Yakirevich E, 2003, CLIN CANCER RES, V9, P6453; YOSHINO I, 1994, J IMMUNOL, V152, P2393; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Ziegler SF, 2007, EUR J IMMUNOL, V37, P21, DOI 10.1002/eji.200636929; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	89	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3409	10.1371/journal.pone.0003409	http://dx.doi.org/10.1371/journal.pone.0003409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923710	Green Submitted, gold, Green Published			2022-12-27	WOS:000265121800007
J	Volinia, S; Mascellani, N; Marchesini, J; Veronese, A; Ormondroyd, E; Alder, H; Palatini, J; Negrini, M; Croce, CM				Volinia, Stefano; Mascellani, Nicoletta; Marchesini, Jlenia; Veronese, Angelo; Ormondroyd, Elizabeth; Alder, Hansjuerg; Palatini, Jeff; Negrini, Massimo; Croce, Carlo M.			Genome Wide Identification of Recessive Cancer Genes by Combinatorial Mutation Analysis	PLOS ONE			English	Article								We devised a novel procedure to identify human cancer genes acting in a recessive manner. Our strategy was to combine the contributions of the different types of genetic alterations to loss of function: amino-acid substitutions, frame-shifts, gene deletions. We studied over 20,000 genes in 3 Gigabases of coding sequences and 700 array comparative genomic hybridizations. Recessive genes were scored according to nucleotide mismatches under positive selective pressure, frame-shifts and genomic deletions in cancer. Four different tests were combined together yielding a cancer recessive p-value for each studied gene. One hundred and fifty four candidate recessive cancer genes (p-value < 1.5 x 10(-7), FDR = 0.39) were identified. Strikingly, the prototypical cancer recessive genes TP53, PTEN and CDKN2A all ranked in the top 0.5% genes. The functions significantly affected by cancer mutations are exactly overlapping those of known cancer genes, with the critical exception for the absence of tyrosine kinases, as expected for a recessive gene-set.	[Volinia, Stefano; Mascellani, Nicoletta; Marchesini, Jlenia] Univ Ferrara, I-44100 Ferrara, Italy; [Volinia, Stefano; Alder, Hansjuerg; Palatini, Jeff; Croce, Carlo M.] Ohio State Univ, Comprehensive Canc Ctr, Dept Mol Virol, Immunol & Mol Genet, Columbus, OH USA; [Veronese, Angelo; Negrini, Massimo] Univ Ferrara, Ctr Interdipt Ricerca Cancro, Dipartimento Med Sperimentale Diagnost, I-44100 Ferrara, Italy; [Ormondroyd, Elizabeth] Inst Canc Res, Surrey, England	University of Ferrara; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Ferrara; University of London; Institute of Cancer Research - UK	Volinia, S (corresponding author), Univ Ferrara, I-44100 Ferrara, Italy.	carlo.croce@osumc.edu	Negrini, Massimo/J-2377-2016; Veronese, Angelo/I-4292-2019; Volinia, Stefano/A-3029-2010; Young, Richard A/F-6495-2012; marchesini, jlenia jm/K-2872-2016; Volinia, Stefano/AAA-9264-2019	Negrini, Massimo/0000-0002-0007-1920; Volinia, Stefano/0000-0003-0910-3893; Young, Richard A/0000-0001-8855-8647; marchesini, jlenia jm/0000-0002-1911-5938; Volinia, Stefano/0000-0003-0910-3893; Veronese, Angelo/0000-0002-1451-1392; Palatini, Jeffrey/0000-0001-9280-4417; Ormondroyd, Elizabeth/0000-0002-9116-4064	National Cancer Institute [P01CA76259]; AIRC; PRRIITT Regione Emilia Romagna; MIUR; NATIONAL CANCER INSTITUTE [P01CA076259] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AIRC(Fondazione AIRC per la ricerca sul cancro); PRRIITT Regione Emilia Romagna(Regione Emilia Romagna); MIUR(Ministry of Education, Universities and Research (MIUR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Program Project Grant No. P01CA76259 from the National Cancer Institute (CMC) and by grants from AIRC, PRRIITT Regione Emilia Romagna and MIUR (SV).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davison AC, 1997, BOOTSTRAP METHODS TH; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Irizarry K, 2000, NAT GENET, V26, P233, DOI 10.1038/79981; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Murphy JA, 2004, HUM MUTAT, V24, P296, DOI 10.1002/humu.20083; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Qiu P, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-4; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stratton M, 2008, NAT BIOTECHNOL, V26, P65, DOI 10.1038/nbt0108-65; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; 1997, BREAST CANC LINKAGE, V349, P1505	25	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3380	10.1371/journal.pone.0003380	http://dx.doi.org/10.1371/journal.pone.0003380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846217	Green Published, Green Submitted, gold			2022-12-27	WOS:000265114500009
J	Watts, KM; Hunstad, DA				Watts, Kristin M.; Hunstad, David A.			Components of SurA Required for Outer Membrane Biogenesis in Uropathogenic Escherichia coli	PLOS ONE			English	Article								Background: SurA is a periplasmic peptidyl-prolyl isomerase ( PPIase) and chaperone of Escherichia coli and other Gram-negative bacteria. In contrast to other PPIases, SurA appears to have a distinct role in chaperoning newly synthesized porins destined for insertion into the outer membrane. Previous studies have indicated that the chaperone activity of SurA rests in its "core module'' (the N- plus C-terminal domains), based on in vivo envelope phenotypes and in vitro binding and protection of non-native substrates. Methodology/Principal Findings: In this study, we determined the components of SurA required for chaperone activity using in vivo phenotypes relevant to disease causation by uropathogenic E. coli (UPEC), namely membrane resistance to permeation by antimicrobials and maturation of the type 1 pilus usher FimD. FimD is a SurA-dependent, integral outer membrane protein through which heteropolymeric type 1 pili, which confer bladder epithelial binding and invasion capacity upon uropathogenic E. coli, are assembled and extruded. Consistent with prior results, the in vivo chaperone activity of SurA in UPEC rested primarily in the core module. However, the PPIase domains I and II were not expendable for wild-type resistance to novobiocin in broth culture. Steady-state levels of FimD were substantially restored in the UPEC surA mutant complemented with the SurA N- plus C-terminal domains. The addition of PPIase domain I augmented FimD maturation into the outer membrane, consistent with a model in which domain I enhances stability of and/or substrate binding by the core module. Conclusions/Significance: Our results confirm the core module of E. coli SurA as a potential target for novel anti-infective development.	[Watts, Kristin M.; Hunstad, David A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Hunstad, David A.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Watts, KM (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	dhunstad@wustl.edu		Hunstad, David/0000-0002-9848-0975	National Institutes of Health [DK067894, DK076556]; Child Health Research Center of Excellence at Washington University [K12-HD01487]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK067894, R03DK076556] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Child Health Research Center of Excellence at Washington University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK067894 and DK076556 (to D.A.H.) and by the Child Health Research Center of Excellence at Washington University (K12-HD01487). Funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arie JP, 2001, MOL MICROBIOL, V39, P199, DOI 10.1046/j.1365-2958.2001.02250.x; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Bitto E, 2004, FEBS LETT, V568, P94, DOI 10.1016/j.febslet.2004.05.014; Bitto E, 2003, J BIOL CHEM, V278, P49316, DOI 10.1074/jbc.M308853200; Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Hennecke G, 2005, J BIOL CHEM, V280, P23540, DOI 10.1074/jbc.M413742200; HORNE SM, 1995, ARCH MICROBIOL, V163, P357, DOI 10.1007/s002030050215; Hunstad DA, 2005, INFECT IMMUN, V73, P3999, DOI 10.1128/IAI.73.7.3999-4006.2005; Justice SS, 2006, INFECT IMMUN, V74, P4793, DOI 10.1128/IAI.00355-06; Justice SS, 2005, J BACTERIOL, V187, P7680, DOI 10.1128/JB.187.22.7680-7686.2005; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; LIU J, 1990, P NATL ACAD SCI USA, V87, P4028, DOI 10.1073/pnas.87.11.4028; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Ramm K, 2000, J BIOL CHEM, V275, P17106, DOI 10.1074/jbc.M910234199; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; Sydenham M, 2000, INFECT IMMUN, V68, P1109, DOI 10.1128/IAI.68.3.1109-1115.2000; Webb HM, 2001, J BIOL CHEM, V276, P45622, DOI 10.1074/jbc.M107508200; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069	31	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3359	10.1371/journal.pone.0003359	http://dx.doi.org/10.1371/journal.pone.0003359			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836534	Green Published, gold			2022-12-27	WOS:000265113500012
J	Todoroki, S				Todoroki, Shin-ichi			In Situ Observation of Modulated Light Emission of Fiber Fuse Synchronized with Void Train over Hetero-Core Splice Point	PLOS ONE			English	Article								Background: Fiber fuse is a process of optical fiber destruction under the action of laser radiation, found 20 years ago. Once initiated, opical discharge runs along the fiber core region to the light source and leaves periodic voids whose shape looks like a bullet pointing the direction of laser beam. The relation between damage pattern and propagation mode of optical discharge is still unclear even after the first in situ observation three years ago. Methodology/Principal Findings: Fiber fuse propagation over hetero-core splice point (Corning SMF-28e and HI 1060) was observed in situ. Sequential photographs obtained at intervals of 2.78 mu s recorded a periodic emission at the tail of an optical discharge pumped by 1070 nm and 9 W light. The signal stopped when the discharge ran over the splice point. The corresponding damage pattern left in the fiber core region included a segment free of periodicity. Conclusions: The spatial modulation pattern of the light emission agreed with the void train formed over the hetero-core splice point. Some segments included a bullet-shaped void pointing in the opposite direction to the laser beam propagation although the sequential photographs did not reveal any directional change in the optical discharge propagation.	[Todoroki, Shin-ichi] Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki, Japan	National Institute for Materials Science	Todoroki, S (corresponding author), Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki, Japan.	TODOROKI.Shin-ichi@nims.go.jp	Todoroki, Shin-ichi/A-9922-2008	Todoroki, Shin-ichi/0000-0003-3986-1900	National Institute for Materials Science	National Institute for Materials Science	National Institute for Materials Science	BUFETOV IA, 2007, P 33 EUR C OPT COMM, P79; HAND DP, 1988, OPT LETT, V13, P767, DOI 10.1364/OL.13.000767; KASHYAP R, 1988, ELECTRON LETT, V24, P47, DOI 10.1049/el:19880032; Todoroki S, 2005, OPT EXPRESS, V13, P9248, DOI 10.1364/OPEX.13.009248; Todoroki S, 2005, OPT LETT, V30, P2551, DOI 10.1364/OL.30.002551; Todoroki S, 2005, OPT EXPRESS, V13, P6381, DOI 10.1364/OPEX.13.006381	6	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2008	3	9							e3276	10.1371/journal.pone.0003276	http://dx.doi.org/10.1371/journal.pone.0003276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MH	18815621	gold, Green Submitted, Green Published			2022-12-27	WOS:000264431900003
J	Hageman, JA; Hendriks, MMWB; Westerhuis, JA; van der Werf, MJ; Berger, R; Smilde, AK				Hageman, Jos A.; Hendriks, Margriet M. W. B.; Westerhuis, Johan A.; van der Werf, Mariet J.; Berger, Ruud; Smilde, Age K.			Simplivariate Models: Ideas and First Examples	PLOS ONE			English	Article							MASS-SPECTROMETRY; METABOLOMICS	One of the new expanding areas in functional genomics is metabolomics: measuring the metabolome of an organism. Data being generated in metabolomics studies are very diverse in nature depending on the design underlying the experiment. Traditionally, variation in measurements is conceptually broken down in systematic variation and noise where the latter contains, e. g. technical variation. There is increasing evidence that this distinction does not hold (or is too simple) for metabolomics data. A more useful distinction is in terms of informative and non-informative variation where informative relates to the problem being studied. In most common methods for analyzing metabolomics (or any other high-dimensional x-omics) data this distinction is ignored thereby severely hampering the results of the analysis. This leads to poorly interpretable models and may even obscure the relevant biological information. We developed a framework from first data analysis principles by explicitly formulating the problem of analyzing metabolomics data in terms of informative and non-informative parts. This framework allows for flexible interactions with the biologists involved in formulating prior knowledge of underlying structures. The basic idea is that the informative parts of the complex metabolomics data are approximated by simple components with a biological meaning, e. g. in terms of metabolic pathways or their regulation. Hence, we termed the framework 'simplivariate models' which constitutes a new way of looking at metabolomics data. The framework is given in its full generality and exemplified with two methods, IDR analysis and plaid modeling, that fit into the framework. Using this strategy of 'divide and conquer', we show that meaningful simplivariate models can be obtained using a real-life microbial metabolomics data set. For instance, one of the simple components contained all the measured intermediates of the Krebs cycle of E. coli. Moreover, these simplivariate models were able to uncover regulatory mechanisms present in the phenylalanine biosynthesis route of E. coli.	[Hageman, Jos A.; Westerhuis, Johan A.; Smilde, Age K.] Univ Amsterdam, NL-1012 WX Amsterdam, Netherlands; [Hageman, Jos A.; Hendriks, Margriet M. W. B.; Berger, Ruud] Wilhelmina Childrens Hosp, ABC Metabolom Ctr, Lab Metabol & Endocrine Dis, Utrecht, Netherlands; [van der Werf, Mariet J.; Smilde, Age K.] TNO Quality Life, Zeist, Netherlands	University of Amsterdam; Wilhelmina Kinderziekenhuis; Netherlands Organization Applied Science Research	Hageman, JA (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	j.a.westerhuis@uva.nl	Hageman, Jos/N-1221-2015	Hageman, Jos/0000-0002-5868-587X; Smilde, Age/0000-0002-3052-4644	Netherlands Genomics Initiative (NGI) [BSIK grant]	Netherlands Genomics Initiative (NGI)	This work was part of the BioRange programme of the Netherlands Bioinformatics Centre (NBIC), which is supported by a BSIK grant through the Netherlands Genomics Initiative (NGI). The manuscript was reviewed by all members of the SP2.2.3 project group of NBIC.	Bro R, 2003, J CHEMOMETR, V17, P16, DOI 10.1002/cem.773; Chipman HA, 2005, J APPL STAT, V32, P969, DOI 10.1080/02664760500168648; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; HAGEMAN JA, 2008, GENETIC ALG IN PRESS; Lazzeroni L, 2002, STAT SINICA, V12, P61; Lindon JC, 2003, ANAL CHEM, V75, p384A, DOI 10.1021/ac031386+; *MATL, 1984, MATHW VERS 7 REL 14; Smilde AK, 2005, ANAL CHEM, V77, P6729, DOI 10.1021/ac051080y; Turner H, 2005, COMPUT STAT DATA AN, V48, P235, DOI 10.1016/j.csda.2004.02.003; Turner HL, 2005, IEEE ACM T COMPUT BI, V2, P316, DOI 10.1109/TCBB.2005.49; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; van der Werf MJ, 2007, ANAL BIOCHEM, V370, P17, DOI 10.1016/j.ab.2007.07.022; VANDEGINSTE BGM, 1998, HDB CHEMOMETRICS; VANDENBERG RA, 2008, DISCOVERY FUNCTIONAL; Want EJ, 2005, CHEMBIOCHEM, V6, P1941, DOI 10.1002/cbic.200500151	15	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2008	3	9							e3259	10.1371/journal.pone.0003259	http://dx.doi.org/10.1371/journal.pone.0003259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MA	18810272	Green Published, gold, Green Submitted			2022-12-27	WOS:000264431000002
J	Ho, KM; Knuiman, M; Finn, J; Webb, SA				Ho, Kwok M.; Knuiman, Matthew; Finn, Judith; Webb, Steven A.			Estimating Long-Term Survival of Critically Ill Patients: The PREDICT Model	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; EVALUATION (APACHE)-II SCORE; ACUTE PHYSIOLOGY; HOSPITAL MORTALITY; PROGNOSTIC MODEL; DECISIONS; DETERMINANTS; PHYSICIANS; ADMISSION; OUTCOMES	Background: Long-term survival outcome of critically ill patients is important in assessing effectiveness of new treatments and making treatment decisions. We developed a prognostic model for estimation of long-term survival of critically ill patients. Methodology and Principal Findings: This was a retrospective linked data cohort study involving 11,930 critically ill patients who survived more than 5 days in a university teaching hospital in Western Australia. Older age, male gender, comorbidities, severe acute illness as measured by Acute Physiology and Chronic Health Evaluation II predicted mortality, and more days of vasopressor or inotropic support, mechanical ventilation, and hemofiltration within the first 5 days of intensive care unit admission were associated with a worse long-term survival up to 15 years after the onset of critical illness. Among these seven pre-selected predictors, age (explained 50% of the variability of the model, hazard ratio [HR] between 80 and 60 years old = 1.95) and co-morbidity (explained 27% of the variability, HR between Charlson co-morbidity index 5 and 0 = 2.15) were the most important determinants. A nomogram based on the pre-selected predictors is provided to allow estimation of the median survival time and also the 1-year, 3-year, 5-year, 10-year, and 15-year survival probabilities for a patient. The discrimination (adjusted c-index = 0.757, 95% confidence interval 0.745-0.769) and calibration of this prognostic model were acceptable. Significance: Age, gender, co-morbidities, severity of acute illness, and the intensity and duration of intensive care therapy can be used to estimate long-term survival of critically ill patients. Age and co-morbidity are the most important determinants of long-term prognosis of critically ill patients.	[Ho, Kwok M.; Webb, Steven A.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Ho, Kwok M.; Webb, Steven A.] Univ Western Australia, Sch Med, Royal Perth Hosp, Perth, WA 6009, Australia; [Knuiman, Matthew; Finn, Judith] Univ Western Australia, Sch Populat Hlth, Crawley, WA 6009, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Ho, KM (corresponding author), Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia.	kwok.ho@health.wa.gov.au	Finn, Judith C/B-2678-2010; Knuiman, Matthew W/I-5549-2013; Ho, Kwok M./E-3546-2010	Finn, Judith C/0000-0002-7307-7944; Ho, Kwok M./0000-0002-6705-6004; Knuiman, Matthew/0000-0001-8874-2305	BUPA	BUPA	A grant was received from BUPA to provide support for the cost of linking the databases used in this study. The funding agency has no involvement in the study design, collection of data, analysis and interpretation of data, writing of the report, or in the decision to submit the article for publication.	*AC HLTH DIV DOHS, 1997, REV INT CAR VICT PHA; *AUD COMM, 1999, PLAC EFF EFF CRIT CA; Cabre L, 2005, INTENS CARE MED, V31, P927, DOI 10.1007/s00134-005-2640-2; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Connors AF, 1999, CRIT CARE MED, V27, P5, DOI 10.1097/00003246-199901000-00004; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; COX DR, 1972, J R STAT SOC B, V34, P187; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Elstein AS, 1999, CRIT CARE MED, V27, P58, DOI 10.1097/00003246-199901000-00027; Feringa HHH, 2007, ARCH INTERN MED, V167, P2482, DOI 10.1001/archinte.167.22.2482; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Garland A, 2007, J PALLIAT MED, V10, P1298, DOI 10.1089/jpm.2007.0061; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; HALPERN NA, 1994, CRIT CARE MED, V22, P2001; Hamel MB, 1997, ANN INTERN MED, V127, P195, DOI 10.7326/0003-4819-127-3-199708010-00003; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 2001, REGRESSION MODELING; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; Ho KM, 2007, ANAESTHESIA, V62, P1095, DOI 10.1111/j.1365-2044.2007.05231.x; Ho KM, 2007, ANAESTH INTENS CARE, V35, P515, DOI 10.1177/0310057X0703500409; Ho KM, 2007, ANAESTHESIA, V62, P466, DOI 10.1111/j.1365-2044.2007.04999.x; Ho KM, 2005, INTENS CARE MED, V31, P668, DOI 10.1007/s00134-005-2613-5; Ho KM, 2004, ANAESTH INTENS CARE, V32, P781, DOI 10.1177/0310057X0403200609; Ho KM, 2006, CRIT CARE, V10, DOI 10.1186/cc3913; Ho KM, 2007, J CLIN EPIDEMIOL, V60, P746, DOI 10.1016/j.jclinepi.2006.10.017; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; Kvale R, 2002, INTENS CARE MED, V28, P1110, DOI 10.1007/s00134-002-1378-3; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nathens AB, 2008, J TRAUMA, V64, P81, DOI 10.1097/TA.0b013e31815dd4d7; Poisal JA, 2007, HEALTH AFFAIR, V26, pW242, DOI 10.1377/hlthaff.26.2.w242; POMPEI P, 1991, J CLIN EPIDEMIOL, V44, P1063, DOI 10.1016/0895-4356(91)90008-W; Sinuff T, 2006, CRIT CARE MED, V34, P878, DOI 10.1097/01.CCM.0000201881.58644.41; Williams TA, 2006, ANAESTH INTENS CARE, V34, P307, DOI 10.1177/0310057X0603400316; Williams TA, 2008, CRIT CARE MED, V36, P1523, DOI 10.1097/CCM.0b013e318170a405; Wright JC, 2003, ANAESTHESIA, V58, P637, DOI 10.1046/j.1365-2044.2003.03205.x; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	41	83	84	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3226	10.1371/journal.pone.0003226	http://dx.doi.org/10.1371/journal.pone.0003226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LB	18797505	Green Submitted, Green Published, gold			2022-12-27	WOS:000264428200006
J	Li, RX; Chen, HB; Tu, K; Zhao, SL; Zhou, H; Li, SJ; Dai, J; Li, QR; Nie, S; Li, YX; Jia, WP; Zeng, R; Wu, JR				Li, Rong-Xia; Chen, Hai-Bing; Tu, Kang; Zhao, Shi-Lin; Zhou, Hu; Li, Su-Jun; Dai, Jie; Li, Qing-Run; Nie, Song; Li, Yi-Xue; Jia, Wei-Ping; Zeng, Rong; Wu, Jia-Rui			Localized-Statistical Quantification of Human Serum Proteome Associated with Type 2 Diabetes	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HUMAN PLASMA PROTEOME; CORONARY-ARTERY-DISEASE; MANNOSE-BINDING LECTIN; METABOLIC SYNDROME; COMPLEMENT ACTIVATION; ATHEROSCLEROSIS RISK; IDENTIFICATION; MELLITUS; LIPOPROTEINS	Background: Recent advances in proteomics have shed light to discover serum proteins or peptides as biomarkers for tracking the progression of diabetes as well as understanding molecular mechanisms of the disease. Results: In this work, human serum of non-diabetic and diabetic cohorts was analyzed by proteomic approach. To analyze total 1377 high-confident serum-proteins, we developed a computing strategy called localized statistics of protein abundance distribution (LSPAD) to calculate a significant bias of a particular protein-abundance between these two cohorts. As a result, 68 proteins were found significantly over-represented in the diabetic serum (p < 0.01). In addition, a pathway-associated analysis was developed to obtain the overall pathway bias associated with type 2 diabetes, from which the significant over-representation of complement system associated with type 2 diabetes was uncovered. Moreover, an upstream activator of complement pathway, ficolin-3, was observed over-represented in the serum of type 2 diabetic patients, which was further validated with statistic significance (p=0.012) with more clinical samples. Conclusions: The developed LSPAD approach is well fit for analyzing proteomic data derived from biological complex systems such as plasma proteome. With LSPAD, we disclosed the comprehensive distribution of the proteins associated with diabetes in different abundance levels and the involvement of ficolin-related complement activation in diabetes.	[Li, Rong-Xia; Tu, Kang; Zhao, Shi-Lin; Zhou, Hu; Li, Su-Jun; Dai, Jie; Li, Qing-Run; Nie, Song; Li, Yi-Xue; Zeng, Rong; Wu, Jia-Rui] Chinese Acad Sci, Key Lab Syst Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Chen, Hai-Bing; Jia, Wei-Ping] Jiaotong Univ, Shanghai Peoples Hosp 6, Dept Endocrinol & Metabolism, Shanghai Diabetes Inst, Shanghai, Peoples R China; [Wu, Jia-Rui] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, RX (corresponding author), Chinese Acad Sci, Key Lab Syst Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	wpjia@yahoo.com; zr@sibs.ac.cn; wujr@sibs.ac.cn	Li, Qing-Run/C-7362-2011; Nie, Song/E-9027-2014; nie, song/E-6904-2015	Li, Qing-Run/0000-0002-1644-0508; Nie, Song/0000-0001-5035-1827; 	973 Program [2006CB503900]; Chinese Academy of Sciences [KSCX1-YW-02]; National Natural Science Foundation of China [30521005, 30425021]; National Basic Research Program of China [2006CB910700, 2007AA02Z334]	973 Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by 973 Program #2006CB503900 to JR. Wu and WP Jia; a grant of Knowledge Innovation Program of the Chinese Academy of Sciences KSCX1-YW-02 to JR. Wu; the grants of National Natural Science Foundation of China 30521005 to JR. Wu and R. Zeng, #30425021 to R. Zeng; and National Basic Research Program of China #2006CB910700 to R. Zeng, and High-technology Project # 2007AA02Z334 to R. Zeng.	ANDERSON NL, 2002, HUMAN PLASMA PROTEOM, P845; Barraviera B., 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P479, DOI 10.1590/S0036-46651994000500015; Bolstad B, 2005, BIOINFORMATICS COMPU; Cheng Xi, 2004, World J Surg Oncol, V2, P47, DOI 10.1186/1477-7819-2-47; Dayal B, 2002, J PROTEOME RES, V1, P375, DOI 10.1021/pr010008n; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; Duncan BB, 1999, DIABETES CARE, V22, P767, DOI 10.2337/diacare.22.5.767; Engstrom G, 2005, DIABETES, V54, P570, DOI 10.2337/diabetes.54.2.570; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; Georgiou HM, 2001, PROTEOMICS, V1, P1503, DOI 10.1002/1615-9861(200111)1:12<1503::AID-PROT1503>3.0.CO;2-M; Getz GS, 2004, CURR OPIN LIPIDOL, V15, P261, DOI 10.1097/00041433-200406000-00005; Hansen TK, 2005, HORM METAB RES, V37, pS95, DOI 10.1055/s-2005-8613272; Hansen TK, 2004, DIABETES, V53, P1570, DOI 10.2337/diabetes.53.6.1570; Hansen TK, 2006, ARCH INTERN MED, V166, P2007, DOI 10.1001/archinte.166.18.2007; He P, 2005, PROTEOMICS, V5, P3442, DOI 10.1002/pmic.200401301; Heller M, 2005, PROTEOMICS, V5, P2619, DOI 10.1002/pmic.200401233; Horikawa Y, 2003, HORM METAB RES, V35, P308; Jin WH, 2005, J PROTEOME RES, V4, P613, DOI 10.1021/pr049761h; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlsson H, 2005, PROTEOMICS, V5, P1431, DOI 10.1002/pmic.200401010; Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549; Kim CH, 2002, METABOLISM, V51, P838, DOI 10.1053/meta.2002.33348; Kim EY, 2003, AUTOIMMUNITY, V36, P177, DOI 10.1080/0891693031000101279; Koopman RJ, 2005, ANN FAM MED, V3, P60, DOI 10.1370/afm.214; Korc M, 2003, MOL CELL PROTEOMICS, V2, P399, DOI 10.1074/mcp.R300005-MCP200; Kotite L, 2003, J LIPID RES, V44, P1387, DOI 10.1194/jlr.M300087-JLR200; KUNITAKE ST, 1994, BIOCHEMISTRY-US, V33, P1988, DOI 10.1021/bi00174a003; Lindgren CM, 2002, DIABETES, V51, P1609, DOI 10.2337/diabetes.51.5.1609; Mackness B, 2006, ATHEROSCLEROSIS, V186, P396, DOI 10.1016/j.atherosclerosis.2005.07.028; MCMILLAN DE, 1989, METABOLISM, V38, P1042, DOI 10.1016/0026-0495(89)90038-3; MCVICAR JP, 1984, P NATL ACAD SCI-BIOL, V81, P1356, DOI 10.1073/pnas.81.5.1356; Mirzaei H, 2008, PROTEOMICS, V8, P1516, DOI 10.1002/pmic.200700363; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; O'Brien PJ, 2005, CLIN CHEM, V51, P351, DOI 10.1373/clinchem.2004.040824; On YK, 2007, CIRC J, V71, P868, DOI 10.1253/circj.71.868; Ostergaard J, 2005, CLIN CHIM ACTA, V361, P10, DOI 10.1016/j.cccn.2005.04.028; PASCUAL M, 1995, IMMUNOL TODAY, V16, P58, DOI 10.1016/0167-5699(95)80088-3; Patrick L, 2001, Altern Med Rev, V6, P248; PEETERS A, 2007, MOL GENET METAB; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; RAO AA, 2007, MED HYPOTHESES; Rezaee F, 2006, PROTEOMICS, V6, P721, DOI 10.1002/pmic.200500191; ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615; Rothem L, 2007, FREE RADICAL BIO MED, V43, P730, DOI 10.1016/j.freeradbiomed.2007.05.003; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Scott Eleanor M, 2005, Diab Vasc Dis Res, V2, P54, DOI 10.3132/dvdr.2005.009; SPRECHER DL, 1988, J LIPID RES, V29, P273; Sundsten T, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-22; SYVANNE M, 1994, ATHEROSCLEROSIS, V105, P25, DOI 10.1016/0021-9150(94)90004-3; Takahashi M, 2007, ADV EXP MED BIOL, V598, P93; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thorand B, 2003, ARCH INTERN MED, V163, P93, DOI 10.1001/archinte.163.1.93; Tu CJ, 2005, J PROTEOME RES, V4, P1265, DOI 10.1021/pr0497529; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vendrell J, 2003, ATHEROSCLEROSIS, V167, P257, DOI 10.1016/S0021-9150(02)00429-X; Virella G, 2008, CLIN IMMUNOL, V127, P394, DOI 10.1016/j.clim.2008.02.005; Vorup-Jensen T, 1998, IMMUNOBIOLOGY, V199, P348, DOI 10.1016/S0171-2985(98)80039-9; Whaley K, 1997, SEMIN LIVER DIS, V17, P297, DOI 10.1055/s-2007-1007206; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Zhang LH, 1996, J BIOL CHEM, V271, P1776, DOI 10.1074/jbc.271.3.1776; Zhang RL, 2004, PROTEOMICS, V4, P244, DOI 10.1002/pmic.200300495; Zimmet P, 2003, DIABETES METAB, V29, pS9	66	56	60	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3224	10.1371/journal.pone.0003224	http://dx.doi.org/10.1371/journal.pone.0003224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795103	Green Published, Green Submitted, gold			2022-12-27	WOS:000264428000007
J	Nakagawa, T; Kollmeyer, TM; Morlan, BW; Anderson, SK; Bergstralh, EJ; Davis, BJ; Asmann, YW; Klee, GG; Ballman, KV; Jenkins, RB				Nakagawa, Tohru; Kollmeyer, Thomas M.; Morlan, Bruce W.; Anderson, S. Keith; Bergstralh, Eric J.; Davis, Brian J.; Asmann, Yan W.; Klee, George G.; Ballman, Karla V.; Jenkins, Robert B.			A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy	PLOS ONE			English	Article							NEOADJUVANT HORMONAL-THERAPY; RADIATION-THERAPY; RADICAL PROSTATECTOMY; CLINICAL-SIGNIFICANCE; ANDROGEN DEPRIVATION; BIOCHEMICAL FAILURE; CHROMOSOME 8Q24; GENE; EXPRESSION; ANTIGEN	Background: Many men develop a rising PSA after initial therapy for prostate cancer. While some of these men will develop a local or metastatic recurrence that warrants further therapy, others will have no evidence of disease progression. We hypothesized that an expression biomarker panel can predict which men with a rising PSA would benefit from further therapy. Methodology/Principal Findings: A case-control design was used to test the association of gene expression with outcome. Systemic (SYS) progression cases were men post-prostatectomy who developed systemic progression within 5 years after PSA recurrence. PSA progression controls were matched men post-prostatectomy with PSA recurrence but no evidence of clinical progression within 5 years. Using expression arrays optimized for paraffin-embedded tissue RNA, 1021 cancer-related genes were evaluated-including 570 genes implicated in prostate cancer progression. Genes from 8 previously reported marker panels were included. A systemic progression model containing 17 genes was developed. This model generated an AUC of 0.88 (95% CI: 0.84-0.92). Similar AUCs were generated using 3 previously reported panels. In secondary analyses, the model predicted the endpoints of prostate cancer death (in SYS cases) and systemic progression beyond 5 years (in PSA controls) with hazard ratios 2.5 and 4.7, respectively (log-rank p-values of 0.0007 and 0.0005). Genes mapped to 8q24 were significantly enriched in the model. Conclusions/Significance: Specific gene expression patterns are significantly associated with systemic progression after PSA recurrence. The measurement of gene expression pattern may be useful for determining which men may benefit from additional therapy after PSA recurrence.	[Nakagawa, Tohru; Kollmeyer, Thomas M.; Klee, George G.; Jenkins, Robert B.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Morlan, Bruce W.; Anderson, S. Keith; Bergstralh, Eric J.; Asmann, Yan W.; Ballman, Karla V.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Davis, Brian J.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Nakagawa, T (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA.	rjenkins@mayo.edu		Ballman, Karla/0000-0002-4492-0357; Davis, Brian/0000-0002-8288-1096	NIH [P50 CA91956]; Richard M. Schulze Family Foundation; Minnesota Department of Employment and Economic Development; Ministry of Health, Labor and Welfare of Japan [Grant-in-Aid]; NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard M. Schulze Family Foundation; Minnesota Department of Employment and Economic Development; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the P50 CA91956 Mayo Prostate Cancer SPORE grant from the NIH, and the Richard M. Schulze Family Foundation. It was also supported by the Minnesota Department of Employment and Economic Development from the State's legislative appropriation for the Minnesota Partnership for Biotechnology and Medical Genomics. Tohru Nakagawa was supported in part by a Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan.	Amling CL, 2000, J UROLOGY, V164, P101, DOI 10.1016/S0022-5347(05)67457-5; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Ballman KV, 2004, BIOINFORMATICS, V20, P2778, DOI 10.1093/bioinformatics/bth327; BERGSTRALH EJ, 1995, EPIDEMIOLOGY, V6, P271; Bibikova M, 2004, CLIN CHEM, V50, P2384, DOI 10.1373/clinchem.2004.037432; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Bibikova M, 2007, GENOMICS, V89, P666, DOI 10.1016/j.ygeno.2007.02.005; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; D'Amico AV, 2002, J CLIN ONCOL, V20, P4567, DOI 10.1200/JCO.2002.03.061; D'Amico AV, 2003, J CLIN ONCOL, V21, P2163, DOI 10.1200/JCO.2003.01.075; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Gleave ME, 2001, J UROLOGY, V166, P500, DOI 10.1016/S0022-5347(05)65971-X; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Harald C, 1999, MATH METHODS STAT; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kestin LL, 2004, INT J RADIAT ONCOL, V60, P453, DOI 10.1016/j.ijrobp.2004.03.013; Kube DM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-25; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; LaTulippe E, 2002, CANCER RES, V62, P4499; Lawton CA, 2001, INT J RADIAT ONCOL, V49, P937, DOI 10.1016/S0360-3016(00)01516-9; Luo J, 2001, CANCER RES, V61, P4683; Magee JA, 2001, CANCER RES, V61, P5692; Moul JW, 2004, J UROLOGY, V171, P1141, DOI 10.1097/01.JU.0000113794.34810.D0; Moul JW, 2000, J UROLOGY, V163, P1632, DOI 10.1016/S0022-5347(05)67511-8; Patel DA, 2005, J CLIN ONCOL, V23, P6157, DOI 10.1200/JCO.2005.01.2336; Pilepich MV, 2001, INT J RADIAT ONCOL, V50, P1243, DOI 10.1016/S0360-3016(01)01579-6; Pinover WH, 2003, CANCER-AM CANCER SOC, V97, P1127, DOI 10.1002/cncr.11166; PORKKA KP, 2007, GENE CHROMOSOME CANC, V39, P1; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sandler HM, 2000, INT J RADIAT ONCOL, V48, P629, DOI 10.1016/S0360-3016(00)00717-3; Saramaki O, 2001, AM J PATHOL, V159, P2089, DOI 10.1016/S0002-9440(10)63060-X; Sato K, 1999, JNCI-J NATL CANCER I, V91, P1574, DOI 10.1093/jnci/91.18.1574; Savinainen KJ, 2006, PROSTATE, V66, P1144, DOI 10.1002/pros.20452; Savinainen KJ, 2004, BRIT J CANCER, V90, P1041, DOI 10.1038/sj.bjc.6601648; Schumacher FR, 2007, CANCER RES, V67, P2951, DOI 10.1158/0008-5472.CAN-06-3591; Severi G, 2007, CANCER EPIDEM BIOMAR, V16, P610, DOI 10.1158/1055-9965.EPI-06-0872; Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tollefson MK, 2007, MAYO CLIN PROC, V82, P422, DOI 10.4065/82.4.422; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tsuchiya N, 2002, GENE CHROMOSOME CANC, V34, P363, DOI 10.1002/gcc.10064; Tsuchiya N, 2002, AM J PATHOL, V160, P1799, DOI 10.1016/S0002-9440(10)61126-1; Wang L, 2007, CANCER RES, V67, P2944, DOI 10.1158/0008-5472.CAN-06-3186; Welsh JB, 2001, CANCER RES, V61, P5974; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; ZELEFSKY MJ, 1994, INT J RADIAT ONCOL, V29, P755, DOI 10.1016/0360-3016(94)90563-0	56	143	165	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2318	10.1371/journal.pone.0002318	http://dx.doi.org/10.1371/journal.pone.0002318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18846227	Green Published, gold, Green Submitted			2022-12-27	WOS:000262268500046
J	Egea, PF; Tsuruta, H; de Leon, GP; Napetschnig, J; Walter, P; Stroud, RM				Egea, Pascal F.; Tsuruta, Hiro; de Leon, Gladys P.; Napetschnig, Johanna; Walter, Peter; Stroud, Robert M.			Structures of the Signal Recognition Particle Receptor from the Archaeon Pyrococcus furiosus: Implications for the Targeting Step at the Membrane	PLOS ONE			English	Article								In all organisms, a ribonucleoprotein called the signal recognition particle (SRP) and its receptor (SR) target nascent proteins from the ribosome to the translocon for secretion or membrane insertion. We present the first X-ray structures of an archeal FtsY, the receptor from the hyper-thermophile Pyrococcus furiosus (Pfu), in its free and GDP.magnesium-bound forms. The highly charged N-terminal domain of Pfu-FtsY is distinguished by a long N-terminal helix. The basic charges on the surface of this helix are likely to regulate interactions at the membrane. A peripheral GDP bound near a regulatory motif could indicate a site of interaction between the receptor and ribosomal or SRP RNAs. Small angle X-ray scattering and analytical ultracentrifugation indicate that the crystal structure of Pfu-FtsY correlates well with the average conformation in solution. Based on previous structures of two sub-complexes, we propose a model of the core of archeal and eukaryotic SRPN.SR targeting complexes.	[Egea, Pascal F.; de Leon, Gladys P.; Napetschnig, Johanna; Walter, Peter; Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Tsuruta, Hiro] Stanford Univ, Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA; [Napetschnig, Johanna] Rockefeller Univ, Howard Hughes Med Inst, Lab Cell Biol, New York, NY USA	University of California System; University of California San Francisco; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Howard Hughes Medical Institute; Rockefeller University	Egea, PF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	pascal@msg.ucsf.edu; stroud@msg.ucsf.edu	egea, pascal/V-7662-2019; Egea, Pascal Francois/AAI-2759-2020; Perez-Ponce de Leon, Gerardo/U-3869-2017	egea, pascal/0000-0003-4432-8625; Perez-Ponce de Leon, Gerardo/0000-0001-6472-5113	NIH [GM60641]; Howard Hughes Medical Institute; DOE; Office of Biological and Environmental Research; National Center for Research Resources, Biomedical Technology [5 P41 RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); DOE(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Center for Research Resources, Biomedical Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM60641 to R.M.S. that supports P.F.E and NIH grants to P.W. P.W is an investigator from the Howard Hughes Medical Institute. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory. The SSRL Structural Molecular Biology Program is supported by the DOE, Office of Biological and Environmental Research, and by the NIH, National Center for Research Resources, Biomedical Technology Program Grant Number 5 P41 RR001209. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Angelini S, 2006, J CELL BIOL, V174, P715, DOI 10.1083/jcb.200606093; [Anonymous], ACTA CRYSTALLOGR D, V50, P760; BAHARI L, 2007, J BIOL CHEM; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; BROWN S, 1984, J MOL BIOL, V178, P533, DOI 10.1016/0022-2836(84)90237-7; Chandrasekar S, 2008, J MOL BIOL, V375, P425, DOI 10.1016/j.jmb.2007.09.061; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Eitan A, 2004, J BACTERIOL, V186, P2492, DOI 10.1128/JB.186.8.2492-2494.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Focia PJ, 2006, J MOL BIOL, V360, P631, DOI 10.1016/j.jmb.2006.05.031; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Gariani T, 2006, J STRUCT BIOL, V153, P85, DOI 10.1016/j.jsb.2005.10.003; Gawronski-Salerno J, 2007, PROTEINS, V66, P984, DOI 10.1002/prot.21200; Gawronski-Salerno J, 2007, J STRUCT BIOL, V158, P122, DOI 10.1016/j.jsb.2006.10.025; Hainzl T, 2007, P NATL ACAD SCI USA, V104, P14911, DOI 10.1073/pnas.0702467104; Helmers J, 2003, J BIOL CHEM, V278, P23686, DOI 10.1074/jbc.C300180200; Herskovits AA, 2001, EMBO REP, V2, P1040, DOI 10.1093/embo-reports/kve226; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; *JCSG JCFSG, 2004, STRUCT CELL DIV PROT; Jiang Y, 2008, J CELL BIOL, V180, P1149, DOI 10.1083/jcb.200707196; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 1997, J APPL CRYSTALLOGR, V30, P811, DOI 10.1107/S0021889897001830; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; NEHER SB, 2008, NAT STRUCT MOL BIOL; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARLITZ R, 2007, J BIOL CHEM; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Reyes CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000607; Schwartz TU, 2006, P NATL ACAD SCI USA, V103, P6823, DOI 10.1073/pnas.0602083103; Shan SO, 2003, P NATL ACAD SCI USA, V100, P4480, DOI 10.1073/pnas.0737693100; Shepotinovskaya IV, 2002, BBA-PROTEIN STRUCT M, V1597, P107, DOI 10.1016/S0167-4838(02)00287-X; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; Spanggord RJ, 2005, NAT STRUCT MOL BIOL, V12, P1116, DOI 10.1038/nsmb1025; Stengel KF, 2007, FEBS LETT, V581, P5671, DOI 10.1016/j.febslet.2007.11.024; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Unsworth LD, 2007, FEBS J, V274, P4044, DOI 10.1111/j.1742-4658.2007.05954.x; Weiche B, 2008, J MOL BIOL, V377, P761, DOI 10.1016/j.jmb.2008.01.040	53	17	17	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3619	10.1371/journal.pone.0003619	http://dx.doi.org/10.1371/journal.pone.0003619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978942	Green Published, Green Submitted, gold			2022-12-27	WOS:000265134200007
J	Ghatkesar, MK; Lang, HP; Gerber, C; Hegner, M; Braun, T				Ghatkesar, Murali Krishna; Lang, Hans-Peter; Gerber, Christoph; Hegner, Martin; Braun, Thomas			Comprehensive Characterization of Molecular Interactions Based on Nanomechanics	PLOS ONE			English	Article							MICROFABRICATED CANTILEVER ARRAY; ATOMIC-FORCE MICROSCOPE; LIPID-BILAYER; MELITTIN; VESICLES; BACTERIORHODOPSIN; ADSORPTION; RESONANCE; MEMBRANES; PEPTIDE	Molecular interaction is a key concept in our understanding of the biological mechanisms of life. Two physical properties change when one molecular partner binds to another. Firstly, the masses combine and secondly, the structure of at least one binding partner is altered, mechanically transducing the binding into subsequent biological reactions. Here we present a nanomechanical micro-array technique for bio-medical research, which not only monitors the binding of effector molecules to their target but also the subsequent effect on a biological system in vitro. This label-free and real-time method directly and simultaneously tracks mass and nanomechanical changes at the sensor interface using micro-cantilever technology. To prove the concept we measured lipid vesicle (similar to 748*10(6) Da) adsorption on the sensor interface followed by subsequent binding of the bee venom peptide melittin (2840 Da) to the vesicles. The results show the high dynamic range of the instrument and that measuring the mass and structural changes simultaneously allow a comprehensive discussion of molecular interactions.	[Ghatkesar, Murali Krishna; Lang, Hans-Peter; Gerber, Christoph; Braun, Thomas] Univ Basel, Inst Phys, Natl Ctr Competence Res Nanosci, Basel, Switzerland; [Hegner, Martin; Braun, Thomas] Univ Dublin Trinity Coll, SFI Nanosci Inst, CRANN, Dublin 2, Ireland; [Ghatkesar, Murali Krishna] CALTECH, Pasadena, CA USA	University of Basel; Trinity College Dublin; California Institute of Technology	Ghatkesar, MK (corresponding author), Univ Basel, Inst Phys, Natl Ctr Competence Res Nanosci, Basel, Switzerland.	martin.hegner@tcd.ie; braun.thomas@mac.com	Lang, Hans Peter/G-3884-2011; Ghatkesar, Murali Krishna/B-3007-2018; Gerber, Christoph E/G-4851-2011; Ghatkesar, Murali K/E-5871-2010	Lang, Hans Peter/0000-0002-0012-2564; Ghatkesar, Murali Krishna/0000-0001-8423-3159; Gerber, Christoph/0000-0001-7035-3838; Hegner, Martin/0000-0003-1514-3437	SNF, NCCR Nanoscale Science, Switzerland; Cleven-Becker Stiftung; Endress Foundation (Switzerland); ELTEM Regio; SFI (Ireland); Swiss National Science Foundation (SNSF); Novartis Foundation, Switzerland	SNF, NCCR Nanoscale Science, Switzerland(Swiss National Science Foundation (SNSF)); Cleven-Becker Stiftung; Endress Foundation (Switzerland); ELTEM Regio; SFI (Ireland)(Science Foundation Ireland); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Novartis Foundation, Switzerland(Novartis)	Financial support is acknowledged from SNF (NCCR Nanoscale Science, Switzerland), the Cleven-Becker Stiftung, Endress Foundation (Switzerland), and the ELTEM Regio and SFI (Ireland). Author MKG would like to thank Swiss National Science Foundation (SNSF) and Novartis Foundation, Switzerland for the research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 1994, MOL BIOL CELL, P89; Backmann N, 2005, P NATL ACAD SCI USA, V102, P14587, DOI 10.1073/pnas.0504917102; Balint Z, 2007, LANGMUIR, V23, P7225, DOI 10.1021/la700666p; Battiston FM, 2001, SENSOR ACTUAT B-CHEM, V77, P122, DOI 10.1016/S0925-4005(01)00683-9; Bietsch A, 2004, NANOTECHNOLOGY, V15, P873, DOI 10.1088/0957-4484/15/8/002; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Braun T, 2007, J PHYS CONF SER, V61, P341, DOI 10.1088/1742-6596/61/1/069; Braun T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031907; Braun T, 2006, BIOPHYS J, V90, P2970, DOI 10.1529/biophysj.105.072934; Braun T, 2007, SENSOR ACTUAT B-CHEM, V128, P75, DOI 10.1016/j.snb.2007.05.031; Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; Cha T, 2006, BIOPHYS J, V90, P1270, DOI 10.1529/biophysj.105.061432; Deng Y, 2008, J AM CHEM SOC, V130, P6267, DOI 10.1021/ja800049f; Dohn S, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1948521; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; GHATKESAR MK, SENS ACTUATORS B; Ghatkesar MK, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/44/445502; Hansen KM, 2005, METHODS, V37, P57, DOI 10.1016/j.ymeth.2005.05.011; Kirschner MW, 2005, CELL, V121, P503, DOI 10.1016/j.cell.2005.05.005; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; Mally M, 2007, BBA-BIOMEMBRANES, V1768, P1179, DOI 10.1016/j.bbamem.2007.02.015; Mertens J, 2008, NAT NANOTECHNOL, V3, P301, DOI 10.1038/nnano.2008.91; Pera I, 2007, LANGMUIR, V23, P1543, DOI 10.1021/la0624337; Popplewell JF, 2007, BBA-BIOMEMBRANES, V1768, P13, DOI 10.1016/j.bbamem.2006.05.016; Raghuraman H, 2007, BIOSCIENCE REP, V27, P189, DOI 10.1007/s10540-006-9030-z; Rakhmatullina E, 2008, LANGMUIR, V24, P6254, DOI 10.1021/la8003068; Reimhult E, 2004, ANAL CHEM, V76, P7211, DOI 10.1021/ac0492970; Rex S, 1998, BIOCHEMISTRY-US, V37, P2336, DOI 10.1021/bi971009p; Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523; Sader JE, 2001, J APPL PHYS, V89, P2911, DOI 10.1063/1.1342018; SCHWARZ G, 1995, BBA-BIOMEMBRANES, V1239, P51, DOI 10.1016/0005-2736(95)00134-O; Stromstedt AA, 2007, J COLLOID INTERF SCI, V311, P59, DOI 10.1016/j.jcis.2007.02.070; Watari M, 2007, J AM CHEM SOC, V129, P601, DOI 10.1021/ja065222x; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Zhang J, 2006, NAT NANOTECHNOL, V1, P214, DOI 10.1038/nnano.2006.134	35	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3610	10.1371/journal.pone.0003610	http://dx.doi.org/10.1371/journal.pone.0003610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978938	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000265134200005
J	Chen, ZQ; Harb, OS; Roos, DS				Chen, ZhongQiang; Harb, Omar S.; Roos, David S.			In Silico Identification of Specialized Secretory-Organelle Proteins in Apicomplexan Parasites and In Vivo Validation in Toxoplasma gondii	PLOS ONE			English	Article							HOST-CELL INVASION; INTERCELLULAR-ADHESION MOLECULE-1; PLASMODIUM-FALCIPARUM PROTEINS; SARCOCYSTIS-MURIS APICOMPLEXA; DOMAIN-CONTAINING PROTEIN; APICAL MEROZOITE PROTEIN; MICRONEME PROTEIN; GROWTH-FACTOR; PROTEOMIC ANALYSIS; ANONYMOUS PROTEIN	Apicomplexan parasites, including the human pathogens Toxoplasma gondii and Plasmodium falciparum, employ specialized secretory organelles (micronemes, rhoptries, dense granules) to invade and survive within host cells. Because molecules secreted from these organelles function at the host/parasite interface, their identification is important for understanding invasion mechanisms, and central to the development of therapeutic strategies. Using a computational approach based on predicted functional domains, we have identified more than 600 candidate secretory organelle proteins in twelve apicomplexan parasites. Expression in transgenic T. gondii of eight proteins identified in silico confirms that all enter into the secretory pathway, and seven target to apical organelles associated with invasion. An in silico approach intended to identify possible host interacting proteins yields a dataset enriched in secretory/transmembrane proteins, including most of the antigens known to be engaged by apicomplexan parasites during infection. These domain pattern and projected interactome approaches significantly expand the repertoire of proteins that may be involved in host parasite interactions.	[Chen, ZhongQiang; Harb, Omar S.; Roos, David S.] Univ Penn, Penn Genom Frontiers Inst, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Harb, OS (corresponding author), Univ Penn, Penn Genom Frontiers Inst, Dept Biol, Philadelphia, PA 19104 USA.	oharb@sas.upenn.edu; droos@sas.upenn.edu	Chen, Zhongqiang/Y-5954-2018	Roos, David Siker/0000-0001-6725-4089; Harb, Omar/0000-0003-4446-6200	US National Institutes of Health; Penn Genome Frontiers Institute; Pennsylvania Department of Health	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Genome Frontiers Institute; Pennsylvania Department of Health	This research was supported by grants from the US National Institutes of Health, the Penn Genome Frontiers Institute, and the Pennsylvania Department of Health, although the authors alone are responsible for the analyses, interpretations, and conclusions described herein.	ACHBAROU A, 1991, MOL BIOCHEM PARASIT, V47, P223, DOI 10.1016/0166-6851(91)90182-6; Baglia FA, 1996, J BIOL CHEM, V271, P3652; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Barale JC, 1999, P NATL ACAD SCI USA, V96, P6445, DOI 10.1073/pnas.96.11.6445; Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Black CG, 2003, MOL BIOCHEM PARASIT, V127, P59, DOI 10.1016/S0166-6851(02)00308-0; Black CG, 2001, MOL BIOCHEM PARASIT, V114, P217, DOI 10.1016/S0166-6851(01)00265-1; Blumenschein TMA, 2007, EMBO J, V26, P2808, DOI 10.1038/sj.emboj.7601704; BONNIN A, 1991, INFECT IMMUN, V59, P1703, DOI 10.1128/IAI.59.5.1703-1708.1991; BORK P, 1991, BIOCHEM J, V279, P908, DOI 10.1042/bj2790908; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Brown PJ, 2000, MOL BIOCHEM PARASIT, V107, P91, DOI 10.1016/S0166-6851(00)00179-1; Brydges SD, 2000, MOL BIOCHEM PARASIT, V111, P51, DOI 10.1016/S0166-6851(00)00296-6; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; Carruthers VB, 2005, MOL MICROBIOL, V55, P1617, DOI 10.1111/j.1365-2958.2005.04483.x; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Carruthers Vern B., 1999, Parasitology International, V48, P1; Carruthers VB, 2006, INT J PARASITOL, V36, P595, DOI 10.1016/j.ijpara.2006.02.008; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; DAVIS FP, 2007, PROTEIN SCI; Di Cristina M, 2000, MOL CELL BIOL, V20, P7332, DOI 10.1128/MCB.20.19.7332-7341.2000; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Dowse T, 2004, CURR OPIN MICROBIOL, V7, P388, DOI 10.1016/j.mib.2004.06.013; Dowse TJ, 2005, INT J PARASITOL, V35, P747, DOI 10.1016/j.ijpara.2005.04.001; DUBREMETZ JF, 1980, MOL BIOCHEM PARASIT, V1, P279, DOI 10.1016/0166-6851(80)90061-4; DUBREMETZ JF, 1989, PARASITOL RES, V75, P449, DOI 10.1007/BF00930971; Dyer MD, 2007, BIOINFORMATICS, V23, pI159, DOI 10.1093/bioinformatics/btm208; ESCHENBACHER KH, 1993, MOL BIOCHEM PARASIT, V62, P27, DOI 10.1016/0166-6851(93)90174-V; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Florens L, 2004, MOL BIOCHEM PARASIT, V135, P1, DOI 10.1016/j.molbiopara.2003.12.007; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gaffar FR, 2004, MOL BIOCHEM PARASIT, V136, P25, DOI 10.1016/j.molbiopara.2004.02.006; Ghoneim A, 2007, PARASITOL INT, V56, P31, DOI 10.1016/j.parint.2006.11.001; Green JL, 2006, MOL BIOCHEM PARASIT, V150, P114, DOI 10.1016/j.molbiopara.2006.06.010; Harb OS, 2004, EUKARYOT CELL, V3, P663, DOI 10.1128/EC.3.3.663-674.2004; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hoppe HC, 2000, NAT CELL BIOL, V2, P449, DOI 10.1038/35017090; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; Huynh MH, 2006, PARASITOL RES, V98, P389, DOI 10.1007/s00436-005-0062-2; Huynh MH, 2004, CELL MICROBIOL, V6, P771, DOI 10.1111/j.1462-5822.2004.00403.x; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Joiner KA, 2002, J CELL BIOL, V157, P557, DOI 10.1083/jcb.200112144; KATO H, 1991, BIOCHEMISTRY-US, V30, P11687, DOI 10.1021/bi00114a012; Kawase O, 2007, PROTEOMICS, V7, P3718, DOI 10.1002/pmic.200700362; Keller N, 2004, INFECT IMMUN, V72, P4791, DOI 10.1128/IAI.72.8.4791-4800.2004; KELLEY MR, 1987, CELL, V51, P539, DOI 10.1016/0092-8674(87)90123-1; Klabunde J, 2002, PARASITOL RES, V88, P113, DOI 10.1007/s00436-001-0518-y; Klein H, 1996, PARASITOL RES, V82, P230, DOI 10.1007/s004360050101; Labaied M, 2007, MOL BIOCHEM PARASIT, V153, P158, DOI 10.1016/j.molbiopara.2007.03.001; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; LEVINE ND, 1988, J PROTOZOOL, V35, P518, DOI 10.1111/j.1550-7408.1988.tb04141.x; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Liu Q, 2008, BIOINFORMATICS, V24, P597, DOI 10.1093/bioinformatics/btn004; Madera M, 2002, NUCLEIC ACIDS RES, V30, P4321, DOI 10.1093/nar/gkf544; Marshall VM, 1997, INFECT IMMUN, V65, P4460, DOI 10.1128/IAI.65.11.4460-4467.1997; Marshall VM, 1998, MOL BIOCHEM PARASIT, V94, P13, DOI 10.1016/S0166-6851(98)00045-0; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Meissner M, 2002, J CELL SCI, V115, P563; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; MULLER HM, 1993, EMBO J, V12, P2881, DOI 10.1002/j.1460-2075.1993.tb05950.x; Naitza S, 1998, PARASITOL TODAY, V14, P479, DOI 10.1016/S0169-4758(98)01346-5; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; O'Keeffe AH, 2005, MOL BIOCHEM PARASIT, V140, P61, DOI 10.1016/j.molbiopara.2004.12.003; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; Opitz C, 2002, MOL MICROBIOL, V45, P597, DOI 10.1046/j.1365-2958.2002.03056.x; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; PETERSON DS, 1995, P NATL ACAD SCI USA, V92, P7100, DOI 10.1073/pnas.92.15.7100; Petry F, 1999, INT J PARASITOL, V29, P1249, DOI 10.1016/S0020-7519(99)00080-6; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Rodriguez LE, 2000, PARASITOLOGY, V120, P225, DOI 10.1017/S003118209900551X; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Sam-Yellowe TY, 2004, J PROTEOME RES, V3, P995, DOI 10.1021/pr049926m; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; SHEINER L, 2008, TRAFFIC; Sibley LD, 1998, CURR BIOL, V8, pR12, DOI 10.1016/S0960-9822(98)70008-9; Singh S, 2007, P NATL ACAD SCI USA, V104, P20043, DOI 10.1073/pnas.0709999104; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Spano F, 1998, MOL BIOCHEM PARASIT, V92, P147, DOI 10.1016/S0166-6851(97)00243-0; Striepen B, 2001, MOL BIOCHEM PARASIT, V113, P45, DOI 10.1016/S0166-6851(00)00379-0; Templeton TJ, 2007, TRENDS PARASITOL, V23, P205, DOI 10.1016/j.pt.2007.03.001; Thompson J, 2004, MOL BIOCHEM PARASIT, V134, P225, DOI 10.1016/j.molbiopara.2003.12.003; Tomley FM, 2001, TRENDS PARASITOL, V17, P81, DOI 10.1016/S1471-4922(00)01761-X; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; Treutiger CJ, 1997, NAT MED, V3, P1405, DOI 10.1038/nm1297-1405; Vincensini L, 2005, MOL CELL PROTEOMICS, V4, P582, DOI 10.1074/mcp.M400176-MCP200; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yarovinsky F, 2006, INT J PARASITOL, V36, P255, DOI 10.1016/j.ijpara.2005.12.003; Yuda M, 2001, MOL BIOCHEM PARASIT, V116, P65, DOI 10.1016/S0166-6851(01)00304-8; Zhou XW, 2005, J BIOL CHEM, V280, P34233, DOI 10.1074/jbc.M504160200	107	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3611	10.1371/journal.pone.0003611	http://dx.doi.org/10.1371/journal.pone.0003611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974850	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131700026
J	Critchfield, JW; Young, DH; Hayes, TL; Braun, JV; Garcia, JC; Pollard, RB; Shacklett, BL				Critchfield, J. William; Young, Delandy H.; Hayes, Timothy L.; Braun, Jerome V.; Garcia, Juan C.; Pollard, Richard B.; Shacklett, Barbara L.			Magnitude and Complexity of Rectal Mucosa HIV-1-Specific CD8+T-Cell Responses during Chronic Infection Reflect Clinical Status	PLOS ONE			English	Article								Background: The intestinal mucosa displays robust virus replication and pronounced CD4+ T-cell loss during acute human immunodeficiency virus type 1 (HIV-1) infection. The ability of HIV-specific CD8+ T-cells to modulate disease course has prompted intensive study, yet the significance of virus-specific CD8+ T-cells in mucosal sites remains unclear. Methods and Findings: We evaluated five distinct effector functions of HIV gag-specific CD8+ T-cells in rectal mucosa and blood, individually and in combination, in relationship to clinical status and antiretroviral therapy ( ART). In subjects not on ART, the percentage of rectal Gag-specific CD8+ T- cells capable of 3, 4 or 5 simultaneous effector functions was significantly related to blood CD4 count and inversely related to plasma viral load (PVL) (p<0.05). Polyfunctional rectal CD8+ T-cells expressed higher levels of MIP-1b and CD107a on a per cell basis than mono- or bifunctional cells. The production of TNF alpha, IFN-gamma, and CD107a by Gag-specific rectal CD8+ T-cells each correlated inversely (p<0.05) with PVL, and MIP-1b expression revealed a similar trend. CD107a and IFN-gamma production were positively related to blood CD4 count (p<0.05), with MIP-1b showing a similar trend. IL-2 production by rectal CD8+ T-cells was highly variable and generally low, and showed no relationship to viral load or blood CD4 count. Conclusions: The polyfunctionality of rectal Gag-specific CD8+ T-cells appears to be related to blood CD4 count and inversely related to PVL. The extent to which these associations reflect causality remains to be determined; nevertheless, our data suggest a potentially important role for mucosal T-cells in limiting virus replication during chronic infection.	[Critchfield, J. William; Young, Delandy H.; Hayes, Timothy L.; Shacklett, Barbara L.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Braun, Jerome V.] Univ Calif Davis, Dept Stat, Davis, CA USA; [Garcia, Juan C.] Univ Calif Davis, Sch Med, Div Gastroenterol, Dept Med, Sacramento, CA USA; [Pollard, Richard B.; Shacklett, Barbara L.] Univ Calif Davis, Sch Med, Div Infect Dis, Dept Med, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Critchfield, JW (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	blshacklett@ucdavis.edu	Shacklett, Barbara/A-7288-2009	Shacklett, Barbara/0000-0002-7067-732X; Braun, Jerome/0000-0003-1348-908X	National Institutes of Health, NIAID [R01 AI057020]; California HIV/AIDS Research Program [CH05-D-606]; Research Facilities Improvement Program, National Center for Research Resources, National Institutes of Health [C06 RR-12088-01]; James B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057020] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); California HIV/AIDS Research Program; Research Facilities Improvement Program, National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); James B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the National Institutes of Health (NIH-NIAID R01 AI057020) and the California HIV/AIDS Research Program (CH05-D-606). This investigation was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR-12088-01 from the National Center for Research Resources, National Institutes of Health. The LSR-II violet laser was upgraded with funding from the James B. Pendleton Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; Critchfield JW, 2007, J VIROL, V81, P5460, DOI 10.1128/JVI.02535-06; Dalod M, 1999, J VIROL, V73, P7108, DOI 10.1128/JVI.73.9.7108-7116.1999; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; EMU B, 2008, J VIROL; FETTERHOFF TJ, 1993, CYTOMETRY S6, V6, P27; Geldmacher C, 2007, J VIROL, V81, P13809, DOI 10.1128/JVI.01566-07; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Lopez M, 2008, EUR J IMMUNOL, V38, P1548, DOI 10.1002/eji.200738054; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; McGowan I, 2004, JAIDS-J ACQ IMM DEF, V37, P1228, DOI 10.1097/01.qai.0000131846.12453.29; McGowan I, 2007, JAIDS-J ACQ IMM DEF, V46, P417, DOI 10.1097/QAI.0b013e318156ef16; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; Ng HKT, 2005, STAT MED, V24, P955, DOI 10.1002/sim.1949; Novitsky VA, 2006, VIROLOGY, V349, P142, DOI 10.1016/j.virol.2006.02.006; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Ogg GS, 1999, J VIROL, V73, P797, DOI 10.1128/JVI.73.1.797-800.1999; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Roederer M, 2008, CYTOM PART A, V73A, P384, DOI 10.1002/cyto.a.20549; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shacklett BL, 2004, J IMMUNOL, V173, P641, DOI 10.4049/jimmunol.173.1.641; Shacklett BL, 2003, J IMMUNOL METHODS, V279, P17, DOI 10.1016/S0022-1759(03)00255-2; Shacklett BL, 2003, J VIROL, V77, P5621, DOI 10.1128/JVI.77.10.5621-5631.2003; Wang HC, 2002, J IMMUNOL, V169, P4717, DOI 10.4049/jimmunol.169.9.4717; Wodarz D, 2001, P ROY SOC B-BIOL SCI, V268, P1215, DOI 10.1098/rspb.2001.1608; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	46	48	49	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3577	10.1371/journal.pone.0003577	http://dx.doi.org/10.1371/journal.pone.0003577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974782	Green Published, gold			2022-12-27	WOS:000265131500008
J	Holmes, NP; Spence, C; Hansen, PC; Mackay, CE; Calvert, GA				Holmes, Nicholas P.; Spence, Charles; Hansen, Peter C.; Mackay, Clare E.; Calvert, Gemma A.			The Multisensory Attentional Consequences of Tool Use: A Functional Magnetic Resonance Imaging Study	PLOS ONE			English	Article								Background: Tool use in humans requires that multisensory information is integrated across different locations, from objects seen to be distant from the hand, but felt indirectly at the hand via the tool. We tested the hypothesis that using a simple tool to perceive vibrotactile stimuli results in the enhanced processing of visual stimuli presented at the distal, functional part of the tool. Such a finding would be consistent with a shift of spatial attention to the location where the tool is used. Methodology/Principal Findings: We tested this hypothesis by scanning healthy human participants' brains using functional magnetic resonance imaging, while they used a simple tool to discriminate between target vibrations, accompanied by congruent or incongruent visual distractors, on the same or opposite side to the tool. The attentional hypothesis was supported: BOLD response in occipital cortex, particularly in the right hemisphere lingual gyrus, varied significantly as a function of tool position, increasing contralaterally, and decreasing ipsilaterally to the tool. Furthermore, these modulations occurred despite the fact that participants were repeatedly instructed to ignore the visual stimuli, to respond only to the vibrotactile stimuli, and to maintain visual fixation centrally. In addition, the magnitude of multisensory (visual-vibrotactile) interactions in participants' behavioural responses significantly predicted the BOLD response in occipital cortical areas that were also modulated as a function of both visual stimulus position and tool position. Conclusions/Significance: These results show that using a simple tool to locate and to perceive vibrotactile stimuli is accompanied by a shift of spatial attention to the location where the functional part of the tool is used, resulting in enhanced processing of visual stimuli at that location, and decreased processing at other locations. This was most clearly observed in the right hemisphere lingual gyrus. Such modulations of visual processing may reflect the functional importance of visuospatial information during human tool use.	[Holmes, Nicholas P.; Spence, Charles] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Holmes, Nicholas P.] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; [Hansen, Peter C.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Mackay, Clare E.] Univ Oxford, Ctr Clin Magnet Resonance Res, John Radcliffe Hosp, Dept Psychiat, Oxford OX1 2JD, England; [Calvert, Gemma A.] Univ Warwick, Int Manufacturing Ctr, Warwick Manufacturing Grp, Coventry CV4 7AL, W Midlands, England	University of Oxford; Hebrew University of Jerusalem; University of Birmingham; University of Oxford; University of Warwick	Holmes, NP (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	npholmes@neurobiography.info	Hansen, Peter C/F-3163-2010; Holmes, Nicholas Paul/N-3991-2014	Hansen, Peter C/0000-0002-4948-1007; Holmes, Nicholas Paul/0000-0001-9268-4179; Calvert, Gemma/0000-0002-5487-8076; Mackay, Clare/0000-0001-6111-8318	Wellcome Trust [Studentship]; Royal Commission for the Exhibition of 1851 [Science Research Fellowship]	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Commission for the Exhibition of 1851	NPH was supported by a Wellcome Trust Studentship, and a Science Research Fellowship from the Royal Commission for the Exhibition of 1851.	Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Beauchamp MS, 2005, NEUROINFORMATICS, V3, P93, DOI 10.1385/NI:3:2:093; Beck B. B., 1980, ANIMAL TOOL BEHAV US; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Bonifazi S, 2007, J NEUROPSYCHOL, V1, P101, DOI 10.1348/174866407X180846; Brisben AJ, 1999, J NEUROPHYSIOL, V81, P1548, DOI 10.1152/jn.1999.81.4.1548; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Farne A, 2005, COGN NEUROPSYCHOL, V22, P408, DOI 10.1080/02643290442000112; Farne A, 2005, NEUROPSYCHOLOGIA, V43, P238, DOI 10.1016/j.neuropsychologia.2004.11.010; Farne A, 2000, NEUROREPORT, V11, P1645, DOI 10.1097/00001756-200006050-00010; Farne A, 2007, CORTEX, V43, P436, DOI 10.1016/S0010-9452(08)70468-4; Forti S, 2004, J GEN PSYCHOL, V131, P379; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Hansen KA, 2004, NEUROIMAGE, V23, P233, DOI 10.1016/j.neuroimage.2004.05.012; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; Holmes N. P., 2006, HUMAN BODY PERCEPTIO, P15; Holmes NP, 2007, EXP BRAIN RES, V183, P465, DOI 10.1007/s00221-007-1060-7; Holmes NP, 2007, CORTEX, V43, P469, DOI 10.1016/S0010-9452(08)70471-4; Holmes NP, 2006, BRAIN RES, V1077, P108, DOI 10.1016/j.brainres.2005.11.010; Holmes NP, 2004, NEUROSCI LETT, V372, P62, DOI 10.1016/j.neulet.2004.09.024; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; Lloyd D, 2006, J NEUROPHYSIOL, V95, P205, DOI 10.1152/jn.00614.2005; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; Macaluso E, 2005, NEUROIMAGE, V26, P414, DOI 10.1016/j.neuroimage.2005.02.002; Macaluso E, 2003, EXP BRAIN RES, V149, P62, DOI 10.1007/s00221-002-1335-y; Macaluso E, 2003, CURR BIOL, V13, P990, DOI 10.1016/S0960-9822(03)00377-4; Macaluso E, 2002, J COGNITIVE NEUROSCI, V14, P389, DOI 10.1162/089892902317361912; Macaluso E, 2000, J NEUROPHYSIOL, V83, P3062, DOI 10.1152/jn.2000.83.5.3062; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Maravita A, 2002, COGNITION, V83, pB25, DOI 10.1016/S0010-0277(02)00003-3; Maravita A, 2001, NEUROPSYCHOLOGIA, V39, P580, DOI 10.1016/S0028-3932(00)00150-0; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Mendola JD, 1999, J NEUROSCI, V19, P8560; Nachev P, 2006, CURR OPIN NEUROL, V19, P586, DOI 10.1097/01.wco.0000247609.36482.ae; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pinsk MA, 2004, J NEUROPHYSIOL, V92, P622, DOI 10.1152/jn.00974.2003; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Shomstein S, 2006, J NEUROSCI, V26, P435, DOI 10.1523/JNEUROSCI.4408-05.2006; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spence C, 2004, J PHYSIOL-PARIS, V98, P171, DOI 10.1016/j.jphysparis.2004.03.008; SPENCE C, 2008, HAPTIC RENDERING FDN, P21, DOI DOI 10.1201/B10636-4; St Amant R, 2008, ANIM BEHAV, V75, P1199, DOI 10.1016/j.anbehav.2007.09.028; Tanabe HC, 2005, COGNITIVE BRAIN RES, V22, P385, DOI 10.1016/j.cogbrainres.2004.09.010; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Vandenberghe R, 1997, J NEUROSCI, V17, P3739; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Yamamoto S, 2001, NAT NEUROSCI, V4, P979, DOI 10.1038/nn721	59	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3502	10.1371/journal.pone.0003502	http://dx.doi.org/10.1371/journal.pone.0003502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958150	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000265131100003
J	Wringe, A; Fine, PEM; Sutter, RW; Kew, OM				Wringe, Alison; Fine, Paul E. M.; Sutter, Roland W.; Kew, Olen M.			Estimating the Extent of Vaccine-Derived Poliovirus Infection	PLOS ONE			English	Article								Background: Eight outbreaks of paralytic polio attributable to circulating vaccine-derived poliovirus (cVDPV) have highlighted the risks associated with oral poliovirus vaccine (OPV) use in areas of low vaccination coverage and poor hygiene. As the Polio Eradication Initiative enters its final stages, it is important to consider the extent to which these viruses spread under different conditions, so that appropriate strategies can be devised to prevent or respond to future cVDPV outbreaks. Methods and Findings: This paper examines epidemiological (temporal, geographic, age, vaccine history, social group, ascertainment), and virological (type, genetic diversity, virulence) parameters in order to infer the numbers of individuals likely to have been infected in each of these cVDPV outbreaks, and in association with single acute flaccid paralysis (AFP) cases attributable to VDPVs. Although only 114 virologically-confirmed paralytic cases were identified in the eight cVDPV outbreaks, it is likely that a minimum of hundreds of thousands, and more likely several million individuals were infected during these events, and that many thousands more have been infected by VDPV lineages within outbreaks which have escaped detection. Conclusions: Our estimates of the extent of cVDPV circulation suggest widespread transmission in some countries, as might be expected from endemic wild poliovirus transmission in these same settings. These methods for inferring extent of infection will be useful in the context of identifying future surveillance needs, planning for OPV cessation and preparing outbreak response plans.	[Wringe, Alison; Fine, Paul E. M.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Sutter, Roland W.] World Hlth Org, Polio Eradicat Dept, Geneva, Switzerland; [Kew, Olen M.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA	University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Centers for Disease Control & Prevention - USA	Wringe, A (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	alison.wringe@lshtm.ac.uk			Polio Eradication Initiative of the World Health Organisation	Polio Eradication Initiative of the World Health Organisation	This work was supported by the Polio Eradication Initiative of the World Health Organisation.	ANDRUS JK, 1995, B WORLD HEALTH ORGAN, V73, P33; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1093; Aylward RB, 1997, J INFECT DIS, V175, pS56, DOI 10.1093/infdis/175.Supplement_1.S56; Bellmunt A, 1999, VIROLOGY, V265, P178, DOI 10.1006/viro.1999.0003; BENYESHM.M, 1967, AM J EPIDEMIOL, V86, P112, DOI 10.1093/oxfordjournals.aje.a120717; BERNIER RH, 1984, REV INFECT DIS, V6, pS371; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; BOUCHARD MJ, 1995, J VIROL, V69, P4972, DOI 10.1128/JVI.69.8.4972-4978.1995; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P855; Cherkasova EA, 2002, J VIROL, V76, P6791, DOI 10.1128/JVI.76.13.6791-6799.2002; Chiba Y, 2003, JPN J INFECT DIS, V56, P181; de Oliveira L H, 2000, Rev Panam Salud Publica, V7, P219; Dowdle W, 2006, RISK ANAL, V26, P1449, DOI 10.1111/j.1539-6924.2006.00844.x; Estivariz CF, 2008, J INFECT DIS, V197, P347, DOI 10.1086/525049; Fine P E, 2001, Dev Biol (Basel), V105, P129; FINE PE, 2001, DEV BIOL BASEL, V105, P149; Fine PEM, 2004, B WORLD HEALTH ORGAN, V82, P47; Fine PEM, 1999, AM J EPIDEMIOL, V150, P1001, DOI 10.1093/oxfordjournals.aje.a009924; Gavrilin GV, 2000, J VIROL, V74, P7381, DOI 10.1128/JVI.74.16.7381-7390.2000; GELFAND HM, 1957, AM J HYG, V65, P367, DOI 10.1093/oxfordjournals.aje.a119876; Georgescu MM, 1997, J VIROL, V71, P7758, DOI 10.1128/JVI.71.10.7758-7768.1997; Grassly NC, 2007, LANCET, V369, P1356, DOI 10.1016/S0140-6736(07)60531-5; JOCE R, 1992, BRIT MED J, V305, P79, DOI 10.1136/bmj.305.6845.79; JOHN TJ, 1972, AM J EPIDEMIOL, V96, P263, DOI 10.1093/oxfordjournals.aje.a121457; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kew OM, 1998, J CLIN MICROBIOL, V36, P2893, DOI 10.1128/JCM.36.10.2893-2899.1998; Kohler KA, 2002, B WORLD HEALTH ORGAN, V80, P210; Korotkova EA, 2003, J VIROL, V77, P12460, DOI 10.1128/JVI.77.23.12460-12465.2003; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; MacCallum F O, 1971, Spec Rep Ser Med Res Counc (G B), V310, P72; MacLennan C, 2004, LANCET, V363, P1509, DOI 10.1016/S0140-6736(04)16150-3; Martin J, 2000, J VIROL, V74, P3001, DOI 10.1128/JVI.74.7.3001-3010.2000; MELNICK JL, 1953, AM J HYG, V58, P207, DOI 10.1093/oxfordjournals.aje.a119602; MINOR PD, 1988, J GEN VIROL, V69, P1091, DOI 10.1099/0022-1317-69-5-1091; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; NKOWANE BM, 1987, JAMA-J AM MED ASSOC, V257, P1335, DOI 10.1001/jama.257.10.1335; Patriarca PA, 1997, J INFECT DIS, V175, pS165, DOI 10.1093/infdis/175.Supplement_1.S165; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; POLLARD SR, 1989, J VIROL, V63, P4949, DOI 10.1128/JVI.63.11.4949-4951.1989; Rakoto-Andrianarivelo M, 2008, J INFECT DIS, V197, P1427, DOI 10.1086/587694; REN R, 1991, J VIROL, V65, P1377, DOI 10.1128/JVI.65.3.1377-1382.1991; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004; Shulman LM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000069; Shulman LM, 2000, J CLIN MICROBIOL, V38, P3729, DOI 10.1128/JCM.38.10.3729-3734.2000; STREBEL PM, 1992, CLIN INFECT DIS, V14, P568, DOI 10.1093/clinids/14.2.568; SUTTER R, VACCINES; *UN HAB, UN HAB POP STAT; Vinje J, 2004, J INFECT DIS, V189, P1168, DOI 10.1086/382545; WESTROP GD, 1989, J VIROL, V63, P1338, DOI 10.1128/JVI.63.3.1338-1344.1989; Wood DJ, 2000, B WORLD HEALTH ORGAN, V78, P347; World Health Organization, 2008, COR HLTH IND; Yang CF, 2005, J VIROL, V79, P12623, DOI 10.1128/JVI.79.20.12623-12634.2005; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; 2004, MMWR MORB MORTAL WKL, V53, P820; 2003, MMWR MORB MORTAL WKL, V52, P252; 2002, WKLY EPIDEMIOL REC, V77, P133; 2003, MMWR MORB MORTAL WKL, V52, P913; 2001, MMWR MORB MORTAL WKL, V50, P874; 2005, MMWR MORB MORTAL WKL, V54, P1053; 2005, POLIOMYELITIS SURVEI; 2007, MMWR MORB MORTAL WKL, V56, P996	64	40	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3433	10.1371/journal.pone.0003433	http://dx.doi.org/10.1371/journal.pone.0003433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958288	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000265131100001
J	Salmela, E; Lappalainen, T; Fransson, I; Andersen, PM; Dahlman-Wright, K; Fiebig, A; Sistonen, P; Savontaus, ML; Schreiber, S; Kere, J; Lahermo, P				Salmela, Elina; Lappalainen, Tuuli; Fransson, Ingegerd; Andersen, Peter M.; Dahlman-Wright, Karin; Fiebig, Andreas; Sistonen, Pertti; Savontaus, Marja-Liisa; Schreiber, Stefan; Kere, Juha; Lahermo, Paivi			Genome-Wide Analysis of Single Nucleotide Polymorphisms Uncovers Population Structure in Northern Europe	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; GENETIC SUBSTRUCTURE; GENOTYPE; FINLAND; FINNS; STRATIFICATION; HAPLOTYPE; PACKAGE; SWEDEN; BIAS	Background: Genome-wide data provide a powerful tool for inferring patterns of genetic variation and structure of human populations. Principal Findings: In this study, we analysed almost 250,000 SNPs from a total of 945 samples from Eastern and Western Finland, Sweden, Northern Germany and Great Britain complemented with HapMap data. Small but statistically significant differences were observed between the European populations (F-ST = 0.0040, p < 10(-4)), also between Eastern and Western Finland (F-ST = 0.0032, p < 10(-3)). The latter indicated the existence of a relatively strong autosomal substructure within the country, similar to that observed earlier with smaller numbers of markers. The Germans and British were less differentiated than the Swedes, Western Finns and especially the Eastern Finns who also showed other signs of genetic drift. This is likely caused by the later founding of the northern populations, together with subsequent founder and bottleneck effects, and a smaller population size. Furthermore, our data suggest a small eastern contribution among the Finns, consistent with the historical and linguistic background of the population. Significance: Our results warn against a priori assumptions of homogeneity among Finns and other seemingly isolated populations. Thus, in association studies in such populations, additional caution for population structure may be necessary. Our results illustrate that population history is often important for patterns of genetic variation, and that the analysis of hundreds of thousands of SNPs provides high resolution also for population genetics.	[Salmela, Elina; Kere, Juha] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Salmela, Elina; Lappalainen, Tuuli; Lahermo, Paivi] Univ Helsinki, Inst Mol Med Finland, Finnish Genome Ctr, FIN-00014 Helsinki, Finland; [Fransson, Ingegerd; Dahlman-Wright, Karin; Kere, Juha] Karolinska Univ Hosp, Clin Res Ctr, Huddinge, Sweden; [Fransson, Ingegerd; Dahlman-Wright, Karin; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Andersen, Peter M.] Umea Univ, Hosp, Dept Neurol, S-90187 Umea, Sweden; [Fiebig, Andreas] Univ Kiel, Inst Clin Mol Biol, Popgen Biobank, Kiel, Germany; [Sistonen, Pertti] Finnish Red Cross Blood Transfusion Ctr, Helsinki, Finland; [Savontaus, Marja-Liisa] Univ Turku, Dept Med Genet, SF-20500 Turku, Finland; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Dept Gen Internal Med, Kiel, Germany; [Kere, Juha] Biomed Helsinki, Folkhalsan Inst Genet, Helsinki, Finland	University of Helsinki; University of Helsinki; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Umea University; University of Kiel; University of Turku; University of Kiel; University of Helsinki	Salmela, E (corresponding author), Univ Helsinki, Dept Med Genet, Helsinki, Finland.	paivi.lahermo@helsinki.fi	Kere, Juha/A-9179-2008; Lappalainen, Tuuli/AAE-6532-2020; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Lappalainen, Tuuli/0000-0002-7746-8109; Kere, Juha/0000-0003-1974-0271; Salmela, Elina/0000-0003-1326-4462	Emil Aaltonen foundation; Research Foundation of the University of Helsinki; Graduate School in Computational Biology, Bioinformatics, and Biometry; Sigrid Juselius Foundation; Academy of Finland; Swedish Research Council; Finnish Cultural Foundation; National Genome Research Network (NGFN); German Ministry of Education and Science; DFG; Wellcome Trust [076113]	Emil Aaltonen foundation; Research Foundation of the University of Helsinki; Graduate School in Computational Biology, Bioinformatics, and Biometry; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Swedish Research Council(Swedish Research CouncilEuropean Commission); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); National Genome Research Network (NGFN); German Ministry of Education and Science; DFG(German Research Foundation (DFG)); Wellcome Trust(Wellcome Trust)	Emil Aaltonen foundation (PL, TL), Research Foundation of the University of Helsinki (TL), Graduate School in Computational Biology, Bioinformatics, and Biometry (ES), Sigrid Juselius Foundation (JK), Academy of Finland (JK), Swedish Research Council (JK), Finnish Cultural Foundation (TL, PL), National Genome Research Network (NGFN) and the popgen biobank, both through the German Ministry of Education and Science (AF, SS), DFG excellence cluster "inflammation at interfaces" (SS). Funding for the WTCCC project was provided by the Wellcome Trust under award 076113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULCHENKO Y, 2008, GENABEL GENOME WIDE; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; BUSE DK, 2005, REGIONS GERMANY; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Einarsdottir E, 2007, HEREDITAS, V144, P171, DOI 10.1111/j.2007.0018-0661.02007.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hannelius U, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-54; Hedman A, 2004, FORENSIC SCI INT, V142, P37, DOI 10.1016/j.forsciint.2003.07.003; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kaessmann H, 2002, AM J HUM GENET, V70, P673, DOI 10.1086/339258; Karlsson AO, 2006, EUR J HUM GENET, V14, P963, DOI 10.1038/sj.ejhg.5201651; Kayser M, 2005, HUM GENET, V117, P428, DOI 10.1007/s00439-005-1333-9; Kere J, 2001, ANNU REV GENOM HUM G, V2, P103, DOI 10.1146/annurev.genom.2.1.103; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Kristiansson K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-109; Lahermo P, 1999, EUR J HUM GENET, V7, P447, DOI 10.1038/sj.ejhg.5200316; Lahermo P, 1996, AM J HUM GENET, V58, P1309; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lappalainen T, 2008, ANN HUM GENET, V72, P337, DOI 10.1111/j.1469-1809.2007.00429.x; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; Norio R, 2003, HUM GENET, V112, P441, DOI 10.1007/s00439-002-0875-3; Norio R, 2003, HUM GENET, V112, P457, DOI 10.1007/s00439-002-0876-2; NOVEMBRE J, 2008, NATURE IN PRESS, DOI DOI 10.1038/NATURE07331; NYCHKA D, 2007, FIELDS TOOLS SPATIAL, V4, P1; Pitkanen Kari, 1994, SUOMEN VAESTO, P19; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2018, R LANG ENV STAT COMP; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; SIIRIAINEN A, 2003, CAMBRIDGE HIST SCAND, P43; Steffens M, 2006, HUM HERED, V62, P20, DOI 10.1159/000095850; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Uimari P, 2005, TWIN RES HUM GENET, V8, P185, DOI 10.1375/1832427054253086; Varilo T, 2003, HUM MOL GENET, V12, P51, DOI 10.1093/hmg/ddg005; VIRTARANTAKNOWLES K, 1991, HUM HERED, V41, P248, DOI 10.1159/000154009; WORKMAN PL, 1976, AM J PHYS ANTHROPOL, V44, P341, DOI 10.1002/ajpa.1330440216	52	101	102	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3519	10.1371/journal.pone.0003519	http://dx.doi.org/10.1371/journal.pone.0003519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949038	Green Submitted, Green Published, gold			2022-12-27	WOS:000265126400005
J	Medawar, A; Virolle, T; Rostagno, P; de la Forest-Divonne, S; Gambaro, K; Rouleau, M; Aberdam, D				Medawar, Alain; Virolle, Thierry; Rostagno, Philippe; de la Forest-Divonne, Stephanie; Gambaro, Karen; Rouleau, Matthieu; Aberdam, Daniel			Delta Np63 Is Essential for Epidermal Commitment of Embryonic Stem Cells	PLOS ONE			English	Article								In vivo studies have demonstrated that p63 plays complex and pivotal roles in pluristratified squamous epithelial development, but its precise function and the nature of the isoform involved remain controversial. Here, we investigate the role of p63 in epithelial differentiation, using an in vitro ES cell model that mimics the early embryonic steps of epidermal development. We show that the Delta Np63 isoform is activated soon after treatment with BMP-4, a morphogen required to commit differentiating ES cells from a neuroectodermal to an ectodermal cell fate. Delta Np63 gene expression remains high during epithelial development. P63 loss of function drastically prevents ectodermal cells to commit to the K5/K14-positive stratified epithelial pathway while gain of function experiments show that Delta Np63 allows this commitment. Interestingly, other epithelial cell fates are not affected, allowing the production of K5/K18-positive epithelial cells. Therefore, our results demonstrate that Delta Np63 may be dispensable for some epithelial differentiation, but is necessary for the commitment of ES cells into K5/K14-positive squamous stratified epithelial cells.	[Medawar, Alain; Virolle, Thierry; Rostagno, Philippe; de la Forest-Divonne, Stephanie; Gambaro, Karen; Rouleau, Matthieu; Aberdam, Daniel] Fac Med Nice, INSERM, U898, F-06034 Nice, France; [Medawar, Alain; Virolle, Thierry; Rostagno, Philippe; de la Forest-Divonne, Stephanie; Gambaro, Karen; Rouleau, Matthieu; Aberdam, Daniel] Univ Nice, Sophia Antipolis, F-06108 Nice, France; [Aberdam, Daniel] INSERTECH, Technion, Haifa, Israel	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Medawar, A (corresponding author), Fac Med Nice, INSERM, U898, U210, F-06034 Nice, France.	aberdam@unice.fr	Virolle, Thierry/E-5838-2016; Rouleau, Matthieu/D-5774-2016; Aberdam, Daniel/G-3299-2013	Rouleau, Matthieu/0000-0002-0075-9880; Aberdam, Daniel/0000-0002-4019-5418	Sixth EEC Framework Program within the EPISTEM project [LSHB-CT-2005-019067]; Agence Nationale pour la Recherche; INSERM; Association Francaise de Dermatologie; Societe de Recherche Dermatologique (SRD); Institut National Contre le Cancer (INCa)	Sixth EEC Framework Program within the EPISTEM project; Agence Nationale pour la Recherche(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francaise de Dermatologie; Societe de Recherche Dermatologique (SRD); Institut National Contre le Cancer (INCa)(Institut National du Cancer (INCA) France)	This work was supported by the Sixth EEC Framework Program within the EPISTEM project (LSHB-CT-2005-019067), the Agence Nationale pour la Recherche "projet blanc", INSERM and Association Francaise de Dermatologie, the Societe de Recherche Dermatologique (SRD) and the Institut National Contre le Cancer (INCa).	Aberdam D, 2007, CELL CYCLE, V6, P291, DOI 10.4161/cc.6.3.3800; Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6; Cam H, 2006, CANCER CELL, V10, P281, DOI 10.1016/j.ccr.2006.08.024; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Candi E, 2006, J CELL SCI, V119, P4617, DOI 10.1242/jcs.03265; Chikh A, 2007, BIOCHEM BIOPH RES CO, V361, P1, DOI 10.1016/j.bbrc.2007.06.069; Coraux C, 2003, CURR BIOL, V13, P849, DOI 10.1016/S0960-9822(03)00296-3; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Gambaro K, 2006, CELL DEATH DIFFER, V13, P1075, DOI 10.1038/sj.cdd.4401799; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Koster MI, 2006, DEV BIOL, V289, P253, DOI 10.1016/j.ydbio.2005.10.041; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Romano RA, 2007, J INVEST DERMATOL, V127, P1175, DOI 10.1038/sj.jid.5700652; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	26	67	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3441	10.1371/journal.pone.0003441	http://dx.doi.org/10.1371/journal.pone.0003441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927616	Green Published, gold, Green Submitted			2022-12-27	WOS:000265122400011
J	Baird, NA; Etter, PD; Atwood, TS; Currey, MC; Shiver, AL; Lewis, ZA; Selker, EU; Cresko, WA; Johnson, EA				Baird, Nathan A.; Etter, Paul D.; Atwood, Tressa S.; Currey, Mark C.; Shiver, Anthony L.; Lewis, Zachary A.; Selker, Eric U.; Cresko, William A.; Johnson, Eric A.			Rapid SNP Discovery and Genetic Mapping Using Sequenced RAD Markers	PLOS ONE			English	Article								Single nucleotide polymorphism (SNP) discovery and genotyping are essential to genetic mapping. There remains a need for a simple, inexpensive platform that allows high-density SNP discovery and genotyping in large populations. Here we describe the sequencing of restriction-site associated DNA (RAD) tags, which identified more than 13,000 SNPs, and mapped three traits in two model organisms, using less than half the capacity of one Illumina sequencing run. We demonstrated that different marker densities can be attained by choice of restriction enzyme. Furthermore, we developed a barcoding system for sample multiplexing and fine mapped the genetic basis of lateral plate armor loss in threespine stickleback by identifying recombinant breakpoints in F(2) individuals. Barcoding also facilitated mapping of a second trait, a reduction of pelvic structure, by in silico re-sorting of individuals. To further demonstrate the ease of the RAD sequencing approach we identified polymorphic markers and mapped an induced mutation in Neurospora crassa. Sequencing of RAD markers is an integrated platform for SNP discovery and genotyping. This approach should be widely applicable to genetic mapping in a variety of organisms.	[Baird, Nathan A.; Etter, Paul D.; Shiver, Anthony L.; Lewis, Zachary A.; Selker, Eric U.; Johnson, Eric A.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Atwood, Tressa S.] Floragenex, Eugene, OR USA; [Currey, Mark C.; Cresko, William A.] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Baird, NA (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	eric-johnson@molbio.uoregon.edu	赵, 鹏/B-8401-2009; Cresko, William/H-4010-2014	Johnson, Eric/0000-0003-1037-4228; Lewis, Zachary/0000-0002-1735-8266; Cresko, William/0000-0002-3496-8074	National Human Genome Research Institute [R21HG003834]; National Institute of General Medical Sciences [R24GM79486, GM025690]; National Science Foundation [IOS-0642264]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG003834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025690, R24GM079486] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was supported by grant R21HG003834 from the National Human Genome Research Institute (E.A.J.), grants R24GM79486 (E.A.J. and W.A.C.) and GM025690 (E.U.S.) from the National Institute of General Medical Sciences, and grant IOS-0642264 from the National Science Foundation (W.A.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Chen D, 2008, NAT METHODS, V5, P323, DOI [10.1038/NMETH.1191, 10.1038/nmeth.1191]; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Coyne KJ, 2004, APPL ENVIRON MICROB, V70, P5298, DOI 10.1128/AEM.70.9.5298-5304.2004; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Lai CQ, 2007, NAT METHODS, V4, P839, DOI 10.1038/NMETH1084; Lewis ZA, 2007, GENETICS, V177, P1163, DOI 10.1534/genetics.107.078147; Miller MR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r105; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Stickney HL, 2002, GENOME RES, V12, P1929, DOI 10.1101/gr.777302; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	18	2220	2322	19	827	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3376	10.1371/journal.pone.0003376	http://dx.doi.org/10.1371/journal.pone.0003376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852878	Green Published, Green Submitted, gold			2022-12-27	WOS:000265121600002
J	Shi, YL; Xu, QL; Seemanaplli, SV; McShan, K; Liang, FT				Shi, Yanlin; Xu, Qilong; Seemanaplli, Sunita V.; McShan, Kristy; Liang, Fang Ting			Common and Unique Contributions of Decorin-Binding Proteins A and B to the Overall Virulence of Borrelia burgdorferi	PLOS ONE			English	Article							LYME-DISEASE; OUTER SURFACE; EXPRESSION; INFECTION; IMMUNITY; LIPOPROTEINS; PLASMID-28-1; MODEL; DBPA	As an extracellular bacterium, the Lyme disease spirochete Borrelia burgdorferi resides primarily in the extracellular matrix and connective tissues and between host cells during mammalian infection, where decorin and glycosaminoglycans are abundantly found, so its interactions with these host ligands potentially affect various aspects of infection. Decorin-binding proteins (Dbps) A and B, encoded by a 2-gene operon, are outer surface lipoproteins with similar molecular weights and share approximately 40% identity, and both bind decorin and glycosaminoglycans. To investigate how DbpA and DbpB contribute differently to the overall virulence of B. burgdorferi, a dbpAB mutant was modified to overproduce the adhesins. Overproduction of either DbpA or DbpB resulted in restoration of the infectivity of the mutant to the control level, measured by 50% infectious dose (ID50), indicating that the two virulence factors are interchangeable in this regard. Overproduction of DbpA also allowed the mutant to disseminate to some but not all distal tissues slightly slower than the control, but the mutant with DbpB overproduction showed severely impaired dissemination to all tissues that were analyzed. The mutant with DbpA overproduction colonized all tissues, albeit generating bacterial loads significantly lower than the control in heart and joint, while the mutant overproducing DbpB remained severely defective in heart colonization and registered bacterial loads substantially lower than the control in joint. Taken together, the study indicated that DbpA and DbpB play a similar role in contribution to infectivity as measured by ID50 value but contribute differently to dissemination and tissue colonization.	[Shi, Yanlin; Xu, Qilong; Seemanaplli, Sunita V.; McShan, Kristy; Liang, Fang Ting] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Shi, YL (corresponding author), Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	fliang@vetmed.lsu.edu			NIH/NIAMS; Arthritis Foundation Investigators award; NIH/NCRR [P20RR020159]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation Investigators award; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was financed by a career development award and a grant from NIH/NIAMS, an Arthritis Foundation Investigators award, and P20RR020159 from NIH/NCRR.	Barthold SW, 2006, INFECT IMMUN, V74, P4817, DOI 10.1128/IAI.00469-06; BARTHOLD SW, 1991, J INFECT DIS, V163, P419, DOI 10.1093/infdis/163.2.419; Blevins JS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-82; Brown EL, 2001, J CLIN INVEST, V107, P845, DOI 10.1172/JCI11692; BURGDORFER W, 1988, ANN NY ACAD SCI, V539, P172, DOI 10.1111/j.1749-6632.1988.tb31851.x; Cabello FC, 2007, TRENDS MICROBIOL, V15, P350, DOI 10.1016/j.tim.2007.06.003; Coburn J, 2005, MOL MICROBIOL, V57, P1182, DOI 10.1111/j.1365-2958.2005.04759.x; Cox DL, 1996, P NATL ACAD SCI USA, V93, P7973, DOI 10.1073/pnas.93.15.7973; Feng SL, 1998, INFECT IMMUN, V66, P2827, DOI 10.1128/IAI.66.6.2827-2835.1998; Fischer JR, 2003, P NATL ACAD SCI USA, V100, P7307, DOI 10.1073/pnas.1231043100; Guo BP, 1998, MOL MICROBIOL, V30, P711, DOI 10.1046/j.1365-2958.1998.01103.x; GUO BP, 1995, INFECT IMMUN, V63, P3467, DOI 10.1128/IAI.63.9.3467-3472.1995; Hagman KE, 2000, INFECT IMMUN, V68, P4759, DOI 10.1128/IAI.68.8.4759-4764.2000; Hagman KE, 1998, INFECT IMMUN, V66, P2674, DOI 10.1128/IAI.66.6.2674-2683.1998; Hanson MS, 1998, INFECT IMMUN, V66, P2143, DOI 10.1128/IAI.66.5.2143-2153.1998; JOHNSON RC, 1984, J CLIN MICROBIOL, V20, P1099, DOI 10.1128/JCM.20.6.1099-1101.1984; Labandeira-Rey M, 2003, INFECT IMMUN, V71, P4608, DOI 10.1128/IAI.71.8.4608-4613.2003; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; Liang FT, 2004, MICROB PATHOGENESIS, V37, P35, DOI 10.1016/j.micpath.2004.02.007; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schulze RJ, 2006, MOL MICROBIOL, V59, P1473, DOI 10.1111/j.1365-2958.2006.05039.x; Seiler KP, 1996, CURR OPIN IMMUNOL, V8, P503, DOI 10.1016/S0952-7915(96)80038-0; Shi YL, 2008, INFECT IMMUN, V76, P1239, DOI 10.1128/IAI.00897-07; Shi YL, 2006, INFECT IMMUN, V74, P6509, DOI 10.1128/IAI.00740-06; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; XU Q, 2008, MICROBIOLOG IN PRESS; Xu QL, 2008, MOL MICROBIOL, V69, P15, DOI 10.1111/j.1365-2958.2008.06264.x; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Xu Q, 2007, INFECT IMMUN, V75, P4272, DOI 10.1128/IAI.00560-07; Xu QL, 2005, INFECT IMMUN, V73, P7208, DOI 10.1128/IAI.73.11.7208-7215.2005	33	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3340	10.1371/journal.pone.0003340	http://dx.doi.org/10.1371/journal.pone.0003340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833332	Green Published, gold, Green Submitted			2022-12-27	WOS:000264797400009
J	Pan, JA; Peng, XX; Gao, YJ; Li, ZL; Lu, XL; Chen, YZ; Ishaq, M; Liu, D; DeDiego, ML; Enjuanes, L; Guo, DY				Pan, Ji'An; Peng, Xiaoxue; Gao, Yajing; Li, Zhilin; Lu, Xiaolu; Chen, Yingzhao; Ishaq, Musarat; Liu, Dan; DeDiego, Marta L.; Enjuanes, Luis; Guo, Deyin			Genome-Wide Analysis of Protein-Protein Interactions and Involvement of Viral Proteins in SARS-CoV Replication	PLOS ONE			English	Article								Analyses of viral protein-protein interactions are an important step to understand viral protein functions and their underlying molecular mechanisms. In this study, we adopted a mammalian two-hybrid system to screen the genome-wide intraviral protein-protein interactions of SARS coronavirus (SARS-CoV) and therefrom revealed a number of novel interactions which could be partly confirmed by in vitro biochemical assays. Three pairs of the interactions identified were detected in both directions: non-structural protein (nsp) 10 and nsp14, nsp10 and nsp16, and nsp7 and nsp8. The interactions between the multifunctional nsp10 and nsp14 or nsp16, which are the unique proteins found in the members of Nidovirales with large RNA genomes including coronaviruses and toroviruses, may have important implication for the mechanisms of replication/transcription complex assembly and functions of these viruses. Using a SARS-CoV replicon expressing a luciferase reporter under the control of a transcription regulating sequence, it has been shown that several viral proteins (N, X and SUD domains of nsp3, and nsp12) provided in trans stimulated the replicon reporter activity, indicating that these proteins may regulate coronavirus replication and transcription. Collectively, our findings provide a basis and platform for further characterization of the functions and mechanisms of coronavirus proteins.	[Pan, Ji'An; Peng, Xiaoxue; Gao, Yajing; Li, Zhilin; Lu, Xiaolu; Chen, Yingzhao; Ishaq, Musarat; Liu, Dan; Guo, Deyin] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China; [DeDiego, Marta L.; Enjuanes, Luis] Campus Univ Autonoma, Dept Mol & Cell Biol, CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Wuhan University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Pan, JA (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China.	dguo@whu.edu.cn	Li, Zhilin/AAB-2229-2020; De Diego, Marta Lopez/B-2307-2017; Li, Zhilin/D-2535-2017; Enjuanes, Luis/F-7845-2016; Guo, Deyin/A-9498-2011; Pan, Ji-An/G-6142-2012	De Diego, Marta Lopez/0000-0002-7888-7372; Li, Zhilin/0000-0003-2867-2848; Guo, Deyin/0000-0002-8297-0814; Enjuanes, Luis/0000-0002-0854-0226; Gao, Yajing/0000-0001-7878-1466	China "973" [2006CB504300]; China Natural Science Foundation [30570394]; Ministry of Education "111" project [B06018]; EU DISSECT [SP22-CT-2004-511060]; CICYT [BIO2007-60978]	China "973"(National Basic Research Program of China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education "111" project(Ministry of Education, China - 111 Project); EU DISSECT; CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT))	China "973" basic research program (grant 2006CB504300), China Natural Science Foundation (grant 30570394) and the Ministry of Education "111" project #B06018, the EU DISSECT project (SP22-CT-2004-511060) and the CICYT (BIO2007-60978) project from Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan F, 2004, J VIROL, V78, P12683, DOI 10.1128/JVI.78.22.12683-12688.2004; Almazan F, 2006, J VIROL, V80, P10900, DOI 10.1128/JVI.00385-06; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; Bhardwaj K, 2004, J VIROL, V78, P12218, DOI 10.1128/JVI.78.22.12218-12224.2004; Bhardwaj K, 2008, J BIOL CHEM, V283, P3655, DOI 10.1074/jbc.M708375200; Chen P, 2007, J BIOCHEM MOL BIOL, V40, P649; Choi IR, 2000, VIROLOGY, V267, P185, DOI 10.1006/viro.1999.0117; Decroly E, 2008, J VIROL, V82, P8071, DOI 10.1128/JVI.00407-08; DeDiego ML, 2008, VIROLOGY, V376, P379, DOI 10.1016/j.virol.2008.03.005; DeDiego ML, 2007, J VIROL, V81, P1701, DOI 10.1128/JVI.01467-06; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Donaldson EF, 2007, J VIROL, V81, P6356, DOI 10.1128/JVI.02805-06; Donaldson EF, 2007, J VIROL, V81, P7086, DOI 10.1128/JVI.00049-07; Eckerle LD, 2007, J VIROL, V81, P12135, DOI 10.1128/JVI.01296-07; Egloff MP, 2004, P NATL ACAD SCI USA, V101, P3792, DOI 10.1073/pnas.0307877101; Enjuanes L, 2006, ANNU REV MICROBIOL, V60, P211, DOI 10.1146/annurev.micro.60.080805.142157; Fielding BC, 2006, BIOCHEM BIOPH RES CO, V343, P1201, DOI 10.1016/j.bbrc.2006.03.091; Flajolet M, 2000, GENE, V242, P369, DOI 10.1016/S0378-1119(99)00511-9; Frieman MB, 2006, ADV EXP MED BIOL, V581, P149; Ginalski K, 2006, CELL CYCLE, V5, P2414, DOI 10.4161/cc.5.20.3361; Graham RL, 2005, J VIROL, V79, P13399, DOI 10.1128/JVI.79.21.13399-13411.2005; Guarino LA, 2005, J MOL BIOL, V353, P1106, DOI 10.1016/j.jmb.2005.09.007; Guo DY, 2001, J GEN VIROL, V82, P935, DOI 10.1099/0022-1317-82-4-935; Harcourt BH, 2004, J VIROL, V78, P13600, DOI 10.1128/JVI.78.24.13600-13612.2004; He RT, 2004, BIOCHEM BIOPH RES CO, V316, P476, DOI 10.1016/j.bbrc.2004.02.074; Huang C, 2007, J VIROL, V81, P5423, DOI 10.1128/JVI.02307-06; Huang C, 2006, J VIROL, V80, P7287, DOI 10.1128/JVI.00414-06; Hussain S, 2005, J VIROL, V79, P5288, DOI 10.1128/JVI.79.9.5288-5295.2005; Imbert I, 2006, EMBO J, V25, P4933, DOI 10.1038/sj.emboj.7601368; Imberta I, 2008, VIRUS RES, V133, P136, DOI 10.1016/j.virusres.2007.11.017; Ito N, 2005, J VIROL, V79, P3182, DOI 10.1128/JVI.79.5.3182-3186.2005; Ivanov KA, 2004, J VIROL, V78, P5619, DOI 10.1128/JVI.78.11.5619-5632.2004; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Joseph JS, 2007, J VIROL, V81, P6700, DOI 10.1128/JVI.02817-06; Joseph JS, 2006, J VIROL, V80, P7894, DOI 10.1128/JVI.00467-06; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Law AHY, 2007, J VIROL, V81, P416, DOI 10.1128/JVI.02336-05; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Luo Y, 1997, BIOTECHNIQUES, V22, P350, DOI 10.2144/97222pf02; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Oostra M, 2007, J VIROL, V81, P12323, DOI 10.1128/JVI.01506-07; Peti W, 2005, J VIROL, V79, P12905, DOI 10.1128/JVI.79.20.12905-12913.2005; Putics A, 2005, J VIROL, V79, P12721, DOI 10.1128/JVI.79.20.12721-12731.2005; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Renzi F, 2006, P NATL ACAD SCI USA, V103, P12365, DOI 10.1073/pnas.0602426103; Ricagno S, 2006, P NATL ACAD SCI USA, V103, P11892, DOI 10.1073/pnas.0601708103; Saikatendu KS, 2007, J VIROL, V81, P3913, DOI 10.1128/JVI.02236-06; Schaecher SR, 2007, J VIROL, V81, P718, DOI 10.1128/JVI.01691-06; Schelle B, 2005, J VIROL, V79, P6620, DOI 10.1128/JVI.79.11.6620-6630.2005; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05; Stadler K, 2005, CURR MOL MED, V5, P677, DOI 10.2174/156652405774641124; Su D, 2006, J VIROL, V80, P7902, DOI 10.1128/JVI.00483-06; Surjit M, 2004, BIOCHEM BIOPH RES CO, V317, P1030, DOI 10.1016/j.bbrc.2004.03.154; Tanner JA, 2003, J BIOL CHEM, V278, P39578, DOI 10.1074/jbc.C300328200; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Uetz P, 2004, GENOME RES, V14, P2029, DOI 10.1101/gr.2583304; von Brunn A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000459; von Grotthuss M, 2003, CELL, V113, P701, DOI 10.1016/S0092-8674(03)00424-0; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Zell R, 2005, J GEN VIROL, V86, P2763, DOI 10.1099/vir.0.81144-0; Zhai YJ, 2005, NAT STRUCT MOL BIOL, V12, P980, DOI 10.1038/nsmb999; Zhu Y, 2005, VIRUS GENES, V30, P93, DOI 10.1007/s11262-004-4586-9	73	98	101	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3299	10.1371/journal.pone.0003299	http://dx.doi.org/10.1371/journal.pone.0003299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18827877	Green Published, gold, Green Submitted			2022-12-27	WOS:000264797200006
J	Sen, D; Deerinck, TJ; Ellisman, MH; Parker, I; Cahalan, MD				Sen, Debasish; Deerinck, Thomas J.; Ellisman, Mark H.; Parker, Ian; Cahalan, Michael D.			Quantum Dots for Tracking Dendritic Cells and Priming an Immune Response In Vitro and In Vivo	PLOS ONE			English	Article								Dendritic cells (DCs) play a key role in initiating adaptive immune response by presenting antigen to T cells in lymphoid organs. Here, we investigate the potential of quantum dots (QDs) as fluorescent nanoparticles for in vitro and in vivo imaging of DCs, and as a particle-based antigen-delivery system to enhance DC-mediated immune responses. We used confocal, two-photon, and electron microscopies to visualize QD uptake into DCs and compared CD69 expression, T cell proliferation, and IFN-gamma production by DO11.10 and OT-II T cells in vivo in response to free antigen or antigen-conjugated to QDs. CD11c(+) DCs avidly and preferentially endocytosed QDs, initially into small vesicles near the plasma membrane by an actin-dependent mechanism. Within 10 min DCs contained vesicles of varying size, motion, and brightness distributed throughout the cytoplasm. At later times, endocytosed QDs were compartmentalized inside lysosomes. LPS-induced maturation of DCs reduced the rate of endocytosis and the proportion of cells taking up QDs. Following subcutaneous injection of QDs in an adjuvant depot, DCs that had endocytosed QDs were visualized up to 400 mm deep within draining lymph nodes. When antigen-conjugated QDs were used, T cells formed stable clusters in contact with DCs. Antigen-conjugated QDs induced CD69 expression, T cell proliferation, and IFN-gamma production in vivo with greater efficiency than equivalent amounts of free antigen. These results establish QDs as a versatile platform for immunoimaging of dendritic cells and as an efficient nanoparticle-based antigen delivery system for priming an immune response.	[Sen, Debasish; Parker, Ian; Cahalan, Michael D.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behavior, Irvine, CA 92717 USA; [Deerinck, Thomas J.; Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Deerinck, Thomas J.; Ellisman, Mark H.] Ctr Res Biol Structure, Natl Ctr Microscopy & Imag Res, La Jolla, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Diego	Sen, D (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA.	mcahalan@uci.edu		Sen, Debasish/0000-0001-9879-8345	Graduate Research and Education in Adaptive bioTechnology (GREAT) Training Program of the UC Systemwide Biotechnology Research and Education Program [2004-11]; National Institutes of Health [GM-41514, GM-48071, N01-AI-50019]; National Center for Microscopy and Imaging Research; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041514, R37GM048071, R01GM048071] Funding Source: NIH RePORTER	Graduate Research and Education in Adaptive bioTechnology (GREAT) Training Program of the UC Systemwide Biotechnology Research and Education Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Microscopy and Imaging Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Graduate Research and Education in Adaptive bioTechnology (GREAT) Training Program of the UC Systemwide Biotechnology Research and Education Program, (grant 2004-11), and by National Institutes of Health grants GM-41514 (to M.D.C.), GM-48071 (to I.P.), biodefense subcontract N01-AI-50019 (to M.D.C), and the National Center for Microscopy and Imaging Research.	Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y; Bousso P, 2004, IMMUNITY, V21, P349, DOI 10.1016/j.immuni.2004.08.005; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Brewer JM, 2004, J IMMUNOL, V173, P6143, DOI 10.4049/jimmunol.173.10.6143; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; CAHALAN MD, 2008, ANN REV IMMUNOL; Cambi A, 2007, NANO LETT, V7, P970, DOI 10.1021/nl0700503; COLE NB, 1995, CURR OPIN CELL BIOL, V7, P55, DOI 10.1016/0955-0674(95)80045-X; de Saint-Vis B, 1998, IMMUNITY, V9, P325, DOI 10.1016/S1074-7613(00)80615-9; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Fomina AF, 2003, EXP CELL RES, V291, P150, DOI 10.1016/S0014-4827(03)00372-0; Geiser M, 2005, ENVIRON HEALTH PERSP, V113, P1555, DOI 10.1289/ehp.8006; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Jaiswal Jyoti K, 2007, Methods Mol Biol, V374, P93; Kuhn M, 1998, FEMS MICROBIOL LETT, V160, P87, DOI 10.1016/S0378-1097(98)00017-2; Lidke Diane S, 2007, Methods Mol Biol, V374, P69; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Luhrmann A, 2000, Methods Cell Sci, V22, P329, DOI 10.1023/A:1017963401560; Manolova V., 2008, EUR J IMMUNOL; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Nguyen QT, 2001, CELL CALCIUM, V30, P383, DOI 10.1054/ceca.2001.0246; Nisman R, 2004, J HISTOCHEM CYTOCHEM, V52, P13, DOI 10.1177/002215540405200102; Peek L, 2008, ADV DRUG DELIV REV; Pierre P, 1997, ADV EXP MED BIOL, V417, P179; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Pulendran B, 2005, J IMMUNOL, V174, P2457, DOI 10.4049/jimmunol.174.5.2457; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; REYNOLDS DJ, 1990, INFECT IMMUN, V58, P3208, DOI 10.1128/IAI.58.10.3208-3216.1990; Smith AM, 2006, EXPERT REV MOL DIAGN, V6, P231, DOI 10.1586/14737159.6.2.231; Steinman RM, 1999, HUM IMMUNOL, V60, P562, DOI 10.1016/S0198-8859(99)00030-0; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Tanaka S, 2003, AM J PHYSIOL-CELL PH, V285, pC592, DOI 10.1152/ajpcell.00470.2002; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538	41	63	64	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2008	3	9							e3290	10.1371/journal.pone.0003290	http://dx.doi.org/10.1371/journal.pone.0003290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MN	18820727	gold, Green Published			2022-12-27	WOS:000264432500001
J	Hirokawa, J; Watakabe, A; Ohsawa, S; Yamamori, T				Hirokawa, Junya; Watakabe, Akiya; Ohsawa, Sonoko; Yamamori, Tetsuo			Analysis of Area-Specific Expression Patterns of RORbeta, ER81 and Nurr1 mRNAs in Rat Neocortex by Double In Situ Hybridization and Cortical Box Method	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; PRIMARY VISUAL-CORTEX; CYTOCHROME-OXIDASE; QUANTITATIVE APPROACH; CORTICOCORTICAL CONNECTIONS; DIFFERENTIAL EXPRESSION; SOMATOSENSORY CORTEX; MACAQUE MONKEY; NEURONS; SYSTEM	Background: The mammalian neocortex is subdivided into many areas, each of which exhibits distinctive lamina architecture. To investigate such area differences in detail, we chose three genes for comparative analyses, namely, RORbeta, ER81 and Nurr1, mRNAs of which have been reported to be mainly expressed in layers 4, 5 and 6, respectively. To analyze their qualitative and quantitative coexpression profiles in the rat neocortex, we used double in situ hybridization (ISH) histochemistry and cortical box method which we previously developed to integrate the data of different staining and individuals in a standard three-dimensional space. Principal Findings: Our new approach resulted in three main observations. First, the three genes showed unique area distribution patterns that are mostly complementary to one another. The patterns revealed by cortical box method matched well with the cytoarchitectonic areas defined by Nissl staining. Second, at single cell level, RORbeta and ER81 mRNAs were coexpressed in a subpopulation of layer 5 neurons, whereas Nurr1 and ER81 mRNAs were not colocalized. Third, principal component analysis showed that the order of hierarchical processing in the cortex correlates well with the expression profiles of these three genes. Based on this analysis, the dysgranular zone (DZ) in the somatosensory area was considered to exhibit a profile of a higher order area, which is consistent with previous proposal. Conclusions/Significance: The tight relationship between the expression of the three layer specific genes and functional areas were revealed, demonstrating the usefulness of cortical box method in the study on the cerebral cortex. In particular, it allowed us to perform statistical evaluation and pattern matching, which would become important in interpreting the ever-increasing data of gene expression in the cortex.	[Hirokawa, Junya; Watakabe, Akiya; Ohsawa, Sonoko; Yamamori, Tetsuo] Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan; [Hirokawa, Junya; Watakabe, Akiya; Yamamori, Tetsuo] Grad Univ Advanced Stud, Dept Basic Biol, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Hirokawa, J (corresponding author), Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 444, Japan.	yamamori@nibb.ac.jp	Yamamori, Tetsuo/N-6536-2015; Hirokawa, Junya/GSE-5964-2022	Yamamori, Tetsuo/0000-0001-5016-0078; Hirokawa, Junya/0000-0003-1238-5713	KAKENHI [17024055, 19500304]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (KAKENHI) 17024055 (to T.Y.) and 19500304 (to A. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimatsu Y, 1999, CEREB CORTEX, V9, P569, DOI 10.1093/cercor/9.6.569; Arimatsu Y, 2003, J COMP NEUROL, V466, P180, DOI 10.1002/cne.10875; ARNAULT P, 1990, J COMP NEUROL, V302, P110, DOI 10.1002/cne.903020109; Bayer S.A., 1991, NEOCORTICAL DEV; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Bjaalie JG, 2002, NAT REV NEUROSCI, V3, P322, DOI 10.1038/nrn790; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Brodmann K, 1909, VERGLEICHENDE LOKALI; Casagrande Vivien A., 1994, Cerebral Cortex, V10, P201; CHAPIN JK, 1987, J COMP NEUROL, V263, P326, DOI 10.1002/cne.902630303; Ding Y, 1998, J COMP NEUROL, V391, P429, DOI 10.1002/(SICI)1096-9861(19980222)391:4<429::AID-CNE2>3.0.CO;2-2; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Dragunow M, 1996, BEHAV GENET, V26, P293, DOI 10.1007/BF02359385; Eickhoff SB, 2007, NEUROIMAGE, V34, P1317, DOI 10.1016/j.neuroimage.2006.11.016; FABRI M, 1991, J COMP NEUROL, V311, P405, DOI 10.1002/cne.903110310; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Geyer S, 1998, J COMP NEUROL, V397, P231, DOI 10.1002/(SICI)1096-9861(19980727)397:2<231::AID-CNE6>3.0.CO;2-1; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hatanaka Y, 1999, CEREB CORTEX, V9, P577, DOI 10.1093/cercor/9.6.577; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hirokawa J, 2008, NEUROSCIENCE, V153, P1402, DOI 10.1016/j.neuroscience.2008.01.011; HOF PR, 1995, J COMP NEUROL, V362, P109, DOI 10.1002/cne.903620107; Killackey HP, 2003, J NEUROSCI, V23, P7381; Komatsu Y, 2005, CEREB CORTEX, V15, P96, DOI 10.1093/cercor/bhh112; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liang FY, 2000, J COMP NEUROL, V416, P475, DOI 10.1002/(SICI)1096-9861(20000124)416:4<475::AID-CNE5>3.0.CO;2-V; LIDOW MS, 1989, NEUROSCIENCE, V32, P609, DOI 10.1016/0306-4522(89)90283-2; Liu Q, 2000, J NEUROSCI, V20, P7682; LIVINGSTONE MS, 1982, P NATL ACAD SCI-BIOL, V79, P6098, DOI 10.1073/pnas.79.19.6098; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.ne.11.030188.001345; MacKenzie-Graham A, 2004, J ANAT, V204, P93, DOI 10.1111/j.1469-7580.2004.00264.x; Mataga N, 2001, J NEUROSCI, V21, P9724, DOI 10.1523/JNEUROSCI.21-24-09724.2001; Nguyen PT, 2004, NEUROIMAGE, V23, P252, DOI 10.1016/j.neuroimage.2004.05.014; Palomero-Gallagher N, 2004, RAT NERVOUS SYSTEM, P729; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pierret T, 2000, J NEUROSCI, V20, P7455; PIMENTA AF, 1995, NEURON, V15, P287, DOI 10.1016/0896-6273(95)90034-9; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Schaeren-Wiemers N, 1997, EUR J NEUROSCI, V9, P2687, DOI 10.1111/j.1460-9568.1997.tb01698.x; Schleicher A, 1999, NEUROIMAGE, V9, P165, DOI 10.1006/nimg.1998.0385; SCHLEICHER A, 1990, J MICROSC-OXFORD, V157, P367, DOI 10.1111/j.1365-2818.1990.tb02971.x; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Tochitani S, 2001, EUR J NEUROSCI, V13, P297, DOI 10.1046/j.0953-816X.2000.01390.x; Van Essen DC, 1998, P NATL ACAD SCI USA, V95, P788, DOI 10.1073/pnas.95.3.788; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; von Bonin G., 1947, NEOCORTEX MACACA MUL; Wada M, 2006, NEUROSCI RES, V56, P96, DOI 10.1016/j.neures.2006.05.013; Watakabe A, 2007, CEREB CORTEX, V17, P1918, DOI 10.1093/cercor/bhl102; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; WELKER C, 1976, J COMP NEUROL, V166, P173, DOI 10.1002/cne.901660205; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Xing GQ, 1997, MOL BRAIN RES, V47, P251, DOI 10.1016/S0169-328X(97)00056-9; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075; Zhong Y, 2004, CEREB CORTEX, V14, P1144, DOI 10.1093/cercor/bhh074; Zilles K, 2002, EUR NEUROPSYCHOPHARM, V12, P587, DOI 10.1016/S0924-977X(02)00108-6; ZILLES K, 1980, ANAT EMBRYOL, V159, P335, DOI 10.1007/BF00317655; ZILLES K, 1984, J COMP NEUROL, V226, P391, DOI 10.1002/cne.902260308	65	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2008	3	9							e3266	10.1371/journal.pone.0003266	http://dx.doi.org/10.1371/journal.pone.0003266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MH	18815614	gold, Green Published, Green Submitted			2022-12-27	WOS:000264431900001
J	Zhong, J; Rist, M; Cooper, L; Smith, C; Khanna, R				Zhong, Jie; Rist, Michael; Cooper, Leanne; Smith, Corey; Khanna, Rajiv			Induction of Pluripotent Protective Immunity Following Immunisation with a Chimeric Vaccine against Human Cytomegalovirus	PLOS ONE			English	Article								Based on the life-time cost to the health care system, the Institute of Medicine has assigned the highest priority for a vaccine to control human cytomegalovirus (HCMV) disease in transplant patients and new born babies. In spite of numerous attempts successful licensure of a HCMV vaccine formulation remains elusive. Here we have developed a novel chimeric vaccine strategy based on a replication-deficient adenovirus which encodes the extracellular domain of gB protein and multiple HLA class I & II-restricted CTL epitopes from HCMV as a contiguous polypeptide. Immunisation with this chimeric vaccine consistently generated strong HCMV-specific CD8(+) and CD4(+) T-cells which co-expressed IFN-gamma and TNF-alpha, while the humoral response induced by this vaccine showed strong virus neutralizing capacity. More importantly, immunization with adenoviral chimeric vaccine also afforded protection against challenge with recombinant vaccinia virus encoding HCMV antigens and this protection was associated with the induction of a pluripotent antigen-specific cellular and antibody response. Furthermore, in vitro stimulation with this adenoviral chimeric vaccine rapidly expanded multiple antigen-specific human CD8(+) and CD4(+) T-cells from healthy virus carriers. These studies demonstrate that the adenovirus chimeric HCMV vaccine provides an excellent platform for reconstituting protective immunity to prevent HCMV diseases in different clinical settings.	[Zhong, Jie; Rist, Michael; Cooper, Leanne; Smith, Corey; Khanna, Rajiv] Queensland Inst Med Res, Australian Ctr Vaccine Dev, Tumour Immunol Lab, Div Immunol, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute	Zhong, J (corresponding author), Queensland Inst Med Res, Australian Ctr Vaccine Dev, Tumour Immunol Lab, Div Immunol, Brisbane, Qld 4006, Australia.	rajiv.khanna@qimr.edu.au	Smith, Corey/L-1357-2017; Khanna, Rajiv/A-7691-2008	Smith, Corey/0000-0002-7550-9595; Khanna, Rajiv/0000-0003-2241-0353	National Health and Medical Research Council (Australia)	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by the National Health and Medical Research Council (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; BenMohamed L, 2000, HUM IMMUNOL, V61, P764, DOI 10.1016/S0198-8859(00)00139-7; BenMohamed L, 2002, IMMUNOLOGY, V106, P113, DOI 10.1046/j.1365-2567.2002.01396.x; Berencsi K, 2001, J INFECT DIS, V183, P1171, DOI 10.1086/319680; Bitmansour AD, 2002, J IMMUNOL, V169, P1207, DOI 10.4049/jimmunol.169.3.1207; Boeckh M, 2003, BLOOD, V101, P407, DOI 10.1182/blood-2002-03-0993; Boeckh Michael, 2003, Herpes, V10, P12; Crough T, 2007, J VIROL, V81, P11538, DOI 10.1128/JVI.00581-07; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Davignon JL, 1996, J VIROL, V70, P2162, DOI 10.1128/JVI.70.4.2162-2169.1996; Diamond DJ, 1997, BLOOD, V90, P1751, DOI 10.1182/blood.V90.5.1751; Elkington R, 2005, BLOOD, V105, P1362, DOI 10.1182/blood-2004-07-2602; Elkington R, 2004, EUR J IMMUNOL, V34, P3216, DOI 10.1002/eji.200425203; Elkington R, 2003, J VIROL, V77, P5226, DOI 10.1128/JVI.77.9.5226-5240.2003; Engstrand M, 2000, TRANSPLANTATION, V69, P2243, DOI 10.1097/00007890-200006150-00005; Furebring C, 2002, MOL IMMUNOL, V38, P833, DOI 10.1016/S0161-5890(01)00119-5; Gallez-Hawkins G, 2002, SCAND J IMMUNOL, V55, P592, DOI 10.1046/j.1365-3083.2002.01099.x; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; GAVIN MA, 1993, J IMMUNOL, V151, P3971; Gaytant MA, 2002, OBSTET GYNECOL SURV, V57, P245, DOI 10.1097/00006254-200204000-00024; GONCZOL E, 1995, VACCINE, V13, P1080, DOI 10.1016/0264-410X(95)00048-6; Hebart H, 2002, BLOOD, V99, P3830, DOI 10.1182/blood.V99.10.3830; Kamath A, 2006, J IMMUNOL, V177, P6361, DOI 10.4049/jimmunol.177.9.6361; Kern F, 2002, J INFECT DIS, V185, P1709, DOI 10.1086/340637; Khanna R, 2006, TRENDS MOL MED, V12, P26, DOI 10.1016/j.molmed.2005.11.006; Kondo E, 2004, BLOOD, V103, P630, DOI 10.1182/blood-2003-03-0824; LI CR, 1994, BLOOD, V83, P1971, DOI 10.1182/blood.V83.7.1971.1971; Longmate J, 2001, IMMUNOGENETICS, V52, P165, DOI 10.1007/s002510000271; Manley TJ, 2004, BLOOD, V104, P1075, DOI 10.1182/blood-2003-06-1937; Marshall BC, 2003, VIRAL IMMUNOL, V16, P491, DOI 10.1089/088282403771926319; Marshall GS, 2000, VIRAL IMMUNOL, V13, P329, DOI 10.1089/08828240050144653; Masuoka M, 2001, VIRAL IMMUNOL, V14, P369, DOI 10.1089/08828240152716619; McKay PF, 2002, J IMMUNOL, V168, P332, DOI 10.4049/jimmunol.168.1.332; Morello CS, 2005, J VIROL, V79, P159, DOI 10.1128/JVI.79.1.159-175.2005; Ophorst OJAE, 2004, VACCINE, V22, P3035, DOI 10.1016/j.vaccine.2004.02.011; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Pass RF, 1996, INFECT AGENT DIS, V5, P240; Pass RF, 1999, J INFECT DIS, V180, P970, DOI 10.1086/315022; Plotkin SA, 1999, PEDIATR INFECT DIS J, V18, P313, DOI 10.1097/00006454-199904000-00002; Plotkin SA, 2002, J CLIN VIROL, V25, pS13; Plotkin SA, 2001, ARCH VIR S, V17, P121; Plotkin SA, 1999, AM HEART J, V138, pS484, DOI 10.1016/S0002-8703(99)70281-4; Reddehase MJ, 2002, NAT REV IMMUNOL, V2, P831, DOI 10.1038/nri932; Riddell S R, 1995, Cancer Treat Res, V76, P337; Rist M, 2005, EUR J IMMUNOL, V35, P996, DOI 10.1002/eji.200425746; SACHS G W, 1984, Vaccine, V2, P215, DOI 10.1016/0264-410X(84)90088-4; Schleiss Mark, 2005, Herpes, V12, P66; Schlfiss MR, 2007, J PEDIATR-US, V151, P564, DOI 10.1016/j.jpeds.2007.07.015; STRATTON K, 2001, VACCINES 21 CENTURY, P476; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; THOMSON SA, 1995, P NATL ACAD SCI USA, V92, P5845, DOI 10.1073/pnas.92.13.5845; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wang ZD, 2004, J VIROL, V78, P3965, DOI 10.1128/JVI.78.8.3965-3976.2004; Wang ZD, 2007, VACCINE, V25, P1132, DOI 10.1016/j.vaccine.2006.09.067; Weekes MP, 1999, J VIROL, V73, P2099, DOI 10.1128/JVI.73.3.2099-2108.1999; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Yao ZQ, 2001, VACCINE, V19, P1628, DOI 10.1016/S0264-410X(00)00423-0; Zhong J, 2007, EXPERT REV ANTI-INFE, V5, P449, DOI 10.1586/14787210.5.3.449; Zhong L, 2004, PROTEOMICS, V4, P1216, DOI 10.1002/pmic.200200679	62	35	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3256	10.1371/journal.pone.0003256	http://dx.doi.org/10.1371/journal.pone.0003256			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LY	18806877	Green Submitted, gold, Green Published			2022-12-27	WOS:000264430800006
J	Kalsbeek, A; Foppen, E; Schalij, I; Van Heijningen, C; van der Vliet, J; Fliers, E; Buijs, RM				Kalsbeek, Andries; Foppen, Ewout; Schalij, Ingrid; Van Heijningen, Caroline; van der Vliet, Jan; Fliers, Eric; Buijs, Ruud M.			Circadian Control of the Daily Plasma Glucose Rhythm: An Interplay of GABA and Glutamate	PLOS ONE			English	Article							PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; SUPRACHIASMATIC NUCLEUS; PARAVENTRICULAR NUCLEUS; HYPOTHALAMIC INTEGRATION; MELATONIN SYNTHESIS; AUTONOMIC OUTPUT; GENE-EXPRESSION; DIURNAL RHYTHMS; MESSENGER-RNA; LIVER	The mammalian biological clock, located in the hypothalamic suprachiasmatic nuclei (SCN), imposes its temporal structure on the organism via neural and endocrine outputs. To further investigate SCN control of the autonomic nervous system we focused in the present study on the daily rhythm in plasma glucose concentrations. The hypothalamic paraventricular nucleus (PVN) is an important target area of biological clock output and harbors the pre-autonomic neurons that control peripheral sympathetic and parasympathetic activity. Using local administration of GABA and glutamate receptor (ant)agonists in the PVN at different times of the light/dark-cycle we investigated whether daily changes in the activity of autonomic nervous system contribute to the control of plasma glucose and plasma insulin concentrations. Activation of neuronal activity in the PVN of non-feeding animals, either by administering a glutamatergic agonist or a GABAergic antagonist, induced hyperglycemia. The effect of the GABA-antagonist was time dependent, causing increased plasma glucose concentrations only when administered during the light period. The absence of a hyperglycemic effect of the GABA-antagonist in SCN-ablated animals provided further evidence for a daily change in GABAergic input from the SCN to the PVN. On the other hand, feeding-induced plasma glucose and insulin responses were suppressed by inhibition of PVN neuronal activity only during the dark period. These results indicate that the pre-autonomic neurons in the PVN are controlled by an interplay of inhibitory and excitatory inputs. Liver-dedicated sympathetic pre-autonomic neurons (responsible for hepatic glucose production) and pancreas-dedicated pre-autonomic parasympathetic neurons (responsible for insulin release) are controlled by inhibitory GABAergic contacts that are mainly active during the light period. Both sympathetic and parasympathetic pre-autonomic PVN neurons also receive excitatory inputs, either from the biological clock (sympathetic pre-autonomic neurons) or from non-clock areas (para-sympathetic pre-autonomic neurons), but the timing information is mainly provided by the GABAergic outputs of the biological clock.	[Kalsbeek, Andries; Foppen, Ewout; Schalij, Ingrid; Van Heijningen, Caroline; van der Vliet, Jan; Buijs, Ruud M.] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Kalsbeek, Andries; Foppen, Ewout; Fliers, Eric] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metabolism, NL-1012 WX Amsterdam, Netherlands; [Buijs, Ruud M.] Ciudad Univ, Inst Investigac Biomed UNAM, Mexico City, DF, Mexico	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; Universidad Nacional Autonoma de Mexico	Kalsbeek, A (corresponding author), Netherlands Inst Neurosci, Amsterdam, Netherlands.	A.Kalsbeek@amc.uva.nl	Buijs, Rudolf/AAD-5707-2020; Kalsbeek, Andries/H-3076-2019; Jansen, Heiko T./A-5770-2008	Kalsbeek, Andries/0000-0001-9606-8453; Jansen, Heiko T./0000-0003-0178-396X; Fliers, Eric/0000-0001-8048-9050				Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Alquier T, 2004, ENDOCRINOLOGY, V145, P4022, DOI 10.1210/en.2004-0861; ARMSTRONG S, 1980, NEUROSCI BIOBEHAV R, V4, P27, DOI 10.1016/0149-7634(80)90024-X; Bando H, 2007, J NEUROSCI, V27, P4359, DOI 10.1523/JNEUROSCI.4131-06.2007; BELLINGER LL, 1975, HORM METAB RES, V7, P132, DOI 10.1055/s-0028-1093763; Benavides A, 1998, AM J PHYSIOL-REG I, V275, pR811, DOI 10.1152/ajpregu.1998.275.3.R811; Bester H, 1997, J COMP NEUROL, V383, P245, DOI 10.1002/(SICI)1096-9861(19970707)383:3<245::AID-CNE1>3.0.CO;2-3; Boden G, 1996, DIABETES, V45, P1044, DOI 10.2337/diabetes.45.8.1044; BOLLI GB, 1984, NEW ENGL J MED, V310, P746, DOI 10.1056/NEJM198403223101203; BUIJS RM, 1993, AM J PHYSIOL, V264, pR1186, DOI 10.1152/ajpregu.1993.264.6.R1186; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; BUIJS RM, 1995, J COMP NEUROL, V358, P343, DOI 10.1002/cne.903580304; Buijs RM, 2003, J COMP NEUROL, V464, P36, DOI 10.1002/cne.10765; Cailotto C, 2005, EUR J NEUROSCI, V22, P2531, DOI 10.1111/j.1460-9568.2005.04439.x; Cailotto C, 2008, ENDOCRINOLOGY, V149, P1914, DOI 10.1210/en.2007-0816; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Cole RAL, 2002, J NEUROSCI, V22, P959, DOI 10.1523/JNEUROSCI.22-03-00959.2002; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Corssmit EPM, 2001, METABOLISM, V50, P742, DOI 10.1053/meta.2001.24195; Csaki A, 2000, NEUROSCIENCE, V101, P637, DOI 10.1016/S0306-4522(00)00411-5; DECAVEL C, 1992, J COMP NEUROL, V316, P104, DOI 10.1002/cne.903160109; DRIJFHOUT WJ, 1995, J NEUROSCI METH, V61, P191, DOI 10.1016/0165-0270(94)00041-E; GALE EA, 1985, NETH J MED S, V1, P50; GARDEMANN A, 1992, BIOL CHEM H-S, V373, P195, DOI 10.1515/bchm3.1992.373.1.195; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Hernandez LF, 2003, NEUROCHEM RES, V28, P1819, DOI 10.1023/A:1026115607216; Houghton SG, 2006, SURGERY, V139, P542, DOI 10.1016/j.surg.2005.09.002; JOLIN T, 1973, HORM RES, V4, P153, DOI 10.1159/000178303; Kalsbeek A, 1996, NEUROENDOCRINOLOGY, V63, P69, DOI 10.1159/000126937; Kalsbeek A, 1998, PHYSIOL BEHAV, V63, P553, DOI 10.1016/S0031-9384(97)00493-9; Kalsbeek A, 2006, PROG BRAIN RES, V153, P283, DOI 10.1016/S0079-6123(06)53017-1; Kalsbeek A, 2002, CELL TISSUE RES, V309, P109, DOI 10.1007/s00441-002-0577-0; Kalsbeek A, 2004, J NEUROSCI, V24, P7604, DOI 10.1523/JNEUROSCI.5328-03.2004; Kalsbeek A, 2000, ENDOCRINOLOGY, V141, P3832, DOI 10.1210/en.141.10.3832; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Kalsbeek A, 2008, EUR J NEUROSCI, V27, P818, DOI 10.1111/j.1460-9568.2008.06057.x; KAMINSKY YG, 1987, COMP BIOCHEM PHYS B, V86, P763, DOI 10.1016/0305-0491(87)90224-0; Kita Y, 2002, PHARMACOGENETICS, V12, P55, DOI 10.1097/00008571-200201000-00008; Kreier F, 2006, ENDOCRINOLOGY, V147, P1140, DOI 10.1210/en.2005-0667; la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643; la Fleur SE, 2003, J NEUROENDOCRINOL, V15, P315, DOI 10.1046/j.1365-2826.2003.01019.x; LANG CH, 1995, BRAIN RES BULL, V37, P611, DOI 10.1016/0361-9230(95)00052-G; LUITEN PGM, 1987, PROG NEUROBIOL, V28, P1, DOI 10.1016/0301-0082(87)90004-9; MARTIN DS, 1991, HYPERTENSION, V18, P48, DOI 10.1161/01.HYP.18.1.48; Matsuhisa M, 2000, METABOLISM, V49, P11, DOI 10.1016/S0026-0495(00)90538-9; MIKKELSEN JD, 1992, BRAIN RES BULL, V28, P619, DOI 10.1016/0361-9230(92)90112-B; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; Morin LP, 2007, J BIOL RHYTHM, V22, P3, DOI 10.1177/0748730406296749; Nonogaki K, 2000, DIABETOLOGIA, V43, P533, DOI 10.1007/s001250051341; NONOGAKI K, 1994, J NEUROENDOCRINOL, V6, P443, DOI 10.1111/j.1365-2826.1994.tb00605.x; OGAWA H, 1995, ARCH BIOCHEM BIOPHYS, V321, P115, DOI 10.1006/abbi.1995.1375; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PERET J, 1973, J NUTR, V103, P866, DOI 10.1093/jn/103.6.866; Perreau-Lenz S, 2004, CHRONOBIOL INT, V21, P1, DOI 10.1081/CBI-120027984; Perreau-Lenz S, 2004, EUR J NEUROSCI, V19, P318, DOI 10.1111/j.0953-816X.2003.03132.x; Perreau-Lenz S, 2003, EUR J NEUROSCI, V17, P221, DOI 10.1046/j.1460-9568.2003.02442.x; Puschel GP, 2004, ANAT REC PART A, V280A, P854, DOI 10.1002/ar.a.20091; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; Saper CB, 2006, PROG BRAIN RES, V153, P243, DOI 10.1016/S0079-6123(06)53014-6; Scheving LA, 2000, GASTROENTEROLOGY, V119, P536, DOI 10.1053/gast.2000.9305; SHIMAZU T, 1987, Diabetes Metabolism Reviews, V3, P185; SHIMAZU T, 1967, SCIENCE, V156, P1256, DOI 10.1126/science.156.3779.1256; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; STRUBBE JH, 1987, J AUTONOM NERV SYST, V20, P113, DOI 10.1016/0165-1838(87)90108-1; Takahashi A, 1997, METABOLISM, V46, P897, DOI 10.1016/S0026-0495(97)90076-7; Tanaka M, 1996, NEUROSCI LETT, V215, P119, DOI 10.1016/0304-3940(96)12965-7; Tebbe JJ, 2001, BRAIN RES, V913, P10, DOI 10.1016/S0006-8993(01)02746-9; TERHORST GJ, 1989, NEUROSCIENCE, V31, P785; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; VANDENHOEK AM, 2008, DIABETES IN PRESS; Westerink BHC, 1998, J PHARMACOL EXP THER, V285, P143; YAMAMOTO H, 1984, BIOMED RES-TOKYO, V5, P47, DOI 10.2220/biomedres.5.47	76	77	80	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3194	10.1371/journal.pone.0003194	http://dx.doi.org/10.1371/journal.pone.0003194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791643	Green Published, Green Submitted, gold			2022-12-27	WOS:000264427700001
J	Alvarez-Buylla, ER; Chaos, A; Aldana, M; Benitez, M; Cortes-Poza, Y; Espinosa-Soto, C; Hartasanchez, DA; Lotto, RB; Malkin, D; Santos, GJE; Padilla-Longoria, P				Alvarez-Buylla, Elena R.; Chaos, Alvaro; Aldana, Maximino; Benitez, Mariana; Cortes-Poza, Yuriria; Espinosa-Soto, Carlos; Hartasanchez, Diego A.; Beau Lotto, R.; Malkin, David; Escalera Santos, Gerardo J.; Padilla-Longoria, Pablo			Floral Morphogenesis: Stochastic Explorations of a Gene Network Epigenetic Landscape	PLOS ONE			English	Article							CELL-CYCLE NETWORK; REGULATORY NETWORK; HOMEOTIC GENES; EXPRESSION; ROBUSTNESS; EVOLUTION; MOVEMENT; MODELS; MEMORY; NOISE	In contrast to the classical view of development as a preprogrammed and deterministic process, recent studies have demonstrated that stochastic perturbations of highly non-linear systems may underlie the emergence and stability of biological patterns. Herein, we address the question of whether noise contributes to the generation of the stereotypical temporal pattern in gene expression during flower development. We modeled the regulatory network of organ identity genes in the Arabidopsis thaliana flower as a stochastic system. This network has previously been shown to converge to ten fixed-point attractors, each with gene expression arrays that characterize inflorescence cells and primordial cells of sepals, petals, stamens, and carpels. The network used is binary, and the logical rules that govern its dynamics are grounded in experimental evidence. We introduced different levels of uncertainty in the updating rules of the network. Interestingly, for a level of noise of around 0.5-10%, the system exhibited a sequence of transitions among attractors that mimics the sequence of gene activation configurations observed in real flowers. We also implemented the gene regulatory network as a continuous system using the Glass model of differential equations, that can be considered as a first approximation of kinetic-reaction equations, but which are not necessarily equivalent to the Boolean model. Interestingly, the Glass dynamics recover a temporal sequence of attractors, that is qualitatively similar, although not identical, to that obtained using the Boolean model. Thus, time ordering in the emergence of cell-fate patterns is not an artifact of synchronous updating in the Boolean model. Therefore, our model provides a novel explanation for the emergence and robustness of the ubiquitous temporal pattern of floral organ specification. It also constitutes a new approach to understanding morphogenesis, providing predictions on the population dynamics of cells with different genetic configurations during development.	[Alvarez-Buylla, Elena R.; Chaos, Alvaro; Benitez, Mariana; Espinosa-Soto, Carlos; Escalera Santos, Gerardo J.] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Alvarez-Buylla, Elena R.; Chaos, Alvaro; Aldana, Maximino; Benitez, Mariana; Cortes-Poza, Yuriria; Espinosa-Soto, Carlos; Hartasanchez, Diego A.; Escalera Santos, Gerardo J.; Padilla-Longoria, Pablo] Univ Nacl Autonoma Mexico, Cd Univ, Ctr Ciencias Complejidad, C3, Mexico City, DF, Mexico; [Aldana, Maximino; Hartasanchez, Diego A.] Univ Nacl Autonoma Mexico, Inst Ciencias Fisicas, Cuernavaca, Morelos, Mexico; [Cortes-Poza, Yuriria; Padilla-Longoria, Pablo] Univ Nacl Autonoma Mexico, Cd Univ, Inst Investigac Mat Aplicadas Sist, Mexico City, DF, Mexico; [Beau Lotto, R.; Malkin, David] UCL, Lottolab, London WC1E 6BT, England	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of London; University College London	Alvarez-Buylla, ER (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico.	elena.alvarezbuylla@gmail.com; pablo@mym.iimas.unam.mx	Malkin, David/AAW-8715-2021; Aldana, Maximino/D-9372-2017; Benítez, Mariana/E-2997-2012; Santos, Gerardo J. Escalera/A-8880-2019; Espinosa-Soto, Carlos/L-8473-2017	Aldana, Maximino/0000-0002-3419-6641; Santos, Gerardo J. Escalera/0000-0002-6549-3737; Espinosa-Soto, Carlos/0000-0002-9753-5807; Alvarez-Buylla Roces, Maria Elena/0000-0002-7938-6473; Hartasanchez, Diego/0000-0003-2596-6883; Cortes-Poza, Yuriria/0000-0003-1856-9206	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (UNAM) [IN230002, IX207104, IN112407-3]; University of California-MEXUS ECO IE 271; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CO1.41848/ A-1, CO1.0538/A-1, CO1.0435.B-1, P47836-F]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (UNAM)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); University of California-MEXUS ECO IE 271; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Financial support was provided by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (UNAM) IN230002 and IX207104, University of California-MEXUS ECO IE 271 and Consejo Nacional de Ciencia y Tecnologia (CONACYT) CO1.41848/ A-1, CO1.0538/A-1 and CO1.0435.B-1. Grants to E.A.B. PAPIIT-UNAM grant IN112407-3 y CONACyT grant and P47836-F grants to M.A. Ph.D. and postdoctoral scholarships from CONACYT and UNAM (CEP-UNAM) to C.E.-S, M.B., G.J. E. and A.C. These students were in the Doctorado en Ciencias Biomedicas graduate program at the Instituto de Ecologia from UNAM.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Adam H, 2007, ANN BOT-LONDON, V100, P1, DOI 10.1093/aob/mcm027; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Aldrich J, 1997, STAT SCI, V12, P162; Alvarez-Buylla ER, 2007, CURR OPIN PLANT BIOL, V10, P83, DOI 10.1016/j.pbi.2006.11.008; Ambrose BA, 2006, AM J BOT, V93, P15, DOI 10.3732/ajb.93.1.15; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bomblies K, 1999, DEV BIOL, V216, P260, DOI 10.1006/dbio.1999.9504; Bowman J., 1994, ARABIDOPSIS ATLAS MO, V102, P117; Chaos A, 2006, J PLANT GROWTH REGUL, V25, P278, DOI 10.1007/s00344-006-0068-8; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Escudero C, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.010103; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Fedoroff N, 2002, SCIENCE, V297, P1129, DOI 10.1126/science.1075988; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gershenson C, 2004, ARTIFICIAL LIFE IX, P238; GLASS L, 1975, J THEOR BIOL, V54, P85, DOI 10.1016/S0022-5193(75)80056-7; Han B, 2007, BIOPHYS J, V92, P3755, DOI 10.1529/biophysj.106.094821; Huang K., 1990, STAT MECH; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang Sui, 2006, Breast Dis, V26, P27; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Kaneko K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000434; Kauffman S.A., 1993, ORIGINS ORDER; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; LOHMANN J, 1995, SCIENCE, V270, P1980; LUCAS WJ, 1995, CURR OPIN CELL BIOL, V7, P673, DOI 10.1016/0955-0674(95)80109-X; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; RUDALL P, 1987, ANATOMY FLOWERING PL; Sasai M, 2003, P NATL ACAD SCI USA, V100, P2374, DOI 10.1073/pnas.2627987100; Scheres B, 2001, PLANT PHYSIOL, V125, P112, DOI 10.1104/pp.125.1.112; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Sessions A, 2000, SCIENCE, V289, P779, DOI 10.1126/science.289.5480.779; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Slack JMW, 2002, NAT REV GENET, V3, P889, DOI 10.1038/nrg933; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Waddington C., 1957, STRATEGY GENES; Wang J, 2006, PLOS COMPUT BIOL, V2, P1385, DOI 10.1371/journal.pcbi.0020147; Wang J, 2006, BIOPHYS J, V91, pL54, DOI 10.1529/biophysj.106.086777; Wang ZW, 2007, BIOPHYS CHEM, V125, P281, DOI 10.1016/j.bpc.2006.09.006; Whipple CJ, 2004, DEVELOPMENT, V131, P6083, DOI 10.1242/dev.01523; Wu XL, 2003, DEVELOPMENT, V130, P3735, DOI 10.1242/dev.00577; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101	48	80	81	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3626	10.1371/journal.pone.0003626	http://dx.doi.org/10.1371/journal.pone.0003626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978941	Green Published, gold, Green Submitted			2022-12-27	WOS:000265134200009
J	Mulder, C; Den Hollander, HA; Hendriks, AJ				Mulder, Christian; Den Hollander, Henri A.; Hendriks, A. Jan			Aboveground Herbivory Shapes the Biomass Distribution and Flux of Soil Invertebrates	PLOS ONE			English	Article							BODY-SIZE; FOOD-WEB; NUMERICAL ABUNDANCE; NEMATODE COMMUNITY; FEEDING GUILDS; MASS; BIODIVERSITY; DIVERSITY; SLOPE; COLLEMBOLA	Background: Living soil invertebrates provide a universal currency for quality that integrates physical and chemical variables with biogeography as the invertebrates reflect their habitat and most ecological changes occurring therein. The specific goal was the identification of "reference'' states for soil sustainability and ecosystem functioning in grazed vs. ungrazed sites. Methodology/Principal Findings: Bacterial cells were counted by fluorescent staining and combined direct microscopy and automatic image analysis; invertebrates (nematodes, mites, insects, oligochaetes) were sampled and their body size measured individually to allow allometric scaling. Numerical allometry analyses food webs by a direct comparison of weight averages of components and thus might characterize the detrital soil food webs of our 135 sites regardless of taxonomy. Sharp differences in the frequency distributions are shown. Overall higher biomasses of invertebrates occur in grasslands, and all larger soil organisms differed remarkably. Conclusions/Significance: Strong statistical evidence supports a hypothesis explaining from an allometric perspective how the faunal biomass distribution and the energetic flux are affected by livestock, nutrient availability and land use. Our aim is to propose faunal biomass flux and biomass distribution as quantitative descriptors of soil community composition and function, and to illustrate the application of these allometric indicators to soil systems.	[Mulder, Christian; Den Hollander, Henri A.] RIVM LER, Dept Ecol, Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Hendriks, A. Jan] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Environm Sci, Nijmegen, Netherlands	Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen	Mulder, C (corresponding author), RIVM LER, Dept Ecol, Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands.	Christian.Mulder@rivm.nl	Mulder, Christian/N-4726-2015; Hendriks, Aalbert Jan/C-6767-2013	Mulder, Christian/0000-0001-5735-6989; 	Netherlands' National Institute for Public Health and the Environment	Netherlands' National Institute for Public Health and the Environment	This work was entirely supported by the Netherlands' National Institute for Public Health and the Environment.	Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; Bengtsson J, 1998, APPL SOIL ECOL, V9, P137, DOI 10.1016/S0929-1393(98)00067-5; Bloem J, 2003, TRACE METALS OTHER, V6, P259; BORGMANN U, 1987, CAN J FISH AQUAT SCI, V44, P136, DOI 10.1139/f87-316; Cyr H, 1997, OIKOS, V79, P333, DOI 10.2307/3546017; Duplisea DE, 1999, MAR ECOL PROG SER, V177, P73, DOI 10.3354/meps177073; Fitter AH, 2005, J ECOL, V93, P231, DOI 10.1111/j.0022-0477.2005.00990.x; Griffiths BS, 2000, OIKOS, V90, P279, DOI 10.1034/j.1600-0706.2000.900208.x; Griffiths D, 1998, J ANIM ECOL, V67, P795, DOI 10.1046/j.1365-2656.1998.00244.x; Hendriks AJ, 2008, OECOLOGIA, V155, P705, DOI 10.1007/s00442-007-0952-3; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; INGHAM RE, 1985, ECOL MONOGR, V55, P119, DOI 10.2307/1942528; Kay FR, 1999, BIOL FERT SOILS, V28, P121, DOI 10.1007/s003740050472; KING KL, 1976, J APPL ECOL, V13, P731, DOI 10.2307/2402250; Mulder C, 2005, J BIOGEOGR, V32, P1775, DOI 10.1111/j.1365-2699.2005.01321.x; Mulder C, 2005, ECOL LETT, V8, P80, DOI 10.1111/j.1461-0248.2004.00704.x; Mulder C, 2005, NATURWISSENSCHAFTEN, V92, P314, DOI 10.1007/s00114-005-0634-0; Mulder C, 2003, FUNCT ECOL, V17, P516, DOI 10.1046/j.1365-2435.2003.00755.x; Mulder C, 2006, ECOL COMPLEX, V3, P219, DOI 10.1016/j.ecocom.2006.05.004; Mulder C, 2006, NATURWISSENSCHAFTEN, V93, P467, DOI 10.1007/s00114-006-0130-1; PETERSEN H, 1982, OIKOS, V39, P287, DOI 10.2307/3544689; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Ponge JF, 2000, BIOL FERT SOILS, V32, P508, DOI 10.1007/s003740000285; Reuman DC, 2008, ECOL LETT, V11, P1216, DOI 10.1111/j.1461-0248.2008.01236.x; Reuman DC, 2004, J ANIM ECOL, V73, P852, DOI 10.1111/j.0021-8790.2004.00856.x; Schouten T, 2004, NEMATOL MONOGR PERSP, V2, P469; SCHWINGHAMER P, 1981, CAN J FISH AQUAT SCI, V38, P1255, DOI 10.1139/f81-167; Setala H, 1998, APPL SOIL ECOL, V9, P25, DOI 10.1016/S0929-1393(98)00049-3; SHELDON RW, 1977, J FISH RES BOARD CAN, V34, P2344, DOI 10.1139/f77-314; Shimazaki A, 2005, ECOGRAPHY, V28, P485, DOI 10.1111/j.0906-7590.2005.04105.x; Siemann E, 1999, J ANIM ECOL, V68, P824, DOI 10.1046/j.1365-2656.1999.00326.x; SIEPEL H, 1993, SOIL BIOL BIOCHEM, V25, P1491, DOI 10.1016/0038-0717(93)90004-U; SIEPEL H, 1994, SOIL BIOL BIOCHEM, V26, P1389, DOI 10.1016/0038-0717(94)90222-4; SIEPEL H, 1988, PEDOBIOLOGIA, V31, P339; Sutherland WJ, 2006, J APPL ECOL, V43, P617, DOI 10.1111/j.1365-2664.2006.01188.x; Wardle D., 2002, COMMUNITIES ECOSYSTE; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; YEATES GW, 1979, J NEMATOL, V11, P213; Yeates GW, 2002, EUR J SOIL SCI, V53, P355, DOI 10.1046/j.1365-2389.2002.00466.x; Yeates GW, 1999, ANNU REV PHYTOPATHOL, V37, P127, DOI 10.1146/annurev.phyto.37.1.127; YEATES GW, 1993, J NEMATOL, V25, P315	43	36	37	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3573	10.1371/journal.pone.0003573	http://dx.doi.org/10.1371/journal.pone.0003573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974874	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131700002
J	Zhang, XN; Wu, YJ; Tobias, JW; Brunk, BP; Deitzer, GF; Liu, DM				Zhang, Xiao-Ning; Wu, Yingjie; Tobias, John W.; Brunk, Brian P.; Deitzer, Gerald F.; Liu, Dongmei			HFR1 Is Crucial for Transcriptome Regulation in the Cryptochrome 1-Mediated Early Response to Blue Light in Arabidopsis thaliana	PLOS ONE			English	Article								Cryptochromes are blue light photoreceptors involved in development and circadian clock regulation. They are found in both eukaryotes and prokaryotes as light sensors. Long Hypocotyl in Far-Red 1 (HFR1) has been identified as a positive regulator and a possible transcription factor in both blue and far-red light signaling in plants. However, the gene targets that are regulated by HFR1 in cryptochrome 1 (cry1)-mediated blue light signaling have not been globally addressed. We examined the transcriptome profiles in a cry1- and HFR1-dependent manner in response to 1 hour of blue light. Strikingly, more than 70% of the genes induced by blue light in an HFR1-dependent manner were dependent on cry1, and vice versa. High overrepresentation of W-boxes and OCS elements were found in these genes, indicating that this strong cry1 and HFR1 co-regulation on gene expression is possibly through these two cis-elements. We also found that cry1 was required for maintaining the HFR1 protein level in blue light, and that the HFR1 protein level is strongly correlated with the global gene expression pattern. In summary, HFR1, which is fine-tuned by cry1, is crucial for regulating global gene expression in cry1 mediated early blue light signaling, especially for the function of genes containing W-boxes and OCS elements.	[Zhang, Xiao-Ning; Wu, Yingjie; Liu, Dongmei] Univ Penn, Plant Sci Inst, Dept Biol, Philadelphia, PA 19104 USA; [Tobias, John W.; Brunk, Brian P.] Univ Penn, Ctr Bioinformat, Philadelphia, PA 19104 USA; [Deitzer, Gerald F.] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA	University of Pennsylvania; University of Pennsylvania; University System of Maryland; University of Maryland College Park	Zhang, XN (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	xnzhang@umd.edu	Zhang, Xiao-Ning/J-1737-2019	Zhang, Xiao-Ning/0000-0001-8650-1356	NIH [GM51956]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051956] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant (GM51956) to Dr Anthony R. Cashmore at the University of Pennsylvania when the first authors were doing postdoctoral research in his lab. It is his request not to include his name in this manuscript. We still give our very sincere gratitude to him in the acknowledgment for his generous financial support and the workspace he provided. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; BOUCHEZ D, 1989, EMBO J, V8, P4197, DOI 10.1002/j.1460-2075.1989.tb08605.x; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Canamero RC, 2006, PLANTA, V224, P995, DOI 10.1007/s00425-006-0280-6; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Duek PD, 2004, CURR BIOL, V14, P2296, DOI 10.1016/j.cub.2004.12.026; Duek PD, 2003, PLANT J, V34, P827, DOI 10.1046/j.1365-313X.2003.01770.x; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Fairchild CD, 2000, GENE DEV, V14, P2377; Foley RC, 2004, FEBS LETT, V563, P141, DOI 10.1016/S0014-5793(04)00288-1; Folta KM, 2003, PLANT J, V36, P203, DOI 10.1046/j.1365-313X.2003.01870.x; Folta KM, 2001, PLANT J, V26, P471, DOI 10.1046/j.1365-313x.2001.01038.x; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Guo HW, 1999, PLANT J, V19, P279, DOI 10.1046/j.1365-313X.1999.00525.x; Hong SH, 2008, PLANT J, V55, P361, DOI 10.1111/j.1365-313X.2008.03508.x; Hyun Y, 2006, PLANT MOL BIOL, V61, P283, DOI 10.1007/s11103-006-0010-2; Inada S, 2004, PLANT CELL, V16, P887, DOI 10.1105/tpc.019901; Jang IC, 2005, GENE DEV, V19, P593, DOI 10.1101/gad.1247205; Jiao YL, 2003, PLANT PHYSIOL, V133, P1480, DOI 10.1104/pp.103.029439; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kang XJ, 2006, PLANT CELL, V18, P921, DOI 10.1105/tpc.105.037879; Kang XJ, 2005, PLANT CELL, V17, P822, DOI 10.1105/tpc.104.029165; Kleine T, 2003, PLANT J, V35, P93, DOI 10.1046/j.1365-313X.2003.01787.x; Kleine T, 2007, PLANT PHYSIOL, V144, P1391, DOI 10.1104/pp.107.098293; Kleiner O, 1999, PLANT J, V19, P289, DOI 10.1046/j.1365-313X.1999.00535.x; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Moller SG, 2003, PLANT CELL, V15, P1111, DOI 10.1105/tpc.008649; Ohgishi M, 2004, P NATL ACAD SCI USA, V101, P2223, DOI 10.1073/pnas.0305984101; Padegimas LS, 1998, ANAL BIOCHEM, V260, P149, DOI 10.1006/abio.1998.2719; Park E, 2004, PLANT CELL PHYSIOL, V45, P968, DOI 10.1093/pcp/pch125; Soh MS, 2000, PLANT CELL, V12, P2061, DOI 10.1105/tpc.12.11.2061; Spiegelman JI, 2000, PLANT CELL, V12, P2485, DOI 10.1105/tpc.12.12.2485; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Ward JM, 2005, PLANT CELL, V17, P475, DOI 10.1105/tpc.104.027722; Yang HQ, 2001, PLANT CELL, V13, P2573, DOI 10.1105/tpc.13.12.2573; Yang JP, 2005, PLANT J, V43, P131, DOI 10.1111/j.1365-313X.2005.02433.x; Yang JP, 2005, PLANT CELL, V17, P804, DOI 10.1105/tpc.104.030205; Yang KY, 2003, PLANT PHYSIOL, V133, P1630, DOI 10.1104/pp.103.029751; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200	42	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3563	10.1371/journal.pone.0003563	http://dx.doi.org/10.1371/journal.pone.0003563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974779	Green Published, gold, Green Submitted			2022-12-27	WOS:000265131500002
J	Puhar, A; Dal Molin, F; Horvath, S; Ladants, D; Montecucco, C				Puhar, Andrea; Dal Molin, Federica; Horvath, Stephanie; Ladants, Daniel; Montecucco, Cesare			Anthrax Edema Toxin Modulates PKA- and CREB-Dependent Signaling in Two Phases	PLOS ONE			English	Article								Background: Anthrax edema toxin (EdTx) is an adenylate cyclase which operates in the perinuclear region of host cells. However, the action of EdTx is poorly understood, especially at molecular level. The ability of EdTx to modulate cAMP-dependent signaling was studied in Jurkat T cells and was compared with that of other cAMP-rising agents: Bordetella pertussis adenylate cyclase toxin, cholera toxin and forskolin. Methodology/Principal Findings: EdTx caused a prolonged increase of the intracellular cAMP concentration. This led to nuclear translocation of the cAMP-dependent protein kinase (PKA) catalytic subunit, phosphorylation of cAMP response element binding protein (CREB) and expression of a reporter gene under control of the cAMP response element. Neither p90 ribosomal S6 kinase nor mitogen- and stress-activated kinase, which mediate CREB phosphorylation during T cell activation, were involved. The duration of phospho-CREB binding to chromatin correlated with the spatio-temporal rise of cAMP levels. Strikingly, EdTx pre-treated T cells were unresponsive to other stimuli involving CREB phosphorylation such as addition of forskolin or T cell receptor cross-linking. Conclusions/Significance: We concluded that, in a first intoxication phase, EdTx induces PKA-dependent signaling, which culminates in CREB phosphorylation and activation of gene transcription. Subsequently CREB phosphorylation is impaired and therefore T cells are not able to respond to cues involving CREB. The present data functionally link the perinuclear localization of EdTx to its intoxication mechanism, indicating that this is a specific feature of its intoxication mechanism.	[Puhar, Andrea; Dal Molin, Federica; Horvath, Stephanie; Montecucco, Cesare] Univ Padua, Dipartimento Sci Biomed Sperimentali, Padua, Italy; [Ladants, Daniel] Institut Pasteur, CNRS, URA 2185, Unite Biochim Interact Macromol, Paris, France	University of Padua; Centre National de la Recherche Scientifique (CNRS)	Puhar, A (corresponding author), Inst Pasteur, INSERM, U786, Unite Pathogenie Microbienne Mol, F-75724 Paris, France.	andrea.puhar@pasteur.fr; cesare.montecucco@unipd.it		Puhar, Andrea/0000-0002-9915-002X; LADANT, Daniel/0000-0003-1955-548X	Anthrax-EuroNet; Istituto Superiore della Sanita Italy USA protocol on "Programmi di Ricerca sulle Malattie di Grande Rilievo Sociale-Meccanismi tossinogenici e preparazione di antigeni vaccinali"; Network of Excellence EuroPathoGenomics from the European Commission; Institut Pasteur; EU 6th Framework Programme [LSHB-CT-2004-503582]	Anthrax-EuroNet; Istituto Superiore della Sanita Italy USA protocol on "Programmi di Ricerca sulle Malattie di Grande Rilievo Sociale-Meccanismi tossinogenici e preparazione di antigeni vaccinali"; Network of Excellence EuroPathoGenomics from the European Commission; Institut Pasteur(European Commission); EU 6th Framework Programme(European Commission)	This work was supported by grants from the Anthrax-EuroNet, Istituto Superiore della Sanita Italy USA protocol on "Programmi di Ricerca sulle Malattie di Grande Rilievo Sociale-Meccanismi tossinogenici e preparazione di antigeni vaccinali", and Network of Excellence EuroPathoGenomics from the European Commission to C. M., and grants from Institut Pasteur and from the EU 6th Framework Programme Contract LSHB-CT-2004-503582 (Theravac) to D. L.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen H, 2004, J IMMUNOL, V173, P4847, DOI 10.4049/jimmunol.173.8.4847; Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Bailey JR, 2005, ACAD MANAG LEARN EDU, V4, P134; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Burnett JC, 2005, NAT REV DRUG DISCOV, V4, P281, DOI 10.1038/nrd1694; Castellanos MD, 2002, EUR J IMMUNOL, V32, P3108; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; Cooper DMF, 2005, BIOCHEM SOC T, V33, P1319, DOI 10.1042/BST0331319; Dal Molin F, 2008, BIOCHEM BIOPH RES CO, V376, P429, DOI 10.1016/j.bbrc.2008.09.012; Dal Molin F, 2006, EMBO J, V25, P5405, DOI 10.1038/sj.emboj.7601408; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Fimia GM, 2001, J CELL SCI, V114, P1971; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Fouet A, 2006, CURR OPIN MICROBIOL, V9, P160, DOI 10.1016/j.mib.2006.02.009; Fuld S, 2005, EXP CELL RES, V309, P161, DOI 10.1016/j.yexcr.2005.05.016; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; Guidi-Rontani C, 2000, CELL MICROBIOL, V2, P259, DOI 10.1046/j.1462-5822.2000.00057.x; Hong J, 2007, J BIOL CHEM, V282, P19781, DOI 10.1074/jbc.M700128200; Hughes-Fulford M, 2005, CELL SIGNAL, V17, P1111, DOI 10.1016/j.cellsig.2004.12.016; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kaiser M, 2007, EUR J IMMUNOL, V37, P2583, DOI 10.1002/eji.200636606; Kanda N, 2001, BIOCHEM PHARMACOL, V62, P495, DOI 10.1016/S0006-2952(01)00688-8; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Kim C, 2008, P NATL ACAD SCI USA, V105, P6150, DOI 10.1073/pnas.0800105105; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauer S, 2002, BIOCHEMISTRY-US, V41, P1742, DOI 10.1021/bi0112816; Lissandron V, 2005, J MOL BIOL, V354, P546, DOI 10.1016/j.jmb.2005.09.089; Maldonado-Arocho FJ, 2006, MOL MICROBIOL, V61, P324, DOI 10.1111/j.1365-2958.2006.05232.x; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Moens MJU, 2007, FRONT BIOSCI-LANDMRK, V12, P1814; Muthusamy N, 1998, J BIOL CHEM, V273, P22841, DOI 10.1074/jbc.273.35.22841; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Paccani SR, 2007, CELL MICROBIOL, V9, P924, DOI 10.1111/j.1462-5822.2006.00840.x; Paccani SR, 2005, J EXP MED, V201, P325, DOI 10.1084/jem.20041557; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Puhar A, 2007, TRENDS MICROBIOL, V15, P477, DOI 10.1016/j.tim.2007.10.003; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Ryan PL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001817; Sayner S, 2006, BIOCHEM SOC T, V34, P492, DOI 10.1042/BST0340492; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; Sayner SL, 2004, CIRC RES, V95, P196, DOI 10.1161/01.RES.0000134922.25721.d9; Scobie HM, 2005, J INFECT DIS, V192, P1047, DOI 10.1086/432731; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shen YQ, 2004, P NATL ACAD SCI USA, V101, P3242, DOI 10.1073/pnas.0306552101; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Tasken K, 2006, BIOCHEM SOC T, V34, P476, DOI 10.1042/BST0340476; Tonello F, 2004, BIOCHEM BIOPH RES CO, V313, P496, DOI 10.1016/j.bbrc.2003.11.134; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Turnbull PCB, 2002, CURR TOP MICROBIOL, V271, P1; van Oirschot BA, 2001, J BIOL CHEM, V276, P33854, DOI 10.1074/jbc.M104395200; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Young JJ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030027; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	66	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3564	10.1371/journal.pone.0003564	http://dx.doi.org/10.1371/journal.pone.0003564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958164	Green Published, gold, Green Submitted			2022-12-27	WOS:000265131100020
J	van Schaijk, BCL; Janse, CJ; van Gemert, GJ; van Dijk, MR; Gego, A; Franetich, JF; van de Vegte-Bolmer, M; Yalaoui, S; Silvie, O; Hoffman, SL; Waters, AP; Mazier, D; Sauerwein, RW; Khan, SM				van Schaijk, Ben C. L.; Janse, Chris J.; van Gemert, Geert-Jan; van Dijk, Melissa R.; Gego, Audrey; Franetich, Jean-Francois; van de Vegte-Bolmer, Marga; Yalaoui, Samir; Silvie, Olivier; Hoffman, Stephen L.; Waters, Andrew P.; Mazier, Dominique; Sauerwein, Robert W.; Khan, Shahid M.			Gene Disruption of Plasmodium falciparum p52 Results in Attenuation of Malaria Liver Stage Development in Cultured Primary Human Hepatocytes	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM GAMETOCYTES; X-IRRADIATED SPOROZOITES; PROTECTIVE IMMUNITY; SURFACE PROTEIN; STERILE IMMUNITY; PARASITE; TRANSMISSION; INFECTIVITY; RADIATION; VACCINES	Difficulties with inducing sterile and long lasting protective immunity against malaria with subunit vaccines has renewed interest in vaccinations with attenuated Plasmodium parasites. Immunizations with sporozoites that are attenuated by radiation (RAS) can induce strong protective immunity both in humans and rodent models of malaria. Recently, in rodent parasites it has been shown that through the deletion of a single gene, sporozoites can also become attenuated in liver stage development and, importantly, immunization with these sporozoites results in immune responses identical to RAS. The promise of vaccination using these genetically attenuated sporozoites (GAS) depends on translating the results in rodent malaria models to human malaria. In this study, we perform the first essential step in this transition by disrupting, p52, in P. falciparum an ortholog of the rodent parasite gene, p36p, which we had previously shown can confer long lasting protective immunity in mice. These P. falciparum P52 deficient sporozoites demonstrate gliding motility, cell traversal and an invasion rate into primary human hepatocytes in vitro that is comparable to wild type sporozoites. However, inside the host hepatocyte development is arrested very soon after invasion. This study reveals, for the first time, that disrupting the equivalent gene in both P. falciparum and rodent malaria Plasmodium species generates parasites that become similarly arrested during liver stage development and these results pave the way for further development of GAS for human use.	[van Schaijk, Ben C. L.; van Gemert, Geert-Jan; van de Vegte-Bolmer, Marga; Sauerwein, Robert W.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Nijmegen, Netherlands; [Janse, Chris J.; van Dijk, Melissa R.; Waters, Andrew P.; Khan, Shahid M.] Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 RA Leiden, Netherlands; [Gego, Audrey; Franetich, Jean-Francois; Yalaoui, Samir; Silvie, Olivier; Mazier, Dominique] INSERM, U511, Paris, France; [Gego, Audrey; Franetich, Jean-Francois; Yalaoui, Samir; Silvie, Olivier; Mazier, Dominique] Univ Pierre Marie Curie Paris 6, UMR S511, Paris, France; [Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA; [Mazier, Dominique] AP HP, Grp Hosp Pitie Salpetriere, Serv Parasitol Mycol, Paris, France	Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Sanaria Inc.; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Khan, SM (corresponding author), Radboud Univ Nijmegen, Nijmegen Med Ctr, Nijmegen, Netherlands.	s.m.khan@lumc.nl	Sauerwein, Robert/C-8519-2013; Silvie, Olivier/K-7290-2017; Waters, Andy P/C-9377-2009; Franetich, Jean-François/GZA-9674-2022; Silvie, Olivier/AAF-5437-2021	Silvie, Olivier/0000-0002-0525-6940; Waters, Andy P/0000-0001-8900-2982; Silvie, Olivier/0000-0002-0525-6940; Janse, Chris J/0000-0002-6410-6205; Khan, Shahid/0000-0002-0533-4670	The Netherlands Organisation for Health Research and Development [912-02-083]; Top Institute Pharma (Netherlands) [T4-102]	The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Top Institute Pharma (Netherlands)(Netherlands Government)	MR van Dijk received financial support from The Netherlands Organisation for Health Research and Development (ZonMW; 912-02-083). This study was performed within framework of Top Institute Pharma (Netherlands) project: T4-102.	Alano P, 2007, MOL MICROBIOL, V66, P291, DOI 10.1111/j.1365-2958.2007.05904.x; Aly ASI, 2008, MOL MICROBIOL, V69, P152, DOI 10.1111/j.1365-2958.2008.06271.x; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Bonilla JA, 2007, MOL MICROBIOL, V65, P64, DOI 10.1111/j.1365-2958.2007.05768.x; CALLAWAY E, 2007, NATURE, V449, P266; Carter R, 2001, VACCINE, V19, P2309, DOI 10.1016/S0264-410X(00)00521-1; Carvalho TG, 2005, CURR ISSUES MOL BIOL, V7, P39, DOI 10.21775/cimb.007.039; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Douradinha B, 2007, INT J PARASITOL, V37, P1511, DOI 10.1016/j.ijpara.2007.05.005; Eksi S, 2006, MOL MICROBIOL, V61, P991, DOI 10.1111/j.1365-2958.2006.05284.x; Epstein JE, 2004, VACCINE, V22, P1592, DOI 10.1016/j.vaccine.2004.01.031; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Gerloff DL, 2005, P NATL ACAD SCI USA, V102, P13598, DOI 10.1073/pnas.0502378102; GUGUENGUILLOUZO C, 1982, CELL BIOL INT REP, V6, P625, DOI 10.1016/0309-1651(82)90187-4; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Healer J, 1999, PARASITOLOGY, V119, P425, DOI 10.1017/S0031182099005041; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOFFMAN SL, 1991, SCIENCE, V252, P520, DOI 10.1126/science.2020852; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Ishino T, 2005, MOL MICROBIOL, V58, P1264, DOI 10.1111/j.1365-2958.2005.04801.x; Kappe SHI, 2001, P NATL ACAD SCI USA, V98, P9895, DOI 10.1073/pnas.171185198; Kariu T, 2006, MOL MICROBIOL, V59, P1369, DOI 10.1111/j.1365-2958.2005.05024.x; Kooij TWA, 2005, PLOS PATHOG, V1, P349, DOI 10.1371/journal.ppat.0010044; Labaied M, 2007, INFECT IMMUN, V75, P3758, DOI 10.1128/IAI.00225-07; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; MAZIER D, 1985, SCIENCE, V227, P440, DOI 10.1126/science.3880923; MAZIER D, 1986, SCIENCE, V231, P156, DOI 10.1126/science.3510455; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Pinzon-Charry A, 2008, EXPERT OPIN BIOL TH, V8, P441, DOI [10.1517/14712598.8.4.441, 10.1517/14712598.8.4.441 ]; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P812, DOI 10.1016/0035-9203(82)90116-X; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; PONNUDURAI T, 1986, PARASITOLOGY, V93, P263, DOI 10.1017/S003118200005143X; PONNUDURAI T, 1987, T ROY SOC TROP MED H, V81, P491, DOI 10.1016/0035-9203(87)90172-6; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; Purcell LA, 2008, INFECT IMMUN, V76, P1193, DOI 10.1128/IAI.01399-07; RENIA L, 1990, EUR J IMMUNOL, V20, P1445, DOI 10.1002/eji.1830200706; RENIA L, 1988, J IMMUNOL METHODS, V112, P201, DOI 10.1016/0022-1759(88)90358-4; ROSARIO V, 1981, SCIENCE, V212, P1037, DOI 10.1126/science.7015505; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sambrook J., 2001, MOL CLONING LAB MANU; Silvie O, 2002, PARASITE IMMUNOL, V24, P221, DOI 10.1046/j.1365-3024.2002.00450.x; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; STEWART MJ, 1988, J PROTOZOOL, V35, P389, DOI 10.1111/j.1550-7408.1988.tb04115.x; Stoute JA, 1998, BIODRUGS, V10, P123, DOI 10.2165/00063030-199810020-00004; Su XZ, 1996, NUCLEIC ACIDS RES, V24, P1574, DOI 10.1093/nar/24.8.1574; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; Tarun AS, 2007, J INFECT DIS, V196, P608, DOI 10.1086/519742; Thompson J, 2001, MOL BIOCHEM PARASIT, V118, P147, DOI 10.1016/S0166-6851(01)00377-2; Tomas AM, 2001, EMBO J, V20, P3975, DOI 10.1093/emboj/20.15.3975; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; van Schaijk BCL, 2006, MOL BIOCHEM PARASIT, V149, P216, DOI 10.1016/j.molbiopara.2006.05.015; VANDERBERG JP, 1968, J PARASITOL, V54, P1175, DOI 10.2307/3276987; Waters AP, 2005, SCIENCE, V307, P528, DOI 10.1126/science.1108598; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130	65	74	81	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3549	10.1371/journal.pone.0003549	http://dx.doi.org/10.1371/journal.pone.0003549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958160	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000265130900010
J	Savelieva, KV; Zhao, SL; Pogorelov, VM; Rajan, I; Yang, Q; Cullinan, E; Lanthorn, TH				Savelieva, Katerina V.; Zhao, Shulei; Pogorelov, Vladimir M.; Rajan, Indrani; Yang, Qi; Cullinan, Emily; Lanthorn, Thomas H.			Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants	PLOS ONE			English	Article							TARGETED DISRUPTION; MICE; RECEPTORS; MUTATION; POLYMORPHISMS; ASSOCIATION; DISORDERS; RESPONSES; EFFICACY; VARIANTS	The neurotransmitter serotonin (5-HT) plays an important role in both the peripheral and central nervous systems. The biosynthesis of serotonin is regulated by two rate-limiting enzymes, tryptophan hydroxylase-1 and -2 (TPH1 and TPH2). We used a gene-targeting approach to generate mice with selective and complete elimination of the two known TPH isoforms. This resulted in dramatically reduced central 5-HT levels in Tph2 knockout (TPH2KO) and Tph1/Tph2 double knockout (DKO) mice; and substantially reduced peripheral 5-HT levels in DKO, but not TPH2KO mice. Therefore, differential expression of the two isoforms of TPH was reflected in corresponding depletion of 5-HT content in the brain and periphery. Surprisingly, despite the prominent and evolutionarily ancient role that 5-HT plays in both vertebrate and invertebrate physiology, none of these mutations resulted in an overt phenotype. TPH2KO and DKO mice were viable and normal in appearance. Behavioral alterations in assays with predictive validity for antidepressants were among the very few phenotypes uncovered. These behavioral changes were subtle in the TPH2KO mice; they were enhanced in the DKO mice. Herein, we confirm findings from prior descriptions of TPH1 knockout mice and present the first reported phenotypic evaluations of Tph2 and Tph1/Tph2 knockout mice. The behavioral effects observed in the TPH2 KO and DKO mice strongly confirm the role of 5-HT and its synthetic enzymes in the etiology and treatment of affective disorders.	[Savelieva, Katerina V.; Zhao, Shulei; Pogorelov, Vladimir M.; Rajan, Indrani; Yang, Qi; Cullinan, Emily; Lanthorn, Thomas H.] Lexicon Pharmaceut Inc, The Woodlands, TX USA	Lexicon Pharmaceuticals	Savelieva, KV (corresponding author), Lexicon Pharmaceut Inc, The Woodlands, TX USA.	ksavelieva@lexpharma.com						Bai F, 2001, PHARMACOL BIOCHEM BE, V70, P187, DOI 10.1016/S0091-3057(01)00599-8; Ballenger JC, 1999, BIOL PSYCHIAT, V46, P1579, DOI 10.1016/S0006-3223(99)00220-6; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; Begovic Amra, 2004, Bosn J Basic Med Sci, V4, P79; Bonasera SJ, 2000, PHARMACOL THERAPEUT, V88, P133, DOI 10.1016/S0163-7258(00)00087-5; Bourin M, 2005, BEHAV BRAIN RES, V164, P266, DOI 10.1016/j.bbr.2005.06.015; Buhot MC, 1997, CURR OPIN NEUROBIOL, V7, P243, DOI 10.1016/S0959-4388(97)80013-X; Coon H, 2005, AM J MED GENET B, V135B, P42, DOI 10.1002/ajmg.b.30168; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Delorme R, 2006, BIOL PSYCHIAT, V60, P202, DOI 10.1016/j.biopsych.2005.12.014; Dodick DW, 2007, CNS DRUGS, V21, P73, DOI 10.2165/00023210-200721010-00006; DRUGAN RC, 1989, PHARMACOL BIOCHEM BE, V33, P649, DOI 10.1016/0091-3057(89)90403-6; Ericsson M, 1996, ADDICT BEHAV, V21, P733, DOI 10.1016/0306-4603(96)00032-9; Gershon Michael D, 2003, Rev Gastroenterol Disord, V3 Suppl 2, pS25; Goodman WK, 1999, J CLIN PSYCHIAT, V60, P27; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Haavik J, 2008, HUM MUTAT, V29, P891, DOI 10.1002/humu.20700; Holmes A, 2002, NEUROPSYCHOPHARMACOL, V27, P914, DOI 10.1016/S0893-133X(02)00374-3; Julius D, 1998, P NATL ACAD SCI USA, V95, P15153, DOI 10.1073/pnas.95.26.15153; KOBAYASHI K, 1995, J BIOL CHEM, V270, P27235, DOI 10.1074/jbc.270.45.27235; Kobayashi T, 2008, PSYCHOPHARMACOLOGY, V197, P567, DOI 10.1007/s00213-008-1070-6; Kugaya A, 2003, NEUROPSYCHOPHARMACOL, V28, P413, DOI 10.1038/sj.npp.1300036; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; Leo RJ, 2006, CURR OPIN INVEST DR, V7, P637; Li X, 2006, LIFE SCI, V78, P1933, DOI 10.1016/j.lfs.2005.08.002; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Liu SM, 2008, VITIS, V47, P55; Londei T, 1998, BEHAV BRAIN RES, V94, P249, DOI 10.1016/S0166-4328(97)00162-9; Mann JJ, 1999, NEUROPSYCHOPHARMACOL, V21, pS99, DOI 10.1038/sj.npp.1395364; Martin JR, 1998, J PHARMACOL EXP THER, V286, P913; McKinney J, 2008, MOL PSYCHIATR, V13, P365, DOI 10.1038/sj.mp.4002152; Millan MJ, 2004, J PHARMACOL EXP THER, V309, P921, DOI 10.1124/jpet.103.062414; Nicolas LB, 2006, EUR J PHARMACOL, V547, P106, DOI 10.1016/j.ejphar.2006.07.015; POGORELOV VM, 2008, EXPT MODELS IN PRESS; Renard CE, 2003, FUND CLIN PHARMACOL, V17, P449, DOI 10.1046/j.1472-8206.2003.00160.x; RENSON J, 1962, J BIOL CHEM, V237, P2261; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Serretti A, 2005, PROG NEURO-PSYCHOPH, V29, P1074, DOI 10.1016/j.pnpbp.2005.03.013; Sheehan K, 2005, MOL PSYCHIATR, V10, P944, DOI 10.1038/sj.mp.4001698; Sheehan K, 2007, NEUROSCI LETT, V412, P105, DOI 10.1016/j.neulet.2006.10.043; Singh VP, 2001, BRAIN RES, V915, P218, DOI 10.1016/S0006-8993(01)02854-2; Sommer Claudia, 2006, Curr Pain Headache Rep, V10, P101, DOI 10.1007/s11916-006-0020-4; Veenstra-VanderWeele Jeremy, 2003, Mol Interv, V3, P72, DOI 10.1124/mi.3.2.72; Wallace J Mark, 2007, Curr Pain Headache Rep, V11, P208, DOI 10.1007/s11916-007-0192-6; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Zhao S, 2006, NEUROSCIENCE, V140, P321, DOI 10.1016/j.neuroscience.2006.01.049; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	52	193	199	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3301	10.1371/journal.pone.0003301	http://dx.doi.org/10.1371/journal.pone.0003301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923670	Green Published, gold, Green Submitted			2022-12-27	WOS:000265121800001
J	Kuballa, P; Huett, A; Rioux, JD; Daly, MJ; Xavier, RJ				Kuballa, Petric; Huett, Alan; Rioux, John D.; Daly, Mark J.; Xavier, Ramnik J.			Impaired Autophagy of an Intracellular Pathogen Induced by a Crohn's Disease Associated ATG16L1 Variant	PLOS ONE			English	Article								The genetic risk factors predisposing individuals to the development of inflammatory bowel disease are beginning to be deciphered by genome-wide association studies. Surprisingly, these new data point towards a critical role of autophagy in the pathogenesis of Crohn's disease. A single common coding variant in the autophagy protein ATG16L1 predisposes individuals to the development of Crohn's disease: while ATG16L1 encoding threonine at amino acid position 300 (ATG16L1*300T) confers protection, ATG16L1 encoding for alanine instead of threonine (ATG16L1*300A, also known as T300A) mediates risk towards the development of Crohn's disease. Here we report that, in human epithelial cells, the Crohn's disease-associated ATG16L1 coding variant shows impairment in the capture of internalized Salmonella within autophagosomes. Thus, we propose that the association of ATG16L1*300A with increased risk of Crohn's disease is due to impaired bacterial handling and lowered rates of bacterial capture by autophagy.	[Kuballa, Petric; Huett, Alan; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02115 USA; [Rioux, John D.; Daly, Mark J.] Harvard Univ, Massachusetts Inst Technol, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02138 USA; [Rioux, John D.] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Daly, Mark J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Universite de Montreal; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kuballa, P (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02115 USA.	xavier@molbio.mgh.harvard.edu	Huett, Alan/AAI-7998-2020; Rioux, John D/A-9599-2015; Daly, Mark J/B-2453-2017	Huett, Alan/0000-0001-7385-5585; Rioux, John D/0000-0001-7560-8326; Daly, Mark J/0000-0002-0949-8752	Deutsche Forschungsgemeinschaft [KU2511/1-1]; CCIB; National Institutes of Allergy and Infectious Diseases [AI065687, AI067152]; National Institute of Diabetes and Digestive and Kidney Diseases [DK064869, DK062432]; Crohn's and Colitis Foundation of America [SRA512];  [AI062773];  [HL88297]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773, P01AI065687, U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064869, U01DK062432, P30DK040561] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CCIB; National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	PK is supported by a fellowship award from the Deutsche Forschungsgemeinschaft (KU2511/1-1). RJX is supported by the following grants: AI062773, HL88297 and CCIB development funds. JDR is funded by grants from the National Institutes of Allergy and Infectious Diseases (AI065687; AI067152) from the National Institute of Diabetes and Digestive and Kidney Diseases (DK064869; DK062432) and the Crohn's and Colitis Foundation of America (SRA512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kuballa P, 2007, J BIOL CHEM, V282, P65, DOI 10.1074/jbc.M605117200; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zheng HR, 2004, DNA SEQUENCE, V15, P303, DOI 10.1080/10425170400004104	21	259	271	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3391	10.1371/journal.pone.0003391	http://dx.doi.org/10.1371/journal.pone.0003391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852889	gold, Green Published, Green Submitted			2022-12-27	WOS:000265121600014
J	Hikita, ST; Kosik, KS; Clegg, DO; Bamdad, C				Hikita, Sherry T.; Kosik, Kenneth S.; Clegg, Dennis O.; Bamdad, Cynthia			MUC1*Mediates the Growth of Human Pluripotent Stem Cells	PLOS ONE			English	Article								The MUC1 protein is aberrantly expressed on an estimated 75% of all human solid tumor cancers. We recently reported that a transmembrane cleavage product, MUC1*, is the predominant form of the protein on cancer cells [1]. Further, our evidence indicated that MUC1* functions as a growth factor receptor on tumor cells, while the full-length protein appeared to have no growth promoting activity. Here, we report that MUC1* acts as a growth factor receptor on undifferentiated human embryonic stem cells (hESCs). Cleavage of the full-length ectodomain to form MUC1*, a membrane receptor, appears to make binding to its ligand, NM23, possible. Unexpectedly, we found that newly differentiated cells no longer express the cleaved form, MUC1*, or its ligand, NM23. Newly differentiated stem cells exclusively present full-length MUC1. Antibody-induced dimerization of the MUC1* receptor on hESCs stimulated cell growth to a far greater degree than currently used methods that require the addition of exogenous basic fibroblast growth factor (bFGF) as well as factors secreted by fibroblast "feeder cells''. Further, MUC1* mediated growth was shown to be independent of growth stimulated by bFGF or the milieu of factors secreted by feeder cells. Stimulating the MUC1* receptor with either the cognate antibody or its ligand NM23 enabled hESC growth in a feeder cell-free system and produced pluripotent colonies that resisted spontaneous differentiation. These findings suggest that this primal growth mechanism could be utilized to propagate large numbers of pluripotent stem cells for therapeutic interventions.	[Hikita, Sherry T.; Kosik, Kenneth S.; Clegg, Dennis O.] Univ Calif Santa Barbara, Ctr Stem Cell Biol & Engn, Santa Barbara, CA 93106 USA; [Hikita, Sherry T.; Kosik, Kenneth S.; Clegg, Dennis O.] Univ Calif Santa Barbara, Dept Mol, Cellular & Dev Biol, Santa Barbara, CA USA; [Kosik, Kenneth S.; Clegg, Dennis O.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA USA; [Bamdad, Cynthia] Minerva Biotechnol, Waltham, MA USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Hikita, ST (corresponding author), Univ Calif Santa Barbara, Ctr Stem Cell Biol & Engn, Santa Barbara, CA 93106 USA.	cbamdad@minervabio.com			W.M. Keck Foundation; California Institute for Regenerative Medicine; Advanced Cell Technology, Inc.; Chemicon / Millipore Corp.; TriCounties Blood Bank; Santa Barbara Cottage Hospital	W.M. Keck Foundation(W.M. Keck Foundation); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Advanced Cell Technology, Inc.; Chemicon / Millipore Corp.; TriCounties Blood Bank; Santa Barbara Cottage Hospital	Dr. Ken Kosik is supported in part by the W.M. Keck Foundation. The Center for Stem Cell Biology and Engineering was supported by grants from the California Institute for Regenerative Medicine, Advanced Cell Technology, Inc., Chemicon / Millipore Corp., the TriCounties Blood Bank, Santa Barbara Cottage Hospital, and private individuals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Baruch A, 1997, INT J CANCER, V71, P741; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Dalton S, 2008, REGEN MED, V3, P181, DOI 10.2217/17460751.3.2.181; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; DZIADEK MA, 1983, EMBO J, V2, P549, DOI 10.1002/j.1460-2075.1983.tb01461.x; GIRLING A, 1989, INT J CANCER, V43, P1072, DOI 10.1002/ijc.2910430620; HENDRIKA M, 1997, INT J CANCER, V72, P87; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Kim YI, 2003, BIOCHEM BIOPH RES CO, V307, P281, DOI 10.1016/S0006-291X(03)01195-1; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P227, DOI 10.1023/A:1005580828141; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Levitin F, 2005, J BIOL CHEM, V280, P33374, DOI 10.1074/jbc.M506047200; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Mahanta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002054; Mountford JC, 2008, TRANSFUSION MED, V18, P1, DOI 10.1111/j.1365-3148.2007.00807.x; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Okabe-Kado J, 2002, LEUKEMIA LYMPHOMA, V43, P859, DOI 10.1080/10428190290017006; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; Thathiah A, 2004, BIOCHEM J, V382, P363, DOI 10.1042/BJ20040513; Thathiah A, 2003, J BIOL CHEM, V278, P3386, DOI 10.1074/jbc.M208326200; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971	35	59	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3312	10.1371/journal.pone.0003312	http://dx.doi.org/10.1371/journal.pone.0003312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833326	Green Published, Green Submitted, gold			2022-12-27	WOS:000264797400001
J	Dominguez-Bello, MG; Perez, ME; Bortolini, MC; Salzano, FM; Pericchi, LR; Zambrano-Guzman, O; Linz, B				Dominguez-Bello, Maria G.; Perez, Maria E.; Bortolini, Maria C.; Salzano, Francisco M.; Pericchi, Luis R.; Zambrano-Guzman, Orlisbeth; Linz, Bodo			Amerindian Helicobacter pylori Strains Go Extinct, as European Strains Expand Their Host Range	PLOS ONE			English	Article								We studied the diversity of bacteria and host in the H. pylori-human model. The human indigenous bacterium H. pylori diverged along with humans, into African, European, Asian and Amerindian groups. Of these, Amerindians have the least genetic diversity. Since niche diversity widens the sets of resources for colonizing species, we predicted that the Amerindian H. pylori strains would be the least diverse. We analyzed the multilocus sequence (7 housekeeping genes) of 131 strains: 19 cultured from Africans, 36 from Spanish, 11 from Koreans, 43 from Amerindians and 22 from South American Mestizos. We found that all strains that had been cultured from Africans were African strains (hpAfrica1), all from Spanish were European (hpEurope) and all from Koreans were hspEAsia but that Amerindians and Mestizos carried mixed strains: hspAmerind and hpEurope strains had been cultured from Amerindians and hpEurope and hpAfrica1 were cultured from Mestizos. The least genetically diverse H. pylori strains were hspAmerind. Strains hpEurope were the most diverse and showed remarkable multilocus sequence mosaicism (indicating recombination). The lower genetic structure in hpEurope strains is consistent with colonization of a diversity of hosts. If diversity is important for the success of H. pylori, then the low diversity of Amerindian strains might be linked to their apparent tendency to disappear. This suggests that Amerindian strains may lack the needed diversity to survive the diversity brought by non-Amerindian hosts.	[Dominguez-Bello, Maria G.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Perez, Maria E.; Pericchi, Luis R.] Univ Puerto Rico, Dept Math, San Juan, PR 00936 USA; [Bortolini, Maria C.; Salzano, Francisco M.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Zambrano-Guzman, Orlisbeth] Univ Pedagogica Expt Libertador, Bilingual Intercult Dept, Puerto Ayacucho, Venezuela; [Linz, Bodo] Max Planck Inst Infektionsbiol, Dept Mol Biol, Berlin, Germany	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; Universidade Federal do Rio Grande do Sul; Max Planck Society	Dominguez-Bello, MG (corresponding author), Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA.	mgdbello@uprr.pr	Salzano, Francisco M/L-7916-2015; Pericchi, Luis/W-5342-2018; Perez, Maria-Eglee/W-3868-2017	Pericchi, Luis/0000-0002-7096-3596; Perez, Maria-Eglee/0000-0001-8641-8405	UPR intramural FIPI [880314]; BMBF [0313930B]	UPR intramural FIPI; BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by UPR intramural FIPI grant 880314. B.L. was supported by ERA-Net grant BMBF 0313930B to Mark Achtman.	ACOSTA M, 2002, THESIS U CENTRAL VEN; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; ARENDS T, 1992, ESTRUCTURA GENETICA; Armbrecht I, 2004, SCIENCE, V304, P284, DOI 10.1126/science.1094981; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; CASTRO D, 1993, B SOC ESP ANTROP BIO, V14, P21; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Crespillo M, 2000, INT J LEGAL MED, V114, P130, DOI 10.1007/s004140000158; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; DOMINGUEZBELLO MG, 2008, EVOLUTION HELICOBACT; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Gandon S, 1998, TRENDS ECOL EVOL, V13, P214, DOI 10.1016/S0169-5347(98)01358-5; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Ghose C, 2005, J CLIN MICROBIOL, V43, P2635, DOI 10.1128/JCM.43.6.2635-2641.2005; Gonzalez M., 1997, EPE'97. 7th European Conference on Power Electronics and Applications, P78; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; Horai S, 1996, AM J HUM GENET, V59, P579; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAYRISSE M, 1966, INDIAN SOC VENEZUELA; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Loureiro CL, 2002, J MED VIROL, V68, P357, DOI 10.1002/jmv.10211; MARTINEZ H, 2003, THESIS U CENTRAL VEN; MIURA T, 1994, P NATL ACAD SCI USA, V91, P1124, DOI 10.1073/pnas.91.3.1124; PARSONNET J, 1994, WESTERN J MED, V161, P60; Picornell A, 2005, AM J PHYS ANTHROPOL, V128, P119, DOI 10.1002/ajpa.10423; Pinto F, 1996, ANN HUM GENET, V60, P321, DOI 10.1111/j.1469-1809.1996.tb01195.x; Plaza S, 2003, ANN HUM GENET, V67, P312, DOI 10.1046/j.1469-1809.2003.00039.x; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; R Development Core Team, 2006, R LANG ENV STAT COMP; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Reineking B, 2006, ECOL MODEL, V199, P486, DOI 10.1016/j.ecolmodel.2006.03.038; Rodriguez-Larralde A, 2001, INTERCIENCIA, V26, P8; Salas A, 2017, EUR J HUM GENET, V25, pS33, DOI 10.1038/sj.ejhg.5200202; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; Torres MM, 2006, AM J HUM BIOL, V18, P59, DOI 10.1002/ajhb.20461; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wirth T, 2005, MOL ECOL, V14, P3289, DOI 10.1111/j.1365-294X.2005.02687.x; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101; Zambrano O., 2000, REV ESP ANTROP BIOL, V21, P111; ZAMBRANOGUZMAN O, 1999, THESIS U CENTRAL VEN	53	40	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3307	10.1371/journal.pone.0003307	http://dx.doi.org/10.1371/journal.pone.0003307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830403	Green Published, gold			2022-12-27	WOS:000264797300001
J	Maciel, C; de Oliveira, VX; Fazio, MA; Nacif-Pimenta, R; Miranda, A; Pimenta, PFP; Capurro, ML				Maciel, Ceres; de Oliveira Junior, Vani Xavier; Fazio, Marcos Antonio; Nacif-Pimenta, Rafael; Miranda, Antonio; Pimenta, Paulo F. P.; Capurro, Margareth Lara			Anti-Plasmodium Activity of Angiotensin II and Related Synthetic Peptides	PLOS ONE			English	Article								Plasmodium species are the causative agents of malaria, the most devastating insect-borne parasite of human populations. Finding and developing new drugs for malaria treatment and prevention is the goal of much research. Angiotensins I and II (ang I and ang II) and six synthetic related peptides designated Vaniceres 1-6 (VC1-VC6) were assayed in vivo and in vitro for their effects on the development of the avian parasite, Plasmodium gallinaceum. Ang II and VC5 injected into the thoraces of the insects reduced mean intensities of infection in the mosquito salivary glands by 88% and 76%, respectively. Although the mechanism(s) of action is not completely understood, we have demonstrated that these peptides disrupt selectively the P. gallinaceum cell membrane. Additionally, incubation in vitro of sporozoites with VC5 reduced the infectivity of the parasites to their vertebrate host. VC5 has no observable agonist effects on vertebrates, and this makes it a promising drug for malaria prevention and chemotherapy.	[Maciel, Ceres; Capurro, Margareth Lara] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil; [de Oliveira Junior, Vani Xavier] Fed Univ ABC, Nat & Human Sci Ctr, Santo Andre, Brazil; [Fazio, Marcos Antonio; Miranda, Antonio] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Nacif-Pimenta, Rafael; Pimenta, Paulo F. P.] Fundacao Oswaldo Cruz, FIOCRUZ, Rene Rachou Inst Res, Lab Med Entomol, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade Federal de Sao Paulo (UNIFESP); Fundacao Oswaldo Cruz	Maciel, C (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.	mcapurro@icb.usp.br	Miranda, Antonio/C-8855-2012; Capurro, Margareth L/F-8679-2012; Pimenta, Paulo/AAH-1502-2020; Oliveira, Vani X/E-4645-2012; Fazio, Marcos A/P-9993-2015; Capurro, Margareth/M-5286-2019	Capurro, Margareth L/0000-0002-7480-2116; Oliveira, Vani X/0000-0002-9420-0956; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); CNPq [fellows]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work is supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). A.M., C.M. and M.L.C. are fellows from CNPq.	BARANY G, 1980, PEPTIDES ANAL SYNTHE, V2, P1; Capurro MD, 2000, AM J TROP MED HYG, V62, P427, DOI 10.4269/ajtmh.2000.62.427; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Dagan A, 2002, ANTIMICROB AGENTS CH, V46, P1059, DOI 10.1128/AAC.46.4.1059-1066.2002; Oliveira VX, 2008, J PEPT SCI, V14, P617, DOI 10.1002/pse.957; Efron L, 2002, J BIOL CHEM, V277, P24067, DOI 10.1074/jbc.M202089200; Fazio MA, 2006, BIOPOLYMERS, V84, P205, DOI 10.1002/bip.20396; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghosh JK, 1997, J BIOL CHEM, V272, P31609, DOI 10.1074/jbc.272.50.31609; GWADZ RW, 1989, INFECT IMMUN, V57, P2628, DOI 10.1128/IAI.57.9.2628-2633.1989; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jubilut GN, 1997, J BRAZIL CHEM SOC, V8, P65; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Leung PS, 2005, INT J BIOCHEM CELL B, V37, P237, DOI 10.1016/j.biocel.2004.07.004; Moreira CK, 2007, EXP PARASITOL, V116, P346, DOI 10.1016/j.exppara.2007.01.022; Munstermann LE, 1997, ANNU REV ENTOMOL, V42, P351, DOI 10.1146/annurev.ento.42.1.351; O'Neill PM, 2004, J MED CHEM, V47, P2945, DOI 10.1021/jm030571c; Oliveira VX, 2005, REGUL PEPTIDES, V127, P123, DOI 10.1016/j.regpep.2004.11.001; Oliveira VX, 2003, BIOPOLYMERS, V71, P372; Schneider DS, 2006, EMBO REP, V7, P259, DOI 10.1038/sj.embor.7400643; Shahabuddin M, 1998, EXP PARASITOL, V89, P103, DOI 10.1006/expr.1998.4212; THATHY V, 1994, J PARASITOL, V80, P705, DOI 10.2307/3283249; VIAL HJ, 1998, MALARIA PARASITE BIO, V11, P159; WHO UNICEF, 2005, WORLD MALARIA REPORT; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	25	52	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2008	3	9							e3296	10.1371/journal.pone.0003296	http://dx.doi.org/10.1371/journal.pone.0003296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MN	18820728	Green Published, Green Submitted, gold			2022-12-27	WOS:000264432500006
J	Tomovic, A; Oakeley, EJ				Tomovic, Andrija; Oakeley, Edward J.			Computational Structural Analysis: Multiple Proteins Bound to DNA	PLOS ONE			English	Article							NUCLEIC ACID RECOGNITION; TRANSCRIPTION FACTORS; STATISTICAL-ANALYSIS; REGULATORY MODULES; IDENTIFICATION; COOPERATIVITY; INTERFACES; IDENTIFY; READOUT; PISCES	Background: With increasing numbers of crystal structures of protein: DNA and protein: protein: DNA complexes publically available, it is now possible to extract sufficient structural, physical-chemical and thermodynamic parameters to make general observations and predictions about their interactions. In particular, the properties of macromolecular assemblies of multiple proteins bound to DNA have not previously been investigated in detail. Methodology/Principal Findings: We have performed computational structural analyses on macromolecular assemblies of multiple proteins bound to DNA using a variety of different computational tools: PISA; PROMOTIF; X3DNA; ReadOut; DDNA and DCOMPLEX. Additionally, we have developed and employed an algorithm for approximate collision detection and overlapping volume estimation of two macromolecules. An implementation of this algorithm is available at http://promoterplot.fmi.ch/Collision1/. The results obtained are compared with structural, physical-chemical and thermodynamic parameters from protein: protein and single protein: DNA complexes. Many of interface properties of multiple protein: DNA complexes were found to be very similar to those observed in binary protein: DNA and protein: protein complexes. However, the conformational change of the DNA upon protein binding is significantly higher when multiple proteins bind to it than is observed when single proteins bind. The water mediated contacts are less important (found in less quantity) between the interfaces of components in ternary (protein: protein: DNA) complexes than in those of binary complexes (protein: protein and protein: DNA). The thermodynamic stability of ternary complexes is also higher than in the binary interactions. Greater specificity and affinity of multiple proteins binding to DNA in comparison with binary protein-DNA interactions were observed. However, protein-protein binding affinities are stronger in complexes without the presence of DNA. Conclusions/Significance: Our results indicate that the interface properties: interface area; number of interface residues/atoms and hydrogen bonds; and the distribution of interface residues, hydrogen bonds, van der Walls contacts and secondary structure motifs are independent of whether or not a protein is in a binary or ternary complex with DNA. However, changes in the shape of the DNA reduce the off-rate of the proteins which greatly enhances the stability and specificity of ternary complexes compared to binary ones.	[Tomovic, Andrija; Oakeley, Edward J.] Novo Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Tomovic, A (corresponding author), Novo Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	andrija.tomovic@fmi.ch			Novartis Research Foundation	Novartis Research Foundation	This work was supported by the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2006, NUCLEIC ACIDS RES, V34, pW124, DOI 10.1093/nar/gkl104; Banerjee N, 2003, NUCLEIC ACIDS RES, V31, P7024, DOI 10.1093/nar/gkg894; BAREQUET G, 1996, BOXTREE HIERARCHICAL; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Cho KI, 2006, PROTEINS, V65, P593, DOI 10.1002/prot.21056; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Ellis JJ, 2007, PROTEINS, V66, P903, DOI 10.1002/prot.21211; GOTTSCHALK S, 1996, OBB TREE HIERARCHICA; Gromiha MM, 2004, J MOL BIOL, V337, P285, DOI 10.1016/j.jmb.2004.01.033; GUHAROY M, 2007, BIOINFORMATICS; Hubbard PM, 1996, ACM T GRAPHIC, V15, P179, DOI 10.1145/231731.231732; HUGHES M, 1996, EFFICIENT ACCURATE I; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Janin J, 1999, STRUCT FOLD DES, V7, pR277, DOI 10.1016/S0969-2126(00)88333-1; Jayaram B, 2004, ANNU REV BIOPH BIOM, V33, P343, DOI 10.1146/annurev.biophys.33.110502.140414; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jones S, 2001, NUCLEIC ACIDS RES, V29, P943, DOI 10.1093/nar/29.4.943; Jones S, 1999, J MOL BIOL, V287, P877, DOI 10.1006/jmbi.1999.2659; KRISSINEL E, 2002, COMPUTATIONAL LIFE S, P163; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lejeune D, 2005, PROTEINS, V61, P258, DOI 10.1002/prot.20607; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Luscombe NM, 2000, GENOME BIOL, V1; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MANDELGUTFREUND Y, 1995, J MOL BIOL, V253, P370, DOI 10.1006/jmbi.1995.0559; Martin ACR, 2005, BIOINFORMATICS, V21, P4297, DOI 10.1093/bioinformatics/bti694; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Mirny LA, 2002, NUCLEIC ACIDS RES, V30, P1704, DOI 10.1093/nar/30.7.1704; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Nadassy K, 1999, BIOCHEMISTRY-US, V38, P1999, DOI 10.1021/bi982362d; Pabo CO, 2000, J MOL BIOL, V301, P597, DOI 10.1006/jmbi.2000.3918; Reddy CK, 2001, J MOL BIOL, V314, P619, DOI 10.1006/jmbi.2001.5154; Sarai A, 2005, ANNU REV BIOPH BIOM, V34, P379, DOI 10.1146/annurev.biophys.34.040204.144537; Sinha S, 2008, GENOME RES, V18, P477, DOI 10.1101/gr.6828808; Teschner M, 2003, OPTIMIZED SPATIAL HA; Treger M, 2001, J MOL RECOGNIT, V14, P199, DOI 10.1002/jmr.534; TURK G, 1989, INTERACTIVE COLLISIO; van den Bergen G., 1997, J GRAPH TOOLS, V2, P1, DOI [10.1080/10867651.1997.10487480, DOI 10.1080/10867651.1997.10487480]; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Williamson JR, 2008, NAT CHEM BIOL, V4, P458, DOI 10.1038/nchembio.102; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Zhang C, 2005, J MED CHEM, V48, P2325, DOI 10.1021/jm049314d; Zhao GY, 2007, GENOME RES, V17, P348, DOI 10.1101/gr.5989907	51	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2008	3	9							e3243	10.1371/journal.pone.0003243	http://dx.doi.org/10.1371/journal.pone.0003243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LF	18802470	Green Published, Green Submitted, gold			2022-12-27	WOS:000264428600003
J	Huang, TH; Zhu, MJ; Li, XY; Zhao, SH				Huang, Ting-Hua; Zhu, Meng-Jin; Li, Xin-Yun; Zhao, Shu-Hong			Discovery of Porcine microRNAs and Profiling from Skeletal Muscle Tissues during Development	PLOS ONE			English	Article							GENE-EXPRESSION; ANIMAL MICRORNAS; TARGETS; PIG; DIFFERENTIATION; MICROARRAY; PROTEIN; GROWTH; ZBP-89; IDENTIFICATION	MiRNAs (microRNAs) play critical roles in many important biological processes such as growth and development in mammals. In this study, we identified hundreds of porcine miRNA candidates through in silico prediction and analyzed their expression in developing skeletal muscle using microarray. Microarray screening using RNA samples prepared from a 33-day whole embryo and an extra embryo membrane validated 296 of the predicted candidates. Comparative expression profiling across samples of longissimus muscle collected from 33-day and 65-day post-gestation fetuses, as well as adult pigs, identified 140 differentially expressed miRNAs amongst the age groups investigated. The differentially expressed miRNAs showed seven distinctive types of expression patterns, suggesting possible involvement in certain biological processes. Five of the differentially expressed miRNAs were validated using real-time PCR. In silico analysis of the miRNA-mRNA interaction sites suggested that the potential mRNA targets of the differentially expressed miRNAs may play important roles in muscle growth and development.	[Huang, Ting-Hua; Zhu, Meng-Jin; Li, Xin-Yun; Zhao, Shu-Hong] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China	Huazhong Agricultural University	Huang, TH (corresponding author), Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China.	shzhao@mail.hzau.edu.cn			Key Project of National Basic Research and Developmental Plan [2006CB102105]; National Natural Science Foundation of China [30671138]	Key Project of National Basic Research and Developmental Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by the Key Project of National Basic Research and Developmental Plan (2006CB102105) and the National Natural Science Foundation (30671138) of China.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang TH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-341; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Kim HJ, 2006, GENOME, V49, P1283, DOI 10.1139/G06-120; Law DJ, 2006, NUCLEIC ACIDS RES, V34, P1342, DOI 10.1093/nar/gkl022; Law DJ, 1998, MAMM GENOME, V9, P165, DOI 10.1007/s003359900711; LEFAUCHEUR L, 1995, DEV DYNAM, V203, P27, DOI 10.1002/aja.1002030104; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Luo MY, 2007, PROG BIOCHEM BIOPHYS, V34, P31; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Merchant JL, 1996, MOL CELL BIOL, V16, P6644; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Sawera M, 2005, MAMM GENOME, V16, P594, DOI 10.1007/s00335-005-0013-3; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tanoue T, 2002, PHARMACOL THERAPEUT, V93, P193, DOI 10.1016/S0163-7258(02)00188-2; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; WIGMORE PMC, 1983, J ANAT, V137, P235; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhao SH, 2003, J ANIM SCI, V81, P2179; Zhao SH, 2006, MAMM GENOME, V17, P777, DOI 10.1007/s00335-005-0155-3	36	119	134	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3225	10.1371/journal.pone.0003225	http://dx.doi.org/10.1371/journal.pone.0003225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795099	Green Published, gold, Green Submitted			2022-12-27	WOS:000264428000008
J	Benit, P; Goncalves, S; Dassa, EP; Briere, JJ; Rustin, P				Benit, Paule; Goncalves, Sergio; Dassa, Emmanuel Philippe; Briere, Jean-Jacques; Rustin, Pierre			The Variability of the Harlequin Mouse Phenotype Resembles that of Human Mitochondrial-Complex I-Deficiency Syndromes	PLOS ONE			English	Article								Background: Despite the considerable progress made in understanding the molecular bases of mitochondrial diseases, no effective treatments have been developed to date. Faithful animal models would be extremely helpful for designing such treatments. We showed previously that the Harlequin mouse phenotype was due to a specific mitochondrial complex I deficiency resulting from the loss of the Apoptosis Inducing Factor (Aif) protein. Methodology/Principal Findings: Here, we conducted a detailed evaluation of the Harlequin mouse phenotype, including the biochemical abnormalities in various tissues. We observed highly variable disease expression considering both severity and time course progression. In each tissue, abnormalities correlated with the residual amount of the respiratory chain complex I 20 kDa subunit, rather than with residual Aif protein. Antioxidant enzyme activities were normal except in skeletal muscle, where they were moderately elevated. Conclusions/Significance: Thus, the Harlequin mouse phenotype appears to result from mitochondrial respiratory chain complex I deficiency. Its features resemble those of human complex I deficiency syndromes. The Harlequin mouse holds promise as a model for developing treatments for complex I deficiency syndromes.	[Benit, Paule; Goncalves, Sergio; Dassa, Emmanuel Philippe; Briere, Jean-Jacques; Rustin, Pierre] Hop Robert Debre, INSERM, U676, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Benit, P (corresponding author), Hop Robert Debre, INSERM, U676, F-75019 Paris, France.	pierre.rustin@inserm.fr			Association Francaise contre les Myopathies (AFM) [11639]; Association contre les Maladies Mitochondriales (Ammi); Association Francaise contre l'Ataxie de Friedreich (AFAF); Leducq foundation; ANR MitOxy; European Union	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Association contre les Maladies Mitochondriales (Ammi); Association Francaise contre l'Ataxie de Friedreich (AFAF); Leducq foundation(Leducq Foundation); ANR MitOxy(French National Research Agency (ANR)); European Union(European Commission)	This work was supported by the Association Francaise contre les Myopathies (AFM) Project No. 11639), the Association contre les Maladies Mitochondriales (Ammi), the Association Francaise contre l'Ataxie de Friedreich (AFAF), the Leducq foundation, the ANR MitOxy, and the European Union (EUMITOCOMBAT project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova N, 2006, CELL DEATH DIFFER, V13, P354, DOI 10.1038/sj.cdd.4401776; Barber BR, 1971, MOUSE NEWS LETT, V45, P34; BENIT P, 2006, CLIN CHIM ACTA; BENIT P, 2007, COMPLEX ALTERNATIVE, P157; Benit P, 2008, MOL CELL BIOCHEM, V314, P45, DOI 10.1007/s11010-008-9763-z; Benit Paule, 2004, Current Genomics, V5, P137, DOI 10.2174/1389202043489971; Bodemer C, 1999, PEDIATRICS, V103, P428, DOI 10.1542/peds.103.2.428; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briere JJ, 2004, BBA-BIOENERGETICS, V1659, P172, DOI 10.1016/j.bbabio.2004.07.002; BROWN D, 2006, P NATL ACAD IN PRESS; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Claiborne A., 1985, CATALASE ACTIVITY; Delettre C, 2006, J BIOL CHEM, V281, P18507, DOI 10.1074/jbc.M601751200; DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598; Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; JOZA N, 2008, CELL DEATH DIFFER; KATZ BJ, 2006, AM J MED GENET A; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Larsson NG, 2001, TRENDS MOL MED, V7, P578, DOI 10.1016/S1471-4914(01)02167-0; MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391; Porter AG, 2006, BIOESSAYS, V28, P834, DOI 10.1002/bies.20444; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; QIU XZ, 2008, CELL BIOCH FUNCT; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Tzagoloff A, 1982, MITOCHONDRIA; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; van Empel VPM, 2006, J AM COLL CARDIOL, V48, P824, DOI 10.1016/j.jacc.2006.02.075; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	40	63	63	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3208	10.1371/journal.pone.0003208	http://dx.doi.org/10.1371/journal.pone.0003208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791645	Green Submitted, Green Published, gold			2022-12-27	WOS:000264427700003
J	Rizzi, F; Belloni, L; Crafa, P; Lazzaretti, M; Remondini, D; Ferretti, S; Cortellini, P; Corti, A; Bettuzzi, S				Rizzi, Federica; Belloni, Lucia; Crafa, Pellegrino; Lazzaretti, Mirca; Remondini, Daniel; Ferretti, Stefania; Cortellini, Piero; Corti, Arnaldo; Bettuzzi, Saverio			A Novel Gene Signature for Molecular Diagnosis of Human Prostate Cancer by RT-qPCR	PLOS ONE			English	Article								Background: Prostate cancer (CaP) is one of the most relevant causes of cancer death in Western Countries. Although detection of CaP at early curable stage is highly desirable, actual screening methods present limitations and new molecular approaches are needed. Gene expression analysis increases our knowledge about the biology of CaP and may render novel molecular tools, but the identification of accurate biomarkers for reliable molecular diagnosis is a real challenge. We describe here the diagnostic power of a novel 8-genes signature: ornithine decarboxylase (ODC), ornithine decarboxylase antizyme (OAZ), adenosylmethionine decarboxylase (AdoMetDC), spermidine/spermine N(1)-acetyltransferase (SSAT), histone H3 (H3), growth arrest specific gene (GAS1), glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and Clusterin (CLU) in tumour detection/classification of human CaP. Methodology/Principal Findings: The 8-gene signature was detected by retrotranscription real-time quantitative PCR (RT-qPCR) in frozen prostate surgical specimens obtained from 41 patients diagnosed with CaP and recommended to undergo radical prostatectomy (RP). No therapy was given to patients at any time before RP. The bio-bank used for the study consisted of 66 specimens: 44 were benign-CaP paired from the same patient. Thirty-five were classified as benign and 31 as CaP after final pathological examination. Only molecular data were used for classification of specimens. The Nearest Neighbour (NN) classifier was used in order to discriminate CaP from benign tissue. Validation of final results was obtained with 10-fold crossvalidation procedure. CaP versus benign specimens were discriminated with (80+/-65)% accuracy, (81+/-66)% sensitivity and (78+/-67)% specificity. The method also correctly classified 71% of patients with Gleason score < 7 versus >= 7, an important predictor of final outcome. Conclusions/Significance: The method showed high sensitivity in a collection of specimens in which a significant portion of the total (13/31, equal to 42%) was considered CaP on the basis of having less than 15% of cancer cells. This result supports the notion of the "cancer field effect'', in which transformed cells extend beyond morphologically evident tumour. The molecular diagnosis method here described is objective and less subjected to human error. Although further confirmations are needed, this method posses the potential to enhance conventional diagnosis.	[Rizzi, Federica; Belloni, Lucia; Bettuzzi, Saverio] Univ Parma, Dept Med Sperimentale, I-43100 Parma, Italy; [Rizzi, Federica; Belloni, Lucia; Bettuzzi, Saverio] Ist Nazl Biostrut Biosist, Rome, Italy; [Crafa, Pellegrino; Lazzaretti, Mirca] Univ Parma, Dept Patol Med Lab, Parma, Italy; [Remondini, Daniel] Univ Bologna, I-40126 Bologna, Italy; [Ferretti, Stefania; Cortellini, Piero] Univ Parma, Azienda Ospedaliera, Urol Operat Unit, Parma, Italy; [Corti, Arnaldo] Univ Modena, Dept Sci Biomed, I-41100 Modena, Italy	University of Parma; University of Parma; University of Bologna; University of Parma; University Hospital of Parma; Universita di Modena e Reggio Emilia	Bettuzzi, S (corresponding author), Univ Parma, Dept Med Sperimentale, I-43100 Parma, Italy.	saverio.bettuzzi@unipr.it	Remondini, Daniel/ABA-9971-2020; Bettuzzi, Saverio/B-2609-2009	Rizzi, Federica/0000-0002-6670-2588; Bettuzzi, Saverio/0000-0003-2080-6979; Ferretti, Stefania/0000-0002-2292-5632; Remondini, Daniel/0000-0003-3185-7456	Genprofiler Srl, Bolzano, Italy; University of Parma, Italy; Istituto Nazionale Biostrutture e Biosistemi (INBB), Roma, Italy	Genprofiler Srl, Bolzano, Italy; University of Parma, Italy; Istituto Nazionale Biostrutture e Biosistemi (INBB), Roma, Italy	Contract grant sponsors: Genprofiler Srl, Bolzano, Italy; FIL 2005 and FIL 2006, University of Parma, Italy; Istituto Nazionale Biostrutture e Biosistemi (INBB), Roma, Italy	Astancolle S, 2000, J ENDOCRINOL, V167, P197, DOI 10.1677/joe.0.1670197; Barrier A, 2005, ONCOGENE, V24, P6155, DOI 10.1038/sj.onc.1208984; Bettuzzi S, 2007, POL J VET SCI, V10, P57; Bettuzzi S, 2000, CANCER RES, V60, P1472; Bettuzzi S, 2003, CANCER RES, V63, P3469; Bettuzzi S, 2002, ONCOGENE, V21, P4328, DOI 10.1038/sj.onc.1205594; BETTUZZI S, 1989, BIOCHEM J, V257, P293, DOI 10.1042/bj2570293; Bettuzzi Saverio, 2003, Acta Biomed, V74, P101; Caccamo AE, 2005, CELL DEATH DIFFER, V12, P101, DOI 10.1038/sj.cdd.4401491; Caporali A, 2004, CARCINOGENESIS, V25, P2217, DOI 10.1093/carcin/bgh235; Chandran UR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-45; Chen TG, 2004, CANCER RES, V64, P7412, DOI 10.1158/0008-5472.CAN-04-2077; Cheng Liang, 2004, Clin Prostate Cancer, V3, P26; Chrouser Kristin L, 2004, Curr Urol Rep, V5, P226, DOI 10.1007/s11934-004-0041-7; Crescioli C, 2004, EUR J ENDOCRINOL, V150, P591, DOI 10.1530/eje.0.1500591; Crescioli C, 2003, ENDOCRINOLOGY, V144, P3046, DOI 10.1210/en.2002-0210; CRISSMAN JD, 1993, PROSTATE, V22, P155, DOI 10.1002/pros.2990220208; DELSAL G, 1992, CELL, V70, P595, DOI 10.1016/0092-8674(92)90429-G; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; FAIR WR, 1975, J UROLOGY, V114, P88, DOI 10.1016/S0022-5347(17)66951-9; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gleave M, 2005, WORLD J UROL, V23, P38, DOI 10.1007/s00345-004-0474-0; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Hessels D, 2003, EUR UROL, V44, P8, DOI 10.1016/S0302-2838(03)00201-X; Huppi Konrad, 2004, Curr Urol Rep, V5, P45, DOI 10.1007/s11934-004-0011-0; July LV, 2002, PROSTATE, V50, P179, DOI 10.1002/pros.10047; Koch-Brandt C, 1996, Prog Mol Subcell Biol, V16, P130; Konishi H, 1996, CANCER RES, V56, P434; Lakins J, 1998, J BIOL CHEM, V273, P27887, DOI 10.1074/jbc.273.43.27887; Landers KA, 2005, INT J CANCER, V114, P950, DOI 10.1002/ijc.20760; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Li T, 2004, BIOINFORMATICS, V20, P2429, DOI 10.1093/bioinformatics/bth267; Luo J, 2002, CANCER RES, V62, P2220; Mehrotra J, 2008, PROSTATE, V68, P152, DOI 10.1002/pros.20675; Miyake H, 2000, CANCER RES, V60, P170; Miyake H, 2005, ONCOL REP, V14, P1371; Miyake H, 2006, EXPERT OPIN INV DRUG, V15, P507, DOI 10.1517/13543784.15.5.507; Montironi R, 2005, BJU INT, V95, P1146, DOI 10.1111/j.1464-410X.2005.05540.x; Olapade-Alaopa EO, 1999, CLIN CANCER RES, V5, P569; PEGG AE, 1968, BIOCHEM J, V108, P533, DOI 10.1042/bj1080533; Pelzer AE, 2005, UROLOGY, V66, P1029, DOI 10.1016/j.urology.2005.05.025; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pins MR, 2004, PROSTATE CANCER P D, V7, P243, DOI 10.1038/sj.pcan.4500722; Reddy KB, 1996, BIOCHEMISTRY-US, V35, P6157, DOI 10.1021/bi952981b; Rhodes DR, 2002, CANCER RES, V62, P4427; RHODES JB, 1964, MED EXP, V10, P281; ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V27, P633, DOI 10.1016/1357-2725(95)00027-M; Rubin MA, 2002, JAMA-J AM MED ASSOC, V287, P1662, DOI 10.1001/jama.287.13.1662; Sakr WA, 2001, UROLOGY, V57, P115, DOI 10.1016/S0090-4295(00)00953-5; Scaltriti M, 2004, INT J CANCER, V108, P23, DOI 10.1002/ijc.11496; Scaltriti M, 2006, CARCINOGENESIS, V27, P1047, DOI 10.1093/carcin/bgi287; Scaltriti M, 2004, BRIT J CANCER, V91, P1842, DOI 10.1038/sj.bjc.6602193; Scaltriti M, 2004, CANCER RES, V64, P6174, DOI 10.1158/0008-5472.CAN-04-0920; Scattoni V, 2006, EUR UROL, V50, P202, DOI 10.1016/j.eururo.2006.01.040; Schaefer KL, 2008, EUR J CANCER, V44, P699, DOI 10.1016/j.ejca.2008.01.020; Schmidt U, 2006, PROSTATE, V66, P1521, DOI 10.1002/pros.20490; Sheth A R, 1977, Adv Sex Horm Res, V3, P51; Tinzl M, 2004, EUR UROL, V46, P182, DOI 10.1016/j.eururo.2004.06.004; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Uetsuki H, 2005, J UROLOGY, V174, P514, DOI 10.1097/01.ju.0000165154.41159.b1; Williams-Ashman H G, 1969, Adv Enzyme Regul, V7, P291, DOI 10.1016/0065-2571(69)90024-7; Yang CR, 2000, P NATL ACAD SCI USA, V97, P5907, DOI 10.1073/pnas.97.11.5907; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang XW, 2005, EUR J HUM GENET, V13, P1303, DOI 10.1038/sj.ejhg.5201495	64	43	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3617	10.1371/journal.pone.0003617	http://dx.doi.org/10.1371/journal.pone.0003617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974881	Green Submitted, gold, Green Published			2022-12-27	WOS:000265131700031
J	Won, HH; Kim, HJ; Lee, KA; Kim, JW				Won, Hong-Hee; Kim, Hee-Jin; Lee, Kyung-A; Kim, Jong-Won			Cataloging Coding Sequence Variations in Human Genome Databases	PLOS ONE			English	Article								Background: With the recent growth of information on sequence variations in the human genome, predictions regarding the functional effects and relevance to disease phenotypes of coding sequence variations are becoming increasingly important. The aims of this study were to catalog protein-coding sequence variations (CVs) occurring in genetic variation databases and to use bioinformatic programs to analyze CVs. In addition, we aim to provide insight into the functionality of the reference databases. Methodology and Findings: To catalog CVs on a genome-wide scale with regard to protein function and disease, we investigated three representative databases; the Human Gene Mutation Database (HGMD), the Single Nucleotide Polymorphisms database (dbSNP), and the Haplotype Map (HapMap). Using these three databases, we analyzed CVs at the protein function level with bioinformatic programs. We proposed a combinatorial approach using the Support Vector Machine (SVM) to increase the performance of the prediction programs. By cataloging the coding sequence variations using these databases, we found that 4.36% of CVs from HGMD are concurrently registered in dbSNP (8.11% of CVs from dbSNP are concurrent in HGMD). The pattern of substitutions and functional consequences predicted by three bioinformatic programs was significantly different among concurrent CVs, and CVs occurring solely in HGMD or in dbSNP. The experimental results showed that the proposed SVM combination noticeably outperformed the individual prediction programs. Conclusions: This is the first study to compare human sequence variations in HGMD, dbSNP and HapMap at the genome-wide level. We found that a significant proportion of CVs in HGMD and dbSNP overlap, and we emphasize the need to use caution when interpreting the phenotypic relevance of these concurrent CVs. Combining bioinformatic programs can be helpful in predicting the functional consequences of CVs because it improved the performance of functional predictions.	[Won, Hong-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Won, Hong-Hee] Korea Advanced Inst Sci & Technol, Dept Bio & Brain Engn, Taejon, South Korea; [Kim, Hee-Jin; Kim, Jong-Won] Sungkyunkwan Univ, Sch Med, Dept Lab Med & Genet, Seoul, South Korea; [Lee, Kyung-A] Yonsei Univ, Coll Med, Dept Lab Med, Seoul 120749, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea Advanced Institute of Science & Technology (KAIST); Sungkyunkwan University (SKKU); Yonsei University; Yonsei University Health System	Won, HH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea.	kimjw@skku.edu	Won, Hong-Hee/D-2672-2011; Kim, Jong Won/C-9615-2011; Kim, Hee Jin/F-4594-2014; Kim, Sun/GSN-4867-2022	Won, Hong-Hee/0000-0001-5719-0552; Lee, Kyung-A/0000-0001-5320-6705	Korean HapMap Project from the Korean Ministry of Education, Science and Technology	Korean HapMap Project from the Korean Ministry of Education, Science and Technology	This work was supported by the Korean HapMap Project from the Korean Ministry of Education, Science and Technology.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Bao L, 2005, BIOINFORMATICS, V21, P2185, DOI 10.1093/bioinformatics/bti365; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chan PA, 2007, HUM MUTAT, V28, P683, DOI 10.1002/humu.20492; Chao EC, 2008, HUM MUTAT, V29, P852, DOI 10.1002/humu.20735; Condit CM, 2002, HUM MUTAT, V19, P69, DOI 10.1002/humu.10023; Cotton RGH, 2007, NAT GENET, V39, P433, DOI 10.1038/ng2024; DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Garber JE, 2005, J CLIN ONCOL, V23, P276, DOI 10.1200/JCO.2005.10.042; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hou JY, 2002, TISSUE ANTIGENS, V60, P262, DOI 10.1034/j.1399-0039.2002.600309.x; JOACHIMS T, 2002, LEARNING CLASSIFY TE, pR16; KAUL R, 1994, AM J HUM GENET, V55, P34; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; MORISAKI T, 1992, P NATL ACAD SCI USA, V89, P6457, DOI 10.1073/pnas.89.14.6457; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Patrinos GP, 2004, NUCLEIC ACIDS RES, V32, pD537, DOI 10.1093/nar/gkh006; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stitziel NO, 2004, NUCLEIC ACIDS RES, V32, pD520, DOI 10.1093/nar/gkh104; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Valiaho J, 2002, NUCLEIC ACIDS RES, V30, P232, DOI 10.1093/nar/30.1.232; Vapnik V.N., 1995, NATURE STAT LEARNING, pXV, DOI [10.1007/978-1-4757-2440-0, DOI 10.1007/978-1-4757-2440-0]; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	38	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3575	10.1371/journal.pone.0003575	http://dx.doi.org/10.1371/journal.pone.0003575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974781	gold, Green Published			2022-12-27	WOS:000265131500007
J	Konishi, T; Konishi, F; Takasaki, S; Inoue, K; Nakayama, K; Konagaya, A				Konishi, Tomokazu; Konishi, Fumikazu; Takasaki, Shigeru; Inoue, Kohei; Nakayama, Koji; Konagaya, Akihiko			Coincidence between Transcriptome Analyses on Different Microarray Platforms Using a Parametric Framework	PLOS ONE			English	Article							ANIMAL TEST PROTOCOL; EXPRESSION; OPTIMIZATION; TOXICOGENOMICS	A parametric framework for the analysis of transcriptome data is demonstrated to yield coincident results when applied to data acquired using two different microarray platforms. Microarrays are widely employed to acquire transcriptome information, and several platforms of chips are currently in use. However, discrepancies among studies are frequently reported, particularly among those performed using different platforms, casting doubt on the reliability of collected data. The inconsistency among observations can be largely attributed to differences among the analytical frameworks employed for data analysis. The existing frameworks are based on different philosophies and yield different results, but all involve normalization against a standard determined from the data to be analyzed. In the present study, a parametric framework based on a strict model for normalization is applied to data acquired using several slide-glass-type chips and GeneChip. The model is based on a common statistical characteristic of microarray data, and each set of chip data is normalized on the basis of a linear relationship with this model. In the proposed framework, the expressional changes observed and genes selected are coincident between platforms, achieving superior universality of data compared to other frameworks.	[Konishi, Tomokazu] Akita Prefectural Univ, Dept Bioresource Sci, Nakano Ku, Akita, Japan; [Konishi, Tomokazu; Konishi, Fumikazu; Takasaki, Shigeru; Konagaya, Akihiko] RIKEN, Genom Sci Ctr, Yokohama, Kanagawa, Japan; [Inoue, Kohei; Nakayama, Koji] Mitsubishi Chem Safety Inst Ltd, Res Div Advanced Technol, Ibaraki, Osaka, Japan; [Konagaya, Akihiko] Tokyo Inst Technol, Dept Comp Sci, Tokyo, Japan	Akita Prefectural University; RIKEN; Mitsubishi Chemical Holdings Corporation; Mitsubishi Chemical Safety Institute; Tokyo Institute of Technology	Konishi, T (corresponding author), Akita Prefectural Univ, Dept Bioresource Sci, Nakano Ku, Akita, Japan.	konishi@akita-pu.ac.jpA	Konishi, Tomokazu/K-8067-2012	Konishi, Tomokazu/0000-0003-4826-6265	NEDO (New Energy and Industrial Technology Development Organization) [06002357-0-1]	NEDO (New Energy and Industrial Technology Development Organization)(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported by NEDO (New Energy and Industrial Technology Development Organization) Survey Research Grant: 06002357-0-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah-Sayani A, 2006, NAT CLIN PRACT ONCOL, V3, P501, DOI 10.1038/ncponc0587; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BOLSTAD B, 2003, COMPARISON NORMALIZA; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Frantz S, 2005, NAT REV DRUG DISCOV, V4, P362, DOI 10.1038/nrd1746; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Harris L, 2005, SCIENTIST, V19, P32; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Kerr MK, 2002, STAT SINICA, V12, P203; Konishi T, 2005, NUCLEIC ACIDS RES, V33, P6587, DOI 10.1093/nar/gki967; Konishi T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-5; Konishi Tomokazu, 2006, Genome Inform, V17, P100; Konishi T, 2008, STAT APPL GENET MOL, V7; Kuo WP, 2006, NAT BIOTECHNOL, V24, P832, DOI 10.1038/nbt1217; Nakane T., 2006, International Journal of Cosmetic Science, V28, P299, DOI 10.1111/j.1467-2494.2006.00322.x; Popper K. R., 1994, MYTH FRAMEWORK DEFEN, P33; R Development Core Team, 2007, R LANG ENV STAT COMP; Stafford P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1133; Sumida Kayo, 2007, Journal of Toxicological Sciences, V32, P33, DOI 10.2131/jts.32.33; Sumida Kayo, 2007, Journal of Toxicological Sciences, V32, P19, DOI 10.2131/jts.32.19; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	21	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3555	10.1371/journal.pone.0003555	http://dx.doi.org/10.1371/journal.pone.0003555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958174	Green Published, gold, Green Submitted			2022-12-27	WOS:000265131100013
J	Chow, HK; Xu, J; Shahravan, SH; De Jong, AT; Chen, G; Shin, JA				Chow, Hiu-Kwan; Xu, Jing; Shahravan, S. Hesam; De Jong, Antonia T.; Chen, Gang; Shin, Jumi A.			Hybrids of the bHLH and bZIP Protein Motifs Display Different DNA-Binding Activities In Vivo vs. In Vitro	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; CRYSTAL-STRUCTURE; LEUCINE-ZIPPER; ZINC-FINGER; COGNATE DNA; TRANSCRIPTION FACTORS; BASIC REGION; C-MYC; MAX; RECOGNITION	Minimalist hybrids comprising the DNA-binding domain of bHLH/PAS (basic-helix-loop-helix/Per-Arnt-Sim) protein Arnt fused to the leucine zipper (LZ) dimerization domain from bZIP (basic region-leucine zipper) protein C/EBP were designed to bind the E-box DNA site, CACGTG, targeted by bHLHZ (basic-helix-loop-helix-zipper) proteins Myc and Max, as well as the Arnt homodimer. The bHLHZ-like structure of ArntbHLH-C/EBP comprises the Arnt bHLH domain fused to the C/EBP LZ: i.e. swap of the 330 aa PAS domain for the 29 aa LZ. In the yeast one-hybrid assay (Y1H), transcriptional activation from the E-box was strong by ArntbHLH-C/EBP, and undetectable for the truncated ArntbHLH (PAS removed), as detected via readout from the HIS3 and lacZ reporters. In contrast, fluorescence anisotropy titrations showed affinities for the E-box with ArntbHLH-C/EBP and ArntbHLH comparable to other transcription factors (K-d 148.9 nM and 40.2 nM, respectively), but only under select conditions that maintained folded protein. Although in vivo yeast results and in vitro spectroscopic studies for ArntbHLH-C/EBP targeting the E-box correlate well, the same does not hold for ArntbHLH. As circular dichroism confirms that ArntbHLH-C/EBP is a much more strongly alpha-helical structure than ArntbHLH, we conclude that the nonfunctional ArntbHLH in the Y1H must be due to misfolding, leading to the false negative that this protein is incapable of targeting the E-box. Many experiments, including protein design and selections from large libraries, depend on protein domains remaining well-behaved in the nonnative experimental environment, especially small motifs like the bHLH (60-70 aa). Interestingly, a short helical LZ can serve as a folding-and/or solubility-enhancing tag, an important device given the focus of current research on exploration of vast networks of biomolecular interactions.	[Chow, Hiu-Kwan; Xu, Jing; Shahravan, S. Hesam; De Jong, Antonia T.; Chen, Gang; Shin, Jumi A.] Univ Toronto, Dept Chem, Mississauga, ON L5L 1C6, Canada; [Shin, Jumi A.] Univ Toronto, Inst Biomater & Biomed Engn, Toronto, ON, Canada	University of Toronto; University Toronto Mississauga; University of Toronto	Chow, HK (corresponding author), Univ Toronto, Dept Chem, Mississauga, ON L5L 1C6, Canada.	jumi.shin@utoronto.ca		Chen, Gang/0000-0002-6304-9173	NIH [R01 GM069041]; Premier's Research Excellence Award (PREA); Canadian Foundation for Innovation/Ontario Innovation Trust (CFI/OIT); University of Toronto; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069041, R01GM063220] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Premier's Research Excellence Award (PREA); Canadian Foundation for Innovation/Ontario Innovation Trust (CFI/OIT)(Canada Foundation for Innovation); University of Toronto(University of Toronto); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH (R01 GM069041), Premier's Research Excellence Award (PREA), Canadian Foundation for Innovation/Ontario Innovation Trust (CFI/OIT), and the University of Toronto. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, 1989, SCIENCE, V246, P922, DOI 10.1126/science.2530632; Arpiainen S, 2007, J MOL BIOL, V369, P640, DOI 10.1016/j.jmb.2007.03.075; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Blancafort P, 2004, MOL PHARMACOL, V66, P1361, DOI 10.1124/mol.104.002758; Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429; Brownlie P, 1997, STRUCTURE, V5, P509, DOI 10.1016/S0969-2126(97)00207-4; Chapman-Smith A, 2006, J BIOL CHEM, V281, P12535, DOI 10.1074/jbc.M512145200; Chapman-Smith A, 2004, J BIOL CHEM, V279, P5353, DOI 10.1074/jbc.M310041200; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; *CLONT, 2001, YEAST PROT HDB; Dervan Peter B., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P373, DOI 10.2174/1568011054222346; Dhanasekaran M, 2006, ACCOUNTS CHEM RES, V39, P45, DOI 10.1021/ar050158u; Dreier B, 2005, J BIOL CHEM, V280, P35588, DOI 10.1074/jbc.M506654200; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; GARDNER L, 2002, ENCY CANC; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Hollenbeck JJ, 2000, BIOCHEMISTRY-US, V39, P6380, DOI 10.1021/bi992705n; Hu JZ, 2005, BIOCHEMISTRY-US, V44, P11855, DOI 10.1021/bi050206i; Huffman JL, 2001, J BIOL CHEM, V276, P40537, DOI 10.1074/jbc.M105675200; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Jung KC, 2005, BIOCHEM BIOPH RES CO, V334, P269, DOI 10.1016/j.bbrc.2005.06.088; KELLER W, 1995, J MOL BIOL, V254, P657, DOI 10.1006/jmbi.1995.0645; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; KONIG P, 1993, J MOL BIOL, V233, P139, DOI 10.1006/jmbi.1993.1490; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lajmi AR, 2000, PROTEIN EXPRES PURIF, V18, P394, DOI 10.1006/prep.2000.1209; Lajmi AR, 2000, J AM CHEM SOC, V122, P5638, DOI 10.1021/ja993025a; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEE DK, 2003, CURR TOP MED CHEM, V3, P339; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Meier-Andrejszki L, 2007, BIOCHEMISTRY-US, V46, P12427, DOI 10.1021/bi701081q; Mockli N, 2004, BIOTECHNIQUES, V36, P872; Nagaoka M, 2000, J INORG BIOCHEM, V82, P57, DOI 10.1016/S0162-0134(00)00154-9; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; ONEIL KT, 1991, BIOCHEMISTRY-US, V30, P9030, DOI 10.1021/bi00101a017; REISZPORSZASZ S, 1994, MOL CELL BIOL, V14, P6075, DOI 10.1128/MCB.14.9.6075; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P1310, DOI 10.1021/bi00219a022; Schmid T, 2004, J CELL MOL MED, V8, P423, DOI 10.1111/j.1582-4934.2004.tb00467.x; SELLERS JW, 1989, NATURE, V341, P74, DOI 10.1038/341074a0; Serebriiskii IG, 2000, ANAL BIOCHEM, V285, P1, DOI 10.1006/abio.2000.4672; Shin JA, 1997, BIOORG MED CHEM LETT, V7, P2367, DOI 10.1016/S0960-894X(97)00436-8; STRUHL K, 1989, TRENDS BIOCHEM SCI, V14, P137, DOI 10.1016/0968-0004(89)90145-X; Suga M, 2003, CURR GENET, V43, P206, DOI 10.1007/s00294-003-0385-4; Suga M, 2001, YEAST, V18, P1015, DOI 10.1002/yea.753; Swanson HI, 2002, CHEM-BIOL INTERACT, V141, P63, DOI 10.1016/S0009-2797(02)00066-2; Swanson HI, 1999, NUCLEIC ACIDS RES, V27, P3205, DOI 10.1093/nar/27.15.3205; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; Wu G, 2006, J BIOTECHNOL, V124, P496, DOI 10.1016/j.jbiotec.2006.01.015; Xie YS, 1996, PROTEIN SCI, V5, P517; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Yin XY, 1998, ONCOGENE, V16, P2629, DOI 10.1038/sj.onc.1201777	62	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3514	10.1371/journal.pone.0003514	http://dx.doi.org/10.1371/journal.pone.0003514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949049	Green Published, gold, Green Submitted			2022-12-27	WOS:000265126400003
J	Ai, J; Druhan, LJ; Loveland, MJ; Avalos, BR				Ai, Jing; Druhan, Lawrence J.; Loveland, Megan J.; Avalos, Belinda R.			G-CSFR Ubiquitination Critically Regulates Myeloid Cell Survival and Proliferation	PLOS ONE			English	Article								The granulocyte colony-stimulating factor receptor (G-CSFR) is a critical regulator of granulopoiesis. Mutations in the G-CSFR in patients with severe congenital neutropenia (SCN) transforming to acute myelogenous leukemia (AML) have been shown to induce hypersensitivity and enhanced growth responses to G-CSF. Recent studies have demonstrated the importance of the ubiquitin/proteasome system in the initiation of negative signaling by the G-CSFR. To further investigate the role of ubiquitination in regulating G-CSFR signaling, we generated a mutant form of the G-CSFR (K762R/G-CSFR) which abrogates the attachment of ubiquitin to the lysine residue at position 762 of the G-CSFR that is deleted in the Delta 716 G-CSFR form isolated from patients with SCN/AML. In response to G-CSF, mono-/polyubiquitination of the G-CSFR was impaired in cells expressing the mutant K762R/G-CSFR compared to cells transfected with the WT G-CSFR. Cells stably transfected with the K762R/G-CSFR displayed a higher proliferation rate, increased sensitivity to G-CSF, and enhanced survival following cytokine depletion, similar to previously published data with the Delta 716 G-CSFR mutant. Activation of the signaling molecules Stat5 and Akt were also increased in K762R/G-CSFR transfected cells in response to G-CSF, and their activation remained prolonged after G-CSF withdrawal. These results indicate that ubiquitination is required for regulation of G-CSFR-mediated proliferation and cell survival. Mutations that disrupt G-CSFR ubiquitination at lysine 762 induce aberrant receptor signaling and hyperproliferative responses to G-CSF, which may contribute to leukemic transformation.	[Ai, Jing; Druhan, Lawrence J.; Loveland, Megan J.] Ohio State Univ, Heart & Lung Res Inst, Columbus, OH 43210 USA; [Avalos, Belinda R.] Ohio State Univ, Div Hematol Oncol, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Ai, J (corresponding author), Ohio State Univ, Heart & Lung Res Inst, Columbus, OH 43210 USA.	belinda.avalos@osumc.edu	Druhan, Lawrence/E-2994-2011		National Institute of Diabetes and Digestive and Kidney Diseases [R21-DK068639]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK068639] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (R21-DK068639). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2008, J LEUKOCYTE BIOL, V83, P1277, DOI 10.1189/jlb.1107751; AVALOS BR, 1995, BLOOD, V85, P3117, DOI 10.1182/blood.V85.11.3117.bloodjournal85113117; AVALOS BR, 1990, BLOOD, V75, P851; Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; BEGLEY CG, 1988, EXP HEMATOL, V16, P71; DEMETRI GD, 1991, BLOOD, V78, P2791; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; DONG F, 1994, P NATL ACAD SCI USA, V91, P4480, DOI 10.1073/pnas.91.10.4480; Dong F, 2001, J IMMUNOL, V167, P6447, DOI 10.4049/jimmunol.167.11.6447; DONG F, 1993, MOL CELL BIOL, V13, P7774, DOI 10.1128/MCB.13.12.7774; Druhan LJ, 2005, BLOOD, V105, P584, DOI 10.1182/blood-2004-07-2613; FUKUNAGA R, 1991, EMBO J, V10, P2855, DOI 10.1002/j.1460-2075.1991.tb07835.x; HAMMOND WP, 1992, BLOOD, V79, P2536; HEMAR A, 1995, J CELL BIOL, V129, P55, DOI 10.1083/jcb.129.1.55; Hermans MHA, 2003, BLOOD, V101, P2584, DOI 10.1182/blood-2002-07-2062; Hermans MHA, 1999, J EXP MED, V189, P683, DOI 10.1084/jem.189.4.683; Hunter MG, 1999, BLOOD, V93, P440, DOI 10.1182/blood.V93.2.440.402k23_440_446; Hunter MG, 2000, BLOOD, V95, P2132, DOI 10.1182/blood.V95.6.2132; Hunter MG, 2004, J IMMUNOL, V173, P5036, DOI 10.4049/jimmunol.173.8.5036; Irandoust MI, 2007, EMBO J, V26, P1782, DOI 10.1038/sj.emboj.7601640; ISHIZAKAIKEDA E, 1993, P NATL ACAD SCI USA, V90, P123, DOI 10.1073/pnas.90.1.123; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; Kindwall-Keller TL, 2008, CYTOKINE, V43, P114, DOI 10.1016/j.cyto.2008.04.015; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 2008, J CLIN INVEST, V118, P946, DOI 10.1172/JCI32704; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Rocca A, 2001, MOL BIOL CELL, V12, P1293, DOI 10.1091/mbc.12.5.1293; SCHMITZ S, 1993, EXP HEMATOL, V21, P755; SCHMITZ S, 1994, CELL PROLIFERAT, V27, P655, DOI 10.1111/j.1365-2184.1994.tb01380.x; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Tidow N, 1997, BLOOD, V89, P2369, DOI 10.1182/blood.V89.7.2369; Touw IP, 1996, LEUKEMIA RES, V20, P629, DOI 10.1016/0145-2126(96)00017-3; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216; Ward AC, 1999, BLOOD, V93, P447, DOI 10.1182/blood.V93.2.447; Welte K, 1996, BLOOD, V88, P1907, DOI 10.1182/blood.V88.6.1907.bloodjournal8861907; WILLIAMS GT, 1990, NATURE, V343, P76, DOI 10.1038/343076a0; Yen CH, 2000, J IMMUNOL, V165, P6372, DOI 10.4049/jimmunol.165.11.6372; Yu AX, 2001, J BIOL CHEM, V276, P381, DOI 10.1074/jbc.M007991200	41	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2008	3	10							e3422	10.1371/journal.pone.0003422	http://dx.doi.org/10.1371/journal.pone.0003422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GT	18923646	Green Submitted, Green Published, gold			2022-12-27	WOS:000265122200003
J	Hershkovitz, I; Donoghue, HD; Minnikin, DE; Besra, GS; Lee, OYC; Gernaey, AM; Galili, E; Eshed, V; Greenblatt, CL; Lemma, E; Bar-Gal, GK; Spigelman, M				Hershkovitz, Israel; Donoghue, Helen D.; Minnikin, David E.; Besra, Gurdyal S.; Lee, Oona Y-C.; Gernaey, Angela M.; Galili, Ehud; Eshed, Vered; Greenblatt, Charles L.; Lemma, Eshetu; Bar-Gal, Gila Kahila; Spigelman, Mark			Detection and Molecular Characterization of 9000-Year-Old Mycobacterium tuberculosis from a Neolithic Settlement in the Eastern Mediterranean	PLOS ONE			English	Article							COMPLEX DNA; OSTEOARTHROPATHY; EPIDEMIOLOGY; PHYLOGENY; EVOLUTION; DIAGNOSIS; LIGURIA; ANIMALS; DISEASE; BOVIS	Background: Mycobacterium tuberculosis is the principal etiologic agent of human tuberculosis. It has no environmental reservoir and is believed to have co-evolved with its host over millennia. This is supported by skeletal evidence of the disease in early humans, and inferred from M. tuberculosis genomic analysis. Direct examination of ancient human remains for M. tuberculosis biomarkers should aid our understanding of the nature of prehistoric tuberculosis and the host/pathogen relationship. Methodology/Principal Findings: We used conventional PCR to examine bone samples with typical tuberculosis lesions from a woman and infant, who were buried together in the now submerged site of Atlit-Yam in the Eastern Mediterranean, dating from 9250-8160 years ago. Rigorous precautions were taken to prevent contamination, and independent centers were used to confirm authenticity of findings. DNA from five M. tuberculosis genetic loci was detected and had characteristics consistent with extant genetic lineages. High performance liquid chromatography was used as an independent method of verification and it directly detected mycolic acid lipid biomarkers, specific for the M. tuberculosis complex. Conclusions/Significance: Human tuberculosis was confirmed by morphological and molecular methods in a population living in one of the first villages with evidence of agriculture and animal domestication. The widespread use of animals was not a source of infection but may have supported a denser human population that facilitated transmission of the tubercle bacillus. The similarity of the M. tuberculosis genetic signature with those of today gives support to the theory of a long-term co-existence of host and pathogen.	[Hershkovitz, Israel; Eshed, Vered] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Donoghue, Helen D.; Spigelman, Mark] UCL, Ctr Infect Dis & Int Hlth, London WC1E 6BT, England; [Minnikin, David E.; Besra, Gurdyal S.; Lee, Oona Y-C.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Gernaey, Angela M.] Univ Salford, Biosci Res Inst, Salford M5 4WT, Lancs, England; [Galili, Ehud] Israel Antiquit Authority, Marine Archaeol Branch, Jerusalem, Israel; [Greenblatt, Charles L.; Lemma, Eshetu; Spigelman, Mark] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, IL-91905 Jerusalem, Israel; [Bar-Gal, Gila Kahila] Hebrew Univ Jerusalem, Koret Sch Vet Med, Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; University of London; University College London; University of Birmingham; University of Salford; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Hershkovitz, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.	h.donoghue@ucl.ac.uk	Donoghue, Helen D./D-6805-2013; Greenblatt, Chuck/ABC-8220-2021; Hershkovitz, Israel/ABH-4511-2020	Donoghue, Helen D./0000-0003-3918-5252; Hershkovitz, Israel/0000-0001-5841-6090; Besra, Gurdyal/0000-0002-5605-0395	CARE; MAFCAF; Dan David Foundation; Leverhulme Trust [F/125/AK]; Leverhulme Emeritus Fellow; Deutsche Forschungsgemeinschaft (DFG)	CARE; MAFCAF; Dan David Foundation; Leverhulme Trust(Leverhulme Trust); Leverhulme Emeritus Fellow; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The CARE, MAFCAF and Dan David Foundation supported the archaeological and anthropological work. A grant from The Leverhulme Trust (F/125/AK) to AMG and DEM is acknowledged; DEM is a Leverhulme Emeritus Fellow. MS is funded by the Deutsche Forschungsgemeinschaft (DFG) for a trilateral project between German, Israeli and Palestinian researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Canci A, 1996, INT J OSTEOARCHAEOL, V6, P497, DOI 10.1002/(SICI)1099-1212(199612)6:5<497::AID-OA291>3.0.CO;2-O; CLARK GA, 1987, CURR ANTHROPOL, V28, P45, DOI 10.1086/203490; Cohen MN, 1984, PALEOPATHOLOGY ORIGI, P585; Daniel TM, 2006, RESP MED, V100, P1862, DOI 10.1016/j.rmed.2006.08.006; Donoghue HD, 1998, LETT APPL MICROBIOL, V27, P265; Donoghue HD, 2004, LANCET INFECT DIS, V4, P584, DOI 10.1016/S1473-3099(04)01133-8; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977; FORMICOLA V, 1987, AM J PHYS ANTHROPOL, V72, P1, DOI 10.1002/ajpa.1330720102; GALILI E, 1993, J FIELD ARCHAEOL, V20, P133, DOI 10.1179/jfa.1993.20.2.133; GALILI E, 2005, BASOR, V339, P1, DOI DOI 10.1086/BASOR25066900; Galili E., 2002, J MEDITERR ARCHAEOL, V15, P167; Gernaey AM, 2001, TUBERCULOSIS, V81, P259, DOI 10.1054/tube.2001.0295; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; HARDIE RM, 1992, EPIDEMIOL INFECT, V109, P23; Hershkovitz I, 2002, AM J PHYS ANTHROPOL, V118, P201, DOI 10.1002/ajpa.10077; Hershkovitz I., 1990, HUMAN EVOLUTION, V5, P319; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Huard RC, 2006, J BACTERIOL, V188, P4271, DOI 10.1128/JB.01783-05; Hughes AL, 2002, EMERG INFECT DIS, V8, P1342, DOI 10.3201/eid0811.020064; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kappelman J, 2008, AM J PHYS ANTHROPOL, V135, P110, DOI 10.1002/ajpa.20739; MANCHESTER K, 1984, MED HIST, V28, P162, DOI 10.1017/S0025727300035705; Mays S, 2002, J ARCHAEOL SCI, V29, P1267, DOI 10.1006/jasc.2001.0769; McMichael AJ, 2004, PHILOS T ROY SOC B, V359, P1049, DOI 10.1098/rstb.2004.1480; Mensforth R P, 1978, Med Anthropol, V2, P1, DOI 10.1080/01459740.1978.9986939; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; MINNIKIN DE, 1987, P JAP SOC MED MASS S, V12, P23; Mostowy S, 2002, J INFECT DIS, V186, P74, DOI 10.1086/341068; NUORALA E, 2004, THESES PAPERS SCI AR, V6; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; ORTNER DJ, 1981, IDENTIFICATION PATHO; Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002; Pearce-Duvet JMC, 2006, BIOL REV, V81, P369, DOI 10.1017/S1464793106007020; Rothschild B M, 2003, Reumatismo, V55, P58; Rothschild BM, 1998, J RHEUMATOL, V25, P2221; Rothschild BM, 2001, CLIN INFECT DIS, V33, P305, DOI 10.1086/321886; Spigelman M, 2002, EMERGING PATHOGENS, P175; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Starke JR, 2003, TUBERCULOSIS, V83, P208, DOI 10.1016/S1472-9792(02)00088-4; Steinbock R., 1976, PALEOPATHOLOGICAL DI; Taylor GM, 1996, J ARCHAEOL SCI, V23, P789; Taylor GM, 2005, J CLIN MICROBIOL, V43, P2236, DOI 10.1128/JCM.43.5.2236-2240.2005; Taylor GM, 2003, MICROBIOL-SGM, V149, P3213, DOI 10.1099/mic.0.26654-0; Walls T, 2004, J INFECTION, V48, P13, DOI 10.1016/S0163-4453(03)00121-X; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; *WHO, 2008, 104 WHO; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Zink A, 2001, J MED MICROBIOL, V50, P355, DOI 10.1099/0022-1317-50-4-355; Zink AR, 2003, J CLIN MICROBIOL, V41, P359, DOI 10.1128/JCM.41.1.359-367.2003	51	232	245	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3426	10.1371/journal.pone.0003426	http://dx.doi.org/10.1371/journal.pone.0003426			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432GP	18923677	Green Submitted, gold, Green Published			2022-12-27	WOS:000265121800016
J	Yamaguchi-Kabata, Y; Shimada, MK; Hayakawa, Y; Minoshima, S; Chakraborty, R; Gojobori, T; Imanishi, T				Yamaguchi-Kabata, Yumi; Shimada, Makoto K.; Hayakawa, Yosuke; Minoshima, Shinsei; Chakraborty, Ranajit; Gojobori, Takashi; Imanishi, Tadashi			Distribution and Effects of Nonsense Polymorphisms in Human Genes	PLOS ONE			English	Article								Background: A great amount of data has been accumulated on genetic variations in the human genome, but we still do not know much about how the genetic variations affect gene function. In particular, little is known about the distribution of nonsense polymorphisms in human genes despite their drastic effects on gene products. Methodology/Principal Findings: To detect polymorphisms affecting gene function, we analyzed all publicly available polymorphisms in a database for single nucleotide polymorphisms (dbSNP build 125) located in the exons of 36,712 known and predicted protein-coding genes that were defined in an annotation project of all human genes and transcripts (H-InvDB ver3.8). We found a total of 252,555 single nucleotide polymorphisms ( SNPs) and 8,479 insertion and deletions in the representative transcripts in these genes. The SNPs located in ORFs include 40,484 synonymous and 53,754 nonsynonymous SNPs, and 1,258 SNPs that were predicted to be nonsense SNPs or read-through SNPs. We estimated the density of nonsense SNPs to be 0.85x10(-3) per site, which is lower than that of nonsynonymous SNPs (2.1x10(-3) per site). On average, nonsense SNPs were located 250 codons upstream of the original termination codon, with the substitution occurring most frequently at the first codon position. Of the nonsense SNPs, 581 were predicted to cause nonsense-mediated decay (NMD) of transcripts that would prevent translation. We found that nonsense SNPs causing NMD were more common in genes involving kinase activity and transport. The remaining 602 nonsense SNPs are predicted to produce truncated polypeptides, with an average truncation of 75 amino acids. In addition, 110 read-through SNPs at termination codons were detected. Conclusion/Significance: Our comprehensive exploration of nonsense polymorphisms showed that nonsense SNPs exist at a lower density than nonsynonymous SNPs, suggesting that nonsense mutations have more severe effects than amino acid changes. The correspondence of nonsense SNPs to known pathological variants suggests that phenotypic effects of nonsense SNPs have been reported for only a small fraction of nonsense SNPs, and that nonsense SNPs causing NMD are more likely to be involved in phenotypic variations. These nonsense SNPs may include pathological variants that have not yet been reported. These data are available from Transcript View of H-InvDB and VarySysDB (http://h-invitational.jp/varygene/).	[Yamaguchi-Kabata, Yumi; Shimada, Makoto K.; Hayakawa, Yosuke; Gojobori, Takashi; Imanishi, Tadashi] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tokyo, Japan; [Shimada, Makoto K.; Hayakawa, Yosuke] Japan Biol Informat Consortium, Japan Biol Informat Res Ctr, Tokyo, Japan; [Minoshima, Shinsei] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan; [Chakraborty, Ranajit] Univ Cincinnati, Ctr Genome Informat, Cincinnati, OH 45221 USA; [Gojobori, Takashi] Natl Inst Genet, DNA Data Bank Japan, Ctr Informat Biol, Mishima, Shizuoka, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Hamamatsu University School of Medicine; University of Cincinnati; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Yamaguchi-Kabata, Y (corresponding author), RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan.	t.imanishi@aist.go.jp	SHIMADA, Makoto K./K-4613-2015; Imanishi, Tadashi/R-3076-2019	SHIMADA, Makoto K./0000-0003-0067-0082; Imanishi, Tadashi/0000-0002-1182-9127	Ministry of Economy, Trade and Industry of Japan (METI); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Biological Informatics Consortium (JBIC)	Ministry of Economy, Trade and Industry of Japan (METI); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Biological Informatics Consortium (JBIC)	This research is financially supported by the Ministry of Economy, Trade and Industry of Japan (METI), the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and the Japan Biological Informatics Consortium (JBIC).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; CHANG JC, 1979, P NATL ACAD SCI USA, V76, P2886, DOI 10.1073/pnas.76.6.2886; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Fay JC, 2001, GENETICS, V158, P1227; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Han A, 2007, BIOINFORMATICS, V23, P397, DOI 10.1093/bioinformatics/btl593; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hughes AL, 2003, P NATL ACAD SCI USA, V100, P15754, DOI 10.1073/pnas.2536718100; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Karchin R, 2005, BIOINFORMATICS, V21, P2814, DOI 10.1093/bioinformatics/bti442; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; MIMORI A, 1991, AM J HUM GENET, V48, P103; Minoshima S, 2001, NUCLEIC ACIDS RES, V29, P327, DOI 10.1093/nar/29.1.327; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; NEI M, 1986, MOL BIOL EVOL, V3, P418; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Reumers J, 2005, NUCLEIC ACIDS RES, V33, pD527; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Sherry ST, 1999, GENOME RES, V9, P677; Stitziel NO, 2004, NUCLEIC ACIDS RES, V32, pD520, DOI 10.1093/nar/gkh104; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Takeda J, 2006, NUCLEIC ACIDS RES, V34, P3917, DOI 10.1093/nar/gkl507; THEIN SL, 1990, P NATL ACAD SCI USA, V87, P3924, DOI 10.1073/pnas.87.10.3924; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; Yamasaki C, 2005, GENE, V364, P99, DOI 10.1016/j.gene.2005.05.036; Yamasaki C, 2008, NUCLEIC ACIDS RES, V36, pD793, DOI 10.1093/nar/gkm999; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272	46	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3393	10.1371/journal.pone.0003393	http://dx.doi.org/10.1371/journal.pone.0003393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852891	gold, Green Submitted, Green Published			2022-12-27	WOS:000265121700002
J	Sponarova, J; Nystrom, SN; Westermark, GT				Sponarova, Jana; Nystrom, Sofia N.; Westermark, Gunilla T.			AA-Amyloidosis Can Be Transferred by Peripheral Blood Monocytes	PLOS ONE			English	Article								Spongiform encephalopathies have been reported to be transmitted by blood transfusion even prior to the clinical onset. Experimental AA-amyloidosis shows similarities with prion disease and amyloid-containing organ-extracts can prime a recipient for the disease. In this systemic form of amyloidosis N-terminal fragments of the acute-phase reactant apolipoprotein serum amyloid A are the main amyloid protein. Initial amyloid deposits appear in the perifollicular region of the spleen, followed by deposits in the liver. We used the established murine model and induced AA-amyloidosis in NMRI mice by intravenous injections of purified amyloid fibrils ('amyloid enhancing factor') combined with inflammatory challenge (silver nitrate subcutaneously). Blood plasma and peripheral blood monocytes were isolated, sonicated and re-injected into new recipients followed by an inflammatory challenge during a three week period. When the animals were sacrificed presence of amyloid was analyzed in spleen sections after Congo red staining. Our result shows that some of the peripheral blood monocytes, isolated from animals with detectable amyloid, contained amyloid-seed that primed for AA-amyloid. The seeding material seems to have been phagocytosed by the cells since the AA-precursor (SAA1) was found not be expressed by the monocytes. Plasma recovered from mice with AA amyloidosis lacked seeding capacity. Amyloid enhancing activity can reside in monocytes recovered from mice with AA-amyloidosis and in a prion-like way trigger amyloid formation in conjunction with an inflammatory disorder. Human AA-amyloidosis resembles the murine form and every individual is expected to be exposed to conditions that initiate production of the acute-phase reactant. The monocyte-transfer mechanism should be eligible for the human disease and we point out blood transfusion as a putative route for transfer of amyloidosis.	[Sponarova, Jana; Nystrom, Sofia N.; Westermark, Gunilla T.] Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, Fac Hlth Sci, Linkoping, Sweden	Linkoping University	Sponarova, J (corresponding author), Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, Fac Hlth Sci, Linkoping, Sweden.	Gunwe@ibk.liu.se	Sponarova, Jana/AAM-6003-2020; NystrÃm, Sofia/GYQ-5893-2022	Sponarova, Jana/0000-0002-6345-6879; Nystrom, Sofia/0000-0002-0145-4966	Swedish Research Council; European Union FP6 Program	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union FP6 Program(European Commission)	This work was supported by the Swedish Research Council and the European Union FP6 Program without any interference in the performance of the study.	Aguzzi A, 2000, HAEMATOLOGICA, V85, P3; Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; AXELRAD MA, 1982, LAB INVEST, V47, P139; BENDITT EP, 1989, J EXP MED, V169, P1841, DOI 10.1084/jem.169.5.1841; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; CHA Y, 1990, J BIOL CHEM, V265, P5008; CHRONOPOULOS S, 1994, J PATHOL, V173, P361, DOI 10.1002/path.1711730412; EIN D, 1972, BIOCHEM BIOPH RES CO, V46, P498, DOI 10.1016/S0006-291X(72)80166-9; Fu XY, 2004, FEBS LETT, V563, P179, DOI 10.1016/S0014-5793(04)00295-9; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; HARDT F, 1968, ACTA PATHOL MIC SC, V73, P549; HOL PR, 1986, VIRCHOWS ARCH B, V52, P273, DOI 10.1007/BF02889968; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Kanitakis J, 2004, NEW ENGL J MED, V351, P2661, DOI 10.1056/NEJM200412163512523; KISILEVSKY R, 1983, LAB INVEST, V48, P53; Kluve-Beckerman B, 1999, AM J PATHOL, V155, P123, DOI 10.1016/S0002-9440(10)65107-3; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; NIEWOLD TA, 1987, LAB INVEST, V56, P544; PETERS L, 2008, MPD SNPS; PUCHTLER H, 1965, J HISTOCHEM CYTOCHEM, V13, P693, DOI 10.1177/13.8.693; Rocken C, 2001, AM J PATHOL, V158, P1029, DOI 10.1016/S0002-9440(10)64050-3; ROKITA H, 1987, J IMMUNOL, V139, P3849; SHIRAHAMA T, 1980, AM J PATHOL, V99, P539; SHIRAHAMA T, 1990, LAB INVEST, V62, P61; SLETTEN K, 1974, EUR J BIOCHEM, V41, P117, DOI 10.1111/j.1432-1033.1974.tb03251.x; Solomon A, 2007, P NATL ACAD SCI USA, V104, P10998, DOI 10.1073/pnas.0700848104; Sorby R, 2008, AMYLOID, V15, P20, DOI 10.1080/13506120701815332; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; TEILUM G, 1964, ACTA PATHOL MIC SC, V61, P21, DOI 10.1111/apm.1964.61.1.21; Thorn CF, 2004, SCAND J IMMUNOL, V59, P152, DOI 10.1111/j.0300-9475.2004.01369.x; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; URIELISHOVAL S, 1994, AM J PATHOL, V145, P650; WERDELIN O, 1966, ACTA PATHOL MIC SC, V68, P1; WESTERMARK GT, 1989, SCAND J IMMUNOL, V30, P605, DOI 10.1111/j.1365-3083.1989.tb02468.x; WESTERMARK GT, 1987, LAB INVEST, V57, P57; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; YAMAMOTO K, 1985, P NATL ACAD SCI USA, V82, P2915, DOI 10.1073/pnas.82.9.2915	41	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3308	10.1371/journal.pone.0003308	http://dx.doi.org/10.1371/journal.pone.0003308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830411	Green Published, Green Submitted, gold			2022-12-27	WOS:000264797300002
J	Huang, YC; Hessler, NA				Huang, Ya-Chun; Hessler, Neal A.			Social Modulation during Songbird Courtship Potentiates Midbrain Dopaminergic Neurons	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; FINCHES TAENIOPYGIA-GUTTATA; NUCLEUS-ACCUMBENS DOPAMINE; BASAL GANGLIA CIRCUIT; MALE PRAIRIE VOLES; ZEBRA FINCH; MALE RATS; ACUTE AMPHETAMINE; SEXUAL-BEHAVIOR; UNDIRECTED SONG	Synaptic transmission onto dopaminergic neurons of the mammalian ventral tegmental area (VTA) can be potentiated by acute or chronic exposure to addictive drugs. Because rewarding behavior, such as social affiliation, can activate the same neural circuitry as addictive drugs, we tested whether the intense social interaction of songbird courtship may also potentiate VTA synaptic function. We recorded glutamatergic synaptic currents from VTA of male zebra finches who had experienced distinct social and behavioral conditions during the previous hour. The level of synaptic transmission to VTA neurons, as assayed by the ratio of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) to N-methyl-D-aspartic acid (NMDA) glutamate receptor mediated synaptic currents, was increased after males sang to females, and also after they saw females without singing, but not after they sang while alone. Potentiation after female exposure alone did not appear to result from stress, as it was not blocked by inhibition of glucocorticoid receptors. This potentiation was restricted to synapses of dopaminergic projection neurons, and appeared to be expressed postsynaptically. This study supports a model in which VTA dopaminergic neurons are more strongly activated during singing used for courtship than during non-courtship singing, and thus can provide social context-dependent modulation to forebrain areas. More generally, these results demonstrate that an intense social encounter can trigger the same pathways of neuronal plasticity as addictive drugs.	[Huang, Ya-Chun; Hessler, Neal A.] RIKEN Brain Sci Inst, Vocal Behav Mech Lab, Wako, Saitama, Japan	RIKEN	Huang, YC (corresponding author), RIKEN Brain Sci Inst, Vocal Behav Mech Lab, Wako, Saitama, Japan.	hessler@brain.riken.jp	hessler, neal/A-7328-2010		RIKEN Brain Science Institute	RIKEN Brain Science Institute	Funding provided by RIKEN Brain Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona BJ, 2003, J NEUROSCI, V23, P3483, DOI 10.1523/jneurosci.23-08-03483.2003; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Balfour ME, 2004, NEUROPSYCHOPHARMACOL, V29, P718, DOI 10.1038/sj.npp.1300350; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bonci A, 1999, J NEUROSCI, V19, P3723; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Castelino CB, 2005, EUR J NEUROSCI, V21, P1962, DOI 10.1111/j.1460-9568.2005.04028.x; Castelino CB, 2007, J COMP NEUROL, V502, P544, DOI 10.1002/cne.21337; Colussi-Mas J, 2007, EUR J NEUROSCI, V26, P1011, DOI 10.1111/j.1460-9568.2007.05738.x; Curtis JT, 2005, PHYSIOL BEHAV, V86, P338, DOI 10.1016/j.physbeh.2005.08.022; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dunn AM, 1996, ETHOLOGY, V102, P529; Dunn AM, 1996, ETHOLOGY, V102, P540; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Faleiro LJ, 2004, NEUROPSYCHOPHARMACOL, V29, P2115, DOI 10.1038/sj.npp.1300495; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Fisher H, 2005, J COMP NEUROL, V493, P58, DOI 10.1002/cne.20772; Fisher HE, 2006, PHILOS T R SOC B, V361, P2173, DOI 10.1098/rstb.2006.1938; Gale SD, 2008, J COMP NEUROL, V508, P824, DOI 10.1002/cne.21700; Gale SD, 2006, J NEUROPHYSIOL, V96, P2295, DOI 10.1152/jn.01040.2005; GEISLER S, 2007, NEUROPSYCHOPHARM; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hessler NA, 1999, J NEUROSCI, V19, P10461; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Insel TR, 2003, PHYSIOL BEHAV, V79, P351, DOI 10.1016/S0031-9384(03)00148-3; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; Kelley AE, 2002, J NEUROSCI, V22, P3306; Landys MM, 2004, J EXP BIOL, V207, P143, DOI 10.1242/jeb.00734; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lynch KS, 2008, PHYSIOL BEHAV, V93, P870, DOI 10.1016/j.physbeh.2007.12.004; Manzoni OJ, 1999, J NEUROSCI, V19, P6629; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Peters YM, 2005, BIOL PSYCHIAT, V57, P1205, DOI 10.1016/j.biopsych.2005.02.011; Robinson DL, 2002, J NEUROSCI, V22, P10477; Robinson DL, 2001, NEUROREPORT, V12, P2549, DOI 10.1097/00001756-200108080-00051; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sasaki A, 2006, J NEUROSCI, V26, P9010, DOI 10.1523/JNEUROSCI.1335-06.2006; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; Yanagihara S, 2006, EUR J NEUROSCI, V24, P3619, DOI 10.1111/j.1460-9568.2006.05228.x; ZANN R, 1996, ZEBRA FINCH	50	47	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3281	10.1371/journal.pone.0003281	http://dx.doi.org/10.1371/journal.pone.0003281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RU	18827927	Green Published, gold, Green Submitted			2022-12-27	WOS:000264797200003
J	Velez, DR; Fortunato, SJ; Thorsen, P; Lombardi, SJ; Williams, SM; Menon, R				Velez, Digna R.; Fortunato, Stephen J.; Thorsen, Poul; Lombardi, Salvatore J.; Williams, Scott M.; Menon, Ramkumar			Preterm Birth in Caucasians Is Associated with Coagulation and Inflammation Pathway Gene Variants	PLOS ONE			English	Article								Spontaneous preterm birth (< 37 weeks gestation-PTB) occurs in similar to 12% of pregnancies in the United States, and is the largest contributor to neonatal morbidity and mortality. PTB is a complex disease, potentially induced by several etiologic factors from multiple pathophysiologic pathways. To dissect the genetic risk factors of PTB a large-scale high-throughput candidate gene association study was performed examining 1536 SNP in 130 candidate genes from hypothesized PTB pathways. Maternal and fetal DNA from 370 US Caucasian birth-events (172 cases and 198 controls) was examined. Single locus, haplotype, and multi-locus association analyses were performed separately on maternal and fetal data. For maternal data the strongest associations were found in genes in the complement-coagulation pathway related to decidual hemorrhage in PTB. In this pathway 3 of 6 genes examined had SNPs significantly associated with PTB. These include factor V (FV) that was previously associated with PTB, factor VII (FVII), and tissue plasminogen activator (tPA). The single strongest effect was observed in tPA marker rs879293 with a significant allelic (p = 2.30 x 10(-3)) and genotypic association (p = 2.0 x 10(-6)) with PTB. The odds ratio (OR) for this SNP was 2.80 [Cl 1.77-4.44] for a recessive model. Given that 6 of 8 markers in tPA were statistically significant, sliding window haplotype analyses were performed and revealed an associating 4 marker haplotype in tPA (p = 6.00 x 10(-3)). The single strongest effect in fetal DNA was observed in the inflammatory pathway at rs17121510 in the interleukin-10 receptor antagonist (IL-10RA) gene for allele (p = 0.01) and genotype (p = 3.34 x 10(-4)). The OR for the IL-10RA genotypic additive model was 1.92 [Cl 1.15-3.19] (p = 2.00 x 10(-3)). Finally, exploratory multi-locus analyses in the complement and coagulation pathway were performed and revealed a potentially significant interaction between a marker in FV (rs2187952) and FVII (rs3211719) (p < 0.001). These results support a role for genes in both the coagulation and inflammation pathways, and potentially different maternal and fetal genetic risks for PTB.	[Velez, Digna R.; Williams, Scott M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37203 USA; [Fortunato, Stephen J.; Lombardi, Salvatore J.; Menon, Ramkumar] Perinatal Res Ctr, Nashville, TN USA; [Fortunato, Stephen J.] Yale Univ, Dept Obstet & Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Thorsen, Poul; Menon, Ramkumar] Univ Aarhus, N Atlantic Epidemiol Alliance, DK-8000 Aarhus, Denmark	Vanderbilt University; Yale University; Aarhus University	Velez, DR (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37203 USA.	fortunat@edge.net; smwilliams@chgr.mc.vanderbilt.edu	Williams, Scott/B-9491-2012; Fortunato, Stephen J/L-7545-2013; Williams, Scott/Q-4812-2019; Velez Edwards, Digna/C-1090-2012	Williams, Scott/0000-0002-4835-9544; 	Elsass Foundation, Denmark; Thrasher Research Fund; Maternal-Fetal Group, LLC, Nashville, TN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	Elsass Foundation, Denmark; Thrasher Research Fund; Maternal-Fetal Group, LLC, Nashville, TN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by grants from Elsass Foundation, Denmark (to RM), the Thrasher Research Fund (to SJF) and funds from Maternal-Fetal Group, LLC, (SJF, SJL) Nashville, TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2000, JAMA-J AM MED ASSOC, V283, P1591, DOI 10.1001/jama.283.12.1591; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bogic LV, 1999, BIOL REPROD, V60, P1006, DOI 10.1095/biolreprod60.4.1006; BRYANTGREENWOOD GD, 1995, AM J OBSTET GYNECOL, V172, P63, DOI 10.1016/0002-9378(95)90085-3; Carlini L, 2002, GYNECOL OBSTET INVES, V53, P174, DOI 10.1159/000058370; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; EKWO EE, 1992, OBSTET GYNECOL, V80, P166; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gardella C, 2004, AM J PERINAT, V21, P319, DOI 10.1055/s-2004-831884; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V174, P1618, DOI 10.1016/S0002-9378(96)70617-8; Goldenberg RL, 2001, JAMA-J AM MED ASSOC, V285, P633, DOI 10.1001/jama.285.5.633; Goldenberg RL, 1996, AM J PUBLIC HEALTH, V86, P781, DOI 10.2105/AJPH.86.6.781; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hao K, 2004, HUM MOL GENET, V13, P683, DOI 10.1093/hmg/ddh091; Hitti J, 1997, CLIN INFECT DIS, V24, P1228, DOI 10.1086/513669; HOLLANDER M, 1999, NONPARAMETRIC STAT A; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; JUN Z, 1992, EPIDEMIOLOGY, V3, P428, DOI 10.1097/00001648-199209000-00008; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lockwood CJ, 2002, NEW ENGL J MED, V346, P282, DOI 10.1056/NEJM200201243460412; Lockwood CJ, 2001, ANN NY ACAD SCI, V943, P77, DOI 10.1111/j.1749-6632.2001.tb03793.x; LOCKWOOD CJ, 1993, J CLIN ENDOCR METAB, V76, P231, DOI 10.1210/jc.76.1.231; Lockwood CJ, 2001, PAEDIATR PERINAT EP, V15, P78, DOI 10.1046/j.1365-3016.2001.00010.x; Martin JA, 2005, PEDIATRICS, V115, P619, DOI 10.1542/peds.2004-2695; Mastorakos G, 2003, ANN NY ACAD SCI, V997, P136, DOI 10.1196/annals.1290.016; Mattison DR, 2001, PAEDIATR PERINAT EP, V15, P7, DOI 10.1046/j.1365-3016.2001.00004.x; Matys T, 2004, P NATL ACAD SCI USA, V101, P16345, DOI 10.1073/pnas.0407355101; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; RUSH RW, 1976, BRIT MED J, V2, P965, DOI 10.1136/bmj.2.6042.965; SALAFIA CM, 1995, AM J OBSTET GYNECOL, V173, P1065, DOI 10.1016/0002-9378(95)91327-0; StataCorp L, 2007, STAT DAT AN STAT SOF; Treloar S A, 2000, Twin Res, V3, P80, DOI 10.1375/twin.3.2.80; Varner MW, 2005, BJOG-INT J OBSTET GY, V112, P28, DOI 10.1111/j.1471-0528.2005.00581.x; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	38	54	56	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3283	10.1371/journal.pone.0003283	http://dx.doi.org/10.1371/journal.pone.0003283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818748	Green Submitted, gold, Green Published			2022-12-27	WOS:000264432300005
J	Jaspan, HB; Huang, LC; Cotton, MF; Whitelaw, A; Myer, L				Jaspan, Heather B.; Huang, Lyen C.; Cotton, Mark F.; Whitelaw, Andrew; Myer, Landon			Bacterial Disease and Antimicrobial Susceptibility Patterns in HIV-Infected, Hospitalized Children: A Retrospective Cohort Study	PLOS ONE			English	Article								Background: Serious bacterial infections are a major source of morbidity and mortality in HIV-infected children. The spectrum of disease is wide, and responsible organisms vary according to setting. The use of antibiotic prophylaxis and the emergence of multi-drug resistant bacteria necessitate examination of responsible organisms and their antibiotic susceptibility. Methodology/Principal Findings: A retrospective cohort study of all HIV-positive pediatric admissions at an urban public sector hospital in Cape Town between January 2002 and June 2006 was conducted. Children between the ages of one month and nine years with laboratory confirmed HIV status, serious bacterial infection, and a hospital length of stay of 5 days or more, were eligible for inclusion. Organisms isolated from blood, urine, and cerebral spinal fluid cultures and their antimicrobial susceptibility were examined, and compared according to timing of isolation to distinguish nosocomial versus community-acquired. One hundred and forty-one children were identified (median age 1.2 years), 39% of whom were on antiretrovirals started before or during this hospitalization. Bacterial infections involved all organ systems, however pneumonia was most common (67%). S. pneumoniae and S. aureus were the most common gram positive and K. pneumoniae was the most common gram negative organism. K pneumoniae isolates were resistant to many first and second line antibiotics, and were all considered nosocomial. All S. aureus isolates were methicillin resistant, some of which were community-acquired. Conclusions/Significance: Bacterial infections are an important source of co-morbidity in HIV-infected children in resource-limited settings. Clinicians should have a low threshold to initiate antibiotics in children requiring hospitalization. Broad-spectrum antibiotics should be used judiciously. Clinicians caring for HIV-infected children should be cognizant of the most common organisms affecting such children, and of their local antimicrobial susceptibilities, when treating empirically for serious bacterial infections.	[Jaspan, Heather B.] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7700 Rondebosch, South Africa; [Huang, Lyen C.; Whitelaw, Andrew] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7700 Rondebosch, South Africa; [Cotton, Mark F.] Univ Stellenbosch, Dept Pediat & Child Hlth, Pediat Infect Dis Unit, ZA-7600 Stellenbosch, South Africa; [Whitelaw, Andrew] Univ Cape Town, Div Med Microbiol, Natl Hlth Lab Serv, ZA-7700 Rondebosch, South Africa; [Myer, Landon] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA	University of Cape Town; University of Cape Town; Stellenbosch University; University of Cape Town; Columbia University	Jaspan, HB (corresponding author), Univ Washington, Dept Pediat, Childrens Hosp, Seattle, WA 98195 USA.	heather.jaspan@sbri.org	Cotton, Mark/AAQ-9936-2020; Huang, Lyen/AAM-2144-2021	Cotton, Mark/0000-0003-2559-6034; Huang, Lyen/0000-0002-8605-2631; Whitelaw, Andrew/0000-0001-9070-5247	Palo Alto/University Rotary Club; Waterfront Rotary Club of Cape Town; Rotary Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007233] Funding Source: NIH RePORTER	Palo Alto/University Rotary Club; Waterfront Rotary Club of Cape Town; Rotary Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	LCH was supported in part by the Palo Alto/University Rotary Club, the Waterfront Rotary Club of Cape Town, and the Rotary Foundation, through the Ambassadorial Scholar program, none of whom had any role in the design, conduct, analysis, interpretation and preparation of the research or manuscript.	Abzug MJ, 2006, PEDIATR INFECT DIS J, V25, P920, DOI 10.1097/01.inf.0000237830.33228.c3; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; *CDC, 1987, MMWR-MORBID MORTAL W, V36, P225; COTTON M, 2008, PLOS MED; Franzetti F, 2006, INFECTION, V34, P9, DOI 10.1007/s15010-006-5007-x; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gona P, 2006, JAMA-J AM MED ASSOC, V296, P292, DOI 10.1001/jama.296.3.292; Kapogiannis BG, 2008, PEDIATRICS, V121, pE1229, DOI 10.1542/peds.2007-0871; King J, 1996, PEDIATR RES, V39, P1037; Madhi SA, 2000, CLIN INFECT DIS, V31, P170, DOI 10.1086/313925; Madhi SA, 2005, VACCINE, V23, P5517, DOI 10.1016/j.vaccine.2005.07.038; Madhi SA, 2002, PEDIATR INFECT DIS J, V21, P315, DOI 10.1097/00006454-200204000-00011; Madhi SA, 2007, VACCINE, V25, P2451, DOI 10.1016/j.vaccine.2006.09.019; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Meyers TM, 2000, J TROP PEDIATRICS, V46, P224, DOI 10.1093/tropej/46.4.224; MOFENSON LM, 1991, PEDIATR RES, V29, pA179; Mulenga V, 2007, AIDS, V21, P77, DOI 10.1097/QAD.0b013e3280114ed7; Nesheim SR, 2007, PEDIATRICS, V120, P100, DOI 10.1542/peds.2006-2052; PLETZ M, 2008, INT J ANTIMICROBIAL; Puthanakit T, 2007, CLIN INFECT DIS, V44, P599, DOI 10.1086/510489; Robinson A, 2007, S AFR FAM PRACT, V49, DOI 10.1080/20786204.2007.10873589; SPECTOR SA, 1994, NEW ENGL J MED, V331, P1181, DOI 10.1056/NEJM199411033311802; Viani RM, 2004, CLIN INFECT DIS, V39, P725, DOI 10.1086/423178; von Gottberg A, 2006, B WORLD HEALTH ORGAN, V84, P811, DOI 10.2471/BLT.06.030361; Winters M, 2008, CAN J PUBLIC HEALTH, V99, P57, DOI 10.1007/BF03403742; World Health Organisation, 2006, ANT THER HIV INF INF; Zar HJ, 2001, ACTA PAEDIATR, V90, P119, DOI 10.1080/080352501300049163	28	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3260	10.1371/journal.pone.0003260	http://dx.doi.org/10.1371/journal.pone.0003260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MG	18813340	Green Published, gold			2022-12-27	WOS:000264431800004
J	Grieder, NC; Caussinus, E; Parker, DS; Cadigan, K; Affolter, M; Luschnig, S				Grieder, Nicole C.; Caussinus, Emmanuel; Parker, David S.; Cadigan, Kenneth; Affolter, Markus; Luschnig, Stefan			gamma COP Is Required for Apical Protein Secretion and Epithelial Morphogenesis in Drosophila melanogaster	PLOS ONE			English	Article							GENETIC-CONTROL; TRACHEAL MORPHOGENESIS; TUBE MORPHOGENESIS; VESICLE TRANSPORT; SALIVARY-GLAND; GTPASE; CHITIN; TRAFFICKING; EXPRESSION; COMPONENTS	Background: There is increasing evidence that tissue-specific modifications of basic cellular functions play an important role in development and disease. To identify the functions of COPI coatomer-mediated membrane trafficking in Drosophila development, we were aiming to create loss-of-function mutations in the gamma COP gene, which encodes a subunit of the COPI coatomer complex. Principal Findings: We found that gamma COP is essential for the viability of the Drosophila embryo. In the absence of zygotic gamma COP activity, embryos die late in embryogenesis and display pronounced defects in morphogenesis of the embryonic epidermis and of tracheal tubes. The coordinated cell rearrangements and cell shape changes during tracheal tube morphogenesis critically depend on apical secretion of certain proteins. Investigation of tracheal morphogenesis in gamma COP loss-of-function mutants revealed that several key proteins required for tracheal morphogenesis are not properly secreted into the apical lumen. As a consequence, gamma COP mutants show defects in cell rearrangements during branch elongation, in tube dilation, as well as in tube fusion. We present genetic evidence that a specific subset of the tracheal defects in gamma COP mutants is due to the reduced secretion of the Zona Pellucida protein Piopio. Thus, we identified a critical target protein of COPI-dependent secretion in epithelial tube morphogenesis. Conclusions/Significance: These studies highlight the role of COPI coatomer-mediated vesicle trafficking in both general and tissue-specific secretion in a multicellular organism. Although COPI coatomer is generally required for protein secretion, we show that the phenotypic effect of gamma COP mutations is surprisingly specific. Importantly, we attribute a distinct aspect of the gamma COP phenotype to the effect on a specific key target protein.	[Grieder, Nicole C.; Caussinus, Emmanuel; Affolter, Markus] Biozentrum Univ Basel, Abt Zellbiol, Basel, Switzerland; [Parker, David S.; Cadigan, Kenneth] Univ Michigan, Dept Mol, Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Luschnig, Stefan] Univ Zurich, Inst Zool, CH-8006 Zurich, Switzerland	University of Basel; University of Michigan System; University of Michigan; University of Zurich	Grieder, NC (corresponding author), NICHD, NIH, Bethesda, MD USA.	nicole.grieder@unibas.ch	Luschnig, Stefan E/A-7253-2010	Luschnig, Stefan E/0000-0002-0634-3368; Cadigan, Ken/0000-0003-2431-1703; Affolter, Markus/0000-0002-5171-0016	Kantons Basel-Stadt; Basel-Land; German Research Foundation; The Swiss National Science Foundation; EMBO [fellowship]; FEBS [fellowship]; Treubel-Fonds, Basel; NIH [RO1 GM082994]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082994] Funding Source: NIH RePORTER	Kantons Basel-Stadt; Basel-Land; German Research Foundation(German Research Foundation (DFG)); The Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); EMBO(European Molecular Biology Organization (EMBO)); FEBS; Treubel-Fonds, Basel; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Kantons Basel-Stadt and Basel-Land (MA), the German Research Foundation (SL), The Swiss National Science Foundation, an EMBO long term fellowship (EC), a FEBS fellowship (EC), the Treubel-Fonds, Basel (NCG) and the NIH grant RO1 GM082994 (KC).	Abrams EW, 2005, DEVELOPMENT, V132, P2743, DOI 10.1242/dev.01863; Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7; CADIGAN KM, 1994, GENE DEV, V8, P899, DOI 10.1101/gad.8.8.899; CAMPBELL RE, 2002, MONOMETRIC RED FLUOR; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Coutinho P, 2004, DEV CELL, V7, P547, DOI 10.1016/j.devcel.2004.07.020; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; FARQUHAR MG, 1997, GOLGI APPARATUS, P65; Gaynor EC, 1998, BBA-MOL CELL RES, V1404, P33, DOI 10.1016/S0167-4889(98)00045-7; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; GLOOR GB, 1993, GENETICS, V135, P81; Grieder NC, 2005, GENE EXPR PATTERNS, V6, P11, DOI 10.1016/j.modgep.2005.06.001; Hoffman GR, 2003, MOL CELL, V12, P615, DOI 10.1016/j.molcel.2003.08.002; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964; Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049; Jiang L, 2007, DEV BIOL, V311, P487, DOI 10.1016/j.ydbio.2007.08.049; Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012; Kerman BE, 2006, DIFFERENTIATION, V74, P326, DOI 10.1111/j.1432-0436.2006.00095.x; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; LaJeunesse DR, 2004, BIOTECHNIQUES, V36, P784, DOI 10.2144/04365ST01; Lay D, 2006, BBA-MOL CELL RES, V1763, P1678, DOI 10.1016/j.bbamcr.2006.08.036; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lee S, 2002, DEVELOPMENT, V129, P1509; Liegeois S, 2007, GENETICS, V175, P709, DOI 10.1534/genetics.106.066035; Lippincott-Schwartz Jennifer, 2006, Trends Cell Biol, V16, pe1, DOI 10.1016/j.tcb.2006.08.008; Liu J, 2003, DEV CELL, V5, P487, DOI 10.1016/S1534-5807(03)00262-4; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Malhotra V, 2006, NATURE, V441, P939, DOI 10.1038/441939a; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Miyasaka H, 2002, J MOL EVOL, V55, P52, DOI 10.1007/s00239-001-0090-1; Parker DS, 2002, DEVELOPMENT, V129, P2565; Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Samakovlis C, 1996, DEVELOPMENT, V122, P3531; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Swanson LE, 2006, CURR BIOL, V16, pR51, DOI 10.1016/j.cub.2006.01.008; TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697; Thummel CS, 1992, DROS INF SERV, V71, P150; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; Wang JB, 2006, APPL MATH COMPUT, V180, P185, DOI 10.1016/j.amc.2005.11.162; Wegmann D, 2004, MOL CELL BIOL, V24, P1070, DOI 10.1128/MCB.24.3.1070-1080.2004	55	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2008	3	9							e3241	10.1371/journal.pone.0003241	http://dx.doi.org/10.1371/journal.pone.0003241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LF	18802472	Green Published, Green Submitted, gold			2022-12-27	WOS:000264428600001
J	Yafetto, L; Carroll, L; Cui, YL; Davis, DJ; Fischer, MWF; Henterly, AC; Kessler, JD; Kilroy, HA; Shidler, JB; Stolze-Rybczynski, JL; Sugawara, Z; Money, NP				Yafetto, Levi; Carroll, Loran; Cui, Yunluan; Davis, Diana J.; Fischer, Mark W. F.; Henterly, Andrew C.; Kessler, Jordan D.; Kilroy, Hayley A.; Shidler, Jacob B.; Stolze-Rybczynski, Jessica L.; Sugawara, Zachary; Money, Nicholas P.			The Fastest Flights in Nature: High-Speed Spore Discharge Mechanisms among Fungi	PLOS ONE			English	Article								Background: A variety of spore discharge processes have evolved among the fungi. Those with the longest ranges are powered by hydrostatic pressure and include "squirt guns'' that are most common in the Ascomycota and Zygomycota. In these fungi, fluid-filled stalks that support single spores or spore-filled sporangia, or cells called asci that contain multiple spores, are pressurized by osmosis. Because spores are discharged at such high speeds, most of the information on launch processes from previous studies has been inferred from mathematical models and is subject to a number of errors. Methodology/ Principal Findings: In this study, we have used ultra-high-speed video cameras running at maximum frame rates of 250,000 fps to analyze the entire launch process in four species of fungi that grow on the dung of herbivores. For the first time we have direct measurements of launch speeds and empirical estimates of acceleration in these fungi. Launch speeds ranged from 2 to 25 m s(-1) and corresponding accelerations of 20,000 to 180,000 g propelled spores over distances of up to 2.5 meters. In addition, quantitative spectroscopic methods were used to identify the organic and inorganic osmolytes responsible for generating the turgor pressures that drive spore discharge. Conclusions/Significance: The new video data allowed us to test different models for the effect of viscous drag and identify errors in the previous approaches to modeling spore motion. The spectroscopic data show that high speed spore discharge mechanisms in fungi are powered by the same levels of turgor pressure that are characteristic of fungal hyphae and do not require any special mechanisms of osmolyte accumulation.	[Yafetto, Levi; Cui, Yunluan; Davis, Diana J.; Henterly, Andrew C.; Kessler, Jordan D.; Kilroy, Hayley A.; Shidler, Jacob B.; Stolze-Rybczynski, Jessica L.; Sugawara, Zachary; Money, Nicholas P.] Miami Univ, Dept Bot, Oxford, OH 45056 USA; [Carroll, Loran; Davis, Diana J.; Fischer, Mark W. F.] Coll Mt St Joseph, Dept Chem & Phys Sci, Cincinnati, OH USA	University System of Ohio; Miami University; Mount St. Joseph University	Yafetto, L (corresponding author), Miami Univ, Dept Bot, Oxford, OH 45056 USA.	moneynp@muohio.edu	Yafetto, Levi/Q-7350-2018	Yafetto, Levi/0000-0002-7787-0325	National Science Foundation; National Institutes of Health; Direct For Biological Sciences [0743074] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors' studies on spore discharge are funded by the National Science Foundation and National Institutes of Health.	Buller AHR, 1934, RES FUNGI, V6; Elbert W., 2006, ATMOS CHEM PHYS DISC, V6, P11317; Fischer M, 2004, FUNGAL GENET BIOL, V41, P698, DOI 10.1016/j.fgb.2004.03.005; HIGGINS MK, 1994, ANAL CHEM, V66, P2625; Ingold C., 1971, MYCOLOGIA; INGOLD C. T., 1959, NEW PHYTOL, V58, P46, DOI 10.1111/j.1469-8137.1959.tb05333.x; Lapple CE, 1940, IND ENG CHEM, V32, P605, DOI 10.1021/ie50365a007; Majdalani J., 2006, VISCOUS FLUID FLOW, V3; MICHELI PA, 1729, NOVA PLANTARUM GENER; MONEY NP, 2007, MYCOTA, V8, P237; PAGE RM, 1964, MYCOLOGIA, V56, P363, DOI 10.2307/3756678; Pringle A, 2005, MYCOLOGIA, V97, P866, DOI 10.3852/mycologia.97.4.866; PRINGSHEIM E. G., 1927, JAHRB WISS BOT, V66, P863; ROBINSON J, 1962, NATURE, V193, P353, DOI 10.1038/193353a0; Trail F, 2005, FUNGAL GENET BIOL, V42, P528, DOI 10.1016/j.fgb.2005.03.008; Trail F, 2007, FEMS MICROBIOL LETT, V276, P12, DOI 10.1111/j.1574-6968.2007.00900.x; Tucker K, 2007, FUNGAL GENET BIOL, V44, P641, DOI 10.1016/j.fgb.2006.12.007; van den Berk GEL, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-140; Vogel S, 2005, J BIOSCIENCES, V30, P167, DOI 10.1007/BF02703696; Wakaba L, 2007, THEOR COMP FLUID DYN, V21, P147, DOI 10.1007/s00162-007-0042-5; Webster J., 2007, INTRO FUNGI, V3rd	21	52	55	11	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3237	10.1371/journal.pone.0003237	http://dx.doi.org/10.1371/journal.pone.0003237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LB	18797504	Green Published, gold, Green Submitted			2022-12-27	WOS:000264428200009
J	Grod, ON; Budden, AE; Tregenza, T; Koricheva, J; Leimu, R; Aarssen, LW; Lortie, CJ				Grod, Olyana N.; Budden, Amber E.; Tregenza, Tom; Koricheva, Julia; Leimu, Roosa; Aarssen, Lonnie W.; Lortie, Christopher J.			Systematic Variation in Reviewer Practice According to Country and Gender in the Field of Ecology and Evolution	PLOS ONE			English	Article								The characteristics of referees and the potential subsequent effects on the peer-review process are an important consideration for science since the integrity of the system depends on the appropriate evaluation of merit. In 2006, we conducted an online survey of 1334 ecologists and evolutionary biologists pertaining to the review process. Respondents were from Europe, North America and other regions of the world, with the majority from English first language countries. Women comprised a third of all respondents, consistent with their representation in the scientific academic community. Among respondents we found no correlation between the time typically taken over a review and the reported average rejection rate. On average, Europeans took longer over reviewing a manuscript than North Americans, and females took longer than males, but reviewed fewer manuscripts. Males recommended rejection of manuscripts more frequently than females, regardless of region. Hence, editors and potential authors should consider alternative sets of criteria, to what exists now, when selecting a panel of referees to potentially balance different tendencies by gender or region.	[Grod, Olyana N.; Lortie, Christopher J.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Budden, Amber E.] Natl Ctr Ecol Anal & Synthesis NCEAS, Santa Barbara, CA USA; [Tregenza, Tom] Univ Exeter, Ctr Ecol & Conserv, Exeter EX4 4QJ, Devon, England; [Koricheva, Julia] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Leimu, Roosa] Univ Turku, Sect Ecol, SF-20500 Turku, Finland; [Aarssen, Lonnie W.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	York University - Canada; National Center for Ecological Analysis & Synthesis; University of Exeter; University of London; Royal Holloway University London; University of Turku; Queens University - Canada	Grod, ON (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	olyanag@yorku.ca	Budden, Amber/A-2829-2010; Tregenza, Tom/B-1078-2014; Aarssen, Lonnie W./K-5778-2012; lortie, christopher j/F-6241-2014; Koricheva, Julia/G-6754-2011	Budden, Amber/0000-0003-2885-3980; Tregenza, Tom/0000-0003-4182-2222; lortie, christopher j/0000-0002-4291-7023; Koricheva, Julia/0000-0002-9033-0171	National Center for Ecological Analysis and Synthesis, a Center funded by NSF [DEB-0072909]	National Center for Ecological Analysis and Synthesis, a Center funded by NSF	This work was conducted as part of the role of publication-related biases in ecology Working Group supported by the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant no. DEB-0072909).	Benos DJ, 2007, ADV PHYSIOL EDUC, V31, P145, DOI 10.1152/advan.00104.2006; Budden AE, 2008, TRENDS ECOL EVOL, V23, P4, DOI 10.1016/j.tree.2007.07.008; Cassey P, 2004, BIOSCIENCE, V54, P234, DOI 10.1641/0006-3568(2004)054[0234:PARASE]2.0.CO;2; Frank E, 1996, PREV MED, V25, P102, DOI 10.1006/pmed.1996.0035; GARFUNKEL JM, 1994, JAMA-J AM MED ASSOC, V272, P137, DOI 10.1001/jama.272.2.137; GILBERT JR, 1994, JAMA-J AM MED ASSOC, V272, P139, DOI 10.1001/jama.272.2.139; Handelsman J, 2005, SCIENCE, V309, P1190, DOI 10.1126/science.1113252; KASSIRER JP, 1994, JAMA-J AM MED ASSOC, V272, P96, DOI 10.1001/jama.272.2.96; Kliewer MA, 2005, AM J ROENTGENOL, V184, P1731, DOI 10.2214/ajr.184.6.01841731; Kliewer MA, 2004, AM J ROENTGENOL, V183, P1545, DOI 10.2214/ajr.183.6.01831545; LLOYD ME, 1990, J APPL BEHAV ANAL, V23, P539, DOI 10.1901/jaba.1990.23-539; LOCK S, 1990, JAMA-J AM MED ASSOC, V263, P1341, DOI 10.1001/jama.263.10.1341; Lortie CJ, 2007, OIKOS, V116, P1247, DOI 10.1111/j.0030-1299.2007.15686.x; Millett D, 2006, J ORTHOD, V33, P1, DOI 10.1179/146531205225021321; Moller AP, 2001, TRENDS ECOL EVOL, V16, P580, DOI 10.1016/S0169-5347(01)02235-2; *NAT SCI BOARD, 2006, SCI ENG IND 2006; Neff BD, 2006, BIOSCIENCE, V56, P333, DOI 10.1641/0006-3568(2006)56[333:IPRAGO]2.0.CO;2; NYLENNA M, 1994, JAMA-J AM MED ASSOC, V272, P149, DOI 10.1001/jama.272.2.149; *SAS I INC, 2003, REL 5 1 1; Sokal R.R., 2012, BIOMETRY; Tregenza T, 2002, TRENDS ECOL EVOL, V17, P349, DOI 10.1016/S0169-5347(02)02545-4; *UNESCO, 2000, UNESCO WORLD CULT RE, P312; *UNESCO I STAT COL, 2006, UIS B SCI TECHN STAT; Weller A.C, 2001, EDITORIAL PEER REV I; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; YANKAUER A, 1990, JAMA-J AM MED ASSOC, V263, P1338; Zar J. H., 1996, BIOSTATISTICAL ANAL	27	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3202	10.1371/journal.pone.0003202	http://dx.doi.org/10.1371/journal.pone.0003202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787653	gold, Green Published, Green Submitted			2022-12-27	WOS:000264426200007
J	Penny, MA; Maire, N; Studer, A; Schapira, A; Smith, TA				Penny, Melissa A.; Maire, Nicolas; Studer, Alain; Schapira, Allan; Smith, Thomas A.			What Should Vaccine Developers Ask? Simulation of the Effectiveness of Malaria Vaccines	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; AFRICAN CHILDREN; EXPANDED PROGRAM; TRANSMISSION; INFECTION; EFFICACY; IMMUNIZATION; PROTECTION; DURATION; DENSITY	Background: A number of different malaria vaccine candidates are currently in pre-clinical or clinical development. Even though they vary greatly in their characteristics, it is unlikely that any of them will provide long-lasting sterilizing immunity against the malaria parasite. There is great uncertainty about what the minimal vaccine profile should be before registration is worthwhile; how to allocate resources between different candidates with different profiles; which candidates to consider combining; and what deployment strategies to consider. Methods and Findings: We use previously published stochastic simulation models, calibrated against extensive epidemiological data, to make quantitative predictions of the population effects of malaria vaccines on malaria transmission, morbidity and mortality. The models are fitted and simulations obtained via volunteer computing. We consider a range of endemic malaria settings with deployment of vaccines via the Expanded program on immunization (EPI), with and without additional booster doses, and also via 5-yearly mass campaigns for a range of coverages. The simulation scenarios account for the dynamic effects of natural and vaccine induced immunity, for treatment of clinical episodes, and for births, ageing and deaths in the cohort. Simulated pre-erythrocytic vaccines have greatest benefits in low endemic settings (<EIR of 10.5) where between 12% and 14% of all deaths are averted when initial efficacy is 50%. In some high transmission scenarios (>EIR of 84) PEV may lead to increased incidence of severe disease in the long term, if efficacy is moderate to low (<70%). Blood stage vaccines (BSV) are most useful in high transmission settings, and are comparable to PEV for low transmission settings. Combinations of PEV and BSV generally perform little better than the best of the contributing components. A minimum half-life of protection of 2-3 years appears to be a precondition for substantial epidemiological effects. Herd immunity effects can be achieved with even moderately effective (>20%) malaria vaccines (either PEV or BSV) when deployed through mass campaigns targeting all age-groups as well as EPI, and especially if combined with highly efficacious transmission-blocking components. Conclusions: We present for the first time a stochastic simulation approach to compare likely effects on morbidity, mortality and transmission of a range of malaria vaccines and vaccine combinations in realistic epidemiological and health systems settings. The results raise several issues for vaccine clinical development, in particular appropriateness of vaccine types for different transmission settings; the need to assess transmission to the vector and duration of protection; and the importance of deployment additional to the EPI, which again may make the issue of number of doses required more critical. To test the validity and robustness of our conclusions there is a need for further modeling (and, of course, field research) using alternative formulations for both natural and vaccine induced immunity. Evaluation of alternative deployment strategies outside EPI needs to consider the operational implications of different approaches to mass vaccination.	[Penny, Melissa A.; Maire, Nicolas; Studer, Alain; Schapira, Allan; Smith, Thomas A.] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Penny, Melissa A.; Maire, Nicolas; Studer, Alain; Schapira, Allan; Smith, Thomas A.] Swiss Trop Inst, Dept Publ Hlth & Epidemiol, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swiss Tropical & Public Health Institute	Penny, MA (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	Thomas-A.Smith@unibas.ch	Smith, Thomas/B-5569-2015; Penny, Melissa A/N-6838-2015; Schapira, Allan/AAZ-8116-2020	Smith, Thomas/0000-0002-3650-9381; Penny, Melissa A/0000-0002-4972-593X; 	Bill and Melinda Gates Foundation [39777]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by The Bill and Melinda Gates Foundation, project #39777. The funders had no role in study design, development of the model, decision to publish, or preparation of the manuscript.	Alonso PL, 1996, J INFECT DIS, V174, P367, DOI 10.1093/infdis/174.2.367; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ANDERSON RM, 1989, PARASITOLOGY, V99, pS59, DOI 10.1017/S0031182000083426; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Carter R, 2002, INT J PARASITOL, V32, P1617, DOI 10.1016/S0020-7519(02)00190-X; DEZOYSA APK, 1988, T ROY SOC TROP MED H, V82, P548, DOI 10.1016/0035-9203(88)90500-7; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Girard MP, 2007, VACCINE, V25, P1567, DOI 10.1016/j.vaccine.2006.09.074; Goodman C, 2000, EC ANAL MALARIA CONT; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Halloran ME, 1996, AM J EPIDEMIOL, V144, P83, DOI 10.1093/oxfordjournals.aje.a008858; Jensen JLWV, 1906, ACTA MATH-DJURSHOLM, V30, P175, DOI 10.1007/BF02418571; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Maire N, 2006, AM J TROP MED HYG, V75, P111, DOI 10.4269/ajtmh.2006.75.111; Maire N, 2006, AM J TROP MED HYG, V75, P19, DOI 10.4269/ajtmh.2006.75.19; Maire N, 2006, AM J TROP MED HYG, V75, P104, DOI 10.4269/ajtmh.2006.75.104; MOORTHY VS, 2007, VACCINE IN PRESS; Ross A, 2006, AM J TROP MED HYG, V75, P32, DOI 10.4269/ajtmh.2006.75.32; Saul A, 2007, CURR OPIN INFECT DIS, V20, P476, DOI 10.1097/QCO.0b013e3282a95e12; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; SMITH T, 2008, PARASITOLOG IN PRESS; Smith T, 2006, AM J TROP MED HYG, V75, P1; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; STRUCHINER CJ, 1989, MATH BIOSCI, V94, P87, DOI 10.1016/0025-5564(89)90073-4; Tediosi F, 2006, AM J TROP MED HYG, V75, P131, DOI 10.4269/ajtmh.2006.75.131; Tediosi F, 2006, AM J TROP MED HYG, V75, P90, DOI 10.4269/ajtmh.2006.75.90; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	29	55	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3193	10.1371/journal.pone.0003193	http://dx.doi.org/10.1371/journal.pone.0003193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784833	Green Published, gold, Green Submitted			2022-12-27	WOS:000264425900012
J	Grodstein, F; van Oijen, M; Irizarry, MC; Rosas, HD; Hyman, BT; Growdon, JH; De Vivo, I				Grodstein, Francine; van Oijen, Marieke; Irizarry, Michael C.; Rosas, H. Diana; Hyman, Bradley T.; Growdon, John H.; De Vivo, Immaculata			Shorter Telomeres May Mark Early Risk of Dementia: Preliminary Analysis of 62 Participants from the Nurses' Health Study	PLOS ONE			English	Article								Background: Dementia takes decades to develop, and effective prevention will likely require early intervention. Thus, it is critical to identify biomarkers of preclinical disease, allowing targeting of high-risk subjects for preventive efforts. Since telomeres shorten with age and oxidative stress, both of which are important contributors to the onset of dementia, telomere length might be a valuable biomarker. Methodology/Principal Findings: Among 62 participants of the Nurses' Health Study, we conducted neurologic evaluations, including patient and caregiver interviews, physical exam, neurologic exam, and neuropsychologic testing. We also conducted magnetic resonance imaging (MRI) in a sample of 29 of these women. In these preliminary data, after adjustment for numerous health and lifestyle factors, we found that truncated telomeres in peripheral blood leukocytes segregate with preclinical dementia states, including mild cognitive impairment (MCI); the odds of MCI were 12-fold higher (odds ratio = 12.00, 95% confidence interval 1.24-116.5) for those with shorter telomere length compared to longer telomere length. In addition, decreasing telomere length was strongly related to decreasing hippocampal volume (p = 0.038). Conclusions: These preliminary data suggest that telomere length may be a possible early marker of dementia risk, and merits further study in large, prospective investigations.	[Grodstein, Francine; De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Grodstein, Francine; De Vivo, Immaculata] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [van Oijen, Marieke] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Oijen, Marieke] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Irizarry, Michael C.] GlaxoSmithKline Inc, Res Triangle Pk, NC USA; [Rosas, H. Diana; Hyman, Bradley T.; Growdon, John H.] Massachusetts Gen Hosp, Harvard Med Sch, Dept Neurol, Massachusetts Alzheimer Dis Res Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; GlaxoSmithKline; Harvard University; Harvard Medical School; Massachusetts General Hospital	Grodstein, F (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 75 Francis St, Boston, MA 02115 USA.	fgrodstein@partners.org			National Institutes of Health [AG15424, AG05134, CA87969]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134, R01AG015424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by grants AG15424, AG05134, and CA87969 from the National Institutes of Health. The funders had no part in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript	Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349; den Heijer T, 2002, NEUROLOGY, V59, P746, DOI 10.1212/WNL.59.5.746; Flanary BE, 2007, REJUV RES, V10, P61, DOI 10.1089/rej.2006.9096; Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894; KAWAS C, 1994, ARCH NEUROL-CHICAGO, V51, P901, DOI 10.1001/archneur.1994.00540210073015; Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2	12	81	81	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1590	10.1371/journal.pone.0001590	http://dx.doi.org/10.1371/journal.pone.0001590			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18795148	Green Published, gold			2022-12-27	WOS:000260535900024
J	Silander, K; Alanne, M; Kristiansson, K; Saarela, O; Ripatti, S; Auro, K; Karvanen, J; Kulathinal, S; Niemela, M; Ellonen, P; Vartiainen, E; Jousilahti, P; Saarela, J; Kuulasmaa, K; Evans, A; Perola, M; Salomaa, V; Peltonen, L				Silander, Kaisa; Alanne, Mervi; Kristiansson, Kati; Saarela, Olli; Ripatti, Samuli; Auro, Kirsi; Karvanen, Juha; Kulathinal, Sangita; Niemela, Matti; Ellonen, Pekka; Vartiainen, Erkki; Jousilahti, Pekka; Saarela, Janna; Kuulasmaa, Kari; Evans, Alun; Perola, Markus; Salomaa, Veikko; Peltonen, Leena			Gender Differences in Genetic Risk Profiles for Cardiovascular Disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SINGLE-NUCLEOTIDE POLYMORPHISMS; ISCHEMIC-STROKE; MYOCARDIAL-INFARCTION; ASSOCIATION ANALYSIS; SEX-DIFFERENCES; WOMEN; IDENTIFICATION; COUNTRIES; GENOTYPE	Background: Cardiovascular disease (CVD) incidence, complications and burden differ markedly between women and men. Although there is variation in the distribution of lifestyle factors between the genders, they do not fully explain the differences in CVD incidence and suggest the existence of gender-specific genetic risk factors. We aimed to estimate whether the genetic risk profiles of coronary heart disease (CHD), ischemic stroke and the composite end-point of CVD differ between the genders. Methodology/Principal Findings: We studied in two Finnish population cohorts, using the case-cohort design the association between common variation in 46 candidate genes and CHD, ischemic stroke, CVD, and CVD-related quantitative risk factors. We analyzed men and women jointly and also conducted genotype-gender interaction analysis. Several allelic variants conferred disease risk for men and women jointly, including rs1801020 in coagulation factor XII (HR = 1.31 (1.08-1.60) for CVD, uncorrected p = 0.006 multiplicative model). Variant rs11673407 in the fucosyltransferase 3 gene was strongly associated with waist/hip ratio (uncorrected p = 0.00005) in joint analysis. In interaction analysis we found statistical evidence of variant-gender interaction conferring risk of CHD and CVD: rs3742264 in the carboxypeptidase B2 gene, p(interaction) = 0.009 for CHD, and rs2774279 in the upstream stimulatory factor 1 gene, p(interaction) = 0.007 for CHD and CVD, showed strong association in women but not in men, while rs2069840 in interleukin 6 gene, p(interaction) = 0.004 for CVD, showed strong association in men but not in women (uncorrected p-values). Also, two variants in the selenoprotein S gene conferred risk for ischemic stroke in women, p(interaction) = 0.003 and 0.007. Importantly, we identified a larger number of gender-specific effects for women than for men. Conclusions/Significance: A false discovery rate analysis suggests that we may expect half of the reported findings for combined gender analysis to be true positives, while at least third of the reported genotype-gender interaction results are true positives. The asymmetry in positive findings between the genders could imply that genetic risk loci for CVD are more readily detectable in women, while for men they are more confounded by environmental/lifestyle risk factors. The possible differences in genetic risk profiles between the genders should be addressed in more detail in genetic studies of CVD, and more focus on female CVD risk is also warranted in genome-wide association studies.	[Silander, Kaisa; Alanne, Mervi; Kristiansson, Kati; Ripatti, Samuli; Auro, Kirsi; Ellonen, Pekka; Saarela, Janna; Perola, Markus; Peltonen, Leena] Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; [Silander, Kaisa; Alanne, Mervi; Kristiansson, Kati; Ripatti, Samuli; Auro, Kirsi; Ellonen, Pekka; Saarela, Janna; Perola, Markus; Peltonen, Leena] Inst Mol Med Finland, FIMM, Helsinki, Finland; [Saarela, Olli; Karvanen, Juha; Niemela, Matti; Vartiainen, Erkki; Jousilahti, Pekka; Kuulasmaa, Kari; Salomaa, Veikko] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland; [Ripatti, Samuli] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Kulathinal, Sangita] Indic Soc Ed & Dev, Nasik, India; [Evans, Alun] Queens Univ Belfast, Belfast BT7 1NN, Antrim, North Ireland; [Perola, Markus; Peltonen, Leena] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Peltonen, Leena] Wellcome Trust Sanger Inst, Dept Human Genet, Cambridge, England; [Peltonen, Leena] Harvard Univ, MIT, Broad Inst, Boston, MA USA	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Karolinska Institutet; Queens University Belfast; University of Helsinki; Wellcome Trust Sanger Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Silander, K (corresponding author), Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland.	kaisa.silander@ktl.fi	Ripatti, Samuli/H-9446-2014; Saarela, Janna S/E-5369-2014	Ripatti, Samuli/0000-0002-0504-1202; Karvanen, Juha/0000-0001-5530-769X; Kuulasmaa, Kari/0000-0003-2165-1411; Kristiansson, Kati/0000-0003-4688-107X; Saarela, Janna/0000-0002-0853-6219; Kinnunen, Mervi/0000-0002-2448-8763; Ellonen, Pekka/0000-0001-6072-0489	European Commission [QLG2-CT-2002-01254]; Nordic Centre of Excellence is Disease Genetics; Academy of Finland Centre of Excellence in Complex Disease Genetics; Biocentrum Helsinki; Sigrid Juselius Foundation; Jenny and Antti Wihuri Foundation; Aarne Koskelo Foundation; Finnish Foundation for Cardiovascular Research; Research Foundation of Orion Corporation; Paulo Foundation; ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Nordic Centre of Excellence is Disease Genetics; Academy of Finland Centre of Excellence in Complex Disease Genetics(Academy of Finland); Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jenny and Antti Wihuri Foundation; Aarne Koskelo Foundation; Finnish Foundation for Cardiovascular Research; Research Foundation of Orion Corporation; Paulo Foundation; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was part of the GenomEUtwin project www genomeutwin org, which was supported by the European Commission under the programme Quality of Life and Management of the Living Resources of 5th Framework Programme no (QLG2-CT-2002-01254). The Sigrid Juselius Foundation has supported Veikko Salomaa and Markus Perola. Jenny and Antti Wihuri Foundation, Aarne Koskelo Foundation, the Finnish Foundation for Cardiovascular Research, the Research Foundation of Orion Corporation, and the Paulo Foundation are acknowledged for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanne M, 2007, HUM GENET, V122, P355, DOI 10.1007/s00439-007-0402-7; Auro K, 2006, ARTERIOSCL THROM VAS, V26, P942, DOI 10.1161/01.ATV.0000208365.45200.41; Auro K, 2007, PLOS GENET, V3, P1244, DOI 10.1371/journal.pgen.0030120; Bak S, 2002, STROKE, V33, P769, DOI 10.1161/hs0302.103619; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cakir B, 2004, J INTERN MED, V255, P40, DOI 10.1046/j.1365-2796.2003.01263.x; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Endler G, 2001, BRIT J HAEMATOL, V115, P1007, DOI 10.1046/j.1365-2141.2001.03201.x; Evans A, 2005, INT J EPIDEMIOL, V34, P21, DOI 10.1093/ije/dyh327; Evans A, 2003, TWIN RES, V6, P432, DOI 10.1375/136905203770326439; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Janis MT, 2004, J LIPID RES, V45, P2303, DOI 10.1194/jlr.M400250-JLR200; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Komulainen K, 2006, PLOS GENET, V2, P672, DOI 10.1371/journal.pgen.0020069; Kulathinal S, 2005, DESCRIPTION MORGAM C; Kulathinal Sangita, 2007, Epidemiol Perspect Innov, V4, P15; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; LAU PP, 1994, P NATL ACAD SCI USA, V91, P8522, DOI 10.1073/pnas.91.18.8522; LEE JC, 2007, ARTERIOSCLE IN PRESS; Liao W, 1999, BIOCHEM BIOPH RES CO, V260, P398, DOI 10.1006/bbrc.1999.0925; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Matarin M, 2007, LANCET NEUROL, V6, P414, DOI 10.1016/S1474-4422(07)70081-9; McCarthy JJ, 2007, NUTR METAB CARDIOVAS, V17, P153, DOI 10.1016/j.numecd.2006.01.005; McCarthy JJ, 2004, J MED GENET, V41, P334, DOI 10.1136/jmg.2003.016584; McCarthy JJ, 2003, HUM GENET, V114, P87, DOI 10.1007/s00439-003-1026-1; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pare G, 2007, AM J HUM GENET, V80, P673, DOI 10.1086/513286; Patsopoulos NA, 2007, JAMA-J AM MED ASSOC, V298, P880, DOI 10.1001/jama.298.8.880; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Pilote L, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.051455; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Russo F, 1997, MATURITAS, V26, P193, DOI 10.1016/S0378-5122(96)01094-8; SAHI T, 1977, AM J CLIN NUTR, V30, P476, DOI 10.1093/ajcn/30.4.476; Salomaa V, 2000, J INTERN MED, V247, P689, DOI 10.1046/j.1365-2796.2000.00682.x; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; SCHUNKERT H, 2008, CIRCULATION; Silander K, 2005, TWIN RES HUM GENET, V8, P368, DOI 10.1375/twin.8.4.368; Silander K, 2003, TWIN RES, V6, P391, DOI 10.1375/136905203770326394; SINNWELL J, 2007, HAPLO STATS PACKAGE; STRIMMER K, 2007, FDRTOOL PACKAGE VERS; Suviolahti E, 2006, HUM MOL GENET, V15, P377, DOI 10.1093/hmg/ddi448; Tikka-Kleemola P, 2007, MOL CELL PROBE, V21, P216, DOI 10.1016/j.mcp.2006.12.003; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Touze E, 2007, LANCET NEUROL, V6, P125, DOI 10.1016/S1474-4422(06)70683-4; Tunstall-Pedoe H, 1998, LANCET, V351, P1425, DOI 10.1016/S0140-6736(97)11321-6; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Wang MM, 2006, SEMIN NEUROL, V26, P523, DOI 10.1055/s-2006-951625; *WHO, 2006, WORLD HLTH 2006; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; Yamada Y, 2006, THROMB HAEMOSTASIS, V96, P220, DOI 10.1160/TH06-02-0117; Yamada Y, 2006, ARTERIOSCL THROM VAS, V26, P1920, DOI 10.1161/01.ATV.0000229694.97827.38; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	65	63	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3615	10.1371/journal.pone.0003615	http://dx.doi.org/10.1371/journal.pone.0003615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974842	Green Submitted, Green Published, gold			2022-12-27	WOS:000265131700029
J	Foerstner, KU; Doerks, T; Creevey, CJ; Doerks, A; Bork, P				Foerstner, Konrad U.; Doerks, Tobias; Creevey, Christopher J.; Doerks, Anja; Bork, Peer			A Computational Screen for Type I Polyketide Synthases in Metagenomics Shotgun Data	PLOS ONE			English	Article								Background: Polyketides are a diverse group of biotechnologically important secondary metabolites that are produced by multi domain enzymes called polyketide synthases (PKS). Methodology/Principal Findings: We have estimated frequencies of type I PKS (PKS I) - a PKS subgroup - in natural environments by using Hidden-Markov-Models of eight domains to screen predicted proteins from six metagenomic shotgun data sets. As the complex PKS I have similarities to other multi-domain enzymes (like those for the fatty acid biosynthesis) we increased the reliability and resolution of the dataset by maximum-likelihood trees. The combined information of these trees was then used to discriminate true PKS I domains from evolutionary related but functionally different ones. We were able to identify numerous novel PKS I proteins, the highest density of which was found in Minnesota farm soil with 136 proteins out of 183,536 predicted genes. We also applied the protocol to UniRef database to improve the annotation of proteins with so far unknown function and identified some new instances of horizontal gene transfer. Conclusions/Significance: The screening approach proved powerful in identifying PKS I sequences in large sequence data sets and is applicable to many other protein families.	[Foerstner, Konrad U.; Doerks, Tobias; Creevey, Christopher J.; Doerks, Anja; Bork, Peer] European Mol Biol Lab, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Foerstner, KU (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	bork@embl.de	Creevey, Christopher James/A-1836-2013; Förstner, Konrad U./B-1531-2010; Bork, Peer/F-1813-2013	Creevey, Christopher James/0000-0001-7183-1555; Förstner, Konrad U./0000-0002-1481-2996; Bork, Peer/0000-0002-2627-833X	MetaHit [HEALTH-F4-2007-201052]	MetaHit	MetaHit (HEALTH-F4-2007-201052)	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Calestani C, 2003, DEVELOPMENT, V130, P4587, DOI 10.1242/dev.00647; Castoe TA, 2007, GENE, V392, P47, DOI 10.1016/j.gene.2006.11.005; Cheng YQ, 2003, P NATL ACAD SCI USA, V100, P3149, DOI 10.1073/pnas.0537286100; Creevey CJ, 2005, BIOINFORMATICS, V21, P390, DOI 10.1093/bioinformatics/bti020; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Jenke-Kodama H, 2006, PLOS COMPUT BIOL, V2, P1210, DOI 10.1371/journal.pcbi.0020132; John U, 2008, PROTIST, V159, P21, DOI 10.1016/j.protis.2007.08.001; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Minowa Y, 2007, J MOL BIOL, V368, P1500, DOI 10.1016/j.jmb.2007.02.099; Moore BS, 2001, CHEMBIOCHEM, V2, P35, DOI 10.1002/1439-7633(20010105)2:1<35::AID-CBIC35>3.3.CO;2-T; Muller R, 2004, CHEM BIOL, V11, P4, DOI 10.1016/S1074-5521(04)00006-7; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Podar M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-42; Raes J, 2007, CURR OPIN MICROBIOL, V10, P490, DOI 10.1016/j.mib.2007.09.001; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Ridley CP, 2008, P NATL ACAD SCI USA, V105, P4595, DOI 10.1073/pnas.0710107105; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Schirmer A, 2005, APPL ENVIRON MICROB, V71, P4840, DOI 10.1128/AEM.71.8.4840-4849.2005; Shen B, 2003, CURR OPIN CHEM BIOL, V7, P285, DOI 10.1016/S1367-5931(03)00020-6; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; Yadav G, 2003, NUCLEIC ACIDS RES, V31, P3654, DOI 10.1093/nar/gkg607; Yun J, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-8; Zhu G, 2002, GENE, V298, P79, DOI 10.1016/S0378-1119(02)00931-9; Zucko J, 2007, BIOINFORMATICS, V23, P2543, DOI 10.1093/bioinformatics/btm381	43	24	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3515	10.1371/journal.pone.0003515	http://dx.doi.org/10.1371/journal.pone.0003515			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953415	Green Published, gold			2022-12-27	WOS:000265130500001
J	Yang, JSJ; Bai, JM; Lee, TM				Yang, Jacob Shun-Jen; Bai, Jia-Min; Lee, Tzumin			Dynein-Dynactin Complex Is Essential for Dendritic Restriction of TM1-Containing Drosophila Dscam	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; KINESIN SUPERFAMILY MOTOR; CYTOPLASMIC DYNEIN; K+ CHANNEL; NEUROBLAST PROLIFERATION; MUSHROOM BODIES; SELF-AVOIDANCE; BETA-SUBUNIT; NEURONS; PROTEIN	Background: Many membrane proteins, including Drosophila Dscam, are enriched in dendrites or axons within neurons. However, little is known about how the differential distribution is established and maintained. Methodology/Principal Findings: Here we investigated the mechanisms underlying the dendritic targeting of Dscam[TM1]. Through forward genetic mosaic screens and by silencing specific genes via targeted RNAi, we found that several genes, encoding various components of the dynein-dynactin complex, are required for restricting Dscam[TM1] to the mushroom body dendrites. In contrast, compromising dynein/dynactin function did not affect dendritic targeting of two other dendritic markers, Nod and Rdl. Tracing newly synthesized Dscam[TM1] further revealed that compromising dynein/dynactin function did not affect the initial dendritic targeting of Dscam[TM1], but disrupted the maintenance of its restriction to dendrites. Conclusions/Significance: The results of this study suggest multiple mechanisms of dendritic protein targeting. Notably, dynein-dynactin plays a role in excluding dendritic Dscam, but not Rdl, from axons by retrograde transport.	[Yang, Jacob Shun-Jen; Lee, Tzumin] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Bai, Jia-Min] Univ Illinois, Neurosci Program, Urbana, IL USA	University of Massachusetts System; University of Massachusetts Worcester; University of Illinois System; University of Illinois Urbana-Champaign	Yang, JSJ (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA.	Tzumin.Lee@umassmed.edu	Yang, Shun-Jen/G-2968-2015		March of Dimes Birth Defects Foundation; National Institutes of Health	March of Dimes Birth Defects Foundation(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The March of Dimes Birth Defects Foundation and the National Institutes of Health	Allen MJ, 1999, J NEUROSCI, V19, P9374; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Clark IE, 1997, DEVELOPMENT, V124, P461; Clark SW, 2005, MOL BIOL CELL, V16, P3999, DOI 10.1091/mbc.e05-02-0093; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Endoh T, 2004, BRAIN RES, V1024, P212, DOI 10.1016/j.brainres.2004.07.074; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; KIM YT, 1990, J NEUROGENET, V7, P1, DOI 10.3109/01677069009084149; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Koonce MP, 2004, TRENDS CELL BIOL, V14, P612, DOI 10.1016/j.tcb.2004.09.013; Kurusu M, 2002, DEVELOPMENT, V129, P409; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCGRAIL M, 1995, J CELL BIOL, V131, P411, DOI 10.1083/jcb.131.2.411; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reuter JE, 2003, DEVELOPMENT, V130, P1203, DOI 10.1242/dev.00319; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Rolls MM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-7; Saito N, 1997, NEURON, V18, P425, DOI 10.1016/S0896-6273(00)81243-X; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sanchez-Soriano N, 2005, DEV BIOL, V288, P126, DOI 10.1016/j.ydbio.2005.09.026; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shi L, 2007, J NEUROSCI, V27, P6723, DOI 10.1523/JNEUROSCI.1517-07.2007; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Wang J, 2006, DEVELOPMENT, V133, P1231, DOI 10.1242/dev.02299; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045; Zhu SJ, 2005, J NEUROSCI, V25, P4189, DOI 10.1523/JNEUROSCI.0149-05.2005	60	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3504	10.1371/journal.pone.0003504	http://dx.doi.org/10.1371/journal.pone.0003504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IH	18946501	Green Published, gold			2022-12-27	WOS:000265126200007
J	Klink, PC; van Ee, R; van Wezel, RJA				Klink, P. Christiaan; van Ee, Raymond; van Wezel, Richard J. A.			General Validity of Levelt's Propositions Reveals Common Computational Mechanisms for Visual Rivalry	PLOS ONE			English	Article							STRUCTURE-FROM-MOTION; PERCEPTUAL BI-STABILITY; BINOCULAR-RIVALRY; NEURAL MODEL; BISTABLE PERCEPTION; AMBIGUOUS STIMULI; VOLUNTARY CONTROL; NETWORK MODEL; DYNAMICS; COMPETITION	The mechanisms underlying conscious visual perception are often studied with either binocular rivalry or perceptual rivalry stimuli. Despite existing research into both types of rivalry, it remains unclear to what extent their underlying mechanisms involve common computational rules. Computational models of binocular rivalry mechanisms are generally tested against Levelt's four propositions, describing the psychophysical relation between stimulus strength and alternation dynamics in binocular rivalry. Here we use a bistable rotating structure-from-motion sphere, a generally studied form of perceptual rivalry, to demonstrate that Levelt's propositions also apply to the alternation dynamics of perceptual rivalry. Importantly, these findings suggest that bistability in structure-from-motion results from active cross-inhibition between neural populations with computational principles similar to those present in binocular rivalry. Thus, although the neural input to the computational mechanism of rivalry may stem from different cortical neurons and different cognitive levels the computational principles just prior to the production of visual awareness appear to be common to the two types of rivalry.	[Klink, P. Christiaan; van Wezel, Richard J. A.] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [van Ee, Raymond] Univ Utrecht, Dept Phys & Helmholtz Inst, NL-3508 TC Utrecht, Netherlands	Utrecht University; Utrecht University	Klink, PC (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	P.C.Klink@uu.nl	van Wezel, Richard R J/G-4455-2011; van Ee, Raymond/C-4881-2013; Klink, Chris/P-5074-2019	van Wezel, Richard R J/0000-0001-5753-7069; Klink, Chris/0000-0002-6784-7842; van Ee, Raymond/0000-0002-1134-8665	Netherlands Organization for Scientific Research (NWO) [VIDI]; Utrecht University	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Utrecht University	This work was supported by two VIDI grants from the Netherlands Organization for Scientific Research (NWO) awarded to RvW and RvE as well as a High Potential grant from Utrecht University awarded jointly to RvE and RvW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 1998, TRENDS COGN SCI, V2, P222, DOI 10.1016/S1364-6613(98)01181-4; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R., 2001, BRAIN MIND, V2, P5, DOI [https://doi.org/10.1023/A:1017925416289, DOI 10.1023/A:1017925416289, 10.1023/A:1017925416289]; BOSSINK CJH, 1993, VISION RES, V33, P1413, DOI 10.1016/0042-6989(93)90047-Z; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brascamp JW, 2006, J VISION, V6, P1244, DOI 10.1167/6.11.8; Brascamp JW, 2005, J VISION, V5, P287, DOI 10.1167/5.4.1; Brouwer GJ, 2006, VISION RES, V46, P3393, DOI 10.1016/j.visres.2006.03.016; Carter OL, 2003, PERCEPTION, V32, P295, DOI 10.1068/p3472; Freeman ED, 2006, VISION RES, V46, P4007, DOI 10.1016/j.visres.2006.07.008; Grossmann JK, 2006, VISION RES, V46, P285, DOI 10.1016/j.visres.2005.06.002; Hol K, 2003, J VISION, V3, P486, DOI 10.1167/3.7.3; Hupe JM, 2003, VISION RES, V43, P531, DOI 10.1016/S0042-6989(02)00593-X; Kalarickal GJ, 2000, NEUROCOMPUTING, V32, P843, DOI 10.1016/S0925-2312(00)00252-6; KLINK PC, 2008, J VIS, V8, P1611; Koch Christof, 2004, QUEST CONSCIOUSNESS; Krekelberg B, 2006, J NEUROSCI, V26, P8988, DOI 10.1523/JNEUROSCI.1983-06.2006; Laing CR, 2002, J COMPUT NEUROSCI, V12, P39, DOI 10.1023/A:1014942129705; Lankheet MJM, 2006, J VISION, V6, P304, DOI 10.1167/6.4.1; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; LEVELT WJM, 1966, BRIT J PSYCHOL, V57, P225, DOI 10.1111/j.2044-8295.1966.tb01023.x; Li HCO, 1999, VISION RES, V39, P881, DOI 10.1016/S0042-6989(98)00247-8; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Meng M, 2004, J VISION, V4, P539, DOI 10.1167/4.7.2; Moreno-Bote R, 2007, J NEUROPHYSIOL, V98, P1125, DOI 10.1152/jn.00116.2007; MUELLER TJ, 1989, BIOL CYBERN, V61, P223, DOI 10.1007/BF00198769; MUELLER TJ, 1990, VISUAL NEUROSCI, V4, P63, DOI 10.1017/S0952523800002777; NAWROT M, 1991, VISUAL NEUROSCI, V6, P219, DOI 10.1017/S0952523800006234; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pettigrew J D, 2001, BRAIN MIND, V2, P85, DOI [10.1023/A:1017929617197, DOI 10.1023/A:1017929617197]; Rubin N., 2005, BINOCULAR RIVALRY; SCHWARTZ BL, 1983, B PSYCHONOMIC SOC; Shpiro A, 2007, J NEUROPHYSIOL, V97, P462, DOI 10.1152/jn.00604.2006; Sohn W, 2006, J VISION, V6, P119, DOI 10.1167/6.2.3; Stollenwerk L, 2003, NEURAL COMPUT, V15, P2863, DOI 10.1162/089976603322518777; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; TREUE S, 1995, VISION RES, V35, P139, DOI 10.1016/0042-6989(94)E0069-W; van Dam LCJ, 2006, VISION RES, V46, P787, DOI 10.1016/j.visres.2005.10.011; van Ee R, 2005, VISION RES, V45, P41, DOI 10.1016/j.visres.2004.07.030; van Ee R, 2006, VISION RES, V46, P3129, DOI 10.1016/j.visres.2006.03.017; van Ee R, 2005, VISION RES, V45, P29, DOI 10.1016/j.visres.2004.07.039; Wannig A, 2007, NEURON, V54, P639, DOI 10.1016/j.neuron.2007.05.001; Wilson HR, 2007, VISION RES, V47, P2741, DOI 10.1016/j.visres.2007.07.007	46	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3473	10.1371/journal.pone.0003473	http://dx.doi.org/10.1371/journal.pone.0003473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IG	18941522	gold, Green Published, Green Submitted			2022-12-27	WOS:000265126100004
J	Ato, M; Ikebe, T; Kawabata, H; Takemori, T; Watanabe, H				Ato, Manabu; Ikebe, Tadayoshi; Kawabata, Hiroki; Takemori, Toshitada; Watanabe, Haruo			Incompetence of Neutrophils to Invasive Group A streptococcus Is Attributed to Induction of Plural Virulence Factors by Dysfunction of a Regulator	PLOS ONE			English	Article							SHOCK-LIKE SYNDROME; STREPTOLYSIN-O; CYSTEINE PROTEASE; ENHANCING EVASION; PYOGENES; PATHOGENESIS; INFECTIONS; EXPRESSION; MODULATE; GENE	Group A streptococcus (GAS) causes variety of diseases ranging from common pharyngitis to life-threatening severe invasive diseases, including necrotizing fasciitis and streptococcal toxic shock-like syndrome. The characteristic of invasive GAS infections has been thought to attribute to genetic changes in bacteria, however, no clear evidence has shown due to lack of an intriguingly study using serotype-matched isolates from clinical severe invasive GAS infections. In addition, rare outbreaks of invasive infections and their distinctive pathology in which infectious foci without neutrophil infiltration hypothesized us invasive GAS could evade host defense, especially neutrophil functions. Herein we report that a panel of serotype-matched GAS, which were clinically isolated from severe invasive but not from non-invaive infections, could abrogate functions of human polymorphnuclear neutrophils (PMN) in at least two independent ways; due to inducing necrosis to PMN by enhanced production of a pore-forming toxin streptolysin O (SLO) and due to impairment of PMN migration via digesting interleukin-8, a PMN attracting chemokine, by increased production of a serine protease ScpC. Expression of genes was upregulated by a loss of repressive function with the mutation of csrS gene in the all emm49 severe invasive GAS isolates. The csrS mutants from clinical severe invasive GAS isolates exhibited high mortality and disseminated infection with paucity of neutrophils, a characteristic pathology seen in human invasive GAS infection, in a mouse model. However, GAS which lack either SLO or ScpC exhibit much less mortality than the csrS-mutated parent invasive GAS isolate to the infected mice. These results suggest that the abilities of GAS to abrogate PMN functions can determine the onset and severity of invasive GAS infection.	[Ato, Manabu] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan; [Ikebe, Tadayoshi; Kawabata, Hiroki; Watanabe, Haruo] Natl Inst Infect Dis, Dept Bacteriol, Tokyo, Japan; [Takemori, Toshitada] Riken Res Ctr Allergy & Immunol, Lab Immunol Memory, Kanagawa, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); RIKEN	Ato, M (corresponding author), Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan.	tdikebe@nih.go.jp	Ato, Manabu/K-6452-2019	Ato, Manabu/0000-0002-3178-2645	Ministry of Health, Labour and Welfare of Japan [H19-Shinkou-Ippan-002]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant (H19-Shinkou-Ippan-002, to H.W) from the Ministry of Health, Labour and Welfare of Japan.	Ato M, 2002, NAT IMMUNOL, V3, P1185, DOI 10.1038/ni861; Bakleh M, 2005, CLIN INFECT DIS, V40, P410, DOI 10.1086/427286; Bhakdi S, 1996, ARCH MICROBIOL, V165, P73, DOI 10.1007/s002030050300; BHAKDI S, 1985, INFECT IMMUN, V48, P713, DOI 10.1128/IAI.48.3.713-719.1985; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; BREIMAN RF, 1993, JAMA-J AM MED ASSOC, V269, P390, DOI 10.1001/jama.1993.03500030088038; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Eriksson BKG, 1998, CLIN INFECT DIS, V27, P1428, DOI 10.1086/515012; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Hasegawa T, 2004, MICROBES INFECT, V6, P1073, DOI 10.1016/j.micinf.2004.06.001; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; HIRSCH JG, 1963, J EXP MED, V118, P223, DOI 10.1084/jem.118.2.223; Ikebe T, 2005, JPN J INFECT DIS, V58, P272; Ikebe T, 2004, JPN J INFECT DIS, V57, P187; Ikebe T, 2003, EPIDEMIOL INFECT, V130, P569, DOI 10.1017/S0950268803008331; ITH A, 2005, LANCET INFECT DIS, V5, P494; Iversen PO, 2002, AM J PHYSIOL-REG I, V282, pR166, DOI 10.1152/ajpregu.2002.282.1.R166; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; MARHOFFER W, 1992, DIABETES CARE, V15, P256, DOI 10.2337/diacare.15.2.256; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Miyoshi-Akiyama T, 2005, J INFECT DIS, V192, P107, DOI 10.1086/430617; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Propst-Graham KL, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-94; Ruiz N, 1998, MOL MICROBIOL, V27, P337, DOI 10.1046/j.1365-2958.1998.00681.x; Sambrook J., 1990, MOL CLONING LAB MANU, V2nd; Sierig G, 2003, INFECT IMMUN, V71, P446, DOI 10.1128/IAI.71.1.446-455.2003; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Sumby P, 2008, INFECT IMMUN, V76, P978, DOI 10.1128/IAI.01354-07; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Urban CF, 2006, CELL MICROBIOL, V8, P1687, DOI 10.1111/j.1462-5822.2006.00792.x; Voyich JM, 2004, MICROBES INFECT, V6, P1117, DOI 10.1016/j.micinf.2004.05.022; Walev I, 2001, FASEB J, V15, P237, DOI 10.1096/fj.01-0572fje; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612	44	45	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3455	10.1371/journal.pone.0003455	http://dx.doi.org/10.1371/journal.pone.0003455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941623	gold, Green Published, Green Submitted			2022-12-27	WOS:000265125900003
J	Lovell, PV; Clayton, DF; Replogle, KL; Mello, CV				Lovell, Peter V.; Clayton, David F.; Replogle, Kirstin L.; Mello, Claudio V.			Birdsong "Transcriptomics": Neurochemical Specializations of the Oscine Song System	PLOS ONE			English	Article								Background: Vocal learning is a rare and complex behavioral trait that serves as a basis for the acquisition of human spoken language. In songbirds, vocal learning and production depend on a set of specialized brain nuclei known as the song system. Methodology/Principal Findings: Using high-throughput functional genomics we have identified,200 novel molecular markers of adult zebra finch HVC, a key node of the song system. These markers clearly differentiate HVC from the general pallial region to which HVC belongs, and thus represent molecular specializations of this song nucleus. Bioinformatics analysis reveals that several major neuronal cell functions and specific biochemical pathways are the targets of transcriptional regulation in HVC, including: 1) cell-cell and cell-substrate interactions (e. g., cadherin/catenin-mediated adherens junctions, collagen-mediated focal adhesions, and semaphorin-neuropilin/plexin axon guidance pathways); 2) cell excitability (e. g., potassium channel subfamilies, cholinergic and serotonergic receptors, neuropeptides and neuropeptide receptors); 3) signal transduction (e. g., calcium regulatory proteins, regulators of G-protein-related signaling); 4) cell proliferation/death, migration and differentiation (e. g., TGF-beta/BMP and p53 pathways); and 5) regulation of gene expression (candidate retinoid and steroid targets, modulators of chromatin/nucleolar organization). The overall direction of regulation suggest that processes related to cell stability are enhanced, whereas proliferation, growth and plasticity are largely suppressed in adult HVC, consistent with the observation that song in this songbird species is mostly stable in adulthood. Conclusions/Significance: Our study represents one of the most comprehensive molecular genetic characterizations of a brain nucleus involved in a complex learned behavior in a vertebrate. The data indicate numerous targets for pharmacological and genetic manipulations of the song system, and provide novel insights into mechanisms that might play a role in the regulation of song behavior and/or vocal learning.	[Lovell, Peter V.; Mello, Claudio V.] Oregon Hlth & Sci Univ, Inst Neurol Sci, Beaverton, OR USA; [Clayton, David F.; Replogle, Kirstin L.] Univ Illinois, Urbana, IL USA	Oregon Health & Science University; University of Illinois System; University of Illinois Urbana-Champaign	Lovell, PV (corresponding author), Oregon Hlth & Sci Univ, Inst Neurol Sci, Beaverton, OR USA.	melloc@ohsu.edu	Clayton, David/B-2190-2008	Clayton, David/0000-0002-6395-3488; Mello, Claudio/0000-0002-9826-8421	NIH/NIDCD [DC002853]; NIH/NINDS [NS054267, NS045264]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045264, F32NS054267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002853, R29DC002853] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH/NIDCD grant DC002853 (to CVM), and NIH/NINDS grant NS054267 (to PVL), and Initiative NIH/NINDS grant NS045264 (to DFC).	Agate RJ, 2002, BIOL REPROD, V66, P1127, DOI 10.1095/biolreprod66.4.1127; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1992, J NEUROBIOL, V23, P396, DOI 10.1002/neu.480230406; AlvarezBuylla A, 1997, J NEUROBIOL, V33, P585, DOI 10.1002/(SICI)1097-4695(19971105)33:5<585::AID-NEU7>3.0.CO;2-0; Bailey DJ, 2002, J NEUROBIOL, V52, P43, DOI 10.1002/neu.10070; BRENOWITZ EA, 1991, J NEUROSCI, V11, P1367; Brenowitz EA, 1997, J NEUROBIOL, V33, P517, DOI 10.1002/(SICI)1097-4695(19971105)33:5<517::AID-NEU3>3.0.CO;2-7; Dabrowski M, 2003, J NEUROCHEM, V85, P1279, DOI 10.1046/j.1471-4159.2003.01753.x; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; Denisenko-Nehrbass NI, 2000, NEURON, V27, P359, DOI 10.1016/S0896-6273(00)00043-X; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Duffy DL, 1999, BRAIN RES, V844, P78, DOI 10.1016/S0006-8993(99)01915-0; Dutar P, 1998, J NEUROPHYSIOL, V80, P1828, DOI 10.1152/jn.1998.80.4.1828; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; GEORGE JM, 1992, MOL BRAIN RES, V12, P323, DOI 10.1016/0169-328X(92)90134-W; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Hofmann HA, 2003, J NEUROBIOL, V54, P272, DOI 10.1002/neu.10172; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Jarvis ED, 1997, NEUROREPORT, V8, P2073, DOI 10.1097/00001756-199705260-00052; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; KIRN JR, 1991, J NEUROSCI, V11, P1756; Li R, 1997, BRAIN RES, V763, P239, DOI 10.1016/S0006-8993(97)00417-4; Li XC, 2007, P NATL ACAD SCI USA, V104, P6834, DOI 10.1073/pnas.0701619104; Lomax MI, 2000, HEARING RES, V147, P293, DOI 10.1016/S0378-5955(00)00139-8; Lombardo F, 2004, FASEB J, V18, P52, DOI 10.1096/fj.03-0521com; Malyala A, 2004, NEUROCHEM RES, V29, P1189, DOI 10.1023/B:NERE.0000023606.13670.1d; Massengill JL, 1997, J NEUROSCI, V17, P3136; Mello C V, 1997, Methods Mol Biol, V85, P205; MELLO CV, 1994, J NEUROSCI, V14, P6652; Mello CV, 1998, J COMP NEUROL, V395, P137; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Reiner A, 2004, ANN NY ACAD SCI, V1016, P77, DOI 10.1196/annals.1298.013; Renn SCP, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-42; Replogle K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-131; Rho JY, 2004, ENDOCR RES, V30, P257, DOI 10.1081/ERC-120039579; ROUSSELOT P, 1995, J COMP NEUROL, V356, P629, DOI 10.1002/cne.903560411; ROUSSELOT P, 1995, J COMP NEUROL, V351, P51, DOI 10.1002/cne.903510106; RYAN SM, 1981, J COMP NEUROL, V202, P211, DOI 10.1002/cne.902020207; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Shea SD, 2003, NEURON, V40, P1213, DOI 10.1016/S0896-6273(03)00723-2; SHEN P, 1995, J COMP NEUROL, V360, P172, DOI 10.1002/cne.903600113; SHEN P, 1994, MOL BRAIN RES, V24, P227, DOI 10.1016/0169-328X(94)90136-8; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Takita J, 2004, GENE CHROMOSOME CANC, V40, P120, DOI 10.1002/gcc.20021; Torres-Munoz JE, 2004, MOL BRAIN RES, V127, P105, DOI 10.1016/j.molbrainres.2004.05.017; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Velho TAF, 2007, J COMP NEUROL, V500, P477, DOI 10.1002/cne.21180; Wada K, 2004, J COMP NEUROL, V476, P44, DOI 10.1002/cne.20201; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; WATSON JT, 1988, J COMP NEUROL, V274, P255, DOI 10.1002/cne.902740209; WEISER M, 1995, J NEUROSCI, V15, P4298; WEISER M, 1994, J NEUROSCI, V14, P949, DOI 10.1523/JNEUROSCI.14-03-00949.1994; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Wilbrecht L, 2003, MENT RETARD DEV D R, V9, P135, DOI 10.1002/mrdd.10073; Wilbrecht L, 2006, J NEUROSCI, V26, P9135, DOI 10.1523/JNEUROSCI.4869-05.2006; Wild JM, 2005, J COMP NEUROL, V483, P76, DOI 10.1002/cne.20403; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Wood WE, 2008, DEV NEUROBIOL, V68, P1213, DOI 10.1002/dneu.20642; Zeigler H. P., 2004, BEHAV NEUROBIOLOGY B, V1016	64	70	72	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3440	10.1371/journal.pone.0003440	http://dx.doi.org/10.1371/journal.pone.0003440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941504	Green Published, Green Submitted, gold			2022-12-27	WOS:000265125600004
J	Okubadejo, N; Britton, A; Crews, C; Akinyemi, R; Hardy, J; Singleton, A; Bras, J				Okubadejo, Njideka; Britton, Angela; Crews, Cynthia; Akinyemi, Rufus; Hardy, John; Singleton, Andrew; Bras, Jose			Analysis of Nigerians with Apparently Sporadic Parkinson Disease for Mutations in LRRK2, PRKN and ATXN3	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; COMMON FOUNDER; GENE; ONSET; G2019S; POLYMORPHISMS; FAMILIES	Several genetic variations have been associated with Parkinson disease in different populations over the past few years. Although a considerable number of worldwide populations have been screened for these variants, results from Sub-Saharan populations are very scarce in the literature. In the present report we have screened a cohort of Parkinson disease patients (n = 57) and healthy controls (n = 51) from Nigeria for mutations in the genes PRKN, LRRK2 and ATXN3. No pathogenic mutations were found in any of the genes. Hence, common pathogenic mutations in these genes, observed in several different populations, are not a frequent cause of Parkinson disease in Nigeria.	[Okubadejo, Njideka] Univ Lagos, Coll Med, Dept Med, Neurol Unit, Lagos, Nigeria; [Britton, Angela; Crews, Cynthia; Singleton, Andrew; Bras, Jose] NIA, Lab Neurogenet, NIH, Bethesda, MD USA; [Akinyemi, Rufus] Fed Med Ctr, Dept Med, Neurol Unit, Abeokuta, Nigeria; [Hardy, John] Reta Lila Weston Inst, Inst Neurol, Dept Mol Neurosci & Neurodegenerat Dis, London, England; [Bras, Jose] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3000 Coimbra, Portugal	University of Lagos; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; Universidade de Coimbra	Okubadejo, N (corresponding author), Univ Lagos, Coll Med, Dept Med, Neurol Unit, Lagos, Nigeria.	brasj@mail.nih.gov	Bras, Jose MT/A-1428-2011; Hardy, John/C-2451-2009; Singleton, Andrew B/C-3010-2009	Hardy, John/0000-0002-3122-0423; Okubadejo, Njideka/0000-0003-2975-8803; Bras, Jose/0000-0001-8186-0333; Akinyemi, Rufus/0000-0001-5286-428X	Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services [Z01-AG000957-05]; Portuguese FCT [SFRH/BD/29647/2006]; NATIONAL INSTITUTE ON AGING [Z01AG000957] Funding Source: NIH RePORTER; Medical Research Council [G0701075] Funding Source: researchfish; MRC [G0701075] Funding Source: UKRI	Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Portuguese FCT(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services; Annual Report number Z01-AG000957-05 and Portuguese FCT grant #SFRH/BD/29647/2006.	Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bras JM, 2005, MOVEMENT DISORD, V20, P1653, DOI 10.1002/mds.20682; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Gwinn-Hardy K, 2001, ARCH NEUROL-CHICAGO, V58, P296, DOI 10.1001/archneur.58.2.296; Gwinn-Hardy K, 2000, NEUROLOGY, V55, P800, DOI 10.1212/WNL.55.6.800; Hoehn MM, 2001, NEUROLOGY, V57, pS11; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klein C, 2007, LANCET NEUROL, V6, P652, DOI 10.1016/S1474-4422(07)70174-6; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Lesage S, 2005, AM J HUM GENET, V77, P330, DOI 10.1086/432422; Lincoln SJ, 2003, MOVEMENT DISORD, V18, P1306, DOI 10.1002/mds.10601; Lucking CB, 2003, ARCH NEUROL-CHICAGO, V60, P1253, DOI 10.1001/archneur.60.9.1253; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Okubadejo NU, 2008, PARKINSONISM RELAT D, V14, P177, DOI 10.1016/j.parkreldis.2007.08.006; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Paisan-Ruiz C, 2008, HUM MUTAT, V29, P485, DOI 10.1002/humu.20668; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Simon-Sanchez J, 2008, HUM MUTAT, V29, P315, DOI 10.1002/humu.20626; Subramony SH, 2002, MOVEMENT DISORD, V17, P1068, DOI 10.1002/mds.10241; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	26	46	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3421	10.1371/journal.pone.0003421	http://dx.doi.org/10.1371/journal.pone.0003421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927607	gold, Green Published, Green Submitted			2022-12-27	WOS:000265122400002
J	Selvarajoo, K; Takada, Y; Gohda, J; Helmy, M; Akira, S; Tomita, M; Tsuchiya, M; Inoue, J; Matsuo, K				Selvarajoo, Kumar; Takada, Yasunari; Gohda, Jin; Helmy, Mohamed; Akira, Shizuo; Tomita, Masaru; Tsuchiya, Masa; Inoue, Jun-ichiro; Matsuo, Koichi			Signaling Flux Redistribution at Toll-Like Receptor Pathway Junctions	PLOS ONE			English	Article								Various receptors on cell surface recognize specific extracellular molecules and trigger signal transduction altering gene expression in the nucleus. Gain or loss-of-function mutations of one molecule have shown to affect alternative signaling pathways with a poorly understood mechanism. In Toll-like receptor (TLR) 4 signaling, which branches into MyD88- and TRAM-dependent pathways upon lipopolysaccharide (LPS) stimulation, we investigated the gain or loss-of-function mutations of MyD88. We predict, using a computational model built on the perturbation-response approach and the law of mass conservation, that removal and addition of MyD88 in TLR4 activation, enhances and impairs, respectively, the alternative TRAM-dependent pathway through signaling flux redistribution (SFR) at pathway branches. To verify SFR, we treated MyD88- deficient macrophages with LPS and observed enhancement of TRAM-dependent pathway based on increased IRF3 phosphorylation and induction of Cxcl10 and Ifit2. Furthermore, increasing the amount of MyD88 in cultured cells showed decreased TRAM binding to TLR4. Investigating another TLR4 pathway junction, from TRIF to TRAF6, RIP1 and TBK1, the removal of MyD88- dependent TRAF6 increased expression of TRAM-dependent Cxcl10 and Ifit2. Thus, we demonstrate that SFR is a novel mechanism for enhanced activation of alternative pathways when molecules at pathway junctions are removed. Our data suggest that SFR may enlighten hitherto unexplainable intracellular signaling alterations in genetic diseases where gain or loss-of-function mutations are observed.	[Selvarajoo, Kumar; Helmy, Mohamed; Tomita, Masaru; Tsuchiya, Masa] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Takada, Yasunari; Matsuo, Koichi] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 108, Japan; [Gohda, Jin; Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Tokyo, Japan; [Akira, Shizuo] Osaka Univ, Res Inst Microb Dis, Dept Host Defense, Suita, Osaka 565, Japan	Keio University; Keio University; University of Tokyo; Osaka University	Selvarajoo, K (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	kumar@ttck.keio.ac.jp; matsuo@sc.itc.keio.ac.jp	Matsuo, Koichi/K-5695-2012; Akira, Shizuo/C-3134-2009	Matsuo, Koichi/0000-0002-1490-8955; Helmy, Mohamed/0000-0002-9561-7956; Selvarajoo, Kumar/0000-0002-0314-9666	Keio University [Differing Fields Collaboration]; Naito Foundation; CREST of Japan, Science and Technology, and Tsuruoka City Yamagata prefecture	Keio University; Naito Foundation(Naito Memorial Foundation); CREST of Japan, Science and Technology, and Tsuruoka City Yamagata prefecture	This study is funded by the Differing Fields Collaboration Grant from Keio University, a grant-in-aid for Scientific Research on Priority Areas and the Naito Foundation, CREST of Japan, Science and Technology, and Tsuruoka City Yamagata prefecture. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Carpenter S, 2007, CELL MICROBIOL, V9, P1891, DOI 10.1111/j.1462-5822.2007.00965.x; Ehlting C, 2007, J IMMUNOL, V178, P2813, DOI 10.4049/jimmunol.178.5.2813; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Ray N, 2006, INT IMMUNOL, V18, P671, DOI 10.1093/intimm/dxl004; Ross J, 2008, J PHYS CHEM A, V112, P2134, DOI 10.1021/jp711313e; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Selvarajoo K, 2006, FEBS LETT, V580, P1457, DOI 10.1016/j.febslet.2006.01.046; SELVARAJOO K, 2007, INTRO SYSTEMS BIOL, P449; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Takahashi K, 2003, BIOINFORMATICS, V19, P1727, DOI 10.1093/bioinformatics/btg221; Vance W, 2002, P NATL ACAD SCI USA, V99, P5816, DOI 10.1073/pnas.022049699; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yeo ZX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000776	32	39	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3430	10.1371/journal.pone.0003430	http://dx.doi.org/10.1371/journal.pone.0003430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927610	gold, Green Submitted, Green Published			2022-12-27	WOS:000265122400005
J	Burioni, R; Mancini, N; De Marco, D; Clementi, N; Perotti, M; Nitti, G; Sassi, M; Canducci, F; Shvela, K; Bagnarelli, P; Mascola, JR; Clementi, M				Burioni, Roberto; Mancini, Nicasio; De Marco, Donata; Clementi, Nicola; Perotti, Mario; Nitti, Giovanni; Sassi, Monica; Canducci, Filippo; Shvela, Krisha; Bagnarelli, Patrizia; Mascola, John R.; Clementi, Massimo			Anti-HIV-1 Response Elicited in Rabbits by Anti-Idiotype Monoclonal Antibodies Mimicking the CD4-Binding Site	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEINS; CD4-BOUND STATE; HIV-1 ENVELOPE; FAB FRAGMENTS; CD4 RECEPTOR; GP120; VACCINE; PROTECTION	Antibodies against conserved epitopes on HIV-1 envelope glycoproteins (Env), such as the gp120 CD4-binding site (CD4bs), could contribute to protection against HIV-1. Env-based immunogens inducing such a response could be a major component of future anti-HIV-1 strategies. In this proof-of-concept study we describe the generation of two anti-idiotype (AI) murine antibodies mimicking the CD4bs epitope. Sera were collected from long-term non-progressor patients to obtain CD4bs-directed IgG, through sequential purification steps. The purified IgG were then used as Fab fragments to immunize mice for hybridoma generation. Two hybridomas (P1 and P2), reacting only against the CD4bs-directed IgG, were identified and characterized. The P1 and P2 antibodies were shown to recognize the idiotype of the broadly neutralizing anti-CD4bs human mAb b12. Both P1 and P2 Fabs were able to induce a strong anti-gp120 response in rabbits. Moreover, the rabbits' sera were shown to neutralize two sensitive tier 1 strains of HIV-1 in an Env-pseudotype neutralization assay. In particular, 3/5 rabbits in the P1 group and 1/5 in the P2 group showed greater than 80% neutralizing activity against the HXB2 pseudovirus. Two rabbits also neutralized the pseudovirus HIV-MN. Overall, these data describe the first anti-idiotypic vaccine approach performed to generate antibodies to the CD4bs of the HIV-1 gp120. Although future studies will be necessary to improve strength and breadth of the elicited neutralizing response, this proof-of-concept study documents that immunogens designed on the idiotype of broadly neutralizing Abs are feasible and could help in the design of future anti-HIV strategies.	[Burioni, Roberto; Mancini, Nicasio; De Marco, Donata; Clementi, Nicola; Perotti, Mario; Nitti, Giovanni; Sassi, Monica; Canducci, Filippo; Clementi, Massimo] Univ Vita Salute San Raffaele, Ist Sci San Raffaele Diagnost & Ric San Raf, Lab Microbiol & Virol, Milan, Italy; [Shvela, Krisha; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD USA; [Bagnarelli, Patrizia] Univ Politecn Marche, Lab Viro, Ancona, Italy	Vita-Salute San Raffaele University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Marche Polytechnic University	Burioni, R (corresponding author), Univ Vita Salute San Raffaele, Ist Sci San Raffaele Diagnost & Ric San Raf, Lab Microbiol & Virol, Milan, Italy.	burioni.roberto@hsr.it	Bagnarelli, Patrizia/AAL-2750-2020; Clementi, Massimo/F-6646-2013; Clementi, Nicola/G-8545-2014; Mancini, Nicasio/AAN-6203-2020; Mascola, John/AAI-7193-2021; Burioni, Roberto/F-2396-2012	Bagnarelli, Patrizia/0000-0001-5231-9660; Clementi, Nicola/0000-0002-1822-9861; Clementi, Massimo/0000-0002-7461-5898; Canducci, Filippo/0000-0002-5637-6205; MANCINI, Nicasio/0000-0003-0637-0910	Intramural Research Program of the Vaccine Research Center, NIAID, NI	Intramural Research Program of the Vaccine Research Center, NIAID, NI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported, in part, by the Intramural Research Program of the Vaccine Research Center, NIAID, NI to J.R.M..	BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339, DOI 10.1073/pnas.89.19.9339; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Braibant M, 2006, AIDS, V20, P1923, DOI 10.1097/01.aids.0000247113.43714.5e; Burioni R, 1998, J IMMUNOL METHODS, V217, P195, DOI 10.1016/S0022-1759(98)00102-1; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Burton DR, 2000, NAT MED, V6, P123, DOI 10.1038/72200; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen XN, 2001, NAT MED, V7, P1225, DOI 10.1038/nm1101-1225; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Dorgham K, 2005, AIDS RES HUM RETROV, V21, P82, DOI 10.1089/aid.2005.21.82; HARIHARAN K, 1993, J VIROL, V67, P953, DOI 10.1128/JVI.67.2.953-960.1993; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Huber M, 2007, J INTERN MED, V262, P5, DOI 10.1111/j.1365-2796.2007.01819.x; Humbert M, 2007, EUR J IMMUNOL, V37, P501, DOI 10.1002/eji.200636560; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Mantis NJ, 2007, J IMMUNOL, V179, P3144, DOI 10.4049/jimmunol.179.5.3144; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Plotkin SA, 2001, PEDIATR INFECT DIS J, V20, P63, DOI 10.1097/00006454-200101000-00013; Saphire EO, 2007, J MOL BIOL, V369, P696, DOI 10.1016/j.jmb.2007.01.060; Scala G, 1999, J IMMUNOL, V162, P6155; Srivastava IK, 2005, HUM VACCINES, V1, P45, DOI 10.4161/hv.1.2.1764; THALI M, 1991, J VIROL, V65, P6188, DOI 10.1128/JVI.65.11.6188-6193.1991; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	41	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2008	3	10							e3423	10.1371/journal.pone.0003423	http://dx.doi.org/10.1371/journal.pone.0003423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GT	18923648	Green Submitted, Green Published, gold			2022-12-27	WOS:000265122200004
J	Kaur, H; Goodman, C; Thompson, E; Thompson, KA; Masanja, I; Kachur, SP; Abdulla, S				Kaur, Harparkash; Goodman, Catherine; Thompson, Eloise; Thompson, Katy-Anne; Masanja, Irene; Kachur, S. Patrick; Abdulla, Salim			A Nationwide Survey of the Quality of Antimalarials in Retail Outlets in Tanzania	PLOS ONE			English	Article								Introduction: Retail pharmaceutical products are commonly used to treat fever and malaria in sub-Saharan African countries. Small scale studies have suggested that poor quality antimalarials are widespread throughout the region, but nationwide data are not available that could lead to generalizable conclusions about the extent to which poor quality drugs are available in African communities. This study aimed to assess the quality of antimalarials available from retail outlets across mainland Tanzania. Methods and Findings: We systematically purchased samples of oral antimalarial tablets from retail outlets across 21 districts in mainland Tanzania in 2005. A total of 1080 antimalarial formulations were collected including 679 antifol antimalarial samples (394 sulfadoxine/pyrimethamine and 285 sulfamethoxypyrazine/pyrimethamine), 260 amodiaquine samples, 63 quinine samples, and 51 artemisinin derivative samples. A systematic subsample of 304 products was assessed for quality by laboratory based analysis to determine the amount of the active ingredient and dissolution profile by following the published United States Pharmacopoeia (USP) monogram for the particular tablet being tested. Products for which a published analytical monogram did not exist were assessed on amount of active ingredient alone. Overall 38 or 12.2% of the samples were found to be of poor quality. Of the antifolate antimalarial drugs tested 13.4% were found to be of poor quality by dissolution and content analysis using high-performance liquid chromatography (HPLC). Nearly one quarter (23.8%) of quinine tablets did not comply within the tolerance limits of the dissolution and quantification analysis. Quality of amodiaquine drugs was relatively better but still unacceptable as 7.5% did not comply within the tolerance limits of the dissolution analysis. Formulations of the artemisinin derivatives all contained the stated amount of active ingredient when analysed using HPLC alone. Conclusions: Substandard antimalarial formulations were widely available in Tanzania at the time of this study. No products were detected that did not contain any amount of the stated active ingredient. Quinine and sulfadoxine/pyrimethamine products were the most widely available and also the most likely to be of poor quality. Substandard products were identified in all parts of the country and were labeled as made by both domestic and international manufacturers. With the expansion of the retail pharmaceutical sector as a delivery channel for antimalarial formulations the need for regular nationwide monitoring of their quality will become increasingly important.	[Kaur, Harparkash] London Sch Hyg & Trop Med, Clin Res Unit, London WC1, England; [Goodman, Catherine] London Sch Hyg & Trop Med, Hlth Policy Unit, London, England; [Thompson, Eloise] London Sch Hyg & Trop Med, Immunol Unit, London, England; [Thompson, Katy-Anne] London Sch Hyg & Trop Med, London, England; [Masanja, Irene; Abdulla, Salim] Ifakara Hlth Res & Dev Ctr, Dar Es Salaam, Tanzania; [Kachur, S. Patrick] US Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA USA	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Ifakara Health Institute; Centers for Disease Control & Prevention - USA	Kaur, H (corresponding author), London Sch Hyg & Trop Med, Clin Res Unit, London WC1, England.	Harparkash.Kaur@lshtm.ac.uk; cgoodman@nairobi.kemri-wellcome.org	Kachur, Patrick/ABE-7220-2021	Goodman, Catherine/0000-0002-2241-3485	US Centers for Disease Control and Prevention; US Agency for International Development; Wellcome Trust; UK Department for International Development; Bill and Melinda Gates Foundation	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Agency for International Development(United States Agency for International Development (USAID)); Wellcome Trust(Wellcome TrustEuropean Commission); UK Department for International Development; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was completed as part of the Interdisciplinary Monitoring Project for Antimalarial Combination Therapy in Tanzania (IMPACT-Tz) with funding from the US Centers for Disease Control and Prevention, the US Agency for International Development and the Wellcome Trust. Catherine Goodman's participation was partially supported by the Consortium for Research in Equitable Health Systems which is funded by the UK Department for International Development. H. Kaur is grateful to the Gates Malaria Partnership for providing support for the analytical facility through an award from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AA, 2007, J CLIN PHARM THER, V32, P429, DOI 10.1111/j.1365-2710.2007.00847.x; [Anonymous], 11 NIH FOG INT CTR; Atemnkeng MA, 2007, TROP MED INT HEALTH, V12, P68, DOI 10.1111/j.1365-3156.2006.01769.x; Basco LK, 2004, AM J TROP MED HYG, V70, P245, DOI 10.4269/ajtmh.2004.70.245; Bate R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002132; BATTERBY A, 2003, IMPROVING SUPPLY DIS, P1; BRAUN M, 2005, QUALITY ASSESSMENT A; Dondorp AM, 2004, TROP MED INT HEALTH, V9, P1241, DOI 10.1111/j.1365-3156.2004.01342.x; Goodman C., 2004, THESIS U LONDON; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; *GOV TANZ CLINT FD, TANZ PIL ACT SUBS RE; HANSON K, 2008, BMC PUBLI H IN PRESS; HETZEL M, 2006, MAL J, V5; Kachur SP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-25; Minzi OMS, 2003, J CLIN PHARM THER, V28, P117, DOI 10.1046/j.1365-2710.2003.00470.x; Newton PN, 2008, PLOS MED, V5, P209, DOI 10.1371/journal.pmed.0050032; Risha PG, 2002, TROP MED INT HEALTH, V7, P701, DOI 10.1046/j.1365-3156.2002.00937.x; *TANZ NAT COORD ME, 2007, GLOB FUND PROP ROUND; *US PHARM CONV INC, 2000, M WASH DC APR 12 16; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; World Health Organization, 1999, DEF DIAGN CLASS DI 1; [No title captured]	23	53	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3403	10.1371/journal.pone.0003403	http://dx.doi.org/10.1371/journal.pone.0003403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923672	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000265121800004
J	Zhou, WY; Alonso, S; Takai, D; Lu, SC; Yamamoto, F; Perucho, M; Huang, S				Zhou, Wenyun; Alonso, Sergio; Takai, Daisaku; Lu, Shelly C.; Yamamoto, Fumiichiro; Perucho, Manuel; Huang, Shi			Requirement of RIZ1 for Cancer Prevention by Methyl-Balanced Diet	PLOS ONE			English	Article								Background: The typical Western diet is not balanced in methyl nutrients that regulate the level of the methyl donor S-adenosylmethionine (SAM) and its derivative metabolite S-adenosylhomocysteine (SAH), which in turn may control the activity of certain methyltransferases. Feeding rodents with amino acid defined and methyl-imbalanced diet decreases hepatic SAM and causes liver cancers. RIZ1 (PRDM2 or KMT8) is a tumor suppressor and functions in transcriptional repression by methylating histone H3 lysine 9. Methodology/Principal Findings: Here we show that a methyl-balanced diet conferred additional survival benefits compared to a tumor-inducing methyl-imbalanced diet only in mice with wild type RIZ1 but not in mice deficient in RIZ1. While absence of RIZ1 was tumorigenic in mice fed the balanced diet, its presence did not prevent tumor formation in mice fed the imbalanced diet. Microarray and gene expression analysis showed that, unlike most of its related enzymes, RIZ1 was upregulated by methyl-balanced diet. Methyl-balanced diet did not fully repress oncogenes such as c-Jun in the absence of RIZ1. Higher RIZ1 activity was associated with greater H3 lysine 9 methylation in RIZ1 target genes as shown by chromatin immunoprecipiation analysis. Conclusions/Significance: The data identify RIZ1 as a critical target of methyl-balanced diet in cancer prevention. The molecular understanding of dietary carcinogenesis may help people make informed choices on diet, which may greatly reduce the incidence of cancer.	[Zhou, Wenyun; Alonso, Sergio; Takai, Daisaku; Yamamoto, Fumiichiro; Perucho, Manuel; Huang, Shi] La Jolla Canc Res Fdn, Canc Res Ctr, Burnham Inst Med Res, La Jolla, CA 92037 USA; [Lu, Shelly C.] Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, Los Angeles, CA USA; [Huang, Shi] Fudan Univ, Ctr Evolutionary Biol, Inst Biomed Sci, Shanghai, Peoples R China	Sanford Burnham Prebys Medical Discovery Institute; University of Southern California; Fudan University	Huang, S (corresponding author), La Jolla Canc Res Fdn, Canc Res Ctr, Burnham Inst Med Res, La Jolla, CA 92037 USA.	shuangtheman@yahoo.com	Alonso, Sergio/GVR-8346-2022; Alonso, Sergio/G-5145-2011; Yamamoto, Fumiichiro/F-1478-2016; Lu, Shelly/AAH-5937-2021	Alonso, Sergio/0000-0001-6497-892X; Yamamoto, Fumiichiro/0000-0001-9690-7034; Lu, Shelly/0000-0003-2128-5407; Perucho, Manuel/0000-0002-2169-2662	NIH [CA105347, CA63585, CA087069, DK51719, AA13847, AT001576]; NATIONAL CANCER INSTITUTE [R01CA087069, R37CA063585, R01CA105347, R01CA063585] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT001576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013847] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH grant CA105347 to S.H., CA63585 to M.P., CA087069 to F.Y., and DK51719, AA13847 and AT001576 to S.C.L.	Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Briknarova K, 2008, BIOCHEM BIOPH RES CO, V366, P807, DOI 10.1016/j.bbrc.2007.12.034; BUYSE IM, 1995, P NATL ACAD SCI USA, V92, P4467, DOI 10.1073/pnas.92.10.4467; DE SC, 1996, P NATL ACAD SCI USA, V93, P7149, DOI DOI 10.1073/PNAS.93.14.7149; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Huang S, 1998, J BIOL CHEM, V273, P15933, DOI 10.1074/jbc.273.26.15933; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; Huang S., 2008, HISTONE METHYLATION; Kim KC, 2003, CANCER RES, V63, P7619; Liu LM, 1997, J BIOL CHEM, V272, P2984, DOI 10.1074/jbc.272.5.2984; Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398; MIKOL YB, 1983, CARCINOGENESIS, V4, P1619, DOI 10.1093/carcin/4.12.1619; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; SHIVAPURKAR N, 1983, CARCINOGENESIS, V4, P1051, DOI 10.1093/carcin/4.8.1051; SHIVAPURKAR N, 1986, J NATL CANCER I, V77, P213; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; WILSON MJ, 1984, BIOCHEM J, V218, P987, DOI 10.1042/bj2180987; Yamamoto F, 2001, ELECTROPHORESIS, V22, P1946, DOI 10.1002/1522-2683(200106)22:10<1946::AID-ELPS1946>3.0.CO;2-Y	20	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3390	10.1371/journal.pone.0003390	http://dx.doi.org/10.1371/journal.pone.0003390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852888	Green Published, Green Submitted, gold			2022-12-27	WOS:000265121600013
J	Ersdal, HL; Verkuyl, DAA; Bjorklund, K; Bergstrom, S				Ersdal, Hege Langli; Verkuyl, Douwe A. A.; Bjorklund, Kenneth; Bergstrom, Staffan			Symphysiotomy in Zimbabwe; Postoperative Outcome, Width of the Symphysis Joint, and Knowledge, Attitudes and Practice among Doctors and Midwives	PLOS ONE			English	Article							OBSTRUCTED LABOR; CESAREAN-SECTION; BREECH	Background: Obstructed labour remains one of the leading causes of maternal and foetal death and morbidity in poorly resourced areas of the world, where the 24 hours availability of a caesarean section (CS) cannot be guaranteed, and the CS related mortality rate is still high. In these settings, reinstatement of symphysiotomy has been advocated. The objectives were, in 1994; to study perioperative and long-term complications of symphysiotomy and compare them to those related to CS for similar indications, in 1996; to measure the symphyseal width after symphysiotomy and compare it to that after normal vaginal delivery, and, in 1998; to assess knowledge, attitudes and practice related to symphysiotomy among doctors and midwives in Zimbabwe. Methods and Findings: Thirty-four women who had undergone symphysiotomy and 29 women who had undergone a CS for obstructed labour were interviewed. The symphyseal widths of 19 women with a previous symphysiotomy were compared to that of 92 women with previous normal vaginal deliveries, using ultrasound technique. Forty-one doctors and 39 midwives, in three central hospitals and seven district hospitals in Zimbabwe, were interviewed about symphysiotomy. None of the 34 women reported serious soft tissue injuries or infections post symphysiotomy. Long-term complications after symphysiotomy do not differ notably from those after CS for similar indications. The intra-articular width of the symphysis pubis is increased after a symphysiotomy. Seventy-nine of the 80 interviewed health care workers knew about symphysiotomy. One obstetrician had performed symphysiotomies. Two-thirds of the participants considered symphysiotomy an obsolete and second-class operation, but lifesaving and appropriate in remote areas of Zimbabwe. Ten of 13 midwives in remote areas wanted to carry out symphysiotomies themselves. Conclusions: No severe complications due to symphysiotomy were revealed in this study. The results suggest that a modest permanent enlargement of the pelvis post symphysiotomy (together with the absence of a scarred uterus) may facilitate subsequent vaginal delivery. Doctors and midwives working in district hospitals have a more positive attitude to symphysiotomies than the colleagues in central hospitals. Obstetricians (who would have to do the teaching), working in the large urban hospitals almost exclude symphysiotomy as an alternative management in Zimbabwe.	[Ersdal, Hege Langli; Bjorklund, Kenneth; Bergstrom, Staffan] Karolinska Inst, Div Int Hlth IHCAR, Stockholm, Sweden; [Verkuyl, Douwe A. A.] United Bulawayo Hosp, Dept Obstet & Gynaecol, Bulawayo, Zimbabwe	Karolinska Institutet	Ersdal, HL (corresponding author), Karolinska Inst, Div Int Hlth IHCAR, Stockholm, Sweden.	hege@ersdal.com			The Research Council of Norway	The Research Council of Norway(Research Council of Norway)	The work presented is partly financed by The Research Council of Norway (student scholarship for the first auther HLE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ABOUZAHR C, 1998, HLTH DIMENSIONS SEX, P243; BARRY AP, 1952, IRAN MED J, V6, P49; BERGSTROM S, 1994, GYNECOL OBSTET INVES, V38, P31, DOI 10.1159/000292441; BIRD GC, 1967, E AFR MED J, V43, P51; Bjorklund K, 2002, BJOG-INT J OBSTET GY, V109, P236, DOI 10.1111/j.1471-0528.2002.01214.x; Bjorklund K, 1996, GYNECOL OBSTET INVES, V42, P151, DOI 10.1159/000291932; DEXEUS S, 1954, Rev Esp Obstet Ginecol, V13, P358; Ezegwui HU, 2004, INT J GYNECOL OBSTET, V85, P272, DOI 10.1016/j.ijgo.2003.09.017; FRANK F, 1910, MONATSCHR GEBURTSHIL, V22, P680; GEBBIE D, 1982, CLIN OBSTET GYNAECOL, V9, P663; GLASTER E, 1999, J GYNECOL OBST BIO R, V28, P519; Goodwin TM, 1997, AM J OBSTET GYNECOL, V177, P463, DOI 10.1016/S0002-9378(97)70218-7; GREISEN G, 1999, INT J GYNECOL OBSTET, V23, P203; Hartfield V J, 1975, Trop Doct, V5, P76; HARTFIELD VJ, 1973, J OBSTET GYN BR COMM, V80, P508; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; KUPFERBERG H, 1927, MONATSSCHR GYNAK GEB, V76, P176; LASBREY AH, 1963, S AFR MED J, V37, P231; MENTICOGLOU SM, 1990, AUST NZ J OBSTET GYN, V30, P1, DOI 10.1111/j.1479-828X.1990.tb03185.x; Mola Glen D. L., 1995, Papua New Guinea Medical Journal, V38, P172; MOLA M, 1981, PNG MED J, V24, P103; OLIVELLA JR, 1935, ARCH MED INT, V1, P254; Onah HE, 2004, INT J GYNECOL OBSTET, V84, P79, DOI 10.1016/S0020-7292(03)00269-8; Onah HE, 2002, INT J GYNECOL OBSTET, V76, P321, DOI 10.1016/S0020-7292(01)00578-1; Pape GL, 1999, TROP DOCT, V29, P248, DOI 10.1177/004947559902900421; PEYTAVIN C, 1931, THESIS; RAMOS AP, 1948, OBSTET GINEC LAT AM, V6, P3; SEEDAT EK, 1962, LANCET, V1, P554; SPENCER JAD, 1987, BRIT J OBSTET GYNAEC, V94, P716, DOI 10.1111/j.1471-0528.1987.tb03183.x; Sunday-Adeoye I M, 2004, J Obstet Gynaecol, V24, P525, DOI 10.1080/01443610410001722572; van Eygen L, 2008, TROP DOCT, V38, P36, DOI 10.1258/td.2007.005019; VANROOSMALEN J, 1990, AM J OBSTET GYNECOL, V163, P1; VANROOSMALEN J, 1987, INT J GYNECOL OBSTET, V25, P451, DOI 10.1016/0020-7292(87)90061-0; Verkuyl DAA, 2007, PLOS MED, V4, P401, DOI 10.1371/journal.pmed.0040071; World Health Organisation, 1999, RED MAT MORT JOINT W; Wykes CB, 2003, BJOG-INT J OBSTET GY, V110, P219; ZARATE E, 1931, ARCH GYNAKOL, V147, P759; 2002, BJOG, V109	38	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3317	10.1371/journal.pone.0003317	http://dx.doi.org/10.1371/journal.pone.0003317			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846216	Green Published, Green Submitted, gold			2022-12-27	WOS:000265114500001
J	Kigel, B; Varshavsky, A; Kessler, O; Neufeld, G				Kigel, Boaz; Varshavsky, Asya; Kessler, Ofra; Neufeld, Gera			Successful Inhibition of Tumor Development by Specific Class-3 Semaphorins Is Associated with Expression of Appropriate Semaphorin Receptors by Tumor Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SUPPRESSOR GENE; CANCER CELLS; ANTI-VEGF; IN-VIVO; NEUROPILIN-1; ANGIOGENESIS; FAMILY; 3F; CONVERTASES	The class-3 semaphorins (sema3s) include seven family members. Six of them bind to neuropilin-1 (np1) or neuropilin-2 (np2) receptors or to both, while the seventh, sema3E, binds to the plexin-D1 receptor. Sema3B and sema3F were previously characterized as tumor suppressors and as inhibitors of tumor angiogenesis. To determine if additional class-3 semaphorins such as sema3A, sema3D, sema3E and sema3G possess anti-angiogenic and anti-tumorigenic properties, we expressed the recombinant full length semaphorins in four different tumorigenic cell lines expressing different combinations of class-3 semaphorin receptors. We show for the first time that sema3A, sema3D, sema3E and sema3G can function as potent anti-tumorigenic agents. All the semaphorins we examined were also able to reduce the concentration of tumor associated blood vessels although the potencies of the anti-angiogenic effects varied depending on the tumor cell type. Surprisingly, there was little correlation between the ability to inhibit tumor angiogenesis and their anti-tumorigenic activity. None of the semaphorins inhibited the adhesion of the tumor cells to plastic or fibronectin nor did they modulate the proliferation of tumor cells cultured in cell culture dishes. However, various semaphorins were able to inhibit the formation of soft agar colonies from tumor cells expressing appropriate semaphorin receptors, although in this case too the inhibitory effect was not always correlated with the anti-tumorigenic effect. In contrast, the anti-tumorigenic effect of each of the semaphorins correlated very well with tumor cell expression of specific signal transducing receptors for particular semaphorins. This correlation was not broken even in cases in which the tumor cells expressed significant concentrations of endogenous semaphorins. Our results suggest that combinations of different class-3 semaphorins may be more effective than single semaphorins in cases in which tumor cells express more than one type of semaphorin receptors.	[Kigel, Boaz; Varshavsky, Asya; Kessler, Ofra; Neufeld, Gera] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc Res & Vasc Biol Ctr, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Kigel, B (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc Res & Vasc Biol Ctr, POB 9649, IL-31096 Haifa, Israel.	gera@tx.technion.ac.il	Neufeld, Gera/F-1524-2019		Israel Science Foundation (ISF); Komen breast cancer foundation; International Union against Cancer (AICR); Rappaport Family Institute for Research in the Medical Sciences of the Faculty of Medicine at the Technion, Israel Institute of Technology	Israel Science Foundation (ISF)(Israel Science Foundation); Komen breast cancer foundation(Susan G. Komen Breast Cancer Foundation); International Union against Cancer (AICR); Rappaport Family Institute for Research in the Medical Sciences of the Faculty of Medicine at the Technion, Israel Institute of Technology	This work was supported by grants from the Israel Science Foundation (ISF), by the Komen breast cancer foundation, by the International Union against Cancer (AICR), and by the by the Rappaport Family Institute for Research in the Medical Sciences of the Faculty of Medicine at the Technion, Israel Institute of Technology (to G. N.). The funding organizations did not take part or affect the design or the conduct of this study.	Acevedo LM, 2008, NAT MED, V14, P372, DOI 10.1038/nm0408-372; Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Akiri G, 2003, CANCER RES, V63, P1657; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bates D, 2003, DEV BIOL, V255, P77, DOI 10.1016/S0012-1606(02)00045-3; Bielenberg DR, 2004, J CLIN INVEST, V114, P1260, DOI 10.1172/JCI200421378; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Christensen C, 2005, CANCER RES, V65, P6167, DOI 10.1158/0008-5472.CAN-04-4309; Cifone M A, 1982, Cancer Metastasis Rev, V1, P335, DOI 10.1007/BF00124216; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Futamura M, 2007, CANCER RES, V67, P1451, DOI 10.1158/0008-5472.CAN-06-2485; GitayGoren H, 1996, J BIOL CHEM, V271, P5519, DOI 10.1074/jbc.271.10.5519; Gluzman-Poltorak Z, 2000, J BIOL CHEM, V275, P18040, DOI 10.1074/jbc.M909259199; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Guttmann-Raviv N, 2007, J BIOL CHEM, V282, P26294, DOI 10.1074/jbc.M609711200; HAMBURGER AW, 1987, INT J CELL CLONING, V5, P89, DOI 10.1002/stem.5530050202; Herman JG, 2007, INT J ONCOL, V30, P1231; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; Nasarre P, 2005, NEOPLASIA, V7, P180, DOI 10.1593/neo.04481; Nasarre P, 2003, NEOPLASIA, V5, P83, DOI 10.1016/S1476-5586(03)80020-9; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Pavelock K, 2001, ENDOCRINOLOGY, V142, P613, DOI 10.1210/en.142.2.613; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Sulpice E, 2008, BLOOD, V111, P2036, DOI 10.1182/blood-2007-04-084269; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taniguchi M, 2005, GENES CELLS, V10, P785, DOI 10.1111/j.1365-2443.2005.00877.x; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; Tse C, 2002, CANCER RES, V62, P542; Vamesu S, 2007, Rom J Morphol Embryol, V48, P25; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Vermeulen PB, 1996, EUR J CANCER, V32A, P2474, DOI 10.1016/S0959-8049(96)00379-6; Whitehurst B, 2007, INT J CANCER, V121, P2181, DOI 10.1002/ijc.22937; Wolman MA, 2004, J NEUROSCI, V24, P8428, DOI 10.1523/JNEUROSCI.2349-04.2004; Xiang RH, 2002, CANCER RES, V62, P2637; Yu HH, 2005, DEV BIOL, V280, P373, DOI 10.1016/j.ydbio.2005.01.029; Zacchigna S, 2008, J CLIN INVEST, V118, P2062, DOI 10.1172/JCI32832; Zhang Wei, 2002, Angiogenesis, V5, P35, DOI 10.1023/A:1021540120521	47	105	112	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3287	10.1371/journal.pone.0003287	http://dx.doi.org/10.1371/journal.pone.0003287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818766	Green Published, Green Submitted, gold			2022-12-27	WOS:000264432300009
J	Kaittanis, C; Nath, S; Perez, JM				Kaittanis, Charalambos; Nath, Sudip; Perez, J. Manuel			Rapid Nanoparticle-Mediated Monitoring of Bacterial Metabolic Activity and Assessment of Antimicrobial Susceptibility in Blood with Magnetic Relaxation	PLOS ONE			English	Article							SERRATIA-MARCESCENS; GOLD NANOPARTICLES; RESISTANCE; NMR	Considering the increased incidence of bacterial infections and the emergence of multidrug resistant bacteria at the global level, we designed superparamagnetic iron oxide nanoparticles as nanosensors for the assessment of antimicrobial susceptibility through magnetic relaxation. In this report, we demonstrate that iron oxide nanosensors, either dextran-coated supplemented with Con A or silica-coated conjugated directly to Con A, can be used for the fast (1) quantification of polysaccharides, (2) assessment of metabolic activity and (3) determination of antimicrobial susceptibility in blood. The use of these polysaccharide nanosensors in the determination of antimicrobial susceptibility in the clinic or the field, and the utilization of these nanoprobes in pharmaceutical R&D are anticipated.	[Kaittanis, Charalambos; Nath, Sudip; Perez, J. Manuel] Univ Cent Florida, Nanosci Technol Ctr, Orlando, FL 32816 USA; [Kaittanis, Charalambos; Perez, J. Manuel] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Perez, J. Manuel] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Kaittanis, C (corresponding author), Univ Cent Florida, Nanosci Technol Ctr, Orlando, FL 32816 USA.	jmperez@mail.ucf.edu			UCF NSTC; NIH [CA101781]; NATIONAL CANCER INSTITUTE [K01CA101781] Funding Source: NIH RePORTER	UCF NSTC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was partially funded by a UCF NSTC Startup Fund and the NIH CA101781 grant, both awarded to Dr. J. Manuel Perez. Besides funding this work, the sponsors did not have any role in designing or conducting these studies.	Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Aslan K, 2004, ANAL BIOCHEM, V330, P145, DOI 10.1016/j.ab.2004.03.032; Bancroft EA, 2007, JAMA-J AM MED ASSOC, V298, P1803, DOI 10.1001/jama.298.15.1803; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Bennett JW, 2000, ADV APPL MICROBIOL, V47, P1, DOI 10.1016/s0065-2164(00)47000-0; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Choi JH, 2007, NANO LETT, V7, P861, DOI 10.1021/nl062306v; Demas V, 2007, J MAGN RESON, V189, P121, DOI 10.1016/j.jmr.2007.08.011; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Grimm J, 2004, CANCER RES, V64, P639, DOI 10.1158/0008-5472.CAN-03-2798; ITO H, 1995, ANTIMICROB AGENTS CH, V39, P824, DOI 10.1128/AAC.39.4.824; IU CI, 2008, SCIENCE, V319, P1391; Kaittanis C, 2007, NANO LETT, V7, P380, DOI 10.1021/nl062553z; Katneni R, 2007, NAT CLIN PRACT NEPHR, V3, P256, DOI 10.1038/ncpneph0447; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Koh I, 2008, ANGEW CHEM INT EDIT, V47, P4119, DOI 10.1002/anie.200800069; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lee JS, 2008, NANO LETT, V8, P529, DOI 10.1021/nl0727563; Lee JS, 2007, ANGEW CHEM INT EDIT, V46, P4093, DOI 10.1002/anie.200700269; Lowery TJ, 2008, ANAL CHEM, V80, P1118, DOI 10.1021/ac702288r; Ma DL, 2006, CHEM MATER, V18, P1920, DOI 10.1021/cm052067x; Mann TS, 2008, ANAL CHEM, V80, P843, DOI 10.1021/ac701829c; Nath S, 2008, ANAL CHEM, V80, P1033, DOI 10.1021/ac701969u; Perez JM, 2003, J AM CHEM SOC, V125, P10192, DOI 10.1021/ja036409g; Perez JM, 2002, J AM CHEM SOC, V124, P2856, DOI 10.1021/ja017773n; Perez JM, 2002, NAT BIOTECHNOL, V20, P816, DOI 10.1038/nbt720; Perlo J, 2005, SCIENCE, V308, P1279, DOI 10.1126/science.1108944; Phillips RL, 2008, ANGEW CHEM INT EDIT, V47, P2590, DOI 10.1002/anie.200703369; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Sun EY, 2006, SMALL, V2, P1144, DOI 10.1002/smll.200600204; Tapsall JW, 2005, CLIN INFECT DIS, V41, pS263, DOI 10.1086/430787; Tsourkas A, 2004, ANGEW CHEM INT EDIT, V43, P2395, DOI 10.1002/anie.200352998; Yoshizumi A, 1999, LANGMUIR, V15, P482, DOI 10.1021/la980374u	35	34	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2008	3	9							e3253	10.1371/journal.pone.0003253	http://dx.doi.org/10.1371/journal.pone.0003253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MA	18810269	Green Published, gold, Green Submitted			2022-12-27	WOS:000264431000001
J	Geft, D; Schwartzenberg, S; Rogowsky, O; Finkelstein, A; Ablin, J; Maysel-Auslender, S; Wexler, D; Keren, G; George, J				Geft, Dael; Schwartzenberg, Shmuel; Rogowsky, Ori; Finkelstein, Ariel; Ablin, Jacob; Maysel-Auslender, Sofia; Wexler, Dov; Keren, Gad; George, Jacob			Circulating Apoptotic Progenitor Cells in Patients with Congestive Heart Failure	PLOS ONE			English	Article								Background: Circulating CD34+ endothelial progenitor cells (EPCs) are capable of differentiating into mature endothelial cells to assist in angiogenesis and vasculogenesis. We sought to quantify the numbers of apoptotic progenitors in patients with congestive heart failure. Methods and Results: Peripheral blood mononuclear cells were isolated by Ficoll density-gradient from 58 patients with various degrees of heart failure and 23 matched controls. Apoptosis in progenitor CD34+ cells was assessed using the Annexin V-PE/PI detection kit, and FACS analysis was performed with triple staining for CD34, annexin-V and propidium iodide. The percentage of early and late apoptotic progenitor cells was determined in the subject groups and was correlated with clinical characteristics. While there was no significant difference in total CD34 positive cells or early apoptotic progenitors between control subjects and CHF patients (p = 0.42) or between severe and mild/moderate CHF groups (p = 0.544), there was an elevated number of late apoptotic progenitors in the severe CHF group compared with the mild/moderate CHF group (p = 0.03). Late apoptotic progenitors were significantly increased in CHF patients as compared to matched controls. There was also an inverse correlation between late apoptotic progenitors and ejection fraction (r = 20.252, p = 0.028) as well as a positive association with NYHA class (r = 0.223, p = 0.046). Conclusion: Severe heart failure patients exhibited higher numbers of late apoptotic progenitors, and this was positively associated with NYHA class and negatively correlated with ejection fraction. This finding may shed light on the numerous factors governing the pathophysiology of CHF.	[Geft, Dael; Schwartzenberg, Shmuel; Rogowsky, Ori; Finkelstein, Ariel; Ablin, Jacob; Maysel-Auslender, Sofia; Wexler, Dov; Keren, Gad; George, Jacob] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Cardiol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Geft, D (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Cardiol, IL-69978 Tel Aviv, Israel.	jacobg@post.tau.ac.il	Ablin, Jacob/V-9716-2019	Ablin, Jacob/0000-0003-2523-4850				Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bernal-Mizrachi L, 2003, AM HEART J, V145, P962, DOI 10.1016/S0002-8703(03)00103-0; Boos CJ, 2006, J AM COLL CARDIOL, V48, P1538, DOI 10.1016/j.jacc.2006.02.078; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Cabezudo E, 1999, TRANSFUSION, V39, P864, DOI 10.1046/j.1537-2995.1999.39080864.x; Chin BSP, 2003, BLOOD COAGUL FIBRIN, V14, P515, DOI 10.1097/00001721-200309000-00001; Dernbach E, 2004, BLOOD, V104, P3591, DOI 10.1182/blood-2003-12-4103; Diamant M, 2004, EUR J CLIN INVEST, V34, P392, DOI 10.1111/j.1365-2362.2004.01355.x; Fischer H, 2005, CLIM DYNAM, V25, P65, DOI 10.1007/s00382-005-0011-x; George J, 2006, EUR J HEART FAIL, V8, P58, DOI 10.1016/j.ejheart.2005.04.015; Giannattasio C, 2001, HYPERTENSION, V38, P1451, DOI 10.1161/hy1201.096528; Horstman LL, 2004, FRONT BIOSCI-LANDMRK, V9, P1118, DOI 10.2741/1270; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Imanishi T, 2004, CLIN EXP PHARMACOL P, V31, P407, DOI 10.1111/j.1440-1681.2004.04022.x; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Leone AM, 2005, EUR HEART J, V26, P1196, DOI 10.1093/eurheartj/ehi164; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Michowitz Y, 2007, HEART, V93, P1046, DOI 10.1136/hrt.2006.102657; Nonaka-Sarukawa M, 2003, HEART, V89, P871, DOI 10.1136/heart.89.8.871; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Schwartzenberg S, 2007, ARTERIOSCL THROM VAS, V27, pE27, DOI 10.1161/ATVBAHA.107.139626; SIENA S, 1991, BLOOD, V77, P400; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Varin R, 2000, CIRCULATION, V102, P351; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02	32	24	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3238	10.1371/journal.pone.0003238	http://dx.doi.org/10.1371/journal.pone.0003238			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800166	Green Submitted, Green Published, gold			2022-12-27	WOS:000264428400007
J	Woolley, LA; Millspaugh, JJ; Woods, RJ; van Rensburg, SJ; Mackey, RL; Page, B; Slotow, R				Woolley, Leigh-Ann; Millspaugh, Joshua J.; Woods, Rami J.; van Rensburg, Samantha Janse; Mackey, Robin L.; Page, Bruce; Slotow, Rob			Population and Individual Elephant Response to a Catastrophic Fire in Pilanesberg National Park	PLOS ONE			English	Article								In predator-free large herbivore populations, where density-dependent feedbacks occur at the limit where forage resources can no longer support the population, environmental catastrophes may play a significant role in population regulation. The potential role of fire as a stochastic mass-mortality event limiting these populations is poorly understood, so too the behavioural and physiological responses of the affected animals to this type of large disturbance event. During September 2005, a wildfire resulted in mortality of 29 (18% population mortality) and injury to 18, African elephants in Pilanesberg National Park, South Africa. We examined movement and herd association patterns of six GPS-collared breeding herds, and evaluated population physiological response through faecal glucocorticoid metabolite (stress) levels. We investigated population size, structure and projected growth rates using a simulation model. After an initial flight response post-fire, severely injured breeding herds reduced daily displacement with increased daily variability, reduced home range size, spent more time in non-tourist areas and associated less with other herds. Uninjured, or less severely injured, breeding herds also shifted into non-tourist areas post-fire, but in contrast, increased displacement rate (both mean and variability), did not adjust home range size and formed larger herds post-fire. Adult cow stress hormone levels increased significantly post-fire, whereas juvenile and adult bull stress levels did not change significantly. Most mortality occurred to the juvenile age class causing a change in post-fire population age structure. Projected population growth rate remained unchanged at 6.5% p.a., and at current fecundity levels, the population would reach its previous level three to four years post-fire. The natural mortality patterns seen in elephant populations during stochastic events, such as droughts, follows that of the classic mortality pattern seen in predator-free large ungulate populations, i.e. mainly involving juveniles. Fire therefore functions in a similar manner to other environmental catastrophes and may be a natural mechanism contributing to population limitation. Welfare concerns of arson fires, burning during "hot-fire'' conditions and the conservation implications of fire suppression (i.e. removal of a potential contributing factor to natural population regulation) should be integrated into fire management strategies for conservation areas.	[Woolley, Leigh-Ann; van Rensburg, Samantha Janse; Mackey, Robin L.; Page, Bruce; Slotow, Rob] Univ KwaZulu Natal, Amarula Elephant Res Programme, Sch Biol & Conservat Sci, Durban, South Africa; [Millspaugh, Joshua J.; Woods, Rami J.] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO USA	University of Kwazulu Natal; University of Missouri System; University of Missouri Columbia	Woolley, LA (corresponding author), Univ KwaZulu Natal, Amarula Elephant Res Programme, Sch Biol & Conservat Sci, Durban, South Africa.	leigh-ann@polka.co.za	Page, Bruce R/G-1245-2010; Slotow, Rob/AAM-9053-2020; Woolley, Leigh-Ann/AAA-6162-2019	Page, Bruce R/0000-0001-7979-5229; Woolley, Leigh-Ann/0000-0002-5295-8734; Slotow, Rob/0000-0001-9469-1508	Amarula (Distell (Pty) Ltd); PPC Cement; National Research Foundation	Amarula (Distell (Pty) Ltd); PPC Cement; National Research Foundation	Funding received from Amarula (Distell (Pty) Ltd), PPC Cement, National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acocks J. P. H., 1988, MEMOIRS BOT SURVEY S; Andersen KF, 1997, AFR J ECOL, V35, P278, DOI 10.1111/j.1365-2028.1997.084-89084.x; BOONZAAIER W. W., 2000, PILANESBERG NATL PAR; Bradshaw GA, 2007, ETHOLOGY, V113, P426, DOI 10.1111/j.1439-0310.2007.01333.x; Brockett BH, 2001, INT J WILDLAND FIRE, V10, P169, DOI 10.1071/WF01024; Burke T, 2005, THESIS U KWAZULU NAT; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Creel S, 1997, CONSERV BIOL, V11, P544, DOI 10.1046/j.1523-1739.1997.95476.x; Dudley JP, 2001, AFR J ECOL, V39, P187, DOI 10.1046/j.0141-6707.2000.00297.x; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; FOWLER CW, 1973, J WILDLIFE MANAGE, V37, P513, DOI 10.2307/3800317; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Ganswindt A, 2003, GEN COMP ENDOCR, V134, P156, DOI 10.1016/S0016-6480(03)00251-X; Gough KF, 2006, ORYX, V40, P434, DOI 10.1017/S0030605306001189; HANKS J, 1973, J ZOOL, V169, P29; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; LEGGATT K, 2003, P NORW BONN PROGR WO; LINDEQUE M, 1991, AFR J ECOL, V29, P196, DOI 10.1111/j.1365-2028.1991.tb01002.x; Loveridge AJ, 2006, J ZOOL, V270, P523, DOI 10.1111/j.1469-7998.2006.00181.x; Mackey RL, 2006, S AFR J WILDL RES, V36, P33; MANGEL M, 1994, ECOLOGY, V75, P607, DOI 10.2307/1941719; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; Millspaugh JJ, 2007, J WILDLIFE MANAGE, V71, P1257, DOI 10.2193/2006-015; Morrison TA, 2005, J ZOOL, V266, P89, DOI 10.1017/S0952836905006631; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; OTTICHILO WK, 1986, AFR J ECOL, V24, P53, DOI 10.1111/j.1365-2028.1986.tb00342.x; Owen-Smith N, 2006, S AFR J SCI, V102, P389; Owen-Smith N, 2005, J ANIM ECOL, V74, P762, DOI 10.1111/j.1365-2656.2005.00973.x; Owen-Smith N, 2005, J ANIM ECOL, V74, P774, DOI 10.1111/j.1365-2656.2005.00974.x; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; SCHWARZENBERGER F, 1991, J REPROD FERTIL, P489; Shakespeare A, 2006, J S AFR VET ASSOC, V77, P70; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; Slotow R., 2004, Koedoe, V47, P91; Stead SK, 2000, J S AFR VET ASSOC, V71, P192; van Aarde R, 1999, ANIM CONSERV, V2, P287, DOI 10.1017/S1367943099000621; van Wilgen BW, 2000, S AFR J SCI, V96, P167; Van Wilgen BW, 2004, CONSERV BIOL, V18, P1533, DOI 10.1111/j.1523-1739.2004.00362.x; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Whitehouse AM, 2000, ORYX, V34, P46, DOI 10.1046/j.1365-3008.2000.00093.x; Whyte I, 1998, ANIM CONSERV, V1, P77, DOI 10.1111/j.1469-1795.1998.tb00014.x; Whyte IJ, 1993, PACHYDERM, V16, P72; Wittemyer G, 2005, AFR J ECOL, V43, P44, DOI 10.1111/j.1365-2028.2004.00543.x; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Woodd A. M., 1999, Koedoe, V42, P97; Woolley LA, 2008, ORYX, V42, P49, DOI 10.1017/S0030605308000495; WU LSY, 1980, AM NAT, V116, P831, DOI 10.1086/283672	50	28	28	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3233	10.1371/journal.pone.0003233	http://dx.doi.org/10.1371/journal.pone.0003233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LB	18797503	gold, Green Published, Green Submitted			2022-12-27	WOS:000264428200008
J	Kamienkowski, JE; Sigman, M				Kamienkowski, Juan Esteban; Sigman, Mariano			Delays without Mistakes: Response Time and Error Distributions in Dual-Task	PLOS ONE			English	Article							CENTRAL BOTTLENECK; MENTAL PROCESSES; DIFFUSION-MODEL; NUMBER; INTERFERENCE; DISCRIMINATION; JUDGMENTS; REPRESENTATIONS; INFORMATION; NUMEROSITY	Background: When two tasks are presented within a short interval, a delay in the execution of the second task has been systematically observed. Psychological theorizing has argued that while sensory and motor operations can proceed in parallel, the coordination between these modules establishes a processing bottleneck. This model predicts that the timing but not the characteristics (duration, precision, variability.) of each processing stage are affected by interference. Thus, a critical test to this hypothesis is to explore whether the qualitiy of the decision is unaffected by a concurrent task. Methodology/Principal Findings: In number comparison-as in most decision comparison tasks with a scalar measure of the evidence-the extent to which two stimuli can be discriminated is determined by their ratio, referred as the Weber fraction. We investigated performance in a rapid succession of two non-symbolic comparison tasks (number comparison and tone discrimination) in which error rates in both tasks could be manipulated parametrically from chance to almost perfect. We observed that dual-task interference has a massive effect on RT but does not affect the error rates, or the distribution of errors as a function of the evidence. Conclusions/Significance: Our results imply that while the decision process itself is delayed during multiple task execution, its workings are unaffected by task interference, providing strong evidence in favor of a sequential model of task execution.	[Kamienkowski, Juan Esteban; Sigman, Mariano] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Phys, Integrat Neurosci Lab, Buenos Aires, DF, Argentina	University of Buenos Aires	Kamienkowski, JE (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Phys, Integrat Neurosci Lab, Buenos Aires, DF, Argentina.	juank@df.uba.ar		Kamienkowski, Juan Esteban/0000-0002-5725-6539	Human Frontiers Science Program (HFSP); SECYT [38636]; National Research Council of Argentina (CONICET) [fellowship]	Human Frontiers Science Program (HFSP)(Human Frontier Science Program); SECYT(Secretaria de Ciencia y Tecnologia (SECYT)); National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	MS is funded by the Human Frontiers Science Program (HFSP) and by the SECYT, PICT 38636. JEK has a fellowship from the National Research Council of Argentina (CONICET).	Arnell KM, 2004, PSYCHON B REV, V11, P77, DOI 10.3758/BF03206464; Arnell KM, 2002, COGNITIVE PSYCHOL, V44, P105, DOI 10.1006/cogp.2001.0762; Barth H, 2006, COGNITION, V98, P199, DOI 10.1016/j.cognition.2004.09.011; Brisson B, 2007, NEUROPSYCHOLOGIA, V45, P3038, DOI 10.1016/j.neuropsychologia.2007.05.022; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; DEHAENE S, 2007, SENSORIMOTOR FDN HIG, V22; DEHAENE S, SYMBOLS QUA IN PRESS; Dell'Acqua R, 2005, EXP BRAIN RES, V165, P54, DOI 10.1007/s00221-005-2281-2; DUNCAN EM, 1980, MEM COGNITION, V8, P612, DOI 10.3758/BF03213781; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Green DM, 1966, SIGNAL DETECTION THE; HARNAD S, 1990, PHYSICA D, V42, P335, DOI 10.1016/0167-2789(90)90087-6; INDOW T, 1977, PERCEPT PSYCHOPHYS, V22, P265, DOI 10.3758/BF03199689; Izard V, 2008, COGNITION, V106, P1221, DOI 10.1016/j.cognition.2007.06.004; Jolicoeur P, 2008, BRAIN RES, V1215, P160, DOI 10.1016/j.brainres.2008.03.059; Kahneman D., 1973, ATTENTION EFFORT; Kantowitz B.H., 1974, HUMAN INFORMATION PR, P41; KRUEGER LE, 1982, PERCEPT PSYCHOPHYS, V31, P175, DOI 10.3758/BF03206218; KRUEGER LE, 1984, PERCEPT PSYCHOPHYS, V35, P536, DOI 10.3758/BF03205949; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; Luce R. D., 1986, RESPONSE TIMES; Luck SJ, 1998, PSYCHOL SCI, V9, P223, DOI 10.1111/1467-9280.00043; Macmillan NA, 2005, DETECTION THEORY USE; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; OSMAN A, 1993, J EXP PSYCHOL HUMAN, V19, P1292, DOI 10.1037/0096-1523.19.6.1292; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; PASHLER H, 1989, Q J EXP PSYCHOL-A, V41, P19, DOI 10.1080/14640748908402351; Pashler H, 1998, ATTENTION, P155, DOI DOI 10.1016/J.TICS.2005.01.008; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Ratcliff R, 2002, PSYCHON B REV, V9, P278, DOI 10.3758/BF03196283; RATCLIFF R, 1988, PSYCHOL REV, V95, P238, DOI 10.1037/0033-295X.95.2.238; Ruthruff E, 2001, PSYCHON B REV, V8, P73, DOI 10.3758/BF03196141; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Schwarz W, 2001, BEHAV RES METH INS C, V33, P457, DOI 10.3758/BF03195403; SCHWEICKERT R, 1989, J MATH PSYCHOL, V33, P328, DOI 10.1016/0022-2496(89)90013-8; SCHWEICKERT R, 1980, SCIENCE, V209, P704, DOI 10.1126/science.7394529; Sessa P, 2007, BRAIN RES, V1137, P131, DOI 10.1016/j.brainres.2006.12.066; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Siegler RS, 2003, PSYCHOL SCI, V14, P237, DOI 10.1111/1467-9280.02438; Sigman M, 2005, PLOS BIOL, V3, P334, DOI 10.1371/journal.pbio.0030037; Sigman M, 2008, J NEUROSCI, V28, P7585, DOI 10.1523/JNEUROSCI.0948-08.2008; Sigman M, 2006, PLOS BIOL, V4, P1227, DOI 10.1371/journal.pbio.0040220; SMITH MC, 1967, PSYCHOL BULL, V67, P202, DOI 10.1037/h0020419; Staffen W, 2002, BRAIN, V125, P1275, DOI 10.1093/brain/awf125; STEMBERG S, 1969, ATTENTION PERFORM, V2, P276; Telford CW, 1931, J EXP PSYCHOL, V14, P1, DOI 10.1037/h0073262; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; VANOEFFELEN MP, 1982, PERCEPT PSYCHOPHYS, V32, P163, DOI 10.3758/BF03204275; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; VICKERS D, 1970, Ergonomics, V13, P37, DOI 10.1080/00140137008931117; Wagenmakers EJ, 2007, PSYCHOL REV, V114, P830, DOI 10.1037/0033-295X.114.3.830; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P3, DOI 10.3758/BF03194023	61	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3196	10.1371/journal.pone.0003196	http://dx.doi.org/10.1371/journal.pone.0003196			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422KI	18787706	Green Published, gold, Green Submitted			2022-12-27	WOS:000264426200002
J	Auger, CJ; Forbes-Lorman, RM				Auger, Catherine J.; Forbes-Lorman, Robin M.			Progestin Receptor-Mediated Reduction of Anxiety-Like Behavior in Male Rats	PLOS ONE			English	Article							FEMALE GUINEA-PIGS; ELEVATED PLUS-MAZE; MEDROXYPROGESTERONE ACETATE; SEXUAL-BEHAVIOR; ESTROUS-CYCLE; NEUROACTIVE STEROIDS; ANXIOLYTIC ACTIVITY; OVARIAN HORMONES; BED NUCLEUS; BRAIN	Background: It is well known progesterone can have anxiolytic-like effects in animals in a number of different behavioral testing paradigms. Although progesterone is known to influence physiology and behavior by binding to classical intracellular progestin receptors, progesterone's anxiety reducing effects have solely been attributed to its rapid non-genomic effects at the GABA(A) receptor. This modulation occurs following the bioconversion of progesterone to allopregnanolone. Seemingly paradoxical results from some studies suggested that the function of progesterone to reduce anxiety-like behavior may not be entirely clear; therefore, we hypothesized that progesterone might also act upon progestin receptors to regulate anxiety. Methodology/Principal Findings: To test this, we examined the anxiolytic-like effects of progesterone in male rats using the elevated plus maze, a validated test of anxiety, and the light/dark chamber in the presence or absence of a progestin receptor antagonist, RU 486. Here we present evidence suggesting that the anxiolytic-like effects of progesterone in male rats can be mediated, in part, by progestin receptors, as these effects are blocked by prior treatment with a progestin receptor antagonist. Conclusion/Significance: This indicates that progesterone can act upon progestin receptors to regulate anxiety-like behavior in the male rat brain.	[Auger, Catherine J.; Forbes-Lorman, Robin M.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Auger, CJ (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	cauger@wisc.edu	Forbes-Lorman, Robin/R-4355-2019	Forbes-Lorman, Robin/0000-0003-3935-6541	Psychology Department, the Graduate School and the College of Letters and Sciences at the University of Wisconsin-Madison	Psychology Department, the Graduate School and the College of Letters and Sciences at the University of Wisconsin-Madison	This research was funded by start-up funds from the Psychology Department, the Graduate School and the College of Letters and Sciences at the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the Psychology Department at The University of Wisconsin-Madison for its continued support.	Andersen ML, 2004, BRAZ J MED BIOL RES, V37, P791, DOI 10.1590/S0100-879X2004000600003; Auger CJ, 2006, BRAIN RES, V1067, P58, DOI 10.1016/j.brainres.2005.10.033; Auger CJ, 2006, J NEUROENDOCRINOL, V18, P187, DOI 10.1111/j.1365-2826.2005.01400.x; Auger CJ, 2002, J NEUROENDOCRINOL, V14, P561, DOI 10.1046/j.1365-2826.2002.00809.x; BARBIERI RL, 1980, ACTA ENDOCRINOL-COP, V94, P419, DOI 10.1530/acta.0.0940419; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; BITRAN D, 1995, J NEUROENDOCRINOL, V7, P171, DOI 10.1111/j.1365-2826.1995.tb00744.x; BITRAN D, 1991, BRAIN RES, V561, P157, DOI 10.1016/0006-8993(91)90761-J; BLAUSTEIN JD, 1977, J COMP PHYSIOL PSYCH, V91, P752, DOI 10.1037/h0077365; BLAUSTEIN JD, 1978, BRAIN RES, V140, P360, DOI 10.1016/0006-8993(78)90469-9; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; BROWN TJ, 1986, BRAIN RES, V373, P103, DOI 10.1016/0006-8993(86)90320-3; BROWN TJ, 1984, BRAIN RES, V301, P343, DOI 10.1016/0006-8993(84)91103-X; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Cornil CA, 2006, BRAIN RES, V1126, P2, DOI 10.1016/j.brainres.2006.07.098; DEBOLD JF, 1994, HORM BEHAV, V28, P445, DOI 10.1006/hbeh.1994.1042; DEBOLD JF, 1994, PSYCHONEUROENDOCRINO, V19, P563, DOI 10.1016/0306-4530(94)90041-8; DEVRIES GJ, 1985, J COMP NEUROL, V233, P236, DOI 10.1002/cne.902330206; DEVRIES GJ, 1983, BRAIN RES, V273, P307, DOI 10.1016/0006-8993(83)90855-7; Dubrovsky B, 2006, PHARMACOL BIOCHEM BE, V84, P644, DOI 10.1016/j.pbb.2006.06.016; Frye CA, 2006, PSYCHOPHARMACOLOGY, V186, P312, DOI 10.1007/s00213-006-0309-3; Frye CA, 2000, PHARMACOL BIOCHEM BE, V67, P587, DOI 10.1016/S0091-3057(00)00392-0; Frye CA, 2004, BRAIN RES, V1004, P116, DOI 10.1016/j.brainres.2004.01.020; FRYE CA, 1994, LIFE SCI, V54, P653, DOI 10.1016/0024-3205(94)00548-6; Gomez C, 2002, PHARMACOL BIOCHEM BE, V72, P543, DOI 10.1016/S0091-3057(02)00722-0; GORDON GG, 1970, J CLIN ENDOCR METAB, V30, P449, DOI 10.1210/jcem-30-4-449; KALRA PS, 1977, ENDOCRINOLOGY, V101, P1821, DOI 10.1210/endo-101-6-1821; Kellogg CK, 1999, PHARMACOL BIOCHEM BE, V63, P441, DOI 10.1016/S0091-3057(99)00041-6; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; LANDGRAF R, 1995, J NEUROSCI, V15, P4250; Mani SK, 1997, HORM BEHAV, V31, P244, DOI 10.1006/hbeh.1997.1393; MCCARTHY MM, 1991, NEUROENDOCRINOLOGY, V53, P473, DOI 10.1159/000125760; MCCARTHY MM, 1995, HORM BEHAV, V29, P279, DOI 10.1006/hbeh.1995.1020; MCEWEN BS, 1990, CIBA F SYMP, V153, P3; MCEWEN BS, 1991, TRENDS PHARMACOL SCI, V12, P141, DOI 10.1016/0165-6147(91)90531-V; Mellon SH, 2002, TRENDS ENDOCRIN MET, V13, P35, DOI 10.1016/S1043-2760(01)00503-3; Mora S, 1996, PSYCHONEUROENDOCRINO, V21, P609, DOI 10.1016/S0306-4530(96)00015-7; Mulac-Jericevic B, 2004, REPRODUCTION, V128, P139, DOI 10.1530/rep.1.00189; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PICAZO O, 1995, BRAIN RES, V680, P135, DOI 10.1016/0006-8993(95)00254-N; PLEIM ET, 1990, HORM BEHAV, V24, P139, DOI 10.1016/0018-506X(90)90001-E; POWERS JB, 1972, PHYSIOL BEHAV, V8, P673, DOI 10.1016/0031-9384(72)90093-5; POWERS JB, 1970, PHYSIOL BEHAV, V5, P831, DOI 10.1016/0031-9384(70)90167-8; RAINBOW TC, 1982, NATURE, V300, P648, DOI 10.1038/300648a0; Reddy DS, 2005, NEUROPHARMACOLOGY, V48, P14, DOI 10.1016/j.neuropharm.2004.09.002; Ring RH, 2005, CURR PHARM DESIGN, V11, P205, DOI 10.2174/1381612053382241; RODRIGUEZSIERRA JF, 1984, PSYCHONEUROENDOCRINO, V9, P293, DOI 10.1016/0306-4530(84)90008-8; Rupprecht R, 1999, STEROIDS, V64, P83, DOI 10.1016/S0039-128X(98)00101-9; Rupprecht R, 2003, PSYCHONEUROENDOCRINO, V28, P139, DOI 10.1016/S0306-4530(02)00064-1; SAR M, 1973, SCIENCE, V182, P1266, DOI 10.1126/science.182.4118.1266; SATYASWAROOP PG, 1978, ENDOCRINOLOGY, V102, P1761, DOI 10.1210/endo-102-6-1761; Schneider JS, 2005, ENDOCRINOLOGY, V146, P4340, DOI 10.1210/en.2005-0490; Toufexis DJ, 2004, J NEUROSCI, V24, P10280, DOI 10.1523/JNEUROSCI.1386-04.2004; TSAI MJ, 1994, ANNU REV BIOCHEM, P63451; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2; ZUMPE D, 1988, PHYSIOL BEHAV, V42, P343, DOI 10.1016/0031-9384(88)90275-2	58	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2008	3	11							e3606	10.1371/journal.pone.0003606	http://dx.doi.org/10.1371/journal.pone.0003606			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LK	18958180	gold, Green Submitted, Green Published			2022-12-27	WOS:000265134400003
J	Nelson, BS; Takahashi, TT				Nelson, Brian S.; Takahashi, Terry T.			Independence of Echo-Threshold and Echo-Delay in the Barn Owl	PLOS ONE			English	Article							PAIRED SOUND SOURCES; INFERIOR COLLICULUS; AUDITORY SPACE; SIMULATED ECHOES; PRECEDENCE; LOCALIZATION; RESPONSES; DISCRIMINATION; INHIBITION; NEURONS	Despite their prevalence in nature, echoes are not perceived as events separate from the sounds arriving directly from an active source, until the echo's delay is long. We measured the head-saccades of barn owls and the responses of neurons in their auditory space-maps while presenting a long duration noise-burst and a simulated echo. Under this paradigm, there were two possible stimulus segments that could potentially signal the location of the echo. One was at the onset of the echo; the other, after the offset of the direct (leading) sound, when only the echo was present. By lengthening the echo's duration, independently of its delay, spikes and saccades were evoked by the source of the echo even at delays that normally evoked saccades to only the direct source. An echo's location thus appears to be signaled by the neural response evoked after the offset of the direct sound.	[Nelson, Brian S.; Takahashi, Terry T.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Nelson, BS (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	bsnelson@uoregon.edu			National Institutes of Deafness and Communication Disorders [DC008267, DC003925]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC008267, R01DC003925] Funding Source: NIH RePORTER	National Institutes of Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Deafness and Communication Disorders: (F32) DC008267 to B.S.N and (RO1) DC003925. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBECK Y, 1995, J NEUROPHYSIOL, V74, P1689, DOI 10.1152/jn.1995.74.4.1689; AOKI S, 1992, HEARING RES, V59, P25, DOI 10.1016/0378-5955(92)90098-8; Bala ADS, 2003, NATURE, V424, P771, DOI 10.1038/nature01835; Bala ADS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000675; Blauert J., 1997, SPATIAL HEARING PSYC; Braasch J., 2003, Acoustical Science and Technology, V24, P233, DOI 10.1250/ast.24.233; Burger RM, 2001, J NEUROSCI, V21, P4830, DOI 10.1523/JNEUROSCI.21-13-04830.2001; CRANFORD JL, 1982, J ACOUST SOC AM, V72, P1309, DOI 10.1121/1.388409; Dent ML, 2005, ACTA ACUST UNITED AC, V91, P463; Dent ML, 2004, J COMP PSYCHOL, V118, P325, DOI 10.1037/0735-7036.118.3.325; Dizon RM, 2006, J ACOUST SOC AM, V119, P2947, DOI 10.1121/1.2189451; Dye RH, 2006, J ACOUST SOC AM, V120, P3946, DOI 10.1121/1.2372588; Euston DR, 2002, J NEUROSCI, V22, P284, DOI 10.1523/JNEUROSCI.22-01-00284.2002; Fitzpatrick DC, 1995, J NEUROPHYSIOL, V74, P2469, DOI 10.1152/jn.1995.74.6.2469; HAAS H, 1951, ACUSTICA, V1, P49; Hartung K, 2001, J ACOUST SOC AM, V110, P1505, DOI 10.1121/1.1390339; Keller CH, 1996, J COMP PHYSIOL A, V178, P499; Keller CH, 2005, J NEUROSCI, V25, P10446, DOI 10.1523/JNEUROSCI.2093-05.2005; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; KELLY JB, 1974, J ACOUST SOC AM, V55, P1277, DOI 10.1121/1.1914697; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; LINDEMANN W, 1986, J ACOUST SOC AM, V80, P1608, DOI 10.1121/1.394325; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; Litovsky RY, 1998, J NEUROPHYSIOL, V80, P1285, DOI 10.1152/jn.1998.80.3.1285; Litovsky RY, 1998, J NEUROPHYSIOL, V80, P1302, DOI 10.1152/jn.1998.80.3.1302; Litovsky RY, 2002, J NEUROPHYSIOL, V87, P976, DOI 10.1152/jn.00568.2001; Litovsky RY, 2001, J ACOUST SOC AM, V109, P346, DOI 10.1121/1.1328792; Litovsky RY, 1997, J ACOUST SOC AM, V102, P1739, DOI 10.1121/1.420106; NELSON BS, 2008, ASS RES OTOLARYNGOL, V295, P295; Pecka M, 2007, J NEUROSCI, V27, P1782, DOI 10.1523/JNEUROSCI.5335-06.2007; PERROTT DR, 1974, J ACOUST SOC AM, V55, P1290, DOI 10.1121/1.1914699; PERROTT DR, 1989, J ACOUST SOC AM, V85, P2669, DOI 10.1121/1.397764; Saberi K, 1998, NEURON, V21, P789, DOI 10.1016/S0896-6273(00)80595-4; Spitzer MW, 2006, J NEUROPHYSIOL, V95, P3571, DOI 10.1152/jn.00982.2005; Spitzer MW, 2004, J NEUROPHYSIOL, V92, P2051, DOI 10.1152/jn.01235.2003; Spitzer MW, 2003, J ACOUST SOC AM, V113, P1631, DOI 10.1121/1.1548152; Tollin DJ, 2004, J NEUROPHYSIOL, V92, P3286, DOI 10.1152/jn.00606.2004; Tollin DJ, 2003, J NEUROPHYSIOL, V90, P2149, DOI 10.1152/jn.00381.2003; TOLLIN DJ, 2004, AUDITORY SIGNAL PROC; Trahiotis C, 2002, HEARING RES, V168, P55, DOI 10.1016/S0378-5955(02)00357-X; WAGNER H, 1993, J NEUROSCI, V13, P371; WALLACH H, 1949, AM J PSYCHOL, V62, P315, DOI 10.2307/1418275; Whitchurch EA, 2006, J NEUROPHYSIOL, V96, P730, DOI 10.1152/jn.00072.2006; WYTTENBACH RA, 1993, J ACOUST SOC AM, V94, P777, DOI 10.1121/1.408207; YIN TCT, 1994, J NEUROSCI, V14, P5170; ZUREK PM, 1980, J ACOUST SOC AM, V67, P952, DOI 10.1121/1.383974	47	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3598	10.1371/journal.pone.0003598	http://dx.doi.org/10.1371/journal.pone.0003598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974886	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131700019
J	Lesma, E; Grande, V; Ancona, S; Carelli, S; Di Giulio, AM; Gorio, A				Lesma, Elena; Grande, Vera; Ancona, Silvia; Carelli, Stephana; Di Giulio, Anna Maria; Gorio, Alfredo			Anti-EGFR Antibody Efficiently and Specifically Inhibits Human TSC2(-)/(-) Smooth Muscle Cell Proliferation. Possible Treatment Options for TSC and LAM	PLOS ONE			English	Article								Background: Tuberous sclerosis complex (TSC), a tumor syndrome caused by mutations in TSC1 or TSC2 genes, is characterized by the development of hamartomas. We previously isolated, from an angiomyolipoma of a TSC2 patient, a homogenous population of smooth muscle-like cells (TSC2(-/-) ASM cells) that have a mutation in the TSC2 gene as well as TSC2 loss of heterozygosity (LOH) and consequently, do not produce the TSC2 gene product, tuberin. TSC2(-/-) ASM cell proliferation is EGF-dependent. Methods and Findings: Effects of EGF on proliferation of TSC2(-/-) ASM cells and TSC2(-/-) ASM cells transfected with TSC2 gene were determined. In contrast to TSC2(-/-) ASM cells, growth of TSC2-transfected cells was not dependent on EGF. Moreover, phosphorylation of Akt, PTEN, Erk and S6 was significantly decreased. EGF is a proliferative factor of TSC2(-/-) ASM cells. Exposure of TSC2(-/-) ASM cells to anti-EGFR antibodies significantly inhibited their proliferation, reverted reactivity to HMB45 antibody, a marker of TSC2(-/-) cell phenotype, and inhibited constitutive phosphorylation of S6 and ERK. Exposure of TSC2(-/-) ASM cells to rapamycin reduced the proliferation rate, but only when added at plating time. Although rapamycin efficiently inhibited S6 phosphorylation, it was less efficient than anti-EGFR antibody in reverting HMB45 reactivity and blocking ERK phosphorylation. In TSC2(-/-) ASM cells specific PI3K inhibitors (e.g. LY294002, wortmannin) and Akt1 siRNA had little effect on S6 and ERK phosphorylation. Following TSC2-gene transfection, Akt inhibitor sensitivity was observed. Conclusion: Our results show that an EGF independent pathway is more important than that involving IGF-I for growth and survival of TSC2(-/-) ASM cells, and such EGF-dependency is the result of the lack of tuberin.	[Lesma, Elena; Grande, Vera; Ancona, Silvia; Carelli, Stephana; Di Giulio, Anna Maria; Gorio, Alfredo] Univ Milan, Fac Med, Dept Med Surg & Dent Polo H San Paolo, Pharmacol Lab, Milan, Italy; [Gorio, Alfredo] IRCCS Humanitas, Milan, Italy	University of Milan	Lesma, E (corresponding author), Univ Milan, Fac Med, Dept Med Surg & Dent Polo H San Paolo, Pharmacol Lab, Milan, Italy.	elena.lesma@unimi.it	Carelli, Stephana/AAB-2365-2021	Carelli, Stephana/0000-0003-4603-396X; Di Giulio, Anna Maria/0000-0002-5702-4623; Lesma, Elena/0000-0002-9096-713X	IRCCS from Ministero Superiore della Sanita; A.S.T. (Italian Tuberous Sclerosis Association); A.I.LAM (Italian Lymphangioleiomyomatosis Association)	IRCCS from Ministero Superiore della Sanita; A.S.T. (Italian Tuberous Sclerosis Association); A.I.LAM (Italian Lymphangioleiomyomatosis Association)	Supported by grants on Rare Disease, IRCCS from Ministero Superiore della Sanita (AG, EL); by grant from A.S.T. (Italian Tuberous Sclerosis Association) (EL); by grant from A.I.LAM (Italian Lymphangioleiomyomatosis Association) (AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbiser JL, 2001, AM J PATHOL, V159, P483, DOI 10.1016/S0002-9440(10)61720-8; Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962; BAGBY SP, 1993, AM J PHYSIOL, V265, pF239, DOI 10.1152/ajprenal.1993.265.2.F239; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Carelli S, 2007, MOL MED, V13, P166, DOI 10.2119/2006-00091.Carelli; CROSS MJ, 1995, J BIOL CHEM, V270, P25352, DOI 10.1074/jbc.270.43.25352; El-Hashemite N, 2005, CANCER RES, V65, P2474, DOI 10.1158/0008-5472.CAN-04-3840; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GOMEZ MR, 1999, TUBEROUS SCLEROSIS; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Han S, 2004, CANCER RES, V64, P812, DOI 10.1158/0008-5472.CAN-03-3277; Harwood FC, 2008, J BIOL CHEM, V283, P2575, DOI 10.1074/jbc.M706173200; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; JANSSEN B, 1994, HUM GENET, V94, P437, DOI 10.1007/BF00201608; Karbowniczek M, 2004, J BIOL CHEM, V279, P29930, DOI 10.1074/jbc.M402591200; Karbowniczek M, 2003, AM J PATHOL, V162, P491, DOI 10.1016/S0002-9440(10)63843-6; Kenerson H, 2005, PEDIATR RES, V57, P67, DOI 10.1203/01.PDR.0000147727.78571.07; Kenerson HL, 2002, CANCER RES, V62, P5645; Kuemmerle JF, 2004, AM J PHYSIOL-GASTR L, V286, pG412, DOI 10.1152/ajpgi.00403.2003; Kuemmerle JF, 1998, AM J PHYSIOL-GASTR L, V275, pG151, DOI 10.1152/ajpgi.1998.275.1.G151; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Lesma E, 2005, AM J PATHOL, V167, P1093, DOI 10.1016/S0002-9440(10)61198-4; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; NELLIST M, 1993, CELL, V75, P1305; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Perugini RA, 2000, J SURG RES, V90, P39, DOI 10.1006/jsre.2000.5833; POWIS G, 1994, CANCER RES, V54, P2419; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Takata M, 1999, J BIOL CHEM, V274, P20611, DOI 10.1074/jbc.274.29.20611; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; Vokes Everett E, 2006, Oncology (Williston Park), V20, P15; Young J, 1998, MOL MED TODAY, V4, P313, DOI 10.1016/S1357-4310(98)01245-3; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	35	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3558	10.1371/journal.pone.0003558	http://dx.doi.org/10.1371/journal.pone.0003558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958173	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131100016
J	Scharfmann, R; Xiao, XW; Heimberg, H; Mallet, J; Ravassard, P				Scharfmann, Raphael; Xiao, Xiangwei; Heimberg, Harry; Mallet, Jacques; Ravassard, Philippe			Beta Cells within Single Human Islets Originate from Multiple Progenitors	PLOS ONE			English	Article								Background: In both humans and rodents, glucose homeostasis is controlled by micro-organs called islets of Langerhans composed of beta cells, associated with other endocrine cell types. Most of our understanding of islet cell differentiation and morphogenesis is derived from rodent developmental studies. However, little is known about human islet formation. The lack of adequate experimental models has restricted the study of human pancreatic development to the histological analysis of different stages of pancreatic development. Our objective was to develop a new experimental model to (i) transfer genes into developing human pancreatic cells and (ii) validate gene transfer by defining the clonality of developing human islets. Methods and Findings: In this study, a unique model was developed combining ex vivo organogenesis from human fetal pancreatic tissue and cell type-specific lentivirus-mediated gene transfer. Human pancreatic progenitors were transduced with lentiviruses expressing GFP under the control of an insulin promoter and grafted to severe combined immunodeficient mice, allowing human beta cell differentiation and islet morphogenesis. By performing gene transfer at low multiplicity of infection, we created a chimeric graft with a subpopulation of human beta cells expressing GFP and found both GFP-positive and GFP-negative beta cells within single islets. Conclusion: The detection of both labeled and unlabeled beta cells in single islets demonstrates that beta cells present in a human islet are derived from multiple progenitors thus providing the first dynamic analysis of human islet formation during development. This human transgenic-like tool can be widely used to elucidate dynamic genetic processes in human tissue formation.	[Scharfmann, Raphael] Univ Paris 05, Fac Med, INSERM, Necker Hosp,U845, Paris, France; [Xiao, Xiangwei; Heimberg, Harry] Free Univ Brussels, Diabetes Res Ctr, B-1050 Brussels, Belgium; [Mallet, Jacques; Ravassard, Philippe] Univ Paris 06, LGN UMR 7091, Ctr Natl Rech Sci, F-75252 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Scharfmann, R (corresponding author), Univ Paris 05, Fac Med, INSERM, Necker Hosp,U845, Paris, France.	ravassar@chups.jussieu.fr	scharfmann, raphael/L-3296-2017; xiao, xiangwei/K-1218-2012	Scharfmann, Raphael/0000-0001-7619-337X; Heimberg, Harry/0000-0003-1954-7375; ravassard, philippe/0000-0002-0393-9262; Xiao, Xiangwei/0000-0003-0890-9203	6th European Union Framework Program (Beta-Cell Therapy Integrated Project); INSERM-JDRF [A03139MS]; French National Program of Research on Diabetes; NIH-BCBC consortium; Association Francaise des Diabetiques (AFD); association de langue francaise pour l'etude du diabete et des maladies metaboliques (ALFEDIAM)	6th European Union Framework Program (Beta-Cell Therapy Integrated Project)(European Commission); INSERM-JDRF; French National Program of Research on Diabetes; NIH-BCBC consortium; Association Francaise des Diabetiques (AFD); association de langue francaise pour l'etude du diabete et des maladies metaboliques (ALFEDIAM)	This work was supported by the 6th European Union Framework Program (Beta-Cell Therapy Integrated Project), INSERM-JDRF Grant (AIP Cellules souches A03139MS), the French National Program of Research on Diabetes, the NIH-BCBC consortium, the Association Francaise des Diabetiques (AFD) and the association de langue francaise pour l'etude du diabete et des maladies metaboliques (ALFEDIAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Attali M, 2007, DIABETES, V56, P1248, DOI 10.2337/db06-1307; Beattie GM, 1997, DIABETES, V46, P244, DOI 10.2337/diabetes.46.2.244; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Bouwens L, 1997, DIABETOLOGIA, V40, P398, DOI 10.1007/s001250050693; Bouwens L, 1998, DIABETOLOGIA, V41, P629, DOI 10.1007/s001250050960; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Buchet D, 2002, MOL CELL NEUROSCI, V19, P389, DOI 10.1006/mcne.2001.1086; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Castaing M, 2005, DEV DYNAM, V234, P339, DOI 10.1002/dvdy.20547; Castaing M, 2005, DIABETOLOGIA, V48, P709, DOI 10.1007/s00125-005-1694-6; Castaing M, 2001, DIABETOLOGIA, V44, P2066, DOI 10.1007/s001250100012; Cras-Meneur C, 2001, DIABETES, V50, P1571, DOI 10.2337/diabetes.50.7.1571; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DELTOUR L, 1991, DEVELOPMENT, V112, P1115; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; FERRER J, 1995, DIABETES, V44, P1369, DOI 10.2337/diabetes.44.12.1369; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Henseleit KD, 2005, DEVELOPMENT, V132, P3139, DOI 10.1242/dev.01875; Keymeulen B, 1998, DIABETOLOGIA, V41, P452, DOI 10.1007/s001250050929; LIKE AA, 1972, DIABETES, V21, P511, DOI 10.2337/diab.21.2.S511; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Madsen OD, 2006, NAT BIOTECHNOL, V24, P1481, DOI 10.1038/nbt1206-1481; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; ORCI L, 1975, LANCET, V2, P1243, DOI 10.1016/S0140-6736(75)92078-4; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Polak M, 2000, DIABETES, V49, P225, DOI 10.2337/diabetes.49.2.225; Scharfmann R, 2000, DIABETOLOGIA, V43, P1083, DOI 10.1007/s001250051498; STEFAN Y, 1983, DIABETES, V32, P293, DOI 10.2337/diabetes.32.4.293; Steiner DF, 1972, DEV EMBRYONIC PANCRE, P25; SWENNE I, 1992, DIABETOLOGIA, V35, P193, DOI 10.1007/BF00400917; Thomas M, 1997, NAT MED, V3, P978, DOI 10.1038/nm0997-978; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	42	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3559	10.1371/journal.pone.0003559	http://dx.doi.org/10.1371/journal.pone.0003559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958289	gold, Green Submitted, Green Published			2022-12-27	WOS:000265131100017
J	Andersson, ER; Prakash, N; Cajanek, L; Minina, E; Bryja, V; Bryjova, L; Yamaguchi, TP; Hall, AC; Wurst, W; Arenas, E				Andersson, Emma R.; Prakash, Nilima; Cajanek, Lukas; Minina, Eleonora; Bryja, Vitezslav; Bryjova, Lenka; Yamaguchi, Terry P.; Hall, Anita C.; Wurst, Wolfgang; Arenas, Ernest			Wnt5a Regulates Ventral Midbrain Morphogenesis and the Development of A9-A10 Dopaminergic Cells In Vivo	PLOS ONE			English	Article								Wnt5a is a morphogen that activates the Wnt/planar cell polarity (PCP) pathway and serves multiple functions during development. PCP signaling controls the orientation of cells within an epithelial plane as well as convergent extension (CE) movements. Wnt5a was previously reported to promote differentiation of A9-10 dopaminergic (DA) precursors in vitro. However, the signaling mechanism in DA cells and the function of Wnt5a during midbrain development in vivo remains unclear. We hereby report that Wnt5a activated the GTPase Rac1 in DA cells and that Rac1 inhibitors blocked the Wnt5a-induced DA neuron differentiation of ventral midbrain (VM) precursor cultures, linking Wnt5a-induced differentiation with a known effector of Wnt/PCP signaling. In vivo, Wnt5a was expressed throughout the VM at embryonic day (E) 9.5, and was restricted to the VM floor and basal plate by E11.5-E13.5. Analysis of Wnt5a-/- mice revealed a transient increase in progenitor proliferation at E11.5, and a precociously induced NR4A2+ (Nurr1) precursor pool at E12.5. The excess NR4A2+ precursors remained undifferentiated until E14.5, when a transient 25% increase in DA neurons was detected. Wnt5a-/- mice also displayed a defect in (mid) brain morphogenesis, including an impairment in midbrain elongation and a rounded ventricular cavity. Interestingly, these alterations affected mostly cells in the DA lineage. The ventral Sonic hedgehog-expressing domain was broadened and flattened, a typical CE phenotype, and the domains occupied by Ngn2+ DA progenitors, NR4A2+ DA precursors and TH+ DA neurons were rostrocaudally reduced and laterally expanded. In summary, we hereby describe a Wnt5a regulation of Wnt/PCP signaling in the DA lineage and provide evidence for multiple functions of Wnt5a in the VM in vivo, including the regulation of VM morphogenesis, DA progenitor cell division, and differentiation of NR4A2+ DA precursors.	[Andersson, Emma R.; Cajanek, Lukas; Bryja, Vitezslav; Bryjova, Lenka; Wurst, Wolfgang; Arenas, Ernest] Karolinska Inst, Mol Neurobiol Lab, Dept Med Biochem & Biophys, Stockholm, Sweden; [Prakash, Nilima; Minina, Eleonora] Tech Univ Munich, Inst Dev Genet, German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Munich, Germany; [Bryja, Vitezslav; Bryjova, Lenka] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, Brno, Czech Republic; [Bryja, Vitezslav; Bryjova, Lenka] Masaryk Univ, Fac Sci, Inst Expt Biol, Brno, Czech Republic; [Yamaguchi, Terry P.] Natl Canc Inst Frederick, Canc & Dev Biol Lab, Frederick, MD USA; [Hall, Anita C.] Imperial Coll London, Div Cell & Mol Biol, London, England; [Wurst, Wolfgang] Max Planck Inst Psychiat, Munich, Germany	Karolinska Institutet; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Imperial College London; Max Planck Society	Andersson, ER (corresponding author), Karolinska Inst, Mol Neurobiol Lab, Dept Med Biochem & Biophys, Stockholm, Sweden.	wurst@helmholtz-muenchen.de; ernest.arenas@ki.se	Bryja, Vít?zslav/H-1925-2014; Prakash, Nilima/AAC-9402-2019; Arenas, Ernest/AAO-5231-2020; Bryja, Vítězslav/P-4217-2019; Andersson, Emma R/J-4236-2012; Cajanek, Lukas/ABG-6559-2020; Andersson, Emma/AAB-8532-2019	Bryja, Vít?zslav/0000-0002-9136-5085; Prakash, Nilima/0000-0002-0568-6262; Arenas, Ernest/0000-0003-0197-6577; Bryja, Vítězslav/0000-0002-9136-5085; Andersson, Emma R/0000-0002-8608-625X; Cajanek, Lukas/0000-0003-2914-8589; Andersson, Emma/0000-0002-8608-625X; Wurst, Wolfgang/0000-0003-4422-7410	Swedish Foundation for Strategic Research; Swedish Royal Academy of Sciences; Knut and Alice Wallenberg Foundation; European Union (Eurostemcell); Swedish MRC; Karolinska Institutet; Federal Ministry of Education and Research (BMBF) [01GN0512]; National Genome Research Network (NGFN); Forderkennzeichen [01GS0476]; Deutsche Forschungsgemeinschaft (DFG) [WU 164/3-1, WU 164/3-2]; Bayerische Forschungsverbund ForNeuroCell; Helmholtz Virtual Institute of Neurodegeneration&Aging [VH-VI-252]; European Union (Eumorphia); NATIONAL CANCER INSTITUTE [ZIABC010841, Z01BC010841] Funding Source: NIH RePORTER	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Royal Academy of Sciences; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Union (Eurostemcell)(European Commission); Swedish MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Karolinska Institutet(Karolinska Institutet); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Genome Research Network (NGFN); Forderkennzeichen; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bayerische Forschungsverbund ForNeuroCell; Helmholtz Virtual Institute of Neurodegeneration&Aging; European Union (Eumorphia)(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Swedish Foundation for Strategic Research, Swedish Royal Academy of Sciences, Knut and Alice Wallenberg Foundation, European Union (Eurostemcell), Swedish MRC and Karolinska Institutet (to EA), and by the Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN), Forderkennzeichen 01GS0476, the BMBF Forderkennzeichen 01GN0512, the Deutsche Forschungsgemeinschaft (DFG) WU 164/3-1 and WU 164/3-2, the Bayerische Forschungsverbund ForNeuroCell, the Helmholtz Virtual Institute of Neurodegeneration&Aging (VH-VI-252) and by European Union (Eumorphia) (to WW). The authors are responsible for the contents of this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Brodski C, 2003, J NEUROSCI, V23, P4199; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; BUSH KT, 1990, ANAT EMBRYOL, V181, P49; Castelo-Branco GA, 2006, MOL CELL NEUROSCI, V31, P251, DOI 10.1016/j.mcn.2005.09.014; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Cau E, 1997, DEVELOPMENT, V124, P1611; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CONLON RA, 1993, METHOD ENZYMOL, V225, P373; Copp AJ, 2003, TRENDS NEUROSCI, V26, P453, DOI 10.1016/S0166-2236(03)00212-1; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; Das G, 2002, DEV CELL, V2, P655, DOI 10.1016/S1534-5807(02)00147-8; Djiane A, 2000, DEVELOPMENT, V127, P3091; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X; Guimera J, 2006, DEVELOPMENT, V133, P3847, DOI 10.1242/dev.02557; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miyoshi G, 2004, J NEUROSCI, V24, P3672, DOI 10.1523/JNEUROSCI.5327-03.2004; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Nakatani T, 2007, DEVELOPMENT, V134, P2783, DOI 10.1242/dev.02870; NEMETH MJ, 2007, P NATL ACAD SCI US; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464; Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107; Puelles E, 2003, NAT NEUROSCI, V6, P453, DOI 10.1038/nn1037; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; RAWAL N, 2006, EXP CELL RES; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shariatmadari M, 2005, MOL CELL NEUROSCI, V30, P437, DOI 10.1016/j.mcn.2005.08.008; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Strutt H, 2006, CURR BIOL, V16, P1329, DOI 10.1016/j.cub.2006.04.041; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2001, INT J DEV BIOL, V45, P225; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; WILSON PA, 1989, DEVELOPMENT, V105, P155; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wolff T, 1998, DEVELOPMENT, V125, P1149; Wu MF, 2006, DEV BIOL, V293, P316, DOI 10.1016/j.ydbio.2005.12.024; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; YBOTGONZALEZ P, 2007, CONVERGENT EXTENSION, P789	71	76	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3517	10.1371/journal.pone.0003517	http://dx.doi.org/10.1371/journal.pone.0003517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953410	Green Published, Green Submitted, gold			2022-12-27	WOS:000265130500002
J	Guan, Y; Abdelwahab, S; Kamin-Lewis, R; DeVico, AL; Lewis, GK				Guan, Yongjun; Abdelwahab, Sayed; Kamin-Lewis, Roberta; DeVico, Anthony L.; Lewis, George K.			'Self-Protection' of Individual CD4(+) T Cells against R5 HIV-1 Infection by the Synthesis of Anti-Viral CCR5 Ligands	PLOS ONE			English	Article								It is well established that paracrine secretion of anti-viral CCR5 ligands by CD8(+) and CD4(+) T cells can block the infection of activated CD4(+) T cells by R5 and dual-tropic isolates of HIV-1. By contrast, because CD4(+) T cells can be infected by HIV-1 and at least some subsets secrete anti-viral CCR5 ligands, it is possible that these ligands protect against HIV-1 via autocrine as well as paracrine pathways. Here we use a model primary CD4(+) T cell response in vitro to show that individual CD4(+) T cells that secrete anti-viral CCR5 ligands are 'self-protected' against infection with R5 but not X4 strains of HIV-1. This protection is selective for CD4(+) T cells that secrete anti-viral CCR5 ligands in that activated CD4(+) T cells in the same cultures remain infectable with R5 HIV-1. These data are most consistent with an autocrine pathway of protection in this system and indicate a previously unappreciated selective pressure on the emergence of viral variants and CD4(+) T cell phenotypes during HIV-1 infection.	[Guan, Yongjun; Abdelwahab, Sayed; Kamin-Lewis, Roberta; DeVico, Anthony L.; Lewis, George K.] Univ Maryland, Sch Med, Inst Human Virol, Div Basic Sci & Vaccine Res, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Guan, Y (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Div Basic Sci & Vaccine Res, Baltimore, MD 21201 USA.	glewis@ihv.umaryland.edu	Guan, Yongjun/V-8117-2019; Abdelwahab, Sayed F./P-1481-2016	Guan, Yongjun/0000-0001-6546-2095; Abdelwahab, Sayed F./0000-0002-9636-7485	NIH; Institute of Human Virology	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Human Virology	The work was supported by NIH grants to GKL AND AD and intramural funds from the Institute of Human Virology. The funders had no role in study design, data collection analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SF, 2003, P NATL ACAD SCI USA, V100, P15006, DOI 10.1073/pnas.2035075100; Bagley KC, 2005, INFECT IMMUN, V73, P413, DOI 10.1128/IAI.73.1.413-421.2005; Bagley KC, 2002, J LEUKOCYTE BIOL, V72, P962; Bagley KC, 2002, INFECT IMMUN, V70, P5533, DOI 10.1128/IAI.70.10.5533-5539.2002; Bueno C, 2006, IMMUNITY, V25, P67, DOI 10.1016/j.immuni.2006.04.012; Buonaguro L, 2006, J VIROL, V80, P9134, DOI 10.1128/JVI.00050-06; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cocchi F, 2000, P NATL ACAD SCI USA, V97, P13812, DOI 10.1073/pnas.240469997; Criado G, 2004, J IMMUNOL, V172, P222, DOI 10.4049/jimmunol.172.1.222; De Rosa SC, 2004, J IMMUNOL, V173, P5372, DOI 10.4049/jimmunol.173.9.5372; DeVico AL, 2004, NAT REV MICROBIOL, V2, P401, DOI 10.1038/nrmicro878; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Garzino-Demo A, 1999, P NATL ACAD SCI USA, V96, P11986, DOI 10.1073/pnas.96.21.11986; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Kamin-Lewis R, 2001, P NATL ACAD SCI USA, V98, P9283, DOI 10.1073/pnas.161298998; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Mosier DE, 1999, J VIROL, V73, P3544, DOI 10.1128/JVI.73.5.3544-3550.1999; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Paxton WA, 1999, IMMUNOL LETT, V66, P71, DOI 10.1016/S0165-2478(98)00154-0; Paxton WA, 1998, VIROLOGY, V244, P66, DOI 10.1006/viro.1998.9082; Paxton WA, 2001, J INFECT DIS, V183, P1678, DOI 10.1086/320701; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000; Riley JL, 1998, J VIROL, V72, P8273, DOI 10.1128/JVI.72.10.8273-8280.1998; Roederer M, 1997, Semin Immunol, V9, P389, DOI 10.1006/smim.1997.0097; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Sabbe R, 2001, J VIROL, V75, P661, DOI 10.1128/JVI.75.2.661-671.2001; Selin LK, 2004, IMMUNITY, V20, P5, DOI 10.1016/S1074-7613(03)00356-X; Sun LL, 2004, INT IMMUNOL, V16, P1623, DOI 10.1093/intimm/dxh164; Wasik TJ, 1999, J IMMUNOL, V162, P4355; Zagury D, 1998, P NATL ACAD SCI USA, V95, P3857, DOI 10.1073/pnas.95.7.3857	43	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3481	10.1371/journal.pone.0003481	http://dx.doi.org/10.1371/journal.pone.0003481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941536	Green Published, gold, Green Submitted			2022-12-27	WOS:000265126100012
J	Chung, H; Young, DJ; Lopez, CG; Le, TAT; Lee, JK; Ream-Robinson, D; Huang, SC; Carethers, JM				Chung, Heekyung; Young, Dennis J.; Lopez, Claudia G.; Le, Thuy-Anh T.; Lee, Jeffrey K.; Ream-Robinson, Deena; Huang, Sherry C.; Carethers, John M.			Mutation Rates of TGFBR2 and ACVR2 Coding Microsatellites in Human Cells with Defective DNA Mismatch Repair	PLOS ONE			English	Article								Microsatellite instability promotes colonic tumorigenesis through generating frameshift mutations at coding microsatellites of tumor suppressor genes, such as TGFBR2 and ACVR2. As a consequence, signaling through these TGF beta family receptors is abrogated in DNA Mismatch repair (MMR)-deficient tumors. How these mutations occur in real time and mutational rates of these human coding sequences have not previously been studied. We utilized cell lines with different MMR deficiencies (hMLH1(-/-), hMSH6(-/-), hMSH3(-/-), and MMR-proficient) to determine mutation rates. Plasmids were constructed in which exon 3 of TGFBR2 and exon 10 of ACVR2 were cloned +1 bp out of frame, immediately after the translation initiation codon of an enhanced GFP (EGFP) gene, allowing a -1 bp frameshift mutation to drive EGFP expression. Mutation-resistant plasmids were constructed by interrupting the coding microsatellite sequences, preventing frameshift mutation. Stable cell lines were established containing portions of TGFBR2 and ACVR2, and nonfluorescent cells were sorted, cultured for 7-35 days, and harvested for flow cytometric mutation detection and DNA sequencing at specific time points. DNA sequencing revealed a 21 bp frameshift mutation (A(9) in TGFBR2 and A(7) in ACVR2) in the fluorescent cells. Two distinct fluorescent populations, M1 (dim, representing heteroduplexes) and M2 (bright, representing full mutants) were identified, with the M2 fraction accumulating over time. hMLH1 deficiency revealed 11 (5.91 x 10(-4)) and 15 (2.18 x 10(-4)) times higher mutation rates for the TGFBR2 and ACVR2 microsatellites compared to hMSH6 deficiency, respectively. The mutation rate of the TGFBR2 microsatellite was similar to 3 times higher in both hMLH1 and hMSH6 deficiencies than the ACVR2 microsatellite. The -1 bp frameshift mutation rates of TGFBR2 and ACVR2 microsatellite sequences are dependent upon the human MMR background.	[Chung, Heekyung; Lopez, Claudia G.; Le, Thuy-Anh T.; Lee, Jeffrey K.; Ream-Robinson, Deena; Carethers, John M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Young, Dennis J.; Carethers, John M.] Univ Calif San Diego, Rebecca & John Moores Comprehensive Canc Ctr, La Jolla, CA 92093 USA; [Huang, Sherry C.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Carethers, John M.] VA San Diego Hlthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Chung, H (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	jcarethers@ucsd.edu	Lopez, Claudia/GXN-1686-2022		United States Public Health Service [DK067287]; UCSD Digestive Diseases Research Development Center [DK080506]; VA Research Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067287, R24DK080506] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); UCSD Digestive Diseases Research Development Center; VA Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the United States Public Health Service (DK067287 to JMC), the UCSD Digestive Diseases Research Development Center (DK080506), and the VA Research Service (Merit Review Award to JMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Akiyama Y, 1997, CANCER RES, V57, P3920; Barbara JT, 2006, INT J CANCER, V118, P2509, DOI 10.1002/ijc.21710; Boyer JC, 2008, MUTAT RES-FUND MOL M, V640, P89, DOI 10.1016/j.mrfmmm.2007.12.005; Carethers JM, 1999, GASTROENTEROLOGY, V117, P123, DOI 10.1016/S0016-5085(99)70558-5; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Gasche C, 2003, P NATL ACAD SCI USA, V100, P1914, DOI 10.1073/pnas.0437965100; Grady WM, 1998, CANCER RES, V58, P3101; GRADY WM, 2008, GASTROENTER IN PRESS, V135; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Harrington JA, 2007, MOL CELL BIOL, V27, P6546, DOI 10.1128/MCB.00855-07; Hempen PM, 2003, CANCER RES, V63, P994; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Jung B, 2004, GASTROENTEROLOGY, V126, P654, DOI 10.1053/j.gastro.2004.01.008; Jung BH, 2007, GASTROENTEROLOGY, V132, P633, DOI 10.1053/j.gastro.2006.11.018; JUNG BH, 2008, TXB GASTROE IN PRESS; KOI M, 1994, CANCER RES, V54, P4308; Luria SE, 1943, GENETICS, V28, P491; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Marra G, 1996, GASTROENTEROL CLIN N, V25, P755, DOI 10.1016/S0889-8553(05)70273-9; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1995, CANCER RES, V55, P5548; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Twerdi CD, 1999, P NATL ACAD SCI USA, V96, P2875, DOI 10.1073/pnas.96.6.2875; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698	30	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3463	10.1371/journal.pone.0003463	http://dx.doi.org/10.1371/journal.pone.0003463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941508	gold, Green Published, Green Submitted			2022-12-27	WOS:000265125900007
J	Guerra, B; Fuentes, T; Delgado-Guerra, S; Guadalupe-Grau, A; Olmedillas, H; Santana, A; Ponce-Gonzalez, JG; Dorado, C; Calbet, JAL				Guerra, Borja; Fuentes, Teresa; Delgado-Guerra, Safira; Guadalupe-Grau, Amelia; Olmedillas, Hugo; Santana, Alfredo; Gustavo Ponce-Gonzalez, Jesus; Dorado, Cecilia; Calbet, Jose A. L.			Gender Dimorphism in Skeletal Muscle Leptin Receptors, Serum Leptin and Insulin Sensitivity	PLOS ONE			English	Article								To determine if there is a gender dimorphism in the expression of leptin receptors (OB-R170, OB-R128 and OB-R98) and the protein suppressor of cytokine signaling 3 (SOCS3) in human skeletal muscle, the protein expression of OB-R, perilipin A, SOCS3 and alpha-tubulin was assessed by Western blot in muscle biopsies obtained from the m. vastus lateralis in thirty-four men (age = 27.1 +/- 6.8 yr) and thirty-three women (age = 26.7 +/- 6.7 yr). Basal serum insulin concentration and HOMA were similar in both genders. Serum leptin concentration was 3.4 times higher in women compared to men (P<0.05) and this difference remained significant after accounting for the differences in percentage of body fat or soluble leptin receptor. OB-R protein was 41% (OB-R170, P<0.05) and 163% (OB-R128, P<0.05) greater in women than men. There was no relationship between OB-R expression and the serum concentrations of leptin or 17 beta-estradiol. In men, muscle OB-R128 protein was inversely related to serum free testosterone. In women, OB-R98 and OB-R128 were inversely related to total serum testosterone concentration, and OB-R128 to serum free testosterone concentration. SOCS3 protein expression was similar in men and women and was not related to OB-R. In women, there was an inverse relationship between the logarithm of free testosterone and SCOS3 protein content in skeletal muscle (r = -0.46, P<0.05). In summary, there is a gender dimorphism in skeletal muscle leptin receptors expression, which can be partly explained by the influence of testosterone. SOCS3 expression in skeletal muscle is not up-regulated in women, despite very high serum leptin concentrations compared to men. The circulating form of the leptin receptor can not be used as a surrogate measure of the amount of leptin receptors expressed in skeletal muscles.	[Guerra, Borja; Fuentes, Teresa; Delgado-Guerra, Safira; Guadalupe-Grau, Amelia; Olmedillas, Hugo; Santana, Alfredo; Gustavo Ponce-Gonzalez, Jesus; Dorado, Cecilia; Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain; [Santana, Alfredo] Chilhood Hosp Materno Infantil Las Palmas, Genet Unit, Las Palmas Gran Canaria, Spain; [Santana, Alfredo] Hosp Gran Canaria Dr Negrin, Res Unit, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria	Guerra, B (corresponding author), Univ Las Palmas Gran Canaria, Dept Phys Educ, Campus Univ Tafira S-N, Las Palmas Gran Canaria, Spain.	lopezcalbet@gmail.com	Fuentes, Teresa/K-7227-2014; PONCE GONZALEZ, JESUS G/R-1836-2019; Calbet, Jose A L/H-6693-2015; Olmedillas, Hugo/F-4809-2015; Guerra, Borja/G-9739-2015; Dorado García, Cecilia/ABC-2792-2021; Guadalupe-Grau, Amelia/H-4961-2016; Cecilia, Dorado-Garcia/B-4586-2010; RODRIGUEZ, ALFREDO SANTANA/AAE-2934-2019; Guerra, Borja/ABE-1138-2021; González, Jesús Gustavo Ponce/H-9500-2015	Fuentes, Teresa/0000-0003-1286-8731; PONCE GONZALEZ, JESUS G/0000-0002-5982-7761; Calbet, Jose A L/0000-0002-9215-6234; Olmedillas, Hugo/0000-0003-4625-2759; Guerra, Borja/0000-0003-4355-5682; Guadalupe-Grau, Amelia/0000-0003-2573-4572; Cecilia, Dorado-Garcia/0000-0001-6616-6810; RODRIGUEZ, ALFREDO SANTANA/0000-0002-1075-9948; Guerra, Borja/0000-0003-4355-5682; González, Jesús Gustavo Ponce/0000-0002-5982-7761; antunez, Ariel/0000-0002-2548-7885	Ministerio de Educacion y Ciencia [BFI2003-09638, BFU2006-13784, FEDER]; Gobierno de Canarias [PI2005/177]; Universidad de Las Palmas de Gran Canaria, Spain [UNI2006/05]; Recursos Humanos y Difusion de la Investigacion Program (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain)	Ministerio de Educacion y Ciencia(Spanish Government); Gobierno de Canarias; Universidad de Las Palmas de Gran Canaria, Spain; Recursos Humanos y Difusion de la Investigacion Program (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain)(Instituto de Salud Carlos III)	This study was supported by grants from the Ministerio de Educacion y Ciencia (BFI2003-09638, BFU2006-13784 and FEDER), Gobierno de Canarias (PI2005/177) and Universidad de Las Palmas de Gran Canaria, Spain (UNI2006/05). Borja Guerra is a fellow of the Recursos Humanos y Difusion de la Investigacion Program (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain). The sponsors of this study had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Alonso A, 2007, EXP BIOL MED, V232, P542; Ara I, 2006, BRIT J NUTR, V96, P1053, DOI 10.1017/BJN20061956; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Brann DW, 1999, STEROIDS, V64, P659, DOI 10.1016/S0039-128X(99)00049-5; Caprio M, 1999, ENDOCRINOLOGY, V140, P4939, DOI 10.1210/en.140.11.4939; Castrogiovanni D, 2003, ENDOCRINE, V22, P203, DOI 10.1385/ENDO:22:3:203; Chan JL, 2002, DIABETES, V51, P2105, DOI 10.2337/diabetes.51.7.2105; Cohen P, 2005, J BIOL CHEM, V280, P10034, DOI 10.1074/jbc.M413684200; Cornish J, 2002, J ENDOCRINOL, V175, P405, DOI 10.1677/joe.0.1750405; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Gallagher D, 2005, AM J CLIN NUTR, V81, P903, DOI 10.1093/ajcn/81.4.903; Ge HF, 2002, J BIOL CHEM, V277, P45898, DOI 10.1074/jbc.M205825200; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Guerra B, 2007, J APPL PHYSIOL, V102, P1786, DOI 10.1152/japplphysiol.01313.2006; Henderson GC, 2007, J PHYSIOL-LONDON, V584, P963, DOI 10.1113/jphysiol.2007.137331; Hikita M, 2000, BIOCHEM BIOPH RES CO, V271, P703, DOI 10.1006/bbrc.2000.2692; Ishikawa T, 2007, ANDROLOGIA, V39, P22, DOI 10.1111/j.1439-0272.2006.00754.x; Isidori AM, 1999, J CLIN ENDOCR METAB, V84, P3673, DOI 10.1210/jc.84.10.3673; Kamikubo Y, 2008, BIOCHEM J, V410, P595, DOI 10.1042/BJ20071137; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lammert A, 2001, BIOCHEM BIOPH RES CO, V283, P982, DOI 10.1006/bbrc.2001.4885; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Liu ZJ, 2007, HORM METAB RES, V39, P489, DOI 10.1055/s-2007-981680; LUNDBY C, 2006, J PHYSL; Luukkaa V, 1998, J CLIN ENDOCR METAB, V83, P3243, DOI 10.1210/jc.83.9.3243; Machinal F, 1999, ENDOCRINOLOGY, V140, P1567, DOI 10.1210/en.140.4.1567; Mannucci E, 1998, EUR J ENDOCRINOL, V139, P198, DOI 10.1530/eje.0.1390198; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Muoio DM, 2002, BEST PRACT RES CL EN, V16, P653, DOI 10.1053/beem.2002.0223; MYERS MG, 2007, ANN REV PHYSL; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Ramsay TG, 2005, J ANIM SCI, V83, P2501; Rieusset J, 2004, DIABETES, V53, P2232, DOI 10.2337/diabetes.53.9.2232; Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Seron K, 2006, BIOCHEM BIOPH RES CO, V348, P1232, DOI 10.1016/j.bbrc.2006.07.068; Shimizu H, 1997, J ENDOCRINOL, V154, P285, DOI 10.1677/joe.0.1540285; Sinha MK, 1996, J CLIN INVEST, V98, P1277, DOI 10.1172/JCI118913; Stein K, 2006, J CLIN ENDOCR METAB, V91, P1021, DOI 10.1210/jc.2005-1394; Steinberg GR, 2002, AM J PHYSIOL-ENDOC M, V283, pE187, DOI 10.1152/ajpendo.00542.2001; Steinberg GR, 2006, J CLIN ENDOCR METAB, V91, P3592, DOI 10.1210/jc.2006-0638; TARNOPOLSKY LJ, 1990, J APPL PHYSIOL, V68, P302, DOI 10.1152/jappl.1990.68.1.302; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tena-Sempere M, 2001, J ENDOCRINOL, V170, P413, DOI 10.1677/joe.0.1700413; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van Dielen FMH, 2002, J CLIN ENDOCR METAB, V87, P1708, DOI 10.1210/jc.87.4.1708; Wabitsch M, 1997, J CLIN INVEST, V100, P808, DOI 10.1172/JCI119595; Wang MY, 1998, P NATL ACAD SCI USA, V95, P714, DOI 10.1073/pnas.95.2.714; Wong SL, 2004, J CLIN ENDOCR METAB, V89, P2672, DOI 10.1210/jc.2003-031931; Zachow RJ, 1999, BIOL REPROD, V61, P1104, DOI 10.1095/biolreprod61.4.1104; Zhang FM, 2005, VITAM HORM, V71, P345, DOI 10.1016/S0083-6729(05)71012-8; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	57	46	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3466	10.1371/journal.pone.0003466	http://dx.doi.org/10.1371/journal.pone.0003466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941624	Green Published, gold			2022-12-27	WOS:000265125900010
J	Hoshikawa, S; Ogata, T; Fujiwara, S; Nakamura, K; Tanaka, S				Hoshikawa, Shinya; Ogata, Toru; Fujiwara, Sayaka; Nakamura, Kozo; Tanaka, Sakae			A Novel Function of RING Finger Protein 10 in Transcriptional Regulation of the Myelin-Associated Glycoprotein Gene and Myelin Formation in Schwann Cells	PLOS ONE			English	Article								Myelin-associated glycoprotein (MAG) has been detected in Schwann cells prior to the onset of myelination, suggesting its functions in the initiation of myelination. However, transcriptional regulatory mechanisms of MAG remain to be elucidated. Here, we analyzed the promoter of the MAG gene by using luciferase reporter systems in the primary rat Schwann cells. We identified a novel cis-acting element located 160 bp upstream from the MAG transcription initiation site. Using the identified cis-element as a bait, we performed yeast one-hybrid screening and isolated a cDNA encoding a RNF10 as a putative trans-acting protein. When overexpressed in Schwann cells, RNF10 enhanced the activity of the MAG promoter. When RNF10 expression in Schwann cells was knocked down by siRNA, endogenous MAG mRNA and protein expression decreased. Furthermore, we evaluated myelin synthesis using Schwann cell-DRG neuron cocultures. When Schwann cells were infected with retrovirus expressing RNF10 siRNA, myelin formation was inhibited. These data suggest that RNF10 regulates MAG expression and is required for myelin formation.	[Hoshikawa, Shinya; Fujiwara, Sayaka; Nakamura, Kozo; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 113, Japan; [Hoshikawa, Shinya; Ogata, Toru] Natl Rehab Ctr, Res Inst, Div Motor Dysfunct, Tokorozawa, Saitama, Japan	University of Tokyo	Hoshikawa, S (corresponding author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 113, Japan.	ogata@rehab.go.jp	Ogata, Toru/ADC-3560-2022; Tanaka, Sakae/Y-3061-2019	Ogata, Toru/0000-0001-9011-8640; Tanaka, Sakae/0000-0001-9210-9414	Ministry of Education, Science and Culture of Japan [Grant-in-Aid]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grant-in-Aid for Exploratory Research and a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan	BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; EINHEBER S, 1995, J CELL BIOL, V129, P443, DOI 10.1083/jcb.129.2.443; Erb M, 2006, MOL CELL NEUROSCI, V31, P613, DOI 10.1016/j.mcn.2005.12.001; GRUBINSKA B, 1994, J NEUROSCI RES, V39, P233, DOI 10.1002/jnr.490390302; Hakli M, 2001, J BIOL CHEM, V276, P23653, DOI 10.1074/jbc.M009891200; Konat GW, 1996, ACTA NEUROBIOL EXP, V56, P281; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; Laszkiewicz I, 1997, J NEUROSCI RES, V50, P928; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Lin JJ, 2005, MOL CELL BIOCHEM, V275, P75, DOI 10.1007/s11010-005-0823-3; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; OWENS GC, 1989, GLIA, V2, P119, DOI 10.1002/glia.440020208; Poukka H, 2000, J CELL SCI, V113, P2991; Quarles RH, 2007, J NEUROCHEM, V100, P1431, DOI 10.1111/j.1471-4159.2006.04319.x; Saito T, 2007, EMBO REP, V8, P504, DOI 10.1038/sj.embor.7400934; Salzer JL, 1997, NEURON, V18, P843, DOI 10.1016/S0896-6273(00)80323-2; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Schaumburg Jochen, 2000, Silva Gabreta, V4, P29; Seki N, 2000, J HUM GENET, V45, P38, DOI 10.1007/s100380050007; TRAPP BD, 1982, J CELL BIOL, V92, P877, DOI 10.1083/jcb.92.3.877; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211	24	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3464	10.1371/journal.pone.0003464	http://dx.doi.org/10.1371/journal.pone.0003464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941509	Green Published, Green Submitted, gold			2022-12-27	WOS:000265125900008
J	Ryge, J; Westerdahl, AC; Alstrom, P; Kiehn, O				Ryge, Jesper; Westerdahl, Ann-Charlotte; Alstrom, Preben; Kiehn, Ole			Gene Expression Profiling of Two Distinct Neuronal Populations in the Rodent Spinal Cord	PLOS ONE			English	Article							LEFT-RIGHT COORDINATION; FALSE DISCOVERY RATE; Y MESSENGER-RNA; MOTOR-NEURONS; COMMISSURAL INTERNEURONS; MICROARRAY ANALYSIS; SUBUNIT COMPOSITION; POTASSIUM CHANNELS; LOCOMOTOR-ACTIVITY; RAT	Background: In the field of neuroscience microarray gene expression profiles on anatomically defined brain structures are being used increasingly to study both normal brain functions as well as pathological states. Fluorescent tracing techniques in brain tissue that identifies distinct neuronal populations can in combination with global gene expression profiling potentially increase the resolution and specificity of such studies to shed new light on neuronal functions at the cellular level. Methodology/Principal Findings: We examine the microarray gene expression profiles of two distinct neuronal populations in the spinal cord of the neonatal rat, the principal motor neurons and specific interneurons involved in motor control. The gene expression profiles of the respective cell populations were obtained from amplified mRNA originating from 50-250 fluorescently identified and laser microdissected cells. In the data analysis we combine a new microarray normalization procedure with a conglomerate measure of significant differential gene expression. Using our methodology we find 32 genes to be more expressed in the interneurons compared to the motor neurons that all except one have not previously been associated with this neuronal population. As a validation of our method we find 17 genes to be more expressed in the motor neurons than in the interneurons and of these only one had not previously been described in this population. Conclusions/Significance: We provide an optimized experimental protocol that allows isolation of gene transcripts from fluorescent retrogradely labeled cell populations in fresh tissue, which can be used to generate amplified aRNA for microarray hybridization from as few as 50 laser microdissected cells. Using this optimized experimental protocol in combination with our microarray analysis methodology we find 49 differentially expressed genes between the motor neurons and the interneurons that reflect the functional differences between these two cell populations in generating and transmitting the motor output in the rodent spinal cord.	[Ryge, Jesper; Westerdahl, Ann-Charlotte; Kiehn, Ole] Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, Stockholm, Sweden; [Alstrom, Preben] CORE AS, Frederiksberg, Denmark	Karolinska Institutet	Ryge, J (corresponding author), Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, Stockholm, Sweden.	jesper.ryge@ki.se; o.kiehn@ki.se	kiehn, ole/AAB-1262-2019; kiehn, ole/AAT-7881-2021	Kiehn, Ole/0000-0002-5954-469X; Ryge, Jesper/0000-0003-1992-7298	Karolinska Institutet; Swedish Medical Research Council; NIH; Schellenberg Foundation	Karolinska Institutet(Karolinska Institutet); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schellenberg Foundation	This work was supported by Karolinska Institutet, The Swedish Medical Research Council, NIH and The Schellenberg Foundation.	Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452; *AFF, 2002, STAT ALG DESCR DOC S; Akinori M, 1998, PROG NEUROBIOL, V54, P499, DOI 10.1016/S0301-0082(97)00077-4; Alizadeh AA, 2001, J PATHOL, V195, P41, DOI 10.1002/path.889; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertrand S, 2002, EUR J NEUROSCI, V16, P1741, DOI 10.1046/j.1460-9568.2002.02233.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Butt SJB, 2003, NEURON, V38, P953, DOI 10.1016/S0896-6273(03)00353-2; Butt SJB, 2002, J NEUROSCI, V22, P9961; Byrnes KR, 2006, GLIA, V53, P420, DOI 10.1002/glia.20295; Campagna JA, 1997, MOL CELL NEUROSCI, V8, P377, DOI 10.1006/mcne.1997.0596; Cazalets JR, 1998, ANN NY ACAD SCI, V860, P168, DOI 10.1111/j.1749-6632.1998.tb09047.x; Coleman SK, 1999, J NEUROCHEM, V73, P849, DOI 10.1046/j.1471-4159.1999.0730849.x; CRONE C, 1988, J PHYSIOL-LONDON, V405, P321, DOI 10.1113/jphysiol.1988.sp017335; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Cui DP, 2006, PHYSIOL GENOMICS, V24, P276, DOI 10.1152/physiolgenomics.00109.2005; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Date Y, 2000, NEUROSCI LETT, V288, P87, DOI 10.1016/S0304-3940(00)01195-2; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; Deuchars SA, 2001, NEUROSCIENCE, V106, P433, DOI 10.1016/S0306-4522(01)00277-9; Di Giovanni S, 2004, FASEB J, V18, P153, DOI 10.1096/fj.04-2694fje; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Diaz E, 2006, NAT NEUROSCI, V9, P10, DOI 10.1038/nn0106-10; Dumoulin A, 1999, J CELL SCI, V112, P811; Edwards L, 2002, J COMP NEUROL, V443, P154, DOI 10.1002/cne.10115; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Fernandez-Medarde A, 2007, NEUROSCIENCE, V146, P272, DOI 10.1016/j.neuroscience.2007.01.022; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GLOVER JC, 1986, J NEUROSCI METH, V18, P243, DOI 10.1016/0165-0270(86)90011-7; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hernandez-Pineda R, 1999, J NEUROPHYSIOL, V82, P1512, DOI 10.1152/jn.1999.82.3.1512; Hokfelt T, 2007, PEPTIDES, V28, P365, DOI 10.1016/j.peptides.2006.07.024; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V405, P345, DOI 10.1113/jphysiol.1988.sp017336; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; Jankowska E, 2003, J NEUROSCI, V23, P1867; Johanson RA, 2000, J NEUROSCI, V20, P2860; Jordan LM, 2002, PROG BRAIN RES, V137, P125; Julien JP, 1998, BRAIN PATHOL, V8, P759, DOI 10.1111/j.1750-3639.1998.tb00199.x; Kettunen P, 2005, NEURON, V45, P95, DOI 10.1016/j.neuron.2004.12.022; KIEHN O, 1992, NEUROSCI LETT, V143, P243, DOI 10.1016/0304-3940(92)90274-B; Kiehn O, 2008, BRAIN RES REV, V57, P56, DOI 10.1016/j.brainresrev.2007.07.002; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; Lindholm T, 2004, NEUROREPORT, V15, P649, DOI 10.1097/00001756-200403220-00015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MADERDRUT JL, 1986, BRAIN RES, V377, P29, DOI 10.1016/0006-8993(86)91187-X; MARTI E, 1992, NEUROREPORT, V3, P401, DOI 10.1097/00001756-199205000-00006; Minson JB, 2001, AUTON NEUROSCI-BASIC, V93, P14, DOI 10.1016/S1566-0702(01)00324-1; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mori K, 2004, NEUROSCI RES, V48, P439, DOI 10.1016/j.neures.2003.12.012; Naef F, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.040902; Nagao S, 1997, NEUROSCIENCE, V78, P929; Nakayama K, 2002, J NEUROSCI, V22, P10388; Nelson SB, 2006, CURR OPIN NEUROBIOL, V16, P571, DOI 10.1016/j.conb.2006.08.006; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Nishimaru H, 2000, BRAIN RES BULL, V53, P661, DOI 10.1016/S0361-9230(00)00399-3; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; Pan HL, 2008, PHARMACOL THERAPEUT, V117, P141, DOI 10.1016/j.pharmthera.2007.09.003; Plumier JCL, 1997, J COMP NEUROL, V384, P409; Pongs O, 1999, FEBS LETT, V452, P31, DOI 10.1016/S0014-5793(99)00535-9; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007; Rasband MN, 2001, J COMP NEUROL, V429, P166, DOI 10.1002/1096-9861(20000101)429:1<166::AID-CNE13>3.0.CO;2-Y; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; REN WZ, 1994, MOL BRAIN RES, V22, P173, DOI 10.1016/0169-328X(94)90045-0; RESTREPO CE, 2005, 7491 SOC NEUR; Robinson D, 1997, J COMP NEUROL, V389, P94, DOI 10.1002/(SICI)1096-9861(19971208)389:1<94::AID-CNE7>3.0.CO;2-9; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Samigullin D, 2004, J PHYSIOL-LONDON, V561, P149, DOI 10.1113/jphysiol.2004.073494; Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0; Schousboe A, 2000, NEUROCHEM RES, V25, P1241, DOI 10.1023/A:1007692012048; Schulz S, 1998, NEUROSCI LETT, V257, P37, DOI 10.1016/S0304-3940(98)00803-9; Schutz B, 2004, J COMP NEUROL, V476, P32, DOI 10.1002/cne.20211; Schweizer U, 2002, J CELL BIOL, V156, P287, DOI 10.1083/jcb.200107009; SEGOND VB, 1999, BRAIN RES, V816, P254; Seitz A, 2003, J NEUROSCI RES, V71, P417, DOI 10.1002/jnr.10482; Shoemaker DD, 2002, CURR OPIN MICROBIOL, V5, P334, DOI 10.1016/S1369-5274(02)00327-2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stokke MF, 2002, J COMP NEUROL, V446, P349, DOI 10.1002/cne.10211; STRUYK AF, 1995, J NEUROSCI, V15, P2141, DOI 10.1523/JNEUROSCI.15-03-02141.1995; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Taccola G, 2004, EUR J NEUROSCI, V19, P533, DOI 10.1111/j.0953-816X.2003.03148.x; Toepfer M, 1999, CELL MOL NEUROBIOL, V19, P297; Tomiyama M, 2001, J NEUROL SCI, V189, P65, DOI 10.1016/S0022-510X(01)00561-5; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uwabe K, 1997, NEUROSCIENCE, V80, P501, DOI 10.1016/S0306-4522(97)00112-7; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Wallis K, 2008, J NEUROSCI, V28, P1904, DOI 10.1523/JNEUROSCI.5163-07.2008; Watson WD, 2003, J NEUROCHEM, V87, P30, DOI 10.1046/j.1471-4159.2003.01962.x; WATTS AG, 1991, P NATL ACAD SCI USA, V88, P7425, DOI 10.1073/pnas.88.16.7425; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wiese S, 1999, EUR J NEUROSCI, V11, P1668, DOI 10.1046/j.1460-9568.1999.00585.x; WIJNHOLDS J, 1995, DEV BIOL, V171, P73, DOI 10.1006/dbio.1995.1261; Wilczak N, 2003, LANCET, V361, P1007, DOI 10.1016/S0140-6736(03)12828-0; WORKMAN C, 2002, GENOME BIOL, V0003; Yamuy J, 2004, J NEUROSCI, V24, P5336, DOI 10.1523/JNEUROSCI.4812-03.2004; YIN KJ, 1995, ANAT REC, V241, P579, DOI 10.1002/ar.1092410415; Zhou L, 1998, J NEUROSCI, V18, P7200	112	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3415	10.1371/journal.pone.0003415	http://dx.doi.org/10.1371/journal.pone.0003415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923679	gold, Green Published, Green Submitted			2022-12-27	WOS:000265121800013
J	Taylor, WRJ; Thinh, BN; Anh, GT; Horby, P; Wertheim, H; Lindegardh, N; de Jong, MD; Stepniewska, K; Hanh, TT; Hien, ND; Bien, NM; Chau, NQ; Fox, A; Ngoc, NM; Crusat, M; Farrar, JJ; White, NJ; Ha, NH; Lien, TT; Trung, NV; Day, N; Binh, NG				Taylor, Walter R. J.; Thinh, Bui Nghia; Anh, Giang Thuc; Horby, Peter; Wertheim, Heiman; Lindegardh, Niklas; de Jong, Menno D.; Stepniewska, Kasia; Hanh, Tran Thuy; Hien, Nguyen Duc; Bien, Ngo Minh; Chau, Ngo Quy; Fox, Annette; Ngoc, Nghiem My; Crusat, Martin; Farrar, Jeremy J.; White, Nicholas J.; Ha, Nguyen Hong; Lien, Trinh Thi; Trung, Nguyen Vu; Day, Nicholas; Binh, Nguyen Gia			Oseltamivir Is Adequately Absorbed Following Nasogastric Administration to Adult Patients with Severe H5N1 Influenza	PLOS ONE			English	Article							A H5N1; PHARMACOKINETICS; CARBOXYLATE; INFECTION; SENSITIVITY; INHIBITORS; VIRUSES; PLASMA	In the absence of a parenteral drug, oral oseltamivir is currently recommended by the WHO for treating H5N1 influenza. Whether oseltamivir absorption is adequate in severe influenza is unknown. We measured the steady state, plasma concentrations of nasogastrically administered oseltamivir 150 mg bid and its active metabolite, oseltamivir carboxylate (OC), in three, mechanically ventilated patients with severe H5N1 (male, 30 yrs; pregnant female, 22 yrs) and severe H3N2 (female, 76 yrs). Treatments were started 6, 7 and 8 days after illness onset, respectively. Both females were sampled while on continuous venovenous haemofiltration. Admission and follow up specimens (trachea, nose, throat, rectum, blood) were tested for RNA viral load by reverse transcriptase PCR. In vitro virus susceptibility to OC was measured by a neuraminidase inhibition assay. Admission creatinine clearances were 66 (male, H5N1), 82 (female, H5N1) and 6 (H3N2) ml/min. Corresponding AUC(0) (12) values (5932, 10,951 and 34,670 ng.h/ml) and trough OC concentrations (376, 575 and 2730 ng/ml) were higher than previously reported in healthy volunteers; the latter exceeded 545 to 3956 fold the H5N1 IC50 (0.69 ng/ml) isolated from the H5N1 infected female. Two patients with follow-up respiratory specimens cleared their viruses after 5 (H5N1 male) and 5 (H3N2 female) days of oseltamivir. Both female patients died of respiratory failure; the male survived. 150 mg bid of oseltamivir was well absorbed and converted extensively to OC. Virus was cleared in two patients but two patients died, suggesting viral efficacy but poor clinical efficacy.	[Taylor, Walter R. J.; Horby, Peter; Wertheim, Heiman; Fox, Annette] Univ Oxford, Clin Res Unit, Hanoi, Vietnam; [Taylor, Walter R. J.; Horby, Peter; Wertheim, Heiman; Lindegardh, Niklas; de Jong, Menno D.; Stepniewska, Kasia; Fox, Annette; Farrar, Jeremy J.; White, Nicholas J.; Day, Nicholas] Churchill Hosp, Ctr Vaccinol & Trop Med, Oxford, England; [Thinh, Bui Nghia; Anh, Giang Thuc; Hanh, Tran Thuy; Bien, Ngo Minh; Chau, Ngo Quy; Binh, Nguyen Gia] Bach Mai Hosp, Hanoi, Vietnam; [Lindegardh, Niklas; Stepniewska, Kasia; White, Nicholas J.; Day, Nicholas] Mahidol Oxford Res Unit, Bangkok, Thailand; [de Jong, Menno D.; Ngoc, Nghiem My; Crusat, Martin; Farrar, Jeremy J.] Univ Oxford, Ho Chi Minh City, Vietnam; [Hien, Nguyen Duc; Ha, Nguyen Hong; Lien, Trinh Thi; Trung, Nguyen Vu] Natl Inst Infect & Trop Dis, Hanoi, Vietnam	University of Oxford; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford	Taylor, WRJ (corresponding author), Univ Oxford, Clin Res Unit, Hanoi, Vietnam.	btaylor@oucru.org	White, Nicholas J/I-4629-2012; Horby, Peter/D-1585-2013; Wertheim, Heiman FL/F-3338-2016; White, Nick/AAC-6527-2019; Farrar, Jeremy J./HGA-7610-2022	Wertheim, Heiman FL/0000-0002-5003-5565; White, Nick/0000-0002-1897-1978; Fox, Annette/0000-0002-0565-7146; Stepniewska, Kasia/0000-0002-1713-6209; Ngo, Quy Chau/0000-0002-6787-2757; Farrar, Jeremy/0000-0002-2700-623X; Horby, Peter/0000-0002-9822-1586	South East Asian Influenza Clinical Research Network	South East Asian Influenza Clinical Research Network	The South East Asian Influenza Clinical Research Network. The sponsor had no role in any aspects of this study.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Abe M, 2006, ANN PHARMACOTHER, V40, P1724, DOI 10.1345/aph.1H174; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P249; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Chapman MJ, 2007, CURR OPIN CRIT CARE, V13, P187, DOI 10.1097/MCC.0b013e3280523a88; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gruber PC, 2007, INT J ANTIMICROB AG, V30, P95, DOI 10.1016/j.ijantimicag.2007.02.013; He G, 1999, CLIN PHARMACOKINET, V37, P471, DOI 10.2165/00003088-199937060-00003; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Lindegardh N, 2007, J CHROMATOGR B, V859, P74, DOI 10.1016/j.jchromb.2007.09.018; Lindegardh N, 2007, ANTIMICROB AGENTS CH, V51, P1835, DOI 10.1128/AAC.01534-06; Lindegardh N, 2006, ANTIMICROB AGENTS CH, V50, P3197, DOI 10.1128/AAC.00500-06; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Rameix-Welti MA, 2006, ANTIMICROB AGENTS CH, V50, P3809, DOI 10.1128/AAC.00645-06; Robson R, 2006, NEPHROL DIAL TRANSPL, V21, P2556, DOI 10.1093/ndt/gfl267; Schentag JJ, 2007, J CLIN PHARMACOL, V47, P689, DOI 10.1177/0091270007299761; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3; Snell P, 2005, BRIT J CLIN PHARMACO, V59, P598, DOI 10.1111/j.1365-2125.2005.02340.x; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0	24	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3410	10.1371/journal.pone.0003410	http://dx.doi.org/10.1371/journal.pone.0003410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GP	18923671	gold, Green Published, Green Submitted			2022-12-27	WOS:000265121800008
J	Stenner, MP; Waschbisch, A; Buck, D; Doerck, S; Einsele, H; Toyka, KV; Wiendl, H				Stenner, Max-Philipp; Waschbisch, Anne; Buck, Dorothea; Doerck, Sebastian; Einsele, Hermann; Toyka, Klaus V.; Wiendl, Heinz			Effects of Natalizumab Treatment on Foxp3+T Regulatory Cells	PLOS ONE			English	Article								Background: Natalizumab, a monoclonal humanized antibody targeting the alpha-4 chain of very late activation antigen 4 (VLA-4) exerts impressive therapeutic effects in patients with relapsing-remitting multiple sclerosis. Our objective was to study impacts of Natalizumab therapy on Foxp3+ T regulatory cells (Tregs) in multiple sclerosis (MS) patients. Methodology: A combined approach of in vitro and ex vivo experiments using T cells isolated from the peripheral blood of healthy donors and Natalizumab treated MS patients was chosen. We determined binding of Natalizumab and its effects on the frequency, transmigratory behaviour and suppressive function of Tregs. Principal Findings: Binding of Natalizumab and expression of CD49d (alpha-4 chain of VLA-4) differed between non-regulatory and regulatory cells. Albeit Foxp3+ Tregs had lower levels of CD49d, Natalizumab blocked the transmigration of Foxp3+ Tregs similar to non-regulatory T cells. The frequency of peripheral blood Tregs was unaffected by Natalizumab treatment. Natalizumab does not alter the suppressive capacity of CD4+CD25(high)CD127(low)Foxp3+ Tregs under in vitro conditions. Furthermore, the impaired function of Tregs in MS patients is not restored by Natalizumab treatment. Conclusions: We provide a first detailed analysis of Natalizumab effects on the regulatory T cell population. Our prospective study shows that Foxp3+ Tregs express lower levels of VLA-4 and bind less Natalizumab. We further the understanding of the mechanisms of action of Natalizumab by demonstrating that unlike other immunomodulatory drugs the beneficial therapeutic effects of the monoclonal antibody are largely independent of alterations in Treg frequency or function.	[Stenner, Max-Philipp; Waschbisch, Anne; Buck, Dorothea; Doerck, Sebastian; Toyka, Klaus V.; Wiendl, Heinz] Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany; [Einsele, Hermann] Julius Maximilians Univ, Dept Internal Med 2, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Stenner, MP (corresponding author), Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany.	heinz.wiendl@klinik.uni-wuerzburg.de	Wiendl, Heinz/AAX-6041-2021	Wiendl, Heinz/0000-0003-4310-3432	Deutsche Forschungsgemeinschaft [Wi 1722/3-2]; BiogenIdec	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BiogenIdec(Biogen)	This study was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG, Wi 1722/3-2, to H.W.) and by BiogenIdec (to H.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baecher-Allan C, 2004, J EXP MED, V200, P273, DOI 10.1084/jem.20040812; Bluestone JA, 2007, NAT REV IMMUNOL, V7, P650, DOI 10.1038/nri2137; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; de Andres C, 2007, J NEUROIMMUNOL, V182, P204, DOI 10.1016/j.jneuroim.2006.09.012; Engelhardt B, 2008, NEURODEGENER DIS, V5, P16, DOI 10.1159/000109933; Feger U, 2007, CLIN EXP IMMUNOL, V147, P412, DOI 10.1111/j.1365-2249.2006.03271.x; Feger U, 2007, BLOOD, V110, P568, DOI 10.1182/blood-2006-11-057125; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Hong J, 2005, P NATL ACAD SCI USA, V102, P6449, DOI 10.1073/pnas.0502187102; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kappos L, 2007, LANCET NEUROL, V6, P431, DOI 10.1016/S1474-4422(07)70078-9; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Kleinschnitz C., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P35; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Mittelbrunn M, 2004, P NATL ACAD SCI USA, V101, P11058, DOI 10.1073/pnas.0307927101; Niino M, 2006, ANN NEUROL, V59, P748, DOI 10.1002/ana.20859; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Prat A, 1999, ANN NEUROL, V46, P253, DOI 10.1002/1531-8249(199908)46:2<253::AID-ANA16>3.0.CO;2-C; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SATO T, 1995, J IMMUNOL, V155, P2938; SCHWAB N, 2008, J NEUROIMMUNOL; Seale AC, 2008, J CLIN LAB ANAL, V22, P153, DOI 10.1002/jcla.20234; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Stuve O, 2007, CNS DRUG REV, V13, P79, DOI 10.1111/j.1527-3458.2007.00003.x; Stuve O, 2006, ANN NEUROL, V59, P743, DOI 10.1002/ana.20858; Stuve O, 1996, ANN NEUROL, V40, P853, DOI 10.1002/ana.410400607; Stuve O, 2006, ARCH NEUROL-CHICAGO, V63, P1383, DOI 10.1001/archneur.63.10.1383; Theien BE, 2001, J CLIN INVEST, V107, P995, DOI 10.1172/JCI11717; Uhm JH, 1999, ANN NEUROL, V46, P319, DOI 10.1002/1531-8249(199909)46:3<319::AID-ANA7>3.0.CO;2-N; Valencia X, 2007, NAT CLIN PRACT RHEUM, V3, P619, DOI 10.1038/ncprheum0624; Venken K, 2006, J NEUROSCI RES, V83, P1432, DOI 10.1002/jnr.20852; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	39	45	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3319	10.1371/journal.pone.0003319	http://dx.doi.org/10.1371/journal.pone.0003319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836525	Green Published, gold, Green Submitted			2022-12-27	WOS:000265113500001
J	Berdasco, M; Alcazar, R; Garcia-Ortiz, MV; Ballestar, E; Fernandez, AF; Roldan-Arjona, T; Tiburcio, AF; Altabella, T; Buisine, N; Quesneville, H; Baudry, A; Lepiniec, L; Alaminos, M; Rodriguez, R; Lloyd, A; Colot, V; Bender, J; Canal, MJ; Esteller, M; Fraga, MF				Berdasco, Maria; Alcazar, Ruben; Victoria Garcia-Ortiz, Maria; Ballestar, Esteban; Fernandez, Agustin F.; Roldan-Arjona, Teresa; Tiburcio, Antonio F.; Altabella, Teresa; Buisine, Nicolas; Quesneville, Hadi; Baudry, Antoine; Lepiniec, Loic; Alaminos, Miguel; Rodriguez, Roberto; Lloyd, Alan; Colot, Vincent; Bender, Judith; Jesus Canal, Maria; Esteller, Manel; Fraga, Mario F.			Promoter DNA Hypermethylation and Gene Repression in Undifferentiated Arabidopsis Cells	PLOS ONE			English	Article								Maintaining and acquiring the pluripotent cell state in plants is critical to tissue regeneration and vegetative multiplication. Histone-based epigenetic mechanisms are important for regulating this undifferentiated state. Here we report the use of genetic and pharmacological experimental approaches to show that Arabidopsis cell suspensions and calluses specifically repress some genes as a result of promoter DNA hypermethylation. We found that promoters of the MAPK12, GSTU10 and BXL1 genes become hypermethylated in callus cells and that hypermethylation also affects the TTG1, GSTF5, SUVH8, fimbrin and CCD7 genes in cell suspensions. Promoter hypermethylation in undifferentiated cells was associated with histone hypoacetylation and primarily occurred at CpG sites. Accordingly, we found that the process specifically depends on MET1 and DRM2 methyltransferases, as demonstrated with DNA methyltransferase mutants. Our results suggest that promoter DNA methylation may be another important epigenetic mechanism for the establishment and/or maintenance of the undifferentiated state in plant cells.	[Berdasco, Maria; Ballestar, Esteban; Fernandez, Agustin F.; Esteller, Manel; Fraga, Mario F.] Spanish Natl Canc Ctr CNIO, Mol Pathol Programme, Canc Epigenet Lab, Madrid, Spain; [Berdasco, Maria; Rodriguez, Roberto; Jesus Canal, Maria] Univ Oviedo, Plant Epigenet Lab, Oviedo, Spain; [Berdasco, Maria; Esteller, Manel] Catalan Inst Oncol ICO, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Alcazar, Ruben; Tiburcio, Antonio F.; Altabella, Teresa] Univ Barcelona, Fac Farm, Unitat Fisiol Vegetal, E-08007 Barcelona, Spain; [Victoria Garcia-Ortiz, Maria; Roldan-Arjona, Teresa] Univ Cordoba, Dept Genet, Cordoba, Spain; [Buisine, Nicolas; Colot, Vincent] Univ Evry Val Essonne, INRA, UMR1165, CNRS, Unite Rech Genom Vegetale, Evry, France; [Quesneville, Hadi] INRA, Unite Rech Genom Info, Evry, France; [Baudry, Antoine; Lepiniec, Loic] Inst Natl Rech Agronom 204, Unite Mixte Rech, Lab Biol Semences, Versailles, France; [Alaminos, Miguel] Univ Granada, Dept Histol, E-18071 Granada, Spain; [Lloyd, Alan] Univ Texas, Inst Cellular & Mol Biol, Austin, TX USA; [Bender, Judith] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA; [Fraga, Mario F.] Ctr Nacl Biotecnol, CSIC, Dept Immunol & Oncol, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Oviedo; Catalan Institute of Oncology; University of Barcelona; Universidad de Cordoba; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE; University of Granada; University of Texas System; University of Texas Austin; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Berdasco, M (corresponding author), Spanish Natl Canc Ctr CNIO, Mol Pathol Programme, Canc Epigenet Lab, Madrid, Spain.	mffraga@cnio.es	Quesneville, Hadi/AAG-1048-2020; ALAMINOS, MIGUEL/N-9960-2016; Esteller, Manel/L-5956-2014; Lepiniec, Loic/G-5808-2012; Cañal, María Jesús/L-1005-2014; Alcazar, Ruben/E-7720-2010; Roldan, Antonio/F-6241-2013; García-Ortiz, M Victoria/L-1623-2014; Fraga, Mario F/H-7824-2017; Fernandez, Agustin F./N-7302-2014; Roldan-Arjona, Teresa/H-5976-2015; Alcazar, Ruben/S-6391-2019; Ballestar, Esteban/ABG-8561-2020; ALTABELLA, TERESA/M-5034-2018	Quesneville, Hadi/0000-0003-3001-4908; ALAMINOS, MIGUEL/0000-0003-4876-2672; Esteller, Manel/0000-0003-4490-6093; Lepiniec, Loic/0000-0002-5845-3323; Cañal, María Jesús/0000-0002-1639-9672; García-Ortiz, M Victoria/0000-0001-6527-4908; Fraga, Mario F/0000-0001-8450-2603; Fernandez, Agustin F./0000-0002-3792-4085; Roldan-Arjona, Teresa/0000-0003-2842-3956; Ballestar, Esteban/0000-0002-1400-2440; Alcazar, Ruben/0000-0002-3567-7586; ALTABELLA, TERESA/0000-0002-6915-5823	Health, Education and Science Departments of the Spanish Government [FIS01-04, PI061267, I+D+I MCYT08-03, FU2004-02073/BMC, MEC09-05]; European Grant [TRANSFOG LSHC-CT-2004-503438]; Spanish Association Against Cancer (AECC)	Health, Education and Science Departments of the Spanish Government; European Grant; Spanish Association Against Cancer (AECC)	This work was supported by the Health (FIS01-04) (PI061267), Education and Science (I+D+I MCYT08-03, FU2004-02073/BMC and Consolider MEC09-05) Departments of the Spanish Government, the European Grant TRANSFOG LSHC-CT-2004-503438, and the Spanish Association Against Cancer (AECC). M.B. is funded by the Association Against Cancer (AECC).	Avivi Y, 2004, DEV DYNAM, V230, P12, DOI 10.1002/dvdy.20006; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Costa S, 2007, TRENDS CELL BIOL, V17, P101, DOI 10.1016/j.tcb.2006.12.005; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Doerner P, 2006, CURR BIOL, V16, pR56, DOI 10.1016/j.cub.2006.01.001; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fraga MF, 2007, ANN NY ACAD SCI, V1100, P60, DOI 10.1196/annals.1395.005; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Fraga MF, 2002, ELECTROPHORESIS, V23, P1677, DOI 10.1002/1522-2683(200206)23:11&lt;1677::AID-ELPS1677&gt;3.0.CO;2-Z; GALWAY ME, 1994, DEV BIOL, V166, P740, DOI 10.1006/dbio.1994.1352; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Grafi G, 2004, TRENDS BIOTECHNOL, V22, P388, DOI 10.1016/j.tibtech.2004.06.001; Grafi G, 2004, DEV BIOL, V268, P1, DOI 10.1016/j.ydbio.2003.12.027; Grafi G, 2007, DEV BIOL, V306, P838, DOI 10.1016/j.ydbio.2007.03.023; Grandbastien M, 2005, CYTOGENET GENOME RES, V110, P229, DOI 10.1159/000084957; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Koornneef M., 1981, ARABID INF SERV, V18, P45; Koukalova B, 2005, PLANT PHYSIOL, V139, P275, DOI 10.1104/pp.105.061788; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Mathur J, 1998, PLANT J, V13, P707, DOI 10.1046/j.1365-313X.1998.00059.x; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Payne CT, 2000, GENETICS, V156, P1349; Poulsen P, 2007, PEDIATR RES, V61, p38R, DOI 10.1203/pdr.0b013e31803c7b98; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Tessadori F, 2007, J CELL SCI, V120, P1200, DOI 10.1242/jcs.000026; Vanyushin BF, 2006, CURR TOP MICROBIOL, V301, P67; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Williams L, 2003, DEV DYNAM, V228, P113, DOI 10.1002/dvdy.10348; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	43	87	92	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3306	10.1371/journal.pone.0003306	http://dx.doi.org/10.1371/journal.pone.0003306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18827894	Green Submitted, Green Published, gold			2022-12-27	WOS:000264797200011
J	Braquart-Varnier, C; Lachat, M; Herbiniere, J; Johnson, M; Caubet, Y; Bouchon, D; Sicard, M				Braquart-Varnier, Christine; Lachat, Marion; Herbiniere, Juline; Johnson, Monique; Caubet, Yves; Bouchon, Didier; Sicard, Mathieu			Wolbachia Mediate Variation of Host Immunocompetence	PLOS ONE			English	Article								Background: After decades during which endosymbionts were considered as silent in their hosts, in particular concerning the immune system, recent studies have revealed the contrary. In the present paper, we addressed the effect of Wolbachia, the most prevalent endosymbiont in arthropods, on host immunocompetence. To this end, we chose the A. vulgare-Wolbachia symbiosis as a model system because it leads to compare consequences of two Wolbachia strains (wVulC and wVulM) on hosts from the same population. Moreover, A. vulgare is the only host-species in which Wolbachia have been directly observed within haemocytes which are responsible for both humoral and cellular immune responses. Methodology/Principal Findings: We sampled gravid females from the same population that were either asymbiotic, infected with wVulC, or infected with wVulM. The offspring from these females were tested and it was revealed that individuals harbouring wVulC exhibited: (i) lower haemocyte densities, (ii) more intense septicaemia in their haemolymph and (iii) a reduced lifespan as compared to individuals habouring wVulM or asymbiotic ones. Therefore, individuals in this population of A. vulgare appeared to suffer more from wVulC than from wVulM. Symbiotic titer and location in the haemocytes did not differ for the two Wolbachia strains showing that these two parameters were not responsible for differences observed in their extended phenotypes in A. vulgare. Conclusion/Significance: The two Wolbachia strains infecting A. vulgare in the same population induced variation in immunocompetence and survival of their hosts. Such variation should highly influence the dynamics of this host-symbiont system. We propose in accordance with previous population genetic works, that wVulM is a local strain that has attenuated its virulence through a long term adaptation process towards local A. vulgare genotypes whereas wVulC, which is a widespread and invasive strain, is not locally adapted.	[Braquart-Varnier, Christine; Lachat, Marion; Herbiniere, Juline; Johnson, Monique; Caubet, Yves; Bouchon, Didier; Sicard, Mathieu] Univ Poitiers, Ecol Lab, CNRS, UMR 6556, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Braquart-Varnier, C (corresponding author), Univ Poitiers, Ecol Lab, CNRS, UMR 6556, 40 Ave Recteur Pineau, Poitiers, France.	mathieu.sicard@univ-poitiers.fr	Bouchon, Didier/B-2419-2012; Sicard, Mathieu/C-4984-2009; Braquart-Varnier, Christine/C-5217-2009	Bouchon, Didier/0000-0002-4938-408X; Sicard, Mathieu/0000-0003-3692-0039; Braquart-Varnier, Christine/0000-0001-6398-7832; CAUBET, Yves/0000-0001-6716-2942	CNRS; French Ministere de l'Education Nationale; de l'Enseignement superieur et de la Recherche; Agence Nationale de la Recherche [ANR-06-BLAN-0316]	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'Education Nationale; de l'Enseignement superieur et de la Recherche; Agence Nationale de la Recherche(French National Research Agency (ANR))	This research was funded by the CNRS, the French Ministere de l'Education Nationale, de l'Enseignement superieur et de la Recherche, and the Agence Nationale de la Recherche (EndoSymbArt ANR-06-BLAN-0316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzocchi C, 2007, PARASITE IMMUNOL, V29, P73, DOI 10.1111/j.1365-3024.2006.00915.x; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; Cordaux R, 2004, HEREDITY, V93, P78, DOI 10.1038/sj.hdy.6800482; De Barro PJ, 2001, ENTOMOL EXP APPL, V99, P225, DOI 10.1046/j.1570-7458.2001.00821.x; Dean MD, 2006, P ROY SOC B-BIOL SCI, V273, P1415, DOI 10.1098/rspb.2005.3453; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Dobson SL, 2002, GENETICS, V160, P1087; Dong P, 2007, J ECON ENTOMOL, V100, P1476, DOI 10.1603/0022-0493(2007)100[1476:IOWIOT]2.0.CO;2; Fleury F, 2000, PARASITOLOGY, V121, P493, DOI 10.1017/S0031182099006599; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; Herbiniere J, 2005, DEV COMP IMMUNOL, V29, P489, DOI 10.1016/j.dci.2004.11.001; Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768; HOFFMANN AA, 1988, GENETICS, V119, P435; HOFFMANN AA, 1990, GENETICS, V126, P933; Huigens ME, 2004, ENTOMOL EXP APPL, V110, P115, DOI 10.1111/j.0013-8703.2004.00126.x; Jiggins FM, 2002, MOL BIOL EVOL, V19, P1341, DOI 10.1093/oxfordjournals.molbev.a004195; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; JUCHAULT P, 1974, Annales d'Embryologie et de Morphogenese, V7, P265; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Pannebakker BA, 2007, P NATL ACAD SCI USA, V104, P213, DOI 10.1073/pnas.0607845104; Rigaud T, 2004, P ROY SOC B-BIOL SCI, V271, P1941, DOI 10.1098/rspb.2004.2804; RIGAUD T, 1991, ENDOCYTOBIOSIS CELL, V7, P259; Rigaud T, 1999, GENETICS, V152, P1669; Siozios S, 2008, INSECT SCI, V15, P89, DOI 10.1111/j.1744-7917.2008.00189.x; Snook RR, 2000, GENETICS, V155, P167; Tagami Y, 2001, J INVERTEBR PATHOL, V78, P267, DOI 10.1006/jipa.2002.5080; Verne S, 2007, GENE, V397, P58, DOI 10.1016/j.gene.2007.04.006; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	37	62	63	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3286	10.1371/journal.pone.0003286	http://dx.doi.org/10.1371/journal.pone.0003286			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818770	Green Submitted, Green Published, gold			2022-12-27	WOS:000264432300008
J	Farrell, J; Ramos, L; Tresguerres, M; Kamenetsky, M; Levin, LR; Buck, J				Farrell, Jeanne; Ramos, Lavoisier; Tresguerres, Martin; Kamenetsky, Margarita; Levin, Lonny R.; Buck, Jochen			Somatic 'Soluble' Adenylyl Cyclase Isoforms Are Unaffected in Sacy(tm1Lex)/Sacy(tm1Lex) 'Knockout' Mice	PLOS ONE			English	Article								Background: Mammalian Soluble adenylyl cyclase (sAC, Adcy10, or Sacy) represents a source of the second messenger cAMP distinct from the widely studied, G protein-regulated transmembrane adenylyl cyclases. Genetic deletion of the second through fourth coding exons in Sacy(tm1Lex)/Sacy(tm1Lex) knockout mice results in a male sterile phenotype. The absence of any major somatic phenotype is inconsistent with the variety of somatic functions identified for sAC using pharmacological inhibitors and RNA interference. Principal Findings: We now use immunological and molecular biological methods to demonstrate that somatic tissues express a previously unknown isoform of sAC, which utilizes a unique start site, and which 'escapes' the design of the Sacy(tm1Lex) knockout allele. Conclusions/Significance: These studies reveal increased complexity at the sAC locus, and they suggest that the known isoforms of sAC play a unique function in male germ cells.	[Farrell, Jeanne; Ramos, Lavoisier; Tresguerres, Martin; Kamenetsky, Margarita; Levin, Lonny R.; Buck, Jochen] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Cornell University	Farrell, J (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA.	llevin@med.cornell.edu	Tresguerres, Martin/J-8628-2012	Tresguerres, Martin/0000-0002-7090-9266; Levin, Lonny/0000-0002-5204-6356	National Institutes of Health [NS55255, GM62328]; American Diabetes Association; Hirschl Weil-Caulier Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Hirschl Weil-Caulier Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health [NS55255 (LRL) and GM62328 (JB)], American Diabetes Association, and the Hirschl Weil-Caulier Trust (LRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAUN T, 1990, P SOC EXP BIOL MED, V194, P58; BRAUN T, 1975, P NATL ACAD SCI USA, V72, P1097, DOI 10.1073/pnas.72.3.1097; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Buck J, 2002, METHOD ENZYMOL, V345, P95; Cann MJ, 2003, J BIOL CHEM, V278, P35033, DOI 10.1074/jbc.M303025200; Chaloupka JA, 2006, MOL REPROD DEV, V73, P361, DOI 10.1002/mrd.20409; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; FARRELL J, 2007, THESIS W CORNELL MED; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; HAN H, 2005, J EXP MED; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; Johnson LR, 1998, ESSENTIAL MED PHYSL; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Kobayashi M, 2004, DEV GENES EVOL, V214, P503, DOI 10.1007/s00427-004-0432-2; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Mogensen EG, 2006, EUKARYOT CELL, V5, P103, DOI 10.1128/EC.5.1.103-111.2006; Moore SW, 2008, J NEUROSCI, V28, P3920, DOI 10.1523/JNEUROSCI.0547-08.2008; NEER EJ, 1978, J BIOL CHEM, V253, P5808; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; PAUNESCU TG, 2007, AM J PHYSL IN PRESS; Pitts RF, 1974, PHYSL KIDNEY BODY FL, V3rd; Putnam RW, 2004, AM J PHYSIOL-CELL PH, V287, pC1493, DOI 10.1152/ajpcell.00282.2004; Reed BY, 2002, J CLIN ENDOCR METAB, V87, P1476, DOI 10.1210/jc.87.4.1476; Schmid A, 2007, J GEN PHYSIOL, V130, P99, DOI 10.1085/jgp.200709784; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; STEEGBORN C, 2005, J BIOL CHEM; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Summers BA, 2002, J NEUROPHYSIOL, V88, P604, DOI 10.1152/jn.2002.88.2.604; Sun XC, 2003, AM J PHYSIOL-CELL PH, V284, pC1114, DOI 10.1152/ajpcell.00400.2002; Wang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1145, DOI 10.1152/ajpcell.00627.2004; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Xie F, 2004, DEV BIOL, V265, P196, DOI 10.1016/j.ydbio.2003.09.020; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Young JJ, 2008, J NEUROSCI RES, V86, P118, DOI 10.1002/jnr.21458; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	43	47	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3251	10.1371/journal.pone.0003251	http://dx.doi.org/10.1371/journal.pone.0003251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LY	18806876	Green Submitted, gold, Green Published			2022-12-27	WOS:000264430800003
J	Wang, YP; Hong, J; Liu, XH; Yang, HL; Liu, R; Wu, J; Wang, AL; Lin, DH; Lai, R				Wang, Yipeng; Hong, Jing; Liu, Xiuhong; Yang, Hailong; Liu, Rui; Wu, Jing; Wang, Aili; Lin, Donghai; Lai, Ren			Snake Cathelicidin from Bungarus fasciatus Is a Potent Peptide Antibiotics	PLOS ONE			English	Article							CYSTEINE PROTEINASE-INHIBITOR; ANTIMICROBIAL PEPTIDES; RAINBOW-TROUT; ANTIBACTERIAL; FAMILY; IDENTIFICATION; BACTENECINS; PURIFICATION; EXPRESSION; DEFENSINS	Background: Cathelicidins are a family of antimicrobial peptides acting as multifunctional effector molecules of innate immunity, which are firstly found in mammalians. Recently, several cathelicidins have also been found from chickens and fishes. No cathelicidins from other non-mammalian vertebrates have been reported. Principal Findings: In this work, a cathelicidin-like antimicrobial peptide named cathelicidin-BF has been purified from the snake venoms of Bungarus fasciatus and its cDNA sequence was cloned from the cDNA library, which confirm the presence of cathelicidin in reptiles. As other cathelicidins, the precursor of cathelicidin-BF has cathelin-like domain at the N terminus and carry the mature cathelicidin-BF at the C terminus, but it has an atypical acidic fragment insertion between the cathelin-like domain and the C-terminus. The acidic fragment is similar to acidic domains of amphibian antimicrobial precursors. Phylogenetic analysis revealed that the snake cathelicidin had the nearest evolution relationship with platypus cathelicidin. The secondary structure of cathelicidin-BF investigated by CD and NMR spectroscopy in the presence of the helicogenic solvent TFE is an amphipathic alpha-helical conformation as many other cathelicidins. The antimicrobial activities of cathelicidin BF against forty strains of microorganisms were tested. Cathelicidin-BF efficiently killed bacteria and some fungal species including clinically isolated drug-resistance microorganisms. It was especially active against Gram-negative bacteria. Furthermore, it could exert antimicrobial activity against some saprophytic fungus. No hemolytic and cytotoxic activity was observed at the dose of up to 400 mg/ml. Cathelicidin-BF could exist stably in the mice plasma for at least 2.5 hours. Conclusion: Discovery of snake cathelicidin with atypical structural and functional characterization offers new insights on the evolution of cathelicidins. Potent, broad spectrum, salt-independent antimicrobial activities make cathelicidin-BF an excellent candidate for clinical or agricultural antibiotics.	[Wang, Yipeng; Yang, Hailong; Wu, Jing; Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Biotoxin Units, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Hong, Jing; Lin, Donghai] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China; [Liu, Xiuhong; Liu, Rui; Wang, Aili; Lai, Ren] Nanjing Agr Univ, Life Sci Coll, Minist Agr, Key Lab Microbiol Engn Agr Environm, Nanjing, Peoples R China; [Wang, Yipeng; Hong, Jing; Yang, Hailong; Wu, Jing] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, YP (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Biotoxin Units, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	dhlin@mail.shcnc.ac.cn; rlai@mail.kiz.ac.cn	yang, hailong/GXH-9625-2022; Wang, Yipeng/AAA-1499-2020	Wang, Yipeng/0000-0003-1385-4470	Ministry of Science and Technology of the People's Republic of China [2007AA02Z192, 2007AA100602]; Chinese Academy of Sciences [KSCX2-YW-G-024, KSCX2-YW-R-20]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants of 2007AA02Z192 and 2007AA100602 from the Ministry of Science and Technology of the People's Republic of China, and KSCX2-YW-G-024 and KSCX2-YW-R-20 from Chinese Academy of Sciences.	Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Bals R, 2001, CLIN DIAGN LAB IMMUN, V8, P370, DOI 10.1128/CDLI.8.2.370-375.2001; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chang CI, 2006, ANTIMICROB AGENTS CH, V50, P185, DOI 10.1128/AAC.50.1.185-195.2006; Chang CI, 2005, INFECT IMMUN, V73, P5053, DOI 10.1128/IAI.73.8.5053-5064.2005; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; Chattopadhyay S, 2006, PROTEINS, V64, P524, DOI 10.1002/prot.20963; Conlon JM, 2004, BBA-PROTEINS PROTEOM, V1696, P1, DOI 10.1016/j.bbapap.2003.09.004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; FRANK RW, 1990, J BIOL CHEM, V265, P18871; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; Ganz T, 2006, CURR TOP MICROBIOL, V306, P183; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; GENNARO R, 1989, INFECT IMMUN, V57, P3142, DOI 10.1128/IAI.57.10.3142-3146.1989; Goddard T. D., SPARKY 3; Goitsuka R, 2007, P NATL ACAD SCI USA, V104, P15063, DOI 10.1073/pnas.0707037104; Hong YH, 2003, J BIOCHEM, V134, P427, DOI 10.1093/jb/mvg160; Kavanagh K, 2004, J PHARM PHARMACOL, V56, P285, DOI 10.1211/0022357022971; Lakshminarayanan R, 2008, J AM CHEM SOC, V130, P4660, DOI 10.1021/ja075659k; Landon C, 2006, BIOPOLYMERS, V81, P92, DOI 10.1002/bip.20370; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Li JX, 2007, FASEB J, V21, P2466, DOI 10.1096/fj.06-7966com; Li JX, 2007, MOL CELL PROTEOMICS, V6, P882, DOI 10.1074/mcp.M600334-MCP200; Lu J, 2008, PEPTIDES, V29, P369, DOI 10.1016/j.peptides.2007.11.013; Lu Y, 2008, MOL IMMUNOL, V45, P678, DOI 10.1016/j.molimm.2007.07.004; Murakami M, 2004, J IMMUNOL, V172, P3070, DOI 10.4049/jimmunol.172.5.3070; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Nagaoka I, 1997, J BIOL CHEM, V272, P22742, DOI 10.1074/jbc.272.36.22742; Nair DG, 2007, BIOCHEM J, V402, P93, DOI 10.1042/BJ20060318; Panyutich A, 1997, INFECT IMMUN, V65, P978, DOI 10.1128/IAI.65.3.978-985.1997; RAISON RL, 1998, HAGFISH IMMUNE SYSTE, P334; RITONJA A, 1989, FEBS LETT, V255, P211, DOI 10.1016/0014-5793(89)81093-2; Santamaria C, 2005, TOXICON, V45, P807, DOI 10.1016/j.toxicon.2004.09.012; Santamaria C, 2005, ANTIMICROB AGENTS CH, V49, P1340, DOI [10.1128/AAC.49.4.1340-1345.2005, 10.1128/AAc.49.4.1340-1345.2005]; SCOCCHI M, 1992, EUR J BIOCHEM, V209, P589, DOI 10.1111/j.1432-1033.1992.tb17324.x; Sorensen OE, 2003, J BIOL CHEM, V278, P28540, DOI 10.1074/jbc.M301608200; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; STILES BG, 1991, TOXICON, V29, P1129, DOI 10.1016/0041-0101(91)90210-I; Termen S, 2003, CELL MOL LIFE SCI, V60, P536, DOI 10.1007/s000180300045; Uzzell T, 2003, PEPTIDES, V24, P1655, DOI 10.1016/j.peptides.2003.08.024; Wang X, 2007, PEPTIDES, V28, P2069, DOI 10.1016/j.peptides.2007.07.020; Whittington CM, 2008, GENOME RES, V18, P986, DOI 10.1101/gr.7149808; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Xu CH, 2007, PEPTIDES, V28, P969, DOI 10.1016/j.peptides.2007.02.008; Zaiou M, 2002, J MOL MED, V80, P549, DOI 10.1007/s00109-002-0350-6; ZANETTI M, 1990, J CELL BIOL, V111, P1363, DOI 10.1083/jcb.111.4.1363; ZANETTI M, 1993, J BIOL CHEM, V268, P522; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao CQ, 2001, ANTIMICROB AGENTS CH, V45, P2695, DOI 10.1128/AAC.45.10.2695-2702.2001	53	164	180	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3217	10.1371/journal.pone.0003217	http://dx.doi.org/10.1371/journal.pone.0003217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795096	Green Published, gold, Green Submitted			2022-12-27	WOS:000264428000001
J	Ferrante, P; Catalanotti, C; Bonente, G; Giuliano, G				Ferrante, Paola; Catalanotti, Claudia; Bonente, Giulia; Giuliano, Giovanni			An Optimized, Chemically Regulated Gene Expression System for Chlamydomonas	PLOS ONE			English	Article								Background: Chlamydomonas reinhardtii is a model system for algal and cell biology and is used for biotechnological applications, such as molecular farming or biological hydrogen production. The Chlamydomonas metal-responsive CYC6 promoter is repressed by copper and induced by nickel ions. However, induction by nickel is weak in some strains, poorly reversible by chelating agents like EDTA, and causes, at high concentrations, toxicity side effects on Chlamydomonas growth. Removal of these bottlenecks will encourage the wide use of this promoter as a chemically regulated gene expression system. Methodology: Using a codon-optimized Renilla luciferase as a reporter gene, we explored several strategies to improve the strength and reversibility of CYC6 promoter induction. Use of the first intron of the RBCS2 gene or of a modified TAP medium increases the strength of CYC6 induction up to 20-fold. In the modified medium, induction is also obtained after addition of specific copper chelators, like TETA. At low concentrations (up to 10 mu M) TETA is a more efficient inducer than Ni, which becomes a very efficient inducer at higher concentrations (50 mM). Neither TETA nor Ni show toxicity effects at the concentrations used. Unlike induction by Ni, induction by TETA is completely reversible by micromolar copper concentrations, thus resulting in a transient "wave'' in luciferase activity, which can be repeated in subsequent growth cycles. Conclusions: We have worked out a chemically regulated gene expression system that can be finely tuned to produce temporally controlled "waves'' in gene expression. The use of cassettes containing the CYC6 promoter, and of modified growth media, is a reliable and economically sustainable system for the temporally controlled expression of foreign genes in Chlamydomonas.	[Ferrante, Paola; Catalanotti, Claudia; Giuliano, Giovanni] Energy & Environm ENEA, Italian Natl Agcy New Technol, Casaccia Res Ctr, Rome, Italy; [Bonente, Giulia] Univ Verona, Dipartimento Sci Tecnol, I-37100 Verona, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; University of Verona	Ferrante, P (corresponding author), Energy & Environm ENEA, Italian Natl Agcy New Technol, Casaccia Res Ctr, Rome, Italy.	giuliano@casaccia.enea.it	Giuliano, Giovanni/A-2701-2012	Giuliano, Giovanni/0000-0002-2486-0510; Ferrante, Paola/0000-0003-3071-2212	Italian Ministry of Research, Special Fund for Strategic Research (FISR), Idrobio Project	Italian Ministry of Research, Special Fund for Strategic Research (FISR), Idrobio Project	Work supported by the Italian Ministry of Research, Special Fund for Strategic Research (FISR), Idrobio Project.	Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; BARDSLEY WG, 1974, BIOCHEM J, V137, P61, DOI 10.1042/bj1370061; Bohner S, 2001, MOL GEN GENET, V264, P860, DOI 10.1007/s004380000376; Boswell CA, 2004, J MED CHEM, V47, P1465, DOI 10.1021/jm030383m; COHEN NL, 1983, BIOCHEM BIOPH RES CO, V113, P127, DOI 10.1016/0006-291X(83)90441-2; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; Franklin SE, 2004, CURR OPIN PLANT BIOL, V7, P159, DOI 10.1016/j.pbi.2004.01.012; Fuhrmann M, 2004, PLANT MOL BIOL, V55, P869, DOI 10.1007/s11103-004-2150-6; Fuhrmann M, 1999, PLANT J, V19, P353, DOI 10.1046/j.1365-313X.1999.00526.x; Hanikenne M, 2005, PLANT PHYSIOL, V137, P428, DOI 10.1104/pp.104.054189; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HUTNER S. H., 1950, PROC AMER PHIL SOC, V94, P152; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; LI YB, 1993, ARCH BIOCHEM BIOPHYS, V300, P346, DOI 10.1006/abbi.1993.1047; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; Ma DS, 2002, NUCL MED BIOL, V29, P91, DOI 10.1016/S0969-8051(01)00287-6; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; Melis A, 2007, PLANTA, V226, P1075, DOI 10.1007/s00425-007-0609-9; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Ohresser M, 1997, CURR GENET, V31, P264, DOI 10.1007/s002940050204; Padidam M, 2003, CURR OPIN PLANT BIOL, V6, P169, DOI 10.1016/S1369-5266(03)00005-0; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; Quinn JM, 2003, EUKARYOT CELL, V2, P995, DOI 10.1128/EC.2.5.995-1002.2003; Quinn JM, 2002, PLANT PHYSIOL, V128, P463, DOI 10.1104/pp.010694; QUINN JM, 1995, PLANT CELL, V7, P623, DOI 10.1105/tpc.7.5.623; SANCHEZ DJ, 1994, RES COMMUN CHEM PATH, V83, P329; Schroda M, 2006, CURR GENET, V49, P69, DOI 10.1007/s00294-005-0042-1; Schroda M, 2000, PLANT J, V21, P121, DOI 10.1046/j.1365-313x.2000.00652.x; Sprengel R, 2007, Handb Exp Pharmacol, P49; Stevens DR, 1996, MOL GEN GENET, V251, P23; Surzycki R, 2007, P NATL ACAD SCI USA, V104, P17548, DOI 10.1073/pnas.0704205104; UEMASU I, 1982, ANAL CHEM, V54, P835, DOI 10.1021/ac00241a061; Villand P, 1997, BIOCHEM J, V327, P51, DOI 10.1042/bj3270051	36	35	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3200	10.1371/journal.pone.0003200	http://dx.doi.org/10.1371/journal.pone.0003200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787710	Green Submitted, Green Published, gold			2022-12-27	WOS:000264426200005
J	Bradshaw, CS; Chen, MY; Fairley, CK				Bradshaw, Catriona S.; Chen, Marcus Y.; Fairley, Christopher K.			Persistence of Mycoplasma genitalium Following Azithromycin Therapy	PLOS ONE			English	Article							IN-VITRO; URETHRITIS; URINE; AGENT	Background: To determine clinical outcomes and cure rates for M. genitalium genital infection in men and women following azithromycin 1 g. Methodology: Patients attending Melbourne Sexual Health Centre between March 2005 and November 2007 with urethritis/epididymitis, cervicitis/pelvic inflammatory disease and sexual contacts of M. genitalium were tested for M. genitalium by polymerase chain reaction (PCR). M. genitalium-infection was treated with 1 g of azithromycin and a test-of-cure (toc) was performed one month post-azithromycin. Response to azithromycin, and response to moxifloxacin (400 mg daily for 10 days) in individuals with persistent infection post-azithromycin, was determined. Principal Findings: Of 1538 males and 313 females tested, 161 males (11%) and 30 females (10%) were infected with M. genitalium. A toc was available on 131 (69%) infected individuals (median = 36 days [range 12-373]). Of 120 individuals prescribed azithromycin only pre-toc, M. genitalium was eradicated in 101 (84%, 95% confidence intervals [CI]: 77-90%) and persisted in 19 (16%, 95% CI: 10-23%). Eleven individuals with persistent infection (9%, 95% CI: 5-15%) had no risk of reinfection from untreated-partners, while eight (7%, 95% CI: 3-12%) may have been at risk of reinfection from doxycycline-treated or untreated-partners. Moxifloxacin was effective in eradicating persistent infection in all cases not responding to azithromycin. Patients with persistent-M. genitalium were more likely to experience persistent symptoms (91%), compared to patients in whom M. genitalium was eradicated (17%), p<0.0001. Conclusion: Use of azithromycin 1 g in M. genitalium-infected patients was associated with unacceptable rates of persistent infection, which was eradicated with moxifloxacin. These findings highlight the importance of follow-up in M. genitalium-infected patients prescribed azithromycin, and the need to monitor for the development of resistance. Research to determine optimal first and second-line therapeutic agents for M. genitalium is needed.	[Bradshaw, Catriona S.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Bradshaw, Catriona S.; Chen, Marcus Y.; Fairley, Christopher K.] Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Bradshaw, Catriona S.; Chen, Marcus Y.; Fairley, Christopher K.] Univ Melbourne, Sch Populat Hlth, Parkville, Vic 3052, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Bradshaw, CS (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	cbradshaw@mshc.org.au		bradshaw, catriona/0000-0002-6643-5678; Christopher, Fairley/0000-0001-9081-1664	National Medical and Research Council Research Fellowship [465164]	National Medical and Research Council Research Fellowship	CSB holds a National Medical and Research Council Research Fellowship, Grant ID 465164.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bjornelius E, 2007, SEX TRANSM INFECT, V84, P72, DOI [10.1136/ti.2007.027375, 10.1136/sti.2007.027375]; Bradshaw CS, 2006, EMERG INFECT DIS, V12, P1149, DOI 10.3201/eid1207.051558; CABRAL SLI, 2005, HETEROGENEITY MGPB G; Clausen HF, 2001, HUM REPROD, V16, P1866, DOI 10.1093/humrep/16.9.1866; Cohen CR, 2005, SEX TRANSM INFECT, V81, P463, DOI 10.1136/sti.2005.015701; Falk L, 2003, SEX TRANSM INFECT, V79, P318, DOI 10.1136/sti.79.4.318; Gaydos CA, 1998, J INFECT DIS, V177, P417, DOI 10.1086/514207; Haggerty CL, 2008, CURR OPIN INFECT DIS, V21, P65, DOI 10.1097/QCO.0b013e3282f3d9ac; HAGGERTY CL, 2006, INFECT DIS OBSTET GY, DOI DOI 10.1155/ID0G/2006/30184; Hamasuna R, 2005, ANTIMICROB AGENTS CH, V49, P4993, DOI 10.1128/AAC.49.12.4993-4998.2005; Hannan PCT, 1998, J MED MICROBIOL, V47, P1115, DOI 10.1099/00222615-47-12-1115; Hjorth SV, 2006, J CLIN MICROBIOL, V44, P2078, DOI 10.1128/JCM.00003-06; Iverson-Cabral SL, 2006, INFECT IMMUN, V74, P3715, DOI 10.1128/IAI.00239-06; Jensen JS, 2004, J EUR ACAD DERMATOL, V18, P1, DOI 10.1111/j.1468-3083.2004.00923.x; Johannisson G, 2000, INT J STD AIDS, V11, P324, DOI 10.1258/0956462001915958; Ma L, 2007, MOL MICROBIOL, V66, P220, DOI 10.1111/j.1365-2958.2007.05911.x; Maeda S, 2001, SEX TRANSM DIS, V28, P472, DOI 10.1097/00007435-200108000-00010; MROCZKOWSKI TF, 2005, RANDOMIZED COMP AZIT, P304; SVENSTRUP HF, 2007, FERTIL STERIL; Yasuda M, 2005, CLIN INFECT DIS, V41, P1357, DOI 10.1086/496983; Yoshida T, 2002, J CLIN MICROBIOL, V40, P1451, DOI 10.1128/JCM.40.4.1451-1455.2002	22	84	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3618	10.1371/journal.pone.0003618	http://dx.doi.org/10.1371/journal.pone.0003618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978939	gold, Green Published			2022-12-27	WOS:000265134200006
J	Saidi, H; Melki, MT; Gougeon, ML				Saidi, Hela; Melki, Marie-Therese; Gougeon, Marie-Lise			HMGB1-Dependent Triggering of HIV-1 Replication and Persistence in Dendritic Cells as a Consequence of NK-DC Cross-Talk	PLOS ONE			English	Article								Background: HIV-1 has evolved ways to exploit DCs, thereby facilitating viral dissemination and allowing evasion of antiviral immunity. Recently, the fate of DCs has been found to be extremely dependent on the interaction with autologous NK cells, but the mechanisms by which NK-DC interaction controls viral infections remain unclear. Here, we investigate the impact of NK-DC cross-talk on maturation and functions of HIV-infected immature DCs. Methodology/Principal Findings: Immature DCs were derived from primary monocytes, cultured in the presence of IL-4 and GM-CSF. In some experiments, DCs were infected with R5-HIV-1(BaL) or X4-HIV-1(NDK), and viral replication, proviral HIV-DNA and the frequency of infected DCs were measured. Autologous NK cells were sorted and either kept unstimulated in the presence of suboptimal concentration of IL-2, or activated by a combination of PHA and IL-2. The impact of 24 h NK-DC cross-talk on the fate of HIV-1-infected DCs was analyzed. We report that activated NK cells were required for the induction of maturation of DCs, whether uninfected or HIV-1-infected, and this process involved HMGB1. However, the cross-talk between HIV-1-infected DCs and activated NK cells was functionally defective, as demonstrated by the strong impairment of DCs to induce Th1 polarization of naive CD4 T cells. This was associated with the defective production of IL-12 and IL-18 by infected DCs. Moreover, the crosstalk between activated NK cells and HIV-infected DCs resulted in a dramatic increase in viral replication and proviral DNA expression in DCs. HMGB1, produced both by NK cells and DCs, was found to play a pivotal role in this process, and inhibition of HMGB1 activity by glycyrrhizin, known to bind specifically to HMGB1, or blocking anti-HMGB1 antibodies, abrogated NK-dependent HIV-1 replication in DCs. Conclusion: These observations provide evidence for the crucial role of NK-DC cross-talk in promoting viral dissemination, and challenge the question of the in vivo involvement of HMGB1 in the triggering of HIV-1 replication and replenishment of viral reservoirs in AIDS.	[Saidi, Hela; Melki, Marie-Therese; Gougeon, Marie-Lise] Inst Pasteur, INSERM, Antiviral Immun Biotherapy & Vaccine Unit, U668, F-75724 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Saidi, H (corresponding author), Inst Pasteur, INSERM, Antiviral Immun Biotherapy & Vaccine Unit, U668, F-75724 Paris, France.	mlgougeo@pasteur.fr	Saïdi, Héla/P-2519-2014		Institut Pasteur; Sidaction [postdoctoral fellowship]; Ministere de la Recherche	Institut Pasteur(European Commission); Sidaction; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This research was supported by Institutional grant from Institut Pasteur. HS was supported by a postdoctoral fellowship from Sidaction, and MTM by a PhD grant from the Ministere de la Recherche.	AGAUGUE S, 2008, BLOOD; Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Borg C, 2004, BLOOD, V104, P3267, DOI 10.1182/blood-2004-01-0380; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; Canque B, 1999, BLOOD, V93, P3866, DOI 10.1182/blood.V93.11.3866.411k43_3866_3875; Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO;2-F; Chiesa MD, 2003, EUR J IMMUNOL, V33, P1657, DOI 10.1002/eji.200323986; Clynes R, 2007, CURR MOL MED, V7, P743; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Dumitriu IE, 2007, J LEUKOCYTE BIOL, V81, P84, DOI 10.1189/jlb.0306171; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Gurney KB, 2005, J VIROL, V79, P5762, DOI 10.1128/JVI.79.9.5762-5773.2005; Kiertscher SM, 1996, J LEUKOCYTE BIOL, V59, P208, DOI 10.1002/jlb.59.2.208; Kottilil S, 2006, J IMMUNOL, V176, P1107, DOI 10.4049/jimmunol.176.2.1107; Lecoeur H, 2008, METHOD ENZYMOL, V442, P51, DOI 10.1016/S0076-6879(08)01403-1; Ledru E, 2003, BLOOD, V101, P3102, DOI 10.1182/blood-2002-08-2499; Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mailliard RB, 2003, J IMMUNOL, V171, P2366, DOI 10.4049/jimmunol.171.5.2366; Manfredi AA, 2008, J IMMUNOL, V180, P2270, DOI 10.4049/jimmunol.180.4.2270; Marcenaro E, 2005, J IMMUNOL, V174, P3992, DOI 10.4049/jimmunol.174.7.3992; Mavilio D, 2006, J EXP MED, V203, P2339, DOI 10.1084/jem.20060894; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Moser B, 2006, ARTHRITIS RHEUM-US, V54, P14, DOI 10.1002/art.21522; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; Nowak P, 2006, CYTOKINE, V34, P17, DOI 10.1016/j.cyto.2006.03.010; Nowak P, 2007, AIDS, V21, P869, DOI 10.1097/QAD.0b013e3280b079b6; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Piguet V, 2004, J CLIN INVEST, V114, P605, DOI 10.1172/JCI200422812; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Saidi Hela, 2008, AIDS Res Ther, V5, P10, DOI 10.1186/1742-6405-5-10; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Smed-Sorensen A, 2004, BLOOD, V104, P2810, DOI 10.1182/blood-2003-07-2314; Stros M, 2002, J BIOL CHEM, V277, P7157, DOI 10.1074/jbc.M110233200; Thierry S, 2007, AIDS, V21, P283, DOI 10.1097/QAD.0b013e3280115b50; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zeh HJ, 2005, J IMMUNOTHER, V28, P1, DOI 10.1097/00002371-200501000-00001	57	41	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3601	10.1371/journal.pone.0003601	http://dx.doi.org/10.1371/journal.pone.0003601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974890	gold, Green Published, Green Submitted			2022-12-27	WOS:000265131700022
J	Wegmann, D; Dupanloup, I; Excoffier, L				Wegmann, Daniel; Dupanloup, Isabelle; Excoffier, Laurent			Width of Gene Expression Profile Drives Alternative Splicing	PLOS ONE			English	Article							SELECTION PRESSURE; EXON CREATION; GENOME; EVOLUTION; DATABASE; EVENTS; MOUSE; DIVERSITY; MODEL; ASD	Alternative splicing generates an enormous amount of functional and proteomic diversity in metazoan organisms. This process is probably central to the macromolecular and cellular complexity of higher eukaryotes. While most studies have focused on the molecular mechanism triggering and controlling alternative splicing, as well as on its incidence in different species, its maintenance and evolution within populations has been little investigated. Here, we propose to address these questions by comparing the structural characteristics as well as the functional and transcriptional profiles of genes with monomorphic or polymorphic splicing, referred to as MS and PS genes, respectively. We find that MS and PS genes differ particularly in the number of tissues and cell types where they are expressed. We find a striking deficit of PS genes on the sex chromosomes, particularly on the Y chromosome where it is shown not to be due to the observed lower breadth of expression of genes on that chromosome. The development of a simple model of evolution of cis-regulated alternative splicing leads to predictions in agreement with these observations. It further predicts the conditions for the emergence and the maintenance of cis-regulated alternative splicing, which are both favored by the tissue specific expression of splicing variants. We finally propose that the width of the gene expression profile is an essential factor for the acquisition of new transcript isoforms that could later be maintained by a new form of balancing selection.	[Wegmann, Daniel; Dupanloup, Isabelle; Excoffier, Laurent] Univ Bern, Inst Ecol & Evolut, Computat & Mol Populat Genet Lab, Bern, Switzerland	University of Bern	Wegmann, D (corresponding author), Univ Bern, Inst Ecol & Evolut, Computat & Mol Populat Genet Lab, Bern, Switzerland.	laurent.excoffier@zoo.unibe.ch	Dupanloup, Isabelle/O-8609-2017; Excoffier, Laurent/D-3498-2013; Dupanloup, Isabelle/AAD-5372-2020; Wegmann, Daniel/K-2199-2012	Dupanloup, Isabelle/0000-0002-9258-6963; Excoffier, Laurent/0000-0002-7507-6494; Wegmann, Daniel/0000-0003-2866-6739	University of Bern; Swiss NSF [3100-112072]	University of Bern; Swiss NSF(Swiss National Science Foundation (SNSF))	This work was supported by the University of Bern and by a Swiss NSF grant No. 3100-112072 to LE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko AV, 2007, RNA, V13, P661, DOI 10.1261/rna.325107; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cusack BP, 2005, MOL BIOL EVOL, V22, P2198, DOI 10.1093/molbev/msi218; Ermakova EO, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-84; Ewens W.J., 2004, MATH POPULATION GENE, DOI [DOI 10.1007/978-0-387-21822-9, 10.1007/978-0-387-21822-9]; Gavrilets S, 2006, J THEOR BIOL, V239, P172, DOI 10.1016/j.jtbi.2005.08.041; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Holste D, 2006, NUCLEIC ACIDS RES, V34, pD56, DOI 10.1093/nar/gkj048; Hubbard T, 2005, NUCLEIC ACIDS RES, V33, pD447, DOI 10.1093/nar/gki138; Izquierdo JM, 2006, GENE DEV, V20, P1679, DOI 10.1101/gad.1449106; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Kelso J, 2003, GENOME RES, V13, P1222, DOI 10.1101/gr.985203; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kim N, 2005, GENOME RES, V15, P566, DOI 10.1101/gr.3030405; Kondrashov FA, 2001, HUM MOL GENET, V10, P2661, DOI 10.1093/hmg/10.23.2661; Koren E, 2007, PLOS COMPUT BIOL, V3, P895, DOI 10.1371/journal.pcbi.0030095; Kriventseva EV, 2003, TRENDS GENET, V19, P124, DOI 10.1016/S0168-9525(03)00023-4; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee C, 2003, NUCLEIC ACIDS RES, V31, P101, DOI 10.1093/nar/gkg029; Leipzig J, 2004, NUCLEIC ACIDS RES, V32, P3977, DOI 10.1093/nar/gkh731; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Letunic I, 2002, HUM MOL GENET, V11, P1561, DOI 10.1093/hmg/11.13.1561; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Pan Q, 2005, TRENDS GENET, V21, P73, DOI 10.1016/j.tig.2004.12.004; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Pennisi E, 2005, SCIENCE, V309, P80, DOI 10.1126/science.309.5731.80; ROGOZIN IB, 2005, BRIEFINGS BIOINFORMA, V6; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Sharov AA, 2005, GENOME RES, V15, P748, DOI 10.1101/gr.3269805; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; Sneath RJS, 1998, J CLIN PATHOL-MOL PA, V51, P191, DOI 10.1136/mp.51.4.191; Sorek R, 2004, MOL CELL, V14, P221, DOI 10.1016/S1097-2765(04)00181-9; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Sugnet CW, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P66; Thanaraj TA, 2004, NUCLEIC ACIDS RES, V32, pD64, DOI 10.1093/nar/gkh030; Thanaraj TA, 2003, NUCLEIC ACIDS RES, V31, P2544, DOI 10.1093/nar/gkg355; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Urrutia AO, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r25; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Xing Y, 2005, P NATL ACAD SCI USA, V102, P13526, DOI 10.1073/pnas.0501213102; Xing Y, 2004, TRENDS GENET, V20, P472, DOI 10.1016/j.tig.2004.07.009; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zheng CL, 2005, RNA, V11, P1777, DOI 10.1261/rna.2660805; Zheng CL, 2005, RNA, V11, P1767, DOI 10.1261/rna.2650905	59	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3587	10.1371/journal.pone.0003587	http://dx.doi.org/10.1371/journal.pone.0003587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974852	Green Published, gold			2022-12-27	WOS:000265131700010
J	Rutvisuttinunt, W; Meyer, PR; Scott, WA				Rutvisuttinunt, Wiriya; Meyer, Peter R.; Scott, Walter A.			Interactions between HIV-1 Reverse Transcriptase and the Downstream Template Strand in Stable Complexes with Primer-Template	PLOS ONE			English	Article								Background: Human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) forms stable ternary complexes in which RT is bound tightly at fixed positions on the primer-template (P/T). We have probed downstream interactions between RT and the template strand in the complex containing the incoming dNTP (+1 dNTP.RT.P/T complex) and in the complex containing the pyrophosphate analog, foscarnet (foscarnet.RT.P/T complex). Methods and Results: UV-induced cross-linking between RT and the DNA template strand was most efficient when a bromodeoxyuridine residue was placed in the +2 position (the first template position downstream from the incoming dNTP). Furthermore, formation of the +1 dNT.RT.P/T complex on a biotin-containing template inhibited binding of streptavidin when biotin was in the +2 position on the template but not when the biotin was in the +3 position. Streptavidin pre-bound to a biotin residue in the template caused RT to stall two to three nucleotides upstream from the biotin residue. The downstream border of the complex formed by the stalled RT was mapped by digestion with exonuclease RecJF. UV-induced cross-linking of the complex formed by the pyrophosphate analog, foscarnet, with RT and P/T occurred preferentially with bromodeoxyuridine in the +1 position on the template in keeping with the location of RT one base upstream in the foscarnet.RT.P/T complex (i.e., in the pre-translocation position). Conclusions: For +1 dNTP.RT.P/T and foscarnetNRTNP/T stable complexes, tight interactions were observed between RT and the first unpaired template nucleotide following the bound dNTP or the primer terminus, respectively.	[Rutvisuttinunt, Wiriya; Meyer, Peter R.; Scott, Walter A.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Coral Gables, FL 33124 USA	University of Miami	Rutvisuttinunt, W (corresponding author), Armed Forces Res Inst Med Sci, Dept Immunol & Med, Bangkok 10400, Thailand.	wscott@med.miami.edu			National Institute of Allergy and Infectious Disease [AI-39973]; American Heart Association Predoctoral Fellowship [025082B]; American Foundation for AIDS Research Postdoctoral Fellowship [70567-31-RF]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039973, P30AI073961] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association Predoctoral Fellowship(American Heart Association); American Foundation for AIDS Research Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the National Institute of Allergy and Infectious Disease (AI-39973 to W.A.S.), the American Heart Association Predoctoral Fellowship (025082B to W.R.), and the American Foundation for AIDS Research Postdoctoral Fellowship (70567-31-RF to P.R.M.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian A, 2007, J MOL BIOL, V373, P127, DOI 10.1016/j.jmb.2007.07.044; BOYER PL, 1994, P NATL ACAD SCI USA, V91, P4882, DOI 10.1073/pnas.91.11.4882; Coman MM, 2004, J MOL BIOL, V342, P1457, DOI 10.1016/j.jmb.2004.07.097; Cruchaga C, 2006, J BIOL CHEM, V281, P27744, DOI 10.1074/jbc.M603360200; DAQUILA RT, 1989, J ACQ IMMUN DEF SYND, V2, P579; Dash C, 2006, J BIOL CHEM, V281, P27873, DOI 10.1074/jbc.M603970200; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Fisher TS, 2003, J MOL BIOL, V325, P443, DOI 10.1016/S0022-2836(02)01225-1; Fisher TS, 2002, J BIOL CHEM, V277, P22345, DOI 10.1074/jbc.M200282200; Golinelli MP, 2002, BIOCHEMISTRY-US, V41, P5894, DOI 10.1021/bi0160415; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kovall R, 1997, SCIENCE, V277, P1824, DOI 10.1126/science.277.5333.1824; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; LOWE DM, 1988, BIOCHEMISTRY-US, V27, P8884, DOI 10.1021/bi00425a002; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; METZGER W, 1993, P NATL ACAD SCI USA, V90, P5909, DOI 10.1073/pnas.90.13.5909; Meyer PR, 2007, J MOL BIOL, V369, P41, DOI 10.1016/j.jmb.2007.03.006; Meyer PR, 2004, J BIOL CHEM, V279, P45389, DOI 10.1074/jbc.M405072200; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2003, J VIROL, V77, P6127, DOI 10.1128/JVI.77.11.6127-6137.2003; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; Peletskaya EN, 2004, J VIROL, V78, P3387, DOI 10.1128/JVI.78.7.3387-3397.2004; Peletskaya EN, 2001, J VIROL, V75, P9435, DOI 10.1128/JVI.75.19.9435-9445.2001; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sharma B, 2002, BIOCHEMISTRY-US, V41, P15685, DOI 10.1021/bi026311z; Srivastava A, 2003, BIOCHEMISTRY-US, V42, P3645, DOI 10.1021/bi026699y; TAN CK, 1991, BIOCHEMISTRY-US, V30, P2651, DOI 10.1021/bi00224a013; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Turner RM, 2003, BIOCHEMISTRY-US, V42, P2373, DOI 10.1021/bi026566c; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; Winshell J, 2004, J BIOL CHEM, V279, P52924, DOI 10.1074/jbc.M409134200; Winshell J, 2001, J MOL BIOL, V306, P931, DOI 10.1006/jmbi.2001.4439; WOHRL BM, 1995, BIOCHEMISTRY-US, V34, P5343	39	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3561	10.1371/journal.pone.0003561	http://dx.doi.org/10.1371/journal.pone.0003561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974785	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131500001
J	Hertz-Fowler, C; Figueiredo, LM; Quail, MA; Becker, M; Jackson, A; Bason, N; Brooks, K; Churcher, C; Fahkro, S; Goodhead, I; Heath, P; Kartvelishvili, M; Mungall, K; Harris, D; Hauser, H; Sanders, M; Saunders, D; Seeger, K; Sharp, S; Taylor, JE; Walker, D; White, B; Young, R; Cross, GAM; Rudenko, G; Barry, JD; Louis, EJ; Berriman, M				Hertz-Fowler, Christiane; Figueiredo, Luisa M.; Quail, Michael A.; Becker, Marion; Jackson, Andrew; Bason, Nathalie; Brooks, Karen; Churcher, Carol; Fahkro, Samah; Goodhead, Ian; Heath, Paul; Kartvelishvili, Magdalena; Mungall, Karen; Harris, David; Hauser, Heidi; Sanders, Mandy; Saunders, David; Seeger, Kathy; Sharp, Sarah; Taylor, Jesse E.; Walker, Danielle; White, Brian; Young, Rosanna; Cross, George A. M.; Rudenko, Gloria; Barry, J. David; Louis, Edward J.; Berriman, Matthew			Telomeric Expression Sites Are Highly Conserved in Trypanosoma brucei	PLOS ONE			English	Article							GENE-EXPRESSION; ANTIGENIC VARIATION; MEGABASE CHROMOSOMES; TRANSFERRIN RECEPTOR; MOLECULAR KARYOTYPE; PROTEIN; PROMOTER; SEQUENCE; FAMILY; RECOMBINATION	Subtelomeric regions are often under-represented in genome sequences of eukaryotes. One of the best known examples of the use of telomere proximity for adaptive purposes are the bloodstream expression sites (BESs) of the African trypanosome Trypanosoma brucei. To enhance our understanding of BES structure and function in host adaptation and immune evasion, the BES repertoire from the Lister 427 strain of T. brucei were independently tagged and sequenced. BESs are polymorphic in size and structure but reveal a surprisingly conserved architecture in the context of extensive recombination. Very small BESs do exist and many functioning BESs do not contain the full complement of expression site associated genes (ESAGs). The consequences of duplicated or missing ESAGs, including ESAG9, a newly named ESAG12, and additional variant surface glycoprotein genes (VSGs) were evaluated by functional assays after BESs were tagged with a drug-resistance gene. Phylogenetic analysis of constituent ESAG families suggests that BESs are sequence mosaics and that extensive recombination has shaped the evolution of the BES repertoire. This work opens important perspectives in understanding the molecular mechanisms of antigenic variation, a widely used strategy for immune evasion in pathogens, and telomere biology.	[Hertz-Fowler, Christiane; Quail, Michael A.; Jackson, Andrew; Bason, Nathalie; Brooks, Karen; Churcher, Carol; Fahkro, Samah; Goodhead, Ian; Heath, Paul; Mungall, Karen; Harris, David; Hauser, Heidi; Sanders, Mandy; Saunders, David; Seeger, Kathy; Walker, Danielle; White, Brian; Berriman, Matthew] Wellcome Trust Sanger Inst, Hinxton, England; [Figueiredo, Luisa M.; Kartvelishvili, Magdalena; Cross, George A. M.] Rockefeller Univ, New York, NY USA; [Becker, Marion; Sharp, Sarah; Louis, Edward J.] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham, England; [Taylor, Jesse E.] Univ Oxford, Dept Stat, Oxford OX1 2JD, England; [Young, Rosanna; Rudenko, Gloria] Univ Oxford, Peter Medawar Building Pathogen Res, Oxford OX1 2JD, England; [Barry, J. David] Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G12 8QQ, Lanark, Scotland	Wellcome Trust Sanger Institute; Rockefeller University; University of Nottingham; University of Oxford; University of Oxford; University of Glasgow	Hertz-Fowler, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England.	chf@sanger.ac.uk	Cross, George A M/B-7444-2011; Figueiredo, Luisa Miranda/C-3908-2018; Hall, Neil/A-8717-2013; Goodhead, Ian/ABC-9200-2020; Berriman, Matthew/A-7618-2011; Louis, Edward/B-7920-2008; Quail, michael/ABE-6131-2020	Cross, George A M/0000-0003-1374-6955; Figueiredo, Luisa Miranda/0000-0002-5752-6586; Hall, Neil/0000-0002-7995-3810; Berriman, Matthew/0000-0002-9581-0377; Louis, Edward/0000-0003-1157-3608; Rudenko, Gloria/0000-0003-1884-4933; Young, Rosanna/0000-0002-1062-5691; Goodhead, Ian/0000-0002-3110-9442; Hertz-Fowler, Christiane/0000-0002-0729-6479	The Wellcome Trust; Sanger Institute Pathogen Genomics group; National Institute of Allergy And Infectious Diseases (NIAID) [R01AI021729]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021729] Funding Source: NIH RePORTER	The Wellcome Trust(Wellcome TrustEuropean Commission); Sanger Institute Pathogen Genomics group; National Institute of Allergy And Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Wellcome Trust supports the Sanger Institute Pathogen Genomics group. LMF, MK and GAMC are supported in part by Grant Number R01AI021729 from the National Institute of Allergy And Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitcheson N, 2005, MOL MICROBIOL, V57, P1608, DOI 10.1111/j.1365-2958.2005.04795.x; Ansorge I, 1999, MOL BIOCHEM PARASIT, V101, P81, DOI 10.1016/S0166-6851(99)00060-2; Barnes RL, 2007, NUCLEIC ACIDS RES, V35, P3478, DOI 10.1093/nar/gkm249; Barry JD, 2005, BIOCHEM SOC T, V33, P986, DOI 10.1042/BST20050986; Becker M, 2004, GENOME RES, V14, P2319, DOI 10.1101/gr.2955304; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Berriman M, 2002, MOL BIOCHEM PARASIT, V122, P131, DOI 10.1016/S0166-6851(02)00092-0; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Callejas S, 2006, GENOME RES, V16, P1109, DOI 10.1101/gr.5147406; Carruthers VB, 1996, MOL BIOCHEM PARASIT, V81, P65, DOI 10.1016/0166-6851(96)02672-2; Cross M, 1998, MOL CELL BIOL, V18, P198, DOI 10.1128/MCB.18.1.198; Dreesen O, 2007, NAT REV MICROBIOL, V5, P70, DOI 10.1038/nrmicro1577; Dreesen O, 2006, MOL CELL BIOL, V26, P4911, DOI 10.1128/MCB.00212-06; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; FLORENT IC, 1991, MOL CELL BIOL, V11, P2180, DOI 10.1128/MCB.11.4.2180; GOTTESDIENER KM, 1992, MOL CELL BIOL, V12, P4784, DOI 10.1128/MCB.12.10.4784; GOTTESDIENER KM, 1994, MOL BIOCHEM PARASIT, V63, P143, DOI 10.1016/0166-6851(94)90017-5; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Haber JE, 2006, GENETICS, V173, P1181; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hoek M, 2002, MOL BIOCHEM PARASIT, V120, P269, DOI 10.1016/S0166-6851(02)00009-9; Hoek M, 2000, J CELL SCI, V113, P3959; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Jackson AP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-54; JOHNSON JG, 1979, BIOCHEM J, V178, P689, DOI 10.1042/bj1780689; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; LAMONT GS, 1986, PARASITOLOGY, V92, P355, DOI 10.1017/S003118200006412X; Leech V, 2004, METH MOL B, V270, P335; LIGTENBERG MJL, 1994, EMBO J, V13, P2565, DOI 10.1002/j.1460-2075.1994.tb06546.x; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Melville SE, 1998, MOL BIOCHEM PARASIT, V94, P155, DOI 10.1016/S0166-6851(98)00054-1; Melville SE, 2000, MOL BIOCHEM PARASIT, V111, P261, DOI 10.1016/S0166-6851(00)00316-9; Morgan RW, 1996, J BIOL CHEM, V271, P9771, DOI 10.1074/jbc.271.16.9771; MYLER PJ, 1988, MOL BIOCHEM PARASIT, V29, P227, DOI 10.1016/0166-6851(88)90078-3; Navarro M, 1996, MOL CELL BIOL, V16, P3615; PAINDAVOINE P, 1992, MOL CELL BIOL, V12, P1218, DOI 10.1128/MCB.12.3.1218; Pays E, 2005, TRENDS PARASITOL, V21, P517, DOI 10.1016/j.pt.2005.08.016; PAYS E, 1983, CELL, V35, P721, DOI 10.1016/0092-8674(83)90105-8; Pays E, 2001, MOL BIOCHEM PARASIT, V114, P1, DOI 10.1016/S0166-6851(01)00242-0; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Redpath MB, 2000, MOL BIOCHEM PARASIT, V111, P223, DOI 10.1016/S0166-6851(00)00305-4; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rudenko G, 1998, MOL BIOCHEM PARASIT, V95, P97, DOI 10.1016/S0166-6851(98)00099-1; RUDENKO G, 1995, CELL, V83, P547, DOI 10.1016/0092-8674(95)90094-2; Rudenko G, 1996, MOL BIOCHEM PARASIT, V80, P65, DOI 10.1016/0166-6851(96)02669-2; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salmon D, 1997, EMBO J, V16, P7272, DOI 10.1093/emboj/16.24.7272; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Sheader K, 2005, P NATL ACAD SCI USA, V102, P8716, DOI 10.1073/pnas.0501886102; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Luenen HGAM, 2005, MOL MICROBIOL, V58, P151, DOI 10.1111/j.1365-2958.2005.04831.x; Vanhamme L, 2000, MOL MICROBIOL, V36, P328, DOI 10.1046/j.1365-2958.2000.01844.x; WIRTZ E, 1994, NUCLEIC ACIDS RES, V22, P3887, DOI 10.1093/nar/22.19.3887; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	58	191	192	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3527	10.1371/journal.pone.0003527	http://dx.doi.org/10.1371/journal.pone.0003527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953401	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000265130500005
J	Fan, J; Guise, KG; Liu, X; Wang, HB				Fan, Jin; Guise, Kevin G.; Liu, Xun; Wang, Hongbin			Searching for the Majority: Algorithms of Voluntary Control	PLOS ONE			English	Article							CHOICE REACTION TIME; INFORMATION; ATTENTION; DECISIONS; OBJECTS; SPEED	Voluntary control of information processing is crucial to allocate resources and prioritize the processes that are most important under a given situation; the algorithms underlying such control, however, are often not clear. We investigated possible algorithms of control for the performance of the majority function, in which participants searched for and identified one of two alternative categories (left or right pointing arrows) as composing the majority in each stimulus set. We manipulated the amount (set size of 1, 3, and 5) and content (ratio of left and right pointing arrows within a set) of the inputs to test competing hypotheses regarding mental operations for information processing. Using a novel measure based on computational load, we found that reaction time was best predicted by a grouping search algorithm as compared to alternative algorithms (i.e., exhaustive or self-terminating search). The grouping search algorithm involves sampling and resampling of the inputs before a decision is reached. These findings highlight the importance of investigating the implications of voluntary control via algorithms of mental operations.	[Fan, Jin; Guise, Kevin G.; Liu, Xun] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Fan, Jin] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Wang, Hongbin] Univ Texas Hlth Sci Ctr Houston, Sch Hlth Informat Sci, Houston, TX USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Health Science Center Houston	Fan, J (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY USA.	Jin.Fan@mssm.edu	Fan, Jin/L-2055-2019; Liu, Xun/C-2400-2009; Fan, Jin/A-6716-2009; Guise, Kevin G/C-1145-2009	Fan, Jin/0000-0001-9630-8330; Liu, Xun/0000-0003-1366-8926; Fan, Jin/0000-0001-9630-8330; Lauwereyns, Jan/0000-0003-0551-2550	NARSAD [Young Investigator Award]; NIMH [MH083164]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083164] Funding Source: NIH RePORTER	NARSAD(NARSAD); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by a Young Investigator Award from the NARSAD and by a NIMH grant MH083164 to JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrasco M, 2003, NAT NEUROSCI, V6, P699, DOI 10.1038/nn1079; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fitts P.M., 1964, CATEGORIES HUM LEARN, VVol. 35, P37; Franconeri SL, 2007, J EXP PSYCHOL HUMAN, V33, P1003, DOI 10.1037/0096-1523.33.5.1003; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; HYMAN R, 1953, J EXP PSYCHOL, V45, P188, DOI 10.1037/h0056940; KORNBLUM S, 1968, SCIENCE, V159, P432, DOI 10.1126/science.159.3813.432; Marr D., 1982, VISION; MERVIS CB, 1981, ANNU REV PSYCHOL, V32, P89, DOI 10.1146/annurev.ps.32.020181.000513; Niwa M, 2008, J NEUROSCI, V28, P4435, DOI 10.1523/JNEUROSCI.5564-07.2008; Posner M.I, 1986, CHRONOMETRIC EXPLORA; Posner MI, 1998, PHILOS T R SOC B, V353, P1915, DOI 10.1098/rstb.1998.0344; POSNER MI, 1965, J EXP PSYCHOL, V70, P496, DOI 10.1037/h0022545; POSNER MI, 1964, PSYCHOL REV, V71, P491, DOI 10.1037/h0041120; Shannon C. E., 1949, MATH THEORY COMMUNIC; SMITH EE, 1968, PSYCHOL BULL, V69, P77, DOI 10.1037/h0020189; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; VERGHESE P, 1992, VISION RES, V32, P983, DOI 10.1016/0042-6989(92)90040-P; WALUS K, 2004, 38 AS C SIGN SYST CO; 2001, INFORM THEORY APPL I	28	21	21	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3522	10.1371/journal.pone.0003522	http://dx.doi.org/10.1371/journal.pone.0003522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IJ	18949039	Green Published, gold			2022-12-27	WOS:000265126400007
J	Yin, S; Ai, JS; Shi, LH; Wei, L; Yuan, J; Ouyang, YC; Hou, Y; Chen, DY; Schatten, H; Sun, QY				Yin, Shen; Ai, Jun-Shu; Shi, Li-Hong; Wei, Liang; Yuan, Ju; Ouyang, Ying-Chun; Hou, Yi; Chen, Da-Yuan; Schatten, Heide; Sun, Qing-Yuan			Shugoshin1 May Play Important Roles in Separation of Homologous Chromosomes and Sister Chromatids during Mouse Oocyte Meiosis	PLOS ONE			English	Article								Background: Homologous chromosomes separate in meiosis I and sister chromatids separate in meiosis II, generating haploid gametes. To address the question why sister chromatids do not separate in meiosis I, we explored the roles of Shogoshin1 (Sgo1) in chromosome separation during oocyte meiosis. Methodology/Principal Findings: Sgo1 function was evaluated by exogenous overexpression to enhance its roles and RNAi to suppress its roles during two meioses of mouse oocytes. Immunocytochemistry and chromosome spread were used to evaluate phenotypes. The exogenous Sgo1 overexpression kept homologous chromosomes and sister chromatids not to separate in meiosis I and meiosis II, respectively, while the Sgo1 RNAi promoted premature separation of sister chromatids. Conclusions: Our results reveal that prevention of premature separation of sister chromatids in meiosis I requires the retention of centromeric Sgo1, while normal separation of sister chromatids in meiosis II requires loss of centromeric Sgo1.	[Yin, Shen; Ai, Jun-Shu; Shi, Li-Hong; Wei, Liang; Yuan, Ju; Ouyang, Ying-Chun; Hou, Yi; Chen, Da-Yuan; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Yin, Shen; Ai, Jun-Shu; Shi, Li-Hong; Wei, Liang; Yuan, Ju] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Missouri System; University of Missouri Columbia	Yin, S (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn	Wei, Liang/U-4349-2017; Yin, Shen/N-6607-2013		National Basic Research Program of China [2006CB944001, 2006CB504004]; National Natural Science Foundation of China [30430530, 30570944]; Knowledge Innovation Program of the CAS [KSCX2-YW-R-52]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the CAS(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by the National Basic Research Program of China (2006CB944001, 2006CB504004), National Natural Science Foundation of China (No. 30430530, 30570944) and Knowledge Innovation Program of the CAS (KSCX2-YW-R-52).	Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; CHOI AHC, 1980, CAN J GENET CYTOL, V22, P261, DOI 10.1139/g80-031; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; HAN F, 2007, PLANT CELL; Jones KT, 2008, HUM REPROD UPDATE, V14, P143, DOI 10.1093/humupd/dmm043; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; LEE J, 2007, NAT CELL BIOL; Lee J, 2006, CELL CYCLE, V5, P1448, DOI 10.4161/cc.5.13.2903; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llano E, 2008, GENE DEV, V22, P2400, DOI 10.1101/gad.475308; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; MOLNAR M, 1995, GENETICS, V141, P61; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Puschendorf M, 2006, BIOCHEM BIOPH RES CO, V347, P36, DOI 10.1016/j.bbrc.2006.06.106; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tsurumi C, 2004, J CELL BIOL, V167, P1037, DOI 10.1083/jcb.200405165; Vaur S, 2005, CURR BIOL, V15, P2263, DOI 10.1016/j.cub.2005.11.034; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Wu JQ, 2007, P NATL ACAD SCI USA, V104, P16564, DOI 10.1073/pnas.0707537104; Wu QJ, 2007, CURR BIOL, V17, P213, DOI 10.1016/j.cub.2006.12.045; Yin S, 2006, CELL CYCLE, V5, P2130, DOI 10.4161/cc.5.18.3170	31	21	22	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3516	10.1371/journal.pone.0003516	http://dx.doi.org/10.1371/journal.pone.0003516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949044	Green Published, Green Submitted, gold			2022-12-27	WOS:000265126400004
J	Sagaspe, P; Taillard, J; Akerstedt, T; Bayon, V; Espie, S; Chaumet, G; Bioulac, B; Philip, P				Sagaspe, Patricia; Taillard, Jacques; Akerstedt, Torbjorn; Bayon, Virginie; Espie, Stephane; Chaumet, Guillaume; Bioulac, Bernard; Philip, Pierre			Extended Driving Impairs Nocturnal Driving Performances	PLOS ONE			English	Article							MOTOR-VEHICLE CRASHES; AUTOMOBILE DRIVERS; SLEEP RESTRICTION; DAYTIME SLEEPINESS; TRAFFIC ACCIDENTS; FALLING ASLEEP; TRUCK DRIVERS; FATIGUE; WORK; RISK	Though fatigue and sleepiness at the wheel are well-known risk factors for traffic accidents, many drivers combine extended driving and sleep deprivation. Fatigue-related accidents occur mainly at night but there is no experimental data available to determine if the duration of prior driving affects driving performance at night. Participants drove in 3 nocturnal driving sessions (3-5am, 1-5am and 9pm-5am) on open highway. Fourteen young healthy men (mean age [+/- SD] = 23.4 [+/- 61.7] years) participated Inappropriate line crossings (ILC) in the last hour of driving of each session, sleep variables, self-perceived fatigue and sleepiness were measured. Compared to the short (3-5am) driving session, the incidence rate ratio of inappropriate line crossings increased by 2.6 (95% CI, 1.1 to 6.0; P<.05) for the intermediate (1-5am) driving session and by 4.0 (CI, 1.7 to 9.4; P<.001) for the long (9pm-5am) driving session. Compared to the reference session (9-10pm), the incidence rate ratio of inappropriate line crossings were 6.0 (95% CI, 2.3 to 15.5; P<.001), 15.4 (CI, 4.6 to 51.5; P<.001) and 24.3 (CI, 7.4 to 79.5; P<.001), respectively, for the three different durations of driving. Self-rated fatigue and sleepiness scores were both positively correlated to driving impairment in the intermediate and long duration sessions (P<.05) and increased significantly during the nocturnal driving sessions compared to the reference session (P<.01). At night, extended driving impairs driving performances and therefore should be limited.	[Sagaspe, Patricia; Taillard, Jacques; Chaumet, Guillaume; Bioulac, Bernard; Philip, Pierre] CHU Pellegrin, GENPPHASS, Bordeaux, France; [Sagaspe, Patricia; Espie, Stephane] INRETS, MSIS, Paris, France; [Taillard, Jacques; Bioulac, Bernard; Philip, Pierre] CNRS, UMR 5227, Bordeaux, France; [Akerstedt, Torbjorn] Karolinska Sleep Inst, Stockholm, Sweden; [Bayon, Virginie] Hop Hotel Dieu, Paris, France; [Chaumet, Guillaume; Bioulac, Bernard; Philip, Pierre] Univ Bordeaux 2, F-33076 Bordeaux, France	CHU Bordeaux; Universite Gustave-Eiffel; Institut National de Recherche sur les Transports et leur Securite (INRETS); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite de Bordeaux	Sagaspe, P (corresponding author), CHU Pellegrin, GENPPHASS, Bordeaux, France.	pr.philip@free.fr	PHILIP, Pierre/AAS-8889-2020; Taillard, Jacques/H-5063-2018	PHILIP, Pierre/0000-0003-3267-634X; Taillard, Jacques/0000-0001-9067-8189; SAGASPE, Patricia/0000-0003-2845-1199	French National Agency for Research (ANR); Program for Research on Transport (PREDIT GO3 VIGISIM)	French National Agency for Research (ANR)(French National Research Agency (ANR)); Program for Research on Transport (PREDIT GO3 VIGISIM)	This research was supported by a grant from the French National Agency for Research (ANR) and the Program for Research on Transport (PREDIT GO3 VIGISIM).	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Arnold PK, 1997, ACCIDENT ANAL PREV, V29, P471, DOI 10.1016/S0001-4575(97)00026-2; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; BOVERIE S, 2008, IFAC WORLD C SEOUL K; CARSKADON MA, 1981, PSYCHOPHYSIOLOGY, V18, P107, DOI 10.1111/j.1469-8986.1981.tb02921.x; CARSKADON MA, 1979, PERCEPT MOTOR SKILL, V48, P495, DOI 10.2466/pms.1979.48.2.495; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; DEMENT WC, 1982, SLEEP, V5, pS56, DOI 10.1093/sleep/5.S2.S56; Folkard S, 2005, IND HEALTH, V43, P20, DOI 10.2486/indhealth.43.20; Folkard S, 2006, CHRONOBIOL INT, V23, P1181, DOI 10.1080/07420520601096443; Folkard S, 2006, AM J IND MED, V49, P953, DOI 10.1002/ajim.20307; FROBERG JE, 1977, BIOL PSYCHOL, V5, P119, DOI 10.1016/0301-0511(77)90008-4; GRANDJEAN E, 1979, BRIT J IND MED, V36, P175; HAMELIN P, 1987, ERGONOMICS, V30, P1323, DOI 10.1080/00140138708966026; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; KANEKO T, 1992, ACCIDENT ANAL PREV, V24, P437, DOI 10.1016/0001-4575(92)90055-N; Lal SKL, 2001, BIOL PSYCHOL, V55, P173, DOI 10.1016/S0301-0511(00)00085-5; LAVIE P, 1986, ELECTROEN CLIN NEURO, V63, P414, DOI 10.1016/0013-4694(86)90123-9; Lyznicki JM, 1998, JAMA-J AM MED ASSOC, V279, P1908, DOI 10.1001/jama.279.23.1908; Mitler MM, 1997, NEW ENGL J MED, V337, P755, DOI 10.1056/NEJM199709113371106; Nabi H, 2006, BRIT MED J, V333, P75, DOI 10.1136/bmj.38863.638194.AE; OHANLON JF, 1995, NEUROPSYCHOBIOLOGY, V31, P81, DOI 10.1159/000119177; OHANLON JF, 1986, ACTA PSYCHIAT SCAND, V74, P95, DOI 10.1111/j.1600-0447.1986.tb08985.x; Pack AI, 1995, ACCIDENT ANAL PREV, V27, P769, DOI 10.1016/0001-4575(95)00034-8; Philip P, 2005, SLEEP, V28, P1511, DOI 10.1093/sleep/28.12.1511; Philip P, 2005, ACCIDENT ANAL PREV, V37, P473, DOI 10.1016/j.aap.2004.07.007; Philip P, 2003, SLEEP, V26, P277, DOI 10.1093/sleep/26.3.277; Philip P, 2001, BRIT MED J, V322, P829, DOI 10.1136/bmj.322.7290.829; Philip P, 1996, J PSYCHOSOM RES, V41, P279, DOI 10.1016/0022-3999(96)00127-4; Philip P, 1999, SLEEP, V22, P475, DOI 10.1093/sleep/22.4.475; Philip P, 2006, ANN INTERN MED, V144, P785, DOI 10.7326/0003-4819-144-11-200606060-00004; Powell NB, 2001, LARYNGOSCOPE, V111, P887, DOI 10.1097/00005537-200105000-00024; Powell NB, 2007, SLEEP, V30, P331, DOI 10.1093/sleep/30.3.331; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; RAMAEKERS JG, 1994, EUR J CLIN PHARMACOL, V47, P261, DOI 10.1007/BF02570506; Reyner LA, 1998, INT J LEGAL MED, V111, P120, DOI 10.1007/s004140050131; Sagaspe P, 2007, SLEEP, V30, P1808, DOI 10.1093/sleep/30.12.1808; Sagberg F, 1999, ACCIDENT ANAL PREV, V31, P639, DOI 10.1016/S0001-4575(99)00023-8	38	65	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3493	10.1371/journal.pone.0003493	http://dx.doi.org/10.1371/journal.pone.0003493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IG	18941525	Green Published, gold, Green Submitted			2022-12-27	WOS:000265126100023
J	Regulapati, R; Bhasi, A; Singh, CK; Senapathy, P				Regulapati, Rahul; Bhasi, Ashwini; Singh, Chandan Kumar; Senapathy, Periannan			Origination of the Split Structure of Spliceosomal Genes from Random Genetic Sequences	PLOS ONE			English	Article								The mechanism by which protein-coding portions of eukaryotic genes came to be separated by long non-coding stretches of DNA, and the purpose for this perplexing arrangement, have remained unresolved fundamental biological problems for three decades. We report here a plausible solution to this problem based on analysis of open reading frame (ORF) length constraints in the genomes of nine diverse species. If primordial nucleic acid sequences were random in sequence, functional proteins that are innately long would not be encoded due to the frequent occurrence of stop codons. The best possible way that a long protein-coding sequence could have been derived was by evolving a split-structure from the random DNA (or RNA) sequence. Results of the systematic analyses of nine complete genome sequences presented here suggests that perhaps the major underlying structural features of split-genes have evolved due to the indigenous occurrence of split protein-coding genes in primordial random nucleotide sequence. The results also suggest that intron-rich genes containing short exons may have been the original form of genes intrinsically occurring in random DNA, and that intron-poor genes containing long exons were perhaps derived from the original intron-rich genes.	[Regulapati, Rahul] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Bhasi, Ashwini; Senapathy, Periannan] Genome Int Corp, Madison, WI USA; [Singh, Chandan Kumar; Senapathy, Periannan] Int Ctr Advanced Genom & Proteom, Dept Bioinformat, Chennai, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Regulapati, R (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	ps@genome.com	Senapathy, Periannan/N-1120-2019		Genome International Corporation	Genome International Corporation	This project has been internally funded by Genome International Corporation. This project is purely an academic project, fulfilling the academic interest of the corresponding author, who owns the company.	Bhasi A, 2007, BIOINFORMATICS, V23, P1815, DOI 10.1093/bioinformatics/btm084; Bhattacharya D, 1996, MOL BIOL EVOL, V13, P978, DOI 10.1093/oxfordjournals.molbev.a025666; BLAKE CCF, 1978, NATURE, V273, P267, DOI 10.1038/273267a0; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; CAVALIERSMITH T, 1985, NATURE, V315, P283, DOI 10.1038/315283b0; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; de Souza SJ, 2003, GENETICA, V118, P117, DOI 10.1023/A:1024193323397; De Souza SJ, 1998, P NATL ACAD SCI USA, V95, P5094, DOI 10.1073/pnas.95.9.5094; deSouza SJ, 1996, P NATL ACAD SCI USA, V93, P14632, DOI 10.1073/pnas.93.25.14632; DOOLITTLE WF, 1978, NATURE, V272, P581, DOI 10.1038/272581a0; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Forterre P, 1999, BIOESSAYS, V21, P871, DOI 10.1002/(SICI)1521-1878(199910)21:10<871::AID-BIES10>3.0.CO;2-Q; GILBERT W, 1987, COLD SPRING HARB SYM, V52, P901, DOI 10.1101/SQB.1987.052.01.098; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Glansdorff N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-29; Labedan B, 1999, J MOL EVOL, V49, P461, DOI 10.1007/PL00006569; LEWIN B, 1994, GENES, V5; Logsdon JM, 2004, P NATL ACAD SCI USA, V101, P11195, DOI 10.1073/pnas.0404148101; Long MY, 2000, MOL BIOL EVOL, V17, P1789, DOI 10.1093/oxfordjournals.molbev.a026279; Lu Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-102; Lynch M, 2002, CURR OPIN GENET DEV, V12, P701, DOI 10.1016/S0959-437X(02)00360-X; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; Nei M., 1987, MOL EVOLUTIONARY GEN; Palmer JD, 1991, CURR OPIN GENET DEV, V1, P470, DOI 10.1016/S0959-437X(05)80194-7; Qiu WG, 2004, MOL BIOL EVOL, V21, P1252, DOI 10.1093/molbev/msh120; Robart AR, 2005, CYTOGENET GENOME RES, V110, P589, DOI 10.1159/000084992; Rodriguez-Trelles F, 2006, ANNU REV GENET, V40, P47, DOI 10.1146/annurev.genet.40.110405.090625; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Roy SW, 2003, P NATL ACAD SCI USA, V100, P7158, DOI 10.1073/pnas.1232297100; Roy SW, 2003, GENETICA, V118, P251, DOI 10.1023/A:1024190617462; Roy SW, 2005, P NATL ACAD SCI USA, V102, P1986, DOI 10.1073/pnas.0408355101; SENAPATHY P, 1988, P NATL ACAD SCI USA, V85, P1129, DOI 10.1073/pnas.85.4.1129; SENAPATHY P, 1995, SCIENCE, V268, P1366, DOI 10.1126/science.7761858; SENAPATHY P, 1986, P NATL ACAD SCI USA, V83, P2133, DOI 10.1073/pnas.83.7.2133; SENAPATHY P, 1994, INDEPENDENT BIRTH OR; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; SUBAKSHARPE H, 1966, COLD SPRING HARB SYM, V31, P737, DOI 10.1101/SQB.1966.031.01.094	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3456	10.1371/journal.pone.0003456	http://dx.doi.org/10.1371/journal.pone.0003456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941625	Green Published, Green Submitted, gold			2022-12-27	WOS:000265125600014
J	Harkonmaki, K; Silventoinen, K; Levalahti, E; Pitkaniemi, J; Huunan-Seppala, A; Klaukka, T; Koskenvuo, M; Kaprio, J				Harkonmaki, Karoliina; Silventoinen, Karri; Levalahti, Esko; Pitkaniemi, Janne; Huunan-Seppala, Antti; Klaukka, Timo; Koskenvuo, Markku; Kaprio, Jaakko			The Genetic Liability to Disability Retirement: A 30-Year Follow-Up Study of 24,000 Finnish Twins	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; COMPREHENSIVE DEVELOPMENTAL MODEL; DEPENDENT DIABETES-MELLITUS; LOW-BACK-PAIN; MAJOR DEPRESSION; CHILDHOOD ADVERSITIES; RISK-FACTORS; LIFE EVENTS; POPULATION; HERITABILITY	Background: No previous studies on the effect of genetic factors on the liability to disability retirement have been carried out. The main aim of this study was to investigate the contribution of genetic factors on disability retirement due to the most common medical causes, including depressive disorders. Methods: The study sample consisted of 24 043 participants (49.7% women) consisting of 11 186 complete same-sex twin pairs including 3519 monozygotic (MZ) and 7667dizygotic (DZ) pairs. Information on retirement events during 1.1.1975-31.12.2004, including disability pensions (DPs) with diagnoses, was obtained from the Finnish nationwide official pension registers. Correlations in liability for MZ and DZ twins and discrete time correlated frailty model were used to investigate the genetic liability to age at disability retirement. Results: The 30 year cumulative incidence of disability retirement was 20%. Under the best fitting genetic models, the heritability estimate for DPs due to any medical cause was 0.36 (95% CI 0.32-0.40), due to musculoskeletal disorders 0.37 (0.30-0.43), cardiovascular diseases 0.48 (0.39-0.57), mental disorders 0.42 (0.35-0.49) and all other reasons 0.24 (0.17-0.31). The effect of genetic factors decreased with increasing age of retirement. For DP due to depressive disorders, 28% of the variance was explained by environmental factors shared by family members (95% CI 21-36) and 58% of the variance by the age interval specific environmental factors (95% CI 44-71). Conclusions: A moderate genetic contribution to the variation of disability retirement due to any medical cause was found. The genetic effects appeared to be stronger at younger ages of disability retirement suggesting the increasing influence of environmental factors not shared with family members with increasing age. Familial aggregation in DPs due to depressive disorders was best explained by the common environmental factors and genetic factors were not needed to account for the pattern of familial aggregation.	[Harkonmaki, Karoliina; Silventoinen, Karri; Levalahti, Esko; Pitkaniemi, Janne; Koskenvuo, Markku; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Harkonmaki, Karoliina] Local Gov Pensions Inst, Helsinki, Finland; [Huunan-Seppala, Antti] Univ Tampere, Dept Gen Practice, FIN-33101 Tampere, Finland; [Klaukka, Timo] Social Insurance Inst, Helsinki, Finland; [Kaprio, Jaakko] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland	University of Helsinki; Tampere University; Finland National Institute for Health & Welfare	Harkonmaki, K (corresponding author), Univ Helsinki, Dept Publ Hlth, Helsinki, Finland.	karoliina.harkonmaki@helsinki.fi	Kaprio, Jaakko/A-1820-2008	Kaprio, Jaakko/0000-0002-3716-2455; Silventoinen, Karri/0000-0003-1759-3079	Social Insurance Institution, Finland; Academy of Finland Center of Excellence in Complex Disease Genetics	Social Insurance Institution, Finland; Academy of Finland Center of Excellence in Complex Disease Genetics(Academy of Finland)	This study has been carried out as a part of the TwinKela-project, which is a collaborative project between the Social Insurance Institution of Finland (KELA) and the Department of Public Health, University of Helsinki. The TwinKela-project has been supported by the Social Insurance Institution, Finland. The Finnish Twin Cohort studies are supported by the Academy of Finland Center of Excellence in Complex Disease Genetics.	Appelberg K, 1996, J PSYCHOSOM RES, V40, P157, DOI 10.1016/0022-3999(95)00576-5; AROMAA A, 2002, TERVEYS JA TOIMINTAK, P103; Battie MC, 2007, PAIN, V131, P272, DOI 10.1016/j.pain.2007.01.010; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Biering-Sorensen F, 1999, DAN MED BULL, V46, P258; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P67, DOI 10.1001/archpsyc.55.1.67; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Eaton WW, 2007, ACTA PSYCHIAT SCAND, V116, P182, DOI 10.1111/j.1600-0447.2007.01017.x; Evans A, 2003, TWIN RES, V6, P432, DOI 10.1375/136905203770326439; Fejer R, 2006, RHEUMATOLOGY, V45, P589, DOI 10.1093/rheumatology/kei224; Gaist D, 2003, TWIN RES, V6, P442, DOI 10.1375/136905203770326448; Goldberg D, 2001, BRIT J PSYCHIAT, V178, pS69, DOI 10.1192/bjp.178.40.s69; Goldberg D, 2006, PSYCHOL MED, V36, P1341, DOI 10.1017/S0033291706007665; Harkonmaki K, 2007, THESIS U HELSINKI HE; Harkonmaki K, 2007, J EPIDEMIOL COMMUN H, V61, P479, DOI 10.1136/jech.2006.052670; Hartvigsen J, 2007, SPINE, V32, P76, DOI 10.1097/01.brs.0000250292.18121.ce; Haug TT, 2004, PSYCHOSOM MED, V66, P845, DOI 10.1097/01.psy.0000145823.85658.0c; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Isometsa E, 1997, ACTA PSYCHIAT SCAND, V96, P122, DOI 10.1111/j.1600-0447.1997.tb09916.x; Jokela M, 2007, ARCH GEN PSYCHIAT, V64, P356, DOI 10.1001/archpsyc.64.3.356; Jurvisalo J., 2005, MENTAL DISORDERS MAJ, P27; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Kaprio J, 2002, TWIN RES, V5, P358, DOI 10.1375/twin.5.5.358; Karpansalo M, 2003, OCCUP ENVIRON MED, V60, P765, DOI 10.1136/oem.60.10.765; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Kendler KS, 2002, AM J PSYCHIAT, V159, P1133, DOI 10.1176/appi.ajp.159.7.1133; Kieseppa T, 2004, AM J PSYCHIAT, V161, P1814, DOI 10.1176/appi.ajp.161.10.1814; Korhonen T, 2007, PSYCHOL MED, V37, P705, DOI 10.1017/S0033291706009639; Korkeila K, 2005, SOC PSYCH PSYCH EPID, V40, P700, DOI 10.1007/s00127-005-0969-x; Krause N, 1997, SCAND J WORK ENV HEA, V23, P403, DOI 10.5271/sjweh.262; Lindeman S, 2000, ACTA PSYCHIAT SCAND, V102, P178, DOI 10.1034/j.1600-0447.2000.102003178.x; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Mausner-Dorsch H, 2000, AM J PUBLIC HEALTH, V90, P1765, DOI 10.2105/AJPH.90.11.1765; Muthen B, 2005, J EDUC BEHAV STAT, V30, P27, DOI 10.3102/10769986030001027; MUTHEN B, 1981, FACTOR ANAL MEASUREM; Muthen B., 2010, MPLUS USERS GUIDE; MUTHEN LK, 2007, WORKSH LAT VAR MOD M; NEALE MC, 1992, NATO ASI SERIES; Pan W, 2008, HUM GENET, V124, P225, DOI 10.1007/s00439-008-0545-1; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; RISSANEN AM, 1979, AM J CARDIOL, V44, P60, DOI 10.1016/0002-9149(79)90251-0; Romanov K, 2003, ACTA PSYCHIAT SCAND, V107, P25, DOI 10.1034/j.1600-0447.2003.01419.x; SARNA S, 1978, HUM HERED, V28, P241, DOI 10.1159/000152964; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Sobocki P, 2006, J MENT HEALTH POLICY, V9, P87; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Tennant C, 2002, AUST NZ J PSYCHIAT, V36, P173, DOI 10.1046/j.1440-1614.2002.01007.x; Upmark M, 1999, J EPIDEMIOL COMMUN H, V53, P223, DOI 10.1136/jech.53.4.223; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x; Zdravkovic S, 2007, TWIN RES HUM GENET, V10, P848, DOI 10.1375/twin.10.6.848	55	57	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2008	3	10							e3402	10.1371/journal.pone.0003402	http://dx.doi.org/10.1371/journal.pone.0003402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432GP	18923678	gold, Green Published, Green Submitted			2022-12-27	WOS:000265121800003
J	van Oppen, MJH; Lutz, A; De'ath, G; Peplow, L; Kininmonth, S				van Oppen, Madeleine J. H.; Lutz, Adrian; De'ath, Glenn; Peplow, Lesa; Kininmonth, Stuart			Genetic Traces of Recent Long-Distance Dispersal in a Predominantly Self-Recruiting Coral	PLOS ONE			English	Article								Background: Understanding of the magnitude and direction of the exchange of individuals among geographically separated subpopulations that comprise a metapopulation (connectivity) can lead to an improved ability to forecast how fast coral reef organisms are likely to recover from disturbance events that cause extensive mortality. Reef corals that brood their larvae internally and release mature larvae are believed to show little exchange of larvae over ecological times scales and are therefore expected to recover extremely slowly from large-scale perturbations. Methodology/Principal Findings: Using analysis of ten DNA microsatellite loci, we show that although Great Barrier Reef (GBR) populations of the brooding coral, Seriatopora hystrix, are mostly self-seeded and some populations are highly isolated, a considerable amount of sexual larvae (up to similar to 4%) has been exchanged among several reefs 10 s to 100 s km apart over the past few generations. Our results further indicate that S. hystrix is capable of producing asexual propagules with similar long-distance dispersal abilities (similar to 1.4% of the sampled colonies had a multilocus genotype that also occurred at another sampling location), which may aid in recovery from environmental disturbances. Conclusions/Significance: Patterns of connectivity in this and probably other GBR corals are complex and need to be resolved in greater detail through genetic characterisation of different cohorts and linkage of genetic data with fine-scale hydrodynamic models.	[van Oppen, Madeleine J. H.; Lutz, Adrian; De'ath, Glenn; Peplow, Lesa; Kininmonth, Stuart] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	van Oppen, MJH (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	m.vanoppen@aims.gov.au	van Oppen, Madeleine JH/C-3261-2008; Kininmonth, Stuart/N-9299-2013; Lutz, Adrian/O-9805-2016	Kininmonth, Stuart/0000-0001-9198-3396; Lutz, Adrian/0000-0002-8392-3921; van Oppen, Madeleine/0000-0003-4607-0744	Australian Institute of Marine Science	Australian Institute of Marine Science	All the work was funded by the Australian Institute of Marine Science. Design and conduct of the study, the collection, analysis, and interpretation of the data, and the preparation of the manuscript was conducted by the authors.	Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; ATODA K, 1951, REPORTS TOHOKU U, V19, P48; AYRE DJ, 1994, EVOLUTION, V48, P1183, DOI 10.1111/j.1558-5646.1994.tb05304.x; Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; AYRE DJ, 1986, MAR BIOL, V90, P187, DOI 10.1007/BF00569126; Ayre DJ, 2000, EVOLUTION, V54, P1590; BAIRD AH, 2001, THESIS J COOK U TOWN; BARTON NH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P13; Benjamini Y, 2001, ANN STAT, V29, P1165; BENZIE JAH, 1995, MAR BIOL, V121, P731, DOI 10.1007/BF00349309; Brinkman R, 2002, ESTUAR COAST SHELF S, V54, P655, DOI 10.1006/ecss.2001.0850; Cantin NE, 2007, MAR ECOL PROG SER, V344, P81, DOI 10.3354/meps07059; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harrison P.L., 1990, P133; Hartl D., 1989, PRINCIPLES POPULATIO; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 2002, ECOLOGY, V83, P436, DOI 10.2307/2680026; Isomura N, 2001, CORAL REEFS, V20, P309, DOI 10.1007/s003380100180; Johnson MS, 2006, EVOLUTION, V60, P2498; JOKIEL PL, 1984, CORAL REEFS, V3, P113, DOI 10.1007/BF00263761; Luick JL, 2007, CONT SHELF RES, V27, P757, DOI 10.1016/j.csr.2006.11.020; Mackenzie JB, 2004, MOL ECOL, V13, P9, DOI 10.1046/j.1365-294X.2003.02019.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Michalek-Wagner K, 2001, CORAL REEFS, V19, P231, DOI 10.1007/s003380170003; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Negri AP, 2002, MAR POLLUT BULL, V44, P111, DOI 10.1016/S0025-326X(01)00128-X; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palumbi SR, 2003, ECOL APPL, V13, pS146; PEAKALL R, 2005, GENALEX, V6; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; SAMMARCO PW, 1982, MAR ECOL PROG SER, V10, P57, DOI 10.3354/meps010057; Sherman CDH, 2008, HEREDITY, V100, P296, DOI 10.1038/sj.hdy.6801076; Sherman CDH, 2006, CORAL REEFS, V25, P7, DOI 10.1007/s00338-005-0053-x; Smith-Keune C, 2006, CORAL REEFS, V25, P493, DOI 10.1007/s00338-006-0129-2; STEINBERG C. R., 2007, CLIMATE CHANGE GREAT, P52; Tanner JE, 1996, CORAL REEFS, V15, P59, DOI 10.1007/s003380050028; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; Underwood JN, 2006, MOL ECOL NOTES, V6, P176, DOI 10.1111/j.1471-8286.2005.01183.x; Van Oppen MJH, 2006, MOL ECOL, V15, P3863, DOI 10.1111/j.1365-294X.2006.03026.x; Veron J. E. N., 2000, CORALS WORLD, V2; Wachenfeld D., 2007, CLIMATE CHANGE GREAT, P1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitaker K, 2006, MAR ECOL PROG SER, V306, P115, DOI 10.3354/meps306115; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0; Young AG, 2002, BIOL CONSERV, V106, P71, DOI 10.1016/S0006-3207(01)00230-0	55	72	73	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3401	10.1371/journal.pone.0003401	http://dx.doi.org/10.1371/journal.pone.0003401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852897	Green Published, Green Submitted, gold			2022-12-27	WOS:000265121700008
J	Siniscalchi, M; Quaranta, A; Rogers, LJ				Siniscalchi, Marcello; Quaranta, Angelo; Rogers, Lesley J.			Hemispheric Specialization in Dogs for Processing Different Acoustic Stimuli	PLOS ONE			English	Article							ORIENTING ASYMMETRIES; LATERALIZED BEHAVIOR; CANIS-FAMILIARIS; RHESUS-MONKEYS; PAW PREFERENCE; VOCALIZATIONS; PERCEPTION; CALLS; COMMUNICATION; BRAIN	Considerable experimental evidence shows that functional cerebral asymmetries are widespread in animals. Activity of the right cerebral hemisphere has been associated with responses to novel stimuli and the expression of intense emotions, such as aggression, escape behaviour and fear. The left hemisphere uses learned patterns and responds to familiar stimuli. Although such lateralization has been studied mainly for visual responses, there is evidence in primates that auditory perception is lateralized and that vocal communication depends on differential processing by the hemispheres. The aim of the present work was to investigate whether dogs use different hemispheres to process different acoustic stimuli by presenting them with playbacks of a thunderstorm and their species-typical vocalizations. The results revealed that dogs usually process their species-typical vocalizations using the left hemisphere and the thunderstorm sounds using the right hemisphere. Nevertheless, conspecific vocalizations are not always processed by the left hemisphere, since the right hemisphere is used for processing vocalizations when they elicit intense emotion, including fear. These findings suggest that the specialisation of the left hemisphere for intraspecific communication is more ancient that previously thought, and so is specialisation of the right hemisphere for intense emotions.	[Siniscalchi, Marcello; Quaranta, Angelo] Univ Bari, Dept Anim Prod, Bari, Italy; [Rogers, Lesley J.] Univ New England, Ctr Neurosci & Anim Behaviour, Armidale, NSW, Australia	Universita degli Studi di Bari Aldo Moro; University of New England	Siniscalchi, M (corresponding author), Univ Bari, Dept Anim Prod, Bari, Italy.	m.siniscalchi@veterinaria.uniba.it	Rogers, Lesley J./Y-5722-2019	Rogers, Lesley J./0000-0002-9956-1769; Lauwereyns, Jan/0000-0003-0551-2550; Quaranta, Angelo/0000-0001-7835-2485	Giovanni Putignano Educational Award	Giovanni Putignano Educational Award	This work was supported by grant from the Giovanni Putignano Educational Award to M.S.	ADAMS CL, 1987, DEV NEUROPSYCHOL, V3, P175, DOI 10.1080/87565648709540375; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; BOUISSOU MF, 1995, BEHAV PROCESS, V34, P81, DOI 10.1016/0376-6357(94)00056-M; Boye M, 2005, EUR J NEUROSCI, V21, P1727, DOI 10.1111/j.1460-9568.2005.04005.x; Bradshaw JL., 1993, EVOLUTION LATERAL AS; Branson NJ, 2006, J COMP PSYCHOL, V120, P176, DOI 10.1037/0735-7036.120.3.176; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Feddersen-Petersen DU, 2000, ARCH TIERZUCHT, V43, P387, DOI 10.5194/aab-43-387-2000; George I, 2002, CR BIOL, V325, P197, DOI 10.1016/S1631-0691(02)01430-0; Ghazanfar AA, 2001, BRAIN BEHAV EVOLUT, V58, P163, DOI 10.1159/000047270; Gil-da-Costa R, 2006, P ROY SOC B-BIOL SCI, V273, P2313, DOI 10.1098/rspb.2006.3580; Hauser MD, 1998, ANIM BEHAV, V56, P41, DOI 10.1006/anbe.1998.0738; HAUSER MD, 1994, P NATL ACAD SCI USA, V91, P3946, DOI 10.1073/pnas.91.9.3946; HAUSER MD, 1993, SCIENCE, V261, P475, DOI 10.1126/science.8332914; Henderson JV, 2000, APPL ANIM BEHAV SCI, V69, P241, DOI 10.1016/S0168-1591(00)00132-5; Hook-Costigan MA, 1998, NEUROPSYCHOLOGIA, V36, P1265, DOI 10.1016/S0028-3932(98)00037-2; Molnar C, 2008, ANIM COGN, V11, P389, DOI 10.1007/s10071-007-0129-9; Ohl Frauke, 1996, Zoologische Beitraege, V37, P199; Palleroni A, 2003, SCIENCE, V299, P1195, DOI 10.1126/science.1078813; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Quaranta A, 2007, CURR BIOL, V17, pR199, DOI 10.1016/j.cub.2007.02.008; Quaranta A, 2004, BEHAV BRAIN RES, V153, P521, DOI 10.1016/j.bbr.2004.01.009; Rogers L., 2003, SPIRIT WILD DOG WORL; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Rogers LJ, 2002, COMP VERTEBRATE LATE; Scheumann M, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-3; Schonwiesner M, 2005, EUR J NEUROSCI, V22, P1521, DOI 10.1111/j.1460-9568.2005.04315.x; Teufel C, 2007, ANIM BEHAV, V73, P249, DOI 10.1016/j.anbehav.2006.04.011; Vallortigara G, 2008, PLOS BIOL, V6, P208, DOI 10.1371/journal.pbio.0060042; Wells DL, 2003, BEHAV PROCESS, V61, P27, DOI 10.1016/S0376-6357(02)00161-4; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016	34	116	117	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3349	10.1371/journal.pone.0003349	http://dx.doi.org/10.1371/journal.pone.0003349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432DQ	18843371	Green Submitted, Green Published, gold			2022-12-27	WOS:000265114100001
J	Beltran, S; Cezilly, F; Boissier, J				Beltran, Sophie; Cezilly, Frank; Boissier, Jerome			Genetic Dissimilarity between Mates, but Not Male Heterozygosity, Influences Divorce in Schistosomes	PLOS ONE			English	Article							MICROSATELLITE MARKERS; MANSONI; CHOICE; BIRDS; OYSTERCATCHER; RELATEDNESS; SIMILARITY; PAIRS; LOCI	Background: Correlational studies strongly suggest that both genetic similarity and heterozygosity can influence female mate choice. However, the influence of each variable has usually been tested independently, although similarity and heterozygosity might be correlated. We experimentally determined the relative influence of genetic similarity and heterozygosity in divorce and re-mating in the monogamous endoparasite Schistosoma mansoni. Methodology/Principal Findings: We performed sequential infections of vertebrate hosts with controlled larval populations of parasites, where sex and individual genetic diversity and similarity were predetermined before infection. Divorce rate increased significantly when females were given the opportunity to increase genetic dissimilarity through re-mating with a new partner, independently of the intensity of male-male competition. We found however no evidence for females attempting to maximize the level of heterozygosity of their reproductive partner through divorce. Conclusions/Significance: Female preference for genetically dissimilar males should result in more heterozygous offspring. Because genetic heterozygosity might partly determine the ability of parasites to counter host resistance, adaptive divorce could be an important factor in the evolutionary arms race between schistosomes and their hosts.	[Beltran, Sophie; Boissier, Jerome] Univ Perpignan, CNRS, EPHE UPVD, Lab Biol & Ecol Trop & Mediterraneenne,UMR 5244, F-66025 Perpignan, France; [Cezilly, Frank] Univ Bourgogne, UMR CNRS 5561 Biogeosci, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Beltran, S (corresponding author), Univ Perpignan, CNRS, EPHE UPVD, Lab Biol & Ecol Trop & Mediterraneenne,UMR 5244, F-66025 Perpignan, France.	boissier@univ.perp.fr	BOISSIER, Jérôme/B-2996-2010; Beltran, Sophie/AAE-1075-2019; BELTRAN-BECH, Sophie/A-9070-2010	Beltran, Sophie/0000-0003-4379-0463; BELTRAN-BECH, Sophie/0000-0003-4379-0463	French Ministere de l'Enseignement Superieur et de la Recherche; CNRS; Agence Nationale de la Recherche (Program Monogamix)	French Ministere de l'Enseignement Superieur et de la Recherche; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (Program Monogamix)(French National Research Agency (ANR))	This work was supported financially by the French Ministere de l'Enseignement Superieur et de la Recherche, the CNRS and the Agence Nationale de la Recherche (Program Monogamix).	Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Beltran S, 2008, TRENDS PARASITOL, V24, P386, DOI 10.1016/j.pt.2008.05.009; Bishop JM, 2007, BIOL LETTERS, V3, P176, DOI 10.1098/rsbl.2006.0607; Black J.M., 1996, PARTNERSHIPS BIRDS S; Blair L, 2001, MOL ECOL NOTES, V1, P93, DOI 10.1046/j.1471-8278.2001.00042.x; Boissier J, 2000, PARASITOLOGY, V121, P379, DOI 10.1017/S0031182099006393; Boissier J, 2001, MOL BIOCHEM PARASIT, V112, P139, DOI 10.1016/S0166-6851(00)00344-3; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; Castillo-Chavez C, 2008, MATH BIOSCI, V211, P333, DOI 10.1016/j.mbs.2007.11.001; *CDC, 2004, SCHIST FACT SHEET; Cezilly F, 2000, BEHAV PROCESS, V51, P83, DOI 10.1016/S0376-6357(00)00120-0; CHOUDHURY S, 1995, ANIM BEHAV, V50, P413, DOI 10.1006/anbe.1995.0256; CLOUGH ER, 1981, J PARASITOL, V67, P535, DOI 10.2307/3280487; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Curtis J, 2001, MOL ECOL NOTES, V1, P143, DOI 10.1046/j.1471-8278.2001.00053.x; Dhondt AA, 2002, TRENDS ECOL EVOL, V17, P55, DOI 10.1016/S0169-5347(01)02407-7; Dubois F, 2002, BEHAV ECOL SOCIOBIOL, V52, P357, DOI 10.1007/s00265-002-0521-z; Durand P, 2000, MOL ECOL, V9, P997, DOI 10.1046/j.1365-294x.2000.00939-4.x; DUVALL RH, 1967, AM J TROP MED HYG, V16, P483, DOI 10.4269/ajtmh.1967.16.483; ENS BJ, 1993, ANIM BEHAV, V45, P1199, DOI 10.1006/anbe.1993.1142; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hatchwell BJ, 2000, P ROY SOC B-BIOL SCI, V267, P813, DOI 10.1098/rspb.2000.1076; Heg D, 2003, ANIM BEHAV, V66, P175, DOI 10.1006/anbe.2003.2188; Jeschke JM, 2007, BEHAV ECOL, V18, P460, DOI 10.1093/beheco/arl109; Kempenaers B, 1998, ANIM BEHAV, V56, P737, DOI 10.1006/anbe.1998.0800; Mays HL, 2004, TRENDS ECOL EVOL, V19, P554, DOI 10.1016/j.tree.2004.07.018; Mone H, 2004, ADV PARASIT, V57, P89, DOI 10.1016/S0065-308X(04)57002-1; Pica-Mattoccia L, 2000, PARASITOLOGY, V120, P495, DOI 10.1017/S0031182099005685; Prugnolle F, 2004, J PARASITOL, V90, P507, DOI 10.1645/GE-150R; Prugnolle F, 2002, MOL ECOL, V11, P1231, DOI 10.1046/j.1365-294X.2002.01518.x; PRUGNOLLE F, COMMUNICATION; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roberts SC, 2006, J EVOLUTION BIOL, V19, P558, DOI 10.1111/j.1420-9101.2005.01003.x; Roberts SC, 2003, NAT GENET, V35, P103, DOI 10.1038/ng1231; Rodrigues NB, 2002, MEM I OSWALDO CRUZ, V97, P71, DOI 10.1590/S0074-02762002000900015; Smith SB, 2005, J AVIAN BIOL, V36, P146, DOI 10.1111/j.0908-8857.2005.03417.x; Taborsky B, 1999, J AVIAN BIOL, V30, P143, DOI 10.2307/3677123; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Wang JL, 2002, GENETICS, V160, P1203; Weatherhead PJ, 1999, BEHAV ECOL, V10, P619, DOI 10.1093/beheco/10.6.619	40	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3328	10.1371/journal.pone.0003328	http://dx.doi.org/10.1371/journal.pone.0003328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841198	Green Published, gold, Green Submitted			2022-12-27	WOS:000265113900001
J	Milloy, MJS; Kerr, T; Tyndall, M; Montaner, J; Wood, E				Milloy, M-J. S.; Kerr, Thomas; Tyndall, Mark; Montaner, Julio; Wood, Evan			Estimated Drug Overdose Deaths Averted by North America's First Medically-Supervised Safer Injection Facility	PLOS ONE			English	Article							NONFATAL HEROIN OVERDOSE; USERS; COHORT; RISK; INTERVENTION; AUSTRALIA; MORTALITY	Background: Illicit drug overdose remains a leading cause of premature mortality in urban settings worldwide. We sought to estimate the number of deaths potentially averted by the implementation of a medically supervised safer injection facility (SIF) in Vancouver, Canada. Methodology/Principal Findings: The number of potentially averted deaths was calculated using an estimate of the local ratio of non-fatal to fatal overdoses. Inputs were derived from counts of overdose deaths by the British Columbia Vital Statistics Agency and non-fatal overdose rates from published estimates. Potentially-fatal overdoses were defined as events within the SIF that required the provision of naloxone, a 911 call or an ambulance. Point estimates and 95% Confidence Intervals (95% CI) were calculated using a Monte Carlo simulation. Between March 1, 2004 and July 1, 2008 there were 1004 overdose events in the SIF of which 453 events matched our definition of potentially fatal. In 2004, 2005 and 2006 there were 32, 37 and 38 drug-induced deaths in the SIF's neighbourhood. Owing to the wide range of non-fatal overdose rates reported in the literature (between 5% and 30% per year) we performed sensitivity analyses using non-fatal overdose rates of 50, 200 and 300 per 1,000 person years. Using these model inputs, the number of averted deaths were, respectively: 50.9 (95% CI: 23.6-78.1); 12.6 (95% CI: 9.6-15.7); 8.4 (95% CI: 6.5-10.4) during the study period, equal to 1.9 to 11.7 averted deaths per annum. Conclusions/Significance: Based on a conservative estimate of the local ratio of non-fatal to fatal overdoses, the potentially fatal overdoses in the SIF during the study period could have resulted in between 8 and 51 deaths had they occurred outside the facility, or from 6% to 37% of the total overdose mortality burden in the neighborhood during the study period. These data should inform the ongoing debates over the future of the pilot project.	[Milloy, M-J. S.; Kerr, Thomas; Tyndall, Mark; Montaner, Julio; Wood, Evan] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Milloy, M-J. S.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Kerr, Thomas; Tyndall, Mark; Montaner, Julio; Wood, Evan] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia	Milloy, MJS (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	uhri-ew@cfenet.ubc.ca	Montaner, Julio/K-7621-2012; Milloy, M-J/AAY-3618-2020	Tyndall, Mark/0000-0003-4450-5679	Health Canada; Canadian Institutes of Health Research; Vancouver Coastal Health	Health Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Vancouver Coastal Health	The SIF evaluation was originally funded by a contribution from Health Canada, although the views expressed in this analysis do not represent the official policies of Health Canada. The evaluation is now supported by the Canadian Institutes of Health Research and Vancouver Coastal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRESEN M, 2008, COST BENEFIT COST EF; Bargagli AM, 2006, EUR J PUBLIC HEALTH, V16, P198, DOI 10.1093/eurpub/cki168; BENNETT GA, 1999, ACCIDENTAL OVERDOSE; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; *BRIT COL VIT STAT, 2002, ANN REP 2001 BRIT CO; *BRIT COL VIT STAT, 2005, ANN REP 2004 BRIT CO; *BRIT COL VIT STAT, 1999, ANN REP 1998 BRIT CO; *BRIT COL VIT STAT, 2006, ANN REP 2005 BRIT CO; *BRIT COL VIT STAT, 2001, ANN REP 2000 BRIT CO; *BRIT COL VIT STAT, 2007, ANN REP 2006 BRIT CO; *BRIT COL VIT STAT, 2000, ANN REP 1999 BRIT CO; *BRIT COL VIT STAT, 2003, ANN REP 2002 BRIT CO; *BRIT COL VIT STAT, 2004, ANN REP 2003 BRIT CO; Coffin PO, 2007, ACAD EMERG MED, V14, P616, DOI [10.1197/j.aem.2007.04.005, 10.1111/j.1553-2712.2007.tb01846.x]; Darke S, 2005, DRUG ALCOHOL REV, V24, P425, DOI 10.1080/09595230500286005; Darke S, 2003, ADDICTION, V98, P1169, DOI 10.1046/j.1360-0443.2003.00474.x; Darke S, 2003, J URBAN HEALTH, V80, P189, DOI 10.1093/jurban/jtg022; Darke S, 1996, ADDICTION, V91, P405, DOI 10.1111/j.1360-0443.1996.tb02289.x; Darke S, 2007, J URBAN HEALTH, V84, P283, DOI 10.1007/s11524-006-9156-0; Degenhardt Louisa, 2005, J Clin Forensic Med, V12, P187, DOI 10.1016/j.jcfm.2004.11.003; Fischer B, 2004, CAN MED ASSOC J, V171, P235, DOI 10.1503/cmaj.1031416; Fischer B, 2006, CAN J PUBLIC HEALTH, V97, P384, DOI 10.1007/BF03405347; Gossop M, 1996, BRIT MED J, V313, P402; Hulse GK, 1999, ADDICTION, V94, P221, DOI 10.1046/j.1360-0443.1999.9422216.x; Kerr T, 2005, LANCET, V366, P316, DOI 10.1016/S0140-6736(05)66475-6; Kerr T, 2007, INT J DRUG POLICY, V18, P37, DOI 10.1016/j.drugpo.2006.12.008; Kerr T, 2007, DRUG ALCOHOL DEPEN, V87, P39, DOI 10.1016/j.drugalcdep.2006.07.009; Kerr T, 2006, INT J DRUG POLICY, V17, P436, DOI 10.1016/j.drugpo.2006.05.008; McGregor C, 1998, ADDICTION, V93, P701, DOI 10.1046/j.1360-0443.1998.9357016.x; Milloy MJS, 2008, AM J DRUG ALCOHOL AB, V34, P499, DOI 10.1080/00952990802122457; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P1263, DOI 10.1001/jama.279.16.1263-a; Ochoa KC, 2005, DRUG ALCOHOL DEPEN, V80, P297, DOI 10.1016/j.drugalcdep.2005.04.012; OPPENHEIMER E, 1994, ADDICTION, V89, P1299, DOI 10.1111/j.1360-0443.1994.tb03309.x; POSCHADE S, 2003, EVALUATION ARBEIT DR; Remis R.S, 1998, CONSORTIUM CHARACTER; SCHECHTER MT, 1999, GUESSTIMATING NUMBER; SELBY P, 2007, CANADIAN MED ASS J E; *STAND COMM HLTH P, 2008, EV THURSD MAY 29 200; Uniting, 2021, UN MED SUP INJ CTR; Van Beek I., 2004, CRIT PUBLIC HEALTH, V14, P391, DOI DOI 10.1080/09581590400027528; Vingoe L., 1999, J SUBST USE, V4, P88, DOI DOI 10.3109/14659899909053019; Warner-Smith M, 2002, ADDICTION, V97, P963, DOI 10.1046/j.1360-0443.2002.00132.x; Wood E, 2006, NEW ENGL J MED, V354, P2512, DOI 10.1056/NEJMc052939; Wood E, 2000, AIDS, V14, P1229, DOI 10.1097/00002030-200006160-00021; Wood E, 2006, AM J PUBLIC HEALTH, V96, P770, DOI 10.2105/AJPH.2004.057828; Wood E, 2006, ADDICTION, V101, P689, DOI 10.1111/j.1360-0443.2006.01385.x; Wood E, 2004, CAN MED ASSOC J, V171, P731, DOI 10.1503/cmaj.1040774; Wood E, 2006, CAN MED ASSOC J, V175, P1399, DOI 10.1503/cmaj.060863; Wood Evan, 2004, Harm Reduct J, V1, P9, DOI 10.1186/1477-7517-1-9; WOOD RA, 2008, INT J DRUG POLICY; 2007, MMWR MORBIDITY MORTA, V56, P93	51	80	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2008	3	10							e3351	10.1371/journal.pone.0003351	http://dx.doi.org/10.1371/journal.pone.0003351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432DM	18839040	Green Published, gold, Green Submitted			2022-12-27	WOS:000265113700001
J	Rae, C; Koudelka, KJ; Destito, G; Estrada, MN; Gonzalez, MJ; Manchester, M				Rae, Chris; Koudelka, Kristopher J.; Destito, Giuseppe; Estrada, Mayra N.; Gonzalez, Maria J.; Manchester, Marianne			Chemical Addressability of Ultraviolet-Inactivated Viral Nanoparticles (VNPs)	PLOS ONE			English	Article								Background: Cowpea Mosaic Virus (CPMV) is increasingly being used as a nanoparticle platform for multivalent display of molecules via chemical bioconjugation to the capsid surface. A growing variety of applications have employed the CPMV multivalent display technology including nanoblock chemistry, in vivo imaging, and materials science. CPMV nanoparticles can be inexpensively produced from experimentally infected cowpea plants at high yields and are extremely stable. Although CPMV has not been shown to replicate in mammalian cells, uptake in mammalian cells does occur in vitro and in vivo. Thus, inactivation of the virus RNA genome is important for biosafety considerations, however the surface characteristics and chemical reactivity of the particles must be maintained in order to preserve chemical and structural functionality. Methodology/Principal Findings: Short wave (254 nm) UV irradiation was used to crosslink the RNA genome within intact particles. Lower doses of UV previously reported to inactivate CPMV infectivity inhibited symptoms on inoculated leaves but did not prohibit systemic virus spread in plants, whereas higher doses caused aggregation of the particles and an increase in chemical reactivity further indicating broken particles. Intermediate doses of 2.0-2.5 J/cm(2) were shown to maintain particle structure and chemical reactivity, and cellular binding properties were similar to CPMV-WT. Conclusions: These studies demonstrate that it is possible to inactivate CPMV infectivity while maintaining particle structure and function, thus paving the way for further development of CPMV nanoparticles for in vivo applications.	[Rae, Chris; Koudelka, Kristopher J.; Destito, Giuseppe; Estrada, Mayra N.; Gonzalez, Maria J.; Manchester, Marianne] Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA	Scripps Research Institute	Rae, C (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA.	marim@scripps.edu		Manchester, Marianne/0000-0002-7143-5744	NIH [CA112075]; NATIONAL CANCER INSTITUTE [R01CA112075] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH CA112075 to M.M. The NIH was not involved in any way in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Brennan FR, 1999, MICROBIOL-SGM, V145, P211, DOI 10.1099/13500872-145-1-211; Brennan FR, 1999, VACCINE, V17, P1846, DOI 10.1016/S0264-410X(98)00485-X; Brennan FR, 1999, J VIROL, V73, P930, DOI 10.1128/JVI.73.2.930-938.1999; Brennan FR, 1999, MICROBIOL-SGM, V145, P2061, DOI 10.1099/13500872-145-8-2061; Chatterji A, 2004, CHEM BIOL, V11, P855, DOI 10.1016/j.chembiol.2004.04.011; DEJAGER CP, 1970, VIROLOGY, V41, P281, DOI 10.1016/0042-6822(70)90080-2; Destito G, 2007, CHEM BIOL, V14, P1152, DOI 10.1016/j.chembiol.2007.08.015; Durrani Z, 1998, J IMMUNOL METHODS, V220, P93, DOI 10.1016/S0022-1759(98)00145-8; Gilleland HE, 2000, FEMS IMMUNOL MED MIC, V27, P291, DOI 10.1111/j.1574-695X.2000.tb01442.x; Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; Horowitz B, 1995, Curr Opin Hematol, V2, P484; Koudelka KJ, 2007, J VIROL, V81, P1632, DOI 10.1128/JVI.00960-06; Langeveld JPM, 2001, VACCINE, V19, P3661, DOI 10.1016/S0264-410X(01)00083-4; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Lin TW, 1999, VIROLOGY, V265, P20, DOI 10.1006/viro.1999.0038; LOMONOSSOFF GP, 1991, PROG BIOPHYS MOL BIO, V55, P107, DOI 10.1016/0079-6107(91)90003-B; MCINTOSH PD, 1999, FOREST PRACTICES NEW, V1, P17; Medintz IL, 2005, LANGMUIR, V21, P5501, DOI 10.1021/la0468287; Nuanualsuwan S, 2003, APPL ENVIRON MICROB, V69, P350, DOI 10.1128/AEM.69.1.350-357.2003; Ochoa WF, 2006, CHEM BIOL, V13, P771, DOI 10.1016/j.chembiol.2006.05.014; Phelps JP, 2007, J VIROL METHODS, V141, P146, DOI 10.1016/j.jviromet.2006.12.008; PORTA C, 1994, VIROLOGY, V202, P949, DOI 10.1006/viro.1994.1417; Portney NG, 2005, LANGMUIR, V21, P2098, DOI 10.1021/la047525f; RAE CS, 2005, VIROLOGY; Raja KS, 2003, BIOMACROMOLECULES, V4, P472, DOI 10.1021/bm025740+; Raja KS, 2003, CHEMBIOCHEM, V4, P1348, DOI 10.1002/cbic.200300759; RAJA KS, 2004, ARTIFICIAL IN PRESS; Sapsford KE, 2006, BIOSENS BIOELECTRON, V21, P1668, DOI 10.1016/j.bios.2005.09.003; Sen Gupta S, 2005, BIOCONJUGATE CHEM, V16, P1572, DOI 10.1021/bc050147l; Singh Pratik, 2006, J Nanobiotechnology, V4, P2, DOI 10.1186/1477-3155-4-2; Steinmetz NF, 2006, LANGMUIR, V22, P3488, DOI 10.1021/la060078e; Steinmetz NF, 2006, SMALL, V2, P530, DOI 10.1002/smll.200500453; Steinmetz NF, 2008, BIOMACROMOLECULES, V9, P456, DOI 10.1021/bm700797b; Steinmetz NF, 2007, ORG BIOMOL CHEM, V5, P2891, DOI 10.1039/b708175h; Steinmetz NF, 2006, LANGMUIR, V22, P10032, DOI 10.1021/la0621362; VANKAMME.A, 1968, VIROLOGY, V34, P312, DOI 10.1016/0042-6822(68)90241-9; VANKAMMEN A, 1970, VIROLOGY, V41, P274, DOI 10.1016/0042-6822(70)90079-6; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Wang Q, 2002, ANGEW CHEM INT EDIT, V41, P459; Wang Q, 2002, CHEM BIOL, V9, P813, DOI 10.1016/S1074-5521(02)00166-7; WANG Q, 2002, CHEM BIOL, V9; YOUNG M, 2008, ANN REV PHYTOPATHOL	42	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3315	10.1371/journal.pone.0003315	http://dx.doi.org/10.1371/journal.pone.0003315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830402	Green Published, Green Submitted, gold			2022-12-27	WOS:000264797300006
J	Fiorillo, CD				Fiorillo, Christopher D.			Towards a General Theory of Neural Computation Based on Prediction by Single Neurons	PLOS ONE			English	Article								Although there has been tremendous progress in understanding the mechanics of the nervous system, there has not been a general theory of its computational function. Here I present a theory that relates the established biophysical properties of single generic neurons to principles of Bayesian probability theory, reinforcement learning and efficient coding. I suggest that this theory addresses the general computational problem facing the nervous system. Each neuron is proposed to mirror the function of the whole system in learning to predict aspects of the world related to future reward. According to the model, a typical neuron receives current information about the state of the world from a subset of its excitatory synaptic inputs, and prior information from its other inputs. Prior information would be contributed by synaptic inputs representing distinct regions of space, and by different types of non-synaptic, voltage-regulated channels representing distinct periods of the past. The neuron's membrane voltage is proposed to signal the difference between current and prior information ("prediction error'' or "surprise''). A neuron would apply a Hebbian plasticity rule to select those excitatory inputs that are the most closely correlated with reward but are the least predictable, since unpredictable inputs provide the neuron with the most "new'' information about future reward. To minimize the error in its predictions and to respond only when excitation is "new and surprising,'' the neuron selects amongst its prior information sources through an anti-Hebbian rule. The unique inputs of a mature neuron would therefore result from learning about spatial and temporal patterns in its local environment, and by extension, the external world. Thus the theory describes how the structure of the mature nervous system could reflect the structure of the external world, and how the complexity and intelligence of the system might develop from a population of undifferentiated neurons, each implementing similar learning algorithms.	[Fiorillo, Christopher D.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Fiorillo, CD (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	chris@monkeybiz.stanford.edu	Fiorillo, Christopher Dante/C-1718-2011	Fiorillo, Christopher/0000-0002-7232-9505				Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; BARLOW H, 1989, COMP NEUR S, P54; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BELL CC, 1993, P NATL ACAD SCI USA, V90, P4650, DOI 10.1073/pnas.90.10.4650; Bell CC, 2001, CURR OPIN NEUROBIOL, V11, P481, DOI 10.1016/S0959-4388(00)00238-5; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dayan P, 2001, COMPUTATIONAL NEUROS; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Dickinson A., 1980, CONT ANIMAL LEARNING; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Hawkins J, 2004, INTELLIGENCE; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Jaynes E.T., 2003, PROBABILITY THEORY L; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marr D., 1982, VISION; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; PALMIERI F, 1993, IEEE T NEURAL NETWOR, V4, P748, DOI 10.1109/72.248453; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Rieke F., 1997, SPIKES EXPLORING NEU; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; VONHELMHOLZ H, 1896, TREATISE PHYSL OPTIC; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	42	37	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3298	10.1371/journal.pone.0003298	http://dx.doi.org/10.1371/journal.pone.0003298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18827880	Green Published, gold, Green Submitted			2022-12-27	WOS:000264797200005
J	Lescano, AR; Blazes, DL; Montano, SM; Moran, Z; Naquira, C; Ramirez, E; Lie, R; Martin, GJ; Lescano, AG; Zunt, JR				Lescano, A. Roxana; Blazes, David L.; Montano, Silvia M.; Moran, Zoe; Naquira, Cesar; Ramirez, Edwin; Lie, Reidar; Martin, Gregory J.; Lescano, Andres G.; Zunt, Joseph R.			Research Ethics Training in Peru: A Case Study	PLOS ONE			English	Article								With the rapidly increasing number of health care professionals seeking international research experience, comes an urgent need for enhanced capacity of host country institutional review boards (IRB) to review research proposals and ensure research activities are both ethical and relevant to the host country customs and needs. A successful combination of distance learning, interactive courses and expert course instructors has been applied in Peru since 2004 through collaborations between the U. S. Naval Medical Research Center Detachment, the University of Washington and the Department of Clinical Bioethics of the National Institutes of Health to provide training in ethical conduct of research to IRB members and researchers from Peru and other Latin American countries. All training activities were conducted under the auspices of the Peruvian National Institute of Health (INS), Ministry of Health. To date, 927 people from 12 different Latin American countries have participated in several of these training activities. In this article we describe our training model.	[Lescano, A. Roxana; Blazes, David L.; Montano, Silvia M.; Moran, Zoe; Martin, Gregory J.; Lescano, Andres G.] USN, Med Res Ctr Detachment, Lima, Peru; [Naquira, Cesar] Inst Nacl Salud, Peruvian Minist Hlth, Lima, Peru; [Ramirez, Edwin] Hosp Nacl Dos Mayo, Lima, Peru; [Lie, Reidar] Univ Washington, Dept Clin Bioeth, NIH, Seattle, WA 98195 USA; [Zunt, Joseph R.] Univ Washington, Dept Neurol, Glob Hlth & Med, Seattle, WA 98195 USA	Instituto Nacional de Salud - Peru; National Institutes of Health (NIH) - USA; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lescano, AR (corresponding author), USN, Med Res Ctr Detachment, Lima, Peru.	Roxana.Lescano@med.navy.mil	Martin, Gregory/CAG-8518-2022; Lescano, Andres G/B-8479-2008; Zunt, Joseph/ABD-2886-2021; Lescano, Andres G./M-9849-2019	Lescano, Andres G/0000-0001-9779-633X; Lescano, Andres G./0000-0001-9779-633X; Naquira, Cesar/0000-0003-0271-4165; Lescano, Roxana/0000-0002-3132-6287	 [847705 82000 25GB B0016];  [R21NS048838];  [AI27757];  [1D43TW007393-01]; FOGARTY INTERNATIONAL CENTER [D43TW007393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS048838] Funding Source: NIH RePORTER	; ; ; ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by work unit number No. 847705 82000 25GB B0016 and by Grants number R21NS048838, AI27757 and 1D43TW007393-01, Title: Fogarty International Center Grant, AIDS Research and (CFAR) Grant and Fogarty Global Infectious Diseases Training.	Drain PK, 2007, ACAD MED, V82, P226, DOI 10.1097/ACM.0b013e3180305cf9; *WEMOS, 2007, BITT PILL RISK CARR	2	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3274	10.1371/journal.pone.0003274	http://dx.doi.org/10.1371/journal.pone.0003274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818763	Green Submitted, Green Published, gold			2022-12-27	WOS:000264432300002
J	Josse, T; Maurel-Zaffran, C; de Vanssay, A; Teysset, L; Todeschini, AL; Delmarre, V; Chaminade, N; Anxolabehere, D; Ronsseray, S				Josse, Thibaut; Maurel-Zaffran, Corinne; de Vanssay, Augustin; Teysset, Laure; Todeschini, Anne-Laure; Delmarre, Valerie; Chaminade, Nicole; Anxolabehere, Dominique; Ronsseray, Stephane			Telomeric Trans-Silencing in Drosophila melanogaster. Tissue Specificity, Development and Functional Interactions between Non-Homologous Telomeres	PLOS ONE			English	Article								Background: The study of P element repression in Drosophila melanogaster led to the discovery of the telomeric Trans-Silencing Effect (TSE), a homology-dependent repression mechanism by which a P-transgene inserted in subtelomeric heterochromatin (Telomeric Associated Sequences, "TAS'') has the capacity to repress in trans, in the female germline, a homologous P-lacZ transgene located in euchromatin. TSE can show variegation in ovaries, displays a maternal effect as well as an epigenetic transmission through meiosis and involves heterochromatin and RNA silencing pathways. Principal Findings: Here, we analyze phenotypic and genetic properties of TSE. We report that TSE does not occur in the soma at the adult stage, but appears restricted to the female germline. It is detectable during development at the third instar larvae where it presents the same tissue specificity and maternal effect as in adults. Transgenes located in TAS at the telomeres of the main chromosomes can be silencers which in each case show the maternal effect. Silencers located at non-homologous telomeres functionally interact since they stimulate each other via the maternally-transmitted component. All germinally-expressed euchromatic transgenes tested, located on all major chromosomes, were found to be repressed by a telomeric silencer: thus we detected no TSE escaper. The presence of the euchromatic target transgene is not necessary to establish the maternal inheritance of TSE, responsible for its epigenetic behavior. A single telomeric silencer locus can simultaneously repress two P-lacZ targets located on different chromosomal arms. Conclusions and Significance: Therefore TSE appears to be a widespread phenomenon which can involve different telomeres and work across the genome. It can explain the P cytotype establishment by telomeric P elements in natural Drosophila populations.	[Josse, Thibaut; Maurel-Zaffran, Corinne; de Vanssay, Augustin; Teysset, Laure; Todeschini, Anne-Laure; Delmarre, Valerie; Anxolabehere, Dominique; Ronsseray, Stephane] Univ Paris 06, CNRS, UMR7592, Inst Jacques Monod, Lab Dynam Genome Evol, F-75252 Paris, France; [Josse, Thibaut; Maurel-Zaffran, Corinne; de Vanssay, Augustin; Teysset, Laure; Todeschini, Anne-Laure; Delmarre, Valerie; Anxolabehere, Dominique; Ronsseray, Stephane] Univ Paris 07, F-75221 Paris, France; [de Vanssay, Augustin; Teysset, Laure; Todeschini, Anne-Laure; Delmarre, Valerie; Ronsseray, Stephane] Univ Paris 06, CNRS, UMR7622, Lab Biol Dev, F-75252 Paris, France; [Chaminade, Nicole] CNRS, Bat 13, UPR 9034, Lab Evol, Genomes, Speciat, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Josse, T (corresponding author), Univ Paris 05, UPR2228, CNRS, UFR Biomed, Paris, France.	stephane.ronsseray@snv.jussieu.fr	Ronsseray, Stephane/AAD-6378-2021; Josse, Thibaut/F-5606-2016	Josse, Thibaut/0000-0002-6607-506X; Teysset, Laure/0000-0002-7413-1850	Centre National de la Recherche Scientifique; Universite Pierre & Marie Curie - Paris 6; Universite Paris-Diderot - Paris 7; Action Concertee Incitative - Biologie Moleculaire et Structurale" programme; Association pour la Recherche sur le Cancer; French government (Ministere de l'Enseignement Superieur et de la Recherche) [graduate student fellowships]; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre & Marie Curie - Paris 6; Universite Paris-Diderot - Paris 7; Action Concertee Incitative - Biologie Moleculaire et Structurale" programme; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); French government (Ministere de l'Enseignement Superieur et de la Recherche); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the "Centre National de la Recherche Scientifique" ("Institut Jacques Monod - Unite Mixte de Recherche 7592" and "Laboratoire de Biologie du developpement - Unite Mixte de Recherche 7622"), by the Universite Pierre & Marie Curie - Paris 6, by the Universite Paris-Diderot - Paris 7, by the "Action Concertee Incitative - Biologie Moleculaire et Structurale" programme and by the "Association pour la Recherche sur le Cancer". T.J and A.V. were supported by graduate student fellowships from the French government (Ministere de l'Enseignement Superieur et de la Recherche). T.J was also supported by the "Association pour la Recherche sur le Cancer". A.L.T. was supported by a post-doctoral position fellowship from the "Fondation pour la Recherche Medicale." We thank these organizations for their funding.	Andreyeva EN, 2005, J CELL SCI, V118, P5465, DOI 10.1242/jcs.02654; ANXOLABEHERE D, 1988, MOL BIOL EVOL, V5, P252; ANXOLABEHERE D, 1987, EVOLUTION, V41, P846, DOI 10.1111/j.1558-5646.1987.tb05857.x; Biessmann H, 2005, GENETICS, V171, P1767, DOI 10.1534/genetics.105.048827; BINGHAM PM, 1982, CELL, V29, P995, DOI 10.1016/0092-8674(82)90463-9; BLACK DM, 1987, EMBO J, V6, P4125, DOI 10.1002/j.1460-2075.1987.tb02758.x; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; Boivin A, 2003, GENETICS, V164, P195; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Chalvet F, 1999, EMBO J, V18, P2659, DOI 10.1093/emboj/18.9.2659; COEN D, 1994, GENETICA, V93, P61, DOI 10.1007/BF01435240; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; DANIELS SB, 1987, GENETICS, V115, P711; Desset S, 2003, GENETICS, V164, P501; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Dorer DR, 1997, GENETICS, V147, P1181; ENGELS WR, 1979, P NATL ACAD SCI USA, V76, P4011, DOI 10.1073/pnas.76.8.4011; ENGELS WR, 1989, P ELEMENTS DROSOPHIL, P437; Frydrychova RC, 2007, MOL CELL BIOL, V27, P4991, DOI 10.1128/MCB.00515-07; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; GLOOR GB, 1993, GENETICS, V135, P81; Golubovsky MD, 2001, GENETICS, V158, P1111; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; JENSEN PA, 2008, GENETICS; Josse T, 2007, PLOS GENET, V3, P1633, DOI 10.1371/journal.pgen.0030158; KARPEN GH, 1992, GENETICS, V132, P737; KIDWELL MG, 1977, GENETICS, V86, P813; KIDWELL MG, 1983, P NATL ACAD SCI-BIOL, V80, P1655, DOI 10.1073/pnas.80.6.1655; LEMAITRE B, 1993, GENETICS, V135, P149; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; LEVIS RW, 1989, CELL, V58, P791, DOI 10.1016/0092-8674(89)90112-8; LEVIS RW, 1993, CELL, V75, P1083, DOI 10.1016/0092-8674(93)90318-K; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Marin L, 2000, GENETICS, V155, P1841; Mason JM, 2008, BIOESSAYS, V30, P25, DOI 10.1002/bies.20688; Mason JM, 2003, GENETICS, V163, P917; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; MISRA S, 1993, GENETICS, V135, P785; MISRA S, 1990, CELL, V62, P269, DOI 10.1016/0092-8674(90)90365-L; Niemi JB, 2004, GENETICS, V166, P255, DOI 10.1534/genetics.166.1.255; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; PELISSON A, 2006, J VIROL; PRESTON CR, 1989, PROG NUCLEIC ACID RE, V36, P71; RASMUSSON KE, 1993, GENETICS, V133, P605; Reiss D, 2004, MOL GENET GENOMICS, V272, P336, DOI 10.1007/s00438-004-1061-1; RIO DC, 1991, TRENDS GENET, V7, P282, DOI 10.1016/0168-9525(91)90176-Q; Rio Donald C., 2002, P484; ROBERTSON HM, 1989, GENETICS, V123, P815; Roche SE, 1998, GENETICS, V149, P1839; Ronsseray S, 1996, GENETICS, V143, P1663; RONSSERAY S, 1993, MOL GEN GENET, V241, P115, DOI 10.1007/BF00280208; RONSSERAY S, 1989, CHROMOSOMA, V98, P207, DOI 10.1007/BF00329685; Ronsseray S, 1998, GENETICS, V149, P1857; RONSSERAY S, 1991, GENETICS, V129, P501; Ronsseray S, 2003, GENETICA, V117, P327, DOI 10.1023/A:1022929121828; Ronsseray S, 2001, GENETICS, V159, P1631; ROSEMAN RR, 1995, GENETICS, V141, P1061; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Simmons MJ, 2007, GENETICS, V176, P1945, DOI 10.1534/genetics.106.066746; Simmons MJ, 2004, GENETICS, V166, P243, DOI 10.1534/genetics.166.1.243; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Stuart JR, 2002, GENETICS, V162, P1641; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	71	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3249	10.1371/journal.pone.0003249	http://dx.doi.org/10.1371/journal.pone.0003249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LY	18813361	Green Published, Green Submitted, gold			2022-12-27	WOS:000264430800001
J	Hashimoto, K; Nishiyama, S; Ohba, H; Matsuo, M; Kobashi, T; Takahagi, M; Iyo, M; Kitashoji, T; Tsukada, H				Hashimoto, Kenji; Nishiyama, Shingo; Ohba, Hiroyuki; Matsuo, Masaaki; Kobashi, Tatsuhiko; Takahagi, Makoto; Iyo, Masaomi; Kitashoji, Takeru; Tsukada, Hideo			[C-11]CHIBA-1001 as a Novel PET Ligand for alpha 7 Nicotinic Receptors in the Brain: A PET Study in Conscious Monkeys	PLOS ONE			English	Article								Background: The alpha 7 nicotinic acetylcholine receptors (nAChRs) play an important role in the pathophysiology of neuropsychiatric diseases such as schizophrenia and Alzheimer's disease. However, there are currently no suitable positron emission tomography (PET) radioligands for imaging a7 nAChRs in the intact human brain. Here we report the novel PET radioligand [C-11] CHIBA-1001 for in vivo imaging of alpha 7 nAChRs in the non-human primate brain. Methodology/Principal Findings: A receptor binding assay showed that CHIBA-1001 was a highly selective ligand at alpha 7 nAChRs. Using conscious monkeys, we found that the distribution of radioactivity in the monkey brain after intravenous administration of [C-11] CHIBA-1001 was consistent with the regional distribution of alpha 7 nAChRs in the monkey brain. The distribution of radioactivity in the brain regions after intravenous administration of [C-11] CHIBA-1001 was blocked by pretreatment with the selective alpha 7 nAChR agonist SSR180711 (5.0 g/kg). However, the distribution of [C-11] CHIBA-1001 was not altered by pretreatment with the selective alpha 4 beta 2 nAChR agonist A85380 (1.0 mg/kg). Interestingly, the binding of [C-11]CHIBA-1001 in the frontal cortex of the monkey brain was significantly decreased by subchronic administration of the N-methyl-D-aspartate (NMDA) receptor antagonist phencyclidine (0.3 mg/kg, twice a day for 13 days); which is a non-human primate model of schizophrenia. Conclusions/Significance: The present findings suggest that [C-11]CHIBA-1001 could be a novel useful PET ligand for in vivo study of the receptor occupancy and pathophysiology of alpha 7 nAChRs in the intact brain of patients with neuropsychiatric diseases such as schizophrenia and Alzheimer's disease.	[Hashimoto, Kenji] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan; [Iyo, Masaomi] Chiba Univ, Ctr Forensic Mental Hlth, Div Med Treatment & Rehab, Chiba, Japan; [Nishiyama, Shingo; Ohba, Hiroyuki; Tsukada, Hideo] Hamamatsu Photonics K K, Cent Res Lab, PET Ctr, Hamamatsu, Shizuoka, Japan; [Matsuo, Masaaki; Kobashi, Tatsuhiko; Takahagi, Makoto; Kitashoji, Takeru] Nard Inst Ltd, Amagasaki, Hyogo, Japan; [Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan	Chiba University; Chiba University; Hamamatsu Photonics; Chiba University	Hashimoto, K (corresponding author), Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015; Waldvogel, Henry/D-6691-2012	Hashimoto, Kenji/0000-0002-8892-0439; Waldvogel, Henry/0000-0003-2165-8568	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan; Research Program on Development of Innovative Technology, Japan Science and Technology Agency (JST); CREST, JST	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan(National Institute of Biomedical Innovation); Research Program on Development of Innovative Technology, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was supported in part by grants from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan (to K.H.), Research Program on Development of Innovative Technology, Japan Science and Technology Agency (JST), and CREST, JST (to H.T.). These funders had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report, and in the decision to submit the paper for publication.	Biton B, 2007, NEUROPSYCHOPHARMACOL, V32, P1, DOI 10.1038/sj.npp.1301189; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Briggs CA, 2008, BRIT J PHARMACOL, V153, P1054, DOI 10.1038/sj.bjp.0707649; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; Brody AL, 2006, ARCH GEN PSYCHIAT, V63, P907, DOI 10.1001/archpsyc.63.8.907; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Burghaus L, 2000, MOL BRAIN RES, V76, P385; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Court J, 2001, BIOL PSYCHIAT, V49, P175, DOI 10.1016/S0006-3223(00)01116-1; D'Andrea MR, 2006, CURR PHARM DESIGN, V12, P677, DOI 10.2174/138161206775474224; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; FREEDMAN R, 1994, HARVARD REV PSYCHIAT, V2, P179, DOI 10.3109/10673229409017136; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Gallezot JD, 2005, J NUCL MED, V46, P240; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Han ZY, 2003, J COMP NEUROL, V461, P49, DOI 10.1002/cne.10659; Hashimoto K, 2004, NEUROPSYCHOPHARMACOL, V29, P2018, DOI 10.1038/sj.npp.1300512; Hashimoto K., 2007, NEUROGENETICS PSYCHI, P81; Hashimoto K, 2008, BIOL PSYCHIAT, V63, P92, DOI 10.1016/j.biopsych.2007.04.034; Hashimoto K, 2007, BIOL PSYCHIAT, V61, P577, DOI 10.1016/j.biopsych.2006.03.019; Hashimoto K, 2005, CURR PSYCHIATRY REV, V1, P151, DOI 10.2174/1573400054065569; Hashimoto Kenji, 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P171, DOI 10.2174/1568015054863828; Hashimoto K, 2006, EUR J PHARMACOL, V553, P191, DOI 10.1016/j.ejphar.2006.09.055; Heiss WD, 2006, J NUCL MED, V47, P302; Hellstrom-Lindahl E, 1999, MOL BRAIN RES, V66, P94, DOI 10.1016/S0169-328X(99)00030-3; Horti AG, 2006, CURR PHARM DESIGN, V12, P3877, DOI 10.2174/138161206778559605; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; Jessen F, 2001, AM J PSYCHIAT, V158, P1319, DOI 10.1176/appi.ajp.158.8.1319; Kadir A, 2006, PSYCHOPHARMACOLOGY, V188, P509, DOI 10.1007/s00213-006-0447-7; Koike K, 2005, SCHIZOPHR RES, V76, P67, DOI 10.1016/j.schres.2004.12.016; Kulak JM, 2006, EUR J NEUROSCI, V23, P2604, DOI 10.1111/j.1460-9568.2006.04804.x; Kulak JM, 2004, BRAIN RES, V999, P193, DOI 10.1016/j.brainres.2003.10.062; Leonard S, 2002, ARCH GEN PSYCHIAT, V59, P1085, DOI 10.1001/archpsyc.59.12.1085; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Martin-Ruiz CM, 2003, BIOL PSYCHIAT, V54, P1222, DOI 10.1016/S0006-3223(03)00348-2; Marutle A, 2001, J CHEM NEUROANAT, V22, P115, DOI 10.1016/S0891-0618(01)00117-X; Nomikos GG, 2000, BEHAV BRAIN RES, V113, P97, DOI 10.1016/S0166-4328(00)00204-7; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; Olincy A, 2006, ARCH GEN PSYCHIAT, V63, P630, DOI 10.1001/archpsyc.63.6.630; ONOE H, 1994, BRAIN RES, V663, P191, DOI 10.1016/0006-8993(94)91263-7; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Pichat P, 2007, NEUROPSYCHOPHARMACOL, V32, P17, DOI 10.1038/sj.npp.1301188; Rueter LE, 2006, CNS DRUG REV, V12, P100, DOI 10.1111/j.1527-3458.2006.00100.x; Sihver W, 2000, BEHAV BRAIN RES, V113, P143, DOI 10.1016/S0166-4328(00)00209-6; Sullivan JP, 1996, NEUROPHARMACOLOGY, V35, P725, DOI 10.1016/0028-3908(96)84644-2; TAKECHI H, 1994, NEUROSCI LETT, V182, P279, DOI 10.1016/0304-3940(94)90816-8; Tsukada H, 2005, NEUROPSYCHOPHARMACOL, V30, P1861, DOI 10.1038/sj.npp.1300732; Watanabe M, 1997, IEEE T NUCL SCI, V44, P1277, DOI 10.1109/23.597001	51	51	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3231	10.1371/journal.pone.0003231	http://dx.doi.org/10.1371/journal.pone.0003231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800169	gold, Green Published, Green Submitted			2022-12-27	WOS:000264428400002
J	Yan, RHY; Malisch, JL; Hannon, RM; Hurd, PL; Garland, T				Yan, Reginia H. Y.; Malisch, Jessica L.; Hannon, Robert M.; Hurd, Peter L.; Garland, Theodore, Jr.			Selective Breeding for a Behavioral Trait Changes Digit Ratio	PLOS ONE			English	Article							WHEEL-RUNNING BEHAVIOR; FINGER-LENGTH RATIOS; SEXUAL-DIMORPHISM; POPULATION DIFFERENCES; PHASIANUS-COLCHICUS; FETAL TESTOSTERONE; 4TH-DIGIT RATIO; HOUSE MICE; AGGRESSION; WOMEN	The ratio of the length of the second digit (index finger) divided by the fourth digit (ring finger) tends to be lower in men than in women. This 2D:4D digit ratio is often used as a proxy for prenatal androgen exposure in studies of human health and behavior. For example, 2D:4D ratio is lower (i.e. more "masculinized'') in both men and women of greater physical fitness and/or sporting ability. Lab mice have also shown variation in 2D:4D as a function of uterine environment, and mouse digit ratios seem also to correlate with behavioral traits, including daily activity levels. Selective breeding for increased rates of voluntary exercise (wheel running) in four lines of mice has caused correlated increases in aerobic exercise capacity, circulating corticosterone level, and predatory aggression. Here, we show that this selection regime has also increased 2D:4D. This apparent "feminization'' in mice is opposite to the relationship seen between 2D:4D and physical fitness in human beings. The present results are difficult to reconcile with the notion that 2D: 4D is an effective proxy for prenatal androgen exposure; instead, it may more accurately reflect effects of glucocorticoids, or other factors that regulate any of many genes.	[Yan, Reginia H. Y.; Hurd, Peter L.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Malisch, Jessica L.; Hannon, Robert M.; Garland, Theodore, Jr.] Univ Calif Riverside, Dept Biol, Riverside, CA USA	University of Alberta; University of California System; University of California Riverside	Yan, RHY (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.	phurd@ualberta.ca	Hurd, Peter L/A-4342-2009	Hurd, Peter L/0000-0002-4389-0846; Malisch, Jessica/0000-0002-0251-2398; Garland, Theodore/0000-0002-7916-3552	Natural Sciences and Engineering Research Council (NSERC Canada) [249685]; National Science Foundation [IOB-0543429]; University of California Office of the President Dissertation Award	Natural Sciences and Engineering Research Council (NSERC Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); University of California Office of the President Dissertation Award	Supported by Natural Sciences and Engineering Research Council (NSERC Canada) PGS-M scholarship to R.H.Y., NSERC Discovery Grant (249685) to P.L.H., and National Science Foundation grant (IOB-0543429) to T.G. J.L.M was supported by the University of California Office of the President Dissertation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AA, 2005, GENES BRAIN BEHAV, V4, P318, DOI 10.1111/j.1601-183X.2004.00110.x; Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; BAKER F, 1888, AM ANTHROPOL, V1, P51, DOI DOI 10.1525/AA.1888.1.1.02A00040; Benderlioglu Z, 2004, HORM BEHAV, V46, P558, DOI 10.1016/j.yhbeh.2004.06.004; Brown WM, 2002, HORM BEHAV, V42, P380, DOI 10.1006/hbeh.2002.1830; Brown WM, 2002, ANAT RECORD, V267, P231, DOI 10.1002/ar.10108; Burley NT, 2004, P ROY SOC B-BIOL SCI, V271, P239, DOI 10.1098/rspb.2003.2562; Chang JL, 2006, CAN J ZOOL, V84, P1489, DOI 10.1139/Z06-144; Forstmeier W, 2005, P R SOC B, V272, P2641, DOI 10.1098/rspb.2005.3264; Gammie SC, 2003, HORM BEHAV, V44, P209, DOI 10.1016/S0018-506X(03)00140-5; GARLAND T, 2009, EXPT EVOLUT IN PRESS; George R, 1930, ANAT REC, V46, P199, DOI 10.1002/ar.1090460210; Gitau R, 2005, ARCH DIS CHILD-FETAL, V90, P166, DOI 10.1136/adc.2004.049320; Gobrogge KL, 2008, ARCH SEX BEHAV, V37, P112, DOI 10.1007/s10508-007-9272-2; Honekopp J, 2006, HORM BEHAV, V49, P545, DOI 10.1016/j.yhbeh.2005.11.006; Hurd PL, 2008, ARCH SEX BEHAV, V37, P9, DOI 10.1007/s10508-007-9259-z; Hurd PL, 2006, GENES BRAIN BEHAV, V5, P300; KLOEPFER HW, 1946, ANN EUGENIC, V13, P35, DOI 10.1111/j.1469-1809.1946.tb02342.x; Loehlin JC, 2006, ARCH SEX BEHAV, V35, P739, DOI 10.1007/s10508-006-9039-1; Lombardo MP, 2008, ANAT REC, V291, P433, DOI 10.1002/ar.20657; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Malisch JL, 2008, GEN COMP ENDOCR, V156, P210, DOI 10.1016/j.ygcen.2008.01.020; MALSICH JL, 2007, PHYS BIOCH ZOOL, V80, P146; Manning JT, 2007, AM J HUM BIOL, V19, P416, DOI 10.1002/ajhb.20603; Manning JT, 2000, EVOL HUM BEHAV, V21, P163, DOI 10.1016/S1090-5138(00)00029-5; Manning JT, 2003, ANN HUM BIOL, V30, P579, DOI 10.1080/0301446032000112689; Manning JT, 2003, MED HYPOTHESES, V60, P340, DOI 10.1016/S0306-9877(02)00400-0; Manning JT, 2002, J SPORT MED PHYS FIT, V42, P446; Manning JT, 2001, EVOL HUM BEHAV, V22, P61, DOI 10.1016/S1090-5138(00)00063-5; Manning JT., 2002, DIGIT RATIO POINTER; McIntyre MH, 2007, PERS INDIV DIFFER, V42, P755, DOI 10.1016/j.paid.2006.08.009; McIntyre MH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-10; Okten A, 2002, EARLY HUM DEV, V70, P47, DOI 10.1016/S0378-3782(02)00073-7; Paul SN, 2006, BRIT J SPORT MED, V40, P981, DOI 10.1136/bjsm.2006.027193; Paul SN, 2006, TWIN RES HUM GENET, V9, P215, DOI 10.1375/twin.9.2.215; PHELPS VR, 1952, AM J HUM GENET, V4, P72; Pokrywka L, 2005, AM J HUM BIOL, V17, P796, DOI 10.1002/ajhb.20449; Putz DA, 2004, EVOL HUM BEHAV, V25, P182, DOI 10.1016/j.evolhumbehav.2004.03.005; Rezende EL, 2006, J APPL PHYSIOL, V101, P477, DOI 10.1152/japplphysiol.00042.2006; Romano M, 2005, HORM BEHAV, V48, P342, DOI 10.1016/j.yhbeh.2005.03.007; Rubolini D, 2006, ANAT REC PART A, V288A, P491, DOI 10.1002/ar.a.20323; Saino N, 2007, NATURWISSENSCHAFTEN, V94, P207, DOI 10.1007/s00114-006-0188-9; Sokal RR, 1995, BIOMETRY; Swallow JG, 1998, BEHAV GENET, V28, P227, DOI 10.1023/A:1021479331779; van Anders SM, 2006, HORM BEHAV, V49, P315, DOI 10.1016/j.yhbeh.2005.08.003; Voracek M, 2006, GENES BRAIN BEHAV, V5, P299, DOI 10.1111/j.1601-183x.2006.00217.x; WILSON GD, 1983, PERS INDIV DIFFER, V4, P111, DOI 10.1016/0191-8869(83)90061-2	47	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3216	10.1371/journal.pone.0003216	http://dx.doi.org/10.1371/journal.pone.0003216			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422LB	18797502	Green Published, gold			2022-12-27	WOS:000264428200004
J	Chiao, JY; Bowman, NE; Gill, H				Chiao, Joan Y.; Bowman, Nicholas E.; Gill, Harleen			The Political Gender Gap: Gender Bias in Facial Inferences that Predict Voting Behavior	PLOS ONE			English	Article							HUMAN MATE PREFERENCES; ATTRACTIVENESS; METAANALYSIS; WOMEN; APPEARANCE; DOMINANCE; LEADERS; FACES	Background: Throughout human history, a disproportionate degree of political power around the world has been held by men. Even in democracies where the opportunity to serve in top political positions is available to any individual elected by the majority of their constituents, most of the highest political offices are occupied by male leaders. What psychological factors underlie this political gender gap? Contrary to the notion that people use deliberate, rational strategies when deciding whom to vote for in major political elections, research indicates that people use shallow decision heuristics, such as impressions of competence solely from a candidate's facial appearance, when deciding whom to vote for. Because gender has previously been shown to affect a number of inferences made from the face, here we investigated the hypothesis that gender of both voter and candidate affects the kinds of facial impressions that predict voting behavior. Methodology/Principal Finding: Male and female voters judged a series of male and female political candidates on how competent, dominant, attractive and approachable they seemed based on their facial appearance. Then they saw a series of pairs of political candidates and decided which politician they would vote for in a hypothetical election for President of the United States. Results indicate that both gender of voter and candidate affect the kinds of facial impressions that predict voting behavior. All voters are likely to vote for candidates who appear more competent. However, male candidates that appear more approachable and female candidates who appear more attractive are more likely to win votes. In particular, men are more likely to vote for attractive female candidates whereas women are more likely to vote for approachable male candidates. Conclusions/Significance: Here we reveal gender biases in the intuitive heuristics that voters use when deciding whom to vote for in major political elections. Our findings underscore the impact of gender and physical appearance on shaping voter decision-making and provide novel insight into the psychological foundations underlying the political gender gap.	[Chiao, Joan Y.; Gill, Harleen] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Chiao, Joan Y.; Bowman, Nicholas E.] Northwestern Univ, Interdept Neurosci Program, Evanston, IL 60208 USA; [Gill, Harleen] Smith Coll, Neurosci Program, Northampton, MA USA	Northwestern University; Northwestern University; Smith College	Chiao, JY (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.	jchiao@northwestern.edu		Gill, Harleen/0000-0002-6654-9878	Praxis; NSF [BCS-0720312, BCS-0722326]	Praxis; NSF(National Science Foundation (NSF))	This work is supported by Praxis grant to H.G. and NSF BCS-0720312 and BCS-0722326 grants to J.Y.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBADY N, 1992, PSYCHOL BULL, V111, P256, DOI 10.1037/0033-2909.111.2.256; BEAMAN L, 2008, 0814 MIT DEP EC; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Chattopadhyay R, 2004, ECONOMETRICA, V72, P1409, DOI 10.1111/j.1468-0262.2004.00539.x; Eagly A. H., 1987, SEX DIFFERENCES SOCI, DOI [10.1037/0022-3514.65.5.1010, DOI 10.4324/]; EAGLY AH, 1995, PSYCHOL BULL, V117, P125, DOI 10.1037/0033-2909.117.1.125; Eagly AH, 2003, PSYCHOL BULL, V129, P569, DOI 10.1037/0033-2909.129.4.569; EAGLY AH, 1991, PSYCHOL BULL, V110, P109, DOI 10.1037/0033-2909.110.1.109; GALLUP, 2002, GALLUP POLL PUBLIC O; Hess U, 2004, EMOTION, V4, P378, DOI 10.1037/1528-3542.4.4.378; Jalalzai F, 2004, WOMEN POLIT, V26, P85, DOI 10.1300/J014v26n03_04; KEATING CF, 1985, SOC PSYCHOL QUART, V48, P61, DOI 10.2307/3033782; LAMMERS J, 2008, EUROPEAN J SOCIAL PS; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; MACRAE CN, 1994, J PERS SOC PSYCHOL, V66, P37, DOI 10.1037/0022-3514.66.1.37; MAZUR A, 1994, ETHOL SOCIOBIOL, V15, P87, DOI 10.1016/0162-3095(94)90019-1; Rhodes G, 2002, FACIAL ATTRACTIVENES; Roberts SC, 2004, P ROY SOC B-BIOL SCI, V271, pS270, DOI 10.1098/rsbl.2004.0174; Senior C, 1999, BEHAV RES METH INS C, V31, P341, DOI 10.3758/BF03207730; Shackelford TK, 2005, PERS INDIV DIFFER, V39, P447, DOI 10.1016/j.paid.2005.01.023; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; UNICEF, 2007, STAT WORLDS CHILDR W; Zebrowitz L. A., 1997, READING FACES WINDOW	25	58	58	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3666	10.1371/journal.pone.0003666	http://dx.doi.org/10.1371/journal.pone.0003666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432KK	18974841	Green Published, gold, Green Submitted			2022-12-27	WOS:000265131700033
J	Liesa, M; Borda-d'Agua, B; Medina-Gomez, G; Lelliott, CJ; Paz, JC; Rojo, M; Palacin, M; Vidal-Puig, A; Zorzano, A				Liesa, Marc; Borda-d'Agua, Barbara; Medina-Gomez, Gema; Lelliott, Christopher J.; Carlos Paz, Jose; Rojo, Manuel; Palacin, Manuel; Vidal-Puig, Antonio; Zorzano, Antonio			Mitochondrial Fusion Is Increased by the Nuclear Coactivator PGC-1 beta	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ADAPTIVE THERMOGENESIS; INSULIN-RESISTANCE; IN-VITRO; 2A GENE; MITOFUSIN-2; METABOLISM; DISEASE; MFN2; PGC-1-ALPHA	Background: There is no evidence to date on whether transcriptional regulators are able to shift the balance between mitochondrial fusion and fission events through selective control of gene expression. Methodology/Principal Findings: Here, we demonstrate that reduced mitochondrial size observed in knock-out mice for the transcriptional regulator PGC-1 beta is associated with a selective reduction in Mitofusin 2 (Mfn2) expression, a mitochondrial fusion protein. This decrease in Mfn2 is specific since expression of the remaining components of mitochondrial fusion and fission machinery were not affected. Furthermore, PGC-1 beta increases mitochondrial fusion and elongates mitochondrial tubules. This PGC-1 beta-induced elongation specifically requires Mfn2 as this process is absent in Mfn2-ablated cells. Finally, we show that PGC-1 beta increases Mfn2 promoter activity and transcription by coactivating the nuclear receptor Estrogen Related Receptor alpha (ERR alpha). Conclusions/Significance: Taken together, our data reveal a novel mechanism by which mammalian cells control mitochondrial fusion. In addition, we describe a novel role of PGC-1 beta in mitochondrial physiology, namely the control of mitochondrial fusion mainly through Mfn2.	[Liesa, Marc; Borda-d'Agua, Barbara; Carlos Paz, Jose; Palacin, Manuel; Zorzano, Antonio] IRB Barcelona, Barcelona, Spain; [Liesa, Marc; Borda-d'Agua, Barbara; Carlos Paz, Jose; Palacin, Manuel; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim Biol Mol, E-08007 Barcelona, Spain; [Liesa, Marc; Carlos Paz, Jose; Zorzano, Antonio] CIBERDEM, Barcelona, Spain; [Medina-Gomez, Gema; Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Metabol Res Lab, Inst Metabol Sci, Cambridge CB2 1TN, England; [Lelliott, Christopher J.] AstraZeneca R&D, Dept Biosci, Molndal, Sweden; [Rojo, Manuel] Univ Victor Segalen, CNRS, UMR5095, IBGC, Bordeaux, France	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; AstraZeneca; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Zorzano, A (corresponding author), IRB Barcelona, Barcelona, Spain.	antonio.zorzano@irbbarcelona.org	Zorzano, Antonio/R-5479-2018; Medina-Gomez, Gema/CAI-1063-2022; Medina-Gomez, Gema/CAF-4668-2022; Paz, Jose Carlos/I-5783-2015; Medina-Gomez, Gema/F-5667-2016; Liesa, Marc/K-8590-2019; Lelliott, Christopher J/G-4620-2011; Rojo, Manuel/AAM-7352-2021	Medina-Gomez, Gema/0000-0001-8169-681X; Medina-Gomez, Gema/0000-0001-8169-681X; Paz, Jose Carlos/0000-0001-9684-9735; Medina-Gomez, Gema/0000-0001-8169-681X; Liesa, Marc/0000-0002-5909-8570; Lelliott, Christopher J/0000-0001-8087-4530; Rojo, Manuel/0000-0002-9680-9263; Vidal-Puig, Antonio/0000-0003-4220-9577; Palacin, Manuel/0000-0002-8670-293X	Ministerio de Educacion y Cultura [SAF 2005-00445, SAF2008-03803, predoctoral fellowship]; Generalitat de Catalunya [2005SGR00947]; CIBERDEM (Instituto de Salud Carlos III); University of Barcelona [Science Intensification Award]; MRC [G0400192] Funding Source: UKRI	Ministerio de Educacion y Cultura(German Research Foundation (DFG)); Generalitat de Catalunya(Generalitat de Catalunya); CIBERDEM (Instituto de Salud Carlos III)(Instituto de Salud Carlos III); University of Barcelona; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by research grants from the Ministerio de Educacion y Cultura (SAF 2005-00445; SAF2008-03803), Grant 2005SGR00947 from the Generalitat de Catalunya, and CIBERDEM (Instituto de Salud Carlos III). A.Z. is the recipient of a Science Intensification Award from the University of Barcelona. M.L. is the recipient of a predoctoral fellowship from the Ministerio de Educacion y Cultura, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACSADI G, 1994, GENE THER, V1, P338; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Baumgartner BG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001183; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lelliott CJ, 2007, ARTERIOSCL THROM VAS, V27, P2707, DOI 10.1161/ATVBAHA.107.155739; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086; Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Staiger H, 2006, DIABETOLOGIA, V49, P212, DOI 10.1007/s00125-005-0061-y; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	33	137	140	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3613	10.1371/journal.pone.0003613	http://dx.doi.org/10.1371/journal.pone.0003613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974884	gold, Green Published, Green Submitted			2022-12-27	WOS:000265131700027
J	Haskew-Layton, RE; Rudkouskaya, A; Jin, YQ; Feustel, PJ; Kimelberg, HK; Mongin, AA				Haskew-Layton, Renee E.; Rudkouskaya, Alena; Jin, Yiqiang; Feustel, Paul J.; Kimelberg, Harold K.; Mongin, Alexander A.			Two Distinct Modes of Hypoosmotic Medium-Induced Release of Excitatory Amino Acids and Taurine in the Rat Brain In Vivo	PLOS ONE			English	Article							SH-SY5Y NEUROBLASTOMA-CELLS; ISCHEMIC CORTICAL PENUMBRA; REGULATORY VOLUME DECREASE; SENSITIVE ANION CHANNELS; CEREBRAL-CORTEX; CULTURED ASTROCYTES; CHLORIDE CHANNELS; GLIAL-CELLS; HIPPOCAMPAL SLICES; MOLECULAR IDENTITY	A variety of physiological and pathological factors induce cellular swelling in the brain. Changes in cell volume activate several types of ion channels, which mediate the release of inorganic and organic osmolytes and allow for compensatory cell volume decrease. Volume-regulated anion channels (VRAC) are thought to be responsible for the release of some of organic osmolytes, including the excitatory neurotransmitters glutamate and aspartate. In the present study, we compared the in vivo properties of the swelling-activated release of glutamate, aspartate, and another major brain osmolyte taurine. Cell swelling was induced by perfusion of hypoosmotic (low [NaCl]) medium via a microdialysis probe placed in the rat cortex. The hypoosmotic medium produced several-fold increases in the extracellular levels of glutamate, aspartate and taurine. However, the release of the excitatory amino acids differed from the release of taurine in several respects including: (i) kinetic properties, (ii) sensitivity to isoosmotic changes in [NaCl], and (iii) sensitivity to hydrogen peroxide, which is known to modulate VRAC. Consistent with the involvement of VRAC, hypoosmotic medium-induced release of the excitatory amino acids was inhibited by the anion channel blocker DNDS, but not by the glutamate transporter inhibitor TBOA or Cd(2+), which inhibits exocytosis. In order to elucidate the mechanisms contributing to taurine release, we studied its release properties in cultured astrocytes and cortical synaptosomes. Similarities between the results obtained in vivo and in synaptosomes suggest that the swelling-activated release of taurine in vivo may be of neuronal origin. Taken together, our findings indicate that different transport mechanisms and/or distinct cellular sources mediate hypoosmotic medium-induced release of the excitatory amino acids and taurine in vivo.	[Haskew-Layton, Renee E.; Rudkouskaya, Alena; Feustel, Paul J.; Mongin, Alexander A.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Haskew-Layton, Renee E.] Cornell Univ, Burke Med Res Inst, White Plains, NY USA; [Jin, Yiqiang; Kimelberg, Harold K.] Ordway Res Inst, Albany, NY USA	Albany Medical College; Cornell University; Ordway Research Institute	Mongin, AA (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	MonginA@mail.amc.edu	Mongin, Alexander A./A-5526-2008; Feustel, Paul/AAW-5157-2021	Mongin, Alexander A./0000-0002-2501-3778; Feustel, Paul/0000-0002-6963-4349; Rudkouskaya, Alena/0000-0002-3632-9743	NIH [F31 NS046961, R01 NS035205, R21 NS052516]; AMC [201-311053]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS046961, R01NS035205, R21NS052516] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AMC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH grants F31 NS046961 (to REH-L), R01 NS035205 (to HKK), R21 NS052516 (to AAM), and AMC grant 201-311053 (to AAM). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2006, J PHYSIOL-LONDON, V572, P677, DOI 10.1113/jphysiol.2005.103820; Anderson CM, 2000, GLIA, V32, P1; BANDERALI U, 1992, AM J PHYSIOL, V263, pC1200, DOI 10.1152/ajpcell.1992.263.6.C1200; Basarsky TA, 1999, J NEUROSCI, V19, P6439; Boese SH, 1996, AM J PHYSIOL-RENAL, V271, pF498, DOI 10.1152/ajprenal.1996.271.3.F498; Bothwell JH, 2001, J NEUROCHEM, V77, P1632, DOI 10.1046/j.1471-4159.2001.00403.x; Calvert DT, 1998, ACTA PHYSIOL SCAND, V162, P97, DOI 10.1046/j.1365-201X.1998.0267f.x; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; CHEBABO SR, 1995, J PHYSIOL-LONDON, V487, P685, DOI 10.1113/jphysiol.1995.sp020910; Cheema TA, 2007, J PHARMACOL EXP THER, V320, P1068, DOI 10.1124/jpet.106.115741; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DECAVEL C, 1995, J COMP NEUROL, V354, P13, DOI 10.1002/cne.903540103; Estevez AY, 1999, NEUROCHEM RES, V24, P447, DOI 10.1023/A:1020902104056; Feustel PJ, 2004, STROKE, V35, P1164, DOI 10.1161/01.STR.0000124127.57946.a1; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Franco R, 2003, ADV EXP MED BIOL, V526, P189; Franco R, 2001, PFLUG ARCH EUR J PHY, V442, P791; Franco R, 2000, J NEUROSCI RES, V61, P701, DOI 10.1002/1097-4547(20000915)61:6<701::AID-JNR14>3.3.CO;2-K; HAJOS F, 1975, BRAIN RES, V93, P485, DOI 10.1016/0006-8993(75)90186-9; Haskew RE, 2002, J NEUROCHEM, V82, P903, DOI 10.1046/j.1471-4159.2002.01037.x; Haskew-Layton RE, 2005, J BIOL CHEM, V280, P3548, DOI 10.1074/jbc.M409803200; Heacock AM, 2004, J PHARMACOL EXP THER, V311, P1097, DOI 10.1124/jpet.104.072553; Hussy N, 2000, PROG NEUROBIOL, V62, P113, DOI 10.1016/S0301-0082(99)00071-4; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; HYSLOP PA, 1995, BRAIN RES, V671, P181, DOI 10.1016/0006-8993(94)01291-O; JACKSON PS, 1994, AM J PHYSIOL-CELL PH, V267, pC1203, DOI 10.1152/ajpcell.1994.267.5.C1203; JACKSON PS, 1993, AM J PHYSIOL, V265, pC1489, DOI 10.1152/ajpcell.1993.265.6.C1489; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Junankar PR, 2000, CELL PHYSIOL BIOCHEM, V10, P355, DOI 10.1159/000016368; Kimelberg HK, 2003, J NEUROSURG, V99, P138, DOI 10.3171/jns.2003.99.1.0138; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Kimelberg HK, 2000, NEUROREPORT, V11, P2675, DOI 10.1097/00001756-200008210-00014; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Kirk K, 1998, ANNU REV PHYSIOL, V60, P719, DOI 10.1146/annurev.physiol.60.1.719; KOHUT JJ, 1992, STROKE, V23, P93, DOI 10.1161/01.STR.23.1.93; LAMBERT IH, 1994, J MEMBRANE BIOL, V142, P289; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; LAW RO, 1994, BBA-MOL CELL RES, V1221, P21, DOI 10.1016/0167-4889(94)90211-9; Law RO, 1996, BBA-MOL CELL RES, V1314, P34, DOI 10.1016/S0167-4889(96)00070-5; LEHMANN A, 1990, J NEUROCHEM, V54, P126, DOI 10.1111/j.1471-4159.1990.tb13291.x; LEHMANN A, 1989, J NEUROCHEM, V53, P525, DOI 10.1111/j.1471-4159.1989.tb07365.x; Liu X, 2001, J NEUROENDOCRINOL, V13, P894, DOI 10.1046/j.1365-2826.2001.00711.x; MADSEN S, 1985, NEUROSCI LETT, V60, P255, DOI 10.1016/0304-3940(85)90586-5; Minami A, 2001, BRAIN RES, V894, P336, DOI 10.1016/S0006-8993(01)02022-4; Mongin AA, 1999, AM J PHYSIOL-CELL PH, V276, pC1226, DOI 10.1152/ajpcell.1999.276.5.C1226; Mongin AA, 1997, NEUROCHEM INT, V31, P835, DOI 10.1016/S0197-0186(97)00033-8; Mongin AA, 1999, AM J PHYSIOL-CELL PH, V277, pC823, DOI 10.1152/ajpcell.1999.277.4.C823; MONGIN AA, 2005, NEUROGLIA, P550; Mongin Alexander A, 2007, Pathophysiology, V14, P183, DOI 10.1016/j.pathophys.2007.09.009; Morales I, 2007, AM J PHYSIOL-CELL PH, V292, pC1934, DOI 10.1152/ajpcell.00593.2006; MORAN J, 1994, ADV EXP MED BIOL, V359, P361; Nedvetsky PI, 2000, BIOCHEMISTRY-MOSCOW+, V65, P1027; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Okada Y, 2006, CONTRIB NEPHROL, V152, P9, DOI 10.1159/000096285; Olson JE, 1997, GLIA, V20, P254, DOI 10.1002/(SICI)1098-1136(199707)20:3<254::AID-GLIA9>3.0.CO;2-7; PASANTESMORALES H, 1994, AM J PHYSIOL, V266, pC172, DOI 10.1152/ajpcell.1994.266.1.C172; PASANTESMORALES H, 1990, GLIA, V3, P427, DOI 10.1002/glia.440030514; Phillis JW, 1998, BRAIN RES, V780, P352, DOI 10.1016/S0006-8993(97)01352-8; Phillis JW, 1997, BRAIN RES, V758, P9, DOI 10.1016/S0006-8993(97)00155-8; Phillis JW, 1999, BRAIN RES, V828, P1, DOI 10.1016/S0006-8993(99)01235-4; Pow DV, 2002, GLIA, V37, P153, DOI 10.1002/glia.10026; ROY G, 1995, J MEMBRANE BIOL, V147, P35; Rutledge EM, 1996, J NEUROSCI, V16, P7803; SANCHEZOLEA R, 1993, NEUROSCI LETT, V156, P141, DOI 10.1016/0304-3940(93)90458-W; Saransaari P, 2006, AMINO ACIDS, V31, P35, DOI 10.1007/s00726-006-0290-5; SCHOUSBOE A, 1991, J NEUROSCI RES, V30, P661, DOI 10.1002/jnr.490300409; Seki Y, 1999, STROKE, V30, P433, DOI 10.1161/01.STR.30.2.433; SHARP T, 1990, NEUROSCIENCE, V39, P629, DOI 10.1016/0306-4522(90)90247-2; Shennan DB, 2008, CELL PHYSIOL BIOCHEM, V21, P15, DOI 10.1159/000113743; SHENNAN DB, 1994, EXP PHYSIOL, V79, P797, DOI 10.1113/expphysiol.1994.sp003808; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; STORMMATHISEN J, 1986, MED BIOL, V64, P127; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; Stutzin A, 1999, AM J PHYSIOL-CELL PH, V277, pC392, DOI 10.1152/ajpcell.1999.277.3.C392; Sykova E, 2000, PROG BRAIN RES, V125, P155; TAYLOR DL, 1995, J NEUROCHEM, V65, P275; Tomassen SFB, 2004, AM J PHYSIOL-CELL PH, V286, pC1417, DOI 10.1152/ajpcell.00468.2003; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Tuz K, 2004, EUR J NEUROSCI, V19, P916, DOI 10.1111/j.0953-816X.2004.03209.x; WADE JV, 1988, J NEUROCHEM, V51, P740, DOI 10.1111/j.1471-4159.1988.tb01807.x; Waseem TV, 2005, NEUROCHEM INT, V46, P235, DOI 10.1016/j.neuint.2004.09.002; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; Zhang YH, 2005, EXP NEUROL, V196, P41, DOI 10.1016/j.expneurol.2005.07.002; Zhang YH, 2008, EXP NEUROL, V210, P514, DOI 10.1016/j.expneurol.2007.11.027	86	52	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3543	10.1371/journal.pone.0003543	http://dx.doi.org/10.1371/journal.pone.0003543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958155	Green Submitted, Green Published, gold			2022-12-27	WOS:000265130900005
J	Zito, G; Richiusa, P; Bommarito, A; Carissimi, E; Russo, L; Coppola, A; Zerilli, M; Rodolico, V; Criscimanna, A; Amato, M; Pizzolanti, G; Galluzzo, A; Giordano, C				Zito, Giovanni; Richiusa, Pierina; Bommarito, Alessandra; Carissimi, Elvira; Russo, Leonardo; Coppola, Antonina; Zerilli, Monica; Rodolico, Vito; Criscimanna, Angela; Amato, Marco; Pizzolanti, Giuseppe; Galluzzo, Aldo; Giordano, Carla			In Vitro Identification and Characterization of CD133(pos) Cancer Stem-Like Cells in Anaplastic Thyroid Carcinoma Cell Lines	PLOS ONE			English	Article							HEMATOPOIETIC STEM; EXPRESSION; CARCINOGENESIS; FRAMEWORK; MARKER; LUNG; RNA	Background: Recent publications suggest that neoplastic initiation and growth are dependent on a small subset of cells, termed cancer stem cells (CSCs). Anaplastic Thyroid Carcinoma (ATC) is a very aggressive solid tumor with poor prognosis, characterized by high dedifferentiation. The existence of CSCs might account for the heterogeneity of ATC lesions. CD133 has been identified as a stem cell marker for normal and cancerous tissues, although its biological function remains unknown. Methodology/Principal Findings: ATC cell lines ARO, KAT-4, KAT-18 and FRO were analyzed for CD133 expression. Flow cytometry showed CD133(pos) cells only in ARO and KAT-4 (64 +/- 9% and 57 +/- 12%, respectively). These data were confirmed by qRT-PCR and immunocytochemistry. ARO and KAT-4 were also positive for fetal marker oncofetal fibronectin and negative for thyrocyte-specific differentiating markers thyroglobulin, thyroperoxidase and sodium/iodide symporter. Sorted ARO/CD133(pos) cells exhibited higher proliferation, self-renewal, colony-forming ability in comparison with ARO/CD133(neg). Furthermore, ARO/CD133(pos) showed levels of thyroid transcription factor TTF-1 similar to the fetal thyroid cell line TAD-2, while the expression in ARO/CD133(neg) was negligible. The expression of the stem cell marker OCT-4 detected by RT-PCR and flow cytometry was markedly higher in ARO/CD133(pos) in comparison to ARO/CD133(neg) cells. The stem cell markers c-KIT and THY-1 were negative. Sensitivity to chemotherapy agents was investigated, showing remarkable resistance to chemotherapy-induced apoptosis in ARO/CD133(pos) when compared with ARO/CD133(neg) cells. Conclusions/Significance: We describe CD133(pos) cells in ATC cell lines. ARO/CD133(pos) cells exhibit stem cell-like features such as high proliferation, self-renewal ability, expression of OCT-4 - and are characterized by higher resistance to chemotherapy. The simultaneous positivity for thyroid specific factor TTF-1 and onfFN suggest they might represent putative thyroid cancer stem-like cells. Our in vitro findings might provide new insights for novel therapeutic approaches.	[Zito, Giovanni; Richiusa, Pierina; Bommarito, Alessandra; Carissimi, Elvira; Russo, Leonardo; Coppola, Antonina; Criscimanna, Angela; Amato, Marco; Pizzolanti, Giuseppe; Galluzzo, Aldo; Giordano, Carla] Univ Palermo, DOSAC, Mol Endocrinol Lab, Endocrinol Sect, Palermo, Italy; [Zerilli, Monica; Rodolico, Vito] Univ Palermo, Dept Human Pathol, I-90133 Palermo, Italy	University of Palermo; University of Palermo	Giordano, C (corresponding author), Univ Palermo, DOSAC, Mol Endocrinol Lab, Endocrinol Sect, Palermo, Italy.	cgiordan@unipa.it	Coppola, Antonina/AAE-5901-2021; Coppola, Antonina/AAO-8203-2020; , Zito/O-3836-2019; GIORDANO, Carla/R-4296-2017; Pizzolanti, Giuseppe/I-4547-2019; Coppola, Antonina/AAJ-6763-2020; Pizzolanti, Giuseppe/K-7097-2016	Coppola, Antonina/0000-0001-6664-8553; , Zito/0000-0002-0482-6729; GIORDANO, Carla/0000-0003-1731-9395; Pizzolanti, Giuseppe/0000-0001-6052-8438; RODOLICO, VITO/0000-0003-1409-4207	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was partly supported by grants from the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) 60% (C.G.)	AACE/AME, 2006, ENDOCR PRACT, V12, P63; Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Alderden RA, 2006, J CHEM EDUC, V83, P728, DOI 10.1021/ed083p728; Baguley BC, 2006, RECENT PAT ANTI-CANC, V1, P121, DOI 10.2174/157489206775246494; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; CHO W, 2008, CURR OPIN GENE DEV, V18, P1; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Giordano C, 1997, SCIENCE, V275, P960, DOI 10.1126/science.275.5302.960; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Liedtke S, 2007, CELL STEM CELL, V1, P364, DOI 10.1016/j.stem.2007.09.003; Lin RY, 2007, THYROID, V17, P1019, DOI 10.1089/thy.2007.0183; Liu DX, 2007, CLIN CANCER RES, V13, P1341, DOI 10.1158/1078-0432.CCR-06-1753; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Michael M, 2005, J CLIN ONCOL, V23, P205, DOI 10.1200/JCO.2005.02.120; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mitsutake N, 2007, ENDOCRINOLOGY, V148, P1797, DOI 10.1210/en.2006-1553; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ordonez NG, 2000, ADV ANAT PATHOL, V7, P123, DOI 10.1097/00125480-200007020-00007; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; SCHWEPPE RE, 2008, J CLIN ENDOCRINOL ME; Seigel GM, 2007, MOL VIS, V13, P823; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Takano T, 2005, THYROID, V15, P432, DOI 10.1089/thy.2005.15.432; Takano T, 2007, JPN J CLIN ONCOL, V37, P647, DOI 10.1093/jjco/hym084; Takano T, 2007, SEMIN CANCER BIOL, V17, P233, DOI 10.1016/j.semcancer.2006.02.001; Thomas D, 2008, ENDOCR-RELAT CANCER, V15, P51, DOI 10.1677/ERC-07-0210; Thomas T, 2006, THYROID, V16, P537, DOI 10.1089/thy.2006.16.537; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zangrossi S, 2007, STEM CELLS, V25, P1675, DOI 10.1634/stemcells.2006-0611	43	79	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3544	10.1371/journal.pone.0003544	http://dx.doi.org/10.1371/journal.pone.0003544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958156	Green Published, Green Submitted, gold			2022-12-27	WOS:000265130900006
J	Brodeur, M; Bacon, BA; Renoult, L; Prevost, M; Lepage, M; Debruille, JB				Brodeur, Mathieu; Bacon, Benoit A.; Renoult, Louis; Prevost, Marie; Lepage, Martin; Debruille, J. Bruno			On the Functional Significance of the P1 and N1 Effects to Illusory Figures in the Notch Mode of Presentation	PLOS ONE			English	Article							LATERAL OCCIPITAL COMPLEX; VISUAL-EVOKED-POTENTIALS; KANIZSA SUBJECTIVE FIGURES; CORTICAL NEURON RESPONSES; SELECTIVE ATTENTION; FORM PERCEPTION; APPARENT DEPTH; TEXTURE SEGREGATION; BORDER OWNERSHIP; SALIENT REGIONS	The processing of Kanizsa figures have classically been studied by flashing the full "pacmen" inducers at stimulus onset. A recent study, however, has shown that it is advantageous to present illusory figures in the "notch" mode of presentation, that is by leaving the round inducers on screen at all times and by removing the inward-oriented notches delineating the illusory figure at stimulus onset. Indeed, using the notch mode of presentation, novel P1 and N1 effects have been found when comparing visual potentials (VEPs) evoked by an illusory figure and the VEPs to a control figure whose onset corresponds to the removal of outward-oriented notches, which prevents their integration into one delineated form. In Experiment 1, we replicated these findings, the illusory figure was found to evoke a larger P1 and a smaller N1 than its control. In Experiment 2, real grey squares were placed over the notches so that one condition, that with inward-oriented notches, shows a large central grey square and the other condition, that with outward-oriented notches, shows four unconnected smaller grey squares. In response to these "real" figures, no P1 effect was found but a N1 effect comparable to the one obtained with illusory figures was observed. Taken together, these results suggest that the P1 effect observed with illusory figures is likely specific to the processing of the illusory features of the figures. Conversely, the fact that the N1 effect was also obtained with real figures indicates that this effect may be due to more global processes related to depth segmentation or surface/object perception.	[Brodeur, Mathieu; Renoult, Louis; Prevost, Marie; Lepage, Martin; Debruille, J. Bruno] Douglas Mental Hlth McGill Univ Inst, Dept Psychiat, Montreal, PQ, Canada; [Bacon, Benoit A.] Bishops Univ, Dept Psychol, Sherbrooke, PQ, Canada	Bishops University	Brodeur, M (corresponding author), Douglas Mental Hlth McGill Univ Inst, Dept Psychiat, Montreal, PQ, Canada.	bruno.debruille@douglas.mcgill.ca	Debruille, J. Bruno/E-3115-2016; Renoult, Louis/A-7426-2013	Debruille, J. Bruno/0000-0001-8285-7427; Renoult, Louis/0000-0001-7861-0552	Canadian Institute for Health Research (CIHR) [MSH-40304]; Fonds de la Recherche en Sante du Quebec [96997-10]	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	J. Bruno Debruille was supported by scholarship MSH-40304 from the Canadian Institute for Health Research (CIHR). The study was supported by grant 96997-10 from the Fonds de la Recherche en Sante du Quebec allocated to J. Bruno Debruille. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MK, 2001, VISION RES, V41, P2827, DOI 10.1016/S0042-6989(01)00151-1; Altmann CF, 2004, J COGNITIVE NEUROSCI, V16, P794, DOI 10.1162/089892904970825; Bach M, 2000, VISION RES, V40, P3559, DOI 10.1016/S0042-6989(00)00195-4; BACH M, 1992, VISION RES, V32, P417, DOI 10.1016/0042-6989(92)90233-9; Bacon BA, 2002, PERCEPTION, V31, P1037, DOI 10.1068/p3305; Bakin JS, 2000, J NEUROSCI, V20, P8188; BANTON T, 1992, PERCEPT PSYCHOPHYS, V52, P676, DOI 10.3758/BF03211704; Beason-Held LL, 1998, VISUAL NEUROSCI, V15, P503; Blake Randolph, 2005, Behav Cogn Neurosci Rev, V4, P21, DOI 10.1177/1534582305276839; BRADLEY DR, 1982, PERCEPT PSYCHOPHYS, V32, P393, DOI 10.3758/BF03206245; Brodeur M, 2008, NEUROPSYCHOLOGIA, V46, P554, DOI 10.1016/j.neuropsychologia.2007.10.001; Brodeur M, 2006, NEUROREPORT, V17, P157, DOI 10.1097/01.wnr.0000198432.21765.6e; Brodeur M, 2006, BRAIN RES, V1068, P143, DOI 10.1016/j.brainres.2005.10.064; Cant JS, 2007, CEREB CORTEX, V17, P713, DOI 10.1093/cercor/bhk022; Caputo G, 1999, VISION RES, V39, P1597, DOI 10.1016/S0042-6989(98)00270-3; Casco C, 2005, VISION RES, V45, P2384, DOI 10.1016/j.visres.2005.02.022; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; COREN S, 1986, PERCEPT PSYCHOPHYS, V39, P327, DOI 10.3758/BF03202999; COREN S, 1983, PERCEPT PSYCHOPHYS, V33, P197, DOI 10.3758/BF03202840; COREN S, 1972, PSYCHOL REV, V79, P359, DOI 10.1037/h0032940; Davis G, 1998, J EXP PSYCHOL HUMAN, V24, P169; DAVIS G, 1994, NATURE, V371, P791, DOI 10.1038/371791a0; DINNERSTEIN D, 1957, AM J PSYCHOL, V70, P21, DOI 10.2307/1419226; DRESP B, 1993, VISION RES, V33, P759, DOI 10.1016/0042-6989(93)90195-3; EASON RG, 1981, B PSYCHONOMIC SOC, V18, P203; Electrode Nomenclature Committee, 1991, J CLIN NEUROPHYSIOL, V35, P200; Gegenfurtner KR, 1997, PERCEPTION, V26, P1445, DOI 10.1068/p261445; GEISSER S, 1959, PSYCHOMETRIKA, V24, P1582; GRABOWECKY M, 1989, Investigative Ophthalmology and Visual Science, V30, P457; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grossberg S, 2003, NEURAL NETWORKS, V16, P925, DOI 10.1016/S0893-6080(03)00097-2; Grossberg S, 1997, PSYCHOL REV, V104, P618, DOI 10.1037/0033-295X.104.3.618; Gurnsey R, 1996, PERCEPTION, V25, P861, DOI 10.1068/p250861; Halgren E, 2003, NEUROIMAGE, V18, P1001, DOI 10.1016/S1053-8119(03)00045-4; Hayashi E, 2004, NEUROSCI LETT, V359, P29, DOI 10.1016/j.neulet.2004.01.069; HE ZJ, 1992, NATURE, V359, P231, DOI 10.1038/359231a0; Heider B, 2002, J COGNITIVE NEUROSCI, V14, P1018, DOI 10.1162/089892902320474472; Herrmann CS, 1999, CLIN NEUROPHYSIOL, V110, P636, DOI 10.1016/S1388-2457(99)00002-4; Herrmann CS, 2001, NEUROREPORT, V12, P901, DOI 10.1097/00001756-200104170-00007; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hillyard SA, 1998, CURR OPIN NEUROBIOL, V8, P202, DOI 10.1016/S0959-4388(98)80141-4; Holcombe AO, 2003, J VISION, V3, P562, DOI 10.1167/3.8.4; Humphreys GW, 2000, VISION RES, V40, P1569, DOI 10.1016/S0042-6989(00)00042-0; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jeffreys DA, 1996, EXP BRAIN RES, V111, P79; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; KASKEY GB, 1980, BIOL PSYCHOL, V10, P115, DOI 10.1016/0301-0511(80)90032-0; Kavsek M, 2006, PERCEPTION, V35, P215, DOI 10.1068/p5260; KELLMAN PJ, 1983, COGNITIVE PSYCHOL, V15, P483, DOI 10.1016/0010-0285(83)90017-8; Korshunova S G, 1999, Neurosci Behav Physiol, V29, P695, DOI 10.1007/BF02462486; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Kruggel F, 2001, NEUROIMAGE, V14, P1327, DOI 10.1006/nimg.2001.0948; Lamme VAF, 1999, CEREB CORTEX, V9, P406, DOI 10.1093/cercor/9.4.406; LAWSON RB, 1974, J EXP PSYCHOL, V103, P1142, DOI 10.1037/h0037366; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Mendola JD, 1999, J NEUROSCI, V19, P8560; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Murray MM, 2002, J NEUROSCI, V22, P5055, DOI 10.1523/JNEUROSCI.22-12-05055.2002; Nieder A, 2002, J COMP PHYSIOL A, V188, P249, DOI 10.1007/s00359-002-0306-x; NOVIKOVA L A, 1977, Neuroscience and Behavioral Physiology, V8, P192, DOI 10.1007/BF01184057; Otsuka Y, 2003, J EXP CHILD PSYCHOL, V86, P244, DOI 10.1016/S0022-0965(03)00126-7; Pegna AJ, 2002, NEUROREPORT, V13, P965, DOI 10.1097/00001756-200205240-00013; Petry S., 1987, PERCEPTION ILLUSORY; PORAC C, 1978, B PSYCHONOMIC SOC, V11, P103, DOI 10.3758/BF03336778; PREVIC FH, 1988, CLIN VISION SCI, V3, P195; PRITCHARD WS, 1983, J EXP PSYCHOL GEN, V112, P145; Proverbio AM, 2002, NEUROPSYCHOLOGIA, V40, P479, DOI 10.1016/S0028-3932(01)00135-X; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; RAMACHANDRAN VS, 1985, NATURE, V317, P527, DOI 10.1038/317527a0; REYNOLDS RI, 1981, PERCEPTION, V10, P107, DOI 10.1068/p100107; Romani A, 1999, CLIN NEUROPHYSIOL, V110, P86, DOI 10.1016/S0168-5597(98)00048-3; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rubin N, 2001, PERCEPTION, V30, P339, DOI 10.1068/p3173; Seghier M, 2000, CEREB CORTEX, V10, P663, DOI 10.1093/cercor/10.7.663; Seghier ML, 2006, NEUROSCI BIOBEHAV R, V30, P595, DOI 10.1016/j.neubiorev.2005.11.002; Stanley DA, 2005, J VISION, V5, P690, DOI 10.1167/5.9.4; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; STEVENS KA, 1983, PERCEPTION, V12, P491, DOI 10.1068/p120491; SUGAWARA M, 1991, SCAND J PSYCHOL, V32, P352, DOI 10.1111/j.1467-9450.1991.tb00886.x; Sugita Y, 1999, NATURE, V401, P269, DOI 10.1038/45785; Valenza E, 2007, DEVELOPMENTAL SCI, V10, P492, DOI 10.1111/j.1467-7687.2007.00602.x; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V22, P54, DOI 10.3758/BF03206080; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; WALLACH H, 1988, PERCEPT PSYCHOPHYS, V43, P101, DOI 10.3758/BF03214186; WHITMORE CLG, 1976, PERCEPT PSYCHOPHYS, V19, P211, DOI 10.3758/BF03204229; Yoshino A, 2006, BRAIN RES, V1071, P137, DOI 10.1016/j.brainres.2005.11.089; Zhaoping L, 2005, NEURON, V47, P143, DOI 10.1016/j.neuron.2005.04.005	88	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3505	10.1371/journal.pone.0003505	http://dx.doi.org/10.1371/journal.pone.0003505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IJ	18949043	gold, Green Published, Green Accepted			2022-12-27	WOS:000265126400001
J	Lehky, SR; Peng, XM; McAdams, CJ; Sereno, AB				Lehky, Sidney R.; Peng, Xinmiao; McAdams, Carrie J.; Sereno, Anne B.			Spatial Modulation of Primate Inferotemporal Responses by Eye Position	PLOS ONE			English	Article							INFERIOR TEMPORAL NEURONS; PARIETAL CORTEX; COORDINATE TRANSFORMATIONS; OBJECT REPRESENTATIONS; STRIATE CORTEX; SHAPE; PERCEPTION; MONKEY; AREA; RECOGNITION	Background: A key aspect of representations for object recognition and scene analysis in the ventral visual stream is the spatial frame of reference, be it a viewer-centered, object-centered, or scene-based coordinate system. Coordinate transforms from retinocentric space to other reference frames involve combining neural visual responses with extraretinal postural information. Methodology/Principal Findings: We examined whether such spatial information is available to anterior inferotemporal (AIT) neurons in the macaque monkey by measuring the effect of eye position on responses to a set of simple 2D shapes. We report, for the first time, a significant eye position effect in over 40% of recorded neurons with small gaze angle shifts from central fixation. Although eye position modulates responses, it does not change shape selectivity. Conclusions/Significance: These data demonstrate that spatial information is available in AIT for the representation of objects and scenes within a non-retinocentric frame of reference. More generally, the availability of spatial information in AIT calls into questions the classic dichotomy in visual processing that associates object shape processing with ventral structures such as AIT but places spatial processing in a separate anatomical stream projecting to dorsal structures.	[Lehky, Sidney R.] Salk Inst Biol Studies, Computat Neurosci Lab, La Jolla, CA USA; [Lehky, Sidney R.; Peng, Xinmiao; Sereno, Anne B.] Univ Texas, Houston Hlth Sci Ctr, Dept Neurobiol & Anat, Houston, TX USA; [McAdams, Carrie J.] Univ Texas, Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA	Salk Institute; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Lehky, SR (corresponding author), Salk Inst Biol Studies, Computat Neurosci Lab, La Jolla, CA USA.	anne.b.sereno@uth.tmc.edu	McAdams, Carrie J./M-6822-2017	McAdams, Carrie J./0000-0002-4768-6703	NIH [R01 MH63340]; National Alliance for Research on Schizophrenia and Depression (NARSAD); J. S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063340] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); J. S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was supported by NIH grant R01 MH63340, the National Alliance for Research on Schizophrenia and Depression (NARSAD), and the J. S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggelopoulos NC, 2005, EUR J NEUROSCI, V22, P2903, DOI 10.1111/j.1460-9568.2005.04487.x; Andersen R A, 1993, Curr Opin Neurobiol, V3, P171, DOI 10.1016/0959-4388(93)90206-E; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; Barrow H., 1978, COMPUT VIS SYST, V2, P2; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Boussaoud D, 1998, J NEUROPHYSIOL, V80, P1132, DOI 10.1152/jn.1998.80.3.1132; Bremmer F, 2000, NEUROREPORT, V11, P1277, DOI 10.1097/00001756-200004270-00027; BULTHOFF HH, 1995, CEREB CORTEX, V5, P247, DOI 10.1093/cercor/5.3.247; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Committeri G, 2004, J COGNITIVE NEUROSCI, V16, P1517, DOI 10.1162/0898929042568550; COWEY A, 1967, Q J EXP PSYCHOL, V19, P246, DOI 10.1080/14640746708400099; DEAN P, 1976, PSYCHOL BULL, V83, P41, DOI 10.1037/0033-2909.83.1.41; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DeSouza JFX, 2002, CEREB CORTEX, V12, P991, DOI 10.1093/cercor/12.9.991; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Fang F, 2005, NEURON, V45, P793, DOI 10.1016/j.neuron.2005.01.037; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Goodale Melvyn A, 2003, Adv Neurol, V93, P249; Gross C. G., 1973, HDB SENSORY PHYSIOLO, P451; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Guo K, 1997, NEUROREPORT, V8, P1405, DOI 10.1097/00001756-199704140-00017; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; KOMATSU H, 1993, J NEUROPHYSIOL, V70, P677, DOI 10.1152/jn.1993.70.2.677; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; KOWLER E, 1995, VISION RES, V35, P1741, DOI 10.1016/0042-6989(94)00255-K; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Lehky SR, 2007, J NEUROPHYSIOL, V97, P1298, DOI 10.1152/jn.00167.2006; Lehky SR, 2007, J NEUROPHYSIOL, V97, P307, DOI 10.1152/jn.00168.2006; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; LOWE DG, 1989, ARTIF INTELL, V31, P355; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; McKyton A, 2007, CEREB CORTEX, V17, P1164, DOI 10.1093/cercor/bhl027; Merleau-Ponty M., 2002, HUSSERL LIMITS PHENO; MOTTER BC, 1981, J NEUROSCI, V1, P3, DOI 10.1523/JNEUROSCI.01-01-00003.1981; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Norman J, 2002, BEHAV BRAIN SCI, V25, P73, DOI 10.1017/S0140525X0200002X; Nowicka A, 2000, EUR J NEUROSCI, V12, P751, DOI 10.1046/j.1460-9568.2000.00943.x; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; Peng XM, 2008, J NEUROPHYSIOL, V100, P796, DOI 10.1152/jn.01188.2007; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; Saleem KS, 1996, J NEUROSCI, V16, P4757; Salinas E, 2001, Prog Brain Res, V130, P175; Salinas E, 2001, NEUROSCIENTIST, V7, P430, DOI 10.1177/107385840100700512; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Schenk T, 2006, NAT NEUROSCI, V9, P1369, DOI 10.1038/nn1784; SCHLAG J, 1992, EXP BRAIN RES, V90, P302; Sereno AB, 2006, J NEUROPHYSIOL, V95, P1078, DOI 10.1152/jn.00431.2005; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Siegel RM, 2003, J NEUROPHYSIOL, V90, P1279, DOI 10.1152/jn.01179.2002; Snyder LH, 2000, CURR OPIN NEUROBIOL, V10, P747, DOI 10.1016/S0959-4388(00)00152-5; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vishwanath D, 2003, VISION RES, V43, P1637, DOI 10.1016/S0042-6989(03)00168-8; Vogels R, 2001, J COGNITIVE NEUROSCI, V13, P444, DOI 10.1162/08989290152001871; Wurtz RH, 2003, PROG BRAIN RES, V144, P47, DOI 10.1016/S0079-6123(03)14400-3; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	70	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3492	10.1371/journal.pone.0003492	http://dx.doi.org/10.1371/journal.pone.0003492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IH	18946508	Green Submitted, gold, Green Published			2022-12-27	WOS:000265126200001
J	Bonnet, E; Touyarot, K; Alfos, S; Pallet, V; Higueret, P; Abrous, DN				Bonnet, Emilie; Touyarot, Katia; Alfos, Serge; Pallet, Veronique; Higueret, Paul; Abrous, Djoher Nora			Retinoic Acid Restores Adult Hippocampal Neurogenesis and Reverses Spatial Memory Deficit in Vitamin A Deprived Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DIFFERENTIAL EXPRESSION; HYPO-EXPRESSION; RECEPTORS; NEURONS; GROWTH; INDUCTION; SURVIVAL; BRAIN; ONSET	A dysfunction of retinoid hippocampal signaling pathway has been involved in the appearance of affective and cognitive disorders. However, the underlying neurobiological mechanisms remain unknown. Hippocampal granule neurons are generated throughout life and are involved in emotion and memory. Here, we investigated the effects of vitamin A deficiency (VAD) on neurogenesis and memory and the ability of retinoic acid (RA) treatment to prevent VAD-induced impairments. Adult retinoid-deficient rats were generated by a vitamin A-free diet from weaning in order to allow a normal development. The effects of VAD and/or RA administration were examined on hippocampal neurogenesis, retinoid target genes such as neurotrophin receptors and spatial reference memory measured in the water maze. Long-term VAD decreased neurogenesis and led to memory deficits. More importantly, these effects were reversed by 4 weeks of RA treatment. These beneficial effects may be in part related to an up-regulation of retinoid-mediated molecular events, such as the expression of the neurotrophin receptor TrkA. We have demonstrated for the first time that the effect of vitamin A deficient diet on the level of hippoccampal neurogenesis is reversible and that RA treatment is important for the maintenance of the hippocampal plasticity and function.	[Bonnet, Emilie; Touyarot, Katia; Alfos, Serge; Pallet, Veronique; Higueret, Paul] Univ Bordeaux 1, Nutr & Neurosci Lab, F-33405 Talence, France; [Bonnet, Emilie; Touyarot, Katia; Alfos, Serge; Pallet, Veronique; Higueret, Paul; Abrous, Djoher Nora] Univ Bordeaux 2, F-33076 Bordeaux, France; [Abrous, Djoher Nora] Bordeaux Neurosci Res Ctr, INSERM 862, Neurogenesis & Pathophysiol Lab, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bonnet, E (corresponding author), Univ Bordeaux 1, Nutr & Neurosci Lab, F-33405 Talence, France.	k.touyarot@istab.u-bordeaux1.fr	Abrous, Nora-Djoher/N-6977-2017	abrous, nora/0000-0002-8589-305X; ALFOS, Serge/0000-0001-7092-4370	University of Bordeaux 1; University of Bordeaux 2; Conseil Regional d'Aquitaine; French National Institute Of Health and Medical Research (INSERM)	University of Bordeaux 1; University of Bordeaux 2; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); French National Institute Of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by University of Bordeaux 1 and Bordeaux 2, the Conseil Regional d'Aquitaine and the French National Institute Of Health and Medical Research (INSERM).	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ABROUS DN, 2008, NEUROGENESIS HIPPOCA, P445; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Bremmer JD, 2008, PROG NEURO-PSYCHOPH, V32, P315, DOI 10.1016/j.pnpbp.2007.07.001; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Carta M, 2006, NEUROSCIENCE, V139, P1163, DOI 10.1016/j.neuroscience.2006.01.027; Cellerino A, 1996, NEUROSCIENCE, V70, P613, DOI 10.1016/S0306-4522(96)83001-6; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Cooper-Kuhn CM, 2004, J NEUROSCI RES, V77, P155, DOI 10.1002/jnr.20116; Corcoran JPT, 2004, EUR J NEUROSCI, V20, P896, DOI 10.1111/j.1460-9568.2004.03563.x; Crandall J, 2004, P NATL ACAD SCI USA, V101, P5111, DOI 10.1073/pnas.0306336101; Drager UC, 1997, PROG RETIN EYE RES, V16, P323, DOI 10.1016/S1350-9462(96)00029-8; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; DUPRET D, 2008, PLOSONE IN PRESS; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Eichenbaum H, 1999, BEHAV BRAIN RES, V103, P123, DOI 10.1016/S0166-4328(99)00044-3; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; Etchamendy N, 2001, J NEUROSCI, V21, P6423, DOI 10.1523/JNEUROSCI.21-16-06423.2001; Feart C, 2005, NEUROBIOL AGING, V26, P729, DOI 10.1016/j.neurobiolaging.2004.06.004; Ferguson SA, 2007, NEUROTOXICOL TERATOL, V29, P219, DOI 10.1016/j.ntt.2006.10.008; Frielingsdorf H, 2007, NEUROBIOL DIS, V26, P47, DOI 10.1016/j.nbd.2006.11.015; Goodman AB, 1998, P NATL ACAD SCI USA, V95, P7240, DOI 10.1073/pnas.95.13.7240; Goodman AB, 2003, P NATL ACAD SCI USA, V100, P2901, DOI 10.1073/pnas.0437937100; Goodman AB, 2006, J CELL PHYSIOL, V209, P598, DOI 10.1002/jcp.20784; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Haskell GT, 2005, J NEUROSCI, V25, P7636, DOI 10.1523/JNEUROSCI.0485-05.2005; Hellweg R, 1997, MOL BRAIN RES, V45, P177, DOI 10.1016/S0169-328X(96)00310-5; HOLST A, 1997, EUR J NEUROSCI, V9, P2169; Husson M, 2004, MOL BRAIN RES, V123, P7, DOI 10.1016/j.molbrainres.2003.12.012; Husson M, 2006, NEUROBIOL DIS, V23, P1, DOI 10.1016/j.nbd.2006.01.008; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; KIM YW, 1994, J BIOCHEM TOXICOL, V9, P225, DOI 10.1002/jbt.2570090502; Klein RL, 2000, BRAIN RES, V875, P144, DOI 10.1016/S0006-8993(00)02634-2; KOBAYASHI M, 1994, FEBS LETT, V356, P60, DOI 10.1016/0014-5793(94)01238-5; Krezel W, 1999, NEUROSCIENCE, V89, P1291, DOI 10.1016/S0306-4522(98)00342-X; Krugers HJ, 2007, SYNAPSE, V61, P221, DOI 10.1002/syn.20359; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; LECLERCQ M, 1981, REV I PASTEUR LYON, V14, P475; Lemaire V, 2006, BIOL PSYCHIAT, V59, P786, DOI 10.1016/j.biopsych.2005.11.009; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; McCaffery P, 2000, CYTOKINE GROWTH F R, V11, P233, DOI 10.1016/S1359-6101(00)00002-2; McCaffery PJ, 2003, EUR J NEUROSCI, V18, P457, DOI 10.1046/j.1460-9568.2003.02765.x; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; Mey J, 2006, J NEUROBIOL, V66, P757, DOI 10.1002/neu.20238; Mingaud F, 2008, J NEUROSCI, V28, P279, DOI 10.1523/JNEUROSCI.4065-07.2008; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; OKEEFE J, 1979, BEHAV BRAIN SCI, V2, P487, DOI 10.1017/S0140525X00063949; Palha JA, 2006, BRAIN RES REV, V51, P61, DOI 10.1016/j.brainresrev.2005.10.001; Piatti VC, 2006, NEUROSCIENTIST, V12, P463, DOI 10.1177/1073858406293538; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; RODRIGUEZTEBAR A, 1991, DEVELOPMENT, V112, P813; Russell RM, 2000, AM J CLIN NUTR, V71, P878; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sommer A., 1995, VITAMIN A DEFICIENCY, V3rd; Stancampiano R, 2007, NEUROREPORT, V18, P241, DOI 10.1097/WNR.0b013e3280115c0c; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang TW, 2005, DEVELOPMENT, V132, P2721, DOI 10.1242/dev.01867; Wu G, 1998, J NEUROCYTOL, V27, P1, DOI 10.1023/A:1006910001869; Xie P, 1997, NEUROREPORT, V8, P1067, DOI 10.1097/00001756-199703240-00001; Zetterstrom RH, 1999, EUR J NEUROSCI, V11, P407, DOI 10.1046/j.1460-9568.1999.00444.x; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562	70	88	94	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3487	10.1371/journal.pone.0003487	http://dx.doi.org/10.1371/journal.pone.0003487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941534	Green Published, Green Submitted, gold			2022-12-27	WOS:000265126100018
J	Finan, C; Ota, MOC; Marchant, A; Newport, MJ				Finan, Chris; Ota, Martin O. C.; Marchant, Arnaud; Newport, Melanie J.			Natural Variation in Immune Responses to Neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian Infants	PLOS ONE			English	Article								Background: There is a need for new vaccines for tuberculosis ( TB) that protect against adult pulmonary disease in regions where BCG is not effective. However, BCG could remain integral to TB control programmes because neonatal BCG protects against disseminated forms of childhood TB and many new vaccines rely on BCG to prime immunity or are recombinant strains of BCG. Interferon-gamma (IFN-gamma) is required for immunity to mycobacteria and used as a marker of immunity when new vaccines are tested. Although BCG is widely given to neonates IFN-gamma responses to BCG in this age group are poorly described. Characterisation of IFN-gamma responses to BCG is required for interpretation of vaccine immunogenicity study data where BCG is part of the vaccination strategy. Methodology/Principal Findings: 236 healthy Gambian babies were vaccinated with M. bovis BCG at birth. IFN-gamma, interleukin (IL)-5 and IL-13 responses to purified protein derivative (PPD), killed Mycobacterium tuberculosis (KMTB), M. tuberculosis short term culture filtrate (STCF) and M. bovis BCG antigen 85 complex (Ag85) were measured in a whole blood assay two months after vaccination. Cytokine responses varied up to 10 log-fold within this population. The majority of infants (89-98% depending on the antigen) made IFN-gamma responses and there was significant correlation between IFN-gamma responses to the different mycobacterial antigens (Spearman's coefficient ranged from 0.340 to 0.675, p = 10(-6)-10(-22)). IL-13 and IL-5 responses were generally low and there were more non-responders (33-75%) for these cytokines. Nonetheless, significant correlations were observed for IL-13 and IL-5 responses to different mycobacterial antigens Conclusions/Significance: Cytokine responses to mycobacterial antigens in BCG-vaccinated infants are heterogeneous and there is significant inter-individual variation. Further studies in large populations of infants are required to identify the factors that determine variation in IFN-gamma responses.	[Finan, Chris; Newport, Melanie J.] Brighton & Sussex Med Sch, Dept Med, Falmer, Sussex, England; [Ota, Martin O. C.] MRC Labs, Fajara, Gambia; [Marchant, Arnaud] Free Univ Brussels, Inst Med Immunol, B-1050 Brussels, Belgium	University of Brighton; University of Sussex; MRC Laboratory Molecular Biology; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Finan, C (corresponding author), Brighton & Sussex Med Sch, Dept Med, Falmer, Sussex, England.	m.j.newport@bsms.ac.uk		Newport, Melanie/0000-0002-8946-7525	MRC UK; British Lung Foundation; The Wellcome Trust [061147]; Medical Research Council [MC_U190071468] Funding Source: researchfish; MRC [MC_U190071468] Funding Source: UKRI	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Lung Foundation; The Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MRC UK, British Lung Foundation (CF), The Wellcome Trust (MN, grant number 061147). The study sponsors had no role in study design; collection, analysis, and interpretation of data; writing of the paper; or decision to submit it for publication.	Behr MA, 2002, LANCET INFECT DIS, V2, P86, DOI 10.1016/S1473-3099(02)00182-2; BENNETT S, 1992, J IMMUNOL METHODS, V146, P229, DOI 10.1016/0022-1759(92)90232-I; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Black GF, 2001, J INFECT DIS, V184, P322, DOI 10.1086/322042; Black GF, 2001, INT J TUBERC LUNG D, V5, P664; Bonecini-Almeida MG, 1998, J IMMUNOL, V160, P4490; Brookes RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002921; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Dai G, 1998, FRONT BIOSCI, V3, P110; Davids V, 2006, J INFECT DIS, V193, P531, DOI 10.1086/499825; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Dupuis S, 2000, IMMUNOL REV, V178, P129, DOI 10.1034/j.1600-065X.2000.17810.x; Ellner JJ, 2000, CLIN INFECT DIS, V30, pS279, DOI 10.1086/313874; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Fletcher Helen, 2006, Expert Opin Emerg Drugs, V11, P207, DOI 10.1517/14728214.11.2.207; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Hill PC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-156; Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Mahomed H, 2006, INT J TUBERC LUNG D, V10, P310; Malhotra I, 1999, J IMMUNOL, V162, P6843; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Marchant A, 1999, J IMMUNOL, V163, P2249; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; O'Donovan D, 2000, AIDS, V14, P441, DOI 10.1097/00002030-200003100-00019; Ota MOC, 2006, J TROP PEDIATRICS, V52, P136, DOI 10.1093/tropej/fmi087; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Poland Gregory A., 1998, Current Opinion in Pediatrics, V10, P208; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; REICHMAN LB, 1979, CHEST, V76, P764, DOI 10.1378/chest.76.6.764; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sirugo G, 2008, HUM GENET, V123, P557, DOI 10.1007/s00439-008-0511-y; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Vekemans J, 2001, EUR J IMMUNOL, V31, P1531, DOI 10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1; Weir RE, 2006, CLIN EXP IMMUNOL, V146, P390, DOI 10.1111/j.1365-2249.2006.03222.x; WEIR RE, 1994, J IMMUNOL METHODS, V176, P93, DOI 10.1016/0022-1759(94)90353-0; *WHO, 2004, WHOHTMTB2004331; World Health Organization, 2006, STOP TB STRATEGY BUI; Wu B, 2007, INFECT IMMUN, V75, P3658, DOI 10.1128/IAI.00244-07	46	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3485	10.1371/journal.pone.0003485	http://dx.doi.org/10.1371/journal.pone.0003485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941532	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000265126100016
J	Dilernia, DA; Jones, L; Rodriguez, S; Turk, G; Rubio, AE; Pampuro, S; Gomez-Carrillo, M; Bautista, C; Deluchi, G; Benetucci, J; Lasala, MB; Lourtau, L; Losso, MH; Perez, H; Cahn, P; Salomon, H				Alberto Dilernia, Dario; Jones, Leandro; Rodriguez, Sabrina; Turk, Gabriela; Rubio, Andrea E.; Pampuro, Sandra; Gomez-Carrillo, Manuel; Bautista, Christian; Deluchi, Gabriel; Benetucci, Jorge; Beatriz Lasala, Maria; Lourtau, Leonardo; Losso, Marcelo Horacio; Perez, Hector; Cahn, Pedro; Salomon, Horacio			HLA-Driven Convergence of HIV-1 Viral Subtypes B and F Toward the Adaptation to Immune Responses in Human Populations	PLOS ONE			English	Article							T-LYMPHOCYTE RESPONSE; CTL ESCAPE; VIREMIA; SELECTION; POLYMORPHISMS; TRANSMISSION; ASSOCIATION; PHYLOGENIES; DIVERSITY; EVOLUTION	Background: Cytotoxic T-Lymphocyte (CTL) response drives the evolution of HIV-1 at a host-level by selecting HLA-restricted escape mutations. Dissecting the dynamics of these escape mutations at a population-level would help to understand how HLA-mediated selection drives the evolution of HIV-1. Methodology/Principal Findings: We undertook a study of the dynamics of HIV-1 CTL-escape mutations by analyzing through statistical approaches and phylogenetic methods the viral gene gag sequenced in plasma samples collected between the years 1987 and 2006 from 302 drug-naive HIV-positive patients. By applying logistic regression models and after performing correction for multiple test, we identified 22 potential CTL-escape mutations (p-value<0.05; q-value<0.2); 10 of these associations were confirmed in samples biologically independent by a Bayesian Markov Chain Monte-Carlo method. Analyzing their prevalence back in time we found that escape mutations that are the consensus residue in samples collected after 2003 have actually significantly increased in time in one of either B or F subtype until becoming the most frequent residue, while dominating the other viral subtype. Their estimated prevalence in the viral subtype they did not dominate was lower than 30% for the majority of samples collected at the end of the 80's. In addition, when screening the entire viral region, we found that the 75% of positions significantly changing in time (p<0.05) were located within known CTL epitopes. Conclusions: Across HIV Gag protein, the rise of polymorphisms from independent origin during the last twenty years of epidemic in our setting was related to an association with an HLA allele. The fact that these mutations accumulated in one of either B or F subtypes have also dominated the other subtype shows how this selection might be causing a convergence of viral subtypes to variants which are more likely to evade the immune response of the population where they circulate.	[Alberto Dilernia, Dario; Turk, Gabriela; Rubio, Andrea E.; Pampuro, Sandra; Gomez-Carrillo, Manuel; Salomon, Horacio] Univ Buenos Aires, Fac Med, Dept Microbiol, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina; [Jones, Leandro] Estac Fotobiol Playa Union, Chubut, Argentina; [Rodriguez, Sabrina] INTA Castelar, Ctr Investigac Ciencias Vet Agronom, Inst Virol, Buenos Aires, DF, Argentina; [Bautista, Christian] Univ Nacl Mayor San Marcos, Inst Med Trop Daniel A Carrion, Lima, Peru; [Deluchi, Gabriel; Benetucci, Jorge] Capital Fed, Hosp Enfermedades Infecciosas Francisco Javier, Dept Enfermedades Infecciosas, Buenos Aires, DF, Argentina; [Beatriz Lasala, Maria] Capital Fed, Hosp Clin Jose de San Martin, Div Infectol, Buenos Aires, DF, Argentina; [Lourtau, Leonardo; Losso, Marcelo Horacio] Hosp Gen Agudos Jose Maria Ramos Mejia, Serv Inmunocomprometidos, Buenos Aires, DF, Argentina; [Perez, Hector; Cahn, Pedro] Capital Fed, Hosp Gen Agudos Juan A Fernandez, Unid Enfermedades Infecciosas, Buenos Aires, DF, Argentina; [Cahn, Pedro] Capital Fed, Fdn Huesped, Buenos Aires, DF, Argentina	University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA); Universidad Nacional Mayor de San Marcos; University of Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires; University of Buenos Aires	Dilernia, DA (corresponding author), Univ Buenos Aires, Fac Med, Dept Microbiol, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina.	hsalomon@fmed.uba.ar	PEREZ, HECTOR M./S-9366-2019	Jones, Leandro/0000-0002-5877-4194; Bautista, Christian/0000-0002-1228-0754	Argentinean National Research Council (CONICET)	Argentinean National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	DAD, LJ, GT, SP, MGC and HS are supported by the Argentinean National Research Council (CONICET).	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Altfeld M, 2006, TRENDS IMMUNOL, V27, P504, DOI 10.1016/j.it.2006.09.007; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arien KK, 2005, AIDS, V19, P1555, DOI 10.1097/01.aids.0000185989.16477.91; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; BRUMME ZL, 2008, J VIROL; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FRAHM N, 2006, HIV MOL IMMUNOLOGY D; Geels MJ, 2006, VIROLOGY, V345, P209, DOI 10.1016/j.virol.2005.09.023; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goulder PJR, 1997, EUR J IMMUNOL, V27, P1515, DOI 10.1002/eji.1830270630; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heckerman D, 2007, J COMPUT BIOL, V14, P736, DOI 10.1089/cmb.2007.R013; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07	39	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3429	10.1371/journal.pone.0003429	http://dx.doi.org/10.1371/journal.pone.0003429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941505	Green Published, gold, Green Submitted			2022-12-27	WOS:000265125900001
J	Shlush, LI; Atzmon, G; Weisshof, R; Behar, D; Yudkovsky, G; Barzilai, N; Skorecki, K				Shlush, Liran I.; Atzmon, Gil; Weisshof, Roni; Behar, Doron; Yudkovsky, Guenady; Barzilai, Nir; Skorecki, Karl			Ashkenazi Jewish Centenarians Do Not Demonstrate Enrichment in Mitochondrial Haplogroup J	PLOS ONE			English	Article								Background: Association of mitochondrial haplogroup J with longevity has been reported in several population subgroups. While studies from northern Italy and Finland, have described a higher frequency of haplogroup J among centenarians in comparison to non-centenarian, several other studies could not replicate these results and suggested various explanations for the discrepancy. Methodology/Principal Findings: We have evaluated haplogroup frequencies among Ashkenazi Jewish centenarians using two different sets of matched controls. No difference was observed in the haplogroup J frequencies between the centenarians or either matched control group, despite adequate statistical power to detect such a difference. Furthermore, the lack of association was robust to population substructure in the Ashkenazi Jewish population. Given this discrepancy with the previous reported associations in the northern Italian and the Finnish populations, we conducted re-analysis of these previously published data, which supported one of several possible explanations: i) inadequate matching of cases and controls; ii) inadequate adjustment for multiple comparison testing; iii) cryptic population stratification. Conclusions/Significance: There does not exist a universal association of mitochondrial haplogroup J with longevity across all population groups. Reported associations in specialized populations may reflect genetic or other interactions specific to those populations or else cryptic confounding influences, such as inadequate matching attributable to population substructure, which are of general relevance to all studies of the possible association of mitochondrial DNA haplogroups with common complex phenotypes.	[Shlush, Liran I.; Weisshof, Roni; Yudkovsky, Guenady; Skorecki, Karl] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Shlush, Liran I.; Behar, Doron; Yudkovsky, Guenady; Skorecki, Karl] Mol Med Lab, Rambam Hlth Care Campus, Haifa, Israel; [Atzmon, Gil; Barzilai, Nir] Albert Einstein Coll Med, Dept Med, Diabetes Res & Training Ctr, Inst Aging Res, Bronx, NY USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Yeshiva University; Albert Einstein College of Medicine	Shlush, LI (corresponding author), Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel.	lshlush@tx.technion.ac.il			Israel Science Foundation; Legacy Heritage Fund; Veronique Elek Fund of the Canadian Technion Society; Arthur and Rosalinde Gilbert Fund of the American Technion Society; Microsoft TCI	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Fund; Veronique Elek Fund of the Canadian Technion Society; Arthur and Rosalinde Gilbert Fund of the American Technion Society; Microsoft TCI(Microsoft)	Support for this study was provided by the Israel Science Foundation, by the Legacy Heritage Fund, the Veronique Elek Fund of the Canadian Technion Society, the Arthur and Rosalinde Gilbert Fund of the American Technion Society, and a Microsoft TCI grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich D, 1997, AM J HUM GENET, V60, P505; Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Atzmon G, 2008, J GERONTOL A-BIOL, V63, P447, DOI 10.1093/gerona/63.5.447; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Behar DM, 2004, EUR J HUM GENET, V12, P355, DOI 10.1038/sj.ejhg.5201156; Behar DM, 2004, HUM GENET, V114, P354, DOI 10.1007/s00439-003-1073-7; Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K; Cohen T, 2004, ANN HUM BIOL, V31, P38, DOI 10.1080/0301446032000159255; Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; Feder J, 2007, EUR J HUM GENET, V15, P498, DOI 10.1038/sj.ejhg.5201764; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Ivanova R, 1998, GERONTOLOGY, V44, P349, DOI 10.1159/000022041; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014; MCGUE M, 1993, J GERONTOL, V48, pB237, DOI 10.1093/geronj/48.6.B237; MEINER V, 1991, AM J HUM GENET, V49, P443; Mogentale-Profizi N, 2001, ANN HUM GENET, V65, P153, DOI 10.1017/S0003480001008545; Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Perls TT, 1999, AGE AGEING, V28, P193, DOI 10.1093/ageing/28.2.193; Raule N, 2007, MITOCHONDRION, V7, P29, DOI 10.1016/j.mito.2006.11.013; ROFF DA, 1989, MOL BIOL EVOL, V6, P539; Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8; Ross OA, 2001, EXP GERONTOL, V36, P1161, DOI 10.1016/S0531-5565(01)00094-8; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Shlush LI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002105; Stenico M, 1998, P ROY SOC B-BIOL SCI, V265, P555, DOI 10.1098/rspb.1998.0330; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Templeton AR, 2008, BIOESSAYS, V30, P470, DOI 10.1002/bies.20745; Torroni A, 1996, GENETICS, V144, P1835; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399	40	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2008	3	10							e3425	10.1371/journal.pone.0003425	http://dx.doi.org/10.1371/journal.pone.0003425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GT	18923645	Green Published, Green Submitted, gold			2022-12-27	WOS:000265122200006
J	Hailer, F; Leonard, JA				Hailer, Frank; Leonard, Jennifer A.			Hybridization among Three Native North American Canis Species in a Region of Natural Sympatry	PLOS ONE			English	Article								Background: Population densities of many species throughout the world are changing due to direct persecution as well as anthropogenic habitat modification. These changes may induce or increase the frequency of hybridization among taxa. If extensive, hybridization can threaten the genetic integrity or survival of endangered species. Three native species of the genus Canis, coyote (C. latrans), Mexican wolf (C. lupus baileyi) and red wolf (C. rufus), were historically sympatric in Texas, United States. Human impacts caused the latter two to go extinct in the wild, although they survived in captive breeding programs. Morphological data demonstrate historic reproductive isolation between all three taxa. While the red wolf population was impacted by introgressive hybridization with coyotes as it went extinct in the wild, the impact of hybridization on the Texas populations of the other species is not clear. Methodology/Principal Findings: We surveyed variation at maternally and paternally inherited genetic markers (mitochondrial control region sequence and Y chromosome microsatellites) in coyotes from Texas, Mexican wolves and red wolves from the captive breeding programs, and a reference population of coyotes from outside the historic red wolf range. Levels of variation and phylogenetic analyses suggest that hybridization has occasionally taken place between all three species, but that the impact on the coyote population is very small. Conclusion/Significance: Our results demonstrate that the factors driving introgressive hybridization in sympatric Texan Canis are multiple and complex. Hybridization is not solely determined by body size or sex, and density-dependent effects do not fully explain the observed pattern either. No evidence of hybridization was identified in the Mexican wolf captive breeding program, but introgression appears to have had a greater impact on the captive red wolves.	[Hailer, Frank; Leonard, Jennifer A.] Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, Uppsala, Sweden; [Hailer, Frank; Leonard, Jennifer A.] Smithsonian Inst, Natl Mus Nat Hist, Natl Zool Pk, Ctr Conservat & Evolutionary Genet, Washington, DC USA	Uppsala University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Hailer, F (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, Uppsala, Sweden.	jennifer.leonard@ebc.uu.se	Hailer, Frank/C-9114-2012; Hailer, Frank/Y-3595-2019; Leonard, Jennifer/A-7894-2010	Hailer, Frank/0000-0002-2340-1726; Hailer, Frank/0000-0002-2340-1726; Leonard, Jennifer/0000-0003-0291-7819	Carl Trygger Foundation; Swedish Research Council	Carl Trygger Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was provided by the Carl Trygger Foundation and Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2003, MOL ECOL, V12, P2175, DOI 10.1046/j.1365-294X.2003.01895.x; Adams JR, 2003, MOL ECOL, V12, P541, DOI 10.1046/j.1365-294X.2003.01708.x; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Boitani Luigi, 2003, P317; Carbyn L.N., 1987, P358; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Coyne J.A., 2004, SPECIATION; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flagstad O, 2003, MOL ECOL, V12, P869, DOI 10.1046/j.1365-294X.2003.01784.x; Fredrickson RJ, 2006, CONSERV BIOL, V20, P1272, DOI 10.1111/j.1523-1739.2006.00401.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; GarciaMoreno J, 1996, CONSERV BIOL, V10, P376, DOI 10.1046/j.1523-1739.1996.10020376.x; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; GOTTELLI D, 1994, MOL ECOL, V3, P301, DOI 10.1111/j.1365-294X.1994.tb00070.x; Hedrick PW, 2008, MOL ECOL, V17, P344, DOI 10.1111/j.1365-294X.2007.03400.x; Hedrick PW, 1997, ZOO BIOL, V16, P47, DOI 10.1002/(SICI)1098-2361(1997)16:1<47::AID-ZOO7>3.0.CO;2-B; Hellborg L, 2004, MOL BIOL EVOL, V21, P158, DOI 10.1093/molbev/msh008; Konishi M, 2004, CONSERV GENET, V5, P463, DOI 10.1023/B:COGE.0000041027.64785.77; Kyle CJ, 2006, CONSERV GENET, V7, P273, DOI 10.1007/s10592-006-9130-0; LEHMAN N, 1991, EVOLUTION, V45, P104, DOI 10.1111/j.1558-5646.1991.tb05270.x; LEHMAN N, 1991, GENETICS, V128, P405; Leonard JA, 2005, MOL ECOL, V14, P9, DOI 10.1111/j.1365-294X.2004.02389.x; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Leonard JA, 2008, BIOL LETTERS, V4, P95, DOI 10.1098/rsbl.2007.0354; Lode T, 2005, J HERED, V96, P89, DOI 10.1093/jhered/esi021; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; McCARLEY HOWARD, 1962, SOUTHWESTERN NAT, V7, P227, DOI 10.2307/3668845; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; NEI M, 1978, GENETICS, V89, P583; Nowak RM, 2002, SOUTHEAST NAT, V1, P95, DOI 10.1656/1528-7092(2002)001[0095:TOSOWI]2.0.CO;2; O'Reilly PT, 2004, MOL ECOL, V13, P1799, DOI 10.1111/j.1365-294X.2004.02214.x; Olivier M, 1999, CHROMOSOME RES, V7, P223, DOI 10.1023/A:1009203500926; PARADISO JL, 1968, AM MIDL NAT, V80, P529, DOI 10.2307/2423543; Pilgrim KL, 1998, J WILDLIFE MANAGE, V62, P683, DOI 10.2307/3802344; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485; Ropiquet A, 2006, MOL PHYLOGENET EVOL, V41, P395, DOI 10.1016/j.ympev.2006.05.033; Roy MS, 1996, CONSERV BIOL, V10, P1413, DOI 10.1046/j.1523-1739.1996.10051413.x; ROY MS, 1994, MOL BIOL EVOL, V11, P553; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMITZ OJ, 1985, J MAMMAL, V66, P402, DOI 10.2307/1381262; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Sundqvist AK, 2006, GENETICS, V172, P1121, DOI 10.1534/genetics.105.042358; Sundqvist AK, 2001, MOL ECOL, V10, P1959, DOI 10.1046/j.1365-294X.2001.01326.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Vila C, 2003, HEREDITY, V90, P17, DOI 10.1038/sj.hdy.6800175; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; WAYNE RK, 1991, NATURE, V351, P565, DOI 10.1038/351565a0; Wilson PJ, 2000, CAN J ZOOL, V78, P2156, DOI 10.1139/cjz-78-12-2156; Young S.P., 1944, WOLVES N AM; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	57	78	80	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2008	3	10							e3333	10.1371/journal.pone.0003333	http://dx.doi.org/10.1371/journal.pone.0003333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DO	18841199	Green Published, Green Accepted, gold			2022-12-27	WOS:000265113900003
J	Tachado, SD; Samrakandi, MM; Cirillo, JD				Tachado, Souvenir D.; Samrakandi, Mustapha M.; Cirillo, Jeffrey D.			Non-Opsonic Phagocytosis of Legionella pneumophila by Macrophages Is Mediated by Phosphatidylinositol 3-Kinase	PLOS ONE			English	Article								Background: Legionella pneumophila, is an intracellular pathogen that causes Legionnaires' disease in humans, a potentially lethal pneumonia. L. pneumophila has the ability to enter and replicate in the host and is essential for pathogenesis. Methodology/Principal Findings: Phagocytosis was measured by cell invasion assays. Construction of PI3K mutant by PCR cloning and expression of dominant negative mutant was detected by Western blot. PI3K activity was measured by P-32 labeling and detection of phospholipids products by thin layer chromatography. Infection of macrophages with virulent L. pneumophila stimulated the formation of phosphatidylinositol 3-phosphate (PIP3), a phosphorylated lipid product of PI3K whereas two structurally distinct phosphatidylinositol 3 kinase (PI3K) inhibitors, wortmannin and LY294002, reduced L. pneumophila entry into macrophages in a dose-dependent fashion. Furthermore, PI3K activation led to Akt stimulation, a serine/threonine kinase, which was also inhibited by wortmannin and LY294002. In contrast, PI3K and protein kinase B (PKB/Akt) activities were lower in macrophages infected with an avirulent bacterial strain. Only virulent L. pneumophila increased lipid kinase activity present in immunoprecipitates of the p85 alpha subunit of class I PI3K and tyrosine phosphorylated proteins. In addition, macrophages expressing a specific dominant negative mutant of PI3K reduced L. pneumophila entry into these cells. Conclusion/Significance: Entry of L. pneumophila is mediated by PI3K/Akt signaling pathway. These results suggest an important role for PI3K and Akt in the L. pneumophila infection process. They point to possible novel strategies for undermining L. pneumophila host uptake and reducing pathogenesis of Legionnaires' disease.	[Tachado, Souvenir D.; Samrakandi, Mustapha M.; Cirillo, Jeffrey D.] Texas A&M Hlth Sci Ctr, Dept Microb & Mol Pathogenesis, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Tachado, SD (corresponding author), Beth Israel Deaconess Med Ctr, Div Pulm & Crit Med, Dept Med, Boston, MA 02215 USA.	jdcirillo@medicine.tamhsc.edu	Cirillo, Jeffrey D./L-4286-2019	Cirillo, Jeffrey D./0000-0003-3058-2702; Tachado, Souvenir/0000-0002-8368-6102	National Institutes of Health [AI40165]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI40165 (JDC).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Allen LAH, 2002, CURR BIOL, V12, P1762, DOI 10.1016/S0960-9822(02)01216-2; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Briand G, 1997, VIROLOGY, V228, P171, DOI 10.1006/viro.1996.8399; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Celli J, 2001, EMBO J, V20, P1245, DOI 10.1093/emboj/20.6.1245; Cirillo JD, 1999, INFECT IMMUN, V67, P4427, DOI 10.1128/IAI.67.9.4427-4434.1999; Cirillo SLG, 2002, MICROBIOL-SGM, V148, P1667, DOI 10.1099/00221287-148-6-1667; Coombes BK, 2002, CELL MICROBIOL, V4, P447, DOI 10.1046/j.1462-5822.2002.00203.x; Coxon PY, 1998, INFECT IMMUN, V66, P2905, DOI 10.1128/IAI.66.6.2905-2913.1998; DAVIS GS, 1983, J INFECT DIS, V148, P823, DOI 10.1093/infdis/148.5.823; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; ENGLEBERG NC, 1984, INFECT IMMUN, V44, P222, DOI 10.1128/IAI.44.2.222-227.1984; Forney JR, 1999, INFECT IMMUN, V67, P844, DOI 10.1128/IAI.67.2.844-852.1999; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; GLAVIN FL, 1979, ANN INTERN MED, V90, P555, DOI 10.7326/0003-4819-90-4-555; GREENBERG S, 1995, TRENDS CELL BIOL, V5, P93, DOI 10.1016/S0962-8924(00)88957-6; HORWITZ MA, 1984, CELL, V36, P27, DOI 10.1016/0092-8674(84)90070-9; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; Khelef N, 2001, INFECT IMMUN, V69, P5157, DOI 10.1128/IAI.69.8.5157-5161.2001; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lin YL, 1998, BIOCHEM BIOPH RES CO, V246, P172, DOI 10.1006/bbrc.1998.8488; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; MOFFAT JF, 1994, MOL MICROBIOL, V12, P693, DOI 10.1111/j.1365-2958.1994.tb01057.x; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; NINOMIYA N, 1994, J BIOL CHEM, V269, P22732; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; Procyk KJ, 1999, INFECT IMMUN, V67, P1011, DOI 10.1128/IAI.67.3.1011-1017.1999; Ravetch J, 2007, IMMUNOL REV, V219, P5, DOI 10.1111/j.1600-065X.2007.00568.x; REYNOLDS HY, 1974, J LAB CLIN MED, V84, P559; Salh B, 1998, J IMMUNOL, V161, P6947; Samrakandi MM, 2002, J CLIN MICROBIOL, V40, P1352, DOI 10.1128/JCM.40.4.1352-1362.2002; Stokes RW, 1998, J IMMUNOL, V160, P5514; Susa M, 1999, INFECT IMMUN, V67, P4490, DOI 10.1128/IAI.67.9.4490-4498.1999; Tachado SD, 2005, AM J RESP CELL MOL, V33, P610, DOI 10.1165/rcmb.2004-0341OC; Tachado SD, 2007, J LEUKOCYTE BIOL, V81, P205, DOI 10.1189/jlb.1005580; Todorov AG, 2000, J BIOL CHEM, V275, P32182, DOI 10.1074/jbc.M909440199; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Villalta F, 1998, BIOCHEM BIOPH RES CO, V249, P247, DOI 10.1006/bbrc.1998.9127; WADOWSKY RM, 1988, APPL ENVIRON MICROB, V54, P2677, DOI 10.1128/AEM.54.11.2677-2682.1988; Wilkowsky SE, 2001, EXP CELL RES, V264, P211, DOI 10.1006/excr.2000.5123; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; YAMAMOTO Y, 1992, INFECT IMMUN, V60, P3452, DOI 10.1128/IAI.60.8.3452-3455.1992; YANO H, 1993, J BIOL CHEM, V268, P25846	52	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3324	10.1371/journal.pone.0003324	http://dx.doi.org/10.1371/journal.pone.0003324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830409	Green Published, gold, Green Submitted			2022-12-27	WOS:000264797300012
J	Buelow, B; Scharenberg, AM				Buelow, Ben; Scharenberg, Andrew M.			Characterization of Parameters Required for Effective Use of Tamoxifen-Regulated Recombination	PLOS ONE			English	Article								Conditional gene targeting using the Cre-loxp system is a well established technique in numerous in vitro and in vivo systems. Ligand regulated forms of Cre have been increasingly used in these applications in order to gain temporal and spatial control over conditional targeting. The tamoxifen-regulated Cre variant mer-Cre-mer (mCrem) is widely utilized because of its reputation for tight regulation in the absence of its tamoxifen ligand. In the DT40 chicken B cell line, we generated an mCrem-based reversible switch for conditional regulation of a transgene, and in contrast with previous work, observed significant constitutive activity of mCrem. This prompted us to use our system for analysis of the parameters governing tamoxifen-regulated mCrem recombination of a genomic target. We find that robust mCrem expression correlates with a high level of tamoxifen-independent Cre activity, while clones expressing mCrem at the limit of western blot detection exhibit extremely tight regulation. We also observe time and dose-dependent effects on mCrem activity which suggest limitations on the use of conditional targeting approaches for applications which require tight temporal coordination of Cre action within a cell population.	Univ Washington, Seattle Childrens Hosp Res Inst, Dept Pediat, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle	Buelow, B (corresponding author), Univ Washington, Seattle Childrens Hosp Res Inst, Dept Pediat, Seattle, WA 98195 USA.	andrewms@u.washington.edu			ARCS foundation; NCI; NIH [R01 GM64091]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064091] Funding Source: NIH RePORTER	ARCS foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ARCS foundation, NCI training grant, NIH R01 GM64091	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alinikula Jukka, 2006, Subcell Biochem, V40, P189; [Anonymous], 2007, NATURE, V449, P378; Baba Y, 2005, MICROBIOL IMMUNOL, V49, P559, DOI 10.1111/j.1348-0421.2005.tb03753.x; Badea TC, 2003, J NEUROSCI, V23, P2314; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Bree RT, 2007, CELL CYCLE, V6, P2310, DOI 10.4161/cc.6.18.4723; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Caldwell Randolph B, 2006, Subcell Biochem, V40, P25; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heidmann D, 2001, DEV GENES EVOL, V211, P458, DOI 10.1007/s004270100167; Kanayama N, 2005, BIOCHEM BIOPH RES CO, V327, P70, DOI 10.1016/j.bbrc.2004.11.143; Lahti JM, 1999, METHODS, V17, P305, DOI 10.1006/meth.1999.0744; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Okada Masahiro, 2006, Subcell Biochem, V40, P91; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Rainey Michael D, 2006, Subcell Biochem, V40, P107; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Semprini S, 2007, NUCLEIC ACIDS RES, V35, P1402, DOI 10.1093/nar/gkl1108; Shinohara Hisaaki, 2006, Subcell Biochem, V40, P145; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	37	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2008	3	9							e3264	10.1371/journal.pone.0003264	http://dx.doi.org/10.1371/journal.pone.0003264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MA	18810268	gold, Green Published, Green Submitted			2022-12-27	WOS:000264431000006
J	Cimmino, A; Capasso, R; Muller, F; Sambri, I; Masella, L; Raimo, M; De Bonis, ML; D'Angelo, S; Zappia, V; Galletti, P; Ingrosso, D				Cimmino, Amelia; Capasso, Rosanna; Muller, Fabbri; Sambri, Irene; Masella, Lucia; Raimo, Marianna; De Bonis, Maria Luigia; D'Angelo, Stefania; Zappia, Vincenzo; Galletti, Patrizia; Ingrosso, Diego			Protein Isoaspartate Methyltransferase Prevents Apoptosis Induced by Oxidative Stress in Endothelial Cells: Role of Bcl-X-l Deamidation and Methylation	PLOS ONE			English	Article								Background: Natural proteins undergo in vivo spontaneous post-biosynthetic deamidation of specific asparagine residues with isoaspartyl formation. Deamidated-isomerized molecules are both structurally and functionally altered. The enzyme isoaspartyl protein carboxyl-O-methyltransferase (PCMT; EC 2.1.1.77) has peculiar substrate specificity towards these deamidated proteins. It catalyzes methyl esterification of the free alpha-carboxyl group at the isoaspartyl site, thus initiating the repair of these abnormal proteins through the conversion of the isopeptide bond into a normal alpha-peptide bond. Deamidation occurs slowly during cellular and molecular aging, being accelerated by physical-chemical stresses brought to the living cells. Previous evidence supports a role of protein deamidation in the acquisition of susceptibility to apoptosis. Aim of this work was to shed a light on the role of PCMT in apoptosis clarifying the relevant mechanism(s). Methodology/Principal Findings: Endothelial cells transiently transfected with various constructs of PCMT, i.e. overexpressing wild type PCMT or negative dominants, were used to investigate the role of protein methylation during apoptosis induced by oxidative stress (H2O2; 0.1-0.5 mM range). Results show that A) Cells overexpressing "wild type'' human PCMT were resistant to apoptosis, whereas overexpression of antisense PCMT induces high sensitivity to apoptosis even at low H2O2 concentrations. B) PCMT protective effect is specifically due to its methyltransferase activity rather than to any other non-enzymatic interactions. In fact negative dominants, overexpressing PCMT mutants devoid of catalytic activity do not prevent apoptosis. C) Cells transfected with antisense PCMT, or overexpressing a PCMT mutant, accumulate isoaspartyl-containing damaged proteins upon H2O2 treatment. Proteomics allowed the identification of proteins, which are both PCMT substrates and apoptosis effectors, whose deamidation occurs under oxidative stress conditions leading to programmed cell death. These proteins, including Hsp70, Hsp90, actin, and Bcl-xL, are recognized and methylated by PCMT, according to the general repair mechanism of this methyltransferase. Conclusion/Significance: Apoptosis can be modulated by "on/off'' switch partitioning the amount of specific protein effectors, which are either in their active (native) or inactive (deamidated) molecular forms. Deamidated proteins can also be functionally restored through methylation. Bcl-xL provides a case for the role of PCMT in the maintenance of functional stability of this antiapoptotic protein.	[Cimmino, Amelia; Capasso, Rosanna; Sambri, Irene; Masella, Lucia; Raimo, Marianna; De Bonis, Maria Luigia; Zappia, Vincenzo; Galletti, Patrizia; Ingrosso, Diego] Univ Naples 2, Dept Biochem & Biophys, Sch Med & Surg, Naples, Italy; [Muller, Fabbri] Ohio State Univ, Comprehensive Canc Ctr, Columbus, OH 43210 USA; [D'Angelo, Stefania] Parthenope Univ, Fac Motor Sci, Naples, Italy	Universita della Campania Vanvitelli; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Parthenope University Naples	Cimmino, A (corresponding author), Univ Naples 2, Dept Biochem & Biophys, Sch Med & Surg, Naples, Italy.	patrizia.galletti@unina2.it	D'Angelo, Stefania/AAI-2594-2019; Ingrosso, Diego/AHE-4980-2022	D'Angelo, Stefania/0000-0001-7585-5052; Cimmino, Amelia/0000-0002-0004-9299	M.I.U.R.-P.R.I.N. [2005062199_003, 2004057129_003]	M.I.U.R.-P.R.I.N.(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported in part by Grant 2005062199_003 from M.I.U.R.-P.R.I.N. to D. Ingrosso and by Grant 2004057129_003 from M.I.U.R.-P.R.I.N. to P.Galletti.	Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; ASWAD DW, 1995, DEAMIDATION ISOASPAR, P91; ASWAD DW, 1995, DEAMIDATION ISOASPAR, P7; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Beere HM, 2005, J CLIN INVEST, V115, P2633, DOI 10.1172/JCI26471; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; D'Angelo S, 2001, FREE RADICAL BIO MED, V31, P1, DOI 10.1016/S0891-5849(01)00518-4; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Deverman BE, 2003, CELL, V115, P503, DOI 10.1016/S0092-8674(03)00892-4; DeVry CG, 1996, ARCH BIOCHEM BIOPHYS, V335, P321, DOI 10.1006/abbi.1996.0513; Fujita N, 1998, ONCOGENE, V17, P1295, DOI 10.1038/sj.onc.1202065; GALLETTI P, 1995, BIOCHEM J, V306, P313, DOI 10.1042/bj3060313; GALLETTI P, 1988, EUR J BIOCHEM, V177, P233, DOI 10.1111/j.1432-1033.1988.tb14367.x; Galletti P, 2007, FEBS J, V274, P5263, DOI 10.1111/j.1742-4658.2007.06048.x; Huebscher KJ, 1999, GENE, V240, P333, DOI 10.1016/S0378-1119(99)00443-6; Hurst GB, 2004, J AM SOC MASS SPECTR, V15, P832, DOI 10.1016/S1044-0305(04)00154-0; Ingrosso D, 2002, EUR J BIOCHEM, V269, P2032, DOI 10.1046/j.1432-1033.2002.02838.x; INGROSSO D, 1989, J BIOL CHEM, V264, P20131; Ingrosso D, 1996, BRIT J HAEMATOL, V93, P38, DOI 10.1046/j.1365-2141.1996.451990.x; Ingrosso D, 2000, EUR J BIOCHEM, V267, P4397, DOI 10.1046/j.1432-1327.2000.01485.x; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kindrachuk J, 2003, J BIOL CHEM, V278, P50880, DOI 10.1074/jbc.M308423200; Lanthier J, 2004, EXP CELL RES, V293, P96, DOI 10.1016/j.yexcr.2003.10.003; LOWENSON JD, 1990, J BIOL CHEM, V265, P3106; MACFARLANE DE, 1984, J BIOL CHEM, V259, P1357; MACLAREN DC, 1995, PROTEIN EXPRES PURIF, V6, P99, DOI 10.1006/prep.1995.1013; Pepperkok R, 2000, J CELL BIOL, V148, P715, DOI 10.1083/jcb.148.4.715; PERNA AF, 1993, J CLIN INVEST, V91, P2497; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; Robinson A B, 1974, Curr Top Cell Regul, V8, P247; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; ROGERS SW, 1988, J BIOL CHEM, V263, P19850; Ruchalski K, 2006, J BIOL CHEM, V281, P7873, DOI 10.1074/jbc.M513728200; Takehara T, 2003, CANCER RES, V63, P3054; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Weber DJ, 1997, J PROTEIN CHEM, V16, P257, DOI 10.1023/A:1026300924908; Weber DJ, 1997, J PROTEIN CHEM, V16, P269, DOI 10.1023/A:1026352908978; WRIGHT HT, 1991, CRIT REV BIOCHEM MOL, V26, P1, DOI 10.1080/10409230490440532; Zhao R, 2007, PLOS BIOL, V5, P39, DOI 10.1371/journal.pbio.0050001; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	45	48	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3258	10.1371/journal.pone.0003258	http://dx.doi.org/10.1371/journal.pone.0003258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LY	18806875	Green Published, gold			2022-12-27	WOS:000264430800008
J	Ronicke, R; Klemm, A; Meinhardt, J; Schroder, UH; Fandrich, M; Reymann, KG				Roenicke, Raik; Klemm, Anja; Meinhardt, Jessica; Schroeder, Ulrich H.; Faendrich, Marcus; Reymann, Klaus G.			A beta Mediated Diminution of MTT Reduction-An Artefact of Single Cell Culture?	PLOS ONE			English	Article							HIPPOCAMPAL SLICE CULTURES; MITOCHONDRIAL SUCCINATE-DEHYDROGENASE; ORGANOTYPIC CULTURES; SYNAPTIC PLASTICITY; BIOLOGICAL-ACTIVITY; ALZHEIMERS-DISEASE; NATURAL OLIGOMERS; AMYLOID PEPTIDES; REDOX ACTIVITY; IN-VITRO	The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazoliumbromide (MTT) reduction assay is a frequently used and easily reproducible method to measure beta-amyloid (Ab) toxicity in different types of single cell culture. To our knowledge, the influence of Ab on MTT reduction has never been tested in more complex tissue. Initially, we reproduced the disturbed MTT reduction in neuron and astroglia primary cell cultures from rats as well as in the BV2 microglia cell line, utilizing four different Ab species, namely freshly dissolved Ab (25-35), fibrillar Ab (1-40), oligomeric Ab (1-42) and oligomeric Ab (1-40). In contrast to the findings in single cell cultures, none of these Ab species altered MTT reduction in rat organotypic hippocampal slice cultures (OHC). Moreover, application of Ab to acutely isolated hippocampal slices from adult rats and in vivo intracerebroventricular injection of Ab also did not influence the MTT reduction in the respective tissue. Failure of Ab penetration into the tissue cannot explain the differences between single cells and the more complex brain tissue. Thus electrophysiological investigations disclosed an impairment of long-term potentiation (LTP) in the CA1 region of hippocampal slices from rat by application of oligomeric Ab (1-40), but not by freshly dissolved Ab (25-35) or fibrillar Ab (140). In conclusion, the experiments revealed a glaring discrepancy between single cell cultures and complex brain tissue regarding the effect of different Ab species on MTT reduction. Particularly, the differential effect of oligomeric versus other Ab forms on LTP was not reflected in the MTT reduction assay. This may indicate that the Ab oligomer effect on synaptic function reflected by LTP impairment precedes changes in formazane formation rate or that cells embedded in a more natural environment in the tissue are less susceptible to damage by Ab, raising cautions against the consideration of single cell MTT reduction activity as a reliable assay in Alzheimer's drug discovery studies.	[Roenicke, Raik; Klemm, Anja; Schroeder, Ulrich H.; Reymann, Klaus G.] Leibniz Inst Neurobiol, Project Grp Neuropharmacol, Magdeburg, Germany; [Reymann, Klaus G.] Res Inst Appl Neurosci GmbH, Magdeburg, Germany; [Meinhardt, Jessica] Leibniz Inst Age Res, Fritz Lipmann Inst, Jena, Germany; [Faendrich, Marcus] Max Planck Res Unit Enzymol Protein Fold, Halle, Germany; [Faendrich, Marcus] Martin Luther Univ Halle Wittenberg, Halle, Germany	Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Max Planck Society; Martin Luther University Halle Wittenberg	Ronicke, R (corresponding author), Leibniz Inst Neurobiol, Project Grp Neuropharmacol, Magdeburg, Germany.	roenicke@zenit-magdeburg.de	Schröder, Ulrich/ABB-3026-2021; Reymann, Klaus G/J-8507-2013		Leibniz Institute for Neurobiology; Research Institute for Applied Neurosciences gGmbH	Leibniz Institute for Neurobiology; Research Institute for Applied Neurosciences gGmbH	Leibniz Institute for Neurobiology, Research Institute for Applied Neurosciences gGmbH	Abe K, 1997, NEUROSCI RES, V29, P129, DOI 10.1016/S0168-0102(97)00081-3; Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; Baldauf K, 2005, BRAIN RES, V1056, P158, DOI 10.1016/j.brainres.2005.07.035; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Baskys A, 2001, BRAIN RES, V907, P188, DOI 10.1016/S0006-8993(01)02517-3; Bieschke J, 2008, BIOCHEMISTRY-US, V47, P50, DOI 10.1021/bi701757v; Boutaud O, 2006, J NEUROCHEM, V96, P917, DOI 10.1111/j.1471-4159.2005.03586.x; Braun H, 2006, J NEUROSCI METH, V157, P32, DOI 10.1016/j.jneumeth.2006.03.019; Breder J, 2000, NEUROPHARMACOLOGY, V39, P1779, DOI 10.1016/S0028-3908(00)00027-7; Choi SJ, 2006, AMYLOID, V13, P6, DOI 10.1080/13506120500535636; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Christopeit T, 2005, PROTEIN SCI, V14, P2125, DOI 10.1110/ps.051470405; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Connelly CA, 2000, J NEUROSCI METH, V99, P1, DOI 10.1016/S0165-0270(00)00205-3; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Gengler S, 2007, EXP BRAIN RES, V179, P621, DOI 10.1007/s00221-006-0819-6; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; Gil A, 2001, EUR J NEUROSCI, V13, P1380, DOI 10.1046/j.0953-816x.2001.01509.x; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hayon T, 2003, LEUKEMIA LYMPHOMA, V44, P1957, DOI 10.1080/1042819031000116607; Christian H, 2007, EUR J PHARMACOL, V561, P85, DOI 10.1016/j.ejphar.2007.01.040; Imai T, 2007, NEUROSCIENCE, V147, P639, DOI 10.1016/j.neuroscience.2007.04.057; Ioudina M, 2003, EXP NEUROL, V184, P923, DOI 10.1016/S0014-4886(03)00314-5; Ishige K, 2007, J PHARMACOL SCI, V104, P46, DOI 10.1254/jphs.FP0061533; Ito Y, 2003, BRAIN RES, V985, P98, DOI 10.1016/S0006-8993(03)03173-1; Johansson S, 2006, EXP BRAIN RES, V168, P11, DOI 10.1007/s00221-005-0069-z; KACHADORIAN WA, 1981, J CELL BIOL, V91, P584, DOI 10.1083/jcb.91.2.584; KANEKO I, 1995, J NEUROCHEM, V65, P2585; Kato M, 1997, J NEUROCHEM, V68, P1889; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KIMURA T, 1967, J BIOL CHEM, V242, P4987; KOROTZER AR, 1995, EUR J PHARM-MOLEC PH, V288, P125, DOI 10.1016/0922-4106(95)90006-3; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lane RM, 2005, J LIPID RES, V46, P949, DOI 10.1194/jlr.M400486-JLR200; Latini A, 2005, MOL GENET METAB, V86, P188, DOI 10.1016/j.ymgme.2005.05.002; LEE CC, 2007, NEUROBIOL AGING; Liu ML, 2005, EXP MOL MED, V37, P559, DOI 10.1038/emm.2005.69; Liu YB, 1999, PROG NEURO-PSYCHOPH, V23, P377, DOI 10.1016/S0278-5846(99)00003-2; Liu YB, 1997, J NEUROCHEM, V69, P2285; Lushnikova IV, 2004, J CELL MOL MED, V8, P241, DOI 10.1111/j.1582-4934.2004.tb00279.x; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PODLISNY MB, 1993, AM J PATHOL, V142, P17; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; Rowan MJ, 2007, BIOCHEM SOC T, V35, P1219, DOI 10.1042/BST0351219; Schroder UH, 2004, EUR J PHARMACOL, V502, P99, DOI 10.1016/j.ejphar.2004.08.046; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Szegedi V, 2006, FASEB J, V20, P1191, DOI 10.1096/fj.05-4891fje; Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang X, 2007, EUR J NEUROSCI, V26, P2142, DOI 10.1111/j.1460-9568.2007.05853.x; WILLIAMSON R, 2007, FASEB J; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Xu KX, 1999, GLIA, V25, P390, DOI 10.1002/(SICI)1098-1136(19990215)25:4<390::AID-GLIA8>3.0.CO;2-7; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	62	31	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2008	3	9							e3236	10.1371/journal.pone.0003236	http://dx.doi.org/10.1371/journal.pone.0003236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LD	18800168	Green Submitted, gold, Green Published			2022-12-27	WOS:000264428400006
J	Mulligan, CJ; Kitchen, A; Miyamoto, MM				Mulligan, Connie J.; Kitchen, Andrew; Miyamoto, Michael M.			Updated Three-Stage Model for the Peopling of the Americas	PLOS ONE			English	Article								Background: We re-assess support for our three stage model for the peopling of the Americas in light of a recent report that identified nine non-Native American mitochondrial genome sequences that should not have been included in our initial analysis. Removal of these sequences results in the elimination of an early (i.e.,40,000 years ago) expansion signal we had proposed for the proto-Amerind population. Methodology/Findings: Bayesian skyline plot analysis of a new dataset of Native American mitochondrial coding genomes confirms the absence of an early expansion signal for the proto-Amerind population and allows us to reduce the variation around our estimate of the New World founder population size. In addition, genetic variants that define New World founder haplogroups are used to estimate the amount of time required between divergence of proto-Amerinds from the Asian gene pool and expansion into the New World. Conclusions/Significance: The period of population isolation required for the generation of New World mitochondrial founder haplogroup-defining genetic variants makes the existence of three stages of colonization a logical conclusion. Thus, our three stage model remains an important and useful working hypothesis for researchers interested in the peopling of the Americas and the processes of colonization.	[Mulligan, Connie J.; Kitchen, Andrew] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Miyamoto, Michael M.] Univ Florida, Dept Zool, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mulligan, CJ (corresponding author), Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA.	mulligan@anthro.ufl.edu			National Science Foundation [BSR-0518530]; Department of Zoology, University of Florid	National Science Foundation(National Science Foundation (NSF)); Department of Zoology, University of Florid	This study was supported by a grant from the National Science Foundation to CJM (BSR-0518530) and by funds from the Department of Zoology, University of Florida to MMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Elias SA, 1996, NATURE, V382, P60, DOI 10.1038/382060a0; Fagundes NJR, 2008, AM J HUM GENET, V83, P146, DOI 10.1016/j.ajhg.2008.06.016; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; FAGUNDES NJR, PLOS ONE IN PRESS; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Goebel T, 2007, SCIENCE, V315, P194, DOI 10.1126/science.1137564; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Ho SYW, 2008, AM J HUM GENET, V83, P142, DOI 10.1016/j.ajhg.2008.06.014; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; Hopkins D.M., 1982, PALEOECOLOGY BERINGI, P3, DOI DOI 10.1016/B978-0-12-355860-2.50008-9; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kitchen A, 2008, MOL PHYLOGENET EVOL, V46, P673, DOI 10.1016/j.ympev.2007.09.005; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Mandryk CAS, 2001, QUATERNARY SCI REV, V20, P301, DOI 10.1016/S0277-3791(00)00115-3; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mulligan CJ, 2004, ANNU REV GENOM HUM G, V5, P295, DOI 10.1146/annurev.genom.5.061903.175920; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; WEST FH, 1996, BERINGIA NEW WORLD O; Zazula GD, 2003, NATURE, V423, P603, DOI 10.1038/423603a	27	96	96	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3199	10.1371/journal.pone.0003199	http://dx.doi.org/10.1371/journal.pone.0003199			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LB	18797500	gold, Green Submitted, Green Published			2022-12-27	WOS:000264428200003
J	Cassano, M; Biressi, S; Finan, A; Benedetti, L; Omes, C; Boratto, R; Martin, F; Allegretti, M; Broccoli, V; De Angelis, GC; Comoglio, PM; Basilico, C; Torrente, Y; Michieli, P; Cossu, G; Sampaolesi, M				Cassano, Marco; Biressi, Stefano; Finan, Amanda; Benedetti, Laura; Omes, Claudia; Boratto, Renata; Martin, Frank; Allegretti, Marcello; Broccoli, Vania; De Angelis, Gabriella Cusella; Comoglio, Paolo M.; Basilico, Cristina; Torrente, Yvan; Michieli, Paolo; Cossu, Giulio; Sampaolesi, Maurilio			Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from Apoptosis	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR SCATTER FACTOR; DYSTROPHIN MINIGENE TRANSFER; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; PROTEOLYTIC CLEAVAGE; CELL ACTIVATION; STEM-CELLS; RECEPTOR; EXPRESSION	Background: Hepatocyte Growth Factor (HGF) is a pleiotropic cytokine of mesenchymal origin that mediates a characteristic array of biological activities including cell proliferation, survival, motility and morphogenesis. Its high affinity receptor, the tyrosine kinase Met, is expressed by a wide range of tissues and can be activated by either paracrine or autocrine stimulation. Adult myogenic precursor cells, the so called satellite cells, express both HGF and Met. Following muscle injury, autocrine HGF-Met stimulation plays a key role in promoting activation and early division of satellite cells, but is shut off in a second phase to allow myogenic differentiation. In culture, HGF stimulation promotes proliferation of muscle precursors thereby inhibiting their differentiation. Methodology/Principal Findings: Magic-Factor 1 (Met-Activating Genetically Improved Chimeric Factor-1 or Magic-F1) is an HGF-derived, engineered protein that contains two Met-binding domains repeated in tandem. It has a reduced affinity for Met and, in contrast to HGF it elicits activation of the AKT but not the ERK signaling pathway. As a result, Magic-F1 is not mitogenic but conserves the ability to promote cell survival. Here we show that Magic-F1 protects myogenic precursors against apoptosis, thus increasing their fusion ability and enhancing muscular differentiation. Electrotransfer of Magic-F1 gene into adult mice promoted muscular hypertrophy and decreased myocyte apoptosis. Magic-F1 transgenic mice displayed constitutive muscular hypertrophy, improved running performance and accelerated muscle regeneration following injury. Crossing of Magic-F1 transgenic mice with alpha-sarcoglycan knock-out mice-a mouse model of muscular dystrophy- or adenovirus-mediated Magic-F1 gene delivery resulted in amelioration of the dystrophic phenotype as measured by both anatomical/histological analysis and functional tests. Conclusions/Significance: Because of these features Magic-F1 represents a novel molecular tool to counteract muscle wasting in major muscular diseases such as cachexia or muscular dystrophy.	[Cassano, Marco; Sampaolesi, Maurilio] KULeuven, SCIL, Louvain, Belgium; [Cassano, Marco] Univ Rome Sapienza, Dept Histol & Med Embryol, Rome, Italy; [Biressi, Stefano; Finan, Amanda; Broccoli, Vania; Cossu, Giulio] HS Raffaele, Stem Cell Res Inst, Milan, Italy; [Benedetti, Laura; Omes, Claudia; Boratto, Renata; De Angelis, Gabriella Cusella; Sampaolesi, Maurilio] Univ Pavia, Pavia, Italy; [Martin, Frank; Allegretti, Marcello] Dompe Phrma Res Ctr, Laquila, Italy; [Comoglio, Paolo M.; Basilico, Cristina; Michieli, Paolo] Inst Canc Res & Treatment IRCC, Div Mol Oncol, Turin, Italy; [Torrente, Yvan] Univ Milan, Ospedale Maggiore Policlin, Dept Neurol Sci, Milan, Italy	KU Leuven; Sapienza University Rome; University of Pavia; Dompe; IRCCS Fondazione del Piemonte per l'Oncologia; University of Milan	Cassano, M (corresponding author), KULeuven, SCIL, Louvain, Belgium.	sampa@unipv.it	Cassano, Marco/T-3473-2019; Omes, Claudia/AAO-8280-2020; Michieli, Paolo/A-2588-2011; Biressi, Stefano/AAD-8956-2020; Broccoli, Vania/K-3464-2016; Sampaolesi, Maurilio/H-6509-2013; Basilico, Cristina/A-3253-2011; Omes, Claudia/G-4696-2013; TORRENTE, YVAN/A-2964-2015	Omes, Claudia/0000-0003-0663-6168; Michieli, Paolo/0000-0002-3093-8871; Broccoli, Vania/0000-0003-4050-0926; Sampaolesi, Maurilio/0000-0002-2422-3757; Omes, Claudia/0000-0003-0663-6168; Cassano, Marco/0000-0002-8526-1319; TORRENTE, YVAN/0000-0002-2705-3984; Comoglio, Paolo/0000-0002-7056-5328; Biressi, Stefano Augusto Maria/0000-0001-8631-3419	FWO Odysseus Program [G.0907.08]; Wicka Funds [zkb8720]; Italian Ministry of University and Scientific Research [2005067555_003]; Muscular Dystrophy Association; Telethon; Association Francoise contre les Myopathies; Parent Project Onlus; CARIPLO	FWO Odysseus Program; Wicka Funds; Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Muscular Dystrophy Association(Muscular Dystrophy Association); Telethon(Fondazione Telethon); Association Francoise contre les Myopathies; Parent Project Onlus; CARIPLO(Fondazione Cariplo)	This work was supported in part by: FWO Odysseus Program n. G.0907.08; Wicka Funds n. zkb8720; the Italian Ministry of University and Scientific Research (grant n. 2005067555_003, COFIN 2006 08), the Muscular Dystrophy Association, Telethon, Association Francoise contre les Myopathies, Parent Project Onlus, CARIPLO.	Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Andermarcher E, 1996, DEV GENET, V18, P254, DOI 10.1002/(SICI)1520-6408(1996)18:3<254::AID-DVG6>3.0.CO;2-8; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cioce V, 1996, J BIOL CHEM, V271, P13110, DOI 10.1074/jbc.271.22.13110; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Cossu G, 2004, TRENDS MOL MED, V10, P516, DOI 10.1016/j.molmed.2004.08.007; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Feero WG, 1997, HUM GENE THER, V8, P371, DOI 10.1089/hum.1997.8.4-371; Fiaccavento R, 2005, J PATHOL, V205, P397, DOI 10.1002/path.1717; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Gal-Levi R, 1998, BBA-MOL CELL RES, V1402, P39, DOI 10.1016/S0167-4889(97)00124-9; HARTMANN G, 1992, P NATL ACAD SCI USA, V89, P11574, DOI 10.1073/pnas.89.23.11574; Kos L, 1999, PIGM CELL RES, V12, P13, DOI 10.1111/j.1600-0749.1999.tb00503.x; Leshem Y, 2000, J CELL PHYSIOL, V184, P101, DOI 10.1002/(SICI)1097-4652(200007)184:1<101::AID-JCP11>3.0.CO;2-D; Li YW, 2003, CIRCULATION, V107, P2499, DOI 10.1161/01.CIR.0000065579.19126.B8; Lochmuller H, 1996, GENE THER, V3, P706; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; MARK MR, 1992, J BIOL CHEM, V267, P26166; Matsumoto K, 1998, J BIOL CHEM, V273, P22913, DOI 10.1074/jbc.273.36.22913; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Michieli P, 2002, NAT BIOTECHNOL, V20, P488, DOI 10.1038/nbt0502-488; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357, DOI 10.1016/0304-419X(93)90015-5; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schwall RH, 1996, J CELL BIOL, V133, P709, DOI 10.1083/jcb.133.3.709; Sheehan SM, 2000, MUSCLE NERVE, V23, P239, DOI 10.1002/(SICI)1097-4598(200002)23:2<239::AID-MUS15>3.0.CO;2-U; Takahara T, 2008, HEPATOLOGY, V47, P2010, DOI 10.1002/hep.22243; Takayama H, 1996, P NATL ACAD SCI USA, V93, P5866, DOI 10.1073/pnas.93.12.5866; Tamagnone Luca, 1997, Cytokine and Growth Factor Reviews, V8, P129, DOI 10.1016/S1359-6101(97)00007-5; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; VILQUIN JT, 1995, HUM GENE THER, V6, P1391, DOI 10.1089/hum.1995.6.11-1391; Wagner KR, 2002, ANN NEUROL, V52, P832, DOI 10.1002/ana.10385; WOOLF AS, 1995, J CELL BIOL, V128, P171, DOI 10.1083/jcb.128.1.171; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Yang L, 1998, GENE THER, V5, P369, DOI 10.1038/sj.gt.3300600; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177	54	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3223	10.1371/journal.pone.0003223	http://dx.doi.org/10.1371/journal.pone.0003223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795097	Green Published, gold, Green Submitted			2022-12-27	WOS:000264428000006
J	Sheth, BR; Janvelyan, D; Khan, M				Sheth, Bhavin R.; Janvelyan, Davit; Khan, Murtuza			Practice Makes Imperfect: Restorative Effects of Sleep on Motor Learning	PLOS ONE			English	Article							TIME-COURSE; MEMORY CONSOLIDATION; CHUNKING; ACQUISITION; IMPROVEMENT	Emerging evidence suggests that sleep plays a key role in procedural learning, particularly in the continued development of motor skill learning following initial acquisition. We argue that a detailed examination of the time course of performance across sleep on the finger-tapping task, established as the paradigm for studying the effect of sleep on motor learning, will help distinguish a restorative role of sleep in motor skill learning from a proactive one. Healthy subjects rehearsed for 12 trials and, following a night of sleep, were tested. Early training rapidly improved speed as well as accuracy on pre-sleep training. Additional rehearsal caused a marked slow-down in further improvement or partial reversal in performance to observed levels below theoretical upper limits derived on the basis of early pre-sleep rehearsal. This decrement in learning efficacy does not occur always, but if and only if it does, overnight sleep has an effect in fully or partly restoring the efficacy and actual performance to the optimal theoretically achieveable level. Our findings re-interpret the sleep-dependent memory enhancement in motor learning reported in the literature as a restoration of fatigued circuitry specialized for the skill. In providing restitution to the fatigued brain, sleep eliminates the rehearsal-induced synaptic fatigue of the circuitry specialized for the task and restores the benefit of early pre-sleep rehearsal. The present findings lend support to the notion that latent sleep-dependent enhancement of performance is a behavioral expression of the brain's restitution in sleep.	[Sheth, Bhavin R.] Univ Houston, Houston, TX 77004 USA; [Janvelyan, Davit; Khan, Murtuza] California Inst Technol, Pasadena, CA USA	University of Houston System; University of Houston; California Institute of Technology	Sheth, BR (corresponding author), Univ Houston, Houston, TX 77004 USA.	brsheth@uh.edu			University of Houston; UH-PURS [fellowship]; Caltech [SURF fellowship];  [Cline Discovery]	University of Houston; UH-PURS; Caltech; 	This research was supported in part by funds from the University of Houston (BRS) and a Cline Discovery Grant (BRS, Caltech). MZ was supported by a UH-PURS fellowship. DJ was supported by a Caltech-SURF fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Censor N, 2006, VISION RES, V46, P4071, DOI 10.1016/j.visres.2006.07.022; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Mednick SC, 2002, NAT NEUROSCI, V5, P677, DOI 10.1038/nn864; ROSENBAUM DA, 1983, J EXP PSYCHOL HUMAN, V9, P86, DOI 10.1037/0096-1523.9.1.86; Sakai K, 2003, EXP BRAIN RES, V152, P229, DOI 10.1007/s00221-003-1548-8; Sheth BR, 2005, BEHAV BRAIN SCI, V28, P81, DOI 10.1017/S0140525X05390029; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Stickgold R, 1998, J COGNITIVE NEUROSCI, V10, P77; Stocker C, 2004, PSYCHOL RES-PSYCH FO, V68, P126, DOI 10.1007/s00426-003-0150-9; Vertes RP, 2005, BEHAV BRAIN SCI, V28, P86, DOI 10.1017/S0140525X05440029; Verwey WB, 1996, J MOTOR BEHAV, V28, P71, DOI 10.1080/00222895.1996.9941735; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, SLEEP, V26, pA441; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930	26	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3190	10.1371/journal.pone.0003190	http://dx.doi.org/10.1371/journal.pone.0003190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422KI	18787652	Green Published, gold, Green Accepted			2022-12-27	WOS:000264426200001
J	Kastberger, G; Schmelzer, E; Kranner, I				Kastberger, Gerald; Schmelzer, Evelyn; Kranner, Ilse			Social Waves in Giant Honeybees Repel Hornets	PLOS ONE			English	Article							COLONY DEFENSE; MIGRATION; BEHAVIOR; DORSATA	Giant honeybees (Apis dorsata) nest in the open and have evolved a plethora of defence behaviors. Against predatory wasps, including hornets, they display highly coordinated Mexican wave-like cascades termed 'shimmering'. Shimmering starts at distinct spots on the nest surface and then spreads across the nest within a split second whereby hundreds of individual bees flip their abdomens upwards. However, so far it is not known whether prey and predator interact and if shimmering has anti-predatory significance. This article reports on the complex spatial and temporal patterns of interaction between Giant honeybee and hornet exemplified in 450 filmed episodes of two A. dorsata colonies and hornets (Vespa sp.). Detailed frame-by-frame analysis showed that shimmering elicits an avoidance response from the hornets showing a strong temporal correlation with the time course of shimmering. In turn, the strength and the rate of the bees' shimmering are modulated by the hornets' flight speed and proximity. The findings suggest that shimmering creates a 'shelter zone' of around 50 cm that prevents predatory wasps from foraging bees directly from the nest surface. Thus shimmering appears to be a key defence strategy that supports the Giant honeybees' open-nesting life-style.	[Kastberger, Gerald; Schmelzer, Evelyn] Graz Univ, Inst Zool, A-8010 Graz, Austria; [Kranner, Ilse] Royal Botan Gardens, Seed Conservat Dept, Richmond, Surrey, England	University of Graz; Royal Botanic Gardens, Kew	Kastberger, G (corresponding author), Graz Univ, Inst Zool, A-8010 Graz, Austria.	gerald.kastberger@uni-graz.at	Kranner, Ilse/B-1039-2011	Kranner, Ilse/0000-0003-4959-9109	University Graz; EU [I-SWARM]; Austrian Scientific Foundation	University Graz; EU(European Commission); Austrian Scientific Foundation(Austrian Science Fund (FWF))	The data collection in Nepal was granted by the research funds of the University Graz. The data analysis was partially supported by an EU grant (I-SWARM) and the Austrian Scientific Foundation.	Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; BUTLER CG, 1962, WORLD HONEYBEE; Caro Tim, 2005, pXIII; CREWE RM, 1976, J APICULT RES, V15, P149, DOI 10.1080/00218839.1976.11099850; Das B.P., 1989, ORIENTAL INSECTS MON, V11; EIBLEIBESFELDT J, 1978, GRUNDRISS VERGLEICHE; Farkas I, 2002, NATURE, V419, P131, DOI 10.1038/419131a; Jeschke JM, 2007, ANIM BEHAV, V74, P387, DOI 10.1016/j.anbehav.2006.08.020; Kastberger G, 2003, BEHAV RES METH INS C, V35, P429, DOI 10.3758/BF03195520; Kastberger G, 1996, APIDOLOGIE, V27, P381, DOI 10.1051/apido:19960506; Kastberger G, 1998, ETHOLOGY, V104, P27, DOI 10.1111/j.1439-0310.1998.tb00027.x; Kastberger G, 2000, APIDOLOGIE, V31, P727, DOI 10.1051/apido:2000157; KASTBERGER G, 2001, P DTSCH ZOOLOGISCHE, P7; Ken T, 2005, NATURWISSENSCHAFTEN, V92, P492, DOI 10.1007/s00114-005-0026-5; KOENIGER N, 1975, Zeitschrift fuer Tierpsychologie, V37, P99; KOENIGER N, 1980, J APICULT RES, V19, P21, DOI 10.1080/00218839.1980.11099994; Koeniger N, 1996, APIDOLOGIE, V27, P341, DOI 10.1051/apido:19960502; Krause J, 2002, LIVING GROUPS; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; LINDAUER M, 1952, Z VERGL PHYSIOL, V38, P521; MORSE RA, 1969, APIS DORSATA PHILLIP; OLDROYD B, 1995, APIDOLOGIE, V26, P119, DOI 10.1051/apido:19950205; OLDROYD BP, 2006, ASIAN HONEY BEES; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; Paar J, 2000, NATURE, V406, P475, DOI 10.1038/35020196; Paar J, 2004, J HERED, V95, P119, DOI 10.1093/jhered/esh026; Roepke W, 1930, BEOBACHTUNGEN INDISC; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Sakagami S. F., 1960, Acta Hymenopterologica, V1, P171; SCHMELZER E, 2004, P DTSCH ZOOLOGISCHE, P71; SEELEY TD, 1982, ECOL MONOGR, V52, P43, DOI 10.2307/2937344; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; UNDERWOOD BA, 1990, NATL GEOGR RES, V6, P276; Wickler W., 1968, MIMICRY PLANTS ANIMA	35	73	76	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3141	10.1371/journal.pone.0003141	http://dx.doi.org/10.1371/journal.pone.0003141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KD	18781205	Green Published, gold, Green Submitted			2022-12-27	WOS:000264425700004
J	Frankenstein, Z; Sperling, J; Sperling, R; Eisenstein, M				Frankenstein, Ziv; Sperling, Joseph; Sperling, Ruth; Eisenstein, Miriam			FitEM2EM-Tools for Low Resolution Study of Macromolecular Assembly and Dynamics	PLOS ONE			English	Article								Studies of the structure and dynamics of macromolecular assemblies often involve comparison of low resolution models obtained using different techniques such as electron microscopy or atomic force microscopy. We present new computational tools for comparing (matching) and docking of low resolution structures, based on shape complementarity. The matched or docked objects are represented by three dimensional grids where the value of each grid point depends on its position with regard to the interior, surface or exterior of the object. The grids are correlated using fast Fourier transformations producing either matches of related objects or docking models depending on the details of the grid representations. The procedures incorporate thickening and smoothing of the surfaces of the objects which effectively compensates for differences in the resolution of the matched/docked objects, circumventing the need for resolution modification. The presented matching tool FitEM2EMIN successfully fitted electron microscopy structures obtained at different resolutions, different conformers of the same structure and partial structures, ranking correct matches at the top in every case. The differences between the grid representations of the matched objects can be used to study conformation differences or to characterize the size and shape of substructures. The presented low-to-low docking tool FitEM2EMOUT ranked the expected models at the top.	[Frankenstein, Ziv] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Sperling, Joseph] Weizmann Inst Sci, Dept Organ Chem, Rehovot, Israel; [Sperling, Ruth] Hebrew Univ Jerusalem, Dept Genet, IL-91905 Jerusalem, Israel; [Eisenstein, Miriam] Weizmann Inst Sci, Dept Chem Res Support, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Hebrew University of Jerusalem; Weizmann Institute of Science	Frankenstein, Z (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	miriam.eisenstein@weizmann.ac.il			Kimmelman Center for Macromolecular Structure and Assembly at the Weizmann Institute of Science; US NIH [GM079549]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079549] Funding Source: NIH RePORTER	Kimmelman Center for Macromolecular Structure and Assembly at the Weizmann Institute of Science; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ZF is partially supported by the Kimmelman Center for Macromolecular Structure and Assembly at the Weizmann Institute of Science. JS and RS thank the US NIH, grant GM079549. The funding source had no role in the design and execution of the computations or in the analyses of the results or the preparation of the manuscript.	Barcena M, 2001, EMBO J, V20, P1462, DOI 10.1093/emboj/20.6.1462; Ben-Zeev E, 2003, PROTEINS, V52, P24, DOI 10.1002/prot.10391; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen DH, 2006, STRUCTURE, V14, P1711, DOI 10.1016/j.str.2006.09.010; Clarey MG, 2006, NAT STRUCT MOL BIOL, V13, P684, DOI 10.1038/nsmb1121; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; De Carlo S, 2006, GENE DEV, V20, P1485, DOI 10.1101/gad.1418306; Eisenstein M, 1997, J MOL BIOL, V266, P135, DOI 10.1006/jmbi.1996.0773; Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929; Fabiola F, 2005, STRUCTURE, V13, P389, DOI 10.1016/j.str.2005.01.007; Frank J, 2002, ANNU REV BIOPH BIOM, V31, P303, DOI 10.1146/annurev.biophys.31.082901.134202; FRANK J, 1991, J CELL BIOL, V115, P597, DOI 10.1083/jcb.115.3.597; Frank J., 1996, 3 DIMENSIONAL ELECT, Ved, ppp 54; Gilbertt RJC, 2007, P NATL ACAD SCI USA, V104, P5788, DOI 10.1073/pnas.0606880104; Gomez-Llorente Y, 2005, J BIOL CHEM, V280, P40909, DOI 10.1074/jbc.M509760200; Grob P, 2006, STRUCTURE, V14, P511, DOI 10.1016/j.str.2005.11.020; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Heifetz A, 2002, PROTEIN SCI, V11, P571, DOI 10.1110/ps.26002; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kim LA, 2004, NEURON, V41, P513, DOI 10.1016/S0896-6273(04)00050-9; Klaholz BP, 2004, NATURE, V427, P862, DOI 10.1038/nature02332; Kowalsman N, 2007, BIOINFORMATICS, V23, P421, DOI 10.1093/bioinformatics/btl524; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Leschziner AE, 2007, ANNU REV BIOPH BIOM, V36, P43, DOI 10.1146/annurev.biophys.36.040306.132742; Mitra K, 2006, ANNU REV BIOPH BIOM, V35, P299, DOI 10.1146/annurev.biophys.35.040405.101950; Puri T, 2007, J MOL BIOL, V366, P179, DOI 10.1016/j.jmb.2006.11.030; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Rossmann MG, 2000, ACTA CRYSTALLOGR D, V56, P1341, DOI 10.1107/S0907444900009562; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; San Martin C, 1998, STRUCTURE, V6, P501; SanMartin MC, 1997, J MOL BIOL, V268, P15, DOI 10.1006/jmbi.1997.0952; Scheuring S, 2007, J STRUCT BIOL, V159, P268, DOI 10.1016/j.jsb.2007.01.021; Schoehn G, 2006, J BIOL CHEM, V281, P36327, DOI 10.1074/jbc.M604417200; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Stahlberg H, 2008, ACS CHEM BIOL, V3, P268, DOI 10.1021/cb800037d; Stark H, 2006, ANNU REV BIOPH BIOM, V35, P435, DOI 10.1146/annurev.biophys.35.040405.101953; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Wriggers W, 2001, STRUCTURE, V9, P779, DOI 10.1016/S0969-2126(01)00648-7; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3594	10.1371/journal.pone.0003594	http://dx.doi.org/10.1371/journal.pone.0003594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974836	gold, Green Published, Green Submitted			2022-12-27	WOS:000265131700015
J	Aranda-Orgilles, B; Aigner, J; Kunath, M; Lurz, R; Schneider, R; Schweiger, S				Aranda-Orgilles, Beatriz; Aigner, Johanna; Kunath, Melanie; Lurz, Rudi; Schneider, Rainer; Schweiger, Susann			Active Transport of the Ubiquitin Ligase MID1 along the Microtubules Is Regulated by Protein Phosphatase 2A	PLOS ONE			English	Article							LINKED OPITZ-SYNDROME; SYNDROME GENE-PRODUCT; CATALYTIC SUBUNIT; NEURONAL POLARITY; MOTOR PROTEINS; G/BBB SYNDROME; MUTATIONS; BINDING; COMPLEX; DOMAIN	Mutations in the MID1 protein have been found in patients with Opitz BBB/G syndrome (OS), which is characterised by multiple malformations of the ventral midline. MID1 is a microtubule-associated protein that stabilizes microtubules and, in association with the regulatory subunit of protein phosphatase 2A (PP2A), alpha 4, provides ubiquitin ligase activity for the ubiquitin-specific modification of PP2A. Using Fluorescence Recovery After Photobleaching (FRAP) technology, we show here that MID1 is actively and bi-directionally transported along the microtubules, and that this movement is directly linked to its MAP kinase and PP2A-mediated phosphorylation status. Intact transport depends on both kinesins and dyneins and is inhibited upon colcemide treatments. MID1 proteins carrying missense mutations in the alpha 4 binding domain still bind the microtubules but cannot be actively transported. Likewise, knock-down of the alpha 4 protein, inhibition of PP2A activity by okadaic acid and fostriecin or the simulation of permanent phosphorylation at Ser96 in MID1 stop the migration of MID1-GFP, while preserving its microtubule-association. In summary, our data uncover an unexpected and novel function for PP2A, its regulatory subunit alpha 4 and PP2A/alpha 4/mTOR signaling in the active transport of the MID1 ubiquitin ligase complex along the cytoskeleton. Furthermore, a failure in the microtubule directed transport of this protein complex would be an attractive mechanism underlying the pathogenesis of OS in patients with B-box1 mutations.	[Aranda-Orgilles, Beatriz; Aigner, Johanna; Kunath, Melanie; Lurz, Rudi; Schweiger, Susann] Max Planck Inst Mol Genet, Berlin, Germany; [Schneider, Rainer] Univ Innsbruck, Inst Biochem, A-6020 Innsbruck, Austria; [Schweiger, Susann] Univ Dundee, Ninewells Hosp, Div Pathol & Neurosci, Dundee DD1 4HN, Scotland	Max Planck Society; University of Innsbruck; University of Dundee	Aranda-Orgilles, B (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	schweiger@molgen.mpg.de			Volkswagen Stiftung; Deutsche Forschungsgemeinschaft [SFB 577]; Austrian Science Fund [FWF-SFB021/03]	Volkswagen Stiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund(Austrian Science Fund (FWF))	Financial support was given by the Volkswagen Stiftung (Lichtenberg Professur to S.S.), the Deutsche Forschungsgemeinschaft (DFG, SFB 577) and the Austrian Science Fund (FWF-SFB021/03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARANDAORGILLES B, 2008, HUM GENET; Cainarca S, 1999, HUM MOL GENET, V8, P1387, DOI 10.1093/hmg/8.8.1387; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; Cox TC, 2000, HUM MOL GENET, V9, P2553, DOI 10.1093/hmg/9.17.2553; De Falco F, 2003, AM J MED GENET A, V120A, P222, DOI 10.1002/ajmg.a.10265; Duhl DM, 2005, CURR OPIN DRUG DISC, V8, P431; Ferrentino R, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9480; Gaudenz K, 1998, AM J HUM GENET, V63, P703, DOI 10.1086/302010; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Henry J, 1998, MOL BIOL EVOL, V15, P1696, DOI 10.1093/oxfordjournals.molbev.a025896; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Jiang XY, 2006, CANCER RES, V66, P5258, DOI 10.1158/0008-5472.CAN-05-4510; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; Mnayer L, 2006, MOL GENET METAB, V87, P198, DOI 10.1016/j.ymgme.2005.10.014; Munro EM, 2006, CURR OPIN CELL BIOL, V18, P86, DOI 10.1016/j.ceb.2005.12.007; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Perry J, 1999, GENOMICS, V62, P385, DOI 10.1006/geno.1999.6043; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Pinson L, 2004, J MED GENET, V41, P381, DOI 10.1136/jmg.2003.014829; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Schweiger S, 1999, P NATL ACAD SCI USA, V96, P2794, DOI 10.1073/pnas.96.6.2794; Schweiger S, 2003, BIOESSAYS, V25, P356, DOI 10.1002/bies.10256; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; SHIMIZU T, 1995, METHOD CELL BIOL, V47, P497, DOI 10.1016/S0091-679X(08)60851-1; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; So J, 2005, AM J MED GENET A, V132A, P1, DOI 10.1002/ajmg.a.30407; Steinhauer J, 2006, DEV DYNAM, V235, P1455, DOI 10.1002/dvdy.20770; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Wu XF, 2006, TRENDS CELL BIOL, V16, P135, DOI 10.1016/j.tcb.2006.01.004; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	35	35	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3507	10.1371/journal.pone.0003507	http://dx.doi.org/10.1371/journal.pone.0003507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949047	Green Published, gold			2022-12-27	WOS:000265126400002
J	Zanotto, PMD; Krakauer, DC				de Andrade Zanotto, Paolo Marinho; Krakauer, David C.			Complete Genome Viral Phylogenies Suggests the Concerted Evolution of Regulatory Cores and Accessory Satellites	PLOS ONE			English	Article							DNA-SEQUENCE DISSIMILARITY; NEODIPRION-SERTIFER; DISTANCE; VIRUS; GENE; LIKELIHOOD; ALIGNMENT; IDENTIFICATION; BACULOVIRUSES; HERPESVIRUS	We consider the concerted evolution of viral genomes in four families of DNA viruses. Given the high rate of horizontal gene transfer among viruses and their hosts, it is an open question as to how representative particular genes are of the evolutionary history of the complete genome. To address the concerted evolution of viral genes, we compared genomic evolution across four distinct, extant viral families. For all four viral families we constructed DNA-dependent DNA polymerase-based (DdDp) phylogenies and in addition, whole genome sequence, as quantitative descriptions of inter-genome relationships. We found that the history of the polymerase gene was highly predictive of the history of the genome as a whole, which we explain in terms of repeated, co-divergence events of the core DdDp gene accompanied by a number of satellite, accessory genetic loci. We also found that the rate of gene gain in baculovirus and poxviruses proceeds significantly more quickly than the rate of gene loss and that there is convergent acquisition of satellite functions promoting contextual adaptation when distinct viral families infect related hosts. The congruence of the genome and polymerase trees suggests that a large set of viral genes, including polymerase, derive from a phylogenetically conserved core of genes of host origin, secondarily reinforced by gene acquisition from common hosts or co-infecting viruses within the host. A single viral genome can be thought of as a mutualistic network, with the core genes acting as an effective host and the satellite genes as effective symbionts. Larger virus genomes show a greater departure from linkage equilibrium between core and satellites functions.	[de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Inst Ciencias Biomed ICB 2, Sao Paulo, Brazil; [Krakauer, David C.] Santa Fe Inst, Santa Fe, NM USA	Universidade de Sao Paulo; The Santa Fe Institute	Zanotto, PMD (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed ICB 2, Sao Paulo, Brazil.	pzanotto@usp.br	de A. Zanotto, Paolo M./B-9286-2019	de A. Zanotto, Paolo M./0000-0002-8167-0625	Santa Fe Institute (USA); FAPESP (Brazil) [07/55282-0]; CNPq PQ Productivity Scholarship	Santa Fe Institute (USA); FAPESP (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq PQ Productivity Scholarship	This work was funded by both the Santa Fe Institute (USA) and FAPESP (Brazil), project number 07/55282-0. PMAZ has a CNPq PQ Productivity Scholarship.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alba MM, 2001, GENOME RES, V11, P43, DOI 10.1101/gr.149801; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREWES C, 1967, VIRUSES EVOLUTION; [Anonymous], 2014, TRACER V1 6; Auch AF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-350; Bell PJL, 2001, J MOL EVOL, V53, P251; Bideshi DK, 2003, J GEN VIROL, V84, P2531, DOI 10.1099/vir.0.19256-0; Booy FP, 1996, VIROLOGY, V215, P134, DOI 10.1006/viro.1996.0016; BRAITHWAITE DK, 1999, NUCLEIC ACIDS RES, V21, P787; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; Wolff JL, 2008, J GEN VIROL, V89, P1202, DOI 10.1099/vir.0.83581-0; Chen F, 1996, VIROLOGY, V219, P170, DOI 10.1006/viro.1996.0234; CHIAHSIUNG C, 2002, J VIROL, V76, P9024; Oliveira JVD, 2006, J GEN VIROL, V87, P3233, DOI 10.1099/vir.0.82161-0; Delhon G, 2004, J VIROL, V78, P168, DOI 10.1128/JVI.78.1.168-177.2004; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EIGEN M, 1979, HYPERCYCLE PRINCIPLE, P86; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Forterre P, 2005, BIOCHIMIE, V87, P793, DOI 10.1016/j.biochi.2005.03.015; Garcia-Maruniak A, 2004, J VIROL, V78, P7036, DOI 10.1128/JVI.78.13.7036-7051.2004; Green R G, 1935, Science, V82, P443, DOI 10.1126/science.82.2132.443; HAWTIN RE, 1995, VIROLOGY, V212, P673, DOI 10.1006/viro.1995.1525; Henz Stefan R, 2005, Bioinformatics, V21, P2329, DOI 10.1093/bioinformatics/bth324; Herniou EA, 2004, J VIROL, V78, P3244, DOI 10.1128/JVI.78.7.3244-3251.2004; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Hohl M, 2007, SYST BIOL, V56, P206, DOI 10.1080/10635150701294741; HUTCHINSON CA, 1999, SCIENCE, V286, P5447; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; KRAKAUER DC, 2007, PROTOCELLS BRIDGING; Laidlaw Patrick P, 1938, VIRUS DIS VIRUSES; Lauzon HAM, 2006, J GEN VIROL, V87, P1477, DOI 10.1099/vir.0.81727-0; MADDISON DR, 2005, MACCLADE 4 RELEASE V; McGeoch DJ, 2000, J VIROL, V74, P10401, DOI 10.1128/JVI.74.22.10401-10406.2000; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100; Monier A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-456; Montague MG, 2000, P NATL ACAD SCI USA, V97, P5334, DOI 10.1073/pnas.97.10.5334; Morse Stephen S., 1994, P1; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; PAGE RDM, 1990, CLADISTICS, V6, P119, DOI 10.1111/j.1096-0031.1990.tb00532.x; PAGE RDM, 1994, CLADISTICS, V10, P155, DOI 10.1006/clad.1994.1010; Page RDM, 2002, TANGLED TREES PHYLOG; Pertsemlidis A, 2001, GENOME BIOL, V2; Peterson SN, 2001, GENOME BIOL, V2; POSSEE RD, 1997, BACULOVIRUSES, P109; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; RAO VB, 1988, J MOL BIOL, V200, P475, DOI 10.1016/0022-2836(88)90537-2; Romano CM, 2006, ARCH VIROL, V151, P2215, DOI 10.1007/s00705-006-0792-1; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Senkevich TG, 1997, VIROLOGY, V233, P19, DOI 10.1006/viro.1997.8607; Spencer M, 2005, MOL BIOL EVOL, V22, P1161, DOI 10.1093/molbev/msi123; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ulitsky I, 2006, J COMPUT BIOL, V13, P336, DOI 10.1089/cmb.2006.13.336; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Wu TJ, 1997, BIOMETRICS, V53, P1431, DOI 10.2307/2533509; Wu TJ, 2001, BIOMETRICS, V57, P441, DOI 10.1111/j.0006-341X.2001.00441.x; ZANOTTO PMD, 1993, J INVERTEBR PATHOL, V62, P147, DOI 10.1006/jipa.1993.1090	60	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3500	10.1371/journal.pone.0003500	http://dx.doi.org/10.1371/journal.pone.0003500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941535	Green Submitted, Green Published, gold			2022-12-27	WOS:000265126100026
J	Srikrishnan, AK; Venkatesh, KK; Solomon, S; Thamburaj, E; Anand, S; Kosalaraman, KG; Balakrishnan, P; Mayer, KH				Srikrishnan, A. K.; Venkatesh, Kartik K.; Solomon, Suniti; Thamburaj, Easter; Anand, S.; Kosalaraman, K. G.; Balakrishnan, Pachamuthu; Mayer, Kenneth H.			Expansion of HIV Laboratory Diagnostic Services in Chennai, India 2001-2006: Is the Growth Commensurate with the Need?	PLOS ONE			English	Article							PREGNANT-WOMEN; ANTIRETROVIRAL THERAPY; NATURAL-HISTORY; GULF STATES; ATTITUDES; DISEASE; URBAN; PUNE; INFECTION; HIV/AIDS	Objective: To describe the changes in HIV services provided and the patient population utilizing voluntary counseling and testing (VCT) services at private testing laboratories in Chennai, India in 2001 and 2006. Methods: In 2001, a cross-sectional descriptive survey was conducted to assess the services provided and client population of 1,031 private laboratories. A subset of labs (9%) that had been surveyed in 2001 were also studied in 2006. Results: In 2001, significantly more high volume labs (. 10 HIV tests per month) offered HIV diagnostic tests than low volume labs (, 10 HIV test per month) (p<0.001). More high volume labs (20.0%) provided pre-test counseling as part of HIV testing than low volume labs (11.1%) (p = 0.003). Between 2001 and 2006, the number of labs that provided HIV diagnostic tests significantly increased, including ELISA (87.8% vs. 40.0%), Western Blot (84.4% vs. 13.3%), and Tridot (98.9% vs. 72.2%) (p<0.001). Also the number of labs that reported greater than 10 women seeking HIV testing per month significantly increased from 14.5% to 79.0% (p = 0.006). More labs provided pre-test counseling in 2006 (34.4%) than in 2001 (21.1%) (p = 0.046). Conclusions: Though HIV diagnostic testing services have increasingly become available, counseling services have not expanded commensurately. Further outreach and education is necessary to expand comprehensive HIV VCT services in both urban and rural India.	[Srikrishnan, A. K.; Solomon, Suniti; Thamburaj, Easter; Anand, S.; Kosalaraman, K. G.; Balakrishnan, Pachamuthu] VHS, YRG CARE, Madras, Tamil Nadu, India; [Venkatesh, Kartik K.; Mayer, Kenneth H.] Brown Univ, Sch Med, Div Infect Dis, Miriam Hosp, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital	Srikrishnan, AK (corresponding author), VHS, YRG CARE, Madras, Tamil Nadu, India.	Kenneth_Mayer@Brown.edu	Balakrishnan, Pachamuthu/ABV-6282-2022	Balakrishnan, Pachamuthu/0000-0002-1710-9155	Brown University's AIDS International Research and Training Program of the Fogarty International Center at the National Institutes of Health (NIH), USA [D43TW00237]; Lifespan/Tufts/Brown Center for AIDS Research (CFAR) of the NIH, USA [P30 AI42853]; FOGARTY INTERNATIONAL CENTER [D43TW000237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER	Brown University's AIDS International Research and Training Program of the Fogarty International Center at the National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Lifespan/Tufts/Brown Center for AIDS Research (CFAR) of the NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to the research survey staff at the YRG Centre for AIDS Research and Education, VHS, Chennai, India, for their facilitation of the study. The authors would like to thank Brown University's AIDS International Research and Training Program of the Fogarty International Center at the National Institutes of Health (NIH), USA, (grant no. D43TW00237), and the Lifespan/Tufts/Brown Center for AIDS Research (CFAR) of the NIH, USA (grant no. #P30 AI42853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, INCR ACC HIV TEST CO; Anvikar AR, 2005, ACTA TROP, V93, P289, DOI 10.1016/j.actatropica.2004.10.009; Bentley ME, 1998, AIDS, V12, P1869, DOI 10.1097/00002030-199814000-00019; Bharucha KE, 2005, INT J STD AIDS, V16, P553, DOI 10.1258/0956462054679250; Brown H, 2001, INT J STD AIDS, V12, P390, DOI 10.1258/0956462011923345; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Day JH, 2003, AIDS CARE, V15, P665, DOI 10.1080/0954012030001595140; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; KANDELA P, 1994, BRIT MED J, V308, P617, DOI 10.1136/bmj.308.6929.617b; Kielmann K, 2005, SOC SCI MED, V61, P1540, DOI 10.1016/j.socscimed.2005.02.008; Kumarasamy N, 2005, CLIN INFECT DIS, V41, P1525, DOI 10.1086/497267; Kumarasamy N, 2003, CLIN INFECT DIS, V36, P79, DOI 10.1086/344756; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; *NACO, NACO HIV TEST MAN LA; *NACO, 2001, COUNTR SCEN 2000 200; *NACO, 2006, FACTS FIG; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; Rogers A, 2006, AIDS PATIENT CARE ST, V20, P803, DOI 10.1089/apc.2006.20.803; Shah SA, 1999, INT J STD AIDS, V10, P812, DOI 10.1258/0956462991913600; Sheikh K, 2005, NATL MED J INDIA, V18, P32; Sinha PK, 2003, JAIDS-J ACQ IMM DEF, V33, P407, DOI 10.1097/00126334-200307010-00017; Solomon S, 2004, AIDS EDUC PREV, V16, P155, DOI 10.1521/aeap.16.3.5.155.35534; Solomon S, 1998, INT J STD AIDS, V9, P98, DOI 10.1258/0956462981921756; Solomon S., 2000, AIDS BEHAV, V4, P71, DOI 10.1023/A:1009540908691; Solomon S, 2006, AIDS BEHAV, V10, P415, DOI 10.1007/s10461-006-9070-1; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; *UNAIDS, 2000, VOL COUNS TEST VCT U; *UNAIDS, 2007, UNAIDS WHO AIDS EP U; *UNAIDS, 2004, KNOW MOR NO MOR AIDS	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3471	10.1371/journal.pone.0003471	http://dx.doi.org/10.1371/journal.pone.0003471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IE	18941613	Green Published, gold, Green Submitted			2022-12-27	WOS:000265125900014
J	Lizano, S; Luo, F; Tengra, FK; Bessen, DE				Lizano, Sergio; Luo, Feng; Tengra, Farah K.; Bessen, Debra E.			Impact of Orthologous Gene Replacement on the Circuitry Governing Pilus Gene Transcription in Streptococci	PLOS ONE			English	Article							VIRULENCE GENES; PYOGENES; RECOMBINATION; EXPRESSION; ROFA; EVOLUTION; REGULATOR; SELECTION; ANTIGENS; NETWORK	Background: The evolutionary history of several genes of the bacterial pathogen Streptococcus pyogenes strongly suggests an origin in another species, acquired via replacement of the counterpart gene (ortholog) following a recombination event. An example of orthologous gene replacement is provided by the nra/rofA locus, which encodes a key regulator of pilus gene transcription. Of biological importance is the previous finding that the presence of the nra- and rofA-lineage alleles, which are similar to 35% divergent, correlates strongly with genetic markers for streptococcal infection at different tissue sites in the human host (skin, throat). Methodology/Principal Findings: In this report, the impact of orthologous gene replacement targeting the nra/rofA locus is experimentally addressed. Replacement of the native nra-lineage allele with a rofA-lineage allele, plus their respective upstream regions, preserved the polarity of Nra effects on pilus gene transcription (i.e., activation) in the skin strain Alab49. Increased pilus gene transcription in the rofA chimera correlated with a higher rate of bacterial growth at the skin. The transcriptional regulator MsmR, which represses nra and pilus gene transcription in the Alab49 parent strain, has a slight activating effect on pilus gene expression in the rofA chimera construct. Conclusions/Significance: Data show that exchange of orthologous forms of a regulatory gene is stable and robust, and pathogenicity is preserved. Yet, new phenotypes may also be introduced by altering the circuitry within a complex transcriptional regulatory network. It is proposed that orthologous gene replacement via interspecies exchange is an important mechanism in the evolution of highly recombining bacteria such as S. pyogenes.	[Lizano, Sergio; Luo, Feng; Tengra, Farah K.; Bessen, Debra E.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY USA	New York Medical College	Lizano, S (corresponding author), IDEXX Labs, Westbrook, ME USA.	debra_bessen@nymc.edu			NIH [R01-AI053826]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053826] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work was supported by funding from the N.I.H. (R01-AI053826).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; ANDERSON R M, 1991; Anderson RM, 1998, BIOMED RES REP, P23; Beckert S, 2001, INFECT IMMUN, V69, P534, DOI 10.1128/IAI.69.1.534-537.2001; Bessen DE, 2005, J BACTERIOL, V187, P4163, DOI 10.1128/JB.187.12.4163-4172.2005; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Bessen DE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-59; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; FOGG GC, 1994, MOL MICROBIOL, V11, P671, DOI 10.1111/j.1365-2958.1994.tb00345.x; Granok AB, 2000, J BACTERIOL, V182, P1529, DOI 10.1128/JB.182.6.1529-1540.2000; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Kalia A, 2002, INFECT IMMUN, V70, P1971, DOI 10.1128/IAI.70.4.1971-1983.2002; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Kreikemeyer B, 2005, J BIOL CHEM, V280, P33228, DOI 10.1074/jbc.M502896200; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreikemeyer B, 2002, MICROBIOL-SGM, V148, P1501, DOI 10.1099/00221287-148-5-1501; Kreikemeyer B, 2007, INFECT IMMUN, V75, P5698, DOI 10.1128/IAI.00175-07; Kwinn LA, 2007, J BACTERIOL, V189, P1322, DOI 10.1128/JB.01256-06; LEBLANC DJ, 1991, ANTIMICROB AGENTS CH, V35, P1804, DOI 10.1128/AAC.35.9.1804; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizano S, 2007, J BACTERIOL, V189, P1426, DOI 10.1128/JB.01179-06; Luo F, 2008, INFECT IMMUN, V76, P2490, DOI 10.1128/IAI.01567-07; Luo F, 2008, MICROB PATHOGENESIS, V45, P217, DOI 10.1016/j.micpath.2008.05.009; McGregor KF, 2004, J BACTERIOL, V186, P4285, DOI 10.1128/JB.186.13.4285-4294.2004; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Nakata M, 2005, MOL MICROBIOL, V57, P786, DOI 10.1111/j.1365-2958.2005.04730.x; Podbielski A, 1999, MOL MICROBIOL, V31, P1051, DOI 10.1046/j.1365-2958.1999.01241.x; Scaramuzzino DA, 2000, INFECT IMMUN, V68, P2880, DOI 10.1128/IAI.68.5.2880-2887.2000; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; Svensson MD, 2002, MICROBIOL-SGM, V148, P3933, DOI 10.1099/00221287-148-12-3933; Winfield MD, 2004, P NATL ACAD SCI USA, V101, P17162, DOI 10.1073/pnas.0406038101	34	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3450	10.1371/journal.pone.0003450	http://dx.doi.org/10.1371/journal.pone.0003450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941636	Green Published, gold, Green Submitted			2022-12-27	WOS:000265125600009
J	Curry, JM; Eubank, TD; Roberts, RD; Wang, YJ; Pore, N; Maity, A; Marsh, CB				Curry, Jennifer M.; Eubank, Tim D.; Roberts, Ryan D.; Wang, Yijie; Pore, Nabendu; Maity, Amit; Marsh, Clay B.			M-CSF Signals through the MAPK/ERK Pathway via Sp1 to Induce VEGF Production and Induces Angiogenesis In Vivo	PLOS ONE			English	Article								Background: M-CSF recruits mononuclear phagocytes which regulate processes such as angiogenesis and metastases in tumors. VEGF is a potent activator of angiogenesis as it promotes endothelial cell proliferation and new blood vessel formation. Previously, we reported that in vitro M-CSF induces the expression of biologically-active VEGF from human monocytes. Methodology and Results: In this study, we demonstrate the molecular mechanism of M-CSF-induced VEGF production. Using a construct containing the VEGF promoter linked to a luciferase reporter, we found that a mutation reducing HIF binding to the VEGF promoter had no significant effect on luciferase production induced by M-CSF stimulation. Further analysis revealed that M-CSF induced VEGF through the MAPK/ERK signaling pathway via the transcription factor, Sp1. Thus, inhibition of either ERK or Sp1 suppressed M-CSF-induced VEGF at the mRNA and protein level. M-CSF also induced the nuclear localization of Sp1, which was blocked by ERK inhibition. Finally, mutating the Sp1 binding sites within the VEGF promoter or inhibiting ERK decreased VEGF promoter activity in M-CSF-treated human monocytes. To evaluate the biological significance of M-CSF induced VEGF production, we used an in vivo angiogenesis model to illustrate the ability of M-CSF to recruit mononuclear phagocytes, increase VEGF levels, and enhance angiogenesis. Importantly, the addition of a neutralizing VEGF antibody abolished M-CSF-induced blood vessel formation. Conclusion: These data delineate an ERK- and Sp1-dependent mechanism of M-CSF induced VEGF production and demonstrate for the first time the ability of M-CSF to induce angiogenesis via VEGF in vivo.	[Curry, Jennifer M.; Eubank, Tim D.; Roberts, Ryan D.; Wang, Yijie; Marsh, Clay B.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Curry, Jennifer M.; Roberts, Ryan D.; Marsh, Clay B.] Ohio State Univ, Coll Med & Publ Hlth, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Eubank, Tim D.; Wang, Yijie; Marsh, Clay B.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Pore, Nabendu; Maity, Amit] Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Pennsylvania	Curry, JM (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	clay.marsh@osumc.edu	Eubank, Tim/E-3043-2011; Roberts, Ryan D/D-2573-2013	Roberts, Ryan D/0000-0001-5028-744X; Eubank, Tim/0000-0002-8225-7824; Maity, Amit/0000-0001-7151-2845				Baran CP, 2004, CURR PHARM DESIGN, V10, P855, DOI 10.2174/1381612043452866; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Besse A, 2000, CYTOKINE, V12, P522, DOI 10.1006/cyto.1999.0580; Bhatt NY, 2002, J IMMUNOL, V169, P6427, DOI 10.4049/jimmunol.169.11.6427; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Eubank TD, 2004, IMMUNITY, V21, P831, DOI 10.1016/j.immuni.2004.10.011; Eubank TD, 2003, J IMMUNOL, V171, P2637, DOI 10.4049/jimmunol.171.5.2637; FALKENBURG JHF, 1990, J IMMUNOL, V144, P4657; Gasparini G, 2000, Oncologist, V5 Suppl 1, P37; Gosse SG, 2005, CELL SIGNAL, V17, P1352, DOI 10.1016/j.cellsig.2005.02.002; Green M, 2000, J HEMATOTH STEM CELL, V9, P237, DOI 10.1089/152581600319450; Gridelli C, 2007, ONCOLOGIST, V12, P1183, DOI 10.1634/theoncologist.12-10-1183; HAMILTON JA, 1988, J CELL PHYSIOL, V134, P405, DOI 10.1002/jcp.1041340311; Himes SR, 2006, J IMMUNOL, V176, P2219, DOI 10.4049/jimmunol.176.4.2219; Junttila I, 2003, J LEUKOCYTE BIOL, V73, P281, DOI 10.1189/jlb.0702359; Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393; Leonard-Barton D, 1990, ORGAN SCI, V1, P248, DOI 10.1287/orsc.1.3.248; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Majer M, 2007, ANTI-CANCER AGENT ME, V7, P492, DOI 10.2174/187152007781668742; Mancino AT, 2001, J SURG RES, V100, P18, DOI 10.1006/jsre.2001.6204; Marsh CB, 1999, J IMMUNOL, V162, P6217; McDermott RS, 2002, EUR CYTOKINE NETW, V13, P121; Milanini J, 1998, J BIOL CHEM, V273, P18165, DOI 10.1074/jbc.273.29.18165; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; MISAGO M, 1993, INT J HEMATOL, V58, P43; Novak EM, 2003, GENE THER, V10, P1992, DOI 10.1038/sj.gt.3302111; Okazaki T, 2007, AM J PATHOL, V171, P1093, DOI 10.2353/ajpath.2007.061191; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Ramos MC, 2004, BIOL CHEM, V385, P75, DOI 10.1515/BC.2004.010; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sasaki A, 2006, SURGERY, V139, P755, DOI 10.1016/j.surg.2005.10.009; Scholl SM, 1996, BREAST CANCER RES TR, V39, P275, DOI 10.1007/BF01806155; Smith JL, 2000, MOL CELL BIOL, V20, P8026, DOI 10.1128/MCB.20.21.8026-8034.2000; Tojo N, 1999, BBA-MOL CELL RES, V1452, P275, DOI 10.1016/S0167-4889(99)00127-5; Varney ML, 2005, J INTERF CYTOK RES, V25, P674, DOI 10.1089/jir.2005.25.674; Varney ML, 2002, IN VIVO, V16, P471; VARTICOVSKI L, 1989, NATURE, V342, P699, DOI 10.1038/342699a0; WANG JM, 1988, J IMMUNOL, V141, P575; Wang YJ, 2007, AM J RESP CELL MOL, V36, P68, DOI 10.1165/rcmb.2006-0165OC; Yu Y, 1999, J CELL PHYSIOL, V178, P235, DOI 10.1002/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.3.CO;2-J; Yuan A, 2000, INT J CANCER, V89, P475, DOI 10.1002/1097-0215(20001120)89:6<475::AID-IJC2>3.0.CO;2-T	43	74	77	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2008	3	10							e3405	10.1371/journal.pone.0003405	http://dx.doi.org/10.1371/journal.pone.0003405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GO	18852899	Green Published, Green Submitted, gold			2022-12-27	WOS:000265121700010
J	Percival, JM; Anderson, KNE; Gregorevic, P; Chamberlain, JS; Froehner, SC				Percival, Justin M.; Anderson, Kendra N. E.; Gregorevic, Paul; Chamberlain, Jeffrey S.; Froehner, Stanley C.			Functional Deficits in nNOS mu-Deficient Skeletal Muscle: Myopathy in nNOS Knockout Mice	PLOS ONE			English	Article								Skeletal muscle nNOSm (neuronal nitric oxide synthase mu) localizes to the sarcolemma through interaction with the dystrophin-associated glycoprotein (DAG) complex, where it synthesizes nitric oxide (NO). Disruption of the DAG complex occurs in dystrophinopathies and sarcoglycanopathies, two genetically distinct classes of muscular dystrophy characterized by progressive loss of muscle mass, muscle weakness and increased fatigability. DAG complex instability leads to mislocalization and downregulation of nNOSm; but this is thought to play a minor role in disease pathogenesis. This view persists without knowledge of the role of nNOS in skeletal muscle contractile function in vivo and has influenced gene therapy approaches to dystrophinopathy, the majority of which do not restore sarcolemmal nNOSm. We address this knowledge gap by evaluating skeletal muscle function in nNOS knockout (KN1) mice using an in situ approach, in which the muscle is maintained in its normal physiological environment. nNOS-deficiency caused reductions in skeletal muscle bulk and maximum tetanic force production in male mice only. Furthermore, nNOS-deficient muscles from both male and female mice exhibited increased susceptibility to contraction-induced fatigue. These data suggest that aberrant nNOSm signaling can negatively impact three important clinical features of dystrophinopathies and sarcoglycanopathies: maintenance of muscle bulk, force generation and fatigability. Our study suggests that restoration of sarcolemmal nNOSm expression in dystrophic muscles may be more important than previously appreciated and that it should be a feature of any fully effective gene therapy-based intervention.	[Percival, Justin M.; Anderson, Kendra N. E.; Froehner, Stanley C.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Gregorevic, Paul; Chamberlain, Jeffrey S.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Gregorevic, Paul; Chamberlain, Jeffrey S.; Froehner, Stanley C.] Univ Washington, Senator Paul D Wellstone MD Cooperat Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Percival, JM (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	justinp2@u.washington.edu	Gregorevic, Paul/AAH-6040-2021	Gregorevic, Paul/0000-0002-7418-8945; Chamberlain, Jeffrey/0000-0001-5299-0059	NIH [NS046788, NS33145, U54 HD047175]; Parent Project for Muscular Dystrophy Research Fellowship; MDA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD047175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033145, P01NS046788] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parent Project for Muscular Dystrophy Research Fellowship; MDA(Muscular Dystrophy Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS046788 and NS33145 (S.C.F.), NIH grant U54 HD047175 (S.C.F. and J.S.C.), a Parent Project for Muscular Dystrophy Research Fellowship (J.M.P) and a MDA Development Grant (J.M.P).	Adams ME, 2004, J NEUROSCI, V24, P10302, DOI 10.1523/JNEUROSCI.3408-04.2004; Ameredes BT, 1999, J APPL PHYSIOL, V87, P142, DOI 10.1152/jappl.1999.87.1.142; Asai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000806; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Brunelli S, 2007, P NATL ACAD SCI USA, V104, P264, DOI 10.1073/pnas.0608277104; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Chao DS, 1996, J EXP MED, V184, P609, DOI 10.1084/jem.184.2.609; Crosbie RH, 2002, FASEB J, V16, P1786, DOI 10.1096/fj.02-0519com; Dellorusso C, 2001, J MUSCLE RES CELL M, V22, P467, DOI 10.1023/A:1014587918367; Eu JP, 2003, P NATL ACAD SCI USA, V100, P15229, DOI 10.1073/pnas.2433468100; Gregorevic P, 2004, MUSCLE NERVE, V30, P295, DOI 10.1002/mus.20082; Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; Haller R, 2004, MYOLOGY, V3rd, P665; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; Matecki S, 2001, NEUROMUSCULAR DISORD, V11, P171, DOI 10.1016/S0960-8966(00)00179-6; Mongini T, 2002, NEUROPEDIATRICS, V33, P109, DOI 10.1055/s-2002-32374; Odom GL, 2007, BBA-MOL BASIS DIS, V1772, P243, DOI 10.1016/j.bbadis.2006.09.007; Reid MB, 1998, COMP BIOCHEM PHYS A, V119, P211, DOI 10.1016/S1095-6433(97)00417-0; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Silvagno F, 1996, J BIOL CHEM, V271, P11204, DOI 10.1074/jbc.271.19.11204; SOCKOLOV R, 1977, ARCH PHYS MED REHAB, V58, P195; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Thomas GD, 2003, CIRC RES, V92, P554, DOI 10.1161/01.RES.0000061570.83105.52; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Vermeer S, 2004, PEDIATR NEUROL, V30, P291, DOI 10.1016/j.pediatrneurol.2003.11.006; Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wehling-Henricks M, 2005, HUM MOL GENET, V14, P1921, DOI 10.1093/hmg/ddi197; Yue YP, 2006, MOL THER, V14, P79, DOI 10.1016/j.ymthe.2006.01.007	31	66	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3387	10.1371/journal.pone.0003387	http://dx.doi.org/10.1371/journal.pone.0003387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852886	gold, Green Published			2022-12-27	WOS:000265121600011
J	Ding, GH; Yu, ZH; Zhao, J; Wang, Z; Li, Y; Xing, XB; Wang, CA; Liu, L; Li, YX				Ding, Guohui; Yu, Zhonghao; Zhao, Jing; Wang, Zhen; Li, Yun; Xing, Xiaobin; Wang, Chuan; Liu, Lei; Li, Yixue			Tree of Life Based on Genome Context Networks	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; RNA SECONDARY STRUCTURE; SYMBIOBACTERIUM-THERMOPHILUM; SEQUENCE; EVOLUTION; DATABASE; RECONSTRUCTION; PHYLOGENOMICS; BACTERIUM; INSIGHTS	Efforts in phylogenomics have greatly improved our understanding of the backbone tree of life. However, due to the systematic error in sequence data, a sequence-based phylogenomic approach leads to well-resolved but statistically significant incongruence. Thus, independent test of current phylogenetic knowledge is required. Here, we have devised a distance-based strategy to reconstruct a highly resolved backbone tree of life, on the basis of the genome context networks of 195 fully sequenced representative species. Along with strongly supporting the monophylies of three superkingdoms and most taxonomic sub-divisions, the derived tree also suggests some intriguing results, such as high G+C gram positive origin of Bacteria, classification of Symbiobacterium thermophilum and Alcanivorax borkumensis in Firmicutes. Furthermore, simulation analyses indicate that addition of more gene relationships with high accuracy can greatly improve the resolution of the phylogenetic tree. Our results demonstrate the feasibility of the reconstruction of highly resolved phylogenetic tree with extensible gene networks across all three domains of life. This strategy also implies that the relationships between the genes (gene network) can define what kind of species it is.	[Ding, Guohui; Wang, Zhen; Li, Yun; Xing, Xiaobin; Wang, Chuan; Liu, Lei; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Bioinformat Ctr, Shanghai, Peoples R China; [Ding, Guohui; Wang, Zhen; Li, Yun; Xing, Xiaobin] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Yu, Zhonghao; Zhao, Jing; Li, Yixue] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai, Peoples R China; [Zhao, Jing; Liu, Lei; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences	Ding, GH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Bioinformat Ctr, Shanghai, Peoples R China.	yxli@sibs.ac.cn	Zhao, Jing/S-3581-2019; Yu, Zhonghao/F-5459-2011	Zhao, Jing/0000-0002-2439-2876; Yu, Zhonghao/0000-0001-7144-9356; Li, Yun/0000-0001-8414-2724	973 National Key Basic Research Program of China [2006CB910705, 2003CB715901, 2002CB512801]	973 National Key Basic Research Program of China(National Basic Research Program of China)	The 973 National Key Basic Research Program of China (grant no. 2006CB910705, 2003CB715901, 2002CB512801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JF, 2007, NATURE, V445, P610, DOI 10.1038/445610a; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson JO, 1999, CURR OPIN GENET DEV, V9, P664, DOI 10.1016/S0959-437X(99)00024-6; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Danchin A., 2002, DELPHIC BOAT WHAT GE; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Galtier N, 1999, SCIENCE, V283, P220, DOI 10.1126/science.283.5399.220; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Ge F, 2005, PLOS BIOL, V3, P1709, DOI 10.1371/journal.pbio.0030316; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Heymans M, 2003, BIOINFORMATICS, V19, pi138, DOI 10.1093/bioinformatics/btg1018; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Koch AL, 2003, TRENDS MICROBIOL, V11, P166, DOI 10.1016/S0966-842X(03)00063-5; Kreil DP, 2001, NUCLEIC ACIDS RES, V29, P1608, DOI 10.1093/nar/29.7.1608; Kurland CG, 2005, BIOESSAYS, V27, P741, DOI 10.1002/bies.20258; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Lake JA, 2004, MOL BIOL EVOL, V21, P681, DOI 10.1093/molbev/msh061; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lewontin RC, 2002, ANNU REV GENET, V36, P1, DOI 10.1146/annurev.genet.36.052902.102704; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Ogurtsov AY, 2006, BIOINFORMATICS, V22, P1317, DOI 10.1093/bioinformatics/btl083; Ohno M, 2000, INT J SYST EVOL MICR, V50, P1829, DOI 10.1099/00207713-50-5-1829; Perriere G, 2000, GENOME RES, V10, P379, DOI 10.1101/gr.10.3.379; Podani J, 2001, NAT GENET, V29, P54, DOI 10.1038/ng708; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneiker S, 2006, NAT BIOTECHNOL, V24, P997, DOI 10.1038/nbt1232; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Ueda K, 2004, NUCLEIC ACIDS RES, V32, P4937, DOI 10.1093/nar/gkh830; Wang ML, 2006, MOL BIOL EVOL, V23, P2444, DOI 10.1093/molbev/msl117; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Welch JJ, 2005, TRENDS ECOL EVOL, V20, P320, DOI 10.1016/j.tree.2005.02.007; Whitfield J, 2007, NATURE, V446, P247, DOI 10.1038/446247a; Woese CR, 2004, MICROBIOL MOL BIOL R, V68, P173, DOI 10.1128/MMBR.68.2.173-186.2004; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wolf YI, 2002, TRENDS GENET, V18, P472, DOI 10.1016/S0168-9525(02)02744-0; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Zhang Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-252	49	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3357	10.1371/journal.pone.0003357	http://dx.doi.org/10.1371/journal.pone.0003357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DQ	18852873	Green Published, gold, Green Submitted			2022-12-27	WOS:000265114100003
J	Lihoreau, M; Zimmer, C; Rivault, C				Lihoreau, Mathieu; Zimmer, Cedric; Rivault, Colette			Mutual Mate Choice: When it Pays Both Sexes to Avoid Inbreeding	PLOS ONE			English	Article							BLATTELLA-GERMANICA; SEXUAL SELECTION; REPRODUCTIVE SUCCESS; KIN RECOGNITION; COCKROACH; PREFERENCES; PHEROMONE; COMPATIBILITY; EVOLUTION; RATIOS	Theoretical models of sexual selection predict that both males and females of many species should benefit by selecting their mating partners. However, empirical evidence testing and validating this prediction is scarce. In particular, whereas inbreeding avoidance is expected to induce sexual conflicts, in some cases both partners could benefit by acting in concert and exerting mutual mate choice for non-assortative pairings. We tested this prediction with the gregarious cockroach Blattella germanica (L.). We demonstrated that males and females base their mate choice on different criteria and that choice occurs at different steps during the mating sequence. Males assess their relatedness to females through antennal contacts before deciding to court preferentially non-siblings. Conversely, females biased their choice towards the most vigorously courting males that happened to be non-siblings. This study is the first to demonstrate mutual mate choice leading to close inbreeding avoidance. The fact that outbred pairs were more fertile than inbred pairs strongly supports the adaptive value of this mating system, which includes no "best phenotype'' as the quality of two mating partners is primarily linked to their relatedness. We discuss the implications of our results in the light of inbreeding conflict models.	[Lihoreau, Mathieu; Zimmer, Cedric; Rivault, Colette] Univ Rennes 1, CNRS, UMR Ethos 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Lihoreau, M (corresponding author), Univ Rennes 1, CNRS, UMR Ethos 6552, Campus Beaulieu, Rennes, France.	mathieu.lihoreau@univ-rennes1.fr	Lihoreau, Mathieu/H-7623-2013; Zimmer, Cédric/C-5654-2011	Zimmer, Cedric/0000-0001-8160-2836; Lihoreau, Mathieu/0000-0002-2463-2040	CNRS; University of Rennes 1	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Rennes 1	CNRS, University of Rennes 1	ADMUNDSEN T, 2001, P NATL ACAD SCI USA, V98, P13155; Anderson WW, 2007, P NATL ACAD SCI USA, V104, P4484, DOI 10.1073/pnas.0611152104; Andersson Malte, 1994; Archie EA, 2007, MOL ECOL, V16, P4138, DOI 10.1111/j.1365-294X.2007.03483.x; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bateson P., 1983, P257; BELL WJ, 1978, J INSECT PHYSIOL, V24, P369, DOI 10.1016/0022-1910(78)90077-X; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; BREED M D, 1975, Zeitschrift fuer Tierpsychologie, V39, P24; CHENOWETH SF, 2003, EVOL DEV, P2326; CLUTTONBROCK TH, 1991, NATURE, V351, P58; COCHRAN DG, 1979, ENTOMOL EXP APPL, V26, P259, DOI 10.1111/j.1570-7458.1979.tb02927.x; Cornwell P.B., 1968, COCKROACH, V1; Darwin C., 1874, DESCENT MAN SELECTIO; Drickamer LC, 2003, ANIM BEHAV, V65, P105, DOI 10.1006/anbe.2002.2027; Eliyahu D, 2008, J CHEM ECOL, V34, P229, DOI 10.1007/s10886-007-9409-8; Gowaty PA, 2002, EVOLUTION, V56, P2537, DOI 10.1111/j.0014-3820.2002.tb00178.x; GWYNNE DT, 1981, SCIENCE, V213, P779, DOI 10.1126/science.213.4509.779; HILL GE, 1993, EVOLUTION, V47, P1515, DOI 10.1111/j.1558-5646.1993.tb02172.x; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnstone RA, 1997, BEHAV ECOL SOCIOBIOL, V40, P51, DOI 10.1007/s002650050315; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; JONES IL, 1993, NATURE, V362, P238, DOI 10.1038/362238a0; Kokko H, 2001, ECOL LETT, V4, P159, DOI 10.1046/j.1461-0248.2001.00212.x; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Kokko H, 2002, PHILOS T R SOC B, V357, P319, DOI 10.1098/rstb.2001.0926; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; LIHOREAU M, BEHAV ECOL IN PRESS; Lihoreau M, 2008, ANIM BEHAV, V75, P1965, DOI 10.1016/j.anbehav.2007.12.006; Lihoreau M, 2007, BEHAV ECOL, V18, P880, DOI 10.1093/beheco/arm046; McCullagh P, 1989, GEN LINEAR MODELS; MOORE AJ, 1988, ANIM BEHAV, V36, P303, DOI 10.1016/S0003-3472(88)80278-1; Moore PJ, 1997, NATURE, V389, P25, DOI 10.1038/37888; MULLINS DE, 1980, NATURE, V283, P567, DOI 10.1038/283567a0; Nojima S, 1999, NATURWISSENSCHAFTEN, V86, P193, DOI 10.1007/s001140050596; Nojima S, 2005, SCIENCE, V307, P1104, DOI 10.1126/science.1107163; OWENS IPF, 1994, P ROY SOC B-BIOL SCI, V258, P93, DOI 10.1098/rspb.1994.0148; PARKER AG, 1983, MATE CHOICE, P141; Parker G.A., 1979, P123; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; RIVAULT C, 1990, ENTOMOL EXP APPL, V57, P85, DOI 10.1007/BF00349598; RIVAULT C, 1989, ENTOMOL EXP APPL, V53, P247, DOI 10.1007/BF00162856; ROTH LM, 1952, AM MIDL NAT, V47, P66, DOI 10.2307/2421700; Ryan KK, 2001, BEHAV ECOL SOCIOBIOL, V50, P436; Servedio MR, 2006, EVOLUTION, V60, P674; SIMMONS LW, 1991, ANIM BEHAV, V41, P493, DOI 10.1016/S0003-3472(05)80852-8; Singer TL, 1998, AM ZOOL, V38, P394; Thunken T, 2007, CURR BIOL, V17, P225, DOI 10.1016/j.cub.2006.11.053; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vander Meer RK., 1998, PHEROMONE COMMUNICAT, P159; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585	56	52	53	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3365	10.1371/journal.pone.0003365	http://dx.doi.org/10.1371/journal.pone.0003365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DQ	18843373	Green Published, gold, Green Submitted			2022-12-27	WOS:000265114100007
J	Jung, KH; Dardick, C; Bartley, LE; Cao, PJ; Phetsom, J; Canlas, P; Seo, YS; Shultz, M; Ouyang, S; Yuan, Q; Frank, BC; Ly, E; Zheng, L; Jia, Y; Hsia, AP; An, K; Chou, HH; Rocke, D; Lee, GC; Schnable, PS; An, G; Buell, CR; Ronald, PC				Jung, Ki-Hong; Dardick, Christopher; Bartley, Laura E.; Cao, Peijian; Phetsom, Jirapa; Canlas, Patrick; Seo, Young-Su; Shultz, Michael; Ouyang, Shu; Yuan, Qiaoping; Frank, Bryan C.; Ly, Eugene; Zheng, Li; Jia, Yi; Hsia, An-Ping; An, Kyungsook; Chou, Hui-Hsien; Rocke, David; Lee, Geun Cheol; Schnable, Patrick S.; An, Gynheung; Buell, C. Robin; Ronald, Pamela C.			Refinement of Light-Responsive Transcript Lists Using Rice Oligonucleotide Arrays: Evaluation of Gene-Redundancy	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; RUBISCO ACTIVASE; MICROARRAY DATA; PLANT PEROXISOMES; DRAFT SEQUENCE; ARABIDOPSIS; EXPRESSION; FAMILY; ANNOTATION; PROTEIN	Studies of gene function are often hampered by gene-redundancy, especially in organisms with large genomes such as rice (Oryza sativa). We present an approach for using transcriptomics data to focus functional studies and address redundancy. To this end, we have constructed and validated an inexpensive and publicly available rice oligonucleotide near-whole genome array, called the rice NSF45K array. We generated expression profiles for light-vs. dark-grown rice leaf tissue and validated the biological significance of the data by analyzing sources of variation and confirming expression trends with reverse transcription polymerase chain reaction. We examined trends in the data by evaluating enrichment of gene ontology terms at multiple false discovery rate thresholds. To compare data generated with the NSF45K array with published results, we developed publicly available, web-based tools (www.ricearray.org). The Oligo and EST Anatomy Viewer enables visualization of EST-based expression profiling data for all genes on the array. The Rice Multi-platform Microarray Search Tool facilitates comparison of gene expression profiles across multiple rice microarray platforms. Finally, we incorporated gene expression and biochemical pathway data to reduce the number of candidate gene products putatively participating in the eight steps of the photorespiration pathway from 52 to 10, based on expression levels of putatively functionally redundant genes. We confirmed the efficacy of this method to cope with redundancy by correctly predicting participation in photorespiration of a gene with five paralogs. Applying these methods will accelerate rice functional genomics.	[Jung, Ki-Hong; Bartley, Laura E.; Cao, Peijian; Phetsom, Jirapa; Canlas, Patrick; Seo, Young-Su; Shultz, Michael; Rocke, David; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Dardick, Christopher] USDA ARS, Appalachian Fruit Res Stat, Kearneysville, WV USA; [Ouyang, Shu; Yuan, Qiaoping; Frank, Bryan C.; Ly, Eugene; Zheng, Li; Buell, C. Robin] J Craig Venter Inst, Rockville, MD USA; [Jia, Yi; Hsia, An-Ping; Chou, Hui-Hsien; Schnable, Patrick S.] Iowa State Univ, Ctr Plant Genom, Ames, IA 50011 USA; [An, Kyungsook; An, Gynheung] Pohang Univ Sci & Technol, Funct Genom Ctr, Pohang, South Korea; [Lee, Geun Cheol] Konkuk Univ, Coll Business Adm, Seoul, South Korea	University of California System; University of California Davis; United States Department of Agriculture (USDA); J. Craig Venter Institute; Iowa State University; Pohang University of Science & Technology (POSTECH); Konkuk University	Jung, KH (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	pcronald@ucdavis.edu	Rocke, David M/I-7044-2013; Jung, Ki Hong/L-5570-2019; Jia, Yi/F-7476-2010; Bartley, Laura/AAF-2217-2020; Ronald, Pamela/AAK-7664-2020; Cao, Peijian/U-6776-2019	Rocke, David M/0000-0002-3958-7318; Jung, Ki Hong/0000-0003-0427-5901; Bartley, Laura/0000-0001-8610-7551; Schnable, Patrick/0000-0001-9169-5204; Buell, C Robin/0000-0002-6727-4677; Yuan, Qiaoping/0000-0002-5880-8702	National Science Foundation Plant Genome Program [DBI0313887]; USDA [2004-35604-14226]; NIH [5R01GM055962-0]; Biogreen 21 Program [20070401-034-001-007-03-00]; National Research Laboratory Program funded by the Ministry of Science and Technology [M10600000270-06J0000-27010]; Korea Research Foundation [KRF-2005-C00155]; Hatch Act; State of Iowa; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055962] Funding Source: NIH RePORTER	National Science Foundation Plant Genome Program(National Science Foundation (NSF)); USDA(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biogreen 21 Program(Rural Development Administration (RDA), Republic of Korea); National Research Laboratory Program funded by the Ministry of Science and Technology; Korea Research Foundation(National Research Foundation of Korea); Hatch Act(United States Department of Agriculture (USDA)); State of Iowa; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded in part by a competitive grants from the National Science Foundation Plant Genome Program (award: #DBI0313887), the USDA (# 2004-35604-14226) and the NIH (#5R01GM055962-0) to P.C. Ronald, a grant from the Biogreen 21 Program (20070401-034-001-007-03-00) to G. An, and a grant from the National Research Laboratory Program funded by the Ministry of Science and Technology (M10600000270-06J0000-27010) to G. An. K.H. Jung was supported by a Korea Research Foundation Grant (KRF-2005-C00155). Support was also provided by the Hatch Act and State of Iowa funds.	Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; *AFF, 2001, AFF MICR SUIT US GUI; Affymetrix, 2002, STAT ALG DESCR DOC; Ain R, 2004, P NATL ACAD SCI USA, V101, P16543, DOI 10.1073/pnas.0406185101; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Berger JA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-194; Boldt R, 2005, PLANT CELL, V17, P2413, DOI 10.1105/tpc.105.033993; Britten RJ, 2005, P NATL ACAD SCI USA, V102, P5466, DOI 10.1073/pnas.0501008102; Budhu A, 2007, CARCINOGENESIS, V28, P1552, DOI 10.1093/carcin/bgm075; Chou HH, 2004, BIOINFORMATICS, V20, P2893, DOI 10.1093/bioinformatics/bth347; Corpas FJ, 2001, TRENDS PLANT SCI, V6, P145, DOI 10.1016/S1360-1385(01)01898-2; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Devos KM, 1999, GENOME RES, V9, P825, DOI 10.1101/gr.9.9.825; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; EDWARDS JW, 1989, PLANT CELL, V1, P241, DOI 10.1105/tpc.1.2.241; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fare TL, 2003, ANAL CHEM, V75, P4672, DOI 10.1021/ac034241b; Feuillet C, 2002, ANN BOT-LONDON, V89, P3, DOI 10.1093/aob/mcf008; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Green JA, 2004, P NATL ACAD SCI USA, V101, P16397, DOI 10.1073/pnas.0406934101; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hiei Y, 1997, PLANT MOL BIOL, V35, P205, DOI 10.1023/A:1005847615493; Igarashi D, 2003, PLANT J, V33, P975, DOI 10.1046/j.1365-313X.2003.01688.x; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jeon JS, 2001, PLANT SCI, V161, P211, DOI 10.1016/S0168-9452(01)00414-9; Jiao YL, 2005, PLANT CELL, V17, P3239, DOI 10.1105/tpc.105.035840; Johns MA, 2007, FUNCT INTEGR GENOMIC, V7, P135, DOI 10.1007/s10142-006-0036-1; Jung KH, 2003, PLANT CELL PHYSIOL, V44, P463, DOI 10.1093/pcp/pcg064; Jung KH, 2005, PLANT CELL, V17, P2705, DOI 10.1105/tpc.105.034090; Jung KH, 2008, NAT REV GENET, V9, P91, DOI 10.1038/nrg2286; Jung KH, 2006, PLANT CELL, V18, P3015, DOI 10.1105/tpc.106.042044; Jung KH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000164; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Komari T, 1998, CURR OPIN PLANT BIOL, V1, P161, DOI 10.1016/S1369-5266(98)80019-8; Komatsu S, 2003, MOL CELL PROTEOMICS, V2, P2, DOI 10.1074/mcp.R200008-MCP200; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kurek I, 2007, PLANT CELL, V19, P3230, DOI 10.1105/tpc.107.054171; LAN Y, 1992, PLANT PHYSIOL, V99, P304, DOI 10.1104/pp.99.1.304; Leegood RC, 2007, NAT BIOTECHNOL, V25, P539, DOI 10.1038/nbt0507-539; Li MN, 2007, PLANT PHYSIOL, V144, P1797, DOI 10.1104/pp.107.101600; Liepman AH, 2001, PLANT J, V25, P487, DOI 10.1046/j.1365-313x.2001.00961.x; Lu RX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-314; Ma LG, 2005, GENOME RES, V15, P1274, DOI 10.1101/gr.3657405; Matsumoto F, 2004, PLANT PHYSIOL, V135, P2379, DOI 10.1104/pp.104.042408; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Miki D, 2005, PLANT PHYSIOL, V138, P1903, DOI 10.1104/pp.105.063933; Nyathi Y, 2006, BBA-MOL CELL RES, V1763, P1478, DOI 10.1016/j.bbamcr.2006.08.031; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Paterson AH, 2000, PLANT CELL, V12, P1523, DOI 10.1105/tpc.12.9.1523; Pollock SV, 2003, PLANT PHYSIOL, V133, P1854, DOI 10.1104/pp.103.032078; Raghavachari N, 2003, ANAL BIOCHEM, V312, P101, DOI 10.1016/S0003-2697(02)00440-2; Ren XY, 2005, PLANT PHYSIOL, V138, P923, DOI 10.1104/pp.104.055673; Rensink W, 2005, GENOME, V48, P598, DOI 10.1139/G05-034; Rensink Willem Albert, 2005, Functional & Integrative Genomics, V5, P201, DOI 10.1007/s10142-005-0141-6; Reumann S, 2006, BBA-MOL CELL RES, V1763, P1496, DOI 10.1016/j.bbamcr.2006.09.008; Richards KD, 1998, PLANT PHYSIOL, V116, P409, DOI 10.1104/pp.116.1.409; Rocke DM, 2004, SEMIN CELL DEV BIOL, V15, P703, DOI 10.1016/j.semcdb.2004.09.007; Rohila JS, 2006, PLANT J, V46, P1, DOI 10.1111/j.1365-313X.2006.02671.x; Sharma A, 2002, BIOCHEM BIOPH RES CO, V290, P690, DOI 10.1006/bbrc.2001.6269; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shimamoto K, 2002, ANNU REV PLANT BIOL, V53, P399, DOI 10.1146/annurev.arplant.53.092401.134447; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Somerville CR, 2001, PLANT PHYSIOL, V125, P20, DOI 10.1104/pp.125.1.20; Stangeland B, 2005, J EXP BOT, V56, P2495, DOI 10.1093/jxb/eri242; Sterck L, 2007, CURR OPIN PLANT BIOL, V10, P199, DOI 10.1016/j.pbi.2007.01.004; STITT M, 1984, PLANT PHYSIOL, V75, P554, DOI 10.1104/pp.75.3.554; Tian CG, 2004, PLANT MOL BIOL, V54, P519, DOI 10.1023/B:PLAN.0000038256.89809.57; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Voll LM, 2006, PLANT PHYSIOL, V140, P59, DOI 10.1104/pp.105.071399; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Werner T, 2008, CURR OPIN BIOTECH, V19, P50, DOI 10.1016/j.copbio.2007.11.005; Yang DH, 1998, PLANT PHYSIOL, V118, P827, DOI 10.1104/pp.118.3.827; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yuan QP, 2005, PLANT PHYSIOL, V138, P17, DOI 10.1104/pp.104.059063; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1	86	89	95	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3337	10.1371/journal.pone.0003337	http://dx.doi.org/10.1371/journal.pone.0003337			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836531	Green Published, gold, Green Submitted			2022-12-27	WOS:000265113500005
J	Dux, PE; Marois, R				Dux, Paul E.; Marois, Rene			Distractor Inhibition Predicts Individual Differences in the Attentional Blink	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; SELECTION; SUPPRESSION; MECHANISMS; VIEWS	Background: The attentional blink (AB) refers to humans' impaired ability to detect the second of two targets (T2) in a rapid serial visual presentation (RSVP) stream of distractors if it appears within 200-600 ms of the first target (T1). Here we examined whether humans' ability to inhibit distractors in the RSVP stream is a key determinant of individual differences in T1 performance and AB magnitude. Methodology/Principal Findings: We presented subjects with RSVP streams (93.3 ms/item) of letters containing white distractors, a red T1 and a green T2. Subjects' ability to suppress distractors was assessed by determining the extent to which their second target performance was primed by a preceding distractor that shared the same identity as T2. Individual subjects' magnitude of T2 priming from this distractor was found to be negatively correlated with their T1 accuracy and positively related to their AB magnitude. In particular, subjects with attenuated ABs showed negative priming (i.e., worse T2 performance when the priming distractor appeared in the RSVP stream compared to when it was absent), whereas those with large ABs displayed positive priming (i.e., better T2 performance when the priming distractor appeared in the RSVP stream compared to when it was absent). Thus, a subject's ability to suppress distractors, as assessed by T2 priming magnitude, predicted both their T1 performance and AB magnitude. Conclusions/Significance: These results confirm that distractor suppression plays a key role in RSVP target selection and support the hypothesis that the AB results, at least in part, from a failure of distractor inhibition.	[Dux, Paul E.; Marois, Rene] Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Nashville, TN 37240 USA	Vanderbilt University	Dux, PE (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Nashville, TN 37240 USA.	paul.dux@vanderbilt.edu	Dux, Paul/I-1098-2014	Dux, Paul/0000-0002-4270-2583	NIMH [R01MH70776]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070776] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	An NIMH grant (R01MH70776) to R.M. supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bundesen C, 2005, PSYCHOL REV, V112, P291, DOI 10.1037/0033-295X.112.2.291; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Dux PE, 2007, PSYCHON B REV, V14, P723, DOI 10.3758/BF03196828; Dux PE, 2006, COGNITION, V99, P355, DOI 10.1016/j.cognition.2005.04.002; Dux PE, 2005, PSYCHOL SCI, V16, P775, DOI 10.1111/j.1467-9280.2005.01613.x; MAKI WS, 1994, PSYCHON B REV, V1, P499, DOI 10.3758/BF03210954; Maki WS, 1997, J EXP PSYCHOL HUMAN, V23, P1014, DOI 10.1037/0096-1523.23.4.1014; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P1083, DOI 10.1037/0096-1523.32.5.1083; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Tipper SP, 2001, Q J EXP PSYCHOL-A, V54, P321, DOI 10.1080/02724980042000183; Watson DG, 1997, PSYCHOL REV, V104, P90, DOI 10.1037/0033-295X.104.1.90	18	41	42	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3330	10.1371/journal.pone.0003330	http://dx.doi.org/10.1371/journal.pone.0003330			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RW	18833325	gold, Green Published, Green Submitted			2022-12-27	WOS:000264797400006
J	Yumoto, N; Wakatsuki, S; Kurisaki, T; Hara, Y; Osumi, N; Frisen, J; Sehara-Fujisawa, A				Yumoto, Norihiro; Wakatsuki, Shuji; Kurisaki, Tomohiro; Hara, Yoshinobu; Osumi, Noriko; Frisen, Jonas; Sehara-Fujisawa, Atsuko			Meltrin beta/ADAM19 Interacting with EphA4 in Developing Neural Cells Participates in Formation of the Neuromuscular Junction	PLOS ONE			English	Article								Background: Development of the neuromuscular junction (NMJ) is initiated by the formation of postsynaptic specializations in the central zones of muscles, followed by the arrival of motor nerve terminals opposite the postsynaptic regions. The post- and presynaptic components are then stabilized and modified to form mature synapses. Roles of ADAM (A Disintegrin And Metalloprotease) family proteins in the formation of the NMJ have not been reported previously. Principal Findings: We report here that Meltrin beta, ADAM19, participates in the formation of the NMJ. The zone of acetylcholine receptor alpha mRNA distribution was broader and excess sprouting of motor nerve terminals was more prominent in meltrin beta-deficient than in wild-type embryonic diaphragms. A microarray analysis revealed that the preferential distribution of ephrin-A5 mRNA in the synaptic region of muscles was aberrant in the meltrin beta-deficient muscles. Excess sprouting of motor nerve terminals was also found in ephrin-A5 knockout mice, which lead us to investigate a possible link between Meltrin beta and ephrin-A5-Eph signaling in the development of the NMJ. Meltrin beta and EphA4 interacted with each other in developing motor neurons, and both of these proteins localized in the NMJ. Coexpression of Meltrin beta and EphA4 strongly blocked vesicular internalization of ephrin-A5-EphA4 complexes without requiring the protease activity of Meltrin beta, suggesting a regulatory role of Meltrin beta in ephrin-A5-Eph signaling. Conclusion: Meltrin beta plays a regulatory role in formation of the NMJ. The endocytosis of ephrin-Eph complexes is required for efficient contact-dependent repulsion between ephrin and Eph. We propose that Meltrin beta stabilizes the interaction between ephrin-A5 and EphA4 by regulating endocytosis of the ephrinA5-EphA complex negatively, which would contribute to the fine-tuning of the NMJ during development.	[Yumoto, Norihiro; Wakatsuki, Shuji; Kurisaki, Tomohiro; Sehara-Fujisawa, Atsuko] Kyoto Univ, Dept Growth Regulat, Inst Frontier Med Sci, Kyoto, Japan; [Hara, Yoshinobu; Osumi, Noriko] Tohoku Univ, Sch Med, Ctr Translat & Advanced Anim Res CTTAR, Div Dev Neurosci, Sendai, Miyagi, Japan; [Frisen, Jonas] Medical Nobel Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Kyoto University; Tohoku University	Yumoto, N (corresponding author), Kyoto Univ, Dept Growth Regulat, Inst Frontier Med Sci, Kyoto, Japan.	asehara@frontier.kyoto-u.ac.jp	Osumi, Noriko/T-2823-2019	Osumi, Noriko/0000-0003-0548-6452; hara, Yoshinobu/0000-0001-6339-5116	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare; CREST (Core Research for Evolutional Science and Technology); Japan Science and Technology Corporation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); CREST (Core Research for Evolutional Science and Technology)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST))	Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology, Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare, Research Grant from CREST (Core Research for Evolutional Science and Technology), the Japan Science and Technology Corporation	Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Eberhart J, 2004, J NEUROSCI, V24, P1070, DOI 10.1523/JNEUROSCI.4719-03.2004; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Holmberg J, 2002, TRENDS NEUROSCI, V25, P239, DOI 10.1016/S0166-2236(02)02149-5; Inoue D, 1998, J BIOL CHEM, V273, P4180, DOI 10.1074/jbc.273.7.4180; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kishi M, 2005, J CELL BIOL, V169, P355, DOI 10.1083/jcb.200411012; Komatsu K, 2007, DEV BIOL, V303, P82, DOI 10.1016/j.ydbio.2006.10.037; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Kurisaki T, 1998, MECH DEVELOP, V73, P211, DOI 10.1016/S0925-4773(98)00043-4; Kurohara K, 2004, DEV BIOL, V267, P14, DOI 10.1016/j.ydbio.2003.10.021; Lai KO, 2001, MOL CELL NEUROSCI, V17, P1034, DOI 10.1006/mcne.2001.0997; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Marignani PA, 2001, J CELL BIOL, V154, P177, DOI 10.1083/jcb.200103134; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; MARTIN PT, 1995, SCIENCE, V269, P413, DOI 10.1126/science.7618109; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Schwander M, 2004, J NEUROSCI, V24, P8181, DOI 10.1523/JNEUROSCI.1345-04.2004; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Wakatsuki S, 2004, J NEUROCHEM, V89, P119, DOI 10.1046/j.1471-4159.2003.02303.x; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Weinl C, 2003, DEVELOPMENT, V130, P1635, DOI 10.1242/dev.00386; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Yokozeki T, 2007, GENES CELLS, V12, P329, DOI 10.1111/j.1365-2443.2007.01060.x; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	52	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3322	10.1371/journal.pone.0003322	http://dx.doi.org/10.1371/journal.pone.0003322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830404	Green Submitted, Green Published, gold			2022-12-27	WOS:000264797300010
J	Liu, DQ; Li, LM; Guo, YL; Bai, R; Wang, C; Bian, Z; Zhang, CY; Zen, K				Liu, Dan-Qing; Li, Li-Min; Guo, Ya-Lan; Bai, Rui; Wang, Chen; Bian, Zhen; Zhang, Chen-Yu; Zen, Ke			Signal Regulatory Protein alpha Negatively Regulates beta(2) Integrin-Mediated Monocyte Adhesion, Transendothelial Migration and Phagocytosis	PLOS ONE			English	Article								Background: Signal regulate protein alpha (SIRP alpha) is involved in many functional aspects of monocytes. Here we investigate the role of SIRP alpha in regulating beta(2) integrin-mediated monocyte adhesion, transendothelial migration (TEM) and phagocytosis. Methodology/Principal Findings: THP-1 monocytes/macropahges treated with advanced glycation end products (AGEs) resulted in a decrease of SIRP alpha expression but an increase of beta(2) integrin cell surface expression and beta(2) integrin-mediated adhesion to tumor necrosis factor-alpha (TNF alpha)-stimulated human microvascular endothelial cell (HMEC-1) monolayers. In contrast, SIRP alpha overexpression in THP-1 cells showed a significant less monocyte chemotactic protein-1 (MCP-1)-triggered cell surface expression of beta(2) integrins, in particular CD11b/CD18. SIRP alpha overexpression reduced beta(2) integrin-mediated firm adhesion of THP-1 cells to either TNF alpha-stimulated HMEC-1 monolayers or to immobilized intercellular adhesion molecule-1 (ICAM-1). SIRP alpha overexpression also reduced MCP-1-initiated migration of THP-1 cells across TNF alpha-stimulated HMEC-1 monolayers. Furthermore, beta(2) integrin-mediated THP-1 cell spreading and actin polymerization in response to MCP-1, and phagocytosis of bacteria were both inhibited by SIRP alpha overexpression. Conclusions/Significance: SIRP alpha negatively regulates beta(2) integrin-mediated monocyte adhesion, transendothelial migration and phagocytosis, thus may serve as a critical molecule in preventing excessive activation and accumulation of monocytes in the arterial wall during early stage of atherosclerosis.	[Liu, Dan-Qing; Li, Li-Min; Guo, Ya-Lan; Bai, Rui; Wang, Chen; Bian, Zhen; Zhang, Chen-Yu; Zen, Ke] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Res Ctr, Nanjing, Jiangsu, Peoples R China; [Li, Li-Min; Zen, Ke] Nanjing Univ, Joint Inst Virol, Jiangsu CDC, Nanjing, Peoples R China	Nanjing University; Nanjing University	Liu, DQ (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Res Ctr, Nanjing, Jiangsu, Peoples R China.	kzen@nju.edu.cn	wang, chen/GWM-9481-2022		China Basic Science 973 program	China Basic Science 973 program(National Basic Research Program of China)	This work was supported in part by China Basic Science 973 program (CYZ, KZ).	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Brown E, 2001, J CLIN INVEST, V107, P1499, DOI 10.1172/JCI13315; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Capo C, 2003, J IMMUNOL, V170, P4217, DOI 10.4049/jimmunol.170.8.4217; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Gafa V, 2005, J MED VIROL, V76, P361, DOI 10.1002/jmv.20358; GERRITY RG, 1981, AM J PATHOL, V103, P181; Han KH, 2003, J LIPID RES, V44, P1332, DOI 10.1194/jlr.M200427-JLR200; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Liu SQ, 2005, J BIOL CHEM, V280, P39294, DOI 10.1074/jbc.M503866200; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Liu Y, 2005, J BIOL CHEM, V280, P36132, DOI 10.1074/jbc.M506419200; Luscinskas FW, 1996, J IMMUNOL, V157, P326; Mateo W, 2002, BLOOD, V100, P2882, DOI 10.1182/blood-2001-12-0217; MIYAGAWA K, 1994, CARDIOL ELDER, V2, P1; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; Oshima K, 2002, FEBS LETT, V519, P1, DOI 10.1016/S0014-5793(02)02703-5; Papayannopoulou T, 2003, BLOOD, V101, P4739, DOI 10.1182/blood-2002-09-2741; Patel V, 2002, EUR J IMMUNOL, V32, P1865, DOI 10.1002/1521-4141(200207)32:7<1865::AID-IMMU1865>3.0.CO;2-F; Peppa M, 2003, DIABETES, V52, P2805, DOI 10.2337/diabetes.52.11.2805; Rosenfeld ME, 2002, ARTERIOSCL THROM VAS, V22, P361, DOI 10.1161/hq0302.104847; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Ryu JW, 2004, ARTERIOSCL THROM VAS, V24, P864, DOI 10.1161/01.ATV.0000125705.28058.eb; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Shahabuddin S, 2000, J IMMUNOL, V164, P3847, DOI 10.4049/jimmunol.164.7.3847; Sharlow ER, 2000, J CELL SCI, V113, P3093; Shi C, 2004, J CLIN INVEST, V114, P408, DOI 10.1172/jci200421100; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; Smith RE, 2003, BLOOD, V102, P2532, DOI 10.1182/blood-2002-11-3596; Sotiriou SN, 2006, FASEB J, V20, P559, DOI 10.1096/fj.05-4857fje; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Valcourt U, 2007, J BIOL CHEM, V282, P5691, DOI 10.1074/jbc.M610536200; van Royen N, 2003, CIRC RES, V92, P218, DOI 10.1161/01.RES.0000052313.23087.3F; Weber KSC, 1999, MOL BIOL CELL, V10, P861, DOI 10.1091/mbc.10.4.861; Wu CJ, 2000, ONCOGENE, V19, P3999, DOI 10.1038/sj.onc.1203748; Yamao T, 2002, J BIOL CHEM, V277, P39833, DOI 10.1074/jbc.M203287200; Zen K, 2002, J IMMUNOL, V169, P5270, DOI 10.4049/jimmunol.169.9.5270; ZEN K, 2007, J MOL BIOL; Zhang H, 2002, AM J PATHOL, V160, P2219, DOI 10.1016/S0002-9440(10)61169-8	49	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2008	3	9							e3291	10.1371/journal.pone.0003291	http://dx.doi.org/10.1371/journal.pone.0003291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MN	18820737	Green Submitted, Green Published, gold			2022-12-27	WOS:000264432500002
J	Taylor, WD; Kuchibhatla, M; Payne, ME; MacFall, JR; Sheline, YI; Krishnan, KR; Doraiswamy, PM				Taylor, Warren D.; Kuchibhatla, Maragatha; Payne, Martha E.; MacFall, James R.; Sheline, Yvette I.; Krishnan, K. Ranga; Doraiswamy, P. Murali			Frontal White Matter Anisotropy and Antidepressant Remission in Late-Life Depression	PLOS ONE			English	Article							MRI SUBCORTICAL HYPERINTENSITIES; DORSOLATERAL PREFRONTAL CORTEX; ANTERIOR CINGULATE CORTEX; TREATMENT RESPONSE; MAJOR DEPRESSION; DIFFUSION-TENSOR; MICROSTRUCTURAL ABNORMALITIES; GERIATRIC DEPRESSION; WATER DIFFUSION; NERVOUS-SYSTEM	Introduction: Neuroanatomic features associated with antidepressant treatment outcomes in older depressed individuals are not well established. This study used diffusion tensor imaging to examine frontal white matter structure in depressed subjects undergoing a 12-week trial of sertraline. We hypothesized that remission would be associated with higher frontal anisotropy measures, and failure to remit with lower anisotropy. Methods: 74 subjects with Major Depressive Disorder and age 60 years or older were enrolled in a twelve-week open-label trial of sertraline and completed clinical assessments and 1.5T magnetic resonance brain imaging. The apparent diffusion coefficient (ADC) and fractional anisotropy (FA) were measured in regions of interest placed in the white matter of the dorsolateral prefrontal cortex, anterior cingulate cortex, and corpus callosum. Differences in ADC and FA values between subjects who did and did not remit to treatment over the study period were assessed using generalized estimating equations, controlling for age, sex, medical comorbidity and baseline depression severity. Results: Subjects who did not remit to sertraline exhibited higher FA values in the superior frontal gyri and anterior cingulate cortices bilaterally. There were no statistically significant associations between ADC measures and remission. Conclusions: Failure to remit to sertraline is associated with higher frontal FA values. Functional imaging studies demonstrate that depression is characterized by functional disconnection between frontal and limbic regions. Those individuals where this disconnection is related to structural changes as detected by DTI may be more likely to respond to antidepressants.	[Taylor, Warren D.; Kuchibhatla, Maragatha; Payne, Martha E.; Krishnan, K. Ranga] Dept Psychiat, Durham, NC USA; [Kuchibhatla, Maragatha; Doraiswamy, P. Murali] Dept Biostat & Bioinformat, Durham, NC USA; [MacFall, James R.] Dept Radiol, Durham, NC USA; [Kuchibhatla, Maragatha] Ctr Study Aging & Human Dev, Durham, NC USA; [Taylor, Warren D.; Payne, Martha E.; MacFall, James R.] Neuropsychiat Imaging Res Lab, Durham, NC USA; [Sheline, Yvette I.] Washington Univ, Dept Psychiat, St Louis, MO 63130 USA; [Krishnan, K. Ranga] Duke NUS Grad Med Sch, Singapore, Singapore	Washington University (WUSTL); National University of Singapore	Taylor, WD (corresponding author), Dept Psychiat, Durham, NC USA.	taylo066@mc.duke.edu	Taylor, Warren D/J-3687-2014	Sheline, Yvette/0000-0002-6929-9659	NIMH [K23 MH 65939, R01 MH 62158, R01 MH 078216]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078216, K23MH065939, R01MH062158] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was supported by NIMH grants K23 MH 65939, R01 MH 62158, and R01 MH 078216. Sertraline was provided by Pfizer. These funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 2008, AM J PSYCHIAT, V165, P238, DOI 10.1176/appi.ajp.2007.07050744; Alexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929; Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, P1334, DOI 10.1038/sj.npp.1300725; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; Baldwin R, 2004, PSYCHOL MED, V34, P125, DOI 10.1017/S0033291703008870; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Cotter D, 2001, ARCH GEN PSYCHIAT, V58, P545, DOI 10.1001/archpsyc.58.6.545; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Fujikawa T, 1996, STROKE, V27, P2040, DOI 10.1161/01.STR.27.11.2040; Giuliani NR, 2005, SCHIZOPHR RES, V74, P135, DOI 10.1016/j.schres.2004.08.019; Guy W, 1976, ECDEU ASSESSMENT MAN, P217; Hawley CJ, 2002, J AFFECT DISORDERS, V72, P177, DOI 10.1016/S0165-0327(01)00451-7; HICKIE I, 1995, BIOL PSYCHIAT, V37, P151, DOI 10.1016/0006-3223(94)00174-2; Iosifescu DV, 2006, BRIT J PSYCHIAT, V188, P180, DOI 10.1192/bjp.188.2.180; Janssen J, 2007, INT J GERIATR PSYCH, V22, P468, DOI 10.1002/gps.1790; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; Krishnan K R, 1998, Depress Anxiety, V8, P142, DOI 10.1002/(SICI)1520-6394(1998)8:4<142::AID-DA2>3.0.CO;2-N; Kubicki M, 2003, BIOL PSYCHIAT, V54, P1171, DOI 10.1016/S0006-3223(03)00419-0; LATOUR LL, 1994, P NATL ACAD SCI USA, V91, P1229, DOI 10.1073/pnas.91.4.1229; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nobuhara K, 2006, J NEUROL NEUROSUR PS, V77, P120, DOI 10.1136/jnnp.2004.055129; Oslin DW, 2002, J AM GERIATR SOC, V50, P823, DOI 10.1046/j.1532-5415.2002.50206.x; Papakostas GI, 2005, PSYCHIAT RES-NEUROIM, V140, P301, DOI 10.1016/j.pscychresns.2005.09.001; Patankar TF, 2007, J AFFECT DISORDERS, V97, P265, DOI 10.1016/j.jad.2006.06.024; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pillay SS, 1997, BIOL PSYCHIAT, V42, P79, DOI 10.1016/S0006-3223(96)00335-6; Rajkowska G, 2005, BIOL PSYCHIAT, V58, P297, DOI 10.1016/j.biopsych.2005.04.013; Salloway S, 2002, AM J GERIAT PSYCHIAT, V10, P107, DOI 10.1176/appi.ajgp.10.1.107; Salloway S, 2002, J NEUROL SCI, V203, P227, DOI 10.1016/S0022-510X(02)00296-4; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Simpson S, 1998, PSYCHOL MED, V28, P1015, DOI 10.1017/S003329179800693X; Sneed JR, 2007, AM J GERIAT PSYCHIAT, V15, P553, DOI 10.1097/JGP.0b013e3180302513; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Steffens DC, 2005, INT PSYCHOGERIATR, V17, P41, DOI 10.1017/S1041610205000979; Taylor WD, 2007, AM J ROENTGENOL, V188, P1695, DOI 10.2214/AJR.06.1163; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Taylor WD, 2001, BIOL PSYCHIAT, V50, P179, DOI 10.1016/S0006-3223(01)01160-X; Taylor WD, 2003, ARCH GEN PSYCHIAT, V60, P1090, DOI 10.1001/archpsyc.60.11.1090; Taylor WD, 2005, PSYCHIAT RES-NEUROIM, V139, P1, DOI 10.1016/j.pscychresns.2004.08.004; Thomas AJ, 2002, ARCH GEN PSYCHIAT, V59, P785, DOI 10.1001/archpsyc.59.9.785; Yang Q, 2007, INT PSYCHOGERIATR, V19, P757, DOI 10.1017/S1041610207004875	50	76	82	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3267	10.1371/journal.pone.0003267	http://dx.doi.org/10.1371/journal.pone.0003267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422MG	18813343	Green Submitted, gold, Green Published			2022-12-27	WOS:000264431800006
J	Kielbasa, SM; Vingron, M				Kielbasa, Szymon M.; Vingron, Martin			Transcriptional Autoregulatory Loops Are Highly Conserved in Vertebrate Evolution	PLOS ONE			English	Article								Background: Feedback loops are the simplest building blocks of transcriptional regulatory networks and therefore their behavior in the course of evolution is of prime interest. Methodology: We address the question of enrichment of the number of autoregulatory feedback loops in higher organisms. First, based on predicted autoregulatory binding sites we count the number of autoregulatory loops. We compare it to estimates obtained either by assuming that each (conserved) gene has the same chance to be a target of a given factor or by assuming that each conserved sequence position has an equal chance to be a binding site of the factor. Conclusions: We demonstrate that the numbers of putative autoregulatory loops conserved between human and fugu, danio or chicken are significantly higher than expected. Moreover we show, that conserved autoregulatory binding sites cluster close to the factors' starts of transcription. We conclude, that transcriptional autoregulatory feedback loops constitute a core transcriptional network motif and their conservation has been maintained in higher vertebrate organism evolution.	[Kielbasa, Szymon M.; Vingron, Martin] Max Planck Inst Mol Genet, Berlin, Germany	Max Planck Society	Kielbasa, SM (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	szymon.kielbasa@molgen.mpg.de	Kiełbasa, Szymon M./K-2792-2019; Kiełbasa, Szymon/G-1636-2018	Kiełbasa, Szymon/0000-0003-2805-6535	German Ministry for Research and Education (NGFN/BMBF)	German Ministry for Research and Education (NGFN/BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by grants from the German Ministry for Research and Education (NGFN/BMBF).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Aota S, 2003, DEV BIOL, V257, P1, DOI 10.1016/S0012-1606(03)00058-7; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Birney E, 2004, NUCLEIC ACIDS RES, V32, pD468, DOI 10.1093/nar/gkh038; Conant GC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-62; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Packer AI, 1998, DEVELOPMENT, V125, P1991; RAHMANN S, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1032; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; SETH A, 1990, ONCOGENE, V5, P1761; Smith SB, 2000, J BIOL CHEM, V275, P36910, DOI 10.1074/jbc.M005202200; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Tao Y, 2004, J THEOR BIOL, V229, P147, DOI 10.1016/j.jtbi.2004.03.011; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904	23	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3210	10.1371/journal.pone.0003210	http://dx.doi.org/10.1371/journal.pone.0003210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791639	Green Published, gold			2022-12-27	WOS:000264427700005
J	Morozova, O; Morozov, V; Hoffman, BG; Helgason, CD; Marra, MA				Morozova, Olena; Morozov, Vyacheslav; Hoffman, Brad G.; Helgason, Cheryl D.; Marra, Marco A.			A Seriation Approach for Visualization-Driven Discovery of Co-Expression Patterns in Serial Analysis of Gene Expression (SAGE) Data	PLOS ONE			English	Article							MICROARRAY; INTEGRATION; PROFILES	Background: Serial Analysis of Gene Expression (SAGE) is a DNA sequencing-based method for large-scale gene expression profiling that provides an alternative to microarray analysis. Most analyses of SAGE data aimed at identifying co-expressed genes have been accomplished using various versions of clustering approaches that often result in a number of false positives. Principal Findings: Here we explore the use of seriation, a statistical approach for ordering sets of objects based on their similarity, for large-scale expression pattern discovery in SAGE data. For this specific task we implement a seriation heuristic we term 'progressive construction of contigs' that constructs local chains of related elements by sequentially rearranging margins of the correlation matrix. We apply the heuristic to the analysis of simulated and experimental SAGE data and compare our results to those obtained with a clustering algorithm developed specifically for SAGE data. We show using simulations that the performance of seriation compares favorably to that of the clustering algorithm on noisy SAGE data. Conclusions: We explore the use of a seriation approach for visualization-based pattern discovery in SAGE data. Using both simulations and experimental data, we demonstrate that seriation is able to identify groups of co-expressed genes more accurately than a clustering algorithm developed specifically for SAGE data. Our results suggest that seriation is a useful method for the analysis of gene expression data whose applicability should be further pursued.	[Morozova, Olena; Marra, Marco A.] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Morozov, Vyacheslav] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Hoffman, Brad G.; Helgason, Cheryl D.] BC Canc Res Ctr, Dept Canc Endocrinol, Vancouver, BC, Canada	British Columbia Cancer Agency; University of Toronto; British Columbia Cancer Agency	Morozova, O (corresponding author), British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada.	omorozova@bcgsc.ca	Marra, Marco A/B-5987-2008	Marra, Marco A/0000-0001-7146-7175; Hoffman, Brad/0000-0002-5420-4493; Vaske, Olena/0000-0002-1677-417X	Genome Canada; Natural Sciences and Engineering Research Council of Canada fellowship; Michael Smith Foundation for Health Research	Genome Canada(Genome Canada); Natural Sciences and Engineering Research Council of Canada fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	Support for this work was received as part of the Genome Canada-funded Mammalian Organogenesis Regulation by Gene Expression Networks (MORGEN) project led by Marco Marra, Pamela Hoodless, Steven Jones, Cheryl Helgason and Aly Karsan. O. M. is supported by a Natural Sciences and Engineering Research Council of Canada fellowship, and is a Junior Trainee of the Michael Smith Foundation for Health Research. C.D.H. is a scholar and M.A.M. is a senior scholar of the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Cai L, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r51; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Dennis JL, 2005, J PATHOL, V205, P236, DOI 10.1002/path.1702; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Firulli AB, 2003, GENE, V312, P27, DOI 10.1016/S0378-1119(03)00669-3; GASA R, 2007, INDUCTION PANCREATIC; Griffith OL, 2005, GENOMICS, V86, P476, DOI 10.1016/j.ygeno.2005.06.009; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hoffman BG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r99; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Kendall D., 1971, MATH ARCHAEOLOGICAL, P215; Kim SK, 2002, CURR OPIN GENET DEV, V12, P540, DOI 10.1016/S0959-437X(02)00338-6; Kitamura T, 2007, ENDOCR J, V54, P507, DOI 10.1507/endocrj.KR-109; Marsich E, 2003, BIOCHEM J, V376, P707, DOI 10.1042/BJ20031021; PETRIE WMF, 1899, J ANTHR I GREAT BRIT, V29, P295, DOI DOI 10.2307/2843012; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Puolamaki K, 2006, PLOS COMPUT BIOL, V2, P62, DOI 10.1371/journal.pcbi.0020006; Robertson N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r6; Robinson WS, 1951, AM ANTIQUITY, V16, P293, DOI 10.2307/276978; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Siddiqui AS, 2005, P NATL ACAD SCI USA, V102, P18485, DOI 10.1073/pnas.0509455102; SOKAL RR, 1958, U KANSAS SCI B, V38, P1409; Thalamuthu A, 2006, BIOINFORMATICS, V22, P2405, DOI 10.1093/bioinformatics/btl406; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Westerman BA, 2003, BBA-GENE STRUCT EXPR, V1629, P1, DOI 10.1016/j.bbaexp.2003.08.002; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3205	10.1371/journal.pone.0003205	http://dx.doi.org/10.1371/journal.pone.0003205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787709	Green Submitted, Green Published, gold			2022-12-27	WOS:000264426200010
J	Faye, B; Arnaud, F; Peyretaillade, E; Brasset, E; Dastugue, B; Vaury, C				Faye, Babacar; Arnaud, Frederick; Peyretaillade, Eric; Brasset, Emilie; Dastugue, Bernard; Vaury, Chantal			Functional Characteristics of a Highly Specific Integrase Encoded by an LTR-Retrotransposon	PLOS ONE			English	Article								Background: The retroviral Integrase protein catalyzes the insertion of linear viral DNA into host cell DNA. Although different retroviruses have been shown to target distinctive chromosomal regions, few of them display a site-specific integration. ZAM, a retroelement from Drosophila melanogaster very similar in structure and replication cycle to mammalian retroviruses is highly site-specific. Indeed, ZAM copies target the genomic 5'-CGCGCg-3' consensus-sequences. To enlighten the determinants of this high integration specificity, we investigated the functional properties of its integrase protein denoted ZAM-IN. Principal Findings: Here we show that ZAM-IN displays the property to nick DNA molecules in vitro. This endonuclease activity targets specific sequences that are present in a 388 bp fragment taken from the white locus and known to be a genomic ZAM integration site in vivo. Furthermore, ZAM-IN displays the unusual property to directly bind specific genomic DNA sequences. Two specific and independent sites are recognized within the 388 bp fragment of the white locus: the CGCGCg sequence and a closely apposed site different in sequence. Conclusion: This study strongly argues that the intrinsic properties of ZAM-IN, ie its binding properties and its endonuclease activity, play an important part in ZAM integration specificity. Its ability to select two binding sites and to nick the DNA molecule reminds the strategy used by some site-specific recombination enzymes and forms the basis for site-specific integration strategies potentially useful in a broad range of genetic engineering applications.	[Faye, Babacar; Arnaud, Frederick; Peyretaillade, Eric; Brasset, Emilie; Dastugue, Bernard; Vaury, Chantal] Univ Clermont Ferrand, INSERM, CNRS, Fac Med,UMR 6247,U931, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Faye, B (corresponding author), Univ Clermont Ferrand, INSERM, CNRS, Fac Med,UMR 6247,U931, Clermont Ferrand, France.	Chantal.VAURY@inserm.u-clermont1.fr	Vaury, Chantal/I-4658-2015; Brasset, Emilie/J-6684-2015; Arnaud, Frédérick/F-4892-2019	Vaury, Chantal/0000-0002-7725-5760; Arnaud, Frédérick/0000-0001-6893-9848; Brasset, Emilie/0000-0003-2479-7969	CNRS [GDR2157]; Action Concertee Incitative [BCMS408]; Canceropcle Lyon Auvergne Rhcne-Alpes; Region Auvergne; Ministere de l'Enseignement Superieur et de la Recherche (MESR); Fondation Recherche Medicale (FRM)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Action Concertee Incitative; Canceropcle Lyon Auvergne Rhcne-Alpes; Region Auvergne(Region Auvergne-Rhone-Alpes); Ministere de l'Enseignement Superieur et de la Recherche (MESR)(Ministry of Research, France); Fondation Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	Our research is supported by grants from CNRS (GDR2157), Action Concertee Incitative (ACI BCMS408), Canceropcle Lyon Auvergne Rhcne-Alpes (CLARA, Projet EpiPro), and Region Auvergne to CV. F.A. received a grant from the Ministere de l'Enseignement Superieur et de la Recherche (MESR), and the Fondation Recherche Medicale (FRM).	Arnaud F, 2005, INSECT BIOCHEM MOLEC, V35, P323, DOI 10.1016/j.ibmb.2004.12.008; Baldrich E, 1997, GENETICA, V100, P131, DOI 10.1023/A:1018317209658; Boeke JD, 1998, CELL, V93, P1087, DOI 10.1016/S0092-8674(00)81450-6; Brady Troy L., 2008, V435, P153, DOI 10.1007/978-1-59745-232-8_11; BUSHMAN F, 1995, SCIENCE, V267, P1443, DOI 10.1126/science.7878462; Bushman FD, 2003, CELL, V115, P135, DOI 10.1016/S0092-8674(03)00760-8; CHALKER DL, 1993, P NATL ACAD SCI USA, V90, P4927, DOI 10.1073/pnas.90.11.4927; Check E, 2002, NATURE, V419, P545, DOI 10.1038/419545a; Christensen SM, 2005, MOL CELL BIOL, V25, P6617, DOI 10.1128/MCB.25.15.6617-6628.2005; Coffin JMHS, 1997, RETROVIRUS; Dai JB, 2007, MOL CELL, V27, P289, DOI 10.1016/j.molcel.2007.06.010; Desset S, 1999, MOL BIOL EVOL, V16, P54, DOI 10.1093/oxfordjournals.molbev.a026038; Devine SE, 1996, GENE DEV, V10, P620, DOI 10.1101/gad.10.5.620; Engelman A, 2003, CURR TOP MICROBIOL, V281, P209; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; FINNEGAN DJ, 1994, CURR BIOL, V4, P641, DOI 10.1016/S0960-9822(00)00142-1; GOFF SP, 1992, ANNU REV GENET, V26, P527, DOI 10.1146/annurev.ge.26.120192.002523; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Johnson EP, 2001, VIROLOGY, V286, P304, DOI 10.1006/viro.2001.0978; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; KIRCHNER J, 1995, SCIENCE, V267, P1488, DOI 10.1126/science.7878467; Leblanc P, 1997, EMBO J, V16, P7521, DOI 10.1093/emboj/16.24.7521; Leblanc P, 1999, J VIROL, V73, P7061, DOI 10.1128/JVI.73.8.7061-7064.1999; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Lewinski MK, 2005, ADV GENET, V55, P147, DOI 10.1016/S0065-2660(05)55005-3; Maxfield LF, 2005, P NATL ACAD SCI USA, V102, P1436, DOI 10.1073/pnas.0409204102; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, EMBO J, V11, P291, DOI 10.1002/j.1460-2075.1992.tb05052.x; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Taganov KD, 2004, J VIROL, V78, P5848, DOI 10.1128/JVI.78.11.5848-5855.2004; Wah DA, 1997, NATURE, V388, P97, DOI 10.1038/40446; Wu X, 2004, CELL MOL LIFE SCI, V61, P2588, DOI 10.1007/s00018-004-4206-9; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Xie WW, 2001, MOL CELL BIOL, V21, P6606, DOI 10.1128/MCB.21.19.6606-6614.2001; Zhu YX, 1999, GENE DEV, V13, P2738, DOI 10.1101/gad.13.20.2738; Zhu YX, 2003, P NATL ACAD SCI USA, V100, P5891, DOI 10.1073/pnas.1036705100	37	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3185	10.1371/journal.pone.0003185	http://dx.doi.org/10.1371/journal.pone.0003185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784842	gold, Green Published, Green Submitted			2022-12-27	WOS:000264425900006
J	Bragg, JG; Chisholm, SW				Bragg, Jason G.; Chisholm, Sallie W.			Modeling the Fitness Consequences of a Cyanophage-Encoded Photosynthesis Gene	PLOS ONE			English	Article							LATENT-PERIOD EVOLUTION; IN-VIVO; BACTERIOPHAGE; PROCHLOROCOCCUS; GROWTH; PHAGES; VIRUS; HOST; PHOTOINHIBITION; PROKARYOTE	Background: Phages infecting marine picocyanobacteria often carry a psbA gene, which encodes a homolog to the photosynthetic reaction center protein, D1. Host encoded D1 decays during phage infection in the light. Phage encoded D1 may help to maintain photosynthesis during the lytic cycle, which in turn could bolster the production of deoxynucleoside triphosphates (dNTPs) for phage genome replication. Methodology / Principal Findings: To explore the consequences to a phage of encoding and expressing psbA, we derive a simple model of infection for a cyanophage/host pair - cyanophage P-SSP7 and Prochlorococcus MED4- for which pertinent laboratory data are available. We first use the model to describe phage genome replication and the kinetics of psbA expression by host and phage. We then examine the contribution of phage psbA expression to phage genome replication under constant low irradiance (25 mu E m(-2) s(-1)). We predict that while phage psbA expression could lead to an increase in the number of phage genomes produced during a lytic cycle of between 2.5 and 4.5% (depending on parameter values), this advantage can be nearly negated by the cost of psbA in elongating the phage genome. Under higher irradiance conditions that promote D1 degradation, however, phage psbA confers a greater advantage to phage genome replication. Conclusions / Significance: These analyses illustrate how psbA may benefit phage in the dynamic ocean surface mixed layer.	[Bragg, Jason G.; Chisholm, Sallie W.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Chisholm, Sallie W.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bragg, JG (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jbragg@mit.edu	Bragg, Jason G/A-4473-2012; Bragg, Jason/P-7675-2019; Bragg, Jason/R-5611-2016	Bragg, Jason G/0000-0003-0093-4981; Bragg, Jason/0000-0002-7621-7295; Bragg, Jason/0000-0002-7621-7295; Chisholm, Sallie/0000-0003-1480-2445	US National Science Foundation; Gordon and Betty Moore Foundation Marine Microbiology Initiative; US Department of Energy GTL Program; NSF	US National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation Marine Microbiology Initiative(Gordon and Betty Moore Foundation); US Department of Energy GTL Program(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	This work was supported in part by funds from the US National Science Foundation, the Gordon and Betty Moore Foundation Marine Microbiology Initiative, and the US Department of Energy GTL Program. It is an NSF C-MORE contribution.	ABEDON ST, 1989, MICROB ECOL, V18, P79, DOI 10.1007/BF02030117; Abedon ST, 2003, APPL ENVIRON MICROB, V69, P7499, DOI 10.1128/AEM.69.12.7499-7506.2003; Abedon ST, 2001, APPL ENVIRON MICROB, V67, P4233, DOI 10.1128/AEM.67.9.4233-4241.2001; Bailey S, 2004, RES MICROBIOL, V155, P720, DOI 10.1016/j.resmic.2004.06.002; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Breitbart M, 2007, OCEANOGRAPHY, V20, P135, DOI 10.5670/oceanog.2007.58; Brown CM, 2006, J MAR BIOL ASSOC UK, V86, P491, DOI 10.1017/S0025315406013397; BUCHHOLTZ F, 1987, BIOPHYS CHEM, V26, P171, DOI 10.1016/0301-4622(87)80020-0; Bull JJ, 2006, J THEOR BIOL, V241, P928, DOI 10.1016/j.jtbi.2006.01.027; Chen F, 2002, APPL ENVIRON MICROB, V68, P2589, DOI 10.1128/AEM.68.5.2589-2594.2002; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DONLIN MJ, 1994, BIOCHEMISTRY-US, V33, P14908, DOI 10.1021/bi00253a030; Endy D, 2000, P NATL ACAD SCI USA, V97, P5375, DOI 10.1073/pnas.090101397; Endy D, 1997, BIOTECHNOL BIOENG, V55, P375, DOI 10.1002/(SICI)1097-0290(19970720)55:2<375::AID-BIT15>3.0.CO;2-G; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kim H, 2004, BIOTECHNOL BIOENG, V88, P148, DOI 10.1002/bit.20226; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MACKENZIE JJ, 1972, VIROLOGY, V49, P517, DOI 10.1016/0042-6822(72)90503-X; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Mann NH, 2003, FEMS MICROBIOL REV, V27, P17, DOI 10.1016/S0168-6445(03)00016-0; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Murray J. D., 1989, MATH BIOL, DOI DOI 10.1007/978-3-662-08539-4; OHAD I, 1984, J CELL BIOL, V99, P481, DOI 10.1083/jcb.99.2.481; PARTENSKY F, 1993, PLANT PHYSIOL, V101, P285, DOI 10.1104/pp.101.1.285; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; RABKIN SD, 1990, VIROLOGY, V174, P585, DOI 10.1016/0042-6822(90)90111-4; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Sharon I, 2007, ISME J, V1, P492, DOI 10.1038/ismej.2007.67; Six C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001341; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; SUTTLE CA, 1994, APPL ENVIRON MICROB, V60, P3167, DOI 10.1128/AEM.60.9.3167-3174.1994; TYYSTJARVI E, 1994, PHOTOSYNTH RES, V41, P439, DOI 10.1007/BF02183046; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; Wang IN, 1996, EVOL ECOL, V10, P545, DOI 10.1007/BF01237884; Wang IN, 2006, GENETICS, V172, P17, DOI 10.1534/genetics.105.045922; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; You L, 2006, IEE P SYST BIOL, V153, P46, DOI 10.1049/ip-syb:20050026; You LC, 2002, GENETICS, V160, P1273; You LC, 2002, J BACTERIOL, V184, P1888, DOI 10.1128/JB.184.7.1888-1894.2002	47	63	67	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3550	10.1371/journal.pone.0003550	http://dx.doi.org/10.1371/journal.pone.0003550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958282	Green Submitted, gold, Green Published			2022-12-27	WOS:000265131100009
J	Uddin, LQ; Davies, MS; Scott, AA; Zaidel, E; Bookheimer, SY; Iacoboni, M; Dapretto, M				Uddin, Lucina Q.; Davies, Mari S.; Scott, Ashley A.; Zaidel, Eran; Bookheimer, Susan Y.; Iacoboni, Marco; Dapretto, Mirella			Neural Basis of Self and Other Representation in Autism: An fMRI Study of Self-Face Recognition	PLOS ONE			English	Article								Background: Autism is a developmental disorder characterized by decreased interest and engagement in social interactions and by enhanced self-focus. While previous theoretical approaches to understanding autism have emphasized social impairments and altered interpersonal interactions, there is a recent shift towards understanding the nature of the representation of the self in individuals with autism spectrum disorders (ASD). Still, the neural mechanisms subserving self-representations in ASD are relatively unexplored. Methodology/Principal Findings: We used event-related fMRI to investigate brain responsiveness to images of the subjects' own face and to faces of others. Children with ASD and typically developing (TD) children viewed randomly presented digital morphs between their own face and a gender-matched other face, and made "self/other'' judgments. Both groups of children activated a right premotor/prefrontal system when identifying images containing a greater percentage of the self face. However, while TD children showed activation of this system during both self- and other-processing, children with ASD only recruited this system while viewing images containing mostly their own face. Conclusions/Significance: This functional dissociation between the representation of self versus others points to a potential neural substrate for the characteristic self-focus and decreased social understanding exhibited by these individuals, and suggests that individuals with ASD lack the shared neural representations for self and others that TD children and adults possess and may use to understand others.	[Uddin, Lucina Q.] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA; [Uddin, Lucina Q.; Davies, Mari S.; Zaidel, Eran] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Scott, Ashley A.; Bookheimer, Susan Y.; Iacoboni, Marco; Dapretto, Mirella] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behavior, Los Angeles, CA 90024 USA	Stanford University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Uddin, LQ (corresponding author), Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA.	lucina@stanford.edu	Uddin, Lucina/ABE-1972-2021; Uddin, Lucina/AAE-7168-2019	Uddin, Lucina/0000-0003-2278-8962; Lauwereyns, Jan/0000-0003-0551-2550; Bookheimer, Susan/0000-0002-3417-5891	NICHD [PO1 HD035470]; National Alliance for Autism Research; National Science Foundation [Graduate Research Fellowship]; Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; Ahmanson Foundation; Tamkin Foundation; Jennifer Jones-Simon Foundation; Capital Group Companies Charitable Foundation; William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation; Northstar Fund; National Center for Research Resources (NCRR), NIH [RR12169, RR13642, RR00865]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD035470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642, M01RR000865, C06RR012169] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Alliance for Autism Research; National Science Foundation(National Science Foundation (NSF)); Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; Ahmanson Foundation; Tamkin Foundation; Jennifer Jones-Simon Foundation; Capital Group Companies Charitable Foundation; William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation; Northstar Fund; National Center for Research Resources (NCRR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by grants from NICHD (PO1 HD035470), the National Alliance for Autism Research, and a National Science Foundation Graduate Research Fellowship to L.Q. Uddin. For generous support the authors also wish to thank the Brain Mapping Medical Research Organization, Brain Mapping Support Foundation, Pierson-Lovelace Foundation, Ahmanson Foundation, Tamkin Foundation, Jennifer Jones-Simon Foundation, Capital Group Companies Charitable Foundation, Robson Family, William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation, and Northstar Fund. This project was in part also supported by grants (RR12169, RR13642 and RR00865) from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH); its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Baron-Cohen S, 2004, J NEUROL NEUROSUR PS, V75, P945, DOI 10.1136/jnnp.2003.018713; Baron-Cohen S., 2005, LOST SELF PATHOLOGIE, P166, DOI [10.1093/acprof:oso/9780195173413.003.0011, DOI 10.1093/ACPROF:OSO/9780195173413.003.0011]; BEHRENS T, 2003, MULTI SUBJECT NULL H; Bernier R, 2007, BRAIN COGNITION, V64, P228, DOI 10.1016/j.bandc.2007.03.004; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Charman T, 1998, INF MENTAL HLTH J, V19, P260, DOI 10.1002/(SICI)1097-0355(199822)19:2<260::AID-IMHJ12>3.0.CO;2-W; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; DAWSON G, 1984, J AUTISM DEV DISORD, V14, P383, DOI 10.1007/BF02409829; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; DEVIGNEMONT F, 2006, TRENDS COGN SCI; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Frith CD, 2008, NEURON, V57, P331, DOI 10.1016/j.neuron.2008.01.014; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Gallese V, 2006, BRAIN RES, V1079, P15, DOI 10.1016/j.brainres.2006.01.054; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; GALLUP GG, 1977, AM PSYCHOL, V32, P329, DOI 10.1037/0003-066X.32.5.329; Gopnik A., 1994, SELF AWARENESS ANIMA, P166; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Iacoboni M, 2006, TRENDS COGN SCI, V10, P431, DOI 10.1016/j.tics.2006.08.002; Kanner L, 1943, NERV CHILD, V2, P217; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Kennedy DN, 1998, CEREB CORTEX, V8, P372, DOI 10.1093/cercor/8.4.372; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Lepage JF, 2007, DEVELOPMENTAL SCI, V10, P513, DOI 10.1111/j.1467-7687.2007.00631.x; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Makris N, 1999, NEUROIMAGE, V9, P18, DOI 10.1006/nimg.1998.0384; NEUMAN CJ, 1978, DEV PSYCHOBIOL, V11, P571, DOI 10.1002/dev.420110606; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Pfeifer JH, 2008, NEUROIMAGE, V39, P2076, DOI 10.1016/j.neuroimage.2007.10.032; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Platek SM, 2006, HUM BRAIN MAPP, V27, P91, DOI 10.1002/hbm.20168; PREYER W, 1889, MIND CHILD 2; Rogers S. J., 1991, DEV PSYCHOPATHOL, V3, P137, DOI [10.1017/S0954579400000043, DOI 10.1017/S0954579400000043]; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Sigman M, 2004, MENT RETARD DEV D R, V10, P221, DOI 10.1002/mrdd.20046; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; SPIKER D, 1984, CHILD DEV, V55, P214, DOI 10.1111/j.1467-8624.1984.tb00285.x; Sugiura M, 2005, NEUROIMAGE, V24, P143, DOI 10.1016/j.neuroimage.2004.07.063; Theoret H, 2005, CURR BIOL, V15, pR84, DOI 10.1016/j.cub.2005.01.022; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; UDDIN LQ, 2007, TRENDS COGN SCI; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; Wakabayashi A, 2007, J AUTISM DEV DISORD, V37, P491, DOI 10.1007/s10803-006-0181-3; Wang AT, 2006, BRAIN, V129, P932, DOI 10.1093/brain/awl032; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Williams DL, 2007, NEUROIMAG CLIN N AM, V17, P495, DOI 10.1016/j.nic.2007.07.007; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8; Williams JHG, 2006, NEUROPSYCHOLOGIA, V44, P610, DOI 10.1016/j.neuropsychologia.2005.06.010; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	65	77	81	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3526	10.1371/journal.pone.0003526	http://dx.doi.org/10.1371/journal.pone.0003526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958161	Green Published, gold, Green Submitted			2022-12-27	WOS:000265131100005
J	Diekelmann, S; Landolt, HP; Lahl, O; Born, J; Wagner, U				Diekelmann, Susanne; Landolt, Hans-Peter; Lahl, Olaf; Born, Jan; Wagner, Ullrich			Sleep Loss Produces False Memories	PLOS ONE			English	Article							RECOGNITION MEMORY; COGNITIVE NEUROSCIENCE; PREFRONTAL CORTEX; DECLARATIVE MEMORY; ILLUSORY MEMORIES; WORKING-MEMORY; DEPRIVATION; BRAIN; CONSOLIDATION; RETRIEVAL	People sometimes claim with high confidence to remember events that in fact never happened, typically due to strong semantic associations with actually encoded events. Sleep is known to provide optimal neurobiological conditions for consolidation of memories for long-term storage, whereas sleep deprivation acutely impairs retrieval of stored memories. Here, focusing on the role of sleep-related memory processes, we tested whether false memories can be created (a) as enduring memory representations due to a consolidation-associated reorganization of new memory representations during post-learning sleep and/or (b) as an acute retrieval-related phenomenon induced by sleep deprivation at memory testing. According to the Deese, Roediger, McDermott (DRM) false memory paradigm, subjects learned lists of semantically associated words (e. g., "night'', "dark'', "coal'',...), lacking the strongest common associate or theme word (here: "black''). Subjects either slept or stayed awake immediately after learning, and they were either sleep deprived or not at recognition testing 9, 33, or 44 hours after learning. Sleep deprivation at retrieval, but not sleep following learning, critically enhanced false memories of theme words. This effect was abolished by caffeine administration prior to retrieval, indicating that adenosinergic mechanisms can contribute to the generation of false memories associated with sleep loss.	[Diekelmann, Susanne; Born, Jan; Wagner, Ullrich] Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; [Landolt, Hans-Peter] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Inst Pharmacol & Toxicol, CH-8006 Zurich, Switzerland; [Lahl, Olaf] Univ Dusseldorf, Heinrich Heine, Inst Expt Psychol, D-4000 Dusseldorf, Germany; [Wagner, Ullrich] Univ Geneva, Univ Med Sch, Dept Neurosci, CH-1211 Geneva, Switzerland	University of Lubeck; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Heinrich Heine University Dusseldorf; University of Geneva	Diekelmann, S (corresponding author), Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany.	diekelmann@kfg.uni-luebeck.de; wagner@kfg.uni-luebeck.de	Born, Jan/K-2596-2016; Landolt, Hans-Peter/H-6951-2016	Born, Jan/0000-0002-1847-6248; Landolt, Hans-Peter/0000-0003-0887-9403; Lauwereyns, Jan/0000-0003-0551-2550	Deutsche Forschungsgemeinschaft [SFB 654]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 654, Plasticity and Sleep). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquas E, 2002, NEUROPSYCHOPHARMACOL, V27, P182, DOI 10.1016/S0893-133X(02)00290-7; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Basheer R, 2000, BIOL SIGNAL RECEPT, V9, P319; Bonnet MH, 2005, SLEEP, V28, P1163, DOI 10.1093/sleep/28.9.1163; Boonstra TW, 2007, CELL MOL LIFE SCI, V64, P934, DOI 10.1007/s00018-007-6457-8; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Chee MWL, 2008, J NEUROSCI, V28, P5519, DOI 10.1523/JNEUROSCI.0733-08.2008; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Corson Y, 2007, PSYCHOL SCI, V18, P208, DOI 10.1111/j.1467-9280.2007.01874.x; Curran T, 2001, J COGNITIVE NEUROSCI, V13, P201, DOI 10.1162/089892901564261; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; Diekelmann S, 2007, NAT NEUROSCI, V10, P1085, DOI 10.1038/nn0907-1085; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Drosopoulos S, 2005, LEARN MEMORY, V12, P44, DOI 10.1101/lm.83805; Drummond SPA, 2000, NATURE, V403, P655, DOI 10.1038/35001068; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Gardiner JM, 2002, MEMORY, V10, P83, DOI 10.1080/09658210143000281; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Henson RNA, 1999, BRAIN, V122, P1367, DOI 10.1093/brain/122.7.1367; HORNE JA, 1993, BRIT J PSYCHIAT, V162, P413, DOI 10.1192/bjp.162.3.413; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Knott LM, 2007, MEM COGNITION, V35, P1954, DOI 10.3758/BF03192928; Kubota Y, 2006, NEUROIMAGE, V31, P1783, DOI 10.1016/j.neuroimage.2006.02.003; Loftus E, 2003, NAT REV NEUROSCI, V4, P231, DOI 10.1038/nrn1054; Loftus EF, 1995, MEMORY DISTORTION, P47; Mitchell KJ, 2004, J COGNITIVE NEUROSCI, V16, P921, DOI 10.1162/0898929041502724; Payne JD, 2002, MEMORY, V10, P1, DOI 10.1080/09658210143000119; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Retey JV, 2007, CLIN PHARMACOL THER, V81, P692, DOI 10.1038/sj.clpt.6100102; Retey JV, 2006, J NEUROSCI, V26, P10472, DOI 10.1523/JNEUROSCI.1538-06.2006; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Rugg MD, 1996, BRAIN, V119, P2073, DOI 10.1093/brain/119.6.2073; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P13527, DOI 10.1073/pnas.93.24.13527; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; Schacter DL, 2004, NEURON, V44, P149, DOI 10.1016/j.neuron.2004.08.017; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Seamon JG, 2002, MEM COGNITION, V30, P1054, DOI 10.3758/BF03194323; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Smeets T, 2006, BIOL PSYCHOL, V72, P164, DOI 10.1016/j.biopsycho.2005.09.004; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stadler MA, 1999, MEM COGNITION, V27, P494, DOI 10.3758/BF03211543; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Thomas S, 2000, J Clin Pediatr Dent, V24, P335; Toglia MP, 1999, MEMORY, V7, P233, DOI 10.1080/741944069; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; WAGNER U, STRESS IN PRESS; Wagner U, 2007, NEUROBIOL LEARN MEM, V87, P679, DOI 10.1016/j.nlm.2007.01.004; Wilhelm I, 2007, PSYCHONEUROENDOCRINO, V32, P358, DOI 10.1016/j.psyneuen.2007.01.008; Yoo SS, 2007, NAT NEUROSCI, V10, P385, DOI 10.1038/nn1851	64	76	78	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3512	10.1371/journal.pone.0003512	http://dx.doi.org/10.1371/journal.pone.0003512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432IH	18946511	Green Submitted, Green Published, gold			2022-12-27	WOS:000265126200011
J	Cenciarini, C; Courtois, S; Raoult, D; La Scola, B				Cenciarini, Claire; Courtois, Sophie; Raoult, Didier; La Scola, Bernard			Influence of Long Time Storage in Mineral Water on RNA Stability of Pseudomonas aeruginosa and Escherichia coli after Heat Inactivation	PLOS ONE			English	Article								Background: Research of RNA viability markers was previously studied for many bacterial species. Few and different targets of each species have been checked and motley results can be found in literature. No research has been done about Pseudomonas aeruginosa in this way. Methodology/Principal Findings: Disappearance of 48 transcripts was analyzed by two-steps reverse transcription and real time polymerase chain reaction (RT-PCR) after heat-killing of Pseudomonas aeruginosa previously stored in mineral water or not. Differential results were obtained for each target. 16S rRNA, 23S rRNA, groEL, and rpmE were showed as the most persistent transcripts and rplP, rpV, rplE and rpsD were showed as the most labile transcripts after P. aeruginosa death. However, the labile targets appeared more persistent in bacteria previously stored in mineral water than freshly cultivated (non stored). These nine transcripts were also analyzed in Escherichia coli after heat-killing and different to opposite results were obtained, notably for groEL which was the most labile transcript of E. coli. Moreover, opposite results were obtained between mineral water stored and freshly cultivated E. coli. Conclusions and Significance: This study highlights four potential viability markers for P. aeruginosa and four highly persistent transcripts. In a near future, these targets could be associated to develop an efficient viability kit. The present study also suggests that it would be difficult to determine universal RNA viability markers for environmental bacteria, since opposite results were obtained depending on the bacterial species and the physiological conditions.	[Cenciarini, Claire; Courtois, Sophie] CIRSEE Suez Environm, Le Pecq, France; [Cenciarini, Claire; Raoult, Didier; La Scola, Bernard] Univ Aix Marseille 2, Fac Med, URMITE, CNRS IRD, UMR 6236, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Cenciarini, C (corresponding author), CIRSEE Suez Environm, Le Pecq, France.	bernard.lascola@medecine.univ-mrs.fr	LA SCOLA, Bernard/P-6477-2016; RAOULT, Didier/A-8434-2008	LA SCOLA, Bernard/0000-0001-8006-7704; RAOULT, Didier/0000-0002-0633-5974; Courtois, Sophie/0000-0002-3213-6418				Aellen S, 2006, ANTIMICROB AGENTS CH, V50, P1913, DOI 10.1128/AAC.00869-05; Armisen TG, 2004, WATER SCI TECHNOL, V50, P271; Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; Bartoloni JA, 2006, J AM DENT ASSOC, V137, P363, DOI 10.14219/jada.archive.2006.0186; Baudart J, 2002, APPL ENVIRON MICROB, V68, P5057, DOI 10.1128/AEM.68.10.5057-5063.2002; Baudart J, 2005, FEMS MICROBIOL LETT, V243, P405, DOI 10.1016/j.femsle.2005.01.001; Bentsink L, 2002, J APPL MICROBIOL, V93, P647, DOI 10.1046/j.1365-2672.2002.01725.x; BISCHOFBERGER T, 1990, INT J FOOD MICROBIOL, V11, P51, DOI 10.1016/0168-1605(90)90039-8; Branger S, 2003, J CLIN MICROBIOL, V41, P4435, DOI 10.1128/JCM.41.9.4435-4437.2003; BUTTIAUX R, 1960, ANN I PASTEUR LILLE, P43; CHURRUCA E, 2007, INT J FOOD MICROBIOL; Cools I, 2006, J MICROBIOL METH, V66, P313, DOI 10.1016/j.mimet.2005.12.004; Coutard F, 2005, J APPL MICROBIOL, V98, P951, DOI 10.1111/j.1365-2672.2005.02534.x; Deza MA, 2005, LETT APPL MICROBIOL, V40, P341, DOI 10.1111/j.1472-765X.2005.01679.x; Fykse EM, 2007, APPL ENVIRON MICROB, V73, P1457, DOI 10.1128/AEM.01635-06; Garcia-Armisen T, 2004, J MICROBIOL METH, V58, P269, DOI 10.1016/j.mimet.2004.04.014; Hallier-Soulier S, 2003, ENVIRON MICROBIOL, V5, P592, DOI 10.1046/j.1462-2920.2003.00442.x; Hellyer TJ, 1999, J CLIN MICROBIOL, V37, P290, DOI 10.1128/JCM.37.2.290-295.1999; JOSEPHSON KL, 1993, APPL ENVIRON MICROB, V59, P3513, DOI 10.1128/AEM.59.10.3513-3515.1993; Keer JT, 2003, J MICROBIOL METH, V53, P175, DOI 10.1016/S0167-7012(03)00025-3; Klancnik A, 2006, INT J FOOD MICROBIOL, V112, P200, DOI 10.1016/j.ijfoodmicro.2006.03.015; Klein PG, 1997, APPL ENVIRON MICROB, V63, P4441, DOI 10.1128/AEM.63.11.4441-4448.1997; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Kyte JA, 2005, CANCER GENE THER, V12, P579, DOI 10.1038/sj.cgt.7700837; Leclerc H, 1998, TECHNOLOGY BOTTLED W, P223; Lleo MD, 2000, APPL ENVIRON MICROB, V66, P4564; Marois C, 2002, VET MICROBIOL, V89, P17, DOI 10.1016/S0378-1135(02)00159-1; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; McKillip JL, 1999, J FOOD PROTECT, V62, P839, DOI 10.4315/0362-028X-62.8.839; McKillip JL, 1998, APPL ENVIRON MICROB, V64, P4264; Min JH, 2002, ANAL BIOCHEM, V303, P186, DOI 10.1006/abio.2002.5593; Noce L, 2000, J Can Dent Assoc, V66, P262; Oliver JD, 2005, J MICROBIOL, V43, P93; Periago PM, 2002, APPL ENVIRON MICROB, V68, P3486, DOI 10.1128/AEM.68.7.3486-3495.2002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piqueres P, 2006, RES MICROBIOL, V157, P345, DOI 10.1016/j.resmic.2005.09.003; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Regnault B, 2000, INT J FOOD MICROBIOL, V55, P281, DOI 10.1016/S0168-1605(00)00204-X; Ricicova M, 2003, FEMS YEAST RES, V4, P119, DOI 10.1016/S1567-1356(03)00145-4; Rozen S, 2000, Methods Mol Biol, V132, P365; SHARMA JK, 1992, NUCLEIC ACIDS RES, V20, P6117, DOI 10.1093/nar/20.22.6117; Sheridan GEC, 1998, APPL ENVIRON MICROB, V64, P1313; Sheridan GEC, 1999, LETT APPL MICROBIOL, V29, P375, DOI 10.1046/j.1472-765X.1999.00644.x; Simpkins SA, 2000, LETT APPL MICROBIOL, V30, P75, DOI 10.1046/j.1472-765X.2000.00670.x; Sung KD, 2004, AVIAN DIS, V48, P254, DOI 10.1637/7062; Sung K, 2005, FOODBORNE PATHOG DIS, V2, P130, DOI 10.1089/fpd.2005.2.130; Susin MF, 2006, J BACTERIOL, V188, P8044, DOI 10.1128/JB.00824-06; Szita G, 2007, LETT APPL MICROBIOL, V45, P42, DOI 10.1111/j.1472-765X.2007.02145.x; Uyttendaele M, 1997, INT J FOOD MICROBIOL, V37, P13, DOI 10.1016/S0168-1605(97)00039-1; VANDERVLIET GME, 1994, ANTIMICROB AGENTS CH, V38, P1959, DOI 10.1128/AAC.38.9.1959; Villarino A, 2000, RES MICROBIOL, V151, P755, DOI 10.1016/S0923-2508(00)01141-4; WILLIAMS HN, 1994, CAN J MICROBIOL, V40, P127, DOI 10.1139/m94-020; Yaron S, 2002, J APPL MICROBIOL, V92, P633, DOI 10.1046/j.1365-2672.2002.01563.x; Zietz BP, 2006, J APPL MICROBIOL, V100, P1239, DOI 10.1111/j.1365-2672.2006.02875.x	54	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3443	10.1371/journal.pone.0003443	http://dx.doi.org/10.1371/journal.pone.0003443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941615	gold, Green Published, Green Submitted			2022-12-27	WOS:000265125600005
J	Nanda, S; Havert, MB; Calderon, GM; Thomson, M; Jacobson, C; Kastner, D; Liang, TJ				Nanda, Santosh; Havert, Michael B.; Calderon, Gloria M.; Thomson, Michael; Jacobson, Christian; Kastner, Daniel; Liang, T. Jake			Hepatic Transcriptome Analysis of Hepatitis C Virus Infection in Chimpanzees Defines Unique Gene Expression Patterns Associated with Viral Clearance	PLOS ONE			English	Article								Hepatitis C virus infection leads to a high rate of chronicity. Mechanisms of viral clearance and persistence are still poorly understood. In this study, hepatic gene expression analysis was performed to identify any molecular signature associated with the outcome of hepatitis C virus (HCV) infection in chimpanzees. Acutely HCV-infected chimpanzees with self-limited infection or progression to chronicity were studied. Interferon stimulated genes were induced irrespective of the outcome of infection. Early induction of a set of genes associated with cell proliferation and immune activation was associated with subsequent viral clearance. Specifically, two of the genes: interleukin binding factor 3 (ILF3) and cytotoxic granule-associated RNA binding protein (TIA1), associated with robust T-cell response, were highly induced early in chimpanzees with self-limited infection. Up-regulation of genes associated with CD8+ T cell response was evident only during the clearance phase of the acute self-limited infection. The induction of these genes may represent an initial response of cellular injury and proliferation that successfully translates to a "danger signal'' leading to induction of adaptive immunity to control viral infection. This primary difference in hepatic gene expression between self-limited and chronic infections supports the concept that successful activation of HCV-specific T-cell response is critical in clearance of acute HCV infection.	[Nanda, Santosh; Havert, Michael B.; Calderon, Gloria M.; Thomson, Michael; Liang, T. Jake] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Jacobson, Christian; Kastner, Daniel] NIAMS, Genet & Genom Branch, NIH, Bethesda, MD USA; [Nanda, Santosh; Havert, Michael B.] FDA, CBER, Bethesda, MD USA; [Thomson, Michael] GlaxoSmithKline, Virol Dept, Res Triangle Pk, NC USA; [Jacobson, Christian] Univ Waterloo, Dept Biol & Mech & Mechatron Engn, Waterloo, ON N2L 3G1, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); US Food & Drug Administration (FDA); GlaxoSmithKline; University of Waterloo	Nanda, S (corresponding author), NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA.	JakeL@intra.niddk.nih.gov			Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH.	Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; Choudhury JA, 2003, MOL BIOL CELL, V14, P1334, DOI 10.1091/mbc.E02-07-0378; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Cucchiarini M, 2000, CELL IMMUNOL, V203, P111, DOI 10.1006/cimm.2000.1683; Damdinsuren B, 2005, INT J ONCOL, V26, P319; Dasu MRK, 2004, GENE, V327, P51, DOI 10.1016/j.gene.2003.11.015; Diepolder HM, 1996, J MOL MED-JMM, V74, P583, DOI 10.1007/s001090050062; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Droin NM, 2003, MOL CELL BIOL, V23, P7638, DOI 10.1128/MCB.23.21.7638-7647.2003; Fernandez J, 2004, J VIROL, V78, P9782, DOI 10.1128/JVI.78.18.9782-9789.2004; Fujimoto S, 2007, INT IMMUNOL, V19, P1175, DOI 10.1093/intimm/dxm085; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Kaplan DE, 2007, GASTROENTEROLOGY, V132, P654, DOI 10.1053/j.gastro.2006.11.044; Khan J, 1998, CANCER RES, V58, P5009; Khan J, 1999, BBA-REV CANCER, V1423, pM17, DOI 10.1016/S0304-419X(99)00004-9; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Major ME, 2004, HEPATOLOGY, V39, P1709, DOI 10.1002/hep.20239; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Neumann-Haefelin C, 2005, J CLIN VIROL, V32, P75, DOI 10.1016/j.jcv.2004.05.008; Ollila J, 1998, BIOCHEM BIOPH RES CO, V249, P475, DOI 10.1006/bbrc.1998.9176; Rahman F, 2004, HEPATOLOGY, V40, P87, DOI 10.1002/hep.20253; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Shore SM, 2003, GENE, V307, P175, DOI 10.1016/S0378-1119(03)00466-9; Smith MW, 2003, HEPATOLOGY, V38, P1458, DOI [10.1016/jhep.2003.09.024, 10.1053/jhep.2003.09024]; Smyk-Pearson S, 2008, J VIROL, V82, P1827, DOI 10.1128/JVI.01581-07; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Thomson M, 2001, GASTROENTEROLOGY, V121, P1226, DOI 10.1053/gast.2001.28669; Thomson M, 2003, J VIROL, V77, P862, DOI 10.1128/JVI.77.2.862-870.2003; Tsunedomi R, 2006, INT J ONCOL, V29, P1445	38	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3442	10.1371/journal.pone.0003442	http://dx.doi.org/10.1371/journal.pone.0003442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927617	Green Submitted, gold, Green Published			2022-12-27	WOS:000265122400012
J	Chandrasekharan, B; Bala, V; Kolachala, VL; Vijay-Kumar, M; Jones, D; Gewirtz, AT; Sitaraman, SV; Srinivasan, S				Chandrasekharan, Bindu; Bala, Vanitha; Kolachala, Vasantha L.; Vijay-Kumar, Matam; Jones, Dean; Gewirtz, Andrew T.; Sitaraman, Shanthi V.; Srinivasan, Shanthi			Targeted Deletion of Neuropeptide Y (NPY) Modulates Experimental Colitis	PLOS ONE			English	Article								Background: Neurogenic inflammation plays a major role in the pathogenesis of inflammatory bowel disease (IBD). We examined the role of neuropeptide Y (NPY) and neuronal nitric oxide synthase (nNOS) in modulating colitis. Methods: Colitis was induced by administration of dextran sodium sulphate (3% DSS) or streptomycin pre-treated Salmonella typhimurium (S.T.) in wild type (WT) and NPY (NPY-/-) knockout mice. Colitis was assessed by clinical score, histological score and myeloperoxidase activity. NPY and nNOS expression was assessed by immunostaining. Oxidative stress was assessed by measuring catalase activity, glutathione and nitrite levels. Colonic motility was assessed by isometric muscle recording in WT and DSS-treated mice. Results: DSS/S. T. induced an increase in enteric neuronal NPY and nNOS expression in WT mice. WT mice were more susceptible to inflammation compared to NPY-/- as indicated by higher clinical & histological scores, and myeloperoxidase (MPO) activity (p<0.01). DSS-WT mice had increased nitrite, decreased glutathione (GSH) levels and increased catalase activity indicating more oxidative stress. The lower histological scores, MPO and chemokine KC in S.T.-treated nNOS(-/-) and NPY-/-/nNOS(-/-) mice supported the finding that loss of NPY-induced nNOS attenuated inflammation. The inflammation resulted in chronic impairment of colonic motility in DSS-WT mice. NPY -treated rat enteric neurons in vitro exhibited increased nitrite and TNF-alpha production. Conclusions: NPY mediated increase in nNOS is a determinant of oxidative stress and subsequent inflammation. Our study highlights the role of neuronal NPY and nNOS as mediators of inflammatory processes in IBD.	[Chandrasekharan, Bindu; Bala, Vanitha; Kolachala, Vasantha L.; Sitaraman, Shanthi V.; Srinivasan, Shanthi] Emory Univ, Div Digest Dis, Atlanta, GA 30322 USA; [Vijay-Kumar, Matam; Gewirtz, Andrew T.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Jones, Dean] Emory Univ, Div Pulmonary Med, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Chandrasekharan, B (corresponding author), Emory Univ, Div Digest Dis, Atlanta, GA 30322 USA.	ssrini2@emory.edu	Srinivasan, Shanthi/A-6133-2013; chandrasekharan, bindu/AAU-5479-2021; Chandrasekharan, Bindu/CAA-0476-2022	Chandrasekharan, Bindu/0000-0003-2943-3902	CCFA; NIH [KO8 DK067045, RO3 DK078552, DK06411]; Digestive Diseases Research Center [DK064399]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK078552, R24DK064399, K08DK067045] Funding Source: NIH RePORTER	CCFA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by CCFA Research Fellowship Awards (B. Chandrasekharan & M. Vijay Kumar), NIH grants KO8 DK067045 and RO3 DK078552 (S.Srinivasan) and DK06411 (S.V. Sitaraman), Digestive Diseases Research Center grant (DK064399).	Anitha M, 2006, J CLIN INVEST, V116, P344, DOI 10.1172/JCI26295; Anitha M, 2006, GASTROENTEROLOGY, V131, P1164, DOI 10.1053/j.gastro.2006.07.019; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bedoui S, 2002, J NEUROIMMUNOL, V132, P25, DOI 10.1016/S0165-5728(02)00278-3; BERGMEYER HU, 1955, BIOCHEM Z, V327, P255; Collins SM, 1996, GASTROENTEROLOGY, V111, P1683, DOI 10.1016/S0016-5085(96)70034-3; COOPER HS, 1993, LAB INVEST, V69, P238; di Mola FF, 2000, GUT, V46, P670, DOI 10.1136/gut.46.5.670; Dimitrijevic M, 2005, REGUL PEPTIDES, V124, P163, DOI 10.1016/j.regpep.2004.07.012; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; HAFSTROM I, 1993, ACTA PHYSIOL SCAND, V148, P341, DOI 10.1111/j.1748-1716.1993.tb09565.x; HOGABOAM CM, 1995, AM J PHYSIOL-GASTR L, V268, pG673, DOI 10.1152/ajpgi.1995.268.4.G673; Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7; Levite M, 2001, ANN ONCOL, V12, pS19, DOI 10.1093/annonc/12.suppl_2.S19; Li Q, 2003, MOL BRAIN RES, V114, P46, DOI 10.1016/S0169-328X(03)00131-1; Lomax AE, 2005, NEUROGASTROENT MOTIL, V17, P4, DOI 10.1111/j.1365-2982.2004.00607.x; LUNDBERG JM, 1990, ANN NY ACAD SCI, V611, P166; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; MANTYH CR, 1988, P NATL ACAD SCI USA, V85, P3235, DOI 10.1073/pnas.85.9.3235; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Okajima K, 2006, CURR MED CHEM, V13, P2241, DOI 10.2174/092986706777935131; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Rachmilewitz D, 1998, AM J GASTROENTEROL, V93, P409, DOI 10.1016/S0002-9270(98)00009-4; RACHMILEWITZ D, 1995, GUT, V37, P247, DOI 10.1136/gut.37.2.247; Sang Q, 1998, ANAT REC, V251, P185; Song F, 1999, J IMMUNOL, V162, P2275; Takahashi T, 1997, GASTROENTEROLOGY, V113, P1535, DOI 10.1053/gast.1997.v113.pm9352855; Tomobuchi M, 2001, CLIN EXP PHARMACOL P, V28, P13, DOI 10.1046/j.1440-1681.2001.03396.x; Vasina V, 2006, AUTON NEUROSCI-BASIC, V126, P264, DOI 10.1016/j.autneu.2006.02.025; Vijay-Kumar M, 2007, INFLAMM BOWEL DIS, V13, P856, DOI 10.1002/ibd.20142; Villarroya H, 1997, J NEUROSCI RES, V49, P592, DOI 10.1002/(SICI)1097-4547(19970901)49:5<592::AID-JNR9>3.0.CO;2-6; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Woolf CJ, 1996, J NEUROSCI, V16, P2716; Yamaguchi T, 2001, HEPATO-GASTROENTEROL, V48, P118	36	54	56	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3304	10.1371/journal.pone.0003304	http://dx.doi.org/10.1371/journal.pone.0003304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18836554	gold, Green Published, Green Submitted			2022-12-27	WOS:000264797200009
J	Jarvinen, AP; Hiissa, J; Elo, LL; Aittokallio, T				Jarvinen, Aki P.; Hiissa, Jukka; Elo, Laura L.; Aittokallio, Tero			Predicting Quantitative Genetic Interactions by Means of Sequential Matrix Approximation	PLOS ONE			English	Article								Despite the emerging experimental techniques for perturbing multiple genes and measuring their quantitative phenotypic effects, genetic interactions have remained extremely difficult to predict on a large scale. Using a recent high-resolution screen of genetic interactions in yeast as a case study, we investigated whether the extraction of pertinent information encoded in the quantitative phenotypic measurements could be improved by computational means. By taking advantage of the observation that most gene pairs in the genetic interaction screens have no significant interactions with each other, we developed a sequential approximation procedure which ranks the mutation pairs in order of evidence for a genetic interaction. The sequential approximations can efficiently remove background variation in the double-mutation screens and give increasingly accurate estimates of the single-mutant fitness measurements. Interestingly, these estimates not only provide predictions for genetic interactions which are consistent with those obtained using the measured fitness, but they can even significantly improve the accuracy with which one can distinguish functionally-related gene pairs from the non-interacting pairs. The computational approach, in general, enables an efficient exploration and classification of genetic interactions in other studies and systems as well.	[Jarvinen, Aki P.; Hiissa, Jukka; Elo, Laura L.; Aittokallio, Tero] Univ Turku, Dept Math, Biomat Res Grp, SF-20500 Turku, Finland; [Elo, Laura L.; Aittokallio, Tero] Turku Ctr Biotechnol, Data Mining Res Grp, Turku, Finland	University of Turku; University of Turku	Jarvinen, AP (corresponding author), Univ Turku, Dept Math, Biomat Res Grp, SF-20500 Turku, Finland.	tero.aittokallio@utu.fi	Elo, Laura/A-9449-2015; Aittokallio, Tero/B-6583-2009	Elo, Laura/0000-0001-5648-4532; Aittokallio, Tero/0000-0002-0886-9769	Academy of Finland [120569]; Graduate School in Computational Biology, Bioinformatics and Biometry (ComBi)	Academy of Finland(Academy of Finland); Graduate School in Computational Biology, Bioinformatics and Biometry (ComBi)	The Academy of Finland (grant 120569) and the Graduate School in Computational Biology, Bioinformatics and Biometry (ComBi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axler S., 1997, LINEAR ALGEBRA DONE; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; DELEEUW J, 2006, DEP STAT PAPERS; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Dror O, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-69; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hintze A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040023; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Lehner B, 2007, J EXP BIOL, V210, P1559, DOI 10.1242/jeb.002311; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Taylor RJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r160; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Ulitsky I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100144; Ulitsky I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.42; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Ye P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100034	30	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3284	10.1371/journal.pone.0003284	http://dx.doi.org/10.1371/journal.pone.0003284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818762	Green Submitted, Green Published, gold			2022-12-27	WOS:000264432300006
J	Richards, ZT; van Oppen, MJH; Wallace, CC; Willis, BL; Miller, DJ				Richards, Zoe T.; van Oppen, Madeleine J. H.; Wallace, Carden C.; Willis, Bette L.; Miller, David J.			Some Rare Indo-Pacific Coral Species Are Probable Hybrids	PLOS ONE			English	Article								Background: Coral reefs worldwide face a variety of threats and many coral species are increasingly endangered. It is often assumed that rare coral species face higher risks of extinction because they have very small effective population sizes, a predicted consequence of which is decreased genetic diversity and adaptive potential. Methodology/Principal Findings: Here we show that some Indo-Pacific members of the coral genus Acropora have very small global population sizes and are likely to be unidirectional hybrids. Whether this reflects hybrid origins or secondary hybridization following speciation is unclear. Conclusions/Significance: The interspecific gene flow demonstrated here implies increased genetic diversity and adaptive potential in these coral species. Rare Acropora species may therefore be less vulnerable to extinction than has often been assumed because of their propensity for hybridization and introgression, which may increase their adaptive potential.	[Richards, Zoe T.; van Oppen, Madeleine J. H.; Willis, Bette L.; Miller, David J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Richards, Zoe T.; Wallace, Carden C.] Museum Trop Queensland, Townsville, Qld, Australia; [van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld, Australia; [Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Miller, David J.] James Cook Univ, Comparative Genom Ctr, Townsville, Qld, Australia	James Cook University; Australian Institute of Marine Science; James Cook University; James Cook University	Richards, ZT (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	David.Miller@jcu.edu.au	van Oppen, Madeleine JH/C-3261-2008	van Oppen, Madeleine/0000-0003-4607-0744	Australian Research Council; Queensland State Government (Smart State PhD funding); Winifred Violet Scott Estate; International Society for Reef Studies	Australian Research Council(Australian Research Council); Queensland State Government (Smart State PhD funding); Winifred Violet Scott Estate; International Society for Reef Studies	Principal funding source: Australian Research Council. Other funding: Queensland State Government (Smart State PhD funding), Winifred Violet Scott Estate, International Society for Reef Studies (fellowship to ZR)	Ayre DJ, 2000, EVOLUTION, V54, P1590; CABALLERO A, 1994, HEREDITY, V73, P6657; Frankham R., 1995, GENETIC RESOURCES, V66, P995; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES TP, 1992, TRENDS ECOL EVOL, V7, P292, DOI 10.1016/0169-5347(92)90225-Z; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Marquez LM, 2002, MOL ECOL, V11, P1339, DOI 10.1046/j.1365-294X.2002.01526.x; NYLANDER JAA, 2004, MRMODELTEST2 2; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; TAVARE S, 1984, THEOR POPUL BIOL, V26, P119, DOI 10.1016/0040-5809(84)90027-3; Van Oppen MJH, 2000, MOL ECOL, V9, P1363, DOI 10.1046/j.1365-294x.2000.01010.x; Van Oppen MJH, 2002, MOL ECOL, V11, P1363, DOI 10.1046/j.1365-294X.2002.01527.x; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Wallace CC, 2006, P ROY SOC B-BIOL SCI, V273, P975, DOI 10.1098/rspb.2005.3307; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136; Wolstenholme JK, 2003, CORAL REEFS, V22, P155, DOI 10.1007/s00338-003-0299-0	20	52	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2008	3	9							e3240	10.1371/journal.pone.0003240	http://dx.doi.org/10.1371/journal.pone.0003240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MG	18813338	gold, Green Published, Green Accepted			2022-12-27	WOS:000264431800001
J	Parone, PA; Da Cruz, S; Tondera, D; Mattenberger, Y; James, DI; Maechler, P; Barja, F; Martinou, JC				Parone, Philippe A.; Da Cruz, Sandrine; Tondera, Daniel; Mattenberger, Yves; James, Dominic I.; Maechler, Pierre; Barja, Francois; Martinou, Jean-Claude			Preventing Mitochondrial Fission Impairs Mitochondrial Function and Leads to Loss of Mitochondrial DNA	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; MAMMALIAN-CELLS; FUSION; DYNAMICS; APOPTOSIS; DYSFUNCTION; MORPHOLOGY; GTPASE; YEAST; FIS1	Mitochondria form a highly dynamic tubular network, the morphology of which is regulated by frequent fission and fusion events. However, the role of mitochondrial fission in homeostasis of the organelle is still unknown. Here we report that preventing mitochondrial fission, by down-regulating expression of Drp1 in mammalian cells leads to a loss of mitochondrial DNA and a decrease of mitochondrial respiration coupled to an increase in the levels of cellular reactive oxygen species (ROS). At the cellular level, mitochondrial dysfunction resulting from the lack of fission leads to a drop in the levels of cellular ATP, an inhibition of cell proliferation and an increase in autophagy. In conclusion, we propose that mitochondrial fission is required for preservation of mitochondrial function and thereby for maintenance of cellular homeostasis.	[Parone, Philippe A.; Da Cruz, Sandrine; Tondera, Daniel; Mattenberger, Yves; James, Dominic I.; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva, Switzerland; [Maechler, Pierre] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Barja, Francois] Univ Geneva, Lab Bioenerget Microbiol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Parone, PA (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	Jean-Claude.Martinou@cellbio.unige.ch	James, Dominic/G-6435-2016	James, Dominic/0000-0002-0452-2178; Maechler, Pierre/0000-0002-2005-1433; martinou, Jean-claude/0000-0002-9847-2051; Mattenberger, Yves/0000-0002-1651-7691	Swiss National Science Foundation [3100A0-109419/1]; OncoSuisse Trust; Geneva Department of Education	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); OncoSuisse Trust; Geneva Department of Education	This work was funded by the Swiss National Science Foundation (subside: 3100A0-109419/1), OncoSuisse Trust and the Geneva Department of Education.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Arnoult D, 2005, CURR BIOL, V15, P2112, DOI 10.1016/j.cub.2005.10.041; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Delivani P, 2006, MOL CELL, V21, P761, DOI 10.1016/j.molcel.2006.01.034; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ESTAQUIER J, 2007, CELL DEATH DIFFER; FRANCIS B, 2001, SEX ED, V1, P1; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Gemin A, 2005, BIOCHEM BIOPH RES CO, V332, P1122, DOI 10.1016/j.bbrc.2005.05.061; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Rube DA, 2004, MOL CELL BIOCHEM, V256, P331, DOI 10.1023/B:MCBI.0000009879.01256.f6; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Skulachev VP, 2004, MOL CELL BIOCHEM, V256, P341, DOI 10.1023/B:MCBI.0000009880.94044.49; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Tolkovsky AM, 2002, BIOCHIMIE, V84, P233, DOI 10.1016/S0300-9084(02)01371-8; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; VANDENBOGERT C, 1988, EXP CELL RES, V178, P143, DOI 10.1016/0014-4827(88)90385-0; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; Xu JX, 2004, ANN NY ACAD SCI, V1011, P57, DOI 10.1196/annals.1293.006; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Yoon YS, 2004, ANN NY ACAD SCI, V1011, P123, DOI 10.1196/annals.1293.013; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	44	304	325	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3257	10.1371/journal.pone.0003257	http://dx.doi.org/10.1371/journal.pone.0003257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LY	18806874	Green Published, gold, Green Submitted			2022-12-27	WOS:000264430800007
J	Tully, T; Ferriere, R				Tully, Thomas; Ferriere, Regis			Reproductive Flexibility: Genetic Variation, Genetic Costs and Long-Term Evolution in a Collembola	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; ADAPTIVE PHENOTYPIC PLASTICITY; FOLSOMIA-CANDIDA COLLEMBOLA; EGG SIZE PLASTICITY; OFFSPRING SIZE; TRADE-OFFS; ENVIRONMENT INTERACTIONS; SEED BEETLE; FOOD; ALLOCATION	In a variable yet predictable world, organisms may use environmental cues to make adaptive adjustments to their phenotype. Such phenotypic flexibility is expected commonly to evolve in life history traits, which are closely tied to Darwinian fitness. Yet adaptive life history flexibility remains poorly documented. Here we introduce the collembolan Folsomia candida, a soil-dweller, parthenogenetic (all-female) microarthropod, as a model organism to study the phenotypic expression, genetic variation, fitness consequences and long-term evolution of life history flexibility. We demonstrate that collembola have a remarkable adaptive ability for adjusting their reproductive phenotype: when transferred from harsh to good conditions (in terms of food ration and crowding), a mother can fine-tune the number and the size of her eggs from one clutch to the next. The comparative analysis of eleven clonal populations of worldwide origins reveals (i) genetic variation in mean egg size under both good and bad conditions; (ii) no genetic variation in egg size flexibility, consistent with convergent evolution to a common physiological limit; (iii) genetic variation of both mean reproductive investment and reproductive investment flexibility, associated with a reversal of the genetic correlation between egg size and clutch size between environmental conditions; (iv) a negative genetic correlation between reproductive investment flexibility and adult lifespan. Phylogenetic reconstruction shows that two life history strategies, called HIFLEX and LOFLEX, evolved early in evolutionary history. HIFLEX includes six of our 11 clones, and is characterized by large mean egg size and reproductive investment, high reproductive investment flexibility, and low adult survival. LOFLEX (the other five clones) has small mean egg size and low reproductive investment, low reproductive investment flexibility, and high adult survival. The divergence of HIFLEX and LOFLEX could represent different adaptations to environments differing in mean quality and variability, or indicate that a genetic polymorphism of reproductive investment reaction norms has evolved under a physiological tradeoff between reproductive investment flexibility and adult lifespan.	[Tully, Thomas; Ferriere, Regis] Ecole Normale Super, CNRS, UMR 7625, Lab Fonctionnement & Evolut Syst Ecol, Paris, France; [Tully, Thomas] Univ Paris 04, Inst Univ Format Maitres, F-75230 Paris, France; [Ferriere, Regis] Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Arizona	Tully, T (corresponding author), Ecole Normale Super, CNRS, UMR 7625, Lab Fonctionnement & Evolut Syst Ecol, Paris, France.	tully@biologie.ens.fr	Ferriere, Regis/S-8050-2017	Ferriere, Regis/0000-0002-5806-5566; Tully, Thomas/0000-0003-1847-7504	French Ministry of Education and Research; French Ministry of Environment; The European Research Training Network ModLife [HPRN-CT-2000-00051]; NSF [0623632]	French Ministry of Education and Research; French Ministry of Environment; The European Research Training Network ModLife; NSF(National Science Foundation (NSF))	Our research was funded by: 1) The French Ministry of Education and Research (ACI "Jeunes Chercheurs 2001"), the French Ministry of Environment (ACI "Invasions biologiques"); 2) The European Research Training Network ModLife (HPRN-CT-2000-00051); 3) The NSF REU Biomath program; 4) The NSF FIBR grant #0623632.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; Badyaev AV, 2003, J EVOLUTION BIOL, V16, P1065, DOI 10.1046/j.1420-9101.2003.00628.x; Badyaev AV, 2002, BEHAV ECOL, V13, P591, DOI 10.1093/beheco/13.5.591; Bashey F, 2006, EVOLUTION, V60, P348, DOI 10.1554/05-087.1; Bernardo J, 1996, AM ZOOL, V36, P216; Brauer VS, 2007, EVOLUTION, V61, P216, DOI 10.1111/j.1558-5646.2007.00018.x; Caley MJ, 2001, EVOLUTION, V55, P1245; Czesak ME, 2006, AM NAT, V168, P323, DOI 10.1086/506919; Czesak ME, 2003, EVOLUTION, V57, P1121; DEJONG G, 1992, AM NAT, V139, P749, DOI 10.1086/285356; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; DRAHEIM R, 1995, ACTA ZOOL FENN, P168; Ernande B, 2004, J EVOLUTION BIOL, V17, P342, DOI 10.1046/j.1420-9101.2003.00674.x; Evans MEK, 2007, AM NAT, V169, P184, DOI 10.1086/510599; Evans MEK, 2005, Q REV BIOL, V80, P431, DOI 10.1086/498282; Fischer K, 2006, J EVOLUTION BIOL, V19, P380, DOI 10.1111/j.1420-9101.2005.01046.x; Fountain MT, 2005, ANNU REV ENTOMOL, V50, P201, DOI 10.1146/annurev.ento.50.071803.130331; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; Fox CW, 1999, EVOLUTION, V53, P552, DOI [10.2307/2640791, 10.1111/j.1558-5646.1999.tb03790.x]; Fox CW, 1997, AM NAT, V149, P149, DOI 10.1086/285983; Gabriel W, 2005, J EVOLUTION BIOL, V18, P873, DOI 10.1111/j.1420-9101.2005.00959.x; GEBHARDTHENRICH SG, 1991, J EVOLUTION BIOL, V4, P341, DOI 10.1046/j.1420-9101.1991.4030341.x; GLIWICZ ZM, 1992, OECOLOGIA, V91, P463, DOI 10.1007/BF00650317; GOMULKIEWICZ R, 1992, EVOLUTION, V46, P390, DOI [10.2307/2409860, 10.1111/j.1558-5646.1992.tb02047.x]; Gutteling EW, 2007, HEREDITY, V98, P28, DOI 10.1038/sj.hdy.6800894; Gutteling EW, 2007, HEREDITY, V98, P206, DOI 10.1038/sj.hdy.6800929; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Hopkin S. P., 1997, BIOL SPRINGTAILS; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jordan MA, 2002, OECOLOGIA, V130, P44, DOI 10.1007/s004420100776; Kingsolver JG, 2006, EVOL ECOL RES, V8, P703; Kontiainen P, 2008, J EVOLUTION BIOL, V21, P88, DOI 10.1111/j.1420-9101.2007.01468.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LEVINS RICHARD, 1968; Lorenzon P, 2001, EVOLUTION, V55, P392; LYNCH M, 1997, GENETIC ANAL QUANTIT; Manly BFJ, 1997, RANDOMIZATION BOOTST; MARSHALL V. G., 1962, CANADIAN ENTOMOL, V94, P575; MASSOT M, 1995, BEHAV ECOL SOCIOBIOL, V37, P413, DOI 10.1007/s002650050209; Merila J, 2004, J EVOLUTION BIOL, V17, P1132, DOI 10.1111/j.1420-9101.2004.00744.x; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; Meylan S, 2007, OIKOS, V116, P650, DOI 10.1111/j.2007.0030-1299.15432.x; Milne S., 1960, Proceedings of the Royal Entomological Society of London (A), V35, P133; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Oda GA, 2000, J THEOR BIOL, V206, P515, DOI 10.1006/jtbi.2000.2151; PALEVODY C, 1974, PEDOBIOLOGIA, V14, P196; Phelan JP, 2003, EVOLUTION, V57, P527, DOI 10.1111/j.0014-3820.2003.tb01544.x; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pike N, 2004, P ROY SOC B-BIOL SCI, V271, P2143, DOI 10.1098/rspb.2004.2834; Pinheiro J, 2001, MIXED EFFECTS MODELS; POTAPOW M, 2001, ISOTOMIDAE; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Rasband W., 2003, IMAGEJ; Relyea RA, 2002, AM NAT, V159, P272, DOI 10.1086/338540; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; REZNICK D, 1993, ECOLOGY, V74, P2011, DOI 10.2307/1940844; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Ris N, 2004, OIKOS, V106, P451, DOI 10.1111/j.0030-1299.2004.13274.x; ROFF DA, 2001, LIFE HIST EVOLUTION; Rueffler C, 2004, THEOR POPUL BIOL, V65, P165, DOI 10.1016/j.tpb.2003.10.001; SCHAFFER WM, 1974, AM NAT, V108, P783, DOI 10.1086/282954; Sgro CM, 2004, HEREDITY, V93, P241, DOI 10.1038/sj.hdy.6800532; SINERVO B, 1991, SCIENCE, V252, P1300, DOI 10.1126/science.252.5010.1300; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stam EM, 1996, OECOLOGIA, V107, P283, DOI 10.1007/BF00328444; STEARNS S, 1991, TRENDS ECOL EVOL, V6, P122, DOI 10.1016/0169-5347(91)90090-K; Stearns S.C., 2000, EVOLUTION INTRO; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; Stillwell RC, 2007, OECOLOGIA, V153, P309, DOI 10.1007/s00442-007-0748-5; Svensson E, 1998, OIKOS, V83, P466, DOI 10.2307/3546674; Therneau T.M., 2000, MODELING SURVIVAL DA; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.1093/biomet/77.1.147; Tully T, 2005, OIKOS, V111, P479, DOI 10.1111/j.1600-0706.2005.14062.x; TULLY T, 2004, FOLSOMIA CANDIDA; Tully T, 2006, PEDOBIOLOGIA, V50, P95, DOI 10.1016/j.pedobi.2005.11.003; VANAMELSVOORT PAM, 1989, PEDOBIOLOGIA, V33, P61; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; West SA, 2002, SCIENCE, V295, P1685, DOI 10.1126/science.1069043; WESTEBERHARD MJ, 2003, DEV PLASTICITY EVOLU, P1; Wilson AJ, 2006, PLOS BIOL, V4, P1270, DOI 10.1371/journal.pbio.0040216; WINKLER DW, 1987, AM NAT, V129, P708, DOI 10.1086/284667; Yamahira K, 2002, ECOLOGY, V83, P1252, DOI 10.1890/0012-9658(2002)083[1252:IVILVI]2.0.CO;2; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	88	38	40	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3207	10.1371/journal.pone.0003207	http://dx.doi.org/10.1371/journal.pone.0003207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791644	Green Published, Green Submitted, gold			2022-12-27	WOS:000264427700002
J	Atik, B; Skwor, TA; Kandel, RP; Sharma, B; Adhikari, HK; Steiner, L; Erlich, H; Dean, D				Atik, Berna; Skwor, Troy A.; Kandel, Ram Prasad; Sharma, Bassant; Adhikari, Him Kant; Steiner, Lori; Erlich, Henry; Dean, Deborah			Identification of Novel Single Nucleotide Polymorphisms in Inflammatory Genes as Risk Factors Associated with Trachomatous Trichiasis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; OCULAR CHLAMYDIA-TRACHOMATIS; CD8(+) T-CELLS; FACTOR-ALPHA; SCARRING TRACHOMA; GAMBIAN COMMUNITY; IMMUNE-RESPONSE; PROMOTER REGION; MASS TREATMENT; IFN-GAMMA	Background: Trachoma is the leading preventable cause of global blindness. A balanced Th1/Th2/Th3 immune response is critical for resolving Chlamydia trachomatis infection, the primary cause of trachoma. Despite control programs that include mass antibiotic treatment, reinfection and recurrence of trachoma are common after treatment cessation. Furthermore, a subset of infected individuals develop inflammation and are at greater risk for developing the severe sequela of trachoma known as trachomatous trichiasis (TT). While there are a number of environmental and behavioral risk factors for trachoma, genetic factors that influence inflammation and TT risk remain ill defined. Methodology/Findings: We identified single nucleotide polymorphisms (SNP) in 36 candidate inflammatory genes and interactions among these SNPs that likely play a role in the overall risk for TT. We conducted a case control study of 538 individuals of Tharu ethnicity residing in an endemic region of Nepal. Trachoma was graded according to World Health Organization guidelines. A linear array was used to genotype 51 biallelic SNPs in the 36 genes. Analyses were performed using logic regression modeling, which controls for multiple comparisons. We present, to our knowledge, the first significant association of TNFA (-308GA), LTA (252A), VCAM1 (-1594TC), and IL9 (T113M) polymorphisms, synergistic SNPs and risk of TT. TT risk decreased 5 times [odds ratio=0.2 (95% confidence interval 0.11.-0.33), p=0.001] with the combination of TNFA (-308A), LTA (252A), VCAM1 (-1594C), SCYA 11 (23T) minor allele, and the combination of TNFA (-308A), IL9 (113M), IL1B (5'UTR-T), and VCAM1 (-1594C). However, TT risk increased 13.5 times [odds ratio=13.5 (95% confidence interval 3.3-22), p=0.001] with the combination of TNFA (-308G), VDR (intron G), IL4R (50V), and ICAM1 (56M) minor allele. Conclusions: Evaluating genetic risk factors for trachoma will advance our understanding of disease pathogenesis, and should be considered in the context of designing global control programs.	[Atik, Berna; Skwor, Troy A.; Dean, Deborah] Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; [Kandel, Ram Prasad; Sharma, Bassant; Adhikari, Him Kant] Lumbini Rana Ambika Eye Hosp, Bhairahawa, Nepal; [Steiner, Lori; Erlich, Henry] Roche Mol Syst, Pleasanton, CA USA; [Erlich, Henry] Childrens Hosp, Oakland Res Inst, HLA Lab, Oakland, CA USA; [Dean, Deborah] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA; [Dean, Deborah] Univ Calif San Francisco, Joint Grad Grp Bioengn, San Francisco, CA 94143 USA; [Dean, Deborah] Univ Calif Berkeley, Berkeley, CA 94720 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Roche Holding; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Atik, B (corresponding author), Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA.	ddean@chori.org	Skwor, Troy/W-9224-2019	Skwor, Troy/0000-0002-1920-0788	Public Health Service from the National Institutes of Health [R01 AI059647, R01 EY/AI012219, R01 AI059647-1S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059647] Funding Source: NIH RePORTER	Public Health Service from the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by Public Health Service from the National Institutes of Health, R01 AI059647 (to DD), R01 EY/AI012219 (to DD) and R01 AI059647-1S1 (to DD). The funding agencies/sponsors listed above had no involvement in the design and conduct of study; in the collection, management, analysis or interpretation of the data; or in the preparation, review or approval of the manuscript.	Abu El-Asrar AM, 1998, EYE, V12, P453, DOI 10.1038/eye.1998.104; AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; Atik B, 2006, JAMA-J AM MED ASSOC, V296, P1488, DOI 10.1001/jama.296.12.1488; Bacon AS, 1998, INVEST OPHTH VIS SCI, V39, P322; Barcellos LF, 2004, ANN NEUROL, V55, P793, DOI 10.1002/ana.20092; Bellamy R, 2003, AM J RESP CRIT CARE, V167, P946, DOI 10.1164/rccm.2301005; Bobo L, 1996, INFECT IMMUN, V64, P3273, DOI 10.1128/IAI.64.8.3273-3279.1996; Bowman RJC, 2002, BRIT J OPHTHALMOL, V86, P339, DOI 10.1136/bjo.86.3.339; Broman AT, 2006, INVEST OPHTH VIS SCI, V47, P99, DOI 10.1167/iovs.05-0326; Burton MJ, 2007, INVEST OPHTH VIS SCI, V48, P4440, DOI 10.1167/iovs.07-0315; Burton MJ, 2005, LANCET, V365, P1321, DOI 10.1016/S0140-6736(05)61029-X; Burton MJ, 2004, INFECT IMMUN, V72, P7352, DOI 10.1128/IAI.72.12.7352-7356.2004; Conway DJ, 1997, INFECT IMMUN, V65, P1003, DOI 10.1128/IAI.65.3.1003-1006.1997; DEAN D, 2002, DUANES FDN CLIN OPHT, P1; Dean D, 2008, PLOS MED, V5, P57, DOI 10.1371/journal.pmed.0050014; Faal N, 2005, CLIN EXP IMMUNOL, V142, P347, DOI 10.1111/j.1365-2249.2005.02917.x; Grohmann U, 2000, J IMMUNOL, V164, P4197, DOI 10.4049/jimmunol.164.8.4197; HOLBROOK ST, 1991, BLOOD, V77, P2129; Holland MJ, 1996, CLIN EXP IMMUNOL, V105, P429, DOI 10.1046/j.1365-2249.1996.d01-792.x; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; IGIETSEME JU, 1994, INFECT IMMUN, V62, P5195, DOI 10.1128/IAI.62.11.5195-5197.1994; Igietseme JU, 2001, INFECT IMMUN, V69, P1832, DOI 10.1128/IAI.69.3.1832-1840.2001; *INT MULT SCLER GE, 2007, NEW ENGL J MED, V257, P851; Kaifi JT, 2001, J IMMUNOL, V166, P6795, DOI 10.4049/jimmunol.166.11.6795; Kelly KA, 1997, INFECT IMMUN, V65, P5198, DOI 10.1128/IAI.65.12.5198-5208.1997; Khandekar R, 2007, OPHTHAL EPIDEMIOL, V14, P267, DOI 10.1080/09286580601160622; King JD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000299; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; Lard LR, 2003, ARTHRITIS RHEUM-US, V48, P1841, DOI 10.1002/art.11160; Li WD, 2008, J IMMUNOL, V180, P3375, DOI 10.4049/jimmunol.180.5.3375; McCusker SM, 2001, LANCET, V357, P436, DOI 10.1016/S0140-6736(00)04008-3; Melese M, 2005, BRIT J OPHTHALMOL, V89, P1084, DOI 10.1136/bjo.2005.066076; Miller K, 2004, OPHTHAL EPIDEMIOL, V11, P255, DOI 10.1080/09286580490514577; MODI WS, 1991, CYTOGENET CELL GENET, V57, P114, DOI 10.1159/000133126; Mozzato-Chamay N, 2001, GENES IMMUN, V2, P153, DOI 10.1038/sj.gene.6363753; Mozzato-Chamay N, 2000, J INFECT DIS, V182, P1545, DOI 10.1086/315891; Munoz B, 1999, INT J EPIDEMIOL, V28, P1167, DOI 10.1093/ije/28.6.1167; Natividad A, 2007, GENES IMMUN, V8, P288, DOI 10.1038/sj.gene.6364384; Natividad A, 2005, GENES IMMUN, V6, P332, DOI 10.1038/sj.gene.6364182; Natividad A, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-40; Ngondi J, 2008, T ROY SOC TROP MED H, V102, P432, DOI 10.1016/j.trstmh.2008.02.014; Ngondi Jeremiah, 2007, BMC Ophthalmol, V7, P12, DOI 10.1186/1471-2415-7-12; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; Perfettini JL, 2000, INFECT IMMUN, V68, P2237, DOI 10.1128/IAI.68.4.2237-2244.2000; Perry LL, 1998, J IMMUNOL, V160, P2905; REACHER MH, 1991, OPHTHALMOLOGY, V98, P334; RENAULD J, 1998, CYTOKINE HDB; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Roan NR, 2006, J IMMUNOL, V177, P7974, DOI 10.4049/jimmunol.177.11.7974; Roan NR, 2006, P NATL ACAD SCI USA, V103, P12069, DOI 10.1073/pnas.0603866103; Ruczinski I, 2003, J COMPUT GRAPH STAT, V12, P475, DOI 10.1198/1061860032238; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; Shaw J, 2002, INFECT IMMUN, V70, P1097, DOI 10.1128/IAI.70.3.1097-1105.2002; SHEMERAVNI Y, 1988, INFECT IMMUN, V56, P2503, DOI 10.1128/IAI.56.9.2503-2506.1988; Skwor TA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000264; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; TANAKA H, 1994, PATHOL INT, V44, P268; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; UYTTENHOVE C, 1988, P NATL ACAD SCI USA, V85, P6934, DOI 10.1073/pnas.85.18.6934; West ES, 2005, INVEST OPHTH VIS SCI, V46, P83, DOI 10.1167/iovs.04-0327; West SK, 2007, INVEST OPHTH VIS SCI, V48, P1492, DOI 10.1167/iovs.06-0625; WEST SK, 1991, INT J EPIDEMIOL, V20, P1088, DOI 10.1093/ije/20.4.1088; WILLIAMS DM, 1989, INFECT IMMUN, V57, P1351, DOI 10.1128/IAI.57.5.1351-1355.1989; World Health Organization, 1997, 1 M WHO ALL GLOB EL; Wu B, 2008, CLIN IMMUNOL, V126, P202, DOI 10.1016/j.clim.2007.09.009; Zhang H, 2004, ARCH OPHTHALMOL-CHIC, V122, P511, DOI 10.1001/archopht.122.4.511	67	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3600	10.1371/journal.pone.0003600	http://dx.doi.org/10.1371/journal.pone.0003600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974840	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131700021
J	Saha, SK; Darmstadt, GL; Baqui, AH; Hossain, B; Islam, M; Foster, D; Al-Emran, H; Naheed, A; El Arifeen, S; Luby, SP; Santosham, M; Crook, D				Saha, Samir K.; Darmstadt, Gary L.; Baqui, Abdullah H.; Hossain, Belal; Islam, Maksuda; Foster, Dona; Al-Emran, Hassan; Naheed, Aliya; El Arifeen, Shams; Luby, Stephen P.; Santosham, Mathuram; Crook, Derrick			Identification of Serotype in Culture Negative Pneumococcal Meningitis Using Sequential Multiplex PCR: Implication for Surveillance and Vaccine Design	PLOS ONE			English	Article								Background: PCR-based serotyping of Streptococcus pneumoniae has been proposed as a simpler approach than conventional methods, but has not been applied to strains in Asia where serotypes are diverse and different from other part of the world. Furthermore, PCR has not been used to determine serotype distribution in culture-negative meningitis cases. Methodology: Thirty six serotype-specific primers, 7 newly designed and 29 previously published, were arranged in 7 multiplex PCR sets, each in new hierarchies designed for overall serotype distribution in Bangladesh, and specifically for meningitis and non-meningitis isolates. Culture-negative CSF specimens were then tested directly for serotype-specific sequences using the meningitis-specific set of primers. PCR-based serotyping of 367 strains of 56 known serotypes showed 100% concordance with quellung reaction test. The first 7 multiplex reactions revealed the serotype of 40% of all, and 31% and 48% non-meningitis and meningitis isolates, respectively. By redesigning the multiplex scheme specifically for non-meningitis or meningitis, the quellung reaction of 43% and 48% of respective isolates could be identified. Direct examination of 127 culture-negative CSF specimens, using the meningitis-specific set of primers, yielded serotype for 51 additional cases. Conclusions: This PCR approach, could improve ascertainment of pneumococcal serotype distributions, especially for meningitis in settings with high prior use of antibiotics.	[Saha, Samir K.; Hossain, Belal; Islam, Maksuda; Al-Emran, Hassan] Bangladesh Inst Child Hlth, Dept Microbiol, Dhaka Shishu Children Hosp, Dhaka, Bangladesh; [Darmstadt, Gary L.; Baqui, Abdullah H.; Santosham, Mathuram] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; [Foster, Dona; Crook, Derrick] Univ Oxford, Oxford OX1 2JD, England; [Naheed, Aliya; El Arifeen, Shams; Luby, Stephen P.] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Oxford; International Centre for Diarrhoeal Disease Research (ICDDR)	Saha, SK (corresponding author), Bangladesh Inst Child Hlth, Dept Microbiol, Dhaka Shishu Children Hosp, Dhaka, Bangladesh.	sksaha@bangla.net	Darmstadt, Gary/AAU-7488-2020; A, Naheed/AHB-2941-2022; A, Naheed/AHB-2940-2022	A, Naheed/0000-0002-6016-5603; A, Naheed/0000-0002-6016-5603; Arifeen, Shams/0000-0002-5372-5932; Darmstadt, Gary/0000-0002-7522-5824	Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative, UK; GAVI's PneumoADIP; Johns Hopkins University, USA; Dhaka Shishu Hospital, Dhaka, Bangladesh	Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative, UK(Burroughs Wellcome FundWellcome Trust); GAVI's PneumoADIP; Johns Hopkins University, USA(Johns Hopkins University); Dhaka Shishu Hospital, Dhaka, Bangladesh	The study was partially supported by the Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative, UK; GAVI's PneumoADIP, Johns Hopkins University, USA, and Dhaka Shishu Hospital, Dhaka, Bangladesh.	Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P345; BAGGETT H, 2008, CLIN INFE S IN PRESS; Batt SL, 2005, J CLIN MICROBIOL, V43, P2656, DOI 10.1128/JCM.43.6.2656-2661.2005; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Brooks WA, 2007, AM J TROP MED HYG, V77, P795, DOI 10.4269/ajtmh.2007.77.795; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; FACKLAM RR, 1991, AM J MED, V91, pS3, DOI 10.1016/0002-9343(91)90301-D; Facklam RR, 1991, MANUAL CLIN MICROBIO, P238; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lawrence ER, 2000, J CLIN MICROBIOL, V38, P1319, DOI 10.1128/JCM.38.4.1319-1323.2000; Lawrence ER, 2003, J CLIN MICROBIOL, V41, P601, DOI 10.1128/JCM.41.2.601-607.2003; MASTRO TD, 1991, LANCET, V337, P156, DOI 10.1016/0140-6736(91)90813-5; MOISI J, 2008, CLIN INFE S IN PRESS; Morais L, 2007, J MED MICROBIOL, V56, P1181, DOI 10.1099/jmm.0.47346-0; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Ratnamohan VM, 1998, J VIROL METHODS, V72, P59, DOI 10.1016/S0166-0934(98)00020-2; Rubin LG, 2004, J MED MICROBIOL, V53, P595, DOI 10.1099/jmm.0.45550-0; Saha SK, 2008, PEDIATR INFECT DIS J, V27, P49, DOI 10.1097/INF.0b013e31814d4e55; Saha SK, 1999, J CLIN MICROBIOL, V37, P798, DOI 10.1128/JCM.37.3.798-800.1999; Saha SK, 2005, PEDIATR INFECT DIS J, V24, P1093, DOI 10.1097/01.inf.0000190030.75892.78; Saha SK, 2003, J CLIN MICROBIOL, V41, P5582, DOI 10.1128/JCM.41.12.5582-5587.2003; Saha SK, 2005, J PEDIATR-US, V146, P227, DOI 10.1016/j.jpeds.2004.09.007; Saha SK, 1997, J CLIN MICROBIOL, V35, P785, DOI 10.1128/JCM.35.3.785-787.1997; SAHA SK, 2008, CLIN INFE S IN PRESS; SAHA SK, 2006, 5 INT S PNEUM PNEUM; Thomas K, 1999, LANCET, V353, P1216, DOI 10.1016/S0140-6736(98)07228-6; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P93; Yu JG, 2005, J CLIN MICROBIOL, V43, P156, DOI 10.1128/JCM.43.1.156-162.2005	34	58	61	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3576	10.1371/journal.pone.0003576	http://dx.doi.org/10.1371/journal.pone.0003576			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974887	Green Published, Green Submitted, gold			2022-12-27	WOS:000265131700003
J	Young, ME; Norman, GR; Humphreys, KR				Young, Meredith E.; Norman, Geoffrey R.; Humphreys, Karin R.			Medicine in the Popular Press: The Influence of the Media on Perceptions of Disease	PLOS ONE			English	Article							RISK PERCEPTION; SOCIAL AMPLIFICATION; STRESS; NEWS; EXPOSURE; CHILDREN; STORIES; HEALTH	In an age of increasing globalization and discussion of the possibility of global pandemics, increasing rates of reporting of these events may influence public perception of risk. The present studies investigate the impact of high levels of media reporting on the perceptions of disease. Undergraduate psychology and medical students were asked to rate the severity, future prevalence and disease status of both frequently reported diseases (e.g. avian flu) and infrequently reported diseases (e.g. yellow fever). Participants considered diseases that occur frequently in the media to be more serious, and have higher disease status than those that infrequently occur in the media, even when the low media frequency conditions were considered objectively 'worse' by a separate group of participants. Estimates of severity also positively correlated with popular print media frequency in both student populations. However, we also see that the concurrent presentation of objective information about the diseases can mitigate this effect. It is clear from these data that the media can bias our perceptions of disease.	[Young, Meredith E.; Humphreys, Karin R.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Norman, Geoffrey R.] McMaster Univ, Dept Clin Epidemiol & Biostat, PERD, Program Educ Res & Dev, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Young, ME (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	youngme2@mcmaster.ca			National Science and Engineering Research Council	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors would like to extend thanks to the National Science and Engineering Research Council for full funding of this research project. This research was funded by the National Science and Engineering Research Council (NSERC), and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WC, 1992, PUBLIC RELATIONS Q, V37, P28; Ahern J., 2005, The trauma of terrorism: sharing knowledge and shared care, an international handbook, P109; Ahern J, 2002, PSYCHIATRY, V65, P289, DOI 10.1521/psyc.65.4.289.20240; Bubela TM, 2004, CAN MED ASSOC J, V170, P1399, DOI 10.1503/cmaj.1030762; COMBS B, 1979, JOURNALISM QUART, V56, P837, DOI 10.1177/107769907905600420; Cooper CP, 2000, PUBLIC HEALTH REP, V115, P331, DOI 10.1093/phr/115.4.331; Dougall AL, 2005, PSYCHIATRY, V68, P28, DOI 10.1521/psyc.68.1.28.64188; FISCHHOFF B, 1993, ANNU REV PUBL HEALTH, V14, P183, DOI 10.1146/annurev.pu.14.050193.001151; Frewer LJ, 2002, RISK ANAL, V22, P701, DOI 10.1111/0272-4332.00062; Frick U, 2002, INT J HYG ENVIR HEAL, V205, P353, DOI 10.1078/1438-4639-00170; Frost K, 1997, AM J PUBLIC HEALTH, V87, P842, DOI 10.2105/AJPH.87.5.842; Galea S, 2005, CNS SPECTRUMS, V10, P107, DOI 10.1017/S1092852900019441; GORNEY C, 1992, JOURNALISM QUART, V69, P455, DOI 10.1177/107769909206900219; Johnson B., 1993, RISK ISSUES HLTH SAF, V4, P3; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; KATZ E, 1977, JOURNALISM QUART, V54, P231, DOI 10.1177/107769907705400201; Kennedy Christine, 2004, J Pediatr Nurs, V19, P329, DOI 10.1016/j.pedn.2004.09.003; KRISTIANSEN CM, 1983, EUR J SOC PSYCHOL, V13, P193, DOI 10.1002/ejsp.2420130208; Liu SP, 1998, RISK ANAL, V18, P689, DOI 10.1111/j.1539-6924.1998.tb01113.x; MAZUR A, 1993, SOC STUD SCI, V23, P681, DOI 10.1177/030631293023004003; MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990; Miller JD, 2003, MED MYCOL, V41, P271, DOI 10.1080/1369378031000137350; Moulder JE, 1999, RADIAT RES, V151, P513, DOI 10.2307/3580028; NEUMAN WR, 1974, PUBLIC OPIN QUART, V40, P115; Nisbett R. E., 1980, HUMAN INFERENCE STRA; Pfefferbaum B, 2001, PSYCHIATRY, V64, P202, DOI 10.1521/psyc.64.3.202.18462; Pfefferbaum B, 2001, Mil Med, V166, P49; Pfefferbaum B, 1999, J Okla State Med Assoc, V92, P164; Pfefferbaum B, 2000, PSYCHIATRY, V63, P358, DOI 10.1080/00332747.2000.11024929; Pfefferbaum B, 2003, ANN CLIN PSYCHIAT, V15, P1, DOI DOI 10.3109/10401230309085664; RAHU M, 1997, RADIAT RES, V160, P653; Sandman P. M., 1994, RISK, V5, P251, DOI DOI 10.1016/B978-0-08-052100-8.50022-1; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581; Schuster MA, 2001, NEW ENGL J MED, V345, P1507, DOI 10.1056/NEJM200111153452024; Silver RC, 2002, JAMA-J AM MED ASSOC, V288, P1235, DOI 10.1001/jama.288.10.1235; Sjoberg L., 2000, J RISK RES, V3, P31, DOI DOI 10.1080/136698700376699; SLOVIC P, 2002, PERCEPTION RISK EXTR; SOUMERAI SB, 1992, MILBANK Q, V70, P155, DOI 10.2307/3350088; STAUFFER J, 1983, J COMMUN, V33, P29, DOI 10.1111/j.1460-2466.1983.tb02371.x; Stephan V, 2005, NATURE, V437, P181, DOI 10.1038/437181b; Sun A, 2007, J HEALTH COMMUN, V12, P157, DOI 10.1080/10810730601150106; Vasterman P, 2005, EPIDEMIOL REV, V27, P107, DOI 10.1093/epirev/mxi002; *WHO, 1995, HLTH CONS CHERN ACC; WILSON CE, 1974, JOURNALISM QUART, V51, P111, DOI 10.1177/107769907405100118; WILSON K, 2004, BMC PUBL HLTH	45	97	98	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3552	10.1371/journal.pone.0003552	http://dx.doi.org/10.1371/journal.pone.0003552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432KE	18958167	gold, Green Published, Green Submitted			2022-12-27	WOS:000265131100011
J	King, TE; Pawar, SC; Majuta, L; Sroka, IC; Wynn, D; Demetriou, MC; Nagle, RB; Porreca, F; Cress, AE				King, Tamara E.; Pawar, Sangita C.; Majuta, Lisa; Sroka, Isis C.; Wynn, Danyel; Demetriou, Manolis C.; Nagle, Raymond B.; Porreca, Frank; Cress, Anne E.			The Role of Alpha 6 Integrin in Prostate Cancer Migration and Bone Pain in a Novel Xenograft Model	PLOS ONE			English	Article							ALPHA-6-INTEGRIN CLEAVAGE; DIFFERENTIAL EXPRESSION; BINDING INTEGRINS; MURINE MODEL; MARROW; ECTODOMAIN; CELLS; IDENTIFICATION; METASTASIS; MOLECULES	Of the estimated 565,650 people in the U. S. who will die of cancer in 2008, almost all will have metastasis. Breast, prostate, kidney, thyroid and lung cancers metastasize to the bone. Tumor cells reside within the bone using integrin type cell adhesion receptors and elicit incapacitating bone pain and fractures. In particular, metastatic human prostate tumors express and cleave the integrin A6, a receptor for extracellular matrix components of the bone, i.e., laminin 332 and laminin 511. More than 50% of all prostate cancer patients develop severe bone pain during their remaining lifetime. One major goal is to prevent or delay cancer induced bone pain. We used a novel xenograft mouse model to directly determine if bone pain could be prevented by blocking the known cleavage of the A6 integrin adhesion receptor. Human tumor cells expressing either the wildtype or mutated A6 integrin were placed within the living bone matrix and 21 days later, integrin expression was confirmed by RT-PCR, radiographs were collected and behavioral measurements of spontaneous and evoked pain performed. All animals independent of integrin status had indistinguishable tumor burden and developed bone loss 21 days after surgery. A comparison of animals containing the wild type or mutated integrin revealed that tumor cells expressing the mutated integrin resulted in a dramatic decrease in bone loss, unicortical or bicortical fractures and a decrease in the ability of tumor cells to reach the epiphyseal plate of the bone. Further, tumor cells within the bone expressing the integrin mutation prevented cancer induced spontaneous flinching, tactile allodynia, and movement evoked pain. Preventing A6 integrin cleavage on the prostate tumor cell surface decreased the migration of tumor cells within the bone and the onset and degree of bone pain and fractures. These results suggest that strategies for blocking the cleavage of the adhesion receptors on the tumor cell surface can significantly prevent cancer induced bone pain and slow disease progression within the bone. Since integrin cleavage is mediated by Urokinase-type Plasminogen Activator (uPA), further work is warranted to test the efficacy of uPA inhibitors for prevention or delay of cancer induced bone pain.	[King, Tamara E.; Majuta, Lisa; Porreca, Frank] Univ Arizona, Arizona Canc Ctr, Dept Pharmacol, Tucson, AZ 85721 USA; [Pawar, Sangita C.; Sroka, Isis C.; Cress, Anne E.] Univ Arizona, Arizona Canc Ctr, Dept Cell Biol & Anat, Tucson, AZ 85721 USA; [Wynn, Danyel] Univ Arizona, Arizona Canc Ctr, Dept Physiol, Tucson, AZ 85721 USA; [Demetriou, Manolis C.] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [King, Tamara E.; Pawar, Sangita C.; Nagle, Raymond B.] Univ Arizona, Arizona Canc Ctr, Dept Pathol, Tucson, AZ 85721 USA	Arizona Center Cancer Care; University of Arizona; Arizona Center Cancer Care; University of Arizona; Arizona Center Cancer Care; University of Arizona; University of Cyprus; Arizona Center Cancer Care; University of Arizona	Porreca, F (corresponding author), Univ Arizona, Arizona Canc Ctr, Dept Pharmacol, Tucson, AZ 85721 USA.	frankp@u.arizona.edu; acress@azcc.arizona.edu	Cress, Anne/V-6527-2019	Cress, Anne/0000-0001-6194-0061	NIH [CA56666, CA23074, GM008718]; NATIONAL CANCER INSTITUTE [P30CA023074, P01CA056666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008718] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported in part by NIH grants CA56666, CA23074, and GM008718. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONKHOFF H, 1993, HUM PATHOL, V24, P243, DOI 10.1016/0046-8177(93)90033-D; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Conacci -Sorrell M, 2005, CANCER RES, V65, P11605, DOI 10.1158/0008-5472.CAN-05-2647; CRESS AE, 1995, CANCER METAST REV, V14, P219, DOI 10.1007/BF00690293; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Davis TL, 2001, PROSTATE, V46, P240; Davis TL, 2002, CELL GROWTH DIFFER, V13, P107; Davis TL, 2001, J BIOL CHEM, V276, P26099, DOI 10.1074/jbc.M102811200; Dello Sbarba P, 2002, BIOL CHEM, V383, P69; Demetriou MC, 2004, EXP CELL RES, V294, P550, DOI 10.1016/j.yexcr.2003.11.023; Demetriou MC, 2004, J CELL BIOCHEM, V91, P26, DOI 10.1002/jcb.10675; Dina OA, 2004, EUR J NEUROSCI, V19, P634, DOI 10.1111/j.1460-9568.2004.03169.x; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Gu YC, 2003, BLOOD, V101, P877, DOI 10.1182/blood-2002-03-0796; Gu YC, 1999, BLOOD, V93, P2533, DOI 10.1182/blood.V93.8.2533.408k22_2533_2542; JEMAL A, 2008, CA CANC J CLIN; King T, 2007, PAIN, V132, P154, DOI 10.1016/j.pain.2007.06.026; KNOX JD, 1994, AM J PATHOL, V145, P167; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; MAJDA JA, 1994, EXP CELL RES, V210, P46, DOI 10.1006/excr.1994.1007; Mantyh PW, 2006, NAT REV NEUROSCI, V7, P797, DOI 10.1038/nrn1914; Mercurio A M, 2001, Surg Oncol Clin N Am, V10, P313; MERCURIO AM, 2001, SURG ONCOL CLIN N AM, V10, pR8; Morrissey C, 2007, J CELL BIOCHEM, V101, P873, DOI 10.1002/jcb.21214; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; NAGLE RB, 1994, J CELL BIOCHEM, P232; NAGLE RB, 1995, AM J PATHOL, V146, P1498; Najy AJ, 2008, CANCER RES, V68, P1092, DOI 10.1158/0008-5472.CAN-07-2432; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Pawar SC, 2007, INT J RADIAT BIOL, V83, P761, DOI 10.1080/09553000701633135; Pawar SC, 2007, EXP CELL RES, V313, P1080, DOI 10.1016/j.yexcr.2007.01.006; Putz E, 1999, CANCER RES, V59, P241; RABINOVITZ I, 1995, CLIN EXP METASTAS, V13, P481, DOI 10.1007/BF00118187; Schwei MJ, 1999, J NEUROSCI, V19, P10886, DOI 10.1523/JNEUROSCI.19-24-10886.1999; Siler U, 2000, BLOOD, V96, P4194; Siler U, 2002, BRIT J HAEMATOL, V119, P212, DOI 10.1046/j.1365-2141.2002.03800.x; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Vessella RL, 2006, CLIN CANCER RES, V12, p6285S, DOI 10.1158/1078-0432.CCR-06-0813; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877	39	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2008	3	10							e3535	10.1371/journal.pone.0003535	http://dx.doi.org/10.1371/journal.pone.0003535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KC	18958175	gold, Green Submitted, Green Published			2022-12-27	WOS:000265130900001
J	Durcova-Hills, G; Tang, FC; Doody, G; Tooze, R; Surani, MA				Durcova-Hills, Gabriela; Tang, Fuchou; Doody, Gina; Tooze, Reuben; Surani, M. Azim			Reprogramming Primordial Germ Cells into Pluripotent Stem Cells	PLOS ONE			English	Article							FIBROBLASTS; REPRESSION; DERIVATION; BLIMP-1	Background: Specification of primordial germ cells (PGCs) results in the conversion of pluripotent epiblast cells into monopotent germ cell lineage. Blimp1/Prmt5 complex plays a critical role in the specification and maintenance of the early germ cell lineage. However, PGCs can be induced to dedifferentiate back to a pluripotent state as embryonic germ (EG) cells when exposed to exogenous signaling molecules, FGF-2, LIF and SCF. Methodology and Principal Findings: Here we show that Trichostatin A (TSA), an inhibitor of histone deacetylases, is a highly potent agent that can replace FGF-2 to induce dedifferentiation of PGCs into EG cells. A key early event during dedifferentiation of PGCs in response to FGF-2 or TSA is the down-regulation of Blimp1, which reverses and apparently relieves the cell fate restriction imposed by it. Notably, the targets of Blimp1, which include c-Myc and Klf-4, which represent two of the key factors known to promote reprogramming of somatic cells to pluripotent state, are up-regulated. We also found early activation of the LIF/Stat-3 signaling pathway with the translocation of Stat-3 into the nucleus. By contrast, while Prmt5 is retained in EG cells, it translocates from the nucleus to the cytoplasm where it probably has an independent role in regulating pluripotency. Conclusions/Significance: We propose that dedifferentiation of PGCs into EG cells may provide significant mechanistic insights on early events associated with reprogramming of committed cells to a pluripotent state.	[Durcova-Hills, Gabriela; Tang, Fuchou; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge, England; [Doody, Gina; Tooze, Reuben] Univ Leeds, Leeds Inst Mol Med, Div Expt Haematol, Leeds LS2 9JT, W Yorkshire, England	University of Cambridge; University of Leeds	Durcova-Hills, G (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge, England.	gd225@camac.uk; as10021@mole.bio.cam.ac.uk	Doody, Gina/AAN-8246-2021	Doody, Gina/0000-0003-0665-6759; Tooze, Reuben/0000-0003-2915-7119; Surani, Azim/0000-0002-8640-4318	BBSRC; MRC; Wellcome Trust; Medical Research Council [G108/500] Funding Source: researchfish; MRC [G108/500] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	G.D-H is BBSRC-funded MRC Career Development Stem Cell Fellow. We are grateful to the Wellcome Trust (M.A.S), BBSRC (G.D-H), and MRC (G.D-H) for financial support.	Adams IR, 2004, DEV DYNAM, V229, P733, DOI 10.1002/dvdy.10471; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; CHENG LZ, 1994, DEVELOPMENT, V120, P3145; Durcova-Hills G, 2004, HDB STEM CELLS, V1, P451; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Muller AJ, 2000, P NATL ACAD SCI USA, V97, P8421, DOI 10.1073/pnas.140208197; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	24	118	127	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2008	3	10							e3531	10.1371/journal.pone.0003531	http://dx.doi.org/10.1371/journal.pone.0003531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432JY	18953407	Green Published, gold, Green Submitted			2022-12-27	WOS:000265130500009
J	Gonzalo-Asensio, J; Mostowy, S; Harders-Westerveen, J; Huygen, K; Hernandez-Pando, R; Thole, J; Behr, M; Gicquel, B; Martin, C				Gonzalo-Asensio, Jesus; Mostowy, Serge; Harders-Westerveen, Jose; Huygen, Kris; Hernandez-Pando, Rogelio; Thole, Jelle; Behr, Marcel; Gicquel, Brigitte; Martin, Carlos			PhoP: A Missing Piece in the Intricate Puzzle of Mycobacterium tuberculosis Virulence	PLOS ONE			English	Article							HYPOXIC RESPONSE; GENE-EXPRESSION; BOVIS BCG; TRANSCRIPTION FACTOR; METHYLCITRATE CYCLE; 2-COMPONENT SYSTEM; CALMETTE-GUERIN; IDENTIFICATION; MACROPHAGES; PERSISTENCE	Inactivation of the transcriptional regulator PhoP results in Mycobacterium tuberculosis attenuation. Preclinical testing has shown that attenuated M. tuberculosis phoP mutants hold promise as safe and effective live vaccine candidates. We focused this study to decipher the virulence networks regulated by PhoP. A combined transcriptomic and proteomic analysis revealed that PhoP controls a variety of functions including: hypoxia response through DosR crosstalking, respiratory metabolism, secretion of the major T-cell antigen ESAT-6, stress response, synthesis of pathogenic lipids and the M. tuberculosis persistence through transcriptional regulation of the enzyme isocitrate lyase. We also demonstrate that the M. tuberculosis phoP mutant SO2 exhibits an antigenic capacity similar to that of the BCG vaccine. Finally, we provide evidence that the SO2 mutant persists better in mouse organs than BCG. Altogether, these findings indicate that PhoP orchestrates a variety of functions implicated in M. tuberculosis virulence and persistence, making phoP mutants promising vaccine candidates.	[Gonzalo-Asensio, Jesus; Martin, Carlos] Univ Zaragoza, Fac Med, Dept Microbiol, Grp Genet Micobacterias, Zaragoza, Spain; [Mostowy, Serge; Behr, Marcel] Montreal Gen Hosp, Div Infect Dis & Med Microbiol, Montreal, PQ, Canada; [Harders-Westerveen, Jose] Cent Vet Inst, Lelystad, Netherlands; [Huygen, Kris] WIV Pasteur Inst Brussels, Brussels, Belgium; [Hernandez-Pando, Rogelio] Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Pathol, Expt Pathol Sect, Mexico City, DF, Mexico; [Thole, Jelle] TuBerculosis Vaccine Initiative, Lelystad, Netherlands; [Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, Paris, France; [Gonzalo-Asensio, Jesus; Martin, Carlos] CIBER Enfermedades Respirat, Illes Balears, Spain	University of Zaragoza; McGill University; Wageningen University & Research; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Gonzalo-Asensio, J (corresponding author), Univ Zaragoza, Fac Med, Dept Microbiol, Grp Genet Micobacterias, Zaragoza, Spain.	carlos@unizar.es	Martin, Carlos/A-7283-2008; Gonzalo-Asensio, Jesús/E-4122-2013	Martin, Carlos/0000-0003-2993-5478; Gonzalo-Asensio, Jesús/0000-0001-8841-6593; Mostowy, Serge/0000-0002-7286-6503; Hernandez-Pando, Rogelio/0000-0003-1292-3833; Huygen, Kris/0000-0001-7808-0512	Spanish MEC [BIO2005-07949-C02-01]; EU FP6 TB-VAC [LSHP-CT203-503367]	Spanish MEC(Spanish Government); EU FP6 TB-VAC(European Commission)	This work was supported by the Spanish MEC (BIO2005-07949-C02-01) and EU FP6 TB-VAC (LSHP-CT203-503367). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio JAG, 2008, EXPERT OPIN BIOL TH, V8, P201, DOI 10.1517/14712598.8.2.201 ; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Chan K, 2002, P NATL ACAD SCI USA, V99, P3920, DOI 10.1073/pnas.002024599; Chen JM, 2003, INFECT IMMUN, V71, P708, DOI 10.1128/IAI.71.2.708-716.2003; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Dubnau E, 2002, INFECT IMMUN, V70, P2787, DOI 10.1128/IAI.70.6.2787-2795.2002; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gao Q, 2004, TUBERCULOSIS, V84, P188, DOI 10.1016/j.tube.2003.12.013; GONZALOASENSIO J, 2008, J BACTERIOL; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hobson RJ, 2002, MICROBIOL-SGM, V148, P1571, DOI 10.1099/00221287-148-5-1571; HONAKER RW, 2008, INFECT IMMUN; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Hutter B, 1998, FEMS MICROBIOL LETT, V167, P7, DOI 10.1111/j.1574-6968.1998.tb13200.x; KINGER AK, 1993, GENE, V131, P113, DOI 10.1016/0378-1119(93)90678-V; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; Mattow J, 2001, ELECTROPHORESIS, V22, P2936, DOI 10.1002/1522-2683(200108)22:14<2936::AID-ELPS2936>3.0.CO;2-S; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rosenkrands I, 2002, J BACTERIOL, V184, P3485, DOI 10.1128/JB.184.13.3485-3491.2002; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Senaratne RH, 2006, MOL MICROBIOL, V59, P1744, DOI 10.1111/j.1365-2958.2006.05075.x; Senaratne RH, 2007, J MED MICROBIOL, V56, P454, DOI 10.1099/jmm.0.46983-0; Sharma V, 2000, NAT STRUCT BIOL, V7, P663, DOI 10.1038/77964; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Waddell SJ, 2007, CURR MOL MED, V7, P287, DOI 10.2174/156652407780598548; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Wayne L. G., 1998, Tubercle and Lung Disease, V79, P127, DOI 10.1054/tuld.1998.0015; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Winau F, 2005, APOPTOSIS, V10, P707, DOI 10.1007/s10495-005-2940-6; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x	65	160	172	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3496	10.1371/journal.pone.0003496	http://dx.doi.org/10.1371/journal.pone.0003496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IH	18946503	Green Submitted, Green Published, gold			2022-12-27	WOS:000265126200003
J	Altmann, A; Rosen-Zvi, M; Prosperi, M; Aharoni, E; Neuvirth, H; Schulter, E; Buch, J; Struck, D; Peres, Y; Incardona, F; Sonnerborg, A; Kaiser, R; Zazzi, M; Lengauer, T				Altmann, Andre; Rosen-Zvi, Michal; Prosperi, Mattia; Aharoni, Ehud; Neuvirth, Hani; Schuelter, Eugen; Buech, Joachim; Struck, Daniel; Peres, Yardena; Incardona, Francesca; Soennerborg, Anders; Kaiser, Rolf; Zazzi, Maurizio; Lengauer, Thomas			Comparison of Classifier Fusion Methods for Predicting Response to Anti HIV-1 Therapy	PLOS ONE			English	Article							EVOLUTIONARY PATHWAYS; GENETIC BARRIER; COMBINATION	Background: Analysis of the viral genome for drug resistance mutations is state-of-the-art for guiding treatment selection for human immunodeficiency virus type 1 (HIV-1)-infected patients. These mutations alter the structure of viral target proteins and reduce or in the worst case completely inhibit the effect of antiretroviral compounds while maintaining the ability for effective replication. Modern anti-HIV-1 regimens comprise multiple drugs in order to prevent or at least delay the development of resistance mutations. However, commonly used HIV-1 genotype interpretation systems provide only classifications for single drugs. The EuResist initiative has collected data from about 18,500 patients to train three classifiers for predicting response to combination antiretroviral therapy, given the viral genotype and further information. In this work we compare different classifier fusion methods for combining the individual classifiers. Principal Findings: The individual classifiers yielded similar performance, and all the combination approaches considered performed equally well. The gain in performance due to combining methods did not reach statistical significance compared to the single best individual classifier on the complete training set. However, on smaller training set sizes (200 to 1,600 instances compared to 2,700) the combination significantly outperformed the individual classifiers (p<0.01; paired one-sided Wilcoxon test). Together with a consistent reduction of the standard deviation compared to the individual prediction engines this shows a more robust behavior of the combined system. Moreover, using the combined system we were able to identify a class of therapy courses that led to a consistent underestimation (about 0.05 AUC) of the system performance. Discovery of these therapy courses is a further hint for the robustness of the combined system. Conclusion: The combined EuResist prediction engine is freely available at http://engine.euresist.org.	[Altmann, Andre; Buech, Joachim; Lengauer, Thomas] Max Planck Inst Informat, Saarbrucken, Germany; [Rosen-Zvi, Michal; Aharoni, Ehud; Neuvirth, Hani] IBM Res Lab Haifa, Machine Learning Grp, Haifa, Israel; [Prosperi, Mattia] Univ Roma TRE, Dept Comp Sci & Automat, Rome, Italy; [Schuelter, Eugen; Kaiser, Rolf] Univ Cologne, Inst Virol, D-5000 Cologne, Germany; [Struck, Daniel] CRP Sante, Retrovirol Lab, Luxembourg, Luxembourg; [Peres, Yardena] IBM Res Lab, Hlth Care & Life Sci Grp, Haifa, Israel; [Incardona, Francesca] Informa SRL, Rome, Italy; [Soennerborg, Anders] Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden; [Zazzi, Maurizio] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy	Max Planck Society; International Business Machines (IBM); Roma Tre University; University of Cologne; Luxembourg Institute of Health; International Business Machines (IBM); Karolinska Institutet; University of Siena	Altmann, A (corresponding author), Max Planck Inst Informat, Saarbrucken, Germany.	altmann@mpi-inf.mpg.de	Rosen-Zvi, Michal/AAF-4649-2020; Sönnerborg, Anders/W-2011-2019; Zazzi, Maurizio/K-3422-2018; Altmann, Andre/ABF-1675-2020	Sönnerborg, Anders/0000-0001-8928-3374; Zazzi, Maurizio/0000-0002-0344-6281; Altmann, Andre/0000-0002-9265-2393; Rosen-Zvi, Michal/0000-0001-7616-9724	EuResist project [IST-2004-027173]	EuResist project	This work is supported by the EuResist project (IST-2004-027173).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altmann A, 2007, ANTIVIR THER, V12, P169; Beerenwinkel N, 2005, J INFECT DIS, V191, P1953, DOI 10.1086/430005; Beerenwinkel N, 2005, J COMPUT BIOL, V12, P584, DOI 10.1089/cmb.2005.12.584; Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Hall M.A, 1999, CORRELATION BASED FE; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; HUANG Y, 1995, IEEE T PATTERN ANAL, V17, P1177, DOI 10.1109/34.476510; Johnson NP, 2007, OPTO-ELECTRON REV, V15, P125, DOI 10.2478/s11772-007-0009-5; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Kuncheva L I, 2004, COMBINING PATTERN CL; Kuncheva LI, 2002, IEEE T SYST MAN CY B, V32, P146, DOI 10.1109/3477.990871; Kuncheva LI, 2001, PATTERN RECOGN, V34, P299, DOI 10.1016/S0031-3203(99)00223-X; Larder B, 2007, ANTIVIR THER, V12, P15; Lathrop RH, 1999, J COMB OPTIM, V3, P301, DOI 10.1023/A:1009846028730; LE CS, 1992, APPL STAT, V41, P191; Lengauer T, 2006, NAT REV MICROBIOL, V4, P790, DOI 10.1038/nrmicro1477; LIU R, 2001, INFORM FUSION, V2, P163; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; ROGOVA G, 1994, NEURAL NETWORKS, V7, P777, DOI 10.1016/0893-6080(94)90099-X; Roomp K, 2006, LECT NOTES COMPUT SC, V4075, P185; Rosen-Zvi M, 2008, BIOINFORMATICS, V24, pI399, DOI 10.1093/bioinformatics/btn141; Sinisi SE, 2007, STAT APPL GENET MOL, V6; Woods K, 1997, IEEE T PATTERN ANAL, V19, P405, DOI 10.1109/34.588027	25	37	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2008	3	10							e3470	10.1371/journal.pone.0003470	http://dx.doi.org/10.1371/journal.pone.0003470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IE	18941628	Green Published, gold, Green Submitted			2022-12-27	WOS:000265125900013
J	Welch, TR; Blystone, LW				Welch, Thomas R.; Blystone, Lisa W.			Immune Complex Glomerulonephritis Following Bone Marrow Transplantation in C3 Deficient Mice	PLOS ONE			English	Article							TUBULAR EPITHELIAL-CELLS; MEDIATES STIMULATION; GENE-EXPRESSION; ACTIVATION; COMPONENT; C4	Background: The role of circulating complement in host defense and immune disease is well established. Although a number of cells and tissues are capable of synthesizing complement components locally, the importance of such local synthesis in immune disease has been difficult to establish. Methodology/Principal Findings: We used bone marrow transplantation (BMT) between C3 knockout (C3KO) and wild type (WT) mice to construct animals that were discordant for systemic (hepatic) and local (monocytic) C3 synthetic capacity. An immune complex glomerulonephritis (GN) was then induced using intraperitoneal injections of horse spleen apoferritin (HSA) with a lipopolysaccharide (LPS) adjuvant. All HSA/LPS animals developed a proliferative GN with glomerular infiltration by monocytes. By sensitive ELISA, monocyte C3 synthesis could be detected in C3KO animals transplanted with WT bone marrow cells. Despite this, there were no significant differences among groups of mice in measures of clinical (proteinuria, renal function) or histologic (glomerular cellularity, crescents) disease severity. Conclusions/Significance: In this model of GN, local synthesis of C3 by infiltrating cells does not appear to be of pathologic importance.	[Welch, Thomas R.; Blystone, Lisa W.] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Welch, TR (corresponding author), SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY USA.	welcht@upstate.edu		Welch, Thomas/0000-0002-5893-4020				BROOIMANS RA, 1991, J CLIN INVEST, V88, P379, DOI 10.1172/JCI115314; Drouin SM, 1996, MOL IMMUNOL, V33, P1025, DOI 10.1016/S0161-5890(96)00071-5; Farrar CA, 2006, FASEB J, V20, P217, DOI 10.1096/fj.05-4747com; Jose MD, 2003, TRANSPLANTATION, V76, P1015, DOI 10.1097/01.TP.0000083507.67995.13; LAUFER J, 1995, IMMUNOLOGY, V84, P207; Li K, 2004, J AM SOC NEPHROL, V15, P2414, DOI 10.1097/01.ASN.0000135974.06478.7B; PASSWELL J, 1988, J CLIN INVEST, V82, P1676, DOI 10.1172/JCI113780; Peng Q, 2008, BLOOD, V111, P2452, DOI 10.1182/blood-2007-06-095018; Reis ES, 2008, MOL IMMUNOL, V45, P1952, DOI 10.1016/j.molimm.2007.10.031; SEELEN MAJ, 1993, KIDNEY INT, V44, P50, DOI 10.1038/ki.1993.212; Sund S, 2004, CLIN NEPHROL, V62, P121; Thurman JM, 2007, J IMMUNOL, V178, P1819, DOI 10.4049/jimmunol.178.3.1819; Verschoor A, 2001, J IMMUNOL, V167, P2446, DOI 10.4049/jimmunol.167.5.2446; Welch TR, 2005, CLIN IMMUNOL, V115, P80, DOI 10.1016/j.clim.2004.10.008; WELCH TR, 1993, J CLIN INVEST, V92, P1451, DOI 10.1172/JCI116722; Welch TR, 2002, CLIN EXP IMMUNOL, V130, P43, DOI 10.1046/j.1365-2249.2002.01957.x; Welch TR, 2001, NEPHRON, V88, P199, DOI 10.1159/000045990; Welch TR, 2000, PEDIATR RES, V48, P200, DOI 10.1203/00006450-200008000-00013; WITTE DP, 1991, AM J PATHOL, V139, P717	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3334	10.1371/journal.pone.0003334	http://dx.doi.org/10.1371/journal.pone.0003334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836527	Green Published, Green Submitted, gold			2022-12-27	WOS:000265113500003
J	Wang, HB; Xie, HR; Dey, SK				Wang, Haibin; Xie, Huirong; Dey, Sudhansu K.			Loss of Cannabinoid Receptor CB1 Induces Preterm Birth	PLOS ONE			English	Article								Background: Preterm birth accounting approximate 10% of pregnancies in women is a tremendous social, clinical and economic burden. However, its underlying causes remain largely unknown. Emerging evidence suggests that endocannabinoid signaling via cannabinoid receptor CB1 play critical roles in multiple early pregnancy events in both animals and humans. Since our previous studies demonstrated that loss of CB1 defers the normal implantation window in mice, we surmised that CB1 deficiency would influence parturition events. Methods and Findings: Exploiting mouse models with targeted deletion of Cnr1, Cnr2 and Ptgs1 encoding CB1, CB2 and cyclooxygenase-1, respectively, we examined consequences of CB1 or CB2 silencing on the onset of parturition. We observed that genetic or pharmacological inactivation of CB1, but not CB2, induced preterm labor in mice. Radioimmunoassay analysis of circulating levels of ovarian steroid hormones revealed that premature birth resulting from CB1 inactivation is correlated with altered progesterone/ estrogen ratios prior to parturition. More strikingly, the phenotypic defects of prolonged pregnancy length and parturition failure in mice missing Ptgs1 were corrected by introducing CB1 deficiency into Ptgs1 null mice. In addition, loss of CB1 resulted in aberrant secretions of corticotrophin-releasing hormone and corticosterone during late gestation. The pathophysiological significance of this altered corticotrophin-releasing hormone-driven endocrine activity in the absence of CB1 was evident from our subsequent findings that a selective corticotrophin-releasing hormone antagonist was able to restore the normal parturition timing in Cnr1 deficient mice. In contrast, wild-type females receiving excessive levels of corticosterone induced preterm birth. Conclusions: CB1 deficiency altering normal progesterone and estrogen levels induces preterm birth in mice. This defect is independent of prostaglandins produced by cyclooxygenase-1. Moreover, CB1 inactivation resulted in aberrant corticotrophin-releasing hormone and corticosterone activities prior to parturition, suggesting that CB1 regulates labor by interacting with the corticotrophin-releasing hormone-driven endocrine axis.	[Wang, Haibin; Xie, Huirong; Dey, Sudhansu K.] Vanderbilt Univ, Med Ctr, Dept Pediat, Cell & Dev Biol, & Pharmacol, Nashville, TN USA	Vanderbilt University	Wang, HB (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sk.dey@cchmc.org			US National Institutes of Health NIH [DA06668, HD12304, CA77839, HD050315]; National Institute on Drug Abuse NIDA [MERIT Awards]; National Institute of Child Health and Human Development NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD050315, R37HD012304, R01HD012304] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006668, R37DA006668] Funding Source: NIH RePORTER	US National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Child Health and Human Development NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in parts by US National Institutes of Health (NIH) Grants DA06668, HD12304 & CA77839 to SKD, and HD050315 to HW. SKD is recipient of Method to Extend Research in Time (MERIT) Awards from the National Institute on Drug Abuse (NIDA) and the National Institute of Child Health and Human Development (NICHD).	Bayatti N, 2005, ENDOCRINOLOGY, V146, P1205, DOI 10.1210/en.2004-1154; Calogero AE, 1996, ENDOCRINOLOGY, V137, P4161, DOI 10.1210/en.137.10.4161; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Comings DE, 1997, MOL PSYCHIATR, V2, P161, DOI 10.1038/sj.mp.4000247; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cota D, 2007, ENDOCRINOLOGY, V148, P1574, DOI 10.1210/en.2005-1649; DAS SK, 1995, P NATL ACAD SCI USA, V92, P4332, DOI 10.1073/pnas.92.10.4332; DAS SK, 1994, DEVELOPMENT, V120, P1071; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Dennedy MC, 2004, AM J OBSTET GYNECOL, V190, P2, DOI 10.1016/j.ajog.2003.07.013; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dey SK, 2005, NATURE, V435, P34, DOI 10.1038/435034a; FernandezRuiz J, 1997, BIOCHEM PHARMACOL, V53, P1919; FIELD E, 1986, J PHARMACOL EXP THER, V238, P1034; Fride E, 2003, EUR J PHARMACOL, V461, P27, DOI 10.1016/S0014-2999(03)01295-0; Fride E, 2002, NEUROREPORT, V13, P1833, DOI 10.1097/00001756-200210280-00001; Gadzicki D, 1999, MOL CELL PROBE, V13, P321, DOI 10.1006/mcpr.1999.0249; Gammon CM, 2005, ENDOCRINOLOGY, V146, P4491, DOI 10.1210/en.2004-1672; Gross GA, 1998, P NATL ACAD SCI USA, V95, P11875, DOI 10.1073/pnas.95.20.11875; Guo Y, 2005, J BIOL CHEM, V280, P23429, DOI 10.1074/jbc.C500168200; Habayeb OMH, 2004, J CLIN ENDOCR METAB, V89, P5482, DOI 10.1210/jc.2004-0681; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Karalis K, 1996, NAT MED, V2, P556, DOI 10.1038/nm0596-556; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Linzer DIH, 1999, MOL ENDOCRINOL, V13, P837, DOI 10.1210/me.13.6.837; Maccarrone M, 2000, LANCET, V355, P1326, DOI 10.1016/S0140-6736(00)02115-2; Maccarrone M, 2002, VITAM HORM, V65, P225, DOI 10.1016/S0083-6729(02)65066-6; MASTORAKOS G, 1993, J CLIN INVEST, V92, P961, DOI 10.1172/JCI116672; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Mesiano S, 2007, SEMIN CELL DEV BIOL, V18, P321, DOI 10.1016/j.semcdb.2007.05.003; Mitchell MD, 2008, AM J PHYSIOL-ENDOC M, V294, pE352, DOI 10.1152/ajpendo.00495.2007; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; PARIA BC, 1995, P NATL ACAD SCI USA, V92, P9460, DOI 10.1073/pnas.92.21.9460; Paria BC, 2001, J BIOL CHEM, V276, P20523, DOI 10.1074/jbc.M100679200; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V284, P644; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; ROUZER CA, 2006, BIOCH J; Schmid PC, 1997, P NATL ACAD SCI USA, V94, P4188, DOI 10.1073/pnas.94.8.4188; Scorticati C, 2004, P NATL ACAD SCI USA, V101, P11891, DOI 10.1073/pnas.0404366101; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Song H, 2002, DEVELOPMENT, V129, P2879; STEGER RW, 1981, FERTIL STERIL, V35, P567; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Taylor AH, 2007, HUM REPROD UPDATE, V13, P501, DOI 10.1093/humupd/dmm018; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Wang HB, 2006, ENDOCR REV, V27, P427, DOI 10.1210/er.2006-0006; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wang HB, 2003, P NATL ACAD SCI USA, V100, P14914, DOI 10.1073/pnas.2436379100; Wang J, 1999, BIOL REPROD, V60, P839, DOI 10.1095/biolreprod60.4.839; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	58	48	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3320	10.1371/journal.pone.0003320	http://dx.doi.org/10.1371/journal.pone.0003320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833324	Green Submitted, Green Published, gold			2022-12-27	WOS:000264797400002
J	Mathew, A; O'Bryan, J; Marshall, W; Kotwal, GJ; Terajima, M; Green, S; Rothman, AL; Ennis, FA				Mathew, Anuja; O'Bryan, Joel; Marshall, William; Kotwal, Girish J.; Terajima, Masanori; Green, Sharone; Rothman, Alan L.; Ennis, Francis A.			Robust Intrapulmonary CD8 T Cell Responses and Protection with an Attenuated N1L Deleted Vaccinia Virus	PLOS ONE			English	Article								Background: Vaccinia viruses have been used as a model for viral disease and as a protective live vaccine. Methodology and Principal Findings: We investigated the immunogenicity of an attenuated strain of vaccinia virus engineered to inactivate the N1L gene (vGK5). Using the intranasal route, this recombinant virus was 2 logs less virulent compared to the wildtype VACV-WR. Infection by the intranasal, intraperitoneal, and tail scarification routes resulted in the robust induction of cytolytic virus-specific CD8 T cells in the spleens and the lungs. VACV- specific antibodies were also detected in the sera of mice infected 3-5 months prior with the attenuated vGK5 virus. Finally, mice immunized with vGK5 were significantly protected when challenged with a lethal dose of VACV-WR. Conclusions: These results indicate that the attenuated vGK5 virus protects against subsequent infection and suggest that the N1L protein limits the strength of the early antiviral CD8 T cell response following respiratory infection.	[Mathew, Anuja; O'Bryan, Joel; Terajima, Masanori; Green, Sharone; Rothman, Alan L.; Ennis, Francis A.] Univ Massachusetts, Ctr Infect Dis & Vaccine Res, Sch Med, Worcester, MA 01605 USA; [Marshall, William; Kotwal, Girish J.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Mathew, A (corresponding author), Univ Massachusetts, Ctr Infect Dis & Vaccine Res, Sch Med, Worcester, MA 01605 USA.	anuja.mathew@umassmed.edu	Mathew, Anuja/V-6711-2019	Mathew, Anuja/0000-0002-6752-009X; Rothman, Alan/0000-0002-4064-6848	National Institute of Allergy and Infectious Diseases, National Institutes of Health [N01-AI-25490, U19 AI057319, R01 AI070940, R21AI069167]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070940, N01AI025490, R21AI069167, U19AI057319] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, under Contract No. N01-AI-25490 and grant U19 AI057319 to FAE and R01 AI070940 and R21AI069167 to WLM.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; ANDREW ME, 1989, IMMUNOL CELL BIOL, V67, P331, DOI 10.1038/icb.1989.48; Aoyagi M, 2007, PROTEIN SCI, V16, P118, DOI 10.1110/ps.062454707; Bartlett N, 2002, J GEN VIROL, V83, P1965, DOI 10.1099/0022-1317-83-8-1965; Billings B, 2004, ANN NY ACAD SCI, V1030, P297, DOI 10.1196/annals.1329.037; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; de Moissac D, 1999, J BIOL CHEM, V274, P29505, DOI 10.1074/jbc.274.41.29505; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; Gurt I, 2006, ANTIVIR RES, V69, P158, DOI 10.1016/j.antiviral.2005.11.006; Haga IR, 2005, PARASITOLOGY, V130, pS11, DOI 10.1017/S0031182005008127; Harrington LE, 2002, J VIROL, V76, P3329, DOI 10.1128/JVI.76.7.3329-3337.2002; Hayasaka D, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-22; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KOTWAL GJ, 1989, VIROLOGY, V171, P579, DOI 10.1016/0042-6822(89)90627-2; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Mathew A, 2005, J IMMUNOL, V174, P2212, DOI 10.4049/jimmunol.174.4.2212; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; Parker LC, 2005, J LEUKOCYTE BIOL, V77, P886, DOI 10.1189/jlb.1104636; Phelps A, 2005, VACCINE, V23, P3500, DOI 10.1016/j.vaccine.2005.02.005; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Reading PC, 2003, J EXP MED, V197, P1269, DOI 10.1084/jem.20022201; REED JC, 1987, SCIENCE, V236, P1295, DOI 10.1126/science.3495884; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rosenthal SR, 2001, EMERG INFECT DIS, V7, P920, DOI 10.3201/eid0706.010602; Smee DF, 2001, ANTIVIR CHEM CHEMOTH, V12, P71, DOI 10.1177/095632020101200105; Smee DF, 2001, ANTIVIR RES, V52, P55, DOI 10.1016/S0166-3542(01)00159-0; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Turner G S, 1967, J Gen Virol, V1, P399, DOI 10.1099/0022-1317-1-3-399; Wiley JA, 2001, J IMMUNOL, V167, P3293, DOI 10.4049/jimmunol.167.6.3293; WILLIAMSON JD, 1990, J GEN VIROL, V71, P2761, DOI 10.1099/0022-1317-71-11-2761; Woodland DL, 2001, IMMUNOL RES, V24, P53, DOI 10.1385/IR:24:1:53; Zhang ZN, 2005, ANN NY ACAD SCI, V1056, P69, DOI 10.1196/annals.1352.005	38	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3323	10.1371/journal.pone.0003323	http://dx.doi.org/10.1371/journal.pone.0003323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830408	gold, Green Published, Green Submitted			2022-12-27	WOS:000264797300011
J	Meyer, DH; Bailis, AM				Meyer, Damon H.; Bailis, Adam M.			Telomerase Deficiency Affects the Formation of Chromosomal Translocations by Homologous Recombination in Saccharomyces cerevisiae	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-REPAIR; MITOTIC RECOMBINATION; REVERSE-TRANSCRIPTASE; MULTIPLE PATHWAYS; HUMAN FIBROBLASTS; YEAST TELOMERASE; DYSFUNCTION; CELLS; RAD52	Telomerase is a ribonucleoprotein complex required for the replication and protection of telomeric DNA in eukaryotes. Cells lacking telomerase undergo a progressive loss of telomeric DNA that results in loss of viability and a concomitant increase in genome instability. We have used budding yeast to investigate the relationship between telomerase deficiency and the generation of chromosomal translocations, a common characteristic of cancer cells. Telomerase deficiency increased the rate of formation of spontaneous translocations by homologous recombination involving telomere proximal sequences during crisis. However, telomerase deficiency also decreased the frequency of translocation formation following multiple HO-endonuclease catalyzed DNA double-strand breaks at telomere proximal or distal sequences before, during and after crisis. This decrease correlated with a sequestration of the central homologous recombination factor, Rad52, to telomeres determined by chromatin immuno-precipitation. This suggests that telomerase deficiency results in the sequestration of Rad52 to telomeres, limiting the capacity of the cell to repair double-strand breaks throughout the genome. Increased spontaneous translocation formation in telomerase-deficient yeast cells undergoing crisis is consistent with the increased incidence of cancer in elderly humans, as the majority of our cells lack telomerase. Decreased translocation formation by recombinational repair of double-strand breaks in telomerase-deficient yeast suggests that the reemergence of telomerase expression observed in many human tumors may further stimulate genome rearrangement. Thus, telomerase may exert a substantial effect on global genome stability, which may bear significantly on the appearance and progression of cancer in humans.	[Meyer, Damon H.; Bailis, Adam M.] Beckman Res Inst City Hope, Div Mol Biol, Duarte, CA USA; [Meyer, Damon H.] City of Hope, Grad Sch Biol Sci, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope	Meyer, DH (corresponding author), Beckman Res Inst City Hope, Div Mol Biol, Duarte, CA USA.	abailis@coh.org		Bailis, Adam/0000-0001-5628-0468	National Institutes of Health [GM057484]; Department of Defense Breast Cancer Research [W81XWH0410407]; Beckman Institute of the City of Hope; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research(United States Department of Defense); Beckman Institute of the City of Hope; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health Grant (GM057484 to AMB), Department of Defense Breast Cancer Research Program Grant (W81XWH0410407 to DHM), institutional funds from Beckman Institute of the City of Hope	ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Beliveau A, 2007, P NATL ACAD SCI USA, V104, P4431, DOI 10.1073/pnas.0700260104; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chan SWL, 2003, MOL CELL, V11, P1379, DOI 10.1016/S1097-2765(03)00174-6; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Cheung ALM, 2008, FRONT BIOSCI-LANDMRK, V13, P2075, DOI 10.2741/2825; Cooper DM, 1998, MAMM GENOME, V9, P355, DOI 10.1007/s003359900769; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Du XB, 2004, MOL CELL BIOL, V24, P8437, DOI 10.1128/MCB.24.19.8437-8446.2004; DuBois ML, 2002, GENETICS, V161, P995; FASULLO MT, 1988, MOL CELL BIOL, V8, P4370, DOI 10.1128/MCB.8.10.4370; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Flint J, 1996, HUM MOL GENET, V5, P1163, DOI 10.1093/hmg/5.8.1163; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Hackett JA, 2003, MOL CELL BIOL, V23, P8450, DOI 10.1128/MCB.23.23.8450-8461.2003; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Heacock ML, 2007, NUCLEIC ACIDS RES, V35, P6490, DOI 10.1093/nar/gkm472; HEALY KC, 1995, ONCOL RES, V7, P121; HUANG CH, 1981, BIOCHEMISTRY-US, V20, P233, DOI 10.1021/bi00505a001; Iadonato S P, 1996, Methods Mol Biol, V54, P75; KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774; Knight W., 2006, CONFIDENCE INTERVALS; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Le S, 1999, GENETICS, V152, P143; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; LESLIE M, 2005, SCI AGING KNOWLEDGE, pNF41; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; MANIATIS T, 1989, MOL CLONING LAB MANU, V2; Manthey GM, 2002, MOL CELL BIOL, V22, P5347, DOI 10.1128/MCB.22.15.5347-5356.2002; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Meeker AK, 2004, CLIN CANCER RES, V10, P3317, DOI 10.1158/1078-0432.CCR-0984-03; Meeker AK, 2004, CURR OPIN ONCOL, V16, P32, DOI 10.1097/00001622-200401000-00007; Meyer DH, 2007, GENETICS, V175, P1533, DOI 10.1534/genetics.106.068130; MEYER DH, 2008, MOL MICROBI IN PRESS; Mieczkowski PA, 2003, P NATL ACAD SCI USA, V100, P10854, DOI 10.1073/pnas.1934561100; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Murnane JP, 2004, BIOESSAYS, V26, P1164, DOI 10.1002/bies.20125; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; ONNO M, 1992, ONCOGENE, V7, P2519; Pannunzio NR, 2008, DNA REPAIR, V7, P788, DOI 10.1016/j.dnarep.2008.02.003; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Perera SA, 2008, CARCINOGENESIS, V29, P747, DOI 10.1093/carcin/bgn050; RENAN MJ, 1993, MOL CARCINOGEN, V7, P139; RESNICK MA, 1979, NUCLEIC ACIDS RES, V6, P3145, DOI 10.1093/nar/6.9.3145; Riha K, 2006, ANNU REV GENET, V40, P237, DOI 10.1146/annurev.genet.39.110304.095755; Rizki A, 2001, NATURE, V411, P713, DOI 10.1038/35079641; RONNE H, 1988, P NATL ACAD SCI USA, V85, P2696, DOI 10.1073/pnas.85.8.2696; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SCHILD D, 1983, CLONING YEAST RECOMB; Sharma GG, 2003, ONCOGENE, V22, P131, DOI 10.1038/sj.onc.1206063; SHAY JW, 1993, EXP CELL RES, V209, P45, DOI 10.1006/excr.1993.1283; Sherman F., 1986, METHODS YEAST GENETI; Shin KH, 2004, CLIN CANCER RES, V10, P2551, DOI 10.1158/1078-0432.CCR-0669-3; SIKORSKI RS, 1989, GENETICS, V122, P19; Singer MS, 1998, GENETICS, V150, P613; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Strout MP, 1998, P NATL ACAD SCI USA, V95, P2390, DOI 10.1073/pnas.95.5.2390; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; SUNG P, 1993, J BIOL CHEM, V268, P26391; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; THOMAS BJ, 1989, GENETICS, V123, P725; TOMKINSON AE, 1993, NATURE, V362, P860, DOI 10.1038/362860a0; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Wu Y, 2006, J BIOL CHEM, V281, P40001, DOI 10.1074/jbc.M608071200; ZWELLING LA, 1981, BIOCHEMISTRY-US, V20, P6553, DOI 10.1021/bi00526a006	82	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3318	10.1371/journal.pone.0003318	http://dx.doi.org/10.1371/journal.pone.0003318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830407	Green Submitted, Green Published, gold			2022-12-27	WOS:000264797300008
J	Tran, TA; de Herve, MGD; Hendel-Chavez, H; Dembele, B; Le Nevot, E; Abbed, K; Pallier, C; Goujard, C; Gasnault, J; Delfraissy, JF; Balazuc, AM; Taoufik, Y				Tran, Tu-Anh; de Herve, Marie-Ghislaine de Goer; Hendel-Chavez, Houria; Dembele, Bamory; Le Nevot, Emilie; Abbed, Karim; Pallier, Coralie; Goujard, Cecile; Gasnault, Jacques; Delfraissy, Jean-Francois; Balazuc, Anne-Marie; Taoufik, Yassine			Resting Regulatory CD4 T Cells: A Site of HIV Persistence in Patients on Long-Term Effective Antiretroviral Therapy	PLOS ONE			English	Article								Background: In HIV-infected patients on long-term HAART, virus persistence in resting long-lived CD4 T cells is a major barrier to curing the infection. Cell quiescence, by favouring HIV latency, reduces the risk of recognition and cell destruction by cytotoxic lymphocytes. Several cell-activation-based approaches have been proposed to disrupt cell quiescence and then virus latency, but these approaches have not eradicated the virus. CD4(+)CD25(+) regulatory T cells (Tregs) are a CD4(+) T-cell subset with particular activation properties. We investigated the role of these cells in virus persistence in patients on long-term HAART. Methodology/Principal Findings: We found evidence of infection of resting Tregs (HLADR(-)CD69(-)CD25(hi)FoxP3(+)CD4(+) T cells) purified from patients on prolonged HAART. HIV DNA harbouring cells appear more abundant in the Treg subset than in non-Tregs. The half-life of the Treg reservoir was estimated at 20 months. Since Tregs from patients on prolonged HAART showed hyporesponsiveness to cell activation and inhibition of HIV-specific cytotoxic T lymphocyte-related functions upon activation, therapeutics targeting cell quiescence to induce virus expression may not be appropriate for purging the Treg reservoir. Conclusions: Our results identify Tregs as a particular compartment within the latent reservoir that may require a specific approach for its purging.	[Tran, Tu-Anh; de Herve, Marie-Ghislaine de Goer; Dembele, Bamory; Goujard, Cecile; Gasnault, Jacques; Delfraissy, Jean-Francois; Taoufik, Yassine] Univ Paris 11, INSERM, U802, Le Kremlin Bicetre, France; [Hendel-Chavez, Houria; Le Nevot, Emilie; Abbed, Karim; Taoufik, Yassine] AP HP, Hop Bicetre, Unite Immunol Biol, Le Kremlin Bicetre, France; [Goujard, Cecile; Gasnault, Jacques; Delfraissy, Jean-Francois] AP HP, Hop Bicetre, Serv Med Interne, Le Kremlin Bicetre, France; [Pallier, Coralie] AP HP, Hop Bicetre, Lab Virol, Le Kremlin Bicetre, France; [Balazuc, Anne-Marie] Inst Pasteur, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tran, TA (corresponding author), Univ Paris 11, INSERM, U802, Le Kremlin Bicetre, France.	yacine.taoufik@bct.aphp.fr		DEMBELE, Bamory/0000-0002-6165-9090; TRAN, Tu-Anh/0000-0001-6587-1876	INSERM; ANRS; SIDACTION; Universite Paris 11	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANRS(ANRSFrench National Research Agency (ANR)); SIDACTION; Universite Paris 11	The work was supported by grants from INSERM, ANRS, SIDACTION and Universite Paris 11.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Camara NOS, 2003, EUR J IMMUNOL, V33, P3473, DOI 10.1002/eji.200323966; Chase AJ, 2007, J VIROL, V81, P12748, DOI 10.1128/JVI.00841-07; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Demoustier A, 2002, AIDS, V16, P1749, DOI 10.1097/00002030-200209060-00006; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; GEERAERT L, 2007, ANN REV MED; Grant C, 2006, PLOS PATHOG, V2, P303, DOI 10.1371/journal.ppat.0020033; Harnaha J, 2006, DIABETES, V55, P158, DOI 10.2337/diabetes.55.01.06.db05-0340; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Iyasere C, 2003, J VIROL, V77, P10900, DOI 10.1128/JVI.77.20.10900-10909.2003; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Lambotte O, 2002, AIDS, V16, P2151, DOI 10.1097/00002030-200211080-00007; Lambotte O, 2000, J ACQ IMMUN DEF SYND, V23, P114; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Li LQ, 2005, BLOOD, V106, P3068, DOI 10.1182/blood-2005-04-1531; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Ramratnam B, 2004, JAIDS-J ACQ IMM DEF, V35, P33, DOI 10.1097/00126334-200401010-00004; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; von Boehmer H, 2003, J EXP MED, V198, P845, DOI 10.1084/jem.20031358; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yang QE, 2004, MED SCI MONITOR, V10, pRA155; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	51	67	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2008	3	10							e3305	10.1371/journal.pone.0003305	http://dx.doi.org/10.1371/journal.pone.0003305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RU	18827929	Green Submitted, Green Published, gold			2022-12-27	WOS:000264797200010
J	Nasr, S; Moeeny, A; Esteky, H				Nasr, Shahin; Moeeny, Ali; Esteky, Hossein			Neural Correlate of Filtering of Irrelevant Information from Visual Working Memory	PLOS ONE			English	Article							FRONTAL EYE FIELDS; PREFRONTAL CORTEX; PARIETAL CORTEX; ATTENTION; CONNECTIVITY; MODULATION; CAPACITY	In a dynamic environment stimulus task relevancy could be altered through time and it is not always possible to dissociate relevant and irrelevant objects from the very first moment they come to our sight. In such conditions, subjects need to retain maximum possible information in their WM until it is clear which items should be eliminated from WM to free attention and memory resources. Here, we examined the neural basis of irrelevant information filtering from WM by recording human ERP during a visual change detection task in which the stimulus irrelevancy was revealed in a later stage of the task forcing the subjects to keep all of the information in WM until test object set was presented. Assessing subjects' behaviour we found that subjects' RT was highly correlated with the number of irrelevant objects and not the relevant one, pointing to the notion that filtering, and not selection, process was used to handle the distracting effect of irrelevant objects. In addition we found that frontal N150 and parietal N200 peak latencies increased systematically as the amount of irrelevancy load increased. Interestingly, the peak latency of parietal N200, and not frontal N150, better correlated with subjects' RT. The difference between frontal N150 and parietal N200 peak latencies varied with the amount of irrelevancy load suggesting that functional connectivity between modules underlying fronto-parietal potentials vary concomitant with the irrelevancy load. These findings suggest the existence of two neural modules, responsible for irrelevant objects elimination, whose activity latency and functional connectivity depend on the number of irrelevant object.	[Nasr, Shahin; Moeeny, Ali; Esteky, Hossein] IPM, Sch Cognit Sci, Tehran, Iran; [Nasr, Shahin; Moeeny, Ali; Esteky, Hossein] Shahid Beheshti Univ, Sch Med, Res Ctr Brain & Cognit Sci, Tehran, Iran; [Esteky, Hossein] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran	Shahid Beheshti University; Shahid Beheshti University Medical Sciences	Nasr, S (corresponding author), IPM, Sch Cognit Sci, Tehran, Iran.	esteky@ipm.ir		Lauwereyns, Jan/0000-0003-0551-2550				Banich MT, 2001, PROG BRAIN RES, V134, P459; Barbas H, 2005, CEREB CORTEX, V15, P1356, DOI 10.1093/cercor/bhi018; Beck DM, 2006, CEREB CORTEX, V16, P712, DOI 10.1093/cercor/bhj017; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Buchel C, 2000, NEURAL NETWORKS, V13, P871, DOI 10.1016/S0893-6080(00)00066-6; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; CHAO LL, 1995, NEUROREPORT, V6, P1605, DOI 10.1097/00001756-199508000-00005; Griffin IC, 2003, J COGNITIVE NEUROSCI, V15, P1176, DOI 10.1162/089892903322598139; Honey GD, 2002, NEUROIMAGE, V17, P573, DOI 10.1006/nimg.2002.1193; Hopf JM, 2000, CEREB CORTEX, V10, P1233, DOI 10.1093/cercor/10.12.1233; Lepsien J, 2005, NEUROIMAGE, V26, P733, DOI 10.1016/j.neuroimage.2005.02.026; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Medalla M, 2007, CEREB CORTEX, V17, pI136, DOI 10.1093/cercor/bhm068; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 1996, J NEUROSCI, V16, P5154; Muggleton NG, 2003, J NEUROPHYSIOL, V89, P3340, DOI 10.1152/jn.01086.2002; O'Shea J, 2006, VIS COGN, V14, P934, DOI 10.1080/13506280500197363; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; Posner MI, 1998, ATTENTIVE BRAIN, P401; Rainer G, 2002, NEUROSCIENTIST, V8, P6, DOI 10.1177/107385840200800104; Rowe J, 2002, NEUROIMAGE, V17, P988, DOI 10.1006/nimg.2002.1156; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48	31	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3282	10.1371/journal.pone.0003282	http://dx.doi.org/10.1371/journal.pone.0003282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422ML	18818772	Green Submitted, Green Published, gold			2022-12-27	WOS:000264432300004
J	Hall, KJ; Harper, MT; Gilio, K; Cosemans, JM; Heemskerk, JWM; Poole, AW				Hall, Kellie J.; Harper, Matthew T.; Gilio, Karen; Cosemans, Judith M.; Heemskerk, Johan W. M.; Poole, Alastair W.			Genetic Analysis of the Role of Protein Kinase C theta in Platelet Function and Thrombus Formation	PLOS ONE			English	Article								Background: PKC theta is a novel protein kinase C isozyme, predominately expressed in T cells and platelets. PKC theta(-/-) T cells exhibit reduced activation and PKC theta(-/-) mice are resistant to autoimmune disease, making PKC theta an attractive therapeutic target for immune modulation. Collagen is a major agonist for platelets, operating through an immunoreceptor-like signalling pathway from its receptor GPVI. Although it has recently been shown that PKC theta positively regulates outside-in signalling through integrin alpha(IIb)beta(3) in platelets, the role of PKC theta in GPVI-dependent signalling and functional activation of platelets has not been assessed. Methodology/Principal Findings: In the present study we assessed static adhesion, cell spreading, granule secretion, integrin alpha(IIb)beta(3) activation and platelet aggregation in washed mouse platelets lacking PKC theta. Thrombus formation on a collagen-coated surface was assessed in vitro under flow. PKC theta(-/-) platelets exhibited reduced static adhesion and filopodia generation on fibrinogen, suggesting that PKC theta positively regulates outside-in signalling, in agreement with a previous report. In contrast, PKC theta(-/-) platelets also exhibited markedly enhanced GPVI-dependent alpha-granule secretion, although dense granule secretion was unaffected, suggesting that PKC theta differentially regulates these two granules. Inside-out regulation of alpha(IIb)beta(3) activation was also enhanced downstream of GPVI stimulation. Although this did not result in increased aggregation, importantly thrombus formation on collagen under high shear (1000 s(-1)) was enhanced. Conclusions/Significance: These data suggest that PKC theta is an important negative regulator of thrombus formation on collagen, potentially mediated by alpha-granule secretion and aIIbb3 activation. PKC theta therefore may act to restrict thrombus growth, a finding that has important implications for the development and safe clinical use of PKC theta inhibitors.	[Hall, Kellie J.; Harper, Matthew T.; Poole, Alastair W.] Univ Bristol, Dept Physiol & Pharmacol, Bristol, Avon, England; [Gilio, Karen; Cosemans, Judith M.; Heemskerk, Johan W. M.] Univ Maastricht, Dept Biochem, Maastricht, Netherlands	University of Bristol; Maastricht University	Hall, KJ (corresponding author), Univ Bristol, Dept Physiol & Pharmacol, Bristol, Avon, England.	a.poole@bris.ac.uk	Cosemans, Judith MEM/C-8161-2016; Heemskerk, Johan/AAM-8323-2021; Harper, Matthew T/G-5630-2013	Cosemans, Judith MEM/0000-0001-7429-0109; Heemskerk, Johan/0000-0002-2848-5121; Harper, Matthew T/0000-0002-4740-637X; Poole, Alastair/0000-0002-0868-297X	British Heart Foundation [RG/05/015]; Netherlands Foundation for Scientific research [11-400-076]; BBSRC Research Development Fellow [BB/E024637/1]; BBSRC [BB/E024637/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E024637/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Netherlands Foundation for Scientific research(Netherlands Organization for Scientific Research (NWO)); BBSRC Research Development Fellow(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a British Heart Foundation programme grant to AWP (grant no. RG/05/015) and a grant from the Netherlands Foundation for Scientific research to JWMH (11-400-076). AWP is a BBSRC Research Development Fellow (BB/E024637/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2006, AUTOIMMUNITY, V39, P469, DOI 10.1080/08916930600907954; BAIER G, 1993, J BIOL CHEM, V268, P4997; BALDWIN BG, 1992, MOL PHYLOGENET EVOL, V1, P2; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; CHANG JD, 1993, J BIOL CHEM, V268, P14208; CRABOS M, 1991, BIOCHEM BIOPH RES CO, V178, P878, DOI 10.1016/0006-291X(91)90973-B; Crosby D, 2003, J BIOL CHEM, V278, P24533, DOI 10.1074/jbc.M301847200; Crosby D, 2002, J BIOL CHEM, V277, P9958, DOI 10.1074/jbc.M108965200; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; GRABAREK J, 1992, J BIOL CHEM, V267, P10011; Harper MT, 2007, BIOCHEM SOC T, V35, P1005, DOI 10.1042/BST0351005; Healy AM, 2006, J IMMUNOL, V177, P1886, DOI 10.4049/jimmunol.177.3.1886; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; McCarty OJT, 2005, J BIOL CHEM, V280, P39474, DOI 10.1074/jbc.M504672200; McGovern SL, 2003, J MED CHEM, V46, P1478, DOI 10.1021/jm020427b; Mosyak L, 2007, BIOCHEM SOC T, V35, P1027, DOI 10.1042/BST0351027; Murugappan S, 2004, J BIOL CHEM, V279, P2360, DOI 10.1074/jbc.M306960200; Nesbitt WS, 2006, J MOL MED, V84, P989, DOI 10.1007/s00109-006-0101-1; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Pula G, 2006, BLOOD, V108, P4035, DOI 10.1182/blood-2006-05-023739; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; Strehl A, 2007, J BIOL CHEM, V282, P7046, DOI 10.1074/jbc.M611367200; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tabuchi A, 2003, J BIOL CHEM, V278, P26374, DOI 10.1074/jbc.M212407200; Tan SL, 2006, J IMMUNOL, V176, P2872, DOI 10.4049/jimmunol.176.5.2872; Thornber K, 2006, FEBS J, V273, P5032, DOI 10.1111/j.1742-4658.2006.05500.x; WANG F, 1993, BIOCHEM BIOPH RES CO, V191, P240, DOI 10.1006/bbrc.1993.1208; Yoshioka A, 2001, J BIOL CHEM, V276, P39379, DOI 10.1074/jbc.M102933200	32	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2008	3	9							e3277	10.1371/journal.pone.0003277	http://dx.doi.org/10.1371/journal.pone.0003277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MH	18815612	Green Submitted, Green Published, gold			2022-12-27	WOS:000264431900004
J	Yu, YH; Kuo, HK; Chang, KW				Yu, Yau-Hua; Kuo, Hsu-Ko; Chang, Kuo-Wei			The Evolving Transcriptome of Head and Neck Squamous Cell Carcinoma: A Systematic Review	PLOS ONE			English	Review								Background: Numerous studies were performed to illuminate mechanisms of tumorigenesis and metastases from gene expression profiles of Head and Neck Squamous Cell Carcinoma (HNSCC). The objective of this review is to conduct a network-based meta-analysis to identify the underlying biological signatures of the HNSCC transcriptome. Methods and Findings: We included 63 HNSCC transcriptomic studies into three specific categories of comparisons: Pre, premalignant lesions v.s. normal; TvN, primary tumors v.s. normal; and Meta, metastatic or invasive v. s. primary tumors. Reported genes extracted from the literature were systematically analyzed. Participation of differential gene activities across three progressive stages deciphered the evolving nature of HNSCC. In total, 1442 genes were verified, i.e. reported at least twice, with ECM1, EMP1, CXCL10 and POSTN shown to be highly reported across all three stages. Knowledge-based networks of the HNSCC transcriptome were constructed, demonstrating integrin signaling and antigen presentation pathways as highly enriched. Notably, functional estimates derived from topological characteristics of integrin signaling networks identified such important genes as ITGA3 and ITGA5, which were supported by findings of invasiveness in vitro [1]. Moreover, we computed genome-wide probabilities of reporting differential gene activities for the Pre, TvN, and Meta stages, respectively. Results highlighted chromosomal regions of 6p21, 19p13 and 19q13, where genomic alterations were shown to be correlated with the nodal status of HNSCC [2]. Conclusions: By means of a systems-biology approach via network-based meta-analyses, we provided a deeper insight into the evolving nature of the HNSCC transcriptome. Enriched canonical signaling pathways, hot-spots of transcriptional profiles across the genome, as well as topologically significant genes derived from network analyses were highlighted for each of the three progressive stages, Pre, TvN, and Meta, respectively.	[Yu, Yau-Hua; Chang, Kuo-Wei] Natl Yang Ming Univ, Sch Dent, Taipei 112, Taiwan; [Yu, Yau-Hua; Chang, Kuo-Wei] Taipei Vet Gen Hosp, Dept Med Res & Ed, Dept Dent, Taipei, Taiwan; [Kuo, Hsu-Ko] Natl Taiwan Univ Hosp, Dept Internal Med, Dept Geriat & Gerontol, Taipei, Taiwan; [Kuo, Hsu-Ko] Natl Hlth Res Inst, Div Gerontol Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Yu, YH (corresponding author), Natl Yang Ming Univ, Sch Dent, Taipei 112, Taiwan.	yauhuayu@gmail.com; hsukokuo@yahoo.com			Ministry of Education, Aim for the Top University Plan, Taiwan; National Health and Research Institutes [GE-095-CP0]	Ministry of Education, Aim for the Top University Plan, Taiwan(Ministry of Education, Taiwan); National Health and Research Institutes(National Health Research Institutes - Taiwan)	Dr. Yu was supported by a grant from Ministry of Education, Aim for the Top University Plan, Taiwan. Dr. Kuo was supported by the National Health and Research Institutes (Project code: GE-095-CP0).	Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Choi P, 2005, CANCER-AM CANCER SOC, V104, P1113, DOI 10.1002/cncr.21293; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hu ZJ, 2007, NAT BIOTECHNOL, V25, P547, DOI 10.1038/nbt1304; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nagata M, 2003, INT J CANCER, V106, P683, DOI 10.1002/ijc.11283; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Roepman P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r117; Scherrer K, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100123; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Seiwert TY, 2007, NAT CLIN PRACT ONCOL, V4, P156, DOI 10.1038/ncponc0750; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Vachani A, 2007, CLIN CANCER RES, V13, P2905, DOI 10.1158/1078-0432.CCR-06-1670; Weber F, 2007, JAMA-J AM MED ASSOC, V297, P187, DOI 10.1001/jama.297.2.187; YU YH, 2005, INTEGRATIVE GENOMICS, P146; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	22	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2008	3	9							e3215	10.1371/journal.pone.0003215	http://dx.doi.org/10.1371/journal.pone.0003215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KX	18791647	gold, Green Submitted, Green Published			2022-12-27	WOS:000264427700010
J	Wamstad, JA; Corcoran, CM; Keating, AM; Bardwell, VJ				Wamstad, Joseph Alan; Corcoran, Connie Marie; Keating, Anne Marjorie; Bardwell, Vivian J.			Role of the Transcriptional Corepressor Bcor in Embryonic Stem Cell Differentiation and Early Embryonic Development	PLOS ONE			English	Article								Bcor (BCL6 corepressor) is a widely expressed gene that is mutated in patients with X-linked Oculofaciocardiodental (OFCD) syndrome. BCOR regulates gene expression in association with a complex of proteins capable of epigenetic modification of chromatin. These include Polycomb group (PcG) proteins, Skp-Cullin-F-box (SCF) ubiquitin ligase components and a Jumonji C (Jmjc) domain containing histone demethylase. To model OFCD in mice and dissect the role of Bcor in development we have characterized two loss of function Bcor alleles. We find that Bcor loss of function results in a strong parent-of-origin effect, most likely indicating a requirement for Bcor in extraembryonic development. Using Bcor loss of function embryonic stem (ES) cells and in vitro differentiation assays, we demonstrate that Bcor plays a role in the regulation of gene expression very early in the differentiation of ES cells into ectoderm, mesoderm and downstream hematopoietic lineages. Normal expression of affected genes (Oct3/4, Nanog, Fgf5, Bmp4, Brachyury and Flk1) is restored upon re-expression of Bcor. Consistent with these ES cell results, chimeric animals generated with the same loss of function Bcor alleles show a low contribution to B and T cells and erythrocytes and have kinked and shortened tails, consistent with reduced Brachyury expression. Together these results suggest that Bcor plays a role in differentiation of multiple tissue lineages during early embryonic development.	[Wamstad, Joseph Alan; Bardwell, Vivian J.] Univ Minnesota, Mol Cellular Dev Biol & Genet Grad Program, Minneapolis, MN 55455 USA; [Corcoran, Connie Marie; Bardwell, Vivian J.] Univ Minnesota, Canc Ctr, Dept Genet, Cell Biol & Dev, Minneapolis, MN USA; [Keating, Anne Marjorie] Univ Minnesota, Biochem, Mol Biol & Biophys Grad Program, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wamstad, JA (corresponding author), Univ Minnesota, Mol Cellular Dev Biol & Genet Grad Program, Minneapolis, MN 55455 USA.	bardw001@umn.edu			NCI [R01 CA071540]; NIH [T32DE07288]; University of Minnesota Cancer Center; NATIONAL CANCER INSTITUTE [R01CA071540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Cancer Center(University of Minnesota System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for this work was provided by NCI (R01 CA071540), NIH (T32DE07288) and the University of Minnesota Cancer Center. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, MAMM GENOME, V11, P238, DOI 10.1007/s003350010044; Asari S, 2005, EXP HEMATOL, V33, P26, DOI 10.1016/j.exphem.2004.10.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Carter M, 2005, P NATL ACAD SCI USA, V102, P12843, DOI 10.1073/pnas.0501963102; Choi YJ, 2005, CRIT REV EUKAR GENE, V15, P207, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.30; Collins EC, 2002, MOL CELL BIOL, V22, P7313, DOI 10.1128/MCB.22.20.7313-7324.2002; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Davies W, 2005, NAT GENET, V37, P625, DOI 10.1038/ng1577; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; HAUB O, 1991, DEVELOPMENT, V112, P397; HEBERT JM, 1991, DEVELOPMENT, V112, P407; Hedera P, 2003, AM J MED GENET A, V123A, P261, DOI 10.1002/ajmg.a.20444; Hemberger M, 2002, CYTOGENET GENOME RES, V99, P210, DOI 10.1159/000071595; HILTON E, 2008, INBORN ERRO IN PRESS; Hilton EN, 2007, HUM MOL GENET, V16, P1773, DOI 10.1093/hmg/ddm125; Huynh KD, 2000, GENE DEV, V14, P1810; Ichii H, 2007, INT IMMUNOL, V19, P427, DOI 10.1093/intimm/dxm007; Jardin F, 2007, PATHOL BIOL, V55, P73, DOI 10.1016/j.patbio.2006.04.001; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kennedy M, 2003, METHOD ENZYMOL, V365, P39; Kojima S, 2001, DEVELOPMENT, V128, P57; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; LEDBETTER JA, 1979, IMMUNOGENETICS, V8, P347, DOI 10.1007/BF01561445; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; McGovern E, 2006, INT J ORAL MAX SURG, V35, P1060, DOI 10.1016/j.ijom.2006.05.001; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Newkirk KM, 2007, TOXICOL PATHOL, V35, P817, DOI 10.1080/01926230701584197; Ng D, 2004, NAT GENET, V36, P411, DOI 10.1038/ng1321; Ng D, 2002, AM J MED GENET, V110, P308, DOI 10.1002/ajmg.10484; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Osoegawa K, 2000, GENOME RES, V10, P116; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Park C, 2005, EXP HEMATOL, V33, P965, DOI 10.1016/j.exphem.2005.06.003; Pasqualucci L, 2003, LEUKEMIA LYMPHOMA, V44, pS5, DOI 10.1080/10428190310001621588; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Raefski AS, 2005, NAT GENET, V37, P620, DOI 10.1038/ng1567; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; ROVERA G, 1978, ANAL BIOCHEM, V85, P506, DOI 10.1016/0003-2697(78)90248-8; Russell JE, 1998, BLOOD, V92, P3057, DOI 10.1182/blood.V92.9.3057.421k57_3057_3063; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Srinivasan RS, 2003, ONCOGENE, V22, P3395, DOI 10.1038/sj.onc.1206361; Staudt L M, 1999, Int Rev Immunol, V18, P381, DOI 10.3109/08830189909088490; STOTT D, 1993, GENE DEV, V7, P197, DOI 10.1101/gad.7.2.197; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tovar V, 2000, IMMUNOGENETICS, V51, P788, DOI 10.1007/s002510000209; Wamstad JA, 2007, GENE EXPR PATTERNS, V7, P550, DOI 10.1016/j.modgep.2007.01.006; WHITNEY JB, 1979, P NATL ACAD SCI USA, V76, P867, DOI 10.1073/pnas.76.2.867; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wolf NS, 2000, EXP EYE RES, V70, P683, DOI 10.1006/exer.2000.0835; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zhang WJ, 2003, METHOD ENZYMOL, V365, P186	66	58	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2814	10.1371/journal.pone.0002814	http://dx.doi.org/10.1371/journal.pone.0002814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18795143	gold, Green Submitted, Green Published			2022-12-27	WOS:000264304300033
J	Fridley, JD				Fridley, Jason D.			Of Asian Forests and European Fields: Eastern US Plant Invasions in a Global Floristic Context	PLOS ONE			English	Article							ALIEN PLANTS; INVASIVENESS; DIVERSITY; AMERICA; PATTERN	Background: Biogeographic patterns of species invasions hold important clues to solving the recalcitrant 'who', 'where', and 'why' questions of invasion biology, but the few existing studies make no attempt to distinguish alien floras (all non-native occurrences) from invasive floras (rapidly spreading species of significant management concern), nor have invasion biologists asked whether particular habitats are consistently invaded by species from particular regions. Methodology/Principal Findings: Here I describe the native floristic provenances of the 2629 alien plant taxa of the Eastern Deciduous Forest of the Eastern U. S. (EUS), and contrast these to the subset of 449 taxa that EUS management agencies have labeled 'invasive'. Although EUS alien plants come from all global floristic regions, nearly half (45%) have native ranges that include central and northern Europe or the Mediterranean (39%). In contrast, EUS invasive species are most likely to come from East Asia (29%), a pattern that is magnified when the invasive pool is restricted to species that are native to a single floristic region (25% from East Asia, compared to only 11% from northern/central Europe and 2% from the Mediterranean). Moreover, East Asian invaders are mostly woody (56%, compared to just 23% of the total alien flora) and are significantly more likely to invade intact forests and riparian areas than European species, which dominate managed or disturbed ecosystems. Conclusions/Significance: These patterns suggest that the often-invoked 'imperialist dogma' view of global invasions equating invasion events with the spread of European colonialism is at best a restricted framework for invasion in disturbed ecosystems. This view must be superseded by a biogeographic invasion theory that is explicitly habitat-specific and can explain why particular world biotas tend to dominate particular environments.	[Fridley, Jason D.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Fridley, JD (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	fridley@syr.edu						Binggeli P, 1996, J VEG SCI, V7, P121, DOI 10.2307/3236424; BOUFFORD DE, 1983, ANN MO BOT GARD, V70, P423, DOI 10.2307/2992081; Braun E.L, 1950, SOIL SCI, V71, P155, DOI [10.1097/00010694-195102000-00012, DOI 10.1097/00010694-195102000-00012]; Brown JH, 2004, AUSTRAL ECOL, V29, P530, DOI 10.1111/j.1442-9993.2004.01340.x; Cassey P, 2005, AUSTRAL ECOL, V30, P475, DOI 10.1111/j.1442-9993.2005.01505.x; Cox CB, 2001, J BIOGEOGR, V28, P511; Crawley M. J., 1987, COLONIZATION SUCCESS, V26, P429; Crawley MJ, 1996, PHILOS T R SOC B, V351, P1251, DOI 10.1098/rstb.1996.0108; Crosby Alfred W., 1986, ECOLOGICAL IMPERIALI; Daehler CC, 1998, BIOL CONSERV, V84, P167, DOI 10.1016/S0006-3207(97)00096-7; Darwin Charles, 1859, ORIGIN SPECIES FACSI; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Diamond, 1999, GUNS GERMS STEEL FAT; diCastri F, 1989, BIOL INVASIONS GLOBA, P1; *FLOR N AM ED COMM, 1993, FLOR N AM N MEX; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Gleason H.A., 1991, MANUAL VASCULAR PLAN, V2nd ed.; Good R, 1964, GEOGRAPHY FLOWERING; Good R., 1974, GEOGRAPHY FLOWERING; Good R., 1947, GEOGRAPHY FLOWERING; Good R., 1953, GEOGRAPHY FLOWERING; Goodwin BJ, 1999, CONSERV BIOL, V13, P422, DOI 10.1046/j.1523-1739.1999.013002422.x; Grime J. P., 1979, Plant strategies and vegetation processes.; Groves R. H., 1991, Biogeography of mediterranean invasions., P427, DOI 10.1017/CBO9780511525544.034; HARAGAN PD, 1991, WEEDS KENTUCKY ADJAC; Heywood VH, 1989, BIOL INVASIONS GLOBA, V37, P31; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hoffman R., 1997, WISCONSIN MANUAL CON; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Legendre P., 2012, NUMERICAL ECOLOGY; Li H. L., 1952, Transactions of the American Philosophical Society, Philadelphia, V42, P371, DOI 10.2307/1005654; Liu J, 2006, BIOL INVASIONS, V8, P1461, DOI 10.1007/s10530-005-5838-x; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Mack RN, 2003, ANN MO BOT GARD, V90, P77, DOI 10.2307/3298528; Mack RN, 2003, INT J PLANT SCI, V164, pS185, DOI 10.1086/368399; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek P, 1998, OIKOS, V82, P282, DOI 10.2307/3546968; Qian H, 2002, AM NAT, V160, P317, DOI 10.1086/341523; R Development Core Team, 2006, R LANG ENV STAT COMP; Rejmanek M, 1996, BIOL CONSERV, V78, P171, DOI 10.1016/0006-3207(96)00026-2; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Ruesink J. L., 1995, BioScience, V45, P465, DOI 10.2307/1312790; Salisbury E. J., 1961, WEEDS ALIENS; *SE EX PEST PLANT, 1996, INV EX PEST PLANTS T; Sokal R. H., 1995, BIOMETRY PRINCIPLES; SWEARINGEN J, 2008, WEEDUS DATABASE PLAN; Takhtajan A, 1986, FLORISTIC REGIONS WO, P522; Thompson K, 1995, ECOGRAPHY, V18, P390, DOI 10.1111/j.1600-0587.1995.tb00142.x; *USDA ARS, 2007, GERMPL RES INF NETW; USDA NRCS, 2007, PLANTS DAT; Uva RH., 1997, WEEDS NE, P408; Vermeij GJ, 1996, BIOL CONSERV, V78, P3, DOI 10.1016/0006-3207(96)00013-4; Vermeij GJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P315; Vila M, 2001, BIOL CONSERV, V100, P397, DOI 10.1016/S0006-3207(01)00047-7; WEAKLEY A, 2008, FLORA CAROLINAS VIRG; Webster CR, 2006, J FOREST, V104, P366; WHITE PS, 1983, ANN MO BOT GARD, V70, P734, DOI 10.2307/2398988; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0	63	54	56	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3630	10.1371/journal.pone.0003630	http://dx.doi.org/10.1371/journal.pone.0003630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978940	Green Published, gold			2022-12-27	WOS:000265134200012
J	Kwak, J; Willse, A; Matsumura, K; Opiekun, MC; Yi, WG; Preti, G; Yamazaki, K; Beauchamp, GK				Kwak, Jae; Willse, Alan; Matsumura, Koichi; Opiekun, Maryanne Curran; Yi, Weiguang; Preti, George; Yamazaki, Kunio; Beauchamp, Gary K.			Genetically-Based Olfactory Signatures Persist Despite Dietary Variation	PLOS ONE			English	Article								Individual mice have a unique odor, or odortype, that facilitates individual recognition. Odortypes, like other phenotypes, can be influenced by genetic and environmental variation. The genetic influence derives in part from genes of the major histocompatibility complex (MHC). A major environmental influence is diet, which could obscure the genetic contribution to odortype. Because odortype stability is a prerequisite for individual recognition under normal behavioral conditions, we investigated whether MHC-determined urinary odortypes of inbred mice can be identified in the face of large diet-induced variation. Mice trained to discriminate urines from panels of mice that differed both in diet and MHC type found the diet odor more salient in generalization trials. Nevertheless, when mice were trained to discriminate mice with only MHC differences (but on the same diet), they recognized the MHC difference when tested with urines from mice on a different diet. This indicates that MHC odor profiles remain despite large dietary variation. Chemical analyses of urinary volatile organic compounds (VOCs) extracted by solid phase microextraction (SPME) and analyzed by gas chromatography/mass spectrometry (GC/MS) are consistent with this inference. Although diet influenced VOC variation more than MHC, with algorithmic training (supervised classification) MHC types could be accurately discriminated across different diets. Thus, although there are clear diet effects on urinary volatile profiles, they do not obscure MHC effects.	[Kwak, Jae; Matsumura, Koichi; Opiekun, Maryanne Curran; Yi, Weiguang; Preti, George; Yamazaki, Kunio; Beauchamp, Gary K.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Willse, Alan] Battelle Mem Inst, Pacific NW Div, Richland, WA USA; [Preti, George] Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA	Monell Chemical Senses Center; Battelle Memorial Institute; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Pennsylvania	Kwak, J (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	beauchamp@monell.org	Kwak, Jae/E-5781-2011	Kwak, Jae/0000-0003-4216-2019	ARO [DAAD19-03-1-0109]	ARO	This work is supported by ARO contract DAAD19-03-1-0109. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the United States Government.	ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Beauchamp GK, 2003, BIOCHEM SOC T, V31, P147; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boehm T, 2006, TRENDS NEUROSCI, V29, P100, DOI 10.1016/j.tins.2005.11.006; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Brown RE, 1996, PHYSIOL BEHAV, V60, P365, DOI 10.1016/0031-9384(96)00030-3; Cheetham SA, 2007, CURR BIOL, V17, P1771, DOI 10.1016/j.cub.2007.10.007; Ferkin MH, 1997, ANIM BEHAV, V53, P133, DOI 10.1006/anbe.1996.0284; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gallagher M, 2008, ENVIRON SCI TECHNOL, V42, P243, DOI 10.1021/es071555y; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Kayali-Sayadi MN, 2003, J CHROMATOGR B, V796, P55, DOI 10.1016/j.jchromb.2003.08.001; KWAK J, 2007, 29 ANN M ASS CHEM SC; KWAK J, PHYSL BEHAV IN PRESS; Legendre P., 2012, NUMERICAL ECOLOGY; LEON M, 1975, PHYSIOL BEHAV, V14, P311, DOI 10.1016/0031-9384(75)90039-6; LIEBICH HM, 1977, BIOMED MASS SPECTROM, V4, P69, DOI 10.1002/bms.1200040202; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Lynch M., 1998, GENETICS ANAL QUANTI; Novotny MV, 2007, J CHEM ECOL, V33, P417, DOI 10.1007/s10886-006-9230-9; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; Penn D, 1998, ADV IMMUNOL, V69, P411, DOI 10.1016/S0065-2776(08)60612-4; POTTS WK, 1991, NATURE, V352, P619, DOI 10.1038/352619a0; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Restrepo D, 2006, TRENDS NEUROSCI, V29, P604, DOI 10.1016/j.tins.2006.08.001; Rock F, 2006, J CHEM ECOL, V32, P1333, DOI 10.1007/s10886-006-9091-2; Saini S, 2001, Biologist (London), V48, P229; Schellinck HM, 1997, ANIM LEARN BEHAV, V25, P193, DOI 10.3758/BF03199058; SCHWENDE FJ, 1986, J CHEM ECOL, V12, P277, DOI 10.1007/BF01045611; Sherborne AL, 2007, CURR BIOL, V17, P2061, DOI 10.1016/j.cub.2007.10.041; Singer AG, 1997, P NATL ACAD SCI USA, V94, P2210, DOI 10.1073/pnas.94.6.2210; SINGER AG, 1993, J CHEM ECOL, V19, P569, DOI 10.1007/BF00994326; VALENTA JG, 1968, SCIENCE, V161, P599, DOI 10.1126/science.161.3841.599; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Walker V, 2001, CLIN CHIM ACTA, V306, P51, DOI 10.1016/S0009-8981(01)00390-4; Willse A, 2005, ANAL CHEM, V77, P2348, DOI 10.1021/ac048711t; Willse A, 2006, IMMUNOGENETICS, V58, P967, DOI 10.1007/s00251-006-0162-x; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; YAMAZAKI K, 1994, P NATL ACAD SCI USA, V91, P3735, DOI 10.1073/pnas.91.9.3735; YAMAZAKI K, 1986, P NATL ACAD SCI USA, V83, P4438, DOI 10.1073/pnas.83.12.4438; Yamazaki K, 2002, P NATL ACAD SCI USA, V99, P5612, DOI 10.1073/pnas.082093099	41	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3591	10.1371/journal.pone.0003591	http://dx.doi.org/10.1371/journal.pone.0003591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974891	Green Submitted, Green Published, gold			2022-12-27	WOS:000265131700012
J	Pizarro, JC; Stevens, L				Pizarro, Juan Carlos; Stevens, Lori			A New Method for Forensic DNA Analysis of the Blood Meal in Chagas Disease Vectors Demonstrated Using Triatoma infestans from Chuquisaca, Bolivia	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; POPULATION-STRUCTURE; FEEDING SOURCES; IDENTIFICATION; REDUVIIDAE; HEMIPTERA; WILD; INFECTION; PCR; TRANSMISSION	Background: Feeding patterns of the vector are important in the epidemiology of Chagas disease, the leading cause of heart disease in Latin America. Chagas disease is caused by the parasite, Trypanasoma cruzi, which is transmitted by blood feeding insects. Historically, feeding behaviours of haematophagous insects have been investigated using serological reactions, which have detection limits in terms of both taxonomic resolution, and quantity and quality of the blood meal. They are labor intensive, require technical expertise, need fresh or frozen samples and antibodies often are either not available commercially or the resources for synthesis and purification are not available. We describe an assay to identify vertebrate blood meal sources, and the parasite T. cruzi using species-specific PCR assays from insect vectors and use the method to provide information regarding three questions: (1) Do domestic and peri-domestic (chicken coop and animal corral) habitats vary in the blood meals detected in the vectors? (2) What is the pattern of multiple blood meals? (3) Does the rate of T. cruzi infection vary among habitats and is it associated with specific blood meal types? Methodology/Principal Findings: Assays based on the polymerase chain reaction were evaluated for identification of the blood meal source in the heamatophagous Chagas disease vector Triatoma infestans. We evaluate a technique to identify 11 potential vertebrate food sources from the complex mixture extracted from the vector's abdomen. We tested the assay on 81 T. infestans specimens collected from the Andean highlands in the department of Chuquisaca, located in central Bolivia, one of the regions in South America where sylvatic T. infestans have been reported. This area is suggested to be the geographic origin of T. infestans and has very high human infection rates that may be related to sylvatic vector populations. Conclusion/Significance: The results of the assays revealed that a high percentage of insects collected in human dwellings had fed on peri-domestic animals. In contrast, one insect from a chicken coop but no bugs from corrals tested positive for human blood. Forty-eight percent of insects tested positive for more than one vertebrate species. T. cruzi infection was detected in 42% of the specimens. From the epidemiological point of view, the results reveal an overall pattern of movement from peri-domestic structures to human habitations for T. infestans in this region of Bolivia as well as the important role of pigs, dogs, chickens and guinea pigs in the dynamics of T. cruzi infection.	[Pizarro, Juan Carlos; Stevens, Lori] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Pizarro, Juan Carlos] Univ San Francisco Xavier Chuquisaca, Fac Bioquim, Sucre, Bolivia	University of Vermont	Pizarro, JC (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05405 USA.	lxsteven@uvm.edu		Stevens, Lori/0000-0003-3847-5979	Fulbright Fellowship	Fulbright Fellowship	We gratefully acknowledge financial support from a Fulbright Fellowship (JCP). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2005, AN ACAD BRAS CIENC, V77, P437, DOI 10.1590/S0001-37652005000300007; Ali Oshaghi M, 2006, EXP PARASITOL, V112, P232, DOI 10.1016/j.exppara.2005.11.008; Bosseno MF, 2006, AM J TROP MED HYG, V74, P303, DOI 10.4269/ajtmh.2006.74.303; Breniere SF, 2002, MEM I OSWALDO CRUZ, V97, P289, DOI 10.1590/S0074-02762002000300002; Breniere SF, 1998, J MED ENTOMOL, V35, P911, DOI 10.1093/jmedent/35.6.911; Ceballos LA, 2005, ACTA TROP, V95, P149, DOI 10.1016/j.actatropica.2005.05.010; Cecere M C, 1999, Rev Panam Salud Publica, V5, P392; Cecere MC, 1997, MED VET ENTOMOL, V11, P383, DOI 10.1111/j.1365-2915.1997.tb00426.x; Cecere MC, 2004, AM J TROP MED HYG, V71, P803, DOI 10.4269/ajtmh.2004.71.803; CECERE MC, 1997, PAN AM J PUBLIC HLTH, V1, P273; CECERE MC, 1997, EMERG INFECT DIS, V12, P1096; Cook S, 2005, J MED ENTOMOL, V42, P19, DOI 10.1603/0022-2585(2005)042[0019:MMFMIO]2.0.CO;2; Cortez MR, 2007, ACTA TROP, V102, P47, DOI 10.1016/j.actatropica.2007.02.014; Cortez MR, 2006, EXP PARASITOL, V114, P305, DOI 10.1016/j.exppara.2006.04.010; Dujardin JP, 1998, MED VET ENTOMOL, V12, P20, DOI 10.1046/j.1365-2915.1998.00076.x; Dujardin JP, 1996, ACTA TROP, V61, P263, DOI 10.1016/0001-706X(96)00008-3; DUJARDIN JP, 1987, J MED ENTOMOL, V24, P40, DOI 10.1093/jmedent/24.1.40; Giordano R, 2005, MEM I OSWALDO CRUZ, V100, P753, DOI 10.1590/S0074-02762005000700014; Guillen G, 1997, MEM I OSWALDO CRUZ, V92, P1, DOI 10.1590/S0074-02761997000100001; Gurtler RE, 1996, J MED ENTOMOL, V33, P15, DOI 10.1093/jmedent/33.1.15; Gurtler RE, 1997, J APPL ECOL, V34, P699, DOI 10.2307/2404917; Gurtler RE, 1996, AM J TROP MED HYG, V55, P24, DOI 10.4269/ajtmh.1996.55.1.TM0550010024; JIRON LF, 1982, REV BIOL TROP, V30, P151; Krzywinski J, 2004, GENETICS, V166, P1291, DOI 10.1534/genetics.166.3.1291; Kusama T, 2004, J FOOD PROTECT, V67, P1289, DOI 10.4315/0362-028X-67.6.1289; LENT H, 1979, B AM MUS NAT HIST, V163, P127; MINTER DM, 1976, PAN AM HLTH ORG SCI, V318, P330; MOSER DR, 1989, J CLIN MICROBIOL, V27, P1477, DOI 10.1128/JCM.27.7.1477-1482.1989; Mota J, 2007, VECTOR-BORNE ZOONOT, V7, P617, DOI 10.1089/vbz.2007.0106; Mukabana WR, 2002, TRENDS PARASITOL, V18, P505, DOI 10.1016/S1471-4922(02)02364-4; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; Noireau F, 2005, AN ACAD BRAS CIENC, V77, P431, DOI 10.1590/S0001-37652005000300006; Noireau F, 2005, TRENDS PARASITOL, V21, P7, DOI 10.1016/j.pt.2004.10.007; Oshaghi MA, 2006, EXP PARASITOL, V114, P259, DOI 10.1016/j.exppara.2006.04.001; Panzera F, 2004, EMERG INFECT DIS, V10, P438, DOI 10.3201/eid1003.020812; Pineda V, 2008, REV INST MED TROP SP, V50, P113, DOI 10.1590/S0036-46652008000200009; Pizarro J. C., 1996, ARCH BOLIVIANOS MED, V3, P29; Pizarro Juan Carlos, 2007, Kinetoplastid Biol Dis, V6, P1, DOI 10.1186/1475-9292-6-1; Pizarro JC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000202; Richer W, 2007, TROP MED INT HEALTH, V12, P759, DOI 10.1111/j.1365-3156.2007.01846.x; Sakagami M, 1999, MAMM GENOME, V10, P930, DOI 10.1007/s003359901117; SASAKI H, 2002, MED ENTOMOL ZOOL, V51, P283; Schofield CJ, 1999, ADV PARASIT, V42, P1, DOI 10.1016/S0065-308X(08)60147-5; SCHOFIELD CJ, 1985, ANN SOC BELG MED TR, V65, P149; Torrico RA, 1946, LAB CENTRAL COCHABAM, V1, P19; Walker JA, 2003, ANAL BIOCHEM, V316, P259, DOI 10.1016/S0003-2697(03)00095-2; Walker JA, 2004, GENOMICS, V83, P518, DOI 10.1016/j.ygeno.2003.09.003; Walker JA, 2003, ANAL BIOCHEM, V315, P122, DOI 10.1016/S0003-2697(03)00081-2; Wisnivesky-Colli C., 1987, P99; ZELEDON R, 1973, J MED ENTOMOL, V10, P363, DOI 10.1093/jmedent/10.4.363	50	53	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3585	10.1371/journal.pone.0003585	http://dx.doi.org/10.1371/journal.pone.0003585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974787	gold, Green Published, Green Submitted			2022-12-27	WOS:000265131500011
J	McCallum, FJ; Persson, KEM; Mugyenyi, CK; Fowkes, FJI; Simpson, JA; Richards, JS; Williams, TN; Marsh, K; Beeson, JG				McCallum, Fiona J.; Persson, Kristina E. M.; Mugyenyi, Cleopatra K.; Fowkes, Freya J. I.; Simpson, Julie A.; Richards, Jack S.; Williams, Thomas N.; Marsh, Kevin; Beeson, James G.			Acquisition of Growth-Inhibitory Antibodies against Blood-Stage Plasmodium falciparum	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; C-TERMINAL FRAGMENT; INVASION IN-VITRO; CLINICAL MALARIA; ERYTHROCYTE INVASION; SERUM ANTIBODIES; PARASITE GROWTH; PREGNANT-WOMEN; PROTECTION; RESPONSES	Background: Antibodies that inhibit the growth of blood-stage Plasmodium falciparum may play an important role in acquired and vaccine-induced immunity in humans. However, the acquisition and activity of these antibodies is not well understood. Methods: We tested dialysed serum and purified immunoglobulins from Kenyan children and adults for inhibition of P. falciparum blood-stage growth in vitro using different parasite lines. Serum antibodies were measured by ELISA to blood-stage parasite antigens, extracted from P. falciparum schizonts, and to recombinant merozoite surface protein 1 (42 kDa C-terminal fragment, MSP1-42). Results: Antibodies to blood-stage antigens present in schizont protein extract and to recombinant MSP1-42 significantly increased with age and were highly correlated. In contrast, growth-inhibitory activity was not strongly associated with age and tended to decline marginally with increasing age and exposure, with young children demonstrating the highest inhibitory activity. Comparison of growth-inhibitory activity among samples collected from the same population at different time points suggested that malaria transmission intensity influenced the level of growth-inhibitory antibodies. Antibodies to recombinant MSP1-42 were not associated with growth inhibition and high immunoglobulin G levels were poorly predictive of inhibitory activity. The level of inhibitory activity against different isolates varied. Conclusions: Children can acquire growth-inhibitory antibodies at a young age, but once they are acquired they do not appear to be boosted by on-going exposure. Inhibitory antibodies may play a role in protection from early childhood malaria.	[McCallum, Fiona J.; Persson, Kristina E. M.; Fowkes, Freya J. I.; Richards, Jack S.; Beeson, James G.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [McCallum, Fiona J.; Richards, Jack S.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Mugyenyi, Cleopatra K.; Williams, Thomas N.; Marsh, Kevin] CGMRC, Wellcome Trust Collaborat Program, Kenya Med Res Inst, Kilifi, Kenya; [Simpson, Julie A.] Univ Melbourne, Ctr Mol, Environm, Genet & Anal Epidemiol, Carlton, Vic, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Kenya Medical Research Institute; University of Melbourne	McCallum, FJ (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	beeson@wehi.edu.au	Simpson, Julie A/P-7299-2014	Simpson, Julie/0000-0002-2660-2013; Fowkes, Freya/0000-0001-5832-9464; Persson, Kristina E M/0000-0003-2661-3115; Richards, Jack/0000-0001-5786-6989	National Health and Medical Research Council of Australia [Career Development Award, Postgraduate Research Fellowships]; Welcome Trust; Walter and Eliza Hall Institute [Miller Fellowship]; Teggerstiftelsen, Maud and Birger Gustavssons Stiftelse; Wenner-Gren Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Welcome Trust(Wellcome Trust); Walter and Eliza Hall Institute; Teggerstiftelsen, Maud and Birger Gustavssons Stiftelse; Wenner-Gren Fellowship	National Health and Medical Research Council of Australia (Project grant and Career Development Award to J. Beeson; Postgraduate Research Fellowships to F. McCallum and J. Richards), the Welcome Trust (Project grant to K. Marsh and J. Beeson; Program grant to K. Marsh; Fellowships to K. Marsh and T. Williams), the Miller Fellowship of the Walter and Eliza Hall Institute (to J. Beeson), the Teggerstiftelsen, Maud and Birger Gustavssons Stiftelse (K. E. M. Persson) and Wenner-Gren Fellowship (K. E. M Persson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; BROWN GV, 1982, NATURE, V297, P591, DOI 10.1038/297591a0; Cavanagh DR, 2004, INFECT IMMUN, V72, P6492, DOI 10.1128/IAI.72.11.6492-6502.2004; Cavanagh DR, 1998, J IMMUNOL, V161, P347; CHAPPEL JA, 1993, MOL BIOCHEM PARASIT, V60, P303, DOI 10.1016/0166-6851(93)90141-J; COHEN S, 1969, NATURE, V223, P368, DOI 10.1038/223368a0; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; DENT AE, PLOS ONE IN PRESS; Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Elliott SR, 2008, CLIN INFECT DIS, V46, P1794, DOI 10.1086/588049; Good MF, 2004, IMMUNOL REV, V201, P254, DOI 10.1111/j.0105-2896.2004.00178.x; Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; MBOGO CNM, 1995, AM J TROP MED HYG, V52, P201, DOI 10.4269/ajtmh.1995.52.201; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Narum DL, 2000, INFECT IMMUN, V68, P1964, DOI 10.1128/IAI.68.4.1964-1966.2000; Nwuba RI, 2002, INFECT IMMUN, V70, P5328, DOI 10.1128/IAI.70.9.5328-5331.2002; Nyakeriga AM, 2004, J INFECT DIS, V190, P439, DOI 10.1086/422331; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Rotman HL, 1998, J IMMUNOL, V161, P1908; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; SY NE, 1990, AM J TROP MED HYG, V43, P243, DOI 10.4269/ajtmh.1990.43.243; WILSON RJM, 1976, NATURE, V263, P132, DOI 10.1038/263132a0; Wipasa J, 2002, IMMUNOL CELL BIOL, V80, P401, DOI 10.1046/j.1440-1711.2002.01107.x	49	79	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2008	3	10							e3571	10.1371/journal.pone.0003571	http://dx.doi.org/10.1371/journal.pone.0003571			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KE	18958278	Green Published, gold			2022-12-27	WOS:000265131100024
J	Qi, HY; Chen, YJ; Fu, X; Lin, CP; Zheng, XFS; Liu, LF				Qi, Haiyan; Chen, Yongjie; Fu, Xuan; Lin, Chao-Po; Zheng, X. F. Steven; Liu, Leroy F.			TOR Regulates Cell Death Induced by Telomere Dysfunction in Budding Yeast	PLOS ONE			English	Article								Telomere dysfunction is known to induce growth arrest (senescence) and cell death. However, the regulation of the senescence-death process is poorly understood. Here using a yeast dysfunctional telomere model cdc13-1, which carries a temperature sensitive-mutant telomere binding protein Cdc13p, we demonstrate that inhibition of TOR (Target of Rapamycin), a central regulator of nutrient pathways for cell growth, prevents cell death, but not growth arrest, induced by inactivation of Cdc13-1p. This function of TOR is novel and separable from its G1 inhibition function, and not associated with alterations in the telomere length, the amount of G-tails, and the telomere position effect (TPE) in cdc13-1 cells. Furthermore, antioxidants were also shown to prevent cell death initiated by inactivation of cdc13-1. Moreover, inhibition of TOR was also shown to prevent cell death induced by inactivation of telomerase in an est1 mutant. Interestingly, rapamycin did not prevent cell death induced by DNA damaging agents such as etoposide and UV. In the aggregate, our results suggest that the TOR signaling pathway is specifically involved in the regulation of cell death initiated by telomere dysfunction.	[Qi, Haiyan; Chen, Yongjie; Fu, Xuan; Lin, Chao-Po; Zheng, X. F. Steven; Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Qi, HY (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	qiha@umdnj.edu		Liu, Leroy/0000-0001-9396-763X; Lin, Chao-Po/0000-0002-1457-1635	NIH [CA102463, CA39662]; NATIONAL CANCER INSTITUTE [R01CA102463, R01CA039662] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Chao-Po Lin and Leroy Liu were supported by NIH grants CA102463 and CA39662. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDAPE RA, 1992, J BIOL CHEM, V267, P16029; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Barberis M, 2005, BIOCHEM J, V387, P639, DOI 10.1042/BJ20041299; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; de Bruin D, 2000, MOL CELL BIOL, V20, P7991, DOI 10.1128/MCB.20.21.7991-8000.2000; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Qi HY, 2003, J BIOL CHEM, V278, P15136, DOI 10.1074/jbc.M212808200; Qi HY, 2000, GENE DEV, V14, P1777; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; STAN R, 1994, J BIOL CHEM, V269, P32027; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127; Zinzalla V, 2007, MOL MICROBIOL, V63, P1482, DOI 10.1111/j.1365-2958.2007.05599.x	47	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2008	3	10							e3520	10.1371/journal.pone.0003520	http://dx.doi.org/10.1371/journal.pone.0003520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IJ	18949037	gold, Green Submitted, Green Published			2022-12-27	WOS:000265126400006
J	Lutskiy, MI; Park, JY; Remold, SK; Remold-O'Donnell, E				Lutskiy, Maxim I.; Park, Jun Y.; Remold, Susanna K.; Remold-O'Donnell, Eileen			Evolution of Highly Polymorphic T Cell Populations in Siblings with the Wiskott-Aldrich Syndrome	PLOS ONE			English	Article								Population level evolutionary processes can occur within a single organism when the germ line contains a mutation that confers a cost at the level of the cell. Here we describe how multiple compensatory mutations arose through a within-individual evolutionary process in two brothers with the immune deficiency Wiskott-Aldrich Syndrome (WAS). As a result, both brothers have T lymphocyte populations that are highly polymorphic at the locus of the germ line defect, and no single allele achieves fixation. WASP, the gene product affected in this disease, is specific to white blood cells where it is responsible for regulating actin cytoskeleton dynamics in a wide range of cellular responses. The brothers inherited a rare allele predicted to result in truncated WASP lacking the carboxy-terminal VCA domains, the region that directly catalyzes actin filament generation. Although the brothers' T cell populations are highly polymorphic, all share a corrective effect relative to the inherited allele in that they restore the VCA domain. This indicates massive selection against the truncated germ line allele. No single somatic allele becomes fixed in the circulating T cell population of either brother, indicating that a regulated step in maturation of the affected cell lineage is severely compromised by the germ line allele. Based on the finding of multiple somatic mutations, the known maturation pathway for T-lineage cells and the known defects of T cells and precursor thymocytes in mice with truncated WASP, we hypothesize that the presence of truncated WASP (WASP Delta VCA) confers an extreme disadvantage in early developing thymocytes, above and beyond the known cost of absence of full-length WASP, and that the disadvantage likely occurs through dominant negative competition of WASP Delta VCA with N-WASP, a protein that otherwise partially compensates for WASP absence in developing thymocytes.	[Lutskiy, Maxim I.; Park, Jun Y.; Remold-O'Donnell, Eileen] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Lutskiy, Maxim I.; Remold-O'Donnell, Eileen] Harvard Univ, Sch Med, Dept Pediat, Boston, MA USA; [Remold, Susanna K.] Univ Louisville, Dept Biol, Program Dis Evolution, Louisville, KY 40292 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Louisville	Lutskiy, MI (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA.	remold@cbrinstitute.org			National Institutes of Health [HL59561, AI39574, HL081407]; National Science Foundation [DEB-0452163]; Jeffrey Modell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059561, R21HL081407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039574, R01AI039574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Jeffrey Modell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants HL59561, AI39574 and HL081407, National Science Foundation grant DEB-0452163, and the Jeffrey Modell Foundation.	Agematsu K, 2000, IMMUNOL TODAY, V21, P204, DOI 10.1016/S0167-5699(00)01605-4; Almeida ARM, 2005, SEMIN IMMUNOL, V17, P239, DOI 10.1016/j.smim.2005.02.002; Ariga T, 1998, BLOOD, V92, P699, DOI 10.1182/blood.V92.2.699; Ariga T, 2001, J IMMUNOL, V166, P5245, DOI 10.4049/jimmunol.166.8.5245; Burns S, 2004, BLOOD, V104, P3454, DOI 10.1182/blood-2004-04-1678; Cavazzana-Calvo M, 2007, J CLIN INVEST, V117, P1456, DOI 10.1172/JCI30953; Chinen J, 2004, CURR OPIN ALLERGY CL, V4, P523, DOI 10.1097/00130832-200412000-00008; Cotta-de-Almeida V, 2007, P NATL ACAD SCI USA, V104, P15424, DOI 10.1073/pnas.0706881104; DAVIS BR, 2008, BLOOD; Du W, 2006, HUM MUTAT, V27, P370, DOI 10.1002/humu.20308; Dupre L, 2002, IMMUNITY, V17, P157, DOI 10.1016/S1074-7613(02)00360-6; Filipovich AH, 2001, BLOOD, V97, P1598, DOI 10.1182/blood.V97.6.1598; Hirschhorn R, 1996, NAT GENET, V13, P290, DOI 10.1038/ng0796-290; Imai K, 2004, BLOOD, V103, P456, DOI 10.1182/blood-2003-05-1480; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Jones LN, 2002, BLOOD CELL MOL DIS, V28, P392, DOI 10.1006/bcmd.2002.0523; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; KWAN SP, 1995, P NATL ACAD SCI USA, V92, P4706, DOI 10.1073/pnas.92.10.4706; Lutskiy MI, 2005, J IMMUNOL, V175, P1329, DOI 10.4049/jimmunol.175.2.1329; Lutskiy MI, 2005, BLOOD, V106, P2815, DOI 10.1182/blood-2004-12-4724; Lutskiy MI, 2002, BLOOD, V100, P2763, DOI 10.1182/blood-2002-02-0388; MOLINA IJ, 1993, J IMMUNOL, V151, P4383; Park JY, 2004, CLIN EXP IMMUNOL, V136, P104, DOI 10.1111/j.1365-2249.2004.02409.x; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; RemoldODonnell E, 1997, J IMMUNOL, V158, P4021; Rieux-Laucat F, 2006, NEW ENGL J MED, V354, P1913, DOI 10.1056/NEJMoa053750; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Scherbina A, 1999, J IMMUNOL, V163, P6314; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; STEWART DM, 2006, J CLIN IMMUNOL; SULLIVAN KE, 1994, J PEDIATR-US, V125, P876, DOI 10.1016/S0022-3476(05)82002-5; Takenawa T, 2001, J CELL SCI, V114, P1801; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Wada T, 2005, BLOOD, V106, P2099, DOI 10.1182/blood-2005-03-0936; Wada T, 2003, J CLIN INVEST, V111, P1389, DOI 10.1172/JCI200315485; Wada T, 2001, P NATL ACAD SCI USA, V98, P8697, DOI 10.1073/pnas.151260498; WENGLER G, 1995, BLOOD, V85, P2471, DOI 10.1182/blood.V85.9.2471.bloodjournal8592471; WISKOTT A, 1937, MONATSSCHR KINDERH, V68, P212; Zhang JY, 2002, P NATL ACAD SCI USA, V99, P2240, DOI 10.1073/pnas.042686099; ZHU QL, 1995, BLOOD, V86, P3797, DOI 10.1182/blood.V86.10.3797.bloodjournal86103797	42	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3444	10.1371/journal.pone.0003444	http://dx.doi.org/10.1371/journal.pone.0003444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941616	Green Published, Green Submitted, gold			2022-12-27	WOS:000265125600006
J	Becerra, JX; Venable, DL				Becerra, Judith X.; Venable, D. Lawrence			Sources and Sinks of Diversification and Conservation Priorities for the Mexican Tropical Dry Forest	PLOS ONE			English	Article							EVOLUTIONARY; TRENDS	Elucidating the geographical history of diversification is critical for inferring where future diversification may occur and thus could be a valuable aid in determining conservation priorities. However, it has been difficult to recognize areas with a higher likelihood of promoting diversification. We reconstructed centres of origin of lineages and identified areas in the Mexican tropical dry forest that have been important centres of diversification (sources) and areas where species are maintained but where diversification is less likely to occur (diversity sinks). We used a molecular phylogeny of the genus Bursera, a dominant member of the forest, along with information on current species distributions. Results indicate that vast areas of the forest have historically functioned as diversity sinks, generating few or no extant Bursera lineages. Only a few areas have functioned as major engines of diversification. Long-term preservation of biodiversity may be promoted by incorporation of such knowledge in decision-making.	[Becerra, Judith X.] Univ Arizona, Dept Biosphere 2, Tucson, AZ 85721 USA; [Venable, D. Lawrence] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Becerra, JX (corresponding author), Univ Arizona, Dept Biosphere 2, Tucson, AZ 85721 USA.	becerra@ag.arizona.edu		Becerra, Judith/0000-0002-3749-9058	NSF [DEB 0212782, DEB-9815648]; Arnold and Mabel Beckman Foundation [Young Investigator Award]	NSF(National Science Foundation (NSF)); Arnold and Mabel Beckman Foundation	Funding for this work was provided by NSF grants DEB 0212782, DEB 0212782 to DLV and a NSF CAREER grant DEB-9815648 and a Young Investigator Award from the Arnold and Mabel Beckman Foundation to JXB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerra JX, 2007, P NATL ACAD SCI USA, V104, P7483, DOI 10.1073/pnas.0608253104; Becerra JX, 2005, P NATL ACAD SCI USA, V102, P10919, DOI 10.1073/pnas.0409127102; Becerra JX, 2003, P NATL ACAD SCI USA, V100, P12804, DOI 10.1073/pnas.2133013100; Becerra JX, 1999, P NATL ACAD SCI USA, V96, P12626, DOI 10.1073/pnas.96.22.12626; Becerra JX, 1999, AM J BOT, V86, P1047, DOI 10.2307/2656622; Becerra JX, 2003, MOL PHYLOGENET EVOL, V26, P300, DOI 10.1016/S1055-7903(02)00256-7; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; Brooks D. R., 2002, NATURE DIVERSITY EVO; Cowling RM, 2001, P NATL ACAD SCI USA, V98, P5452, DOI 10.1073/pnas.101093498; ERWIN TL, 1991, SCIENCE, V253, P750, DOI 10.1126/science.253.5021.750; KOHLMANN B, 1984, METODOS CUANTITATIVO; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; LOPEZRAMOS E, 1985, GEOLOGIA MEXICO; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Moran-Zenteno D., 1994, GEOLOGY MEXICAN REPU; MURPHY RW, 1983, OCCAS PAP CALIF ACAD, V137, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nieto-Samaniego AF, 1999, GEOL SOC AM BULL, V111, P347, DOI 10.1130/0016-7606(1999)111<0347:VOCEAV>2.3.CO;2; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; RONQUIST F, 1996, DIVA VER 1 1 COMPUTE; Rzedowski J., 1978, VEGETACION MEXICO; Trejo I, 2002, BIODIVERS CONSERV, V11, P2063, DOI 10.1023/A:1020876316013	24	26	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3436	10.1371/journal.pone.0003436	http://dx.doi.org/10.1371/journal.pone.0003436			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927613	gold, Green Published, Green Submitted			2022-12-27	WOS:000265122400008
J	Chien, KL; Su, TC; Jeng, JS; Hsu, HC; Chang, WT; Chen, MF; Lee, YT; Hu, FB				Chien, Kuo-Liong; Su, Ta-Chen; Jeng, Jiann-Shing; Hsu, Hsiu-Ching; Chang, Wei-Tien; Chen, Ming-Fong; Lee, Yuan-Teh; Hu, Frank B.			Carotid Artery Intima-Media Thickness, Carotid Plaque and Coronary Heart Disease and Stroke in Chinese	PLOS ONE			English	Article							OPERATING CHARACTERISTIC CURVES; WALL SHEAR-STRESS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; RISK-FACTOR; ISCHEMIC-STROKE; ATHEROSCLEROSIS; EVENTS; ASSOCIATION; PROGRESSION	Background: Our aim was to prospectively investigate the association between carotid artery intima-media thickness (IMT) as well as carotid plaque and incidence of coronary heart disease (CHD) and stroke in Chinese, among whom data are limited. Methods and Findings: We conducted a community-based cohort study composed of 2190 participants free of cardiovascular disease at baseline in one community. During a median 10.5-year follow up, we documented 68 new cases of coronary heart disease and 94 cases of stroke. The multivariate relative risks (RRs) associated with a change of 1 standard deviation of maximal common carotid IMT were 1.38 (95% confidence interval [CI], 1.12-1.70) for CHD and 1.47 (95% CI, 1.28-1.69) for stroke. The corresponding RRs with internal carotid IMT were 1.47 (95% CI, 1.21-1.79) for CHD and 1.52 (95% CI, 1.31-1.76) for stroke. Carotid plaque measured by the degree of diameter stenosis was also significantly associated with increased risk of CHD (p for trend, 0.0001) and stroke (p for trend, 0.0001). However, these associations were largely attenuated when adjusting for IMT measurements. Conclusions: This prospective study indicates a significant association between carotid IMT and incidence of CHD and stroke in Chinese adults. These measurements may be useful for cardiovascular risk assessment and stratification in Chinese.	[Chien, Kuo-Liong] Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan; [Chien, Kuo-Liong; Su, Ta-Chen; Hsu, Hsiu-Ching; Chen, Ming-Fong; Lee, Yuan-Teh] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chang, Wei-Tien] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA USA	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Chien, KL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan.	ytlee@ha.mc.ntu.edu.tw; fhu@hsph.harvard.edu	Chen, Ming/GVU-8412-2022	CHIEN, KUO-LIONG/0000-0003-4979-8351; CHANG, WEI-TIEN/0000-0002-1880-7932; SU, TA-CHEN/0000-0001-7523-7166; JENG, JIANN-SHING/0000-0002-1456-3686	National Science Council in Taiwan [97-2314-B-002 -130 -MY3, 96-2314-B-002-155-]; American Heart Association Established Investigator Award	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); American Heart Association Established Investigator Award(American Heart Association)	This study was supported partly by grants from the National Science Council in Taiwan (NSC 97-2314-B-002 -130 -MY3, NSC 96-2314-B-002-155- ). Dr. Frank Hu's research is partly supported by American Heart Association Established Investigator Award.	Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Brook RD, 2006, ARTERIOSCL THROM VAS, V26, P656, DOI 10.1161/01.ATV.0000200079.18690.60; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Chien KL, 2005, EUR J CARDIOV PREV R, V12, P95, DOI 10.1097/00149831-200504000-00003; Chien KL, 2002, STROKE, V33, P39, DOI 10.1161/hs0102.101626; Chien KL, 1999, ATHEROSCLEROSIS, V143, P267, DOI 10.1016/S0021-9150(98)00298-6; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Foerch C, 2003, HYPERTENSION, V42, pE17, DOI 10.1161/01.HYP.0000103164.73172.30; Freedman BI, 2005, DIABETOLOGIA, V48, P2511, DOI 10.1007/s00125-005-0017-2; Gnasso A, 1997, STROKE, V28, P993, DOI 10.1161/01.STR.28.5.993; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hernandez SAR, 2003, HYPERTENSION, V42, P56, DOI 10.1161/01.HYP.0000077983.66161.6F; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hollander M, 2003, STROKE, V34, P2367, DOI 10.1161/01.STR.0000091393.32060.0E; Hosmer Jr DW, 1989, MULTIPLE LOGISTIC RE, P25; Irace C, 2004, STROKE, V35, P464, DOI 10.1161/01.STR.0000111597.34179.47; Jacobowitz GR, 2003, J VASC SURG, V38, P705, DOI 10.1016/S0741-5214(03)00730-4; Johnson HM, 2007, STROKE, V38, P900, DOI 10.1161/01.STR.0000258003.31194.0a; Kanadasi M, 2006, ANGIOLOGY, V57, P585, DOI 10.1177/0003319706293123; Kitamura A, 2004, STROKE, V35, P2788, DOI 10.1161/01.STR.0000147723.52033.9e; Lacroix P, 2006, VASC MED, V11, P93, DOI 10.1191/1358863x06vm677oa; Lee YT, 2001, SCI TOTAL ENVIRON, V280, P165, DOI 10.1016/S0048-9697(01)00823-3; Lee YT, 2000, J CLIN EPIDEMIOL, V53, P838, DOI 10.1016/S0895-4356(00)00198-0; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Murakami S, 2005, BIOMED PHARMACOTHER, V59, pS49, DOI 10.1016/S0753-3322(05)80010-1; Nichols WW, 1999, NEW ENGL J MED, V340, P1762; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Prabhakaran S, 2006, STROKE, V37, P2696, DOI 10.1161/01.STR.0000244780.82190.a4; Prati P, 2006, CEREBROVASC DIS, V22, P416, DOI 10.1159/000094993; Pruissen DMO, 2007, STROKE, V38, P1371, DOI 10.1161/01.STR.0000260220.37016.88; Reddy KS, 2004, NEW ENGL J MED, V350, P2438, DOI 10.1056/NEJMp048024; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Rockman CB, 2004, J VASC SURG, V39, P44, DOI 10.1016/j.jvs.2003.07.008; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; RUBIN MR, 2006, ATHEROSCLEROSIS; SALONEN JT, 1991, ARTERIOSCLER THROMB, V11, P1245, DOI 10.1161/01.ATV.11.5.1245; SCHMID C, 1998, ENCY BIOSTATISTICS; Scuteri A, 2004, J AM COLL CARDIOL, V43, P187, DOI 10.1016/j.jacc.2003.08.035; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Su T, 1999, J MED ULTRASOUND, V7, P73; Su TC, 2006, INT J CLIN PRACT, V60, P134, DOI 10.1111/j.1742-1241.2006.00777.x; Su TC, 2001, STROKE, V32, P2265, DOI 10.1161/str.32.10.2265; SZETO CC, 2007, J AM SOC NEPHROL; TANG TY, 2007, CORRELATION CAROTID; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; Touboul PJ, 2000, CIRCULATION, V102, P313; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; WIELAND H, 1983, J LIPID RES, V24, P904; Yamasaki Y, 2000, DIABETES CARE, V23, P1310, DOI 10.2337/diacare.23.9.1310; YATES JF, 1982, ORGAN BEHAV HUM PERF, V30, P132, DOI 10.1016/0030-5073(82)90237-9; Zhang Yi-na, 2005, Chinese Medical Sciences Journal, V20, P10	56	58	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3435	10.1371/journal.pone.0003435	http://dx.doi.org/10.1371/journal.pone.0003435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927612	Green Published, gold, Green Submitted			2022-12-27	WOS:000265122400007
J	Quimbo, S; Florentino, J; Peabody, JW; Shimkhada, R; Panelo, C; Solon, O				Quimbo, Stella; Florentino, Jhiedon; Peabody, John W.; Shimkhada, Riti; Panelo, Carlo; Solon, Orville			Underutilization of Social Insurance among the Poor: Evidence from the Philippines	PLOS ONE			English	Article							HEALTH-CARE; EXPENDITURE; PAYMENTS; SERVICES; CHILDREN; POVERTY; ACCESS	Background: Many developing countries promote social health insurance as a means to eliminate unmet health needs. However, this strategy may be ineffective if there are barriers to fully utilizing insurance. Methods: We analyzed the utilization of social health insurance in 30 hospital districts in the central regions of the Philippines between 2003 and 2007. Data for the study came from the Quality Improvement Demonstration Study (QIDS) and included detailed patient information from exit interviews of children under 5 years of age conducted in seven waves among public hospital districts located in the four central regions of the Philippines. These data were used to estimate and identify predictors of underutilization of insurance benefits - defined as the likelihood of not filing claims despite having legitimate insurance coverage - using logistic regression. Results: Multivariate analyses using QIDS data from 2004 to 2007 reveal that underutilization averaged about 15% throughout the study period. Underutilization, however, declined over time. Among insured hospitalized children, increasing length of stay in the hospital and mother's education, were associated with less underutilization. Being in a QIDS intervention site was also associated with less underutilization and partially accounts for the downward trend in underutilization over time. Discussion: The surprisingly high level of insurance underutilization by insured patients in the QIDS sites undermines the potentially positive impact of social health insurance on the health of the marginalized. In the Philippines, where the largest burden of health care spending falls on households, underutilization suggests ineffective distribution of public funds, failing to reach a significant proportion of households which are by and large poor. Interventions that improve benefit awareness may combat the problem of underutilization and should be the focus of further research in this area.	[Quimbo, Stella; Florentino, Jhiedon; Solon, Orville] Univ Philippines, Sch Econ, Quezon City 1101, Philippines; [Peabody, John W.; Shimkhada, Riti] Univ Calif San Francisco, Inst Glob Hlth, San Francisco, CA 94143 USA; [Panelo, Carlo] Univ Philippines, Coll Med, Manila, Philippines	University of the Philippines System; University of the Philippines Diliman; University of California System; University of California San Francisco; University of the Philippines System; University of the Philippines Manila	Quimbo, S (corresponding author), Univ Philippines, Sch Econ, Quezon City 1101, Philippines.	peabody@psg.ucsf.edu	Shimkhada, Riti/N-7823-2016	Shimkhada, Riti/0000-0002-5177-4853	U.S. National Institutes for Health [HD042117]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042117] Funding Source: NIH RePORTER	U.S. National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Quality Improvement Demonstration Study is funded by the U.S. National Institutes for Health through an R01 grant (HD042117).	ABELSMITH B, 1992, HEALTH POLICY PLANN, V7, P329, DOI 10.1093/heapol/7.4.329; Aizer A, 2003, AM ECON REV, V93, P238, DOI 10.1257/000282803321947119; Asgary Ali, 2004, Eur J Health Econ, V5, P209, DOI 10.1007/s10198-004-0233-6; Chen CS, 2003, HEALTH POLICY, V64, P99, DOI 10.1016/S0168-8510(02)00141-0; Cunningham P, 2004, HEALTH AFFAIR, V23, P234, DOI 10.1377/hlthaff.23.4.234; Dror DM, 2005, HEALTH POLICY, V73, P263, DOI 10.1016/j.healthpol.2004.11.018; Duong DV, 2004, SOC SCI MED, V59, P2585, DOI 10.1016/j.socscimed.2004.04.007; Falkingham J, 2004, SOC SCI MED, V58, P247, DOI 10.1016/S0277-9536(03)00008-X; GERTLER P, 1999, WHO BENEFITS SOCIAL; Hsiao WC, 2007, WBI DEV STUD, P1, DOI 10.1596/978-0-8213-6949-4; Jowett M, 2007, WBI DEV STUD, P81; Normand C., 2009, SOCIAL HLTH INSURANC; *PHIL NAT STAT COO, 2004, PHIL NAT HLTH ACC; Quimbo SA, 2008, SOC SCI MED, V67, P505, DOI 10.1016/j.socscimed.2008.04.013; Riddell TJ, 2007, B WORLD HEALTH ORGAN, V85, P674, DOI 10.2471/BLT.06.036137; RON A, 1990, HLTH INSURANCE DEV C; SCHNEIDER P, 2004, IMPACT PHILHEALTH IN; Shimkhada Riti, 2008, Health Res Policy Syst, V6, P5, DOI 10.1186/1478-4505-6-5; Solon O, 2008, J PEDIATR-US, V152, P237, DOI 10.1016/j.jpeds.2007.09.008; Van Damme W, 2004, TROP MED INT HEALTH, V9, P273, DOI 10.1046/j.1365-3156.2003.01194.x; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; World Health Organization, 2005, SUST HLTH FIN UN COV; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	23	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3379	10.1371/journal.pone.0003379	http://dx.doi.org/10.1371/journal.pone.0003379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432GN	18852881	gold, Green Published, Green Submitted			2022-12-27	WOS:000265121600005
J	Mai, TQL; Heiman, FLW; Hien, DN; Walter, T; Phuong, VMH; Cuong, DV; Hang, LKN; Ha, HN; Thai, QN; Trung, VN; Trang, DV; Bich, TN; Thinh, NB; Binh, GN; Liem, TN; San, TL; Phuc, HP; Hung, VP; Tung, N; Annette, F; Cam, VN; Ha, QD; Martin, C; Jeremy, F; Hien, TN; Menno, DD; Peter, H				Mai T. Q. Le; Heiman F. L. Wertheim; Hien D. Nguyen; Walter Taylor; Phuong V. M. Hoang; Cuong D. Vuong; Hang L. K. Nguyen; Ha H. Nguyen; Thai Q. Nguyen; Trung V. Nguyen; Trang D. Van; Bich T. Ngoc; Thinh N. Bui; Binh G. Nguyen; Liem T. Nguyen; San T. Luong; Phuc H. Phan; Hung V. Pham; Tung Nguyen; Annette Fox; Cam V. Nguyen; Ha Q. Do; Martin Crusat; Jeremy Farrar; Hien T. Nguyen; Menno D. de Jong; Peter Horby			Influenza A H5N1 Clade 2.3.4 Virus with a Different Antiviral Susceptibility Profile Replaced Clade 1 Virus in Humans in Northern Vietnam	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; RESISTANCE; INFECTION; EMERGENCE	Background: Prior to 2007, highly pathogenic avian influenza ( HPAI) H5N1 viruses isolated from poultry and humans in Vietnam were consistently reported to be clade 1 viruses, susceptible to oseltamivir but resistant to amantadine. Here we describe the re-emergence of human HPAI H5N1 virus infections in Vietnam in 2007 and the characteristics of the isolated viruses. Methods and Findings: Respiratory specimens from patients suspected to be infected with avian influenza in 2007 were screened by influenza and H5 subtype specific polymerase chain reaction. Isolated H5N1 strains were further characterized by genome sequencing and drug susceptibility testing. Eleven poultry outbreak isolates from 2007 were included in the sequence analysis. Eight patients, all of them from northern Vietnam, were diagnosed with H5N1 in 2007 and five of them died. Phylogenetic analysis of H5N1 viruses isolated from humans and poultry in 2007 showed that clade 2.3.4 H5N1 viruses replaced clade 1 viruses in northern Vietnam. Four human H5N1 strains had eight-fold reduced in-vitro susceptibility to oseltamivir as compared to clade 1 viruses. In two poultry isolates the I117V mutation was found in the neuraminidase gene, which is associated with reduced susceptibility to oseltamivir. No mutations in the M2 gene conferring amantadine resistance were found. Conclusion: In 2007, H5N1 clade 2.3.4 viruses replaced clade 1 viruses in northern Vietnam and were susceptible to amantadine but showed reduced susceptibility to oseltamivir. Combination antiviral therapy with oseltamivir and amantadine for human cases in Vietnam is recommended.	[Mai T. Q. Le; Phuong V. M. Hoang; Cuong D. Vuong; Hang L. K. Nguyen; Hien T. Nguyen] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Heiman F. L. Wertheim; Walter Taylor; Bich T. Ngoc; Annette Fox; Peter Horby] Univ Oxford, Clin Res Unit, Hanoi, Vietnam; [Hien D. Nguyen; Ha H. Nguyen; Thai Q. Nguyen; Trung V. Nguyen; Trang D. Van] Natl Inst Infect & Trop Dis, Hanoi, Vietnam; [Thinh N. Bui; Binh G. Nguyen] Bach Mai Hosp, Hanoi, Vietnam; [Liem T. Nguyen; San T. Luong; Phuc H. Phan; Hung V. Pham] Natl Hosp Pediat, Hanoi, Vietnam; [Tung Nguyen; Cam V. Nguyen] Natl Ctr Vet Diagnosis, Hanoi, Vietnam; [Ha Q. Do; Martin Crusat; Jeremy Farrar; Menno D. de Jong] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Heiman F. L. Wertheim; Walter Taylor; Annette Fox; Ha Q. Do; Martin Crusat; Jeremy Farrar; Menno D. de Jong; Peter Horby] John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford, England	National Institute of Hygiene & Epidemiology (NIHE); University of Oxford; University of Oxford; University of Oxford	Mai, TQL (corresponding author), Natl Inst Hyg & Epidemiol, Hanoi, Vietnam.	hwertheim@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Wertheim, Heiman/F-3338-2016	Farrar, Jeremy/0000-0002-2700-623X; Horby, Peter/0000-0002-9822-1586; Fox, Annette/0000-0002-0565-7146; Wertheim, Heiman/0000-0002-5003-5565; My, Robinson/0000-0002-3602-1060	Center for Disease Control, United States of America (NIHE - National Influenza Project); South East Asian Influenza Clinical Research Network (SEAICRN); Wellcome Trust	Center for Disease Control, United States of America (NIHE - National Influenza Project); South East Asian Influenza Clinical Research Network (SEAICRN); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Center for Disease Control, United States of America (NIHE - National Influenza Project) the South East Asian Influenza Clinical Research Network (SEAICRN), and the Wellcome Trust. The funding sources did not have a role in the design, data acquisition, analysis or writing of this report.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Buxton RC, 2000, ANAL BIOCHEM, V280, P291, DOI 10.1006/abio.2000.4517; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Gubareva LV, 2002, ANTIVIR RES, V53, P47, DOI 10.1016/S0166-3542(01)00192-9; Hayden FG, 2006, J INFECT DIS, V194, pS119, DOI 10.1086/507552; He GM, 2008, ANTIVIR RES, V77, P72, DOI 10.1016/j.antiviral.2007.08.007; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Ilyushina NA, 2007, ANTIVIR THER, V12, P363; Ilyushina NA, 2006, ANTIVIR RES, V70, P121, DOI 10.1016/j.antiviral.2006.01.012; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; Morrison D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001305; Nguyen TD, 2008, EMERG INFECT DIS, V14, P632, DOI 10.3201/eid1404.071343; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; WHO, CLIN MAN HUM INF AV	22	57	59	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2008	3	10							e3339	10.1371/journal.pone.0003339	http://dx.doi.org/10.1371/journal.pone.0003339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DK	18836532	Green Published, gold			2022-12-27	WOS:000265113500006
J	Yang, ZH; Yu, HJ; Pan, A; Du, JY; Ruan, YC; Ko, WH; Chan, HC; Zhou, WL				Yang, Zi-Huan; Yu, Hai-Jie; Pan, Ao; Du, Jian-Yang; Ruan, Ye-Chun; Ko, Wing-Hung; Chan, Hsiao-Chang; Zhou, Wen-Liang			Cellular Mechanisms Underlying the Laxative Effect of Flavonol Naringenin on Rat Constipation Model	PLOS ONE			English	Article								Background & Aims: Symptoms of constipation are extremely common, especially in the elderly. The present study aim to identify an efficacious treatment strategy for constipation by evaluating the secretion-promoting and laxative effect of a herbal compound, naringenin, on intestinal epithelial anion secretion and a rat constipation model, respectively. Methods/Principal Findings: In isolated rat colonic crypts, mucosal addition of naringenin (100 mM) elicited a concentration-dependent and sustained increase in the short-circuit current (I-SC), which could be inhibited in Cl- free solution or by bumetanide and DPC (diphenylamine-2-carboxylic acid), but not by DIDS (4, 4'-diisothiocyanatostilbene-2, 2'-disulfonic acid). Naringenin could increase intracellular cAMP content and PKA activity, consisted with that MDL-12330A (N-(Cis-2-phenyl-cyclopentyl) azacyclotridecan-2-imine-hydrochloride) pretreatment reduced the naringenin-induced ISC. In addition, significant inhibition of the naringenin-induced I-SC by quinidine indicated that basolateral K+ channels were involved in maintaining this cAMP-dependent Cl- secretion. Naringenin-evoked whole cell current which exhibited a linear I-V relationship and time-and voltage-independent characteristics was inhibited by DPC, indicating that the cAMP activated Cl- conductance most likely CFTR (cystic fibrosis transmembrane conductance regulator) was involved. In rat constipation model, administration of naringenin restored the level of fecal output, water content and mucus secretion compared to loperamide-administrated group. Conclusions: Taken together, our data suggest that naringenin could stimulate Cl- secretion in colonic epithelium via a signaling pathway involving cAMP and PKA, hence provide an osmotic force for subsequent colonic fluid secretion by which the laxative effect observed in the rat constipation model. Naringenin appears to be a novel alternative treatment strategy for constipation.	[Yang, Zi-Huan; Yu, Hai-Jie; Pan, Ao; Du, Jian-Yang; Ruan, Ye-Chun; Zhou, Wen-Liang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Ko, Wing-Hung; Chan, Hsiao-Chang] Chinese Univ Hong Kong, Dept Physiol, Fac Med, Sha Tin 100083, Peoples R China	Sun Yat Sen University; Chinese University of Hong Kong	Yang, ZH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	hsiaocchan@cuhk.edu.hk; lsszwl@mail.sysu.edu.cn	Chan, Hsiao Chang/E-1507-2016; Du, Jianyang/B-3883-2010; Ko, Hung/R-1802-2018; RUAN, Ye Chun/T-5919-2017; Ruan, Ye Chun/T-7531-2019	Ko, Hung/0000-0002-2041-402X; RUAN, Ye Chun/0000-0002-4266-6789; Ruan, Ye Chun/0000-0002-4266-6789	National Natural Science Foundation of China [30770817]; South China National Research Center for Integrated Biosciences [2006CB504002]; Sun Yat-sen University [2006CB504002]; National 973 project foundation [2006CB504002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); South China National Research Center for Integrated Biosciences; Sun Yat-sen University; National 973 project foundation(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (No. 30770817) and the South China National Research Center for Integrated Biosciences in Collaboration with Sun Yat-sen University and National 973 project foundation (No. 2006CB504002).	Altabas K, 2003, COLLEGIUM ANTROPOL, V27, P197; ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; BARRETT KE, 1993, AM J PHYSIOL, V265, pC859; Boockfor FR, 1998, AM J PHYSIOL-CELL PH, V274, pC922, DOI 10.1152/ajpcell.1998.274.4.C922; Busti AJ, 2004, PHARMACOTHERAPY, V24, P526, DOI 10.1592/phco.24.5.526.33351; CLIFF WH, 1990, P NATL ACAD SCI USA, V87, P4956, DOI 10.1073/pnas.87.13.4956; Cuppoletti J, 2004, AM J PHYSIOL-CELL PH, V287, pC1173, DOI 10.1152/ajpcell.00528.2003; Del Castillo IC, 2005, AM J PHYSIOL-CELL PH, V289, pC1332, DOI 10.1152/ajpcell.00580.2004; deMedina FS, 1997, LIFE SCI, V61, P2049; EWE K, 1988, PHARMACOLOGY, V36, P73, DOI 10.1159/000138424; FORTE LR, 1992, AM J PHYSIOL, V263, pC607, DOI 10.1152/ajpcell.1992.263.3.C607; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; Grondahl ML, 1998, J MED MICROBIOL, V47, P151, DOI 10.1099/00222615-47-2-151; Hollman PCH, 1999, FREE RADICAL RES, V31, pS75, DOI 10.1080/10715769900301351; HUANG SJ, 1993, AM J PHYSIOL, V264, pC794, DOI 10.1152/ajpcell.1993.264.4.C794; HUGHES S, 1984, GUT, V25, P931, DOI 10.1136/gut.25.9.931; Illek B, 2000, AM J PHYSIOL-CELL PH, V279, pC1838, DOI 10.1152/ajpcell.2000.279.6.C1838; Johanson John F, 2007, MedGenMed, V9, P25; Kawaii S, 1999, J AGR FOOD CHEM, V47, P3565, DOI 10.1021/jf990153+; Kim WR, 2000, GASTROENTEROLOGY, V119, P1631, DOI 10.1053/gast.2000.20197; Ko WH, 2002, AM J PHYSIOL-GASTR L, V282, pG508, DOI 10.1152/ajpgi.00291.2001; LENCER WI, 1992, J CELL BIOL, V117, P1197, DOI 10.1083/jcb.117.6.1197; Middleton E, 2000, PHARMACOL REV, V52, P673; Minagawa N, 2007, GASTROENTEROLOGY, V133, P1592, DOI 10.1053/j.gastro.2007.08.020; Rivkin A, 2006, CLIN THER, V28, P2008, DOI 10.1016/j.clinthera.2006.12.013; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Shimotoyodome A, 2000, COMP BIOCHEM PHYS A, V126, P203, DOI 10.1016/S1095-6433(00)00194-X; Sohji Y, 1978, Nihon Yakurigaku Zasshi, V74, P155; Sonawane ND, 2007, GASTROENTEROLOGY, V132, P1234, DOI 10.1053/j.gastro.2007.02.018; TAKASAKI K, 1994, JPN J PHARMACOL, V65, P67, DOI 10.1254/jjp.65.67; Tenore A, 1996, J ENDOCRINOL, V151, P431, DOI 10.1677/joe.0.1510431; Yue GGL, 2004, J BIOL CHEM, V279, P39310, DOI 10.1074/jbc.M406787200; Zhang ZR, 2000, BIOPHYS J, V79, P298, DOI 10.1016/S0006-3495(00)76292-8	33	51	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3348	10.1371/journal.pone.0003348	http://dx.doi.org/10.1371/journal.pone.0003348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833323	Green Published, gold, Green Submitted			2022-12-27	WOS:000264797400012
J	Loerch, PM; Lu, T; Dakin, KA; Vann, JM; Isaacs, A; Geula, C; Wang, J; Pan, Y; Gabuzda, DH; Li, C; Prolla, TA; Yankner, BA				Loerch, Patrick M.; Lu, Tao; Dakin, Kelly A.; Vann, James M.; Isaacs, Adrian; Geula, Chengiz; Wang, Jianbin; Pan, Ying; Gabuzda, Dana H.; Li, Cheng; Prolla, Tomas A.; Yankner, Bruce A.			Evolution of the Aging Brain Transcriptome and Synaptic Regulation	PLOS ONE			English	Article								Alzheimer's disease and other neurodegenerative disorders of aging are characterized by clinical and pathological features that are relatively specific to humans. To obtain greater insight into how brain aging has evolved, we compared age-related gene expression changes in the cortex of humans, rhesus macaques, and mice on a genome-wide scale. A small subset of gene expression changes are conserved in all three species, including robust age-dependent upregulation of the neuroprotective gene apolipoprotein D (APOD) and downregulation of the synaptic cAMP signaling gene calcium/calmodulin-dependent protein kinase IV (CAMK4). However, analysis of gene ontology and cell type localization shows that humans and rhesus macaques have diverged from mice due to a dramatic increase in age-dependent repression of neuronal genes. Many of these age-regulated neuronal genes are associated with synaptic function. Notably, genes associated with GABA-ergic inhibitory function are robustly age-downregulated in humans but not in mice at the level of both mRNA and protein. Gene downregulation was not associated with overall neuronal or synaptic loss. Thus, repression of neuronal gene expression is a prominent and recently evolved feature of brain aging in humans and rhesus macaques that may alter neural networks and contribute to age-related cognitive changes.	[Loerch, Patrick M.; Lu, Tao; Dakin, Kelly A.; Isaacs, Adrian; Pan, Ying; Yankner, Bruce A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Vann, James M.; Prolla, Tomas A.] Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA; [Geula, Chengiz] Northwestern Univ, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL USA; [Wang, Jianbin; Gabuzda, Dana H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Loerch, Patrick M.; Li, Cheng] Harvard Uni, Harvard Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat, Boston, MA USA	Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health	Loerch, PM (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	bruce_yankner@hms.harvard.edu			National Institute on Aging [AG26651, AG27040, AG27916]; Ellison Medical Foundation Senior Scholar award; NIH [T32GM074897]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027916, R01AG027040, R01AG026651] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation Senior Scholar award(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute on Aging (grant numbers AG26651, AG27040, AG27916), and an Ellison Medical Foundation Senior Scholar award to B.A.Y.. P.L. was supported by NIH training grant T32GM074897.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Backman L, 1997, J COGNITIVE NEUROSCI, V9, P378, DOI 10.1162/jocn.1997.9.3.378; Belloir B, 2001, J NEUROSCI RES, V64, P61, DOI 10.1002/jnr.1054; Bussiere T, 2003, NEUROSCIENCE, V117, P577, DOI 10.1016/S0306-4522(02)00942-9; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Ervin JF, 2007, J NEUROPATH EXP NEUR, V66, P1093, DOI 10.1097/nen.0b013e31815c196a; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fraser HB, 2005, PLOS BIOL, V3, P1653, DOI 10.1371/journal.pbio.0030274; Geula C, 2003, J COMP NEUROL, V455, P249, DOI 10.1002/cne.10475; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Kalman J, 2000, NEUROL RES, V22, P330; KINGSBURY AE, 1995, MOL BRAIN RES, V28, P318; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Martin GM, 2005, CELL, V120, P523, DOI 10.1016/j.cell.2005.01.031; Mohler H, 2007, J NEUROCHEM, V102, P1, DOI 10.1111/j.1471-4159.2007.04454.x; Peters A, 1998, CEREB CORTEX, V8, P671, DOI 10.1093/cercor/8.8.671; Petrella JR, 2007, RADIOLOGY, V245, P224, DOI 10.1148/radiol.2451061847; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; TIGGES J, 1988, AM J PRIMATOL, V15, P263, DOI 10.1002/ajp.1350150308; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Walker DW, 2006, CURR BIOL, V16, P674, DOI 10.1016/j.cub.2006.01.057; Wang JB, 2006, J NEUROVIROL, V12, P472, DOI 10.1080/13550280601039659; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201	37	219	223	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3329	10.1371/journal.pone.0003329	http://dx.doi.org/10.1371/journal.pone.0003329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830410	Green Published, gold, Green Submitted			2022-12-27	WOS:000264797300013
J	Chain, FJJ; Ilieva, D; Evans, BJ				Chain, Frederic J. J.; Ilieva, Dora; Evans, Ben J.			Single-Species Microarrays and Comparative Transcriptomics	PLOS ONE			English	Article							DENSITY OLIGONUCLEOTIDE ARRAYS; GENE-EXPRESSION ANALYSIS; SEQUENCE DIVERGENCE; DNA MICROARRAYS; XENOPUS-LAEVIS; CLAWED FROGS; EVOLUTION; NORMALIZATION; MODEL; STERILITY	Background: Prefabricated expression microarrays are currently available for only a few species but methods have been proposed to extend their application to comparisons between divergent genomes. Methodology/Principal Findings: Here we demonstrate that the hybridization intensity of genomic DNA is a poor basis on which to select unbiased probes on Affymetrix expression arrays for studies of comparative transcriptomics, and that doing so produces spurious results. We used the Affymetrix Xenopus laevis microarray to evaluate expression divergence between X. laevis, X. borealis, and their F1 hybrids. When data are analyzed with probes that interrogate only sequences with confirmed identity in both species, we recover results that differ substantially analyses that use genomic DNA hybridizations to select probes. Conclusions/Significance: Our findings have implications for the experimental design of comparative expression studies that use single-species microarrays, and for our understanding of divergent expression in hybrid clawed frogs. These findings also highlight important limitations of single-species microarrays for studies of comparative transcriptomics of polyploid species.	[Chain, Frederic J. J.; Evans, Ben J.] McMaster Univ, Dept Biol, Ctr Environm Genom, Hamilton, ON, Canada; [Ilieva, Dora] McMaster Univ, Michael DeGroote Sch Med, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Chain, FJJ (corresponding author), McMaster Univ, Dept Biol, Ctr Environm Genom, Hamilton, ON, Canada.	evansb@mcmaster.ca		Chain, Frederic/0000-0001-6169-7399; Evans, Ben/0000-0002-9512-8845	Canadian Foundation for Innovation; National Science and Engineering Research Council; McMaster University	Canadian Foundation for Innovation(Canada Foundation for Innovation); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); McMaster University	This research was supported by the Canadian Foundation for Innovation, the National Science and Engineering Research Council, and McMaster University.	*AFF, 2001, AFF GENECHIP EXPR AN; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bar-Or C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-110; Becher M, 2004, PLANT J, V37, P251, DOI 10.1046/j.1365-313X.2003.01959.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOLSTAD B, 2007, RMA EXPRESS; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buckley BA, 2007, J EXP BIOL, V210, P1602, DOI 10.1242/jeb.002402; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Cambon AC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-146; Chain FJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-43; Chain FJJ, 2006, PLOS GENET, V2, P478, DOI 10.1371/journal.pgen.0020056; Chismar JD, 2002, BIOTECHNIQUES, V33, P516, DOI 10.2144/02333st01_11836a; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Evans BJ, 2007, GENETICS, V176, P1119, DOI 10.1534/genetics.106.069690; Evans BJ, 2005, MOL BIOL EVOL, V22, P1193, DOI 10.1093/molbev/msi104; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Gilad Y, 2005, GENOME RES, V15, P674, DOI 10.1101/gr.3335705; Gilad Y, 2006, CURR OPIN GENET DEV, V16, P553, DOI 10.1016/j.gde.2006.09.005; Grigoryev DN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-62; Hammond JP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-10; Hammond JP, 2006, NEW PHYTOL, V170, P239, DOI 10.1111/j.1469-8137.2006.01662.x; Hellsten U, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-31; Hsieh WP, 2003, GENETICS, V165, P747; HUGHES MK, 1993, MOL BIOL EVOL, V10, P1360; Ji W, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh084; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Kirst M, 2006, PLANT BIOTECHNOL J, V4, P489, DOI 10.1111/j.1467-7652.2006.00198.x; Malone JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000781; Malone JH, 2008, SCIENCE, V319, P59, DOI 10.1126/science.1148231; Malone JH, 2006, J MOL EVOL, V63, P427, DOI 10.1007/s00239-005-0263-4; Malone JH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-82; Meiklejohn CD, 2003, P NATL ACAD SCI USA, V100, P9894, DOI 10.1073/pnas.1630690100; Michalak P, 2003, MOL BIOL EVOL, V20, P1070, DOI 10.1093/molbev/msg119; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Oshlack A, 2007, BIOINFORMATICS, V23, P1235, DOI 10.1093/bioinformatics/btm111; Poole R, 2007, FUNCT INTEGR GENOMIC, V7, P207, DOI 10.1007/s10142-007-0046-7; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sartor MA, 2006, NUCLEIC ACIDS RES, V34, P185, DOI 10.1093/nar/gkj413; Semon M, 2008, P NATL ACAD SCI USA, V105, P8333, DOI 10.1073/pnas.0708705105; Sinner D, 2006, DEVELOPMENT, V133, P1955, DOI 10.1242/dev.02358; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; TINSLEY RC, 1996, BIOL XENOPUS, P81; Uddin M, 2004, P NATL ACAD SCI USA, V101, P2957, DOI 10.1073/pnas.0308725100; Weber M, 2004, PLANT J, V37, P269, DOI 10.1046/j.1365-313X.2003.01960.x; WERTH CR, 1991, AM NAT, V137, P515, DOI 10.1086/285180; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zakharkin SO, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-214	52	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2008	3	9							e3279	10.1371/journal.pone.0003279	http://dx.doi.org/10.1371/journal.pone.0003279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MH	18815615	gold, Green Published, Green Submitted			2022-12-27	WOS:000264431900005
J	Frazier, CRM; Mason, P; Zhuang, XX; Beeler, JA				Frazier, Cristianne R. M.; Mason, Peggy; Zhuang, Xiaoxi; Beeler, Jeff A.			Sucrose Exposure in Early Life Alters Adult Motivation and Weight Gain	PLOS ONE			English	Article							LOW-PROTEIN DIET; THRIFTY PHENOTYPE HYPOTHESIS; ENERGY-BALANCE; FOOD STORES; HIGH-FAT; NEIGHBORHOOD CHARACTERISTICS; DIABETES-MELLITUS; CHILDHOOD OBESITY; PRENATAL EXPOSURE; LEPTIN SYNTHESIS	The cause of the current increase in obesity in westernized nations is poorly understood but is frequently attributed to a 'thrifty genotype,' an evolutionary predisposition to store calories in times of plenty to protect against future scarcity. In modern, industrialized environments that provide a ready, uninterrupted supply of energy-rich foods at low cost, this genetic predisposition is hypothesized to lead to obesity. Children are also exposed to this 'obesogenic' environment; however, whether such early dietary experience has developmental effects and contributes to adult vulnerability to obesity is unknown. Using mice, we tested the hypothesis that dietary experience during childhood and adolescence affects adult obesity risk. We gave mice unlimited or no access to sucrose for a short period post-weaning and measured sucrose-seeking, food consumption, and weight gain in adulthood. Unlimited access to sucrose early in life reduced sucrose-seeking when work was required to obtain it. When high-sugar/high-fat dietary options were made freely-available, however, the sucrose-exposed mice gained more weight than mice without early sucrose exposure. These results suggest that early, unlimited exposure to sucrose reduces motivation to acquire sucrose but promotes weight gain in adulthood when the cost of acquiring palatable, energy dense foods is low. This study demonstrates that early post-weaning experience can modify the expression of a ` thrifty genotype' and alter an adult animal's response to its environment, a finding consistent with evidence of pre- and peri-natal programming of adult obesity risk by maternal nutritional status. Our findings suggest the window for developmental effects of diet may extend into childhood, an observation with potentially important implications for both research and public policy in addressing the rising incidence of obesity.	[Frazier, Cristianne R. M.; Mason, Peggy; Zhuang, Xiaoxi] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; [Mason, Peggy; Zhuang, Xiaoxi; Beeler, Jeff A.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Frazier, CRM (corresponding author), Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA.	jabeeler@uchicago.edu		Beeler, Jeff/0000-0002-1344-1337	NIMH [MH66216]; NIDA [1 F32 DA020427-01]; USPHS [T32-DA-07255]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA020427, T32DA007255] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by NIMH MH66216 (XZ), NIDA 1 F32 DA020427-01 (JB), USPHS T32-DA-07255 (CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Bellinger L, 2005, CLIN SCI, V109, P413, DOI 10.1042/CS20050127; Bellinger L, 2006, INT J OBESITY, V30, P729, DOI 10.1038/sj.ijo.0803205; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berthoud HR, 2007, PHYSIOL BEHAV, V91, P486, DOI 10.1016/j.physbeh.2006.12.016; BINDRA D, 1974, PSYCHOL REV, V81, P199, DOI 10.1037/h0036330; Clark HR, 2007, J PUBLIC HEALTH-UK, V29, P132, DOI 10.1093/pubmed/fdm012; COUSINS MS, 1993, PHARMACOL BIOCHEM BE, V46, P943, DOI 10.1016/0091-3057(93)90226-J; Delva J, 2007, AM J PREV MED, V33, pS226, DOI 10.1016/j.amepre.2007.07.018; Delva J, 2007, AM J PREV MED, V33, pS178, DOI 10.1016/j.amepre.2007.07.008; Drewnowski A, 2007, EPIDEMIOL REV, V29, P160, DOI 10.1093/epirev/mxm011; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; ELIZALDE G, 1990, APPETITE, V15, P189, DOI 10.1016/0195-6663(90)90019-5; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; Figlewicz DP, 2007, PHYSIOL BEHAV, V91, P473, DOI 10.1016/j.physbeh.2006.10.008; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gibson SA, 1996, INT J FOOD SCI NUTR, V47, P405, DOI 10.3109/09637489609006954; Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hoek J, 2006, J HEALTH COMMUN, V11, P409, DOI 10.1080/10810730600671888; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Kelly B, 2007, PUBLIC HEALTH NUTR, V10, P1234, DOI 10.1017/S1368980007687126; Kosti Rena I., 2006, Central European Journal of Public Health, V14, P151; Langley-Evans SC, 2005, MATERN CHILD NUTR, V1, P142, DOI 10.1111/j.1740-8709.2005.00015.x; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Levine AS, 2003, AM J CLIN NUTR, V78, p834S, DOI 10.1093/ajcn/78.4.834S; Levitsky DA, 2005, PHYSIOL BEHAV, V86, P623, DOI 10.1016/j.physbeh.2005.08.053; Lewis SR, 2005, PHYSIOL BEHAV, V85, P546, DOI 10.1016/j.physbeh.2005.06.003; McMillen IC, 2004, P NUTR SOC, V63, P405, DOI 10.1079/PNS2004370; McMillen IC, 2006, REPRODUCTION, V131, P415, DOI 10.1530/rep.1.00303; Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040; MOORE LV, 2008, AM J EPIDEMIOL; Moreno LA, 2007, CURR OPIN CLIN NUTR, V10, P336, DOI 10.1097/MCO.0b013e3280a94f59; Morland K, 2006, AM J PREV MED, V30, P333, DOI 10.1016/j.amepre.2005.11.003; Morland K, 2002, AM J PREV MED, V22, P23, DOI 10.1016/S0749-3797(01)00403-2; Muhlhausler BS, 2006, FASEB J, V20, P1257, DOI 10.1096/fj.05-5241fje; Neel JV, 1999, NUTR REV, V57, pS2, DOI 10.1111/j.1753-4887.1999.tb01782.x; NEEL JV, 1962, AM J HUM GENET, V14, P353; Ogden Cynthia L, 2004, Adv Data, P1; Poppitt SD, 2002, AM J CLIN NUTR, V75, P11, DOI 10.1093/ajcn/75.1.11; Powell LM, 2007, PEDIATRICS, V120, P576, DOI 10.1542/peds.2006-3595; Ravussin E, 2000, BRIT J NUTR, V83, pS17; Saris WHM, 2000, INT J OBESITY, V24, P1310, DOI 10.1038/sj.ijo.0801451; Sumiyoshi M, 2006, J NUTR, V136, P582, DOI 10.1093/jn/136.3.582; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wing RR, 2001, DIABETES CARE, V24, P117, DOI 10.2337/diacare.24.1.117; WURTMAN JJ, 1979, SCIENCE, V205, P321, DOI 10.1126/science.451607; Zheng HY, 2007, CURR OPIN PHARMACOL, V7, P607, DOI 10.1016/j.coph.2007.10.011	56	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2008	3	9							e3221	10.1371/journal.pone.0003221	http://dx.doi.org/10.1371/journal.pone.0003221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422LB	18797507	gold, Green Submitted, Green Published			2022-12-27	WOS:000264428200005
J	Saint-Geniez, M; Maharaj, ASR; Walshe, TE; Tucker, BA; Sekiyama, E; Kurihara, T; Darland, DC; Young, MJ; D'Amore, PA				Saint-Geniez, Magali; Maharaj, Arindel S. R.; Walshe, Tony E.; Tucker, Budd A.; Sekiyama, Eiichi; Kurihara, Tomoki; Darland, Diane C.; Young, Michael J.; D'Amore, Patricia A.			Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Muller Cells and Photoreceptors	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; FIBRILLARY ACIDIC PROTEIN; TGF-BETA; IN-VITRO; IMMUNOCYTOCHEMICAL LOCALIZATION; INTRAVITREAL BEVACIZUMAB; VASCULAR-PERMEABILITY; CHOROIDAL ISCHEMIA; PROLONGS SURVIVAL	Background: Vascular endothelial growth factor ( VEGF) is well known for its role in normal and pathologic neovascularization. However, a growing body of evidence indicates that VEGF also acts on non-vascular cells, both developmentally as well as in the adult. In light of the widespread use of systemic and intraocular anti-VEGF therapies for the treatment of angiogenesis associated with tumor growth and wet macular degeneration, systematic investigation of the role of VEGF in the adult retina is critical. Methods and Findings: Using immunohistochemistry and Lac-Z reporter mouse lines, we report that VEGF is produced by various cells in the adult mouse retina and that VEGFR2, the primary signaling receptor, is also widely expressed, with strong expression by Muller cells and photoreceptors. Systemic neutralization of VEGF was accomplished in mice by adenoviral expression of sFlt1. After 14 days of VEGF neutralization, there was no effect on the inner and outer retina vasculature, but a significant increase in apoptosis of cells in the inner and outer nuclear layers. By four weeks, the increase in neural cell death was associated with reduced thickness of the inner and outer nuclear layers and a decline in retinal function as measured by electroretinograms. siRNA-based suppression of VEGF expression in a Muller cell line in vitro supports the existence of an autocrine role for VEGF in Muller cell survival. Similarly, the addition of exogenous VEGF to freshly isolated photoreceptor cells and outer-nuclear-layer explants demonstrated VEGF to be highly neuroprotective. Conclusions: These results indicate an important role for endogenous VEGF in the maintenance and function of adult retina neuronal cells and indicate that anti-VEGF therapies should be administered with caution.	[Saint-Geniez, Magali; Maharaj, Arindel S. R.; Walshe, Tony E.; Tucker, Budd A.; Sekiyama, Eiichi; Kurihara, Tomoki; Young, Michael J.; D'Amore, Patricia A.] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02115 USA; [Saint-Geniez, Magali; Walshe, Tony E.; Tucker, Budd A.; Sekiyama, Eiichi; Young, Michael J.; D'Amore, Patricia A.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [D'Amore, Patricia A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA; [Darland, Diane C.] Univ N Dakota, Grand Forks, ND USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of North Dakota Grand Forks	Saint-Geniez, M (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02115 USA.	patricia.damore@schepens.harvard.edu	SAINT-GENIEZ, MAGALI/P-3509-2019; Walshe, Tony/AAJ-8833-2020; D'Amore, Patricia A/G-5660-2017	SAINT-GENIEZ, MAGALI/0000-0001-9897-138X; D'Amore, Patricia A/0000-0001-9652-8974; Tucker, Budd/0000-0003-2178-1742	NIH [EY05318, EY015435]; Core grant for Vision Research [P30EY14104]; NSF [R15 NSF057807]; Lincy Foundation; Discovery Eye Foundation; NSERC; NATIONAL EYE INSTITUTE [R01EY015435, P30EY014104] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core grant for Vision Research; NSF(National Science Foundation (NSF)); Lincy Foundation; Discovery Eye Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was supported by NIH grant EY05318 and EY015435 to P.D and by the Core grant for Vision Research P30EY14104. ND-EPSCOR (NSF) and R15 NSF057807 to D.C.D, by the Lincy Foundation and Discovery Eye Foundation to M.Y. B.D. is supported by NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Brekken RA, 2000, CANCER RES, V60, P5117; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; BRYAN BA, 2007, MOL BIOL CELL; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; CARMIGNOTO G, 1991, EXP NEUROL, V111, P302, DOI 10.1016/0014-4886(91)90097-V; COGAN DG, 1967, ARCH OPHTHALMOL-CHIC, V78, P133; COGAN DG, 1961, ARCH OPHTHALMOL-CHIC, V66, P366, DOI 10.1001/archopht.1961.00960010368014; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; DAMORE PA, 2007, AM J PATHOL; Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Duh EJ, 2004, AM J OPHTHALMOL, V137, P668, DOI 10.1016/j.ajo.2003.11.015; ENGERMAN RL, 1967, LAB INVEST, V17, P738; Erickson Kathryn K., 2007, Angiogenesis, V10, P103, DOI 10.1007/s10456-007-9067-z; Famiglietti EV, 2003, BRAIN RES, V969, P195, DOI 10.1016/S0006-8993(02)03766-6; Feng D, 2000, J HISTOCHEM CYTOCHEM, V48, P545, DOI 10.1177/002215540004800412; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; Fontaine V, 1998, J NEUROSCI, V18, P9662; Fragoso R, 2007, LEUKEMIA LYMPHOMA, V48, P481, DOI 10.1080/10428190601064720; Garcia M, 2003, HISTOL HISTOPATHOL, V18, P1205, DOI 10.14670/HH-18.1205; Garcia M, 2002, INVEST OPHTH VIS SCI, V43, P3735; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gerhardinger C, 1998, AM J PATHOL, V152, P1453; Gilbert RE, 1998, LAB INVEST, V78, P1017; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guan FX, 2006, AM J PHYSIOL-RENAL, V291, pF422, DOI 10.1152/ajprenal.00448.2005; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Isenmann S, 2003, PROG RETIN EYE RES, V22, P483, DOI 10.1016/S1350-9462(03)00027-2; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Kim I, 1999, INVEST OPHTH VIS SCI, V40, P2115; KIM I, 2000, INVEST OPHTH VIS SCI, V41, P368; Kuo CJ, 2001, P NATL ACAD SCI USA, V98, P4605, DOI 10.1073/pnas.081615298; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; LINSENMEIER RA, 1990, GRAEF ARCH CLIN EXP, V228, P143, DOI 10.1007/BF02764309; Maharaj ASR, 2008, J EXP MED, V205, P491, DOI 10.1084/jem.20072041; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mercurio AM, 2004, SEMIN CANCER BIOL, V14, P115, DOI 10.1016/j.semcancer.2003.09.016; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; MohandSaid S, 1997, OPHTHALMIC RES, V29, P290, DOI 10.1159/000268027; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; Ng YS, 2001, DEV DYNAM, V220, P112, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Peters S, 2007, AM J OPHTHALMOL, V143, P995, DOI 10.1016/j.ajo.2007.03.007; Pinto LH, 2007, DOC OPHTHALMOL, V115, P127, DOI 10.1007/s10633-007-9064-y; Ramsauer M, 2007, J CELL SCI, V120, P1810, DOI 10.1242/jcs.003533; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Robinson GS, 2001, FASEB J, V15, P1215, DOI 10.1096/fj.00-0598fje; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; Saito Y, 1998, RETINA-J RET VIT DIS, V18, P103, DOI 10.1097/00006982-199818020-00002; Sathish S, 2000, CLIN EXP OPHTHALMOL, V28, P387, DOI 10.1046/j.1442-9071.2000.00342.x; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Seki M, 2003, INVEST OPHTH VIS SCI, V44, P3211, DOI 10.1167/iovs.02-1089; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Spandau UHM, 2006, AM J OPHTHALMOL, V142, P1068, DOI 10.1016/j.ajo.2006.06.048; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; STEIN I, 1995, MOL CELL BIOL, V15, P5363; Stitt AW, 1998, J PATHOL, V186, P306, DOI 10.1002/(SICI)1096-9896(1998110)186:3<306::AID-PATH183>3.0.CO;2-B; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Tilton RG, 1997, J CLIN INVEST, V99, P2192, DOI 10.1172/JCI119392; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; VECINO E, 1998, UNDERSTANDING GLIA, P103; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Vinores SA, 2001, HISTOL HISTOPATHOL, V16, P1061, DOI 10.14670/HH-16.1061; Wang YM, 2007, J NEUROSCI, V27, P304, DOI 10.1523/JNEUROSCI.4433-06.2007; Weinberger AWA, 2007, AM J OPHTHALMOL, V144, P294, DOI 10.1016/j.ajo.2007.03.024; Yokomori H, 2003, LIVER INT, V23, P467, DOI 10.1111/j.1478-3231.2003.00880.x; Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375, DOI 10.1152/ajpcell.2001.280.6.C1375	83	487	505	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2008	3	11							e3554	10.1371/journal.pone.0003554	http://dx.doi.org/10.1371/journal.pone.0003554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432LI	18978936	gold, Green Published, Green Submitted			2022-12-27	WOS:000265134200001
J	Boada, JN; Boada, C; Garcia-Saiz, M; Garcia, M; Fernandez, E; Gomez, E				Boada, Jose N.; Boada, Carlos; Garcia-Saiz, Mar; Garcia, Marcelino; Fernandez, Eduardo; Gomez, Eugenio			Net Efficacy Adjusted for Risk (NEAR): A Simple Procedure for Measuring Risk: Benefit Balance	PLOS ONE			English	Article								Background: Although several mathematical models have been proposed to assess the risk: benefit of drugs in one measure, their use in practice has been rather limited. Our objective was to design a simple, easily applicable model. In this respect, measuring the proportion of patients who respond favorably to treatment without being affected by adverse drug reactions (ADR) could be a suitable endpoint. However, remarkably few published clinical trials report the data required to calculate this proportion. As an approach to the problem, we calculated the expected proportion of this type of patients. Methodology/Principal Findings: Theoretically, responders without ADR may be obtained by multiplying the total number of responders by the total number of subjects that did not suffer ADR, and dividing the product by the total number of subjects studied. When two drugs are studied, the same calculation may be repeated for the second drug. Then, by constructing a 262 table with the expected frequencies of responders with and without ADR, and non-responders with and without ADR, the odds ratio and relative risk with their confidence intervals may be easily calculated and graphically represented on a logarithmic scale. Such measures represent "net efficacy adjusted for risk'' (NEAR). We assayed the model with results extracted from several published clinical trials or meta-analyses. On comparing our results with those originally reported by the authors, marked differences were found in some cases, with ADR arising as a relevant factor to balance the clinical benefit obtained. The particular features of the adverse reaction that must be weighed against benefit is discussed in the paper. Conclusion: NEAR representing overall risk-benefit may contribute to improving knowledge of drug clinical usefulness. As most published clinical trials tend to overestimate benefits and underestimate toxicity, our measure represents an effort to change this trend.	[Boada, Jose N.; Boada, Carlos; Garcia-Saiz, Mar; Garcia, Marcelino; Fernandez, Eduardo; Gomez, Eugenio] Univ La Laguna, Clin Pharmacol Unit, Pharmacovigilance Ctr, Univ Hosp Canary Isl, E-38207 San Cristobal la Laguna, Santa Cruz Tene, Spain	Universidad de la Laguna	Boada, JN (corresponding author), Univ La Laguna, Clin Pharmacol Unit, Pharmacovigilance Ctr, Univ Hosp Canary Isl, E-38207 San Cristobal la Laguna, Santa Cruz Tene, Spain.	boadajuarez@gmail.com	Fernandez, Eduardo/S-8206-2016	Fernandez, Eduardo/0000-0002-7052-6011				CHUANGSTEIN C, 1991, STAT MED, V10, P1349, DOI 10.1002/sim.4780100904; File TM, 2001, J ANTIMICROB CHEMOTH, V48, P67, DOI 10.1093/jac/48.1.67; GIMENO A, 2005, AN PEDIAT, V63, P212; Gimeno Navarro A, 2007, An Pediatr (Barc), V67, P309; HARTZEMA A, 1991, PHARMACOEPIDEM DR S, P142; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Josan K, 2008, CAN MED ASSOC J, V178, P576, DOI 10.1503/cmaj.070675; Lago P, 2002, EUR J PEDIATR, V161, P202, DOI 10.1007/s00431-002-0915-y; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Oliva MAE, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-88; PETERSEN P, 1989, LANCET, V1, P175; Quan H, 2007, STAT MED, V26, P4703, DOI 10.1002/sim.2893; Schechtman E, 2002, VALUE HEALTH, V5, P431; Schulzer M, 1996, INT J EPIDEMIOL, V25, P704, DOI 10.1093/ije/25.4.704; Shakespeare TP, 2001, LANCET, V357, P1349, DOI 10.1016/S0140-6736(00)04522-0; TUBERTBITTER P, 1995, STAT MED, V14, P1129, DOI 10.1002/sim.4780140933; Van Overmeire B, 2000, NEW ENGL J MED, V343, P674, DOI 10.1056/NEJM200009073431001	17	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3580	10.1371/journal.pone.0003580	http://dx.doi.org/10.1371/journal.pone.0003580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974868	Green Published, gold, Green Submitted			2022-12-27	WOS:000265131700006
J	Wagner, J; Short, K; Catto-Smith, AG; Cameron, DJS; Bishop, RF; Kirkwood, CD				Wagner, Josef; Short, Kirsty; Catto-Smith, Anthony G.; Cameron, Don J. S.; Bishop, Ruth F.; Kirkwood, Carl D.			Identification and Characterisation of Pseudomonas 16S Ribosomal DNA from Ileal Biopsies of Children with Crohn's Disease	PLOS ONE			English	Article								Molecular analysis of bacterial 16S rRNA genes has made a significant contribution to the identification and characterisation of bacterial flora in the human gut. In particular, this methodology has helped characterise bacterial families implicated in the aetiology of inflammatory bowel disease (IBD). In this study we have used a genus specific bacterial 16S PCR to investigate the prevalence and diversity of Pseudomonas species derived from the ileum of children with Crohn's disease (CD), and from control children with non-inflammatory bowel disease (non-IBD) undergoing their initial endoscopic examination. Fifty eight percent of CD patients (18/32) were positive using the Pseudomonas PCR, while significantly fewer children in the non-IBD group, 33% (12/36), were PCR positive for Pseudomonas (p<0.05, Fischer's exact test). Pseudomonas specific 16S PCR products from 13 CD and 12 non-IBD children were cloned and sequenced. Five hundred and eighty one sequences were generated and used for the comparative analysis of Pseudomonas diversity between CD and non-IBD patients. Pseudomonas species were less diverse in CD patients compared with non-IBD patients. In particular P. aeruginosa was only identified in non-IBD patients.	[Wagner, Josef; Bishop, Ruth F.; Kirkwood, Carl D.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Enter Virus Grp, Parkville, Vic 3052, Australia; [Short, Kirsty] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Catto-Smith, Anthony G.; Cameron, Don J. S.] Royal Childrens Hosp, Dept Gastroenterol & Clin Nutr, Parkville, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne	Wagner, J (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Enter Virus Grp, Flemington Rd, Parkville, Vic 3052, Australia.	carl.kirkwood@mcri.edu.au	Catto-Smith, Anthony G/H-3698-2012; Catto-Smith, Anthony/AAG-1485-2019	Short, Kirsty/0000-0003-4963-6184	Murdoch Childrens Research Institute; The Crohn's and Colitis Foundation of Australia; The CASS Foundation; The Lynne Quayle Charitable Trust; Equity Trustees Ltd; Murdoch Children Research Institute [fellowship]; NHMRC RD Wright Research Fellowship [334364]	Murdoch Childrens Research Institute; The Crohn's and Colitis Foundation of Australia; The CASS Foundation; The Lynne Quayle Charitable Trust; Equity Trustees Ltd; Murdoch Children Research Institute; NHMRC RD Wright Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by research grants from the Murdoch Childrens Research Institute, The Crohn's and Colitis Foundation of Australia, The CASS Foundation, and The Lynne Quayle Charitable Trust, Equity Trustees Ltd. Dr. Josef Wagner is supported by a Murdoch Children Research Institute fellowship. Dr. Carl Kirkwood is supported by an NHMRC RD Wright Research Fellowship (334364).	AUER IO, 1983, SCAND J GASTROENTERO, V18, P217, DOI 10.3109/00365528309181586; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Bousvaros A, 2006, INFLAMM BOWEL DIS, V12, P885, DOI 10.1097/01.mib.0000228358.25364.8b; BROWN WR, 1995, GASTROENTEROLOGY, V108, P1589, DOI 10.1016/0016-5085(95)90710-6; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Coenye T, 2004, THORAX, V59, P952, DOI 10.1136/thx.2003.019810; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Cuchacovich R, 2002, J RHEUMATOL, V29, P1426; Dabboussi F, 2002, INT J SYST EVOL MICR, V52, P363, DOI 10.1099/00207713-52-2-363; DALHOFF A, 1987, INFECTION, V15, pS60, DOI 10.1007/BF01644194; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Duerr RH, 2003, J CLIN GASTROENTEROL, V37, P358, DOI 10.1097/00004836-200311000-00003; Eckburg PB, 2007, CLIN INFECT DIS, V44, P256, DOI 10.1086/510385; FINEGOLD SM, 1977, AM J CLIN NUTR, V30, P1781, DOI 10.1093/ajcn/30.11.1781; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; GRAHAM DY, 1983, J LAB CLIN MED, V101, P940; Guarner F, 2005, CURR OPIN GASTROEN, V21, P414; Hildebrand H, 2003, GUT, V52, P1432, DOI 10.1136/gut.52.10.1432; Hugot JP, 2003, LANCET, V362, P2012, DOI 10.1016/S0140-6736(03)15024-6; KLINGER JD, 1985, DIAGN MICR INFEC DIS, V3, P149, DOI 10.1016/0732-8893(85)90025-2; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lamps LW, 2003, AM J SURG PATHOL, V27, P220, DOI 10.1097/00000478-200302000-00011; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Olofsson TC, 2007, INT J FOOD MICROBIOL, V118, P233, DOI 10.1016/j.ijfoodmicro.2007.07.017; PARENT K, 1976, GASTROENTEROLOGY, V71, P365; PARENT K, 1978, GASTROENTEROLOGY, V75, P368; PARMELY M, 1990, INFECT IMMUN, V58, P3009, DOI 10.1128/IAI.58.9.3009-3014.1990; Phavichitr N, 2003, J GASTROEN HEPATOL, V18, P329, DOI 10.1046/j.1440-1746.2003.02975.x; Picot L, 2001, MICROBES INFECT, V3, P985, DOI 10.1016/S1286-4579(01)01462-9; Prindiville T, 2004, INFLAMM BOWEL DIS, V10, P824, DOI 10.1097/00054725-200411000-00017; ROWBOTHAM DS, 1995, GUT, V37, P660, DOI 10.1136/gut.37.5.660; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schwartz D, 2000, CLIN MICROBIOL INFEC, V6, P303, DOI 10.1046/j.1469-0691.2000.00093.x; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; Soler-Palacin P, 2007, ALLERGOL IMMUNOPATH, V35, P83, DOI 10.1157/13106774; Spilker T, 2004, J CLIN MICROBIOL, V42, P2074, DOI 10.1128/JCM.42.5.2074-2079.2004; Sutton CL, 2000, GASTROENTEROLOGY, V119, P23, DOI 10.1053/gast.2000.8519; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Timmer A, 1998, GASTROENTEROLOGY, V114, P1143, DOI 10.1016/S0016-5085(98)70419-6; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wang X, 2003, J APPL MICROBIOL, V95, P508, DOI 10.1046/j.1365-2672.2003.02005.x; Wei B, 2002, INFECT IMMUN, V70, P6567, DOI 10.1128/IAI.70.12.6567-6575.2002; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yao T, 2000, DIS COLON RECTUM, V43, pS85, DOI 10.1007/BF02237231; 1983, LANCET, V2, P257	53	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3578	10.1371/journal.pone.0003578	http://dx.doi.org/10.1371/journal.pone.0003578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974839	gold, Green Published			2022-12-27	WOS:000265131700004
J	Puppo, A; Chun, JT; Gragnaniello, G; Garante, E; Santella, L				Puppo, A.; Chun, Jong T.; Gragnaniello, Giovanni; Garante, Ezio; Santella, Luigia			Alteration of the Cortical Actin Cytoskeleton Deregulates Ca2+ Signaling, Monospermic Fertilization, and Sperm Entry	PLOS ONE			English	Article								Background: When preparing for fertilization, oocytes undergo meiotic maturation during which structural changes occur in the endoplasmic reticulum (ER) that lead to a more efficient calcium response. During meiotic maturation and subsequent fertilization, the actin cytoskeleton also undergoes dramatic restructuring. We have recently observed that rearrangements of the actin cytoskeleton induced by actin-depolymerizing agents, or by actin-binding proteins, strongly modulate intracellular calcium (Ca2+) signals during the maturation process. However, the significance of the dynamic changes in F-actin within the fertilized egg has been largely unclear. Methodology/Principal Findings: We have measured changes in intracellular Ca2+ signals and F-actin structures during fertilization. We also report the unexpected observation that the conventional antagonist of the InsP(3) receptor, heparin, hyperpolymerizes the cortical actin cytoskeleton in postmeiotic eggs. Using heparin and other pharmacological agents that either hypo- or hyperpolymerize the cortical actin, we demonstrate that nearly all aspects of the fertilization process are profoundly affected by the dynamic restructuring of the egg cortical actin cytoskeleton. Conclusions/Significance: Our findings identify important roles for subplasmalemmal actin fibers in the process of sperm-egg interaction and in the subsequent events related to fertilization: the generation of Ca2+ signals, sperm penetration, cortical granule exocytosis, and the block to polyspermy.	[Puppo, A.; Chun, Jong T.; Gragnaniello, Giovanni; Garante, Ezio; Santella, Luigia] Stn Zool A Dohrn, I-80121 Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Puppo, A (corresponding author), Stn Zool A Dohrn, I-80121 Naples, Italy.	santella@szn.it	Santella, Luigia/AAM-3524-2020; Chun, Jong Tai/AAM-3394-2020	Santella, Luigia/0000-0001-7159-0499; Chun, Jong Tai/0000-0002-6070-4953	Regione di Campania	Regione di Campania	This work was partly supported by Regione di Campania Research Grant to L.S. The funder had no roles in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Boyle JA, 2001, ZYGOTE, V9, P167, DOI 10.1017/S0967199401001186; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Calaghan SC, 2004, PROG BIOPHYS MOL BIO, V84, P29, DOI 10.1016/S0079-6107(03)00057-9; Carafoli E, 2004, TRENDS BIOCHEM SCI, V29, P371, DOI 10.1016/j.tibs.2004.05.006; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Chun JT, 2007, N COMP BIOC, V41, P425; CLINE CA, 1983, CELL MOTIL CYTOSKEL, V3, P513, DOI 10.1002/cm.970030518; DALE B, 1981, EXP CELL RES, V132, P505, DOI 10.1016/0014-4827(81)90132-4; DALE B, 1981, GAMETE RES, V4, P151, DOI 10.1002/mrd.1120040209; DAN JC, 1954, BIOL BULL, V107, P203, DOI 10.2307/1538607; Ducibella T, 2008, DEV BIOL, V315, P257, DOI 10.1016/j.ydbio.2007.12.012; Eliyahu E, 2005, REPRODUCTION, V129, P161, DOI 10.1530/rep.1.00424; FORSCHER P, 1989, TRENDS NEUROSCI, V12, P468, DOI 10.1016/0166-2236(89)90098-2; FUJIMOTO T, 1995, J CELL SCI, V108, P7; Furuyashiki T, 2002, P NATL ACAD SCI USA, V99, P14458, DOI 10.1073/pnas.212148999; GALIONE A, 1993, SCIENCE, V261, P348, DOI 10.1126/science.8392748; Giusti AF, 2000, ZYGOTE, V8, pS16; IKADAI H, 1981, DEV GROWTH DIFFER, V23, P73; JAFFE LA, 1976, NATURE, V261, P68, DOI 10.1038/261068a0; Kuroda R, 2001, DEVELOPMENT, V128, P4405; KYOZUKA K, 1988, GAMETE RES, V20, P275, DOI 10.1002/mrd.1120200304; Lange K, 1999, J CELL PHYSIOL, V180, P19, DOI 10.1002/(SICI)1097-4652(199907)180:1<19::AID-JCP3>3.0.CO;2-K; LEE HC, 1993, SCIENCE, V261, P352, DOI 10.1126/science.8392749; Lim D, 2003, J BIOL CHEM, V278, P42505, DOI 10.1074/jbc.M301851200; Lim D, 2002, FASEB J, V16, P1050, DOI 10.1096/fj.02-0021com; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; McAvey BA, 2002, BIOL REPROD, V67, P1342, DOI 10.1095/biolreprod67.4.1342; MEIJER L, 1984, INT REV CYTOL, V86, P129, DOI 10.1016/S0074-7696(08)60179-5; Miralles F, 2006, CURR OPIN CELL BIOL, V18, P261, DOI 10.1016/j.ceb.2006.04.009; Miyata K, 2006, DEV GROWTH DIFFER, V48, P605, DOI 10.1111/j.1440-169x.2006.00896.x; MIYAZAKI S, 1979, DEV BIOL, V70, P327, DOI 10.1016/0012-1606(79)90031-9; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; Moccia F, 2004, CELL CALCIUM, V36, P515, DOI 10.1016/j.ceca.2004.05.004; Moccia F, 2003, FASEB J, V17, P1907, DOI 10.1096/fj.03-0178fje; MOHRI T, 1995, DEV BIOL, V172, P139, DOI 10.1006/dbio.1995.0011; NUCCITELLI R, 1993, DEV BIOL, V158, P200, DOI 10.1006/dbio.1993.1179; Nusco GA, 2002, BIOCHEM BIOPH RES CO, V290, P1015, DOI 10.1006/bbrc.2001.6286; Nusco GA, 2006, BIOCHEM BIOPH RES CO, V348, P109, DOI 10.1016/j.bbrc.2006.07.023; Parrington J, 2007, DEV DYNAM, V236, P2027, DOI 10.1002/dvdy.21255; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; RAKOW TL, 1990, P NATL ACAD SCI USA, V87, P9285, DOI 10.1073/pnas.87.23.9285; Ramos-Franco J, 1998, BIOPHYS J, V75, P834, DOI 10.1016/S0006-3495(98)77572-1; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Runft LL, 2002, DEV BIOL, V245, P237, DOI 10.1006/dbio.2002.0600; Runge KE, 2007, DEV BIOL, V304, P317, DOI 10.1016/j.ydbio.2006.12.041; Sabala P, 2002, BIOCHEM BIOPH RES CO, V296, P484, DOI 10.1016/S0006-291X(02)00893-8; Sanchez-Gutierrez M, 2002, MOL REPROD DEV, V63, P518, DOI 10.1002/mrd.10203; Santella L, 2000, J BIOL CHEM, V275, P8301, DOI 10.1074/jbc.275.12.8301; Santella L, 2004, TRENDS BIOCHEM SCI, V29, P400, DOI 10.1016/j.tibs.2004.06.009; Santella L, 1999, EXP CELL RES, V248, P567, DOI 10.1006/excr.1999.4425; Santella L, 2008, INT J DEV BIOL, V52, P571, DOI 10.1387/ijdb.072560ls; SARDET C, 1992, DEV GROWTH DIFFER, V34, P37; Schuel H., 1985, BIOL FERTILIZATION, V3, P1; SELDEN LA, 1987, FEBS LETT, V217, P89, DOI 10.1016/0014-5793(87)81249-8; SHEN SS, 1993, DEV BIOL, V157, P157, DOI 10.1006/dbio.1993.1120; Spira ME, 2001, CELL MOL NEUROBIOL, V21, P591, DOI 10.1023/A:1015135617557; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; STRICKER SA, 1994, DEV BIOL, V166, P34, DOI 10.1006/dbio.1994.1295; Swann K, 2008, INT J DEV BIOL, V52, P585, DOI 10.1387/ijdb.072530ks; Terada Y, 2000, MOL REPROD DEV, V56, P89, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;89::AID-MRD11&gt;3.0.CO;2-I; Thaler CD, 2004, DEV GROWTH DIFFER, V46, P413, DOI 10.1111/j.1440-169x.2004.00758.x; TILNEY LG, 1980, J CELL BIOL, V87, P771, DOI 10.1083/jcb.87.3.771; Turvey MR, 2005, J CELL SCI, V118, P971, DOI 10.1242/jcs.01693; Wang Y, 2002, J NEUROCHEM, V82, P945, DOI 10.1046/j.1471-4159.2002.01059.x; WEHLAND J, 1977, P NATL ACAD SCI USA, V74, P5613, DOI 10.1073/pnas.74.12.5613; Yozuka K, 2008, DEV BIOL, V320, P426, DOI 10.1016/j.ydbio.2008.05.549	67	53	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2008	3	10							e3588	10.1371/journal.pone.0003588	http://dx.doi.org/10.1371/journal.pone.0003588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KI	18974786	Green Published, gold, Green Submitted			2022-12-27	WOS:000265131500012
J	Mattei, C; Wen, PJ; Nguyen-Huu, TD; Alvarez, M; Benoit, E; Bourdelais, AJ; Lewis, RJ; Baden, DG; Molgo, J; Meunier, FA				Mattei, Cesar; Wen, Peter J.; Nguyen-Huu, Truong D.; Alvarez, Martha; Benoit, Evelyne; Bourdelais, Andrea J.; Lewis, Richard J.; Baden, Daniel G.; Molgo, Jordi; Meunier, Frederic A.			Brevenal Inhibits Pacific Ciguatoxin-1B-Induced Neurosecretion from Bovine Chromaffin Cells	PLOS ONE			English	Article								Ciguatoxins and brevetoxins are neurotoxic cyclic polyether compounds produced by dinoflagellates, which are responsible for ciguatera and neurotoxic shellfish poisoning (NSP) respectively. Recently, brevenal, a natural compound was found to specifically inhibit brevetoxin action and to have a beneficial effect in NSP. Considering that brevetoxin and ciguatoxin specifically activate voltage-sensitive Na(+) channels through the same binding site, brevenal has therefore a good potential for the treatment of ciguatera. Pacific ciguatoxin-1B (P-CTX-1B) activates voltage-sensitive Na(+) channels and promotes an increase in neurotransmitter release believed to underpin the symptoms associated with ciguatera. However, the mechanism through which slow Na(+) influx promotes neurosecretion is not fully understood. In the present study, we used chromaffin cells as a model to reconstitute the sequence of events culminating in ciguatoxin-evoked neurosecretion. We show that P-CTX-1B induces a tetrodotoxin-sensitive rise in intracellular Na(+), closely followed by an increase in cytosolic Ca(2+) responsible for promoting SNARE-dependent catecholamine secretion. Our results reveal that brevenal and beta-naphtoyl-brevetoxin prevent P-CTX-1B secretagogue activity without affecting nicotine or barium-induced catecholamine secretion. Brevenal is therefore a potent inhibitor of ciguatoxin-induced neurotoxic effect and a potential treatment for ciguatera.	[Mattei, Cesar; Benoit, Evelyne; Molgo, Jordi] CNRS, Inst Neurobiol Alfred Fessard, Lab Neurobiol Cellulaire Mol, Gif Sur Yvette, France; [Wen, Peter J.; Nguyen-Huu, Truong D.; Alvarez, Martha; Meunier, Frederic A.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Wen, Peter J.; Nguyen-Huu, Truong D.; Alvarez, Martha; Meunier, Frederic A.] Queensland Brain Inst, Brisbane, Qld, Australia; [Alvarez, Martha] Tecnol Monterrey, Photon & Math Opt Grp, Monterrey, Mexico; [Bourdelais, Andrea J.; Baden, Daniel G.] Univ N Carolina, Ctr Marine Sci, Wilmington, NC USA; [Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Queensland; University of Queensland; Tecnologico de Monterrey; University of North Carolina; University of North Carolina Wilmington; University of Queensland	Mattei, C (corresponding author), Delegat Gen Armement, Bagneux, France.	Jordi.Molgo@nbcm.cnrs-gif.fr; f.meunier@uq.edu.au	Lewis, Richard J/E-8674-2013; Mattei, Cesar/K-5286-2015; Lewis, Richard/T-8763-2019; Meunier, Frederic A/C-8161-2009	Lewis, Richard J/0000-0003-3470-923X; Mattei, Cesar/0000-0002-2214-2611; Lewis, Richard/0000-0003-3470-923X; Meunier, Frederic A/0000-0001-6400-1107; BENOIT, Evelyne/0000-0001-5501-0888	National Health and Medical Research Council; DGA; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES010594] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); DGA; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant from the National Health and Medical Research Council (to F.A.M.), and C.M. was supported by a fellowship from DGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WM, 2005, AM J RESP CRIT CARE, V171, P26, DOI 10.1164/rccm.200406-735OC; Achaibar Kira C, 2007, Pract Neurol, V7, P316, DOI 10.1136/jnnp.2007.129049; Barclay JW, 2005, CELL CALCIUM, V38, P343, DOI 10.1016/j.ceca.2005.06.012; Benoit E, 1996, NEUROSCIENCE, V71, P1121, DOI 10.1016/0306-4522(95)00506-4; BIDARD JN, 1984, J BIOL CHEM, V259, P8353; Bourdelais AJ, 2005, J NAT PROD, V68, P2, DOI 10.1021/np049797o; Bourdelais AJ, 2004, CELL MOL NEUROBIOL, V24, P553, DOI 10.1023/B:CEMN.0000023629.81595.09; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; CHEEK TR, 1990, FEBS LETT, V266, P91, DOI 10.1016/0014-5793(90)81514-O; CHEEK TR, 1993, J BIOL CHEM, V268, P27076; Dechraoui MYB, 2006, TOXICON, V48, P702, DOI 10.1016/j.toxicon.2006.07.032; GAWLEY RE, 1995, CHEM BIOL, V2, P533, DOI 10.1016/1074-5521(95)90187-6; Hidalgo J, 2002, BRIT J PHARMACOL, V137, P1055, DOI 10.1038/sj.bjp.0704980; Hogg RC, 1998, NEUROSCI LETT, V252, P103, DOI 10.1016/S0304-3940(98)00575-8; Isbister GK, 2005, LANCET NEUROL, V4, P219, DOI 10.1016/S1474-4422(05)70041-7; LAWRENCE GW, 1994, EUR J BIOCHEM, V222, P325, DOI 10.1111/j.1432-1033.1994.tb18871.x; Legrand AM, 1989, J APPL PHYCOL, V1, P183, DOI 10.1007/BF00003882; LePage KT, 2007, J PHARMACOL EXP THER, V323, P174, DOI 10.1124/jpet.107.124271; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; Li WI, 2001, P NATL ACAD SCI USA, V98, P7599, DOI 10.1073/pnas.121085898; LOMBET A, 1987, FEBS LETT, V219, P355, DOI 10.1016/0014-5793(87)80252-1; LOPEZ MG, 1995, J PHYSIOL-LONDON, V482, P15, DOI 10.1113/jphysiol.1995.sp020496; MARXEN P, 1991, N-S ARCH PHARMACOL, V344, P387; Mattei C, 1999, BRAIN RES, V847, P50, DOI 10.1016/S0006-8993(99)02032-6; Mattei C, 1997, NEUROSCI LETT, V234, P75, DOI 10.1016/S0304-3940(97)00665-4; Mattei Cesar, 1999, Journal de la Societe de Biologie, V193, P329; Meunier FA, 2000, J CELL SCI, V113, P1119; Meunier FA, 1997, NEUROSCIENCE, V78, P883, DOI 10.1016/S0306-4522(96)00568-4; Michelliza S, 2007, CHEMBIOCHEM, V8, P2233, DOI 10.1002/cbic.200700317; MOLGO J, 1990, BRIT J PHARMACOL, V99, P695, DOI 10.1111/j.1476-5381.1990.tb12991.x; MOLGO J, 1993, NEUROSCI LETT, V160, P65, DOI 10.1016/0304-3940(93)9000-4; MOLGO J, 1993, NEUROSCI LETT, V158, P147, DOI 10.1016/0304-3940(93)90250-O; MURATA M, 1990, J AM CHEM SOC, V112, P4380, DOI 10.1021/ja00167a040; OSULLIVAN AJ, 1989, EMBO J, V8, P401, DOI 10.1002/j.1460-2075.1989.tb03391.x; Pearn J, 2001, J NEUROL NEUROSUR PS, V70, P4, DOI 10.1136/jnnp.70.1.4; POLI MA, 1986, MOL PHARMACOL, V30, P129; Shone CC, 1995, CURR TOP MICROBIOL, V195, P143; Soma S, 2006, J PHARMACOL SCI, V102, P88, DOI 10.1254/jphs.FPJ06006X; Strachan LC, 1999, J PHARMACOL EXP THER, V288, P379; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; WADA A, 1992, J PHARMACOL EXP THER, V263, P1347; Zerbes M, 2001, CELL CALCIUM, V29, P49, DOI 10.1054/ceca.2000.0160	45	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3448	10.1371/journal.pone.0003448	http://dx.doi.org/10.1371/journal.pone.0003448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941627	gold, Green Published			2022-12-27	WOS:000265125600008
J	Vollmers, C; Panda, S; DiTacchio, L				Vollmers, Christopher; Panda, Satchidananda; DiTacchio, Luciano			A High-Throughput Assay for siRNA-Based Circadian Screens in Human U2OS Cells	PLOS ONE			English	Article							GENE-EXPRESSION; CLOCK; REVEALS; CRYPTOCHROME; RHYTHMS; MOUSE; FBXL3	The advent of siRNA-based screens has revolutionized the efficiency by which functional components of biological processes are identified. A notable exception has been the field of mammalian circadian rhythms. Here, we outline a medium-to high-throughput siRNA-based approach that, in combination with real-time bioluminescence measurement of a circadian reporter gene, can be utilized to elucidate the effects of gene knockdown across several days in human cells.	[Vollmers, Christopher; Panda, Satchidananda; DiTacchio, Luciano] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Vollmers, Christopher] Heidelberg Univ Biochem Ctr BZH, Heidelberg, Germany	Salk Institute; Ruprecht Karls University Heidelberg	Vollmers, C (corresponding author), Salk Inst Biol Studies, Regulatory Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ldeharo@salk.edu	DiTacchio, Luciano/D-6341-2011; Panda, Satchidananda/J-6891-2012	DiTacchio, Luciano/0000-0001-9570-7348; 	Pew Scholars Program in Biomedical Sciences; Dana Foundation; Whitehall Foundation; NIH [EY016807]; NRSA [1F32GM082083-01]; NATIONAL EYE INSTITUTE [R01EY016807] Funding Source: NIH RePORTER	Pew Scholars Program in Biomedical Sciences; Dana Foundation; Whitehall Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Pew Scholars Program in Biomedical Sciences, Dana Foundation, Whitehall Foundation and NIH grants EY016807 (to S.P.), and by NRSA 1F32GM082083-01 (to L.D.)	Antoch MP, 2008, CELL CYCLE, V7, P1197, DOI 10.4161/cc.7.9.5886; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Chau NM, 2005, CANCER RES, V65, P4918, DOI 10.1158/0008-5472.CAN-04-4453; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Emery P, 2004, NEURON, V43, P443, DOI 10.1016/j.neuron.2004.08.009; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Isojima Y, 2003, J BIOCHEM, V134, P777, DOI 10.1093/jb/mvg219; Kondratov RV, 2007, COLD SPRING HARB SYM, V72, P477, DOI 10.1101/sqb.2007.72.050; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Metlaine A, 2005, IND HEALTH, V43, P11, DOI 10.2486/indhealth.43.11; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104; Sahar S, 2007, CELL CYCLE, V6, P1329, DOI 10.4161/cc.6.11.4295; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Staels B, 2006, NAT MED, V12, P54, DOI 10.1038/nm0106-54; Straume M, 2004, METHOD ENZYMOL, V383, P149; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang JH, 2005, J BIOMOL SCREEN, V10, P695, DOI 10.1177/1087057105279149; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	30	31	32	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2008	3	10							e3457	10.1371/journal.pone.0003457	http://dx.doi.org/10.1371/journal.pone.0003457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IB	18941634	gold, Green Published, Green Submitted			2022-12-27	WOS:000265125600015
J	Hall, MD; Bussiere, LF; Brooks, R				Hall, Matthew D.; Bussiere, Luc F.; Brooks, Robert			The Effect of Diet Quality and Wing Morph on Male and Female Reproductive Investment in a Nuptial Feeding Ground Cricket	PLOS ONE			English	Article							REQUENA-VERTICALIS ORTHOPTERA; MALE BUSH-CRICKETS; SEXUAL SELECTION; TRADE-OFFS; PARENTAL INVESTMENT; FIELD CRICKETS; GRYLLUS-FIRMUS; MATE CHOICE; LIFE-SPAN; EVOLUTION	A common approach in the study of life-history trade-off evolution is to manipulate the nutrient content of diets during the life of an individual in order observe how the acquisition of resources influences the relationship between reproduction, lifespan and other life-history parameters such as dispersal. Here, we manipulate the quality of diet that replicate laboratory populations received as a thorough test of how diet quality influences the life-history trade-offs associated with reproductive investment in a nuptial feeding Australian ground cricket (Pteronemobius sp.). In this species, both males and females make significant contributions to the production of offspring, as males provide a nuptial gift by allowing females to chew on a modified tibial spur during copulation and feed directing on their haemolymph. Individuals also have two distinct wing morphs, a short-winged flightless morph and a long-winged morph that has the ability to disperse. By manipulating the quality of diet over seven generations, we found that the reproductive investment of males and females were affected differently by the diet quality treatment and wing morph of the individual. We discuss the broader implications of these findings including the differences in how males and females balance current and future reproductive effort in nuptial feeding insects, the changing nature of sexual selection when diets vary, and how the life-history trade-offs associated with the ability to disperse are expected to differ among populations.	[Hall, Matthew D.; Brooks, Robert] Univ New S Wales, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Bussiere, Luc F.] Univ Stirling, Sch Biol & Environm Sci, Stirling FK9 4LA, Scotland	University of New South Wales Sydney; University of Stirling	Hall, MD (corresponding author), Univ New S Wales, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	m.hall@student.unsw.edu.au	Hall, Matthew D/A-2006-2009; Bussiere, Luc/T-2134-2018; Brooks, Robert/A-1251-2008	Hall, Matthew D/0000-0002-4738-203X; Bussiere, Luc/0000-0001-8937-8381; Brooks, Robert/0000-0001-6926-0781	UNSW; Australian Research Council; NSERC	UNSW; Australian Research Council(Australian Research Council); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from UNSW and the Australian Research Council, an Australian Postgraduate Award to MH, and NSERC fellowship to LFB and an ARC Fellowship to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Bonduriansky R, 2007, AM NAT, V169, P9, DOI 10.1086/510214; Brown WD, 1996, EVOLUTION, V50, P2400, DOI [10.2307/2410708, 10.1111/j.1558-5646.1996.tb03627.x]; Bussiere LF, 2005, BEHAV ECOL, V16, P223, DOI 10.1093/beheco/arh156; Chenoweth SF, 2005, AM NAT, V165, P281, DOI 10.1086/427271; Crnokrak P, 1998, ANIM BEHAV, V56, P433, DOI 10.1006/anbe.1998.0741; Crnokrak P, 2000, J EVOLUTION BIOL, V13, P396, DOI 10.1046/j.1420-9101.2000.00188.x; CUMMING JM, 1994, CAN ENTOMOL, V126, P907, DOI 10.4039/Ent126907-3; De Luca PA, 1998, BEHAVIOUR, V135, P777, DOI 10.1163/156853998792640422; DUSSOURD DE, 1991, P NATL ACAD SCI USA, V88, P9224, DOI 10.1073/pnas.88.20.9224; Fedorka KM, 2002, FLA ENTOMOL, V85, P317, DOI 10.1653/0015-4040(2002)085[0317:TSFIGC]2.0.CO;2; Fedorka KM, 2002, EVOLUTION, V56, P590, DOI 10.1111/j.0014-3820.2002.tb01369.x; Fedorka KM, 2002, ANIM BEHAV, V64, P361, DOI 10.1006/anbe.2002.3052; Glazier DS, 1999, EVOL ECOL, V13, P539, DOI 10.1023/A:1006793600600; GWYNNE DT, 1993, ECOLOGY, V74, P1406, DOI 10.2307/1940070; GWYNNE DT, 1990, NATURE, V346, P172, DOI 10.1038/346172a0; GWYNNE DT, 1990, AM NAT, V136, P474, DOI 10.1086/285108; GWYNNE DT, 1982, ANIM BEHAV, V30, P734, DOI 10.1016/S0003-3472(82)80145-0; Holzer B, 2003, BEHAV ECOL, V14, P353, DOI 10.1093/beheco/14.3.353; HOULE D, 1991, EVOLUTION, V45, P630, DOI 10.1111/j.1558-5646.1991.tb04334.x; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kokko H, 2001, ECOL LETT, V4, P159, DOI 10.1046/j.1461-0248.2001.00212.x; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Lynch M., 1998, GENETICS ANAL QUANTI; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Mappes J, 1996, P ROY SOC B-BIOL SCI, V263, P785, DOI 10.1098/rspb.1996.0117; MAYS D L, 1971, Florida Entomologist, V54, P113, DOI 10.2307/3493557; Post E, 1999, P NATL ACAD SCI USA, V96, P4467, DOI 10.1073/pnas.96.8.4467; Raubenheimer D, 2005, P ROY SOC B-BIOL SCI, V272, P2429, DOI 10.1098/rspb.2005.3271; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; ROFF DA, 1986, EVOLUTION, V40, P1009, DOI 10.1111/j.1558-5646.1986.tb00568.x; ROFF DA, 1991, AM ZOOL, V31, P243; ROFF DA, 1984, OECOLOGIA, V63, P30, DOI 10.1007/BF00379781; ROFF DA, 1994, AM NAT, V144, P772, DOI 10.1086/285706; Roff DA, 2003, J EVOLUTION BIOL, V16, P744, DOI 10.1046/j.1420-9101.2003.00570.x; Roff DA, 2002, EVOLUTION, V56, P84, DOI 10.1111/j.0014-3820.2002.tb00851.x; Roff Derek A., 1992; Simmons LW, 2006, P ROY SOC B-BIOL SCI, V273, P465, DOI 10.1098/rspb.2005.3309; SIMMONS LW, 1993, BEHAV ECOL SOCIOBIOL, V32, P135, DOI 10.1007/BF00164046; SIMMONS LW, 1992, BEHAV ECOL SOCIOBIOL, V31, P57, DOI 10.1007/BF00167816; SIMMONS LW, 1992, NATURE, V358, P61, DOI 10.1038/358061a0; SIMMONS LW, 1993, P ROY SOC B-BIOL SCI, V252, P1, DOI 10.1098/rspb.1993.0038; SIMMONS LW, 1994, J EVOLUTION BIOL, V7, P189, DOI 10.1046/j.1420-9101.1994.7020189.x; Simpson SJ, 2007, J GERONTOL A-BIOL, V62, P707, DOI 10.1093/gerona/62.7.707; Sokal RR, 1995, BIOMETRY; Stearns S.C., 1992, pi; Trivers R., 1972, SEXUAL SELECTION DES, P139; Tu MP, 2003, AGING CELL, V2, P327, DOI 10.1046/j.1474-9728.2003.00064.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Warbrick-Smith J, 2006, P NATL ACAD SCI USA, V103, P14045, DOI 10.1073/pnas.0605225103; WEDELL N, 1994, BEHAV ECOL, V5, P418, DOI 10.1093/beheco/5.4.418; Zera AJ, 2000, J INSECT PHYSIOL, V46, P1207, DOI 10.1016/S0022-1910(00)00041-X; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	59	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3437	10.1371/journal.pone.0003437	http://dx.doi.org/10.1371/journal.pone.0003437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927614	Green Published, gold			2022-12-27	WOS:000265122400009
J	Shoham, DA; Durazo-Arvizu, R; Kramer, H; Luke, A; Vupputuri, S; Kshirsagar, A; Cooper, RS				Shoham, David A.; Durazo-Arvizu, Ramon; Kramer, Holly; Luke, Amy; Vupputuri, Suma; Kshirsagar, Abhijit; Cooper, Richard S.			Sugary Soda Consumption and Albuminuria: Results from the National Health and Nutrition Examination Survey, 1999-2004	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; FRUCTOSE; RISK; HYPERTENSION; PREVALENCE; POPULATION; OBESITY	Background: End-stage renal disease rates rose following widespread introduction of high fructose corn syrup in the American diet, supporting speculation that fructose harms the kidney. Sugar-sweetened soda is a primary source of fructose. We therefore hypothesized that sugary soda consumption was associated with albuminuria, a sensitive marker for kidney disease. Methodology/Principal Findings: Design was a cross-sectional analysis. Data were drawn from the National Health and Nutrition Examination Survey (NHANES), 1999-2004. The setting was a representative United States population sample. Participants included adults 20 years and older with no history of diabetes mellitus (n = 12,601); after exclusions for missing outcome and covariate information (n = 3,243), the analysis dataset consisted of 9,358 subjects. Exposure was consumption of two or more sugary soft drinks, based on 24-hour dietary recall. The main outcome measure was Albuminuria, defined by albumin to creatinine ratio cutpoints of >17 mg/g (males) and >25 mg/g (females). Logistic regression adjusted for confounders (diet soda, age, race-ethnicity, gender, poverty). Interactions between age, race-ethnicity, gender, and overweight-obesity were explored. Further analysis adjusted for potential mediators: energy intake, basal metabolic rate, obesity, hypertension, lipids, serum uric acid, smoking, energy expenditure, and glycohemoglobin. Alternative soda intake definitions and cola consumption were employed. Results: Weighted albuminuria prevalence was 11%, and 17% consumed 2+ sugary soft drinks/day. The confounder-adjusted odds ratio for sugary soda was 1.40 (95% confidence interval: 1.13, 1.74). Associations were modified by gender (p = 0.008) and overweight-obesity (p = 0.014). Among women, the OR was 1.86 (95% CI: 1.37, 2.53); the OR among males was not significant. In the group with body mass under 25 kg/m(2), OR = 2.15 (95% confidence interval: 1.42, 3.25). Adjustment for potential mediators and use of alternative definitions of albuminuria and soda consumption did not appreciably change results. Diet sodas were not associated with albuminuria. Conclusions: Findings suggest that sugary soda consumption may be associated with kidney damage, although moderate consumption of 1 or fewer sodas does not appear to be harmful. Additional studies are needed to assess whether HFCS itself, overall excess intake of sugar, or unmeasured lifestyle and confounding factors are responsible.	[Shoham, David A.; Durazo-Arvizu, Ramon; Kramer, Holly; Luke, Amy; Cooper, Richard S.] Loyola Univ Chicago, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL USA; [Kramer, Holly] Loyola Univ, Dept Med, Div Nephrol, New Orleans, LA 70118 USA; [Vupputuri, Suma; Kshirsagar, Abhijit] Univ N Carolina, UNC Kidney Ctr, Chapel Hill, NC USA; [Vupputuri, Suma] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Vupputuri, Suma] Kaiser Permanente, Ctr Hlth Res, Atlanta, GA USA	Loyola University Chicago; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Kaiser Permanente	Shoham, DA (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL USA.	dshoham@lumc.edu		Kramer, Holly/0000-0002-6374-837X				BEATON GH, 1979, AM J CLIN NUTR, V32, P2546, DOI 10.1093/ajcn/32.12.2546; Bourdieu P., 1984, DISTINCTION SOCIAL C; Brantsma AH, 2006, J AM SOC NEPHROL, V17, P331, DOI 10.1681/ASN.2005111153; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Centers for Disease Control and Prevention, 2007, NAT HLTH NUTR EX SUR; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CHOI HK, 2008, SOFT DRINKS FRUCTOSE; Coresh J, 2004, CURR OPIN NEPHROL HY, V13, P73, DOI 10.1097/00041552-200401000-00011; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Gersch MS, 2007, AM J PHYSIOL-RENAL, V293, pF1256, DOI 10.1152/ajprenal.00181.2007; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hebert JR, 1997, AM J EPIDEMIOL, V146, P1046, DOI 10.1093/oxfordjournals.aje.a009233; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Kaufman Jay S, 2004, Epidemiol Perspect Innov, V1, P4, DOI 10.1186/1742-5573-1-4; KLESGES RC, 1995, J CONSULT CLIN PSYCH, V63, P438; Kramer H, 2005, HYPERTENSION, V46, P38, DOI 10.1161/01.HYP.0000171189.48911.18; Kramer H, 2005, AM J KIDNEY DIS, V46, P587, DOI 10.1053/j.ajkd.2005.06.007; Kroke A, 1999, AM J CLIN NUTR, V70, P439; KRONMAL RA, 1993, J ROY STAT SOC A STA, V156, P379, DOI 10.2307/2983064; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; LUTSEY PL, 2008, DIETARY INTAKE DEV M; Martins D, 2006, AM J KIDNEY DIS, V47, P965, DOI 10.1053/j.ajkd.2006.02.179; Mattix HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341034; Muntner P, 2003, J AM SOC NEPHROL, V14, P1568, DOI 10.1097/01.ASN.0000067420.83632.C1; National Kidney Foundation, 2002, K DOQI CLIN PRACT GU; *NCHS, 2006, AN REP GUID NAT HLTH; Neilson EG, 2007, J AM SOC NEPHROL, V18, P2619, DOI 10.1681/ASN.2007070750; Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005; Pollan Michael, 2006, OMNIVORES DILEMMA NA; Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529; PORT FK, 1992, AM J KIDNEY DIS, V20, P3; Reungjui S, 2007, J AM SOC NEPHROL, V18, P2724, DOI 10.1681/ASN.2007040416; Rothman K. J., 2002, Epidemiology: an introduction; ROZA AM, 1984, AM J CLIN NUTR, V40, P168, DOI 10.1093/ajcn/40.1.168; Saldana TM, 2007, EPIDEMIOLOGY, V18, P501, DOI 10.1097/EDE.0b013e3180646338; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF423, DOI 10.1152/ajprenal.00124.2006; Shoham DA, 2007, AM J KIDNEY DIS, V49, P217, DOI 10.1053/j.ajkd.2006.11.031; STIRPE F, 1970, LANCET, V2, P1310; Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092; Taylor EN, 2008, KIDNEY INT, V73, P207, DOI 10.1038/sj.ki.5002588; *USDA, 2007, FOOD AV; *USRDS, 2007, ANN DAT REP ATL CHR; Verhave JC, 2004, KIDNEY INT, V66, pS18, DOI 10.1111/j.1523-1755.2004.09205.x; Wang ZQ, 2006, INT J EPIDEMIOL, V35, P1331, DOI 10.1093/ije/dyl115; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Yuyun MF, 2004, AM J EPIDEMIOL, V159, P284, DOI 10.1093/aje/kwh037	54	79	83	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2008	3	10							e3431	10.1371/journal.pone.0003431	http://dx.doi.org/10.1371/journal.pone.0003431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GV	18927611	Green Published, Green Submitted, gold			2022-12-27	WOS:000265122400006
J	Dace, DS; Khan, AA; Kelly, J; Apte, RS				Dace, Dru S.; Khan, Aslam A.; Kelly, Jennifer; Apte, Rajendra S.			Interleukin-10 Promotes Pathological Angiogenesis by Regulating Macrophage Response to Hypoxia during Development	PLOS ONE			English	Article								Aberrant angiogenesis in the eye is the most common cause of blindness. The current study examined the role of interleukin-10 (IL-10) in ischemia-induced pathological angiogenesis called neovascularization during postnatal development. IL-10 deficiency resulted in significantly reduced pathological retinal angiogenesis. In contrast to the choroicapillaris where IL-10 interferes with macrophage influx, IL-10 did not prevent anti-angiogenic macrophages from migrating to the retina in response to hypoxia. Instead, IL-10 promoted retinal angiogenesis by altering macrophage angiogenic function, as macrophages from wild-type mice demonstrated increased vascular endothelial growth factor (VEGF) and nitric oxide (NO) compared to IL-10 deficient macrophages. IL-10 appears to directly affect macrophage responsiveness to hypoxia, as macrophages responded to hypoxia with increased levels of IL-10 and STAT3 phosphorylation as opposed to IL-10 deficient macrophages. Also, IL-10 deficient macrophages inhibited the proliferation of vascular endothelial cells in response to hypoxia while wild-type macrophages failed to do so. These findings suggest that hypoxia guides macrophage behavior to a pro-angiogenic phenotype via IL-10 activated pathways.	[Dace, Dru S.; Khan, Aslam A.; Kelly, Jennifer; Apte, Rajendra S.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Apte, Rajendra S.] Washington Univ, Sch Med, Dev Biol Program, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Dace, DS (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	apte@vision.wustl.edu			NIH [K08EY016139]; Carl Marshall Reeves and Mildred Almen Reeves Foundation Inc. Award; RPB Career Development Award; American Federation for Aging; Knights Templar Eye Foundation, Inc.; International Retina Research Foundation Alston Callahan Scholar Award; NATIONAL EYE INSTITUTE [K08EY016139] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carl Marshall Reeves and Mildred Almen Reeves Foundation Inc. Award; RPB Career Development Award; American Federation for Aging; Knights Templar Eye Foundation, Inc.; International Retina Research Foundation Alston Callahan Scholar Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH Grant K08EY016139 (R.S.A.), Carl Marshall Reeves and Mildred Almen Reeves Foundation Inc. Award (R.S.A.), RPB Career Development Award (R.S.A.), American Federation for Aging Research Grant (R.S.A.), The Knights Templar Eye Foundation, Inc. (D.S.D.) and the International Retina Research Foundation Alston Callahan Scholar Award (D.S.D)	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Ando A, 2002, J CELL PHYSIOL, V191, P116, DOI 10.1002/jcp.10083; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Arfken CL, 1998, DIABETES CARE, V21, P792, DOI 10.2337/diacare.21.5.792; BERSE B, 1992, MOL BIOL CELL, V3, P211, DOI 10.1091/mbc.3.2.211; Canataroglu H, 2005, OCUL IMMUNOL INFLAMM, V13, P375, DOI 10.1080/09273940490518900; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; Davies M, 2006, MOL VIS, V12, P467; ESSER P, 1993, BRIT J OPHTHALMOL, V77, P731, DOI 10.1136/bjo.77.11.731; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Jacobs F, 1998, CLIN EXP IMMUNOL, V113, P59, DOI 10.1046/j.1365-2249.1998.00637.x; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Lewis C, 2005, AM J PATHOL, V167, P627, DOI 10.1016/S0002-9440(10)62038-X; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mechoulam H, 2005, INVEST OPHTH VIS SCI, V46, P4409, DOI 10.1167/iovs.05-0632; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Naug HL, 2000, CLIN EXP OPHTHALMOL, V28, P48, DOI 10.1046/j.1442-9071.2000.00226.x; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; Prasad Anita G, 2007, Compr Ophthalmol Update, V8, P259; Qiao H, 2007, J LEUKOCYTE BIOL, V81, P1012, DOI 10.1189/jlb.0506342; Sennlaub F, 2001, J CLIN INVEST, V107, P717, DOI 10.1172/JCI10874; Shen JK, 2007, INVEST OPHTH VIS SCI, V48, P4335, DOI 10.1167/iovs.07-0113; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Silvestre JS, 2000, CIRC RES, V87, P448; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Tsurumi Y, 1997, NAT MED, V3, P879, DOI 10.1038/nm0897-879; White JR, 2004, GENOMICS, V83, P1, DOI 10.1016/S0888-7543(03)00215-5; Yoshida A, 1999, HISTOL HISTOPATHOL, V14, P1287, DOI 10.14670/HH-14.1287; Yoshida S, 2003, J LEUKOCYTE BIOL, V73, P137, DOI 10.1189/jlb.0302117	41	111	113	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3381	10.1371/journal.pone.0003381	http://dx.doi.org/10.1371/journal.pone.0003381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852882	Green Published, Green Submitted, gold			2022-12-27	WOS:000265121600006
J	Ludewig, F; Huser, A; Fromm, H; Beauclair, L; Bouche, N				Ludewig, Frank; Hueser, Anke; Fromm, Hillel; Beauclair, Linda; Bouche, Nicolas			Mutants of GABA Transaminase (POP2) Suppress the Severe Phenotype of succinic semialdehyde dehydrogenase (ssadh) Mutants in Arabidopsis	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; QUORUM-SENSING SIGNAL; THERMOLUMINESCENCE; METABOLISM; SHUNT; GENE; ACCUMULATION; EXPRESSION; PLANTS	Background: The gamma-aminubutyrate (GABA) shunt bypasses two steps of the tricarboxylic acid cycle, and is present in both prokaryotes and eukaryotes. In plants, the pathway is composed of the calcium/calmodulin-regulated cytosolic enzyme glutamate decarboxylase (GAD), the mitochondrial enzymes GABA transaminase (GABA-T; POP2) and succinic semialdehyde dehydrogenase (SSADH). We have previously shown that compromising the function of the GABA-shunt, by disrupting the SSADH gene of Arabidopsis, causes enhanced accumulation of reactive oxygen intermediates (ROIs) and cell death in response to light and heat stress. However, to date, genetic investigations of the relationships between enzymes of the GABA shunt have not been reported. Principal Findings: To elucidate the role of succinic semialdehyde (SSA), gamma-hydroxybutyrate (GHB) and GABA in the accumulation of ROIs, we combined two genetic approaches to suppress the severe phenotype of ssadh mutants. Analysis of double pop2 ssadh mutants revealed that pop2 is epistatic to ssadh. Moreover, we isolated EMS-generated mutants suppressing the phenotype of ssadh revealing two new pop2 alleles. By measuring thermoluminescence at high temperature, the peroxide contents of ssadh and pop2 mutants were evaluated, showing that only ssadh plants accumulate peroxides. In addition, pop2 ssadh seedlings are more sensitive to exogenous SSA or GHB relative to wild type, because GHB and/or SSA accumulate in these plants. Significance: We conclude that the lack of supply of succinate and NADH to the TCA cycle is not responsible for the oxidative stress and growth retardations of ssadh mutants. Rather, we suggest that the accumulation of SSA, GHB, or both, produced downstream of the GABA-T transamination step, is toxic to the plants, resulting in high ROI levels and impaired development.	[Ludewig, Frank; Hueser, Anke] Univ Cologne, Inst Bot, D-5000 Cologne, Germany; [Fromm, Hillel] Tel Aviv Univ, Fac Life Sci, Dept Plant Sci, IL-69978 Tel Aviv, Israel; [Beauclair, Linda; Bouche, Nicolas] INRA, Inst Jean Pierre Bourgin, Stat Genet Ameliorat Plantes, UR254, Versailles, France	University of Cologne; Tel Aviv University; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Ludewig, F (corresponding author), Univ Cologne, Inst Bot, Gyrhofstr 15, D-5000 Cologne, Germany.	bouche@versailles.inra.fr	FROMM, HILLEL/AAF-6783-2019	FROMM, HILLEL/0000-0003-1977-1211; Bouche, Nicolas/0000-0002-3800-2613	German-Israel Foundation [I-933-239.12/2006]; The German Science Foundation [LU1199/2-1]	German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development); The German Science Foundation	This work was supported in part by grants from the German-Israel Foundation (I-933-239.12/2006) to H.F. and F.L., and from The German Science Foundation (LU1199/2-1) to F.L.	Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Bouche N, 2004, PLANT MOL BIOL, V55, P315, DOI 10.1007/s11103-004-0650-z; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Bouche N, 2003, TRENDS CELL BIOL, V13, P607, DOI 10.1016/j.tcb.2003.10.001; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Breitkreuz KE, 2003, J BIOL CHEM, V278, P41552, DOI 10.1074/jbc.M305717200; Chevrot R, 2006, P NATL ACAD SCI USA, V103, P7460, DOI 10.1073/pnas.0600313103; Coleman ST, 2001, J BIOL CHEM, V276, P244, DOI 10.1074/jbc.M007103200; Dingledine R, 1999, PHARMACOL REV, V51, P7; DUCRUET JM, 1992, PHOTOSYNTH RES, V33, P15, DOI 10.1007/BF00032979; Ducruet JM, 2003, J EXP BOT, V54, P2419, DOI 10.1093/jxb/erg268; Fait A, 2005, FEBS LETT, V579, P415, DOI 10.1016/j.febslet.2004.12.004; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; GIBSON KM, 2006, DIS NEUROTRANSMISSIO, P199; Gupta M, 2003, ANN NEUROL, V54, pS81, DOI 10.1002/ana.10625; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Hogema BM, 2001, NAT GENET, V29, P212, DOI 10.1038/ng727; Kinnersley AM, 2000, CRIT REV PLANT SCI, V19, P479, DOI 10.1016/S0735-2689(01)80006-X; Lacombe B, 2001, SCIENCE, V292, P1486, DOI 10.1126/science.292.5521.1486b; Lam HM, 1998, NATURE, V396, P125, DOI 10.1038/24066; Li J, 2006, PLANT CELL, V18, P340, DOI 10.1105/tpc.105.037713; METZER E, 1990, J BACTERIOL, V172, P3250, DOI 10.1128/jb.172.6.3250-3256.1990; Meyer A, 2006, J BIOL CHEM, V281, P7197, DOI 10.1074/jbc.M510766200; Mirabella R, 2008, PLANT J, V53, P197, DOI 10.1111/j.1365-313X.2007.03323.x; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Pearl PL, 2004, CURR OPIN NEUROL, V17, P107, DOI 10.1097/00019052-200404000-00005; Sauer SW, 2007, NEUROCHEM INT, V50, P653, DOI 10.1016/j.neuint.2006.12.009; SCHREIBER U, 1977, PLANTA, V136, P233, DOI 10.1007/BF00385990; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; Snedden WA, 1999, PLANT RESPONSES ENV; Storici P, 1999, BIOCHEMISTRY-US, V38, P8628, DOI 10.1021/bi990478j; Studart-Guimaraes C, 2007, PLANT PHYSIOL, V145, P626, DOI 10.1104/pp.107.103101; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; TILLAKARATNE NJK, 1995, COMP BIOCHEM PHYS A, V112, P247, DOI 10.1016/0300-9629(95)00099-2; Vass I, 1996, PHOTOSYNTH RES, V48, P117, DOI 10.1007/BF00041002; VAVILIN DV, 1991, BIOL MEMBRANY, V8, P58; Vavilin DV, 1998, PHOTOCHEM PHOTOBIOL, V68, P191, DOI 10.1111/j.1751-1097.1998.tb02488.x; Wang C, 2006, MOL MICROBIOL, V62, P45, DOI 10.1111/j.1365-2958.2006.05351.x; Yu GH, 2006, CHEM BIOL, V13, P723, DOI 10.1016/j.chembiol.2006.05.007	39	68	77	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3383	10.1371/journal.pone.0003383	http://dx.doi.org/10.1371/journal.pone.0003383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846220	Green Published, gold, Green Submitted			2022-12-27	WOS:000265114500010
J	Ord, RL; Tami, A; Sutherland, CJ				Ord, Rosalynn L.; Tami, Adriana; Sutherland, Colin J.			ama1 Genes of Sympatric Plasmodium vivax and P. falciparum from Venezuela Differ Significantly in Genetic Diversity and Recombination Frequency	PLOS ONE			English	Article								Background: We present the first population genetic analysis of homologous loci from two sympatric human malaria parasite populations sharing the same human hosts, using full-length sequences of ama1 genes from Plasmodium vivax and P. falciparum collected in the Venezuelan Amazon. Methodology/Principal Findings: Significant differences between the two species were found in genetic diversity at the ama1 locus, with 18 distinct haplotypes identified among the 73 Pvama1 sequences obtained, compared to 6 unique haplotypes from 30 Pfama1 sequences, giving overall diversity estimates of h = 0.9091, and h = 0.538 respectively. Levels of recombination were also found to differ between the species, with P. falciparum exhibiting very little recombination across the 1.77kb sequence. In contrast, analysis of patterns of nucleotide substitutions provided evidence that polymorphisms in the ama1 gene of both species are maintained by balancing selection, particularly in domain I. The two distinct population structures observed are unlikely to result from different selective forces acting upon the two species, which share both human and mosquito hosts in this setting. Rather, the highly structured P. falciparum population appears to be the result of a population bottleneck, while the much less structured P. vivax population is likely to be derived from an ancient pool of diversity, as reflected in a larger estimate of effective population size for this species. Greatly reduced mosquito transmission in 1997, due to low rainfall prior to the second survey, was associated with far fewer P. falciparum infections, but an increase in P. vivax infections, probably due to hypnozoite activation. Conclusions/Significance: The relevance of these findings to putative competitive interactions between these two important human pathogen species is discussed. These results highlight the need for future control interventions to employ strategies targeting each of the parasite species present in endemic areas.	[Ord, Rosalynn L.; Tami, Adriana; Sutherland, Colin J.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Ord, RL (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	colin.sutherland@lshtm.ac.uk	Sutherland, Colin/AAN-3939-2020	Sutherland, Colin/0000-0003-1592-6407; Tami, Adriana/0000-0002-1918-9144	UK Health Protection Agency	UK Health Protection Agency	This study was not externally funded. CJS is supported by the UK Health Protection Agency.	Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Bruce MC, 2002, CURR OPIN MICROBIOL, V5, P431, DOI 10.1016/S1369-5274(02)00348-X; CHENG Q, 1994, MOL BIOCHEM PARASIT, V65, P183, DOI 10.1016/0166-6851(94)90127-9; Craig AA, 1996, J INFECT DIS, V174, P373, DOI 10.1093/infdis/174.2.373; Cui LW, 2003, AM J TROP MED HYG, V68, P613, DOI 10.4269/ajtmh.2003.68.613; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Figtree M, 2000, MOL BIOCHEM PARASIT, V108, P53, DOI 10.1016/S0166-6851(00)00204-8; Franks S, 2003, INFECT IMMUN, V71, P3485, DOI 10.1128/IAI.71.6.3485-3495.2003; FU YX, 1993, GENETICS, V133, P693; Grynberg P, 2007, CLIN MICROBIOL INFEC, V13, P1089, DOI 10.1111/j.1469-0691.2007.01815.x; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Gunasekera AM, 2007, MOL BIOL EVOL, V24, P939, DOI 10.1093/molbev/msm013; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1985, GENETICS, V111, P147; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Kirchgatter K, 1998, J INFECT DIS, V177, P511, DOI 10.1086/517389; LEWONTIN RC, 1964, GENETICS, V49, P49; Maguire JD, 2002, LANCET, V360, P58, DOI 10.1016/S0140-6736(02)09336-4; Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X; Maitland K, 1997, PARASITOL TODAY, V13, P227, DOI 10.1016/S0169-4758(97)01061-2; Mason Daniel Philippe, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P57; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Mueller I, 2002, AM J TROP MED HYG, V67, P459, DOI 10.4269/ajtmh.2002.67.459; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; Ord R, 2005, MOL BIOCHEM PARASIT, V144, P86, DOI 10.1016/j.molbiopara.2005.08.005; ORD RL, 2008, GENETIC DIVERSITY PL; Polley SD, 2003, GENETICS, V165, P555; Polley SD, 2001, GENETICS, V158, P1505; Rajesh V, 2007, EXP PARASITOL, V116, P252, DOI 10.1016/j.exppara.2007.01.006; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Smith T, 2001, AM J TROP MED HYG, V64, P262, DOI 10.4269/ajtmh.2001.64.262; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Sutherland CJ, 2002, AM J TROP MED HYG, V67, P578, DOI 10.4269/ajtmh.2002.67.578; Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089; TAJIMA F, 1989, GENETICS, V123, P585; Tami A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-7; Tami A, 2002, PARASITOLOGY, V124, P569, DOI 10.1017/S0031182002001713; Tan-Ariya Peerapan, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P784	46	48	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2008	3	10							e3366	10.1371/journal.pone.0003366	http://dx.doi.org/10.1371/journal.pone.0003366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DU	18846221	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000265114500006
J	Lim, KY; Soltis, DE; Soltis, PS; Tate, J; Matyasek, R; Srubarova, H; Kovarik, A; Pires, JC; Xiong, ZY; Leitch, AR				Lim, K. Yoong; Soltis, Douglas E.; Soltis, Pamela S.; Tate, Jennifer; Matyasek, Roman; Srubarova, Hana; Kovarik, Ales; Pires, J. Chris; Xiong, Zhiyong; Leitch, Andrew R.			Rapid Chromosome Evolution in Recently Formed Polyploids in Tragopogon (Asteraceae)	PLOS ONE			English	Article								Background: Polyploidy, frequently termed "whole genome duplication'', is a major force in the evolution of many eukaryotes. Indeed, most angiosperm species have undergone at least one round of polyploidy in their evolutionary history. Despite enormous progress in our understanding of many aspects of polyploidy, we essentially have no information about the role of chromosome divergence in the establishment of young polyploid populations. Here we investigate synthetic lines and natural populations of two recently and recurrently formed allotetraploids Tragopogon mirus and T. miscellus (formed within the past 80 years) to assess the role of aberrant meiosis in generating chromosomal/genomic diversity. That diversity is likely important in the formation, establishment and survival of polyploid populations and species. Methodology/Principal Findings: Applications of fluorescence in situ hybridisation (FISH) to natural populations of T. mirus and T. miscellus suggest that chromosomal rearrangements and other chromosomal changes are common in both allotetraploids. We detected extensive chromosomal polymorphism between individuals and populations, including (i) plants monosomic and trisomic for particular chromosomes (perhaps indicating compensatory trisomy), (ii) intergenomic translocations and (iii) variable sizes and expression patterns of individual ribosomal DNA (rDNA) loci. We even observed karyotypic variation among sibling plants. Significantly, translocations, chromosome loss, and meiotic irregularities, including quadrivalent formation, were observed in synthetic (S(0) and S(1) generations) polyploid lines. Our results not only provide a mechanism for chromosomal variation in natural populations, but also indicate that chromosomal changes occur rapidly following polyploidisation. Conclusions/Significance: These data shed new light on previous analyses of genome and transcriptome structures in de novo and establishing polyploid species. Crucially our results highlight the necessity of studying karyotypes in young (< 150 years old) polyploid species and synthetic polyploids that resemble natural species. The data also provide insight into the mechanisms that perturb inheritance patterns of genetic markers in synthetic polyploids and populations of young natural polyploid species.	[Lim, K. Yoong; Leitch, Andrew R.] Univ London, Queen Mary Coll, Sch Biol & Chem Sci, London, England; [Soltis, Douglas E.] Univ Florida, Genet Inst, Dept Bot, Gainesville, FL 32611 USA; [Soltis, Pamela S.] Univ Florida, Genet Inst, Florida Mus Nat Hist, Gainesville, FL 32611 USA; [Tate, Jennifer] Massey Univ, Inst Mol Biosci, Palmerston North, New Zealand; [Matyasek, Roman; Srubarova, Hana; Kovarik, Ales] Acad Sci Czech Republic, Inst Biophys, Brno, Czech Republic; [Pires, J. Chris; Xiong, Zhiyong] Univ Missouri, Life Sci Ctr, Div Biol Sci, Columbia, MO 65211 USA	University of London; Queen Mary University London; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Massey University; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Missouri System; University of Missouri Columbia	Lim, KY (corresponding author), Univ London, Queen Mary Coll, Sch Biol & Chem Sci, London, England.	a.r.leitch@qmul.ac.uk	Pires, J. Chris/O-5122-2014; Soltis, Douglas/L-5957-2015; Leitch, Andrew R/J-6385-2014; Soltis, Pamela S/L-5184-2015; Xiong, Zhiyong/AAO-8735-2021; Kovarik, Ales/H-1952-2014; Soltis, Pamela S/GNH-5557-2022; Auer Malinská, Hana/AAI-3707-2021	Pires, J. Chris/0000-0001-9682-2639; Leitch, Andrew R/0000-0001-8574-302X; Xiong, Zhiyong/0000-0003-1894-7588; Soltis, Pamela S/0000-0001-9310-8659; Auer Malinská, Hana/0000-0001-7150-4044; Matyasek, Roman/0000-0001-8982-2358; Kovarik, Ales/0000-0003-2896-0698; Tate, Jennifer A./0000-0001-5138-2115	NERC; Grant Agency of the Czech Republic [521/07/0116]; USA National Science Foundation [MCB-0346437, DEB-0608268, DBI 0638536, DBI 0501712]	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); USA National Science Foundation(National Science Foundation (NSF))	The authors thank NERC, Grant Agency of the Czech Republic (521/07/0116), and the USA National Science Foundation (grants MCB-0346437, DEB-0608268, DBI 0638536 and DBI 0501712) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2007, MOL ECOL, V16, P1023, DOI 10.1111/j.1365-294X.2007.03169.x; Abbott RJ, 2004, BIOL J LINN SOC, V82, P467, DOI 10.1111/j.1095-8312.2004.00333.x; Ainouche ML, 2004, BIOL J LINN SOC, V82, P475, DOI 10.1111/j.1095-8312.2004.00334.x; AVERY AG, 1959, GENUS DATURA; BLAKESLEE AF, 1927, GENETICS DATURA, P117; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Buggs RJA, 2008, CASTANEA, V73, P74, DOI 10.2179/0008-7475(2008)73[74:DPDBPG]2.0.CO;2; BURK LG, 1973, J HERED, V64, P348, DOI 10.1093/oxfordjournals.jhered.a108438; Cook LM, 1998, MOL ECOL, V7, P1293, DOI 10.1046/j.1365-294x.1998.00453.x; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Fulnecek J, 2002, HEREDITY, V88, P19, DOI 10.1038/sj/hdy/6800001; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; GOODSPEED TH, 1954, GENUS NICOTIANA; Hegarty MJ, 2006, CURR BIOL, V16, P1652, DOI 10.1016/j.cub.2006.06.071; JACKSON RC, 1973, EVOLUTION, V27, P243, DOI 10.1111/j.1558-5646.1973.tb00669.x; Kovarik A, 1996, THEOR APPL GENET, V92, P1108, DOI 10.1007/BF00224057; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; Kovarik A, 2008, ANN BOT-LONDON, V101, P815, DOI 10.1093/aob/mcn019; KUSH GS, 1967, GENETICS, V56, P297; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; LEITCH AR, 2001, PLANT CELL BIOL PRAC, P267; Lim KY, 2004, BIOL J LINN SOC, V82, P599, DOI 10.1111/j.1095-8312.2004.00344.x; Liu Z, 2007, J INTEGR PLANT BIOL, V49, P1080, DOI 10.1111/j.1672-9072.2007.00462.x; Markova M, 2007, CHROMOSOME RES, V15, P1051, DOI 10.1007/s10577-007-1180-8; Matyasek R, 2007, GENETICS, V176, P2509, DOI 10.1534/genetics.107.072751; Mavrodiev EV, 2005, INT J PLANT SCI, V166, P117, DOI 10.1086/425206; Mavrodiev EV, 2007, INT J PLANT SCI, V168, P889, DOI 10.1086/518258; Nicolas SD, 2007, GENETICS, V175, P487, DOI 10.1534/genetics.106.062968; NOVAK SJ, 1991, AM J BOT, V78, P1586, DOI 10.2307/2444984; OWNBEY M, 1953, AM J BOT, V40, P788, DOI 10.2307/2438276; OWNBEY M, 1950, AM J BOT, V37, P487, DOI 10.2307/2438023; OWNBEY MARION, 1954, RHODORA, V56, P7; Pires JC, 2004, AM J BOT, V91, P1022, DOI 10.3732/ajb.91.7.1022; RILEY RALPH, 1960, HEREDITY, V15, P407, DOI 10.1038/hdy.1960.106; ROOSE ML, 1976, EVOLUTION, V30, P818, DOI 10.1111/j.1558-5646.1976.tb00963.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SAINI RS, 1981, J HERED, V72, P354, DOI 10.1093/oxfordjournals.jhered.a109523; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; SEARS ER, 1953, AM NAT, V87, P245, DOI 10.1086/281780; SEARS ER, 1954, MO EXP STA RES B, V572, P1; Singh R.J., 2002, PLANT CYTOGENETICS; Soltis DE, 2004, BIOL J LINN SOC, V82, P485, DOI 10.1111/j.1095-8312.2004.00335.x; SOLTIS DE, 1989, AM J BOT, V76, P1119, DOI 10.2307/2444824; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P8089, DOI 10.1073/pnas.92.18.8089; Soltis DE, 2008, SYST BOT, V33, P7, DOI 10.1600/036364408783887401; SOLTIS PS, 1991, SYST BOT, V16, P407, DOI 10.2307/2419333; SOLTIS PS, 1995, AM J BOT, V82, P1329, DOI 10.2307/2446255; Tate JA, 2006, GENETICS, V173, P1599, DOI 10.1534/genetics.106.057646; Telgmann-Rauber A, 2007, MOL GENET GENOMICS, V278, P221, DOI 10.1007/s00438-007-0235-z; Urbanska KM, 1997, PLANT SYST EVOL, V204, P233, DOI 10.1007/BF00989208	51	131	134	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3353	10.1371/journal.pone.0003353	http://dx.doi.org/10.1371/journal.pone.0003353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DQ	18843372	Green Published, Green Submitted, gold			2022-12-27	WOS:000265114100002
J	Brunet, S; Dumont, J; Lee, KW; Kinoshita, K; Hikal, P; Gruss, OJ; Maro, B; Verlhac, MH				Brunet, Stephane; Dumont, Julien; Lee, Karen W.; Kinoshita, Kazuhisa; Hikal, Pascale; Gruss, Oliver J.; Maro, Bernard; Verlhac, Marie-Helene			Meiotic Regulation of TPX2 Protein Levels Governs Cell Cycle Progression in Mouse Oocytes	PLOS ONE			English	Article								Formation of female gametes requires acentriolar spindle assembly during meiosis. Mitotic spindles organize from centrosomes and via local activation of the RanGTPase on chromosomes. Vertebrate oocytes present a RanGTP gradient centred on chromatin at all stages of meiotic maturation. However, this gradient is dispensable for assembly of the first meiotic spindle. To understand this meiosis I peculiarity, we studied TPX2, a Ran target, in mouse oocytes. Strikingly, TPX2 activity is controlled at the protein level through its accumulation from meiosis I to II. By RNAi depletion and live imaging, we show that TPX2 is required for spindle assembly via two distinct functions. It controls microtubule assembly and spindle pole integrity via the phosphorylation of TACC3, a regulator of MTOCs activity. We show that meiotic spindle formation in vivo depends on the regulation of at least a target of Ran, TPX2, rather than on the regulation of the RanGTP gradient itself.	[Brunet, Stephane; Dumont, Julien; Lee, Karen W.; Hikal, Pascale; Maro, Bernard; Verlhac, Marie-Helene] Univ Paris 06, CNRS, UMR7622, Paris, France; [Kinoshita, Kazuhisa] RIKEN, Chromosome Dynam Lab, Wako, Saitama, Japan; [Gruss, Oliver J.] Zent Mol Biol Univ Heidelberg ZMBH, Heidelberg, Germany; [Maro, Bernard] Ramat Univ, Tel Aviv Univ, Dept Cell & Dev Biol, Tel Aviv, Israel	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; RIKEN; Ruprecht Karls University Heidelberg; Tel Aviv University	Brunet, S (corresponding author), Univ Paris 06, CNRS, UMR7622, Bat C,5E,9 Quai St Bernard, Paris, France.	marie-helene.verlhac@upmc.fr	Maro, Bernard/AAL-2220-2020; BRUNET, Stéphane/O-6953-2018; Brunet, Stephane/L-2604-2017; Holt, Janet E/B-2415-2013; Dumont, Julien/G-6624-2013; Lee, Karen/GVT-9602-2022	BRUNET, Stéphane/0000-0003-1990-1477; Brunet, Stephane/0000-0003-1990-1477; Kinoshita, Kazuhisa/0000-0002-0882-4296; VERLHAC, Marie-Helene/0000-0001-8377-9010	Association pour la Recherche sur le Cancer [ARC3877]; Agence Nationale pour la Recherche [ANRNT05-1-43120]; INSERM; KAKENHI [19770173]	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale pour la Recherche(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Association pour la Recherche sur le Cancer (ARC3877 to M.H.V.) and from the Agence Nationale pour la Recherche (ANRNT05-1-43120 to M.H.V.). S.B. is a recipient of INSERM. J.D. is a recipient of an Association pour la Recherche sur le Cancer doctoral fellowship. K.W.L. is supported by the Agence Nationale pour la Recherche (ANRNT05-1-43120). K.K. is supported by KAKENHI (19770173).	Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Brittle AL, 2005, CURR BIOL, V15, pR880, DOI 10.1016/j.cub.2005.10.022; Brunet S, 1998, CURR BIOL, V8, P1231, DOI 10.1016/S0960-9822(07)00516-7; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Dumont J, 2007, J CELL BIOL, V176, P295, DOI 10.1083/jcb.200605199; Eichenlaub-Ritter U, 1989, Prog Clin Biol Res, V318, P259; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Ledan E, 2001, DEV BIOL, V232, P400, DOI 10.1006/dbio.2001.0188; Lefebvre C, 2002, J CELL BIOL, V157, P603, DOI 10.1083/jcb.200202052; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Polanski Z, 1998, DEVELOPMENT, V125, P4989; Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406; Reis A, 2007, NAT CELL BIOL, V9, P1192, DOI 10.1038/ncb1640; SARDON T, 2008, EMBO J; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Stewart S, 2005, MOL CELL BIOL, V25, P10516, DOI 10.1128/MCB.25.23.10516-10527.2005; SZOLLOSI D, 1972, J CELL SCI, V11, P521; Terret ME, 2003, DEVELOPMENT, V130, P5169, DOI 10.1242/dev.00731; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tsurumi C, 2004, J CELL BIOL, V167, P1037, DOI 10.1083/jcb.200405165; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; Verlhac MH, 2000, CURR BIOL, V10, P1303, DOI 10.1016/S0960-9822(00)00753-3; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zheng YX, 2004, ANNU REV CELL DEV BI, V20, P867, DOI 10.1146/annurev.cellbio.20.012103.094648	37	79	82	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3338	10.1371/journal.pone.0003338	http://dx.doi.org/10.1371/journal.pone.0003338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833336	Green Published, gold, Green Submitted			2022-12-27	WOS:000264797400008
J	Cavarelli, M; Karlsson, I; Zanchetta, M; Antonsson, L; Plebani, A; Giaquinto, C; Fenyo, EM; De Rossi, A; Scarlatti, G				Cavarelli, Mariangela; Karlsson, Ingrid; Zanchetta, Marisa; Antonsson, Liselotte; Plebani, Anna; Giaquinto, Carlo; Fenyo, Eva Maria; De Rossi, Anita; Scarlatti, Gabriella			HIV-1 with Multiple CCR5/CXCR4 Chimeric Receptor Use Is Predictive of Immunological Failure in Infected Children	PLOS ONE			English	Article								Background: HIV-1 R5 viruses are characterized by a large phenotypic variation, that is reflected by the mode of coreceptor use. The ability of R5 HIV-1 to infect target cells expressing chimeric receptors between CCR5 and CXCR4 (R5(broad) viruses), was shown to correlate with disease stage in HIV-1 infected adults. Here, we ask the question whether phenotypic variation of R5 viruses could play a role also in mother-to-child transmission (MTCT) of HIV-1 and pediatric disease progression. Methodology/Principal Findings: Viral isolates obtained from a total of 59 HIV-1 seropositive women (24 transmitting and 35 non transmitting) and 28 infected newborn children, were used to infect U87. CD4 cells expressing wild type or six different CCR5/CXCR4 chimeric receptors. HIV-1 isolates obtained from newborn infants had predominantly R5(narrow) phenotype (n = 20), but R5(broad) and R5X4 viruses were also found in seven and one case, respectively. The presence of R5(broad) and R5X4 phenotypes correlated significantly with a severe decline of the CD4+ T cells (CDC stage 3) or death within 2 years of age. Forty-three percent of the maternal R5 isolates displayed an R5(broad) phenotype, however, the presence of the R5(broad) virus was not predictive for MTCT of HIV-1. Of interest, while only 1 of 5 mothers with an R5X4 virus transmitted the dualtropic virus, 5 of 6 mothers carrying R5(broad) viruses transmitted viruses with a similar broad chimeric coreceptor usage. Thus, the maternal R5(broad) phenotype was largely preserved during transmission and could be predictive of the phenotype of the newborn's viral variant. Conclusions/Significance: Our results show that R5(broad) viruses are not hampered in transmission. When transmitted, immunological failure occurs earlier than in children infected with HIV-1 of R5(narrow) phenotype. We believe that this finding is of utmost relevance for therapeutic interventions in pediatric HIV-1 infection.	[Cavarelli, Mariangela; Scarlatti, Gabriella] Fdn Ctr San Raffaele, DIBIT, Viral Evolut & Transmiss Unit, Milan, Italy; [Karlsson, Ingrid; Fenyo, Eva Maria] Lund Univ, Dept Lab Med, Div Med Microbiol Virol, S-22100 Lund, Sweden; [Zanchetta, Marisa; De Rossi, Anita] Univ Padua, AIDS Reference Ctr, Dept Oncol & Surgical Sci, Unit Viral Oncol, I-35100 Padua, Italy; [Antonsson, Liselotte] Lund Univ, Dept Expt Med Sci, Div Cellular & Mol Pharmacol, S-22100 Lund, Sweden; [Plebani, Anna] Univ Milan, Clin Marchi, Dept Pediat, I-20122 Milan, Italy; [Giaquinto, Carlo] Univ Padua, Dept Pediat, I-35100 Padua, Italy	Lund University; University of Padua; Lund University; University of Milan; University of Padua	Cavarelli, M (corresponding author), Fdn Ctr San Raffaele, DIBIT, Viral Evolut & Transmiss Unit, Milan, Italy.	cavarelli.mariangela@hsr.it	Plebani, Alessandro/C-8593-2011; De Rossi, A./L-3128-2015; De Rossi, Anita/Q-4845-2019; scarlatti, gabriella/H-1482-2018; Giaquinto, Carlo/AAB-5016-2020	De Rossi, A./0000-0001-6435-7509; De Rossi, Anita/0000-0001-6435-7509; scarlatti, gabriella/0000-0003-2316-2689; CAVARELLI, MARIANGELA/0000-0002-8468-0263; GIAQUINTO, CARLO/0000-0001-9365-0413	Swedish Research Council; Istituto Superiore di Sanita within the framework of the National program for AIDS research [40G.21, 45G.12, 40G.56]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Istituto Superiore di Sanita within the framework of the National program for AIDS research	The financial support was received by the Swedish Research Council and by the Istituto Superiore di Sanita within the framework of the National program for AIDS research, Grant no.40G.21, 45G.12 and 40G.56. Only financial support.	Antonsson L, 2003, AIDS, V17, P2571, DOI 10.1097/00002030-200312050-00004; Bjorndal A, 1997, J VIROL, V71, P7478; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Casper C, 2002, AIDS RES HUM RETROV, V18, P343, DOI 10.1089/088922202753519124; CONTROL CFD, 1993, MMWR-MORBID MORTAL W, V41, P1; CONTROL CFD, 1994, MMWR-MORBID MORTAL W, V43, P1; DEROSSI A, 1991, AIDS, V5, P15, DOI 10.1097/00002030-199101000-00002; Jansson M, 1996, P NATL ACAD SCI USA, V93, P15382, DOI 10.1073/pnas.93.26.15382; KARLSSON A, 1994, J CLIN MICROBIOL, V32, P364, DOI 10.1128/JCM.32.2.364-370.1994; Karlsson I, 2004, J VIROL, V78, P11807, DOI 10.1128/JVI.78.21.11807-11815.2004; Karlsson I, 2003, AIDS, V17, P2561, DOI 10.1097/00002030-200312050-00003; Koning FA, 2003, J INFECT DIS, V188, P864, DOI 10.1086/377105; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0; Mo HM, 1998, AIDS RES HUM RETROV, V14, P607, DOI 10.1089/aid.1998.14.607; MOK JQ, 1987, LANCET, V1, P1164; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; OMETTO L, 1995, AIDS, V9, P427, DOI 10.1097/00002030-199509050-00003; Ometto L, 1999, AIDS RES HUM RETROV, V15, P1441, DOI 10.1089/088922299309955; Ometto L, 2000, AIDS, V14, P1721, DOI 10.1097/00002030-200008180-00006; Pasquier C, 1998, J VIROL, V72, P8493, DOI 10.1128/JVI.72.11.8493-8501.1998; Peters PJ, 2006, J VIROL, V80, P6324, DOI 10.1128/JVI.02328-05; Salvatori F, 2001, AIDS RES HUM RETROV, V17, P925, DOI 10.1089/088922201750290041; SCARLATTI G, 1991, AIDS, V5, P1173, DOI 10.1097/00002030-199110000-00003; Scarlatti G, 2004, AIDS REV, V6, P67; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; SCARLATTI G, 1993, VIROLOGY, V197, P624, DOI 10.1006/viro.1993.1637; SCHUITEMAKER H, 1991, J VIROL, V65, P356, DOI 10.1128/JVI.65.1.356-363.1991; Sleasman JW, 1996, AIDS, V10, P1477, DOI 10.1097/00002030-199611000-00004; Tuttle DL, 2004, AIDS RES HUM RETROV, V20, P305, DOI 10.1089/088922204322996545; Tuttle DL, 2002, AIDS RES HUM RETROV, V18, P353, DOI 10.1089/088922202753519133; UNAIDS, 2007, REP GLOB AIDS EP; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316	34	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2008	3	9							e3292	10.1371/journal.pone.0003292	http://dx.doi.org/10.1371/journal.pone.0003292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MN	18820725	gold, Green Published, Green Submitted			2022-12-27	WOS:000264432500003
J	Tella, JL; Lemus, JA; Carrete, M; Blanco, G				Tella, Jose L.; Lemus, Jesus A.; Carrete, Martina; Blanco, Guillermo			The PHA Test Reflects Acquired T-Cell Mediated Immunocompetence in Birds	PLOS ONE			English	Article								Background: cological immunology requires techniques to reliably measure immunocompetence in wild vertebrates. The PHA-skin test, involving subcutaneous injection of a mitogen (phytohemagglutinin, PHA) and measurement of subsequent swelling as a surrogate of T-cell mediated immunocompetence, has been the test of choice due to its practicality and ease of use in the field. However, mechanisms involved in local immunological and inflammatory processes provoked by PHA are poorly known, and its use and interpretation as an acquired immune response is currently debated. Methodology: Here, we present experimental work using a variety of parrot species, to ascertain whether PHA exposure produces larger secondary than primary responses as expected if the test reflects acquired immunocompetence. Moreover, we simultaneously quantified T-lymphocyte subsets (CD4(+), CD5(+) and CD8(+)) and plasma proteins circulating in the bloodstream, potentially involved in the immunological and inflammatory processes, through flow cytometry and electrophoresis. Principal Findings: Our results showed stronger responses after a second PHA injection, independent of species, time elapsed and changes in body mass of birds between first and second injections, thus supporting the adaptive nature of this immune response. Furthermore, the concomitant changes in the plasma concentrations of T-lymphocyte subsets and globulins indicate a causal link between the activation of the T-cell mediated immune system and local tissue swelling. Conclusions/Significance: These findings justify the widespread use of the PHA-skin test as a reliable evaluator of acquired T-cell mediated immunocompetence in diverse biological disciplines. Further experimental research should be aimed at evaluating the relative role of innate immunocompetence in wild conditions, where the access to dietary proteins varies more than in captivity, and to ascertain how PHA responses relate to particular host-parasite interactions.	[Tella, Jose L.; Carrete, Martina] CSIC, Estac Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Lemus, Jesus A.; Blanco, Guillermo] CSIC, Museo Nacl Ciencias Naturales, Dept Evolut Ecol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Tella, JL (corresponding author), CSIC, Estac Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain.	tella@ebd.csic.es	Carrete, Martina/A-6376-2009; Tella, José L/I-3707-2015; Carrete, Martina/D-2618-2017; Blanco, Guillermo/L-3170-2014	Carrete, Martina/0000-0002-0491-2950; Tella, José L/0000-0002-3038-7424; Blanco, Guillermo/0000-0001-5742-4929				Alonso-Alvarez C, 2001, CAN J ZOOL, V79, P101, DOI 10.1139/cjz-79-1-101; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Amo L, 2007, BIOL CONSERV, V135, P77, DOI 10.1016/j.biocon.2006.09.020; Baos R, 2006, ENVIRON TOXICOL CHEM, V25, P1153, DOI 10.1897/05-395R.1; Bayyari GR, 1997, POULTRY SCI, V76, P289, DOI 10.1093/ps/76.2.289; Bize P, 2008, AM NAT, V171, P107, DOI 10.1086/523943; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Carrete M, 2008, FRONT ECOL ENVIRON, V6, P207, DOI 10.1890/070075; Cho BK, 2001, P NATL ACAD SCI USA, V98, P1723, DOI 10.1073/pnas.98.4.1723; Clotfelter ED, 2007, BEHAV ECOL, V18, P1139, DOI 10.1093/beheco/arm090; Cooper MD, 2002, IMMUNOL REV, V185, P175, DOI 10.1034/j.1600-065X.2002.18515.x; Cray C, 1998, J AVIAN MED SURG, V12, P4; Del Hoyo, 1997, HDB BIRDS WORLD SAND; ELGERT KD, 1996, IMMUNOLOGY; Finkelstein M, 2003, ARCH ENVIRON CON TOX, V44, P502, DOI 10.1007/s00244-002-2075-5; Franson JC, 2007, J TOXICOL ENV HEAL A, V70, P861, DOI 10.1080/15287390701212760; GENTRY PA, 1999, CLIN CHEM LAB ANIMAL; Gervasi SS, 2008, FUNCT ECOL, V22, P100, DOI 10.1111/j.1365-2435.2007.01340.x; GOTO N, 1978, POULTRY SCI, V57, P246, DOI 10.3382/ps.0570246; Hale KA, 2007, ANIM CONSERV, V10, P2, DOI 10.1111/j.1469-1795.2006.00059.x; Hawley DM, 2007, FUNCT ECOL, V21, P520, DOI 10.1111/j.1365-2435.2007.01254.x; Horak P, 2002, CAN J ZOOL, V80, P636, DOI 10.1139/Z02-038; Horak P, 2007, AM NAT, V170, P625, DOI 10.1086/521232; Hueza IM, 2007, J VET MED A, V54, P179, DOI 10.1111/j.1439-0442.2007.00917.x; Johnsen A, 2000, NATURE, V406, P296, DOI 10.1038/35018556; Kaneko JJ., 1997, CLIN BIOCH DOMESTIC, V5th edn, P117137; Keller JM, 2005, VET IMMUNOL IMMUNOP, V103, P269, DOI 10.1016/j.vetimm.2004.09.029; Kennedy MW, 2006, TRENDS ECOL EVOL, V21, P653, DOI 10.1016/j.tree.2006.09.017; Laiolo P, 2007, BEHAV ECOL, V18, P507, DOI 10.1093/beheco/arm008; Lavoie ET, 2005, ARCH ENVIRON CON TOX, V48, P552, DOI 10.1007/s00244-004-0128-7; Lehmer EM, 2007, PHYSIOL BIOCHEM ZOOL, V80, P514, DOI 10.1086/520128; Lumeij J. T., 1996, Journal of Avian Medicine and Surgery, V10, P150; Martinez MC, 2006, EDUC POLICY, V20, P299, DOI 10.1177/0895904805285017; Milston RH, 2003, FISH SHELLFISH IMMUN, V15, P145, DOI 10.1016/S1050-4648(02)00151-1; Navarro J, 2007, OECOLOGIA, V151, P150, DOI 10.1007/s00442-006-0559-0; Nguyen HT, 1999, CLIN CHEM LAB ANIMAL; Owen JP, 2007, TRENDS ECOL EVOL, V22, P228, DOI 10.1016/j.tree.2007.02.003; Pitala N, 2007, BIOL LETTERS, V3, P418, DOI 10.1098/rsbl.2007.0135; Reid JM, 2003, P ROY SOC B-BIOL SCI, V270, P2151, DOI 10.1098/rspb.2003.2480; Roulin A, 2007, BIOL J LINN SOC, V90, P703, DOI 10.1111/j.1095-8312.2007.00759.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; Spottiswoode CN, 2008, BEHAV ECOL SOCIOBIOL, V62, P963, DOI 10.1007/s00265-007-0521-0; STADECKER MJ, 1977, J IMMUNOL, V118, P1564; Tella JL, 2002, P ROY SOC B-BIOL SCI, V269, P1059, DOI 10.1098/rspb.2001.1951; Tella JL, 2000, OECOLOGIA, V123, P453, DOI 10.1007/s004420000331; TIZARD I, 2000, INTRO VET IMMUNOLOGY; Uchiyama R, 2005, J VET MED SCI, V67, P441, DOI 10.1292/jvms.67.441; Vance CK, 2004, J ZOO WILDLIFE MED, V35, P435, DOI 10.1638/04-014; Vila JM, 2001, J IMMUNOL, V166, P396, DOI 10.4049/jimmunol.166.1.396	50	127	130	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2008	3	9							e3295	10.1371/journal.pone.0003295	http://dx.doi.org/10.1371/journal.pone.0003295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MN	18820730	Green Published, Green Submitted, gold			2022-12-27	WOS:000264432500005
J	Carroll, RG; Carpenito, C; Shan, XC; Danet-Desnoyers, G; Liu, RH; Jiang, SG; Albelda, SM; Golovina, T; Coukos, G; Riley, JL; Jonak, ZL; June, CH				Carroll, Richard G.; Carpenito, Carmine; Shan, Xiaochuan; Danet-Desnoyers, Gwenn; Liu, Ronghua; Jiang, Shuguang; Albelda, Steven M.; Golovina, Tatiana; Coukos, George; Riley, James L.; Jonak, Zdenka L.; June, Carl H.			Distinct Effects of IL-18 on the Engraftment and Function of Human Effector CD8(+) T Cells and Regulatory T Cells	PLOS ONE			English	Article								IL-18 has pleotropic effects on the activation of T cells during antigen presentation. We investigated the effects of human IL-18 on the engraftment and function of human T cell subsets in xenograft mouse models. IL-18 enhanced the engraftment of human CD8(+) effector T cells and promoted the development of xenogeneic graft versus host disease (GVHD). In marked contrast, IL-18 had reciprocal effects on the engraftment of CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) in the xenografted mice. Adoptive transfer experiments indicated that IL-18 prevented the suppressive effects of Tregs on the development of xenogeneic GVHD. The IL-18 results were robust as they were observed in two different mouse strains. In addition, the effects of IL-18 were systemic as IL-18 promoted engraftment and persistence of human effector T cells and decreased Tregs in peripheral blood, peritoneal cavity, spleen and liver. In vitro experiments indicated that the expression of the IL-18R alpha was induced on both CD4 and CD8 effector T cells and Tregs, and that the duration of expression was less sustained on Tregs. These preclinical data suggest that human IL-18 may have use as an adjuvant for immune reconstitution after cytotoxic therapies, and to augment adoptive immunotherapy, donor leukocyte infusions, and vaccine strategies.	[Carroll, Richard G.; Carpenito, Carmine; Shan, Xiaochuan; Liu, Ronghua; Jiang, Shuguang; Golovina, Tatiana; Coukos, George; Riley, James L.; June, Carl H.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Carroll, Richard G.; Riley, James L.; June, Carl H.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Danet-Desnoyers, Gwenn; Albelda, Steven M.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Coukos, George] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Jonak, Zdenka L.] GlaxoSmithKline Inc, Biopharm CEDD, King Of Prussia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; GlaxoSmithKline	Carroll, RG (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	cjune@mail.med.upenn.edu	Coukos, George/ABG-7389-2020	Coukos, George/0000-0001-8813-7367; Riley, James/0000-0002-1057-576X	GlaxoSmithKline; NATIONAL CANCER INSTITUTE [R01CA105216] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by research funding from GlaxoSmithKline to CHJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAUGUE S, 2008, BLOOD           0625; BASU S, 2008, J IMMUNOL IN PRESS; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Calvani N, 2005, AUTOIMMUN REV, V4, P542, DOI 10.1016/j.autrev.2005.04.009; Cho D, 2000, CANCER RES, V60, P2703; Christianson SW, 1997, J IMMUNOL, V158, P3578; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Dai SM, 2007, ANN RHEUM DIS, V66, P1411, DOI 10.1136/ard.2006.067793; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; Efthimiou P, 2007, NAT CLIN PRACT RHEUM, V3, P328, DOI 10.1038/ncprheum0510; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Godfrey WR, 2004, BLOOD, V104, P453, DOI 10.1182/blood-2004-01-0151; Gracie JA, 1999, J CLIN INVEST, V104, P1393, DOI 10.1172/JCI7317; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Greene CM, 2000, J IMMUNOL, V165, P4718, DOI 10.4049/jimmunol.165.8.4718; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Herzyk DJ, 2002, CYTOKINE, V20, P38, DOI 10.1006/cyto.2002.1978; Hodi FS, 2008, P NATL ACAD SCI USA, V105, P3005, DOI 10.1073/pnas.0712237105; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Hultgren O, 2007, AUTOIMMUNITY, V40, P529, DOI 10.1080/08916930701622783; Iwai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002404; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; June CH, 2006, SEMIN IMMUNOL, V18, P78, DOI 10.1016/j.smim.2006.01.006; Kirkpatrick RB, 2003, PROTEIN EXPRES PURIF, V27, P279, DOI 10.1016/S1046-5928(02)00606-X; Leonard JP, 1997, BLOOD, V90, P2541; Lin YJ, 2008, LUPUS, V17, P124, DOI 10.1177/0961203307086031; Logan Theodore F, 2006, Curr Oncol Rep, V8, P114, DOI 10.1007/s11912-006-0046-0; Luo YP, 2005, CANCER RES, V65, P3419, DOI 10.1158/0008-5472.CAN-04-3120; Marshall DJ, 2006, VACCINE, V24, P244, DOI 10.1016/j.vaccine.2005.07.087; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Mathur AN, 2006, BLOOD, V108, P1595, DOI 10.1182/blood-2006-04-015016; Mutis T, 2006, CLIN CANCER RES, V12, P5520, DOI 10.1158/1078-0432.CCR-06-0035; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Pittoni V, 2002, ANN RHEUM DIS, V61, P723, DOI 10.1136/ard.61.8.723; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Reddy P, 2001, J EXP MED, V194, P1433, DOI 10.1084/jem.194.10.1433; Robertson MJ, 2006, CLIN CANCER RES, V12, P4265, DOI 10.1158/1078-0432.CCR-06-0121; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Son YI, 2001, CANCER RES, V61, P884; Stoll S, 1998, EUR J IMMUNOL, V28, P3231, DOI 10.1002/(SICI)1521-4141(199810)28:10<3231::AID-IMMU3231>3.0.CO;2-Q; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Takada H, 1999, BRIT J HAEMATOL, V106, P182, DOI 10.1046/j.1365-2141.1999.01504.x; Takeuchi M, 1997, CELL TISSUE RES, V289, P499, DOI 10.1007/s004410050895; Tanaka Y, 2002, J AUTOIMMUN, V18, P9, DOI 10.1006/jaut.2001.0559; Tatsumi T, 2002, CANCER RES, V62, P5853; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Tedeschi A, 2007, CLIN EXP DERMATOL, V32, P568, DOI 10.1111/j.1365-2230.2007.02450.x; Trenado A, 2006, J IMMUNOL, V176, P1266, DOI 10.4049/jimmunol.176.2.1266; Tsutsui H, 1996, J IMMUNOL, V157, P3967; Ushio S, 1996, J IMMUNOL, V156, P4274; Vidal-Vanaclocha F, 2006, CANCER METAST REV, V25, P417, DOI 10.1007/s10555-006-9013-3; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Woo EY, 2001, CANCER RES, V61, P4766; Xu B, 2007, GENE THER, V14, P1181, DOI 10.1038/sj.gt.3302966; Zeiser R, 2007, BIOL BLOOD MARROW TR, V13, P1427, DOI 10.1016/j.bbmt.2007.08.041; Zhang B, 2004, LEUKEMIA RES, V28, P91, DOI 10.1016/S0145-2126(03)00121-8; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	65	38	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2008	3	9							e3289	10.1371/journal.pone.0003289	http://dx.doi.org/10.1371/journal.pone.0003289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422ML	18818761	Green Submitted, Green Published, gold			2022-12-27	WOS:000264432300011
J	Tan, Y; Wei, QH; Chen, LJ; Chan, PC; Lai, WS; He, ML; Kung, HF; Lee, SS				Tan, Yi; Wei, Qi Hou; Chen, Liu Jun; Chan, Pui Chung; Lai, Wen Sheng; He, Ming Liang; Kung, Hsiang Fu; Lee, Shui Shan			Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China	PLOS ONE			English	Article								Background: Hepatitis C virus (HCV) mono-infection and HCV/HIV (human immunodeficiency virus) co-infection are growing problems in injection drug users (IDU). Their prevalence and genotypic patterns vary with geographic locations. Access to harm reduction measures is opening up opportunities for improving the HIV/HCV profiling of IDU in China, where IDUs account for a significant proportion of the two infections especially in the southern part of the country. Methodology/Principal Findings: A cross sectional study was conducted. Through the Liuzhou Methadone Clinic, a total of 117 injection drug users (IDUs) were recruited from Guangxi, Southern China. A majority of the IDUs (96%) were HCV antibody positive, of which 21% were HIV infected. Unlike HCV monoinfection, there was spatial heterogeneity in the distribution of HIV/HCV coinfection, the latter also characterized by a higher prevalence of needle-sharing. Phylogenetic analysis revealed that genotype 6a was predominant in the study population. There were shorter genetic distances among the 6a sequences compared to the other HCV subtypes-1a, 3a, and 3b. Conclusion/Significance: The results suggested that HIV and HCV were introduced at around the same time to the IDU populations in Southern China, followed by their differential spread as determined by the biologic characteristics of the virus and the intensity of behavioural risk. This pattern is different from that in other South East Asian countries where HCV infections have probably predated HIV.	[Tan, Yi; Chan, Pui Chung; He, Ming Liang; Kung, Hsiang Fu; Lee, Shui Shan] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Wei, Qi Hou; Chen, Liu Jun; Lai, Wen Sheng] Liuzhou Ctr Dis Control & Prevent, Guangxi, Peoples R China; [Lee, Shui Shan] Chinese Univ Hong Kong, Dept Microbiol, Sha Tin 100083, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Tan, Y (corresponding author), Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	sslee@cuhk.edu.hk	Lee, Shui Shan/B-9374-2008; HE, Ming-Liang/AAG-3397-2022; HE, Ming-Liang/AFK-4738-2022	Lee, Shui Shan/0000-0003-1448-765X; He, Ming-Liang/0000-0002-4317-2836; HE, Mingliang/0000-0002-9942-9151	Liuzhou CDC; Stanley Ho Centre for Emerging Infectious Diseases	Liuzhou CDC; Stanley Ho Centre for Emerging Infectious Diseases	Studies included in this report were funded directly by Liuzhou CDC and Stanley Ho Centre for Emerging Infectious Diseases. No external fundings have been received.	Alter MJ, 1999, J HEPATOL, V31, P88, DOI 10.1016/S0168-8278(99)80381-X; Amini S, 2006, VIRUS GENES, V33, P271, DOI 10.1007/s11262-006-0065-9; Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003; Cantaloube JF, 2006, J CLIN MICROBIOL, V44, P2051, DOI 10.1128/JCM.02463-05; Cantaloube JF, 2005, J CLIN MICROBIOL, V43, P3624, DOI 10.1128/JCM.43.8.3624-3629.2005; Djebbi A, 2004, EUR J EPIDEMIOL, V19, P555, DOI 10.1023/B:EJEP.0000032348.83087.01; Du WJ, 2008, DRUG ALCOHOL DEPEN, V94, P158, DOI 10.1016/j.drugalcdep.2007.11.009; Franco S, 2007, VIRUS RES, V123, P161, DOI 10.1016/j.virusres.2006.09.001; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Kurbanov F, 2003, J MED VIROL, V69, P367, DOI 10.1002/jmv.10298; Lee DS, 1996, J MED VIROL, V49, P55, DOI 10.1002/(SICI)1096-9071(199605)49:1&lt;55::AID-JMV9&gt;3.0.CO;2-J; Lee KCK, 2008, J CLIN VIROL, V41, P297, DOI 10.1016/j.jcv.2007.09.013; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Noppornpanth S, 2007, J VIROL, V81, P12496, DOI 10.1128/JVI.01059-07; Noppornpanth S, 2006, J VIROL, V80, P7569, DOI 10.1128/JVI.00312-06; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479; RUXRUNGTHAM K, 2001, J MED ASS THAI S1, V84, P1; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Todd CS, 2007, EMERG INFECT DIS, V13, P1327, DOI 10.3201/eid1309.070036; Uuskula A, 2008, J PUBLIC HEALTH-UK, V30, P119, DOI 10.1093/pubmed/fdn014	23	55	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2008	3	10							e3608	10.1371/journal.pone.0003608	http://dx.doi.org/10.1371/journal.pone.0003608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432KK	18974888	gold, Green Submitted, Green Published			2022-12-27	WOS:000265131700024
J	Watanabe, Y; Morita, E; Fukada, Y; Doi, K; Yasui, K; Kitayama, M; Nakano, T; Nakashima, K				Watanabe, Yasuhiro; Morita, Eri; Fukada, Yasuyo; Doi, Koji; Yasui, Kenichi; Kitayama, Michio; Nakano, Toshiya; Nakashima, Kenji			Adherent Monomer- Misfolded SOD1	PLOS ONE			English	Article								Background: Multiple cellular functions are compromised in amyotrophic lateral sclerosis (ALS). In familial ALS (FALS) with Cu/Zn superoxide dismutase (SOD1) mutations, the mechanisms by which the mutation in SOD1 leads to such a wide range of abnormalities remains elusive. Methodology/Principal Findings: To investigate underlying cellular conditions caused by the SOD1 mutation, we explored mutant SOD1-interacting proteins in the spinal cord of symptomatic transgenic mice expressing a mutant SOD1, SOD1(Leu126delTT) with a (F) under bar LAG sequence (DF mice). This gene product is structurally unable to form a functional homodimer. Tissues were obtained from both DF mice and disease-free mice expressing (w) under bar ild-type with (F) under bar LAG SOD1 (WF mice). Both FLAG-tagged SOD1 and cross-linking proteins were enriched and subjected to a shotgun proteomic analysis. We identified 34 proteins (or protein subunits) in DF preparations, while in WF preparations, interactions were detected with only 4 proteins. Conclusions/Significance: These results indicate that disease-causing mutant SOD1 likely leads to inadequate protein-protein interactions. This could be an early and crucial process in the pathogenesis of FALS.	[Watanabe, Yasuhiro; Morita, Eri; Fukada, Yasuyo; Doi, Koji; Yasui, Kenichi; Kitayama, Michio; Nakano, Toshiya; Nakashima, Kenji] Tottori Univ, Fac Med, Dept Neurol, Inst Neurol Sci, Yonago, Tottori 683, Japan	Tottori University	Watanabe, Y (corresponding author), Tottori Univ, Fac Med, Dept Neurol, Inst Neurol Sci, Yonago, Tottori 683, Japan.	yawatana@med.tottori-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid]; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	A Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. A Grant from the Research Committee of CNS Degenerative Diseases, Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Aperia A, 2007, J INTERN MED, V261, P44, DOI 10.1111/j.1365-2796.2006.01745.x; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cottrell BA, 2005, ANN NEUROL, V58, P277, DOI 10.1002/ana.20554; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Ellis DZ, 2003, J NEUROSCI, V23, P43; Golden WC, 2003, NEUROCHEM RES, V28, P1883, DOI 10.1023/A:1026132110850; Lukas TJ, 2006, MOL CELL PROTEOMICS, V5, P1233, DOI 10.1074/mcp.M500431-MCP200; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Massignan T, 2007, BIOCHEM BIOPH RES CO, V353, P719, DOI 10.1016/j.bbrc.2006.12.075; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; NAKASHIMA K, 1995, NEUROLOGY, V45, P1019, DOI 10.1212/WNL.45.5.1019-a; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; TAKAHASHI K, 1972, ARCH NEUROL-CHICAGO, V27, P292, DOI 10.1001/archneur.1972.00490160020003; Watanabe Y, 1997, ACTA NEUROL SCAND, V95, P167, DOI 10.1111/j.1600-0404.1997.tb00090.x; Watanabe Y, 1997, FEBS LETT, V400, P108, DOI 10.1016/S0014-5793(96)01362-2; Watanabe Y, 2005, MOL BRAIN RES, V135, P12, DOI 10.1016/j.molbrainres.2004.11.019; Watanabe Y, 2000, AMYOTROPH LATERAL SC, V1, P251, DOI 10.1080/14660820050515070	28	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2008	3	10							e3497	10.1371/journal.pone.0003497	http://dx.doi.org/10.1371/journal.pone.0003497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IH	18946506	gold, Green Submitted, Green Published			2022-12-27	WOS:000265126200004
J	Chickarmane, V; Peterson, C				Chickarmane, Vijay; Peterson, Carsten			A Computational Model for Understanding Stem Cell, Trophectoderm and Endoderm Lineage Determination	PLOS ONE			English	Article							SELF-RENEWAL; PLURIPOTENCY; DIFFERENTIATION; FIBROBLASTS; EXPRESSION; OCT-4	Background: Recent studies have associated the transcription factors, Oct4, Sox2 and Nanog as parts of a self-regulating network which is responsible for maintaining embryonic stem cell properties: self renewal and pluripotency. In addition, mutual antagonism between two of these and other master regulators have been shown to regulate lineage determination. In particular, an excess of Cdx2 over Oct4 determines the trophectoderm lineage whereas an excess of Gata-6 over Nanog determines differentiation into the endoderm lineage. Also, under/over-expression studies of the master regulator Oct4 have revealed that some self-renewal/pluripotency as well as differentiation genes are expressed in a biphasic manner with respect to the concentration of Oct4. Methodology/Principal Findings: We construct a dynamical model of a minimalistic network, extracted from ChIP-on-chip and microarray data as well as literature studies. The model is based upon differential equations and makes two plausible assumptions; activation of Gata-6 by Oct4 and repression of Nanog by an Oct4-Gata-6 heterodimer. With these assumptions, the results of simulations successfully describe the biphasic behavior as well as lineage commitment. The model also predicts that reprogramming the network from a differentiated state, in particular the endoderm state, into a stem cell state, is best achieved by over-expressing Nanog, rather than by suppression of differentiation genes such as Gata-6. Conclusions: The computational model provides a mechanistic understanding of how different lineages arise from the dynamics of the underlying regulatory network. It provides a framework to explore strategies of reprogramming a cell from a differentiated state to a stem cell state through directed perturbations. Such an approach is highly relevant to regenerative medicine since it allows for a rapid search over the host of possibilities for reprogramming to a stem cell state.	[Chickarmane, Vijay] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Peterson, Carsten] Lund Univ, Dept Theoretical Phys, S-22100 Lund, Sweden; [Peterson, Carsten] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therapy, S-22100 Lund, Sweden	California Institute of Technology; Lund University; Lund University	Chickarmane, V (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	carsten@thep.lu.se			Swedish Foundation for Strategic Research; National Science Foundation-FIBR Award [EF-0330786]	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); National Science Foundation-FIBR Award	This research was in part supported by the Swedish Foundation for Strategic Research through a Senior Individual Grant and the National Science Foundation-FIBR Award EF-0330786. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Hasty J, 2001, CHAOS, V11, P207, DOI 10.1063/1.1345702; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Johnson BV, 2006, CURR OPIN GENET DEV, V16, P447, DOI 10.1016/j.gde.2006.08.012; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mullen EM, 2007, PPAR RES, V2007, DOI 10.1155/2007/61563; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; SCHOLER HR, 1991, CELL, V66, P291, DOI 10.1016/0092-8674(91)90619-A; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	101	104	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2008	3	10							e3478	10.1371/journal.pone.0003478	http://dx.doi.org/10.1371/journal.pone.0003478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432IG	18941526	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000265126100009
J	Ghosh, AK; Kanda, T; Steele, R; Ray, RB				Ghosh, Asish K.; Kanda, Tatsuo; Steele, Robert; Ray, Ratna B.			Knockdown of MBP-1 in Human Foreskin Fibroblasts Induces p53-p21 Dependent Senescence	PLOS ONE			English	Article							CELLULAR SENESCENCE; FUNCTIONAL DOMAINS; ONCOGENIC RAS; P53; INHIBITION; CLONING; GROWTH; CELLS; PML	MBP-1 acts as a general transcriptional repressor. Overexpression of MBP-1 induces cell death in a number of cancer cells and regresses tumor growth. However, the function of endogenous MBP-1 in normal cell growth regulation remains unknown. To unravel the role of endogenous MBP-1, we knocked down MBP-1 expression in primary human foreskin fibroblasts (HFF) by RNA interference. Knockdown of MBP-1 in HFF (HFF-MBPsi-4) resulted in an induction of premature senescence, displayed flattened cell morphology, and increased senescence-associated beta-galactosidase activity. FACS analysis of HFF-MBPsi-4 revealed accumulation of a high number of cells in the G1-phase. A significant upregulation of cyclin D1 and reduction of cyclin A was detected in HFF-MBPsi-4 as compared to control HFF. Senescent fibroblasts exhibited enhanced expression of phosphorylated and acetylated p53, and cyclin-dependent kinase inhibitor, p21. Further analysis suggested that promyolocytic leukemia protein (PML) bodies are dramatically increased in HFF-MBPsi-4. Together, these results demonstrated that knockdown of endogenous MBP-1 is involved in cellular senescence of HFF through p53-p21 pathway.	[Ghosh, Asish K.; Kanda, Tatsuo; Steele, Robert; Ray, Ratna B.] St Louis Univ, Dept Pathol, St Louis, MO USA; [Ray, Ratna B.] St Louis Univ, Canc Ctr, St Louis, MO USA	Saint Louis University; Saint Louis University	Ghosh, AK (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	rayrb@slu.edu		Kanda, Tatsuo/0000-0002-1654-5385	National Institutes of Health [CA52977]; Saint Louis University [Seed]; NATIONAL CANCER INSTITUTE [R01CA052977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by PHS grant CA52977 from the National Institutes of Health and Seed Grant from Saint Louis University.	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Blander G, 2003, J BIOL CHEM, V278, P38966, DOI 10.1074/jbc.M307146200; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ferbeyre G, 2000, GENE DEV, V14, P2015; Ghosh AK, 2005, CANCER RES, V65, P718; Ghosh AK, 1999, MOL CELL BIOL, V19, P2880; Ghosh AK, 2002, ONCOGENE, V21, P2775, DOI 10.1038/sj.onc.1205384; Ghosh AK, 2006, J BIOL CHEM, V281, P23652, DOI 10.1074/jbc.M602930200; Ghosh AK, 2006, CANCER RES, V66, P11907, DOI 10.1158/0008-5472.CAN-06-2754; GIALLONGO A, 1986, P NATL ACAD SCI USA, V83, P6741, DOI 10.1073/pnas.83.18.6741; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; RAY R, 1991, MOL CELL BIOL, V11, P2154, DOI 10.1128/MCB.11.4.2154; Roninson IB, 2003, CANCER RES, V63, P2705; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Takaha N, 2004, PROSTATE, V60, P160, DOI 10.1002/pros.20049; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005; Young JI, 2001, J BIOL CHEM, V276, P19610, DOI 10.1074/jbc.M009470200	28	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2008	3	10							e3384	10.1371/journal.pone.0003384	http://dx.doi.org/10.1371/journal.pone.0003384			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432GN	18852884	Green Published, gold			2022-12-27	WOS:000265121600008
J	Lavigne, JP; Nicolas-Chanoine, MH; Bourg, G; Moreau, J; Sotto, A				Lavigne, Jean-Philippe; Nicolas-Chanoine, Marie-Helene; Bourg, Gisele; Moreau, Jerome; Sotto, Albert			Virulent Synergistic Effect between Enterococcus faecalis and Escherichia coli Assayed by Using the Caenorhabditis elegans Model	PLOS ONE			English	Article								Background: The role of enterococci in the pathogenesis of polymicrobial infections is still debated. The purpose of this study was to evaluate the effect of virulent enterococci in the presence or absence of Escherichia coli strains in the in vivo Caenorhabditis elegans model. Principal Findings: This study demonstrated that there was a synergistic effect on virulence when an association of enterococci and E. coli (LT50 = 1.6 days +/- 0.1 according to the tested strains and death of nematodes in 4 days +/- 0.5) was tested in comparison with enterococci alone (LT50 = 4.6 days +/- 0.1 and death in 10.4 days +/- 0.6) or E. coli alone (LT50 = 2.1 +/- 0.9 and deaths 6.6 +/- 0.6) (p < 0.001). In addition, there was a relation between the virulence of E. faecalis strains alone and the virulence potential of the association with E. coli strains. Finally, in the presence of avirulent E. coli strains, enterococci have no effect (LT50 = 4.3 +/- 0.5 and deaths in 10.8 +/- 0.8), independently of the level of their own virulence, demonstrating that the 'enterococci effect' only occurred in the presence of virulent E. coli strains. Conclusion: This study allows a better understanding of a bacterial cooperation. Moreover, it could help to optimize the antibiotic regimen during polymicrobial infections.	[Lavigne, Jean-Philippe; Bourg, Gisele; Sotto, Albert] Univ Montpellier 1, INSERM, ESPRI 26, UFR Med, Nimes, France; [Lavigne, Jean-Philippe] CHU Caremeau, Lab Bacteriol, Virol, Parasitol, Nimes, France; [Nicolas-Chanoine, Marie-Helene] Hop AP HP Beaujon, Serv Microbiol, Clichy, France; [Nicolas-Chanoine, Marie-Helene] Univ Paris 07, U773, Inst Natl Sante Rech Med, F-75221 Paris, France; [Moreau, Jerome] Univ Bourgogne, Equipe Ecol Evolut UMR 5561 Biogeosci, F-21004 Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Nimes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Bourgogne	Lavigne, JP (corresponding author), Univ Montpellier 1, INSERM, ESPRI 26, UFR Med, Nimes, France.	albert.sotto@chu-nimes.fr	moreau, jerome/A-3496-2013; Sotto, Albert/AFJ-9023-2022; Lavigne, Jean-Philippe/E-1756-2014	Lavigne, Jean-Philippe/0000-0002-9484-0304; Sotto, Albert/0000-0002-6463-9386	INSERM; Universite de Montpellier 1; Ville de Nimes; La Region Languedoc Roussillon	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Montpellier 1; Ville de Nimes; La Region Languedoc Roussillon(Region Occitanie)	INSERM Espri 26 is supported by INSERM, Universite de Montpellier 1, La Ville de Nimes and La Region Languedoc Roussillon. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blot S, 2005, DRUGS, V65, P1611, DOI 10.2165/00003495-200565120-00002; Chatterjee Indranil, 2007, Crit Care Resusc, V9, P69; COQUE TM, 1995, J INFECT DIS, V171, P1223, DOI 10.1093/infdis/171.5.1223; Creti R, 2004, J MED MICROBIOL, V53, P13, DOI 10.1099/jmm.0.05353-0; Diard M, 2007, MICROBES INFECT, V9, P214, DOI 10.1016/j.micinf.2006.11.009; DUNNY GM, 1979, PLASMID, V2, P454, DOI 10.1016/0147-619X(79)90029-5; Dupont H, 1998, INFECT IMMUN, V66, P2570, DOI 10.1128/IAI.66.6.2570-2575.1998; DUPONT H, 2007, DIAGN MICROBIOL INFE, V60, P247; Dupont H, 2007, INT J INFECT DIS, V11, pS1, DOI 10.1016/S1201-9712(07)60001-0; Franz CMAP, 2001, APPL ENVIRON MICROB, V67, P4385, DOI 10.1128/AEM.67.9.4385-4389.2001; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Harbarth S, 2004, EUR J CLIN MICROBIOL, V23, P73, DOI 10.1007/s10096-003-1078-0; Jansen WTM, 2002, INFECT IMMUN, V70, P5202, DOI 10.1128/IAI.70.9.5202-5207.2002; Kothe M, 2003, CELL MICROBIOL, V5, P343, DOI 10.1046/j.1462-5822.2003.00280.x; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Lavigne JP, 2006, CLIN MICROBIOL INFEC, V12, P1199, DOI 10.1111/j.1469-0691.2006.01536.x; Lavigne JP, 2005, PATHOL BIOL, V53, P539, DOI 10.1016/j.patbio.2005.06.005; Maadani A, 2007, INFECT IMMUN, V75, P2634, DOI 10.1128/IAI.01372-06; MONTRAVERS P, 1994, J INFECT DIS, V169, P821, DOI 10.1093/infdis/169.4.821; Montravers P, 1997, INFECT IMMUN, V65, P144, DOI 10.1128/IAI.65.1.144-149.1997; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Neeleman C, 2004, J CLIN MICROBIOL, V42, P4355, DOI 10.1128/JCM.42.9.4355-4357.2004; NICHOLS RL, 1992, CLIN INFECT DIS, V15, P72, DOI 10.1093/clinids/15.1.72; ONDERDONK AB, 1976, INFECT IMMUN, V13, P22, DOI 10.1128/IAI.13.1.22-26.1976; Schulenburg H, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-49; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; Tenor JL, 2004, CURR BIOL, V14, P1018, DOI 10.1016/j.cub.2004.05.050; Vankerckhoven V, 2004, J CLIN MICROBIOL, V42, P4473, DOI 10.1128/JCM.42.10.4473-4479.2004; Vergis EN, 2002, CLIN INFECT DIS, V35, P570, DOI 10.1086/341977	30	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3370	10.1371/journal.pone.0003370	http://dx.doi.org/10.1371/journal.pone.0003370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DQ	18843374	gold, Green Published, Green Submitted			2022-12-27	WOS:000265114100008
J	Lund, SS; Tarnow, L; Astrup, AS; Hovind, P; Jacobsen, PK; Alibegovic, AC; Parving, I; Pietraszek, L; Frandsen, M; Rossing, P; Parving, HH; Vaag, AA				Lund, Soren Sogaard; Tarnow, Lise; Astrup, Anne Sofie; Hovind, Peter; Jacobsen, Peter Karl; Alibegovic, Amra Ciric; Parving, Ida; Pietraszek, Lotte; Frandsen, Merete; Rossing, Peter; Parving, Hans-Henrik; Vaag, Allan Arthur			Effect of Adjunct Metformin Treatment in Patients with Type-1 Diabetes and Persistent Inadequate Glycaemic Control. A Randomized Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; THERAPY; ADOLESCENTS; RISK	Background: Despite intensive insulin treatment, many patients with type-1 diabetes (T1DM) have longstanding inadequate glycaemic control. Metformin is an oral hypoglycaemic agent that improves insulin action in patients with type-2 diabetes. We investigated the effect of a one-year treatment with metformin versus placebo in patients with T1DM and persistent poor glycaemic control. Methodology/Principal Findings: One hundred patients with T1DM, preserved hypoglycaemic awareness and HaemoglobinA(1c) (HbA(1c)) >= 8.5% during the year before enrolment entered a one-month run-in on placebo treatment. Thereafter, patients were randomized (baseline) to treatment with either metformin (1 g twice daily) or placebo for 12 months (double-masked). Patients continued ongoing insulin therapy and their usual outpatient clinical care. The primary outcome measure was change in HbA(1c) after one year of treatment. At enrolment, mean (standard deviation) HbA(1c) was 9.48% (0.99) for the metformin group (n=49) and 9.60% (0.86) for the placebo group (n=51). Mean (95% confidence interval) baseline-adjusted differences after 12 months with metformin (n=48) versus placebo (n=50) were: HbA(1c), 0.13% (-0.19; 0.44), p=0.422; Total daily insulin dose, -5.7 U/day (-8.6; -2.9), p < 0.001; body weight, -1.74 kg (-3.32; -0.17), p=0.030. Minor and overall major hypoglycaemia was not significantly different between treatments. Treatments were well tolerated. Conclusions/Significance: In patients with poorly controlled T1DM, adjunct metformin therapy did not provide any improvement of glycaemic control after one year. Nevertheless, adjunct metformin treatment was associated with sustained reductions of insulin dose and body weight. Further investigations into the potential cardiovascular-protective effects of metformin therapy in patients with T1DM are warranted.	[Lund, Soren Sogaard; Tarnow, Lise; Astrup, Anne Sofie; Hovind, Peter; Jacobsen, Peter Karl; Alibegovic, Amra Ciric; Parving, Ida; Pietraszek, Lotte; Frandsen, Merete; Rossing, Peter; Vaag, Allan Arthur] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Parving, Hans-Henrik] Univ Copenhagen, Rigshosp, Dept Med Endocrinol, DK-1168 Copenhagen, Denmark; [Parving, Hans-Henrik] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Vaag, Allan Arthur] Lund Univ, Dept Endocrinol, S-22100 Lund, Sweden	Steno Diabetes Center; Rigshospitalet; University of Copenhagen; Aarhus University; Lund University	Lund, SS (corresponding author), Steno Diabet Ctr, DK-2820 Gentofte, Denmark.	sqrl@steno.dk	Astrup, Anne Sofie/AAF-3647-2019; rossing, peter/AAZ-3415-2021; rossing, peter/AAH-7879-2021; Jacobsen, Peter Karl/AAK-7609-2021	rossing, peter/0000-0002-1531-4294; Jacobsen, Peter Karl/0000-0002-1520-8774; Tarnow, Lise/0000-0002-8735-966X; Vaag, Allan Arthur/0000-0002-3690-2191	Clinical Development Foundation at the Steno Diabetes Center; Danish Medical Association	Clinical Development Foundation at the Steno Diabetes Center; Danish Medical Association	The Clinical Development Foundation at the Steno Diabetes Center and the Danish Medical Association co-sponsored the study. Hexal A/S (GEA Ltd.) supplied metformin and metformin-placebo tablets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Brown, 2006, APPL MIXED MODELS ME; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; COSCELLI C, 1984, CURR THER RES CLIN E, V35, P1058; DEFRONZO RA, 1982, DIABETOLOGIA, V23, P313; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; DeVries JH, 2004, DIABETIC MED, V21, P1263, DOI 10.1111/j.1464-5491.2004.01386.x; FERGUSON AW, 1961, LANCET, V1, P1367; Garber AJ, 1997, AM J MED, V103, P491, DOI 10.1016/S0002-9343(97)00254-4; GIN H, 1989, DIABETES RES CLIN PR, V6, P61, DOI 10.1016/0168-8227(89)90058-2; GIN H, 1982, DIABETOLOGIA, V23, P34; GIN H, 1985, METABOLISM, V34, P923, DOI 10.1016/0026-0495(85)90139-8; Gomez R, 2002, J PEDIATR ENDOCR MET, V15, P1147; Hamilton J, 2003, DIABETES CARE, V26, P138, DOI 10.2337/diacare.26.1.138; Hundal RS, 2003, DRUGS, V63, P1879, DOI 10.2165/00003495-200363180-00001; JANSSEN M, 1991, BIOMED PHARMACOTHER, V45, P363, DOI 10.1016/0753-3322(91)90067-4; Khan ASA, 2006, DIABETIC MED, V23, P1079, DOI 10.1111/j.1464-5491.2006.01966.x; Lacigova S, 2001, Cas Lek Cesk, V140, P302; LESTRADET H, 1960, PRESSE MED, V68, P391; Lund SS, 2007, DIABETES OBES METAB, V9, P394, DOI 10.1111/j.1463-1326.2007.00713.x; Meyer L, 2002, DIABETES CARE, V25, P2153, DOI 10.2337/diacare.25.12.2153; Moon RJ, 2007, DIABETES OBES METAB, V9, P143, DOI 10.1111/j.1463-1326.2006.00599.x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; PAGANO G, 1983, DIABETOLOGIA, V24, P351; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; SAENZ A, 2005, COCHRANE DB SYST REV, V3, P1; Sarnblad S, 2003, EUR J ENDOCRINOL, V149, P323, DOI 10.1530/eje.0.1490323; SCHATZ H, 1975, DIABETES METAB, V1, P211; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; WHO, 1999, WHO LAB MAN EX HUM S, P1; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	33	64	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2008	3	10							e3363	10.1371/journal.pone.0003363	http://dx.doi.org/10.1371/journal.pone.0003363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432DQ	18852875	gold, Green Submitted, Green Published			2022-12-27	WOS:000265114100006
J	Ding, M; King, RS; Berry, EC; Wang, Y; Hardin, J; Chisholm, AD				Ding, Mei; King, Ryan S.; Berry, Emily C.; Wang, Ying; Hardin, Jeff; Chisholm, Andrew D.			The Cell Signaling Adaptor Protein EPS-8 Is Essential for C-elegans Epidermal Elongation and Interacts with the Ankyrin Repeat Protein VAB-19	PLOS ONE			English	Article								Background: The epidermal cells of the C. elegans embryo undergo coordinated cell shape changes that result in the morphogenetic process of elongation. The cytoskeletal ankyrin repeat protein VAB-19 is required for cell shape changes and localizes to cell-matrix attachment structures. The molecular functions of VAB-19 in this process are obscure, as no previous interactors for VAB-19 have been described. Methodology/Principal Findings: In screens for VAB-19 binding proteins we identified the signaling adaptor EPS-8. Within C. elegans epidermal cells, EPS-8 and VAB-19 colocalize at cell-matrix attachment structures. The central domain of EPS-8 is necessary and sufficient for its interaction with VAB-19. eps-8 null mutants, like vab-19 mutants, are defective in epidermal elongation and in epidermal-muscle attachment. The eps-8 locus encodes two isoforms, EPS-8A and EPS-8B, that appear to act redundantly in epidermal elongation. The function of EPS-8 in epidermal development involves its N-terminal PTB and central domains, and is independent of its C-terminal SH3 and actin-binding domains. VAB-19 appears to act earlier in the biogenesis of attachment structures and may recruit EPS-8 to these structures. Conclusions/Significance: EPS-8 and VAB-19 define a novel pathway acting at cell-matrix attachments to regulate epithelial cell shape. This is the first report of a role for EPS-8 proteins in cell-matrix attachments. The existence of EPS-8B-like isoforms in Drosophila suggests this function of EPS-8 proteins could be conserved among other organisms.	[Ding, Mei; Wang, Ying; Chisholm, Andrew D.] Univ Calif Santa Cruz, Dept Mol, Cellular & Dev Biol, Santa Cruz, CA 95064 USA; [King, Ryan S.; Hardin, Jeff] Univ Wisconsin, Dept Zool, Cellular & Mol Biol Grad Program, Madison, WI 53706 USA; [Berry, Emily C.; Chisholm, Andrew D.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Hardin, Jeff] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of California System; University of California Santa Cruz; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison	Ding, M (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China.	chisholm@ucsd.edu		Chisholm, Andrew/0000-0001-5091-0537	NIH [T32 GM07215, R01 GM54657]; National Science Foundation [IOB 0518081]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM054657] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Predoctoral Training Grant in Molecular Biosciences T32 GM07215 (R.K.), National Science Foundation Grant IOB 0518081 (to J.H.) and NIH R01 GM54657 (A.D.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; BRENNER S, 1974, GENETICS, V77, P71; CASTAGNINO P, 1995, ONCOGENE, V10, P723; Chisholm AD., EPIDERMAL MORPHOGENE, DOI [10.1895/wormbook.1.35.1, DOI 10.1895/WORMBOOK.1.35.1]; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; Di Fiore PP, 2002, INT J BIOCHEM CELL B, V34, P1178, DOI 10.1016/S1357-2725(02)00064-X; Ding M, 2003, DEVELOPMENT, V130, P5791, DOI 10.1242/dev.00791; Diogon M, 2007, DEVELOPMENT, V134, P2469, DOI 10.1242/dev.005074; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Hresko MC, 1999, J CELL BIOL, V146, P659, DOI 10.1083/jcb.146.3.659; HRESKO MC, 1994, J CELL BIOL, V124, P491, DOI 10.1083/jcb.124.4.491; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; KARLSSON T, 1995, ONCOGENE, V10, P1475; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Martinu L, 2002, J BIOL CHEM, V277, P50996, DOI 10.1074/jbc.M204869200; Matoskova B, 1996, ONCOGENE, V12, P2679; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Mei D, 2004, EXP CELL RES, V301, P84, DOI 10.1016/j.yexcr.2004.08.017; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Piekny AJ, 2003, DEVELOPMENT, V130, P5695, DOI 10.1242/dev.00807; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Sarkar S, 2002, J BIOL CHEM, V277, P36585, DOI 10.1074/jbc.M204244200; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Stetak A, 2006, EMBO J, V25, P2347, DOI 10.1038/sj.emboj.7601137; Tocchetti A, 2003, GENOMICS, V81, P234, DOI 10.1016/S0888-7543(03)00002-8; Wissmann A, 1999, DEV BIOL, V209, P111, DOI 10.1006/dbio.1999.9242; Woo WM, 2004, DEV BIOL, V267, P216, DOI 10.1016/j.ydbio.2003.11.007; Zhu Y, 2008, BBA-GEN SUBJECTS, V1780, P128, DOI 10.1016/j.bbagen.2007.09.017	36	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2008	3	10							e3346	10.1371/journal.pone.0003346	http://dx.doi.org/10.1371/journal.pone.0003346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RW	18833327	Green Published, Green Submitted, gold			2022-12-27	WOS:000264797400011
J	Chen, ZH; Kim, HP; Sciurba, FC; Lee, SJ; Feghali-Bostwick, C; Stolz, DB; Dhir, R; Landreneau, RJ; Schuchert, MJ; Yousem, SA; Nakahira, K; Pilewski, JM; Lee, JS; Zhang, Y; Ryter, SW; Choi, AMK				Chen, Zhi-Hua; Kim, Hong Pyo; Sciurba, Frank C.; Lee, Seon-Jin; Feghali-Bostwick, Carol; Stolz, Donna B.; Dhir, Rajiv; Landreneau, Rodney J.; Schuchert, Mathew J.; Yousem, Samuel A.; Nakahira, Kiichi; Pilewski, Joseph M.; Lee, Janet S.; Zhang, Yingze; Ryter, Stefan W.; Choi, Augustine M. K.			Egr-1 Regulates Autophagy in Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article								Background: Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by abnormal cellular responses to cigarette smoke, resulting in tissue destruction and airflow limitation. Autophagy is a degradative process involving lysosomal turnover of cellular components, though its role in human diseases remains unclear. Methodology and Principal Findings: Increased autophagy was observed in lung tissue from COPD patients, as indicated by electron microscopic analysis, as well as by increased activation of autophagic proteins (microtubule-associated protein-1 light chain-3B, LC3B, Atg4, Atg5/12, Atg7). Cigarette smoke extract (CSE) is an established model for studying the effects of cigarette smoke exposure in vitro. In human pulmonary epithelial cells, exposure to CSE or histone deacetylase (HDAC) inhibitor rapidly induced autophagy. CSE decreased HDAC activity, resulting in increased binding of early growth response-1 (Egr-1) and E2F factors to the autophagy gene LC3B promoter, and increased LC3B expression. Knockdown of E2F-4 or Egr-1 inhibited CSE-induced LC3B expression. Knockdown of Egr-1 also inhibited the expression of Atg4B, a critical factor for LC3B conversion. Inhibition of autophagy by LC3B-knockdown protected epithelial cells from CSE-induced apoptosis. Egr-1(-/-) mice, which displayed basal airspace enlargement, resisted cigarette-smoke induced autophagy, apoptosis, and emphysema. Conclusions: We demonstrate a critical role for Egr-1 in promoting autophagy and apoptosis in response to cigarette smoke exposure in vitro and in vivo. The induction of autophagy at early stages of COPD progression suggests novel therapeutic targets for the treatment of cigarette smoke induced lung injury.	[Chen, Zhi-Hua; Kim, Hong Pyo; Sciurba, Frank C.; Lee, Seon-Jin; Feghali-Bostwick, Carol; Nakahira, Kiichi; Pilewski, Joseph M.; Lee, Janet S.; Zhang, Yingze; Ryter, Stefan W.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA 15260 USA; [Chen, Zhi-Hua; Kim, Hong Pyo; Lee, Seon-Jin; Nakahira, Kiichi; Ryter, Stefan W.; Choi, Augustine M. K.] Harvard Univ, Harvard Med Sch, Brigham & Womens Hosp, Cambridge, MA 02138 USA; [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Ctr Biol Imag, Pittsburgh, PA 15260 USA; [Dhir, Rajiv; Yousem, Samuel A.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Landreneau, Rodney J.; Schuchert, Mathew J.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, ZH (corresponding author), Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA 15260 USA.	amchoi@rics.bwh.harvard.edu	Pilewski, Joseph/AAF-5149-2021; Lee, Seon-Jin/AAJ-8258-2020; Sciurba, Frank/AAZ-9339-2021	Lee, Janet/0000-0002-6812-6043	NIH [R01-HL60234, R01-HL55330, R01-HL079904, P01-HL70807, P50HL084948]; American Heart Association [0335035N, 0525552U]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079904, P50HL084948, P01HL070807, R01HL060234, R01HL055330] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants R01-HL60234, R01-HL55330, R01-HL079904, and P01-HL70807 awarded to A. M. K. Choi, awards from the American Heart Association to S. W. Ryter (AHA #0335035N), and H.P. Kim (AHA #0525552U), and NIH grant 1 P50HL084948 to F. C. Sciurba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cann GM, 2008, DEV DYNAM, V237, P187, DOI 10.1002/dvdy.21392; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; DUNHILL MS, 1962, THORAX, V17, P320; Ferreira R, 1998, P NATL ACAD SCI USA, V95, P10493, DOI 10.1073/pnas.95.18.10493; *GOLD, 2001, NIH PUBL, V2701; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Henson Peter M, 2006, Proc Am Thorac Soc, V3, P713, DOI 10.1513/pats.200605-104SF; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Landesberg LJ, 2001, AM J PHYSIOL-LUNG C, V281, pL1138, DOI 10.1152/ajplung.2001.281.5.L1138; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lu Z, 2006, ONCOGENE, V25, P230, DOI 10.1038/sj.onc.1209025; Mayer AS, 2001, RESP PHYSIOL, V128, P3, DOI 10.1016/S0034-5687(01)00258-4; Myerburg MM, 2007, AM J PHYSIOL-LUNG C, V292, pL1352, DOI 10.1152/ajplung.00328.2006; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shapiro SD, 2004, AM J RESP CELL MOL, V31, P481, DOI 10.1165/rcmb.F285; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Wang IM, 2008, AM J RESP CRIT CARE, V177, P402, DOI 10.1164/rccm.200703-390OC; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yan SF, 2000, J CLIN INVEST, V105, P553, DOI 10.1172/JCI9513; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yokohori N, 2004, CHEST, V125, P626, DOI 10.1378/chest.125.2.626; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	46	330	349	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2008	3	10							e3316	10.1371/journal.pone.0003316	http://dx.doi.org/10.1371/journal.pone.0003316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RV	18830406	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000264797300007
J	McDaniel, L; Breitbart, M; Mobberley, J; Long, A; Haynes, M; Rohwer, F; Paul, JH				McDaniel, Lauren; Breitbart, Mya; Mobberley, Jennifer; Long, Amy; Haynes, Matthew; Rohwer, Forest; Paul, John H.			Metagenomic Analysis of Lysogeny in Tampa Bay: Implications for Prophage Gene Expression	PLOS ONE			English	Article							MARINE VIRUSES; BACTERIOPLANKTON; COMMUNITIES; INDUCTION; ABUNDANCE; BACTERIA; SEA	Phage integrase genes often play a role in the establishment of lysogeny in temperate phage by catalyzing the integration of the phage into one of the host's replicons. To investigate temperate phage gene expression, an induced viral metagenome from Tampa Bay was sequenced by 454/Pyrosequencing. The sequencing yielded 294,068 reads with 6.6% identifiable. One hundred-three sequences had significant similarity to integrases by BLASTX analysis (e <= 0.001). Four sequences with strongest amino-acid level similarity to integrases were selected and real-time PCR primers and probes were designed. Initial testing with microbial fraction DNA from Tampa Bay revealed 1.9x10(7), and 1300 gene copies of Vibrio-like integrase and Oceanicola-like integrase L-1 respectively. The other two integrases were not detected. The integrase assay was then tested on microbial fraction RNA extracted from 200 ml of Tampa Bay water sampled biweekly over a 12 month time series. Vibrio-like integrase gene expression was detected in three samples, with estimated copy numbers of 2.4-1280 L-1. Clostridium-like integrase gene expression was detected in 6 samples, with estimated copy numbers of 37 to 265 L-1. In all cases, detection of integrase gene expression corresponded to the occurrence of lysogeny as detected by prophage induction. Investigation of the environmental distribution of the two expressed integrases in the Global Ocean Survey Database found the Vibrio-like integrase was present in genome equivalents of 3.14% of microbial libraries and all four viral metagenomes. There were two similar genes in the library from British Columbia and one similar gene was detected in both the Gulf of Mexico and Sargasso Sea libraries. In contrast, in the Arctic library eleven similar genes were observed. The Clostridium-like integrase was less prevalent, being found in 0.58% of the microbial and none of the viral libraries. These results underscore the value of metagenomic data in discovering signature genes that play important roles in the environment through their expression, as demonstrated by integrases in lysogeny.	[McDaniel, Lauren; Breitbart, Mya; Mobberley, Jennifer; Paul, John H.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Long, Amy] Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commission, St Petersburg, FL USA; [Haynes, Matthew; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	State University System of Florida; University of South Florida; Florida Fish & Wildlife Conservation Commission; California State University System; San Diego State University	McDaniel, L (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	mcdaniel@marine.usf.edu	Breitbart, Mya/B-1366-2009; Rohwer, Forest/AAC-5315-2019	Breitbart, Mya/0000-0003-3210-2899; Mobberley, Jennifer/0000-0001-5865-8145; Rohwer, Forest/0000-0003-1548-5429; Long, Amy/0000-0002-9670-981X	National Science Foundation [OCE-0221763, EF-0801593, MCB-0701984]; Alfred P. Sloan Foundation [BR-4772]	National Science Foundation(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	L.M. and J.P. were supported by grants OCE-0221763 and EF-0801593 from the National Science Foundation. M.B. was supported by grant MCB-0701984 from the National Science Foundation. M.B. also received grant support from the Alfred P. Sloan Foundation (BR-4772).	Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Ackermann HW, 1987, VIRUSES PROKARYOTES, V1; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; CARPENTER DJ, 1980, PRIMARY PRODUCTIVITY, P161; Chen F, 2001, APPL ENVIRON MICROB, V67, P539, DOI 10.1128/AEM.67.2.539-545.2001; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Jiang SC, 1996, MAR ECOL PROG SER, V142, P27, DOI 10.3354/meps142027; JIANG SC, 1994, MAR ECOL PROG SER, V104, P163, DOI 10.3354/meps104163; KIRCHMAN D, 1985, APPL ENVIRON MICROB, V49, P599, DOI 10.1128/AEM.49.3.599-607.1985; Laybourn-Parry J, 2007, POLAR BIOL, V30, P351, DOI 10.1007/s00300-006-0191-9; Leitet C, 2006, J MAR BIOL ASSOC UK, V86, P567, DOI 10.1017/S0025315406013488; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McDaniel L, 2005, APPL ENVIRON MICROB, V71, P842, DOI 10.1128/AEM.71.2.842-850.2005; McDaniel L, 2002, NATURE, V415, P496, DOI 10.1038/415496a; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; *NAT RES COUNC NAT, 2007, NEW SCI MET REV SECR; PAUL JH, 2008, ISME J IN PRESS; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sambrook J., 2001, MOL CLONING LAB MANU; Sharon I, 2007, ISME J, V1, P492, DOI 10.1038/ismej.2007.67; STOPAR D, 2006, MICROB ECOL, V46, P249; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Weinbauer MG, 2003, LIMNOL OCEANOGR, V48, P1457, DOI 10.4319/lo.2003.48.4.1457; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Williamson SJ, 2002, APPL ENVIRON MICROB, V68, P4307, DOI 10.1128/AEM.68.9.4307-4314.2002; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	37	46	49	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2008	3	9							e3263	10.1371/journal.pone.0003263	http://dx.doi.org/10.1371/journal.pone.0003263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422MA	18810270	gold, Green Published, Green Submitted			2022-12-27	WOS:000264431000005
J	Gocke, CB; Yu, HT				Gocke, Christian B.; Yu, Hongtao			ZNF198 Stabilizes the LSD1-CoREST-HDAC1 Complex on Chromatin through Its MYM-Type Zinc Fingers	PLOS ONE			English	Article								Histone modifications in chromatin regulate gene expression. A transcriptional co-repressor complex containing LSD1-CoREST-HDAC1 (termed LCH hereafter for simplicity) represses transcription by coordinately removing histone modifications associated with transcriptional activation. RE1-silencing transcription factor (REST) recruits LCH to the promoters of neuron-specific genes, thereby silencing their transcription in non-neuronal tissues. ZNF198 is a member of a family of MYM-type zinc finger proteins that associate with LCH. Here, we show that ZNF198-like proteins are required for the repression of E-cadherin (a gene known to be repressed by LSD1), but not REST-responsive genes. ZNF198 binds preferentially to the intact LCH ternary complex, but not its individual subunits. ZNF198- and REST-binding to the LCH complex are mutually exclusive. ZNF198 associates with chromatin independently of LCH. Furthermore, modification of HDAC1 by small ubiquitin-like modifier (SUMO) in vitro weakens its interaction with CoREST whereas sumoylation of HDAC1 stimulates its binding to ZNF198. Finally, we mapped the LCH- and HDAC1-SUMO-binding domains of ZNF198 to tandem repeats of MYM-type zinc fingers. Therefore, our results suggest that ZNF198, through its multiple protein-protein interaction interfaces, helps to maintain the intact LCH complex on specific, non-REST-responsive promoters and may also prevent SUMO-dependent dissociation of HDAC1.	[Gocke, Christian B.; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Pharmacol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gocke, CB (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Pharmacol, Dallas, TX 75390 USA.	hongtao.yu@utsouthwestern.edu		Yu, Hongtao/0000-0002-8861-049X	Welch foundation; WM Keck Foundation; March of Dimes Foundation; Leukemia and Lymphoma Society; Howard Hughes Medical Institute [Investigator]	Welch foundation(The Welch Foundation); WM Keck Foundation(W.M. Keck Foundation); March of Dimes Foundation(March of Dimes); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Welch foundation, the WM Keck Foundation, the March of Dimes Foundation, and the Leukemia and Lymphoma Society. HY is an Investigator at the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DAVIDSSON P, 2002, INT J ENTREPRENEURSH, V1, P1; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kunapuli P, 2006, EXP CELL RES, V312, P3739, DOI 10.1016/j.yexcr.2006.06.037; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 2003, CURR OPIN GENET DEV, V13, P127, DOI 10.1016/S0959-437X(03)00026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Raffa GD, 2005, MOL CELL, V20, P821, DOI 10.1016/j.molcel.2005.12.003; Reiter A, 1998, BLOOD, V92, P1735, DOI 10.1182/blood.V92.5.1735.417k11_1735_1742; Romanowski P, 1996, P NATL ACAD SCI USA, V93, P10189, DOI 10.1073/pnas.93.19.10189; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Smedley D, 1999, GENOMICS, V60, P244, DOI 10.1006/geno.1999.5918; Smedley D, 1998, HUM MOL GENET, V7, P637, DOI 10.1093/hmg/7.4.637; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; vanderMaarel SM, 1996, HUM MOL GENET, V5, P887, DOI 10.1093/hmg/5.7.887; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Warren JT, 2001, MOL CELL ENDOCRINOL, V181, P1, DOI 10.1016/S0303-7207(01)00404-X; Wismar J, 2000, DEV BIOL, V226, P1, DOI 10.1006/dbio.2000.9811; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Xiao S, 1998, NAT GENET, V18, P84, DOI 10.1038/ng0198-84; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhao YM, 2004, J BIOL CHEM, V279, P20999, DOI 10.1074/jbc.M401541200	56	58	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3255	10.1371/journal.pone.0003255	http://dx.doi.org/10.1371/journal.pone.0003255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LY	18806873	Green Published, gold, Green Submitted			2022-12-27	WOS:000264430800005
J	Sullivan, PS; Denniston, M; Mokotoff, E; Buskin, S; Broyles, S; McNaghten, AD				Sullivan, Patrick S.; Denniston, Maxine; Mokotoff, Eve; Buskin, Susan; Broyles, Stephanie; McNaghten, A. D.			Quality of Care for HIV Infection Provided by Ryan White Program-Supported versus Non-Ryan White Program-Supported Facilities	PLOS ONE			English	Article							UNITED-STATES; CLINICAL SURVEILLANCE; SERVICES	Background: The Ryan White HIV/AIDS Care Act (now the Treatment Modernization Act; Ryan White Program, or RWP) is a source of federal public funding for HIV care in the United States. The Health Services and Resources Administration requires that facilities or providers who receive RWP funds ensure that HIV health services are accessible and delivered according to established HIV-related treatment guidelines. We used data from population-based samples of persons in care for HIV infection in three states to compare the quality of HIV care in facilities supported by the RWP, with facilities not supported by the RWP. Methodology/Principal Findings: Within each area (King County in Washington State; southern Louisiana; and Michigan), a probability sample of patients receiving care for HIV infection in 1998 was drawn. Based on medical records abstraction, information was collected on prescription of antiretroviral therapy according to treatment recommendations, prescription of prophylactic therapy, and provision of recommended vaccinations and screening tests. We calculated population-level estimates of the extent to which HIV care was provided according to then-current treatment guidelines in RWP-supported and non-RWP-supported facilities. For all treatment outcomes analyzed, the compliance with care guidelines was at least as good for patients who received care at RWP-supported (vs non-RWP supported) facilities. For some outcomes in some states, delivery of recommended care was significantly more common for patients receiving care in RWP-supported facilities: for example, in Louisiana, patients receiving care in RWP-supported facilities were more likely to receive indicated prophylaxis for Pneumocystis jirovecii pneumonia and Mycobacterium avium complex, and in all three states, women receiving care in RWP-supported facilities were more likely to have received an annual Pap smear. Conclusions/Significance: The quality of HIV care provided in 1998 to patients in RWP-supported facilities was of equivalent or better quality than in non-RWP supported facilities; however, there were significant opportunities for improvement in all facility types. Data from population-based clinical outcomes surveillance data can be used as part of a broader strategy to evaluate the quality of publicly-supported HIV care.	[Sullivan, Patrick S.; Denniston, Maxine; McNaghten, A. D.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Sullivan, Patrick S.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Mokotoff, Eve] Michigan Dept Community Hlth, Detroit, MI USA; [Buskin, Susan] Publ Hlth Seattle & King County, Seattle, WA USA; [Broyles, Stephanie] Louisiana Dept Publ Hlth, New Orleans, LA USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	Sullivan, PS (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	patrick.sullivan@emory.edu	Broyles, Stephanie/C-8647-2011	Broyles, Stephanie/0000-0003-3168-0056; Sullivan, Patrick Sean/0000-0002-7728-0587	Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work and the effort of its authors was supported by a cooperative agreement from the Centers for Disease Control and Prevention (CDC). CDC authors conducted the analyses reported in this manuscript.	[Anonymous], 1997, MMWR RECOMM REP, V46, P1; Coyne KM, 2008, INT J STD AIDS, V19, P351, DOI 10.1258/ijsa.2007.007263; Fleming PL, 2000, AM J PUBLIC HEALTH, V90, P1037, DOI 10.2105/AJPH.90.7.1037; Frankel MR, 1999, HEALTH SERV RES, V34, P969; Gallagher KM, 2007, J INFECT DIS, V196, P339, DOI 10.1086/519165; Hirschhorn LR, 2006, WOMEN HEALTH ISS, V16, P104, DOI 10.1016/j.whi.2006.02.004; *HLTH RES SERV ADM, CLIENT LEV DAT PROJ; *HLTH RES SERV ADM, HIV AIDS BUR CLIN PE; Landon BE, 2005, ARCH INTERN MED, V165, P1133, DOI 10.1001/archinte.165.10.1133; McInnes K, 2004, AIDS CARE, V16, P851, DOI 10.1080/09540120412331290202; McNaghten AD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000550; OSTER A, 2008, 2008 EP INT SERV C A; Sullivan PS, 2007, PUBLIC HEALTH REP, V122, P1; Sullivan PS, 2005, PUBLIC HEALTH REP, V120, P230, DOI 10.1177/003335490512000304; TESHALE EH, 2006, INF DIS SOC AM ANN C; Teshale EH, 2007, CLIN INFECT DIS, V44, P879, DOI 10.1086/511862; Tobias C, 2006, AIDS PATIENT CARE ST, V20, P205, DOI 10.1089/apc.2006.20.205; *US PUBL HLTH SERV, 1998, GUID US ANT AG HIV I; Wilson IB, 2005, ANN INTERN MED, V143, P729, DOI 10.7326/0003-4819-143-10-200511150-00010; WILSON IB, 2007, BRIT MED J, V335, P1055	20	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2008	3	9							e3250	10.1371/journal.pone.0003250	http://dx.doi.org/10.1371/journal.pone.0003250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422LY	18806878	Green Submitted, Green Published, gold			2022-12-27	WOS:000264430800002
J	Luo, Y; Alvarez, M; Xia, LC; Casadevall, A				Luo, Yong; Alvarez, Mauricio; Xia, Lingchuan; Casadevall, Arturo			The Outcome of Phagocytic Cell Division with Infectious Cargo Depends on Single Phagosome Formation	PLOS ONE			English	Article								Given that macrophages can proliferate and that certain microbes survive inside phagocytic cells, the question arises as to the post-mitotic distribution of microbial cargo. Using macrophage-like cells we evaluated the post-mitotic distribution of intracellular Cryptococcus yeasts and polystyrene beads by comparing experimental data to a stochastic model. For beads, the post-mitotic distribution was that expected from chance alone. However, for yeast cells the post-mitotic distribution was unequal, implying preferential sorting to one daughter cell. This mechanism for unequal distribution was phagosomal fusion, which effectively reduced the intracellular particle number. Hence, post-mitotic intracellular particle distribution is stochastic, unless microbial and/or host factors promote unequal distribution into daughter cells. In our system unequal cargo distribution appeared to benefit the microbe by promoting host cell exocytosis. Post-mitotic infectious cargo distribution is a new parameter to consider in the study of intracellular pathogens since it could potentially define the outcome of phagocytic-microbial interactions.	[Luo, Yong; Alvarez, Mauricio; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Xia, Lingchuan] Jiaomen 13th Yuan, Beijing, Peoples R China; [Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Luo, Y (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	yluo@aecom.yu.edu			NIH [AI033142-11, AI033774-11, HL059842]; Northeastern Biodefense Center [AI057158-05]; National Cancer Institute under Immunology and Immunooncology training program [5T32CA009173]; NATIONAL CANCER INSTITUTE [T32CA009173] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI033774, R37AI033142, R01AI033142] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeastern Biodefense Center; National Cancer Institute under Immunology and Immunooncology training program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The present study was supported by NIH grants AI033142-11, AI033774-11 and HL059842. AC is also supported in part by the Northeastern Biodefense Center under grant AI057158-05. YL is also supported by the National Cancer Institute under Immunology and Immunooncology training program 5T32CA009173.	Alvarez M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-16; Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; CINATL J, 1982, NATURE, V298, P388, DOI 10.1038/298388a0; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; De S. P., 2005, Journal of Infection and Chemotherapy, V11, P115, DOI 10.1007/s10156-005-0387-x; DEBAKKER JM, 1985, J SUBMICR CYTOL PATH, V17, P133; DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; FORBES IJ, 1966, J IMMUNOL, V96, P734; FORBES IJ, 1963, LANCET, V2, P1203; Goldman DL, 2000, INFECT IMMUN, V68, P832, DOI 10.1128/IAI.68.2.832-838.2000; GORDON S, 1973, INT REV CYTOL, V36, P171, DOI 10.1016/S0074-7696(08)60218-1; HECHEMY KE, 1993, INFECT IMMUN, V61, P4485, DOI 10.1128/IAI.61.10.4485-4488.1993; KOZEL TR, 1984, INFECT IMMUN, V43, P879, DOI 10.1128/IAI.43.3.879-886.1984; LIN HS, 1974, J CELL PHYSIOL, V83, P369, DOI 10.1002/jcp.1040830307; LIN HS, 1973, NATURE-NEW BIOL, V243, P176, DOI 10.1038/newbio243176a0; Luo Y, 2006, CLIN EXP IMMUNOL, V145, P380, DOI 10.1111/j.1365-2249.2006.03132.x; Luo Y, 2005, J IMMUNOL, V174, P7226, DOI 10.4049/jimmunol.174.11.7226; Ma HS, 2006, CURR BIOL, V16, P2156, DOI 10.1016/j.cub.2006.09.032; MACKANESS GB, 1962, J EXP MED, V116, P381, DOI 10.1084/jem.116.3.381; Meyuhas D, 1996, BIOPHYS J, V71, P2602, DOI 10.1016/S0006-3495(96)79452-3; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Nosanchuk JD, 1997, INFECT IMMUN, V65, P1836, DOI 10.1128/IAI.65.5.1836-1841.1997; RALPH P, 1975, J IMMUNOL, V114, P898; ROMAN MJ, 1986, J GEN MICROBIOL, V132, P1415; Santangelo R, 2004, INFECT IMMUN, V72, P2229, DOI 10.1128/IAI.72.4.2229-2239.2004; Shao XP, 2005, J IMMUNOL, V175, P3244, DOI 10.4049/jimmunol.175.5.3244; SMALL JM, 1986, INFECT IMMUN, V54, P742, DOI 10.1128/IAI.54.3.742-750.1986; Steenbergen JN, 2003, MICROBES INFECT, V5, P667, DOI 10.1016/S1286-4579(03)00092-3; STEWART CC, 1975, J EXP MED, V141, P1114, DOI 10.1084/jem.141.5.1114; STEWART CC, 1981, METHODS STUDYING MON, P5; STEWART CC, 1980, MONONUCLEAR PHAGOC 1; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; VANDERZEIJST BAM, 1978, J EXP MED, V147, P1253, DOI 10.1084/jem.147.4.1253; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; VOLKMAN A, 1965, BRIT J EXP PATHOL, V46, P50; VOLKMAN A, 1965, BRIT J EXP PATHOL, V46, P62; WALKER WS, 1988, CELL IMMUNOL, V111, P492, DOI 10.1016/0008-8749(88)90112-8; WESTERMANN J, 1989, J LEUKOCYTE BIOL, V46, P263, DOI 10.1002/jlb.46.3.263; Zaragoza O, 2003, EUR J IMMUNOL, V33, P1957, DOI 10.1002/eji.200323848	41	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2008	3	9							e3219	10.1371/journal.pone.0003219	http://dx.doi.org/10.1371/journal.pone.0003219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LA	18795151	Green Published, gold, Green Submitted			2022-12-27	WOS:000264428000003
J	Diep, BA; Palazzolo-Ballance, AM; Tattevin, P; Basuino, L; Braughton, KR; Whitney, AR; Chen, L; Kreiswirth, BN; Otto, M; Deleo, FR; Chambers, HF				Diep, Binh An; Palazzolo-Ballance, Amy M.; Tattevin, Pierre; Basuino, Li; Braughton, Kevin R.; Whitney, Adeline R.; Chen, Liang; Kreiswirth, Barry N.; Otto, Michael; DeLeo, Frank R.; Chambers, Henry F.			Contribution of Panton-Valentine Leukocidin in Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis	PLOS ONE			English	Article								Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strains typically carry genes encoding Panton-Valentine leukocidin (PVL). We used wild-type parental and isogenic PVL-deletion (Delta pvl) strains of USA300 (LAC and SF8300) and USA400 (MW2) to test whether PVL alters global gene regulatory networks and contributes to pathogenesis of bacteremia, a hallmark feature of invasive staphylococcal disease. Microarray and proteomic analyses revealed that PVL does not alter gene or protein expression, thereby demonstrating that any contribution of PVL to CA-MRSA pathogenesis is not mediated through interference of global gene regulatory networks. Inasmuch as a direct role for PVL in CA-MRSA pathogenesis remains to be determined, we developed a rabbit bacteremia model of CA-MRSA infection to evaluate the effects of PVL. Following experimental infection of rabbits, an animal species whose granulocytes are more sensitive to the effects of PVL compared with the mouse, we found a contribution of PVL to pathogenesis over the time course of bacteremia. At 24 and 48 hours post infection, PVL appears to play a modest, but measurable role in pathogenesis during the early stages of bacteremic seeding of the kidney, the target organ from which bacteria were not cleared. However, the early survival advantage of this USA300 strain conferred by PVL was lost by 72 hours post infection. These data are consistent with the clinical presentation of rapid-onset, fulminant infection that has been associated with PVL-positive CA-MRSA strains. Taken together, our data indicate a modest and transient positive effect of PVL in the acute phase of bacteremia, thereby providing evidence that PVL contributes to CA-MRSA pathogenesis.	[Diep, Binh An; Tattevin, Pierre; Basuino, Li; Chambers, Henry F.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; [Palazzolo-Ballance, Amy M.; Braughton, Kevin R.; Whitney, Adeline R.; Otto, Michael; DeLeo, Frank R.] National Inst Allergy & Infect Dis, NIH, Rocky Mt Lab, Lab Human Bacterial Pathogenesis, Hamilton, MT USA; [Chen, Liang; Kreiswirth, Barry N.] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rutgers State University New Brunswick; Rutgers State University Medical Center	Diep, BA (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.	hchambers@medsfgh.ucsf.edu	Chen, Liang/D-3583-2009	Chen, Liang/0000-0001-5845-2235; Otto, Michael/0000-0002-2222-4115; DeLeo, Frank/0000-0003-3150-2516	US Public Health Service [AI070289]; Intramural Research Program of the National Institutes of Health, National Institutes of Allergy and Infectious Diseases; Societe de Pathologie Infectieuse de Langue Francaise (SPILF); Pontchaillou University Hospital, Rennes, France; Microbial Pathogenesis and Host Defense Postdoctoral Fellowship [5T32AI060537-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904, Z01AI001079, T32AI060537, R01AI070289] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Intramural Research Program of the National Institutes of Health, National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Societe de Pathologie Infectieuse de Langue Francaise (SPILF); Pontchaillou University Hospital, Rennes, France; Microbial Pathogenesis and Host Defense Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US Public Health Service Grant AI070289 (H.F. Chambers) and the Intramural Research Program of the National Institutes of Health, National Institutes of Allergy and Infectious Diseases (F.R. DeLeo and M. Otto). P. Tattevin was supported by a grant from the Societe de Pathologie Infectieuse de Langue Francaise (SPILF) and by the Pontchaillou University Hospital, Rennes, France. B.A. Diep was supported by a Microbial Pathogenesis and Host Defense Postdoctoral Fellowship (5T32AI060537-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Chen J, 2007, MICROBIOL-SGM, V153, P1604, DOI 10.1099/mic.0.2007/006247-0; Colin DA, 2003, INFECT IMMUN, V71, P3724, DOI 10.1128/IAI.71.7.3724-3729.2003; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Hota B, 2007, ARCH INTERN MED, V167, P1026, DOI 10.1001/archinte.167.10.1026; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; KONIG B, 1995, J INFECT DIS, V171, P607, DOI 10.1093/infdis/171.3.607; KONIG B, 1994, INFECT IMMUN, V62, P4831; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; McNamara PJ, 1998, J BACTERIOL, V180, P2609, DOI 10.1128/JB.180.10.2609-2615.1998; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nguyen DM, 2005, EMERG INFECT DIS, V11, P526, DOI 10.3201/eid1104.041094; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; Szmigielski S, 1999, ZBL BAKT-INT J MED M, V289, P185; SZMIGIELSKI S, 1966, J PATHOL BACTERIOL, V91, P599, DOI 10.1002/path.1700910237; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; WARDENBURG JB, 2008, J INFECT DI IN PRESS; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405	32	154	156	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3198	10.1371/journal.pone.0003198	http://dx.doi.org/10.1371/journal.pone.0003198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787708	Green Published, gold, Green Submitted			2022-12-27	WOS:000264426200004
J	Madan, M; Amar, S				Madan, Monika; Amar, Salomon			Toll-Like Receptor-2 Mediates Diet and/or Pathogen Associated Atherosclerosis: Proteomic Findings	PLOS ONE			English	Article								Background: Accumulating evidence implicates a fundamental link between the immune system and atherosclerosis. Toll-like receptors are principal sensors of the innate immune system. Here we report an assessment of the role of the TLR2 pathway in atherosclerosis associated with a high-fat diet and/or bacteria in ApoE(+/)-mice. Methods and Results: To explore the role of TLR2 in inflammation-and infection-associated atherosclerosis, 10 week-old ApoE(+/-)-TLR(2+/+), ApoE(+/-)-TLR2(+/-) and ApoE(+/-)-TLR2(-/-) mice were fed either a high fat diet or a regular chow diet. All mice were inoculated intravenously, once per week for 24 consecutive weeks, with 50 mu l live Porphyromonas gingivalis (P. g) (10(7) CFU) or vehicle (normal saline). Animals were euthanized 24 weeks after the first inoculation. ApoE(+/-)-TLR2(+/+) mice showed a significant increase in atheromatous lesions in proximal aorta and aortic tree compared to ApoE(+/-)-TLR2(+/-) and ApoE(+/-)-TLR2(-/-) mice for all diet conditions. They also displayed profound changes in plaque composition, as evidenced by increased macrophage infiltration and apoptosis, increased lipid content, and decreased smooth muscle cell mass, all reflecting an unstable plaque phenotype. SAA levels from ApoE(+/-)TLR2(+/+) mice were significantly higher than from ApoE(+/-)-TLR2(+/-) and ApoE(+/-)-TLR(+/-) mice. Serum cytokine analysis revealed increased levels of pro-inflammatory cytokines in ApoE(+/-)-TLR2(+/+) mice compared to ApoE(+/-)-TLR(+/-) and TLR2(-/-)-mice, irrespective of diet or bacterial challenge. ApoE(+/)--TLR(2+/+) mice injected weekly for 24 weeks with FSL-1 (a TLR2 agonist) also demonstrated significant increases in atherosclerotic lesions, SAA and serum cytokine levels compared to ApoE(+/-)-TLR2(-/-) mice under same treatment condition. Finally, mass-spectrometry (MALDI-TOF-MS) of aortic samples analyzed by 2-dimentional gel electrophoresis differential display, identified 6 proteins upregulated greater than 2-fold in ApoE(+/)-TLR(2+/+) mice fed the high fat diet and inoculated with P. g compared to any other group. Conclusion: Genetic deficiency of TLR2 reduces diet-and/or pathogen- associated atherosclerosis in ApoE(+/)-mice, along with differences in plaque composition suggesting greater structural stability while TLR-2 ligand-specific activation triggers atherosclerosis. The present data offers new insights into the pathophysiological pathways involved in atherosclerosis and paves the way for new pharmacological interventions aimed at reducing atherosclerosis.	[Madan, Monika; Amar, Salomon] Boston Univ, Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02215 USA	Boston University	Madan, M (corresponding author), Boston Univ, Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02215 USA.	samar@bu.edu		Amar, Salomon/0000-0002-0017-5930	NHLBI [R01 HL076801]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076801] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NHLBI grant R01 HL076801 supported the study.	Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Barillari G, 2001, ATHEROSCLEROSIS, V154, P377, DOI 10.1016/S0021-9150(00)00506-2; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Chi HH, 2004, CIRCULATION, V110, P1678, DOI 10.1161/01.CIR.0000142085.39015.31; Chiu B, 1999, AM HEART J, V138, pS534, DOI 10.1016/S0002-8703(99)70294-2; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hajishengallis G, 2002, INFECT IMMUN, V70, P6658, DOI 10.1128/IAI.70.12.6658-6664.2002; Hajishengallis George, 2002, Ann Periodontol, V7, P72, DOI 10.1902/annals.2002.7.1.72; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Howe J, 2008, INNATE IMMUN-LONDON, V14, P39, DOI 10.1177/1753425907087257; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kockx MM, 2000, CARDIOVASC RES, V45, P736, DOI 10.1016/S0008-6363(99)00235-7; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Madan M, 2008, ATHEROSCLEROSIS, V197, P504, DOI 10.1016/j.atherosclerosis.2007.02.023; Madan M, 2007, ATHEROSCLEROSIS, V190, P62, DOI 10.1016/j.atherosclerosis.2006.02.026; Mallat Z, 2001, CIRC RES, V89, pE41, DOI 10.1161/hh1901.098735; MEDHITOV RHC, 2000, N ENGL J MED; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Nakamura J, 2002, MICROBIOL IMMUNOL, V46, P151, DOI 10.1111/j.1348-0421.2002.tb02680.x; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; Ozinsky A, 2000, J ENDOTOXIN RES, V6, P393, DOI 10.1179/096805100101532333; Prescott SM, 2002, ARTERIOSCL THROM VAS, V22, P727, DOI 10.1161/01.ATV.0000016153.47693.B2; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Rifai N, 2001, CLIN CHEM, V47, P403; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schoneveld AH, 2005, CARDIOVASC RES, V66, P162, DOI 10.1016/j.cardiores.2004.12.016; Shah PK, 2000, CIRCULATION, V101, P1758, DOI 10.1161/01.CIR.101.15.1758; Shin WS, 2002, ATHEROSCLEROSIS, V160, P91, DOI 10.1016/S0021-9150(01)00571-8; Shiomi M, 2001, ANN NY ACAD SCI, V947, P419; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Takeda K, 2004, J DERMATOL SCI, V34, P73, DOI 10.1016/j.jdermsci.2003.10.002; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang JC, 2000, CIRCULATION, V102, P3046; YUE TL, 1994, CIRC RES, V75, P1, DOI 10.1161/01.RES.75.1.1	48	76	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2008	3	9							e3204	10.1371/journal.pone.0003204	http://dx.doi.org/10.1371/journal.pone.0003204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KI	18787704	gold, Green Published, Green Submitted			2022-12-27	WOS:000264426200009
J	Hatada, I; Namihira, M; Morita, S; Kimura, M; Horii, T; Nakashima, K				Hatada, Izuho; Namihira, Masakazu; Morita, Sumiyo; Kimura, Mika; Horii, Takuro; Nakashima, Kinichi			Astrocyte-Specific Genes Are Generally Demethylated in Neural Precursor Cells Prior to Astrocytic Differentiation	PLOS ONE			English	Article							DNA METHYLATION; EMBRYONIC STEM; METHYLTRANSFERASE ACTIVITY; CHANNEL GENE; EXPRESSION; LINEAGE; ASSOCIATION; BRAIN; NANOG; PLURIPOTENCY	Epigenetic changes are thought to lead to alterations in the property of cells, such as differentiation potential. Neural precursor cells (NPCs) differentiate only into neurons in the midgestational brain, yet they become able to generate astrocytes in the late stage of development. This differentiation-potential switch could be explained by epigenetic changes, since the promoters of astrocyte-specific marker genes, glial fibrillary acidic protein (Gfap) and S100b, have been shown to become demethylated in late-stage NPCs prior to the onset of astrocyte differentiation; however, whether demethylation occurs generally in other astrocyctic genes remains unknown. Here we analyzed DNA methylation changes in mouse NPCs between the mid-(E11.5) and late (E14.5) stage of development by a genome-wide DNA methylation profiling method using microarrays and found that many astrocytic genes are demethylated in late-stage NPCs, enabling the cell to become competent to express these genes. Although these genes are already demethylated in late-stage NPCs, they are not expressed until cells differentiate into astrocytes. Thus, late-stage NPCs have epigenetic potential which can be realized in their expression after astrocyte differentiation.	[Hatada, Izuho; Morita, Sumiyo; Kimura, Mika; Horii, Takuro] Gunma Univ, Inst Mol & Cellular Regulat, Biosignal Genome Resource Ctr, Lab Genome Sci, Maebashi, Gunma 371, Japan; [Namihira, Masakazu; Nakashima, Kinichi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol Neurosci, Ikoma, Japan	Gunma University; Nara Institute of Science & Technology	Hatada, I (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Biosignal Genome Resource Ctr, Lab Genome Sci, Maebashi, Gunma 371, Japan.	ihatada@showa.gunma-u.ac.jp	Namihira, Masakazu/M-7531-2018	Namihira, Masakazu/0000-0003-2108-5712	Japanese Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan	Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by grants from the Japanese Science and Technology Agency, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cho RJ, 2000, TRENDS GENET, V16, P409, DOI 10.1016/S0168-9525(00)02065-5; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hatada I, 2006, ONCOGENE, V25, P3059, DOI 10.1038/sj.onc.1209331; Hatada I, 2002, J HUM GENET, V47, P448, DOI 10.1007/s100380200063; Hatada I, 2008, J HUM GENET, V53, P185, DOI 10.1007/s10038-007-0228-0; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; Higashimori H, 2007, GLIA, V55, P1668, DOI 10.1002/glia.20574; Lenzen KP, 2005, EPILEPSY RES, V63, P113, DOI 10.1016/j.eplepsyres.2005.01.002; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; McKinnon PJ, 1996, BRAIN RES, V709, P27, DOI 10.1016/0006-8993(95)01224-9; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Namihira M, 2004, FEBS LETT, V572, P184, DOI 10.1016/j.febslet.2004.07.029; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ohgane J, 1998, DEV GENET, V22, P132, DOI 10.1002/(SICI)1520-6408(1998)22:2<132::AID-DVG3>3.0.CO;2-7; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rajan P, 1998, J NEUROSCI, V18, P3620; RAZIN A, 1984, P NATL ACAD SCI-BIOL, V81, P2275, DOI 10.1073/pnas.81.8.2275; Scalabrini D, 2007, NEUROSCI LETT, V425, P173, DOI 10.1016/j.neulet.2007.08.020; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Walther EU, 1998, P NATL ACAD SCI USA, V95, P2615, DOI 10.1073/pnas.95.5.2615; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	37	60	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2008	3	9							e3189	10.1371/journal.pone.0003189	http://dx.doi.org/10.1371/journal.pone.0003189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KF	18784832	Green Published, Green Submitted, gold			2022-12-27	WOS:000264425900009
